PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Perez-Riverol, A; Miehe, M; Jabs, F; Seismman, H; Fernandes, LGR; Zollner, RD; Jakob, T; Braga, MRB; Spillner, E				Perez-Riverol, Amilcar; Miehe, Michaela; Jabs, Frederic; Seismman, Henning; Romani Fernandes, Luis Gustavo; Zollner, Ricardo de Lima; Jakob, Thilo; Brochetto Braga, Marcia R.; Spillner, Edzard			Venoms of Neotropical wasps lack cross-reactive carbohydrate determinants enabling reliable protein-based specific IgE determination	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SENSITIZATION; HYMENOPTERA		[Perez-Riverol, Amilcar; Brochetto Braga, Marcia R.] Univ Sao Paulo State UNESP, Inst Biosci, Sao Paulo, Brazil; [Miehe, Michaela; Jabs, Frederic; Spillner, Edzard] Aarhus Univ, Immunol Biotechnol, Dept Engn, Aarhus, Denmark; [Seismman, Henning] Euroimmun AG, Lubeck, Germany; [Romani Fernandes, Luis Gustavo; Zollner, Ricardo de Lima] Univ Campinas UNICAMP, Lab Translat Immunol, Fac Med, Sao Paulo, Brazil; [Jakob, Thilo] Justus Liebig Univ Giessen, Dept Dermatol & Allergol, Univ Ctr Giessen andMarburg, Giessen, Germany	Universidade Estadual Paulista; Aarhus University; EUROIMMUN; Universidade Estadual de Campinas; Justus Liebig University Giessen	Spillner, E (corresponding author), Aarhus Univ, Immunol Biotechnol, Dept Engn, Aarhus, Denmark.	e.spillner@eng.au.dk	Fernandes, Luís Gustavo Romani/R-5599-2019; Perez-Riverol, Amilcar/N-7640-2017; Fernandes, Luís Gustavo Romani/B-7948-2013; BRAGA, MARCIA REGINA BROCHETTO/AAE-9366-2019; Zollner, Ricardo de Lima/E-7932-2010	Fernandes, Luís Gustavo Romani/0000-0003-0771-1027; Perez-Riverol, Amilcar/0000-0002-1294-0142; BRAGA, MARCIA REGINA BROCHETTO/0000-0002-7982-0743; Zollner, Ricardo de Lima/0000-0002-1639-2841; spillner, edzard/0000-0003-0999-5254	FAPESP (Sao Paulo Research Foundation) [2014/13936-7]; CAPES-PDSE [88881.132448/2016-01]; CAPES-DS; Postgraduate Program of Biological Sciences (Cellular and Molecular Biology) at UNESP, Rio Claro	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-PDSE(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-DS(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Postgraduate Program of Biological Sciences (Cellular and Molecular Biology) at UNESP, Rio Claro	We acknowledge the financial support received from FAPESP (Sao Paulo Research Foundation) (grant no. 2014/13936-7), CAPES-PDSE (grant no. 88881.132448/2016-01), and CAPES-DS and Postgraduate Program of Biological Sciences (Cellular and Molecular Biology) at UNESP, Rio Claro (for providing doctoral scholarships to A.P.R.).	Blank S, 2013, J ALLERGY CLIN IMMUN, V131, P1239, DOI 10.1016/j.jaci.2012.10.047; Frick M, 2016, J ALLERGY CLIN IMMUN, V138, P1663, DOI 10.1016/j.jaci.2016.04.024; Golden DBK, 2014, CURR OPIN ALLERGY CL, V14, P334, DOI 10.1097/ACI.0000000000000072; Homann A, 2017, J ALLERGY CLIN IMMUN, V140, P356, DOI 10.1016/j.jaci.2017.04.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Locher GA, 2014, SOCIOBIOLOGY, V61, P225; Pedersen CT, 2017, PLANT J, V91, P394, DOI 10.1111/tpj.13570; Perez-Riverol A, 2015, TOXINS, V7, P2551, DOI 10.3390/toxins7072551; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; Sole D, 2011, CLINICS, V66, P943, DOI 10.1590/S1807-59322011000600004	10	9	10	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1917	+		10.1016/j.jaci.2017.12.990	http://dx.doi.org/10.1016/j.jaci.2017.12.990			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29408709	Bronze, Green Published			2022-12-18	WOS:000432148200044
J	Blom, LH; Juel-Berg, N; Larsen, LF; Hansen, KS; Poulsen, LK				Blom, Lars H.; Juel-Berg, Nanna; Larsen, Lau Fabricius; Hansen, Kirsten S.; Poulsen, Lars K.			Circulating allergen-specific T(H)2 lymphocytes: CCR4(+) rather than CLA(+) is the predominant phenotype in peanut-allergic subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ATOPIC-DERMATITIS; T-CELLS; RESPONSES; IL-5(+)		[Blom, Lars H.; Juel-Berg, Nanna; Larsen, Lau Fabricius; Hansen, Kirsten S.; Poulsen, Lars K.] Copenhagen Univ Hosp Herlev Gentofte, Dept Dermatol & Allergy, Allergy Clin, Copenhagen, Denmark; [Juel-Berg, Nanna; Hansen, Kirsten S.] Copenhagen Univ Hosp Herlev Gentofte, Dept Pediat, Copenhagen, Denmark		Blom, LH (corresponding author), Copenhagen Univ Hosp Herlev Gentofte, Dept Dermatol & Allergy, Allergy Clin, Copenhagen, Denmark.	lars.blom@regionh.dk	Poulsen, Lars K/J-3065-2019	Poulsen, Lars K/0000-0002-1730-847X; Larsen, Lau/0000-0001-6433-3961	Toyota Foundation; Else and Helene Alstrups Foundation	Toyota Foundation; Else and Helene Alstrups Foundation	We thank the Toyota Foundation and the Else and Helene Alstrups Foundation for their generous support in the funding of new instruments, making this investigation possible.	Blom LH, 2017, ALLERGY, V72, P1081, DOI 10.1111/all.13129; Blom L, 2013, J IMMUNOL METHODS, V397, P55, DOI 10.1016/j.jim.2013.08.008; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P1329, DOI 10.1016/j.jaci.2014.06.032; Chan SMH, 2012, ALLERGY, V67, P336, DOI 10.1111/j.1398-9995.2011.02765.x; Czarnowicki T, 2017, ALLERGY, V72, P366, DOI 10.1111/all.13080; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Mikhak Z, 2013, J EXP MED, V210, P1855, DOI 10.1084/jem.20130091; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Prussin C, 2009, J ALLERGY CLIN IMMUN, V124, P1326, DOI 10.1016/j.jaci.2009.09.048; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015	12	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1498	+		10.1016/j.jaci.2017.10.037	http://dx.doi.org/10.1016/j.jaci.2017.10.037			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29225086	Bronze			2022-12-18	WOS:000429197800040
J	Clay, CD; Strait, RT; Mahler, A; Khodoun, MV; Finkelman, FD				Clay, Corey D.; Strait, Richard T.; Mahler, Ashley; Khodoun, Marat V.; Finkelman, Fred D.			Anti-Fc gamma RIIB mAb suppresses murine IgG-dependent anaphylaxis by Fc domain targeting of Fc gamma RIII	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Fc receptors; anaphylaxis; mouse; signaling; IgG; IgE	IN-VIVO; SYSTEMIC-ANAPHYLAXIS; MEDIATED ANAPHYLAXIS; EFFECTOR FUNCTIONS; IMMUNOGLOBULIN-G; MOUSE IGD; RECEPTORS; ANTIBODIES; CELLS; RESPONSES	Background: The inhibitory receptor Fc gamma RIIB is expressed on human and murine bone marrow-derived cells and limits inflammation by suppressing signaling through stimulatory receptors. Objective: We sought to evaluate the effects of K9.361, a mouse IgG(2a) alloantibody to mouse Fc gamma RIIB, on murine anaphylaxis. Methods: Wild-type and Fc gamma R-deficient mice were used to study anaphylaxis, which was induced by injection of 2.4G2 (rat IgG(2b) mAb that binds both Fc gamma RIIB and the stimulatory receptor Fc gamma RIII), by actively immunizing IgE-deficient mice and then challenging with the immunizing antigen, and by passive immunization with IgG or IgE anti-2,4,6-trinitrophenyl mAb, followed by injection of 2,4,6-trinitrophenyl-ovalbumin. Pretreatment with K9.361 was assessed for its ability to influence anaphylaxis. Results: Unexpectedly, K9.361 injection induced mild anaphylaxis, which was both Fc gamma RIIB and Fc gamma RIII dependent and greatly enhanced by beta-adrenergic blockade. K9.361 injection also decreased expression of stimulatory Fc gamma receptors, especially Fc gamma RIII, and strongly suppressed IgG-mediated anaphylaxis without strongly affecting IgE-mediated anaphylaxis. The F(ab')(2) fragment of K9.361 did not induce anaphylaxis, even after b-adrenergic blockade, and did not deplete Fc gamma RIII or suppress IgG-mediated anaphylaxis but prevented intact K9.361-induced anaphylaxis without diminishing intact K9.36 suppression of IgG-mediated anaphylaxis. Conclusion: Cross-linking Fc gamma RIIB to stimulatory Fc gamma Rs through the Fc domains of an anti-Fc gamma RIIB mAb induces and then suppresses IgG-mediated anaphylaxis without affecting IgE-mediated anaphylaxis. Because IgG-and IgE-mediated anaphylaxis can be mediated by the same cell types, this suggests that desensitization acts at the receptor rather than cellular level. Sequential treatment with the F(ab')(2) fragment of anti-Fc gamma RIIB mAb followed by intact anti-Fc gamma RIIB safely prevents IgG-mediated anaphylaxis.	[Clay, Corey D.; Khodoun, Marat V.; Finkelman, Fred D.] Univ Cincinnati, Med Ctr, Dept Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA; [Strait, Richard T.; Khodoun, Marat V.] Cincinnati Vet Affairs Med Ctr, Dept Res, Cincinnati, OH USA; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH USA; [Strait, Richard T.; Mahler, Ashley] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Finkelman, FD (corresponding author), Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA.	finkelfd@UCMAIL.UC.EDU			National Institutes of Health (NIH) [R01 AI113162]; US Department of Veterans Affairs; NIH [T32AI060515-11]; Department of Internal Medicine, University of Cincinnati Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060515, R01AI113162] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Internal Medicine, University of Cincinnati Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health (NIH) grant R01 AI113162, a Merit Award to F.D.F. from the US Department of Veterans Affairs, the NIH-supported Immunology/Allergy Fellowship Training Program (T32AI060515-11), and the Department of Internal Medicine, University of Cincinnati Medical Center.	Bandukwala HS, 2007, J EXP MED, V204, P1875, DOI 10.1084/jem.20061134; Baudino L, 2008, J IMMUNOL, V180, P1948, DOI 10.4049/jimmunol.180.3.1948; Beers SA, 2016, BLOOD, V127, P1097, DOI 10.1182/blood-2015-09-625343; Bergtold A, 2006, J IMMUNOL, V177, P7287, DOI 10.4049/jimmunol.177.10.7287; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; CHAMPION BR, 1991, IMMUNOLOGY, V72, P336; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; FINKELMAN FD, 1981, J IMMUNOL, V126, P680; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Getahun A, 2015, IMMUNOL REV, V268, P66, DOI 10.1111/imr.12336; Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254; GOROFF DK, 1988, J IMMUNOL, V140, P2919; Hashimoto T, 2012, J PATHOL, V228, P1, DOI 10.1002/path.4062; Hirano M, 2007, NAT IMMUNOL, V8, P762, DOI 10.1038/ni1477; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V132, P1375, DOI 10.1016/j.jaci.2013.09.008; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V131, P1555, DOI 10.1016/j.jaci.2013.02.043; KIMURA S, 1981, IMMUNOGENETICS, V14, P3, DOI 10.1007/BF00344295; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Radeke HH, 2002, J BIOL CHEM, V277, P27535, DOI 10.1074/jbc.M200419200; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; SVETIC A, 1991, J IMMUNOL, V147, P2391; Tipton TRW, 2015, BLOOD, V126, P2643, DOI 10.1182/blood-2015-09-671339; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Watanabe N, 1999, BLOOD, V94, P3855; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562	42	9	9	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1373	+		10.1016/j.jaci.2017.05.027	http://dx.doi.org/10.1016/j.jaci.2017.05.027			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	28624610	Green Accepted, Bronze			2022-12-18	WOS:000429197800023
J	de Chambrun, MP; Mathian, A; Luyt, CE; Combes, A; Amoura, Z				de Chambrun, Marc Pineton; Mathian, Alexis; Luyt, Charles-Edouard; Combes, Alain; Amoura, Zahir		EureClark Study Grp	Myocardial dysfunction is frequent in systemic capillary-leak syndrome (Clarkson disease) severe episodes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[de Chambrun, Marc Pineton; Mathian, Alexis; Amoura, Zahir] Inst E3M, Serv Med Interne 2, Paris, France; [de Chambrun, Marc Pineton; Luyt, Charles-Edouard; Combes, Alain] Sorbonne Univ, Hop La Pitie Salpetriere, AP HP, Inst Cardiol,Serv Reanimat Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Amoura, Z (corresponding author), Inst E3M, Serv Med Interne 2, Paris, France.	zahir.amoura@aphp.fr			Bayer Healthcare; MSD	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); MSD	C.-E. Luyt has received advisory board participation fees from Bayer Healthcare; lecture fees from MSD; and nonfinancial equipment support from Curetis. The rest of the authors declare that they have no relevant conflicts of interest.	Claessens YE, 1999, INTENS CARE MED, V25, P334, DOI 10.1007/s001340050849; de Chambrun MP, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.05.023; Druey KM, 2017, J ALLERGY CLIN IMMUN, V140, P663, DOI 10.1016/j.jaci.2016.10.042; Ertel A, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0181-6; Guillaume M, 2011, Rev Med Interne, V32, pe69, DOI 10.1016/j.revmed.2010.06.002; Ledochowski S, 2015, ANAESTH CRIT CARE PA, V34, P251, DOI 10.1016/j.accpm.2015.05.003; Pineton M, 2017, CRIT CARE MED, V45, P1216, DOI 10.1097/CCM.0000000000002496	7	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1539	1540		10.1016/j.jaci.2017.11.055	http://dx.doi.org/10.1016/j.jaci.2017.11.055			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29477581	Bronze			2022-12-18	WOS:000429197800055
J	Jupe, S; Ray, K; Roca, CD; Varusai, T; Shamovsky, V; Stein, L; D'Eustachio, P; Hermjakob, H				Jupe, Steve; Ray, Keith; Roca, Corina Duenas; Varusai, Thawfeek; Shamovsky, Veronica; Stein, Lincoln; D'Eustachio, Peter; Hermjakob, Henning			Interleukins and their signaling pathways in the Reactome biological pathway database	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Interleukins; pathways; signaling; database; Reactome; diagram; illustration	NOMENCLATURE	Background: There is a wealth of biological pathway information available in the scientific literature, but it is spread across many thousands of publications. Alongside publications that contain definitive experimental discoveries are many others that have been dismissed as spurious, found to be irreproducible, or are contradicted by later results and consequently now considered controversial. Many descriptions and images of pathways are incomplete stylized representations that assume the reader is an expert and familiar with the established details of the process, which are consequently not fully explained. Pathway representations in publications frequently do not represent a complete, detailed, and unambiguous description of the molecules involved; their precise posttranslational state; or a full account of the molecular events they undergo while participating in a process. Although this might be sufficient to be interpreted by an expert reader, the lack of detail makes such pathways less useful and difficult to understand for anyone unfamiliar with the area and of limited use as the basis for computational models. Objective: Reactome was established as a freely accessible knowledge base of human biological pathways. It is manually populated with interconnected molecular events that fully detail the molecular participants linked to published experimental data and background material by using a formal and open data structure that facilitates computational reuse. These data are accessible on a Web site in the form of pathway diagrams that have descriptive summaries and annotations and as downloadable data sets in several formats that can be reused with other computational tools. The entire database and all supporting software can be downloaded and reused under a Creative Commons license. Methods: Pathways are authored by expert biologists who work with Reactome curators and editorial staff to represent the consensus in the field. Pathways are represented as interactive diagrams that include as much molecular detail as possible and are linked to literature citations that contain supporting experimental details. All newly created events undergo a peer-review process before they are added to the database and made available on the associated Web site. New content is added quarterly. Results: The 63rd release of Reactome in December 2017 contains 10,996 human proteins participating in 11,426 events in 2,179 pathways. In addition, analytic tools allow data set submission for the identification and visualization of pathway enrichment and representation of expression profiles as an overlay on Reactome pathways. Protein-protein and compound-protein interactions from several sources, including custom user data sets, can be added to extend pathways. Pathway diagrams and analytic result displays can be downloaded as editable images, human-readable reports, and files in several standard formats that are suitable for computational reuse. Reactome content is available programmatically through a REpresentational State Transfer (REST)-based content service and as a Neo4J graph database. Signaling pathways for IL-1 to IL-38 are hierarchically classified within the pathway "signaling by interleukins.'' The classification used is largely derived from Akdis et al. Conclusion: The addition to Reactome of a complete set of the known human interleukins, their receptors, and established signaling pathways linked to annotations of relevant aspects of immune function provides a significant computationally accessible resource of information about this important family. This information can be extended easily as new discoveries become accepted as the consensus in the field. A key aim for the future is to increase coverage of gene expression changes induced by interleukin signaling.	[Jupe, Steve; Roca, Corina Duenas; Varusai, Thawfeek; Hermjakob, Henning] EBI, EMBL, Wellcome Genome Campus, Hinxton, England; [Ray, Keith] VHsquared, Cambridge, England; [Shamovsky, Veronica; D'Eustachio, Peter] NYU, Langone Med Ctr, New York, NY USA; [Stein, Lincoln] Ontario Inst Canc Res, Toronto, ON, Canada; [Stein, Lincoln] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hermjakob, Henning] Beijing Inst Radiat Med, PHOENIX Ctr, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China	European Molecular Biology Laboratory (EMBL); New York University; NYU Langone Medical Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Academy of Military Medical Sciences - China	Hermjakob, H (corresponding author), EBI, EMBL, Wellcome Trust Genome Campus, Cambridge, England.	hhe@ebi.ac.uk	Hermjakob, Henning/AFM-3497-2022	Hermjakob, Henning/0000-0001-8479-0262; D'Eustachio, Peter/0000-0002-5494-626X; Varusai, Thawfeek/0000-0002-7864-5971	National Institutes of Health (NIH) BD2K grant [U54 GM114833]; National Human Genome Research Institute at the NIH [U41 HG003751]; European Bioinformatics Institute (EMBL-EBI), Open Targets (The target validation platform); Medicine by Design (University of Toronto); NIH [U54 GM114833]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG003751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114833] Funding Source: NIH RePORTER	National Institutes of Health (NIH) BD2K grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Bioinformatics Institute (EMBL-EBI), Open Targets (The target validation platform); Medicine by Design (University of Toronto); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) BD2K grant (U54 GM114833), the National Human Genome Research Institute at the NIH (U41 HG003751), the European Bioinformatics Institute (EMBL-EBI), Open Targets (The target validation platform), and Medicine by Design (University of Toronto). Funding for open access charge was from the NIH (U54 GM114833).	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5979, DOI 10.1111/bph.13353; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; [Anonymous], 1979, Eur J Immunol, V9, P920; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brocker Chad, 2010, Human Genomics, V5, P30; Burley SK, 2017, METHODS MOL BIOL, V1606, P627, DOI 10.1007/978-1-4939-7000-1_26; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Fabregat A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1559-2; Hastings J, 2016, NUCLEIC ACIDS RES, V44, pD1214, DOI 10.1093/nar/gkv1031; Jupe S, 2014, CONTROLLED VOCABULAR, V2014; KAZATCHKINE M, 1991, B WORLD HEALTH ORGAN, V69, P483; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Mizel SB, 1985, IN SELF DEFENSE; Perini L, 2013, KNOWL ENG REV, V28, P273, DOI 10.1017/S0269888913000246; Sidiropoulos K, 2017, BIOINFORMATICS, V33, P3461, DOI 10.1093/bioinformatics/btx441; Sims JE, 2001, TRENDS IMMUNOL, V22, P536, DOI 10.1016/S1471-4906(01)02040-3; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Turner MW, 1997, B WORLD HEALTH ORGAN, V75, P175	25	9	9	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1411	1416		10.1016/j.jaci.2017.12.992	http://dx.doi.org/10.1016/j.jaci.2017.12.992			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29378288	hybrid, Green Accepted			2022-12-18	WOS:000429197800026
J	Grattan, C				Grattan, Clive			Autoimmune chronic spontaneous urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Grattan, Clive] Guys Hosp, London, England	Guy's & St Thomas' NHS Foundation Trust	Grattan, C (corresponding author), Guys Hosp, London, England.	clive.e.grattan@gstt.nhs.uk						Altrich ML, 2009, ALLERGY ASTHMA PROC, V30, P28, DOI 10.2500/aap.2009.30.3185; Coombs R.R.A., 1963, CLIN ASPECTS IMMUNOL, Vpublication, P317; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; GRUBER BL, 1988, J INVEST DERMATOL, V90, P213, DOI 10.1111/1523-1747.ep12462239; Kay AB, 2008, ALLERGY ALLERGIC DIS, P19; Kolkhir P, 2017, J ALLERGY CLIN IMMUN, V139, P1772, DOI 10.1016/j.jaci.2016.08.050; Weetman AP, 2001, HYPERSENSITIVITY STI, P1	7	9	9	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1165	1166		10.1016/j.jaci.2017.09.014	http://dx.doi.org/10.1016/j.jaci.2017.09.014			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	29102068	Bronze			2022-12-18	WOS:000426974800050
J	Busse, WW; Haselkorn, T; Rosen, K; Trzaskoma, BL; Ortiz, B; Szefler, SJ				Busse, William W.; Haselkorn, Tmirah; Rosen, Karin; Trzaskoma, Benjamin L.; Ortiz, Benjamin; Szefler, Stanley J.			Greater Treatment Benefit with Omalizumab in Children with Increased Asthma Severity: Exploratory Analyses from the Inner-City Anti-IgE Therapy for Asthma (ICATA) Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Busse, William W.] Sch Med & Publ Hlth, Madison, WI USA; [Haselkorn, Tmirah] EpiMetrix Inc, Los Altos, CA USA; [Rosen, Karin; Trzaskoma, Benjamin L.] Genentech Inc, San Francisco, CA 94080 USA; [Ortiz, Benjamin] Novartis Pharmaceut, E Hanover, NJ USA; [Szefler, Stanley J.] Childrens Hosp Colorado, Aurora, CO USA	Roche Holding; Genentech; Novartis; Children's Hospital Colorado									0	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		43	AB14	AB14		10.1016/j.jaci.2017.12.045	http://dx.doi.org/10.1016/j.jaci.2017.12.045			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700044
J	Hindley, JP; Filep, S; Block, DS; King, EM; Chapman, MD				Hindley, James P.; Filep, Stephanie; Block, Denise S.; King, Eva M.; Chapman, Martin D.			Dose of allergens in a peanut snack (Bamba) associated with prevention of peanut allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ATOPIC-DERMATITIS; TOPICAL PIMECROLIMUS; CONSUMPTION; CHILDREN; INFANTS; GROWTH; RISK		[Hindley, James P.] INDOOR Biotechnol Ltd, Cardiff, S Glam, Wales; [Filep, Stephanie; Block, Denise S.; King, Eva M.; Chapman, Martin D.] INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA	INDOOR Biotechnologies; INDOOR Biotechnologies	Chapman, MD (corresponding author), INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA.	mdc@inbio.com		Chapman, Martin/0000-0002-0845-3632; Hindley, James/0000-0002-3262-2897; Filep, Stephanie/0000-0003-2135-5161	INDOOR Biotechnologies; European Union [FP7-KBBE-2012-6-312147]	INDOOR Biotechnologies; European Union(European Commission)	This work was funded in part by INDOOR Biotechnologies and by a grant from the European Union 7th Framework, Project No. FP7-KBBE-2012-6-312147, Integrated Approaches to Food Allergen and Allergy Management (iFAAM).	Barbier N, 2004, BRIT J DERMATOL, V150, P96, DOI 10.1111/j.1365-2133.2004.05696.x; Collins L.M., 2009, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Feeney M, 2016, J ALLERGY CLIN IMMUN, V138, P1108, DOI 10.1016/j.jaci.2016.04.016; Filep S, 2017, J ALLERGY CLIN IMMUN; Fleischer DM, 2015, PEDIATRICS, V136, P600, DOI 10.1542/peds.2015-2394; Kapoor R, 2009, PEDIATR DERMATOL, V26, P682, DOI 10.1111/j.1525-1470.2009.01013.x; Kapp A, 2002, J ALLERGY CLIN IMMUN, V110, P277, DOI 10.1067/mai.2002.126500; Lack G, 2015, NEW ENGL J MED, V372, P2165, DOI 10.1056/NEJMc1504021; Margolis DJ, 2013, J DERMATOL SCI, V70, P67, DOI 10.1016/j.jdermsci.2012.11.594; Margolis DJ, 2011, J INVEST DERMATOL, V131, P1765, DOI 10.1038/jid.2011.102; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Skrondal A., 2004, GEN LATENT VARIABLE; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x	16	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					780	+		10.1016/j.jaci.2017.05.050	http://dx.doi.org/10.1016/j.jaci.2017.05.050			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28709966	Bronze			2022-12-18	WOS:000424410800037
J	Kuang, FL; Alao, H; Kumar, S; Powers, A; Quezado, M; Wang, ZF; Ware, J; Wetzler, L; Brown, T; Khoury, P; Klion, AD				Kuang, Fei Li; Alao, Hawaa; Kumar, Sheila; Powers, Astin; Quezado, Martha; Wang, Zengfeng; Ware, JeanAnne; Wetzler, Lauren; Brown, Thomas; Khoury, Paneez; Klion, Amy D.			Benralizumab (anti-IL5R alpha) depletes gut tissue eosinophilia and improves symptoms in hypereosinophilic syndrome with gastrointestinal involvement	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Kuang, Fei Li; Khoury, Paneez] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Alao, Hawaa; Kumar, Sheila] NIDDK, Digest Dis Branch, Bethesda, MD 20892 USA; [Powers, Astin; Quezado, Martha; Wang, Zengfeng] NCI, Pathol Lab, Bldg 10, Bethesda, MD 20892 USA; [Ware, JeanAnne; Wetzler, Lauren; Brown, Thomas] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Klion, Amy D.] NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA			Khoury, Paneez/ABH-1951-2020	Khoury, Paneez/0000-0003-1800-0079					0	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		618	AB196	AB196		10.1016/j.jaci.2017.12.622	http://dx.doi.org/10.1016/j.jaci.2017.12.622			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX					2022-12-18	WOS:000429306700617
J	Lai, PS; Massoud, AH; Xia, MC; Petty, CR; Cunningham, A; Chatila, TA; Phipatanakul, W				Lai, Peggy S.; Massoud, Amir H.; Xia, Mingcan; Petty, Carter R.; Cunningham, Amparito; Chatila, Talal A.; Phipatanakul, Wanda			Gene-environment interaction between an IL4R variant and school endotoxin exposure contributes to asthma symptoms in inner-city children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							AIRWAY INFLAMMATION; AIRBORNE ALLERGENS; CELLS; DESIGN; MORBIDITY		[Lai, Peggy S.] Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA; [Lai, Peggy S.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Lai, Peggy S.; Massoud, Amir H.; Xia, Mingcan; Cunningham, Amparito; Chatila, Talal A.; Phipatanakul, Wanda] Harvard Med Sch, Boston, MA 02115 USA; [Massoud, Amir H.; Xia, Mingcan; Chatila, Talal A.; Phipatanakul, Wanda] Boston Childrens Hosp, Allergy & Immunol, Boston, MA 02115 USA; [Petty, Carter R.] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Phipatanakul, W (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Phipatanakul, W (corresponding author), Boston Childrens Hosp, Allergy & Immunol, Boston, MA 02115 USA.	wanda.phipatanakul@childrens.harvard.edu	Massoud, Amir Hossein/AAO-2940-2021	Chatila, Talal/0000-0001-7439-2762	National Institutes of Health [R01 AI 073964, U01 AI 110397, K24 AI 106822, U01 AI 126614, R01 AI065617, K23 ES023700, P30 ES000002, 5T32AI007512]; American College of Allergy, Asthma, and Immunology Young Faculty Award; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, NIH) [UL1 TR001102]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065617, R01AI073964, U01AI143514, U01AI126614, U01AI110397, K24AI106822, T32AI007512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES023700, P30ES000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Allergy, Asthma, and Immunology Young Faculty Award; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, NIH); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Institutes of Health (grant nos. R01 AI 073964, U01 AI 110397, K24 AI 106822, and U01 AI 126614 to W.P, grant no. R01 AI065617 to T.A.C., grant no. K23 ES023700 to P.S.L, grant no. P30 ES000002 to Doug Dockery [PI], and grant no. 5T32AI007512 to M.X.). This work was also supported by the American College of Allergy, Asthma, and Immunology Young Faculty Award. This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH Award no. UL1 TR001102) and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.	Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Custis NJ, 2003, CLIN EXP ALLERGY, V33, P986, DOI 10.1046/j.1365-2222.2003.01706.x; Eriksson L., 2013, MULTIAND MEGAVARIATE; Forno E, 2009, CURR OPIN ALLERGY CL, V9, P154, DOI 10.1097/ACI.0b013e3283292207; Glader P, 2010, EUR RESPIR J, V36, P1155, DOI 10.1183/09031936.00170609; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Kaliste E, 2004, LAB ANIM-UK, V38, P25, DOI 10.1258/00236770460734362; Kulis M, 2013, MOL NUTR FOOD RES, V57, P906, DOI 10.1002/mnfr.201200410; Kulis M, 2011, J ALLERGY CLIN IMMUN, V127, P81, DOI 10.1016/j.jaci.2010.09.014; Lai PS, 2015, CHEST, V148, P1251, DOI 10.1378/chest.15-0098; Livanos AE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.140, 10.1038/nmicrobiol.2016.140]; Macartney S., 2013, ACSBR1117 US CENS BU; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; Mitchell H, 1997, PEDIATR PULM, V24, P237; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Phipatanakul W, 2011, J ASTHMA, V48, P1007, DOI 10.3109/02770903.2011.624235; Platts-Mills JA, 2005, CONTEMP TOP LAB ANIM, V44, P12; Rosa-Rosa L, 1999, J ALLERGY CLIN IMMUN, V104, P1008, DOI 10.1016/S0091-6749(99)70082-5; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Thompson AL, 2012, J IMMUNOL, V188, P2834, DOI 10.4049/jimmunol.1100254; Thorne PS, 2015, AM J RESP CRIT CARE, V192, P1287, DOI 10.1164/rccm.201502-0251OC; Tischer C, 2015, EUR RESPIR J, V45, P328, DOI 10.1183/09031936.00060214; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Xia MC, 2015, J ALLERGY CLIN IMMUN, V136, P441, DOI 10.1016/j.jaci.2015.02.014	25	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					794	+		10.1016/j.jaci.2017.08.023	http://dx.doi.org/10.1016/j.jaci.2017.08.023			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28943468	Green Accepted, Bronze			2022-12-18	WOS:000424410800042
J	Ludka-Gaulke, T; Ghera, P; Waring, SC; Keifer, M; Seroogy, C; Gern, JE; Kirkhorn, S				Ludka-Gaulke, Tiffany; Ghera, Princy; Waring, Stephen C.; Keifer, Matthew; Seroogy, Christine; Gern, James E.; Kirkhorn, Steven			Farm exposure in early childhood is associated with a lower risk of severe respiratory illnesses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							1ST-YEAR; WHEEZE; ASTHMA		[Ludka-Gaulke, Tiffany; Ghera, Princy] Marshfield Clin Fdn Med Res & Educ, Dept Med Pediat, Marshfield, WI USA; [Waring, Stephen C.] Essentia Inst Rural Hlth, Duluth, MN USA; [Keifer, Matthew; Kirkhorn, Steven] Marshfield Clin Res Fdn, Natl Farm Med Ctr, Marshfield, WI USA; [Seroogy, Christine; Gern, James E.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53726 USA; [Kirkhorn, Steven] Marshfield Clin Fdn Med Res & Educ, Dept Occupat Med, Marshfield, WI USA; [Ludka-Gaulke, Tiffany] Providence Med Grp, Spokane, WA USA; [Keifer, Matthew] Vet Adm Puget Sound Healthcare Syst, Seattle, WA USA; [Kirkhorn, Steven] Vet Adm Heath Care Ctr, Minneapolis, MN USA	Marshfield Clinic; University of Wisconsin System; University of Wisconsin Madison; Marshfield Clinic	Seroogy, C (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53726 USA.	cmseroogy@wisc.edu	Waring, Stephen/AAR-6870-2021	Waring, Stephen/0000-0002-9674-0083; Ghera, Princy/0000-0003-2100-0416	Marshfield Clinic Research Foundation through Robert G. Zach Family Foundation; National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases [U19 AI104317]; Clinical and Translational Science Award program, through the NIH National Center for Advancing Translational Sciences [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104317, P01AI050500] Funding Source: NIH RePORTER	Marshfield Clinic Research Foundation through Robert G. Zach Family Foundation; National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clinical and Translational Science Award program, through the NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Marshfield Clinic Research Foundation through a major grant from the Robert G. Zach Family Foundation, the National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (grant no. U19 AI104317), and the Clinical and Translational Science Award program, through the NIH National Center for Advancing Translational Sciences (grant no. UL1TR000427).	Asher MI, 1998, CLIN EXP ALLERGY, V28, P52; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; DeStefano F, 1996, J CLIN EPIDEMIOL, V49, P643, DOI 10.1016/0895-4356(96)00008-X; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fuchs O, 2012, J ALLERGY CLIN IMMUN, V130, P382, DOI 10.1016/j.jaci.2012.04.049; Gern JE, 2006, J ALLERGY CLIN IMMUN, V117, P72, DOI 10.1016/j.jaci.2005.10.002; Loss G, 2015, J ALLERGY CLIN IMMUN, V135, P56, DOI 10.1016/j.jaci.2014.08.044; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871	10	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					454	+		10.1016/j.jaci.2017.07.032	http://dx.doi.org/10.1016/j.jaci.2017.07.032			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	28870458	Bronze, Green Accepted			2022-12-18	WOS:000419312200063
J	Sheehan, WJ; Gaffin, JM; Peden, DB; Bush, RK; Phipatanakul, W				Sheehan, William J.; Gaffin, Jonathan M.; Peden, David B.; Bush, Robert K.; Phipatanakul, Wanda			Advances in environmental and occupational disorders in 2016	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aeroallergens; fungi; air pollutants; viral respiratory tract infections; climate change; occupational asthma	INNER-CITY CHILDREN; EARLY-LIFE EXPOSURE; AIR-POLLUTION; LUNG-FUNCTION; DIESEL EXHAUST; ALLERGEN EXPOSURE; CHILDHOOD ASTHMA; RISK-FACTORS; IMMUNE-RESPONSE; CYSTIC-FIBROSIS	In this review we highlight recent studies that advance the knowledge and understanding of the effects of various environmental factors and associated immune responses in patients with allergic diseases. This review will focus on new literature regarding allergic and immune responses to a variety of environmental factors, including aeroallergens, stinging insects, fungi, pollutants, viral respiratory tract infections, climate change, and microbial exposures.	[Sheehan, William J.; Phipatanakul, Wanda] Boston Childrens Hosp, Div Allergy & Immunol, 300 Longwood Ave, Boston, MA 02115 USA; [Gaffin, Jonathan M.] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Sheehan, William J.; Gaffin, Jonathan M.; Phipatanakul, Wanda] Harvard Med Sch, Boston, MA USA; [Sheehan, William J.] Childrens Natl Hlth Syst, Div Allergy & Immunol, Washington, DC USA; [Peden, David B.] Univ N Carolina, Sch Med, Ctr Environm Med Asthma & Lung Biol, Div Allergy & Immunol, Chapel Hill, NC USA; [Bush, Robert K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Allergy Immunol Pulm Crit Care & Sleep Med, Madison, WI 53706 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Children's National Health System; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Phipatanakul, W (corresponding author), Boston Childrens Hosp, Div Allergy & Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	wanda.phipatanakul@childrens.harvard.edu		GAFFIN, JONATHAN/0000-0003-2213-4504; Peden, David/0000-0003-4526-4627	National Institutes of Health [K23AI104780, K23AI106945, K24AI106822]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI110397, K23AI106945, K24AI106822, K23AI104780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by grants K23AI104780, K23AI106945, and K24AI106822 from the National Institutes of Health.	Amaral AFS, 2016, J ALLERGY CLIN IMMUN, V137, P1788, DOI 10.1016/j.jaci.2015.09.037; Anderson EL, 2016, ALLERGY, V71, P977, DOI 10.1111/all.12861; Annesi-Maesano I, 2016, J ALLERGY CLIN IMMUN, V138, P57, DOI 10.1016/j.jaci.2016.02.043; Asarnoj A, 2016, J ALLERGY CLIN IMMUN, V137, P813, DOI 10.1016/j.jaci.2015.09.052; Bandoli G, 2016, J ALLERGY CLIN IMMUN, V138, P918, DOI 10.1016/j.jaci.2016.04.012; Baxi SN, 2016, J ALLER CL IMM-PRACT, V4, P396, DOI 10.1016/j.jaip.2016.01.008; Becker S, 2016, INT ARCH ALLERGY IMM, V170, P132, DOI 10.1159/000447694; Bellanger AP, 2017, J IMMUNOL METHODS, V440, P67, DOI 10.1016/j.jim.2016.11.009; Bowatte G, 2017, J ALLERGY CLIN IMMUN, V139, P122, DOI 10.1016/j.jaci.2016.05.008; Brandt EB, 2016, J ALLERGY CLIN IMMUN, V138, P924, DOI 10.1016/j.jaci.2016.03.037; Brandt EB, 2015, J ALLERGY CLIN IMMUN, V136, P295, DOI 10.1016/j.jaci.2014.11.043; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Carroll KN, 2017, J ALLERGY CLIN IMMUN, V139, P66, DOI 10.1016/j.jaci.2016.01.055; Clifford RL, 2017, J ALLERGY CLIN IMMUN, V139, P112, DOI 10.1016/j.jaci.2016.03.046; Coleman AT, 2015, J ALLERGY CLIN IMMUN, V136, P1127, DOI 10.1016/j.jaci.2015.05.038; Cornejo-Garcia JA, 2016, CURR PHARM DESIGN, V22, P6725, DOI 10.2174/1381612822666160927114941; D'Amato G, 2017, J ALLERGY CLIN IMMUN, V139, P1786, DOI 10.1016/j.jaci.2017.03.003; De Grove KC, 2017, J ALLERGY CLIN IMMUN, V139, P246, DOI 10.1016/j.jaci.2016.03.044; Demoly P, 2016, J ALLERGY CLIN IMMUN, V137, P444, DOI 10.1016/j.jaci.2015.06.036; DiMango E, 2016, J ALLER CL IMM-PRACT, V4, P671, DOI 10.1016/j.jaip.2016.01.016; Dodd KE, 2016, MMWR-MORBID MORTAL W, V65, P1325, DOI 10.15585/mmwr.mm6547a1; Elphick HE, 2016, COCHRANE DB SYST REV, V11; Frick M, 2016, J ALLERGY CLIN IMMUN, V138, P1663, DOI 10.1016/j.jaci.2016.04.024; Froidure A, 2016, EUR RESPIR J, V47, P304, DOI 10.1183/13993003.01824-2014; Frush BW, 2016, J ALLERGY CLIN IMMUN, V138, P1213, DOI 10.1016/j.jaci.2016.03.052; Ganson NJ, 2016, J ALLERGY CLIN IMMUN, V137, P1610, DOI 10.1016/j.jaci.2015.10.034; Gernez Y, 2016, J ALLERGY CLIN IMMUN, V138, P1195, DOI 10.1016/j.jaci.2016.04.002; Gieras A, 2016, J ALLERGY CLIN IMMUN, V137, P1557, DOI 10.1016/j.jaci.2015.08.055; Han MY, 2016, J ALLERGY CLIN IMMUN, V138, P1619, DOI 10.1016/j.jaci.2016.01.037; Hector A, 2016, J ALLERGY CLIN IMMUN, V138, P1183, DOI 10.1016/j.jaci.2016.01.031; Horner CC, 2016, J ALLERGY CLIN IMMUN, V138, P1196, DOI 10.1016/j.jaci.2016.01.054; Ierodiakonou D, 2016, J ALLERGY CLIN IMMUN, V137, P390, DOI 10.1016/j.jaci.2015.05.028; Jackson DJ, 2017, J ALLERGY CLIN IMMUN, V139, P379, DOI 10.1016/j.jaci.2016.12.941; Jacobino SR, 2016, J ALLERGY CLIN IMMUN, V138, P1477, DOI 10.1016/j.jaci.2016.06.001; Jhun I, 2017, J ALLER CL IMM-PRACT, V5, P154, DOI 10.1016/j.jaip.2016.07.018; Jusot JF, 2017, J ALLERGY CLIN IMMUN, V139, P977, DOI 10.1016/j.jaci.2016.04.062; Karrasch S, 2017, THORAX, V72, P109, DOI 10.1136/thoraxjnl-2016-208704; Larenas-Linnemann D, 2016, J ALLER CL IMM-PRACT, V4, P405, DOI 10.1016/j.jaip.2015.10.015; Levetin E, 2016, J ALLER CL IMM-PRACT, V4, P375, DOI 10.1016/j.jaip.2015.10.012; Liu AH, 2016, J ALLERGY CLIN IMMUN, V138, P1042, DOI 10.1016/j.jaci.2016.06.060; Lomholt FK, 2016, J ALLERGY CLIN IMMUN, V138, P1404, DOI 10.1016/j.jaci.2016.05.022; London NR, 2016, J ALLERGY CLIN IMMUN, V138, P1736, DOI 10.1016/j.jaci.2016.06.027; Loser S, 2017, J ALLERGY CLIN IMMUN, V139, P1496, DOI 10.1016/j.jaci.2016.07.033; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; Matsui EC, 2017, JAMA-J AM MED ASSOC, V317, P1027, DOI 10.1001/jama.2016.21048; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Mehta AK, 2016, J ALLERGY CLIN IMMUN, V137, P278, DOI 10.1016/j.jaci.2015.05.007; Mendola P, 2016, J ALLERGY CLIN IMMUN, V138, P432, DOI 10.1016/j.jaci.2015.12.1309; Michel J, 2016, ALLERGY, V71, P651, DOI 10.1111/all.12850; Millon L, 2016, J ALLERGY CLIN IMMUN, V138, P1738, DOI 10.1016/j.jaci.2016.06.037; Mirkovic B, 2016, J ALLERGY CLIN IMMUN, V137, P436, DOI 10.1016/j.jaci.2015.07.045; Nishimura KK, 2016, J ALLERGY CLIN IMMUN, V138, P1703, DOI 10.1016/j.jaci.2016.03.058; Pali-Scholl I, 2016, CURR OPIN IMMUNOL, V42, P113, DOI 10.1016/j.coi.2016.08.004; Pongracic JA, 2016, J ALLERGY CLIN IMMUN, V138, P1030, DOI 10.1016/j.jaci.2016.06.059; Povsic TJ, 2016, J ALLERGY CLIN IMMUN, V138, P1712, DOI 10.1016/j.jaci.2016.04.058; Pralong JA, 2016, J ALLERGY CLIN IMMUN, V137, P412, DOI 10.1016/j.jaci.2015.06.026; Rabito FA, 2017, J ALLERGY CLIN IMMUN, V140, P565, DOI [10.1016/j.jaci.2016.10.019, 10.1016/j.jaci.2016.12.221]; Rava M, 2017, ENVIRON HEALTH PERSP, V125, P207, DOI 10.1289/EHP376; Rider CF, 2016, J ALLERGY CLIN IMMUN, V138, P1690, DOI 10.1016/j.jaci.2016.02.038; Roux M, 2016, J ALLERGY CLIN IMMUN, V138, P451, DOI 10.1016/j.jaci.2016.03.039; Rubner FJ, 2017, J ALLERGY CLIN IMMUN, V139, P501, DOI 10.1016/j.jaci.2016.03.049; Schiavoni G, 2017, ANN ALLERG ASTHMA IM, V118, P269, DOI 10.1016/j.anai.2016.12.019; Schrautzer C, 2016, J ALLERGY CLIN IMMUN, V137, P1603, DOI 10.1016/j.jaci.2015.10.041; Schultz ES, 2016, J ALLERGY CLIN IMMUN, V138, P930, DOI 10.1016/j.jaci.2016.04.014; Schultzl ES, 2016, AM J RESP CRIT CARE, V193, P171, DOI 10.1164/rccm.201505-0928OC; Schyllert C, 2016, OCCUP ENVIRON MED, V73, P663, DOI 10.1136/oemed-2016-103595; Sheehan WJ, 2017, JAMA PEDIATR, V171, P31, DOI 10.1001/jamapediatrics.2016.2543; Sheehan WJ, 2016, CURR OPIN PEDIATR, V28, P772, DOI 10.1097/MOP.0000000000000421; Shelfoon C, 2016, J ALLERGY CLIN IMMUN, V138, P114, DOI 10.1016/j.jaci.2015.12.1308; Sokolowska M, 2017, J ALLERGY CLIN IMMUN, V139, P1379, DOI 10.1016/j.jaci.2016.09.031; Somineni HK, 2016, J ALLERGY CLIN IMMUN, V137, P797, DOI 10.1016/j.jaci.2015.10.021; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Takeda T, 2016, J ALLERGY CLIN IMMUN, V138, P1395, DOI 10.1016/j.jaci.2016.01.032; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Toussaint M, 2017, NAT MED, V23, P681, DOI 10.1038/nm.4332; Uriarte SA, 2016, ALLERGY, V71, P1066, DOI 10.1111/all.12917; Williams PB, 2016, J ALLER CL IMM-PRACT, V4, P386, DOI 10.1016/j.jaip.2015.11.016; Zoratti EM, 2016, J ALLERGY CLIN IMMUN, V138, P1016, DOI 10.1016/j.jaci.2016.06.061	78	9	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1683	1692		10.1016/j.jaci.2017.09.032	http://dx.doi.org/10.1016/j.jaci.2017.09.032			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	29080787	Green Accepted, Bronze			2022-12-18	WOS:000417206000023
J	Sheehan, WJ; Brough, HA; Makinson, K; Petty, CR; Lack, G; Phipatanakul, W				Sheehan, William J.; Brough, Helen A.; Makinson, Kerry; Petty, Carter R.; Lack, Gideon; Phipatanakul, Wanda			Distribution of peanut protein in school and home environments of inner-city children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA; DUST; EXPOSURE; ALLERGY; DESIGN		[Sheehan, William J.; Phipatanakul, Wanda] Boston Childrens Hosp, Div Allergy & Immunol, Boston, MA 02115 USA; [Sheehan, William J.; Phipatanakul, Wanda] Harvard Med Sch, Boston, MA 02115 USA; [Brough, Helen A.; Makinson, Kerry; Lack, Gideon] Kings Coll London, Guys Hosp, Dept Asthma Allergy & Resp Sci, London, England; [Brough, Helen A.; Lack, Gideon] St Thomas Hosp, Childrens Allergy Serv, London, England; [Petty, Carter R.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Harvard University; Boston Children's Hospital	Phipatanakul, W (corresponding author), Boston Childrens Hosp, Div Allergy & Immunol, Boston, MA 02115 USA.; Phipatanakul, W (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	wanda.phipatanakul@childrens.harvard.edu		Sheehan, William/0000-0002-4680-4923; Lack, Gideon/0000-0001-7350-4021	National Institutes of Health [R01AI073964, R01AI073964-02S1, K24AI106822, K23AI104780, U01AI110397, L40AI107923]; Boston Children's Hospital Division of Immunology Clinical Research Advisory Group Research Grant; Allergy and Asthma Awareness Initiative, Inc.; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI110397, R01AI073964, K23AI104780, K24AI106822] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital Division of Immunology Clinical Research Advisory Group Research Grant; Allergy and Asthma Awareness Initiative, Inc.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (grant nos. R01AI073964, R01AI073964-02S1, K24AI106822, K23AI104780, U01AI110397, and L40AI107923). This work was also supported in part by the Boston Children's Hospital Division of Immunology Clinical Research Advisory Group Research Grant and The Allergy and Asthma Awareness Initiative, Inc.	Arbes SJ, 2005, ENVIRON HEALTH PERSP, V113, P665, DOI 10.1289/ehp.7648; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P867, DOI 10.1016/j.jaci.2014.08.011; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P623, DOI 10.1016/j.jaci.2013.02.035; Mitchell H, 1997, PEDIATR PULM, V24, P237; Perry TT, 2004, J ALLERGY CLIN IMMUN, V113, P973, DOI 10.1016/j.jaci.2004.02.035; Phipatanakul W, 2011, J ASTHMA, V48, P1007, DOI 10.3109/02770903.2011.624235; Smedje G, 1997, CLIN EXP ALLERGY, V27, P1270, DOI 10.1111/j.1365-2222.1997.tb01171.x	9	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1724	1726		10.1016/j.jaci.2017.05.042	http://dx.doi.org/10.1016/j.jaci.2017.05.042			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28647585	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000417206000034
J	Hosoki, K; Redding, D; Itazawa, T; Chakraborty, A; Tapryal, N; Qian, S; Qi, HB; Aguilera-Aguirre, L; Brasier, AR; Phani, VS; Hazra, TK; Boldogh, I; Sur, S				Hosoki, Koa; Redding, David; Itazawa, Toshiko; Chakraborty, Anirban; Tapryal, Nisha; Qian, Sun; Qi, Huibin; Aguilera-Aguirre, Leopoldo; Brasier, Allan R.; Phani, Veeranki Sreenivas; Hazra, Tapas K.; Boldogh, Istvan; Sur, Sanjiv			Innate mechanism of pollen- and cat dander- induced oxidative stress and DNA damage in the airways	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC LUNG INFLAMMATION; CELLS; ACTIVATION; ANTIGEN; SIGNAL; ROS		[Hosoki, Koa; Redding, David; Itazawa, Toshiko; Qian, Sun; Qi, Huibin; Brasier, Allan R.; Sur, Sanjiv] Univ Texas Med Branch, Dept Internal Med, Div Allergy & Immunol, Galveston, TX 77555 USA; [Chakraborty, Anirban; Tapryal, Nisha; Hazra, Tapas K.] Univ Texas Med Branch, Dept Internal Med, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Brasier, Allan R.; Boldogh, Istvan; Sur, Sanjiv] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Phani, Veeranki Sreenivas] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sur, S (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Allergy & Immunol, Galveston, TX 77555 USA.; Sur, S (corresponding author), Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA.	sasur@UTMB.EDU	CHAKRABORTY, ANIRBAN/ABC-6552-2020; Aguilera-Aguirre, Leopoldo/B-9864-2012	Hosoki, Koa/0000-0003-4228-2176; Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402; Brasier, Allan/0000-0002-5012-4090	National Institutes of Allergy and Infectious Diseases [P01 AI062885-06]; National Institute of Environmental Health Sciences (NIEHS) [RO1 ES18948]; National Heart, Lung, and Blood Institute Proteomic Center [N01HV00245]; NIEHS [T32 ES007254]; National Institute of Neurological Disorder and Stroke [R01 NS073976]; University of Texas Medical Branch; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007254] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute Proteomic Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Texas Medical Branch; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Allergy and Infectious Diseases grant P01 AI062885-06; National Institute of Environmental Health Sciences (NIEHS) grant RO1 ES18948; National Heart, Lung, and Blood Institute Proteomic Center grant N01HV00245; NIEHS T32 ES007254; National Institute of Neurological Disorder and Stroke grant R01 NS073976; and a Leon Bromberg Professorship at the University of Texas Medical Branch.	Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Bacsi A, 2005, FREE RADICAL BIO MED, V39, P1650, DOI 10.1016/j.freeradbiomed.2005.08.013; Bacsi A, 2013, DNA REPAIR, V12, P18, DOI 10.1016/j.dnarep.2012.10.002; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Boldogh I, 2003, TOXICOLOGY, V193, P137, DOI 10.1016/j.tox.2003.08.013; Cui W, 2012, MOL CELL BIOL, V32, P3990, DOI 10.1128/MCB.00722-12; Dharajiya N, 2007, J ALLERGY CLIN IMMUN, V119, P646, DOI 10.1016/j.jaci.2006.11.634; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hosoki K, 2016, J ALLERGY CLIN IMMUN, V137, P1506, DOI 10.1016/j.jaci.2015.09.036; Hosoki K, 2016, AM J RESP CELL MOL, V54, P81, DOI 10.1165/rcmb.2015-0044OC; ILIOPOULOS O, 1990, J ALLERGY CLIN IMMUN, V86, P851, DOI 10.1016/S0091-6749(05)80146-0; Lehle S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1349; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Lumry W, 2003, ALLERGY ASTHMA PROC, V24, P203; Shi HX, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002057; Sur S, 1996, J IMMUNOL, V157, P4173; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	20	9	10	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1436	+		10.1016/j.jaci.2017.04.044	http://dx.doi.org/10.1016/j.jaci.2017.04.044			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28583369	Bronze			2022-12-18	WOS:000414304300025
J	Lynch, MD; McFadden, JP; White, JM; Banerjee, P; White, IR				Lynch, Magnus David; McFadden, John Paul; White, Jonathan Michael; Banerjee, Piu; White, Ian Richard			Age-specific profiling of cutaneous allergy at high temporal resolution suggests age-related alterations in regulatory immune function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONTACT ALLERGY; T-CELLS		[Lynch, Magnus David; McFadden, John Paul; White, Jonathan Michael; Banerjee, Piu; White, Ian Richard] Guys Hosp, St Johns Inst Dermatol, Dept Cutaneous Allergy, London, England; [Banerjee, Piu] Lewisham Hosp, Dept Dermatol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lynch, MD (corresponding author), Guys Hosp, St Johns Inst Dermatol, Dept Cutaneous Allergy, London, England.	magnus.lynch@kcl.ac.uk		Lynch, Magnus/0000-0001-7586-4338				Buckley DA, 2003, BRIT J DERMATOL, V149, P986, DOI 10.1111/j.1365-2133.2003.05491.x; Girard JP, 1977, CLIN EXP IMMUNOL, P2785; Green CM, 2007, CONTACT DERMATITIS, V56, P229, DOI 10.1111/j.1600-0536.2006.01084.x; Hwang KA, 2009, MECH AGEING DEV, V130, P509, DOI 10.1016/j.mad.2009.06.003; Lundov MD, 2010, CONTACT DERMATITIS, V63, P164, DOI 10.1111/j.1600-0536.2010.01774.x; McFadden JP, 2013, CONTACT DERMATITIS, V69, P129, DOI 10.1111/cod.12100; Schnuch A, 1998, BRIT J DERMATOL, V138, P467; Sun LS, 2012, AGING CELL, V11, P509, DOI 10.1111/j.1474-9726.2012.00812.x; Zhao L, 2007, J LEUKOCYTE BIOL, V81, P1386, DOI 10.1189/jlb.0506364	9	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1451	+		10.1016/j.jaci.2017.03.054	http://dx.doi.org/10.1016/j.jaci.2017.03.054			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28606588	Bronze			2022-12-18	WOS:000414304300030
J	Wright, AKA; Weston, C; Rana, BMJ; Brightling, CE; Cousins, DJ				Wright, Adam K. A.; Weston, Cathryn; Rana, Batika M. J.; Brightling, Christopher E.; Cousins, David J.			Human group 2 innate lymphoid cells do not express the IL-5 receptor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EXACERBATIONS; ASTHMA		[Wright, Adam K. A.; Weston, Cathryn; Brightling, Christopher E.; Cousins, David J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Rana, Batika M. J.; Cousins, David J.] Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, London, England; [Rana, Batika M. J.] MRC Lab Mol Biol, Cambridge, England; [Brightling, Christopher E.] Univ Hosp Leicester NHS Trust, Inst Lung Hlth, NIHR Leicester Resp Biomed Unit, Leicester, Leics, England	University of Leicester; University of London; King's College London; MRC Laboratory Molecular Biology; University Hospitals of Leicester NHS Trust; University of Leicester	Wright, AKA (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	adam.wright@le.ac.uk		Wright, Adam/0000-0003-1621-1622; Cousins, David/0000-0003-3821-9596; brightling, chris/0000-0002-9345-4903	Airway Disease Predicting Outcomes through Patient Specific Computational Modelling (AirPROM) project; European Union; Wellcome Senior Fellowship; Medical Research Council (MRC); Asthma UK from National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust [G1000758]; King's College London from Midlands Asthma and Allergy Research Association; NIHR Leicester Respiratory Biomedical Unit; MRC; Asthma UK; NIHR	Airway Disease Predicting Outcomes through Patient Specific Computational Modelling (AirPROM) project; European Union(European Commission); Wellcome Senior Fellowship; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK from National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London from Midlands Asthma and Allergy Research Association; NIHR Leicester Respiratory Biomedical Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK; NIHR(National Institute for Health Research (NIHR))	This work was part funded by (for C.E.B.) Airway Disease Predicting Outcomes through Patient Specific Computational Modelling (AirPROM) project (funded through FP7 European Union grant), Wellcome Senior Fellowship (for D.J.C.), Medical Research Council (MRC), and Asthma UK (Centre grant no. G1000758), from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, an equipment grant from the Midlands Asthma and Allergy Research Association and (for C.E.B. and D.J.C.) the NIHR Leicester Respiratory Biomedical Unit. B.M.J.R. was funded by an MRC and Asthma UK PhD studentship. This article presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health.	Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Kolbeck R, 2010, J ALLERGY CLIN IMMUN, V125, P1344, DOI 10.1016/j.jaci.2010.04.004; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; Martinez-Gonzalez I, 2015, TRENDS IMMUNOL, V36, P189, DOI 10.1016/j.it.2015.01.005; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; Russell R, 2016, EXPERT REV RESP MED, V10, P607, DOI 10.1080/17476348.2016.1176532; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; TAVERNIER J, 1992, P NATL ACAD SCI USA, V89, P7041, DOI 10.1073/pnas.89.15.7041; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Varricchi G, 2016, CURR OPIN ALLERGY CL, V16, P186, DOI 10.1097/ACI.0000000000000251; Wright A, 2016, J IMMUNOL, V196, P4877, DOI 10.4049/jimmunol.1501585	13	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1430	+		10.1016/j.jaci.2017.04.025	http://dx.doi.org/10.1016/j.jaci.2017.04.025			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28502824	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000414304300023
J	Watkin, LB; Mishra, R; Gil, A; Aslan, N; Ghersi, D; Luzuriaga, K; Selin, LK				Watkin, Levi B.; Mishra, Rabinarayan; Gil, Anna; Aslan, Nuray; Ghersi, Dario; Luzuriaga, Katherine; Selin, Liisa K.			Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFECTIOUS-MONONUCLEOSIS; HETEROLOGOUS IMMUNITY; EPSTEIN-BARR; VIRUS		[Watkin, Levi B.; Mishra, Rabinarayan; Gil, Anna; Aslan, Nuray; Selin, Liisa K.] Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA 01605 USA; [Watkin, Levi B.; Luzuriaga, Katherine; Selin, Liisa K.] Univ Massachusetts, Med Sch, Immunol & Microbiol Program, Worcester, MA 01605 USA; [Ghersi, Dario] Univ Nebraska, Sch Interdisciplinary Informat, Omaha, NE 68182 USA; [Luzuriaga, Katherine] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Nebraska System; University of Massachusetts System; University of Massachusetts Worcester	Selin, LK (corresponding author), Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA 01605 USA.; Selin, LK (corresponding author), Univ Massachusetts, Med Sch, Immunol & Microbiol Program, Worcester, MA 01605 USA.	liisa.selin@umassmed.edu		Watkin, Levi/0000-0003-0404-4548; Selin, Liisa/0000-0002-6993-4333	National Institutes of Health [AI-49320, AI-046629, AI-109858]; Center for Diabetes Research Core [DR32520]; National Institute of Allergy and Infectious Diseases [T32-AI-007349-17]; UMass Center for Clinical and Translational Science [UL1-TR001453]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109858, P01AI046629, P01AI049320, T32AI007349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Diabetes Research Core; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UMass Center for Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Lambrecht, R. Brody, and M. McManus for assistance and Drs R. Welsh, L. Stern, S. Waggoner, E. Szomolanyi-Tsuda, M. Cornberg, and A. Prince for manuscript review. The study was supported by the National Institutes of Health (grant nos. AI-49320 to L.K.S. and K.L., AI-046629 to L.K.S., and AI-109858 to L.K.S.), the Center for Diabetes Research Core (grant no. DR32520), the National Institute of Allergy and Infectious Diseases (grant no. T32-AI-007349-17 to L.B.W.), and the UMass Center for Clinical and Translational Science (grant no. UL1-TR001453). Contents of this publication are solely the responsibility of authors and do not represent the official view of the National Institutes of Health.	Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Clute SC, 2010, J IMMUNOL, V185, P6753, DOI 10.4049/jimmunol.1000812; Cornberg M, 2016, CURR OPIN VIROL, V16, P41, DOI 10.1016/j.coviro.2016.01.005; Cornberg M, 2010, J IMMUNOL, V184, P2825, DOI 10.4049/jimmunol.0902168; Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116; Song I, 2017, NAT STRUCT MOL BIOL, V160, P2842; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x	9	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1206	+		10.1016/j.jaci.2017.05.037	http://dx.doi.org/10.1016/j.jaci.2017.05.037			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28629751	Green Accepted, Bronze			2022-12-18	WOS:000412172900047
J	Goleva, E; Harris, JK; Robertson, CE; Jackson, LP; Martin, RJ; Leung, DYM				Goleva, Elena; Harris, J. Kirk; Robertson, Charles E.; Jackson, Leisa P.; Martin, Richard J.; Leung, Donald Y. M.			Airway microbiome and responses to corticosteroids in corticosteroid-resistant asthma patients treated with acid suppression medications	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMMUNITY-ACQUIRED PNEUMONIA; PROTON PUMP INHIBITORS; RISK		[Goleva, Elena; Jackson, Leisa P.; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Martin, Richard J.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Harris, J. Kirk; Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Robertson, Charles E.; Martin, Richard J.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Robertson, Charles E.; Martin, Richard J.] Hlth Sci Ctr, Aurora, CO USA	National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Goleva, E (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	golevae@njhealth.org		Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121	National Institutes of Health [AI070140, HL036577]; National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Institute (CTSI) grant [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Institute (CTSI) grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by National Institutes of Health grants (#AI070140, #HL036577) and a National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Institute (CTSI) grant (#UL1 TR001082).	Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Harris JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128346; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Houghton LA, 2016, NAT REV GASTRO HEPAT, V13, P445, DOI 10.1038/nrgastro.2016.91; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; MERCER RR, 1994, AM J RESP CELL MOL, V10, P613, DOI 10.1165/ajrcmb.10.6.8003339; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Shahinas D, 2013, PLOS ONE, V8; Vesper BJ, 2009, CURR DRUG METAB, V10, P84, DOI 10.2174/138920009787048392	11	9	10	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					860	+		10.1016/j.jaci.2017.03.011	http://dx.doi.org/10.1016/j.jaci.2017.03.011			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28477847	Bronze			2022-12-18	WOS:000409241500026
J	Singh, MV; Cicha, MZ; Kumar, S; Meyerholz, DK; Irani, K; Chapleau, MW; Abboud, FM				Singh, Madhu V.; Cicha, Michael Z.; Kumar, Santosh; Meyerholz, David K.; Irani, Kaikobad; Chapleau, Mark W.; Abboud, Francois M.			Abnormal CD161(+) immune cells and retinoic acid receptor-related orphan receptor gamma t-mediate enhanced IL-17F expression in the setting of genetic hypertension	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hypertension; innate immune system; Toll-like receptor; retinoic acid receptor-related orphan receptor gamma t; digoxin; T cells; T(H)17; CD161; IL-17; spontaneously hypertensive rat; gene expression	NICOTINIC ACETYLCHOLINE-RECEPTORS; INTERLEUKIN 17; ENDOTHELIAL DYSFUNCTION; ORGAN DAMAGE; TH17 CELLS; DIFFERENTIATION; ACTIVATION; INFLAMMATION; LYMPHOCYTES; RESPONSES	Background: Hypertension is considered an immunologic disorder. However, the role of the IL-17 family in genetic hypertension in the spontaneously hypertensive rat (SHR) has not been investigated. Objective: We tested the hypothesis that enhanced T(H)17 programming and IL-17 expression in abundant CD161(+) immune cells in SHRs represent an abnormal proinflammatory adaptive immune response. Furthermore, we propose that this response is driven by the master regulator retinoic acid receptor-related orphan receptor gamma t (ROR gamma t) and a nicotinic proinflammatory innate immune response. Methods: We measured expression of the CD161 surface marker on splenocytes in SHRs and normotensive control Wistar-Kyoto (WKY) rats from birth to adulthood. We compared expression of IL-17A and IL-17F in splenic cells under different conditions. We then determined the functional effect of these cytokines on vascular reactivity. Finally, we tested whether pharmacologic inhibition of ROR gamma t can attenuate hypertension in SHRs. Results: SHRs exhibited an abnormally large population of CD161(+) cells at birth that increased with age, reaching more than 30% of the splenocyte population at 38 weeks. The SHR splenocytes constitutively expressed more ROR gamma t than those of WKY rats and produced more IL-17F on induction. Exposure of WKY rat aortas to IL-17F impaired endothelium-dependent vascular relaxation, whereas IL-17A did not. Moreover, in vivo inhibition of ROR gamma t by digoxin decreased systolic blood pressure in SHRs. Conclusions: SHRs have a markedly enhanced potential for ROR gamma t-driven expression of proinflammatory and prohypertensive IL-17F in response to innate immune activation. Increased ROR gamma t and IL-17F levels contribute to SHR hypertension and might be therapeutic targets.	[Singh, Madhu V.; Cicha, Michael Z.; Kumar, Santosh; Irani, Kaikobad; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Singh, Madhu V.; Cicha, Michael Z.; Kumar, Santosh; Irani, Kaikobad; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Abboud Cardiovasc Res Ctr, Carver Coll Med, Iowa City, IA 52242 USA; [Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Cicha, Michael Z.; Chapleau, Mark W.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Singh, MV; Abboud, FM (corresponding author), Univ Iowa, Abboud Cardiovasc Res Ctr, Carver Coll Med, Iowa City, IA 52242 USA.	madhu-singh@uiowa.edu; francois-abboud@uiowa.edu	Kumar, Santosh/N-9922-2014; Meyerholz, David/J-8131-2019; Singh, Madhu V./AAJ-8507-2020	Kumar, Santosh/0000-0003-1418-2020; Meyerholz, David/0000-0003-1552-3253; Singh, Madhu V./0000-0003-3048-4432; Irani, Kaikobad/0000-0001-9194-7387; Abboud, Francois/0000-0002-7284-9148; Chapleau, Mark/0000-0001-6961-931X	National Institutes of Health [HL 14388]; VA Merit Review Award [I01 BX001414]; American Heart Association [16IRG27260323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL014388] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Award(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Supported by a National Institutes of Health Program Project Grant to F.M.A. (HL 14388), a VA Merit Review Award to M.W.C. (I01 BX001414), and an American Heart Association Innovative Research Grant to M.V.S. (16IRG27260323).	Abboud FM, 2012, HYPERTENSION, V59, P755, DOI 10.1161/HYPERTENSIONAHA.111.186833; Adamik J, 2013, CYTOKINE, V64, P404, DOI 10.1016/j.cyto.2013.05.010; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Amador CA, 2014, HYPERTENSION, V63, P797, DOI 10.1161/HYPERTENSIONAHA.113.02883; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Esler M, 2011, EXP PHYSIOL, V96, P1, DOI 10.1113/expphysiol.2011.052332; Filippini P, 2012, CURR DRUG TARGETS, V13, P644, DOI 10.2174/138945012800399008; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gu XG, 2008, EXP HEMATOL, V36, P1417, DOI 10.1016/j.exphem.2008.06.003; Guzik TJ, 2014, HYPERTENSION, V64, P224, DOI 10.1161/HYPERTENSIONAHA.114.03340; Harrison David G, 2008, Curr Cardiol Rep, V10, P464; Harwani SC, 2016, CIRC RES, V119, P1101, DOI 10.1161/CIRCRESAHA.116.309402; Harwani SC, 2012, CIRC RES, V111, P1190, DOI 10.1161/CIRCRESAHA.112.277475; Haudenschild DR, 2006, PROSTATE, V66, P1268, DOI 10.1002/pros.20422; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Iantorno M, 2014, J BIOL REG HOMEOS AG, V28, P169; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Karbach S, 2014, ARTERIOSCL THROM VAS, V34, P2658, DOI 10.1161/ATVBAHA.114.304108; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Li YL, 2014, HYPERTENSION, V64, P305, DOI 10.1161/HYPERTENSIONAHA.113.02604; Liu ZD, 2014, ATHEROSCLEROSIS, V233, P291, DOI 10.1016/j.atherosclerosis.2013.12.004; Liu ZG, 2014, IMMUNOL INVEST, V43, P667, DOI 10.3109/08820139.2014.914532; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mian MOR, 2016, J HYPERTENS, V34, P97, DOI 10.1097/HJH.0000000000000761; Mihovilovic M, 1997, J NEUROIMMUNOL, V79, P176, DOI 10.1016/S0165-5728(97)00120-3; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Nordman JC, 2014, MOL PHARMACOL, V85, P50, DOI 10.1124/mol.113.088484; OFOSUAPPIAH W, 1992, CELL IMMUNOL, V145, P130, DOI 10.1016/0008-8749(92)90318-J; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Pober JS, 2014, J CLIN INVEST, V124, P4234, DOI 10.1172/JCI77766; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Ryan MJ, 2009, AM J PHYSIOL-REG I, V296, pR1258, DOI 10.1152/ajpregu.90864.2008; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Schiffrin EL, 2013, CAN J CARDIOL, V29, P543, DOI 10.1016/j.cjca.2012.06.009; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Singh MV, 2015, HYPERTENSION, V66, P647, DOI 10.1161/HYPERTENSIONAHA.115.06011; Steinmetz OM, 2011, J AM SOC NEPHROL, V22, P472, DOI 10.1681/ASN.2010040435; Tipton AJ, 2014, HYPERTENSION, V64, P557, DOI 10.1161/HYPERTENSIONAHA.114.03512; Toussirot Eric, 2012, Inflammation & Allergy Drug Targets, V11, P159; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Trott DW, 2014, ADV PHYSIOL EDUC, V38, P20, DOI 10.1152/advan.00063.2013; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Yu H, 2011, ARTHRITIS RHEUM-US, V63, P981, DOI 10.1002/art.30219; Zhang JD, 2015, CURR OPIN PHARMACOL, V21, P14, DOI 10.1016/j.coph.2014.12.003; Zhang SB, 1996, INT J IMMUNOPHARMACO, V18, P467, DOI 10.1016/S0192-0561(96)00054-9; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	71	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					809	+		10.1016/j.jaci.2016.11.039	http://dx.doi.org/10.1016/j.jaci.2016.11.039			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28093217	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000409241500019
J	Gibson, A; Faulkner, L; Wood, S; Park, BK; Naisbitt, DJ				Gibson, Andrew; Faulkner, Lee; Wood, Sally; Park, B. Kevin; Naisbitt, Dean J.			Identification of drug-and drug-metabolite immune responses originating from both naive and memory T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NITROSO SULFAMETHOXAZOLE; IN-VITRO; INDIVIDUALS; CARBAMAZEPINE; SULFONAMIDES; CD4(+)		[Gibson, Andrew; Faulkner, Lee; Wood, Sally; Park, B. Kevin; Naisbitt, Dean J.] Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Clin & Mol Pharmacol, Liverpool, Merseyside, England	University of Liverpool	Naisbitt, DJ (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Clin & Mol Pharmacol, Liverpool, Merseyside, England.	dnes@liv.ac.uk		Gibson, Andrew/0000-0001-9653-3298; Naisbitt, Dean/0000-0003-4107-7832	BBSRC; MRC Centre for Drug Safety Science [G0700654]; MIP-DILI project (European Community under the Innovative Medicines Initiative Programme) [115336]; MRC [G0700654, MR/L006758/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1233823] Funding Source: researchfish; Medical Research Council [MR/L006758/1, G0700654] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Centre for Drug Safety Science(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MIP-DILI project (European Community under the Innovative Medicines Initiative Programme); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.G. is a PhD student funded by the BBSRC. The project received core funding from the MRC Centre for Drug Safety Science (grant no. G0700654) and also the MIP-DILI project (supported by the European Community under the Innovative Medicines Initiative Programme through grant agreement no. 115336).	Callan HE, 2009, CHEM RES TOXICOL, V22, P937, DOI 10.1021/tx900034r; Castrejon JL, 2010, J ALLERGY CLIN IMMUN, V125, P411, DOI 10.1016/j.jaci.2009.10.031; Engler OB, 2004, TOXICOLOGY, V197, P47, DOI 10.1016/j.tox.2003.12.008; Faulkner L, 2012, TOXICOL SCI, V127, P150, DOI 10.1093/toxsci/kfs080; Gill HJ, 1997, J PHARMACOL EXP THER, V282, P795; Lucas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117160; MAURIHELLWEG D, 1995, J IMMUNOL, V155, P462; Naisbitt DJ, 2003, MOL PHARMACOL, V63, P732, DOI 10.1124/mol.63.3.732; Nassif A, 2004, J ALLERGY CLIN IMMUN, V114, P1209, DOI 10.1016/j.jaci.2004.07.047; Sanderson JP, 2007, J IMMUNOL, V178, P5533, DOI 10.4049/jimmunol.178.9.5533; Schnyder B, 2000, J IMMUNOL, V164, P6647, DOI 10.4049/jimmunol.164.12.6647	11	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					578	+		10.1016/j.jaci.2016.11.032	http://dx.doi.org/10.1016/j.jaci.2016.11.032			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28087328	Bronze			2022-12-18	WOS:000406855500030
J	Novick, D; Dinarello, CA				Novick, Daniela; Dinarello, Charles A.			IL-18 binding protein reverses the life-threatening hyperinflammation of a baby with the NLRC4 mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							JUVENILE IDIOPATHIC ARTHRITIS; MACROPHAGE ACTIVATION SYNDROME; INTERLEUKIN-18		[Novick, Daniela] Weizmann Inst Sci, Mol Genet, Rehovot, Israel; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO USA	Weizmann Institute of Science; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Novick, D (corresponding author), Weizmann Inst Sci, Mol Genet, Rehovot, Israel.	daniela.novick@weizmann.ac.il	Dinarello, Charles/C-8524-2013		Ares Serono Ltd; National Institutes of Health [AI15614, AI2532359]	Ares Serono Ltd; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	D. Novick's institution received a grant from Ares Serono Ltd for this work. C. Dinarello's institution received National Institutes of Health grants AI15614 and AI2532359 for this work.	Canna SW, 2016, J ALLERGY CLIN IMMUN; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Put K, 2015, RHEUMATOLOGY, V54, P1507, DOI 10.1093/rheumatology/keu524; Shimizu M, 2015, CLIN IMMUNOL, V160, P277, DOI 10.1016/j.clim.2015.06.005; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133	9	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					316	316		10.1016/j.jaci.2017.02.037	http://dx.doi.org/10.1016/j.jaci.2017.02.037			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28457594	Bronze			2022-12-18	WOS:000404542000044
J	Stemeseder, T; Freier, R; Wildner, S; Fuchs, JE; Briza, P; Lang, R; Batanero, E; Lidholm, J; Liedl, KR; Campo, P; Hawranek, T; Villalba, M; Brandstetter, H; Ferreira, F; Gadermaier, G				Stemeseder, Teresa; Freier, Regina; Wildner, Sabrina; Fuchs, Julian E.; Briza, Peter; Lang, Roland; Batanero, Eva; Lidholm, Jonas; Liedl, Klaus R.; Campo, Paloma; Hawranek, Thomas; Villalba, Mayte; Brandstetter, Hans; Ferreira, Fatima; Gadermaier, Gabriele			Crystal structure of Pla l 1 reveals both structural similarity and allergenic divergence within the Ole e 1-like protein family	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PLANTAGO-LANCEOLATA; MAIN ALLERGEN; POLLEN; OLE-E-1; IGE		[Stemeseder, Teresa; Freier, Regina; Briza, Peter; Brandstetter, Hans; Ferreira, Fatima; Gadermaier, Gabriele] Salzburg Univ, Dept Mol Biol, Salzburg, Austria; [Wildner, Sabrina; Brandstetter, Hans; Gadermaier, Gabriele] Salzburg Univ, Christian Doppler Lab Biosimilar Characterizat, Salzburg, Austria; [Fuchs, Julian E.; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, Ctr Mol Biosci Innsbruck, Innsbruck, Austria; [Lang, Roland; Hawranek, Thomas] Paracelsus Med Univ Salzburg, Dept Dermatol, Salzburg, Austria; [Batanero, Eva; Villalba, Mayte] Univ Complutense, Dept Bioquim & Biol Mol 1, Madrid, Spain; [Lidholm, Jonas] Thermo Fisher Sci, Uppsala, Sweden; [Campo, Paloma] Reg Univ Hosp Malaga, Allergy Unit, Inst Invest Biomed Malaga, Malaga, Spain	Salzburg University; Salzburg University; University of Innsbruck; Paracelsus Private Medical University; Complutense University of Madrid; Thermo Fisher Scientific	Gadermaier, G (corresponding author), Salzburg Univ, Dept Mol Biol, Salzburg, Austria.; Gadermaier, G (corresponding author), Salzburg Univ, Christian Doppler Lab Biosimilar Characterizat, Salzburg, Austria.	Gabriele.Gadermaier@sbg.ac.at	Liedl, Klaus/ABB-4725-2021; Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Wildner, Sabrina/M-1753-2016; Brandstetter, Hans/E-6754-2011; Gadermaier, Gabriele/L-5997-2015; Briza, Peter/D-7309-2012; Villalba, María Teresa/AAW-1067-2020; Liedl, Klaus R/F-3099-2015	Liedl, Klaus/0000-0002-0985-2299; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Wildner, Sabrina/0000-0003-2348-7598; Brandstetter, Hans/0000-0002-6089-3045; Gadermaier, Gabriele/0000-0002-4886-417X; Briza, Peter/0000-0002-4941-6782; Villalba, María Teresa/0000-0002-0042-9953; Liedl, Klaus R/0000-0002-0985-2299; Freier, Regina/0000-0002-8202-5599; Lidholm, Jonas/0000-0002-7779-3411	Austrian Science Funds [W_01213]; Austrian Federal Ministry of Science, Research and Economy; National Foundation of Research, Technology and Development, Land Salzburg; Institute of Health "Carlos III'' of the Ministry of Economy and Competitiveness (European Regional Development Fund) [PI12/00900]; Institute of Health "Carlos III'' of the Ministry of Economy and Competitiveness (Red de Reacciones Adversas a Alergenos y Farmacos) [RD12/0013/0001];  [SAF2011-26716]	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science, Research and Economy; National Foundation of Research, Technology and Development, Land Salzburg; Institute of Health "Carlos III'' of the Ministry of Economy and Competitiveness (European Regional Development Fund); Institute of Health "Carlos III'' of the Ministry of Economy and Competitiveness (Red de Reacciones Adversas a Alergenos y Farmacos); 	Supported by the Austrian Science Funds (project W_01213), the Austrian Federal Ministry of Science, Research and Economy and the National Foundation of Research, Technology and Development, Land Salzburg, the Institute of Health "Carlos III'' of the Ministry of Economy and Competitiveness (grants cofounded by European Regional Development Fund: PI12/00900, Red de Reacciones Adversas a Alergenos y Farmacos RD12/0013/0001), and SAF2011-26716.	Barderas R, 2005, J ALLERGY CLIN IMMUN, V115, P351, DOI 10.1016/j.jaci.2004.10.001; Calabozo B, 2001, CLIN EXP ALLERGY, V31, P322, DOI 10.1046/j.1365-2222.2001.00985.x; Castro AJ, 2007, J INVEST ALLERG CLIN, V17, P41; Castro L, 2014, INT ARCH ALLERGY IMM, V163, P142, DOI 10.1159/000356345; Gadermaier G, 2014, J ALLERGY CLIN IMMUN, V134, P472, DOI 10.1016/j.jaci.2014.02.016; Gonzalez EM, 2006, MOL IMMUNOL, V43, P570, DOI 10.1016/j.molimm.2005.04.015; Imhof K, 2014, ALLERGO J, V23, P18, DOI 10.1007/s15007-014-0553-5; Marazuela EG, 2012, MOL IMMUNOL, V50, P83, DOI 10.1016/j.molimm.2011.12.006; Villalba M, 2014, METHODS, V66, P44, DOI 10.1016/j.ymeth.2013.07.038	9	9	10	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					277	280		10.1016/j.jaci.2016.10.035	http://dx.doi.org/10.1016/j.jaci.2016.10.035			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	27965108	Bronze, Green Accepted			2022-12-18	WOS:000404542000031
J	Chen, J; Zhang, JH; Tachie-Menson, T; Shukla, N; Garrod, DR; Robinson, C				Chen, Jie; Zhang, Jihui; Tachie-Menson, Theresa; Shukla, Neha; Garrod, David R.; Robinson, Clive			Allergen-dependent oxidant formation requires purinoceptor activation of ADAM 10 and prothrombin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AIRWAY INFLAMMATION; OXIDATIVE STRESS; CELL-LINES; ASTHMA; THROMBIN; DER-P-1; ANTIOXIDANTS; DISINTEGRIN; RECEPTORS; MICE		[Chen, Jie; Zhang, Jihui; Tachie-Menson, Theresa; Shukla, Neha; Robinson, Clive] St Georges Univ London, Inst Infect & Immun, London, England; [Garrod, David R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Zhang, Jihui] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	St Georges University London; University of Manchester; Chinese Academy of Sciences; Institute of Microbiology, CAS	Robinson, C (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	c.robinson@sgul.ac.uk		Robinson, Clive/0000-0001-6253-7864; Tachie-Menson, Theresa/0000-0003-0872-4030	Wellcome Trust [087650]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (Award 087650 to C.R.).	Ando S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-31; Basoglu OK, 2005, CHEST, V128, P1905, DOI 10.1378/chest.128.4.1905; Brims FJH, 2009, THORAX, V64, P1037, DOI 10.1136/thx.2009.114439; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI 10.1089/ARS.2008.2425; Cooley LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124331; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; Di Valentin E, 2009, AM J PHYSIOL-LUNG C, V296, pL185, DOI 10.1152/ajplung.90367.2008; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Gieseler F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-86; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Huang CS, 2013, IEEE INT CONF FUZZY, DOI [10.1109/CCMB.2013.6609157, 10.1109/PLASMA.2013.6634859, 10.1109/FUZZ-IEEE.2013.6622495]; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; King MR, 2006, J IMMUNOL, V176, P2765, DOI 10.4049/jimmunol.176.5.2765; Kirkham P, 2006, PHARMACOL THERAPEUT, V111, P476, DOI 10.1016/j.pharmthera.2005.10.015; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Mathews JA, 2011, ALLERGY, V66, P1193, DOI 10.1111/j.1398-9995.2011.02614.x; Miyake Y, 2013, J THROMB HAEMOST, V11, P1903, DOI 10.1111/jth.12392; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Newton GK, 2014, J MED CHEM, V57, P9447, DOI 10.1021/jm501102h; Patel BD, 2006, THORAX, V61, P388, DOI 10.1136/thx.2004.024935; Post S, 2015, ALLERGY, V70, P1545, DOI 10.1111/all.12730; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Robinson C, 2013, FUTURE MED CHEM, V5, P147, DOI [10.4155/FMC.12.204, 10.4155/fmc.12.204]; Sackesen C, 2008, J ALLERGY CLIN IMMUN, V122, P78, DOI 10.1016/j.jaci.2008.03.035; Schulman ES, 1999, AM J RESP CELL MOL, V20, P530, DOI 10.1165/ajrcmb.20.3.3387; Terada M, 2004, AM J RESP CRIT CARE, V169, P373, DOI 10.1164/rccm.200308-1156OC; Vandenbroucke RE, 2013, EMBO MOL MED, V5, P1000, DOI 10.1002/emmm.201202100; Wan H, 2000, EUR RESPIR J, V15, P1058, DOI 10.1034/j.1399-3003.2000.01514.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Winton HL, 1998, CLIN EXP ALLERGY, V28, P1273, DOI 10.1046/j.1365-2222.1998.00354.x; Zhang J, 2007, ALLERGY, V62, P1302, DOI 10.1111/j.1398-9995.2007.01492.x; Zhang JH, 2016, J ALLERGY CLIN IMMUN, V138, P1224, DOI 10.1016/j.jaci.2016.05.006; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	39	9	9	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					2023	+		10.1016/j.jaci.2016.12.954	http://dx.doi.org/10.1016/j.jaci.2016.12.954			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	28111309	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000402724600045
J	Leung, DYM; Jepson, B; Beck, LA; Hanifin, JM; Schneider, LC; Paller, AS; Monti, K; David, G; Canniff, J; Lorenzo, MG; Weinberg, A				Leung, Donald Y. M.; Jepson, Brett; Beck, Lisa A.; Hanifin, Jon M.; Schneider, Lynda C.; Paller, Amy S.; Monti, Katherine; David, Gloria; Canniff, Jennifer; Lorenzo, Margarita Gomez; Weinberg, Adriana			A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; Staphylococcus aureus; eczema; influenza; vaccination; skin; antibody	STAPHYLOCOCCUS-AUREUS; DISEASE; ADULTS; IMMUNOGENICITY; SEVERITY; CHILDREN; SAFETY	Background: Antibody responses to the inactivated seasonal influenza vaccine in patients with atopic dermatitis (AD) have not been carefully characterized. Objective: The primary objective of this study was to compare antibody responses to intradermal vaccination in participants with moderate/severe AD with those in nonatopic participants. Secondary objectives were to evaluate the effect of route of administration, Staphylococcus aureus skin colonization, and disease severity on vaccine response. Methods: This was an open-label study conducted in the 2012-2013 influenza season at 5 US clinical sites. A total of 360 participants with moderate/severe AD or nonatopic subjects were assessed for eligibility, 347 of whom received intradermal or intramuscular vaccination per label and were followed for 28 days after vaccination. The primary outcome was the difference in the proportion of participants achieving seroprotection (hemagglutination-inhibition antibody titer >= 1:40 on day 28 after vaccination). Results: Seroprotection rates for influenza B, H1N1, and H3N2 were not different (1) between participants with AD and nonatopic participants receiving intradermal vaccination and (2) between AD participants receiving intradermal and intramuscular vaccination. After intradermal, but not intramuscular, vaccination, participants with AD with S aureus colonization experienced (1) lower seroprotection and seroconversion rates and lower hemagglutination-inhibition antibody titer geometric mean fold increase against influenza B and (2) lower seroconversion rates against influenza H1N1 than noncolonized participants with AD. Conclusion: Participants with AD colonized with S aureus exhibited a reduced immune response to influenza vaccination compared with noncolonized participants after intradermal but not intramuscular vaccination. Because most patients with AD are colonized with S aureus, intramuscular influenza vaccination should be given preference in these patients.	[Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Jepson, Brett; Monti, Katherine; David, Gloria] Rho, Chapel Hill, NC USA; [Beck, Lisa A.] Univ Rochester, Med Ctr, Dept Dermatol, Rochester, NY 14627 USA; [Hanifin, Jon M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Schneider, Lynda C.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Paller, Amy S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA; [Canniff, Jennifer; Weinberg, Adriana] Univ Colorado Denver, Aurora, CO USA; [Lorenzo, Margarita Gomez] NIAID, Rockville, MD USA	National Jewish Health; Rho; University of Rochester; Oregon Health & Science University; Harvard University; Boston Children's Hospital; Northwestern University; Feinberg School of Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Leung, DYM (corresponding author), Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA.	leungd@njhealth.org	Schneider, Lynda C/AAY-6545-2021	Schneider, Lynda C/0000-0002-5633-0178; Paller, Amy/0000-0001-6187-6549	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) Atopic Dermatitis Research Network [HHSN272201000020C, HHSN272201000017C, U19 AI117673-01, UM2AI117870]; Colorado Clinical and Translational Science Award/Colorado Clinical & Translational Sciences Institute grant from National Center for Research Resources/NIH [UL1 RR025780]; NIH/National Center for Advancing Translational Sciences [UL1 TR000154]; Edelstein Family Foundation; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH) [UL1 TR001102]; Harvard University and its affiliated academic healthcare centers; MedImmune/Astra Zeneca; Sanofi Pasteur; Glaxo SmithKline; Merck; Roche Molecular; Becton Dickinson; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117673, UM2AI117870] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) Atopic Dermatitis Research Network; Colorado Clinical and Translational Science Award/Colorado Clinical & Translational Sciences Institute grant from National Center for Research Resources/NIH; NIH/National Center for Advancing Translational Sciences; Edelstein Family Foundation; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH); Harvard University and its affiliated academic healthcare centers; MedImmune/Astra Zeneca(AstraZeneca); Sanofi Pasteur; Glaxo SmithKline(GlaxoSmithKline); Merck(Merck & Company); Roche Molecular; Becton Dickinson; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All sources of financial and material support and assistance were funded by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) Atopic Dermatitis Research Network contracts HHSN272201000020C and HHSN272201000017C and grants U19 AI117673-01 and UM2AI117870. This included design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Clinical Trial Research Centers are supported in part by the Colorado Clinical and Translational Science Award/Colorado Clinical & Translational Sciences Institute grant UL1 RR025780 from National Center for Research Resources/NIH and from NIH/National Center for Advancing Translational Sciences (grant UL1 TR000154). Additionally, the authors wish to acknowledge The Edelstein Family Foundation for their generous support of our work. This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the NIH. M.G.L. is an NIAID/NIH employee. A.W. has research support from MedImmune/Astra Zeneca, Sanofi Pasteur, Glaxo SmithKline, Merck, Roche Molecular, and Becton Dickinson, and A.W.'s spouse has intellectual property on Zostavax (Merck).	Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Breuer K, 2002, BRIT J DERMATOL, V147, P55, DOI 10.1046/j.1365-2133.2002.04872.x; ClinicalTrials.gov, ADRN INFL VACC PIL; Gevaert P, 2005, ALLERGY, V60, P71, DOI 10.1111/j.1398-9995.2004.00621.x; Hamilton R, 2015, ILA20A3 CLSI; Hamilton RG, 2010, ARCH PATHOL LAB MED, V134, P975, DOI 10.1043/2009-0518-OA.1; Hampel FR., 2011, WILEY SERIES PROBABI; Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426; HOEGER PH, 1992, ACTA PAEDIATR, V81, P542, DOI 10.1111/j.1651-2227.1992.tb12291.x; Huang JT, 2009, PEDIATRICS, V123, pE808, DOI 10.1542/peds.2008-2217; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kieninger D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-343; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Levin MJ, 2008, VACCINE, V26, P4210, DOI 10.1016/j.vaccine.2008.05.054; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271; RAJKA G, 1989, ACTA DERM-VENEREOL, P13; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; Shankar G, 1996, CELL IMMUNOL, V171, P240; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Slifka MK, 2014, J ALLERGY CLIN IMMUN, V133, P439, DOI 10.1016/j.jaci.2013.10.037; Su S, 2014, CLIN INFECT DIS, V59, P252, DOI 10.1093/cid/ciu269; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; U.S. Food and Drug Administration, SAN PAST 271 371 FLU; U.S. Food and Drug Administration, INFL VIR VACC 2011 2; U.S. Food and Drug Administration, INFL VIR VACC 2012 2; Vinnemeier CD, 2014, HUM VACC IMMUNOTHER, V10, P441, DOI 10.4161/hv.27140; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668	31	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1575	+		10.1016/j.jaci.2016.12.952	http://dx.doi.org/10.1016/j.jaci.2016.12.952			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28209343	Green Accepted, Bronze			2022-12-18	WOS:000400465300018
J	Uotila, R; Kukkonen, AK; Greco, D; Pelkonen, AS; Makela, MJ				Uotila, Riikka; Kukkonen, Anna Kaarina; Greco, Dario; Pelkonen, Anna Susanna; Makela, Mika Juhani			Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIBODIES		[Uotila, Riikka; Kukkonen, Anna Kaarina; Pelkonen, Anna Susanna; Makela, Mika Juhani] Univ Helsinki, Skin & Allergy Hosp, Helsinki, Finland; [Uotila, Riikka; Kukkonen, Anna Kaarina; Pelkonen, Anna Susanna; Makela, Mika Juhani] Helsinki Univ Hosp, Helsinki, Finland; [Greco, Dario] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Uotila, R (corresponding author), Univ Helsinki, Skin & Allergy Hosp, Helsinki, Finland.; Uotila, R (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	riikka.uotila@hus.fi	Pelkonen, Anna/D-3153-2018; Greco, Dario/T-7113-2019	Pelkonen, Anna/0000-0002-1482-8947; Greco, Dario/0000-0001-9195-9003; Kukkonen, Anna Kaarina/0000-0003-3379-1139; Makela, Mika/0000-0002-2933-3111	Foundation for Pediatric Research [140061]; Helsinki University Research Funds [TYH2012227, TYH2013228, TYH2014233]; Foundation for Allergy Research; Paivikki and Sakari Sohlberg Foundation; Finnish Society of Allergology and Immunology; Allergy and Asthma Federation; Yrjo Jahnsson Foundation [6793]; Academy of Finland [275151, 292307]	Foundation for Pediatric Research; Helsinki University Research Funds; Foundation for Allergy Research; Paivikki and Sakari Sohlberg Foundation; Finnish Society of Allergology and Immunology; Allergy and Asthma Federation; Yrjo Jahnsson Foundation; Academy of Finland(Academy of Finland)	Supported by the Foundation for Pediatric Research (140061), the Helsinki University Research Funds (TYH2012227, TYH2013228, TYH2014233), the Foundation for Allergy Research (granted 2015), the Paivikki and Sakari Sohlberg Foundation (granted 2014), the Finnish Society of Allergology and Immunology (granted 2015), the Allergy and Asthma Federation (granted 2014), the Yrjo Jahnsson Foundation (6793), and the Academy of Finland (grants 275151 and 292307). Thermo Fisher Scientific provided laboratory kits for the IgG<INF>4</INF> analyses. The sponsors had no involvement in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Glaumann S, 2015, PEDIAT ALLERG IMM-UK, V26, P386, DOI 10.1111/pai.12370; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Kukkonen AK, 2015, ALLERGY, V70, P1239, DOI 10.1111/all.12671; Nowak-Wegrzyn A, 2015, CLIN EXP ALLERGY, V45, P368, DOI 10.1111/cea.12382; Nozawa A, 2014, PEDIAT ALLERG IMM-UK, V25, P323, DOI 10.1111/pai.12243; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P1249, DOI 10.1016/j.jaci.2015.01.012; Schmid JM, 2016, J ALLERGY CLIN IMMUN, V137, P562, DOI 10.1016/j.jaci.2015.05.023; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Wollmann E, 2015, J ALLERGY CLIN IMMUN, V23	9	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2017	139	4					1393	+		10.1016/j.jaci.2016.09.054	http://dx.doi.org/10.1016/j.jaci.2016.09.054			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ER4LR	27916627	Bronze, Green Published			2022-12-18	WOS:000398771800040
J	Levin, M; Goga, A; Doherty, T; Coovadia, H; Sanders, D; Green, RJ; Kling, S				Levin, Michael; Goga, Ameena; Doherty, Tanya; Coovadia, Hoosen; Sanders, David; Green, Robin J.; Kling, Sharon			Allergy and infant feeding guidelines in the context of resource-constrained settings	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food allergy; infant feeding; breast-feeding; early solid introduction; weaning	COHORT		[Levin, Michael] Univ Cape Town, Div Paediat Allergol, Rondebosch, South Africa; [Goga, Ameena] Univ Pretoria, South African Med Res Council, Pretoria, South Africa; [Goga, Ameena] Univ Pretoria, Dept Paediat, Pretoria, South Africa; [Doherty, Tanya] Univ Western Cape, South African Med Res Council, Sch Publ Hlth, Hlth Syst Res Unit, Bellville, South Africa; [Doherty, Tanya] Univ Witwatersrand, Sch Hlth Syst & Publ Hlth, Johannesburg, South Africa; [Coovadia, Hoosen] Univ Witwatersrand, Sch Hlth Syst & Publ Hlth, Match Hlth Syst, Johannesburg, South Africa; [Coovadia, Hoosen] Univ Kwazulu Natal, Paediat & Child Hlth, Durban, South Africa; [Sanders, David] UWC, Sch Publ Hlth, Cape Town, South Africa; [Sanders, David] Univ Cape Town, Dept Paediat & Child Hlth, ZA-7700 Rondebosch, South Africa; [Green, Robin J.] Univ Pretoria, Dept Paediat & Child Hlth, ZA-0002 Pretoria, South Africa; [Kling, Sharon] Univ Stellenbosch, Dept Paediat & Child Hlth, Stellenbosch, South Africa	University of Cape Town; South African Medical Research Council; University of Pretoria; University of Pretoria; South African Medical Research Council; University of the Western Cape; University of Witwatersrand; University of Witwatersrand; University of Kwazulu Natal; University of the Western Cape; University of Cape Town; University of Pretoria; Stellenbosch University	Levin, M (corresponding author), Red Cross Hosp, 516 ICH Bldg,Klifontein Rd, ZA-7700 Cape Town, South Africa.	Michael.levin@uct.ac.za	Levin, Michael/AAT-2370-2020	Levin, Michael/0000-0003-2439-7981; Kling, Sharon/0000-0002-4498-1811				Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Joneja JM, 2012, JPEN-PARENTER ENTER, V36, p49S, DOI 10.1177/0148607111420155; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1	10	9	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					455	458		10.1016/j.jaci.2016.09.039	http://dx.doi.org/10.1016/j.jaci.2016.09.039			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27856332	Green Published, hybrid			2022-12-18	WOS:000397002400010
J	Tahiat, A; Badran, YR; Chou, J; Cangemi, B; Lefranc, G; Labgaa, ZM; Oussalam, S; Kaddouri-Slimani, A; Belarbi, A; Bendissari-Bouzid, K; Gharnaout, M; Geha, RS; Djidjik, R; Massaad, MJ				Tahiat, Azzedine; Badran, Yousef R.; Chou, Janet; Cangemi, Brittney; Lefranc, Gerard; Labgaa, Zakaria-Merouane; Oussalam, Salma; Kaddouri-Slimani, Assia; Belarbi, Ayad; Bendissari-Bouzid, Kheira; Gharnaout, Merzak; Geha, Raif S.; Djidjik, Reda; Massaad, Michel J.			Epidermodysplasia verruciformis as a manifestation of ARTEMIS deficiency in a young adult	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMBINED IMMUNE-DEFICIENCY; HEALTHY-CHILDREN; REFERENCE VALUES; MUTATIONS; HPV; IMMUNODEFICIENCY; SUSCEPTIBILITY; RECOMBINATION; SUBSETS		[Tahiat, Azzedine; Labgaa, Zakaria-Merouane; Djidjik, Reda] Univ Algiers 1, Beni Messous Univ Hosp, Dept Immunol, Algiers Fac Med, Algiers, Algeria; [Badran, Yousef R.; Chou, Janet; Cangemi, Brittney; Geha, Raif S.; Massaad, Michel J.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Badran, Yousef R.; Chou, Janet; Cangemi, Brittney; Geha, Raif S.; Massaad, Michel J.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Lefranc, Gerard] CNRS UPR 1142, Inst Human Genet, Montpellier, France; [Lefranc, Gerard] Univ Montpellier, Montpellier, France; [Oussalam, Salma; Kaddouri-Slimani, Assia; Bendissari-Bouzid, Kheira] Beni Messous Univ Hosp, Dept Pathol, Algiers, Algeria; [Belarbi, Ayad] Douera Hosp, Dept Pathol, Algiers, Algeria; [Gharnaout, Merzak] Rouiba Hosp, Dept Pneumol Phthisiol & Allergy, Algiers, Algeria	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Massaad, MJ (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA USA.; Massaad, MJ (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA USA.	michel.massaad@childrens.harvard.edu		Djidjik, Reda/0000-0003-0820-692X; GHARNAOUT, MERZAK/0000-0002-9463-6071; Tahiat, Azzeddine/0000-0003-3272-8904	Boston Children's Hospital Investigatorship Awards; Jeffrey Modell Foundation Translational Research Program Award; Perkins Foundation; Dubai Harvard Foundation for Medical Research	Boston Children's Hospital Investigatorship Awards; Jeffrey Modell Foundation Translational Research Program Award; Perkins Foundation; Dubai Harvard Foundation for Medical Research	This study was supported by Boston Children's Hospital Investigatorship Awards (M.J.M. and J.C.), a Jeffrey Modell Foundation Translational Research Program Award (J.C.), the Perkins Foundation (R.S.G.), and the Dubai Harvard Foundation for Medical Research (R.S.G.).	Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; Du LK, 2008, J EXP MED, V205, P3031, DOI 10.1084/jem.20081915; Felgentreff K, 2015, J ALLERGY CLIN IMMUN, V136, P140, DOI 10.1016/j.jaci.2015.03.005; JOLLIFF CR, 1982, CLIN CHEM, V28, P126; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Patel T, 2010, DIS MARKERS, V29, P199, DOI [10.1155/2010/345436, 10.3233/DMA-2010-0733]; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Stray-Pedersen A, 2014, J CLIN IMMUNOL, V34, P871, DOI 10.1007/s10875-014-0074-8; Volk T, 2015, HUM MOL GENET, V24, P7361, DOI 10.1093/hmg/ddv437; Woodbine L, 2010, DNA REPAIR, V9, P1003, DOI 10.1016/j.dnarep.2010.07.001	16	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					372	+		10.1016/j.jaci.2016.07.024	http://dx.doi.org/10.1016/j.jaci.2016.07.024			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	27568080	Bronze			2022-12-18	WOS:000393996800044
J	Frush, BW; Li, ZW; Stiles, JV; Cotter, SF; Shofer, SL; Foster, WM; Hollingsworth, JW; Tighe, RM				Frush, Benjamin W.; Li, Zhuowei; Stiles, Jane V.; Cotter, Sarah F.; Shofer, Scott L.; Foster, W. Michael; Hollingsworth, John W.; Tighe, Robert M.			Ozone primes alveolar macrophage-derived innate immunity in healthy human subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RECEPTOR; CELLS; PHENOTYPES; ASTHMA; STAT3; MICE		[Frush, Benjamin W.; Li, Zhuowei; Stiles, Jane V.; Cotter, Sarah F.; Shofer, Scott L.; Foster, W. Michael; Hollingsworth, John W.; Tighe, Robert M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University	Tighe, RM (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	robert.tighe@duke.edu		Tighe, Robert/0000-0002-3465-9861	NHLBI NIH HHS [K08 HL105537] Funding Source: Medline; NIEHS NIH HHS [R01 ES020350, R01 ES016126] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126, R01ES020350] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alexis NE, 2010, INHAL TOXICOL, V22, P593, DOI 10.3109/08958371003596587; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Deenick EK, 2013, J EXP MED, V210, P2739, DOI 10.1084/jem.20130323; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Hollingsworth JW, 2007, J IMMUNOL, V179, P4367, DOI 10.4049/jimmunol.179.7.4367; Hoshino K, 1999, J IMMUNOL, V162, P3749; Lay JC, 2007, J ALLERGY CLIN IMMUN, V120, P719, DOI 10.1016/j.jaci.2007.05.005; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Ma CS, 2015, J ALLERGY CLIN IMMUN, V136, P993, DOI 10.1016/j.jaci.2015.05.036; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Que LG, 2011, J APPL PHYSIOL, V111, P679, DOI 10.1152/japplphysiol.00337.2011; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	13	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1213	1215		10.1016/j.jaci.2016.03.052	http://dx.doi.org/10.1016/j.jaci.2016.03.052			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27325435	Green Accepted, Bronze			2022-12-18	WOS:000385499400034
J	Krause, L; Mourantchanian, V; Brockow, K; Theis, FJ; Schmidt-Weber, CB; Knapp, B; Mueller, NS; Eyerich, S				Krause, Linda; Mourantchanian, Vagkan; Brockow, Knut; Theis, Fabian J.; Schmidt-Weber, Carsten B.; Knapp, Bettina; Mueller, Nikola S.; Eyerich, Stefanie			A computational model to predict severity of atopic eczema from 30 serum proteins	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DERMATITIS		[Krause, Linda; Theis, Fabian J.; Knapp, Bettina; Mueller, Nikola S.] Helmholtz Ctr Munich, Inst Computat Biol, Neuherberg, Germany; [Mourantchanian, Vagkan; Brockow, Knut] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Munich, Germany; [Schmidt-Weber, Carsten B.; Eyerich, Stefanie] Tech Univ, ZAUM Ctr Allergy & Environm, Munich, Germany; [Schmidt-Weber, Carsten B.; Eyerich, Stefanie] Helmholtz Ctr Munich, Munich, Germany; [Schmidt-Weber, Carsten B.; Eyerich, Stefanie] German Ctr Lung Res DZL, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eyerich, S (corresponding author), Tech Univ, ZAUM Ctr Allergy & Environm, Munich, Germany.; Eyerich, S (corresponding author), Helmholtz Ctr Munich, Munich, Germany.; Eyerich, S (corresponding author), German Ctr Lung Res DZL, Munich, Germany.	stefanie.eyerich@tum.de	Schmidt-Weber, Carsten B./AAU-1621-2021; Mueller, Nikola/I-6366-2013; Theis, Fabian J/ABD-5212-2021; Krause, Linda/ACQ-7999-2022	Schmidt-Weber, Carsten B./0000-0002-3203-8084; Mueller, Nikola/0000-0001-8659-4548; Theis, Fabian J/0000-0002-2419-1943; Krause, Linda/0000-0002-8490-5717				Eyerich K, 2008, INT ARCH ALLERGY IMM, V145, P213, DOI 10.1159/000109290; Lin SC, 2011, PEDIAT ALLERG IMM-UK, V22, P869, DOI 10.1111/j.1399-3038.2011.01209.x; R Core Team, R LANG ENV STAT COMP; Thijs J, 2015, CURR OPIN ALLERGY CL, V15, P453, DOI 10.1097/ACI.0000000000000198; Vakirlis E, 2011, J EUR ACAD DERMATOL, V25, P409, DOI 10.1111/j.1468-3083.2010.03800.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	6	9	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1207	1210		10.1016/j.jaci.2016.04.018	http://dx.doi.org/10.1016/j.jaci.2016.04.018			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27315765	Bronze, Green Accepted			2022-12-18	WOS:000385499400032
J	Asare, AL; Carey, VJ; Rotrosen, D; Nepom, GT				Asare, Adam L.; Carey, Vincent J.; Rotrosen, Daniel; Nepom, Gerald T.			Clinical trial data access: Opening doors with TrialShare	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Clinical trials; data sharing; clinical immunology; immune tolerance			[Asare, Adam L.; Nepom, Gerald T.] Immune Tolerance Network, Bethesda, MD USA; [Carey, Vincent J.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Rotrosen, Daniel] NIAID, NIH, Bethesda, MD 20892 USA; [Nepom, Gerald T.] Benaroya Res Inst, Seattle, WA USA	Immune Tolerance Network; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Benaroya Research Institute	Nepom, GT (corresponding author), Benaroya Res Inst, Immune Tolerance Network, 1201 Ninth Ave, Seattle, WA 98101 USA.	nepom@benaroyaresearch.org		Asare, Adam/0000-0002-9299-3518; Nepom, Gerald/0000-0002-8063-1464	National Institutes of Health [UM1AI109565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI109565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	ITN Trialshare is supported by National Institutes of Health award no. UM1AI109565 (Immune Tolerance Network). The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the National Institutes of Health.	[Anonymous], 2015, SHAR CLIN TRIAL DAT; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Shmueli-Blumberg D, 2013, CLIN TRIALS, V10, P977, DOI 10.1177/1740774513503522; Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008	9	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					724	726		10.1016/j.jaci.2016.05.034	http://dx.doi.org/10.1016/j.jaci.2016.05.034			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27474121	hybrid			2022-12-18	WOS:000385496000007
J	Owens, L; Laing, I; Zhang, GC; Le Souef, P				Owens, Louisa; Laing, Ingrid; Zhang, Guicheng; Le Souef, Peter			Early sensitization is associated with reduced lung function from birth into adulthood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							LIFE; ASTHMA; CHILDREN; WHEEZE; COHORT; ATOPY		[Owens, Louisa; Laing, Ingrid; Zhang, Guicheng; Le Souef, Peter] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia	University of Western Australia	Owens, L (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	Louisa.owens@health.wa.gov.au	Laing, Ingrid/I-7092-2013; Zhang, Brad/AAF-8719-2021; Le Souef, Peter N/H-5256-2014	Laing, Ingrid/0000-0002-1641-9899; Owens, Louisa/0000-0001-9023-1467; Le Souef, Peter/0000-0003-0930-1654; Zhang, Guicheng/0000-0001-9888-5385				Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Mullane D, 2013, JAMA PEDIATR, V167, P368, DOI 10.1001/jamapediatrics.2013.633; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; TURNER DJ, 1995, AM J RESP CRIT CARE, V151, P1441, DOI 10.1164/ajrccm.151.5.7735598; Turner S, 2014, THORAX, V69, P1015, DOI 10.1136/thoraxjnl-2013-204931; Young S, 2000, PEDIATR PULM, V29, P331, DOI 10.1002/(SICI)1099-0496(200005)29:5<331::AID-PPUL1>3.0.CO;2-A	9	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1605	1607		10.1016/j.jaci.2015.10.030	http://dx.doi.org/10.1016/j.jaci.2015.10.030			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26686471				2022-12-18	WOS:000376180200042
J	Singh, N; Kumar, B; Aluri, V; Lenert, P				Singh, Namrata; Kumar, Bharat; Aluri, Vijay; Lenert, Petar			Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						B cells; systemic lupus erythematosus; Toll-like receptors; B-cell receptor for antigen; type I interferon; B cell activating factor; Bruton tyrosine kinase; spleen tyrosine kinase; Lyn	PLASMACYTOID DENDRITIC CELLS; BRUTONS TYROSINE KINASE; LYMPHOCYTE STIMULATOR LEVELS; X-LINKED AGAMMAGLOBULINEMIA; LYN-DEFICIENT MICE; AUTOIMMUNE-DISEASE; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; IFN-ALPHA; MONOCLONAL-ANTIBODY	B cells play an important role in systemic lupus erythematosus by acting not only as precursors of autoantibody-producing cells but also as antigen-presenting, cytokine-secreting, and regulatory cells. Unopposed activation of B cells through their B-cell receptor for antigen, as seen in B cells lacking Lyn kinase, results in systemic autoimmunity. The B-cell activating factor of the TNF family (BAFF), nucleic acid-sensing Toll-like receptors (TLRs), and type I interferon can affect B-cell survival and decrease their threshold for activation. Herein we discuss both direct and indirect strategies aimed at targeting B cells in patients with lupus by blocking BAFF, type I interferon, or TLR7 to TLR9. Although BAFF-depleting therapy with belimumab achieved approval for lupus, other BAFF inhibitors were much less beneficial in clinical trials. Inhibitors of the B-cell receptor for antigen signaling and antibodies against type I interferon are in the pipeline. The TLR7 to TLR9 blocker hydroxychloroquine has been in use in patients with lupus for more than 50 years, but oligonucleotide-based inhibitors of TLR7 to TLR9, despite showing promise in animal models of lupus, have not reached the primary end point in a recent phase 1 trial. These data point toward possible redundancies in B-cell signaling/survival pathways, which must be better understood before future clinical trials are executed.	[Singh, Namrata; Kumar, Bharat; Aluri, Vijay; Lenert, Petar] Univ Iowa, Dept Internal Med, Div Immunol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Lenert, P (corresponding author), Carver Coll Med, C428-2GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	petar-lenert@uiowa.edu		Lenert, Petar/0000-0001-9327-0293; Kumar, Bharat/0000-0002-4245-521X; Singh, Namrata/0000-0001-7149-363X				Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-59; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Ashman RF, 2011, INT IMMUNOL, V23, P203, DOI 10.1093/intimm/dxq473; Askanase AD, 2014, RHEUM DIS CLIN N AM, V40, P507, DOI 10.1016/j.rdc.2014.04.007; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bahjat FR, 2008, ARTHRITIS RHEUM-US, V58, P1433, DOI 10.1002/art.23428; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bluml S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3906; Brummel R, 2005, J IMMUNOL, V174, P2429, DOI 10.4049/jimmunol.174.4.2429; Chang NH, 2015, J AUTOIMMUN, V58, P100, DOI 10.1016/j.jaut.2015.01.009; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Dall'Era MC, 2005, ANN RHEUM DIS, V64, P1692, DOI 10.1136/ard.2004.033753; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; Deng Y., 2013, MATH PROBL ENG, V2013, P9, DOI DOI 10.1371/J0URNAL.PGEN.1003336; Desnues B, 2014, P NATL ACAD SCI USA, V111, P1497, DOI 10.1073/pnas.1314121111; Ding HL, 2010, J CELL MOL MED, V14, P1717, DOI 10.1111/j.1582-4934.2009.00817.x; Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Douagi I, 2009, J IMMUNOL, V182, P1991, DOI 10.4049/jimmunol.0802257; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Duxbury B, 2013, LUPUS, V22, P1489, DOI 10.1177/0961203313509295; ESDAILE J, 1991, NEW ENGL J MED, V324, P150; Fleischer SJ, 2014, ARTHRITIS RHEUMATOL, V66, P3424, DOI 10.1002/art.38854; Flierl U, 2015, J EXP MED, V212, P130, DOI 10.1084/jem.20140391; Fliesser EE, 2013, LUPUS, V22, P1523, DOI 10.1177/0961203313504145; Flores-Borja F, 2005, ARTHRITIS RHEUM-US, V52, P3955, DOI 10.1002/art.21416; FUJIBAYASHI T, 1975, J IMMUNOL, V115, P1191; Furie RA, 2015, ANN RHEUM DIS, V74, P1667, DOI 10.1136/annrheumdis-2013-205144; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Ginzler EM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3738; Goeken JA, 2010, LUPUS, V19, P1290, DOI 10.1177/0961203310371157; Gorden KKB, 2006, J IMMUNOL, V177, P8164, DOI 10.4049/jimmunol.177.11.8164; Grammatikos AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074550; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Halcomb KE, 2008, MOL IMMUNOL, V46, P233, DOI 10.1016/j.molimm.2008.08.278; HALPERN MD, 1995, IMMUNOPHARMACOLOGY, V29, P47, DOI 10.1016/0162-3109(95)00043-S; HEREMANS H, 1978, INFECT IMMUN, V21, P925, DOI 10.1128/IAI.21.3.925-930.1978; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Isenberg D, 2015, ANN RHEUM DIS, V74, P2006, DOI 10.1136/annrheumdis-2013-205067; Iwata S, 2015, LUPUS, V24, P695, DOI 10.1177/0961203314560424; Jacob CO, 2006, J IMMUNOL, V177, P2671, DOI 10.4049/jimmunol.177.4.2671; Jacob N, 2011, J IMMUNOL, V186, P4984, DOI 10.4049/jimmunol.1000466; Jacobi AM, 2010, ARTHRITIS RHEUM-US, V62, P201, DOI 10.1002/art.27189; Kahn P, 2008, ARTHRITIS RHEUM, V58, P2824, DOI 10.1002/art.23764; Kalunian KC, 2016, ANN RHEUM DIS, V75, P196, DOI 10.1136/annrheumdis-2014-206090; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kil LP, 2012, BLOOD, V119, P3744, DOI 10.1182/blood-2011-12-397919; KIM T, 1987, CLIN EXP IMMUNOL, V70, P562; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kirou KA, 2013, CLIN IMMUNOL, V148, P303, DOI 10.1016/j.clim.2013.02.013; Klinman DM, 2009, ANN NY ACAD SCI, V1175, P80, DOI 10.1111/j.1749-6632.2009.04970.x; KLINMAN DM, 1990, J IMMUNOL, V144, P506; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Kurosaki T, 2010, IMMUNOL REV, V237, P104, DOI 10.1111/j.1600-065X.2010.00939.x; Lauwerys BR, 2013, ARTHRITIS RHEUM-US, V65, P447, DOI 10.1002/art.37785; Layer T, 2011, CLIN EXP IMMUNOL, V163, P392, DOI 10.1111/j.1365-2249.2010.04307.x; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Lee KG, 2008, J BIOL CHEM, V283, P11189, DOI 10.1074/jbc.M708516200; Lenert P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2710; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Li YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086083, 10.1371/journal.pone.0109665, 10.1371/journal.pone.0094792]; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; McBride JM, 2012, ARTHRITIS RHEUM-US, V64, P3666, DOI 10.1002/art.34632; Merrill JT, 2011, ANN RHEUM DIS, V70, P1905, DOI 10.1136/ard.2010.144485; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mina-Osorio P, 2013, ARTHRITIS RHEUM-US, V65, P2380, DOI 10.1002/art.38047; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nakano S, 2010, RHEUMATOLOGY, V49, P876, DOI 10.1093/rheumatology/keq001; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nemazee D, 2000, Adv Immunol, V74, P89; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Tran NL, 2015, IMMUNOLOGY, V145, P60, DOI 10.1111/imm.12426; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Petri M, 2013, ARTHRITIS RHEUM-US, V65, P1011, DOI 10.1002/art.37824; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Reddy V, 2015, ARTHRITIS RES THE S1, V15, pS2; Rigby W, 2012, ARTHRITIS RHEUM-US, V64, P350, DOI 10.1002/art.33317; Roberts TL, 2011, IMMUNOL CELL BIOL, V89, P517, DOI 10.1038/icb.2010.112; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Salloum R, 2010, ARTHRITIS RHEUM-US, V62, P553, DOI 10.1002/art.27182; Sheriff A, 2004, RHEUM DIS CLIN N AM, V30, P505, DOI 10.1016/j.rdc.2004.04.006; Silver KL, 2007, EUR J IMMUNOL, V37, P2734, DOI 10.1002/eji.200737293; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Stohl W, 2012, ANN RHEUM DIS, V71, P1289, DOI 10.1136/annrheumdis-2011-200706; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Tan E.M., 1989, ADV IMMUNOL, V44, P151, DOI [10.1016/S0065-2776(08)60641-0, DOI 10.1016/S0065-2776(08)60641-0]; Tedder TF, 2009, NAT REV RHEUMATOL, V5, P572, DOI 10.1038/nrrheum.2009.184; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Vallin H, 1999, CLIN EXP IMMUNOL, V115, P196; Vallin H, 1999, J IMMUNOL, V163, P6306; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vincent FB, 2013, CYTOKINE GROWTH F R, V24, P203, DOI 10.1016/j.cytogfr.2013.04.003; Voll RE, 2012, EULAR C BERL GERM JU; Wallace DJ, 2013, LUPUS, V22, P144, DOI 10.1177/0961203312469259; Wallace DJ, 2014, ANN RHEUM DIS, V73, P183, DOI 10.1136/annrheumdis-2012-202760; Wang JM, 2014, EUR J IMMUNOL, V44, P1130, DOI 10.1002/eji.201344030; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Wilson LE, 2002, SEMIN ARTHRITIS RHEU, V32, P163, DOI 10.1053/sarh.2002.37277; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	124	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1325	1333		10.1016/j.jaci.2015.12.1326	http://dx.doi.org/10.1016/j.jaci.2015.12.1326			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26953155	Bronze			2022-12-18	WOS:000376180200004
J	Davis, BP; Epstein, T; Kottyan, L; Amin, P; Martin, LJ; Maddox, A; Collins, MH; Sherrill, JD; Abonia, JP; Rothenberg, ME				Davis, Benjamin P.; Epstein, Tolly; Kottyan, Leah; Amin, Priyal; Martin, Lisa J.; Maddox, Avery; Collins, Margaret H.; Sherrill, Joseph D.; Abonia, J. Pablo; Rothenberg, Marc E.			Association of eosinophilic esophagitis and hypertrophic cardiomyopathy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GASTROESOPHAGEAL-REFLUX DISEASE; INTRAEPITHELIAL EOSINOPHILS; ELIMINATION DIET; EOTAXIN-3; CHILDREN; ADULTS		[Davis, Benjamin P.; Kottyan, Leah; Maddox, Avery; Sherrill, Joseph D.; Abonia, J. Pablo; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Epstein, Tolly; Amin, Priyal] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Epstein, Tolly] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Epstein, Tolly; Amin, Priyal] Univ Cincinnati, Div Allergy & Immunol, Cincinnati, OH USA; [Collins, Margaret H.] Cincinnati Vet Adm Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Rothenberg, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA.	Rothenberg@cchmc.org	Kottyan, Leah C./H-3050-2019; Martin, Lisa/E-2425-2016	Kottyan, Leah C./0000-0003-3979-2220; Martin, Lisa/0000-0001-8702-9946; Abonia, Juan/0000-0003-3788-6485; davis, benjamin/0000-0003-2108-8059	NCATS NIH HHS [UL1 TR001425] Funding Source: Medline; NIAID NIH HHS [U19 AI066738, R37 AI045898, U19 AI070235, T32 AI060515] Funding Source: Medline; NIDDK NIH HHS [R01 DK076893, P30 DK078392] Funding Source: Medline; PHS HHS [R37 A1045898] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI045898, T32AI060515, U19AI066738, U19AI070235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893, P30DK078392] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abonia JP, 2013, J ALLERGY CLIN IMMUN, V132, P378, DOI 10.1016/j.jaci.2013.02.030; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; BROWN LF, 1984, AM J SURG PATHOL, V8, P899, DOI 10.1097/00000478-198412000-00002; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Dranove JE, 2009, J PEDIATR, V154, P96, DOI 10.1016/j.jpeds.2008.07.042; Gersh BJ, 2011, J THORAC CARDIOV SUR, V142, pE153, DOI 10.1016/j.jtcvs.2011.10.020; Iwakura N, 2015, ALIMENT PHARM THER, V41, P776, DOI 10.1111/apt.13141; Katzka DA, 2014, CLIN GASTROENTEROL H, V12, P2023, DOI 10.1016/j.cgh.2014.07.035; KELLY KJ, 1995, GASTROENTEROLOGY, V109, P1503, DOI 10.1016/0016-5085(95)90637-1; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lucendo AJ, 2013, J ALLERGY CLIN IMMUN, V131, P797, DOI 10.1016/j.jaci.2012.12.664; Moawad FJ, 2015, ALIMENT PHARM THER, V42, P231, DOI 10.1111/apt.13258; Moawad FJ, 2014, ALIMENT PHARM THER, V39, P603, DOI 10.1111/apt.12636; Molina-Infante J, 2014, ALIMENT PHARM THER, V40, P955, DOI 10.1111/apt.12914; Molina-Infante J, 2015, REV ESP ENFERM DIG, V107, P29; Molina-Infante J, 2014, J ALLERGY CLIN IMMUN, V134, P1093, DOI 10.1016/j.jaci.2014.07.023; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Ngo P, 2006, AM J GASTROENTEROL, V101, P1666, DOI 10.1111/j.1572-0241.2006.00562.x; Sayej WN, 2009, J PEDIATR GASTR NUTR, V49, P393, DOI 10.1097/MPG.0b013e31819c4b3e; Spechler SJ, 2007, AM J GASTROENTEROL, V102, P1301, DOI 10.1111/j.1572-0241.2007.01179.x; Tian T, 2013, GERONTOLOGY, V59, P199, DOI 10.1159/000346146; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; van Rhijn BD, 2014, CLIN GASTROENTEROL H, V12, P1815, DOI 10.1016/j.cgh.2014.02.037; Warners MJ, 2015, EUR J GASTROEN HEPAT, V27, P506, DOI 10.1097/MEG.0000000000000331; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; WINTER HS, 1982, GASTROENTEROLOGY, V83, P818	27	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					934	936		10.1016/j.jaci.2015.08.026	http://dx.doi.org/10.1016/j.jaci.2015.08.026			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26441228	Green Accepted, Bronze			2022-12-18	WOS:000371897500040
J	Michils, A; Malinovschi, A; Haccuria, A; Michiels, S; Van Muylem, A				Michils, Alain; Malinovschi, Andrei; Haccuria, Amaryllis; Michiels, Sebastien; Van Muylem, Alain			Different patterns of exhaled nitric oxide response to beta(2)-agonists in asthmatic patients according to the site of bronchodilation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; fraction of exhaled nitric oxide; bronchodilation; ventilation distribution	REPEATED SPIROMETRY; HEALTHY-SUBJECTS; AXIAL DIFFUSION; VENTILATION; LOCALIZATION; INFLAMMATION; CHALLENGE; EXCHANGE; IMPACT; SLOPE	Background: In asthmatic patients undergoing airway challenge, fraction of exhaled nitric oxide (FENO) levels decrease after bronchoconstriction. In contrast, model simulations have predicted both decreased and increased FENO levels after bronchodilation, depending on the site of airway obstruction relief. Objective: We sought to investigate whether beta(2)-agonists might induce divergent effects on FENO values in asthmatic patients as a result of airway obstruction relief occurring at different lung depths. Methods: FENO, FEV1, and the slope of phase III of the singlebreath washout test (S) of He (S-He) and sulfur hexafluoride (S-SF6) were measured in 68 asthmatic patients before and after salbutamol inhalation. S-He and S-SF6 decreases reflected preacinar and intra-acinar obstruction relief, respectively. Changes (Delta) were expressed as a percentage from the baseline. Results: No FENO change (vertical bar Delta FENO vertical bar <= 10%) was found in 16 patients (mean [SD]: 2.5% [5.2%]; ie, FENO5 group); a Delta FENO value of greater than 10% was found in 23 patients (31.7% [20.3%]; ie, the FENO+ group); and a Delta FENO value of less than -10% was found in 29 patients (-31.5% [17.3%]; ie, the FENO- group). All groups had similar Delta FEV1 values. In the FENO= group neither S-He nor S-SF6 changed, in the FENO+ group only SHe decreased significantly (-21.8% [SD 28.5%], P = .03), and in the FENO- group both SHe (-29.8% [24.0%], P < .001) and S-SF6 (-27.2% [23.3%], P < .001) decreased. Discussion: Three FENO behaviors were observed in response to beta(2)-agonists: a decrease likely caused by relief of an intra-acinar airway obstruction that we propose reflects amplification of nitric oxide back-diffusion, an increase likely associated with a predominant dilation up to the preacinar airways, and FENO stability when obstruction relief involved predominantly the central airways. In combination, these results suggest a new role for FENO in identifying the site of airway obstruction in asthmatic patients.	[Michils, Alain; Haccuria, Amaryllis; Michiels, Sebastien; Van Muylem, Alain] Univ Libre Bruxelles, Erasme Univ Hosp, Chest Dept, Brussels, Belgium; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden	Universite Libre de Bruxelles; Uppsala University	Van Muylem, A (corresponding author), Univ Libre Bruxelles, CUB Erasme, Chest Dept, 808 Route Lennik, B-1070 Brussels, Belgium.	avmuylem@ulb.ac.be			Chiesi	Chiesi(Chiesi Pharmaceuticals Inc)	Chiesi provided a grant for the Immunobiology of Asthma Unit.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; BARNES PJ, 1983, AM REV RESPIR DIS, V127, P758; Berry M, 2005, EUR RESPIR J, V25, P986, DOI 10.1183/09031936.05.00132404; Condorelli P, 2007, J APPL PHYSIOL, V102, P417, DOI 10.1152/japplphysiol.00533.2006; de Gouw HWFM, 1998, AM J RESP CRIT CARE, V158, P315, DOI 10.1164/ajrccm.158.1.9703005; Deykin A, 2000, AM J RESP CRIT CARE, V161, P1237, DOI 10.1164/ajrccm.161.4.9904086; Deykin A, 1998, AM J RESP CRIT CARE, V157, P769, DOI 10.1164/ajrccm.157.3.9707114; Dutrieue B, 2000, J APPL PHYSIOL, V89, P1859, DOI 10.1152/jappl.2000.89.5.1859; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Estenne M, 2000, AM J RESP CRIT CARE, V162, P1047, DOI 10.1164/ajrccm.162.3.9912063; FAIRSHTER RD, 1980, AM REV RESPIR DIS, V122, P27; Garnier P, 1996, EUR RESPIR J, V9, P1134, DOI 10.1183/09031936.96.09061134; Garriga T, 2012, RESPIRATION, V83, P239, DOI 10.1159/000329440; Haccuria A, 2014, J ALLERGY CLIN IMMUN, V134, P554, DOI 10.1016/j.jaci.2013.12.1070; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; Ho LP, 2000, EUR RESPIR J, V15, P1009, DOI 10.1034/j.1399-3003.2000.01506.x; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kerckx Y, 2008, J APPL PHYSIOL, V104, P918, DOI 10.1152/japplphysiol.01032.2007; Michils A, 2008, EUR RESPIR J, V31, P539, DOI 10.1183/09031936.00020407; Michils A, 2011, J APPL PHYSIOL, V110, P1241, DOI 10.1152/japplphysiol.01401.2010; PAIVA M, 1988, RESP PHYSIOL, V72, P257, DOI 10.1016/0034-5687(88)90085-0; PAIVA M, 1987, PHYSIOL REV, V67, P750, DOI 10.1152/physrev.1987.67.3.750; PAIVA M, 1984, RESP PHYSIOL, V56, P309, DOI 10.1016/0034-5687(84)90067-7; Piacentini GL, 2002, THORAX, V57, P771, DOI 10.1136/thorax.57.9.771; Prieto L, 2013, J ASTHMA, V50, P623, DOI 10.3109/02770903.2013.790418; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; R Core Team, R LANG ENV STAT COMP; Rosner B., 2005, FUNDAMENTALS BIOSTAT, V6th; Shin HW, 2002, J APPL PHYSIOL, V93, P2070, DOI 10.1152/japplphysiol.00129.2002; Silkoff PE, 1999, AM J RESP CRIT CARE, V159, P940, DOI 10.1164/ajrccm.159.3.9805044; Suresh V, 2008, J APPL PHYSIOL, V104, P1743, DOI 10.1152/japplphysiol.01355.2007; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; Van Muylem A, 2000, PEDIATR PULM, V30, P3, DOI 10.1002/1099-0496(200007)30:1<3::AID-PPUL2>3.0.CO;2-L; Van Muylem A, 2003, J APPL PHYSIOL, V94, P119, DOI 10.1152/japplphysiol.00044.2002; Van Muylem A, 2007, AM J RESP CRIT CARE, V175, P731, DOI 10.1164/rccm.200609-1301OC; Van Muylem A, 2013, RESP PHYSIOL NEUROBI, V185, P313, DOI 10.1016/j.resp.2012.09.011; VANMUYLEM A, 1992, AM REV RESPIR DIS, V146, P1167, DOI 10.1164/ajrccm/146.5_Pt_1.1167; Verbanck S, 2008, J APPL PHYSIOL, V104, P925, DOI 10.1152/japplphysiol.01019.2007; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3	39	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					806	812		10.1016/j.jaci.2015.09.054	http://dx.doi.org/10.1016/j.jaci.2015.09.054			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26688519	Bronze			2022-12-18	WOS:000371897500024
J	Mouthuy, J; Viart, S; Ladjemi, MZ; Detry, B; Henket, M; Bachert, C; Louis, R; Pilette, C				Mouthuy, Jonathan; Viart, Sophie; Ladjemi, Maha Z.; Detry, Bruno; Henket, Monique; Bachert, Claus; Louis, Renaud; Pilette, Charles			Mite allergen-specific IgE is detectable in bronchial secretions of patients with non-atopic asthma and correlates with mucosal expression of periostin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SPUTUM		[Mouthuy, Jonathan; Viart, Sophie; Ladjemi, Maha Z.; Detry, Bruno; Pilette, Charles] Catholic Univ Louvain, IREC, Pole Pneumol ORL & Dermatol, B-1200 Brussels, Belgium; [Henket, Monique; Louis, Renaud] CHU Sart Tilman, Dept Pulm Med, B-4000 Liege, Belgium; [Henket, Monique; Louis, Renaud] Univ Liege, IGIGA Res Grp, Liege, Belgium; [Bachert, Claus] Univ Ghent, Upper Airway Res Lab, B-9000 Ghent, Belgium; [Bachert, Claus] Univ Ghent, Dept Otorhinolaryngol, B-9000 Ghent, Belgium	Universite Catholique Louvain; University of Liege; University of Liege; Ghent University; Ghent University	Mouthuy, J (corresponding author), Catholic Univ Louvain, IREC, Pole Pneumol ORL & Dermatol, B-1200 Brussels, Belgium.	charles.pilette@uclouvain.be	Bachert, Claus/J-8825-2012; Ladjemi, M-Z/AAB-2305-2021	Ladjemi, Maha Zohra/0000-0001-5923-0984				Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bobolea I, 2015, ALLERGY, V70, P540, DOI 10.1111/all.12580; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Mouthuy J, 2011, AM J RESP CRIT CARE, V184, P206, DOI 10.1164/rccm.201009-1434OC; Pillai P, 2014, J ALLERGY CLIN IMMUN, V133, P1770, DOI 10.1016/j.jaci.2014.03.027; Rondon C, 2007, J ALLERGY CLIN IMMUN, V119, P899, DOI 10.1016/j.jaci.2007.01.006; Schleich FN, 2014, EUR RESPIR J, V44, P1098, DOI [10.1183/09031936.00201813, 10.1183/09031936.00118014]; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	10	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1685	1688		10.1016/j.jaci.2015.07.018	http://dx.doi.org/10.1016/j.jaci.2015.07.018			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26329515	Green Submitted, Bronze			2022-12-18	WOS:000366044300033
J	Srinivasan, B; Focke-Tejkl, M; Weber, M; Pahr, S; Baar, A; Atreya, R; Neurath, MF; Vogelsang, H; Huber, WD; Valenta, R				Srinivasan, Bharani; Focke-Tejkl, Margarete; Weber, Milena; Pahr, Sandra; Baar, Alexandra; Atreya, Raja; Neurath, Markus F.; Vogelsang, Harald; Huber, Wolf-Dietrich; Valenta, Rudolf			Usefulness of recombinant gamma-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Celiac disease; cloning; recombinant gamma gliadin 1; epitope	B-CELL EPITOPES; TISSUE TRANSGLUTAMINASE; T-CELLS; WHEAT; PROTEINS; IDENTIFICATION; PREVALENCE; DIGESTION; PEPTIDES; SEQUENCE	Background: Celiac disease (CD) is an inflammatory disease of the small intestine caused by an immunologic hypersensitivity reaction to dietary wheat gluten. Objectives: We sought to clone, express, and perform IgA epitope mapping of a CD-specific wheat antigen and to study its usefulness for identifying patients with CD and monitoring adherence to a gluten-free diet. Methods: A synthetic gene coding for gamma-gliadin 1 (GG1) was expressed in Escherichia coli. Recombinant gamma-gliadin 1 (rGG1) was purified and characterized biochemically, structurally, and immunologically by using sera from patients with CD and control subjects. Overlapping GG1 peptides were synthesized for IgA and IgG epitope mapping. GG1 and peptide-specific antibodies were raised for tracing GG1 in cereals and dietary wheat products and to study its resistance to digestion. Results: rGG1 was expressed and purified. rGG1-based IgA ELISAs performed in populations of patients with CD and control subjects showed a specificity of 92.9%, which was higher than that of gliadin extract (e). Furthermore, it allowed monitoring of adherence to a gluten-free diet in patients. A 26-amino-acid peptide from the proline-glutamine-rich repetitive N-terminal region was identified as the immunodominant IgA epitope. GG1-related antigens were found in rye, barley, and spelt but not in oat, rice, or maize. GG1 was detected in dietary wheat products after baking, and in particular, the major IgA epitope-containing region was resistant against digestion. Conclusions: rGG1 and its epitope might be useful for identifying patients with CD, monitoring treatment, and studying the pathomechanisms of CD and development of preventive and therapeutic strategies.	[Srinivasan, Bharani; Focke-Tejkl, Margarete; Weber, Milena; Pahr, Sandra; Baar, Alexandra; Valenta, Rudolf] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, A-1090 Vienna, Austria; [Vogelsang, Harald] Med Univ Vienna, Dept Gastroenterol & Hepatol, A-1090 Vienna, Austria; [Huber, Wolf-Dietrich] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria; [Atreya, Raja; Neurath, Markus F.] Univ Erlangen Nurnberg, Med Clin 1, D-91054 Erlangen, Germany	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Erlangen Nuremberg	Valenta, R (corresponding author), Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	rudolf.valenta@meduniwien.ac.at	Srinivasan, Bharani/O-5593-2019; Srinivasan, Bharani/N-5689-2019	Valenta, Rudolf/0000-0001-5944-3365; Srinivasan, Bharani/0000-0002-8260-4603	FWF-funded PhD program IAI [DK W1212]; Medical University of Vienna; Phadia/Thermo Fisher Scientific, Uppsala, Sweden	FWF-funded PhD program IAI; Medical University of Vienna; Phadia/Thermo Fisher Scientific, Uppsala, Sweden	Supported by the FWF-funded PhD program IAI DK W1212 and the Medical University of Vienna and in part by a research grant from Phadia/Thermo Fisher Scientific, Uppsala, Sweden.	Baar A, 2012, J IMMUNOL, V189, P3018, DOI 10.4049/jimmunol.1200438; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Ehren J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006313; Focke M, 2001, FASEB J, V15, P2042, DOI 10.1096/fj.01-0016fje; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kagnoff MF, 2005, GASTROENTEROLOGY, V128, pS10, DOI 10.1053/j.gastro.2005.02.008; Koskinen O, 2009, J PEDIATR GASTR NUTR, V48, P559, DOI 10.1097/MPG.0b013e3181668635; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagrain B, 2011, J AGR FOOD CHEM, V59, P2034, DOI 10.1021/jf104201u; Leffler DA, 2007, ALIMENT PHARM THER, V26, P1227, DOI 10.1111/j.1365-2036.2007.03501.x; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; MENKOVSKA M, 1987, CEREAL CHEM, V64, P311; Meresse B, 2009, MUCOSAL IMMUNOL, V2, P8, DOI 10.1038/mi.2008.75; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; OKITA TW, 1985, J BIOL CHEM, V260, P8203; Osman AA, 2000, CLIN EXP IMMUNOL, V121, P248, DOI 10.1046/j.1365-2249.2000.01312.x; Qi PF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-168; Rewers M, 2005, GASTROENTEROLOGY, V128, pS47, DOI 10.1053/j.gastro.2005.02.030; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Shapiro DE, 1999, STAT METHODS MED RES, V8, P113, DOI 10.1177/096228029900800203; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simonato B, 2001, J AGR FOOD CHEM, V49, P5668, DOI 10.1021/jf0104984; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Srinivasan B, 2013, AMINO ACIDS, V45, P889, DOI 10.1007/s00726-013-1537-6; SUGIYAMA T, 1986, PLANT SCI, V44, P205, DOI 10.1016/0168-9452(86)90092-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEISS W, 1993, ELECTROPHORESIS, V14, P805, DOI 10.1002/elps.11501401126; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004	32	9	11	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1607	U267		10.1016/j.jaci.2015.04.040	http://dx.doi.org/10.1016/j.jaci.2015.04.040			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26078104	Green Published, hybrid			2022-12-18	WOS:000366044300023
J	Winston, A; Jose, S; Fisher, M; Walsh, J; Nelson, M; Gilson, R; Post, F; Johnson, M; Leen, C; Chadwick, D; Hay, P; Pritchard, J; Tariq, A; Sabin, C				Winston, Alan; Jose, Sophie; Fisher, Martin; Walsh, John; Nelson, Mark; Gilson, Richard; Post, Frank; Johnson, Margaret; Leen, Clifford; Chadwick, David; Hay, Phillip; Pritchard, Jillian; Tariq, Anjum; Sabin, Caroline		UK Collaborative HIV Cohort Study	Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HIV; EMTRICITABINE; INDIVIDUALS; LAMIVUDINE; COHORT		[Winston, Alan; Nelson, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Med, Infect Dis Sect, London, England; [Winston, Alan; Walsh, John] Imperial Healthcare NHS Trust, Dept HIV & GU Med, London, England; [Jose, Sophie; Sabin, Caroline] UCL, Res Dept Infect & Populat Hlth, London, England; [Fisher, Martin] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Nelson, Mark] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Gilson, Richard] UCL, Ctr Sexual Hlth & HIV Res, London, England; [Gilson, Richard] Mortimer Market Ctr, London, England; [Post, Frank] Kings Coll Hosp NHS Fdn Trust, London, England; [Johnson, Margaret] Royal Free Fdn NHS Trust, London, England; [Leen, Clifford] Univ Edinburgh, Western Gen Hosp, Reg Infect Dis Unit, Edinburgh Infect Dis, Edinburgh, Midlothian, Scotland; [Leen, Clifford] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Chadwick, David] South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England; [Hay, Phillip] St Georges Healthcare NHS Trust, London, England; [Pritchard, Jillian] Ashford & St Peters Hosp NHS Fdn Trust, Ashford, Surrey, England; [Tariq, Anjum] Royal Wolverhampton Hosp NHS Trust, Wolverhampton, W Midlands, England	Imperial College London; University of London; University College London; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Imperial College London; University of London; University College London; King's College Hospital NHS Foundation Trust; University of Edinburgh; University of Edinburgh; St Georges University London	Winston, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Infect Dis Sect, London, England.	a.winston@imperial.ac.uk	Winston, Alan/AGZ-3015-2022; Sabin, Caroline/C-2464-2008	Winston, Alan/0000-0002-5847-8416; Sabin, Caroline/0000-0001-5173-2760; Leen, Clifford/0000-0001-8439-7719	Medical Research Council [M004236, MC_UU_12023/15, G0600337, MR/M004236/1, G0000199, G0900274] Funding Source: Medline; MRC [MR/M004236/1, MC_UU_12023/15, G0900274, G0600337] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; Mendez-Lagares G, 2012, J ANTIMICROB CHEMOTH, V67, P1228, DOI 10.1093/jac/dkr594; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Thornhill J, 2014, J INT AIDS SOC, V17, P2, DOI 10.7448/IAS.17.4.19480; UK register of HIV seroconverters (UKRHS) Steering Committee, 1996, EPIDEMIOL INFECT, V117, P305; Williams I, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12119	10	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1682	1685		10.1016/j.jaci.2015.05.047	http://dx.doi.org/10.1016/j.jaci.2015.05.047			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26253341				2022-12-18	WOS:000366044300032
J	Gelb, AF; Nadel, JA				Gelb, Arthur F.; Nadel, Jay A.			Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; emphysema; COPD; asthma-COPD overlap syndrome	ALVEOLAR ATTACHMENTS; COPD OVERLAP; LUNG; EMPHYSEMA; FEATURES		[Gelb, Arthur F.] Lakewood Reg Med Ctr LRMC, Dept Med, Div Pulm, Lakewood, CO USA; [Gelb, Arthur F.] Univ Calif Los Angeles, Med Ctr, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Nadel, Jay A.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA USA; [Nadel, Jay A.] Univ Calif San Francisco, Med Ctr, Dept Physiol, San Francisco, CA USA; [Nadel, Jay A.] Univ Calif San Francisco, Med Ctr, Dept Radiol, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gelb, AF (corresponding author), 3650 E South St,Suite 308, Lakewood, CA 90712 USA.	afgelb@msn.com						Barnes PJ, 2006, AM J RESP CRIT CARE, V174, P240, DOI 10.1164/rccm.2604008; Barnes PJ, 2015, J ALLERGY CLIN IMMUN, V136, P531, DOI 10.1016/j.jaci.2015.05.052; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; FLETCHER CM, 1984, THORAX, V39, P81, DOI 10.1136/thx.39.2.81; Gelb AF, 1998, AM J RESP CRIT CARE, V158, P815, DOI 10.1164/ajrccm.158.3.9801045; Gelb AF, 2015, CHEST, V148, P313, DOI 10.1378/chest.14-2483; Gelb AF, 2014, J ALLERGY CLIN IMMUN, V133, P263, DOI 10.1016/j.jaci.2013.09.045; Ghebre MA, 2015, J ALLERGY CLIN IMMUN, V135, P63, DOI 10.1016/j.jaci.2014.06.035; Gibson PG, 2015, THORAX, V70, P683, DOI 10.1136/thoraxjnl-2014-206740; Global Initiative for COLD, JOINT PROJ GOLD GINA; GOLD WM, 1967, J APPL PHYSIOL, V23, P433, DOI 10.1152/jappl.1967.23.4.433; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Kraft M, 2006, AM J RESP CRIT CARE, V174, P238, DOI 10.1164/rccm.2604007; LEOPOLD J. G., 1957, THORAX, V12, P219, DOI 10.1136/thx.12.3.219; Mauad T, 2004, AM J RESP CRIT CARE, V170, P857, DOI 10.1164/rccm.200403-305OC; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Orie NGM, 1961, BRONCHITIS INT S; Postma DS, 2015, J ALLERGY CLIN IMMUN, V136, P521, DOI 10.1016/j.jaci.2015.06.018; Reddel HK, 2015, J ALLERGY CLIN IMMUN, V136, P546, DOI 10.1016/j.jaci.2015.06.043; SAETTA M, 1985, AM REV RESPIR DIS, V132, P894; Senhorini A, 2013, COPD, V10, P348, DOI 10.3109/15412555.2012.752806; Smolonska J, 2014, EUR RESPIR J, V44, P860, DOI 10.1183/09031936.00001914; VERBEKEN EK, 1992, CHEST, V101, P793, DOI 10.1378/chest.101.3.793; VERMEIRE PA, 1991, EUR RESPIR J, V4, P490; WOOLCOCK AJ, 1968, AM REV RESPIR DIS, V98, P788	26	9	9	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					553	555		10.1016/j.jaci.2015.06.013	http://dx.doi.org/10.1016/j.jaci.2015.06.013			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	26343939	Bronze			2022-12-18	WOS:000360913300004
J	Gold, MJ; Hughes, MR; Antignano, F; Hirota, JA; Zaph, C; McNagny, KM				Gold, Matthew J.; Hughes, Michael R.; Antignano, Frann; Hirota, Jeremy A.; Zaph, Colby; McNagny, Kelly M.			Lineage-specific regulation of allergic airway inflammation by the lipid phosphatase Src homology 2 domain-containing inositol 5-phosphatase (SHIP-1)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; asthma; dendritic cell; house dust mite; IgE; T(H)2	MAST-CELL; HISTAMINE-RELEASE; IMMUNE-SYSTEM; ASTHMA MODEL; MICE; RESPONSES; HYPERRESPONSIVENESS; P110-DELTA; GENERATION; EXPRESSION	Background: Inpp5d (Src homology 2 domain-containing inositol-5-phosphatase [Ship1])-deficient mice experience spontaneous airway inflammation and have enhanced sensitivity to allergen-induced airway inflammation. Objective: We hypothesized that lineage-specific deletion of Ship1 expression in cells known to be crucial for adaptive T(H)2 responses would uncover distinct roles that could either positively or negatively regulate susceptibility to allergic airway inflammation (AAI). Methods: Ship1 expression was deleted in B cells, T cells, or dendritic cells (DCs), and the resulting Ship1(Delta B) cell, Ship1(Delta T cell), Ship1(Delta DC), or Ship1(F/F) (wild-type) control mice were evaluated in a model of house dust mite (HDM)-induced AAI. Results: Unlike germline panhematopoietic Ship1 deletion, deletion of Ship1 selectively in either the B-cell, T-cell, or DC lineages did not result in spontaneous airway inflammation. Strikingly, although loss of Ship1 in the B-cell lineage did not affect HDM-induced AAI, loss of Ship1 in either of the T-cell or DC lineages protected mice from AAI by skewing the typical T(H)2 immune response toward a T(H)1 response. Conclusions: Although panhematopoietic deletion of Ship1 leads to spontaneous lung inflammation, selective deletion of Ship1 in T cells or DCs impairs the formation of an adaptive T(H)2 response and protects animals from HDM-induced AAI.	[Gold, Matthew J.; Hughes, Michael R.; Antignano, Frann; Zaph, Colby; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Zaph, Colby] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; [Hirota, Jeremy A.] St Pauls Hosp, UBC James Hogg Res Ctr, Vancouver, BC V6Z 1Y6, Canada; [Zaph, Colby] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	University of British Columbia; University of British Columbia; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Monash University	McNagny, KM (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	kelly@brc.ubc.ca	Hughes, Michael/N-6039-2015; McNagny, Kelly/P-5239-2014	Hughes, Michael/0000-0002-7925-6070; McNagny, Kelly/0000-0003-4737-3499; Antignano, Frann/0000-0003-0502-5330; Zaph, Colby/0000-0002-9889-9848	AllerGen Network Centre of Excellence; Canadian Institutes of Health Research [MOP-137142]; AllerGen CAIDATI training award; CIHR/Canadian Association of Gastroenterology/Crohn's; Colitis Foundation of Canada; Canadian Banting Postdoctoral fellowship	AllerGen Network Centre of Excellence; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AllerGen CAIDATI training award; CIHR/Canadian Association of Gastroenterology/Crohn's(Canadian Institutes of Health Research (CIHR)); Colitis Foundation of Canada; Canadian Banting Postdoctoral fellowship	Supported by the AllerGen Network Centre of Excellence (K.M.M.) and the Canadian Institutes of Health Research (C.Z. and K.M.M; MOP-137142). M.J.G. was supported by an AllerGen CAIDATI training award, and F.A. is the recipient of a CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada postdoctoral fellowship. J.A.H. is the recipient of a Canadian Banting Postdoctoral fellowship.	Antignano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021893; Antignano F, 2010, J LEUKOCYTE BIOL, V88, P925, DOI 10.1189/jlb.1209825; Antignano F, 2010, J IMMUNOL, V184, P2805, DOI 10.4049/jimmunol.0903170; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Collazo MM, 2012, EUR J IMMUNOL, V42, P1785, DOI 10.1002/eji.201142092; Collazo MM, 2009, BLOOD, V113, P2934, DOI 10.1182/blood-2008-09-181164; Corey SJ, 2012, EUR J IMMUNOL, V42, P1681, DOI 10.1002/eji.201242706; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Ghansah T, 2004, J IMMUNOL, V173, P7324, DOI 10.4049/jimmunol.173.12.7324; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Haddon DJ, 2009, J IMMUNOL, V183, P228, DOI 10.4049/jimmunol.0900427; Hadidi S, 2012, MUCOSAL IMMUNOL, V5, P535, DOI 10.1038/mi.2012.29; Helgason CD, 2000, J EXP MED, V191, P781, DOI 10.1084/jem.191.5.781; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Kang BN, 2012, AM J PHYSIOL-LUNG C, V302, pL1179, DOI 10.1152/ajplung.00005.2012; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Langdon JM, 2008, J LEUKOCYTE BIOL, V84, P1151, DOI 10.1189/jlb.0308172; Leaker BR, 2014, CLIN EXP ALLERGY, V44, P1146, DOI 10.1111/cea.12370; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Lee KS, 2006, J ALLERGY CLIN IMMUN, V118, P403, DOI 10.1016/j.jaci.2006.04.041; Leung WH, 2013, EUR J IMMUNOL, V43, P371, DOI 10.1002/eji.201242809; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Oh SY, 2007, J ALLERGY CLIN IMMUN, V119, P123, DOI 10.1016/j.jaci.2006.08.029; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Park MY, 2014, MUCOSAL IMMUNOL, V7, P1429, DOI 10.1038/mi.2014.32; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Tarasenko T, 2007, P NATL ACAD SCI USA, V104, P11382, DOI 10.1073/pnas.0704853104; Vonakis BM, 2007, J ALLERGY CLIN IMMUN, V119, P441, DOI 10.1016/j.jaci.2006.09.035; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438	35	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					725	+		10.1016/j.jaci.2015.01.019	http://dx.doi.org/10.1016/j.jaci.2015.01.019			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	25746967	Bronze			2022-12-18	WOS:000360913300025
J	Moore, LE; Bhutani, M; Petersen, SR; McMurtry, MS; Byers, BW; Tedjasaputra, V; Stickland, MK				Moore, Linn E.; Bhutani, Mohit; Petersen, Stewart R.; McMurtry, M. Sean; Byers, Bradley W.; Tedjasaputra, Vincent; Stickland, Michael K.			Physical activity, fitness, and vascular health in patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MYOCARDIAL-INFARCTION; ARTERIAL STIFFNESS; HEART-DISEASE; RISK; EVENTS		[Moore, Linn E.; Bhutani, Mohit; Byers, Bradley W.; Tedjasaputra, Vincent; Stickland, Michael K.] Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada; [Moore, Linn E.; Petersen, Stewart R.; Byers, Bradley W.; Tedjasaputra, Vincent] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada; [McMurtry, M. Sean] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada; [Stickland, Michael K.] G MacDonald Ctr Lung Hlth Covenant Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Moore, LE (corresponding author), Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada.	michael.stickland@ualberta.ca		Byers, Bradley/0000-0003-1109-9897				Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Iribarren C, 2012, AM J EPIDEMIOL, V176, P1014, DOI 10.1093/aje/kws181; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Sun WX, 2014, RESP MED, V108, P57, DOI 10.1016/j.rmed.2013.10.021; Teramoto M, 2011, J ASTHMA, V48, P517, DOI 10.3109/02770903.2011.567426; Vlachopoulos C, 2005, CIRCULATION, V112, P2193, DOI 10.1161/CIRCULATIONAHA.105.535435; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Yildiz P, 2004, J ASTHMA, V41, P159, DOI 10.1081/JAS-120026073	10	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					809	+		10.1016/j.jaci.2015.02.033	http://dx.doi.org/10.1016/j.jaci.2015.02.033			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	25913103	hybrid			2022-12-18	WOS:000360913300037
J	Okano, M; Fujiwara, T; Kariya, S; Haruna, T; Higaki, T; Noyama, Y; Makihara, S; Kanai, K; Nishizaki, K				Okano, Mitsuhiro; Fujiwara, Tazuko; Kariya, Shin; Haruna, Takenori; Higaki, Takaya; Noyama, Yasuyuki; Makihara, Sei-ichiro; Kanai, Kengo; Nishizaki, Kazunori			Staphylococcal protein A-formulated immune complexes suppress enterotoxin-induced cellular responses in nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis with nasal polyps; cytokines; enterotoxins; immune complexes; immunoglobulins; immune evasion; Staphylococcus aureus; staphylococcal protein A	CHRONIC RHINOSINUSITIS; T-CELLS; AUREUS; IL-10; INFLAMMATION; ACTIVATION; LIGANDS; DISEASE; EVASION; SERUM	Background: Recent studies have revealed that Staphylococcus aureus and its components participate in the pathogenesis of eosinophilic airway diseases, such as chronic rhinosinusitis with nasal polyps. Objective: We sought to determine whether staphylococcal protein A (SpA) from S aureus regulated cellular responses in nasal polyps, especially when coupled to immunoglobulins in immune complexes (ICs). Methods: Dispersed nasal polyp cells (DNPCs) or peripheral blood monocytes were cultured in vitro with SpA in the presence or absence of IgG, and IL-5, IL-13, IFN-gamma, IL-17A, and IL-10 levels were measured in the supernatants. The effect of SpA exposure on staphylococcal enterotoxin B-induced cytokine production by DNPCs in the presence and absence of IgG, IgA, and autologous serum was also examined. Results: Exposure to SpA induced DNPCs to produce significantly higher IL-10, IL-13, and IL-17A levels than DNPCs without SpA, although the magnitude of the IL-17A increase was less than that of IL-10 and IL-13. SpA induced IL-10 production mainly from adherent DNPCs, and this was significantly enhanced in the presence of IgG; similar results were observed in peripheral blood monocytes. IC formation between SpA and IgG (SpA-IgG ICs) was confirmed by using native polyacrylamide gel electrophoresis. SpA-IgG ICs, but not SpA alone, almost completely suppressed staphylococcal enterotoxin B-induced IL-5, IL-13, IFN-gamma, and IL-17A production by DNPCs; similar inhibition was observed in DNPCs treated with SpA in the presence of either IgA or autologous serum. Conclusions: Our results suggest that SpA can regulate the pathogenesis of enterotoxin-induced inflammation in patients with chronic rhinosinusitis with nasal polyps through coupling to immunoglobulins.	[Okano, Mitsuhiro; Fujiwara, Tazuko; Kariya, Shin; Haruna, Takenori; Higaki, Takaya; Noyama, Yasuyuki; Nishizaki, Kazunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Okayama 7008558, Japan; [Makihara, Sei-ichiro] Kagawa Rosai Hosp, Dept Otorhinolaryngol, Marugame, Kagawa, Japan; [Kanai, Kengo] Kagawa Prefectural Cent Hosp, Dept Otorhinolaryngol, Takamatsu, Kagawa, Japan	Okayama University	Okano, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, 2-5-1 Shikatacho, Okayama 7008558, Japan.	mokano@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23592511, 26670742]; Grants-in-Aid for Scientific Research [25861562] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23592511 and 26670742).	Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Berger S, 1997, EUR J IMMUNOL, V27, P2994, DOI 10.1002/eji.1830271136; Bernstein JM, 2011, LARYNGOSCOPE, V121, P647, DOI 10.1002/lary.21400; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; DiMartino SJ, 2008, CLIN IMMUNOL, V127, P56, DOI 10.1016/j.clim.2007.11.014; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Faith A, 2012, ALLERGY, V67, P1007, DOI 10.1111/j.1398-9995.2012.02852.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Foreman A, 2010, LARYNGOSCOPE, V120, P1701, DOI 10.1002/lary.21024; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; Giai C, 2013, INFECT IMMUN, V81, P4200, DOI 10.1128/IAI.00593-13; Gisch K, 2007, INT ARCH ALLERGY IMM, V144, P183, DOI 10.1159/000103991; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Higaki T, 2012, CLIN EXP ALLERGY, V42, P1217, DOI 10.1111/j.1365-2222.2012.04015.x; Hofmann SR, 2012, CLIN IMMUNOL, V143, P116, DOI 10.1016/j.clim.2012.02.005; Issa R, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-30; Jendeberg L, 1996, BIOCHEMISTRY-US, V35, P22, DOI 10.1021/bi9512814; Kakehata S, 2008, OTOL NEUROTOL, V29, P791, DOI 10.1097/MAO.0b013e31817f73af; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Kim YM, 2014, CLIN BIOCHEM, V47, P96, DOI 10.1016/j.clinbiochem.2013.10.030; Kobayashi SD, 2013, MBIO, V4, DOI 10.1128/mBio.00764-13; Kuroda-Morimoto M, 2010, INT IMMUNOL, V22, P561, DOI 10.1093/intimm/dxq040; Lee GA, 2008, CLIN EXP OPHTHALMOL, V36, P119, DOI 10.1111/j.1442-9071.2008.01680.x; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; MacLellan LM, 2011, ARTHRITIS RHEUM-US, V63, P3897, DOI 10.1002/art.30629; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Okano M, 2011, CLIN EXP ALLERGY, V41, P171, DOI 10.1111/j.1365-2222.2010.03584.x; Okano M, 2011, J ALLERGY CLIN IMMUN, V127, P277, DOI 10.1016/j.jaci.2010.09.029; Okano M, 2009, J ALLERGY CLIN IMMUN, V123, P868, DOI 10.1016/j.jaci.2009.01.047; Parcina M, 2013, J IMMUNOL, V190, P1591, DOI 10.4049/jimmunol.1201222; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Peres AG, 2013, BURNS, V39, P380, DOI 10.1016/j.burns.2012.12.008; Poullin P, 2005, JOINT BONE SPINE, V72, P101, DOI 10.1016/j.jbspin.2004.02.009; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Tejde A, 2004, CLIN EXP IMMUNOL, V137, P521, DOI 10.1111/j.1365-2249.2004.02569.x; Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606; Wehling P, 2007, BIODRUGS, V21, P323, DOI 10.2165/00063030-200721050-00004; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004	40	9	10	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					343	+		10.1016/j.jaci.2014.10.058	http://dx.doi.org/10.1016/j.jaci.2014.10.058			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25724120				2022-12-18	WOS:000359004900015
J	Wawrzyniak, M; Pich, C; Gross, B; Schutz, F; Fleury, S; Quemener, S; Sgandurra, M; Bouchaert, E; Moret, C; Mury, L; Rommens, C; Mottaz, H; Dombrowicz, D; Michalik, L				Wawrzyniak, Marta; Pich, Christine; Gross, Barbara; Schuetz, Frederic; Fleury, Sebastien; Quemener, Sandrine; Sgandurra, Marie; Bouchaert, Emmanuel; Moret, Catherine; Mury, Lionel; Rommens, Corinne; Mottaz, Helene; Dombrowicz, David; Michalik, Liliane			Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor beta/delta regulates vascular permeability and anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Peroxisome proliferator-activated receptor beta/delta; anaphylaxis; vascular permeability; endothelium; smooth muscle cells	NITRIC-OXIDE SYNTHASE; PPAR-BETA/DELTA; MAST-CELLS; VE-CADHERIN; IN-VIVO; SIGNALING PATHWAYS; ADHERENS JUNCTIONS; DIABETIC-RATS; DELTA; INFLAMMATION	Background: Remodeling of quiescent vessels with increases in permeability, vasodilatation, and edema are hallmarks of inflammatory disorders. Factors involved in this type of remodeling represent potential therapeutic targets. Objectives: We investigated whether the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) beta/delta, a regulator of metabolism, fibrosis, and skin homeostasis, is involved in regulation of this type of remodeling. Methods: Wild-type and various Pparb/d mutant mice were used to monitor dermal acute vascular hyperpermeability (AVH) and passive systemic anaphylaxis-induced hypothermia and edema. PPAR beta/delta-dependent kinase activation and remodeling of endothelial cell-cell junctions were addressed by using human endothelial cells. Results: AVHand dilatation of dermal microvessels stimulated by vascular endothelial growth factor A, histamine, and thrombin are severely compromised in PPAR beta/delta-deficient mice. Selective deletion of the Pparb/d-encoding gene in endothelial cells in vivo similarly limits dermal AVH and vasodilatation, providing evidence that endothelial PPAR beta/delta is the major player in regulating acute dermal microvessel remodeling. Furthermore, endothelial PPAR beta/delta regulatory functions are not restricted to the skin vasculature because its deletion in the endothelium, but not in smooth muscle cells, also leads to reduced systemic anaphylaxis, the most severe form of allergic reaction, in which an acute vascular response plays a key role. PPAR beta/delta-dependent AVHactivation likely involves the activation of mitogen-activated protein kinase and Akt pathways and leads to downstream destabilization of endothelial cell-cell junctions. Conclusion: These results unveil not only a novel function of PPAR beta/delta as a direct regulator of acute vessel permeability and dilatation but also provide evidence that antagonizing PPAR beta/delta represents an important strategy to consider for moderating diseases with altered endothelial integrity, such as acute inflammatory and allergic disorders.	[Wawrzyniak, Marta; Pich, Christine; Schuetz, Frederic; Sgandurra, Marie; Moret, Catherine; Mury, Lionel; Mottaz, Helene; Michalik, Liliane] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Gross, Barbara; Fleury, Sebastien; Quemener, Sandrine; Bouchaert, Emmanuel; Rommens, Corinne; Dombrowicz, David] Univ Lille 2, Inst Pasteur Lille, INSERM, U1011, F-59019 Lille, France; [Schuetz, Frederic] SIB Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Swiss Institute of Bioinformatics	Michalik, L (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	david.dombrowicz@pasteur-lille.fr; liliane.michalik@unil.ch	BOUCHAERT, Emmanuel/AFU-7112-2022; Dombrowicz, David/F-7044-2013; Quemener, Sandrine/AAC-2788-2021	BOUCHAERT, Emmanuel/0000-0003-2558-9862; Dombrowicz, David/0000-0002-0485-8923; Quemener, Sandrine/0000-0001-6369-3906; Fleury, Sebastien/0000-0002-0679-3086; GROSS, BARBARA/0000-0001-5566-0004; Michalik, Liliane/0000-0003-2963-2100	Swiss National Science Foundation [FN3100A0-113630/1, FN3100A0-127067]; Etat de Vaud; EGID [ANR-10-LABX-46]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Etat de Vaud; EGID	Supported by grants from the Swiss National Science Foundation (FN3100A0-113630/1 and FN3100A0-127067, individual grant to L.M.) and the Etat de Vaud and from EGID, ANR-10-LABX-46 (to D.D.).	Abbott BD, 2009, REPROD TOXICOL, V27, P246, DOI 10.1016/j.reprotox.2008.10.001; Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Ben-Shoshan M, 2011, ALLERGY, V66, P1, DOI 10.1111/j.1398-9995.2010.02422.x; Bishop-Bailey D, 2011, BIOCHEM SOC T, V39, P1601, DOI 10.1042/BST20110643; Bojic LA, 2014, ARTERIOSCL THROM VAS, V34, P52, DOI 10.1161/ATVBAHA.113.301830; Bojic LA, 2013, CURR OPIN LIPIDOL, V24, P171, DOI 10.1097/MOL.0b013e32835cc949; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cheang WS, 2013, CIRC J, V77, P2664, DOI 10.1253/circj.CJ-13-0647; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; d'Uscio LV, 2012, CARDIOVASC RES, V96, P504, DOI 10.1093/cvr/cvs266; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2012, CURR OPIN HEMATOL, V19, P218, DOI 10.1097/MOH.0b013e3283523e1c; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; Gustafsson E, 2001, J CELL SCI, V114, P671; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Han JK, 2008, CIRCULATION, V118, P1021, DOI 10.1161/CIRCULATIONAHA.108.777169; Harrington LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009526; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heupel WM, 2009, J CELL SCI, V122, P1616, DOI 10.1242/jcs.040212; Huegel R, 2007, J INVEST DERMATOL, V127, P65, DOI 10.1038/sj.jid.5700484; Iglesias J, 2012, J CLIN INVEST, V122, P4105, DOI 10.1172/JCI42127; Jimenez R, 2010, J PHARMACOL EXP THER, V332, P554, DOI 10.1124/jpet.109.159806; Zarzuelo MJ, 2011, HYPERTENSION, V58, P733, DOI 10.1161/HYPERTENSIONAHA.111.174490; Khazaei M, 2012, J DIABETES COMPLICAT, V26, P137, DOI 10.1016/j.jdiacomp.2012.02.005; Kim HJ, 2010, CELL MOL LIFE SCI, V67, P2119, DOI 10.1007/s00018-010-0328-4; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Lamers C, 2012, EXPERT OPIN THER PAT, V22, P803, DOI 10.1517/13543776.2012.699042; Levy B, 2010, INTENS CARE MED, V36, P2019, DOI 10.1007/s00134-010-2045-8; Lim HJ, 2009, ATHEROSCLEROSIS, V202, P446, DOI 10.1016/j.atherosclerosis.2008.05.023; MacKenzie A, 2011, PHARMACOL THERAPEUT, V131, P187, DOI 10.1016/j.pharmthera.2010.11.001; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Quintela AM, 2012, FREE RADICAL BIO MED, V53, P730, DOI 10.1016/j.freeradbiomed.2012.05.045; Mazuc E, 2008, J ALLERGY CLIN IMMUN, V122, P188, DOI 10.1016/j.jaci.2008.04.026; Mazue E, 2008, J ALLERGY CLIN IMMUN, V122, pe181; Meissner M, 2010, J BIOL CHEM, V285, P33797, DOI 10.1074/jbc.M110.137943; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Michalik L, 2003, CURR OPIN LIPIDOL, V14, P129, DOI 10.1097/00041433-200304000-00003; Michalik L, 2007, INT C SERIES, V1302, P45; Michalik L, 2011, PROSTAG LEUKOTR ESS, V85, P235, DOI 10.1016/j.plefa.2011.04.016; Montagner A, 2014, EMBO MOL MED, V6, P80, DOI 10.1002/emmm.201302666; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Muller-Brusselbach S, 2007, EMBO J, V26, P3686, DOI 10.1038/sj.emboj.7601803; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Panesar SS, 2013, ALLERGY, V68, P1353, DOI 10.1111/all.12272; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Peavy RD, 2008, CURR OPIN ALLERGY CL, V8, P310, DOI 10.1097/ACI.0b013e3283036a90; Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]; Plutzky J, 2011, CIRC RES, V108, P1002, DOI 10.1161/CIRCRESAHA.110.226860; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; Punekar S, 2008, PATHOBIOLOGY, V75, P9, DOI 10.1159/000113790; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Santhanam AVR, 2012, BRAIN RES, V1483, P89, DOI 10.1016/j.brainres.2012.09.012; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Simons FER, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f602; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Tian XY, 2012, DIABETES, V61, P3285, DOI 10.2337/db12-0117; Triggiani M, 2008, CLIN EXP IMMUNOL, V153, P7, DOI 10.1111/j.1365-2249.2008.03714.x; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Velasco P, 2009, J INVEST DERMATOL, V129, P2022, DOI 10.1038/jid.2008.447; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702	82	9	10	0	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2015	135	6					1625	U350		10.1016/j.jaci.2014.11.006	http://dx.doi.org/10.1016/j.jaci.2014.11.006			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CK0ZC	25556996	Green Submitted			2022-12-18	WOS:000355933400026
J	Anderson-James, S; Newcombe, PA; Marchant, JM; O'Grady, KAF; Acworth, JP; Stone, DG; Turner, CT; Chang, AB				Anderson-James, Sophie; Newcombe, Peter A.; Marchant, Julie M.; O'Grady, Kerry-Ann F.; Acworth, Jason P.; Stone, D. Grant; Turner, Catherine T.; Chang, Anne B.			An acute cough-specific quality-of-life questionnaire for children: Development and validation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Children; acute cough; quality of life	DISEASE; MANAGEMENT; PARENTS; IMPACT	Background: Patient-relevant outcome measures are essential for high-quality clinical research, and quality-of-life (QoL) tools are the current standard. Currently, there is no validated children's acute cough-specific QoL questionnaire. Objective: The objective of this study was to develop and validate the Parent-proxy Children's Acute Cough-specific QoL Questionnaire (PAC-QoL). Methods: Using focus groups, a 48-item PAC-QoL questionnaire was developed and later reduced to 16 items by using the clinical impact method. Parents of children with a current acute cough (<2 weeks) at enrollment completed 2 validated cough score measures, the preliminary 48-item PAC-QoL, and 3 other questionnaires (the State Trait Anxiety Inventory [STAI], the Short-Form 8-item 24-hour recall Health Survey [SF-8], and the Depression, Anxiety, and Stress 21-item Scale [DASS(21)]). All measures were repeated on days 3 and 14. Results: The median age of the 155 children enrolled was 2.3 years (interquartile range, 1.3-4.6). Median cough duration at enrollment was 3 days (interquartile range, 2-5). The reduced 16-item scale had high internal consistency (Cronbach alpha = 0.95). Evidence for repeatability and criterion validity was shown by significant correlations between the domains and total PAC-QoL scores and the SF-8 (r = -0.36 and -0.51), STAI (r = -0.27 and -0.39), and DASS(21) (r = -0.32 and -0.41) scales on days 0 and 3, respectively. The final PAC-QoL questionnaire was sensitive to change over time, with changes significantly relating to changes in cough score measures (P < .001). Conclusion: The 16-item PAC-QoL is a reliable and valid outcome measure that assesses QoL related to childhood acute cough at a given time point and reflects changes in acute cough-specific QoL over time.	[Anderson-James, Sophie; Newcombe, Peter A.; Marchant, Julie M.; Acworth, Jason P.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Newcombe, Peter A.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Acworth, Jason P.] Univ Queensland, Fac Med & Biomed Sci, Brisbane, Qld, Australia; [Turner, Catherine T.] Univ Queensland, Sch Nursing & Midwifery, Brisbane, Qld, Australia; [O'Grady, Kerry-Ann F.; Chang, Anne B.] Queensland Univ Technol, Queensland Childrens Med Res Inst, Brisbane, Qld 4001, Australia; [Acworth, Jason P.] Royal Childrens Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia; [Stone, D. Grant] Univ Queensland, Mater Childrens Hosp, Dept Emergency Med, Brisbane, Qld 4101, Australia; [Chang, Anne B.] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Darwin, NT 0909, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Queensland University of Technology (QUT); Royal Children's Hospital Brisbane; University of Queensland; Charles Darwin University; Menzies School of Health Research	Anderson-James, S (corresponding author), Royal Childrens Hosp, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia.	s.andersonjames@uq.edu.au	Chang, Anne/F-2066-2013; Newcombe, Peter/C-1480-2016; O'Grady, Kerry-Ann F/F-2529-2010; Turner, Catherine/C-5118-2008; Acworth, Jason/B-1339-2011	Chang, Anne/0000-0002-1331-3706; Newcombe, Peter/0000-0002-5969-396X; O'Grady, Kerry-Ann F/0000-0002-8159-2620; Turner, Catherine/0000-0002-2687-932X; Acworth, Jason/0000-0002-6602-3155; Marchant, Julie/0000-0002-8614-1829	Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship [1058213]; NHMRC Career Development Fellowship [1045157]; Queensland Government Smart Futures Fellowship; Children's Hospital Foundation through a Queensland Children's Medical Research Institute program grant [50004]	Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Smart Futures Fellowship; Children's Hospital Foundation through a Queensland Children's Medical Research Institute program grant	A.B.C. is supported by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship (grant 1058213). K.-A.F.O. is supported by an NHMRC Career Development Fellowship (grant 1045157) and a Queensland Government Smart Futures Fellowship. S.A.-J. is supported by the Children's Hospital Foundation through a Queensland Children's Medical Research Institute program grant (50004; to A.B.C. and J.P.A.).	Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Britt H, 2009, GEN PRACTICE ACTIVIT; Chang AB, 2006, MED J AUSTRALIA, V184, P398, DOI 10.5694/j.1326-5377.2006.tb00290.x; Chang AB, 1998, EUR RESPIR J, V11, P462, DOI 10.1183/09031936.98.11020462; Chang AB, 2007, PULM PHARMACOL THER, V20, P371, DOI 10.1016/j.pupt.2006.10.004; Chang AB, 2013, PEDIATRICS, V131, pE1576, DOI 10.1542/peds.2012-3318; Cherry Donald K, 2008, Natl Health Stat Report, P1; Cohen J., 1988, STAT POWER ANAL BEHA; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; Dart RC, 2009, ANN EMERG MED, V53, P411, DOI 10.1016/j.annemergmed.2008.09.015; Irwin RS, 2006, CHEST, V129, p25S, DOI 10.1378/chest.129.1_suppl.25S; Jacobs B, 2000, J CLIN EPIDEMIOL, V53, P793, DOI 10.1016/S0895-4356(99)00238-3; Juniper EF, 2003, ANN ALLERG ASTHMA IM, V91, P115, DOI 10.1016/S1081-1206(10)62161-8; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1997, J CLIN EPIDEMIOL, V50, P233, DOI 10.1016/S0895-4356(96)00377-0; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; Kapur N, 2012, CHEST, V141, P1018, DOI 10.1378/chest.11-0679; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Kusel MM, 2007, J PAEDIATR CHILD H, V43, P139, DOI 10.1111/j.1440-1754.2007.01033.x; Lee KK, 2013, AM J RESP CRIT CARE, V187, P991, DOI 10.1164/rccm.201209-1686OC; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2; Nathan AM, 2014, PEDIATR PULM, V49, P435, DOI 10.1002/ppul.23001; Newcombe PA, 2008, CHEST, V133, P386, DOI 10.1378/chest.07-0888; Newcombe PA, 2013, J ALLERGY CLIN IMMUN, V131, P1069, DOI 10.1016/j.jaci.2012.10.004; Newcombe PA, 2011, CHEST, V139, P576, DOI 10.1378/chest.10-1476; Newcombe PA, 2010, THORAX, V65, P819, DOI 10.1136/thx.2009.133868; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Paul IM, 2004, PEDIATRICS, V114, pE85, DOI 10.1542/peds.114.1.e85; Raj A. A., 2009, V187, P311, DOI 10.1007/978-3-540-79842-2_16; Saunders NR, 2003, CAN MED ASSOC J, V168, P25; Shikiar Richard, 2005, Health Qual Life Outcomes, V3, P36, DOI 10.1186/1477-7525-3-36; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Ware JE., 2001, SCORE INTERPRET SING, V15, P5; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; Wyrwich Kathleen W, 2004, J Biopharm Stat, V14, P97, DOI 10.1081/BIP-120028508; Yost KJ, 2005, EVAL HEALTH PROF, V28, P172, DOI 10.1177/0163278705275340; Yousaf Nadia, 2011, Cough, V7, P4, DOI 10.1186/1745-9974-7-4	38	9	10	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1179	U554		10.1016/j.jaci.2014.08.036	http://dx.doi.org/10.1016/j.jaci.2014.08.036			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	CH4DA	25441641				2022-12-18	WOS:000353980700010
J	Shaheen, SO; Rutterford, CM; Lewis, SJ; Ring, SM; Holloway, JW; Golding, J; Henderson, AJ				Shaheen, Seif O.; Rutterford, Clare M.; Lewis, Sarah J.; Ring, Susan M.; Holloway, John W.; Golding, Jean; Henderson, A. John			Maternal selenium status in pregnancy, offspring glutathione peroxidase 4 genotype, and childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SINGLE-NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; SUPPLEMENTATION; COMPONENTS		[Shaheen, Seif O.; Rutterford, Clare M.] Barts & London Queen Marys Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England; [Lewis, Sarah J.; Ring, Susan M.; Golding, Jean; Henderson, A. John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Ring, Susan M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Holloway, John W.] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO9 5NH, Hants, England	University of London; Queen Mary University London; University of Bristol; University of Bristol; University of Southampton	Shaheen, SO (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England.	s.shaheen@qmul.ac.uk	Holloway, John W/B-5424-2009	Holloway, John W/0000-0001-9998-0464; Lewis, Sarah/0000-0003-4311-6890; Golding, Jean/0000-0003-2826-3307; Robinson, Clare/0000-0002-2673-2205	Medical Research Council [102215/2/13/2, MC_PC_15018] Funding Source: Medline; Wellcome Trust [102215] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devereux G, 2007, CLIN EXP ALLERGY, V37, P1000, DOI 10.1111/j.1365-2222.2007.02757.x; Golding J, 2013, ENVIRON HEALTH PERSP, V121, P1214, DOI 10.1289/ehp.1206115; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Karunasinghe N, 2012, GENES NUTR, V7, P179, DOI 10.1007/s12263-011-0259-1; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Meplan C, 2008, AM J CLIN NUTR, V87, P1019, DOI 10.1093/ajcn/87.4.1019; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romanowska M, 2007, LUNG CANCER, V55, P35, DOI 10.1016/j.lungcan.2006.09.007; Shaheen SO, 2004, EUR RESPIR J, V24, P292, DOI 10.1183/09031936.04.00117803; THOMSON CD, 1993, BRIT J NUTR, V69, P577, DOI 10.1079/BJN19930057; Villette S, 2002, BLOOD CELL MOL DIS, V29, P174, DOI 10.1006/bcmd.2002.0556	14	9	11	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					1083	1085		10.1016/j.jaci.2014.10.035	http://dx.doi.org/10.1016/j.jaci.2014.10.035			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25488690	Green Published, hybrid			2022-12-18	WOS:000352238600038
J	Tripathi, A; Commins, SP; Heymann, PW; Platts-Mills, TAE				Tripathi, Anubha; Commins, Scott P.; Heymann, Peter W.; Platts-Mills, Thomas A. E.			Diagnostic and experimental food challenges in patients with nonimmediate reactions to food	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Wheat-dependent exercise-induced anaphylaxis; oral food challenge; cofactor-enhanced anaphylaxis; wheat allergy; delayed anaphylaxis to mammalian meat; alpha-gal	EXERCISE-INDUCED ANAPHYLAXIS; HYDROLYZED WHEAT PROTEINS; MAMMALIAN MEAT; ALLERGY; IGE; GALACTOSE-ALPHA-1,3-GALACTOSE		[Tripathi, Anubha; Commins, Scott P.; Heymann, Peter W.; Platts-Mills, Thomas A. E.] Univ Virginia, Div Allergy & Immunol, Med Ctr, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA	University of Virginia	Tripathi, A (corresponding author), Univ Virginia, Div Allergy & Immunol, POB 801355, Charlottesville, VA 22908 USA.	at3jx@virginia.edu		Tripathi, Anubha/0000-0002-8775-3165; Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020565] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brockow K, 2015, J ALLERGY CLIN IMMUN, V135, P977, DOI 10.1016/j.jaci.2014.08.024; Cardona V, 2012, ALLERGY, V67, P1316, DOI [10.1111/j.1398-9995.2012.02877.x, 10.1111/j.1398-9995.2012.02877.x.]; Chinuki Y, 2012, J ALLERGY CLIN IMMUN, V129, P1404, DOI 10.1016/j.jaci.2012.02.049; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2014, J ALLERGY CLIN IMMUN, V134, P108, DOI 10.1016/j.jaci.2014.01.024; Denery-Papini S, 2012, ALLERGY, V67, P1023, DOI 10.1111/j.1398-9995.2012.02860.x; DOHI M, 1991, J ALLERGY CLIN IMMUN, V87, P34, DOI 10.1016/0091-6749(91)90210-F; Erwin EA, 2010, ANN ALLERG ASTHMA IM, V104, P496, DOI 10.1016/j.anai.2010.03.018; Fischer J, 2014, J ALLERGY CLIN IMMUN, V134, P755, DOI 10.1016/j.jaci.2014.05.051; Morisset M, 2012, ALLERGY, V67, P609, DOI 10.1111/j.1398-9995.2012.02799.x; Park HJ, 2012, INT ARCH ALLERGY IMM, V157, P147, DOI 10.1159/000327549; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Snegaroff J, 2006, INT ARCH ALLERGY IMM, V139, P201, DOI 10.1159/000091165; Yokooji T, 2013, ALLERGOL INT, V62, P435, DOI 10.2332/allergolint.13-OA-0561	14	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					985	987		10.1016/j.jaci.2014.11.032	http://dx.doi.org/10.1016/j.jaci.2014.11.032			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25592984				2022-12-18	WOS:000352238600021
J	Ellis, A; Frankish, CW; Armstrong, K; Larche, M; Steacy, L; Hafner, R; O'Hehir, R				Ellis, Anne; Frankish, Charles W.; Armstrong, Kristen; Larche, Mark; Steacy, Lisa; Hafner, Rod; O'Hehir, Robyn			Persistent Treatment Effect with Grass Synthetic Peptide Immuno-Regulatory Epitopes in Grass Allergy Symptoms in an Environmental Exposure Unit Challenge after a Second Season of Natural Pollen Exposure	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Ellis, Anne] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Ellis, Anne] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Frankish, Charles W.] Kanata Allergy Serv, Kanata, ON, Canada; [Armstrong, Kristen] Adiga Life Sci Inc, Hamilton, ON, Canada; [Larche, Mark] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada; [Steacy, Lisa] Kingston Gen Hosp, Allergy Res Unit, Kingston, ON K7L 2V7, Canada; [Hafner, Rod] Circassia Ltd, Oxford, England; [O'Hehir, Robyn] Alfred Hosp, Dept Allergy Immunol & Resp, Melbourne, Vic, Australia; [O'Hehir, Robyn] Monash Univ, Melbourne, Vic 3004, Australia	Queens University - Canada; Queens University - Canada; McMaster University; Queens University - Canada; Florey Institute of Neuroscience & Mental Health; Monash University			O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Larche, Mark/0000-0002-1439-7593					0	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		517	AB158	AB158		10.1016/j.jaci.2014.12.1457	http://dx.doi.org/10.1016/j.jaci.2014.12.1457			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN		Bronze			2022-12-18	WOS:000361129600516
J	Giavina-Bianchi, P				Giavina-Bianchi, Pedro			Defining phenotypes in rhinitis: A step toward personalized medicine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Phenotype; genotype; endotype; personalized medicine; allergic rhinitis; allergic asthma; environment; children	CLUSTER-ANALYSIS; ALLERGIC RHINITIS; ASTHMA		Univ Sao Paulo, Sch Med, Clin Immunol & Allergy Div, BR-05403900 Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Giavina-Bianchi, P (corresponding author), Univ Sao Paulo, Sch Med, Clin Immunol & Allergy Div, Av Dr Eneas Carvalho Aguiar 255,88 Andar, BR-05403900 Sao Paulo, SP, Brazil.	pbianchi@usp.br	Giavina-Bianchi, Pedro/I-3112-2014	Giavina-Bianchi, Pedro/0000-0002-1034-7580				Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; ARSHAD SH, 1992, J ALLERGY CLIN IMMUN, V90, P235, DOI 10.1016/0091-6749(92)90077-F; Borish L, 2005, ANN ALLERG ASTHMA IM, V95, P247, DOI 10.1016/S1081-1206(10)61221-5; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; HOLGATE ST, 1993, ALLERGY; Kurukulaaratchy RJ, 2015, J ALLERGY CLIN IMMUN, V135, P143, DOI 10.1016/j.jaci.2014.06.017; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Rondon C, 2014, J ALLERGY CLIN IMMUN, V133, P1026, DOI 10.1016/j.jaci.2013.10.034	13	9	9	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					151	152		10.1016/j.jaci.2014.10.029	http://dx.doi.org/10.1016/j.jaci.2014.10.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25567044				2022-12-18	WOS:000347298200018
J	Kiritsi, D; Valari, M; Fortugno, P; Hausser, I; Lykopoulou, L; Zambruno, G; Fischer, J; Bruckner-Tuderman, L; Jakob, T; Has, C				Kiritsi, Dimitra; Valari, Manthoula; Fortugno, Paola; Hausser, Ingrid; Lykopoulou, Lilia; Zambruno, Giovanna; Fischer, Judith; Bruckner-Tuderman, Leena; Jakob, Thilo; Has, Cristina			Whole-exome sequencing in patients with ichthyosis reveals modifiers associated with increased IgE levels and allergic sensitizations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPIC-DERMATITIS; PROTEOLYTIC ACTIVATION; CONGENITAL ICHTHYOSIS; MUTATIONS; GENE; POLYMORPHISMS; HOMEOSTASIS; NETHERTON; EPIDERMIS; ECZEMA		[Kiritsi, Dimitra; Bruckner-Tuderman, Leena; Jakob, Thilo; Has, Cristina] Univ Freiburg, Med Ctr, Dept Dermatol, Freiburg, Germany; [Fischer, Judith] Univ Freiburg, Med Ctr, Inst Human Genet, Freiburg, Germany; [Valari, Manthoula] Univ Athens, Agia Sofia Childrens Hosp, Dept Dermatol, Athens, Greece; [Lykopoulou, Lilia] Univ Athens, Agia Sofia Childrens Hosp, Dept Pediat 1, Athens, Greece; [Fortugno, Paola] Bambino Gesu Pediat Hosp, Dermatol Unit, IRCCS, Rome, Italy; [Hausser, Ingrid] Univ Clin Heidelberg, Inst Pathol, Heidelberg, Germany; [Zambruno, Giovanna] IDI IRCCS, Ist Dermopat Immacolata, Mol & Cellular Biol Lab, Rome, Italy	University of Freiburg; University of Freiburg; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; IRCCS Bambino Gesu; Ruprecht Karls University Heidelberg; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Kiritsi, D (corresponding author), Univ Freiburg, Med Ctr, Dept Dermatol, Freiburg, Germany.	cristina.has@uniklinik-freiburg.de	Fortugno, Paola/AAG-9787-2020; Fischer, Judith/E-6327-2016; Has, Cristina/V-2132-2019; Kiritsi, Dimitra/AAL-4762-2020; Paola, Fortugno/AAB-4197-2021; Zambruno, Giavanna/K-2933-2018; Has, Cristina/B-3310-2017; Has, Cristina/AGF-7185-2022	Fortugno, Paola/0000-0002-8445-4004; Fischer, Judith/0000-0002-8580-8118; Has, Cristina/0000-0001-6066-507X; Kiritsi, Dimitra/0000-0002-2331-8981; Paola, Fortugno/0000-0002-0151-6477; Has, Cristina/0000-0001-6066-507X; Has, Cristina/0000-0001-6066-507X; Zambruno, Giovanna/0000-0002-1295-056X				Dahlqvist J, 2007, J MED GENET, V44, P615, DOI 10.1136/jmg.2007.050542; Darsow U, 2004, ALLERGY, V59, P1318, DOI 10.1111/j.1398-9995.2004.00556.x; Fortugno P, 2012, HUM MOL GENET, V21, P4187, DOI 10.1093/hmg/dds243; Fortugno P, 2011, J INVEST DERMATOL, V131, P2223, DOI 10.1038/jid.2011.174; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Li H, 2012, J INVEST DERMATOL, V132, P2368, DOI 10.1038/jid.2012.160; Nishio Y, 2003, GENES IMMUN, V4, P515, DOI 10.1038/sj.gene.6363889; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Sprecher E, 2013, J ALLERGY CLIN IMMUN, V132, P1130, DOI 10.1016/j.jaci.2013.09.026; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Wajid M, 2010, DERMATOLOGY, V220, P8, DOI 10.1159/000265757; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728; Wang IJ, 2011, BRIT J DERMATOL, V164, P791, DOI 10.1111/j.1365-2133.2011.10212.x; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V122, P560, DOI 10.1016/j.jaci.2008.05.050; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317	15	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					280	U458		10.1016/j.jaci.2014.09.042	http://dx.doi.org/10.1016/j.jaci.2014.09.042			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25458912				2022-12-18	WOS:000347298200040
J	Lee, SI; Pham, LD; Shin, YS; Suh, DH; Park, HS				Lee, Seung Ihm; Le Duy Pham; Shin, Yoo Seob; Suh, Dong Hyeon; Park, Hae-Sim			Environmental changes could enhance the biological effect of Hop J pollens on human airway epithelial cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC RESPIRATORY-DISEASES; THYMIC STROMAL LYMPHOPOIETIN; INFLAMMATION		[Lee, Seung Ihm; Le Duy Pham; Shin, Yoo Seob; Suh, Dong Hyeon; Park, Hae-Sim] Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 441749, South Korea	Ajou University	Lee, SI (corresponding author), Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 441749, South Korea.	hspark@ajou.ac.kr		Pham, Duy/0000-0001-5382-9283; Park, Hae-Sim/0000-0003-2614-0303; Shin, Yoo Seob/0000-0002-9855-3185				Beggs PJ, 2010, INT J ENV RES PUB HE, V7, P3006, DOI 10.3390/ijerph7083006; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Jin HJ, 2013, ALLERGY ASTHMA IMMUN, V5, P309, DOI 10.4168/aair.2013.5.5.309; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Matsumura Yasuhiro, 2012, J Allergy (Cairo), V2012, P903659, DOI 10.1155/2012/903659; Oh JW, 2012, ALLERGY ASTHMA IMMUN, V4, P5, DOI 10.4168/aair.2012.4.1.5; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Runswick S, 2007, RESPIROLOGY, V12, P834, DOI 10.1111/j.1440-1843.2007.01175.x	9	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2014	134	2					470	472		10.1016/j.jaci.2014.01.034	http://dx.doi.org/10.1016/j.jaci.2014.01.034			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GB	24636090				2022-12-18	WOS:000341370800028
J	Borte, S; Meeths, M; Liebscher, I; Krist, K; Nordenskjold, M; Hammarstrom, L; von Dobeln, U; Henter, JI; Bryceson, YT				Borte, Stephan; Meeths, Marie; Liebscher, Ines; Krist, Kerstin; Nordenskjold, Magnus; Hammarstrom, Lennart; von Dobeln, Ulrika; Henter, Jan-Inge; Bryceson, Yenan T.			Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MUTATIONS; DISEASES; UNC13D; GUIDELINES; SPECTRUM; STXBP2; FHL3		[Borte, Stephan; Hammarstrom, Lennart] Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden; [Borte, Stephan; Hammarstrom, Lennart] Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Borte, Stephan; Krist, Kerstin] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Borte, Stephan] Hosp St Georg gGmbH Leipzig, ImmunoDeficiencyCtr Leipzig, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, Leipzig, Germany; [Meeths, Marie] Karolinska Inst, Karolinska Univ Hosp Solna, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Meeths, Marie; Nordenskjold, Magnus] Karolinska Inst, Karolinska Univ Hosp Solna, Clin Genet Unit, Dept Mol Med & Surg, Stockholm, Sweden; [Liebscher, Ines] Univ Leipzig, Fac Med, Inst Biochem, Div Mol Biochem, D-04109 Leipzig, Germany; [von Dobeln, Ulrika] Karolinska Inst, Dept Lab Med, Div Metab Dis, Karolinska Univ Hosp Solna, Stockholm, Sweden; [Bryceson, Yenan T.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Bryceson, Yenan T.] Univ Bergen, Broegelmann Res Lab, Gades Inst, Bergen, Norway	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Bergen	Borte, S (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden.	Stephan.Borte@ki.se; Yenan.Bryceson@ki.se	Bryceson, Yenan T/D-2121-2018; Liebscher, Ines/AAX-7478-2020	Bryceson, Yenan T/0000-0002-7783-9934; Liebscher, Ines/0000-0003-4480-8987; Henter, Jan-Inge/0000-0002-0629-2126; Nordenskjold, Magnus/0000-0002-4974-425X				Borte S, 2013, CURR OPIN HEMATOL, V20, P48, DOI 10.1097/MOH.0b013e32835a9130; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Chan K, 2011, MOL GENET METAB, V104, P383, DOI 10.1016/j.ymgme.2011.07.007; Filipovich AH, 2011, CURR OPIN ALLERGY CL, V11, P512, DOI 10.1097/ACI.0b013e32834c22f5; GARVY BA, 1993, BLOOD, V82, P2758; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P428, DOI 10.1111/j.1651-2227.1991.tb11878.x; Meeths M, 2011, BLOOD, V118, P5783, DOI 10.1182/blood-2011-07-369090; Meeths M, 2010, BLOOD, V116, P2635, DOI 10.1182/blood-2010-05-282541; Rohr J, 2010, HAEMATOL-HEMATOL J, V95, P2080, DOI 10.3324/haematol.2010.029389; Seo JY, 2013, ANN HEMATOL, V92, P357, DOI 10.1007/s00277-012-1628-6	12	9	12	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2014	134	1					226	228		10.1016/j.jaci.2014.04.026	http://dx.doi.org/10.1016/j.jaci.2014.04.026			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL2BH	24882743				2022-12-18	WOS:000338930300031
J	Cho, SH; Hong, SJ; Chen, HM; Habib, A; Cho, D; Lee, SH; Kang, J; Ward, T; Boushey, HA; Schleimer, RP; Avila, PC				Cho, Seong H.; Hong, Seung J.; Chen, Haimei; Habib, Ali; Cho, David; Lee, Sun H.; Kang, Joseph; Ward, Theresa; Boushey, Homer A.; Schleimer, Robert P.; Avila, Pedro C.			Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC-ASTHMA		[Cho, Seong H.; Hong, Seung J.; Chen, Haimei; Habib, Ali; Cho, David; Lee, Sun H.; Schleimer, Robert P.; Avila, Pedro C.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Cho, Seong H.; Hong, Seung J.] Kyung Hee Univ, Sch Med, Dept Med, Div Rheumatol, Seoul, South Korea; [Kang, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Ward, Theresa; Boushey, Homer A.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA	Northwestern University; Feinberg School of Medicine; Kyung Hee University; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco	Cho, SH (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA.	seong-cho@northwestern.edu	Cho, Seong/I-7102-2015		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546, R01HL078860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106683, U01AI082984, P01AI050496, R21AI057506] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL078860, R37-HL068546, R01 HL078860, R37 HL068546] Funding Source: Medline; NIAID NIH HHS [R21-AI057506, R21 AI057506, P01-AI050496, P01 AI106683, U01 AI082984, P01 AI050496, U01-AI082984] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cho S, 2011, ANN ALLERG ASTHMA IM, V106, P371, DOI 10.1016/j.anai.2010.12.021; Cho SH, 2000, J IMMUNOL, V165, P3154, DOI 10.4049/jimmunol.165.6.3154; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Ma Z, 2009, CLIN EXP ALLERGY, V39, P1136, DOI 10.1111/j.1365-2222.2009.03272.x; McDonald VM, 2012, CLIN EXP ALLERGY, V42, P670, DOI 10.1111/j.1365-2222.2012.03981.x; Miller EK, 2010, IMMUNOL ALLERGY CLIN, V30, P541, DOI 10.1016/j.iac.2010.08.007; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Pampuch A, 2006, ALLERGY, V61, P234, DOI 10.1111/j.1398-9995.2005.00948.x; Pizzichini MMM, 1998, AM J RESP CRIT CARE, V158, P1178, DOI 10.1164/ajrccm.158.4.9712082	10	9	9	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1465	+		10.1016/j.jaci.2013.11.009	http://dx.doi.org/10.1016/j.jaci.2013.11.009			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24373352	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000335450700032
J	van de Vijver, E; Tool, ATJ; Sanal, O; Cetin, M; Unal, S; Aytac, S; Seeger, K; Pagliara, D; Rutella, S; van den Berg, TK; Kuijpers, TW				van de Vijver, Edith; Tool, Anton T. J.; Sanal, Ozden; Cetin, Mualla; Unal, Sule; Aytac, Selin; Seeger, Karl; Pagliara, Daria; Rutella, Sergio; van den Berg, Timo K.; Kuijpers, Taco W.			Kindlin-3-independent adhesion of neutrophils from patients with leukocyte adhesion deficiency type III	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[van de Vijver, Edith; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [van de Vijver, Edith; Tool, Anton T. J.; van den Berg, Timo K.] Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [Sanal, Ozden] Hacettepe Univ, Pediat Immunol Unit, Ankara, Turkey; [Cetin, Mualla; Unal, Sule; Aytac, Selin] Hacettepe Univ, Pediat Hematol Unit, Ankara, Turkey; [Seeger, Karl] Charite, Otto Heubner Ctr Pediat & Adolescent Med, Dept Pediat Oncol Hematol, D-13353 Berlin, Germany; [Pagliara, Daria; Rutella, Sergio] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol Oncol, Rome, Italy	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Hacettepe University; Ankara University; Hacettepe University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Bambino Gesu	van de Vijver, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.w.kuijpers@amc.uva.nl	Rutella, Sergio/AAF-9187-2020; van den Berg, Timo K/AAC-2479-2022; Rutella, Sergio/AAF-9210-2020; UNAL, SERHAT/I-9034-2013	Rutella, Sergio/0000-0003-1970-7375; UNAL, SERHAT/0000-0003-1184-4711				Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; Kuijpers TW, 2007, BLOOD, V109, P3529, DOI 10.1182/blood-2006-05-021402; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; KUIJPERS TW, 1990, J IMMUNOL, V145, P2588; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; McDowall A, 2003, J CLIN INVEST, V111, P51, DOI 10.1172/JCI200314076; Xue ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056911; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i	9	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2014	133	4					1215	1218		10.1016/j.jaci.2013.10.020	http://dx.doi.org/10.1016/j.jaci.2013.10.020			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AD8QW	24342549				2022-12-18	WOS:000333531700036
J	Rossini, M; Adami, S; Zanotti, R; Viapiana, O; Idolazzi, L; Biondan, M; Gatti, D				Rossini, Maurizio; Adami, Silvano; Zanotti, Roberta; Viapiana, Ombretta; Idolazzi, Luca; Biondan, Marta; Gatti, Davide			Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POSTMENOPAUSAL WOMEN; SCLEROSTIN		[Rossini, Maurizio; Adami, Silvano; Viapiana, Ombretta; Idolazzi, Luca; Biondan, Marta; Gatti, Davide] Univ Verona, Dept Med, Rheumatol Sect, I-37100 Verona, Italy; [Zanotti, Roberta] Univ Verona, Dept Med, Hematol Sect, I-37100 Verona, Italy	University of Verona; University of Verona	Rossini, M (corresponding author), Univ Verona, Dept Med, Rheumatol Sect, I-37100 Verona, Italy.	maurizio.rossini@univr.it	Idolazzi, Luca/X-4024-2019; rossini, maurizio/D-6610-2011	Idolazzi, Luca/0000-0002-7254-4686; gatti, davide/0000-0002-7471-3076; Rossini, Maurizio/0000-0001-9692-2293				Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152; Ardawi MSM, 2011, J BONE MINER RES, V26, P2812, DOI 10.1002/jbmr.479; Mirza FS, 2010, J CLIN ENDOCR METAB, V95, P1991, DOI 10.1210/jc.2009-2283; Rabenhorst A, 2013, J ALLERGY CLIN IMMUN, V132, P1234, DOI 10.1016/j.jaci.2013.06.019; Rossini M, 2011, BONE, V49, P880, DOI 10.1016/j.bone.2011.07.004	5	9	9	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					933	935		10.1016/j.jaci.2013.12.007	http://dx.doi.org/10.1016/j.jaci.2013.12.007			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24439083				2022-12-18	WOS:000332397600056
J	Gill, RK; Al-Subu, A; Elitsur, Y; Gupta, R; Treem, WR; Rabinowitz, S; Schwarz, SM				Gill, Rupinder K.; Al-Subu, Awni; Elitsur, Yoram; Gupta, Raavi; Treem, William R.; Rabinowitz, Simon; Schwarz, Steven M.			Prevalence and characteristics of eosinophilic esophagitis in 2 ethnically distinct pediatric populations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONSENSUS RECOMMENDATIONS; CHILDREN		[Gill, Rupinder K.; Treem, William R.; Rabinowitz, Simon; Schwarz, Steven M.] Suny Downstate Med Ctr, Dept Pediat, Div Gastroenterol, Brooklyn, NY 11203 USA; [Al-Subu, Awni; Elitsur, Yoram] Marshall Univ, Dept Pediat, Div Gastroenterol, Huntington, WV USA; [Gupta, Raavi] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Marshall University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Gill, RK (corresponding author), Suny Downstate Med Ctr, Dept Pediat, Div Gastroenterol, Brooklyn, NY 11203 USA.	Steven.Schwarz@downstate.edu	Al-Subu, Awni/I-1330-2017; Al-Subu, Awni/H-8290-2019	Schwarz, Steven/0000-0002-0871-8506				Assa'ad AH, 2007, J ALLERGY CLIN IMMUN, V119, P731, DOI 10.1016/j.jaci.2006.10.044; Bohm M, 2012, J CLIN GASTROENTEROL, V46, P567, DOI 10.1097/MCG.0b013e31823d3305; Franciosi JP, 2009, CLIN GASTROENTEROL H, V7, P415, DOI 10.1016/j.cgh.2008.10.006; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Jonathan Spergel A M, 2008, J PEDIAT GASTROENTER, V48, P30; Kapel RC, 2008, GASTROENTEROLOGY, V134, P1316, DOI 10.1053/j.gastro.2008.02.016; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Soon IS, 2013, J PEDIATR GASTR NUTR, V57, P72, DOI 10.1097/MPG.0b013e318291fee2; Spergel JM, 2011, J PEDIATR GASTR NUTR, V52, P300, DOI 10.1097/MPG.0b013e3181eb5a9f	9	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					576	577		10.1016/j.jaci.2013.10.042	http://dx.doi.org/10.1016/j.jaci.2013.10.042			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24342547				2022-12-18	WOS:000332397100035
J	Reubsaet, L; Meerding, J; Giezeman, R; de Kleer, I; Arets, B; Prakken, B; Beekman, J; van Wijk, F				Reubsaet, Lieke; Meerding, Jenny; Giezeman, Rianne; de Kleer, Isme; Arets, Bert; Prakken, Berent; Beekman, Jeffrey; van Wijk, Femke			Der p 1-induced CD4(+)FOXP3(+)GATA3(+) T cells have suppressive properties and contribute to the polarization of the T(H)2-associated response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONVERSION; FOXP3		[Reubsaet, Lieke; Meerding, Jenny; Prakken, Berent; van Wijk, Femke] Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Dept Pediat Immunol, Utrecht, Netherlands; [Beekman, Jeffrey] Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Dept Immunol, Utrecht, Netherlands; [Arets, Bert; Beekman, Jeffrey] Wilhelmina Childrens Hosp, Dept Pediat Resp Med, Univ Med Ctr Utrecht, Utrecht, Netherlands; [de Kleer, Isme] Erasmus MC, Lab Pulm Med, Rotterdam, Netherlands; [de Kleer, Isme] Erasmus MC, Dept Pediat Pulmonol, Rotterdam, Netherlands; [Giezeman, Rianne] GGDMN, Dept Publ Child Hlth, Zeist, Netherlands	Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Reubsaet, L (corresponding author), Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Dept Pediat Immunol, Utrecht, Netherlands.	l.l.reubsaet@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014	Beekman, Jeffrey M/0000-0003-4886-3756				Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Hansmann L, 2012, J IMMUNOL, V188, P1275, DOI 10.4049/jimmunol.1102288; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Schirm E, 2004, J CLIN EPIDEMIOL, V57, P737, DOI 10.1016/j.jclinepi.2002.12.001; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Takai T, 2005, BIOCHEM BIOPH RES CO, V328, P944, DOI 10.1016/j.bbrc.2005.01.051; Wang YQ, 2010, J IMMUNOL, V185, P5983, DOI 10.4049/jimmunol.1001255; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456	10	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1440	1444		10.1016/j.jaci.2013.06.028	http://dx.doi.org/10.1016/j.jaci.2013.06.028			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	23900057				2022-12-18	WOS:000327538200028
J	Garrett, JPD; Hoffstad, O; Apter, AJ; Margolis, DJ				Garrett, Jackie P. -D.; Hoffstad, Ole; Apter, Andrea J.; Margolis, David J.			Racial comparison of filaggrin null mutations in asthmatic patients with atopic dermatitis in a US population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							METAANALYSIS; CHILDREN; DISEASE; COHORT; RISK		[Garrett, Jackie P. -D.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Hoffstad, Ole; Margolis, David J.] Univ Penn, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Garrett, Jackie P. -D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Apter, Andrea J.] Univ Penn, Perelman Sch Med, Hosp Univ Penn, Sect Allergy & Immunol,Pulm Allergy & Crit Care D, Philadelphia, PA 19104 USA; [Margolis, David J.] Univ Penn, Perelman Sch Med, Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Garrett, JPD (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	jpdorce@yahoo.com			NIAMS NIH HHS [R01AR056755, R01 AR056755, 5R01AR056755-04] Funding Source: Medline; PHS HHS [R01A056755] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056755] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Kapoor R, 2008, J AM ACAD DERMATOL, V58, P68, DOI 10.1016/j.jaad.2007.06.041; Margolis DJ, 2012, J ALLERGY CLIN IMMUN, V130, P912, DOI 10.1016/j.jaci.2012.07.008; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; McLean WH, 2008, J ALLERGY CLIN IMMUN, V121, P5; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Stefflova K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014495; The American Academy of Allergy, AM AC ALL ASTHM IMM; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433	11	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2013	132	5					1232	1234		10.1016/j.jaci.2013.07.005	http://dx.doi.org/10.1016/j.jaci.2013.07.005			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	242JH	23993222	Green Accepted			2022-12-18	WOS:000326235600032
J	Mohiuddin, MS; Curran-Everett, D; Leung, DYM				Mohiuddin, Maaz S.; Curran-Everett, Douglas; Leung, Donald Y. M.			Vitamin D and food allergy in patients with severe atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							REGULATORY T-CELLS		[Mohiuddin, Maaz S.; Leung, Donald Y. M.] Univ Colorado, Colorado Sch Publ Hlth, Dept Pediat, Div Allergy Immunol, Denver, CO 80202 USA; [Curran-Everett, Douglas] Univ Colorado, Colorado Sch Publ Hlth, Div Biostat & Informat, Natl Jewish Hlth, Denver, CO 80202 USA; [Curran-Everett, Douglas] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Denver, CO 80202 USA	Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Colorado School of Public Health; National Jewish Health; University of Colorado System; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Mohiuddin, MS (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Dept Pediat, Div Allergy Immunol, Denver, CO 80202 USA.	leungd@njhealth.org		Curran-Everett, Douglas/0000-0001-5992-4839				Allen KJ, 2013, J ALLERGY CLIN IMMUN, V131, P1109, DOI 10.1016/j.jaci.2013.01.017; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Muehleisen B, 2013, J ALLERGY CLIN IMMUN, V131, P324, DOI 10.1016/j.jaci.2012.12.1562; R Development Core Team, 2012, R LANG ENV STAT COMP; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759	7	9	9	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					1011	1011		10.1016/j.jaci.2013.06.039	http://dx.doi.org/10.1016/j.jaci.2013.06.039			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23954349				2022-12-18	WOS:000325096500042
J	Notarangelo, LD				Notarangelo, Luigi D.			Partial defects of T-cell development associated with poor T-cell function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunodeficiency; T-cell development; thymus; autoimmunity; tolerance	SEVERE COMBINED IMMUNODEFICIENCY; AUTOSOMAL-RECESSIVE FORM; HYPER-IGE SYNDROME; DOCK8 DEFICIENCY; OMENN-SYNDROME; ORAI1 DEFICIENCY; LYMPHOCYTE TRAFFICKING; CLINICAL PHENOTYPES; SOMATIC MOSAICISM; KINASE-DEFICIENCY	For many years, severe combined immune deficiency diseases, which are characterized by virtual lack of circulating T cells and severe predisposition to infections since early in life, have been considered the prototypic forms of genetic defects of T-cell development. More recently, advances in genome sequencing have allowed identification of a growing number of gene defects that cause severe but incomplete defects in T-cell development, function, or both. Along with recurrent and severe infections, especially cutaneous viral infections, the clinical phenotype of these conditions is characterized by prominent immune dysregulation.	[Notarangelo, Luigi D.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Notarangelo, LD (corresponding author), Childrens Hosp, Div Immunol, Karp Res Bldg,10th Floor,Rm 10217,1 Blackfan Circ, Boston, MA 02115 USA.	luigi.notarangelo@childrens.harvard.edu	Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262	National Institutes of Health [1PO1AI076210-01A1R01]; March of Dimes; Jeffrey Modell Foundation; Manton Foundation; Wiskott-Aldrich Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Jeffrey Modell Foundation; Manton Foundation; Wiskott-Aldrich Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by National Institutes of Health grant 1PO1AI076210-01A1R01, a March of Dimes grant, the Jeffrey Modell Foundation, and the Manton Foundation.; Disclosure of potential conflict of interest: L. D. Notarangelo has received grants from the National Institutes of Health, the Manton Foundation, and the Jeffrey Modell Foundation; has served as a member on the Board of the Immune Disease Institute; is employed by Children's Hospital Boston; has grants/grants pending from the National Institutes of Health, the March of Dimes, and the Wiskott-Aldrich Foundation; and has received royalties from UpToDate.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Al-Herz W, 2012, CLIN IMMUNOL, V143, P266, DOI 10.1016/j.clim.2012.03.002; Alsum Z, 2013, J CLIN IMMUNOL, V33, P55, DOI 10.1007/s10875-012-9769-x; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Atherly LO, 2006, J IMMUNOL, V176, P1571, DOI 10.4049/jimmunol.176.3.1571; Avila EM, 2010, PEDIATRICS, V126, pE1248, DOI 10.1542/peds.2009-3171; Bachmann MF, 1997, J VIROL, V71, P7253, DOI 10.1128/JVI.71.10.7253-7257.1997; Barlogis V, 2011, J ALLERGY CLIN IMMUN, V128, P420, DOI 10.1016/j.jaci.2011.03.025; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Bittner TC, 2010, KLIN PADIATR, V222, P351, DOI 10.1055/s-0030-1265135; Blomberg KEM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-233; Brandao K, 2013, IMMUNOL RES, V55, P261, DOI 10.1007/s12026-012-8371-x; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Cassani B, 2010, J ALLERGY CLIN IMMUN, V125, P209, DOI 10.1016/j.jaci.2009.10.023; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chou J, 2012, J ALLERGY CLIN IMMUN, V130, P1414, DOI 10.1016/j.jaci.2012.06.012; Chu DH, 1999, J IMMUNOL, V163, P2610; Chu EY, 2012, ARCH DERMATOL, V148, P79, DOI 10.1001/archdermatol.2011.262; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; Dalal I, 2005, CLIN IMMUNOL, V115, P70, DOI 10.1016/j.clim.2004.08.016; Dasouki M, 2011, CLIN IMMUNOL, V141, P128, DOI 10.1016/j.clim.2011.06.003; de la Calle-Martin O, 2001, J CLIN INVEST, V108, P117, DOI 10.1172/JCI10993; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Felgentreff K, 2011, CLIN IMMUNOL, V141, P73, DOI 10.1016/j.clim.2011.05.007; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Gatz SA, 2011, BONE MARROW TRANSPL, V46, P552, DOI 10.1038/bmt.2010.169; Ghost S, 2012, CLIN IMMUNOL, V145, P259, DOI 10.1016/j.clim.2012.10.003; Goldman FD, 1998, J CLIN INVEST, V102, P421, DOI 10.1172/JCI3205; Gorska MM, 2012, BLOOD, V119, P1399, DOI 10.1182/blood-2011-04-350686; Gorska MM, 2009, J IMMUNOL, V183, P1675, DOI 10.4049/jimmunol.0900792; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Gu Y, 2005, BLOOD, V105, P1467, DOI 10.1182/blood-2004-04-1604; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Hauck F, 2012, J ALLERGY CLIN IMMUN, V130, P1144, DOI 10.1016/j.jaci.2012.07.029; Hirschhom R, 2007, PRIMARY IMMUNODEFICI, P169; HIRSCHHORN R, 1994, AM J HUM GENET, V55, P59; Hirve N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045158; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Hubert P, 2000, INT IMMUNOL, V12, P449, DOI 10.1093/intimm/12.4.449; Huck K, 2009, J CLIN INVEST, V119, P1350, DOI 10.1172/JCI37901; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Katamura K, 1999, CLIN EXP IMMUNOL, V115, P124; Kawai T, 2012, J CLIN IMMUNOL, V32, P690, DOI 10.1007/s10875-012-9684-1; Kim KD, 2011, J IMMUNOL, V187, P3620, DOI 10.4049/jimmunol.1100847; Kuijpers TW, 2011, BLOOD, V117, P5892, DOI 10.1182/blood-2011-01-329052; Lambe T, 2011, EUR J IMMUNOL, V41, P3423, DOI 10.1002/eji.201141759; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Lin YP, 2010, MOL IMMUNOL, V47, P2022, DOI 10.1016/j.molimm.2010.04.011; Linka RM, 2012, LEUKEMIA, V26, P963, DOI 10.1038/leu.2011.371; Mansouri D, 2012, INT ARCH ALLERGY IMM, V158, P418, DOI 10.1159/000333472; Marrella V, 2011, CURR OPIN ALLERGY CL, V11, P525, DOI 10.1097/ACI.0b013e32834c311a; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; Morgan NV, 2011, J CLIN INVEST, V121, P695, DOI 10.1172/JCI41931; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Picard C, 2010, IMMUNOL ALLERGY CLIN, V30, P173, DOI 10.1016/j.iac.2010.01.001; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Poliani PL, 2012, J ALLERGY CLIN IMMUN; Porubsky S, 2011, EUR J IMMUNOL, V41, P76, DOI 10.1002/eji.201040420; Qi Q, 2012, J IMMUNOL, V188, P3611, DOI 10.4049/jimmunol.1102475; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Robinson LJ, 2012, LAB INVEST, V92, P1071, DOI 10.1038/labinvest.2012.72; Roifman CM, 2012, J ALLERGY CLIN IMMUN, V130, P177, DOI 10.1016/j.jaci.2012.04.029; Roifman CM, 2010, J ALLERGY CLIN IMMUN, V126, P1226, DOI 10.1016/j.jaci.2010.07.029; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sanal O, 2012, J CLIN IMMUNOL, V32, P698, DOI 10.1007/s10875-012-9664-5; Sawabe T, 2001, INT J MOL MED, V7, P609; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Shaw PJ, 2012, J PHYSIOL-LONDON, V590, P4157, DOI 10.1113/jphysiol.2012.233221; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Somech R, 2009, J ALLERGY CLIN IMMUN, V124, P793, DOI 10.1016/j.jaci.2009.06.048; Stepensky P, 2011, HAEMATOL-HEMATOL J, V96, P472, DOI 10.3324/haematol.2010.033910; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Su HC, 2011, ANN NY ACAD SCI, V1246, P26, DOI 10.1111/j.1749-6632.2011.06295.x; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Ueda Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2105; van der Burg M, 2011, EUR J PEDIATR, V170, P561, DOI 10.1007/s00431-011-1452-3; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Volkers M, 2012, J CELL SCI, V125, P287, DOI 10.1242/jcs.090464; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; Wada T, 2008, BLOOD, V112, P1872, DOI 10.1182/blood-2008-04-149708; Wada T, 2008, CURR OPIN ALLERGY CL, V8, P510, DOI 10.1097/ACI.0b013e328314b651; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; WANGE RL, 1992, J BIOL CHEM, V267, P11685; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xie Q, 2012, J MOL BIOL; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105; Zimmer J, 2005, QJM-INT J MED, V98, P719, DOI 10.1093/qjmed/hci112	129	9	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2013	131	5					1297	1305		10.1016/j.jaci.2013.01.020	http://dx.doi.org/10.1016/j.jaci.2013.01.020			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	144AU	23465662	Green Accepted			2022-12-18	WOS:000318912200004
J	Chew, GYJ; Sinha, U; Gatenby, PA; DeMalmanche, T; Adelstein, S; Garsia, R; Hissaria, P; French, MA; Wilson, A; Whittle, B; Kirkpatrick, P; Riminton, DS; Fulcher, DA; Cook, MC				Chew, Gary Y. J.; Sinha, Umang; Gatenby, Paul A.; DeMalmanche, Theo; Adelstein, Stephen; Garsia, Roger; Hissaria, Pravin; French, Martyn A.; Wilson, Anastasia; Whittle, Belinda; Kirkpatrick, Philippa; Riminton, D. Sean; Fulcher, David A.; Cook, Matthew C.			Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Primary antibody deficiency; common variable immunodeficiency; selective IgA deficiency; IgG subclass deficiency; specific antibody deficiency; autoimmunity; protein tyrosine phosphatase nonreceptor type 22	COMMON VARIABLE IMMUNODEFICIENCY; SINGLE-NUCLEOTIDE POLYMORPHISM; MEMORY B-CELLS; IGA DEFICIENCY; C1858T POLYMORPHISM; MOTH-EATEN; MUTATIONS; ALLELE; GENE; TOLERANCE	Background: The 1858T allele of protein tyrosine phosphatase nonreceptor type 22 (PTPN22; R620W) exhibits one of the strongest and most consistent associations with sporadic autoimmune disease. Although autoimmunity is common in patients with primary antibody deficiency (PAD), it remains unknown whether its pathogenesis is similar when it arises in this context compared with in immunocompetent patients. Objective: We set out to determine whether the 1858T allele of PTPN22 was associated with PAD or with autoimmunity in the context of PAD. Methods: We genotyped rs2476601 (g. 1858C>T), a single nucleotide polymorphism encoding substitution of arginine for tryptophan in PTPN22 (R620W), in 193 patients with PAD and 148 control subjects from an Australian cohort. We also performed a subgroup analysis according to the presence of autoimmunity and B-cell phenotypes. Results: C/T and T/T PTPN22 genotypes were more common in patients with PAD than in the matched control subjects (C/T, 18.1% vs 9.5%; T/T, 1.04% vs 0.6%). The T allele was associated with an increased risk of PAD relative to control subjects (odds ratio, 2.10; 95% CI, 1.11-4.00). The distribution of genotypes in control subjects was similar to those reported previously and did not deviate significantly from Hardy-Weinberg equilibrium. We found a strong association between the 1858T allele and PAD with coexistent autoimmune diseases. In patients with PAD and autoimmunity, 16 (43.2%) of 37 had at least one T allele of PTPN22 compared with 27 (17.3%) of 156 with the C/C genotype (P 5.0014; odds ratio, 3.64; 95% CI, 1.68-7.88). We found no evidence that this effect was mediated by enrichment of CD21 low B cells. Conclusion: The 1858T PTPN22 allele is strongly associated with autoimmunity in patients with PAD. (J Allergy Clin Immunol 2013; 131:1130-5.)	[Chew, Gary Y. J.; Sinha, Umang; Gatenby, Paul A.; Wilson, Anastasia; Cook, Matthew C.] Canberra Hosp, Dept Immunol & Translat Res, Woden, ACT, Australia; [Chew, Gary Y. J.; Sinha, Umang; Wilson, Anastasia; Cook, Matthew C.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia; [DeMalmanche, Theo] HAPS Immunol, New Lambton, Australia; [Adelstein, Stephen; Garsia, Roger] Royal Prince Alfred Hosp, Dept Immunol, Camperdown, NSW 2050, Australia; [Hissaria, Pravin] Royal Adelaide Hosp, SA Pathol, Head Translat Clin Res LabIMVS, Adelaide, SA 5000, Australia; [French, Martyn A.] Royal Perth Hosp, Dept Clin Immunol, Perth, WA 6001, Australia; [French, Martyn A.] Univ Western Australia, Path West Lab Med, Perth, WA 6009, Australia; [French, Martyn A.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Whittle, Belinda] Australian Natl Univ, Australian Phen Facil, Canberra, ACT, Australia; [Kirkpatrick, Philippa; Riminton, D. Sean] Concord Hosp, Dept Immunol, Sydney, NSW, Australia; [Fulcher, David A.] Westmead Hosp, Dept Immunopathol, Inst Clin Pathol & Med Res, Sydney, NSW, Australia	Australian National University; Canberra Hospital; Australian National University; John Curtin School of Medical Research; University of Sydney; Royal Adelaide Hospital; SA Pathology; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Australian National University; Concord Repatriation General Hospital; University of Sydney	Cook, MC (corresponding author), Canberra Hosp, Dept Immunol & Translat Res, Level 6,Bldg 10,POB 11, Woden, ACT, Australia.	matthew.cook@anu.edu.au	Cook, matthew/F-4151-2019; Adelstein, Stephen/I-7936-2016	Cook, matthew/0000-0002-3331-9363; Adelstein, Stephen/0000-0001-7221-6298; Riminton, Sean/0000-0002-9953-9959; French, Martyn/0000-0002-4644-1982	National Health and Medical Research Council (Australia) [585464]; CSL; National Health and Medical Research Council; Australasia Society of Clinical Immunology and Allergy	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); CSL; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australasia Society of Clinical Immunology and Allergy	Supported by the National Health and Medical Research Council (Australia) (project grant 585464 to D. A. F. and M. C. C.).; Disclosure of potential conflict of interest: G.Y.J. Chew has received research support from the National Health and Medical Research Council (Australia). P. Hissaria has received consultancy fees from CSL. D. A. Fulcher has received research support from the National Health and Medical Research Council. M. C. Cook has received research support from the National Health and Medical Research Council and the Australasia Society of Clinical Immunology and Allergy. The rest of the authors declare that they have no relevant conflicts of interest.	Agarwal S, 2009, CURR ALLERGY ASTHM R, V9, P347, DOI 10.1007/s11882-009-0051-0; Alachkar H, 2006, CLIN IMMUNOL, V120, P310, DOI 10.1016/j.clim.2006.05.003; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; [Anonymous], 2006, RHEUMATOLOGY, V45, P365, DOI 10.1093/rheumatology/kel005; Barsalou J, 2011, CLIN EXP RHEUMATOL, V29, P125; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bengra C, 2002, CLIN CHEM, V48, P2131; Bloch-Michel C, 2003, REV MED INTERNE, V24, P640, DOI 10.1016/S0248-8663(03)00189-9; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Carneiro-Sampaio M, 2007, ADV IMMUNOL, V95, P51, DOI 10.1016/S0065-2776(07)95002-6; CASSIDY JT, 1969, NEW ENGL J MED, V280, P275; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chapman SJ, 2006, NAT GENET, V38, P499, DOI 10.1038/ng0506-499; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Goldacker S, 2005, CURR OPIN ALLERGY CL, V5, P504, DOI 10.1097/01.all.0000191888.97397.b3; Gomez LM, 2005, GENES IMMUN, V6, P628, DOI 10.1038/sj.gene.6364261; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hawkins JR, 2002, HUM MUTAT, V19, P543, DOI 10.1002/humu.10060; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jacob CMA, 2008, J CLIN IMMUNOL, V28, pS56, DOI 10.1007/s10875-007-9163-2; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Ko J, 2005, CLIN IMMUNOL, V116, P37, DOI 10.1016/j.clim.2005.03.019; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; Kung C, 2000, NAT MED, V6, P343; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lea WW, 2011, LUPUS, V20, P51, DOI 10.1177/0961203310381774; Santiago JL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-54; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Mustelin T, 2004, MOL IMMUNOL, V41, P687, DOI 10.1016/j.molimm.2004.04.015; Notarangelo LD, 2006, ADV IMMUNOL, V89, P321, DOI 10.1016/S0065-2776(05)89008-X; Nunez C, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-25; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Rickert AM, 2004, ANAL BIOCHEM, V330, P288, DOI 10.1016/j.ab.2004.03.035; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Roycroft M, 2009, CLIN ENDOCRINOL, V70, P358, DOI 10.1111/j.1365-2265.2008.03380.x; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Salzer U, 2004, CLIN IMMUNOL, V113, P234, DOI 10.1016/j.clim.2004.07.002; Salzer U, 2009, BLOOD, V113, P1967, DOI 10.1182/blood-2008-02-141937; Sarmiento E, 2005, Allergol Immunopathol (Madr), V33, P69, DOI 10.1157/13072916; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Warnatz K, 2002, IMMUNOBIOLOGY, V206, P502, DOI 10.1078/0171-2985-00198; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001	52	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1130	+		10.1016/j.jaci.2012.06.023	http://dx.doi.org/10.1016/j.jaci.2012.06.023			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	22857794				2022-12-18	WOS:000317187200023
J	Agbotounou, W; Martin, L; Dupont, B; Pascal, I; Vauleon, C; Benhamou, PH				Agbotounou, Wence; Martin, Laurent; Dupont, Bertrand; Pascal, Isabelle; Vauleon, Cecile; Benhamou, Pierre Henri			Epicutaneous Immunotherapy (EPIT) Is Safe for the Treatment of Peanut Allergy in Allergic Patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Agbotounou, Wence; Martin, Laurent; Dupont, Bertrand; Pascal, Isabelle; Vauleon, Cecile] DBV Technol, Bagneux, France; [Benhamou, Pierre Henri] DBV Technol, Paris, France										0	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB91	AB91		10.1016/j.jaci.2012.12.992	http://dx.doi.org/10.1016/j.jaci.2012.12.992			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800330
J	Pandey, RC; Michel, S; Tesse, R; Binia, A; Schedel, M; Liang, LM; Klopp, N; Franke, A; von Berg, A; Bufe, A; Rietschel, E; Heinzmann, A; Laub, O; Simma, B; Frischer, T; Genuneit, J; Illig, T; Kabesch, M				Pandey, Ramesh Chandra; Michel, Sven; Tesse, Riccardina; Binia, Aristea; Schedel, Michaela; Liang, Liming; Klopp, Norman; Franke, Andre; von Berg, Andrea; Bufe, Albrecht; Rietschel, Ernst; Heinzmann, Andrea; Laub, Otto; Simma, Burkhard; Frischer, Thomas; Genuneit, Jon; Illig, Thomas; Kabesch, Michael			Genetic variation in the Toll-like receptor signaling pathway is associated with childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DENDRITIC CELLS; ATOPY		[Pandey, Ramesh Chandra; Michel, Sven; Tesse, Riccardina; Binia, Aristea; Schedel, Michaela; Kabesch, Michael] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Klopp, Norman; Illig, Thomas] Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Neuherberg, Germany; [Klopp, Norman; Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [von Berg, Andrea] Marien Hosp, Childrens Dept, Res Inst Prevent Allerg Dis, Wesel, Germany; [Bufe, Albrecht] Ruhr Univ Bochum, Dept Expt Pneumol, Bochum, Germany; [Rietschel, Ernst] Univ Cologne, Univ Childrens Hosp, D-50931 Cologne, Germany; [Heinzmann, Andrea] Univ Freiburg, Univ Childrens Hosp, D-79106 Freiburg, Germany; [Laub, Otto] Kinder & Jugendarztpraxis Laub, Rosenheim, Germany; [Simma, Burkhard] Landeskrankenhaus Feldkirch, Univ Teaching Hosp, Childrens Dept, Feldkirch, Austria; [Frischer, Thomas] Univ Childrens Hosp Vienna, Vienna, Austria; [Genuneit, Jon] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Kabesch, Michael] Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, Regensburg, Germany	Hannover Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; University of Kiel; St. Marien Hospital; Ruhr University Bochum; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University Hospital Vienna; Ulm University	Pandey, RC (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany.		Genuneit, Jon/I-9323-2012; Kabesch, Michael/AAB-5701-2020; Schedel, Michaela/B-3065-2019; Franke, Andre/B-2151-2010; Kabesch, Michael/GZM-1583-2022	Genuneit, Jon/0000-0001-5764-1528; Schedel, Michaela/0000-0001-8465-2986; Franke, Andre/0000-0003-1530-5811; Bufe, Albrecht/0000-0001-7335-9362; Michel, Sven/0000-0003-3604-3187; Binia, Aristea/0000-0002-8327-049X				Albrecht V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-69; Bullens DMA, 2004, CLIN EXP ALLERGY, V34, P879, DOI 10.1111/j.1365-2222.2004.01955.x; Gerthoffer WT, 2003, RESP PHYSIOL NEUROBI, V137, P237, DOI 10.1016/S1569-9048(03)00150-2; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Nakashima K, 2006, J HUM GENET, V51, P284, DOI 10.1007/s10038-005-0358-1; Re F, 2004, IMMUNOBIOLOGY, V209, P191, DOI 10.1016/j.imbio.2004.03.005; Reijmerink NE, 2010, ALLERGY, V65, P199, DOI 10.1111/j.1398-9995.2009.02111.x; Ringwood L, 2008, CYTOKINE, V42, P1, DOI 10.1016/j.cyto.2007.12.012; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Tesse R, 2011, ALLERGY, V66, P307, DOI 10.1111/j.1398-9995.2010.02489.x	10	9	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					602	605		10.1016/j.jaci.2012.10.061	http://dx.doi.org/10.1016/j.jaci.2012.10.061			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23273951				2022-12-18	WOS:000314661500048
J	Radin, A; Ren, HB; Papino-Wood, P; Chaudhry, U; Hamilton, JD				Radin, Allen; Ren, Haobo; Papino-Wood, Pamela; Chaudhry, Usman; Hamilton, Jennifer D.			First-in-Human Study of REGN668/SAR231893 (IL-4R alpha mAb): Safety, Tolerability and Biomarker Results of a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Radin, Allen; Papino-Wood, Pamela; Chaudhry, Usman; Hamilton, Jennifer D.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Ren, Haobo] Regeneron Pharmaceut Inc, Basking Ridge, NJ USA	Regeneron									0	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB158	AB158		10.1016/j.jaci.2012.12.1224	http://dx.doi.org/10.1016/j.jaci.2012.12.1224			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC		Bronze			2022-12-18	WOS:000316550800556
J	Tsuang, A; Menon, N; Setia, N; Geyman, L; Nowak-Wegrzyn, AH				Tsuang, Angela; Menon, Nikhil; Setia, Natasha; Geyman, Larry; Nowak-Wegrzyn, Anna H.			Multiple Epinephrine Doses in Food-Induced Anaphylaxis in Children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Tsuang, Angela; Menon, Nikhil; Setia, Natasha; Geyman, Larry; Nowak-Wegrzyn, Anna H.] Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai									0	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB90	AB90		10.1016/j.jaci.2012.12.989	http://dx.doi.org/10.1016/j.jaci.2012.12.989			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800327
J	Ghoreschi, K; Fischer, J; Biedermann, T				Ghoreschi, Kamran; Fischer, Joerg; Biedermann, Tilo			Manifestation of rheumatoid arthritis during subcutaneous allergen-specific immunotherapy with bee venom	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Ghoreschi, Kamran; Fischer, Joerg; Biedermann, Tilo] Univ Tubingen, Univ Med Ctr, Dept Dermatol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ghoreschi, K (corresponding author), Univ Tubingen, Univ Med Ctr, Dept Dermatol, Tubingen, Germany.	Tilo.Biedermann@med.uni-tuebingen.de		Ghoreschi, Kamran/0000-0002-5526-7517; Biedermann, Tilo/0000-0002-5352-5105				Kneilling M, 2007, ARTHRITIS RHEUM, V56, P1806, DOI 10.1002/art.22602; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Linneberg A, 2012, J ALLERGY CLIN IMMUN, V129, P413, DOI 10.1016/j.jaci.2011.09.007; Nakajima H, 2003, EUR NEUROL, V50, P248, DOI 10.1159/000073867; Turkcapar N, 2005, RHEUMATOL INT, V26, P182, DOI 10.1007/s00296-005-0606-x; Wenzel J, 2003, ALLERGY, V58, P1176, DOI 10.1034/j.1398-9995.2003.00268.x; Zuberbier T, 2010, ALLERGY, V65, P1525, DOI 10.1111/j.1398-9995.2010.02474.x	7	9	9	0	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2012	130	6					1438	1439		10.1016/j.jaci.2012.08.052	http://dx.doi.org/10.1016/j.jaci.2012.08.052			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	044RP	23098811				2022-12-18	WOS:000311641100036
J	Bisgaard, H; Swern, AS; Knorr, B				Bisgaard, Hans; Swern, Arlene S.; Knorr, Barbara			"To wheeze or not to wheeze'': That is not the question-the sequel	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA; VALIDATION; PARENTS		[Bisgaard, Hans] Univ Copenhagen, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark; [Bisgaard, Hans] Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Copenhagen, Denmark; [Swern, Arlene S.] Celgene Corp, Summit, NJ USA; [Knorr, Barbara] Merck Res Labs, Rahway, NJ USA	University of Copenhagen; University of Copenhagen; Bristol-Myers Squibb; Celgene Corporation; Merck & Company	Bisgaard, H (corresponding author), Univ Copenhagen, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark.	bisgaard@copsac.com	Bisgaard, Hans/N-4761-2016; Kronow, Joern/B-1054-2011	Bisgaard, Hans/0000-0003-4131-7592; 				Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Cane RS, 2001, ARCH DIS CHILD, V84, P31, DOI 10.1136/adc.84.1.31; Knorr B, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e48; Lowe L, 2004, ARCH DIS CHILD, V89, P540, DOI 10.1136/adc.2003.038539; Rivera-Spoljaric K, 2009, J PEDIATR-US, V154, P877, DOI 10.1016/j.jpeds.2008.12.029; Santanello NC, 2000, J ALLERGY CLIN IMMUN, V106, P861, DOI 10.1067/mai.2000.110478; Santanello NC, 1999, ARCH DIS CHILD, V80, P414, DOI 10.1136/adc.80.5.414; Skytt N, 2012, J ALLERGY CLIN IMMUN, V130, P403, DOI 10.1016/j.jaci.2012.04.043; Swern AS, 2008, ANN ALLERG ASTHMA IM, V101, P626, DOI 10.1016/S1081-1206(10)60226-8	10	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					531	532		10.1016/j.jaci.2011.10.047	http://dx.doi.org/10.1016/j.jaci.2011.10.047			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22365706				2022-12-18	WOS:000307002200038
J	Verlaan, DJ; Ouimet, M; Adoue, V; Sirois-Gagnon, D; Lariviere, M; Ge, B; Beaulieu, P; Dias, J; Lam, KCL; Koka, V; Laprise, C; Pastinen, T; Sinnett, D				Verlaan, Dominique J.; Ouimet, Manon; Adoue, Veronique; Sirois-Gagnon, Dave; Lariviere, Mathieu; Ge, Bing; Beaulieu, Patrick; Dias, Joana; Lam, Kevin C. L.; Koka, Vonda; Laprise, Catherine; Pastinen, Tomi; Sinnett, Daniel			Promoter polymorphisms in CHI3L1 are associated with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHITINASE 3-LIKE-1 CHI3L1; GENE-EXPRESSION; POPULATIONS; LUNG		[Verlaan, Dominique J.; Ouimet, Manon; Lariviere, Mathieu; Beaulieu, Patrick; Sinnett, Daniel] St Justine Univ Hlth Ctr, Montreal, PQ, Canada; [Verlaan, Dominique J.; Adoue, Veronique; Ge, Bing; Dias, Joana; Lam, Kevin C. L.; Koka, Vonda; Pastinen, Tomi] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sirois-Gagnon, Dave; Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada; [Sirois-Gagnon, Dave] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Sinnett, Daniel] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; University of Quebec; University of Quebec Chicoutimi; Laval University; Universite de Montreal	Verlaan, DJ (corresponding author), St Justine Univ Hlth Ctr, Montreal, PQ, Canada.	daniel.sinnett@umontreal.ca	sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676; Adoue, Veronique/0000-0003-3548-7456; Laprise, Catherine/0000-0001-5526-9945				Belanger H, 2005, HUM MOL GENET, V14, P2641, DOI 10.1093/hmg/ddi298; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Rathcke CN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006106; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zhao XZ, 2007, AM J HUM GENET, V80, P12, DOI 10.1086/510438	11	9	9	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					533	535		10.1016/j.jaci.2012.03.015	http://dx.doi.org/10.1016/j.jaci.2012.03.015			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22534532				2022-12-18	WOS:000307002200039
J	Saltzman, RW; Monaco-Shawver, L; Zhang, KJ; Sullivan, KE; Filipovich, AH; Orange, JS				Saltzman, Rushani W.; Monaco-Shawver, Linda; Zhang, Kejian; Sullivan, Kathleen E.; Filipovich, Alexandra H.; Orange, Jordan S.			Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							LYMPHOHISTIOCYTOSIS TYPE 5; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS		[Saltzman, Rushani W.; Sullivan, Kathleen E.; Orange, Jordan S.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Monaco-Shawver, Linda; Sullivan, Kathleen E.; Orange, Jordan S.] Childrens Hosp Res Inst, Philadelphia, PA USA; [Zhang, Kejian] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Filipovich, Alexandra H.] Cincinnati Childrens Hosp Med Ctr, Div Hematol Oncol, Immunodeficiency & Histiocytosis Program, Cincinnati, OH USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Saltzman, RW (corresponding author), Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA.	saltzmanr@email.chop.edu	zhang, ke/AAH-8217-2019	orange, jordan/0000-0001-7117-7725; Sullivan, Kathleen/0000-0003-4018-1646	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067946] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI067946, R01 AI067946-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cetica V, 2010, J MED GENET, V47, P595, DOI 10.1136/jmg.2009.075341; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Filipovich AH, 2008, IMMUNOL ALLERGY CLIN, V28, P293, DOI 10.1016/j.iac.2008.01.010; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Meeths M, 2010, BLOOD, V116, P2635, DOI 10.1182/blood-2010-05-282541; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Orange JS, 2011, J CLIN INVEST, V121, P1535, DOI 10.1172/JCI44862; Stadt UZ, 2006, HUM MUTAT, V27, P62, DOI 10.1002/humu.20274; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	9	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1666	1668		10.1016/j.jaci.2011.12.1003	http://dx.doi.org/10.1016/j.jaci.2011.12.1003			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22336081	Green Accepted			2022-12-18	WOS:000304764600029
J	Lotvall, J; Pawankar, R; Wallace, DV; Akdis, CA; Rosenwasser, LJ; Weber, RW; Burks, AW; Casale, TB; Lockey, RF; Papadopoulos, NG; Fineman, SM; Ledford, DK				Lotvall, Jan; Pawankar, Ruby; Wallace, Dana V.; Akdis, Cezmi A.; Rosenwasser, Lanny J.; Weber, Richard W.; Burks, A. Wesley; Casale, Thomas B.; Lockey, Richard F.; Papadopoulos, Nikolaos G.; Fineman, Stanley M.; Ledford, Dennis K.		AAAAI; ACAAI; EAACI; WAO	We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; allergy; immunology	PREVALENCE; TRENDS		[Casale, Thomas B.] Creighton Univ, Omaha, NE 68131 USA; [Lotvall, Jan] Univ Gothenburg, Krefting Res Ctr, Gothenburg, Sweden; [Pawankar, Ruby] Nippon Med Sch, Tokyo 113, Japan; [Wallace, Dana V.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Rosenwasser, Lanny J.] Childrens Mercy Hosp, Kansas City, MO USA; [Weber, Richard W.] Natl Jewish Hlth, Denver, CO USA; [Burks, A. Wesley] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Lockey, Richard F.; Ledford, Dennis K.] Univ S Florida, Div Allergy Immunol, Tampa, FL USA; [Papadopoulos, Nikolaos G.] Univ Athens, Dept Allergy, Pediat Clin 2, GR-10679 Athens, Greece; [Fineman, Stanley M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Creighton University; University of Gothenburg; Nippon Medical School; Nova Southeastern University; Swiss Institute of Allergy & Asthma Research; University of Zurich; Children's Mercy Hospital; National Jewish Health; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of South Florida; National & Kapodistrian University of Athens; Emory University	Casale, TB (corresponding author), Creighton Univ, 601 N 30th St,Suite 5850, Omaha, NE 68131 USA.	tbcasale@creighton.edu	Akdis, Cezmi/AAV-4844-2020; Papadopoulos, Nikolaos/ABE-1774-2021; Casale, Thomas B/K-4334-2013; N.G., Papadopoulos/L-8670-2013	Akdis, Cezmi/0000-0001-8020-019X; Papadopoulos, Nikolaos/0000-0002-4448-3468; Casale, Thomas B/0000-0002-3149-7377; N.G., Papadopoulos/0000-0002-4448-3468; Lotvall, Jan/0000-0001-9195-9249				Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Lotvall J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-94; Pawankar R, 2011, WAOWHITE BOOK ALLERG, P1; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Robinson CL, 2011, THORAX, V66, P1051, DOI 10.1136/thx.2011.158956; Ronmark E, 2002, RESP MED, V96, P1006, DOI 10.1053/rmed.2002.1391; Schoenwetter WF, 2004, CURR MED RES OPIN, V20, P305, DOI 10.1185/030079903125003053; Settipane Russell A, 2007, Clin Allergy Immunol, V19, P23; VARJONEN E, 1992, ALLERGY, V47, P243, DOI 10.1111/j.1398-9995.1992.tb00657.x	9	9	13	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2012	129	4					904	905		10.1016/j.jaci.2012.02.009	http://dx.doi.org/10.1016/j.jaci.2012.02.009			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	917AP	23268470	Green Published			2022-12-18	WOS:000302144600003
J	Gevaert, P; Calus, L; Van Zele, T; Blomme, K; De Ruyck, N; Bauters, W; Hellings, P; De Bacquer, D; Brusselle, G; Van Cauwenberge, P; Bachert, C				Gevaert, P.; Calus, L.; Van Zele, T.; Blomme, K.; De Ruyck, N.; Bauters, W.; Hellings, P.; De Bacquer, D.; Brusselle, G.; Van Cauwenberge, P.; Bachert, C.			Omalizumab Is Effective In Allergic And Non-allergic Patients With Nasal Polyps And Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Gevaert, P.; Calus, L.; Van Zele, T.; Blomme, K.; De Ruyck, N.; Bauters, W.; Hellings, P.; De Bacquer, D.; Brusselle, G.; Van Cauwenberge, P.; Bachert, C.] Univ Ghent, B-9000 Ghent, Belgium	Ghent University			Gevaert, Philippe/ABA-4588-2021; Hellings, Peter W/I-4068-2018; Bachert, Claus/J-8825-2012; De Bacquer, Dirk/HGU-3191-2022; Gevaert, Philippe/AAP-1892-2020	Hellings, Peter W/0000-0001-6898-688X; Gevaert, Philippe/0000-0002-1629-8468; Van Zele, Thibaut/0000-0002-6031-4293					0	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB69	AB69		10.1016/j.jaci.2011.12.749	http://dx.doi.org/10.1016/j.jaci.2011.12.749			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400259
J	Koletzko, S; Filipiak-Pittroff, B; Koletzko, B; von Berg, A; Kramer, U; Berdel, D; Heinrich, J				Koletzko, Sibylle; Filipiak-Pittroff, Birgit; Koletzko, Berthold; von Berg, Andrea; Kraemer, Ursula; Berdel, Dietrich; Heinrich, Joachim		German Infant Nutr Intervention St	No reason to change the current guidelines on allergy prevention	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFANT NUTRITIONAL INTERVENTION; FORMULAS; RISK		[Koletzko, Sibylle; Koletzko, Berthold] Univ Munich, Med Ctr, Hauner Childrens Hosp, Munich, Germany; [Filipiak-Pittroff, Birgit; Heinrich, Joachim] German Res Ctr Environm Hlth GmbH, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [von Berg, Andrea] Marien Hosp Wesel, Dept Paediat, Wesel, Germany; [Kraemer, Ursula] Leibniz Res Inst Environm Med, IUF, Dusseldorf, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; St. Marien Hospital; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Koletzko, S (corresponding author), Univ Munich, Med Ctr, Hauner Childrens Hosp, Munich, Germany.	sibylle.koletzko@med.uni-muenchen.de	Heinrich, Joachim/N-1720-2013	Heinrich, Joachim/0000-0002-9620-1629				Koplin J, 2008, J ALLERGY CLIN IMMUN, V121, P1455, DOI 10.1016/j.jaci.2008.03.017; Lowe AJ, 2011, J ALLERGY CLIN IMMUN, V128, P360, DOI 10.1016/j.jaci.2010.05.006; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003664.pub3; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; von Berg A, 2008, J ALLERGY CLIN IMMUN, V121, P1442, DOI 10.1016/j.jaci.2008.04.021; von Berg A, 2007, J ALLERGY CLIN IMMUN, V119, P718, DOI 10.1016/j.jaci.2006.11.017	6	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					262	262		10.1016/j.jaci.2011.08.038	http://dx.doi.org/10.1016/j.jaci.2011.08.038			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	22035876	Bronze			2022-12-18	WOS:000298634000038
J	Ege, MJ				Ege, Markus Johannes			Intestinal microbial diversity in infancy and allergy risk at school age	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Intestinal microbiome; microbial diversity; allergy; childhood	CHILDHOOD ASTHMA; EXPOSURE		[Ege, Markus Johannes] Univ Childrens Hosp Munich, Munich, Germany	University of Munich	Ege, MJ (corresponding author), Dr von Haunersche Kinderklin, Lindwurmstr 4, D-80337 Munich, Germany.	markus.ege@med.uni-muenchen.de	Ege, Markus/C-1962-2012	Ege, Markus/0000-0001-6643-3923				Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Korthals M, 2008, J MICROBIOL METH, V73, P49, DOI 10.1016/j.mimet.2008.01.010; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10	11	9	9	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2011	128	3					653	654		10.1016/j.jaci.2011.06.044	http://dx.doi.org/10.1016/j.jaci.2011.06.044			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	812HS	21794905				2022-12-18	WOS:000294283400026
J	El-Ghaiesh, S; Sanderson, JP; Farrell, J; Lavergne, SN; Syn, WK; Pirmohamed, M; Park, BK; Naisbitt, DJ				El-Ghaiesh, Sabah; Sanderson, Joseph P.; Farrell, John; Lavergne, Sidonie N.; Syn, Wing-Kin; Pirmohamed, Munir; Park, B. Kevin; Naisbitt, Dean J.			Characterization of drug-specific lymphocyte responses in a patient with drug-induced liver injury	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELLS; ASSOCIATION; REACTIVITY		[El-Ghaiesh, Sabah; Sanderson, Joseph P.; Farrell, John; Pirmohamed, Munir; Park, B. Kevin; Naisbitt, Dean J.] Univ Liverpool, Dept Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England; [El-Ghaiesh, Sabah] Tanta Univ, Dept Pharmacol, Tanta, Egypt; [Lavergne, Sidonie N.] Univ Illinois, Urbana, IL 61801 USA; [Syn, Wing-Kin] Univ Birmingham, Inst Biomed Res, Liver Res Ctr, Birmingham, W Midlands, England; [Syn, Wing-Kin] Univ Basque Country, Dept Physiol, Bilbao, Spain	University of Liverpool; Egyptian Knowledge Bank (EKB); Tanta University; University of Illinois System; University of Illinois Urbana-Champaign; University of Birmingham; University of Basque Country	El-Ghaiesh, S (corresponding author), Univ Liverpool, Dept Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England.	dnes@liv.ac.uk	Sanderson, Joseph/N-8308-2019; Syn, Wing-Kin/AAB-8406-2020; El-Ghaiesh, Sabah H/L-8231-2016; Sanderson, Joseph/C-5169-2008; Pirmohamed, Munir/H-6004-2011	Sanderson, Joseph/0000-0002-1206-8833; El-Ghaiesh, Sabah H/0000-0001-7032-528X; Sanderson, Joseph/0000-0002-1206-8833; Pirmohamed, Munir/0000-0002-7534-7266; Farrell, John/0000-0002-8726-5997; Naisbitt, Dean/0000-0003-4107-7832	Medical Research Council [G0700654] Funding Source: Medline; Wellcome Trust [078598/Z/05/Z] Funding Source: Medline; MRC [G0700654] Funding Source: UKRI; Medical Research Council [G0700654B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Beeler A, 2006, J ALLERGY CLIN IMMUN, V117, P455, DOI 10.1016/j.jaci.2005.10.030; Borchers AT, 2009, SEMIN IMMUNOPATHOL, V31, P309, DOI 10.1007/s00281-009-0167-2; Edberg JC, 2002, ARTHRITIS RHEUM, V46, P2132, DOI 10.1002/art.10438; Edberg JC, 2008, HUM MOL GENET, V17, P1147, DOI 10.1093/hmg/ddn004; Eksteen B, 2004, J EXP MED, V200, P1511, DOI 10.1084/jem.20041035; Eksteen B, 2009, GASTROENTEROLOGY, V137, P320, DOI 10.1053/j.gastro.2009.02.046; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Maria VAJ, 1997, GUT, V41, P534, DOI 10.1136/gut.41.4.534; Mennicke M, 2009, AM J TRANSPLANT, V9, P2197, DOI 10.1111/j.1600-6143.2009.02788.x; Picard D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001116; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rao C. R, 1973, LINEAR STAT INFERENC; Tapia B, 2004, J ALLERGY CLIN IMMUN, V114, P335, DOI 10.1016/j.jaci.2004.04.034; Yawalkar N, 2000, J INVEST DERMATOL, V115, P647, DOI 10.1046/j.1523-1747.2000.00105.x	14	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2011	128	3					680	U368		10.1016/j.jaci.2011.04.031	http://dx.doi.org/10.1016/j.jaci.2011.04.031			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	812HS	21596425				2022-12-18	WOS:000294283400036
J	Metz, M; Schafer, B; Tsai, M; Maurer, M; Galli, SJ				Metz, Martin; Schaefer, Beatrix; Tsai, Mindy; Maurer, Marcus; Galli, Stephen J.			Evidence that the endothelin A receptor can enhance IgE-dependent anaphylaxis in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MAST-CELLS; ASTHMA; CHILDREN; SNAKE; RATS		[Metz, Martin; Schaefer, Beatrix; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Metz, Martin; Maurer, Marcus] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany	Stanford University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Metz, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu	Metz, Martin/M-5237-2013; Metz, Martin/B-8799-2009; Maurer, Marcus/ABG-2174-2020; Li, Yapeng/N-1042-2017	Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X; Li, Yapeng/0000-0002-5042-6881; Tsai, Mindy/0000-0002-8421-4721	NCI NIH HHS [CA072074, R01 CA072074-15, R01 CA072074] Funding Source: Medline; NIAID NIH HHS [AI070813, R01 AI070813, R01 AI023990-20, R01 AI023990, R01 AI070813-01, R37 AI023990] Funding Source: Medline; PHS HHS [A1023990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990, R01AI070813] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Matsushima H, 2004, EUR J IMMUNOL, V34, P1910, DOI 10.1002/eji.200424912; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Metz M, 2006, AM J PATHOL, V169, P815, DOI 10.2353/ajpath.2006.060037; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; SAMPAIO ALF, 1995, J CARDIOVASC PHARM, V26, pS416; Sanchez-Cifuentes MV, 1998, PULM PHARMACOL THER, V11, P215, DOI 10.1006/pupt.1998.0141; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Shigematsu T, 1998, GASTROENTEROLOGY, V115, P348, DOI 10.1016/S0016-5085(98)70201-X; Summers CW, 2008, J ALLERGY CLIN IMMUN, V121, P632, DOI 10.1016/j.jaci.2007.12.003	12	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2011	128	2					424	426		10.1016/j.jaci.2011.04.012	http://dx.doi.org/10.1016/j.jaci.2011.04.012			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	799IQ	21555149	Green Accepted, Bronze			2022-12-18	WOS:000293280800030
J	Lagresle-Peyrou, C; Neven, B; Six, E; Picard, C; Demerens-de Chappedelaine, C; Bertrand, Y; Jabado, N; Chomienne, C; Radford-Weiss, I; Brouzes, C; Asnafi, V; MacIntyre, E; Donadieu, J; Beaupain, B; Fenaux, P; Eclache, V; Fischer, A; Cavazzana-Calvo, M				Lagresle-Peyrou, Chantal; Neven, Benedicte; Six, Emmanuelle; Picard, Capucine; Demerens-de Chappedelaine, Corinne; Bertrand, Yves; Jabado, Nada; Chomienne, Christine; Radford-Weiss, Isabelle; Brouzes, Chantal; Asnafi, Vahid; MacIntyre, Elizabeth; Donadieu, Jean; Beaupain, Blandine; Fenaux, Pierre; Eclache, Virginie; Fischer, Alain; Cavazzana-Calvo, Marina			Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONGENITAL NEUTROPENIA; EXPERIENCE; MUTATIONS		[Lagresle-Peyrou, Chantal; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, AP HP, Dept Biotherapie, Ctr Invest Clin Integre Biotherapies, Paris, France; [Lagresle-Peyrou, Chantal; Six, Emmanuelle; Picard, Capucine; Demerens-de Chappedelaine, Corinne; Fischer, Alain; Cavazzana-Calvo, Marina] Univ Paris 05, Fac Med, Paris, France; [Neven, Benedicte; Fischer, Alain; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, AP HP, Serv Immunol & Hematol Pediat, Paris, France; [Neven, Benedicte; Six, Emmanuelle; Picard, Capucine; Demerens-de Chappedelaine, Corinne; Fischer, Alain; Cavazzana-Calvo, Marina] INSERM, U768, Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Etud Deficits Immunitaires, Paris, France; [Bertrand, Yves] Univ Lyon 1, Inst Hematol & Oncol Pediat, F-69365 Lyon, France; [Jabado, Nada] McGill Univ, Dept Human Genet, Ctr Hlth, Montreal, PQ, Canada; [Chomienne, Christine] Hop St Louis, AP HP, Unite Biol Cellulaire, Paris, France; [Radford-Weiss, Isabelle] Hop Necker Enfants Malad, AP HP, Dept Cytogenet, Paris, France; [Brouzes, Chantal; Asnafi, Vahid; MacIntyre, Elizabeth] Univ Paris 05, CNRS, UMR 8147, Paris, France; [Brouzes, Chantal; Asnafi, Vahid; MacIntyre, Elizabeth] Hop Necker Enfants Malad, AP HP, Dept Hematol, Paris, France; [Donadieu, Jean; Beaupain, Blandine] Hop Trousseau, Serv Hematooncol Pediat, Registre Francais Neutropenies Chron Severes, F-75571 Paris, France; [Fenaux, Pierre; Eclache, Virginie] Hop Avicenne, AP HP, Serv Hematol Clin, F-93009 Bobigny, France; [Fenaux, Pierre; Eclache, Virginie] Univ Paris 13, Bobigny, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite Paris 13	Lagresle-Peyrou, C (corresponding author), Hop Necker Enfants Malad, AP HP, Dept Biotherapie, Ctr Invest Clin Integre Biotherapies, Paris, France.	m.cavazzana@nck.aphp.fr	Six, Emmanuelle/H-7891-2017; Picard, Capucine/H-3914-2017; Peyrou, Chantal Lagresle/AAK-9689-2020; Peyrou, Chantal Lagresle/H-2911-2017; Jabado, Nada/AAN-4026-2020; Demerens de Chappedelaine, Corinne/H-1648-2017	Six, Emmanuelle/0000-0001-7806-0968; Picard, Capucine/0000-0001-8788-5056; Peyrou, Chantal Lagresle/0000-0002-2216-6453; Peyrou, Chantal Lagresle/0000-0002-2216-6453; Demerens de Chappedelaine, Corinne/0000-0003-3651-0646; Macintyre-Davi, Elizabeth Anne/0000-0003-0520-0493; CHOMIENNE, Christine/0000-0001-5513-5752; Cavazzana, Marina/0000-0002-0264-0891				Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Bertrand Y, 2002, BONE MARROW TRANSPL, V29, P759, DOI 10.1038/sj.bmt.1703531; Cavazzana-Calvo Marina, 2005, Annu Rev Med, V56, P585, DOI 10.1146/annurev.med.56.090203.104142; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370	9	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					230	232		10.1016/j.jaci.2011.02.008	http://dx.doi.org/10.1016/j.jaci.2011.02.008			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21458044				2022-12-18	WOS:000292245600037
J	Maloney, JM; Nowak-Wegrzyn, A; Wang, J				Maloney, Jennifer M.; Nowak-Wegrzyn, Anna; Wang, Julie			Children in the inner city of New York have high rates of food allergy and IgE sensitization to common foods	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PREVALENCE; RISK		[Maloney, Jennifer M.; Nowak-Wegrzyn, Anna; Wang, Julie] Mt Sinai Sch Med, Elliot & Roslyn Jaffe Food Allergy Inst, Div Allergy & Immunol, Dept Pediat, New York, NY USA	Icahn School of Medicine at Mount Sinai	Maloney, JM (corresponding author), Mt Sinai Sch Med, Elliot & Roslyn Jaffe Food Allergy Inst, Div Allergy & Immunol, Dept Pediat, New York, NY USA.	julie.wang@mssm.edu		Nowak-Wegrzyn, Anna/0000-0002-0960-9854	NIAID NIH HHS [K23AI059318, K23 AI083883, K23 AI083883-02, K23 AI059318] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI059318, K23AI083883] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Eigenmann PA, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e8; Hill DJ, 2008, CLIN EXP ALLERGY, V38, P161, DOI 10.1111/j.1365-2222.2007.02861.x; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Wang JL, 2005, J ALLERGY CLIN IMMUN, V115, P1076, DOI 10.1016/j.jaci.2005.02.014; WILLIAMS HC, 1995, J AM ACAD DERMATOL, V32, P212, DOI 10.1016/0190-9622(95)90128-0	9	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					214	215		10.1016/j.jaci.2011.04.024	http://dx.doi.org/10.1016/j.jaci.2011.04.024			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21555148	Green Accepted			2022-12-18	WOS:000292245600029
J	Rezaei, N; Wing, JB; Aghamohammadi, A; Heath, AW; Read, RC				Rezaei, N.; Wing, J. B.; Aghamohammadi, A.; Heath, A. W.; Read, R. C.			B-cells and T-cells Cognate Interaction Assay in Common Variable Immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Rezaei, N.] Univ Tehran Med Sci, Mol Immunol Res Ctr, Tehran, Iran; [Rezaei, N.] Univ Tehran Med Sci, Dept Immunol, Tehran, Iran; [Wing, J. B.; Heath, A. W.; Read, R. C.] Univ Sheffield, Dept Infect & Immun, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Aghamohammadi, A.] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Childrens Med Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Sheffield; Tehran University of Medical Sciences			Rezaei, Nima/B-4245-2008	Rezaei, Nima/0000-0002-3836-1827					0	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB18	AB18		10.1016/j.jaci.2010.12.083	http://dx.doi.org/10.1016/j.jaci.2010.12.083			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400067
J	Sharma, HP; Mansoor, DK; Sprunger, AC; Zalos, K; Taylor, H; Martin, X; Mikhail, IJ				Sharma, H. P.; Mansoor, D. K.; Sprunger, A. C.; Zalos, K.; Taylor, H.; Martin, X.; Mikhail, I. J.			Racial Disparities in the Presentation of Pediatric Eosinophilic Esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Sharma, H. P.; Mansoor, D. K.; Sprunger, A. C.; Zalos, K.; Taylor, H.; Martin, X.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Mikhail, I. J.] NIAID, NIH, Bethesda, MD 20892 USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)									0	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB110	AB110		10.1016/j.jaci.2010.12.440	http://dx.doi.org/10.1016/j.jaci.2010.12.440			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400422
J	Zhou, X; Whitworth, HS; E-Khedr, M; Brown, TA; Goswami, R; Eren, E; Lucas, JA; Erlewyn-Lajeunesse, MDS; Summers, CW; Pumphrey, RSH; Wild, G; Pedersen, J; Walls, AF				Zhou, X.; Whitworth, H. S.; E-Khedr, M.; Brown, T. A.; Goswami, R.; Eren, E.; Lucas, J. A.; Erlewyn-Lajeunesse, M. D. S.; Summers, C. W.; Pumphrey, R. S. H.; Wild, G.; Pedersen, J.; Walls, A. F.			Mast Cell Chymase: A Useful Serum Marker in Anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Zhou, X.; Whitworth, H. S.; E-Khedr, M.; Brown, T. A.; Lucas, J. A.; Erlewyn-Lajeunesse, M. D. S.; Walls, A. F.] Univ Southampton, Southampton, Hants, England; [Goswami, R.; Eren, E.] Southampton Univ Hosp Trust, Southampton, Hants, England; [Summers, C. W.; Pumphrey, R. S. H.] Univ Manchester, Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Wild, G.] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; [Pedersen, J.] Unizyme Labs AS, Horsholm, Denmark	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Manchester; Northern General Hospital			Whitworth, Hilary/AAB-1288-2019; KHEDR, MOGIBELRAHMAN M.S./V-6360-2018	KHEDR, MOGIBELRAHMAN M.S./0000-0001-9942-4409; Lucas, Jane/0000-0001-8701-9975; Erlewyn-Lajeunesse, Michel/0000-0003-1982-1397; Walls, Andrew/0000-0003-4803-4595	MRC [G0500729] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB143	AB143		10.1016/j.jaci.2010.12.566	http://dx.doi.org/10.1016/j.jaci.2010.12.566			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400548
J	Apter, AJ				Apter, Andrea J.			Advances in adult asthma diagnosis and treatment and HEDQ in 2010	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; adults; genetics; inhaled corticosteroids; biomarkers; long-acting beta-agonist; tiotropium; anti-IL-5; translational research; comparative effectiveness research	GENOME-WIDE ASSOCIATION; ACTING BETA-AGONISTS; COMMUNITY VIOLENCE; RISK-FACTORS; MEPOLIZUMAB; HOSPITALIZATIONS; ADHERENCE; TRIAL; CORTICOSTEROIDS; EXACERBATIONS	This summary reviews research published over the past year on asthma and through the prism of health care delivery and quality. Special attention is given to management, therapeutics, and the role of environmental exposures and their interactions with genetics. The discussion is framed around the 3 stages of translational research: from bench to first studies in human subjects, then to larger efficacy studies in well-defined patient populations, and finally into practice through effectiveness research in real-world settings. (J Allergy Clin Immunol 2011;127:116-22.)	[Apter, Andrea J.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Apter, AJ (corresponding author), Hosp Univ Penn, 829 Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	apter@mail.med.upenn.edu			National Institutes of Health/National Heart, Lung, and Blood Institute	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A. J. Apter has received research support from the National Institutes of Health/National Heart, Lung, and Blood Institute.	Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P512, DOI 10.1016/j.jaci.2005.12.1353; Apter AJ, 2004, J ALLERGY CLIN IMMUN, V113, P407, DOI 10.1016/j.jaci.2003.12.002; Apter AJ, 2008, J ALLERGY CLIN IMMUN, V121, P839, DOI 10.1016/j.jaci.2007.12.1176; Apter AJ, 2007, J ALLERGY CLIN IMMUN, V119, P563, DOI 10.1016/j.jaci.2007.01.001; Apter AJ, 2010, J ALLERGY CLIN IMMUN, V126, P552, DOI 10.1016/j.jaci.2010.07.014; Apter AJ, 2010, J ALLERGY CLIN IMMUN, V125, P79, DOI 10.1016/j.jaci.2009.11.028; Apter AJ, 2009, J ALLERGY CLIN IMMUN, V123, P35, DOI 10.1016/j.jaci.2008.11.017; Apter Andrea J., 2003, Journal of Allergy and Clinical Immunology, V111, pS780, DOI 10.1067/mai.2003.153; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V126, P1139, DOI 10.1016/j.jaci.2010.10.032; Bateman ED, 2010, J ALLERGY CLIN IMMUN, V125, P600, DOI 10.1016/j.jaci.2009.11.033; Beebe A, 2010, J ALLERGY CLIN IMMUN, V126, P263, DOI 10.1016/j.jaci.2010.03.019; BOBO EG, FDA WARNS INCREASED; Bochner BS, 2010, J ALLERGY CLIN IMMUN, V126, P16, DOI 10.1016/j.jaci.2010.02.026; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Breton MC, 2010, J ALLERGY CLIN IMMUN, V126, P772, DOI 10.1016/j.jaci.2010.08.018; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Camargo CA, 2010, J ALLERGY CLIN IMMUN, V125, P374, DOI 10.1016/j.jaci.2009.11.015; Chapman KR, 2010, J ALLERGY CLIN IMMUN, V125, P609, DOI 10.1016/j.jaci.2010.01.019; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Cohen RT, 2010, J ALLERGY CLIN IMMUN, V126, P491, DOI 10.1016/j.jaci.2010.06.016; Contoli M, 2010, J ALLERGY CLIN IMMUN, V125, P830, DOI 10.1016/j.jaci.2010.01.003; Covar RA, 2010, J ALLERGY CLIN IMMUN, V125, P359, DOI 10.1016/j.jaci.2009.10.037; DeWan AT, 2010, J ALLERGY CLIN IMMUN, V126, P871, DOI 10.1016/j.jaci.2010.06.051; Diaz-Guzman E, 2010, J ALLERGY CLIN IMMUN, V126, P702, DOI 10.1016/j.jaci.2010.08.022; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Gamble C, 2010, J ALLERGY CLIN IMMUN, V126, P1149, DOI 10.1016/j.jaci.2010.08.049; Gerald JK, 2010, J ALLERGY CLIN IMMUN, V125, P643, DOI 10.1016/j.jaci.2009.12.984; Gonzalez-Perez A, 2010, J ALLERGY CLIN IMMUN, V125, P1098, DOI 10.1016/j.jaci.2010.02.009; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gould W, 2010, J ALLERGY CLIN IMMUN, V126, P1131, DOI 10.1016/j.jaci.2010.08.002; Greenberger PA, 2010, J ALLERGY CLIN IMMUN, V125, P511, DOI 10.1016/j.jaci.2009.12.979; Greenberger PA, 2010, J ALLERGY CLIN IMMUN, V125, P305, DOI 10.1016/j.jaci.2009.11.038; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hallstrand TS, 2010, J ALLERGY CLIN IMMUN, V125, P381, DOI 10.1016/j.jaci.2009.12.991; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Juhn YJ, 2010, J ALLERGY CLIN IMMUN, V125, P838, DOI 10.1016/j.jaci.2009.12.998; Kahn JE, 2010, J ALLERGY CLIN IMMUN, V125, P267, DOI 10.1016/j.jaci.2009.10.014; Katial RK, 2010, J ALLERGY CLIN IMMUN, V126, P738, DOI 10.1016/j.jaci.2010.06.036; Kelly MM, 2010, J ALLERGY CLIN IMMUN, V125, P349, DOI 10.1016/j.jaci.2009.09.011; Kim C, 2005, J ALLERGY CLIN IMMUN, V115, P810, DOI 10.1016/j.jaci.2004.11.032; Kim S, 2010, J ALLERGY CLIN IMMUN, V125, P1336, DOI 10.1016/j.jaci.2010.03.028; Kolbeck R, 2010, J ALLERGY CLIN IMMUN, V125, P1344, DOI 10.1016/j.jaci.2010.04.004; Krishnan JA, 2011, J ALLERGY CLIN IMMUN, V127, P123, DOI 10.1016/j.jaci.2010.08.032; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V303, P1353, DOI 10.1001/jama.2010.357; Kulkarni NS, 2010, J ALLERGY CLIN IMMUN, V126, P61, DOI 10.1016/j.jaci.2010.03.026; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lauer MS, 2010, JAMA-J AM MED ASSOC, V303, P2182, DOI 10.1001/jama.2010.726; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V126, P449, DOI 10.1016/j.jaci.2010.05.039; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Maneechotesuwan K, 2010, J ALLERGY CLIN IMMUN, V126, P754, DOI 10.1016/j.jaci.2010.08.005; Massanari M, 2010, J ALLERGY CLIN IMMUN, V125, P383, DOI 10.1016/j.jaci.2009.11.022; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; McElligott S, 2010, J ALLERGY CLIN IMMUN, V125, P651, DOI 10.1016/j.jaci.2010.01.029; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; *NIH, 2007, NIH PUBL, P1; Onyirimba F, 2003, ANN ALLERG ASTHMA IM, V90, P411, DOI 10.1016/S1081-1206(10)61825-X; Pacheco KA, 2010, J ALLERGY CLIN IMMUN, V126, P232, DOI 10.1016/j.jaci.2010.04.019; Perrin K, 2010, J ALLERGY CLIN IMMUN, V126, P505, DOI 10.1016/j.jaci.2010.06.033; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Pongracic JA, 2010, J ALLERGY CLIN IMMUN, V125, P593, DOI 10.1016/j.jaci.2009.10.036; Price D, 2010, J ALLERGY CLIN IMMUN, V126, P511, DOI 10.1016/j.jaci.2010.06.040; Reed CE, 2010, J ALLERGY CLIN IMMUN, V126, P681, DOI 10.1016/j.jaci.2010.05.035; RILEY K, FDA ANNOUNCES NEW SA; Rosenwasser LJ, 2010, J ALLERGY CLIN IMMUN, V125, P1245, DOI 10.1016/j.jaci.2010.04.022; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; ROUFOSSE F, 2010, J ALLERGY CLIN IMMUN, V126, pE3; Roufosse F, 2010, J ALLERGY CLIN IMMUN, V126, P828, DOI 10.1016/j.jaci.2010.06.049; Roy SR, 2010, J ALLERGY CLIN IMMUN, V125, P636, DOI 10.1016/j.jaci.2009.11.046; Scanlon PD, 2010, NEW ENGL J MED, V363, P385, DOI 10.1056/NEJMe1005902; Schatz M, 2010, J ALLERGY CLIN IMMUN, V126, P873, DOI 10.1016/j.jaci.2010.07.035; Silverman RA, 2010, J ALLERGY CLIN IMMUN, V125, P367, DOI 10.1016/j.jaci.2009.10.061; Simons FER, 2010, J ALLERGY CLIN IMMUN, V125, P419, DOI 10.1016/j.jaci.2009.10.056; Sutherland ER, 2010, J ALLERGY CLIN IMMUN, V126, P747, DOI 10.1016/j.jaci.2010.07.024; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P470, DOI 10.1016/j.jaci.2004.12.1123; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; Thomsen SF, 2010, J ALLERGY CLIN IMMUN, V126, P626, DOI 10.1016/j.jaci.2010.06.017; Vercelli D, 2010, J ALLERGY CLIN IMMUN, V125, P347, DOI 10.1016/j.jaci.2009.12.976; Vink NM, 2010, J ALLERGY CLIN IMMUN, V126, P498, DOI 10.1016/j.jaci.2010.06.018; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Williams LK, 2010, J ALLERGY CLIN IMMUN, V126, P225, DOI 10.1016/j.jaci.2010.03.034; Wilson SR, 2010, AM J RESP CRIT CARE, V181, P566, DOI 10.1164/rccm.200906-0907OC; Wise RA, 2009, J ALLERGY CLIN IMMUN, V124, P436, DOI 10.1016/j.jaci.2009.05.041; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007	92	9	11	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					116	122		10.1016/j.jaci.2010.11.017	http://dx.doi.org/10.1016/j.jaci.2010.11.017			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21211646				2022-12-18	WOS:000285917300017
J	Kelso, JM				Kelso, John M.			Administration of influenza vaccines to patients with egg allergy: Update for the 2010-2011 season	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SAFETY		Scripps Clin, Div Allergy Asthma & Immunol, San Diego, CA 92037 USA	Scripps Research Institute	Kelso, JM (corresponding author), Scripps Clin, Div Allergy Asthma & Immunol, San Diego, CA 92037 USA.	kelso.john@scrippshealth.org						Baxter R, 2010, PEDIATR INFECT DIS J, V29, P924, DOI 10.1097/INF.0b013e3181e075be; Chung EY, 2010, PEDIATRICS, V125, pE1024, DOI 10.1542/peds.2009-2512; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gagnon R, 2010, J ALLERGY CLIN IMMUN, V126, P317, DOI 10.1016/j.jaci.2010.05.037; *GLAXOSMITHKLINE, 2010, FLUARIX INFL VIR VAC; *GLAXOSMITHKLINE, 2010, FLULAVAL INFL VIR VA; James JM, 1998, J PEDIATR-US, V133, P624, DOI 10.1016/S0022-3476(98)70101-5; Kelso JM, 2010, J ALLERGY CLIN IMMUN, V125, P800, DOI 10.1016/j.jaci.2010.02.013; Kelso JM, 2009, ANN ALLERG ASTHMA IM, V103, pS1, DOI 10.1016/S1081-1206(10)60350-X; Li JT, 2010, J ALLERGY CLIN IMMUN, V125, P1412, DOI 10.1016/j.jaci.2010.03.009; *MEDIMMUNE, 2010, FLUMIST INFL VACC LI; *NOV, 2010, AGRIFLU INFL VIR VAC; *NOV, 2010, FLUVIRIN INFL VIR VA; *SAN PAST, 2010, FLUZ INFL VIR VACC F; Waibel KH, 2010, J ALLERGY CLIN IMMUN, V125, P749, DOI 10.1016/j.jaci.2009.12.015; 2010, MMWR MORB MORTAL WKL, V59, P989	16	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2010	126	6					1302	1304		10.1016/j.jaci.2010.10.015	http://dx.doi.org/10.1016/j.jaci.2010.10.015			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	689RZ	21134575	Bronze			2022-12-18	WOS:000284947800031
J	Kelly, HW				Kelly, H. William			Alveolar nitric oxide concentration, small airways inflammation, and targeted asthma therapy: Are we there yet?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; alveolar nitric oxide; small airways; FeNO; inhaled corticosteroids; air trapping; inflammation	TREATED ASTHMA; MU-G; HYDROFLUOROALKANE; BECLOMETHASONE; MONTELUKAST; ADULTS; MODEL; MILD		[Kelly, H. William] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA	University of New Mexico	Kelly, HW (corresponding author), 1 Univ New Mexico, Dept Pediat, MSC10-5590, Albuquerque, NM 87131 USA.	hwkelly@salud.unm.edu						Berry M, 2005, EUR RESPIR J, V25, P986, DOI 10.1183/09031936.05.00132404; Bjermer L, 2001, RESP MED, V95, P703, DOI 10.1053/rmed.2001.1148; Fritscher LG, 2009, RESP MED, V103, P296, DOI 10.1016/j.rmed.2008.08.007; Gelb AF, 2004, AM J RESP CRIT CARE, V170, P737, DOI 10.1164/rccm.200403-408OC; Gelb AF, 2008, CAN RESPIR J, V15, P193, DOI 10.1155/2008/415391; Gelfand EW, 2009, J ALLERGY CLIN IMMUN, V124, pS84, DOI 10.1016/j.jaci.2009.07.062; Goldin JG, 1999, J ALLERGY CLIN IMMUN, V104, pS258, DOI 10.1016/S0091-6749(99)70043-6; Lee DKC, 2004, BRIT J CLIN PHARMACO, V58, P26, DOI 10.1111/j.1365-2125.2004.02108.x; Robroeks CMHHT, 2008, ANN ALLERG ASTHMA IM, V100, P601, DOI 10.1016/S1081-1206(10)60052-X; Shelley DA, 2010, J APPL PHYSIOL, V108, P821, DOI 10.1152/japplphysiol.00795.2009; Tsoukias NM, 1998, J APPL PHYSIOL, V85, P653, DOI 10.1152/jappl.1998.85.2.653; Tunon-de-Lara JM, 2007, J ALLERGY CLIN IMMUN, V119, P583, DOI 10.1016/j.jaci.2006.11.005; Van Muylem A, 2010, J ALLERGY CLIN IMMUN, V126, P730, DOI 10.1016/j.jaci.2010.06.019; Yamaguchi M, 2009, PULM PHARMACOL THER, V22, P326, DOI 10.1016/j.pupt.2009.01.005	14	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					736	737		10.1016/j.jaci.2010.07.040	http://dx.doi.org/10.1016/j.jaci.2010.07.040			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20920762				2022-12-18	WOS:000282510000007
J	Kim, HR; Jun, CD; Lee, YJ; Yang, SH; Jeong, ET; Park, SD; Park, DS				Kim, Hak-Ryul; Jun, Chang-Duk; Lee, Young-Jin; Yang, Sei-Hoon; Jeong, Eun-Taik; Park, Seok-Don; Park, Do-Sim			Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CYTOKINE; INFLAMMATION; PNEUMONIA; ASTHMA; SERUM; ST2		[Kim, Hak-Ryul; Yang, Sei-Hoon; Jeong, Eun-Taik] Wonkwang Univ, Sch Med, Dept Internal Med, Iksan, South Korea; [Lee, Young-Jin; Park, Do-Sim] Wonkwang Univ, Sch Med, Dept Lab Med, Iksan, South Korea; [Park, Seok-Don] Wonkwang Univ, Sch Med, Dept Dermatol, Iksan, South Korea; [Park, Do-Sim] Wonkwang Univ, Inst Wonkwang Med Sci, Iksan, South Korea; [Jun, Chang-Duk] GIST, Cell Dynam Res Ctr, Sch Life Sci, Kwangju, South Korea; [Jun, Chang-Duk] GIST, Immune Synapse Res Ctr, Kwangju, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Kim, HR (corresponding author), Wonkwang Univ, Sch Med, Dept Internal Med, Iksan, South Korea.	email@wku.ac.kr	Park, Do-Sim/B-6594-2013; Park, Do-Sim/P-1529-2019	Park, Do-Sim/0000-0002-6001-4223; Park, Do-Sim/0000-0002-6001-4223				BARACH AL, 1960, ARCH INTERN MED, V106, P230, DOI 10.1001/archinte.1960.03820020070010; Chang AB, 1998, EUR RESPIR J, V11, P462, DOI 10.1183/09031936.98.11020462; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; CLSI EP6, 2003, EP6A CLSI, P1; KAPP A, 1993, ALLERGY, V48, P1, DOI 10.1111/j.1398-9995.1993.tb02167.x; Kim DW, 2009, KOREAN J LAB MED, V29, P185, DOI 10.3343/kjlm.2009.29.3.185; KITA H, 2003, MIDDLETONS ALLERGY P, P305; Matsuyama Y, 2010, J RHEUMATOL, V37, P18, DOI 10.3899/jrheum.090492; Niimi A, 1998, CLIN EXP ALLERGY, V28, P233; Oshikawa K, 2001, RESP MED, V95, P532, DOI 10.1053/rmed.2001.1080; PopeHarman AL, 1996, MEDICINE, V75, P334, DOI 10.1097/00005792-199611000-00004; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Stenton C, 2008, OCCUP MED-OXFORD, V58, P226, DOI 10.1093/occmed/kqm162; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; TSUDA S, 1992, Journal of Dermatology (Tokyo), V19, P208; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166	17	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					880	U346		10.1016/j.jaci.2010.06.038	http://dx.doi.org/10.1016/j.jaci.2010.06.038			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20719375				2022-12-18	WOS:000282510000033
J	Raissy, HH; Sternberg, AL; Williams, P; Jacobs, A; Kelly, HW				Raissy, Hengameh H.; Sternberg, Alice L.; Williams, Paul; Jacobs, Aaron; Kelly, H. William		CAMP Res Grp	Risk of cataracts in the Childhood Asthma Management Program Cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POSTERIOR SUBCAPSULAR CATARACTS; INHALED CORTICOSTEROIDS; CHILDREN; BUDESONIDE; THERAPY		[Raissy, Hengameh H.; Jacobs, Aaron; Kelly, H. William] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA; [Sternberg, Alice L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Williams, Paul] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Williams, Paul] Univ Washington, Sch Occupat & Environm Hlth Sci, Seattle, WA 98195 USA	University of New Mexico; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Raissy, HH (corresponding author), Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA.	Hheidarian-raissy@salud.unm.edu		Williams, Paul/0000-0003-3300-1328	DIVISION OF LUNG DISEASES [N01HR016052, N01HR016044, N01HR016048, N01HR016047, N01HR016045, N01HR016049, N01HR016046, N01HR016051, N01HR016050] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719, M01RR000051, M01RR000036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL075232, U01HL075416, U01HL075419, U01HL075409, U01HL075420, U01HL075415, U01HL075408, U01HL075417, U01HL075407] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00036, M01RR02719-14, M01RR00051, M01 RR002719, M01RR0099718-24, M01 RR000051, M01 RR000036] Funding Source: Medline; NHLBI NIH HHS [U01HL075415, N01-HR-16047, N01-HR-16049, U01HL075407, N01-HR-16051, U01 HL075415, U01 HL075232, U01HL075408, U01HL075416, U01HL075417, U01 HL075420-06, U01 HL075416, N01-HR-16052, U01 HL075407, U01 HL075420, U01 HL075419, U01 HL075409, U01 HL075417, U01HL075420, N01HR16044, N01-HR-16045, U01 HL075408, N01-HR-16050, N01-HR-16044, N01-HR-16046, U01HL075419, U01HL075409, N01-HR-16048, U01HL075232] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABUEKTEISH F, 1995, THORAX, V50, P674, DOI 10.1136/thx.50.6.674; Agertoft L, 1998, EUR RESPIR J, V12, P130, DOI 10.1183/09031936.98.12010130; BHAGAT RG, 1984, PEDIATRICS, V73, P626; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Cumming RG, 1999, DRUG SAFETY, V20, P77, DOI 10.2165/00002018-199920010-00007; FORMAN AR, 1977, AM J OPHTHALMOL, V84, P75, DOI 10.1016/0002-9394(77)90328-2; Petkonen A, 2008, J ALLERGY CLIN IMMUN, V122, P832, DOI 10.1016/j.jaci.2008.07.013; SHAPIRO GG, 1976, J ALLERGY CLIN IMMUN, V57, P430, DOI 10.1016/0091-6749(76)90058-0; SIMONS FER, 1993, LANCET, V342, P776, DOI 10.1016/0140-6736(93)91541-S; Smeeth L, 2003, BRIT J OPHTHALMOL, V87, P1247, DOI 10.1136/bjo.87.10.1247	11	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2010	126	2								10.1016/j.jaci.2010.05.007	http://dx.doi.org/10.1016/j.jaci.2010.05.007			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	642IL	20621348	Green Accepted			2022-12-18	WOS:000281203800028
J	Wada, K; Matsuwaki, Y; Yoon, J; Benson, LM; Checkel, JL; Bingemann, TA; Kita, H				Wada, Kota; Matsuwaki, Yoshinori; Yoon, Juhan; Benson, Linda M.; Checkel, James L.; Bingemann, Theresa A.; Kita, Hirohito			Inflammatory responses of human eosinophils to cockroach are mediated through protease-dependent pathways	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACTIVATED RECEPTOR-2; PROTEINASES; RELEASE; ASTHMA		[Wada, Kota; Matsuwaki, Yoshinori; Yoon, Juhan; Checkel, James L.; Bingemann, Theresa A.; Kita, Hirohito] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Wada, Kota; Matsuwaki, Yoshinori; Yoon, Juhan; Checkel, James L.; Bingemann, Theresa A.; Kita, Hirohito] Mayo Clin, Dept Med, Rochester, MN USA; [Benson, Linda M.] Mayo Clin, Mayo Prote Res Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Wada, K (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	kita.hirohito@mayo.edu			NIAID NIH HHS [R01 AI034486, R01 AI034486-14] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034486] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22591904] Funding Source: KAKEN	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Hivrale VK, 2005, COMP BIOCHEM PHYS B, V141, P261, DOI 10.1016/j.cbpc.2005.02.015; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Lourbakos A, 1998, FEBS LETT, V435, P45, DOI 10.1016/S0014-5793(98)01036-9; Miike S, 2001, J IMMUNOL, V167, P6615, DOI 10.4049/jimmunol.167.11.6615; Page K, 2006, ALLERGY, V61, P988, DOI 10.1111/j.1398-9995.2006.01103.x; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Sohn MH, 2004, INT ARCH ALLERGY IMM, V134, P141, DOI 10.1159/000078647	9	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2010	126	1					169	172		10.1016/j.jaci.2010.04.007	http://dx.doi.org/10.1016/j.jaci.2010.04.007			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	627SE	20538330	Green Accepted			2022-12-18	WOS:000280061800033
J	Wise, EL; Bonner, KT; Williams, TJ; Pease, JE				Wise, Emma L.; Bonner, Kandace T.; Williams, Timothy J.; Pease, James E.			A single nucleotide polymorphism in the CCR3 gene ablates receptor export to the plasma membrane	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chemokine receptor; chemokine; CCR3; single nucleotide polymorphism; protein trafficking	CHEMOKINE RECEPTOR; CELL-SURFACE; AIRWAY HYPERRESPONSIVENESS; EOSINOPHIL CHEMOATTRACTANT; ENDOPLASMIC-RETICULUM; CARBOXYL-TERMINUS; MAST-CELLS; EOTAXIN; EXPRESSION; PROTEIN	Background: The chemokine receptor CCR3 orchestrates the migration of eosinophils, basophils, T(H)2 lymphocytes, and mast cells during the allergic response, with CCR3 blockade a potential means of therapeutic intervention. Non-synonymous single nucleotide polymorphisms (SNPs) within the ccr3 gene have previously been described, with little information regarding their effects on CCR3 function. Objective: To characterize the effects of nonsynonymous SNPs within the ccr3 gene. Methods: Site-directed mutagenesis was used to generate N-terminally tagged mutant CCR3 constructs corresponding to reported SNPs. Cell transfectants expressing either wildtype or mutant CCR3 were studied by flow cytometry, Western blotting, and confocal microscopy and examined for their ability to migrate to the CC chemokine ligand CCL11/eotaxin. Results: An L324P mutant CCR3 protein corresponding to the previously identified T971C SNP was not expressed at the cell surface, and cells remained unresponsive to CCL11 in chemotaxis assays. Confocal microscopy confirmed that L324P-CCR3 had a predominantly intracellular distribution compared with wild-type CCR3. A L324A variant of CCR3 had an identical phenotype to the L324P mutant, suggesting that L324 per se is critical for successful trafficking of nascent CCR3 to the cell membrane. The processes involved appear to be specific for CCR3, because an identical mutation in the homologous receptor CCR1 had minor effects. Conclusion: Trafficking to the cell surface of nascent CCR3 is critically dependent on a C-terminal leucine residue, suggestive of specific mechanisms for CCR3 export. Manipulation of these mechanisms may suggest novel means of antagonizing CCR3 function in the treatment of allergy. (J Allergy Clin Immunol 2010;126:150-7.)	[Pease, James E.] Univ London Imperial Coll Sci Technol & Med, NHLI Div, Leukocyte Biol Sect, Natl Heart & Lung Inst, London SW7 2AZ, England	Imperial College London	Pease, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI Div, Leukocyte Biol Sect, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	j.pease@imperial.ac.uk	Pease, James/X-4521-2018	Pease, James/0000-0003-3749-0341	Wellcome Trust [076036/Z/04/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the Wellcome Trust, Project Grant 076036/Z/04/Z.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Auger GA, 2002, EUR J IMMUNOL, V32, P1052, DOI 10.1002/1521-4141(200204)32:4<1052::AID-IMMU1052>3.0.CO;2-L; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cooray SN, 2009, MOL CELL ENDOCRINOL, V300, P17, DOI 10.1016/j.mce.2008.10.004; de Mendonca FL, 2005, J BIOL CHEM, V280, P4808, DOI 10.1074/jbc.M412267200; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Eum SY, 1995, P NATL ACAD SCI USA, V92, P12290, DOI 10.1073/pnas.92.26.12290; Fahy O, 2001, AM J PATHOL, V158, P1053, DOI 10.1016/S0002-9440(10)64052-7; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Fukunaga K, 2001, EUR RESPIR J, V17, P59, DOI 10.1183/09031936.01.17100590; Gauvreau GM, 2008, AM J RESP CRIT CARE, V177, P952, DOI 10.1164/rccm.200708-1251OC; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Janovick JA, 2003, J PHARMACOL EXP THER, V305, P608, DOI 10.1124/jpet.102.048454; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Kato H, 1999, GENES IMMUN, V1, P97, DOI 10.1038/sj.gene.6363638; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lee JH, 2007, J ALLERGY CLIN IMMUN, V120, P1110, DOI 10.1016/j.jaci.2007.08.041; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pease JE, 2006, J ALLERGY CLIN IMMUN, V118, P305, DOI 10.1016/j.jaci.2006.06.010; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Sabroe I, 2005, EUR J IMMUNOL, V35, P1301, DOI 10.1002/eji.200425171; Sabroe I, 1999, J IMMUNOL, V162, P2946; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Shinkai A, 1999, J IMMUNOL, V163, P1602; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; White JR, 1997, J LEUKOCYTE BIOL, V62, P667, DOI 10.1002/jlb.62.5.667; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Wise EL, 2007, J BIOL CHEM, V282, P27935, DOI 10.1074/jbc.M703255200; Wruck CJ, 2005, ARTERIOSCL THROM VAS, V25, P57, DOI 10.1161/01.ATV.0000150662.51436.14; Yamada H, 2000, ALLERGY, V55, P392, DOI 10.1034/j.1398-9995.2000.00474.x; Zeibecoglou K, 1999, J ALLERGY CLIN IMMUN, V103, P99, DOI 10.1016/S0091-6749(99)70532-4; Zimmermann N, 1998, BBA-GENE STRUCT EXPR, V1442, P170, DOI 10.1016/S0167-4781(98)00162-6; Zimmermann N, 1999, J BIOL CHEM, V274, P12611, DOI 10.1074/jbc.274.18.12611	54	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2010	126	1					150	157		10.1016/j.jaci.2010.04.015	http://dx.doi.org/10.1016/j.jaci.2010.04.015			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	627SE	20541248				2022-12-18	WOS:000280061800027
J	Melamed, IR; Robinson, L; Heffron, M				Melamed, I. R.; Robinson, L.; Heffron, M.			The Benefit of Montelukast in Atopic Dermatitis Induced by Food Allergies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Melamed, I. R.; Robinson, L.; Heffron, M.] IMMUNOe Int Res Ctr, Centennial, CO USA										0	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB93	AB93		10.1016/j.jaci.2009.12.366	http://dx.doi.org/10.1016/j.jaci.2009.12.366			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS		Green Published, Green Submitted			2022-12-18	WOS:000280204100367
J	Singh, AM; Evans, MD; Gangnon, R; Roberg, KA; Tisler, C; DaSilva, D; Pappas, T; Salazar, L; Anderson, EL; Gern, JE; Lemanske, RF; Seroogy, CM				Singh, Anne Marie; Evans, Michael D.; Gangnon, Ronald; Roberg, Kathy A.; Tisler, Christopher; DaSilva, Douglas; Pappas, Tressa; Salazar, Lisa; Anderson, Elizabeth L.; Gern, James E.; Lemanske, Robert F., Jr.; Seroogy, Christine M.			Expression patterns of atopic eczema and respiratory illnesses in a high-risk birth cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							1ST 18 MONTHS; DERMATITIS; CHILDHOOD; DISEASES; ALLERGY; LIFE		[Singh, Anne Marie; Roberg, Kathy A.; Tisler, Christopher; DaSilva, Douglas; Pappas, Tressa; Salazar, Lisa; Anderson, Elizabeth L.; Gern, James E.; Lemanske, Robert F., Jr.; Seroogy, Christine M.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Evans, Michael D.; Gangnon, Ronald] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Gangnon, Ronald] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA; [Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Singh, AM (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.	cmseroogy@wisc.edu		Gangnon, Ronald/0000-0003-2587-6714; Evans, Michael/0000-0001-7449-3993	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831, R01HL080072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007635] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080072-01, P01 HL070831-01, R01 HL080072, P01 HL70831-01, P01 HL070831] Funding Source: Medline; NIAID NIH HHS [T32 AI007635, T32 AI007635-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Benn CS, 2004, BRIT MED J, V328, P1223, DOI 10.1136/bmj.38069.512245.FE; Benn CS, 2004, AM J EPIDEMIOL, V160, P217, DOI 10.1093/aje/kwh208; Bufford JD, 2008, CLIN EXP ALLERGY, V38, P1635, DOI 10.1111/j.1365-2222.2008.03018.x; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Ludvigsson JF, 2005, PEDIAT ALLERG IMM-UK, V16, P201, DOI 10.1111/j.1399-3038.2005.00257.x; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1	9	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2					491	493		10.1016/j.jaci.2009.11.026	http://dx.doi.org/10.1016/j.jaci.2009.11.026			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	558RU	20159261	Green Accepted, Bronze			2022-12-18	WOS:000274764000031
J	Varshney, P; Jones, SM; Pons, L; Kulis, M; Steele, PH; Kemper, AR; Scurlock, AM; Perry, TT; Burks, AW				Varshney, P.; Jones, S. M.; Pons, L.; Kulis, M.; Steele, P. H.; Kemper, A. R.; Scurlock, A. M.; Perry, T. T.; Burks, A. W.			Peanut Oral Immunotherapy (OIT) Induces Immunologic Changes Supporting the Development of Tolerance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Varshney, P.; Pons, L.; Kulis, M.; Steele, P. H.; Kemper, A. R.; Burks, A. W.] Duke Univ, Durham, NC USA; [Jones, S. M.; Scurlock, A. M.; Perry, T. T.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	Duke University; University of Arkansas System; University of Arkansas Medical Sciences									0	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB59	AB59		10.1016/j.jaci.2009.12.953	http://dx.doi.org/10.1016/j.jaci.2009.12.953			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100232
J	Apter, AJ				Apter, Andrea J.			Advances in adult asthma diagnosis and treatment in 2009	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; adults; genetics; inhaled corticosteroids; nitric oxide; health disparities; biomarker; leukotriene modifier; obesity	BODY-MASS INDEX; EXHALED NITRIC-OXIDE; CLINICAL-TRIALS; HEALTH DISPARITIES; CHILDHOOD ASTHMA; PEDIATRIC ASTHMA; SELF-MANAGEMENT; LUNG-FUNCTION; MONTELUKAST; RISK	There is a growing need to standardize and validate outcomes for asthma research. In this review of asthma-related publications from the Journal in 2009, efforts to standardize methodology and reporting of translational research, the influence of the environment, therapeutics, and management of asthma are highlighted. (J Allergy Clin Immunol 2010;125: 79-84.)	[Apter, Andrea J.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Apter, AJ (corresponding author), Hosp Univ Penn, 829 Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	apter@mail.med.upenn.edu			National Heart, Lung, and Blood Institute [HL070392, HL088469, RC1 HL099612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073932, RC1HL099612, K02HL088469] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A. J. Apter receives research support from the National Heart, Lung, and Blood Institute. A. J. Apter is supported by grants HL070392, HL088469, and RC1 HL099612.	Adams RJ, 2009, J ALLERGY CLIN IMMUN, V124, P601, DOI 10.1016/j.jaci.2009.05.035; Alexis NE, 2009, J ALLERGY CLIN IMMUN, V124, P1222, DOI 10.1016/j.jaci.2009.07.036; Appleton SL, 2009, J ALLERGY CLIN IMMUN, V123, P124, DOI 10.1016/j.jaci.2008.10.032; Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P512, DOI 10.1016/j.jaci.2005.12.1353; Apter AJ, 2004, J ALLERGY CLIN IMMUN, V113, P407, DOI 10.1016/j.jaci.2003.12.002; Apter AJ, 2008, J ALLERGY CLIN IMMUN, V121, P839, DOI 10.1016/j.jaci.2007.12.1176; Apter AJ, 2007, J ALLERGY CLIN IMMUN, V119, P563, DOI 10.1016/j.jaci.2007.01.001; Apter AJ, 2006, J ASTHMA, V43, P705, DOI 10.1080/02770900600925585; Apter AJ, 2009, J ALLERGY CLIN IMMUN, V123, P1237, DOI 10.1016/j.jaci.2009.04.028; Apter AJ, 2009, J ALLERGY CLIN IMMUN, V123, P35, DOI 10.1016/j.jaci.2008.11.017; Apter AJ, 2008, J GEN INTERN MED, V23, P2117, DOI 10.1007/s11606-008-0803-x; Apter Andrea J., 2003, Journal of Allergy and Clinical Immunology, V111, pS780, DOI 10.1067/mai.2003.153; Balmes JR, 2009, J ALLERGY CLIN IMMUN, V123, P626, DOI 10.1016/j.jaci.2008.10.062; Barton SJ, 2009, J ALLERGY CLIN IMMUN, V123, P1391, DOI 10.1016/j.jaci.2009.03.014; Basu K, 2009, J ALLERGY CLIN IMMUN, V124, P1188, DOI 10.1016/j.jaci.2009.07.043; Blais L, 2009, J ALLERGY CLIN IMMUN, V124, P1229, DOI 10.1016/j.jaci.2009.09.025; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Canino G, 2009, J ALLERGY CLIN IMMUN, V123, P1209, DOI 10.1016/j.jaci.2009.02.043; Clerisme-Beaty EM, 2009, J ALLERGY CLIN IMMUN, V124, P207, DOI 10.1016/j.jaci.2009.05.034; Coogan PF, 2009, J ALLERGY CLIN IMMUN, V123, P89, DOI 10.1016/j.jaci.2008.09.040; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; DeMore JP, 2009, J ALLERGY CLIN IMMUN, V124, P245, DOI 10.1016/j.jaci.2009.05.030; Esteba CA, 2009, J ALLERGY CLIN IMMUN, V124, P238, DOI 10.1016/j.jaci.2009.05.014; FULBRIGGE A, 2009, QUALITY CARE MEASURE, P1; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Gruchalla RS, 2009, J ALLERGY CLIN IMMUN, V124, P213, DOI 10.1016/j.jaci.2009.05.036; Gupta RS, 2009, J ALLERGY CLIN IMMUN, V123, P1297, DOI 10.1016/j.jaci.2009.03.039; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Haahtela T, 2009, J ALLERGY CLIN IMMUN, V124, P1180, DOI 10.1016/j.jaci.2009.09.036; Haller G, 2009, J ALLERGY CLIN IMMUN, V124, P1204, DOI 10.1016/j.jaci.2009.09.013; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; Holbrook JT, 2008, J ALLERGY CLIN IMMUN, V122, P828, DOI 10.1016/j.jaci.2008.07.012; Hope AP, 2009, J ALLERGY CLIN IMMUN, V123, P406, DOI 10.1016/j.jaci.2008.09.048; Janson SL, 2009, J ALLERGY CLIN IMMUN, V123, P840, DOI 10.1016/j.jaci.2009.01.053; Julien JY, 2009, J ALLERGY CLIN IMMUN, V124, P371, DOI 10.1016/j.jaci.2009.05.016; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kelsay K, 2009, J ALLERGY CLIN IMMUN, V124, P697, DOI 10.1016/j.jaci.2009.09.001; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; Lund MB, 2007, EUR RESPIR J, V29, P292, DOI 10.1183/09031936.00044805; Macsali F, 2009, J ALLERGY CLIN IMMUN, V123, P391, DOI 10.1016/j.jaci.2008.10.041; Marcon A, 2009, J ALLERGY CLIN IMMUN, V123, P1069, DOI 10.1016/j.jaci.2009.01.040; Martin MA, 2009, J ALLERGY CLIN IMMUN, V123, P153, DOI 10.1016/j.jaci.2008.10.057; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; Naimi DR, 2009, J ALLERGY CLIN IMMUN, V123, P1335, DOI 10.1016/j.jaci.2009.02.022; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; *NIH, 2007, NIH PUBL, P1; *NIH PUBL HLTH SER, 1997, NIH PUBL; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Patel MM, 2009, CURR OPIN PEDIATR, V21, P235, DOI 10.1097/MOP.0b013e3283267726; Pavord ID, 2009, J ALLERGY CLIN IMMUN, V123, P1083, DOI 10.1016/j.jaci.2009.02.034; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P699, DOI 10.1016/j.jaci.2009.08.011; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P691, DOI 10.1016/j.jaci.2009.08.010; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Rothman KJ, 2002, EPIDEMIOLOGY INTRO, P199; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Smith AD, 2009, J ALLERGY CLIN IMMUN, V124, P714, DOI 10.1016/j.jaci.2009.07.020; Sternthal MJ, 2009, J ALLERGY CLIN IMMUN, V124, P954, DOI 10.1016/j.jaci.2009.07.030; SUCHAREW H, PEDIAT ALLE IN PRESS; Sutherland ER, 2009, J ALLERGY CLIN IMMUN, V123, P1328, DOI 10.1016/j.jaci.2009.04.005; Sverrild A, 2009, J ALLERGY CLIN IMMUN, V124, P928, DOI 10.1016/j.jaci.2009.06.028; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P470, DOI 10.1016/j.jaci.2004.12.1123; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Temprano J, 2009, J ALLERGY CLIN IMMUN, V123, P854, DOI 10.1016/j.jaci.2008.12.009; Thomas M, 2009, J ALLERGY CLIN IMMUN, V123, P116, DOI 10.1016/j.jaci.2008.09.035; Tsai CL, 2009, J ALLERGY CLIN IMMUN, V123, P354, DOI 10.1016/j.jaci.2008.10.051; U.S. Department of Education Institute of Education Sciences, NAT ASS AD LIT; Valet RS, 2009, J ALLERGY CLIN IMMUN, V123, P1220, DOI 10.1016/j.jaci.2008.12.1131; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Wise RA, 2009, J ALLERGY CLIN IMMUN, V124, P436, DOI 10.1016/j.jaci.2009.05.041; Wu AC, 2009, J ALLERGY CLIN IMMUN, V123, P385, DOI 10.1016/j.jaci.2008.10.015; Yong PL, 2009, J ALLERGY CLIN IMMUN, V124, P961, DOI 10.1016/j.jaci.2009.07.027; 2002, J ALLERGY CLIN IMM S, V110, pS141	75	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2010	125	1					79	84		10.1016/j.jaci.2009.11.028	http://dx.doi.org/10.1016/j.jaci.2009.11.028			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	544MG	20109739	Green Accepted			2022-12-18	WOS:000273660500008
J	Fiorini, M; Piovani, G; Schumacher, RF; Magri, C; Bertini, V; Mazzolari, E; Notarangelo, L; Notarangelo, LD; Barlati, S				Fiorini, Maurilia; Piovani, Giovanna; Schumacher, Richard F.; Magri, Chiara; Bertini, Valeria; Mazzolari, Evelina; Notarangelo, Lucia; Notarangelo, Luigi D.; Barlati, Sergio			ITGB2 mutation combined with deleted ring 21 chromosome in a child with leukocyte adhesion deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BETA-SUBUNIT; LFA-1; R(21)		[Fiorini, Maurilia] Univ Brescia, Angelo Nocivelli Inst Mol Med, I-25121 Brescia, Italy; [Schumacher, Richard F.; Mazzolari, Evelina; Notarangelo, Lucia] Univ Brescia, Div Ematooncol Pediat, I-25121 Brescia, Italy; [Notarangelo, Luigi D.] Univ Brescia, Spedali Civili, Osped Bambini, Pediat Clin, I-25121 Brescia, Italy; [Piovani, Giovanna; Magri, Chiara; Bertini, Valeria; Barlati, Sergio] Univ Brescia, Dept Biomed Sci & Biotechnol, I-25121 Brescia, Italy; [Notarangelo, Luigi D.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Childrens Hosp, Sch Med, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	University of Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; University of Brescia; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Fiorini, M (corresponding author), Univ Brescia, Angelo Nocivelli Inst Mol Med, I-25121 Brescia, Italy.	barlati@med.unibs.it	Notarangelo, Luigi D/F-9718-2016; Magri, Chiara/I-4691-2017; Barlati, Sergio/A-2666-2010	Notarangelo, Luigi D/0000-0002-8335-0262; Magri, Chiara/0000-0001-9933-8666; PIOVANI, Giovanna/0000-0003-0001-6435				ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; CORBI AL, 1988, J EXP MED, V167, P1597, DOI 10.1084/jem.167.5.1597; FERRANTE E, 1983, HELV PAEDIATR ACTA, V38, P73; Fischer A, 1988, Immunodefic Rev, V1, P39; IESHIMA A, 1980, HUM GENET, V55, P65, DOI 10.1007/BF00329128; LEJEUNE J, 1964, CR HEBD ACAD SCI, V259, P4187; MARLIN SD, 1986, J EXP MED, V164, P855, DOI 10.1084/jem.164.3.855; Shaffer LG., 2005, INT SYSTEM HUMAN CYT; SOLOMON E, 1988, ANN HUM GENET, V52, P123, DOI 10.1111/j.1469-1809.1988.tb01087.x	9	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2009	124	6					1356	1358		10.1016/j.jaci.2009.07.058	http://dx.doi.org/10.1016/j.jaci.2009.07.058			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	536VH	19864007	Green Submitted			2022-12-18	WOS:000273071500033
J	Kleinheinz, A; Lepp, U; Hausen, BM; Petersen, A; Becker, WM				Kleinheinz, Andreas; Lepp, Ute; Hausen, Bjoern M.; Petersen, Arnd; Becker, Wolf-Meinhard			Anaphylactic reaction to (mixed) fruit juice containing dragon fruit	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Kleinheinz, Andreas; Hausen, Bjoern M.] Dermatol Zentrum Buxtehude, Buxtehude, Germany; [Petersen, Arnd; Becker, Wolf-Meinhard] Res Ctr, Borstel, Germany; [Lepp, Ute] Herz Lungen Praxis Stade, Borstel, Germany	Forschungszentrum Borstel	Kleinheinz, A (corresponding author), Dermatol Zentrum Buxtehude, Buxtehude, Germany.	apetersen@fz-borstel.de						Damiani E, 2008, ALLERGY, V63, P1252, DOI 10.1111/j.1398-9995.2008.01797.x; Kelso JM, 1998, J ALLERGY CLIN IMMUN, V102, P145, DOI 10.1016/S0091-6749(98)70066-1; Palacin A, 2007, J ALLERGY CLIN IMMUN, V120, P1132, DOI 10.1016/j.jaci.2007.07.008; Richard C, 2007, Eur Ann Allergy Clin Immunol, V39, P76	4	9	9	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2009	124	4					841	842		10.1016/j.jaci.2009.05.025	http://dx.doi.org/10.1016/j.jaci.2009.05.025			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	506UV	19596400	Bronze			2022-12-18	WOS:000270802800032
J	Salo, PM; Zeldin, DC				Salo, Paeivi M.; Zeldin, Darryl C.			Does exposure to cats and dogs decrease the risk of allergic sensitization and disease?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Cats; dogs; allergic sensitization; domestic pets	FEL D 1; ASTHMA; PETS; PREVALENCE; CHILDHOOD; CD14; IGE		[Salo, Paeivi M.; Zeldin, Darryl C.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zeldin, DC (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,Room A222, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025041, ZIAES025041] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES025041-11] Funding Source: Medline; NIEHS NIH HHS [Z01 ES025041] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Almqvist C, 2003, J ALLERGY CLIN IMMUN, V111, P800, DOI 10.1067/mai.2003.1334; Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V114, P111, DOI 10.1016/j.jaci.2004.04.036; Bornehag CG, 2003, ALLERGY, V58, P939, DOI 10.1034/j.1398-9995.2003.00050.x; Bufford JD, 2007, CURR ALLERGY ASTHM R, V7, P375, DOI 10.1007/s11882-007-0057-4; *COMM ASS ASTHM IN, 2000, CLEAR AIR ASTHM IND, P105; Heinrich J, 2006, J ALLERGY CLIN IMMUN, V118, P674, DOI 10.1016/j.jaci.2006.06.012; Kerkhof M, 2009, ALLERGY, V64, P1202, DOI 10.1111/j.1398-9995.2009.02016.x; Mandhane PJ, 2009, J ALLERGY CLIN IMMUN, V124, P745, DOI 10.1016/j.jaci.2009.06.038; MARTINEZ FD, 1999, LANCET S2, V354, P2; Patchett K, 1997, J ALLERGY CLIN IMMUN, V100, P755, DOI 10.1016/S0091-6749(97)70269-0; Pearce N, 2000, EUR RESPIR J, V16, P420, DOI 10.1183/9031936.00.16337700; Platts-Mills TAE, 2004, SPRINGER SEMIN IMMUN, V25, P271, DOI 10.1007/s00281-003-0149-8; Simpson A, 2005, CURR ALLERGY ASTHM R, V5, P212, DOI 10.1007/s11882-005-0040-x; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Svanes C, 2003, J ALLERGY CLIN IMMUN, V112, P289, DOI 10.1067/mai.2003.1596; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; Wickman M, 1999, CLIN EXP ALLERGY, V29, P626; Williams LK, 2006, J ALLERGY CLIN IMMUN, V118, P851, DOI 10.1016/j.jaci.2006.07.007	18	9	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2009	124	4					751	752		10.1016/j.jaci.2009.08.012	http://dx.doi.org/10.1016/j.jaci.2009.08.012			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	506UV	19815117	Green Accepted			2022-12-18	WOS:000270802800020
J	Joshi, P; Katelaris, CH; Frankum, B				Joshi, Preeti; Katelaris, Constance H.; Frankum, Brad			Adrenaline (epinephrine) autoinjector use in preschools	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Joshi, Preeti] Childrens Hosp Westmead, Dept Allergy Immunol & Infect Dis, Sydney, NSW, Australia; [Katelaris, Constance H.] Univ Western Sydney, Dept Immunol & Allergy, Penrith, NSW 1797, Australia; [Katelaris, Constance H.; Frankum, Brad] Campbelltown Hosp, Campbelltown, NSW, Australia; [Frankum, Brad] Univ Western Sydney, Dept Clin Educ, Sydney, NSW, Australia; [Frankum, Brad] Camden Hosp, Camden, NSW, Australia	University of Sydney; Western Sydney University; Western Sydney University	Joshi, P (corresponding author), Childrens Hosp Westmead, Dept Allergy Immunol & Infect Dis, Sydney, NSW, Australia.	PreetiJ@chw.edu.au						Arkwright PD, 2006, PEDIATR ALLERGY IMMU, V17, P227, DOI 10.1111/j.1399-3038.2006.00392.x; CLARE WA, 2007, MED J AUSTRALIA, V187, P542; Mehr S, 2007, PEDIAT ALLERG IMM-UK, V18, P448, DOI 10.1111/j.1399-3038.2007.00529.x	3	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2009	124	2					383	384		10.1016/j.jaci.2009.06.033	http://dx.doi.org/10.1016/j.jaci.2009.06.033			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	482CD	19647588				2022-12-18	WOS:000268860400032
J	Schatz, M; Kazzi, AAN; Brenner, B; Camargo, CA; Corbridge, T; Krishnan, JA; Nowak, R; Rachelefsky, G				Schatz, Michael; Kazzi, Amin Antoine Nabih; Brenner, Barry; Camargo, Carlos A., Jr.; Corbridge, Thomas; Krishnan, Jerry A.; Nowak, Richard; Rachelefsky, Gary			Joint Task Force Report: Supplemental Recommendations for the Management and Follow-Up of Asthma Exacerbations Introduction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma exacerbation; acute asthma; emergency department; Expert Panel Report 3; noninvasive positive pressure ventilation; continuous positive airway pressure ventilation; bilevel positive airway pressure ventilation; respiratory failure; intubation; mechanical ventilation; discharge medications; corticosteroids; follow-up care; asthma specialist care			[Schatz, Michael] Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA 92111 USA; [Kazzi, Amin Antoine Nabih] Amer Univ Beirut, Dept Emergency Med, Beirut, Lebanon; [Brenner, Barry] Univ Hosp, Case Med Ctr, Case Western Reserve Sch Med, Dept Emergency Med, Cleveland, OH USA; [Camargo, Carlos A., Jr.] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA; [Camargo, Carlos A., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol,Dept Med, Boston, MA USA; [Corbridge, Thomas] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Krishnan, Jerry A.] Univ Chicago, Dept Med, Asthma & COPD Ctr, Chicago, IL 60637 USA; [Krishnan, Jerry A.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Nowak, Richard] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI USA; [Rachelefsky, Gary] Univ Calif Los Angeles, David Geffen Sch Med, Execut Care Ctr Asthma Allergy & Resp Dis, Los Angeles, CA 90095 USA	Kaiser Permanente; American University of Beirut; Case Western Reserve University; University Hospitals of Cleveland; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schatz, M (corresponding author), Kaiser Permanente Med Ctr, Dept Allergy, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA.		Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654				American Lung Association, AM LUNG ASS ASTHM AD; CDC, 2005, NATL HLTH NUTR EXAMI; Jadad AR, 2000, BRIT MED J, V320, P537, DOI 10.1136/bmj.320.7234.537; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Soroksky A, 2003, CHEST, V123, P1018, DOI 10.1378/chest.123.4.1018	5	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2009	124	2					S1	S4		10.1016/j.jaci.2009.05.001	http://dx.doi.org/10.1016/j.jaci.2009.05.001			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	482CE	19647130	Bronze			2022-12-18	WOS:000268860500001
J	Behnecke, A; Li, W; Chen, L; Saxon, A; Zhang, K				Behnecke, Anne; Li, Wei; Chen, Ling; Saxon, Andrew; Zhang, Ke			IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Gene vaccination; human IgE; dendritic cells; food allergy; IgE high-affinity receptor	FC-EPSILON-RI; HUMAN LANGERHANS CELLS; DENDRITIC CELLS; IMMUNE-RESPONSE; PEANUT ALLERGY; DNA VACCINES; ORAL-MUCOSA; IMMUNIZATION; INHIBITION; EXPRESSION	Background: Treatment of IgE-mediated food allergy with standard protein-based allergen immunotherapy has proved both unsuccessful and hazardous. Allergen gene vaccination represents a promising alternative, but difficulties in gene targeting and expression in antigen-presenting cells represent a major limitation for efficient gene vaccination. Objective: We sought to construct a genetically engineered human E-polylysine (EPL) fusion protein that binds allergen gene expression systems and targets the gene vaccine complex to antigen-presenting cells through the interaction of EPL and the high-affinity receptor for IgE for efficient allergen gene vaccination. Methods: Genetic engineering was used to design and produce the EPL fusion gene, consisting of the human CH epsilon 2-4 linked to 55 lysine residues, and the conventional approaches were used to characterize the biologic features of EPL. Results: EPL was assembled as functional dimers and capable of binding DNA plasmids in both an EPL protein and plasmid DNA concentration-dependent manner. EPL targeted plasmid DNA to the high-affinity receptor for IgE on cell surfaces and increased the model gene uptake/expression. The EPL-DNA complexes were shown not to trigger mast cell degranulation. Conclusion: EPL is able to function as a gene carrier system to target allergen gene to the high-affinity receptor for IgE-expressing cells through ligand receptor-mediated interactions. (J Allergy Clin Immunol 2009;124:108-13.)	[Behnecke, Anne; Li, Wei; Chen, Ling; Saxon, Andrew; Zhang, Ke] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med,Hart & Louise Lyon Immunol Lab, Div Pulm Crit Care & Clin Immunol Allergy,Sect Cl, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhang, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med,Hart & Louise Lyon Immunol Lab, Div Pulm Crit Care & Clin Immunol Allergy,Sect Cl, 37-131 CHS,10833 Conte Ave, Los Angeles, CA 90095 USA.	kzhang@mednet.ucla.edu			Food Allergy and Anaphylaxis Network (FAAN); National Institute of Allergy and Infectious Disease; National Institutes of Health [AI 15251]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015251, R21AI015251] Funding Source: NIH RePORTER	Food Allergy and Anaphylaxis Network (FAAN); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Food Allergy and Anaphylaxis Network (FAAN) and National Institute of Allergy and Infectious Disease, National Institutes of Health grant AI 15251.	Adel-Patient K, 2001, INT ARCH ALLERGY IMM, V126, P59, DOI 10.1159/000049495; Allam JP, 2006, ALLERGY, V61, P166, DOI 10.1111/j.1398-9995.2005.00965.x; Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; Allen LC, 2007, J ALLERGY CLIN IMMUN, V120, P462, DOI 10.1016/j.jaci.2007.04.019; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Burks AW, 2008, LANCET, V371, P1538, DOI 10.1016/S0140-6736(08)60659-5; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; GRABBE J, 1993, BRIT J DERMATOL, V129, P120, DOI 10.1111/j.1365-2133.1993.tb03512.x; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; HAAS N, 1992, ACTA DERM-VENEREOL, V72, P271; Haas N, 1993, Exp Dermatol, V2, P157, DOI 10.1111/j.1600-0625.1993.tb00025.x; Hochreiter R, 2001, INT ARCH ALLERGY IMM, V124, P406, DOI 10.1159/000053772; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jilek S, 2001, J IMMUNOL, V166, P3612, DOI 10.4049/jimmunol.166.5.3612; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; MAURER D, 1995, J IMMUNOL, V154, P6285; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Maurer D, 1998, J IMMUNOL, V161, P2731; MUDDE GC, 1990, IMMUNOL TODAY, V11, P440, DOI 10.1016/0167-5699(90)90172-6; Novak N, 2004, J ALLERGY CLIN IMMUN, V114, P364, DOI 10.1016/j.jaci.2004.05.038; Ross R, 2003, GENE THER, V10, P1035, DOI 10.1038/sj.gt.3301968; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Takashima A, 1999, J LEUKOCYTE BIOL, V66, P350, DOI 10.1002/jlb.66.2.350; Talsma SS, 2006, J CONTROL RELEASE, V112, P271, DOI 10.1016/j.jconrel.2006.02.008; Toda M, 2000, IMMUNOLOGY, V99, P179, DOI 10.1046/j.1365-2567.2000.00935.x; WU GY, 1987, J BIOL CHEM, V262, P4429; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390	30	9	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2009	124	1					108	113		10.1016/j.jaci.2009.03.020	http://dx.doi.org/10.1016/j.jaci.2009.03.020			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	469OR	19423156	Green Accepted			2022-12-18	WOS:000267909700013
J	Erwin, EA; Hosen, J; Pollart, SM; Reid, MJ; Platts-Mills, TAE				Erwin, Elizabeth A.; Hosen, Jake; Pollart, Susan M.; Reid, Michael J.; Platts-Mills, Thomas A. E.			High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INDOOR ALLERGENS; DUST-MITE; ASTHMA; CAT; SENSITIZATION; EXPOSURE		[Erwin, Elizabeth A.; Hosen, Jake; Pollart, Susan M.; Platts-Mills, Thomas A. E.] Univ Virginia, Asthma & Allerg Dis Ctr, Charlottesville, VA 22903 USA; [Reid, Michael J.] Allergy & Immunol Associates, San Francisco, CA USA	University of Virginia	Erwin, EA (corresponding author), Univ Virginia, Asthma & Allerg Dis Ctr, Charlottesville, VA 22903 USA.	tap2z@virginia.edu	Hosen, Jacob/F-9224-2013	Hosen, Jacob/0000-0003-2559-0687; Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020565, K23AI059317] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI020565-25, R01 AI020565, K23 AI059317] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Erwin EA, 2007, J ALLERGY CLIN IMMUN, V119, P359, DOI 10.1016/j.jaci.2006.12.648; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; GLEICH GJ, 1975, SCIENCE, V190, P1106, DOI 10.1126/science.1188389; Grobe K, 1999, EUR J BIOCHEM, V263, P33, DOI 10.1046/j.1432-1327.1999.00462.x; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Platts-Mills TAE, 2007, J ALLERGY CLIN IMMUN, V119, P297, DOI 10.1016/j.jaci.2006.12.647; POLLART SM, 1988, J ALLERGY CLIN IMMUN, V82, P224, DOI 10.1016/0091-6749(88)91003-2; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844	10	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2009	123	3					706	708		10.1016/j.jaci.2008.11.042	http://dx.doi.org/10.1016/j.jaci.2008.11.042			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	426TQ	19152969	Green Accepted			2022-12-18	WOS:000264731200037
J	Baumert, JL; Bush, RK; Levy, MB; Koppelman, SJ; Nordlee, JA; Hefle, SL; Taylor, SL				Baumert, J. L.; Bush, R. K.; Levy, M. B.; Koppelman, S. J.; Nordlee, J. A.; Hefle, S. L.; Taylor, S. L.			Distribution of Intact Peanut Protein and Digestion-Resistant Ara h 2 Peptide in Human Serum and Saliva	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Baumert, J. L.; Nordlee, J. A.; Hefle, S. L.; Taylor, S. L.] Univ Nebraska, Food Allergy Res & Resource Program, Lincoln, NE USA; [Bush, R. K.] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA; [Levy, M. B.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Koppelman, S. J.] HAL Allergy, Leiden, Netherlands	University of Nebraska System; University of Nebraska Lincoln; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin			Taylor, Steve L./V-1341-2019						0	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				1041	S268	S268		10.1016/j.jaci.2008.12.1040	http://dx.doi.org/10.1016/j.jaci.2008.12.1040			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301513
J	Engler, RJM; Silvers, WS; Bielory, L				Engler, Renata J. M.; Silvers, William S.; Bielory, Leonard			Complementary and alternative medicine education: Need for expanded educational resources for American Academy of Allergy, Asthma & Immunology members	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Engler, Renata J. M.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Engler, Renata J. M.] Walter Reed Army Med Ctr, Vaccine Healthcare Ctr Network, Allergy Immunol Dept, Washington, DC 20307 USA; [Silvers, William S.] Univ Colorado, Sch Med, Englewood, CO USA; [Silvers, William S.] Univ Colorado, Allergy Asthma & Immunol Clin Colorado PC, Englewood, CO USA; [Bielory, Leonard] Clin Res & Dev UMDNJ New Jersey Med Sch, Dept Pediat, Div Rheumatol Allergy & Immunol, Newark, NJ USA; [Bielory, Leonard] Clin Res & Dev UMDNJ New Jersey Med Sch, UMDNJ Asthma & Allergy Res Ctr, Newark, NJ USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Engler, RJM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	Renata.engler@gmail.com						[Anonymous], WHAT IS CAM; Bielory L, 2004, ANN ALLERG ASTHMA IM, V93, pS1, DOI 10.1016/S1081-1206(10)61480-9; Hok J, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-48; Ko J, 2006, ANN ALLERG ASTHMA IM, V97, P365, DOI 10.1016/S1081-1206(10)60802-2; Lie Desiree A, 2006, BMC Med Educ, V6, P58, DOI 10.1186/1472-6920-6-58; Qu C, 2007, CLIN EXP ALLERGY, V37, P846, DOI 10.1111/j.1365-2222.2007.02718.x; Wen MC, 2005, J ALLERGY CLIN IMMUN, V116, P517, DOI 10.1016/j.jaci.2005.05.029; Zollman C, 1999, BRIT MED J, V319, P693, DOI 10.1136/bmj.319.7211.693	8	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2					511	512		10.1016/j.jaci.2008.11.020	http://dx.doi.org/10.1016/j.jaci.2008.11.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	409GU	19203668				2022-12-18	WOS:000263495000040
J	Groschwitz, KR; Ahrens, R; Osterfeld, H; Finkelman, FD; Rothenberg, ME; Abrink, M; Pejler, G; Hogan, SP				Groschwitz, K. R.; Ahrens, R.; Osterfeld, H.; Finkelman, F. D.; Rothenberg, M. E.; Abrink, M.; Pejler, G.; Hogan, S. P.			Mast Cell Chymase Regulates Homeostatic Intestinal Barrier Function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Groschwitz, K. R.; Ahrens, R.; Osterfeld, H.; Finkelman, F. D.; Rothenberg, M. E.; Hogan, S. P.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Abrink, M.; Pejler, G.] Swedish Univ Agr Sci, Uppsala, Sweden	Cincinnati Children's Hospital Medical Center; Swedish University of Agricultural Sciences									0	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				827	S215	S215		10.1016/j.jaci.2008.12.821	http://dx.doi.org/10.1016/j.jaci.2008.12.821			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301299
J	Gueant, JL; Gueant-Rodriguez, RM; Cornejo-Garcia, JA; Viola, M; Blanca, M; Romano, A				Gueant, Jean-Louis; Gueant-Rodriguez, Rosa-Maria; Cornejo-Garcia, Jose-Antonio; Viola, Marinella; Blanca, Miguel; Romano, Antonino			Gene variants of IL13, IL4, and IL4RA are predictors of beta-lactam allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PENICILLINS ALLERGY; IMMEDIATE; POLYMORPHISMS		[Gueant, Jean-Louis; Gueant-Rodriguez, Rosa-Maria; Cornejo-Garcia, Jose-Antonio; Blanca, Miguel] Univ Henry Poincare, Fac Med, INSERM, U724, Vandoeuvre Les Nancy, France; [Gueant, Jean-Louis; Romano, Antonino] Univ Hosp Ctr CHU Nancy, Vandoeuvre Les Nancy, France; [Viola, Marinella; Romano, Antonino] IRCCS Oasi Maria SS, Troina, Italy; [Cornejo-Garcia, Jose-Antonio; Blanca, Miguel] Complesso Imegrato Columbus, Unita Allergol, Rome, Italy; Carlos Haya Hosp, Allergy Serv, Malaga, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; IRCCS Oasi Maria SS; Hospital Carlos Haya	Gueant, JL (corresponding author), Univ Henry Poincare, Fac Med, INSERM, U724, Vandoeuvre Les Nancy, France.	jean-louis.gueant@medecine.uhp-nancy.fr	Romano, Antonino/D-3102-2017; Cornejo-García, Jose Antonio/S-7726-2016	Romano, Antonino/0000-0001-9742-9898; Cornejo-García, Jose Antonio/0000-0003-3465-8735	AHRQ HHS [U18 HS010399] Funding Source: Medline; NCRR NIH HHS [P20 RR020741-01, P20 RR020741] Funding Source: Medline; NHLBI NIH HHS [K23 HL004337, K23 HL004337-05] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010399] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004337] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apter AJ, 2008, J ALLERGY CLIN IMMUN, V122, P152, DOI 10.1016/j.jaci.2008.03.037; Gueant JL, 2008, CURR PHARM DESIGN, V14, P2770, DOI 10.2174/138161208786369795; Gueant-Rodriguez RM, 2006, PHARMACOGENET GENOM, V16, P713, DOI 10.1097/01.fpc.0000230409.00276.44; Guglielmi L, 2006, ALLERGY, V61, P921, DOI 10.1111/j.1398-9995.2006.01067.x; Qiao HL, 2005, ALLERGY, V60, P1053, DOI 10.1111/j.1398-9995.2005.00816.x; Yang J, 2005, EUR J CLIN PHARMACOL, V61, P803, DOI 10.1007/s00228-005-0047-1	6	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2					509	509		10.1016/j.jaci.2008.10.058	http://dx.doi.org/10.1016/j.jaci.2008.10.058			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	409GU	19121856	Green Accepted			2022-12-18	WOS:000263495000036
J	Saverino, D; Riccio, AM; Rogkakou, A; Bagnasco, M; Bonadonna, P; Simone, R; Chiappori, A; Gamalero, C; Passalacqua, G; Canonica, GW; Pesce, G				Saverino, Daniele; Riccio, Anna Maria; Rogkakou, Anthi; Bagnasco, Marcello; Bonadonna, Patrizia; Simone, Rita; Chiappori, Alessandra; Gamalero, Cinzia; Passalacqua, Giovanni; Canonica, Giorgio Walter; Pesce, Giampaola			Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CTLA-4		[Saverino, Daniele; Simone, Rita; Chiappori, Alessandra] Univ Genoa, Dept Expt Med, Human Anat Sect, Genoa, Italy; [Riccio, Anna Maria; Rogkakou, Anthi; Gamalero, Cinzia; Passalacqua, Giovanni; Canonica, Giorgio Walter] Univ Genoa, Dept Internal Med, Genoa, Italy; [Bonadonna, Patrizia] Verona Gen Hosp, Allergy Serv, Verona, Italy; [Simone, Rita] Univ Verona, Dept Clin & Expt Med, Verona, Italy	University of Genoa; University of Genoa; University of Verona	Saverino, D (corresponding author), Univ Genoa, Dept Expt Med, Human Anat Sect, Genoa, Italy.	passalacqua@unige.it	canonica, giorgio walter/ABF-2037-2020; Saverino, Daniele/I-4741-2014	canonica, giorgio walter/0000-0001-8467-2557; RICCIO, ANNA MARIA/0000-0001-8392-533X; Pesce, Giampaola/0000-0002-6294-9110				Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wong CK, 2005, CLIN EXP IMMUNOL, V141, P122, DOI 10.1111/j.1365-2249.2005.02815.x	8	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					258	260		10.1016/j.jaci.2008.09.023	http://dx.doi.org/10.1016/j.jaci.2008.09.023			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	18926563	Bronze			2022-12-18	WOS:000262793900040
J	Petkonen, A; Kari, O; Selroos, O; Nikander, K; Haahtela, T; Turpeinen, M				Petkonen, Anna; Kari, Osmo; Selroos, Olof; Nikander, Kurt; Haahtela, Tari; Turpeinen, Markku			Ophthalmologic findings in children with asthma receiving inhaled budesonide	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MILD PERSISTENT ASTHMA; CATARACT; THERAPY		[Petkonen, Anna; Kari, Osmo; Haahtela, Tari; Turpeinen, Markku] Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Selroos, Olof] Semeco AB, Angelholm, Sweden; [Nikander, Kurt] Respironics, Parsippany, NJ USA; [Nikander, Kurt] AstraZeneca R&D, Lund, Sweden	University of Helsinki; Helsinki University Central Hospital; AstraZeneca	Petkonen, A (corresponding author), Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland.	anna.pelkonen@hus.fi	Pelkonen, Anna/D-3153-2018	Pelkonen, Anna/0000-0002-1482-8947				Agertoft L, 1998, EUR RESPIR J, V12, P130, DOI 10.1183/09031936.98.12010130; Behbehani AH, 2005, J PEDIAT OPHTH STRAB, V42, P23; Garbe E, 1998, JAMA-J AM MED ASSOC, V280, P539, DOI 10.1001/jama.280.6.539; Nootheti Sailaja, 2006, Compr Ophthalmol Update, V7, P31; Papadopoulos M, 2007, INVEST OPHTH VIS SCI, V48, P4100, DOI 10.1167/iovs.06-1350; Sheffer AL, 2005, ANN ALLERG ASTHMA IM, V94, P48, DOI 10.1016/S1081-1206(10)61285-9; Sihota R, 2006, J PEDIAT OPHTH STRAB, V43, P14, DOI 10.3928/01913913-20060101-01; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Turpeinen M, 2008, ARCH DIS CHILD, V93, P654, DOI 10.1136/adc.2007.116632; Uboweja A, 2006, FUND CLIN PHARMACOL, V20, P305, DOI 10.1111/j.1472-8206.2006.00397.x	10	9	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					832	834		10.1016/j.jaci.2008.07.013	http://dx.doi.org/10.1016/j.jaci.2008.07.013			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	18760462				2022-12-18	WOS:000259989000034
J	Chinen, J; Shearer, WT				Chinen, Javier; Shearer, William T.			Advances in basic and clinical immunology in 2007	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						basic immunology; antigen presentation; IgE; regulatory T cells; lung immunology; clinical immunology; immunodeficiency; hereditary angioedema; mastocytosis; common variable immunodeficiency; HIV infection	ALLERGIC AIRWAY INFLAMMATION; BONE-MARROW-TRANSPLANTATION; T-REGULATORY CELLS; HEREDITARY ANGIOEDEMA; ATOPIC-DERMATITIS; TRANSMEMBRANE ACTIVATOR; SYSTEMIC MASTOCYTOSIS; IGE; EXPRESSION; MUTATIONS	In 2007, there was significant progress in the area of basic immunology, including investigations that led to a better understanding of the function of antigen-presenting cells, such as the secretion of cytokines that inhibit or induce allergic inflammation on antigen stimulation. Mechanisms of IgE function were better characterized, and the clonality of IgE-producing B cells in allergic responses of monosensitized patients was demonstrated. The hygiene hypothesis was re-examined, with most of the evidence suggesting that the increase of atopy prevalence is best explained by the absence of T(H)1 responses rather than the absence of regulatory T cells. The effects of the environment in the allergic inflammation of the lung received new emphasis. Similar progress took place in the area of clinical immunology. Immune adverse reactions to drugs, such as the toxicity of carbamazepine-specific T cells and the safety and efficacy of drugs for the treatment of hereditary angioedema, were better characterized. There were advances in the molecular characterization of primary immunodeficiencies and their management, remarkably the discovery of signal transducer and activator of transcription 3 gene mutations as the cause of hyper-IgE syndrome. Long-term outcomes of bone marrow transplantation for severe combined immunodeficiencies confirmed the efficacy of this therapy.	[Chinen, Javier; Shearer, William T.] Baylor Coll Med, Dept Pediat, Allergy & Immunol Sect, Houston, TX 77030 USA	Baylor College of Medicine	Chinen, J (corresponding author), Baylor Coll Med, Dept Pediat, Allergy & Immunol Sect, 6621 Fannin St FC 330-01, Houston, TX 77030 USA.	jxchinen@texaschildrenshospital.org		Shearer, William/0000-0002-2483-2130	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD052102] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072705, R01HL078522, R01HL079533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041089, U01AI027551, U01AI069441] Funding Source: NIH RePORTER; NCRR NIH HHS [RR0188] Funding Source: Medline; NHLBI NIH HHS [HL78522, HL72705, HL079533] Funding Source: Medline; NIAID NIH HHS [AI069441, AI41089, AI27551] Funding Source: Medline; NICHD NIH HHS [HD052102, HD41983] Funding Source: Medline; PHS HHS [RAT003084A] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allen LC, 2007, J ALLERGY CLIN IMMUN, V120, P462, DOI 10.1016/j.jaci.2007.04.019; Ando T, 2007, J ALLERGY CLIN IMMUN, V120, P916, DOI 10.1016/j.jaci.2007.05.023; Aspalter RM, 2007, J ALLERGY CLIN IMMUN, V120, P1193, DOI 10.1016/j.jaci.2007.07.004; Bohm A, 2007, J ALLERGY CLIN IMMUN, V120, P192, DOI 10.1016/j.jaci.2007.03.015; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Bree A, 2007, J ALLERGY CLIN IMMUN, V119, P1251, DOI 10.1016/j.jaci.2007.02.009; Buckland KF, 2007, J ALLERGY CLIN IMMUN, V119, P997, DOI 10.1016/j.jaci.2006.12.660; Castigli E, 2007, J ALLERGY CLIN IMMUN, V120, P885, DOI 10.1016/j.jaci.2007.06.012; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Ebner S, 2007, J ALLERGY CLIN IMMUN, V119, P982, DOI 10.1016/j.jaci.2007.01.003; Farkas H, 2007, J ALLERGY CLIN IMMUN, V120, P941, DOI 10.1016/j.jaci.2007.06.026; Fawaz LM, 2007, J ALLERGY CLIN IMMUN, V120, P1208, DOI 10.1016/j.jaci.2007.08.022; Fletcher CV, 2007, J ALLERGY CLIN IMMUN, V119, P747, DOI 10.1016/j.jaci.2006.10.045; Foster SB, 2007, J ALLERGY CLIN IMMUN, V119, P750, DOI 10.1016/j.jaci.2007.01.002; Freeman AF, 2007, J ALLERGY CLIN IMMUN, V119, P1234, DOI 10.1016/j.jaci.2006.12.666; French AR, 2007, J ALLERGY CLIN IMMUN, V120, P924, DOI 10.1016/j.jaci.2007.05.022; Gernez Y, 2007, J ALLERGY CLIN IMMUN, V120, P1441, DOI 10.1016/j.jaci.2007.08.012; Gordon SB, 2007, J ALLERGY CLIN IMMUN, V120, P208, DOI 10.1016/j.jaci.2007.03.050; Guarino MD, 2007, J ALLERGY CLIN IMMUN, V120, P962, DOI 10.1016/j.jaci.2007.05.041; Hajoui O, 2007, J ALLERGY CLIN IMMUN, V120, P1425, DOI 10.1016/j.jaci.2007.07.011; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Heltzer ML, 2007, J ALLERGY CLIN IMMUN, V120, P950, DOI 10.1016/j.jaci.2007.07.026; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Howell MD, 2007, J ALLERGY CLIN IMMUN, V119, P1022, DOI 10.1016/j.jaci.2007.01.044; Janson C, 2007, J ALLERGY CLIN IMMUN, V120, P673, DOI 10.1016/j.jaci.2007.05.003; Jartti T, 2007, J ALLERGY CLIN IMMUN, V120, P177, DOI 10.1016/j.jaci.2007.03.008; Kim BE, 2007, J ALLERGY CLIN IMMUN, V119, P457, DOI 10.1016/j.jaci.2006.10.005; Kim HJ, 2007, J ALLERGY CLIN IMMUN, V119, P1225, DOI 10.1016/j.jaci.2007.01.016; Kinnunen T, 2007, J ALLERGY CLIN IMMUN, V119, P965, DOI 10.1016/j.jaci.2007.01.011; Klunker S, 2007, J ALLERGY CLIN IMMUN, V120, P688, DOI 10.1016/j.jaci.2007.05.034; KNITZ J, 2007, J ALLERGY CLIN IMMUN, V119, P739; Koya T, 2007, J ALLERGY CLIN IMMUN, V119, P1241, DOI 10.1016/j.jaci.2007.01.039; Land MH, 2007, J ALLERGY CLIN IMMUN, V120, P908, DOI 10.1016/j.jaci.2007.08.048; Lavine E, 2007, J ALLERGY CLIN IMMUN, V120, P948, DOI 10.1016/j.jaci.2007.04.038; Lerch M, 2007, J ALLERGY CLIN IMMUN, V119, P1529, DOI 10.1016/j.jaci.2007.02.007; Lim A, 2007, J ALLERGY CLIN IMMUN, V120, P696, DOI 10.1016/j.jaci.2007.05.035; Loza MJ, 2007, J ALLERGY CLIN IMMUN, V119, P235, DOI 10.1016/j.jaci.2006.09.019; Maggi L, 2007, J ALLERGY CLIN IMMUN, V120, P429, DOI 10.1016/j.jaci.2007.05.002; Maric I, 2007, J ALLERGY CLIN IMMUN, V120, P680, DOI 10.1016/j.jaci.2007.05.024; Martin L, 2007, J ALLERGY CLIN IMMUN, V120, P975, DOI 10.1016/j.jaci.2007.07.002; Mazzolari E, 2007, J ALLERGY CLIN IMMUN, V120, P892, DOI 10.1016/j.jaci.2007.08.007; McDonald DR, 2007, J ALLERGY CLIN IMMUN, V120, P900, DOI 10.1016/j.jaci.2007.08.035; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Moschese V, 2007, J ALLERGY CLIN IMMUN, V120, P474, DOI 10.1016/j.jaci.2007.04.002; Mutalithas K, 2007, J ALLERGY CLIN IMMUN, V119, P1274, DOI 10.1016/j.jaci.2007.02.021; Orihara K, 2007, J ALLERGY CLIN IMMUN, V120, P960, DOI 10.1016/j.jaci.2007.05.036; Pahwa S, 2007, J ALLERGY CLIN IMMUN, V119, P1538, DOI 10.1016/j.jaci.2006.12.674; Palmer BE, 2007, J ALLERGY CLIN IMMUN, V120, P184, DOI 10.1016/j.jaci.2007.03.009; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Palmer K, 2007, J ALLERGY CLIN IMMUN, V120, P423, DOI 10.1016/j.jaci.2007.02.047; Persson H, 2007, J ALLERGY CLIN IMMUN, V120, P1186, DOI 10.1016/j.jaci.2007.06.041; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Rogers AJ, 2007, J ALLERGY CLIN IMMUN, V120, P1332, DOI 10.1016/j.jaci.2007.09.037; Romagnani S, 2007, J ALLERGY CLIN IMMUN, V119, P1511, DOI 10.1016/j.jaci.2007.04.005; Rothers J, 2007, J ALLERGY CLIN IMMUN, V120, P1201, DOI 10.1016/j.jaci.2007.07.036; Sands MF, 2007, J ALLERGY CLIN IMMUN, V120, P979, DOI 10.1016/j.jaci.2007.07.041; Sanka M, 2007, J ALLERGY CLIN IMMUN, V120, P952, DOI 10.1016/j.jaci.2007.08.013; da Costa JCS, 2007, J ALLERGY CLIN IMMUN, V119, P219, DOI 10.1016/j.jaci.2006.08.037; Schneider L, 2007, J ALLERGY CLIN IMMUN, V120, P416, DOI 10.1016/j.jaci.2007.04.028; Shearer WT, 2007, J ALLERGY CLIN IMMUN, V120, P1449, DOI 10.1016/j.jaci.2007.08.037; Simon HU, 2007, J ALLERGY CLIN IMMUN, V119, P246, DOI 10.1016/j.jaci.2006.08.025; Sloane DE, 2007, J ALLERGY CLIN IMMUN, V120, P654, DOI 10.1016/j.jaci.2007.06.037; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Soeria-Atmadja D, 2007, J ALLERGY CLIN IMMUN, V120, P1433, DOI 10.1016/j.jaci.2007.07.021; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Triggiani M, 2007, J ALLERGY CLIN IMMUN, V119, P472, DOI 10.1016/j.jaci.2006.09.027; Wang L, 2007, J ALLERGY CLIN IMMUN, V120, P445, DOI 10.1016/j.jaci.2007.03.028; Wells JW, 2007, J ALLERGY CLIN IMMUN, V119, P226, DOI 10.1016/j.jaci.2006.09.004; Williams MA, 2007, J ALLERGY CLIN IMMUN, V119, P488, DOI 10.1016/j.jaci.2006.10.022; Wood RA, 2007, J ALLERGY CLIN IMMUN, V120, P478, DOI 10.1016/j.jaci.2007.04.035; Wu Y, 2007, J ALLERGY CLIN IMMUN, V119, P973, DOI 10.1016/j.jaci.2006.12.617; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001	75	9	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2008	122	1					36	41		10.1016/j.jaci.2008.04.035	http://dx.doi.org/10.1016/j.jaci.2008.04.035			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	325RD	18514804				2022-12-18	WOS:000257605100006
J	Rothenberg, SS; Bratton, D				Rothenberg, Steven S.; Bratton, Donna			The effects of laparoscopic Nissen fundoplication to enhance pulmonary function in the treatment of a patient with severe asthma and gastroesophageal reflux disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							CHILDREN		[Rothenberg, Steven S.] Columbia Univ, Dept Pediat, Rocky Mt Hosp Children, Denver, CO 80218 USA; [Bratton, Donna] Natl Jewish Med & Res Ctr, Denver, CO USA; [Bratton, Donna] Univ Colorado, Denver, CO 80202 USA	Columbia University; National Jewish Health; University of Colorado System; University of Colorado Denver	Rothenberg, SS (corresponding author), Columbia Univ, Dept Pediat, Rocky Mt Hosp Children, 1601 E 19th Ave,Suite 5500, Denver, CO 80218 USA.	Rothenberg@pediatricsurgeon.com						DAVIS RS, 1983, J ALLERGY CLIN IMMUN, V72, P393, DOI 10.1016/0091-6749(83)90505-5; Field SK, 1999, CHEST, V116, P766, DOI 10.1378/chest.116.3.766; Fonkalsrud EW, 1998, PEDIATRICS, V101, P419, DOI 10.1542/peds.101.3.419; Rothenberg SS, 2005, J PEDIATR SURG, V40, P142, DOI 10.1016/j.jpedsurg.2004.09.031; Rothenberg SS, 1997, SURG ENDOSC, V11, P1088, DOI 10.1007/s004649900536; SHAPIRO GG, 1979, PEDIATRICS, V63, P207	6	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2008	121	4					1069	1070		10.1016/j.jaci.2008.02.027	http://dx.doi.org/10.1016/j.jaci.2008.02.027			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286YY	18395555				2022-12-18	WOS:000254884000050
J	Schauber, J; Gallo, RL				Schauber, Juergen; Gallo, Richard L.			Vitamin D deficiency and asthma: Not a strong link-yet	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EXPRESSION		[Schauber, Juergen] Univ Munich, Dept Dermatol, D-8000 Munich, Germany; [Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Gallo, Richard L.] Vet Adm San Diego Healthcare Syst, San Diego, CA USA	University of Munich; University of California System; University of California San Diego	Schauber, J (corresponding author), Univ Munich, Dept Dermatol, Frauenlobstr 9-11, D-8000 Munich, Germany.		Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861	NIAID NIH HHS [R01 AI052453-07, R01 AI052453, R37 AI052453] Funding Source: Medline; NIAMS NIH HHS [R01 AR052728-04, R01 AR052728] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616	7	9	12	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					782	783		10.1016/j.jaci.2007.12.1170	http://dx.doi.org/10.1016/j.jaci.2007.12.1170			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18328898	Green Accepted, Bronze			2022-12-18	WOS:000253918900046
J	Buckmeier, BK; Rothenberg, ME; Collins, MH				Buckmeier, B. K.; Rothenberg, M. E.; Collins, M. H.			The incidence and prevalence of eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Buckmeier, B. K.; Rothenberg, M. E.; Collins, M. H.] Cincinnati Childrens Hosp, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center									0	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		271	S71	S71		10.1016/j.jaci.2007.12.281	http://dx.doi.org/10.1016/j.jaci.2007.12.281			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ		Bronze			2022-12-18	WOS:000253426400272
J	Reed, JL; Kolbeck, R; Molfino, N; Kozhich, AA; Humbles, AA; Erjefalt, JS; Kiener, PA; Busse, WW; Katial, RK; Leon, F; Spitalny, GL; Koike, M; Coyle, AJ; White, B				Reed, J. L.; Kolbeck, R.; Molfino, N.; Kozhich, A. A.; Humbles, A. A.; Erjefalt, J. S.; Kiener, P. A.; Busse, W. W.; Katial, R. K.; Leon, F.; Spitalny, G. L.; Koike, M.; Coyle, A. J.; White, B.			MEDI-563, a humanized anti-IL-5Ra antibody with enhanced effector function, induces reversible blood eosinopenia in mild asthmatics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Reed, J. L.; Kolbeck, R.; Molfino, N.; Kozhich, A. A.; Humbles, A. A.; Kiener, P. A.; Leon, F.; Coyle, A. J.; White, B.] MedImmune, Gaithersburg, MD USA; [Erjefalt, J. S.] Lund Univ, Dept Resp Med, S-22100 Lund, Sweden; [Busse, W. W.] Univ Wisconsin, Sch Publ Hlth & Med, Madison, WI 53706 USA; [Katial, R. K.] Natl Jewish Med & Res Ctr, Div Immunol & Allergy, Denver, CO USA; [Spitalny, G. L.; Koike, M.] BioWa Inc, Princeton, NJ USA	AstraZeneca; Medimmune; Lund University; University of Wisconsin System; University of Wisconsin Madison; National Jewish Health									0	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		183	S47	S47		10.1016/j.jaci.2007.12.191	http://dx.doi.org/10.1016/j.jaci.2007.12.191			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400184
J	Wood, RA				Wood, Robert A.			Food-specific immunotherapy: Past, present, and future	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							PEANUT ALLERGY; CHILDREN; EXTRACT		[Wood, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University	Wood, RA (corresponding author), Johns Hopkins Univ Hosp, CMSC 1102,600 N Wolfe St, Baltimore, MD 21287 USA.	rwood@jhmi.edu						Buchanan AD, 2007, J ALLERGY CLIN IMMUN, V119, P199, DOI 10.1016/j.jaci.2006.09.016; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Meglio P, 2004, ALLERGY, V59, P980, DOI 10.1111/j.1398-9995.2004.00542.x; Nash SD, 2007, J ALLERGY CLIN IMMUN, V119, pS158, DOI 10.1016/j.jaci.2006.11.558; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; OPPENHEIMER JJ, 1992, J ALLERGY CLIN IMMUN, V90, P256, DOI 10.1016/0091-6749(92)90080-L; Patriarca G, 2003, ALIMENT PHARM THER, V17, P459, DOI 10.1046/j.1365-2036.2003.01468.x; Staden U, 2007, ALLERGY, V62, P1261, DOI 10.1111/j.1398-9995.2007.01501.x	10	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2					336	337		10.1016/j.jaci.2007.11.035	http://dx.doi.org/10.1016/j.jaci.2007.11.035			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	265CX	18179815	Bronze			2022-12-18	WOS:000253337800008
J	Hajoui, O; Zheng, H; Guay, J; Letuve, S; Fawaz, LM; Mazer, BD				Hajoui, Oumnia; Zheng, Huaien; Guay, Julie; Letuve, Severine; Fawaz, Lama M.; Mazer, Bruce D.			Regulation of IL-13 receptor alpha 1 expression and signaling on human tonsillar B-lymphocyte subsets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						human B lymphocyte; IgE regulation; IL-13 receptor	KINASE ACTIVATION; IGE PRODUCTION; T-CELLS; INTERLEUKIN-13; TRANSDUCTION; RESPONSES; ASTHMA; MECHANISM; CYTOKINES; PATHWAYS	Background: T(H)2 cytokines play crucial roles in driving human B lymphocytes to produce IgE. However, it is unclear whether IL-4 and IL-13 have parallel or sequential roles in the development of B lymphocytes. Objective: We investigated IL-13 receptor (IL-13R) expression and regulation in mature and immature human B cells. Methods: Purified B cells were isolated from human tonsils. We evaluated IL-13R alpha 1 mRNA expression using real-time PCR and IL-13R alpha 1 and IL-4 receptor (IL-4R) alpha expression using flow cytometry and microscopy. Signal transduction was assessed on the basis of signal transducer and activator of transcription 6 phosphorylation. Results: IL13R alpha 1 mRNA was induced after stimulation with anti-CD40 antibodies, anti-CD40 plus IL-4, or anti-IgM/IgG. Baseline surface IL13R alpha 1 levels were low in unstimulated B cells but increased significantly at 24 hours and were sustained for 5 to 14 days. In contrast, IL4R alpha was constitutively expressed on tonsillar B cells, and levels did not significantly vary after stimulation. B cells activated by CD40 ligation or B-cell receptor cross-linking, but not resting B cells, showed significant increases in signal transducer and activator of transcription 6 phosphorylation in response to IL-13. IL-13R alpha 1 expression was induced on mature and memory B cells, as well as on naive subsets. Conclusions: There is lower constitutive expression and signaling of IL13R alpha 1 in resting tonsillar B lymphocytes compared with that of IL4R alpha. IL-13 is induced on both immature and mature B lymphocytes. Clinical implications: This implies different roles for IL-4 and IL-13 in B-cell development, which would allow for specific targeting of IL-13 in IgE-mediated diseases.	[Hajoui, Oumnia; Zheng, Huaien; Guay, Julie; Letuve, Severine; Fawaz, Lama M.; Mazer, Bruce D.] McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada; [Fawaz, Lama M.; Mazer, Bruce D.] McGill Univ, Div Allergy & Immunol, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada	McGill University; McGill University	Mazer, BD (corresponding author), McGill Univ, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	Bruce.Mazer@McGill.ca	Letuve, Severine/AAF-3339-2021; Letuve, Severine/J-5506-2017	Letuve, Severine/0000-0002-1954-3633; 				Andrews RP, 2002, J BIOL CHEM, V277, P36563, DOI 10.1074/jbc.M200986200; Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Bergeron C, 2003, CLIN EXP ALLERGY, V33, P1389, DOI 10.1046/j.1365-2222.2003.01785.x; BRIERE F, 1993, NOUV REV FR HEMATOL, V35, P233; Chow S, 2001, CYTOMETRY, V46, P72, DOI 10.1002/cyto.1067; Daines MO, 2002, J BIOL CHEM, V277, P10387, DOI 10.1074/jbc.M108109200; DEVRIES JE, 1993, RES IMMUNOL, V144, P597, DOI 10.1016/S0923-2494(05)80009-4; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Fecteau JF, 2003, J IMMUNOL, V171, P4621, DOI 10.4049/jimmunol.171.9.4621; Ford D, 1999, J IMMUNOL, V163, P3185; Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO;2-H; Hajoui O, 2004, J ALLERGY CLIN IMMUN, V114, P657, DOI 10.1016/j.jaci.2004.05.034; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hill S, 1999, AM J RESP CELL MOL, V21, P728, DOI 10.1165/ajrcmb.21.6.3709; Izuhara K, 1999, INT J MOL MED, V3, P3; Izuhara K, 2004, DRUG NEWS PERSPECT, V17, P91, DOI 10.1358/dnp.2004.17.2.829041; Izuhara K., 2002, Current Drug Targets - Inflammation and Allergy, V1, P263, DOI 10.2174/1568010023344661; Izuhara Kenji, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P505; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Kajiwara K, 2004, CELL IMMUNOL, V227, P121, DOI 10.1016/j.cellimm.2004.03.002; KEEGAN AD, 1995, P NATL ACAD SCI USA, V92, P7681, DOI 10.1073/pnas.92.17.7681; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; KRAAN TCV, 1998, CLIN EXP IMMUNOL, V111, P129, DOI DOI 10.1046/J.1365-2249.1998.00471.X; Laporte JC, 2001, AM J RESP CRIT CARE, V164, P141, DOI 10.1164/ajrccm.164.1.2008060; Lund Frances E., 2005, V8, P25; Mayer R. J., 1999, Inflammation Research, V48, P469, DOI 10.1007/s000110050488; Ogata H, 1998, J BIOL CHEM, V273, P9864, DOI 10.1074/jbc.273.16.9864; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2002, J IMMUNOL, V169, P4298, DOI 10.4049/jimmunol.169.8.4298; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yasunaga S, 2003, CYTOKINE, V24, P293, DOI 10.1016/j.cyto.2003.08.006; Zhuang QL, 2001, J ALLERGY CLIN IMMUN, V108, P229, DOI 10.1067/mai.2001.116291	37	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1425	1432		10.1016/j.jaci.2007.07.011	http://dx.doi.org/10.1016/j.jaci.2007.07.011			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	17761275				2022-12-18	WOS:000251653800027
J	Morosco, G; Kiley, J				Morosco, Gregory; Kiley, James			National asthma education and prevention program - Expert panel report 3: Guidelines for the diagnosis and management of asthma summary report 2007 - Preface	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									NHLBI, Div Applicat Res Dicoveries, Bethesda, MD 20892 USA; NHLBI, Div Lung Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Morosco, G (corresponding author), NHLBI, Div Applicat Res Dicoveries, Bethesda, MD 20892 USA.								0	9	9	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2007	120	5		S			S93	S93		10.1016/j.jaci.2007.09.043	http://dx.doi.org/10.1016/j.jaci.2007.09.043			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	235PU					2022-12-18	WOS:000251247600001
J	Bisgaard, H				Bisgaard, Hans			What drives prescription patterns in pediatric asthma management?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACTING BETA(2) AGONISTS		Univ Copenhagen Hosp, Danish Pediat Asthma Ctr, Dept Pediat, DK-2100 Copenhagen, Denmark	University of Copenhagen	Bisgaard, H (corresponding author), Univ Copenhagen Hosp, Danish Pediat Asthma Ctr, Dept Pediat, DK-2100 Copenhagen, Denmark.	Bisgaard@copsac.dk	Kronow, Joern/B-1054-2011; Bisgaard, Hans/N-4761-2016	Bisgaard, Hans/0000-0003-4131-7592				Bender BG, 2002, J ALLERGY CLIN IMMUN, V109, pS554, DOI 10.1067/mai.2002.124570; Bisgaard H, 2006, LANCET, V367, P286, DOI 10.1016/S0140-6736(06)68051-3; Bisgaard H, 2005, J ALLERGY CLIN IMMUN, V115, P708, DOI 10.1016/j.jaci.2004.11.018; Bisgaard H, 2000, PEDIATR PULM, V29, P221, DOI 10.1002/(SICI)1099-0496(200003)29:3<221::AID-PPUL11>3.3.CO;2-G; Bisgaard H, 2003, PEDIATR PULM, V36, P391, DOI 10.1002/ppul.10381; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; *DAN MED AG, 2006, CONS STAT PRIC REIMB; *NAT HEART LUNG BL, 1995, 953659 NHLBI; National Institutes of Health, 2005, NIH PUBL	9	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					969	972		10.1016/j.jaci.2007.06.011	http://dx.doi.org/10.1016/j.jaci.2007.06.011			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17637472	Bronze			2022-12-18	WOS:000250157700041
J	Miller, JD; Naccara, L; Satinover, S; Platts-Mills, TAE				Miller, Jeffrey D.; Naccara, Lisa; Satinover, Shama; Platts-Mills, Thomas A. E.			Nonwoven in contrast to woven mattress encasings accumulate mite and cat allergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ENCASEMENT		Allergy & Asthma Assoc, Danbury, CT USA; Univ Virginia, Hlth Sci Ctr, Charlottesville, VA USA	University of Virginia	Miller, JD (corresponding author), Allergy & Asthma Assoc, Danbury, CT USA.	JeffreyMillerMD@comcast.net		Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020565, R37AI020565] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-20565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arlian LG, 2001, J ALLERGY CLIN IMMUN, V107, pS406, DOI 10.1067/mai.2001.113670; BISCHOFF ERC, 1992, EXP APPL ACAROL, V16, P1, DOI 10.1007/BF01201489; Mahakittikun V, 2003, J ALLERGY CLIN IMMUN, V112, P1239, DOI 10.1016/j.jaci.2003.08.045; Mahakittikun V, 2006, J ALLERGY CLIN IMMUN, V118, P1164, DOI 10.1016/j.jaci.2006.07.025; *NAT I HLTH, 1997, NAT I HLTH PUBL; Platts-Mills TAE, 2004, J ALLERGY CLIN IMMUN, V113, P388, DOI 10.1016/j.jaci.2003.12.027; Vaughan JW, 1999, J ALLERGY CLIN IMMUN, V103, P227, DOI 10.1016/S0091-6749(99)70495-1; WOODFOLK JA, 1994, J ALLERGY CLIN IMMUN, V94, P19, DOI 10.1016/0091-6749(94)90066-3; [No title captured]	9	9	11	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					977	979		10.1016/j.jaci.2007.06.048	http://dx.doi.org/10.1016/j.jaci.2007.06.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17854879				2022-12-18	WOS:000250157700045
J	Madero, MF; Enriquez-Matas, A; Fernandez-Nieto, M; Sastre, B; del Pozo, V; Pastor, C; Quirce, S; Sastre, J				Madero, Mauro F.; Enriquez-Matas, Alicia; Fernandez-Nieto, Mar; Sastre, Beatriz; del Pozo, Victoria; Pastor, Carlos; Quirce, Santiago; Sastre, Joaquin			Characterization of allergens from the fish bait Gaileria mellonella	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		Fdn Jimenez Diaz, Dept Allergy, E-28040 Madrid, Spain; Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain		Madero, MF (corresponding author), Fdn Jimenez Diaz, Dept Allergy, E-28040 Madrid, Spain.	mmadero@fjd.es	Pastor Vargas, Carlos/B-4112-2010; s, q/AAD-7171-2020; Matas, Alicia Enriquez/AAA-8851-2019; Sastre, Beatriz/F-1715-2015	Pastor Vargas, Carlos/0000-0002-4678-7967; Sastre, Beatriz/0000-0002-2394-6849; Enriquez-Matas, Alicia/0000-0001-5517-6933				Di Rienzo V, 2002, ALLERGY, V57, P869, DOI 10.1034/j.1398-9995.2002.23575_13.x; Fernandez-Nieto M, 2006, J ALLERGY CLIN IMMUN, V117, P948, DOI 10.1016/j.jaci.2005.12.1350; Gallego-Delgado J, 2006, J PROTEOME RES, V5, P404, DOI 10.1021/pr0503275; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Quirce S, 2002, ANN ALLERG ASTHMA IM, V89, P197, DOI 10.1016/S1081-1206(10)61938-2; SIRACUSA A, 1994, J ALLERGY CLIN IMMUN, V93, P424, DOI 10.1016/0091-6749(94)90350-6; Siracusa A, 2003, CLIN EXP ALLERGY, V33, P507, DOI 10.1046/j.1365-2222.2003.01641.x; Villalta D, 2004, ALLERGY, V59, P1002, DOI 10.1111/j.1398-9995.2004.00446.x	8	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2007	119	4					1021	1022		10.1016/j.jaci.2006.12.644	http://dx.doi.org/10.1016/j.jaci.2006.12.644			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	157OK	17337298				2022-12-18	WOS:000245729500039
J	Szefler, SJ				Szefler, Stanley J.			Advances in pediatric asthma 2006	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; severe asthma; early intervention in asthma; biomarkers; therapeutics	EXHALED NITRIC-OXIDE; CHILDHOOD ASTHMA; LUNG-FUNCTION; INHALED CORTICOSTEROIDS; AIRWAY INFLAMMATION; PERSISTENT ASTHMA; CHILDREN; FLUTICASONE; RESPONSES; SEVERITY	Because the outcomes experienced in adult asthma often result from pathophysiology that begins in early childhood, this year's summary focuses on recent advances in pediatric asthma. This past year, we have learned that early intervention with inhaled corticosteroids in childhood asthma reduces morbidity but does not alter the natural history of asthma. Theme issues over the last year focused attention on severe asthma and black box warnings. Both of these themes significantly affect the management of childhood asthma. Responsiveness to asthma treatment is heterogeneous even among patients with asthma of similar severity. This heterogeneity calls attention to the importance of assessing control and adjusting treatment accordingly. We are now moving toward an individualized approach to asthma therapy and searching for biomarkers and genetics as a resource to guide treatment. To improve asthma control, we must continue to obtain information on early asthma, severe asthma, asthma exacerbations, and methods to improve asthma control. Evaluation and management of severe asthma in children include verification of the diagnosis, assessment for coexisting illnesses, and identification of effective treatment strategies directed to adherence, medication delivery, and combination therapy. Application of biomarkers and genetics could be useful tools in individualizing our approach to the management of childhood asthma.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Szefler, SJ (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Room J304 Molly Bank Bldg, Denver, CO 80206 USA.	szeflers@njc.org			NCRR NIH HHS [M01 RR00051] Funding Source: Medline; NHLBI NIH HHS [HL081335, HL 51834, HL64288, HR-16048] Funding Source: Medline; NIAID NIH HHS [AI-25496] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR016048] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL051834, U10HL064288, U01HL081335] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P512, DOI 10.1016/j.jaci.2005.12.1353; Ball TM, 2006, J ALLERGY CLIN IMMUN, V117, P306, DOI 10.1016/j.jaci.2005.11.009; Bateman ED, 2006, J ALLERGY CLIN IMMUN, V117, P519, DOI 10.1016/j.jaci.2006.01.028; Campo P, 2006, J ALLERGY CLIN IMMUN, V118, P1271, DOI 10.1016/j.jaci.2006.08.008; Carraro S, 2006, J ALLERGY CLIN IMMUN, V118, P958, DOI 10.1016/j.jaci.2006.07.016; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Covar RA, 2006, J ALLERGY CLIN IMMUN, V117, P709, DOI 10.1016/j.jaci.2006.01.010; de Jong AB, 2006, J ALLERGY CLIN IMMUN, V118, P280, DOI 10.1016/j.jaci.2006.03.013; de Marco R, 2006, J ALLERGY CLIN IMMUN, V117, P1249, DOI 10.1016/j.jaci.2006.03.019; Dinakar C, 2006, J ALLERGY CLIN IMMUN, V117, P212, DOI 10.1016/j.jaci.2005.09.037; Ercan H, 2006, J ALLERGY CLIN IMMUN, V118, P1097, DOI 10.1016/j.jaci.2006.08.012; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; *GINA, 2006 GINA REP GLOB S; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Johnston NW, 2006, J ALLERGY CLIN IMMUN, V117, P557, DOI 10.1016/j.jaci.2005.11.034; Kumar R, 2006, J ALLERGY CLIN IMMUN, V117, P1257, DOI 10.1016/j.jaci.2006.02.049; Lemiere C, 2006, J ALLERGY CLIN IMMUN, V118, P1033, DOI 10.1016/j.jaci.2006.08.003; Marks GB, 2006, J ALLERGY CLIN IMMUN, V118, P53, DOI 10.1016/j.jaci.2006.04.004; McCoy K, 2006, J ALLERGY CLIN IMMUN, V118, P1226, DOI 10.1016/j.jaci.2006.09.006; Montuschi P, 2006, J ALLERGY CLIN IMMUN, V118, P347, DOI 10.1016/j.jaci.2006.04.010; Murray CS, 2006, LANCET, V368, P754, DOI 10.1016/S0140-6736(06)69285-4; Perkin MR, 2006, J ALLERGY CLIN IMMUN, V117, P1374, DOI 10.1016/j.jaci.2006.03.008; Profita M, 2006, J ALLERGY CLIN IMMUN, V118, P1068, DOI 10.1016/j.jaci.2006.07.028; Roberts G, 2006, J ALLERGY CLIN IMMUN, V117, P263, DOI 10.1016/j.jaci.2005.09.054; Schatz M, 2006, J ALLERGY CLIN IMMUN, V118, P1048, DOI 10.1016/j.jaci.2006.07.057; Shapiro GG, 2006, J ALLERGY CLIN IMMUN, V118, P562, DOI 10.1016/j.jaci.2006.07.011; Stoloff SW, 2006, J ALLERGY CLIN IMMUN, V117, P544, DOI 10.1016/j.jaci.2006.01.005; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Szefler SJ, 2006, J ALLERGY CLIN IMMUN, V117, P26, DOI 10.1016/j.jaci.2005.11.006; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Tantisira KG, 2006, J ALLERGY CLIN IMMUN, V117, P1264, DOI 10.1016/j.jaci.2006.01.050; Taylor DR, 2006, J ALLERGY CLIN IMMUN, V117, P259, DOI 10.1016/j.jaci.2005.11.010; Ueda T, 2006, J ALLERGY CLIN IMMUN, V118, P1019, DOI 10.1016/j.jaci.2006.07.032; Vahlkvist S, 2006, J ALLERGY CLIN IMMUN, V117, P1272, DOI 10.1016/j.jaci.2006.03.018; Wenzel S, 2006, J ALLERGY CLIN IMMUN, V117, P508, DOI 10.1016/j.jaci.2005.12.1316; Zeidler MR, 2006, J ALLERGY CLIN IMMUN, V118, P1075, DOI 10.1016/j.jaci.2006.06.042; Zeiger RS, 2006, J ALLERGY CLIN IMMUN, V117, P45, DOI 10.1016/j.jaci.2005.10.012	39	9	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					558	562		10.1016/j.jaci.2006.12.619	http://dx.doi.org/10.1016/j.jaci.2006.12.619			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17270259				2022-12-18	WOS:000244925000004
J	Bernstein, DI; Segall, N; Nayak, A; Casale, T; Korenblatt, P; Martins, E				Bernstein, D. I.; Segall, N.; Nayak, A.; Casale, T.; Korenblatt, P.; Martins, E.			Safety and efficacy of the novel vaccine TOLAMBA (TM) in ragweed allergic adults, a dose finding study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Bernstein, D. I.] Bernstein Allergy Grp, Cincinnati, OH USA; [Segall, N.] Clin Res Atlanta, Stockbridge, GA USA; [Nayak, A.] Sneeze Wheeze & Itch Associates, Normal, IL USA; [Casale, T.] Creighton Univ, Omaha, NE 68178 USA; [Korenblatt, P.] Clin Res Ctr, St Louis, MO USA; [Martins, E.] Dynavax Technol, Berkeley, CA USA	Creighton University									0	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		307	S78	S79		10.1016/j.jaci.2006.11.332	http://dx.doi.org/10.1016/j.jaci.2006.11.332			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400307
J	Du Toit, G; Levin, M; Motala, C; Perkin, M; Stephens, A; Turcanu, V; Lack, G				Du Toit, G.; Levin, M.; Motala, C.; Perkin, M.; Stephens, A.; Turcanu, V.; Lack, G.			Peanut allergy and peanut-specific IgG4 characteristics among xhosa children in Cape Town	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Du Toit, G.; Lack, G.] Kings Coll London, Evelina Childrens Hosp Guys & St Thomas NHS Fdn T, Childrens Allergy Serv, London WC2R 2LS, England; [Levin, M.; Motala, C.] Univ Cape Town, Red Cross Childrens Hosp, ZA-7700 Rondebosch, South Africa; [Perkin, M.] Univ London St Georges Hosp, Sch Med, Div Commun Hlth Sci, London, England; [Stephens, A.; Turcanu, V.] Kings Coll London, London WC2R 2LS, England	University of London; King's College London; University of Cape Town; St Georges University London; University of London; King's College London			Perkin, Michael/AID-7491-2022; Levin, Michael/AAT-2370-2020	Levin, Michael/0000-0003-2439-7981; Perkin, Michael/0000-0001-9272-2585					0	9	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		771	S196	S196		10.1016/j.jaci.2006.12.136	http://dx.doi.org/10.1016/j.jaci.2006.12.136			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401156
J	Lo, E; Levetin, E				Lo, E.; Levetin, E.			Influence of meteorological conditions on early spring pollen in the Tulsa atmosphere from 1987-2006	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Lo, E.; Levetin, E.] Univ Tulsa, Tulsa, OK 74104 USA	University of Tulsa									0	9	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		397	S101	S101		10.1016/j.jaci.2006.11.612	http://dx.doi.org/10.1016/j.jaci.2006.11.612			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400397
J	Singh, K; Bielory, L				Singh, K.; Bielory, L.			Ocular allergy: A national epidemiologic study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Singh, K.; Bielory, L.] Univ Med & Dent New Jersey, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center									0	9	12	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		604	S154	S154		10.1016/j.jaci.2006.11.538	http://dx.doi.org/10.1016/j.jaci.2006.11.538			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400603
J	Lazarus, SC				Lazarus, Stephen C.			Mild persistent asthma: Is any treatment needed?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; inhaled corticosteroid; remodeling; asthma control	INHALED CORTICOSTEROIDS; BUDESONIDE; INTERVENTION	Asthma treatment guidelines are intended to relieve symptoms and to prevent complications such as exacerbations, airway remodeling, and death. The existing recommendations are based on a combination of evidence and expert opinion. Recent data raise questions about the need for chronic controller therapy for those patients at the very low end of the asthma-severity continuum. Although these data are not sufficient to warrant a change in guidelines, the new information points out the need for large, long-term studies on the treatment of mild persistent asthma, with an emphasis on exacerbations, remodeling, and the relationship between these outcomes and markers of asthma control.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lazarus, SC (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus Ave,M-1083, San Francisco, CA 94143 USA.	lazma@ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073098, U10HL074204] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL074204, HL073098] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; LAITINEN A, 1994, AM J RESP CRIT CARE, V150, pS14, DOI 10.1164/ajrccm/150.5_Pt_2.S14; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; *NHLBI, 1997, 2 NHLBI; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; SELROOS O, 1995, CHEST, V108, P1228, DOI 10.1378/chest.108.5.1228; SHEFFLER AL, 1991, NATL ASTHM ED PROGR; Stempel DA, 2002, ANN ALLERG ASTHMA IM, V89, P340, DOI 10.1016/S1081-1206(10)62030-3; Van den Toorn LM, 2001, AM J RESP CRIT CARE, V164, P2107, DOI 10.1164/ajrccm.164.11.2006165	17	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2006	118	4					805	808		10.1016/j.jaci.2006.07.044	http://dx.doi.org/10.1016/j.jaci.2006.07.044			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	097GD	17030230				2022-12-18	WOS:000241434200004
J	Straus, DC; Wilson, SC				Straus, David C.; Wilson, Stephen C.			Respirable trichothecene mycotoxins can be demonstrated in the air of Stachybotrys chartarum-contaminated buildings	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																		Brasel TL, 2005, APPL ENVIRON MICROB, V71, P7376, DOI 10.1128/AEM.71.11.7376-7388.2005; Brasel TL, 2004, ARCH ENVIRON HEALTH, V59, P317; Brasel TL, 2005, APPL ENVIRON MICROB, V71, P114, DOI 10.1128/AEM.71.1.114-122.2005; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; Cho SH, 2005, ATMOS ENVIRON, V39, P5454, DOI 10.1016/j.atmosenv.2005.05.042; MURPHY WK, 1978, CANCER TREAT REP, V62, P1497; Scheel CM, 2001, ARCH ENVIRON HEALTH, V56, P413, DOI 10.1080/00039890109604476	7	9	9	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					760	760		10.1016/j.jaci.2006.06.025	http://dx.doi.org/10.1016/j.jaci.2006.06.025			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950300	Bronze			2022-12-18	WOS:000240649000036
J	Reed, J; Yedulapuram, M; Lieberman, P; Fitzpatrick, E				Reed, J; Yedulapuram, M; Lieberman, P; Fitzpatrick, E			Differences in cytokine production between idiopathic anaphylaxis (IA) subjects and controls	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Univ Tennessee, Coll Med, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center									0	9	10	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		1179	S305	S305		10.1016/j.jaci.2005.12.1206	http://dx.doi.org/10.1016/j.jaci.2005.12.1206			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR		Bronze			2022-12-18	WOS:000235865302257
J	Mazer, BD; Al-Tamemi, S; Yu, JW; Hamid, Q				Mazer, BD; Al-Tamemi, S; Yu, JW; Hamid, Q			Immune supplementation and immune modulation with intravenous immunoglobulin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							KAWASAKI-DISEASE; PRIMARY IMMUNODEFICIENCY; AUTOIMMUNE-DISEASE; GAMMA GLOBULINS; GENE-EXPRESSION; IGG; THERAPY		McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada; McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	qutayba.hamid@mcgill.ca	Al-Tamemi, Salem/T-7687-2017	Al-Tamemi, Salem/0000-0002-7232-2629				Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Binstadt BA, 2003, J ALLERGY CLIN IMMUN, V111, P697, DOI 10.1067/mai.2003.1380; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Buckley Rebecca H., 2003, Journal of Allergy and Clinical Immunology, V111, pS733; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Buckley RH, 2004, J ALLERGY CLIN IMMUN, V113, P793, DOI 10.1016/j.jaci.2004.01.764; Clynes R, 2005, J CLIN INVEST, V115, P25, DOI 10.1172/JCI200523994; Gardulf A, 2004, J ALLERGY CLIN IMMUN, V114, P936, DOI 10.1016/j.jaci.2004.06.053; JANEWAY CA, 1966, NEW ENGL J MED, V275, P826, DOI 10.1056/NEJM196610132751508; Leung DYM, 2002, J PEDIATR-US, V140, P742, DOI 10.1067/mpd.2002.123664; Markert ML, 2004, J ALLERGY CLIN IMMUN, V113, P734, DOI 10.1016/j.jaci.2004.01.766; MAZER BD, 1991, J ALLERGY CLIN IMMUN, V87, P976, DOI 10.1016/0091-6749(91)90420-S; MERLER E, 1967, VOX SANG, V13, P102; Misra N, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-1102-7; Nelson Jr RP, 2003, J ALLERGY CLIN IMMUN, V111, P720; Nomura I, 2005, PEDIATR RES, V57, P49, DOI 10.1203/01.PDR.0000147745.52711.DD; Notarangelo L, 2004, J ALLERGY CLIN IMMUN, V114, P677, DOI 10.1016/j.jaci.2004.06.044; Radinsky S, 2003, J ALLERGY CLIN IMMUN, V112, P630, DOI 10.1067/mai.2003.1688; ROSEN FS, 1966, NEW ENGL J MED, V275, P769, DOI 10.1056/NEJM196610062751407; Sigman K, 1998, J ALLERGY CLIN IMMUN, V102, P421, DOI 10.1016/S0091-6749(98)70130-7; Siragam V, 2005, J CLIN INVEST, V115, P155, DOI 10.1172/JCI200522753; Spahn JD, 1999, J ALLERGY CLIN IMMUN, V103, P421, DOI 10.1016/S0091-6749(99)70466-5	23	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2005	116	4					941	944		10.1016/j.jaci.2005.07.021	http://dx.doi.org/10.1016/j.jaci.2005.07.021			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IF	16210080				2022-12-18	WOS:000235686600042
J	Yacoub, MR; Lemiere, C; Malo, JL				Yacoub, MR; Lemiere, C; Malo, JL			Asthma caused by cyanoacrylate used in a leisure activity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OCCUPATIONAL-ASTHMA; RHINITIS; EXPOSURE		Hop Sacre Coeur, Dept Chest Med, Montreal, PQ H4J 1C5, Canada	Universite de Montreal	Yacoub, MR (corresponding author), Hop Sacre Coeur, Dept Chest Med, 5400 W Gouin Blvd, Montreal, PQ H4J 1C5, Canada.		Yacoub, Mona Rita/AAP-6227-2020	Yacoub, Mona Rita/0000-0003-2417-0410				CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P823, DOI 10.1016/0091-6749(89)90346-1; KopferschmitKubler MC, 1996, REV MAL RESPIR, V13, P305; KOPP SK, 1985, ANN INTERN MED, V102, P613, DOI 10.7326/0003-4819-102-5-613; Piirila P, 1998, CLIN EXP ALLERGY, V28, P1404; Quirce S, 2001, ALLERGY, V56, P446, DOI 10.1034/j.1398-9995.2001.056005446.x; Weytjens K, 1999, ALLERGY, V54, P289, DOI 10.1034/j.1398-9995.1999.00999.x	6	9	9	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2005	116	2					462	462		10.1016/j.jaci.2005.04.015	http://dx.doi.org/10.1016/j.jaci.2005.04.015			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017ID	16083807				2022-12-18	WOS:000235686400035
J	Saito, H; Abe, J; Matsumoto, K				Saito, H; Abe, J; Matsumoto, K			Allergy-related genes in microarray: An update review	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						microarray; DNA chip; transcriptome; bioinformatics	HUMAN MAST-CELLS; EXPRESSION; ASTHMA; IDENTIFICATION; ARRAY; LUNG	Microarrays have attracted tremendous interest among biologists. However, questions have been raised regarding the reproducibility between experiments performed in different laboratories using different platforms. Here, we discuss these problems and reach the following conclusions. First, the reproducibility between different platforms of arrays is low, but bioinformatics may permit compensation at least among oligonucleotide microarrays. Second, it is hard to interpret microarray results generated using mixed cell populations. Hierarchical clustering may be applied to identify whether upregulated transcripts in an inflammatory tissue were caused simply by an increased number of inflammatory cells.	Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, Tokyo 1578535, Japan	National Center for Child Health & Development - Japan	Saito, H (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	hsaito@nch.go.jp		Saito, Hirohisa/0000-0002-6630-8337				[Anonymous], 2002, Nature, V419, P323; Bette Phimister, 1998, NAT GENET, V18, P195, DOI 10.1038/ng0398-195; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Heishi M, 2002, INT ARCH ALLERGY IMM, V129, P57, DOI 10.1159/000065174; Kanno J, 2004, TOXICOL APPL PHARM, V197, P265; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; Nakajima T, 2004, J ALLERGY CLIN IMMUN, V113, P528, DOI 10.1016/j.jaci.2003.12.036; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; OKAYAMA Y, 1992, INT ARCH ALLERGY IMM, V97, P216, DOI 10.1159/000236122; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	16	9	13	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					56	59		10.1016/j.jaci.2005.03.048	http://dx.doi.org/10.1016/j.jaci.2005.03.048			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990774				2022-12-18	WOS:000235686300009
J	Soderhall, C; Marenholz, I; Nickel, R; Gruber, C; Kehrt, R; Rohde, K; Griffioen, RW; Meglio, P; Tarani, L; Gustafsson, D; Hoffmann, U; Gerstner, B; Muller, S; Wahn, W; Lee, YA				Soderhall, C; Marenholz, I; Nickel, R; Gruber, C; Kehrt, R; Rohde, K; Griffioen, RW; Meglio, P; Tarani, L; Gustafsson, D; Hoffmann, U; Gerstner, B; Muller, S; Wahn, W; Lee, YA			Lack of association of the G protein-coupled receptor for asthma susceptibility gene with atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							TRAITS; LOCUS; AGE		Charite Univ Med, D-13353 Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; Univ Roma La Sapienza, Dept Pediat, Rome, Italy; Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands; Tech Univ Munich, Kinderklin Schwabing, D-8000 Munich, Germany; Orebro Med Ctr Hosp, Dept Pediat, S-70185 Orebro, Sweden	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Sapienza University Rome; University of Amsterdam; Academic Medical Center Amsterdam; Technical University of Munich	Soderhall, C (corresponding author), Charite Univ Med, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.		Söderhäll, Cilla/E-3940-2012	Söderhäll, Cilla/0000-0002-8397-3080				Gustafsson D, 2000, ALLERGY, V55, P240, DOI 10.1034/j.1398-9995.2000.00391.x; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HINDS D, 1996, ASPEX PACKAGE; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/88319; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Spielman RS, 1996, AM J HUM GENET, V59, P983; Strachan DP, 1996, BRIT MED J, V312, P1195; Warner JO, 1998, PEDIATR ALLERGY IMMU, V9, P116	9	9	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					220	221		10.1016/j.jaci.2005.03.002	http://dx.doi.org/10.1016/j.jaci.2005.03.002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990798	Green Submitted			2022-12-18	WOS:000235686300033
J	Crimi, N; Mastruzzo, C; Pagano, C; Lisitano, N; Palermo, F; Vancheri, C				Crimi, N; Mastruzzo, C; Pagano, C; Lisitano, N; Palermo, F; Vancheri, C			Montelukast protects against bradykinin-induced bronchospasm	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RELEASE		Univ Catania, Dept Internal & Specialist Med, I-95125 Catania, Italy; Univ Catania, Sect Resp Dis, I-95125 Catania, Italy; Univ Catania, Infect Dis Sect, I-95125 Catania, Italy	University of Catania; University of Catania; University of Catania	Crimi, N (corresponding author), Univ Catania, Dept Internal & Specialist Med, Via Passo Gravina 187, I-95125 Catania, Italy.		Crimi, Nunzio/AAL-2994-2020; VANCHERI, Carlo/K-9417-2016	Crimi, Nunzio/0000-0002-8591-4535; VANCHERI, Carlo/0000-0002-5120-9926				Bisgaard H, 2003, AM J RESP CRIT CARE, V167, P379, DOI 10.1164/rccm.200207-747OC; Dicpinigaitis PV, 2002, J ASTHMA, V39, P291, DOI 10.1081/JAS-120002285; DIMARZO V, 1988, BIOCHEM INT, V17, P235; GEPPETTI P, 1993, REGUL PEPTIDES, V47, P1, DOI 10.1016/0167-0115(93)90268-D; Ishikawa J, 1996, EUR RESPIR J, V9, P486, DOI 10.1183/09031936.96.09030486; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Koyama S, 2000, AM J RESP CELL MOL, V22, P75, DOI 10.1165/ajrcmb.22.1.3752; KUMLIN M, 1992, AM REV RESPIR DIS, V146, P96, DOI 10.1164/ajrccm/146.1.96; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Turner DJ, 2000, PULM PHARMACOL THER, V13, P181, DOI 10.1006/pupt.2000.0247	10	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					870	872		10.1016/j.jaci.2005.01.041	http://dx.doi.org/10.1016/j.jaci.2005.01.041			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15806012	Bronze			2022-12-18	WOS:000228373400031
J	Howell, J				Howell, J			Roger Altounyan and the discovery of cromolyn (sodium cromoglycate)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item									Univ Southampton, Southampton, Hants, England	University of Southampton	Howell, J (corresponding author), Univ Southampton, Southampton, Hants, England.								0	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					882	885		10.1016/j.jaci.2004.12.011	http://dx.doi.org/10.1016/j.jaci.2004.12.011			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15806019	Bronze			2022-12-18	WOS:000228373400041
J	Kaplan, AP				Kaplan, AP			Does C-2 kinin exist?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HEREDITARY ANGIONEUROTIC-EDEMA; VASCULAR-PERMEABILITY; ANGIOEDEMA; BRADYKININ; PLASMA		Med Univ S Carolina, Dept Med, Div Pulm Allergy, Charleston, SC 29425 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA	Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaplan, AP (corresponding author), Med Univ S Carolina, Dept Med, Div Pulm Allergy, 96 Jonathan Lucas St, Charleston, SC 29425 USA.							Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Bowen T, 2004, J ALLERGY CLIN IMMUN, V114, P629, DOI 10.1016/j.jaci.2004.06.043; DONALDSON VH, 1968, J EXP MED, V127, P411, DOI 10.1084/jem.127.3.411; DONALDSON VH, 1977, T ASSOC AM PHYSICIAN, V90, P74; FIELDS T, 1983, J ALLERGY CLIN IMMUN, V72, P54, DOI 10.1016/0091-6749(83)90052-0; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Nussberger J, 1999, J ALLERGY CLIN IMMUN, V104, P1321, DOI 10.1016/S0091-6749(99)70030-8; SHOEMAKER LR, 1994, CLIN EXP IMMUNOL, V95, P22; STRANG CJ, 1988, J EXP MED, V168, P1685, DOI 10.1084/jem.168.5.1685; ZAHEDI R, 1995, J CLIN INVEST, V95, P1299, DOI 10.1172/JCI117780	10	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					876	876		10.1016/j.jaci.2004.12.1132	http://dx.doi.org/10.1016/j.jaci.2004.12.1132			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15806016				2022-12-18	WOS:000228373400034
J	Szefler, SJ				Szefler, SJ			Facing the challenges of childhood asthma: What changes are necessary?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							EXHALED NITRIC-OXIDE; PERSISTENT ASTHMA; CHILDREN; ALBUTEROL		Natl Jewish Med & Res Ctr, Dept Pediat, Div Clin Pharmacol & Allergy, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Div Immunol, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Szefler, SJ (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Clin Pharmacol & Allergy, 1400 Jackson St,Room J304,Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njc.org						Bisgaard H, 2005, J ALLERGY CLIN IMMUN, V115, P708, DOI 10.1016/j.jaci.2004.11.018; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Covar RA, 2005, J ALLERGY CLIN IMMUN, V115, P700, DOI 10.1016/j.jaci.2005.01.034; Covar RA, 2004, AM J RESP CRIT CARE, V170, P234, DOI 10.1164/rccm.200308-1174OC; Covar RA, 2003, J PEDIATR-US, V142, P469, DOI 10.1067/mpd.2003.187; Edwards AM, 2005, J ALLERGY CLIN IMMUN, V115, P885, DOI 10.1016/j.jaci.2005.01.063; Gern JE, 2005, J ALLERGY CLIN IMMUN, V115, P668, DOI 10.1016/j.jaci.2005.01.057; Global Initiative for Asthma (GINA), 2005, NIH PUBL, V02-3659; Howell J, 2005, J ALLERGY CLIN IMMUN, V115, P882, DOI 10.1016/j.jaci.2004.12.011; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Larsen GL, 2005, J ALLERGY CLIN IMMUN, V115, P657, DOI 10.1016/j.jaci.2004.12.1112; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Silkoff PE, 2004, J ALLERGY CLIN IMMUN, V114, P1241, DOI 10.1016/j.jaci.2004.08.042; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P470, DOI 10.1016/j.jaci.2004.12.1123; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014	18	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					685	688		10.1016/j.jaci.2005.01.031	http://dx.doi.org/10.1016/j.jaci.2005.01.031			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15805985				2022-12-18	WOS:000228373400004
J	Chinchilli, VM; Fisher, L; Craig, TJ				Chinchilli, VM; Fisher, L; Craig, TJ			Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						anaphylaxis; food allergy; statistical design; statistical analysis; nonparatnetric analysis; discrete-time survivalval analysis	CHILDREN	The double-blind, placebo-controlled food challenge is a rigorous tool that has become popular for evaluating adverse reactions to foods. The standard use of the double-blind, placebo-controlled food challenge has been to document food allergies for individual patients, but it recently has been gaining acceptance as a procedure for investigating the effectiveness of therapies to prevent/minimize food-induced anaphylaxis. The purpose of this study was to describe the statistical design and analysis issues for clinical trials that use the double-blind, placebo-controlled food challenge in measuring sensitivity to food allergens. Nonparametric tests for within-group and between-group comparisons are described, as well as a discrete-time survival analysis. The statistical methods are applied to simulated data from a clinical trial that compares control therapy and experimental therapy groups. The results indicate that the experimental therapy is significantly better than control in improving the tolerance to peanut Hour in patients with peanut allergy. Although simple nonparametric tests for within-group and between-group comparisons are easy to apply, a discrete-time survival analysis provides the best approach because of its flexibility in accounting for important independent variables (regressors) and longitudinal data. Statistical software packages can be adapted to perform such analyses.	Penn State Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA; Penn State Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chinchilli, VM (corresponding author), Penn State Coll Med, Dept Hlth Evaluat Sci, A210,600 Centerview Dr,Suite 2200, Hershey, PA 17033 USA.	vchinchi@psu.edu						Agresti A, 2002, CATEGORICAL DATA ANA, P282; BOCK SA, 1988, J ALLERGY CLIN IMMUN, V82, P986; Heagerty PJ, 2000, BIOMETRICS, V56, P719, DOI 10.1111/j.0006-341X.2000.00719.x; Hollander M., 1999, NONPARAMETRIC STAT M, P35; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; NOC D, 1998, ALLERGY S46, V53, P75; Rodriguez J, 2000, J ALLERGY CLIN IMMUN, V106, P968, DOI 10.1067/mai.2000.110467; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444, DOI 10.1016/S0091-6749(97)70133-7; *SAS I, 1999, EX 39 11 COMPL LOG L; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Vlieg-Boerstra BJ, 2004, J ALLERGY CLIN IMMUN, V113, P341, DOI 10.1016/j.jaci.2003.10.039	11	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					592	597		10.1016/j.jaci.2005.01.008	http://dx.doi.org/10.1016/j.jaci.2005.01.008			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753909				2022-12-18	WOS:000227687000024
J	Liu, E; Moriyama, H; Abiru, N; Paronen, J; Devendra, D; Finkelman, FD; Eisenbarth, GS				Liu, E; Moriyama, H; Abiru, N; Paronen, J; Devendra, D; Finkelman, FD; Eisenbarth, GS			Preventing peptide-induced anaphylaxis: Addition of C-terminal amino acids to produce a neutral isoelectric point	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						anaphylaxis; diabetes; insulin; peptide; immunotherapy; isoelectric point; 8 : 9-23; NOD; prevention; vaccine; immunization; allergy	MULTIPLE-SCLEROSIS; INSULIN; MOUSE; MICE; AUTOANTIBODIES; PROTECTION; INDUCTION; PLACEBO; LIGAND; TRIAL	Background: Progress in peptide immunotherapy for the treatment of autoimmune diseases has been hampered by reports of anaphylactic reactions in both mice and human subjects. Fatal anaphylaxis in nonobese diabetic (NOD) mice has been described after repeated subcutaneous insulin peptide B:9-23 immunizations. On the basis of observations that rapid systemic delivery of peptide to a sensitized mouse (eg, intravenous delivery) increases the anaphylactic response, it was hypothesized that slowing down the absorption of the peptide would prevent anaphylaxis. Objectives: We sought to prevent anaphylaxis from B:9-23 peptide by altering the isoelectric point (pI) to neutral, thereby decreasing solubility and rate of absorption after subcutaneous injection. Methods: B:9-23 peptide was modified by the addition of 2 arginine (RR) amino acids to the C-terminus to create B:9-23RR, thereby increasing the pI from 5.4 to 7.0. Both native and modified B:9-23 peptide were tested for the ability to induce anaphylaxis in a NOD mouse model of self-peptide anaphylaxis. Results: This modification resulted in a peptide vaccine with decreased solubility when administered subcutaneously at a neutral pH. B:9-23RR significantly protected NOD mice from peptide-induced anaphylaxis compared with B:9-23 peptide. Furthermore, B:9-23RR peptide retains its ability to induce insulin autoantibodies and prevent diabetes in NOD mice. Conclusion: The modification of the pI of a peptide vaccine might be a generalizable method to prevent anaphylaxis without changing the immunologic properties.	Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Sect Gastroenterol Hepatol & Nutr, Denver, CO USA; Childrens Hosp, Denver, CO 80218 USA; Univ Cincinnati, Coll Med, Div Immunol, Cincinnati, OH USA; Vet Adm Med Ctr, Cincinnati, OH 45220 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Liu, E (corresponding author), Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, 4200 E 9th Ave,B140, Denver, CO 80262 USA.	Edwin.liu@uchsc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032083, R01DK055969, P30DK057516, R01DK032083] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI-46374] Funding Source: Medline; NIDDK NIH HHS [P30 DK-57516, DK-32083, 1K08 DK06405-01, DK-55969] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander Clare, 2002, Current Drug Targets - Inflammation and Allergy, V1, P353, DOI 10.2174/1568010023344562; Balasa B, 2001, CLIN IMMUNOL, V99, P241, DOI 10.1006/clim.2001.5012; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; FRIEDMAN A, 1994, P NATL ACAD SCI USA, V91, P6688, DOI 10.1073/pnas.91.14.6688; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Lehoczky Otto, 2002, Orv Hetil, V143, P2189; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; Liu E, 2002, J CLIN INVEST, V110, P1021, DOI 10.1172/JCI200215488; Macglashan Donald Jr., 1998, Frontiers in Bioscience, V3, pD746; Maguire P, 1999, CLIN IMMUNOL, V93, P222, DOI 10.1006/clim.1999.4795; Meyer JD, 1998, J PHARM SCI, V87, P1149, DOI 10.1021/js970419w; Meyer JD, 1998, PHARMACEUT RES, V15, P188, DOI 10.1023/A:1011998014474; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pedotti Rosetta, 2003, BMC Immunol, V4, P2, DOI 10.1186/1471-2172-4-2; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Stratton LP, 1997, J PHARM SCI, V86, P1006, DOI 10.1021/js970034d; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	21	9	11	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2004	114	3					607	613		10.1016/j.jaci.2004.03.052	http://dx.doi.org/10.1016/j.jaci.2004.03.052			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	853AX	15356565				2022-12-18	WOS:000223799600021
J	Bahna, SL				Bahna, SL			You can have fish allergy and eat it too!	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						food allergy; seafood; fish; shellfish; crustacea; mollusks; food cross-reactivity; food processing	PEANUT ALLERGY; FOOD ALLERGY; CROSS-REACTIVITY; NATURAL-HISTORY; SKIN CONTACT; HYPERSENSITIVITY; ALLERGENICITY; CHILDREN; SHRIMP; PREVALENCE		Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Allergy Immunol Sect, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Bahna, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Allergy Immunol Sect, 1501 Kings Highway, Shreveport, LA 71130 USA.	sbahna@lsuhsc.edu						Alonso A, 1999, ALLERGY, V54, P517, DOI 10.1034/j.1398-9995.1999.00046.x; Attaran RR, 2002, EMERG MED J, V19, P474, DOI 10.1136/emj.19.5.474; Bahna SL, 2001, ANN ALLERG ASTHMA IM, V86, P414, DOI 10.1016/S1081-1206(10)62487-8; BAHNA SL, 1994, ALLERGY, V49, P129, DOI 10.1111/j.1398-9995.1994.tb00812.x; BERNHISELBROADBENT J, 1992, J ALLERGY CLIN IMMUN, V89, P730, DOI 10.1016/0091-6749(92)90381-B; BERNHISELBROADBENT J, 1992, J ALLERGY CLIN IMMUN, V90, P622, DOI 10.1016/0091-6749(92)90135-O; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Busse PJ, 2002, NEW ENGL J MED, V347, P1535, DOI 10.1056/NEJM200211073471921; Chung SY, 2003, J AGR FOOD CHEM, V51, P4273, DOI 10.1021/jf021212d; Clark S, 2004, J ALLERGY CLIN IMMUN, V113, P347, DOI 10.1016/j.jaci.2003.10.053; CRESPO JF, 1995, ALLERGY, V50, P257, DOI 10.1111/j.1398-9995.1995.tb01143.x; De Frutos C, 2003, ALLERGY, V58, P1067, DOI 10.1034/j.1398-9995.2003.00265.x; Dominguez C, 1996, ALLERGY ASTHMA PROC, V17, P83, DOI 10.2500/108854196778645092; Goetz DW, 2000, ANN ALLERG ASTHMA IM, V85, P461, DOI 10.1016/S1081-1206(10)62572-0; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Helbling A, 1999, ANN ALLERG ASTHMA IM, V83, P517, DOI 10.1016/S1081-1206(10)62862-1; Hourihane JO, 1998, BRIT MED J, V316, P1271, DOI 10.1136/bmj.316.7140.1271; KAJOSAARI M, 1982, ACTA PAEDIATR SCAND, V71, P815, DOI 10.1111/j.1651-2227.1982.tb09525.x; Kelso JM, 1996, ANN ALLERG ASTHMA IM, V77, P227, DOI 10.1016/S1081-1206(10)63260-7; Lorenzo S, 2000, ALLERGY, V55, P627, DOI 10.1034/j.1398-9995.2000.00471.x; Makinen-Kiljunen S, 2003, ANN ALLERG ASTHMA IM, V91, P413; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; MORGAN JE, 1989, J ALLERGY CLIN IMMUN, V83, P1112, DOI 10.1016/0091-6749(89)90454-5; Sicherer SH, 2004, J ALLERGY CLIN IMMUN, V114, P159, DOI 10.1016/j.jaci.2004.04.018; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Skolnick HS, 2001, J ALLERGY CLIN IMMUN, V107, P367, DOI 10.1067/mai.2001.112129; Solensky R, 2003, ANN ALLERG ASTHMA IM, V91, P411, DOI 10.1016/S1081-1206(10)61690-0; Tan BM, 2001, ANN ALLERG ASTHMA IM, V86, P583, DOI 10.1016/S1081-1206(10)62908-0; Tanaka R, 2000, Arerugi, V49, P479; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]; Vander Leek TK, 2000, J PEDIATR-US, V137, P749, DOI 10.1067/mpd.2000.109376; WARING NP, 1985, J ALLERGY CLIN IMMUN, V76, P440, DOI 10.1016/0091-6749(85)90724-9	32	9	9	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2004	114	1					125	126		10.1016/j.jaci.2004.04.026	http://dx.doi.org/10.1016/j.jaci.2004.04.026			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	836DA	15241354				2022-12-18	WOS:000222534300018
J	Chan, YC; Ho, KH; Chuah, YS; Lau, CC; Thomas, A; Tambyah, PA				Chan, YC; Ho, KH; Chuah, YS; Lau, CC; Thomas, A; Tambyah, PA			Eosinophilic meningitis secondary to allergic Aspergillus sinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DIAGNOSIS; CRITERIA		Natl Univ Singapore Hosp, Dept Med, Singapore 117548, Singapore; Mt Elizabeth Hosp, Singapore, Singapore	National University of Singapore	Chan, YC (corresponding author), Natl Univ Singapore Hosp, Dept Med, 5 Lower Kent Ridge Rd,PD 11907, Singapore 117548, Singapore.							ALLPHIN AL, 1991, LARYNGOSCOPE, V101, P815, DOI 10.1288/00005537-199108000-00003; Andes D, 2000, CLIN INFECT DIS, V31, P202, DOI 10.1086/313938; BENT JP, 1994, OTOLARYNGOL HEAD NEC, V96, P24; DESHAZO RD, 1995, J ALLERGY CLIN IMMUN, V96, P24, DOI 10.1016/S0091-6749(95)70029-3; deShazo RD, 1997, J ALLERGY CLIN IMMUN, V99, P475, DOI 10.1016/S0091-6749(97)70073-3; DeShazo RD, 1997, NEW ENGL J MED, V337, P254, DOI 10.1056/NEJM199707243370407; KATZENSTEIN ALA, 1983, J ALLERGY CLIN IMMUN, V72, P89, DOI 10.1016/0091-6749(83)90057-X; Schubert MS, 2000, ANN ALLERG ASTHMA IM, V85, P90, DOI 10.1016/S1081-1206(10)62445-3; Soto-Aquilar M. C., 1997, Journal of Investigative Medicine, V45, p3A; WELLER PF, 1993, SEMIN NEUROL, V13, P161, DOI 10.1055/s-2008-1041121	10	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2004	114	1					194	195		10.1016/j.jaci.2003.12.593	http://dx.doi.org/10.1016/j.jaci.2003.12.593			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	836DA	15282936				2022-12-18	WOS:000222534300029
J	Lack, G				Lack, G			New developments in food allergy: Old questions remain	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							PEANUT ALLERGY; ANAPHYLAXIS; EPINEPHRINE; MODEL; IGE		St Marys Hosp, Dept Pediat, London W2 1NY, England	Imperial College London	Lack, G (corresponding author), St Marys Hosp, Dept Pediat, S Wharf Rd,Salton House, London W2 1NY, England.			Lack, Gideon/0000-0001-7350-4021				Beyer K, 2003, J ALLERGY CLIN IMMUN, V112, P202, DOI 10.1067/mai.2003.1621; Breiteneder H, 2004, J ALLERGY CLIN IMMUN, V113, P821, DOI [10.1016/j.jaci.2004.01.779, 10.1016/j.jaci.2004.01.079]; Chulada PC, 2004, J ALLERGY CLIN IMMUN, V113, P1002, DOI 10.1016/j.jaci.2003.12.014; Das UN, 2004, J ALLERGY CLIN IMMUN, V113, P1002, DOI 10.1016/j.jaci.2003.12.013; Frossard CP, 2004, J ALLERGY CLIN IMMUN, V113, P958, DOI 10.1016/j.jaci.2003.12.017; Hamid Q, 2004, J ALLERGY CLIN IMMUN, V113, P1006, DOI 10.1016/S0091-6749(04)01072-3; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lee J, 2004, J ALLERGY CLIN IMMUN, V113, P995, DOI 10.1016/j.jaci.2004.01.565; Man AL, 2004, J ALLERGY CLIN IMMUN, V113, P965, DOI 10.1016/j.jaci.2004.02.038; Peeters KABM, 2004, J ALLERGY CLIN IMMUN, V113, P1000, DOI 10.1016/j.jaci.2004.03.005; Perondi MBM, 2004, NEW ENGL J MED, V350, P1722, DOI 10.1056/NEJMoa032440; Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P144, DOI 10.1016/j.jaci.2004.04.009; Perry TT, 2004, J ALLERGY CLIN IMMUN, V113, P973, DOI 10.1016/j.jaci.2004.02.035; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Shreffler WG, 2004, J ALLERGY CLIN IMMUN, V113, P776, DOI 10.1016/j.jaci.2003.12.588; Sicherer SH, 2004, J ALLERGY CLIN IMMUN, V114, P159, DOI 10.1016/j.jaci.2004.04.018; Simons FER, 2004, J ALLERGY CLIN IMMUN, V113, P837, DOI 10.1016/j.jaci.2004.01.079; Siruguri V, 2004, J ALLERGY CLIN IMMUN, V113, P1003, DOI 10.1016/j.jaci.2004.01.571; Sutton SA, 2004, J ALLERGY CLIN IMMUN, V113, P1004, DOI 10.1016/j.jaci.2004.01.572; TenBrook JA, 2004, J ALLERGY CLIN IMMUN, V113, P977, DOI 10.1016/j.jaci.2004.02.043; TIERESSEN MM, 2004, J ALLERGY CLIN IMMUN, V113, P932	21	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2004	114	1					127	130		10.1016/j.jaci.2004.04.033	http://dx.doi.org/10.1016/j.jaci.2004.04.033			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	836DA	15241355				2022-12-18	WOS:000222534300019
J	Siruguri, V; Sesikeran, B; Bhat, RV				Siruguri, V; Sesikeran, B; Bhat, RV			Starlink genetically modified corn and allergenicity in an individual	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Natl Inst Nutr, Indian Council Med Res, Hyderabad 500007, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Siruguri, V (corresponding author), Natl Inst Nutr, Indian Council Med Res, Hyderabad 500007, Andhra Pradesh, India.							Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Martin-Orue SM, 2002, BRIT J NUTR, V87, P533, DOI [10.1079/BJN2002573, 10.1079/BJNBJN2002573]; Sutton SA, 2003, J ALLERGY CLIN IMMUN, V112, P1011, DOI 10.1016/S0091-6749(03)02024-4	3	9	9	2	19	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2004	113	5					1003	1004		10.1016/j.jaci.2004.01.571	http://dx.doi.org/10.1016/j.jaci.2004.01.571			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	818UC	15148966				2022-12-18	WOS:000221269000032
J	Lipworth, BJ; Fardon, TC				Lipworth, BJ; Fardon, TC			Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Dundee, Dundee, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Dundee, Scotland.							Currie GP, 2003, AM J RESP CRIT CARE, V167, P1232, DOI 10.1164/rccm.200209-1116OC; Nelson HS, 2003, J ALLERGY CLIN IMMUN, V112, P29, DOI 10.1067/mai.2003.1558; USMANI OS, 2002, THORAX S3, V57, P10	3	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					178	178		10.1016/j.jaci.2003.10.035	http://dx.doi.org/10.1016/j.jaci.2003.10.035			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713929				2022-12-18	WOS:000187837900027
J	Mahakittikun, V; Jirapongsananuruk, O; Nochot, H; Boitano, JJ; Tungtrongchitr, A				Mahakittikun, V; Jirapongsananuruk, O; Nochot, H; Boitano, JJ; Tungtrongchitr, A			Woven material for bed encasement prevents mite penetration	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGENS; ENCASINGS; MATTRESS; CHILDREN; ASTHMA; CAT		Mahidol Univ, Siriraj Hosp, Dept Parasitol, Fac Med, Bangkok 10700, Thailand; Mahidol Univ, Siriraj Hosp, Dept Pediat, Fac Med, Bangkok 10700, Thailand	Mahidol University; Mahidol University	Mahakittikun, V (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Parasitol, Fac Med, Bangkok 10700, Thailand.			Jirapongsananuruk, Orathai/0000-0002-1603-1106				Frederick JM, 1997, EUR RESPIR J, V10, P361, DOI 10.1183/09031936.97.10020361; Halken S, 2003, J ALLERGY CLIN IMMUN, V111, P169, DOI 10.1067/mai.2003.5; Mahakittikun V, 2003, ALLERGY, V58, P981, DOI 10.1034/j.1398-9995.2003.00095.x; Rijssenbeek-Nouwens LHM, 2002, CLIN EXP ALLERGY, V32, P117, DOI 10.1046/j.0022-0477.2001.01256.x; Tovey E, 1999, J ALLERGY CLIN IMMUN, V103, P179, DOI 10.1016/S0091-6749(99)70488-4; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Tovey ER, 2001, J ALLERGY CLIN IMMUN, V108, P369, DOI 10.1067/mai.2001.117799; Vaughan JW, 1999, J ALLERGY CLIN IMMUN, V103, P227, DOI 10.1016/S0091-6749(99)70495-1	8	9	9	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2003	112	6					1239	1241		10.1016/j.jaci.2003.08.045	http://dx.doi.org/10.1016/j.jaci.2003.08.045			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	752HC	14657890				2022-12-18	WOS:000187154200033
J	Schroer, B; Lockey, R				Schroer, B; Lockey, R			Oral tacrolimus for severe recalcitrant atopic eczema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ S Florida, Coll Med, James A Haley Vet Adm Hosp, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Schroer, B (corresponding author), Univ S Florida, Coll Med, James A Haley Vet Adm Hosp, 13000 Bruce B Downs Blvd 111D, Tampa, FL 33612 USA.							Hauk PJ, 2001, J ALLERGY CLIN IMMUN, V107, P391, DOI 10.1067/mai.2001.112848; Klein IHHT, 2002, TRANSPLANTATION, V73, P732, DOI 10.1097/00007890-200203150-00012; Leung DYM, 2002, IMMUNOL ALLERGY CLIN, V22, P73, DOI 10.1016/S0889-8561(03)00070-5; Panhans-Gross A, 2001, J ALLERGY CLIN IMMUN, V107, P345, DOI 10.1067/mai.2001.112600; Reitamo S, 2001, J ALLERGY CLIN IMMUN, V107, P445, DOI 10.1067/mai.2001.113521; Schneider LC, 2002, IMMUNOL ALLERGY CLIN, V22, P141, DOI 10.1016/S0889-8561(03)00074-2	6	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2003	111	6					1409	1410		10.1067/mai.2003.1509	http://dx.doi.org/10.1067/mai.2003.1509			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	688FZ	12789248				2022-12-18	WOS:000183424700036
J	Garcia-Ara, MC; Sanchez, AV; Martinez, MTB; Pena, JMD				Garcia-Ara, MC; Sanchez, AV; Martinez, MTB; Pena, JMD			Cow's milk-dependent, exercise-induced anaphylaxis: Case report of a patient with previous allergy to cow's milk	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Madrid, Hosp Infantil La Paz, Serv Alergia, Madrid 28046, Spain	Hospital Universitario La Paz	Garcia-Ara, MC (corresponding author), Univ Madrid, Hosp Infantil La Paz, Serv Alergia, Paseo Castellana 261, Madrid 28046, Spain.			Pena, Jose Maria/0000-0002-3303-0455				DOHI M, 1991, J ALLERGY CLIN IMMUN, V87, P34, DOI 10.1016/0091-6749(91)90210-F; MAULITZ RM, 1979, J ALLERGY CLIN IMMUN, V63, P433, DOI 10.1016/0091-6749(79)90218-5; Romano A, 2001, INT ARCH ALLERGY IMM, V125, P264, DOI 10.1159/000053825; Shadick NA, 1999, J ALLERGY CLIN IMMUN, V104, P123, DOI 10.1016/S0091-6749(99)70123-5	4	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2003	111	3					647	648		10.1067/mai.2003.70	http://dx.doi.org/10.1067/mai.2003.70			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	656YW	12642852	Bronze			2022-12-18	WOS:000181639500033
J	Kelso, JM; Connaughton, C; Helm, RM; Burks, W				Kelso, JM; Connaughton, C; Helm, RM; Burks, W			Psychosomatic peanut allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									USN, Med Ctr, Div Allergy, San Diego, CA 92134 USA; Arkansas Childrens Hosp, Div Allergy Immunol, Little Rock, AR 72201 USA	United States Department of Defense; United States Navy; Arkansas Children's Hospital	Kelso, JM (corresponding author), USN, Med Ctr, Div Allergy, San Diego, CA 92134 USA.							HEFLE SL, 1995, J ALLERGY CLIN IMMUN, V95, P837, DOI 10.1016/S0091-6749(95)70127-3; Sicherer SH, 2002, ANN ALLERG ASTHMA IM, V88, P350, DOI 10.1016/S1081-1206(10)62363-0	2	9	9	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2003	111	3					650	651		10.1067/mai.2003.100	http://dx.doi.org/10.1067/mai.2003.100			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	656YW	12642854				2022-12-18	WOS:000181639500035
J	Weiler, JM				Weiler, JM			Why must Olympic athletes prove that they have asthma to be permitted to take inhaled beta(2)-agonists?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							EXERCISE-INDUCED ASTHMA		Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Weiler, JM (corresponding author), POB 2959, Iowa City, IA 52244 USA.							Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P419, DOI 10.1067/mai.2000.108914; Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Anderson SD, 2003, J ALLERGY CLIN IMMUN, V111, P45, DOI 10.1067/mai.2003.1; BARDAGI S, 1993, AM REV RESPIR DIS, V147, P1112, DOI 10.1164/ajrccm/147.5.1112; MOORE NG, 1994, AM J PHYSIOL, V267, pE475, DOI 10.1152/ajpendo.1994.267.3.E475; Rundell KW, 2000, MED SCI SPORT EXER, V32, P309, DOI 10.1097/00005768-200002000-00010; Weiler JM, 1998, J ALLERGY CLIN IMMUN, V102, P722, DOI 10.1016/S0091-6749(98)70010-7; Weiler JM, 1997, ALLERGY ASTHMA PROC, V18, P311, DOI 10.2500/108854197778590542; Weiler JM, 2000, J ALLERGY CLIN IMMUN, V106, P267, DOI 10.1067/mai.2000.108605; Wilber RL, 2000, MED SCI SPORT EXER, V32, P732, DOI 10.1097/00005768-200004000-00003	10	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2003	111	1					36	37		10.1067/mai.2003.113	http://dx.doi.org/10.1067/mai.2003.113			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	636PR	12532093	Bronze			2022-12-18	WOS:000180465500005
J	Hakonarson, H; Whelan, R; Leiter, J; Kim, C; Chen, M; Campbell, D; Grunstein, MM				Hakonarson, H; Whelan, R; Leiter, J; Kim, C; Chen, M; Campbell, D; Grunstein, MM			T lymphocyte-mediated changes in airway smooth muscle responsiveness are attributed to induced autocrine release and actions of IL-5 and IL-1 beta	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL-5; IL-1 beta; airway hyperresponsiveness; airway smooth muscle cells; T lymphocytes; cell-to-cell interactions	ALTERED RESPONSIVENESS; BRONCHOALVEOLAR LAVAGE; CYTOKINE PRODUCTION; MESSENGER-RNA; ASTHMA; EXPRESSION; CELLS; HYPERRESPONSIVENESS; INFLAMMATION; RHINOVIRUS	Background: Bidirectional stimulatory cross-talk was recently found to exist between activated T cells and airway smooth muscle (ASM) cells, a process that involves coligation of specific cellular adhesion-costimulatory molecules that results in the induction of proasthmatic-like changes in ASM responsiveness. Objective: The present study examined whether the cooperative intercellular signaling between activated T cells and ASM cells is coupled to the induced expression and actions of IL-5 and IL-1beta. Methods: Agonist-induced constrictor and relaxant responses were examined in rabbit ASM segments exposed to resting and anti-CD3-activated T cells in the absence and presence of either an anti-IL-5 receptor mAb or the recombinant human IL-1 receptor antagonist. In addition, mRNA and protein expression of IL-5 and IL-1beta were assayed under control and anti-CD3-stimulated conditions. Results: Relative to inactive T cells, incubation of ASM tissues with anti-CD3-activated T cells induced proasthmatic-like changes in agonist-mediated ASM responsiveness. This T cell-induced perturbation in ASM responsiveness was ablated by pretreating the tissues with either an anti-IL-5 receptor mAh or IL-1 receptor antagonist. Moreover, exposure of ASM cells to anti-CD3-activated T cells elicited an initial increased mRNA expression and release of IL-5, followed by an enhanced expression and release of IL-1beta, and the induced release of these cytokines was prevented in ASM cells that were pretreated with an anti-IL-5 receptor mAb. Conclusion: Collectively, these observations provide new evidence demonstrating that exposure of naive ASM cells to activated T cells induces the sequential release of IL-5 and IL-1beta from the ASM cells and that the latter cytokines act in an autocrine manner to elicit the proasthmatic phenotype of altered ASM responsiveness.	Univ Penn, Childrens Hosp Philadelphia, Sch Med,Joseph Stokes Jr Res Inst, Div Pulm Med, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Div Allergy Immunol & Infect Dis, Sch Med,Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia	Hakonarson, H (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med,Joseph Stokes Jr Res Inst, Div Pulm Med, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058245, R01HL059906, R01HL031467, R01HL061038] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-58245, HL-31467, HL-59906, HL-61038] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACKERMAN V, 1994, CHEST, V105, P687, DOI 10.1378/chest.105.3.687; Barnes PJ, 1998, PHARMACOL REV, V50, P515; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Grunstein MM, 2000, AM J PHYSIOL-LUNG C, V278, pL1146, DOI 10.1152/ajplung.2000.278.6.L1146; Hakonarson H, 1998, P NATL ACAD SCI USA, V95, P5257, DOI 10.1073/pnas.95.9.5257; Hakonarson H, 2001, J IMMUNOL, V166, P293, DOI 10.4049/jimmunol.166.1.293; Hakonarson H, 1999, AM J PHYSIOL-LUNG C, V277, pL13, DOI 10.1152/ajplung.1999.277.1.L13; HAKONARSON H, 1995, AM J PHYSIOL-LUNG C, V269, pL645, DOI 10.1152/ajplung.1995.269.5.L645; Hakonarson H, 1999, J CLIN INVEST, V104, P657, DOI 10.1172/JCI7137; Hakonarson H, 1999, J CLIN INVEST, V103, P1077, DOI 10.1172/JCI5809; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Hakonarson H, 1997, J CLIN INVEST, V99, P117, DOI 10.1172/JCI119122; Hakonarson H, 1999, J ALLERGY CLIN IMMUN, V104, P575, DOI 10.1016/S0091-6749(99)70326-X; Hamelmann E, 1999, INT ARCH ALLERGY IMM, V118, P90, DOI 10.1159/000024037; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; JORDANA M, 1994, EUR RESPIR J, V7, P2212, DOI 10.1183/09031936.94.07122212; KELLEY J, 1990, AM REV RESPIR DIS, V141, P765, DOI 10.1164/ajrccm/141.3.765; Koning H, 1997, CYTOKINE, V9, P427, DOI 10.1006/cyto.1996.0185; KOTSIMBOS AT, 1997, MEM I O CRUZ, V2, P75; LITCHFIELD TM, 1992, J ASTHMA, V29, P181, DOI 10.3109/02770909209099026; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mathur M, 1999, AM J RESP CRIT CARE, V159, P580, DOI 10.1164/ajrccm.159.2.9712018; ROBINSON D, 1993, AM REV RESPIR DIS, V148, P401, DOI 10.1164/ajrccm/148.2.401; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; ROMAGNANI S, 1995, J CLIN IMMUNOL, V15, P121, DOI 10.1007/BF01543103; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Umetsu DT, 1997, P SOC EXP BIOL MED, V215, P11; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WATSON ML, 1993, AM J RESP CELL MOL, V8, P365, DOI 10.1165/ajrcmb/8.4.365; YING S, 1995, AM J RESP CELL MOL, V12, P477, DOI 10.1165/ajrcmb.12.5.7742012; ZANGRILLI JG, 1995, AM J RESP CRIT CARE, V151, P1346, DOI 10.1164/ajrccm.151.5.7537586	36	9	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2002	110	4					624	633		10.1067/mai.2002.128529	http://dx.doi.org/10.1067/mai.2002.128529			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	602JJ	12373272				2022-12-18	WOS:000178501900014
J	Dechene, L				Dechene, L			T(H)1/T(H)2 immune response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Fitchburg State Coll, Dept Math, Fitchburg, MA 01420 USA	Massachusetts System of Public Higher Education; Fitchburg State College	Dechene, L (corresponding author), Fitchburg State Coll, Dept Math, 160 Pearl St, Fitchburg, MA 01420 USA.							Renz H, 2002, J ALLERGY CLIN IMMUN, V109, P338, DOI 10.1067/mai.2002.121459	1	9	22	1	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2002	110	3					539	540		10.1067/mai.2002.127436	http://dx.doi.org/10.1067/mai.2002.127436			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	592KM	12209115				2022-12-18	WOS:000177936900041
J	Graham, LM				Graham, LM			Balancing safety and efficacy in the treatment of pediatric asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; pediatric; efficacy; safety; treatment	CHURG-STRAUSS-SYNDROME; LEUKOTRIENE RECEPTOR ANTAGONIST; PERSISTENT ASTHMA; CHILDHOOD ASTHMA; INNER-CITY; CHILDREN; MONTELUKAST; PREVALENCE; POPULATION; BUDESONIDE	The treatment of pediatric asthma requires balancing the efficacy and safety of various asthma medications, facilitating patient and family education, and developing a supportive treatment network. The efficacy and safety of the major asthma controllers-cromolyn, long-acting beta(2)-agonists, inhaled corticosteroids, and leukotriene receptor antagonists-are well tolerated overall when used appropriately. Cromolyn is used often as first-line therapy in treating pediatric asthma, but the inhaled corticosteroids remain the cornerstone of pediatric asthma control. Long-acting beta(2)-agonists are most beneficial when used intermittently or in combination with other asthma medications. The most recent class of drugs, the leukotriene receptor antagonists are effective in controlling asthma and are well tolerated in children as young as 2 years of age. In moderate-to-severe pediatric asthma, combination therapy is often required to achieve optimal asthma control. Leukotriene receptor antagonists combined with inhaled corticosteroids reduce the need for steroid rescue, the rate of serious exacerbations, and the level of inflammation. The treatment of asthma requires the ability to diagnose and treat asthma effectively. In subpopulations with special needs such as very young or inner-city minority children, treating asthma requires a comprehensive approach that includes a supportive patient-physician relationship and the involvement of schools, churches, and neighborhood outreach programs that will identify children with asthma and promote quality care.	Morehouse Sch Med, Atlanta, GA 30342 USA	Morehouse School of Medicine	Graham, LM (corresponding author), Morehouse Sch Med, 1100 Lake Hearn Dr,Suite 450, Atlanta, GA 30342 USA.							Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; Baker JW, 1999, PEDIATRICS, V103, P414, DOI 10.1542/peds.103.2.414; Bisgaard H, 2000, PEDIATR PULM, V29, P221, DOI 10.1002/(SICI)1099-0496(200003)29:3<221::AID-PPUL11>3.3.CO;2-G; Bisgaard H, 1999, AM J RESP CRIT CARE, V160, P1227, DOI 10.1164/ajrccm.160.4.9903004; CARR W, 1992, AM J PUBLIC HEALTH, V82, P59, DOI 10.2105/AJPH.82.1.59; CHURG A, 1995, CHEST, V108, P320, DOI 10.1378/chest.108.2.320; Crain EF, 1998, ARCH PEDIAT ADOL MED, V152, P333; Eggleston PA, 1998, PEDIATRICS, V101, P349, DOI 10.1542/peds.101.3.349; EIGEN H, 1987, J ALLERGY CLIN IMMUN, V80, P612, DOI 10.1016/0091-6749(87)90016-9; GERSTMAN BB, 1989, J ALLERGY CLIN IMMUN, V83, P1032, DOI 10.1016/0091-6749(89)90444-2; Joseph CLM, 1996, J PEDIATR-US, V129, P735, DOI 10.1016/S0022-3476(96)70158-0; Joseph CLM, 2000, CHEST, V117, P1336, DOI 10.1378/chest.117.5.1336; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; Knorr B, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e48; Li X, 1999, AM J RESP CRIT CARE, V160, P1493, DOI 10.1164/ajrccm.160.5.9811052; Lofdahl CG, 1999, BMJ-BRIT MED J, V319, P87, DOI 10.1136/bmj.319.7202.87; Louthrenoo W, 1999, J RHEUMATOL, V26, P1387; Luo ZC, 1998, PEDIATR RES, V44, P563, DOI 10.1203/00006450-199810000-00016; MANNINO D, 1998, MMWR SURVEILLANCE SU, V48, P1; Peden DB, 1998, J ALLERGY CLIN IMMUN, V102, P32, DOI 10.1016/S0091-6749(98)70052-1; Pedersen S, 1997, ALLERGY, V52, P1, DOI 10.1111/j.1398-9995.1997.tb05047.x; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; Simons FER, 1998, NEW ENGL J MED, V339, P704; Szefler S, 2000, NEW ENGL J MED, V343, P1054; TARGONSKI PV, 1994, AM J PUBLIC HEALTH, V84, P1830, DOI 10.2105/AJPH.84.11.1830; VERBERNE AA, 1997, AM J RESP CRIT CARE, V156, P685; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; Wechsler ME, 1999, DRUG SAFETY, V21, P241, DOI 10.2165/00002018-199921040-00001; Weinstein SF, 1998, ANN ALLERG ASTHMA IM, V81, P51, DOI 10.1016/S1081-1206(10)63109-2; WEITZMAN M, 1992, JAMA-J AM MED ASSOC, V268, P2673, DOI 10.1001/jama.268.19.2673; Williams B, 2001, CLIN EXP ALLERGY, V31, P845, DOI 10.1046/j.1365-2222.2001.01085.x	31	9	9	1	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2002	109	6		S			S560	S566		10.1067/mai.2002.124571	http://dx.doi.org/10.1067/mai.2002.124571			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	568JU	12063513				2022-12-18	WOS:000176539300008
J	Spahn, J; Covar, R; Stempel, DA				Spahn, J; Covar, R; Stempel, DA			Asthma: Addressing consistency in results from basic science, clinical trials, and observational experience	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; bronchodilators; corticosteroids	INHALED FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR ANTAGONIST; LONG-TERM TREATMENT; DOUBLE-BLIND TRIAL; AIRWAY INFLAMMATION; GENE-EXPRESSION; ATOPIC ASTHMA; MILD ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; GLUCOCORTICOIDS SUPPRESS	The basic science understanding of the pathophysiology of a disease often serves as the basis for clinical investigations. This knowledge is used to propose new directions in care and confirm initial concepts. The basic science of asthma demonstrates that the most comprehensive management of inflammation appears to be associated with the use of inhaled corticosteroids and proposes a mechanism for combination therapy with the addition of salmeterol. Randomized clinical trials are performed to confirm these initial observations and demonstrate both the safety and efficacy of therapeutic agents. These investigations are either placebo-controlled or direct comparisons of 2 medications. For the treatment of asthma, these studies have all consistently demonstrated that inhaled corticosteroids are the most effective primary controller therapy. Greater improvement in both lung function and patient-oriented symptom control is observed with the use of inhaled corticosteroids. For patients whose symptoms are not controlled with single-drug therapy, the addition of a long-acting bronchodilator appears to be the most effective add-on treatment with the greatest improvement in lung function and symptom control. Clinical trials have been used for the purposes of cost modeling. Therapies that produce the greatest effect size at the lowest incremental costs produce the greatest improvement in cost-effectiveness. Retrospective claims analysis, more recently, have been used to validate these observations from clinical trials. These studies measure both resource use and costs or charges. These analyses have confirmed that initial treatment with inhaled corticosteroids and combined treatment with inhaled corticosteroids and long-acting bronchodilators are the most effective stepwise approaches to the treatment of asthma.	Univ Washington, Virginia Mason Med Ctr, Seattle, WA 98101 USA; Univ Colorado, Sch Med, Natl Jewish Med & Res Ctr, Denver, CO USA	University of Washington; University of Washington Seattle; Virginia Mason Medical Center; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Stempel, DA (corresponding author), Univ Washington, Virginia Mason Med Ctr, 1100 9th Ave, Seattle, WA 98101 USA.							ADELROTH E, 1986, NEW ENGL J MED, V315, P480, DOI 10.1056/NEJM198608213150803; Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; Anderson GP, 2000, AM J RESP CRIT CARE, V161, pS188, DOI 10.1164/ajrccm.161.supplement_2.a1q4-9; Anenden V., 1998, European Respiratory Journal, V12, p157S; BENTLEY AM, 1992, AM REV RESPIR DIS, V146, P500, DOI 10.1164/ajrccm/146.2.500; Bisgaard H, 1999, AM J RESP CRIT CARE, V160, P1227, DOI 10.1164/ajrccm.160.4.9903004; Bleecker ER, 2000, J ALLERGY CLIN IMMUN, V105, P1123, DOI 10.1067/mai.2000.106043; BOOTH H, 1995, AM J RESP CRIT CARE, V152, P45, DOI 10.1164/ajrccm.152.1.7599861; BORISH L, 1992, J IMMUNOL, V149, P3078; BOUMPAS DT, 1991, J CLIN INVEST, V87, P1739, DOI 10.1172/JCI115192; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Bratton DL, 1999, PEDIATR PULM, V28, P402, DOI 10.1002/(SICI)1099-0496(199912)28:6<402::AID-PPUL3>3.0.CO;2-V; Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064; Busse W, 1999, J ALLERGY CLIN IMMUN, V103, P1075, DOI 10.1016/S0091-6749(99)70182-X; Busse W, 2001, J ALLERGY CLIN IMMUN, V107, P461, DOI 10.1067/mai.2001.114657; BUSSE WW, 1994, J ALLERGY CLIN IMMUN, V94, P1250, DOI 10.1016/0091-6749(94)90339-5; BYRON KA, 1992, IMMUNOLOGY, V77, P624; Chetta A, 1996, AM J RESP CRIT CARE, V153, P910, DOI 10.1164/ajrccm.153.3.8630572; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Chung KF, 1998, ALLERGY, V53, P7, DOI 10.1111/j.1398-9995.1998.tb04887.x; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; CONNOR R, IN PRESS CHEST; CULPEPPER JA, 1985, J IMMUNOL, V135, P3191; DeLepeleire I, 1997, CLIN PHARMACOL THER, V61, P83, DOI 10.1016/S0009-9236(97)90184-3; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; ENRIGHT PL, 1994, AM J RESP CRIT CARE, V149, pS9, DOI 10.1164/ajrccm/149.2_Pt_2.S9; Fish JE, 2001, CHEST, V120, P423, DOI 10.1378/chest.120.2.423; Fuhlbrigge AL, 2001, J ALLERGY CLIN IMMUN, V107, P61, DOI 10.1067/mai.2001.111590; GUNDEL RH, 1991, J CLIN INVEST, V87, P1470, DOI 10.1172/JCI115155; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HEGELE RG, 1996, SEVERE ASTHMA PATHOG, P61; HORN BR, 1975, NEW ENGL J MED, V292, P1152, DOI 10.1056/NEJM197505292922204; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; KATO M, 1994, LUNG, V172, P113; KELLY HW, 1999, PHARMACOTHERAPY PATH, P430; KENDRICK AH, 1993, BRIT MED J, V307, P422, DOI 10.1136/bmj.307.6901.422; Kharitonov SA, 1996, AM J RESP CRIT CARE, V153, P454, DOI 10.1164/ajrccm.153.1.8542158; KIDNEY J, 1995, AM J RESP CRIT CARE, V151, P1907, DOI 10.1164/ajrccm.151.6.7767539; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; LAITINEN A, 1994, AM J RESP CRIT CARE, V150, pS14, DOI 10.1164/ajrccm/150.5_Pt_2.S14; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; Laitinen LA, 2000, J ALLERGY CLIN IMMUN, V105, pS582, DOI 10.1016/S0091-6749(00)90062-9; Laviolette M, 1999, AM J RESP CRIT CARE, V160, P1862, DOI 10.1164/ajrccm.160.6.9803042; Majori M, 1997, J ALLERGY CLIN IMMUN, V100, P379, DOI 10.1016/S0091-6749(97)70252-5; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; MAURIZIO M, 1992, J ALLERGY CLIN IMMUN, V89, P1001; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Mulder A, 1999, AM J RESP CRIT CARE, V159, P1562, DOI 10.1164/ajrccm.159.5.9810095; Nakamura Y, 1998, THORAX, V53, P835, DOI 10.1136/thx.53.10.835; Nathan RA, 1999, ANN ALLERG ASTHMA IM, V82, P497, DOI 10.1016/S1081-1206(10)62728-7; Nelson HS, 2000, J ALLERGY CLIN IMMUN, V106, P1088, DOI 10.1067/mai.2000.110920; Nielsen LP, 2000, AM J RESP CRIT CARE, V162, P2053, DOI 10.1164/ajrccm.162.6.9912072; Olivieri D, 1997, AM J RESP CRIT CARE, V155, P1864, DOI 10.1164/ajrccm.155.6.9196087; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; ROBINSON D, 1993, AM REV RESPIR DIS, V148, P401, DOI 10.1164/ajrccm/148.2.401; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROBINSON DS, 1993, J ALLERGY CLIN IMMUN, V92, P397, DOI 10.1016/0091-6749(93)90118-Y; ROLFE FG, 1992, IMMUNOLOGY, V77, P494; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; Sampson AP, 2000, THORAX, V55, pS28, DOI 10.1136/thorax.55.suppl_2.S28; SANDBERG IW, 1992, MULTIDIMENSIONAL SYS, V3, P101; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Simons FER, 2001, J PEDIATR-US, V138, P694, DOI 10.1067/mpd.2001.112899; Spahn JD, 2000, LUNG BIOL HEALTH DIS, V145, P1; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; Stempel DA, 2001, J ALLERGY CLIN IMMUN, V107, P94, DOI 10.1067/mai.2001.112029; Stempel DA, 2001, RESP MED, V95, P227, DOI 10.1053/rmed.2000.1027; Tasche MJA, 2000, THORAX, V55, P913, DOI 10.1136/thorax.55.11.913; TEMPEL DA, 2002, J ALLERGY CLIN IMMUN, V109, P433; TOBLER A, 1992, BLOOD, V79, P45; TRIGG CJ, 1994, AM J RESP CRIT CARE, V150, P17, DOI 10.1164/ajrccm.150.1.8025745; US Department of Health and Human Services, 1997, NIH PUBL, V01-3680; WAAGE A, 1988, IMMUNOLOGY, V63, P299; WARD AJM, 1993, AM REV RESPIR DIS, V147, P518, DOI 10.1164/ajrccm/147.3.518; Westbroek J, 2000, RESP MED, V94, P112, DOI 10.1053/rmed.1999.0618; WILSON JW, 1994, AM J RESP CRIT CARE, V149, P86, DOI 10.1164/ajrccm.149.1.8111605; WU CY, 1991, EUR J IMMUNOL, V21, P2645, DOI 10.1002/eji.1830211053	81	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2002	109	5		S			S490	S502		10.1067/mai.2002.122718	http://dx.doi.org/10.1067/mai.2002.122718			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	554QH	11994721				2022-12-18	WOS:000175747400003
J	Koh, YI; Choi, IS; Lee, SH; Lee, JB; Park, CH; Hong, SN				Koh, YI; Choi, IS; Lee, SH; Lee, JB; Park, CH; Hong, SN			Localized heat urticaria associated with mast cell and eosinophil degranulation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RELEASE; HISTAMINE		Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; Chonnam Natl Univ, Sch Med, Dept Dermatol, Kwangju, South Korea; Chonnam Natl Univ, Res Inst Med Sci, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Koh, YI (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.							DAMAN L, 1978, J ALLERGY CLIN IMMUN, V61, P273, DOI 10.1016/0091-6749(78)90203-8; IRWIN RB, 1985, J ALLERGY CLIN IMMUN, V76, P35, DOI 10.1016/0091-6749(85)90801-2; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; KORO O, 1986, BRIT J DERMATOL, V115, P721, DOI 10.1111/j.1365-2133.1986.tb06654.x; ODONNELL MC, 1983, J EXP MED, V157, P1981, DOI 10.1084/jem.157.6.1981; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; SOTER NA, 1976, NEW ENGL J MED, V294, P687, DOI 10.1056/NEJM197603252941302	7	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2002	109	4					714	715		10.1067/mai.2002.122462	http://dx.doi.org/10.1067/mai.2002.122462			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	543YZ	11941324				2022-12-18	WOS:000175132600023
J	Eggleston, PA				Eggleston, PA			Clinical trials of allergen avoidance in established asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							DUST; REMOVAL; MITES		Johns Hopkins Univ, Baltimore, MD USA	Johns Hopkins University	Eggleston, PA (corresponding author), Johns Hopkins Univ Hosp, CMSC 1102, 600 N Wolfe St, Baltimore, MD 21287 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007527, R55ES007527, P01ES009601] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES07527, ES09601] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Carter MC, 2001, J ALLERGY CLIN IMMUN, V108, P732, DOI 10.1067/mai.2001.119155; Custovic A, 1998, THORAX, V53, P63, DOI 10.1136/thx.53.1.63; DIETEMANN A, 1993, J ALLERGY CLIN IMMUN, V91, P738, DOI 10.1016/0091-6749(93)90193-J; Eggleston PA, 1999, J ALLERGY CLIN IMMUN, V104, P842, DOI 10.1016/S0091-6749(99)70296-4; EHNERT B, 1992, J ALLERGY CLIN IMMUN, V90, P135, DOI 10.1016/S0091-6749(06)80024-2; Gotzsche PC, 1998, BRIT MED J, V317, P1105, DOI 10.1136/bmj.317.7166.1105; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HUSS K, 1992, J ALLERGY CLIN IMMUN, V89, P836, DOI 10.1016/0091-6749(92)90439-9; Marks GB, 1995, CLIN EXP ALLERGY, V25, P1190, DOI 10.1111/j.1365-2222.1995.tb03043.x; Meinert CL, 1986, CLIN TRIALS DESIGN C; *NAT ASTHM ED PREV, 1997, 974051 NAT HEART LUN; Platts-Mills TAE, 1999, BRIT MED J, V318, P870; Platts-Mills TAE, 2000, J ALLERGY CLIN IMMUN, V106, P787, DOI 10.1067/mai.2000.110548; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tovey E, 1999, J ALLERGY CLIN IMMUN, V103, P179, DOI 10.1016/S0091-6749(99)70488-4; WALSHAW MJ, 1986, Q J MED, V58, P199; Williams LW, 1999, J ALLERGY CLIN IMMUN, V104, P702, DOI 10.1016/S0091-6749(99)70346-5; WOOD RA, 1989, J ALLERGY CLIN IMMUN, V83, P730, DOI 10.1016/0091-6749(89)90006-7	18	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2001	108	5					685	687		10.1067/mai.2001.119569	http://dx.doi.org/10.1067/mai.2001.119569			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	498RG	11692089				2022-12-18	WOS:000172523800004
J	Lemiere, C; Taha, R; Olivenstein, R; Hamid, Q				Lemiere, C; Taha, R; Olivenstein, R; Hamid, Q			Comparison of cellular composition of induced sputum analyzed with Wright staining and immunocytochemistry	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; induced sputum; immunocytochemistry; cell count	AIRWAY INFLAMMATION; REPRODUCIBILITY; CELLS	We sought to compare cell counts based on cellular morphology and obtained after Wright staining with cell counts obtained after immunocytochemistry in induced sputum. Counts of eosinophils, neutrophils, macrophages, lymphocytes, and epithelial cells identified after Wright staining were compared with the counts obtained after immunocytochemistry through use of mAbs in 25 samples. Agreement between Wright staining and immunocytochemistry was poor for lymphocytes and epithelial cells. Rather than Wright staining, immunocytochemistry should be used to accurately identify lymphocytes and epithelial cells.	Hop Sacre Coeur, Dept Chest Med, Montreal, PQ H4J 1C5, Canada; McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	Universite de Montreal; McGill University	Lemiere, C (corresponding author), Hop Sacre Coeur, Dept Chest Med, 5400 W Gouin, Montreal, PQ H4J 1C5, Canada.							BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Olivenstein R, 1999, J ALLERGY CLIN IMMUN, V103, P238, DOI 10.1016/S0091-6749(99)70497-5; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Spanevello A, 1997, CLIN EXP ALLERGY, V27, P1138; WATANABE A, 1995, J CLIN INVEST, V96, P1303, DOI 10.1172/JCI118165; Woltmann G, 1999, THORAX, V54, P124, DOI 10.1136/thx.54.2.124	7	9	10	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2001	108	4					521	523						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	485NK	11590375				2022-12-18	WOS:000171760300008
J	Peroni, DG; Piacentini, GL; Vincentini, L; Costella, S; Pietrobelli, A; Boner, AL				Peroni, DG; Piacentini, GL; Vincentini, L; Costella, S; Pietrobelli, A; Boner, AL			Effective allergen avoidance reduces residual volume and sputum eosinophils in children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AIRWAYS		Univ Verona, Policlin GB Rossi, I-37134 Verona, Italy; Ist Pio XII, Misurina, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Peroni, DG (corresponding author), Univ Verona, Policlin GB Rossi, Piazzale Scuro 10, I-37134 Verona, Italy.		Peroni, Diego G/K-4002-2018; Peroni, Diego/K-8795-2016	Peroni, Diego/0000-0002-0234-1373				Kraft M, 1999, EUR RESPIR J, V14, P1403, DOI 10.1183/09031936.99.14614039; LIU A H, 1990, American Review of Respiratory Disease, V141, pA906; Pizzichini E, 1997, J ALLERGY CLIN IMMUN, V99, P539, DOI 10.1016/S0091-6749(97)70082-4; Stanescu D, 1999, CHEST, V116, P231, DOI 10.1378/chest.116.1.231	4	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2001	108	2					308	308		10.1067/mai.2001.117174	http://dx.doi.org/10.1067/mai.2001.117174			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	465HY	11496253				2022-12-18	WOS:000170584600025
J	Brandt, EB; Rothenberg, ME				Brandt, EB; Rothenberg, ME			Eosinophil levels in mice are significantly higher in small blood vessels than in large blood vessels	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MICROVASCULAR ENDOTHELIAL-CELLS; ADHESION		Childrens Hosp, Med Ctr, Dept Pediat, Div Pulm Med Allergy & Clin Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Brandt, EB (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, Div Pulm Med Allergy & Clin Immunol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.			Brandt, Eric/0000-0003-0617-4100				ADEGHE AJH, 1986, LAB ANIM, V20, P70, DOI 10.1258/002367786781062016; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Kuebler WM, 1997, J PHYSIOL-LONDON, V501, P375, DOI 10.1111/j.1469-7793.1997.375bn.x; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Yamaki K, 1998, BRIT J PHARMACOL, V123, P381, DOI 10.1038/sj.bjp.0701617; Yamamoto H, 1998, J IMMUNOL, V161, P971	6	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2001	108	1					142	143		10.1067/mai.2001.116121	http://dx.doi.org/10.1067/mai.2001.116121			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	458AN	11447397				2022-12-18	WOS:000170171200022
J	Affrime, MB; Kosoglou, T				Affrime, MB; Kosoglou, T			The pharmacokinetics of mometasone furoate administered by dry powder inhaler following single and multiple dosing in patients with mild to moderate persistent asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Res Inst, Kenilworth, NJ USA	Merck & Company; Schering-Plough Research Institute									0	9	10	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		346	S104	S104						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300346
J	Alexander, C; Oldfield, WLG; Shirley, KE; Larche, M; Kay, AB				Alexander, C; Oldfield, WLG; Shirley, KE; Larche, M; Kay, AB			A dosing protocol of allergen-derived T cell peptide epitopes for the treatment of allergic disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ London Imperial Coll Sci Technol & Med, NHLI Div, London, England	Imperial College London			Larche, Mark/B-4326-2010	Larche, Mark/0000-0002-1439-7593					0	9	9	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		716	S217	S217						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300712
J	Coghlan-Johnston, M; Lieberman, P				Coghlan-Johnston, M; Lieberman, P			Demographic and clinical characteristics of anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Tennessee, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center									0	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		198	S57	S57						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300198
J	Hong, LL; Wackers, F; Dewar, M; Kashgarian, M; Askenase, PW				Hong, LL; Wackers, F; Dewar, M; Kashgarian, M; Askenase, PW			Atypical fatal hypocomplementemic urticarial vasculitis with involvement of native and homograft aortic valves in an African American man	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						hypocomplementemic urticarial vasculitis; aortic valve			Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Askenase, PW (corresponding author), Yale Univ, Sch Med, Dept Med, 333 Cedar St,POB 208013, New Haven, CT 06520 USA.							BYWATERS EGL, 1950, BRIT HEART J, V12, P101; MCDUFFIE FC, 1973, MAYO CLIN PROC, V48, P340; PALAZZO E, 1993, J RHEUMATOL, V20, P1236; WISNIESKI JJ, 1995, MEDICINE, V74, P24, DOI 10.1097/00005792-199501000-00003; WISNIESKI JJ, 1989, ARTHRITIS RHEUM-US, V32, P1119, DOI 10.1002/anr.1780320910; ZEISS CR, 1980, AM J MED, V68, P867, DOI 10.1016/0002-9343(80)90216-8	6	9	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2000	106	6					1196	1198						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	384ER	11112906				2022-12-18	WOS:000165930300025
J	Avila, PC				Avila, PC			Interactions between allergic inflammation and respiratory viral infections	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							LATENT ADENOVIRAL INFECTION; ANTIGEN BRONCHOPROVOCATION; AIRWAY-OBSTRUCTION; SYNCYTIAL VIRUS; RHINOVIRUS-16; ASTHMA; PATHOGENESIS; PNEUMONIAE; EXPRESSION; CHILDREN		Univ Calif San Francisco, Dept Med & Pediat, Div Allergy & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Avila, PC (corresponding author), Univ Calif San Francisco, Dept Med & Pediat, Div Allergy & Immunol, 5025 Parnassus Ave,M-1303,Box 0130, San Francisco, CA 94143 USA.				NHLBI NIH HHS [HL56385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056385, P50HL056385] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avila PC, 2000, ANN ALLERG ASTHMA IM, V84, P565, DOI 10.1016/S1081-1206(10)62402-7; Avila PC, 2000, J ALLERGY CLIN IMMUN, V105, P923, DOI 10.1067/mai.2000.106214; BATEMAN ED, 1995, AM J RESP CRIT CARE, V151, P170, DOI 10.1164/ajrccm.151.1.7812549; BOLENDER RP, 1993, AM J PHYSIOL, V265, pL521, DOI 10.1152/ajplung.1993.265.6.L521; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; CALHOUN WJ, 1991, AM REV RESPIR DIS, V144, P1267, DOI 10.1164/ajrccm/144.6.1267; Cunningham AF, 1998, EUR RESPIR J, V11, P345, DOI 10.1183/09031936.98.11020345; Diaz PV, 1999, AM J RESP CRIT CARE, V160, P1157, DOI 10.1164/ajrccm.160.4.9804075; DUFF AL, 1993, PEDIATRICS, V92, P535; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Greiff L, 1999, EUR RESPIR J, V13, P41, DOI 10.1183/09031936.99.13104199; Grunberg K, 1999, AM J RESP CRIT CARE, V160, P1375; Hogg JC, 2000, PEDIATR RES, V47, P175, DOI 10.1203/00006450-200002000-00003; Hogg JC, 1999, AM J RESP CRIT CARE, V160, pS26, DOI 10.1164/ajrccm.160.5.8; Johnston SL, 1998, ALLERGY, V53, P922, DOI 10.1111/j.1398-9995.1998.tb03792.x; Keicho N, 1997, AM J RESP CELL MOL, V16, P23, DOI 10.1165/ajrcmb.16.1.8998075; Keicho N, 1997, AM J PHYSIOL-LUNG C, V272, pL1046, DOI 10.1152/ajplung.1997.272.6.L1046; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; MACEK V, 1994, AM J RESP CRIT CARE, V150, P7, DOI 10.1164/ajrccm.150.1.8025775; Marin J, 2000, J INFECTION, V41, P69, DOI 10.1053/jinf.2000.0688; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matsuba T, 1998, AM J RESP CELL MOL, V18, P243, DOI 10.1165/ajrcmb.18.2.2756; MATSUSE T, 1992, AM REV RESPIR DIS, V146, P177, DOI 10.1164/ajrccm/146.1.177; SIMILA S, 1981, CHEST, V80, P127, DOI 10.1378/chest.80.2.127; Stampfli MR, 1998, CLIN EXP ALLERGY, V28, P1581; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Suzuki M, 2000, HUM GENE THER, V11, P827, DOI 10.1089/10430340050015446; Xu Y, 2000, MOL CELL BIOL, V20, P2138, DOI 10.1128/MCB.20.6.2138-2146.2000	29	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2000	106	5					829	831		10.1067/mai.2000.111027	http://dx.doi.org/10.1067/mai.2000.111027			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	417ZK	11080702				2022-12-18	WOS:000167865200004
J	Batard, T; Bukovec, F; Berrouet, C; Destombes, V; Didierlaurent, A; Andre, C				Batard, T; Bukovec, F; Berrouet, C; Destombes, V; Didierlaurent, A; Andre, C			Demonstration of a partially cryptic epitope of the major cat allergen Fel d 1: Consequences for mAb-based standardization of cat extracts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						cat extract; Fel d 1; monoclonal antibody; ELISA; specificity; standardization	D-I; MONOCLONAL-ANTIBODIES	Background: Antiallergen mAbs that do not recognize clinically important isoforms have been described, raising the question of the selection of mAbs for quantifying major allergens in order to standardize allergenic extracts. This question is even more critical if mAbs can discriminate between different forms of allergen molecules with the same amino acid sequence. Objective: We sought to demonstrate that an anti-Fel d 1 mAb was able to discriminate between two forms of the major cat allergen independently of its amino acid sequence and to determine the relative importance and stability of both forms in various cat extracts. Methods: Anti-Fel d 1 mAbs were raised in mice and characterized. By using two of these mAbs, a two-site ELISA was developed to quantify Fel d 1 in mass units. Results: One of the anti-Fel d 1 mAbs developed was shown to specifically recognize a particular form of Fel d 1. A two-site ELISA with this mAb to capture Fel d 1 was able to quantify the allergen specifically in this form. It was then shown that (1) the quantitative importance of this form of Fel d 1 could vary from one cat extract to another, (2) Fel d 1 was converted into this form under certain conditions, and (3) both converted and unconverted forms of Fel d 1 may bear IgE epitopes that are specific. Conclusion: Although the present study emphasizes the issue of selecting mAbs that are not too specific to standardize allergenic extracts, it also demonstrates that very specific mAbs can be of interest, especially to verify the stability of allergens in extracts, since this stability might have clinical implications.	Stallergenes SA, F-92183 Antony, France	Stallergenes Greer	Batard, T (corresponding author), Stallergenes SA, 6 Rue Alexis de Toequeville, F-92183 Antony, France.							CHAPMAN MD, 1988, J IMMUNOL, V140, P812; DeAndrade AD, 1996, CLIN EXP ALLERGY, V26, P178, DOI 10.1111/j.1365-2222.1996.tb00077.x; DEGROOT H, 1988, J ALLERGY CLIN IMMUN, V82, P778, DOI 10.1016/0091-6749(88)90079-6; DUFFORT OA, 1991, MOL IMMUNOL, V28, P301, DOI 10.1016/0161-5890(91)90141-6; Hakkaart GAJ, 1998, CLIN EXP ALLERGY, V28, P169, DOI 10.1046/j.1365-2222.1998.00205.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; VANMILLIGEN FJ, 1992, INT ARCH ALLERGY IMM, V99, P63, DOI 10.1159/000236337; vanRee R, 1997, ALLERGY, V52, P795	9	9	10	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2000	106	4					669	676		10.1067/mai.2000.110227	http://dx.doi.org/10.1067/mai.2000.110227			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	365ZP	11031337				2022-12-18	WOS:000089980600010
J	Cistero-Bahima, A; Enrique, E; Alonso, R; San Miguel, MD				Cistero-Bahima, A; Enrique, E; Alonso, R; San Miguel, MD			Simultaneous occupational allergy to a carnation and its parasite in a greenhouse worker	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter						carnation; Dianthus caryophillus; greenhouse worker; hypersensitivity; occupational asthma; Tetranychus urticae			Inst Univ Dexeus, Dept Internal Med, Allergy & Clin Immunol Unit, E-08017 Barcelona, Spain; Labs Bial Aristegui, I&D, Bilbao, Spain		Cistero-Bahima, A (corresponding author), Inst Univ Dexeus, Dept Internal Med, Allergy & Clin Immunol Unit, Paseo de la Bonanova 69,2, E-08017 Barcelona, Spain.							Delgado J, 1997, CLIN EXP ALLERGY, V27, P640, DOI 10.1111/j.1365-2222.1997.tb01191.x; GAIG P, 1999, ALERGOL IMMUNOL CLIN, V14, P212; Sanchez-Guerrero IM, 1999, J ALLERGY CLIN IMMUN, V104, P181, DOI 10.1016/S0091-6749(99)70132-6; Vidal C, 1998, ALLERGY, V53, P995, DOI 10.1111/j.1398-9995.1998.tb03803.x	4	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2000	106	4					780	780		10.1067/mai.2000.109178	http://dx.doi.org/10.1067/mai.2000.109178			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	365ZP	11031352				2022-12-18	WOS:000089980600025
J	Engler, RJM				Engler, RJM			Alternative and complementary medicine: A source of improved therapies for asthma? A challenge for redefining the specialty?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						alternative medicine; asthma			Walter Reed Army Med Ctr, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Engler, RJM (corresponding author), Walter Reed Army Med Ctr, Bldg 2,1-J Area,6900 Georgia Ave NW, Washington, DC 20307 USA.							Bisset N.G., 1994, HERBAL DRUGS PHYTOPH; Blanc PD, 1997, J ALLERGY CLIN IMMUN, V100, P789, DOI 10.1016/S0091-6749(97)70275-6; BOIK J, 1996, CANC NATURAL MED TXB; Eisenberg DM, 1997, ANN INTERN MED, V127, P61, DOI 10.7326/0003-4819-127-1-199707010-00010; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Katsura H, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P1239; *MED EC, 2000, PHYS DESK REF HERB M; Muller JL, 1997, AM J MANAG CARE, V3, P1753; Studdert DM, 1998, JAMA-J AM MED ASSOC, V280, P1610, DOI 10.1001/jama.280.18.1610; Wetzel MS, 1998, JAMA-J AM MED ASSOC, V280, P784, DOI 10.1001/jama.280.9.784; Yamawaki I, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P1331; Ziment I, 2000, J ALLERGY CLIN IMMUN, V106, P603, DOI 10.1067/mai.2000.109432; 1992, ALTERNATIVE MED EXPA, P183; 1996, HEALING HERBS 299 NA	14	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2000	106	4					627	629		10.1067/mai.2000.110504	http://dx.doi.org/10.1067/mai.2000.110504			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	365ZP	11031331	Bronze			2022-12-18	WOS:000089980600004
J	Nakano, Y; Enomoto, N; Kawamoto, A; Hirai, R; Chida, K				Nakano, Y; Enomoto, N; Kawamoto, A; Hirai, R; Chida, K			Efficacy of adding multiple doses of oxitropium bromide to salbutamol delivered by means of a metered-dose inhaler with a spacer device in adults with acute severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; oxitropium bromide; salbutamol; metered-dose inhaler; bronchodilator treatment	IPRATROPIUM BROMIDE; ADOLESCENT ASTHMA; ACUTE CHILDHOOD; EMERGENCY ROOM; ALBUTEROL; ANTICHOLINERGICS; HOSPITALIZATION; METAANALYSIS; MANAGEMENT; AIRWAYS	Background: The efficacy of combination therapy adding multiple doses of anticholinergics to beta(2)-agonists to improve outcome has not been established in adults with acute severe asthma. Objective: This study was undertaken to compare the outcome of adults with acute severe asthma treated with 4 puffs of salbutamol(100 mu g/actuation) every 20 minutes for 3 doses plus 4 puffs of oxitropium bromide (100 mu g/actuation) with each of the 3 salbutamol doses versus salbutamol alone administered by means of a metered-dose inhaler with a spacer device. Methods: A randomized, single-blind, placebo-controlled study was performed in 74 patients between 18 and 55 years old presenting to the emergency department (ED) for treatment of acute asthma with a peak expiratory flow (PEF) of 50% or less than the normal predicted value. The primary endpoint was improvement in PEF over the course. The secondary endpoint was the need for additional ED treatment at 120 minutes. Results: The increase in PEF over the course was significantly greater in the oxitropium plus salbutamol treatment group (P < .0001). The mean absolute difference in PEF at 120 minutes for combination therapy compared with salbutamol alone was 37.8 L/min (P = .001). In addition, the proportion of need for additional ED treatment was less in the combination group than the group receiving salbutamol alone (odds ratio, 0.32; 95% confidence interval, 0.11-0.90). Conclusion: Adding multiple doses of oxitropium bromide to salbutamol delivered by means of a metered-dose inhaler with a spacer device for acute severe asthma produces a significant improvement in lung function and reduces the need for additional ED treatment.	Hamamatsu Rosai Hosp, Dept Internal Med, Hamamatsu, Shizuoka, Japan; Hamamatsu Univ Sch Med, Dept Internal Med 2, Hamamatsu, Shizuoka 43131, Japan	Hamamatsu University School of Medicine	Nakano, Y (corresponding author), Hamamatsu Rosai Hosp, Dept Internal Med, 25 Shogen Cho, Hamamatsu, Shizuoka, Japan.							[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; BARNES PJ, 1983, AM REV RESPIR DIS, V127, P758; BOWTON DL, 1992, CHEST, V101, P305, DOI 10.1378/chest.101.2.305; COLACONE A, 1993, CHEST, V104, P835, DOI 10.1378/chest.104.3.835; DHARMA A P, 1979, Drugs of the Future, V4, P117; DOUGLAS EB, 1997, J ASTHMA, V34, P357; FitzGerald JM, 1997, CHEST, V111, P311, DOI 10.1378/chest.111.2.311; Garrett JE, 1997, J ALLERGY CLIN IMMUN, V100, P165, DOI 10.1016/S0091-6749(97)70219-7; GROSS NJ, 1988, NEW ENGL J MED, V319, P486; Karpel JP, 1996, CHEST, V110, P611, DOI 10.1378/chest.110.3.611; Lin RY, 1998, ANN EMERG MED, V31, P208, DOI 10.1016/S0196-0644(98)70308-7; Lord J, 1999, BRIT MED J, V319, P1470, DOI 10.1136/bmj.319.7223.1470; LULLING J, 1981, RESPIRATION, V42, P188, DOI 10.1159/000194427; McFadden ER, 1997, AM J MED, V102, P7, DOI 10.1016/S0002-9343(96)00354-3; Minette A, 1979, Rev Inst Hyg Mines (Hasselt), V34, P115; *NAT ASTHM ED PREV, 1997, NAT I HLTH PUBL; ODRISCOLL BR, 1989, LANCET, V1, P1418; PEEL ET, 1984, EUR J RESPIR DIS, V65, P106; Plotnick LH, 1998, BMJ-BRIT MED J, V317, P971, DOI 10.1136/bmj.317.7164.971; PLOTNICK LH, 1997, EFFICACY SAFETY COMB; Qureshi F, 1998, NEW ENGL J MED, V339, P1030, DOI 10.1056/NEJM199810083391503; REBUCK AS, 1987, AM J MED, V82, P59, DOI 10.1016/0002-9343(87)90378-0; Rodrigo C, 1998, CHEST, V113, P593, DOI 10.1378/chest.113.3.593; Rodrigo G, 1999, AM J MED, V107, P363, DOI 10.1016/S0002-9343(99)00243-0; Rodrigo G, 1997, AM J EMERG MED, V15, P8, DOI 10.1016/S0735-6757(97)90039-5; STEIN LM, 1990, ANN INTERN MED, V112, P822, DOI 10.7326/0003-4819-112-11-822; Stoodley RG, 1999, ANN EMERG MED, V34, P8, DOI 10.1016/S0196-0644(99)70266-0; Teramoto S, 1999, EUR RESPIR J, V13, P473, DOI 10.1183/09031936.99.13247399; TSUKIOKA K, 1996, ARERUGI, V45, P4442	29	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2000	106	3					472	478		10.1067/mai.2000.108910	http://dx.doi.org/10.1067/mai.2000.108910			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	356YN	10984366	Bronze			2022-12-18	WOS:000089471900009
J	Strober, S				Strober, S			Natural killer 1.1(+)T cells and "natural suppressor" T cells in the bone marrow	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on New Trends in Immunopharmacology 1998	JUL   25, 1998	TOKYO, JAPAN			T cells; bone marrow; NK1.1 T cells; IL-4; "natural suppressor" cells; mixed leukocyte reaction; graft-versus-host disease	TOTAL LYMPHOID IRRADIATION; NS CELLS; HOST DISEASE; MICE; CD8; THYMOCYTES; TOLERANCE; INVITRO; SPLEEN	Unusual cells in the bone marrow of mice and/or humans suppress immune responses and inhibit the mixed leukocyte reaction, graft-versus-host disease, and systemic autoimmunity. Previous studies showed that these "natural suppressor" T cells expressed the CD4(-)CD8(-) T-cell receptor-alpha beta(+) phenotype, More recent studies demonstrate that the latter cells express the natural killer 1.1 (NK1.1) marker and are members of the NK1.1(+) T-cell family that secrete high levels of IFN-gamma and IL-4 after initial activation, The suppressive activity of the bone marrow NK1.1(+) T cells is dependent on their rapid secretion of high levels of IL-4, This unique cytokine secretion is not observed in conventional NK1.1(-) T cells and can downregulate the function of the latter cells.	Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA	Stanford University	Strober, S (corresponding author), Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, 300 Pasteur Dr,Room S105B, Stanford, CA 94305 USA.							ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; HERTELWULFF B, 1984, J IMMUNOL, V133, P2791; OSEROFF A, 1984, J IMMUNOL, V132, P101; PALATHUMPAT V, 1992, J IMMUNOL, V148, P373; SCHMIDTWOLF IGH, 1992, BLOOD, V80, P3242; SCHWADRON RB, 1989, TRANSPLANTATION, V48, P107, DOI 10.1097/00007890-198907000-00025; Strober S, 1996, IMMUNOL REV, V149, P217, DOI 10.1111/j.1600-065X.1996.tb00906.x; STROBER S, 1984, ANNU REV IMMUNOL, V2, P219, DOI 10.1146/annurev.iy.02.040184.001251; STROBER S, 1987, J IMMUNOL, V138, P699; SYKES M, 1990, CELL IMMUNOL, V129, P478, DOI 10.1016/0008-8749(90)90222-D; SYKES M, 1990, J IMMUNOL, V145, P3209; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zeng DF, 1998, J EXP MED, V187, P525, DOI 10.1084/jem.187.4.525; Zeng DF, 1999, J EXP MED, V189, P1073, DOI 10.1084/jem.189.7.1073	18	9	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2000	106	1	2	S			S113	S114		10.1067/mai.2000.106057	http://dx.doi.org/10.1067/mai.2000.106057			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	339NF	10887344				2022-12-18	WOS:000088482600017
J	Vandenplas, O; Caroyer, JM; Binard-van Cangh, F; Delwiche, JP; Symoens, F; Nolard, N				Vandenplas, O; Caroyer, JM; Binard-van Cangh, F; Delwiche, JP; Symoens, F; Nolard, N			Occupational asthma caused by a natural food colorant derived from Monascus ruber	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ Catholique Louvain, Clin Mont Godinne, Serv Pneumol, B-5530 Yvoir, Belgium; Fond Malad Profess, Brussels, Belgium; Sci Inst Publ Hlth Louis Pasteur, Mycol Sect, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain Hospital	Vandenplas, O (corresponding author), Univ Catholique Louvain, Clin Mont Godinne, Serv Pneumol, B-5530 Yvoir, Belgium.							Juzlova P, 1996, J IND MICROBIOL, V16, P163, DOI 10.1007/BF01569999; Vandenplas O, 1997, EUR RESPIR J, V10, P2612, DOI 10.1183/09031936.97.10112612	2	9	9	0	6	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2000	105	6	1				1241	1242		10.1067/mai.2000.106548	http://dx.doi.org/10.1067/mai.2000.106548			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	327EX	10856161				2022-12-18	WOS:000087781800028
J	Pals, CEGM; Verploegen, SABW; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ				Pals, CEGM; Verploegen, SABW; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ			Identification of cytokine-regulated genes in human leukocytes in vivo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						differential display; leukocyte; neutrophil; allergy; priming; GM-CSF; 5-lipoxygenase-activating protein; PCR	SIGNAL-TRANSDUCTION PATHWAYS; COLONY-STIMULATING FACTOR; PROTEIN-KINASE KINASE; HUMAN EOSINOPHILS; DIFFERENTIAL DISPLAY; ALLERGEN CHALLENGE; CELLS; CHEMOTAXIS; INDUCTION; ASTHMA	Background: Human polymorphic nuclear granulocytes (PMNs) such as neutrophils and eosinophils play a critical role in mediating inflammatory responses to microbial and parasitic infections. Exposure of these leukocytes to cytokines leads to an amplification of granulocyte effector functions by a mechanism termed "priming." Although many studies have investigated the effects of granulocyte priming, Little is known concerning the molecular mechanisms that Lead to this phenomenon. Objective: The purpose of this study was to identify potential markers for granulocyte priming and thus also to gain Further insight into the pathogenesis of inflammatory responses. Methods: We used a modified differential display technique, random arbitrary primed-PCR to identify genes regulated during the priming of human polymorphic nuclear granulocytes by GM-CSF in vitro. Genes identified were validated by Northern blot analysis of in vitro and in vivo primed leukocytes. Results: Several genes were identified and their expression characterized in vitro. One of these genes, 5-lipoxygenase-activating protein, was also found to be up-regulated in leukocytes isolated after allergen challenge of allergic asthmatic patients. Conclusion: The use of differential display technology is a rapid and effective means of identifying genes whose expression is regulated by priming in vitro and in vivo. Further analysis will lead to a better understanding of the priming phenotype and may provide further insight into the pathologic mechanisms of inflammatory processes.	Univ Utrecht, Med Ctr, Dept Pulm Dis, NL-3584 CX Utrecht, Netherlands	Utrecht University	Coffer, PJ (corresponding author), Univ Utrecht, Med Ctr, Dept Pulm Dis, G03-550,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.		Coffer, Paul/AAF-7970-2020; Coffer, Paul J/A-5769-2009; Koenderman, Leo/AAE-7870-2020	Koenderman, Leo/0000-0002-5636-6453				Bracke M, 1998, J IMMUNOL, V161, P6768; BUSSE WW, 1992, ANN ALLERGY, V68, P286; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; Coffer PJ, 1997, IMMUNOL LETT, V57, P27, DOI 10.1016/S0165-2478(97)00067-9; Coffer PJ, 1998, BLOOD, V91, P2547, DOI 10.1182/blood.V91.7.2547.2547_2547_2557; Coffer PJ, 1998, BIOCHEM J, V329, P121; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Evans DJ, 1996, EUR RESPIR J, V9, P703, DOI 10.1183/09031936.96.09040703; Fukuda T, 1995, J ALLERGY CLIN IMMUN, V96, P1076, DOI 10.1016/S0091-6749(95)70193-1; HALLETT MB, 1995, IMMUNOL TODAY, V16, P264, DOI 10.1016/0167-5699(95)80178-2; Kester HA, 1997, J BIOL CHEM, V272, P16637, DOI 10.1074/jbc.272.26.16637; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; KOENDERMAN L, 1996, EUR RESP J SUPPL, P22119; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KUIJPERS TW, 1991, BLOOD, V78, P1105; Kuroki M, 1997, BIOCHEM BIOPH RES CO, V232, P474, DOI 10.1006/bbrc.1997.6296; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Miike S, 1999, J LEUKOCYTE BIOL, V65, P700, DOI 10.1002/jlb.65.5.700; MILLER LL, 1991, P NATL ACAD SCI USA, V88, P4946, DOI 10.1073/pnas.88.11.4946; MOSER R, 1992, BLOOD, V79, P2937; NAGATA M, 1995, J IMMUNOL, V155, P4948; REIMERT CM, 1993, J IMMUNOL METHODS, V166, P183, DOI 10.1016/0022-1759(93)90359-F; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; VANDERBRUGGEN T, 1993, J LEUKOCYTE BIOL, V53, P347, DOI 10.1002/jlb.53.4.347; VENGE P, 1994, ALLERGY, V49, P1, DOI 10.1111/j.1398-9995.1994.tb00765.x; VENGE P, 1988, INT ARCH ALLER A IMM, V87, P306, DOI 10.1159/000234690; WARRINGA RAJ, 1991, BLOOD, V77, P2694; WARRINGA RAJ, 1992, BLOOD, V79, P1836; WARRINGA RAJ, 1993, J ALLERGY CLIN IMMUN, V91, P1198, DOI 10.1016/0091-6749(93)90323-8	34	9	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2000	105	4					760	768		10.1067/mai.2000.104382	http://dx.doi.org/10.1067/mai.2000.104382			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	306PB	10756227	Bronze			2022-12-18	WOS:000086604100015
J	Sakata, N; Kawasome, H; Terada, N; Johnson, GL; Gelfand, EW				Sakata, N; Kawasome, H; Terada, N; Johnson, GL; Gelfand, EW			CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						B cells; apoptosis; cyclic adenosine monophosphate; CD40	CROSS-LINKING; PROTEIN-KINASE; MEMBRANE IMMUNOGLOBULIN; SELECTIVE ACTIVATION; LYMPHOCYTES-B; IN-VIVO; BCL-X; DEATH; INHIBITION; AMP	Background: Antigen receptor ligation induces apoptosis of B lymphocytes, but the molecular mechanisms underlying induction of apoptosis remain unclear, although the growing family of IL-1 beta-converting enzyme cysteine proteases (caspases) are recognized to be major effecters of cellular death. Objective: We sought to delineate and compare the rescue of B-cell apoptosis through CD40 ligand-CD40 interaction and cyclic adenosine monophosphate (cAMP)-dependent protein kinase A in human B cells. Methods: By using tonsillar B cells and the B-lymphoblastoid cell line Ramos, rescue from B-cell apoptosis was compared, as were signaling pathways after activation of cells through CD40 and the adenosine A2 receptor. Results: Both CD40 ligand-CD40 interaction and activation of intracellular cAMP rescue B cells from apoptosis after antigen receptor ligation, Although these pathways do not overlap, they converge by preventing the anti-IgM-induced activation of CPP32 (caspase 3), a member of the IL-1 beta-converting enzyme protease family. Conclusion: These data indicate that the cAMP-protein kinase A-dependent and CD40-signaling pathways regulate B-cell survival and converge at a common point, the inhibition of antigen receptor-induced activation of caspases.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Program Mol Signal Transduct, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Gelfand, EW (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NIAID NIH HHS [AI HL-36577] Funding Source: Medline; NIDDK NIH HHS [DK-37871] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BOYNTON AL, 1981, ADV CYCL NUCL RES<D>, V14, P411; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; COFFINO P, 1975, P NATL ACAD SCI USA, V72, P878, DOI 10.1073/pnas.72.3.878; DELAHARPE J, 1989, J IMMUNOL, V143, P596; ELY SW, 1992, CIRCULATION, V85, P893, DOI 10.1161/01.CIR.85.3.893; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; GOETZL EJ, 1995, J IMMUNOL, V154, P1041; GOLD MR, 1993, J IMMUNOL, V150, P377; GOLD MR, 1992, BIOCHEM J, V287, P269, DOI 10.1042/bj2870269; GOLD MR, 1992, J IMMUNOL, V148, P2012; HOLDER MJ, 1993, EUR J IMMUNOL, V23, P2368, DOI 10.1002/eji.1830230948; ISHIDA T, 1995, J IMMUNOL, V155, P5527; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; KIZAKI H, 1990, J BIOL CHEM, V265, P5280; KNOX KA, 1993, INT IMMUNOL, V5, P1085, DOI 10.1093/intimm/5.9.1085; LEDERMAN S, 1994, J IMMUNOL, V152, P2163; LOMO J, 1995, J IMMUNOL, V154, P1634; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MCCONKEY DJ, 1990, J IMMUNOL, V145, P1227; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; MERINO R, 1995, J IMMUNOL, V155, P3830; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; ROPER RL, 1994, CELL IMMUNOL, V154, P296, DOI 10.1006/cimm.1994.1079; Sakata N, 1995, J BIOL CHEM, V270, P30823, DOI 10.1074/jbc.270.51.30823; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SUMIMOTO SI, 1994, J IMMUNOL, V153, P2488; TORDAI A, 1994, J BIOL CHEM, V269, P7538; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; WANG ZH, 1995, J IMMUNOL, V155, P3722; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	37	9	9	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2000	105	3					522	531		10.1067/mai.2000.104251	http://dx.doi.org/10.1067/mai.2000.104251			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	347UC	10719303				2022-12-18	WOS:000088946700019
J	Konig, P				Konig, P			The effects of cromolyn sodium and nedocromil sodium in early asthma prevention	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						early intervention; asthma; cromolyn sodium; nedocromil sodium; irreversible obstruction; long-term outcome	CHILDHOOD ASTHMA; BECLOMETHASONE DIPROPIONATE; INHALED CORTICOSTEROIDS; MODERATE ASTHMA; IGE PRODUCTION; IN-VIVO; CROMOGLYCATE; CHILDREN; GROWTH; ALBUTEROL	The possibility of irreversible obstruction and therefore the need for early intervention is being much debated, Some investigators suggested that delay in starting inhaled corticosteroids will result in irreversible obstruction, Our own long-term study, specifically designed to detect irreversible obstruction showed that a step-wise approach (starting with cromolyn sodium and switching to inhaled corticosteroids if clinical control and pulmonary function tests are not satisfactorily controlled) resulted in an increase in pulmonary function and not a deterioration. There was no evidence that a delay in starting inhaled corticosteroids will result in irreversible obstruction or clinical worsening. However, delay in starting cromolyn sodium in patients treated with bronchodilators alone did result in worsening pulmonary function tests and worse clinical outcomes. One study from Finland and another study from Australia came to the same conclusion. Even though some studies with cromolyn sodium did not show benefit in the first year of life, other studies did show a good response. The choice between nonsteroidal drugs, such as cromolyn sodium and inhaled corticosteroids as first-line drugs, has to be made on the risk/benefit ratio of these drugs. Although in severe asthma inhaled corticosteroids have greater efficacy, in mild-to-moderate asthma there is comparable efficacy, and the nonsteroidal drugs have better safety, A step-wise approach is still a logical approach (J Allergy Clin Immunol 2000;105:S575-85.).	Univ Missouri, Dept Child Hlth, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Konig, P (corresponding author), Univ Missouri, Dept Child Hlth, M659,1 Hosp Dr, Columbia, MO 65212 USA.		König, Peter/ABB-2380-2020	König, Peter/0000-0003-3654-5267				AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; ALLEN DB, 1994, J ALLERGY CLIN IMMUN, V93, P967, DOI 10.1016/S0091-6749(94)70043-5; Autio P, 1996, AM J RESP CRIT CARE, V153, P1172, DOI 10.1164/ajrccm.153.3.8630563; BARNES PJ, 1993, AM REV RESPIR DIS, V148, pS1, DOI 10.1164/ajrccm/148.4_Pt_2.S1; BLAIR H, 1977, ARCH DIS CHILD, V52, P613, DOI 10.1136/adc.52.8.613; Bray GA, 1999, DIABETES CARE, V22, P623; BROGDEN RN, 1993, DRUGS, V45, P693, DOI 10.2165/00003495-199345050-00007; CAPEWELL S, 1990, BRIT MED J, V300, P1548, DOI 10.1136/bmj.300.6739.1548; COCKCROFT DW, 1995, J ALLERGY CLIN IMMUN, V96, P44, DOI 10.1016/S0091-6749(95)70031-5; DIAZ P, 1984, J ALLERGY CLIN IMMUN, V74, P41, DOI 10.1016/0091-6749(84)90085-X; DOULL IJM, 1995, AM J RESP CRIT CARE, V151, P1715, DOI 10.1164/ajrccm.151.6.7767512; FRANCIS RS, 1984, CLIN ALLERGY, V14, P537, DOI 10.1111/j.1365-2222.1984.tb02241.x; FURFARO S, 1994, ARCH DIS CHILD, V71, P331, DOI 10.1136/adc.71.4.331; GELLERBERNSTEIN C, 1982, RESPIRATION, V43, P294, DOI 10.1159/000194497; GODFREY S, 1974, ARCH DIS CHILD, V49, P591, DOI 10.1136/adc.49.8.591; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; Harris T. A. J., 1996, European Respiratory Journal Supplement, V9, p163S; HENRY RL, 1984, ARCH DIS CHILD, V59, P54, DOI 10.1136/adc.59.1.54; HILLER EJ, 1975, BRIT J DIS CHEST, V69, P103; Hiratsuka S, 1996, J ALLERGY CLIN IMMUN, V98, P107, DOI 10.1016/S0091-6749(96)70232-4; KIMATA H, 1991, CLIN EXP IMMUNOL, V84, P395; KOKKONEN J, 1993, EUR RESPIR J, V6, P657; Konig P, 1996, J ALLERGY CLIN IMMUN, V98, P1103, DOI 10.1016/S0091-6749(96)80198-9; KONIG P, 1985, PHARMACOTHERAPY, V5, P156; Korppi M, 1996, ACTA PAEDIATR, V85, P190, DOI 10.1111/j.1651-2227.1996.tb13990.x; Loh RKS, 1996, J ALLERGY CLIN IMMUN, V97, P1141, DOI 10.1016/S0091-6749(96)70269-5; MAK VHF, 1992, EUR RESPIR J, V5, P1068; MANOLITSAS ND, 1995, AM J RESP CRIT CARE, V151, P1925, DOI 10.1164/ajrccm.151.6.7767541; MARTIN AJ, 1982, AUST PAEDIATR J, V18, P84; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MITCHELL I, 1976, BRIT MED J, V2, P457, DOI 10.1136/bmj.2.6033.457-a; *NAT HEART LUNG BL, 1992, NIH PUBL; NG SH, 1977, POSTGRAD MED J, V53, P315, DOI 10.1136/pgmj.53.620.315; NINAN TK, 1992, ARCH DIS CHILD, V67, P703, DOI 10.1136/adc.67.6.703; OSWALD H, 1977, PEDIAT PULMONOL, V23, P14; PETERSEN W, 1993, EUR RESP J S17, V6, pS356; PRICE JF, 1995, RESP MED, V89, P363, DOI 10.1016/0954-6111(95)90009-8; Reijonen T, 1996, ARCH PEDIAT ADOL MED, V150, P512, DOI 10.1001/archpedi.1996.02170300066013; Roy A, 1996, EUR RESPIR J, V9, P226, DOI 10.1183/09031936.96.09020226; SARSFIELD JK, 1977, PRACTITIONER, V218, P128; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SHAPIRO GG, 1991, J ALLERGY CLIN IMMUN, V88, P742, DOI 10.1016/0091-6749(91)90181-M; TINKELMAN DG, 1993, PEDIATRICS, V92, P64; VANSCHAYCK CP, 1991, BRIT MED J, V303, P1426, DOI 10.1136/bmj.303.6815.1426; WARNER JO, 1989, ARCH DIS CHILD, V64, P1065, DOI 10.1136/adc.64.7.1065; YUKSEL B, 1993, EUR J PEDIATR, V152, P615, DOI 10.1007/BF01954094; Yuksel B, 1996, RESP MED, V90, P467, DOI 10.1016/S0954-6111(96)90173-0; ZIEG G, 1994, J ALLERGY CLIN IMMUN, V94, P222, DOI 10.1016/0091-6749(94)90044-2	48	9	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2000	105	2	2	S			S575	S581		10.1016/S0091-6749(00)90061-7	http://dx.doi.org/10.1016/S0091-6749(00)90061-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286JG	10669542	Bronze			2022-12-18	WOS:000085439600019
J	Warner, JO; Pohunek, P; Marguet, C; Roche, WR; Clough, JB				Warner, JO; Pohunek, P; Marguet, C; Roche, WR; Clough, JB			Issues in understanding childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LUNG-FUNCTION; RISK FACTOR; CHILDREN; INFANTS; LIFE; ALLERGENS; AIRWAYS; DISEASE	Asthma and related allergic disorders in childhood have increased considerably in prevalence over the last few decades. During the same period of increasing morbidity from childhood asthma in the community, there have been dramatic advances in understanding of the basic immunopathologic features of the disease and consequently the development of a far more rational approach to its treatment. The immunopathologic condition of eosinophil-mediated airway inflammation is established very early in the evolution of asthma in childhood. It may even antedate the onset of symptoms. The present state of the art dictates that early intervention with potent therapies cannot be justified on the basis of symptoms alone and may in any case have no influence on the natural history of the condition, This means that current cautious therapeutic guidelines should continue to be followed. However, with the development of more accurate markers predicting ongoing disease, it will be possible to evaluate a whole range of early interventions in the future. Much evidence, though indirect, points to the possibility that the only true prophylaxis that will affect the natural history of asthma will need to be commenced before clinical features are manifest.	Univ Southampton, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Warner, JO (corresponding author), Univ Southampton, Southampton Gen Hosp, Mailpoint 803,Tremona Rd, Southampton SO16 6YD, Hants, England.		Warner, John/AAF-9587-2020; Pohunek, Petr/AAU-9822-2020					AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; AZEVEDO I, 1995, AM J RESP CRIT CARE, V152, P1208, DOI 10.1164/ajrccm.152.4.7551372; BARBATO A, 1995, BRONCHOSCOPE FLEXIBL; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; BURR ML, 1993, EPIDEMIOLOGY CLIN AL, P80; CANONICA GW, 1991, SCHWEIZERISCHE MED W, V121, P38; CARLSEN KCL, 1995, EUR RESPIR J, V8, P1148, DOI 10.1183/09031936.95.08071148; DELACOURT C, 1994, ALLERGY, V49, P843, DOI 10.1111/j.1398-9995.1994.tb00785.x; FERGUSON AC, 1995, J ALLERGY CLIN IMMUN, V95, P23, DOI 10.1016/S0091-6749(95)70148-6; GERRITSEN J, 1989, AM REV RESPIR DIS, V140, P1325, DOI 10.1164/ajrccm/140.5.1325; HANRAHAN JP, 1992, AM REV RESPIR DIS, V145, P1129, DOI 10.1164/ajrccm/145.5.1129; Heaney LG, 1996, CLIN EXP ALLERGY, V26, P799, DOI 10.1046/j.1365-2222.1996.d01-385.x; Hide DW, 1996, ALLERGY, V51, P89, DOI 10.1111/j.1398-9995.1996.tb04563.x; HOLT PG, 1994, LANCET, V344, P456, DOI 10.1016/S0140-6736(94)91776-0; IIKURA Y, 1992, ANN ALLERGY, V68, P233; Konig P, 1996, J ALLERGY CLIN IMMUN, V98, P1103, DOI 10.1016/S0091-6749(96)80198-9; LEWIS S, 1995, EUR RESPIR J, V8, P349, DOI 10.1183/09031936.95.08030349; LOH RKS, 1994, J EXP MED, V180, P663, DOI 10.1084/jem.180.2.663; MARTIN AJ, 1982, AUST PAEDIATR J, V18, P84; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MARTINEZ FD, 1991, AM REV RESPIR DIS, V143, P312, DOI 10.1164/ajrccm/143.2.312; MONTEFORT S, 1992, EUR RESPIR J, V5, P815; Oswald H, 1997, PEDIATR PULM, V23, P14, DOI 10.1002/(SICI)1099-0496(199701)23:1<14::AID-PPUL2>3.0.CO;2-P; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; Pedersen S, 1997, CLIN EXP ALLERGY, V27, P995, DOI 10.1111/j.1365-2222.1997.tb01247.x; ROBERTSON CF, 1995, BAILLIERES CLIN PAED, V3, P253; Twaddell SH, 1996, EUR RESPIR J, V9, P2104, DOI 10.1183/09031936.96.09102104; Warner JO, 1998, PEDIATR ALLERGY IMMU, V9, P116; Warner JO, 1998, PEDIATR ALLERGY IMMU, V9, P53, DOI 10.1111/j.1399-3038.1998.tb00302.x; WARNER JO, 1995, BRIT MED J, V311, P663, DOI 10.1136/bmj.311.7006.663; ZIPG G, 1994, J ALLERGY CLIN IMMUN, V94, P222	31	9	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2000	105	2	2	S			S473	S476		10.1016/S0091-6749(00)90045-9	http://dx.doi.org/10.1016/S0091-6749(00)90045-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286JG	10669526				2022-12-18	WOS:000085439600003
J	Frieri, M; Pergolizzi, R; Millan, C; Dominguez, PJ				Frieri, M; Pergolizzi, R; Millan, C; Dominguez, PJ			Cytokine chemokine, and nitric oxide (NO) release in stimulated small airway epithelial cells (SAEC) treated with agonist enantiomers of albuterol	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Nassau Cty Med Ctr, E Meadow, NY 11554 USA; N Shore Univ Hosp, Manhasset, NY USA	Northwell Health; North Shore University Hospital									0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		858	S292	S293		10.1016/S0091-6749(00)91286-7	http://dx.doi.org/10.1016/S0091-6749(00)91286-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100854
J	Merlos, M; Ramis, I; Balsa, D; Queralt, M; Brazis, P; Puigdemont, A				Merlos, M; Ramis, I; Balsa, D; Queralt, M; Brazis, P; Puigdemont, A			Inhibitory effect of rupatadine on TNF-alpha release from human monocytes and mast cell line HMC-1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UAB, Uriach Res Ctr, Barcelona, Spain; UAB, Dept Pharmacol, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona			puigdemont, anna/AAA-7511-2019	puigdemont, anna/0000-0001-5219-7552					0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		191	S62	S62		10.1016/S0091-6749(00)90622-5	http://dx.doi.org/10.1016/S0091-6749(00)90622-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100190
J	Nayak, A; Lorber, R; Salmun, LM				Nayak, A; Lorber, R; Salmun, LM			Decongestant effects of desloratadine in patients with seasonal allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Corp, Inst Res, Kenilworth, NJ 07033 USA; Univ Illinois, Peoria Sch Med, Peoria, IL USA	Merck & Company; Schering Plough Corporation; University of Illinois System; University of Illinois Peoria									0	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1122	S384	S384		10.1016/S0091-6749(00)91548-3	http://dx.doi.org/10.1016/S0091-6749(00)91548-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530101116
J	Mujtaba, MG; Villarete, L; Johnson, HM				Mujtaba, MG; Villarete, L; Johnson, HM			IFN-tau inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell line	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IFN; IgE; ovalbumin; mouse; human myeloma; lung; infiltration; inhibition	PREGNANCY RECOGNITION HORMONE; INTERFERON-TAU; ATOPIC-DERMATITIS; ENCEPHALOMYELITIS; TROPHOBLAST; ALPHA; MICE; STIMULATION; RESPONSES; INDUCTION	Background: IFN-tau, a type I IFN, is an antiviral, immunomadulating, and antiproliferative agent similar to IFN-alpha and IFN-beta, but IFN-tau lacks the toxicity associated with high concentrations of these IFNs in tissue culture and in animal studies. We have previously shown that IFN-tau inhibits antibody production in a murine model of an autoimmune disease, Objective: me investigate the effectiveness of ovine IFN-tau and other type I IFNs in suppressing the development of allergic sensitization in a murine model of allergy by using ovalbumin (OVA) antigen as an allergen and in suppressing IgE production by using a human IgE-producing myeloma cell line, Methods and Results: Mice that were treated with IFN-tau in vivo before and after intraperitoneal immunization with aluminum hydroxide-precipitated OVA had significantly lower OVA-specific IgE levels than the PBS-treated group. IFN-tau-treated mice had reduced inflammatory cell infiltration into the lung tissue. Furthermore, in vitro IFN-tau treatment of splenocytes taken from OVA-immunized mice suppressed OVA-induced proliferation. Also, treatment of the IgE-producing human myeloma cell line U266BL with IFN-tau-reduced IgE production and inhibited cell proliferation compared with media controls. Similar suppression of proliferation and inhibition of IgE production was seen with other type I IFNs, as well as a humanized IFN-tau/IFN-alpha D chimeric that consists of residues 1 to 27 of the ovine IFN-tau and residues 28 to 166 of the human IFN-alpha D, The chimeric was not toxic to human peripheral white blood cells at concentrations as high as 10(5) U/mL, whereas human IFN-alpha D was toxic at 10(3) U/mL, Conclusion: These data suggest that IFNs may be useful in preventing allergic sensitization by suppressing the production of allergen-specific IgE antibodies without toxic side effects.	Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; Pepgen Corp, Alameda, CA USA	State University System of Florida; University of Florida	Mujtaba, MG (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Bldg 981,Room 1052, Gainesville, FL 32611 USA.				NATIONAL CANCER INSTITUTE [R01CA069959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025904] Funding Source: NIH RePORTER; NCI NIH HHS [CA69959] Funding Source: Medline; NIAID NIH HHS [R37 AI25904] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAZER F W, 1989, Biology of Reproduction, V40, P63; BAZER FW, 1991, AM J REPROD IMMUNOL, V26, P19, DOI 10.1111/j.1600-0897.1991.tb00696.x; BECK L, 1989, CELL IMMUNOL, V123, P1, DOI 10.1016/0008-8749(89)90263-3; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; DOLEN JG, 1995, J INTERF CYTOK RES, V15, P973, DOI 10.1089/jir.1995.15.973; GODKIN JD, 1982, J REPROD FERTIL, V65, P141, DOI 10.1530/jrf.0.0650141; GRUSCHWITZ MS, 1993, INT ARCH ALLERGY IMM, V101, P20, DOI 10.1159/000236494; Hamelmann E, 1997, AM J RESP CELL MOL, V16, P674, DOI 10.1165/ajrcmb.16.6.9191469; Hamelmann E, 1996, J EXP MED, V183, P1719, DOI 10.1084/jem.183.4.1719; Heeke G, 1996, J INTERFERON RES, V16, P119; Hofstra CL, 1998, AM J RESP CELL MOL, V19, P826, DOI 10.1165/ajrcmb.19.5.3027; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; JOHNSON HM, 1994, SCI AM, V270, P68, DOI 10.1038/scientificamerican0594-68; KAY AB, 1992, BRIT MED BULL, V48, P51, DOI 10.1093/oxfordjournals.bmb.a072541; Khan OA, 1998, MULT SCLER, V4, P63, DOI 10.1191/135245898678919573; KIMATA H, 1995, ALLERGY, V50, P837; Lack G, 1996, J IMMUNOL, V157, P1432; LANZAVECCHIA A, 1984, CLIN EXP IMMUNOL, V55, P197; MANCINO D, 1980, INT ARCH ALLER A IMM, V61, P253, DOI 10.1159/000232443; MIGUEL NMR, 1977, INT ARCH ALLER A IMM, V54, P382, DOI 10.1159/000231852; Mujtaba MG, 1998, CELL IMMUNOL, V186, P94, DOI 10.1006/cimm.1998.1300; Mujtaba MG, 1997, J NEUROIMMUNOL, V75, P35, DOI 10.1016/S0165-5728(96)00231-7; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Noh GW, 1998, ALLERGY, V53, P1202, DOI 10.1111/j.1398-9995.1998.tb03842.x; PONTZER CH, 1994, J INTERFERON RES, V14, P133, DOI 10.1089/jir.1994.14.133; PONTZER CH, 1991, CANCER RES, V51, P5304; REVOLTELLA R, 1969, INT ARCH ALLER A IMM, V36, P282, DOI 10.1159/000230749; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; SOOS JM, 1995, J INTERF CYTOK RES, V15, P39, DOI 10.1089/jir.1995.15.39; Soos JM, 1997, J NEUROIMMUNOL, V75, P43, DOI 10.1016/S0165-5728(97)00003-9; SOOS JM, 1995, J IMMUNOL, V155, P2747; Subramaniam PS, 1995, P NATL ACAD SCI USA, V92, P12270, DOI 10.1073/pnas.92.26.12270; Subramaniam PS, 1998, ONCOGENE, V16, P1885, DOI 10.1038/sj.onc.1201712; WARNER NL, 1968, IMMUNOLOGY, V14, P725; WHALEY AE, 1994, J BIOL CHEM, V269, P10864	36	9	12	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1999	104	5					1037	1044		10.1016/S0091-6749(99)70086-2	http://dx.doi.org/10.1016/S0091-6749(99)70086-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	257JH	10550750				2022-12-18	WOS:000083778400028
J	Peat, JK; Allen, J; Oddy, W				Peat, JK; Allen, J; Oddy, W			Beyond breast-feeding	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							RISK-FACTORS; ATOPIC DISEASE; FOLLOW-UP; CHILDHOOD; INFANTS; HEALTH; CHILDREN; SMOKING; ILLNESS; COHORT		Univ Sydney, New Childrens Hosp, Clin Epidemiol Unit, Westmead, NSW, Australia; Univ Sydney, New Childrens Hosp, James Fairfax Inst Paediat Nutr, Dept Paediat & Child Hlth, Westmead, NSW, Australia; TVW Telethon Inst Child Hlth Res, W Perth, Australia	University of Sydney; University of Sydney; Telethon Kids Institute; University of Western Australia	Peat, JK (corresponding author), New Childrens Hosp, POB 3515, Parramatta, NSW, Australia.							BURR ML, 1993, ARCH DIS CHILD, V68, P724, DOI 10.1136/adc.68.6.724; CHANDRA RK, 1989, ANN ALLERGY, V63, P102; CUNNINGHAM AS, 1991, J PEDIATR-US, V118, P659, DOI 10.1016/S0022-3476(05)80023-X; DUNCAN B, 1993, PEDIATRICS, V91, P867; GrummerStrawn LM, 1996, INT J EPIDEMIOL, V25, P94, DOI 10.1093/ije/25.1.94; Hanson Lars A., 1994, Acta Paediatrica Japonica, V36, P557; Heinig MJ, 1996, NUTR RES REV, V9, P89, DOI 10.1079/NRR19960007; HUNTER HH, 1996, NEW GENERATION J NCT, V15, P26; INFANTERIVARD C, 1993, AM J EPIDEMIOL, V137, P834, DOI 10.1093/oxfordjournals.aje.a116745; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Nafstad P, 1996, EUR RESPIR J, V9, P2623, DOI 10.1183/09031936.96.09122623; PEAT JK, 1990, J ALLERGY CLIN IMMUN, V85, P65, DOI 10.1016/0091-6749(90)90223-Q; Peat JK, 1999, J ALLERGY CLIN IMMUN, V103, P1, DOI 10.1016/S0091-6749(99)70517-8; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; RYLANDER E, 1993, EUR J EPIDEMIOL, V9, P517, DOI 10.1007/BF00209530; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; SIKORSKI J, 1999, COCHRANE LIB; Tariq SM, 1998, J ALLERGY CLIN IMMUN, V101, P587, DOI 10.1016/S0091-6749(98)70164-2; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; WOLD AE, 1994, CURR OPIN GASTROEN, V10, P652, DOI 10.1097/00001574-199411000-00014; Wold AE, 1998, ACTA PAEDIATR, V87, P19, DOI 10.1080/08035259850157804; WRIGHT AL, 1995, ARCH PEDIAT ADOL MED, V149, P758, DOI 10.1001/archpedi.1995.02170200048006; WRIGHT AL, 1989, BRIT MED J, V299, P946, DOI 10.1136/bmj.299.6705.946; Wright AL, 1998, PEDIATRICS, V101, P837, DOI 10.1542/peds.101.5.837; Yu G, 1998, ACTA PAEDIATR, V87, P729, DOI 10.1080/080352598750013798	25	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1999	104	3	1				526	529		10.1016/S0091-6749(99)70318-0	http://dx.doi.org/10.1016/S0091-6749(99)70318-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241EP	10482822				2022-12-18	WOS:000082870000010
J	Roisman, GL; Danel, CJ; Lacronique, JG; Alhenc-Gelas, F; Dusser, DJ				Roisman, GL; Danel, CJ; Lacronique, JG; Alhenc-Gelas, F; Dusser, DJ			Decreased expression of angiotensin-converting enzyme in the airway epithelium of asthmatic subjects is associated with eosinophil inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; inflammation; bradykinin; kininase II; airway epithelium	BRADYKININ-INDUCED BRONCHOCONSTRICTION; SUBSTANCE-P; NEUTRAL ENDOPEPTIDASE; RESPIRATORY-TRACT; TISSUE KALLIKREIN; KININASE-II; INDUCTION; RECEPTOR; FLUID; GENE	Background: Angiotensin-converting enzyme (ACE) is a peptidase involved in the metabolism of several bioactive peptides. It may be involved in the airway inflammation and hyperresponsiveness that occur in asthma. Objective: We studied the expression of ACE in the airway mucosa of normal and asthmatic subjects and assessed the relationship between ACE expression and airway inflammation and bronchial hyperresponsiveness in asthma. Methods: We used immunohistochemistry to study the ACE expression and airway inflammation in bronchial biopsy samples obtained by fiberoptic bronchoscopy from 20 asthmatic subjects randomly assigned to groups treated with (n =10) or without inhaled corticosteroids (n = 10) and from normal subjects (n = 10). Airway response to methacholine and bradykinin was also determined for all subjects. Results: In normal subjects ACE was present in the surface epithelium, the endothelial cells of the lamina propria, and the submucosal glands, in which ACE was found in seromucous cells and in secreted mucus. ACE was not detected in smooth muscle cells and in most of the endothelial cells of the vascular network surrounding the glands. ACE was absent or present at lower levels in the surface epithelium of asthmatic subjects not treated with corticosteroids compared with those treated with corticosteroids and the control group. In asthmatic subjects low levels of ACE in the epithelium were associated with larger numbers of eosinophils in the epithelium and lamina propria. There was no relationship between ACE levels in the airway mucosa and airway responsiveness to methacholine and bradykinin. Conclusion: ACE expression is decreased in the epithelium of asthmatic patients and is associated with increased eosinophil inflammation.	Hop Cochin, Serv Pneumol, UFR Cochin Pt Royal, F-75679 Paris 14, France; Univ Paris 05, Assistance Publ Hop, Serv Anatomopathol, Hop Laennec,UFR Necker Enfants Malad, Paris, France; INSERM, U367, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dusser, DJ (corresponding author), Hop Cochin, Serv Pneumol, UFR Cochin Pt Royal, 27 Rue Fg St Jacques, F-75679 Paris 14, France.		Alhenc-Gelas, Francois/F-9511-2017					[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; BARANIUK JN, 1990, AM REV RESPIR DIS, V141, P706, DOI 10.1164/ajrccm/141.3.706; BARNES PJ, 1991, AM REV RESPIR DIS, V144, P1391, DOI 10.1164/ajrccm/144.6.1391; BARNES PJ, 1992, THORAX, V47, P979, DOI 10.1136/thx.47.11.979; Benessiano J, 1997, J ALLERGY CLIN IMMUN, V99, P53, DOI 10.1016/S0091-6749(97)70300-2; CHEN XL, 1993, AM J PHYSIOL, V265, pL243, DOI 10.1152/ajplung.1993.265.3.L243; CHRISTIANSEN SC, 1992, AM REV RESPIR DIS, V145, P900, DOI 10.1164/ajrccm/145.4_Pt_1.900; CHRISTIANSEN SC, 1987, J CLIN INVEST, V79, P188, DOI 10.1172/JCI112782; COCKCROFT DW, 1991, ASTHMA ITS PATHOLOGY, P51; CORFIELD DR, 1991, PULM PHARMACOL, V4, P85, DOI 10.1016/0952-0600(91)90057-A; COSTEROUSSE O, 1993, ADV NEUROIMMUNOL, V3, P217, DOI 10.1016/S0960-5428(05)80023-3; COULTER DM, 1987, BRIT MED J, V294, P1521, DOI 10.1136/bmj.294.6586.1521; DANILOV SM, 1987, HISTOCHEMISTRY, V87, P487, DOI 10.1007/BF00496822; DESIMONE C, 1987, ANN NY ACAD SCI, V496, P226; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; DUSSER DJ, 1988, J PHARMACOL EXP THER, V244, P531; EISER NM, 1983, B EUR PHYSIOPATH RES, V19, P495; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; FRIEDLAND J, 1977, SCIENCE, V197, P64, DOI 10.1126/science.194311; FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; ICHINOSE M, 1992, LANCET, V340, P1248, DOI 10.1016/0140-6736(92)92948-F; ICHINOSE M, 1990, AM REV RESPIR DIS, V142, P1104, DOI 10.1164/ajrccm/142.5.1104; JOHNSON AR, 1985, AM REV RESPIR DIS, V132, P564; KATAYAMA M, 1993, AM J PHYSIOL, V264, pL316, DOI 10.1152/ajplung.1993.264.3.L316; KROEGEL C, 1990, J IMMUNOL, V145, P2581; Lucchini RE, 1997, AM J RESP CRIT CARE, V156, P1963, DOI 10.1164/ajrccm.156.6.96-10088; LUNDBERG JM, 1984, CELL TISSUE RES, V235, P251; LURIE A, 1994, AM J RESP CRIT CARE, V149, P113, DOI 10.1164/ajrccm.149.1.7509244; MCELROY DA, 1992, LAB METHODS HISTOTEC; NIEBER K, 1992, J ALLERGY CLIN IMMUN, V90, P646, DOI 10.1016/0091-6749(92)90138-R; PIEDIMONTE G, 1991, J CLIN INVEST, V88, P40, DOI 10.1172/JCI115302; POLOSA R, 1990, AM REV RESPIR DIS, V142, P1367, DOI 10.1164/ajrccm/142.6_Pt_1.1367; Roisman CL, 1996, AM J RESP CRIT CARE, V153, P381, DOI 10.1164/ajrccm.153.1.8542147; SAETTA M, 1995, AM J RESP CRIT CARE, V151, P489, DOI 10.1164/ajrccm.151.2.7842211; SIBONY M, 1993, HYPERTENSION, V21, P827, DOI 10.1161/01.HYP.21.6.827; SKIDGEL RA, 1987, CLIN EXP HYPERTENS A, V9, P243, DOI 10.3109/10641968709164184; SPILLANTINI MG, 1990, BIOCHEM PHARMACOL, V39, P1353, DOI 10.1016/0006-2952(90)90012-A; WIEDERMANN FJ, 1993, ACTA HAEMATOL-BASEL, V89, P213; Zar J.J., 2010, BIOSTAT ANAL, Vfifth	39	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	1				402	410		10.1016/S0091-6749(99)70385-4	http://dx.doi.org/10.1016/S0091-6749(99)70385-4			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	232HH	10452763	Bronze			2022-12-18	WOS:000082364800034
J	Onorato, J; Esposito, S; Scovena, E; Morandi, B; Morelli, M; Pizzi, M; Zisa, G; Marchisio, P; Principi, N				Onorato, J; Esposito, S; Scovena, E; Morandi, B; Morelli, M; Pizzi, M; Zisa, G; Marchisio, P; Principi, N			Eosinophil involvement and serum IgE level in HIV-1-infected children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION; DISEASE		Univ Milan, L Sacco Hosp, Paediat Dept 4, I-20157 Milan, Italy	University of Milan; Luigi Sacco Hospital	Principi, N (corresponding author), Univ Milan, L Sacco Hosp, Paediat Dept 4, Via GB Grassi 74, I-20157 Milan, Italy.		Marchisio, Paola G/J-7342-2016; Esposito, Susanna/K-3475-2016	Marchisio, Paola G/0000-0002-5691-3920; Esposito, Susanna/0000-0003-4103-2837				[Anonymous], 1994, MMWR Recomm Rep, V43, P1; Bacot BK, 1997, J ALLERGY CLIN IMMUN, V100, P707, DOI 10.1016/S0091-6749(97)70177-5; Kline MW, 1995, PEDIATR AIDS HIV INF, V6, P350; PAGANELLI R, 1995, J ALLERGY CLIN IMMUN, V95, P995, DOI 10.1016/S0091-6749(95)70100-1; PIZZO PA, 1994, CLIN INFECT DIS, V19, P177, DOI 10.1093/clinids/19.1.177; VIGANO A, 1995, J ALLERGY CLIN IMMUN, V95, P627, DOI 10.1016/S0091-6749(95)70326-8	6	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1999	104	1					245	247		10.1016/S0091-6749(99)70146-6	http://dx.doi.org/10.1016/S0091-6749(99)70146-6			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	221QZ	10400872				2022-12-18	WOS:000081738900042
J	Piacentini, GL; Peterson, C; Peroni, DG; Bodini, A; Boner, AL				Piacentini, GL; Peterson, C; Peroni, DG; Bodini, A; Boner, AL			Allergen avoidance at high altitude and urinary eosinophil protein X	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA		Univ Verona, Dept Pediat, I-37100 Verona, Italy; Pharmacia & Upjohn AB, Uppsala, Sweden	University of Verona; Pfizer; Pharmacia Corporation	Boner, AL (corresponding author), Univ Verona, Policlin Borgo Roma, Pediat Clin, I-37134 Verona, Italy.		Peroni, Diego G/K-4002-2018; Peroni, Diego/K-8795-2016	Peroni, Diego/0000-0002-0234-1373				Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Kips JC, 1998, CLIN EXP ALLERGY, V28, P1; Kristjansson S, 1996, J ALLERGY CLIN IMMUN, V97, P1179, DOI 10.1016/S0091-6749(96)70182-3; Lugosi E, 1997, ALLERGY, V52, P584, DOI 10.1111/j.1398-9995.1997.tb02605.x	4	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1999	104	1					243	244		10.1016/S0091-6749(99)70145-4	http://dx.doi.org/10.1016/S0091-6749(99)70145-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	221QZ	10400871				2022-12-18	WOS:000081738900041
J	Kurata, H; Liu, CB; Valkova, J; Koch, AE; Yssel, H; Hirabayashi, Y; Inoue, T; Yokota, T; Arai, K				Kurata, H; Liu, CB; Valkova, J; Koch, AE; Yssel, H; Hirabayashi, Y; Inoue, T; Yokota, T; Arai, K			Recombinant adenovirus vectors for cytokine gene therapy in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology 1997	JUL   12, 1997	TOKYO, JAPAN	Novartis Pharma K K Tokyo		adenoviral vector; cytokine; gene therapy; vitronectin receptor; luciferase; hematopoiesis	THYMIDINE KINASE GENE; HERPES-SIMPLEX VIRUS; HUMAN BONE-MARROW; IN-VIVO; TRANSGENE EXPRESSION; MEDIATED TRANSFER; VIRAL-ANTIGENS; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; MOUSE-LIVER	Background: Adenoviruses have several specific features useful for gene therapy. They infect various lineages of cells irrespective of cell cycle status. However, the exact mechanism of their infection and in vivo kinetics as a gene expression vector have not been elucidated. Objective: Using adenovirus vectors expressing marker genes, we examined the infectivity of these vectors (including cellular and tissue tropism), the duration and intensity of transgene expression, and the side effects. Methods: Various cells were infected with adenovirus expressing LacZ gene at various doses, and beta-galactosidase activity was measured and compared in relation with dose, time course, and cellular vitronectin receptor. Mice were injected with adenoviruses expressing LacZ, luciferase and GM-CSF, and in vivo gene expression was examined. Results: Adenovirus infection induced viral dose-dependent transgene expression that persisted for 2 weeks. Adherent cells were infected much more efficiently than nonadherent cells, probably because the former expressed much higher levels of the vitronectin receptor, one of the main receptors for adenovirus, Studies performed in mice with luciferase-expressing adenovirus revealed that the liver was the main target organ after intravenous injection and showed that the intravenous route was superior to other routes with regard to transgene expression. After intravenous injection of adenovirus expressing human GM-CSF, there was a transient and dose-dependent increase in the serum level of this cytokine. Administration of adenovirus expressing mouse GM-CSP enhanced hematopoiesis in the spleen and bone marrow. Conclusion: These results indicated that adenoviruses can be used for in vivo cytokine gene therapy but suggested the necessity of taking into consideration the route of administration, the duration of transgene expression, the toxic dose, and host immune reactions.	Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, Tokyo 108, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan; Northwestern Univ, Sch Med, Dept Med, Div Arthrit & Connect Tiss Dis, Chicago, IL 60611 USA; INSERM, U454, Montpellier, France; Natl Inst Hlth Sci, Tokyo 158, Japan; Univ Tokyo, Inst Med Sci, Dept Stem Cell Regulat Amgen, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Northwestern University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; National Institute of Health Sciences - Japan; University of Tokyo	Arai, K (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.		Yssel, Hans/C-6406-2009; Yokota, Takashi/F-6021-2011; Koch, Alisa E/B-6894-2011; Yssel, Hans/AFV-2907-2022; Yokota, Takashi/J-8483-2015	Yssel, Hans/0000-0001-7454-1836; Yssel, Hans/0000-0001-7454-1836; 	NIAMS NIH HHS [AR30492, AR41492] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR041492] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABRAMS JS, 1995, CURRENT PROTOCOLS IM; Acsadi G, 1996, HUM GENE THER, V7, P129, DOI 10.1089/hum.1996.7.2-129; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BOVIATSIS EJ, 1994, HUM GENE THER, V5, P183, DOI 10.1089/hum.1994.5.2-183; BRACIAK TA, 1993, J IMMUNOL, V151, P5145; Bramson J, 1996, HUM GENE THER, V7, P333, DOI 10.1089/hum.1996.7.3-333; Bramson JL, 1996, HUM GENE THER, V7, P1995, DOI 10.1089/hum.1996.7.16-1995; BRODY SL, 1994, HUM GENE THER, V5, P437, DOI 10.1089/hum.1994.5.4-437; Brossart P, 1997, J IMMUNOL, V158, P3270; Caruso M, 1996, P NATL ACAD SCI USA, V93, P11302, DOI 10.1073/pnas.93.21.11302; CHANG MW, 1995, SCIENCE, V267, P518, DOI 10.1126/science.7824950; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; CONNELLY S, 1995, HUM GENE THER, V6, P185, DOI 10.1089/hum.1995.6.2-185; Couffinhal T, 1997, HUM GENE THER, V8, P929, DOI 10.1089/hum.1997.8.8-929; COURNOYER D, 1993, ANNU REV IMMUNOL, V11, P297; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DESCAMPS V, 1994, HUM GENE THER, V5, P979, DOI 10.1089/hum.1994.5.8-979; Dong YH, 1996, HUM GENE THER, V7, P713, DOI 10.1089/hum.1996.7.6-713; Elshami AA, 1996, HUM GENE THER, V7, P141, DOI 10.1089/hum.1996.7.2-141; ENGELHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196, DOI 10.1073/pnas.91.13.6196; Foley R, 1997, HUM GENE THER, V8, P545, DOI 10.1089/hum.1997.8.5-545; GILGENKRANTZ H, 1995, HUM GENE THER, V6, P1265, DOI 10.1089/hum.1995.6.10-1265; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; GINSBERG HS, 1984, ADENOVIRUS; Goodman JC, 1996, HUM GENE THER, V7, P1241, DOI 10.1089/hum.1996.7.10-1241; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; Guerette B, 1996, HUM GENE THER, V7, P1455, DOI 10.1089/hum.1996.7.12-1455; HADDADA H, 1993, BIOCHEM BIOPH RES CO, V195, P1174, DOI 10.1006/bbrc.1993.2168; Hashimoto M, 1996, HUM GENE THER, V7, P149, DOI 10.1089/hum.1996.7.2-149; Heike Y, 1997, HUM GENE THER, V8, P1, DOI 10.1089/hum.1997.8.1-1; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HORVATH J, 1988, J VIROL, V62, P341, DOI 10.1128/JVI.62.1.341-345.1988; HUANG SA, 1995, J VIROL, V69, P2257, DOI 10.1128/JVI.69.4.2257-2263.1995; HUARD J, 1995, GENE THER, V2, P107; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jooss K, 1996, HUM GENE THER, V7, P1555, DOI 10.1089/hum.1996.7.13-1555; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kaplan JM, 1997, HUM GENE THER, V8, P1095, DOI 10.1089/hum.1997.8.9-1095; KASSEISLER A, 1993, P NATL ACAD SCI USA, V90, P11498, DOI 10.1073/pnas.90.24.11498; KASSEISLER A, 1994, GENE THER, V1, P395; KAY MA, 1994, P NATL ACAD SCI USA, V91, P2353, DOI 10.1073/pnas.91.6.2353; KAY MA, 1995, NAT GENET, V11, P191, DOI 10.1038/ng1095-191; Ko SC, 1996, HUM GENE THER, V7, P1683, DOI 10.1089/hum.1996.7.14-1683; Kolls JK, 1996, HUM GENE THER, V7, P489, DOI 10.1089/hum.1996.7.4-489; KONISHI H, 1995, J CLIN INVEST, V96, P1125, DOI 10.1172/JCI118099; Lee CT, 1997, HUM GENE THER, V8, P187, DOI 10.1089/hum.1997.8.2-187; Leimig T, 1996, HUM GENE THER, V7, P1233, DOI 10.1089/hum.1996.7.10-1233; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Magovern CJ, 1997, HUM GENE THER, V8, P215, DOI 10.1089/hum.1997.8.2-215; MITANI K, 1994, HUM GENE THER, V5, P941, DOI 10.1089/hum.1994.5.8-941; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MIYAZAKI J, 1989, GENE, V79, P269; MUHLHAUSER J, 1995, HUM GENE THER, V6, P1457, DOI 10.1089/hum.1995.6.11-1457; Muruve DA, 1997, HUM GENE THER, V8, P955, DOI 10.1089/hum.1997.8.8-955; Neering SJ, 1996, BLOOD, V88, P1147, DOI 10.1182/blood.V88.4.1147.bloodjournal8841147; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P1285; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Ohwada A, 1996, HUM GENE THER, V7, P1567, DOI 10.1089/hum.1996.7.13-1567; Ohwada A, 1996, BLOOD, V88, P778; Peeters MJTFDV, 1996, HUM GENE THER, V7, P1693, DOI 10.1089/hum.1996.7.14-1693; QUANTIN B, 1992, P NATL ACAD SCI USA, V89, P2581, DOI 10.1073/pnas.89.7.2581; Richards CD, 1995, ANN NY ACAD SCI, V762, P282; ROESSLER BJ, 1995, HUM GENE THER, V6, P307, DOI 10.1089/hum.1995.6.3-307; RONCAROLO MG, 1988, J EXP MED, V168, P2139, DOI 10.1084/jem.168.6.2139; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; Ross G, 1996, HUM GENE THER, V7, P1781, DOI 10.1089/hum.1996.7.14-1781; SAITO I, 1985, J VIROL, V54, P711, DOI 10.1128/JVI.54.3.711-719.1985; SAKAMOTO H, 1994, P NATL ACAD SCI USA, V91, P12368, DOI 10.1073/pnas.91.26.12368; Salle G. L. G. L., 1993, SCIENCE, V259, P988; Sawchuk SJ, 1996, HUM GENE THER, V7, P499, DOI 10.1089/hum.1996.7.4-499; SETOGUCHI Y, 1994, BLOOD, V84, P2946; SILVER L, 1988, VIROLOGY, V165, P377, DOI 10.1016/0042-6822(88)90582-X; SPITS H, 1982, J IMMUNOL, V128, P95; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; VILQUIN JT, 1995, HUM GENE THER, V6, P1391, DOI 10.1089/hum.1995.6.11-1391; Watanabe T, 1996, BLOOD, V87, P5032, DOI 10.1182/blood.V87.12.5032.bloodjournal87125032; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wolff G, 1997, J VIROL, V71, P624, DOI 10.1128/JVI.71.1.624-629.1997; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Xu X, 1996, HUM GENE THER, V7, P471, DOI 10.1089/hum.1996.7.4-471; Yang YP, 1996, J VIROL, V70, P6370, DOI 10.1128/JVI.70.9.6370-6377.1996; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; YANG YP, 1995, J IMMUNOL, V155, P2564; Yang YP, 1996, J VIROL, V70, P7209, DOI 10.1128/JVI.70.10.7209-7212.1996; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K; ZHANG WW, 1995, HUM GENE THER, V6, P155, DOI 10.1089/hum.1995.6.2-155; ZSENGELLER ZK, 1995, HUM GENE THER, V6, P457, DOI 10.1089/hum.1995.6.4-457	95	9	14	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	2	S			S471	S484		10.1016/S0091-6749(99)70164-8	http://dx.doi.org/10.1016/S0091-6749(99)70164-8			14	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199TV	10329851				2022-12-18	WOS:000080500200010
J	Martin, RJ; Pak, J; Kunselman, SJ; Cherniack, RM				Martin, RJ; Pak, J; Kunselman, SJ; Cherniack, RM		Asthma Clinical Res Network	Assessment of the AirWatch lung function monitoring system	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PEAK EXPIRATORY FLOW; QUALITY-CONTROL; ASTHMA; MANAGEMENT; RATES		Univ Colorado, Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Milton S Hershey Med Ctr, Hershey, PA USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Martin, RJ (corresponding author), Univ Colorado, Natl Jewish Med & Res Ctr, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.				NHLBI NIH HHS [U10 HL51843, U10 HL51834, U10 HL51831] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL051843, U10HL051834, U10HL051831] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1993, BRIT MED J, V306, P776; Fish JE, 1997, AM J RESP CRIT CARE, V156, P1165, DOI 10.1164/ajrccm.156.4.9703012; GAUTRIN D, 1994, CHEST, V106, P1419, DOI 10.1378/chest.106.5.1419; GIBSON PG, 1995, ANN INTERN MED, V123, P488, DOI 10.7326/0003-4819-123-7-199510010-00002; IGNACIOGARCIA JM, 1995, AM J RESP CRIT CARE, V151, P353, DOI 10.1164/ajrccm.151.2.7842191; Irvin CG, 1997, AM J RESP CRIT CARE, V156, P396, DOI 10.1164/ajrccm.156.2.9609054; JANSONBJERKLIE S, 1988, HEART LUNG, V17, P543; MALO JL, 1993, J ALLERGY CLIN IMMUN, V91, P702, DOI 10.1016/0091-6749(93)90189-M	8	9	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1999	103	3	1				535	536		10.1016/S0091-6749(99)70484-7	http://dx.doi.org/10.1016/S0091-6749(99)70484-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	176WU	10069893				2022-12-18	WOS:000079175700028
J	Huang, SK				Huang, SK			Molecular modulation of allergic responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						molecular modulation; cytokine-gene transfer; DNA-based immunization; allergic inflammation	PLASMID DNA IMMUNIZATION; ANTIGEN-INDUCED EOSINOPHIL; IGE ANTIBODY-FORMATION; IN-VIVO; INTERFERON-GAMMA; MURINE MODEL; AIRWAY HYPERRESPONSIVENESS; IMMUNE-RESPONSES; GENE-EXPRESSION; ATOPIC ASTHMA	The pathophysiology of allergic diseases involves an intricate network of molecular and cellular interactions. Elevated levels of serum IgE- and T-H2 cytokine-associated eosinophilic inflammation characterize allergic diseases and provide potential targets for immunomodulation. Recent evidence that antigen-induced allergic responses can be modulated in rodents by mucosal transfer of T-H1-cytokine genes or by immunization with plasmid DNAs encoding the sensitizing antigens suggests promising new prophylactic or therapeutic approaches. Innovative research in mapping the regulatory pathways that typify the atopy network will provide a deeper understanding of the molecular mechanisms underlying these diseases and facilitate the design of more specific and efficacious modulation strategies.	Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Huang, SK (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.		Huang, Shau-Ku/F-5509-2010					A-Mohammadi S, 1998, GENE THER, V5, P76, DOI 10.1038/sj.gt.3300557; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; BARRY MA, 1995, NATURE, V377, P632, DOI 10.1038/377632a0; BOGUNIEWICZ M, 1995, J ALLERGY CLIN IMMUN, V95, P133, DOI 10.1016/S0091-6749(95)70162-1; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54, DOI 10.1165/ajrcmb.13.1.7598937; DeRisi J, 1996, NAT GENET, V14, P457; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Feltquate DM, 1997, J IMMUNOL, V158, P2278; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Gavett SH, 1997, AM J PHYSIOL-LUNG C, V272, pL253, DOI 10.1152/ajplung.1997.272.2.L253; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Geissler M, 1997, J IMMUNOL, V158, P1231; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; Hogan SP, 1998, EUR J IMMUNOL, V28, P413; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; Hsu CH, 1996, INT IMMUNOL, V8, P1405, DOI 10.1093/intimm/8.9.1405; Hsu CH, 1996, NAT MED, V2, P540, DOI 10.1038/nm0596-540; HUANG SK, 1995, J IMMUNOL, V155, P2688; Huang SK, 1998, J ALLERGY CLIN IMMUN, V101, pS55; HumpherySmith I, 1997, J PROTEIN CHEM, V16, P537, DOI 10.1023/A:1026330015280; Irvine KR, 1996, J IMMUNOL, V156, P238; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Iwasaki A, 1997, J IMMUNOL, V159, P11; Kim JJ, 1997, NAT BIOTECHNOL, V15, P641; Kline JN, 1998, J IMMUNOL, V160, P2555; KRISHNASWAMY G, 1993, AM J RESP CELL MOL, V9, P279, DOI 10.1165/ajrcmb/9.3.279; KUNG TT, 1995, AM J RESP CELL MOL, V13, P360, DOI 10.1165/ajrcmb.13.3.7654390; LACK G, 1994, J IMMUNOL, V152, P2546; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lee DJ, 1997, INT ARCH ALLERGY IMM, V113, P227, DOI 10.1159/000237554; Li XM, 1998, J IMMUNOL, V160, P1378; Li XM, 1996, J IMMUNOL, V157, P3216; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lowrey JA, 1998, INT ARCH ALLERGY IMM, V116, P93, DOI 10.1159/000023931; MOR G, 1995, J IMMUNOL, V155, P2039; MOSMANN TR, 1996, IMMUNOL TODAY, V17, P142; NAKAJIMA H, 1994, J IMMUNOL, V153, P1264; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; Nyce JW, 1997, NATURE, V385, P721, DOI 10.1038/385721a0; Padrid PA, 1998, AM J RESP CELL MOL, V18, P453, DOI 10.1165/ajrcmb.18.4.3055; Pertmer TM, 1996, J VIROL, V70, P6119, DOI 10.1128/JVI.70.9.6119-6125.1996; Pietu G, 1996, GENOME RES, V6, P492, DOI 10.1101/gr.6.6.492; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; Platts-Mills TAE, 1998, J ALLERGY CLIN IMMUN, V102, P335, DOI 10.1016/S0091-6749(98)70117-4; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; RENZ H, 1992, J ALLERGY CLIN IMMUN, V89, P1127, DOI 10.1016/0091-6749(92)90296-E; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Sperling AI, 1996, IMMUNOL REV, V153, P155, DOI 10.1111/j.1600-065X.1996.tb00924.x; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; Torres CAT, 1997, J IMMUNOL, V158, P4529; Ulmer JB, 1996, CURR OPIN IMMUNOL, V8, P531, DOI 10.1016/S0952-7915(96)80042-2; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Waisman A, 1996, NAT MED, V2, P899, DOI 10.1038/nm0896-899; Wan JS, 1996, NAT BIOTECHNOL, V14, P1685, DOI 10.1038/nbt1296-1685; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514; Zhou CY, 1997, J ASTHMA, V34, P195, DOI 10.3109/02770909709068189	64	9	10	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1998	102	6	1				887	892		10.1016/S0091-6749(98)70323-9	http://dx.doi.org/10.1016/S0091-6749(98)70323-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	150XE	9847426				2022-12-18	WOS:000077690700002
J	Corne, JM; Linaker, CH; Howarth, PH; Lau, LCK; Merrett, T; Beasely, R; Church, M				Corne, JM; Linaker, CH; Howarth, PH; Lau, LCK; Merrett, T; Beasely, R; Church, M			Effect of systemic beta-agonist therapy on IgE production in allergic subjects in vivo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergic rhinitis; IgE; salbutamol	BETA-2-ADRENOCEPTOR AGONISTS; AIRWAY RESPONSIVENESS; SERUM IGE; ASTHMA; TERBUTALINE; SALBUTAMOL; EXPRESSION; ANTIBODIES; RELEASE; CELLS	Background: Although beta(2)-adrenoceptor agonists are widely used in the treatment of asthma, a number of studies have suggested that their long-term use may exacerbate the condition. One possible mechanism for this stems from the in vitro observation that beta 2-agonists increase IgE synthesis by human blood mononuclear cells. Objective: We sought to examine the effect of regular beta 2-agonist therapy on IgE production in vivo in human volunteers. Methods: Placebo or salbutamol (8 mg ED) tablets were given in a double-blind, randomized fashion to 25 volunteers allergic to grass pollen throughout a period encompassing the UK grass pollen season (April through September), Levels of serum IgE were measured monthly, and nasal IgE was measured at the height and end of the season. Efficacy was assessed through monthly recordings of symptoms of blocked nose (vascular) and other symptoms of rhinitis (nonvascular). Results: For the whole group the geometric mean of serum IgE levls rose from a baseline of 58.7 IU/mL (range, 0 to 1027 IU/mL) to 140 IU/mL (range, 12 to 878 IU/mL) at the height of the pollen season (P = .0001). There was no significant difference between the magnitude of the rise in IgE between the groups with a ratio of increase for salbutamol/placebo of 1.17 (confidence interval = 0.78 to 1.75). There was no change in nasal IgE levels. Total and nonvascular symptom scores were reduced by salbutamol, reaching statistical significance at the height of the pollen season (P < .05). Conclusion: An oral dose of the beta 2-agonist salbutamol, sufficient to maintain therapeutic Icl cls and provide clinical benefit, does not accentuate the seasonal increase of IgE in human atopic volunteers.	Univ Med, Southampton, Hants, England; Wellington Sch Med, Wellington, New Zealand	University of Southampton; University of Otago	Corne, JM (corresponding author), Univ Med, Southampton Gen Hosp, Ctr Block,Tremona Rd, Southampton SO16 6YD, Hants, England.			Howarth, Peter/0000-0003-0619-7927; Beasley, Richard/0000-0003-0337-406X				BABSON AL, 1991, J CLIN IMMUNOASSAY, V14, P83; BORUM P, 1987, ALLERGY, V42, P141, DOI 10.1111/j.1398-9995.1987.tb02372.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; CHUNG KF, 1993, J ROY SOC MED, V86, P96; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; CONOLLY ME, 1971, BRIT J PHARMACOL, V43, P389; COQUERET O, 1995, CLIN EXP ALLERGY, V25, P304, DOI 10.1111/j.1365-2222.1995.tb01047.x; Durham SR, 1997, EUR J IMMUNOL, V27, P2899, DOI 10.1002/eji.1830271123; KESTEN S, 1992, ANN ALLERGY, V69, P415; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; LOWELL FC, 1949, NEW ENGL J MED, V240, P45, DOI 10.1056/NEJM194901132400201; Meier CR, 1997, THORAX, V52, P612, DOI 10.1136/thx.52.7.612; NACLERIO RM, 1993, J ALLERGY CLIN IMMUN, V92, P717, DOI 10.1016/0091-6749(93)90015-8; PAULEUGENE N, 1993, MOL IMMUNOL, V30, P157, DOI 10.1016/0161-5890(93)90087-R; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; QING F, 1994, THORAX, V49, pP1046; SEARS MR, 1987, J ALLERGY CLIN IMMUN, V80, P477, DOI 10.1016/0091-6749(87)90079-0; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SYKES RS, 1988, BIOPHARM DRUG DISPOS, V9, P551, DOI 10.1002/bod.2510090605; TAYLOR DR, 1993, THORAX, V48, P134, DOI 10.1136/thx.48.2.134; TREMBATH PW, 1979, J ALLERGY CLIN IMMUN, V63, P395, DOI 10.1016/0091-6749(79)90212-4; vanderMolen T, 1997, THORAX, V52, P535, DOI 10.1136/thx.52.6.535; VANMETRE TE, 1969, J ALLERGY, V43, P101, DOI 10.1016/0021-8707(69)90130-0; VATHENEN AS, 1988, LANCET, V1, P554; WALLS AF, 1992, CLIN EXP ALLERGY, V22, P1, DOI 10.1111/j.1365-2222.1992.tb00106.x	27	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1998	102	5					727	731		10.1016/S0091-6749(98)70011-9	http://dx.doi.org/10.1016/S0091-6749(98)70011-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	139MR	9819288				2022-12-18	WOS:000077033400005
J	Vianna, EO; Westcott, J; Martin, RJ				Vianna, EO; Westcott, J; Martin, RJ			The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; glucocorticoid; T lymphocytes; common cold; phytohemagglutinin	GLUCOCORTICOID-RESISTANT ASTHMA; RECEPTOR-BINDING AFFINITY; LYMPHOCYTE-ACTIVATION; PERIPHERAL-BLOOD; IN-VITRO; VIRUSES; CD4	Background: The common cold is a potent trigger for asthma symptoms, Although the mechanisms are not completely understood, inflammatory events may play an important role. Objective: We tested the hypothesis that changes in steroid responsiveness are implicated in the relationship between asthma and the common cold. Methods: We investigated the steroid sensitivity of T cells from 10 patients with asthma (not hiring steroids) and 10 control subjects, during upper respiratory; infection and at recovery (6 weeks later), We stimulated peripheral blood manonuclear cells with phytohemagglutinin to measure T-cell proliferation, sensitivity to the inhibitory effects of steroids, and cytokine production. Results: During infection compared with recovery, the asthma group exhibited lower responsiveness to dexamethasone at 10(-10) and 10(-9) mol/L and to 10(-10) mol/L hydrocortisone (P < .05) and both groups had decreased T-cell proliferation (P < .05), During recovery, patients with asthma had greater T-cell proliferation than control subjects (P < .02); the values expressed as uptake of [H-3]-thymidine were 60119 +/- 3944 cpm (asthma) and 39078 +/- 6459 cpm (control subjects). The asthma group had higher TNF-alpha and TPN-gamma production during infection (P < .05); changes in IL-8 and IL-10 levels were not significant, and IL-4 was not detected. Conclusion: During infection, asthmatic subjects exhibit decreased T-cell responsiveness to steroids. The T-cell proliferative response to phytohemagglutinin, higher in asthma, is decreased with a common cold, These findings are associated with changes in the cytokine profile. Thus viral-induced upper respiratory infections can produce an inflammatory milieu with altered steroid function and selective increases in cytokines.	Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA	National Jewish Health	Martin, RJ (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.		Vianna, Elcio/I-2508-2016	Vianna, Elcio/0000-0003-1902-6326	NHLBI NIH HHS [NHLBI 36577] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADCOCK IM, 1994, LIFE SCI, V55, P1147, DOI 10.1016/0024-3205(94)00243-6; ADCOCK IM, 1995, J IMMUNOL, V154, P3500; ALVAREZ J, 1992, J ALLERGY CLIN IMMUN, V89, P714, DOI 10.1016/0091-6749(92)90379-G; BARNES PJ, 1995, QJM-MON J ASSOC PHYS, V88, P455; Borish L, 1997, J ALLERGY CLIN IMMUN, V99, P161, DOI 10.1016/S0091-6749(97)70090-3; BUSSE WW, 1994, AM J RESP CRIT CARE, V150, pS77, DOI 10.1164/ajrccm/150.5_Pt_2.S77; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; CHEUNG D, 1995, AM J RESP CRIT CARE, V152, P1490, DOI 10.1164/ajrccm.152.5.7582282; Cochran WG., 1989, AMES IOWA STATE U PR, V8; Corrigan CJ, 1996, EUR RESPIR J, V9, P2077, DOI 10.1183/09031936.96.09102077; Doi S, 1996, J ALLERGY CLIN IMMUN, V97, P955, DOI 10.1016/S0091-6749(96)80070-4; GERN JE, 1995, AM J RESP CRIT CARE, V152, pS40, DOI 10.1164/ajrccm/152.4_Pt_2.S40; HACZKU A, 1994, J ALLERGY CLIN IMMUN, V93, P510, DOI 10.1016/0091-6749(94)90361-1; KAM JC, 1993, J IMMUNOL, V151, P3460; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Majori M, 1997, J ALLERGY CLIN IMMUN, V100, P379, DOI 10.1016/S0091-6749(97)70252-5; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Nimmagadda SR, 1997, AM J RESP CRIT CARE, V155, P87, DOI 10.1164/ajrccm.155.1.9001294; PATTEMORE PK, 1992, CLIN EXP ALLERGY, V22, P325, DOI 10.1111/j.1365-2222.1992.tb03094.x; Roman M, 1997, AM J RESP CRIT CARE, V156, P190, DOI 10.1164/ajrccm.156.1.9611050; SHER ER, 1994, J CLIN INVEST, V93, P33, DOI 10.1172/JCI116963; Spahn JD, 1996, J ALLERGY CLIN IMMUN, V98, P1073, DOI 10.1016/S0091-6749(96)80194-1; Szefler SJ, 1997, EUR RESPIR J, V10, P1640, DOI 10.1183/09031936.97.10071640; VIANNA EO, 1997, AM J RESP CRIT CARE, V155, pA887; VIRCHOW JC, 1994, J ALLERGY CLIN IMMUN, V94, P240, DOI 10.1016/0091-6749(94)90046-9; 1975, CHEST, V67, P583	26	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1998	102	4	1				592	597		10.1016/S0091-6749(98)70274-X	http://dx.doi.org/10.1016/S0091-6749(98)70274-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	131XK	9802366				2022-12-18	WOS:000076600400008
J	Wolf, BL; Hamilton, RG				Wolf, BL; Hamilton, RG			Near-fetal anaphylaxis after hymenoptera venom immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ANTIBODY		Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Vanderbilt University; Johns Hopkins University	Wolf, BL (corresponding author), 4230 Harding Rd,Suite 307, Nashville, TN 37205 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031867, U19AI031867] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-31867] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOUSQUET J, 1988, ANN ALLERGY, V61, P63; GOLDEN DBK, 1992, J ALLERGY CLIN IMMUN, V90, P386, DOI 10.1016/S0091-6749(05)80019-3; HAMILTON RG, 1993, J ALLERGY CLIN IMMUN, V92, P651, DOI 10.1016/0091-6749(93)90007-3; MULLER U, 1992, J ALLERGY CLIN IMMUN, V89, P529, DOI 10.1016/0091-6749(92)90319-W; YUNGINGER J W, 1982, Journal of Allergy and Clinical Immunology, V69, P139	5	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1998	102	3					527	528		10.1016/S0091-6749(98)70146-0	http://dx.doi.org/10.1016/S0091-6749(98)70146-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	124ZN	9768599				2022-12-18	WOS:000076212800033
J	Kelso, JM; Jones, RT; Yunginger, JW				Kelso, JM; Jones, RT; Yunginger, JW			Anaphylaxis after initial ingestion of rambutan, a tropical fruit	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALLERGENS		USN, Dept Internal Med, Div Allergy, Med Ctr, San Diego, CA 92152 USA; USN, Dept Clin Invest, Med Ctr, San Diego, CA 92152 USA; Mayo Clin & Mayo Fdn, Allerg Dis Res Lab, Rochester, MN 55905 USA	United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; Mayo Clinic	Kelso, JM (corresponding author), USN, Dept Clin Res, Med Ctr, San Diego, CA 92134 USA.							BJORKSTEN F, 1980, ALLERGY, V35, P671, DOI 10.1111/j.1398-9995.1980.tb02020.x; BLANCO C, 1994, ANN ALLERGY, V73, P309; ORTOLANI C, 1993, ANN ALLERGY, V71, P470; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; Valenta R, 1996, J ALLERGY CLIN IMMUN, V97, P893, DOI 10.1016/S0091-6749(96)80062-5; Yunginger JW, 1992, MANUAL CLIN LAB IMMU, V4th, P678; Zee FT, 1995, RAMBUTAN	7	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1998	102	1					145	146		10.1016/S0091-6749(98)70066-1	http://dx.doi.org/10.1016/S0091-6749(98)70066-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	102DX	9679859				2022-12-18	WOS:000074909500021
J	Marliere, V; Beylot-Barry, M; Doutre, MS; Furioli, M; Vergier, B; Dubus, P; Merlio, JP; Beylot, C				Marliere, V; Beylot-Barry, M; Doutre, MS; Furioli, M; Vergier, B; Dubus, P; Merlio, JP; Beylot, C			Lymphomatoid contact dermatitis caused by isopropyl-diphenylenediamine: Two cases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ Bordeaux 1, Hop Haut Leveque, Dept Dermatol, F-33604 Pessac, France; Univ Bordeaux 1, Hop Haut Leveque, Dept Pathol, F-33604 Pessac, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Beylot-Barry, M (corresponding author), Univ Bordeaux 1, Hop Haut Leveque, Dept Dermatol, F-33604 Pessac, France.		Beylot-Barry, Marie/AHC-3163-2022	Dubus, Pierre/0000-0003-1803-4711; Beylot-Barry, Marie/0000-0001-6150-1229				DANESE P, 1995, CONTACT DERMATITIS, V33, P268, DOI 10.1111/j.1600-0536.1995.tb00480.x; Dubus P, 1996, MODERN PATHOL, V9, P1147; ECKER RI, 1981, CONTACT DERMATITIS, V7, P84, DOI 10.1111/j.1600-0536.1981.tb03985.x; GOMEZORBANEJA J, 1976, CONTACT DERMATITIS, V2, P139; IKARASHI Y, 1993, CONTACT DERMATITIS, V28, P77, DOI 10.1111/j.1600-0536.1993.tb03345.x	5	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1998	102	1					152	153		10.1016/S0091-6749(98)70069-7	http://dx.doi.org/10.1016/S0091-6749(98)70069-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	102DX	9679862	Bronze			2022-12-18	WOS:000074909500024
J	Siebers, RW; Rains, N; Fitzharris, P; Crane, J				Siebers, RW; Rains, N; Fitzharris, P; Crane, J			House dust mite allergen (Der p 1) in human hair	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA		Wellington Sch Med, Dept Med, Wellington Asthma Res Grp, Wellington, New Zealand	University of Otago	Siebers, RW (corresponding author), Wellington Sch Med, Dept Med, Wellington Asthma Res Grp, POB 7343, Wellington, New Zealand.		Siebers, Robert/A-4102-2009	Siebers, Robert/0000-0002-6359-3144				Kemp TJ, 1996, BMJ-BRIT MED J, V313, P916, DOI 10.1136/bmj.313.7062.916; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; Naspitz CK, 1997, LANCET, V349, P404, DOI 10.1016/S0140-6736(97)80026-8; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Tovey ER, 1995, J ALLERGY CLIN IMMUN, V96, P999, DOI 10.1016/S0091-6749(95)70239-3	6	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1998	101	3					421	422		10.1016/S0091-6749(98)70257-X	http://dx.doi.org/10.1016/S0091-6749(98)70257-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZC570	9525461				2022-12-18	WOS:000072593900022
J	Merlos, M; Giral, M; Balsa, D; Ferrando, R; Garcia-Rafanell, J; Forn, J				Merlos, M; Giral, M; Balsa, D; Ferrando, R; Garcia-Rafanell, J; Forn, J			Rupatadine inhibits the eosinophil recruitment in BAL fluid of ovalbumin-sensitized guinea pigs.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Cia, Barcelona, Spain										0	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			904	S218	S218						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800901
J	Yamada, H; Chihara, J; Hamada, K; Matsukura, M; Yudate, T; Maeda, K; Tubaki, K; Tezuka, T				Yamada, H; Chihara, J; Hamada, K; Matsukura, M; Yudate, T; Maeda, K; Tubaki, K; Tezuka, T			Immunohistology of skin and oral biopsies in graft-versus-host disease after bone marrow transplantation and cytokine therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology	JUL   06, 1996	TOKYO, JAPAN	Novartis Pharma KK, Tokyo, Japan		graft-versus-host disease; skin; intercellular adhesion molecule-1; keratinocyte; atopic dermatitis; granulocyte-macrophage-colony stimulating factor	EXPRESSION; EOSINOPHILS; INDUCTION; CELLS	Background: Early diagnosis of graft-versus-host-disease (GVHD) after bone marrow transplantation is often difficult, particularly when the patients are immunosuppressed by chemotherapy or irradiation. Objective: To investigate the influence of cytokines on skin lesions after bone marrow transplantation. Methods: Biopsy specimens of skin and oral mucosa were obtained from bone marrow transplant patients with GVHD and were subjected to histologic and immunohistochemical examination. Results: Administration of granulocyte-macrophage colony-stimulating factor caused atopic dermatitis-like lesions in two patients, mho had infiltration of neutrophils, eosinophils, and lymphocytes around the hair follicles of the skin and no signs of GVHD in other organs. Only patients who were treated with cytokines developed acute GVHD. Immunohistochemical examination of skin biopsies from 18 patients with acute GVHD and 11 patients with chronic GVHD after cyclophosphamide administration or ii radiation showed that the maculopapular skin lesions characteristic of acute GVHD contained infiltrates of CD4(+) and CD8(+) lymphocytes. There mas also an increase in numbers of epidermal keratinocytes expressing intercellular adhesion molecule-I and HLA-DR antigens. Conclusion: These findings support the involvement of cytokines in GVHD and suggest that immunostaining of skin biopsies may be useful for the early diagnosis of this condition.	Kinki Univ Hosp, Dept Dermatol, Osaka, Japan; Kinki Univ Hosp, Dept Internal Med, Osaka, Japan; Kinki Univ Hosp, Dept Oral Surg, Osaka, Japan; Akita Univ, Sch Med, Dept Clin Lab & Med, Akita 010, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University); Akita University	Yamada, H (corresponding author), Kinki Univ, Sch Med, Dept Dermatol, Osaka 589, Japan.							ABEDI MR, 1989, BONE MARROW TRANSPL, V4, P255; BROWN MA, 1990, CURR OPIN IMMUNOL, V2, P531, DOI 10.1016/0952-7915(90)90006-3; CHIHARA J, 1990, J EXP MED, V172, P1347, DOI 10.1084/jem.172.5.1347; FERRARA JLM, 1994, BONE MARROW TRANSPL, V14, P183; GUYOTAT D, 1986, TRANSPLANTATION, V41, P340, DOI 10.1097/00007890-198603000-00011; HEYD J, 1988, BLOOD, V72, P442; KORNGOLD R, 1987, TRANSPLANTATION, V44, P335, DOI 10.1097/00007890-198709000-00002; LEIFERMAN KM, 1989, ALLERGY, V44, P20, DOI 10.1111/j.1398-9995.1989.tb02450.x; LESKINEN R, 1992, APMIS, V100, P1115, DOI 10.1111/j.1699-0463.1992.tb04048.x; MAEDA M, IN PRESS J ALLERGY C; NESTEL FP, 1992, J EXP MED, V175, P405, DOI 10.1084/jem.175.2.405; NICKOLOFF BJ, 1988, J INVEST DERMATOL, V90, P17, DOI 10.1111/1523-1747.ep12462420; NICKOLOFF BJ, 1985, BRIT J DERMATOL, V112, P373, DOI 10.1111/j.1365-2133.1985.tb04868.x; NIKAEIN A, 1994, HUM IMMUNOL, V40, P68, DOI 10.1016/0198-8859(94)90023-X; Osawa Junko, 1994, Journal of Dermatology (Tokyo), V21, P25; ROY J, 1995, TRANSPLANTATION, V60, P343; SIMON JC, 1991, J INVEST DERMATOL, V96, P148, DOI 10.1111/1523-1747.ep12515946; TAKATA M, 1993, J CLIN PATHOL, V46, P801, DOI 10.1136/jcp.46.9.801; VOGELSANG GB, 1994, BLOOD, V84, P2061, DOI 10.1182/blood.V84.7.2061.bloodjournal8472061; YAMADA H, 1991, Medical Science Research, V19, P395; YEAGER AM, 1992, BLOOD, V79, P3031	21	9	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1997	100	6	2	S			S73	S76		10.1016/S0091-6749(97)70009-5	http://dx.doi.org/10.1016/S0091-6749(97)70009-5			4	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR026	9440549				2022-12-18	WOS:000071449600009
J	Goldberg, A; ConfinoCohen, R				Goldberg, A; ConfinoCohen, R			A simple device for deliberate Hymenoptera sting challenge	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TEL AVIV UNIV,SACKLER SCH MED,IL-69978 TEL AVIV,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine	Goldberg, A (corresponding author), MEIR HOSP,ALLERGY & CLIN IMMUNOL UNIT,IL-44281 KEFAR SAVA,ISRAEL.							Blaauw PJ, 1996, J ALLERGY CLIN IMMUN, V98, P39, DOI 10.1016/S0091-6749(96)70224-5; GOLDBERG A, 1995, ANN ALLERG ASTHMA IM, V75, P30; LICHTENSTEIN LM, 1994, J ALLERGY CLIN IMMUN, V94, P137, DOI 10.1016/0091-6749(94)90030-2	3	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1997	100	1					139	141		10.1016/S0091-6749(97)70207-0	http://dx.doi.org/10.1016/S0091-6749(97)70207-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XP428	9257800				2022-12-18	WOS:A1997XP42800022
J	Walker, JC; OConnell, MA; Pluss, JL				Walker, JC; OConnell, MA; Pluss, JL			Usual interstitial pneumonitis in a patient with common variable immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EPSTEIN-BARR-VIRUS; IDIOPATHIC PULMONARY FIBROSIS; HEPATITIS-C VIRUS; HYPOGAMMAGLOBULINEMIA; ASSOCIATION; ALVEOLITIS		MADIGAN ARMY MED CTR,PULM MED SERV,FT LEWIS,WA; FITZSIMONS ARMY GARRISON,AURORA,CO	Madigan Army Medical Center	Walker, JC (corresponding author), IRELAND ARMY COMMUNITY HOSP,ALLERGY IMMUNOL SERV,FT KNOX,KY 40121, USA.							BARBERA JA, 1992, AM REV RESPIR DIS, V145, P940, DOI 10.1164/ajrccm/145.4_Pt_1.940; CARRINGTON CB, 1978, NEW ENGL J MED, V298, P801, DOI 10.1056/NEJM197804132981501; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; CROFTS MJ, 1980, POSTGRAD MED J, V56, P263, DOI 10.1136/pgmj.56.654.263; CRYSTAL RG, 1976, ANN INTERN MED, V85, P769, DOI 10.7326/0003-4819-85-6-769; DUKES RJ, 1978, THORAX, V33, P603, DOI 10.1136/thx.33.5.603; EDELSTEIN AD, 1978, AM J HEMATOL, V5, P55, DOI 10.1002/ajh.2830050108; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; EISENSTEIN EM, 1994, ANN ALLERGY, V73, P285; FRIEDMAN R, 1983, AM J DIS CHILD, V137, P774, DOI 10.1001/archpedi.1983.02140340054015; IRVING WL, 1993, AM REV RESPIR DIS, V148, P1683, DOI 10.1164/ajrccm/148.6_Pt_1.1683; KAUFMAN J, 1991, CHEST, V100, P552, DOI 10.1378/chest.100.2.552; KOHLER PF, 1982, J ALLERGY CLIN IMMUN, V70, P299, DOI 10.1016/0091-6749(82)90066-5; LEE ES, 1995, NEW ENGL J MED, V332, P19, DOI 10.1056/NEJM199501053320104; LIEBOW AA, 1973, MED CLIN N AM, V57, P809, DOI 10.1016/S0025-7125(16)32278-7; LIEBOW AA, 1965, AM J MED, V39, P369, DOI 10.1016/0002-9343(65)90206-8; PERKS WH, 1978, THORAX, V33, P101, DOI 10.1136/thx.33.1.101; POPA V, 1988, ANN ALLERGY, V60, P203; SCHWARZ MI, 1993, INTERSTITIAL LUNG DI; SHARMA OP, 1971, AM REV RESPIR DIS, V104, P228; SNELLER MC, 1993, ANN INTERN MED, V118, P720, DOI 10.7326/0003-4819-118-9-199305010-00011; STRIMLAN CV, 1978, ANN INTERN MED, V88, P616, DOI 10.7326/0003-4819-88-5-616; UEDA T, 1992, AM REV RESPIR DIS, V146, P266, DOI 10.1164/ajrccm/146.1.266; VERGNON JM, 1984, LANCET, V2, P768; WATTS WJ, 1986, AM REV RESPIR DIS, V134, P699	25	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				847	851		10.1016/S0091-6749(97)80021-8	http://dx.doi.org/10.1016/S0091-6749(97)80021-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215255				2022-12-18	WOS:A1997XH19300020
J	BelchiHernandez, J; MorenoGrau, S; Bayo, J; Rosique, C; Bartolome, B; Moreno, JM				BelchiHernandez, J; MorenoGrau, S; Bayo, J; Rosique, C; Bartolome, B; Moreno, JM			Zygophyllum fabago L: A new source of allergenic pollen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV HOSP JM MORALES MESEGUER,DEPT ALLERGY,MURCIA,SPAIN; UNIV MURCIA,ESCUELA POLITECN SUPER CARTAGENA,DEPT INGN QUIM,MURCIA,SPAIN; IFIDESA,I&D DEPT,BILBAO,SPAIN	University of Murcia			Moreno, José/L-4503-2014; Bernal, Francisco Javier Bayo/AAT-3742-2021; MORENO-GRAU, STELLA/E-6540-2012	Moreno, José/0000-0002-3684-3726; Bernal, Francisco Javier Bayo/0000-0002-6975-4316; MORENO-GRAU, STELLA/0000-0001-9627-7327				ARIANO R, 1993, ANN ALLERGY, V70, P249; CASASFERRER C, 1995, THESIS U BARCELONA B, P78; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P102; CRONQUIST A, 1981, INTEGRATED SYSTEM CL; *EAACI SKIN TEST S, 1993, ALLERGY S, V48, P15; FERNANDES L, 1995, J ALLERGY CLIN IMMUN, V95, P501, DOI 10.1016/S0091-6749(95)70311-X; GARCIAORTEGA P, 1992, J ALLERGY CLIN IMMUN, V89, P987, DOI 10.1016/0091-6749(92)90221-M; LEWIS WH, 1983, AIRBORNE ALLERGENIC, P556; MALLING HJ, 1987, ALLERGY, V42, P196, DOI 10.1111/j.1398-9995.1987.tb02200.x; MOLLER C, 1984, ALLERGY, V39, P37, DOI 10.1111/j.1398-9995.1984.tb01931.x; MORENOGRAU S, 1995, JPN J PALYNOL, V6, P565; SUAREZCERVERA M, 14 S ASS PAL LANG FR; WIDE L, 1967, LANCET, V2, P1105	13	9	9	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1997	99	4					493	496		10.1016/S0091-6749(97)70075-7	http://dx.doi.org/10.1016/S0091-6749(97)70075-7			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WU274	9111493				2022-12-18	WOS:A1997WU27400011
J	Creticos, PS; Hebert, J; Philip, G				Creticos, PS; Hebert, J; Philip, G			Efficacy of Allervax(R) ragweed peptides in the treatment of ragweed-induced allergy.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	12	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1631	1631						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201627
J	Jarjour, NN; Sedgwick, JB; Swensen, CA; Busse, WW				Jarjour, NN; Sedgwick, JB; Swensen, CA; Busse, WW			Late allergic airway response to segmental bronchopulmonary provocation in allergic subjects is related to peripheral blood basophil histamine release	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						basophil; histamine release; allergen bronchoprovocation; bronchoalveolar lavage; eosinophils	BRONCHOALVEOLAR LAVAGE; ANTIGEN CHALLENGE; INFLAMMATION; ASTHMATICS; IMMEDIATE; MEDIATORS; RHINITIS	Background: Basophil histamine release has been found to correlate with the presence and severity of allergic disease. However it remains to be established whether airway response to antigen is related to basophil involvement and its release of histamine. Objective: The purpose of this study was to investigate whether the intensity of airway response to an inhaled antigen challenge in allergic subjects is related to IgE-dependent peripheral blood basophil histamine release. Methods: The response to segmental bronchoprovocation with antigen was examined in 34 subjects with allergic rhinitis. Bronchoalveolar lavage samples were obtained 5 minutes (immediate response) and 48 hours (late response) after allergen challenge. Peripheral blood maximal basophil histamine release (MBHR) in response to in vitro antigen stimulation was determined in each subject before segmental bronchoprovocation. Results: Bronchoalveolar lavage samples obtained during immediate response showed an increase in histamine whereas the late response was noted Soi a marked enhancement in airway cells, particularly eosinophils. Interestingly, a significant correlation (r = 0.73, p < 0.0001, Spearman Rank test) was noted between MBHR and intensity of bronchoalveolar lavage eosinophilia at 48 hours. Furthermore, subjects with high (greater than or equal to 20%) MBHR had significantly higher total cells and eosinophils in bronchoalveolar lavage fluid 48 hours after antigen segmental bronchoprovocation when compared with subjects with low (<20%) MBHR. Conclusion: Our data suggest that the intensity of airway eosinophilia in response to antigen challenge is correlated with the magnitude of basophil mediator release in allergic subjects.	UNIV WISCONSIN,SCH MED,DEPT MED,SECT ALLERGY & IMMUNOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	Jarjour, NN (corresponding author), UNIV WISCONSIN,SCH MED,DEPT MED,PULM & CRIT CARE MED SECT,MADISON,WI 53706, USA.				NHLBI NIH HHS [HL 2803, HL-42242] Funding Source: Medline; NIAID NIH HHS [AI 26609] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL042242, K08HL002803, P01HL042242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026609] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BOWSHER RR, 1983, J BIOL CHEM, V258, P2215; CALHOUN WJ, 1993, AM REV RESPIR DIS, V147, P1465, DOI 10.1164/ajrccm/147.6_Pt_1.1465; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; GADDY JN, 1986, AM REV RESPIR DIS, V134, P969, DOI 10.1164/arrd.1986.134.5.969; JAMES JM, 1993, J ALLERGY CLIN IMMUN, V91, P1155, DOI 10.1016/0091-6749(93)90318-A; JARJOUR NN, 1990, AM REV RESPIR DIS, V142, P100, DOI 10.1164/ajrccm/142.1.100; JARJOUR NN, 1991, AM REV RESPIR DIS, V144, P83, DOI 10.1164/ajrccm/144.1.83; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; METZGER WJ, 1987, AM REV RESPIR DIS, V135, P433; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; PLAUT M, 1986, J ALLERGY CLIN IMMUN, V78, P968, DOI 10.1016/0091-6749(86)90287-3; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; 1985, J ALLERGY CLIN IMMUN, V76, P145; 1991, J ALLERGY CLIN IMMUN, V88, P808	17	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	1				87	93		10.1016/S0091-6749(97)81048-2	http://dx.doi.org/10.1016/S0091-6749(97)81048-2			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD061	9003215				2022-12-18	WOS:A1997WD06100012
J	Charlesworth, EN				Charlesworth, EN			Late-phase inflammation: Influence on morbidity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						antihistamines; asthma; cetirizine; corticosteroids; late-phase response; misoprostol; terfenadine	PLATELET-ACTIVATING FACTOR; CUTANEOUS ALLERGIC RESPONSES; HISTAMINE-RELEASING ACTIVITY; MEDIATOR RELEASE; HUMAN-SKIN; ANTIGEN CHALLENGE; PAF-ACETHER; HUMAN BASOPHILS; IGE; INTERLEUKIN-1	With the prevalence of asthma and other allergic diseases increasing, the question of late-phase inflammatory response, a dynamic inflammatory response to a single exposure to antigen, has come to the forefront as one possible explanation for this increase in morbidity. If this explanation is acceptable, clinicians must examine their methods of management of allergic diseases and shift from crisis intervention with beta-agonists for asthma and first-generation antihistamines or decongestants for rhinitis to disease control with antiinflammatory agents. Topical application of corticosteroids to the upper airways blocks mediator release from the early and late phase after antigen challenges. In addition, recent studies using the skin-blister chamber model have shown that some of the newer, second-generation antihistamines may attenuate the infiltration and activation of eosinophils, neutrophils, and basophils during the late-phase response. Immunotherapy may have a selective effect, targeting inflammatory aspects of the late-phase response. It is clear that corticosteroids, second-generation antihistamines, and immunotherapy play a role in modifying the late-phase response and that each of these therapeutic modalities may operate by a different mechanism.			Charlesworth, EN (corresponding author), BRENHAM CLIN, 600 N PK ST, BRENHAM, TX 77833 USA.							ALAM R, 1993, AM REV RESPIR DIS, V148, P1066, DOI 10.1164/ajrccm/148.4_Pt_1.1066; ATKINS P, 1973, J ALLERGY CLIN IMMUN, V51, P263, DOI 10.1016/0091-6749(73)90128-0; BASCOM R, 1988, J ALLERGY CLIN IMMUN, V81, P570, DOI 10.1016/0091-6749(88)90198-4; BASRAN GS, 1984, CLIN ALLERGY, V14, P75, DOI 10.1111/j.1365-2222.1984.tb02193.x; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Blackley C. H., 1873, EXPT RES CAUSES NATU, P77; BOCHNER BS, 1990, J ALLERGY CLIN IMMUN, V86, P830, DOI 10.1016/S0091-6749(05)80143-5; BOOIJNOORD H, 1971, J ALLERGY CLIN IMMUN, V48, P344, DOI 10.1016/0091-6749(71)90080-7; BUSSE W, 1989, J ALLERGY CLIN IMMUN, V83, P400, DOI 10.1016/0091-6749(89)90125-5; CHARLESWORTH EN, 1992, J PHARMACOL EXP THER, V262, P964; CHARLESWORTH EN, 1989, J ALLERGY CLIN IMMUN, V83, P905, DOI 10.1016/0091-6749(89)90104-8; CHARLESWORTH EN, 1989, INT ARCH ALLER A IMM, V88, P50, DOI 10.1159/000234747; CHARLESWORTH EN, 1991, J IMMUNOL, V146, P671; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; CHARLESWORTH EN, IN PRESS J ALLERGY C; CHIGNARD M, 1980, BRIT J HAEMATOL, V46, P455, DOI 10.1111/j.1365-2141.1980.tb05993.x; CHILTON FH, 1984, J BIOL CHEM, V259, P2014; COCKCROFT DW, 1989, CLIN EXP ALLERGY, V19, P225, DOI 10.1111/j.1365-2222.1989.tb02368.x; Cooke RA, 1922, J IMMUNOL, V7, P219; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; EVANS R, 1987, CHEST, V91, pS65, DOI 10.1378/chest.91.6_Supplement.65S; FLING JA, 1989, J ALLERGY CLIN IMMUN, V83, P101, DOI 10.1016/0091-6749(89)90483-1; FREW AJ, 1990, J ALLERGY CLIN IMMUN, V85, P533, DOI 10.1016/0091-6749(90)90090-Q; FREW AJ, 1988, J ALLERGY CLIN IMMUN, V81, P1117, DOI 10.1016/0091-6749(88)90878-0; GREEN GR, 1967, J ALLERGY, V40, P224, DOI 10.1016/0021-8707(67)90085-8; HAAKFRENDSCHO M, 1988, J ALLERGY CLIN IMMUN, V82, P218, DOI 10.1016/0091-6749(88)91002-0; HARGREAVE FE, 1986, J ALLERGY CLIN IMMUN, V78, P825, DOI 10.1016/0091-6749(86)90226-5; HENOCQ E, 1986, LANCET, V1, P1378; HERXHEIMER H, 1952, INT ARCH ALLER A IMM, V3, P323, DOI 10.1159/000227979; LEE CE, 1992, J ALLERGY CLIN IMMUN, V89, P1010, DOI 10.1016/0091-6749(92)90224-P; LEPREVOST C, 1988, INT ARCH ALLER A IMM, V87, P9, DOI 10.1159/000234641; LIU MC, 1986, J IMMUNOL, V136, P2588; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MASSEY WA, 1993, CLIN EXP ALLERGY, V23, P399, DOI 10.1111/j.1365-2222.1993.tb00345.x; MICHEL L, 1987, J INVEST DERMATOL, V88, P675, DOI 10.1111/1523-1747.ep12470331; MILLER A R, 1961, Northwest Med, V60, P1190; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; *NAT CTR HTLH STAT, 1980, NAT HLTH INT SURV; NISH WA, 1994, J ALLERGY CLIN IMMUN, V93, P484, DOI 10.1016/0091-6749(94)90358-1; PEPYS J, 1968, EXCERPTA MED INT C S, V162, P221; PIPKORN U, 1987, J CLIN INVEST, V80, P957, DOI 10.1172/JCI113188; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; POOTHULLIL J, 1976, J ALLERGY CLIN IMMUN, V57, P164, DOI 10.1016/0091-6749(76)90035-X; RICHERSON HB, 1979, J ALLERGY CLIN IMMUN, V64, P67, DOI 10.1016/0091-6749(79)90085-X; SCHLEIMER RP, 1986, J IMMUNOL, V136, P649; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V83, P691, DOI 10.1016/0091-6749(89)90084-5; SHALIT M, 1988, J IMMUNOL, V141, P821; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; SUBRAMANIAN N, 1987, J IMMUNOL, V138, P271; TALBOT SF, 1985, J CLIN INVEST, V76, P650, DOI 10.1172/JCI112018; TAMURA N, 1987, BIOCHEM BIOPH RES CO, V142, P638, DOI 10.1016/0006-291X(87)91462-8; THUESON DO, 1979, J IMMUNOL, V123, P633; TING S, 1980, J ALLERGY CLIN IMMUN, V66, P417, DOI 10.1016/0091-6749(80)90122-0; UMEMOTO L, 1976, J ALLERGY CLIN IMMUN, V58, P60, DOI 10.1016/0091-6749(76)90107-X; WARNER JA, 1986, J IMMUNOL, V136, P2583; WARNER JO, 1978, LANCET, V2, P912; WEISS M, 1988, J ALLERGY CLIN IMMUN, V81, P224, DOI 10.1016/0091-6749(88)90459-9; ZWEIMAN B, 1987, J ALLERGY CLIN IMMUN, V79, P169	59	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	3	S			S291	S297		10.1016/S0091-6749(96)80114-X	http://dx.doi.org/10.1016/S0091-6749(96)80114-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WC448	8977540				2022-12-18	WOS:A1996WC44800002
J	Yocum, MW; Jones, RT; Yunginger, JW				Yocum, MW; Jones, RT; Yunginger, JW			Concurrent sensitization to natural rubber latex and human seminal fluid	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGY				Yocum, MW (corresponding author), MAYO CLIN & MAYO FDN,200 1ST ST SW,ROCHESTER,MN 55905, USA.							HUNT LW, 1993, J ALLERGY CLIN IMMUN, V91, P216; KOOISTRA JB, 1980, J ALLERGY CLIN IMMUN, V66, P148, DOI 10.1016/0091-6749(80)90062-7; YUNGINGER JW, 1991, J ALLERGY CLIN IMMUN, V8, P343	3	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	1				1135	1136		10.1016/S0091-6749(96)80209-0	http://dx.doi.org/10.1016/S0091-6749(96)80209-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WB378	8977523				2022-12-18	WOS:A1996WB37800027
J	Chung, KF				Chung, KF			Effects of nedocromil sodium on airway neurogenic mechanisms	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						nedocromil sodium; sensory nerve activation; tachykinins	BRADYKININ-INDUCED BRONCHOCONSTRICTION; DIOXIDE INDUCED BRONCHOCONSTRICTION; ACID-INDUCED COUGH; PIG NASAL-MUCOSA; SUBSTANCE-P; GUINEA-PIG; CIGARETTE-SMOKE; SULFUR-DIOXIDE; PHARMACOLOGICAL MODULATION; MICROVASCULAR LEAKAGE	Evidence shows that nedocromil sodium has a major inhibitory effect on sensory nerve activation. Animal models in which inhibitory effects have been demonstrated include bradykinin- or ovalbumin-induced plasma extravasation; cigarette smoke- or sulfur dioxide-induced bronchial hyperresponsiveness and increase in inflammatory cells in the airway; and bradykinin-induced airway vasodilatation and nasal mucosal edema. Nedocromil sodium has prevented the edema in human skin induced by substance P and neurokinin A, and in the isolated rabbit trachea, has prevented substance P-induced potentiation of cholinergic neural responses at preganglionic (but not postganglionic) sites. In vitro, the drug also has inhibited nonadrenergic noncholinergic bronchoconstriction in guinea pig bronchi. Although a protective effect against citric acid-induced cough in the dog has been reported, no data are available from models of enhanced cough reflex, such as that in asthma. Inhibition of sensory nerve activation and prevention of tachykinin release by nedocromil sodium probably contribute to its beneficial effects in the treatment of asthma.			Chung, KF (corresponding author), ROYAL BROMPTON HOSP,NATL HEART & LUNG INST,DEPT THORAC MED,DOVEHOUSE ST,LONDON SW3 6LY,ENGLAND.		Chung, Kian Fan/I-8456-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426				ALVING K, 1991, BRIT J PHARMACOL, V104, P452, DOI 10.1111/j.1476-5381.1991.tb12450.x; ARMOUR CL, 1991, J AUTON PHARMACOL, V11, P167, DOI 10.1111/j.1474-8673.1991.tb00316.x; BARNES PJ, 1990, ARCH INT PHARMACOD T, V303, P67; BARNES PJ, 1986, LANCET, V1, P242; BIGBY B, 1993, J ALLERGY CLIN IMMUN, V92, P195, DOI 10.1016/0091-6749(93)90106-P; CRIMI N, 1988, CLIN ALLERGY, V18, P375, DOI 10.1111/j.1365-2222.1988.tb02885.x; CROSSMAN DC, 1993, J APPL PHYSIOL, V75, P167, DOI 10.1152/jappl.1993.75.1.167; DAFFONCHIO L, 1990, Pulmonary Pharmacology, V3, P161, DOI 10.1016/0952-0600(90)90048-N; DAFFONCHIO L, 1992, PULM PHARMACOL, V5, P17, DOI 10.1016/0952-0600(92)90013-7; DIXON CMS, 1987, THORAX, V42, P462, DOI 10.1136/thx.42.6.462; DIXON CMS, 1989, BRIT J CLIN PHARMACO, V27, P831, DOI 10.1111/j.1365-2125.1989.tb03446.x; DIXON CMS, 1990, BRIT J CLIN PHARMACO, V30, P371, DOI 10.1111/j.1365-2125.1990.tb03786.x; DIXON M, 1980, BRIT J PHARMACOL, V70, P11, DOI 10.1111/j.1476-5381.1980.tb10898.x; DUSSER DJ, 1989, J CLIN INVEST, V84, P900, DOI 10.1172/JCI114251; DUSSER DJ, 1995, EUR RESPIR J, V8, P47, DOI 10.1183/09031936.95.08010047; EADY RP, 1989, INT ARCH ALLER A IMM, V88, P240, DOI 10.1159/000234797; FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; HANSSON L, 1996, THORAX, V43, P935; HARGREAVES MR, 1995, LANCET, V345, P13, DOI 10.1016/S0140-6736(95)91151-0; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; ICHINOSE M, 1990, J PHARMACOL EXP THER, V253, P594; ICHINOSE M, 1992, LANCET, V340, P1248, DOI 10.1016/0140-6736(92)92948-F; Jackson D M, 1989, Pulm Pharmacol, V2, P179, DOI 10.1016/0952-0600(89)90018-5; JACKSON DM, 1992, EUR J PHARMACOL, V221, P175, DOI 10.1016/0014-2999(92)90790-B; JACKSON DM, 1988, BRIT J PHARMACOL, V93, P609, DOI 10.1111/j.1476-5381.1988.tb10317.x; JAVDAN P, 1995, ALLERGY, V50, P825; JONES PW, 1994, EUR RESPIR J, V7, P55, DOI 10.1183/09031936.94.07010055; JOOS GF, 1989, J ALLERGY CLIN IMMUN, V83, P663, DOI 10.1016/0091-6749(89)90080-8; KAUFMAN MP, 1980, J APPL PHYSIOL, V48, P511, DOI 10.1152/jappl.1980.48.3.511; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LEI YH, 1995, AM J RESP CRIT CARE, V151, P1752, DOI 10.1164/ajrccm.151.6.7767517; LEUNG KBP, 1986, EUR J RESPIR DIS, V69, P223; LOWRY RH, 1988, THORAX, V43, pP256; LUNDBERG JM, 1983, NEUROSCIENCE, V10, P1361, DOI 10.1016/0306-4522(83)90117-3; LUNDBERG JM, 1984, N-S ARCH PHARMACOL, V326, P181, DOI 10.1007/BF00517317; LUNDBERG JM, 1983, NATURE, V302, P251, DOI 10.1038/302251a0; NICHOL GM, 1994, BRIT J PHARMACOL, V111, P918, DOI 10.1111/j.1476-5381.1994.tb14826.x; NICHOL GM, 1989, THORAX, V44, P102; OLLERENSHAW SL, 1991, EUR RESPIR J, V4, P673; OMINI C, 1990, Pulmonary Pharmacology, V3, P145, DOI 10.1016/0952-0600(90)90045-K; RICCIARDOLO FLM, 1994, EUR J PHARMACOL, V261, P127, DOI 10.1016/0014-2999(94)90310-7; ROBERTS AM, 1983, PHYSIOLOGIST, V25, P226; SAKAMOTO T, 1992, BRIT J PHARMACOL, V107, P481, DOI 10.1111/j.1476-5381.1992.tb12771.x; SAKAMOTO T, 1994, AM J RESP CRIT CARE, V149, P387, DOI 10.1164/ajrccm.149.2.8306035; SAKAMOTO T, 1993, EUR J PHARMACOL, V231, P31, DOI 10.1016/0014-2999(93)90680-G; SARIA A, 1988, AM REV RESPIR DIS, V137, P1330, DOI 10.1164/ajrccm/137.6.1330; SNASHALL PD, 1982, THORAX, V37, P118, DOI 10.1136/thx.37.2.118; TAN WC, 1982, THORAX, V37, P671, DOI 10.1136/thx.37.9.671; TATAR M, 1988, J PHYSIOL-LONDON, V402, P411, DOI 10.1113/jphysiol.1988.sp017212; UEDA N, 1984, J PHARMACOL EXP THER, V230, P469; VERLEDEN GM, 1994, AM J RESP CRIT CARE, V149, P138, DOI 10.1164/ajrccm.149.1.8111571; VERLEDEN GM, 1991, AM REV RESPIR DIS, V143, P114, DOI 10.1164/ajrccm/143.1.114; WRIGHT W, 1990, AM REV RESPIR DIS, V141, P1400, DOI 10.1164/ajrccm/141.6.1400	53	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S112	S116		10.1016/S0091-6749(96)70026-X	http://dx.doi.org/10.1016/S0091-6749(96)70026-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939186				2022-12-18	WOS:A1996VW14000025
J	Lee, TH; Laitinen, LA; Pauwels, R; Chung, KF; Konig, P; Makino, S; Davies, RJ; Fabbri, LM; Holgate, ST; Djukanovic, R; Calhoun, WJ; Aalbers, R; Higenbottam, TW; Wenzel, SE; FitzGerald, JM; Virchow, JC; Dahlen, SE; RodriguezRoisin, R				Lee, TH; Laitinen, LA; Pauwels, R; Chung, KF; Konig, P; Makino, S; Davies, RJ; Fabbri, LM; Holgate, ST; Djukanovic, R; Calhoun, WJ; Aalbers, R; Higenbottam, TW; Wenzel, SE; FitzGerald, JM; Virchow, JC; Dahlen, SE; RodriguezRoisin, R			Inflammatory determinants of asthma severity: Mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma - Discussion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material													Fabbri, Leonardo M/I-4055-2012; Chung, Kian Fan/B-1872-2012	Fabbri, Leonardo M/0000-0001-8894-1689; Chung, Kian Fan/0000-0001-7101-1426					0	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S33	S40						8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140					2022-12-18	WOS:A1996VW14000007
J	Pasmans, SGMA; Aalbers, M; Daha, MR; Knol, EF; Jansen, HM; Aalberse, RC				Pasmans, SGMA; Aalbers, M; Daha, MR; Knol, EF; Jansen, HM; Aalberse, RC			Histamine-releasing activity in supernatants of mononuclear cells: Contribution of monocyte chemotactic protein-1 activity compared with IgE-dependent activity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						autoallergy; basophils; histamine-releasing factor; heterogeneity of IgE; MCP-1; MCP-3	HUMAN BASOPHILS; ACTIVATING FACTOR; CHEMOKINES; HETEROGENEITY; INFLAMMATION; POTENT; GRANULOCYTES; WORTMANNIN; CYTOKINES; ASTHMA	Background: Supernatants of cultured human mononuclear cells contain factors that induce histamine release from basophils. Some of the histamine-releasing factors present are IgE-independent, but an IgE-dependent form has also been described. The IgE that does respond to the IgE-dependent histamine-releasing factor was defined as IgE(+). Objective: This study was conducted to analyze the contribution of chemokines, such as monocyte chemotactic protein-1 (IgE-independent), to improve the detection, of IgE-dependent histamine-releasing factor. Methods: Supernatants were prepared from mononuclear cells of three subjects. Monocyte chemotactic protein-1 content and histamine-releasing activity (HRA) were measured. Depletion of chemokine activity was carried out with heparin-Sepharose (Pharmacia, Uppsala, Sweden). Results: Replacing IgE(-) on basophils with IgE(+) serum decreased the correlation between monocyte chemotactic protein-1 and histamine release (rho = 0.80, n = 280 vs rho = 0.12, n = 18; p for difference between rho values: <0.05). After depletion of chemokines in three supernatant derived from mononuclear cells, IgE-dependent HRA was still present. Conclusion: We conclude that in supernatants derived from mononuclear cells, the IgE-independent HRA mask the IgE-dependent HRA. The latter can be more clearly detected after depletion of chemokine activity with heparin-Sepharose.	NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, DEPT BLOOD CELL CHEM, NL-1066 CX AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, EXPT & CLIN IMMUNOL LAB, NL-1012 WX AMSTERDAM, NETHERLANDS; LEIDEN UNIV HOSP, DEPT NEPHROL, NL-2333 AA LEIDEN, NETHERLANDS; UNIV AMSTERDAM, ACAD MED CTR, DEPT PULMONOL, NL-1105 AZ AMSTERDAM, NETHERLANDS	University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam; Academic Medical Center Amsterdam	Pasmans, SGMA (corresponding author), NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, PUBLICAT SECRETARIAT, DEPT ALLERGY, NL-1066 CX AMSTERDAM, NETHERLANDS.		Pasmans, Suzanne/AAI-6016-2021	Pasmans, Suzanne/0000-0003-1018-4475; Knol, Edward/0000-0001-7368-9820				ALAM R, 1992, J CLIN INVEST, V89, P723, DOI 10.1172/JCI115648; ALAM R, 1990, J ALLERGY CLIN IMMUN, V86, P73, DOI 10.1016/S0091-6749(05)80125-3; BAEZA ML, 1988, J IMMUNOL, V141, P2688; BAGGIOLINI M, 1994, IMMUNOL TODAY, V15, P127, DOI 10.1016/0167-5699(94)90156-2; BISCHOFF SC, 1993, EUR J IMMUNOL, V23, P761, DOI 10.1002/eji.1830230329; BISCHOFF SC, 1992, J EXP MED, V175, P1271, DOI 10.1084/jem.175.5.1271; BUSSE WW, 1993, AM REV RESPIR DIS, V147, pS20, DOI 10.1164/ajrccm/147.6_Pt_2.S20; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; GRANT JA, 1991, J ALLERGY CLIN IMMUN, V88, P683, DOI 10.1016/0091-6749(91)90170-S; KAPLAN AP, 1991, ADV IMMUNOL, V50, P237; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; KAPLAN AP, 1994, ALLERGY, V49, P495, DOI 10.1111/j.1398-9995.1994.tb01119.x; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; KNOL EF, 1991, EUR J IMMUNOL, V21, P881, DOI 10.1002/eji.1830210404; Knol EF, 1996, EUR RESPIR J, V9, pS126; KUNA P, 1992, J EXP MED, V175, P489, DOI 10.1084/jem.175.2.489; KUNA P, 1993, J IMMUNOL, V150, P1932; LIAO TN, 1992, J CLIN IMMUNOL, V12, P248, DOI 10.1007/BF00918148; LICHTENSTEIN LM, 1988, J ALLERGY CLIN IMMUN, V81, P814, DOI 10.1016/0091-6749(88)90936-0; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1990, SPRINGER SEMIN IMMUN, V12, P415; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MUL FPJ, 1992, J IMMUNOL METHODS, V149, P207, DOI 10.1016/0022-1759(92)90252-O; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; PASMANS SGMA, 1994, INT ARCH ALLERGY IMM, V103, P44, DOI 10.1159/000236604; PASMANS SGMA, 1992, J ALLERGY CLIN IMMUN, V89, P276; POWIS G, 1994, CANCER RES, V54, P2419; ROBERTS AM, 1992, IMMUNOLOGY, V76, P389; SAMPSON HA, 1993, SPRINGER SEMIN IMMUN, V15, P89; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; VALENTA R, 1995, 9 INT C IMM JUL 23 2; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V82, P270, DOI 10.1016/0091-6749(88)91011-1; YANO H, 1993, J BIOL CHEM, V268, P25846	33	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	1				962	968		10.1016/S0091-6749(96)80013-3	http://dx.doi.org/10.1016/S0091-6749(96)80013-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VU764	8939160				2022-12-18	WOS:A1996VU76400013
J	Boxer, M				Boxer, M			Hand dermatitis: A risk factor for latex hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Boxer, M (corresponding author), COLONIAL BLDG GREAT NECK,560 NORTHERN BLVD,SUITE 209,GREAT NECK,NY 11201, USA.							BOXER MB, 1993, EMERGEN MED, V25, P18; CHAROUS BL, 1994, J ALLERGY CLIN IMMUN, V94, P12, DOI 10.1016/0091-6749(94)90065-5	2	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					855	856		10.1016/S0091-6749(96)70145-8	http://dx.doi.org/10.1016/S0091-6749(96)70145-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876570				2022-12-18	WOS:A1996VM66500029
J	KleineTebbe, J; KageySobotka, A; MacGlashan, DW; Lichtenstein, LM; MacDonald, SM				KleineTebbe, J; KageySobotka, A; MacGlashan, DW; Lichtenstein, LM; MacDonald, SM			Lectins do not distinguish between heterogenous IgE molecules as defined by differential activity of an IgE-dependent histamine releasing factor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						histamine release; HRF; IgE; lectins	HIGH-MANNOSE OLIGOSACCHARIDE; HUMAN BASOPHILS; CARBOHYDRATE UNITS; IMMUNOGLOBULIN; MECHANISM; RECEPTORS	It has been suggested that the differential histamine-releasing activity of an IgE-dependent histamine-releasing factor (HRF), which has recently been cloned, is related to carbohydrate differences in the IgE molecule. Lectins are able to recognize specific glycoforms and might therefore be useful in characterizing the proposed heterogeneity of IgE molecules. As one test of this hypothesis, we examined the histamine release potency of several well-characterized lectins on basophils passively sensitized with serum containing IgE molecules that support HRF-induced histamine release (IgE(+)) or serum that does not support release by this stimulus (IgE(-)). Histamine release was induced by challenging basophils with different concentrations of concanavalin A, Lens culinaris (LcH), and Pisum sativum (PSA). Dose-response curves revealed that LcH caused 30% histamine release at 2 mu g/ml with IgE(+) sensitized cells, whereas the same release with IgE(-) cells required sixfold higher concentrations. Similar values for PSA showed a sevenfold difference. With concanavalin A, the selectivity was reversed in that it was fourfold more active on IgE(-)-sensitized cells. Another pair of sera (IgE(+) vs IgE(-)) revealed the same result for concanavalin A, but no difference occurred in LcH and PSA induced release between the IgE(+) and IgE(-)-sensitived cells. These contrasting findings with different pairs of IgE(+)- and IgE(-)-containing sera indicated that the lectins LcH and PSA are not able to discriminate between IgE(+)- and IgE(-)-sensitized cells as does HRF and therefore cannot be used to further ther define the proposed heterogeneity of IgE. This conclusion was supported by experiments in which basophil preparations from donor possessing natural sensitivity or insensitivity to HRF (having IgE(+) or IgE(-) on their surface) were examined for their response to these lectins. No difference was Sound in the sensitivity of the cells to challenge with LcH ol PSA, and the response to concanavalin A wets the opposite of that found when passively sensitized cells were used (30% histamine release at 0.9 vs 3.5 mu g/ml for IgE(+) vs IgE(-) donors, respectively). We conclude that oligosaccharide-specific lectins no not differentiate between HRF-reactive and HRF-nonreactive IgE molecules on basophils.	JOHNS HOPKINS UNIV,SCH MED,JOHNS HOPKINS ASTHMA & ALLERGY CTR,DIV CLIN IMMUNOL & ALLERGY,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine				Kleine-Tebbe, Joerg/0000-0002-2862-7353	NIAID NIH HHS [AI 07290] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAENZIGER J, 1974, J BIOL CHEM, V249, P1889; BAENZIGER J, 1974, J BIOL CHEM, V249, P1897; CONROY MC, 1977, J IMMUNOL, V118, P1317; DORRINGTON KJ, 1978, IMMUNOL REV, V41, P3, DOI 10.1111/j.1600-065X.1978.tb01458.x; KULCZYCKI A, 1976, J IMMUNOL, V117, P661; LACROIX EL, 1993, MOL IMMUNOL, V30, P321, DOI 10.1016/0161-5890(93)90060-O; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MACDONALD SM, 1988, CLIN RES, V36, pA602; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; REARICK JI, 1983, ARCH BIOCHEM BIOPHYS, V220, P95, DOI 10.1016/0003-9861(83)90391-0; ROBERTSON MW, 1991, J IMMUNOL, V147, P3024; SCHLEIMER RP, 1982, J IMMUNOL, V129, P1632; SHIBASAKI M, 1992, INT ARCH ALLERGY IMM, V98, P18, DOI 10.1159/000236160; SIRAGANIAN RP, 1975, J IMMUNOL, V114, P886; SIRAGANIAN RP, 1975, J IMMUNOL METHODS, V7, P283, DOI 10.1016/0022-1759(75)90025-3	17	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1996	98	1					181	188		10.1016/S0091-6749(96)70241-5	http://dx.doi.org/10.1016/S0091-6749(96)70241-5			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VA692	8765833				2022-12-18	WOS:A1996VA69200022
J	Lessof, MH				Lessof, MH			Pollen-food allergy syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																		AMLOT PL, 1985, INT ARCH ALLER A IMM, V77, P171, DOI 10.1159/000233776; AMLOT PL, 1987, CLIN ALLERGY, V17, P33, DOI 10.1111/j.1365-2222.1987.tb02317.x; HANSEN TK, 1992, ALLERGY, V47, P610, DOI 10.1111/j.1398-9995.1992.tb02383.x; KELSO JM, 1995, J ALLERGY CLIN IMMUN, V96, P275, DOI 10.1016/S0091-6749(95)70022-6	4	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1996	98	1					239	240		10.1016/S0091-6749(96)70252-X	http://dx.doi.org/10.1016/S0091-6749(96)70252-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VA692	8765844				2022-12-18	WOS:A1996VA69200033
J	Little, SA; Warner, JO				Little, SA; Warner, JO			Improved diagnosis of allergic bronchopulmonary aspergillosis with gp66 (formerly antigen 7) of Aspergillus fumigatus for specific IgE detection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aspergillus fumigatus; allergic bronchopulmonary; aspergillosis; cystic fibrosis; ELISA; IgE	CYSTIC-FIBROSIS; ANTIBODIES; COMPONENT; REACTIVITY; ELISA	Background: In cystic fibrosis (CF) serologic tests assume increased significance for discriminating the symptoms of allergic bronchopulmonary aspergillosis (ABPA) from those of bacterial infections. Elevated specific IgE is a sensitive indicator of ABPA, but the high prevalence of patients with CF who have simple allergy to Aspergillus fumigatus means that it lacks specificity. Objective: The aim of this study was to develop an assay to detect IgE to a single allergenic protein of A. fumigatus to increase the discrimination between ABPA and uncomplicated A. fumigatus allergy. Methods: To identify a more selective allergen, serum samples from nine patients with ABPA and five patients with allergy were used to screen A. fumigatus proteins for allergenic activity by crossed radioimmunoelectrophoresis. Molecular weights were determined by electrophoresis and immunoblotting, and carbohydrate content was analyzed by concanavalin A chromatography and endoglycosidase digestion. Results: The allergen identified was found to be a glycoprotein with a molecular weight of 66 kd, referred to as gp66. An ELISA was developed to measure specific IgE to gp66, and the efficacy was compared with IgE detection by using the unfractionated A. fumigatus extract on serum samples from 14 patients with CF and ABPA, 42 patients with CF and allergy but not ABPA, and 23 patients with CF without ABPA or allergy. Conclusion: Use of gp66 increased the specificity of IgE analysis from 58.5% to 78.5%, whereas the sensitivity of 92.9% was maintained.	UNIV SOUTHAMPTON, SOUTHAMPTON, HANTS, ENGLAND	University of Southampton			Warner, John/AAF-9587-2020					ARRUDA LK, 1992, J IMMUNOL, V149, P3354; ARRUDA LK, 1992, J ALLERGY CLIN IMMUN, V89, P1166, DOI 10.1016/0091-6749(92)90301-H; Baldo B. A., 1989, Protein blotting: methodology, research and diagnostic applications., P111; BAUR X, 1989, J ALLERGY CLIN IMMUN, V83, P839, DOI 10.1016/0091-6749(89)90023-7; FORSYTH KD, 1988, ARCH DIS CHILD, V63, P953, DOI 10.1136/adc.63.8.953; HARVEY C, 1986, CLIN ALLERGY, V16, P323, DOI 10.1111/j.1365-2222.1986.tb01964.x; HARVEY C, 1986, CLIN EXP IMMUNOL, V65, P206; HARVEY C, 1987, CLIN EXP IMMUNOL, V70, P247; KAUFFMAN HF, 1989, J ALLERGY CLIN IMMUN, V83, P829, DOI 10.1016/0091-6749(89)90022-5; KNUTSEN AP, 1994, J ALLERGY CLIN IMMUN, V93, P926, DOI 10.1016/0091-6749(94)90387-5; KUMAR A, 1993, J ALLERGY CLIN IMMUN, V91, P1024, DOI 10.1016/0091-6749(93)90215-2; KURUP VP, 1989, J CLIN MICROBIOL, V27, P1312, DOI 10.1128/JCM.27.6.1312-1316.1989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITTLE SA, 1993, CLIN EXP ALLERGY, V23, P835, DOI 10.1111/j.1365-2222.1993.tb00261.x; LONGBOTTOM JL, 1983, J ALLERGY CLIN IMMUN, V72, P668, DOI 10.1016/0091-6749(83)90627-9; LONGBOTTOM JL, 1986, J ALLERGY CLIN IMMUN, V78, P9, DOI 10.1016/0091-6749(86)90108-9; LONGBOTTOM JL, 1989, ADV BIOSCI, V74, P43; MROUEH S, 1994, CHEST, V105, P32, DOI 10.1378/chest.105.1.32; NELSON LA, 1979, AM REV RESPIR DIS, V120, P863; NICOLAI T, 1990, PEDIATR PULM, V8, P12, DOI 10.1002/ppul.1950080106; NIKOLAIZIK WH, 1991, PEDIATR ALLERGY IMMU, V2, P83; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; STEINBUCH M, 1969, ARCH BIOCHEM BIOPHYS, V134, P279, DOI 10.1016/0003-9861(69)90285-9; TAYLOR ML, 1988, J ALLERGY CLIN IMMUN, V81, P537, DOI 10.1016/0091-6749(88)90193-5; TESHIMA R, 1993, J ALLERGY CLIN IMMUN, V92, P698, DOI 10.1016/0091-6749(93)90013-6; WARNER JO, 1976, ARCH DIS CHILD, V51, P507, DOI 10.1136/adc.51.7.507; ZEASKE R, 1988, J ALLERGY CLIN IMMUN, V82, P73, DOI 10.1016/0091-6749(88)90054-1	27	9	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1996	98	1					55	63		10.1016/S0091-6749(96)70226-9	http://dx.doi.org/10.1016/S0091-6749(96)70226-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VA692	8765818				2022-12-18	WOS:A1996VA69200007
J	McMenamin, PG; Morrison, SM; McMenamin, C				McMenamin, PG; Morrison, SM; McMenamin, C			Immunomorphologic studies of mast cell heterogeneity, location, and distribution in the rat conjunctiva	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mast cell; conjunctiva; eye; rat; immunohistochemistry; optical dissector; heterogeneity; ocular allergy; eyelid; proteinases; mucosal immunology	VERNAL CONJUNCTIVITIS; RESPIRATORY-TRACT; HISTAMINE-RELEASE; LACRIMAL GLAND; NUMBER; INFLAMMATION; EOSINOPHILS; MATURATION; ANTIGEN; TISSUES	Mast cells are crucial components of immediate and some delayed-type hypersensitivity reactions. They play a pivotal role in allergic conjuctivitis and other immunoinflammatory disorders of the ocular surface, yet little is known of their distribution and heterogeneity in the conjunctiva of potential animal models, such as the rat. In this study, mast cell types were investigated in histologic sections and corneal-conjunctival-lid whole mounts by using toluidine blue, alcian blue-safranin, and immunohistochemical staining methods (anti-rat mast cell proteinase [RMCP] antibodies). Quantitative analyses were performed on corneal-conjunctival-lid whole mounts by using the optical dissector procedure to obtain the density of mst cells per unit volume in different regions of the conjunctiva. Single and double immunohistochemical analyses revealed that the mast cells in the conjunctiva of the limbus, fornices, and lid margin were strongly RMCP I+, suggesting that they were of the connective tissue phenotype. Mst cells containing the mucosal mast cell proteinase RMCP II were not present in the normal conjunctiva. Histochemical analysis revealed that the maturity of the connective tissue mast cells, as assessed by the presence or absence of safranin (heparin)-positive granules in their cytoplasm varied in different regions. In the lid margin 60% to 78% of the mast cells were solely alcian blue-positive, whereas in the fornices 68% to 78% were safranin-positive. In the limbus the predominant type of mst cell was either safranin-positive or contained mixed granules. Mast cell densities were greatest close to the lid margin (10,000 to 12,000 cells/mm(3)), followed by the limbus (3400 to 4800 cells/mm(3)) and were rare in the remainder of the conjunctiva (500 to 1000 cells/mm(3)), with the exception of the region around the nictitating membrane. This study of rat conjunctival mst cells provides essential baseline data for future studies of the role of mast cells in models of allergic conjunctivitis.	INST CHILD HLTH RES,SUBIACO,WA,AUSTRALIA	Telethon Kids Institute; University of Western Australia	McMenamin, PG (corresponding author), UNIV WESTERN AUSTRALIA,DEPT ANAT & HUMAN BIOL,NEDLANDS,WA 6907,AUSTRALIA.			McMenamin, Paul/0000-0002-7141-1283				ALDENBORG F, 1988, HISTOCHEM J, V20, P19, DOI 10.1007/BF01745965; ALLANSMITH MR, 1978, AM J OPHTHALMOL, V86, P250, DOI 10.1016/S0002-9394(14)76821-7; ALLANSMITH MR, 1979, INVEST OPHTH VIS SCI, V18, P863; ALLANSMITH MR, 1988, CLIN ALLERGY, V18, P1, DOI 10.1111/j.1365-2222.1988.tb02837.x; BARRETT KE, 1987, AM REV RESPIR DIS, V135, P1190; DANNO K, 1988, J INVEST DERMATOL, V90, P806, DOI 10.1111/1523-1747.ep12462027; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P303, DOI 10.1111/apm.1966.66.3.303; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289, DOI 10.1111/apm.1966.66.3.289; ENERBACK L, 1986, MAST CELL DIFFERENTI, P1; GALLI SJ, 1990, LAB INVEST, V62, P5; GALLI SJ, 1987, FED PROC, V46, P1906; GORDON JR, 1990, IMMUNOL TODAY, V11, P458, DOI 10.1016/0167-5699(90)90176-A; GRIENER JV, 1985, AM J OPHTHALMOL, V100, P45; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HOANGXUAN T, 1989, OPHTHALMOLOGY, V96, P1110; HUNTLEY JF, 1992, J COMP PATHOL, V107, P349, DOI 10.1016/0021-9975(92)90010-R; HUNTLEY JF, 1990, APMIS, V98, P933, DOI 10.1111/j.1699-0463.1990.tb05018.x; IHLE JN, 1983, J IMMUNOL, V131, P282; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; IRANI AMA, 1990, J ALLERGY CLIN IMMUN, V86, P34, DOI 10.1016/S0091-6749(05)80120-4; IWAMOTO TAKEO, 1965, INVEST OPHTHALMOL, V4, P815; LIM HW, 1991, J INVEST DERMATOL, V97, P305, DOI 10.1111/1523-1747.ep12480568; MACQUEEN G, 1989, SCIENCE, V243, P83, DOI 10.1126/science.2911721; MATTSON L, 1993, SCAND J DENT RES, V101, P292; METCALFE DD, 1981, CRC CR REV IMMUNOL, V3, P23; MILLER HRP, 1986, MAST CELL DIFFERENTI, P239; OLSSON Y, 1971, ACTA NEUROL SCAND, V47, P357, DOI 10.1111/j.1600-0404.1971.tb07490.x; RATZLAFF RE, 1992, J NEUROIMMUNOL, V41, P89, DOI 10.1016/0165-5728(92)90199-U; SCHILTZ PM, 1993, HISTOCHEM J, V25, P642, DOI 10.1007/BF00157878; SCHWARTZ LB, 1981, J IMMUNOL, V126, P2071; SHANAHAN F, 1985, J IMMUNOL, V135, P1331; SMELSER GK, 1963, EXP EYE RES, V2, P134, DOI 10.1016/S0014-4835(63)80005-6; SPICER SS, 1994, J HISTOCHEM CYTOCHEM, V42, P213, DOI 10.1177/42.2.7507139; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Steptoe R J, 1994, Ocul Immunol Inflamm, V2, P7, DOI 10.3109/09273949409057797; STEPTOE RJ, 1994, BRIT J OPHTHALMOL, V78, P211, DOI 10.1136/bjo.78.3.211; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STEVENS RL, 1986, MAST CELL DIFFERENTI, P183; STOCK EL, 1989, AM J ANAT, V186, P359, DOI 10.1002/aja.1001860405; SULLIVAN DA, 1990, IMMUNOLOGY, V71, P573; TAM EK, 1988, ANAT EMBRYOL, V178, P107, DOI 10.1007/BF02463644; THUESON DO, 1979, J IMMUNOL, V123, P626; TSUBOTA K, 1991, CORNEA, V10, P525, DOI 10.1097/00003226-199111000-00011; UDELL IJ, 1981, AM J OPHTHALMOL, V2, P226; WEIDNER N, 1993, PATHOL RES PRACT, V189, P156, DOI 10.1016/S0344-0338(11)80086-5; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILKES LK, 1992, IMMUNOLOGY, V75, P535; WILLIAMS RM, 1994, J AUTONOM NERV SYST, V47, P95, DOI 10.1016/0165-1838(94)90070-1; WOLFF E, 1961, ANATOMY EYE ORBIT, P192	49	9	10	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1375	1386		10.1016/S0091-6749(96)70207-5	http://dx.doi.org/10.1016/S0091-6749(96)70207-5			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648035				2022-12-18	WOS:A1996VD60700027
J	Vandenplas, O; Depelchin, S; Toussaint, G; Delwiche, JP; Weyer, RV; SaintRemy, JM				Vandenplas, O; Depelchin, S; Toussaint, G; Delwiche, JP; Weyer, RV; SaintRemy, JM			Occupational asthma caused by sarsaparilla root dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INHALATION		UNIV CATHOLIQUE LOUVAIN,EXPT MED UNIT ALLERGY & CLIN IMMUNOL UNIT,B-1200 BRUSSELS,BELGIUM; FONDS MALAD PROFESS,BRUSSELS,BELGIUM	Universite Catholique Louvain	Vandenplas, O (corresponding author), UNIV HOSP MONT GODINNE,DEPT CHEST MED,B-5530 YVOIR,BELGIUM.							CHANYEUNG M, 1990, CHEST, V98, pS148, DOI 10.1378/chest.98.5.148S; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; DUKE JA, 1985, CRC HDB MED HERBS, P446; FALLERONI AE, 1981, J ALLERGY CLIN IMMUN, V68, P156, DOI 10.1016/0091-6749(81)90173-1; LYBARGER JA, 1982, J ALLERGY CLIN IMMUN, V69, P448, DOI 10.1016/0091-6749(82)90120-8; VALDIVIESO R, 1994, J ALLERGY CLIN IMMUN, V94, P928, DOI 10.1016/0091-6749(94)90161-9	6	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1416	1418		10.1016/S0091-6749(96)70214-2	http://dx.doi.org/10.1016/S0091-6749(96)70214-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648042				2022-12-18	WOS:A1996VD60700034
J	SanchezMedina, M; Zarante, I				SanchezMedina, M; Zarante, I			Dust mites at high altitude in a tropical climate	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SanchezMedina, M (corresponding author), FDN SANTAFE BOGOTA,ASOCIAC MED ANDES,ALLERGY SECT,CARRERA 9 117-20,SUITE 508,BOGOTA,COLOMBIA.		Zarante, Ignacio/L-6467-2017; Zarante, Ignacio/AAL-6215-2021	Zarante, Ignacio/0000-0002-0729-6866; Zarante, Ignacio/0000-0002-0729-6866				ARLIAN LG, 1992, J ALLERGY CLIN IMMUN, V90, P292, DOI 10.1016/S0091-6749(05)80006-5; CHARLET LD, 1977, ACAROLOGIA, V19, P302; CHARLET LD, 1977, INT J ACAROL, V4, P23; MULLA MS, 1980, DOMESTIC ACARI COLOM, P30; SPIEKSMA FT, 1971, BMJ-BRIT MED J, V1, P82, DOI 10.1136/bmj.1.5740.82; VERVLOET D, 1982, J ALLERGY CLIN IMMUN, V69, P290, DOI 10.1016/S0091-6749(82)80006-7	6	9	9	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1996	97	5					1167	1168		10.1016/S0091-6749(96)70273-7	http://dx.doi.org/10.1016/S0091-6749(96)70273-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UL261	8626996				2022-12-18	WOS:A1996UL26100019
J	Backman, R; Pickering, CAC; Baumgarten, C; Huskisson, SC				Backman, R; Pickering, CAC; Baumgarten, C; Huskisson, SC			A comparison of fluticasone propionate via Diskus(TM) (Accuhaler(TM)) inhaler and budesonide via Turbuhaler(TM) inhaler in adult asthmatics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				267	267						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600267
J	Thabrew, H; Cairns, JA; Walls, AF				Thabrew, H; Cairns, JA; Walls, AF			Mast cell tryptase is a growth factor for human airway smooth muscle cells.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				348	348						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600348
J	GOLDSMITH, SR; STEINBERG, P				GOLDSMITH, SR; STEINBERG, P			NONCARDIOGENIC PULMONARY-EDEMA INDUCED BY NONIONIC LOW-OSMOLALITY RADIOGRAPHIC CONTRAST-MEDIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							INJECTION		HENNEPIN CTY MED CTR,DEPT MED,MINNEAPOLIS,MN 55415; HENNEPIN CTY MED CTR,DEPT INTERNAL MED,MINNEAPOLIS,MN 55415	Hennepin County Medical Center; Hennepin County Medical Center								BODEN WE, 1982, CHEST, V81, P759, DOI 10.1378/chest.81.6.759; BORISH L, 1984, J ALLERGY CLIN IMMUN, V74, P104, DOI 10.1016/0091-6749(84)90095-2; CAMERON JD, 1974, RADIOLOGY, V111, P89, DOI 10.1148/111.1.89; DELACOUR JL, 1988, INTENS CARE MED, V15, P49; GREGANTI MA, 1979, RADIOLOGY, V132, P583, DOI 10.1148/132.3.583; LIEBERMAN P, 1991, ANN ALLERGY, V67, P91; MADOWITZ JS, 1979, JAMA-J AM MED ASSOC, V241, P2813, DOI 10.1001/jama.241.26.2813; MCCLENNAN BL, 1972, RADIOLOGY, V105, P383, DOI 10.1148/105.2.383; SAWDA SG, 1991, CIRCULATION, V83, P1605	9	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1995	96	5	1				698	699		10.1016/S0091-6749(95)70272-5	http://dx.doi.org/10.1016/S0091-6749(95)70272-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TG528	7499690				2022-12-18	WOS:A1995TG52800019
J	TORRES, MJ; GARCIA, JJ; MORATINOS, AMDC; RONDON, C; BLANCA, M				TORRES, MJ; GARCIA, JJ; MORATINOS, AMDC; RONDON, C; BLANCA, M			FIXED DRUG ERUPTION INDUCED BY MEPIVACAINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									CARLOS HAYA HOSP,ALLERGY SECT,MALAGA,SPAIN	Hospital Carlos Haya			Torres, María José/T-3518-2017; Torres, Maria/GVU-3391-2022	Torres, María José/0000-0001-5228-471X; 				FISHER AA, 1980, CONTACT DERMATITIS; KENNEDY KS, 1986, ARCH OTOLARYNGOL, V112, P671; ROTHMAN S, 1945, J INVEST DERMATOL, V6, P191, DOI 10.1038/jid.1945.15; SCHATZ M, CLIN REV ALLERG, V4, P215; SCHATZ M, 1984, J ALLERGY CLIN IMMUN, V74, P600	5	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1995	96	1					130	131		10.1016/S0091-6749(95)70042-0	http://dx.doi.org/10.1016/S0091-6749(95)70042-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RK383	7622755	Bronze			2022-12-18	WOS:A1995RK38300017
J	CHIANG, BL; CHOU, CC; DING, HJ; HUANG, MS; CHEN, JM; HSIEH, KH				CHIANG, BL; CHOU, CC; DING, HJ; HUANG, MS; CHEN, JM; HSIEH, KH			ESTABLISHMENT OF HUMAN IGE SYSTEM IN SEVERE COMBINED IMMUNODEFICIENT MICE WITH PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HUMAN IGE SYSTEM; ASTHMA; SEVERE COMBINED IMMUNODEFICIENT MICE; DERMATOPHAGOIDES PTERONYSSINUS	SCID-HU MOUSE; AEROSOLIZED ANTIGEN; LYMPHOCYTES; INFECTION	The frequency of allergic diseases, such as asthma, has increased rapidly doting the past decade; however, the exact mechanisms have not been established. In this study we tried to establish an in vivo system to investigate immune regulation of allergic diseases by using severe combined immunodeficient (SCID) mice. Peripheral blood mononuclear cells isolated from asthmatic children or normal adults were injected into peritoneal cavities of SCID mice. Human IgG, IgA, IgM, and IgE could be detected in SCID mice reconstituted with human PBMCs (SCID-PBL-hu mice) 3 weeks later. Moreover the mice injected with peripheral blood mononuclear cells from asthmatic children had much higher IgE levels than mice reconstituted with cells from normal adults. Phenotypic analysis of spleen cells and peritoneal exudate cells from SCID-PBL-hu mice demonstrated that human lymphocytes could survive in the peritoneal cavity and spleen for several months. After in intraperitoneal immunization mite-specific IgE antibodies could also be detected in SCID-PBL-hu mice. This study indicates that the human IgE system can be established in SCID mice and that this model can be used to study the regulation of IgE production and the immunopathogenesis of human allergic disease.	NATL TAIWAN UNIV,COLL MED,DEPT LAB MED,TAIPEI,TAIWAN; NATL TAIWAN UNIV,COLL MED,GRAD INST CLIN MED,DEPT PEDIAT,TAIPEI,TAIWAN	National Taiwan University; National Taiwan University				CHIANG, BOR-LUEN/0000-0002-6705-0286				BARRY TS, 1992, J CLIN IMMUNOL, V12, P311, DOI 10.1007/BF00920788; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CANNON MJ, 1990, J CLIN INVEST, V85, P1333, DOI 10.1172/JCI114573; CARLSSON R, 1992, J IMMUNOL, V148, P1065; CHRETIEN I, 1990, EUR J IMMUNOL, V20, P243, DOI 10.1002/eji.1830200203; DUCHOSAL MA, 1990, J EXP MED, V172, P985, DOI 10.1084/jem.172.3.985; DUCHOSAL MA, 1992, NATURE, V355, P258, DOI 10.1038/355258a0; ITO M, 1992, INT ARCH ALLERGY IMM, V99, P373, DOI 10.1159/000236288; KRAMS SM, 1989, J EXP MED, V170, P1919, DOI 10.1084/jem.170.6.1919; LAI WC, 1990, J INFECT DIS, V161, P1269, DOI 10.1093/infdis/161.6.1269; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; LIN KL, 1992, J CLIN IMMUNOL, V12, P271, DOI 10.1007/BF00918151; MCCUNE JM, 1990, SCIENCE, V247, P564, DOI 10.1126/science.2300816; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; MOSMANN TR, 1991, ANNU REV IMMUNOL, V7, P145; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; NONOYAMA S, 1993, J IMMUNOL, V151, P3894; OKANO M, 1990, AM J PATHOL, V137, P517; PLAUT M, 1990, J IMMUNOL, V144, P4497; RENZ H, 1992, J ALLERGY CLIN IMMUN, V89, P1127, DOI 10.1016/0091-6749(92)90296-E; ROMAGNANI S, 1990, IMMUNOL TODAY, V11, P316, DOI 10.1016/S0167-5699(10)80004-0; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; SALOGA J, 1993, J CLIN INVEST, V91, P133, DOI 10.1172/JCI116162; SAXON A, 1991, J CLIN INVEST, V87, P658, DOI 10.1172/JCI115043; SIMPSON E, 1991, IMMUNOL REV, V124, P97, DOI 10.1111/j.1600-065X.1991.tb00618.x; SUNSHINE GH, 1991, J EXP MED, V174, P1653, DOI 10.1084/jem.174.6.1653; TIGHE H, 1990, EUR J IMMUNOL, V20, P1843, DOI 10.1002/eji.1830200832	29	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	1				69	76		10.1016/S0091-6749(95)70154-0	http://dx.doi.org/10.1016/S0091-6749(95)70154-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QC312	7822666				2022-12-18	WOS:A1995QC31200010
J	DANDEU, JP; RABILLON, J; CARMILEROY, A; DIVANOVIC, A; CAMOIN, L; DAVID, B				DANDEU, JP; RABILLON, J; CARMILEROY, A; DIVANOVIC, A; CAMOIN, L; DAVID, B			EQU-CL, THE HORSE MAJOR ALLERGEN AND ITS CLOSE STRUCTURAL RELATIONSHIP TO THE MOUSE AND RAT MAJOR URINARY PROTEIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		DANDEU JP, 1993, J CHROMATOGR-BIOMED, V621, P23, DOI 10.1016/0378-4347(93)80072-C	1	9	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				348	348						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400828
J	GREEN, SS; LAMB, GC; SCHMITT, S; KAUFMAN, J				GREEN, SS; LAMB, GC; SCHMITT, S; KAUFMAN, J			ORAL VERSUS REPOSITORY CORTICOSTEROID-THERAPY AFTER HOSPITALIZATION FOR TREATMENT OF ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; CORTICOSTEROIDS; REPOSITORY STEROIDS	METHYLPREDNISOLONE; MEDICATION; ADULTS	Tapering regimens of oral steroids may be difficult or confusing for some patients. Repository steroids have been shown to be as effective as tapering oral doses in preventing relapse after emergency treatment. This study was undertaken to determine whether repository steroids are as effective as tapering oral steroids in preventing relapse after hospitalization for treatment of asthma. Twenty-six patients with acute exacerbations of asthma requiring treatment for 24 to 72 hours with parenteral steroids were randomized into two groups. Both groups received oral prednisone, 60 mg daily, when parenteral steroids were discontinued. At discharge, one group received intramuscular placebo and oral prednisone tapered over 8 days, and the other received 80 mg intramuscular methylprednisolone sodium acetate and oral placebo. At discharge and 2-week follow-up, patients were interviewed and examined, and spirometry results were obtained. There was little difference between groups in ratings of symptoms at discharge or follow-up. Both groups had less wheezing at follow-up than at discharge, through the improvement was significant only in the respiratory steroid group (p < 0.05). Mean forced expiratory volume in 1 second, forced vital capacity, peak expiratory flow rate improved at follow-up in both groups. No significant differences in outcome were found between the oral and repository steroid groups.	MED COLL WISCONSIN,MILWAUKEE,WI 53226	Medical College of Wisconsin								BLACKWELL B, 1973, NEW ENGL J MED, V289, P249, DOI 10.1056/NEJM197308022890506; CHAPMAN KR, 1991, NEW ENGL J MED, V324, P788, DOI 10.1056/NEJM199103213241202; FLETCHER SW, 1979, ARCH INTERN MED, V139, P635, DOI 10.1001/archinte.139.6.635; HOFFMAN IB, 1988, CHEST, V93, P11, DOI 10.1378/chest.93.1.11; JONSSON S, 1988, CHEST, V94, P723, DOI 10.1378/chest.94.4.723; LEDERLE FA, 1987, ARCH INTERN MED, V147, P2201, DOI 10.1001/archinte.147.12.2201; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; MYERS ED, 1984, BRIT J CLIN PHARMACO, V17, P21, DOI 10.1111/j.1365-2125.1984.tb04993.x; OGIRALA RG, 1991, NEW ENGL J MED, V324, P585, DOI 10.1056/NEJM199102283240903; RAIMONDI AC, 1986, CHEST, V89, P832, DOI 10.1378/chest.89.6.832; RICKELS K, 1970, J CLIN PHARMACOL N D, V10, P153; TANAKA RM, 1982, CHEST, V82, P438, DOI 10.1378/chest.82.4.438; 1991, GUIDELINES DIAGNOSIS, P36; 1991, AM REV RESPIR DIS, V144, P1202; 1986, AM REV RESPIR DIS, V134, P228	15	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	1				15	22		10.1016/S0091-6749(95)70147-8	http://dx.doi.org/10.1016/S0091-6749(95)70147-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QC312	7822659				2022-12-18	WOS:A1995QC31200003
J	GROSSMAN, J; BRONSKY, E; BUSSE, W; MONTANARO, A; SOUTHERN, I; TINKELMAN, D; DUBB, J; FAIFERMAN, I				GROSSMAN, J; BRONSKY, E; BUSSE, W; MONTANARO, A; SOUTHERN, I; TINKELMAN, D; DUBB, J; FAIFERMAN, I			A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND CLINICAL ACTIVITY OF ORAL, TWICE-DAILY LTA, PRANLUKAST (SB-206312) IN PATIENTS WITH MILD-TO-MODERATE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				352	352						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400844
J	VONMUTIUS, E; MARTINEZ, FD; NICOLAI, T				VONMUTIUS, E; MARTINEZ, FD; NICOLAI, T			SKIN-TEST REACTIVITY AND COAL BURNING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				211	211						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400282
J	THOMAS, LL; HASKELL, MD; SARMIENTO, EU; BILIMORIA, Y				THOMAS, LL; HASKELL, MD; SARMIENTO, EU; BILIMORIA, Y			DISTINGUISHING FEATURES OF BASOPHIL AND NEUTROPHIL ACTIVATION BY MAJOR BASIC-PROTEIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; CELL HISTAMINE-RELEASE; EOSINOPHIL; EXPRESSION; ALLERGEN; GENERATION; APPEARANCE; MEDIATORS; CALCIUM				THOMAS, LL (corresponding author), RUSH MED COLL,DEPT IMMUNOL MICROBIOL,1653 W CONGRESS PKWY,CHICAGO,IL 60612, USA.							ABUGHAZALEH RI, 1992, GRANULOCYTE RESPONSE, P137; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BISCHOFF SC, 1990, J EXP MED, V172, P1577, DOI 10.1084/jem.172.6.1577; CHARLESWORTH EN, 1991, J IMMUNOL, V146, P671; COLUMBO M, 1990, J IMMUNOL, V145, P3855; FOREMAN JC, 1980, BIOCHIM BIOPHYS ACTA, V629, P587, DOI 10.1016/0304-4165(80)90164-6; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; HASKELL MD, UNPUB NEUTROPHIL STI; HIRAI K, 1988, J IMMUNOL, V141, P3958; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; LEMANSKE RF, 1988, J CLIN IMMUNOL, V8, P1, DOI 10.1007/BF00915151; LICHTENSTEIN LM, 1991, ANN NY ACAD SCI, V629, P48; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; MACGLASHAN D, 1991, J LEUKOCYTE BIOL, V49, P29, DOI 10.1002/jlb.49.1.29; MACGLASHAN D, 1993, J IMMUNOL, V150, P980; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; MACGLASHAN DW, UNPUB INCREASES CYTO; MASSEY W, 1993, J IMMUNOL, V150, P1084; MOY JN, 1990, J IMMUNOL, V145, P2626; MOY JN, 1993, J ALLERGY CLIN IMMUN, V92, P598, DOI 10.1016/0091-6749(93)90084-S; ODONNELL MC, 1983, J EXP MED, V157, P1981, DOI 10.1084/jem.157.6.1981; ROHRBACH MS, 1990, J EXP MED, V172, P1271, DOI 10.1084/jem.172.4.1271; SARMIENTO EU, UNPUB IL3 IL5 GM CSF; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SUR S, 1993, ALLERGY PRINCIPLES P, P169; THOMAS LL, 1989, IMMUNOLOGY, V66, P611; WASMOEN TL, 1988, J BIOL CHEM, V263, P12559; WEISBART RH, 1987, BLOOD, V69, P18; WELLER PF, 1991, NEW ENGL J MED, V324, P1110; ZHEUTLIN LM, 1984, J IMMUNOL, V133, P2180; ZWEIMAN B, 1990, J IMMUNOL, V144, P3953	32	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1994	94	6	2	S			1171	1176		10.1016/0091-6749(94)90328-X	http://dx.doi.org/10.1016/0091-6749(94)90328-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA020	7798556				2022-12-18	WOS:A1994QA02000008
J	DEBRUINWELLER, MS; RIJSSENBEEKNOUWENS, LHM; DEMONCHY, JGR				DEBRUINWELLER, MS; RIJSSENBEEKNOUWENS, LHM; DEMONCHY, JGR			LACK OF EFFECT OF CETIRIZINE ON EARLY AND LATE ASTHMATIC RESPONSE AFTER ALLERGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CETIRIZINE; LATE ASTHMATIC RESPONSE; EOSINOPHIL CATIONIC PROTEIN; BRONCHIAL HYPERRESPONSIVENESS	BRONCHIAL HYPERREACTIVITY; EOSINOPHIL RECRUITMENT; ANTAGONIST TREATMENT; CLINICAL EFFICACY; MILD ASTHMA; PAF-ACETHER; HISTAMINE; INFLAMMATION; URTICARIA; RHINITIS	Background: Cetirizine hydrochloride has proved effective in reducing allergic symptoms and can inhibit the infiltration of eosinophils in allergic late-phase responses in the skin. Because eosinophils are likely to play an important role in allergic late-phase reactions, we studied the effect of cetirizine on early and late asthmatic reactions and on levels of eosinophil cationic protein (ECP) in the blood after allergen challenge. Methods: The effect of 15 mg cetirizine given twice daily was studied in 16 patients allergic to house dust mites in a double-blind, placebo-controlled study. patients were treated for 3 weeks. Before and after treatment, bronchial challenges with house-dust mites were performed Blood ECP levels were measured 6 hours after challenge. Methacholine provocation was performed 72 hours before and 24 hours after each challenge. Results: Early and late asthmatic response-measured as mean maximal fall in forced expiratory volume in 1 second (FEV(1)) and the provocative dose of allergen that causes a 15% fall in FEV(1) (PD15 allergen) - were not significantly reduced after treatment with cetirizine, compared with placebo. There was also no significant effect on the concentration of methacholine, which causes a 20% fall in FEV(1) (PC20 methacholine). The increase in the level of ECP in the blood after allergen challenge was reduced after cetirizine treatment, compared with placebo but this difference was not statistically significant. Conclusion: Eighteen days of treatment with cetirizine did not significantly reduce the intensity of the early and late asthmatic responses.	UNIV GRONINGEN,DEPT ALLERGY,GRONINGEN,NETHERLANDS	University of Groningen	DEBRUINWELLER, MS (corresponding author), ASTHMACTR HEIDEHEUVEL,SOESTDIJKERSTRAATWEG 129,1213 VX HILVERSUM,NETHERLANDS.							BERMAN BA, 1990, J ALLERGY CLIN IMMUN, V86, P1004, DOI 10.1016/S0091-6749(05)80244-1; BRIK A, 1987, J ALLERGY CLIN IMMUN, V80, P51, DOI 10.1016/S0091-6749(87)80190-2; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; CHARLESWORTH EN, 1989, J ALLERGY CLIN IMMUN, V83, P905, DOI 10.1016/0091-6749(89)90104-8; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DEMONCHY JGR, 1986, THESIS U GRONINGEN; DIJKMAN JH, 1990, CLIN EXP ALLERGY, V20, P483, DOI 10.1111/j.1365-2222.1990.tb03140.x; DOLOVICH J, 1989, J ALLERGY CLIN IMMUN, V83, P521, DOI 10.1016/0091-6749(89)90032-8; DURHAM SR, 1985, CLIN ALLERGY, V15, P411, DOI 10.1111/j.1365-2222.1985.tb02290.x; FADEL R, 1990, J ALLERGY CLIN IMMUN, V86, P314, DOI 10.1016/S0091-6749(05)80093-4; FADEL R, 1987, CLIN ALLERGY, V17, P373, DOI 10.1111/j.1365-2222.1987.tb02027.x; GHOSH SK, 1991, THORAX, V46, P242, DOI 10.1136/thx.46.4.242; GHOSH SK, 1991, J ALLERGY CLIN IMMUN, V87, P1010, DOI 10.1016/0091-6749(91)90424-M; GLEICH GJ, 1988, J ALLERGY CLIN IMMUN, V81, P776, DOI 10.1016/0091-6749(88)90931-1; HOLGATE ST, 1991, AM REV RESPIR DIS, V143, pS66, DOI 10.1164/ajrccm/143.3_Pt_2.S66; JUHLIN L, 1988, BRIT J DERMATOL, V119, P67, DOI 10.1111/j.1365-2133.1988.tb07103.x; JUHLIN L, 1987, J ALLERGY CLIN IMMUN, V80, P599, DOI 10.1016/0091-6749(87)90014-5; KAISER HB, 1990, J ALLERGY CLIN IMMUN, V86, P1000, DOI 10.1016/S0091-6749(05)80243-X; KALIVAS J, 1990, J ALLERGY CLIN IMMUN, V86, P1014, DOI 10.1016/S0091-6749(05)80246-5; Kay A B, 1989, Prog Clin Biol Res, V297, P183; Kay A B, 1989, Agents Actions Suppl, V28, P147; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; KAY AB, 1985, CLIN EXP IMMUNOL, V62, P1; KURZEJA A, 1989, LANCET, V1, P566; KYANAUNG U, 1992, J ALLERGY CLIN IMMUN, V90, P270, DOI 10.1016/0091-6749(92)90083-E; MASSEY WA, 1990, J ALLERGY CLIN IMMUN, V86, P1019, DOI 10.1016/S0091-6749(05)80247-7; METZGER WJ, 1986, J ALLERGY CLIN IMMUN, V78, P282; MICHEL L, 1988, J ALLERGY CLIN IMMUN, V82, P101, DOI 10.1016/0091-6749(88)90058-9; REDIER H, 1992, J ALLERGY CLIN IMMUN, V90, P215, DOI 10.1016/0091-6749(92)90074-C; RIHOUX JP, 1987, ANN ALLERGY, V59, P235; SEIDEL WF, 1990, J ALLERGY CLIN IMMUN, V86, P1029, DOI 10.1016/S0091-6749(05)80249-0; SIMONS FER, 1988, J ALLERGY CLIN IMMUN, V81, P975, DOI 10.1016/0091-6749(88)90164-9; SNOWMAN AM, 1990, J ALLERGY CLIN IMMUN, V86, P1025, DOI 10.1016/S0091-6749(05)80248-9; SNYDER SH, 1987, ANN ALLERGY, V59, P4; VENGE P, 1977, BRIT J HAEMATOL, V37, P331, DOI 10.1111/j.1365-2141.1977.tb01003.x; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WASSERFALLEN JB, 1993, J ALLERGY CLIN IMMUN, V91, P1189, DOI 10.1016/0091-6749(93)90322-7; WELLER PF, 1991, NEW ENGL J MED, V324, P1110	38	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2					231	239		10.1016/0091-6749(94)90045-0	http://dx.doi.org/10.1016/0091-6749(94)90045-0			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC926	8064075				2022-12-18	WOS:A1994PC92600014
J	FANG, J; VIKSMAN, MY; EBISAWA, M; BOCHNER, BS				FANG, J; VIKSMAN, MY; EBISAWA, M; BOCHNER, BS			INCREASED CIRCULATING LEVELS OF INTERLEUKIN-5 IN A CASE OF STEROID-RESISTANT HYPEREOSINOPHILIC SYNDROME WITH ILEAL INVOLVEMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							EOSINOPHILIC GASTROENTERITIS		JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DIV CLIN IMMUNOL,BALTIMORE,MD	Johns Hopkins University; Johns Hopkins University				Ebisawa, Motohiro/0000-0003-4117-558X	NIAID NIH HHS [AI27429] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI027429] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		HABERKERN CM, 1978, GASTROENTEROLOGY, V74, P896; KLEIN NC, 1970, MEDICINE, V49, P299, DOI 10.1097/00005792-197007000-00003; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SPRY CJF, 1992, EOSINOPHILS BIOL CLI, P403; WALLEN N, 1991, J IMMUNOL, V147, P3490	5	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1994	94	1					129	131		10.1016/0091-6749(94)90079-5	http://dx.doi.org/10.1016/0091-6749(94)90079-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NX393	8027491	Bronze			2022-12-18	WOS:A1994NX39300016
J	BASSETT, CW; TALUSANCANLAS, E; HOLTZIN, L; KUMAR, S; CHIARAMONTE, LT				BASSETT, CW; TALUSANCANLAS, E; HOLTZIN, L; KUMAR, S; CHIARAMONTE, LT			AN ADVERSE REACTION TO PROPOFOL IN A PATIENT WITH EGG HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				242	242						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700475
J	CAWLEY, MF; SHAH, SR; GLEESON, R; WELDON, D; MCGEADY, SJ				CAWLEY, MF; SHAH, SR; GLEESON, R; WELDON, D; MCGEADY, SJ			LATEX HYPERSENSITIVITY IN CHILDREN WITH MYELODYSPLASIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				181	181						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700112
J	SIMONS, KJ; DILAY, DJ; REGGIN, JD; FRASER, TG; PATRICK, JP; SIMONS, FER				SIMONS, KJ; DILAY, DJ; REGGIN, JD; FRASER, TG; PATRICK, JP; SIMONS, FER			CETIRIZINE (C), HYDROXYZINE (H), AND DIPHENHYDRAMINE (D) - STUDIES OF CENTRAL-NERVOUS-SYSTEM (CNS) EFFECTS USING THE P300-EVENT-RELATED POTENTIAL (P300)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				235	235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700437
J	TERAN, LM; JOHNSTON, SL; SHUTE, JK; CHURCH, MK; HOLGATE, ST				TERAN, LM; JOHNSTON, SL; SHUTE, JK; CHURCH, MK; HOLGATE, ST			INCREASED LEVELS OF INTERLEUKIN-8 IN THE NASAL ASPIRATES OF CHILDREN WITH VIRUS-ASSOCIATED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Johnston, Sebastian Lennox/I-2423-2012; Teran, Luis/AAI-9815-2021	Johnston, Sebastian Lennox/0000-0003-3009-9200; 					0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				272	272						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700659
J	HAYES, JP; BARNES, PJ; TAYLOR, AJN; CHUNG, KF				HAYES, JP; BARNES, PJ; TAYLOR, AJN; CHUNG, KF			EFFECT OF A TOPICAL CORTICOSTEROID ON AIRWAY HYPERRESPONSIVENESS AND EOSINOPHILIC INFLAMMATION-INDUCED BY TRIMELLITIC ANHYDRIDE EXPOSURE IN SENSITIZED GUINEA-PIGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						TRIMELLITIC ANHYDRIDE; AIRWAY HYPERRESPONSIVENESS; SENSITIZATION; GUINEA PIG; CORTICOSTEROIDS; BUDESONIDE	INTRADERMAL SENSITIZATION; BRONCHOALVEOLAR LAVAGE; BUDESONIDE; RESPONSES; RESPONSIVENESS; ANTIGEN; ASTHMA; TERBUTALINE; ANAPHYLAXIS; RATS	Background: Topical corticosteroids are effective in the treatment of asthma by improving bronchial hyperresponsiveness and reducing airway inflammation. Methods: We assessed the effect of a nebulized corticosteroid, budesonide, on airway hyperresponsiveness and inflammatory response provoked by inhalation of trimellitic anhydride (TMA) dust, a known cause of occupational asthma in human beings, in guinea pigs sensitized to the free hapten. Male Dunkin-Hartley guinea pigs (n = 24) were injected intradermally with 0.1 ml of 0.3% TMA in com oil, followed by exposure 21 to 28 days later to five consecutive doses of budesonide aerosol (0.5 mg/ml) or saline solution, administered for 10 minutes every 12 hours. They were then exposed (noses only) to TMA dust (8 mg/m3) or air for 1 hour (four groups, n = 6 in each). Airway responsiveness to acetylcholine, defined as the concentration needed to cause a 200% increase in lung resistance (PC200), was measured 8 hours later. Results: In saline-treated guinea pigs exposed to TMA, mean PC200 was 0.094 mmol/L (geometric SEM, 1.4 mmol/L) compared with 0.31 mmol/L (geometric SEM, 1.3 mmol/L, p < 0.05) in those guinea pigs pretreated with budesonide. In sham-exposed sensitized guinea pigs, PC200 was 0.35 mmol/L (geometric SEM, 1.2 mmol/L), which was not significantly different from the budesonide-treated group (0.36 mmol/L; geometric SEM, 1.3 mmol/L). There was a significant increase in the number of eosinophils in the subepithelium of guinea pigs further exposed to TMA dust (71.5 +/- 6.8 cells/unit area [mean +/- SEM]) compared with those exposed to air (22.7 +/- 6 7, p < 0.01). Budesonide did not inhibit the number of subepithelial eosinophils of guinea pigs exposed to TMA dust (54.0 +/- 3.7 cells/unit area) or in those exposed to air (24.3 +/- 6.7 cells/unit area) and did not affect the increase in eosinophils found in bronchoalveolar fluid. Conclusions: Budesonide significantly inhibited the increase in airway responsiveness but not the eosinophilic inflammation induced by exposure to TMA dust in sensitized guinea pigs.	NATL HEART & LUNG INST, DEPT THORAC MED, DOVEHOUSE ST, LONDON SW3 6LY, ENGLAND; NATL HEART & LUNG INST, DEPT OCCUPAT & ENVIRONM MED, LONDON SW3 6LY, ENGLAND	Imperial College London; Imperial College London			Chung, Kian Fan/I-8456-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Barnes, Peter/0000-0002-5122-4018				ABRAHAM WM, 1986, B EUR PHYSIOPATH RES, V22, P387; ADELROTH E, 1990, AM REV RESPIR DIS, V142, P91; ANDERSSON P, 1988, INT ARCH ALLER A IMM, V87, P32, DOI 10.1159/000234645; ANDERSSON P, 1982, BRIT J PHARMACOL, V76, P139, DOI 10.1111/j.1476-5381.1982.tb09199.x; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; DAHLBACK M, 1986, ALLERGY, V41, P210, DOI 10.1111/j.1398-9995.1986.tb00302.x; DAHLBACK M, 1986, ALLERGY, V41, P594, DOI 10.1111/j.1398-9995.1986.tb00352.x; De Marzo N, 1988, Pulm Pharmacol, V1, P15, DOI 10.1016/0952-0600(88)90005-1; DUJKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669; ELWOOD W, 1992, AM REV RESPIR DIS, V145, P1289, DOI 10.1164/ajrccm/145.6.1289; ELWOOD W, 1992, THESIS U LONDON LOND; FABBRI LM, 1985, AM REV RESPIR DIS, V132, P1010; FAWCETT IW, 1977, CLIN ALLERGY, V7, P1, DOI 10.1111/j.1365-2222.1977.tb01418.x; FULLER RW, 1991, CHEST, V100, P670, DOI 10.1378/chest.100.3.670; GULBENKIAN AR, 1990, AM REV RESPIR DIS, V142, P680, DOI 10.1164/ajrccm/142.3.680; HAYES JP, 1992, BRIT J PHARMACOL, V106, P828; HAYES JP, 1992, AM REV RESPIR DIS, V146, P1311, DOI 10.1164/ajrccm/146.5_Pt_1.1311; HAYES JP, 1992, CLIN EXP ALLERGY, V22, P694, DOI 10.1111/j.1365-2222.1992.tb00193.x; HICKS R, 1970, J PHARM PHARMACOL, V22, P170, DOI 10.1111/j.2042-7158.1970.tb08493.x; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; MATSUSE T, 1991, AM REV RESPIR DIS, V144, P368, DOI 10.1164/ajrccm/144.2.368; MOIRA CY, 1986, AM REV RESPIR DIS, V133, P686; SANJAR S, 1990, BRIT J PHARMACOL, V99, P679, DOI 10.1111/j.1476-5381.1990.tb12989.x; VONNEERGAARD K, 1927, Z KLIN MED, V105, P51; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1	26	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1993	92	3					450	456		10.1016/0091-6749(93)90124-X	http://dx.doi.org/10.1016/0091-6749(93)90124-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LX309	8360396	Bronze			2022-12-18	WOS:A1993LX30900011
J	BIGBY, B; BOUSHEY, H				BIGBY, B; BOUSHEY, H			EFFECTS OF NEDOCROMIL SODIUM ON THE BRONCHOMOTOR RESPONSE TO SULFUR-DIOXIDE IN ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article								It is known that cromolyn sodium and nedocromil sodium share similar antiallergic properties. This study examined whether nedocromil sodium, a pyranoquinoline dicarboxylic acid, could inhibit sulfur dioxide (SO2) bronchoconstriction in a dose-dependent manner in 10 men with mild asthma. Previous studies have shown that cromolyn sodium produces such inhibition in allergic monkeys and asthmatic subjects. Subjects in this double-blind, placebo-controlled study were nonsmoking men between the ages of 23 and 40 years (mean age, 30.7 years). The study took place over 5 days within a 3-week period. On the first of 5 days, each subject had a history taken and physical examination, SO2 baseline test, laboratory testing, and a methacholine dose-response test. On each of 4 test days, the subjects received pretreatment with either placebo or a 2, 4, or 8 mg dose of nedocromil sodium in a randomized, double-blind sequence, followed after 30 minutes by an SO2 dose-response test. Results showed that maximum bronchoconstriction response to SO2 was significantly attenuated (p < 0.01) by all three doses of nedocromil sodium, with small differences noted between dose levels. We concluded that nedocromil sodium inhibited SO2-induced bronchospasm at dose levels as low as 2 mg.	UNIV CALIF SAN FRANCISCO,SCH MED,CARDIOVASC RES INST,505 PARNASSUS AVE,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco								EADY RP, 1985, BRIT J PHARMACOL, V85, P3235; MYERS DJ, 1986, AM REV RESPIR DIS, V133, P1150	2	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				195	197		10.1016/0091-6749(93)90106-P	http://dx.doi.org/10.1016/0091-6749(93)90106-P			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8393028				2022-12-18	WOS:A1993LQ35400012
J	ZUBERBIER, T; BOHM, M; CZARNETZKI, BM				ZUBERBIER, T; BOHM, M; CZARNETZKI, BM			FOOD-INTAKE IN COMBINATION WITH A RISE IN BODY-TEMPERATURE - A NEWLY IDENTIFIED CAUSE OF ANGIOEDEMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							EXERCISE				ZUBERBIER, T (corresponding author), RUDOLF VIRCHOW FREE UNIV,UNIV HOSP,DEPT CLIN IMMUNOL ASTHMA,BERLIN,GERMANY.							BIERMAN CW, 1992, ANN ALLERGY, V68, P119; CASALE TB, 1986, JAMA-J AM MED ASSOC, V255, P2049, DOI 10.1001/jama.255.15.2049; OBYRNE PM, 1986, AM REV RESPIR DIS, V134, P69	3	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1993	91	6					1226	1227		10.1016/0091-6749(93)90326-B	http://dx.doi.org/10.1016/0091-6749(93)90326-B			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LG740	8509582				2022-12-18	WOS:A1993LG74000015
J	BRUIJNZEEL, P; STORZ, E; VANDERDONK, E; BRUIJNZEELKOOMEN, C				BRUIJNZEEL, P; STORZ, E; VANDERDONK, E; BRUIJNZEELKOOMEN, C			SKIN EOSINOPHILIA IN PATIENTS WITH ALLERGIC-ASTHMA, PATIENTS WITH NONALLERGIC ASTHMA, AND HEALTHY CONTROLS .2. 20-HYDROXY-LEUKOTRIENE-B4 IS A POTENT INVIVO AND INVITRO EOSINOPHIL CHEMOTACTIC FACTOR IN NONALLERGIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; SKIN EOSINOPHILIA; SKIN WINDOW; CHEMOTAXIS; LEUKOTRIENE-B4; 20-HYDROXY-LEUKOTRIENE-B4	VASCULAR ENDOTHELIAL-CELLS; PLATELET-ACTIVATING FACTOR; BRONCHIAL BIOPSIES; T-CELLS; NEUTROPHILS; INTERLEUKIN-5; ADHESION; LEUKOTRIENES; BINDING; BLOOD	Background: In allergic and nonallergic asthma, eosinophils play an important effector role. However, because the pathogenesis of these types of asthma seems different, the mechanisms responsible for the tissue mobilization of those cells may be different. The in vivo and in vitro migratory response of eosinophils from patients with allergic and nonallergic asthma toward 20-hydroxy-leukotriene B4 (20-OH-LTB4), which is reported here, illustrates this. Methods: By means of the Rebuck skin window technique the in vivo skin mobilizing capacity of intracutaneously applied buffer, LTB4, and 20-hydroxy (OH)-LTB4 was evaluated in healthy subjects (n = 6), subjects with allergic asthma (n = 14), and subjects with nonallergic asthma (n = 17). Also the in vitro chemotactic responsiveness of eosinophils from the circulation of both patient groups (both n = 8) toward buffer, LTB4, and 20-OH-LTB4 were tested by use of a microchemotaxis chamber technique. Results: Although none of the substances were capable of inducing macroscopic observable skin reactions, intracutaneously applied 20-OH-LTB, had an almost similar capacity to mobilize eosinophils in the skin of the subjects with nonallergic asthma as allergens had in subjects with allergic asthma. In 92% of the tested subjects with nonallergic asthma significant skin eosinophilia was observed. By contrast, LTB, did not induce significant skin eosinophilia in both patient groups compared with buffer solution. This in vivo eosinophil mobilizing capacity of 20-OH-LTB, in subjects with nonallergic asthma was confirmed by in vitro chemotaxis studies. Dose ranges of both LTB4 and 20-OH-LTB4 proved to be potent chemoattractants for eosinophils from patients with nonallergic asthma, but not for those of healthy subjects and those with allergic asthma. Conclusions: Our results indicate that 20-OH-LTB4 may be involved in the tissue mobilization of eosinophils in nonallergic asthma and that in vitro 20-OH-LTB4 (and LTB4) may act as potent chemotactic factors on eosinophils from those patients.	SWISS INST ALLERGY & ASTHMA RES,DAVOS,SWITZERLAND; HOCHGEBIRGSKLIN DAVOS WOLFGANG,DAVOS,SWITZERLAND; UNIV UTRECHT,BIJVOET CTR BIOMOLEC RES,UTRECHT,NETHERLANDS	Swiss Institute of Allergy & Asthma Research; Utrecht University	BRUIJNZEEL, P (corresponding author), TNO,MED BIOL LAB,DEPT PHARMACOL,LANGE KLEIWEG 139,2288 GJ RIJSWIJK,NETHERLANDS.							AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BRUIJNZEEL PLB, 1990, BRIT J PHARMACOL, V99, P798, DOI 10.1111/j.1476-5381.1990.tb13009.x; BRUIJNZEEL PLB, 1985, PROSTA LEUKOTR MED, V20, P11; BRUIJNZEELKOOMEN C, 1992, J ALLERGY CLIN IMMUN, V89, P52, DOI 10.1016/S0091-6749(05)80040-5; DAHINDEN CA, 1984, J IMMUNOL, V133, P1477; DEMONCHY JG, 1985, AM REV RESPIR DIS, V426, P373; DURHAM SR, 1989, J ALLERGY CLIN IMMUN, V84, P931, DOI 10.1016/0091-6749(89)90391-6; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P600, DOI 10.1164/ajrccm/136.3.600; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; HENOCQ E, 1988, J ALLERGY CLIN IMMUN, V81, P691, DOI 10.1016/0091-6749(88)91040-8; HENOCQ E, 1986, LANCET, V1, P1379; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; KOENDERMAN L, 1988, J LEUKOCYTE BIOL, V44, P79, DOI 10.1002/jlb.44.2.79; KURIHARA K, 1988, J ALLERGY CLIN IMMUN, V81, P208, DOI 10.1016/0091-6749(88)90395-8; MOSER R, 1989, J CLIN INVEST, V83, P444, DOI 10.1172/JCI113903; MOSER R, 1992, BLOOD, V79, P2937; PALMBLAD J, 1982, FEBS LETT, V144, P81, DOI 10.1016/0014-5793(82)80573-5; ROSENBACH T, 1985, BRIT J DERMATOL, V113, P157, DOI 10.1111/j.1365-2133.1985.tb15647.x; SEHMI R, 1992, BLOOD, V79, P2952; SIGAL CE, 1987, J CLIN IMMUNOL, V7, P179, DOI 10.1007/BF00916012; SPRY CJF, 1988, EOSINOPHILS GUIDE SC, P28; THORNHILL MH, 1991, J IMMUNOL, V146, P592; VERGHESE MW, 1989, HUMAN MONOCYTES; VERHAGEN J, 1984, PROSTA LEUKOTR MED, V13, P15, DOI 10.1016/0262-1746(84)90097-0; VERHAGEN J, 1984, FEBS LETT, V168, P23, DOI 10.1016/0014-5793(84)80199-4; VIRCHOW JC, 1991, ALLERGY CLIN IMMUN S, V1, P182; WALSH GM, 1991, J IMMUNOL, V146, P3419; WALSH GM, 1990, IMMUNOLOGY, V71, P258; WANG JM, 1989, EUR J IMMUNOL, V19, P701, DOI 10.1002/eji.1830190420; WARDLAW AJ, 1986, J CLIN INVEST, V78, P1701, DOI 10.1172/JCI112765; WARRINGA RAJ, 1991, BLOOD, V77, P2694; WARRINGA RAJ, 1992, BLOOD, V79, P1836; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; 1987, AM REV RESPIR DIS, V136, P225	38	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1993	91	2					634	642		10.1016/0091-6749(93)90269-L	http://dx.doi.org/10.1016/0091-6749(93)90269-L			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KN548	8382231	Bronze			2022-12-18	WOS:A1993KN54800011
J	CRETICOS, PS; REED, CE; NORMAN, PS				CRETICOS, PS; REED, CE; NORMAN, PS			THE NIAID COOPERATIVE STUDY OF THE ROLE OF IMMUNOTHERAPY IN SEASONAL RAGWEED-INDUCED ADULT ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				226	226						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100343
J	DAUL, CB; SLATTERY, M; LEHRER, SB				DAUL, CB; SLATTERY, M; LEHRER, SB			SHARED ANTIGENIC/ALLERGENIC EPITOPES BETWEEN SHRIMP PEN-A-I AND FRUIT-FLY EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				341	341						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100800
J	EHNERT, B; LAUSCHADENDORF, S; WEBER, A; SCHULZ, J; WAHN, U				EHNERT, B; LAUSCHADENDORF, S; WEBER, A; SCHULZ, J; WAHN, U			SENSITIZATION TO INDOOR ALLERGENS IN INFANTS AT AGE-1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				324	324						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100731
J	KNOL, EF; KANSAS, GS; TEDDER, TF; SCHLEIMER, RP; BOCHNER, BS				KNOL, EF; KANSAS, GS; TEDDER, TF; SCHLEIMER, RP; BOCHNER, BS			HUMAN EOSINOPHILS USE L-SELECTIN TO BIND TO ENDOTHELIAL-CELLS UNDER NONSTATIC CONDITIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				334	334						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100773
J	LUBAHN, B; KLAPPER, DG				LUBAHN, B; KLAPPER, DG			CLONING AND CHARACTERIZATION OF RAGWEED ALLERGEN AMB-A-VI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV N CAROLINA,SCH MED,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine									0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				338	338						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100787
J	BORTS, MR; DRUCE, HM				BORTS, MR; DRUCE, HM			THE USE OF INTRANASAL ANTICHOLINERGIC AGENTS IN THE TREATMENT OF NONALLERGIC PERENNIAL RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	CONF ON INTRANASAL ANTICHOLINERGIC TREATMENT OF NASAL DISORDERS	MAR   06, 1991	SAN FRANCISCO, CA	BOEHRINGER INGELHEIM PHARM		NONALLERGIC PERENNIAL RHINITIS; IPRATROPIUM BROMIDE; NASAL GLANDS; NASAL METHACHOLINE TEST	CHOLINO-CEPTOR ANTAGONIST; NASAL SEPTAL PERFORATION; NON-ALLERGIC RHINITIS; IPRATROPIUM BROMIDE; VASOMOTOR RHINITIS; CHRONIC RHINORRHEA; ATROVENT NASAL; NOSE; CLEARANCE; EFFICACY	Nonallergic perennial rhinitis is a heterogenous disorder. Although the underlying cause is unknown, there is evidence of an autonomic imbalance with parasympathetic hyperreactivity in affected persons. We review this evidence and the role of ipratropium bromide, an anticholinergic drug with topical activity, in the management of nonallergic perennial rhinitis. The pharmacologic features, safety, and efficacy of ipratropium bromide are reviewed.			BORTS, MR (corresponding author), ST LOUIS UNIV,SCH MED,DIV ALLERGY & IMMUNOL,1402 S GRAND BLVD,ST LOUIS,MO 63104, USA.							Andersen, 1982, NOSE UPPER AIRWAY PH, P45; ANDERSEN I, 1974, ARCH ENVIRON HEALTH, V29, P290, DOI 10.1080/00039896.1974.10666589; ANDERSON I, 1964, AM REV RESPIR DIS, V110, P301; ANGGARD A, 1984, CLIN OTOLARYNGOL, V9, P43, DOI 10.1111/j.1365-2273.1984.tb01470.x; BOK HE, 1983, EUR J RESPIR DIS, V64, P486; BORMS P, 1982, ALLERGY, V37, P67; BORUM P, 1978, Rhinology (Utrecht), V16, P225; Borum P, 1979, Acta Otorhinolaryngol Belg, V33, P528; BORUM P, 1979, CLIN OTOLARYNGOL, V4, P407, DOI 10.1111/j.1365-2273.1979.tb01773.x; BORUM P, 1983, CLIN OTOLARYNGOL, V8, P267, DOI 10.1111/j.1365-2273.1983.tb01440.x; BORUM P, 1979, ACTA OTOLARYNGOL S S, V360, P35; DECKERS W, 1975, POSTGRAD MED J, V51, P76; DOLOVICH J, 1985, J ALLERGY CLIN IMMUN, V75, P160, DOI 10.1016/0091-6749(85)90357-4; DRETTNER B, 1982, Rhinology (Utrecht), V20, P149; DRUCE HM, 1992, ANN ALLERGY, V69, P53; ECCLES R, 1973, J PHYSIOL-LONDON, V230, P213, DOI 10.1113/jphysiol.1973.sp010184; ENSING K, 1989, EUR J CLIN PHARMACOL, V36, P189, DOI 10.1007/BF00609193; FLEECE L, 1984, ALA J MED SCI, V21, P205; GOLDINGWOOD PH, 1973, LARYNGOSCOPE, V83, P1673, DOI 10.1288/00005537-197310000-00008; GORENBERG D, 1979, WESTERN J MED, V131, P313; HOLOPAINEN E, 1982, ACTA OTOLARYNGOLOG S, V386, P270; JONES AS, 1988, BIOMED PHARMACOTHER, V42, P499; KNIGHT A, 1985, ANN ALLERGY, V55, P305; LAFORCE C, 1985, J ALLERGY CLIN IMMUN, V75, P186, DOI 10.1016/0091-6749(85)90461-0; LAURIKAINEN E, 1988, Rhinology (Utrecht), V26, P133; MALCOMSON K G, 1959, J Laryngol Otol, V73, P73, DOI 10.1017/S0022215100054980; MALM L, 1973, ACTA OTO-LARYNGOL, V75, P519, DOI 10.3109/00016487309139783; MALMBERG H, 1983, CLIN OTOLARYNGOL, V8, P273, DOI 10.1111/j.1365-2273.1983.tb01441.x; MILFORD CA, 1990, J LARYNGOL OTOL, V104, P123, DOI 10.1017/S0022215100112022; MULLARKEY MF, 1980, J ALLERGY CLIN IMMUN, V65, P122, DOI 10.1016/0091-6749(80)90196-7; MYGIND N, 1983, EUR J RESPIR DIS, V64, P167; MYGIND N, 1978, ACTA OTO-LARYNGOL, V85, P437; MYGIND N, 1983, ALLERGY PRINCIPLES P, P1107; Mygind N., 1979, NASAL ALLERGY, p224 ; OHI M, 1984, Rhinology (Utrecht), V22, P241; ROMINGER KL, 1979, SCAND J RESPIR DIS S, V103, P116; SAKAKURA Y, 1983, ACTA OTO-LARYNGOL, V96, P167, DOI 10.3109/00016488309132888; SANWIKARJA S, 1986, ANN ALLERGY, V56, P162; SCHOELZEL EP, 1985, JAMA-J AM MED ASSOC, V253, P2046, DOI 10.1001/jama.1985.03350380062017; SJOGREN I, 1983, RHINOLOGY, V21, P341; SLAVIN RG, 1987, IMMUNOL ALLERGY CLIN, V7, P9; SODERBERGWARNER ML, 1984, J PEDIATR-US, V105, P840, DOI 10.1016/S0022-3476(84)80320-0; SORENSEN H, 1978, ARCH OTOLARYNGOL, V104, P606; SPECTOR SL, 1982, CLIN ALLERGY, V12, P187, DOI 10.1111/j.1365-2222.1982.tb01638.x; SPECTOR SL, 1980, J ALLERGY CLIN IMMUN, V66, P129, DOI 10.1016/0091-6749(80)90060-3; TOOHILL RJ, 1981, LARYNGOSCOPE, V91, P1614; VONHAACKE NP, 1983, BRIT MED J, V287, P1258, DOI 10.1136/bmj.287.6401.1258-a; VONHAACKE NP, 1983, EUR J RESPIR DIS, V64, P129; WEINER N, 1985, PHARMACOL BASIS THER, P120	49	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	2	S			1065	1070		10.1016/0091-6749(92)90124-K	http://dx.doi.org/10.1016/0091-6749(92)90124-K			6	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD635	1460209				2022-12-18	WOS:A1992KD63500007
J	SALARI, H; YEUNG, M; HOWARD, S; SCHELLENBERG, RR				SALARI, H; YEUNG, M; HOWARD, S; SCHELLENBERG, RR			INCREASED CONTRACTION AND INOSITOL PHOSPHATE FORMATION OF TRACHEAL SMOOTH-MUSCLE FROM HYPERRESPONSIVE GUINEA-PIGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SMOOTH MUSCLE; INOSITOL PHOSPHATE; CARBACHOL; HISTAMINE; LTD4; AIRWAY HYPERRESPONSIVENESS	SPONTANEOUSLY HYPERTENSIVE RATS; INDUCED AIRWAY HYPERRESPONSIVENESS; GTP-BINDING PROTEIN; INVITRO RESPONSES; ASTHMATIC AIRWAY; TRISPHOSPHATE; HYDROLYSIS; RECEPTOR; POLYPHOSPHOINOSITIDES; RESPONSIVENESS	Tracheal smooth muscle from guinea pigs with documented airway hyperresponsiveness in vivo after multiple antigen challenges produced 30% to 50% greater force than tracheas from control guinea pigs, when stimulated with carbachol, histamine, or leukotriene D4. When cultured smooth muscle cells were incubated with myo[2-H-3]inositol, basal uptake of [H-3]inositol was similar in cells from normal and hyperresponsive guinea pigs, but when these cells were stimulated with contractile agonists, there was increased uptake of inositol in hyperresponsive cells. Analysis of inositol phosphates by column chromatography and high-performance liquid chromatography revealed the presence of inositol-1,4,5-triphosphate, inositol-1,3,4-trisphosphate, inositol-1,4-bisphosphate, and inositol-1-monophosphate. The release of inositol-1,4,5-triphosphate, inositol-1,4-biphosphate, and inositol-1-monophosphate by smooth muscle cells stimulated with carbachol, leukotriene D4, or histamine was 20% to 40% greater in cells derived from hyperresponsive animals than cells from normal animals. These data demonstrate that the increased muscle contraction of hyperresponsive guinea pig tracheas is associated with increased inositol phosphate metabolism in these cells. Delineating the mechanisms of airway smooth muscle contraction should provide new pharmacologic targets for the inhibition of bronchoconstriction in asthma.			SALARI, H (corresponding author), JACK BELL RES CTR,DEPT MED,2660 OAK ST,VANCOUVER V6H 3Z6,BC,CANADA.							ANTHONISSEN LA, 1979, J APPL PHYSIOL, V46, P681; ASANO M, 1988, BRIT J PHARMACOL, V95, P241, DOI 10.1111/j.1476-5381.1988.tb16570.x; ASANO M, 1988, J PHARMACOL EXP THER, V246, P709; AUB DL, 1984, LIFE SCI, V34, P1347, DOI 10.1016/0024-3205(84)90006-7; BATTY IH, 1989, BIOCHEM J, V258, P23, DOI 10.1042/bj2580023; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; CERRINA J, 1986, AM REV RESPIR DIS, V134, P45; CHAN H, 1987, J ALLERGY CLIN IMMUN, V79, P762, DOI 10.1016/0091-6749(87)90208-9; CHILVERS ER, 1990, J PHARMACOL EXP THER, V252, P786; CHUNG KF, 1985, J APPL PHYSIOL, V58, P1347, DOI 10.1152/jappl.1985.58.4.1347; COYLE AJ, 1990, AM REV RESPIR DIS, V142, P587, DOI 10.1164/ajrccm/142.3.587; DEJONGSTE JC, 1987, EUR J RESPIR DIS, V71, P23; DEVORECARTER D, 1988, CELL TISSUE RES, V251, P325, DOI 10.1007/BF00215840; DIAMANT S, 1989, BRAIN RES, V503, P55, DOI 10.1016/0006-8993(89)91703-4; EID H, 1988, HYPERTENSION, V12, P122, DOI 10.1161/01.HYP.12.2.122; GRANDORDY BM, 1986, J PHARMACOL EXP THER, V238, P271; HALL IP, 1988, BRIT J PHARMACOL, V95, P1204, DOI 10.1111/j.1476-5381.1988.tb11757.x; ISHIDA K, 1990, J APPL PHYSIOL, V68, P1316, DOI 10.1152/jappl.1990.68.4.1316; ISHIDA K, 1989, J APPL PHYSIOL, V67, P1133, DOI 10.1152/jappl.1989.67.3.1133; JONES AW, 1988, HYPERTENSION, V11, P627, DOI 10.1161/01.HYP.11.6.627; KONG SK, 1986, J APPL PHYSIOL, V60, P92, DOI 10.1152/jappl.1986.60.1.92; KONG SK, 1990, AM J PHYSIOL, V259, pL53, DOI 10.1152/ajplung.1990.259.2.L53; LANES S, 1986, J APPL PHYSIOL, V61, P864, DOI 10.1152/jappl.1986.61.3.864; LAPETINA EG, 1986, BIOCHIM BIOPHYS ACTA, V884, P219, DOI 10.1016/0304-4165(86)90166-2; MARSH WR, 1985, AM REV RESPIR DIS, V131, P875; MCCAIG DJ, 1980, RESP PHYSIOL, V41, P49, DOI 10.1016/0034-5687(80)90022-5; MITCHELL RW, 1991, AM J RESP CELL MOL, V5, P56, DOI 10.1165/ajrcmb/5.1.56; MURAKAMI T, 1987, J MOL CELL CARDIOL, V19, P199, DOI 10.1016/S0022-2828(87)80562-X; NIXON GF, 1990, J HYPERTENS, V8, P1155, DOI 10.1097/00004872-199012000-00013; NYBORG NCB, 1988, HYPERTENSION, V11, P635, DOI 10.1161/01.HYP.11.6.635; PATTERSON R, 1979, J CLIN INVEST, V57, P586; RUBINFELD AR, 1982, LUNG, V160, P99, DOI 10.1007/BF02719277; SCHELLENBERG RR, 1985, CLIN INVEST MED, V8, pA202; SCHELLENBERG RR, 1984, INT ARCH ALLER A IMM, V75, P237, DOI 10.1159/000233622; SOMLYO AV, 1985, P NATL ACAD SCI USA, V82, P5231, DOI 10.1073/pnas.82.15.5231; SOUHRADA M, 1981, RESP PHYSIOL, V46, P17, DOI 10.1016/0034-5687(81)90065-7; TAKUWA Y, 1986, J BIOL CHEM, V261, P4670; TREMBLAY J, 1990, J HYPERTENS, V8, P115, DOI 10.1097/00004872-199002000-00004; WATSON SP, 1984, J BIOL CHEM, V259, P3199; YOSHIKAWA H, 1990, AM J HYPERTENS, V3, P230, DOI 10.1093/ajh/3.3.230	42	9	9	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	1				918	926		10.1016/0091-6749(92)90464-D	http://dx.doi.org/10.1016/0091-6749(92)90464-D			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD190	1460198				2022-12-18	WOS:A1992KD19000008
J	JACINTO, CM; NELSON, RP; BUCHOLTZ, GA; FERNANDEZCALDAS, E; TRUDEAU, WL; LOCKEY, RF				JACINTO, CM; NELSON, RP; BUCHOLTZ, GA; FERNANDEZCALDAS, E; TRUDEAU, WL; LOCKEY, RF			NASAL AND BRONCHIAL PROVOCATION CHALLENGES WITH BAYBERRY (MYRICA-CERIFERA) POLLEN EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						BAYBERRY; MYRICA-CERIFERA; AEROALLERGEN; NASAL PROVOCATION CHALLENGE; BRONCHIAL PROVOCATION CHALLENGE; PLATE RADIOIMMUNOASSAY (PRIA); SKIN TEST; SENSITIVITY; SPECIFICITY; PREDICTIVE VALUE	ALLERGY	Southern bayberry, distributed throughout the southeastern United States, is the source of the fifth most common windborne tree pollen in Tampa, Fla. Fifteen percent of 400 consecutive subjects evaluated for allergic respiratory symptoms in the Tampa Bay area had positive skin tests to bayberry pollen extract. Bayberry pollen extract was obtained commercially and used to perform 25 nasal and 22 bronchial challenges on 45 subjects. Twelve of 13 (92%) study subjects with allergic rhinitis and positive skin tests to bayberry pollen extract and two of 12 (17%) control subjects with negative skin tests had positive nasal challenges (p = 0.0001). Four of seven (57%) study subjects with extrinsic asthma and positive skin tests to bayberry pollen extract and none of the 15 (0%) control subjects with negative skin tests had positive bronchial challenges (p = 0.001). Sera from 30 subjects who underwent 31 challenges were assayed for bayberry pollen extract-specific IgE by plate radioimmunoassay. Specific IgE antibodies were present in the sera of 8 of 13 (62%) subjects with positive challenges and absent in 15 of 18 (83%) subjects with negative challenges (p = 0.01). Intradermal skin tests with bayberry pollen extract were more predictive of provocation challenge results than plate radioimmunoassay (positive predictive value of 80%, 95% CI 62% to 98%; versus 73%, 95% CI 47% to 99%). Bayberry pollen extract is allergenic, and the Southern bayberry tree fulfills Thommen's criteria defining aeroallergen-producing plants.	JAMES A HALEY VET HOSP,DEPT INTERNAL MED,DIV ALLERGY & CLIN IMMUNOL,VAR 111D,TAMPA,FL 33612; UNIV S FLORIDA,COLL MED,TAMPA,FL 33612	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida								AHLSTEDT S, 1974, CLIN ALLERGY, V4, P131, DOI 10.1111/j.1365-2222.1974.tb01370.x; BERG T, 1971, INT ARCH ALLER A IMM, V40, P770, DOI 10.1159/000230461; BUCHOLTZ GA, 1987, ANN ALLERGY, V59, P52; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CONNELL JT, 1982, ANN ALLERGY, V49, P179; FERNANDEZCALDAS E, 1990, ALLERGY PROC, V11, P263, DOI 10.2500/108854190778879710; LEWIS WH, 1983, AIRBORNE ALLERGENIC, V66, P200; LOCKEY RF, 1991, ANN ALLERGY, V67, P534; MITCHELL J, 1979, BOTANICAL DERMATOLOG, P483; NEWMARK FN, 1979, ALLERGY CLIN IMMUNOL, P626; PRINCE HE, 1977, ANN ALLERGY, V38, P252; SCHUMACHER MJ, 1989, J ALLERGY CLIN IMMUN, V83, P711, DOI 10.1016/0091-6749(89)90001-8; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9	13	9	9	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1992	90	3	1				312	318		10.1016/S0091-6749(05)80008-9	http://dx.doi.org/10.1016/S0091-6749(05)80008-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JP520	1527315	Bronze			2022-12-18	WOS:A1992JP52000006
J	LUSK, RP				LUSK, RP			SURGICAL MODALITIES OTHER THAN ETHMOIDECTOMY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RECURRENT SINUSITIS; CHILDREN; SURGERY; NASAL	When medical management fails to control the symptoms of chronic sinusitis, surgical intervention is frequently considered. The more commonly recommended procedures include tonsilectomy and adenoidectomy, adenoidectomy alone, maxillary sinus irrigation, and nasal antral windows. These procedures have not undergone meticulous prospective evaluation or documentation of chronic sinusitis. It has only recently become known that plain sinus x-ray films are frequently misleading, and there has been a tendency to completely ignore ethmoid disease. Adenoidectomy has been frequently recommended; however, these studies have not documented the duration of symptoms or the extent of disease. Approximately 20% of the patients treated with tonsilectomy and adenoidectomy do not have resolution of symptoms of chronic sinusitis. It is prudent, however, to remove an enlarged obstructive adenoid pad as a first course of therapy. Irrigation has been proposed, but it treats only the maxillary sinus, and the ethmoid sinuses are involved approximately 70% of the itme. One irrigation rarely clears the symptoms. Nasal antral windows in children require well-developed maxillary sinuses and do not maintain their patency. Therefore they are not an effective mechanism for treating chronic sinusitis. Other surgical modalities must therefore be sought.			LUSK, RP (corresponding author), WASHINGTON UNIV, ST LOUIS CHILDRENS HOSP, SCH MED, 400 S KINGSHIGHWAY, 3S-35, ST LOUIS, MO 63130 USA.							Alden AM, 1926, ARCHIV OTOLARYNGOL, V4, P521; ASHERSON N, 1937, LANCET, P1399; BIRRELL JF, 1952, ARCH DIS CHILD, V27, P1, DOI 10.1136/adc.27.131.1; CARMACK JW, 1931, ANN OTO RHINOL LARYN, V40, P515; CLEMINSON FJ, 1921, J LARYNGOL OTOL, V36, P505; Crooks J, 1936, Arch Dis Child, V11, P281; FUJITA A, 1988, ACTA OTO-LARYNGOL, P210; Griffiths I, 1937, LANCET, V2, P723; HAJEK M, 1926, PATHOLOGY TREATMENT; HILDING AC, 1943, ANN OTO RHINOL LARYN, V52, P816; HOSHAW TC, 1974, ARCH OTOLARYNGOL, V100, P194; HUGGILL P H, 1952, J Laryngol Otol, V66, P84, DOI 10.1017/S0022215100047319; KENNEDY DW, 1985, ARCH OTOLARYNGOL, V111, P576; KENNEDY DW, 1987, LARYNGOSCOPE, V97, P1, DOI 10.1288/00005537-198708002-00001; KRAUSE H, 1887, MONZTSCHRIFT OHRENHE, V21, P70; Lund V J, 1988, J Laryngol Otol Suppl, V15, P1; MAES J-J, 1987, Rhinology (Utrecht), V25, P259; MCALISTER WH, 1989, AM J ROENTGENOL, V153, P1259, DOI 10.2214/ajr.153.6.1259; MERCK W, 1974, HNO, V22, P198; MIKULICZ J, 1887, LAGENBECKS ARCH KLIN, V34, P626; MUNTZ HR, 1990, LARYNGOSCOPE, V100, P643; MYERSON MC, 1932, ARCH OTOLARYNGOL, P15; NICKMAN NJ, 1978, LARYNGOSCOPE, V88, P117; PAUL D, 1981, LARYNGOSCOPE, V91, P997; PETERSEN RJ, 1973, LARYNGOSCOPE, V83, P369, DOI 10.1288/00005537-197303000-00007; PRESTON HG, 1955, VA MED MON, V82, P299; PROETZ AW, 1941, ESSAYS APPLIED PHYSL, P356; RITTER FN, 1977, LARYNGOSCOPE, V87, P215; STAMMBERGER H, 1986, ENDOSCOPY, V18, P213, DOI 10.1055/s-2007-1018382; STAMMBERGER H, 1986, OTOLARYNG HEAD NECK, V94, P143, DOI 10.1177/019459988609400202; STCLAIR T, 1937, DISEASES NOSE THROAT, P232; STEVENSON RS, 1947, P ROY SOC MED, V40, P854; WALKER FM, 1947, BRIT MED J, V2, P908, DOI 10.1136/bmj.2.4535.908	33	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1992	90	3	2	S			538	542		10.1016/0091-6749(92)90181-Z	http://dx.doi.org/10.1016/0091-6749(92)90181-Z			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JP521	1527346				2022-12-18	WOS:A1992JP52100022
J	SATO, K; ZWEIMAN, B; MOSKOVITZ, AR; VONALLMEN, C; LANE, A; ATKINS, PC				SATO, K; ZWEIMAN, B; MOSKOVITZ, AR; VONALLMEN, C; LANE, A; ATKINS, PC			EFFECTS OF SKIN-CHAMBER FLUIDS FROM HUMAN ALLERGIC REACTIONS ON NEUTROPHIL ACTIVATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ALLERGIC SKIN REACTION; SKIN CHAMBERS; LACTOFERRIN; SUPEROXIDE; NEUTROPHIL ACTIVATION	CELLULAR INFLAMMATORY RESPONSES; HYDROXYL-RADICAL PRODUCTION; POLYMORPHONUCLEAR LEUKOCYTES; LACTOFERRIN; RELEASE; HISTAMINE; INDIVIDUALS; EXPRESSION	We have found activated neutrophils (PMNs) in skin chambers overlying the site of ongoing human allergic reactions. To determine whether this activation is due to component(s) released early in these IgE-mediated reactions, we investigated the in vitro effects of skin chamber fluids (CF) on resting blood PMNs. These skin CF had been previously obtained, at different time periods, at pollen-antigen-challenged or buffer-control-challenged sites in sensitive human subjects. PMNs incubated with CF obtained during the first hour of antigen challenge (first-hour CF) generated significantly more superoxide (O2-) than spontaneous production (p < 0.001) and more than PMNs incubated with first-hour buffer-site CF (p < 0.002). A pattern similar to O2- generation was observed in lactoferrin secretion during the incubation of the three cell aliquots described above (p < 0.001). After these incubations, the subsequent responsiveness of the PMNs present in the cell buttons to opsonized zymosan, a PMN activator, was assessed. PMNs previously incubated with first-hour CF generated significantly more net O2- in response to opsonized zymosan than did PMNs previously incubated with first-hour buffer-site CF (p < 0.001) or buffered saline (p < 0.001). Again, a similar difference in the patterns of net lactoferrin secretion was observed (p < 0.02). These events were not associated with PMN damage. Analogous studies with CF previously obtained during the second- to first-hour of antigen or buffer challenge stimulated much less than first-hour CF. We conclude that one or more components released early in IgE-mediated skin reactions can activate PMNs. The nature of the activating component(s) is unknown, with no evidence of activation by histamine, antigen, or other components found to date in first-hour CF.	UNIV PENN,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,PHILADELPHIA,PA 19104	University of Pennsylvania					NIAID NIH HHS [AI 14332] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMBRUSO DR, 1981, J CLIN INVEST, V67, P352, DOI 10.1172/JCI110042; ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P371, DOI 10.1016/S0091-6749(05)80100-9; BEDARD PM, 1983, J ALLERGY CLIN IMMUN, V71, P394, DOI 10.1016/0091-6749(83)90068-4; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRITIGAN BE, 1989, BIOCHEM J, V264, P447, DOI 10.1042/bj2640447; BRITIGAN BE, 1986, J BIOL CHEM, V261, P7026; COHEN MS, 1988, FREE RADICAL BIO MED, V5, P81, DOI 10.1016/0891-5849(88)90033-0; DEWALD B, 1985, BIOCHEM BIOPH RES CO, V128, P297, DOI 10.1016/0006-291X(85)91678-X; FLEEKOP PD, 1987, J ALLERGY CLIN IMMUN, V80, P140, DOI 10.1016/0091-6749(87)90122-9; GAY JC, 1986, BLOOD, V67, P931; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; INGRAHAM LM, 1987, BRIT J HAEMATOL, V66, P219, DOI 10.1111/j.1365-2141.1987.tb01302.x; INGRAHAM LM, 1982, BLOOD, V59, P1259; LYNCH JM, 1986, J IMMUNOL, V137, P2653; OFLAHERTY JT, 1986, J CLIN INVEST, V78, P381, DOI 10.1172/JCI112588; SHALIT M, 1987, J ALLERGY CLIN IMMUN, V80, P87, DOI 10.1016/S0091-6749(87)80196-3; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V83, P691, DOI 10.1016/0091-6749(89)90084-5; SHALIT M, 1987, J CLIN IMMUNOL, V7, P456, DOI 10.1007/BF00915055; SHAW JO, 1981, J IMMUNOL, V127, P1250; SHULT PA, 1985, J LAB CLIN MED, V106, P638; STYRT B, 1988, J ALLERGY CLIN IMMUN, V81, P20, DOI 10.1016/0091-6749(88)90215-1; TALBOT SF, 1985, J CLIN INVEST, V76, P650, DOI 10.1172/JCI112018; TAYLOR MB, 1990, J ALLERGY CLIN IMMUN, V86, P740, DOI 10.1016/S0091-6749(05)80178-2; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; VERCELLOTTI G, 1987, BLOOD CELLS, V13, P199; WEENING RS, 1975, J LAB CLIN MED, V85, P245; WHITE MV, 1987, J IMMUNOL, V139, P1624; ZIMMERLI W, 1986, J CLIN INVEST, V77, P925, DOI 10.1172/JCI112391; ZWEIMAN B, 1991, Journal of Allergy and Clinical Immunology, V87, P347; ZWEIMAN B, 1990, J IMMUNOL, V1440, P3953	30	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1992	90	1					21	31		10.1016/S0091-6749(06)80007-2	http://dx.doi.org/10.1016/S0091-6749(06)80007-2			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JE255	1321177				2022-12-18	WOS:A1992JE25500003
J	DHANJAL, MK; TOWLER, AE; TUFT, S; HETZEL, C; RICHARDS, D; KEMENY, DM				DHANJAL, MK; TOWLER, AE; TUFT, S; HETZEL, C; RICHARDS, D; KEMENY, DM			THE DETECTION OF IGE-SECRETING CELLS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IGE-SECRETING CELL; ELISA PLAQUE ASSAY; ATOPIC DERMATITIS; INVITRO IGE PRODUCTION	INTERFERON-GAMMA; INVITRO SYNTHESIS; HUMAN-LYMPHOCYTES; B-CELLS; INTERLEUKIN-4; ANTIBODY; SUPERNATANTS; EXPRESSION; LEUKOCYTES; RELEASE	We report, for the first time, the identification of IgE-secreting cells in human peripheral blood with an ELISA plaque assay that detects the fingerprint of individual IgE-secreting cells. No IgE-secreting cells could be detected in the blood of normal individuals (IgE, < 100 IU/ml) or atopic patients (IgE, < 1000 IU/ml), but in patients with atopic dermatitis (AD) whose IgE was > 2000 IU/ml, there was an average of 49 +/- 9 IgE-secreting cells per 10(6) peripheral blood mononuclear cells (PBMNCs). The rate of IgE production per cell per day from the PMBNCs of patients with AD varied from 0.051 to 0.628 IU/ml, and the number of IgE-secreting cells was positively correlated with the serum-IgE levels of these subjects (r = 0.74; p < 0.001) and the amount of IgE detected in the culture supernatant (r = 0.085; p < 0.02). Secretion of IgE by these cells could be completely inhibited (96.2% +/- 3%) by the addition of 75-mu-g of cyclohexamide to the cultures. Preformed intracellular IgE comprised 10% of the IgE detected in the supernatants of 7-day cultures. PBMNCs from patients with AD depleted of monocytes by adherence and T cells by E rosetting, all contained some detectable IgE-secreting cells, whereas isolated T cells and monocytes did not, supporting the view that cells secreting IgE that were detected were indeed B cells.	UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT ALLERGY & ALLIED RESP DISORDERS,DIV MED,LONDON SE1 9RT,ENGLAND; MOORFIELDS EYE HOSP,LONDON WC1V 7AN,ENGLAND	University of London; King's College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust								BOGUNIEWICZ M, 1990, AM J MED, V88, P365, DOI 10.1016/0002-9343(90)90490-5; BUCKLEY RH, 1978, IMMUNOL REV, V41, P228; BUSSARD AE, 1980, MOL IMMUNOL, V17, P57, DOI 10.1016/0161-5890(80)90124-8; CALLARD RE, 1987, IMMUNOLOGY, V62, P451; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; DELPRETE G, 1988, J IMMUNOL, V140, P4193; DIAZSANCHEZ D, 1990, IMMUNOLOGY, V69, P307; GORDON J, 1987, IMMUNOL TODAY, V8, P339, DOI 10.1016/0167-5699(87)90009-0; GRONOWICZ E, 1976, EUR J IMMUNOL, V6, P588, DOI 10.1002/eji.1830060812; HELM RM, 1986, J ALLERGY CLIN IMMUN, V77, P880, DOI 10.1016/0091-6749(86)90387-8; HOLT PG, 1984, CLIN IMMUNOL IMMUNOP, V30, P159, DOI 10.1016/0090-1229(84)90017-5; HOLT PG, 1989, INT ARCH ALLER A IMM, V89, P381, DOI 10.1159/000234979; KEMENY DM, 1989, J IMMUNOL METHODS, V120, P251, DOI 10.1016/0022-1759(89)90249-4; KEMENY DM, 1987, IMMUNOLOGICAL TECHNI, P47; Kemeny DM., 1991, PRACTICAL GUIDE ELIS; LEUNG DYM, 1989, CLIN RES, V37, P239; MATSUMOTO T, 1981, ANN ALLERGY, V47, P47; NONAKA M, 1981, J EXP MED, V153, P1574, DOI 10.1084/jem.153.6.1574; PAGANELLI R, 1991, CLIN EXP IMMUNOL, V84, P28; PATTERSON R, 1975, CLIN EXP IMMUNOL, V20, P265; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; PFEIL T, 1989, IMMUNOLOGY, V68, P37; RECTOR ES, 1979, EUR J IMMUNOL, V9, P471, DOI 10.1002/eji.1830090611; ROMAGNANI S, 1982, CLIN EXP IMMUNOL, V49, P185; ROMAGNANI S, 1980, CLIN EXP IMMUNOL, V42, P579; SARFATI M, 1988, J IMMUNOL, V141, P2195; SAXON A, 1979, CLIN IMMUNOL IMMUNOP, V14, P474, DOI 10.1016/0090-1229(79)90100-4; SEDGWICK JD, 1983, J EXP MED, V157, P2178, DOI 10.1084/jem.157.6.2178; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; THYPHRONITIS G, 1989, P NATL ACAD SCI USA, V86, P5580, DOI 10.1073/pnas.86.14.5580; TUFT SJ, 1989, EYE, V3, P420, DOI 10.1038/eye.1989.63; TURNER KJ, 1983, CLIN EXP IMMUNOL, V51, P387; TURNER KJ, 1987, CLIN EXP IMMUNOL, V68, P409	36	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1992	89	4					895	904		10.1016/0091-6749(92)90446-9	http://dx.doi.org/10.1016/0091-6749(92)90446-9			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN860	1560170				2022-12-18	WOS:A1992HN86000016
J	SANDERS, BP; PORTMAN, RJ; RAMEY, RA; HILL, M; STRUNK, RC				SANDERS, BP; PORTMAN, RJ; RAMEY, RA; HILL, M; STRUNK, RC			HYPERTENSION DURING REDUCTION OF LONG-TERM STEROID-THERAPY IN YOUNG SUBJECTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; STEROID REDUCTION; HYPERTENSION; ANGIOTENSIN-CONVERTING ENZYME INHIBITOR	CHILDREN; FITNESS	Corticosteroids can induce hypertension, which reportedly remits as the drug is withdrawn. We studied nine patients with steroid-requiring asthma, aged 9 to 16 years, who had elevated blood pressures during corticosteroid treatment. Unlike in previous studies, all nine patients developed hypertension during corticosteroid reduction. Diastolic blood pressures were 50 to 84 mm Hg during maximum corticosteroid therapy (1 to 4 mg/kg/day); these values were in the normal range for seven of the nine patients and in the high normal range for the other two patients. Maximum diastolic pressures were 100 to 120 mm Hg, 1 to 8 weeks after corticosteroid reduction was started. Hypertension occurred at 0% to 70% of their maximum corticosteroid dose. Corticosteroid reduction was the only medication change. Renal causes of hypertension were excluded. Six patients had levels of renin and aldosterone measured before onset of treatment. All six patients had elevated levels of renin, and five patients had elevated levels of aldosterone. Blood pressure elevations were resistant to diuretic therapy but responded rapidly to angiotensin-converting enzyme inhibitors. Caretakers of subjects with asthma need to be aware that hypertension may occur both during maximum corticosteroid use and during corticosteroid reduction.	WASHINGTON UNIV,SCH MED,DEPT PEDIAT,400 S KINGSHIGHWAY BLVD,ST LOUIS,MO 63110; NATL JEWISH CTR IMMUNOL & RESP MED,DEPT NURSING,DENVER,CO; NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DENVER,CO; UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,HOUSTON,TX 77225; ST LOUIS CHILDRENS HOSP,DIV ALLERGY & PULM MED,ST LOUIS,MO 63178	Washington University (WUSTL); National Jewish Health; National Jewish Health; University of Texas System; University of Texas Health Science Center Houston; St. Louis Children's Hospital; Washington University (WUSTL)					NIAID NIH HHS [K07-AI-00543] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K07AI000543] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1987, PEDIATRICS, V79, P1; BACHY C, 1976, BMJ-BRIT MED J, V2, P1287, DOI 10.1136/bmj.2.6047.1287; BUDMAN DR, 1976, ARCH INTERN MED, V136, P1003, DOI 10.1001/archinte.136.9.1003; GORDON DB, 1983, HYPERTENSION, V5, P353, DOI 10.1161/01.HYP.5.3.353; GUTSTADT LB, 1989, AM J DIS CHILD, V143, P471, DOI 10.1001/archpedi.1989.02150160101020; HANDA M, 1984, HYPERTENSION, V6, P236, DOI 10.1161/01.HYP.6.2_Pt_1.236; JACKSON SHD, 1981, CLIN SCI, V61, pS381, DOI 10.1042/cs061381s; KALSNER S, 1969, CIRC RES, V24, P383, DOI 10.1161/01.RES.24.3.383; KRAVOFF L, 1975, AM J MED, V58, P216; LIEBERMAN P, 1972, J ALLERGY CLIN IMMUN, V49, P329, DOI 10.1016/0091-6749(72)90131-5; LOGGIE JMH, 1969, J PEDIATR-US, V74, P331, DOI 10.1016/S0022-3476(69)80190-3; LUKE RG, 1987, KIDNEY INT, V31, P1024, DOI 10.1038/ki.1987.102; MENSTER M, 1982, PEDIATR CLIN N AM, V29, P933; STRUNK RC, 1989, J ALLERGY CLIN IMMUN, V83, P17, DOI 10.1016/0091-6749(89)90473-9; STRUNK RC, 1989, PEDIATRICS, V84, P460; STRUNK RC, 1988, AM J DIS CHILD, V142, P940, DOI 10.1001/archpedi.1988.02150090038019; TUFT L, 1971, ANN ALLERGY, V29, P287; ZIMENT I, 1983, CHEST, V83, P392, DOI 10.1378/chest.83.2.392; 1962, AM REV RESPIR DIS, V85, P762	19	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1992	89	4					816	821		10.1016/0091-6749(92)90436-6	http://dx.doi.org/10.1016/0091-6749(92)90436-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN860	1560165				2022-12-18	WOS:A1992HN86000006
J	GOLLUB, EG; GOSWAMI, SK; SPERBER, K; MAROM, Z				GOLLUB, EG; GOSWAMI, SK; SPERBER, K; MAROM, Z			ISOLATION AND CHARACTERIZATION OF A MACROPHAGE-DERIVED HIGH-MOLECULAR-WEIGHT PROTEIN INVOLVED IN THE REGULATION OF MUCUS-LIKE GLYCOCONJUGATE SECRETION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PULMONARY MACROPHAGES; HYBRIDOMA; MUCOUS GLYCOPROTEIN SECRETAGOGUE; 68KD PROTEIN	SECRETAGOGUE	Pulmonary macrophages release a variety of mediators that are involved in inflammatory processes and probably are involved in respiratory mucus secretion. Conditioned media obtained from activated pulmonary macrophages were found to contain a protein that functioned as a secretagogue for mucus-like glycoconjugate (MLGC) in an in vitro bioassay. A human macrophage-derived hybridoma cell line, HB-63, exhibited the same properties and was very useful in obtaining large amounts of the protein for purification and characterization. With ultrafiltration membranes and gel electrophoresis, the protein isolated from the conditioned media of zymosan- or lipopolysaccharide-treated cells was found to have a molecular weight of approximately 68 kd. The purified protein obtained from hybridoma cells and from pulmonary macrophages exhibited strong biologic activity when it was used to stimulate MLGC secretion, both in human airway explants and in an in vitro human secretory epithelial cancer cell line. The proteins from both sources were found to have similar amino acid compositions. Preliminary results indicate the presence of the 68 kd protein in the bronchoalveolar lavage fluid of a patient with severe chronic bronchitis and mucus hypersecretion. The role of this novel protein in the lungs is, so far, speculative. The 68 kd protein may be a useful tool for studying the biosynthesis and regulation of MLGC secretion and hypersecretion.	MT SINAI MED CTR,DIV CLIN IMMUNOL,NEW YORK,NY 10029	Icahn School of Medicine at Mount Sinai	GOLLUB, EG (corresponding author), MT SINAI MED CTR,DIV PULM & CRIT CARE MED,BOX 1232,1 GUSTAVE LEVY PL,NEW YORK,NY 10029, USA.				NHLBI NIH HHS [NHL-37254] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037254] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMIN DN, 1991, AM J RESP CELL MOL, V4, P135, DOI 10.1165/ajrcmb/4.2.135; GOSWAMI SK, 1990, AM REV RESPIR DIS, V141, P72, DOI 10.1164/ajrccm/141.1.72; GOSWAMI SK, 1989, AM REV RESPIR DIS, V141, P465; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAROM Z, 1984, J EXP MED, V159, P844, DOI 10.1084/jem.159.3.844; MAROM Z, 1985, J CLIN INVEST, V75, P191, DOI 10.1172/JCI111674; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; NISHIDA M, 1985, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V37, P1103; SCHWARTZ E, 1988, J INVEST DERMATOL, V91, P158, DOI 10.1111/1523-1747.ep12464405; SPERBER K, 1990, J IMMUNOL METHODS, V129, P31, DOI 10.1016/0022-1759(90)90417-T; SPERBER K, 1991, J ALLERGY CLIN IMMUN, V87, P490, DOI 10.1016/0091-6749(91)90007-B; SPERBER K, 1991, J ALLERGY CLIN IMMUN, V81, P287; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	15	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1992	89	3					696	702		10.1016/0091-6749(92)90376-D	http://dx.doi.org/10.1016/0091-6749(92)90376-D			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HJ340	1545090				2022-12-18	WOS:A1992HJ34000008
J	SHAPIRO, GG; SINON, RA				SHAPIRO, GG; SINON, RA			BRONCHOPROVOCATION COMMITTEE REPORT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							STANDARDIZATION		AMER ACAD ALLERGY & IMMUNOL,BRONCHOPROVOCAT COMM,MILWAUKEE,WI									CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; RYAN G, 1981, AM REV RESPIR DIS, V123, P195; TOWNLEY RJ, 1987, J ALLERGY CLIN IMMUN, V80, P111, DOI 10.1016/0091-6749(87)90116-3	3	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1992	89	3					775	778		10.1016/0091-6749(92)90387-H	http://dx.doi.org/10.1016/0091-6749(92)90387-H			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HJ340	1545099				2022-12-18	WOS:A1992HJ34000019
J	LEVISCHAFFER, F; SEGAL, V; BARAM, D; MEKORI, YA				LEVISCHAFFER, F; SEGAL, V; BARAM, D; MEKORI, YA			EFFECT OF COCULTURE OF RODENT MAST-CELLS WITH MURINE CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)-DERIVED FIBROBLASTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						RAT PERITONEAL MAST CELLS; MOUSE BONE MARROW-DERIVED MAST CELLS; CHRONIC GRAFT-VERSUS-HOST DISEASE; FIBROBLASTS; COCULTURE	COLLAGEN-SYNTHESIS; SKIN FIBROBLASTS; INVITRO; SCLERODERMA; MOUSE; HISTAMINE; MORPHOLOGY; DEPLETION; RELEASE	We investigated whether murine chronic graft-versus-host disease (cGVHD)-derived skin fibroblasts maintain the viability and functional activity of rat peritoneal connective tissue-mast cells (CTMCs) and whether they affect the change in phenotype of mouse bone marrow-derived mast cells (BMMCs). Skin fibroblasts were isolated before the development of fibrosis (day 5), during overt fibrosis (day 28), and after recovery from fibrosis (day 120). cGVHD fibroblasts of days 5 and 28 exhibited enhanced proliferation, a property that was maintained through several subcultures. CTMCs adhered to the same extent, did not divide, and maintained their viability in all the different cultures. When CTMCs were activated with compound 48/80, they released approximately 80% of their histamine content, indicating that coculture with cGVHD fibroblasts did not adversely affect CTMC function. The amount of histamine found in the medium of 8 days CTMC/cGVHD fibroblast coculture was similar to that found in control culture. These findings suggest that the degranulation of dermal MCs, characteristic of cGVHD, is not due to a direct activating effect of the cGVHD fibroblasts on the MCs. BMMCs seeded on cGVHD fibroblasts acquired the capacity for safranin staining and increased their histamine content, indicative of a change to CTMCs. Thus, cGVHD fibroblasts are able to provide a microenvironment adequate for maintaining viability and activity of CTMCs and for promoting maturation and change in phenotype of BMMCs.	MEIR HOSP,ALLERGY UNIT,KEFAR SAVA,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	LEVISCHAFFER, F (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED SCH,SCH PHARM,DEPT PHARMACOL,IL-91010 JERUSALEM,ISRAEL.							BARAM D, 1991, Journal of Allergy and Clinical Immunology, V87, P287, DOI 10.1016/0091-6749(91)91872-Q; BESCHORNER WE, 1982, CLIN IMMUNOL IMMUNOP, V22, P203, DOI 10.1016/0090-1229(82)90038-1; BUCKINGHAM RB, 1983, J LAB CLIN MED, V101, P659; CHOI KL, 1987, J IMMUNOL, V138, P4093; CLAMAN HN, 1985, J INVEST DERMATOL, V84, P246, DOI 10.1111/1523-1747.ep12265302; CLAMAN HN, 1986, J IMMUNOL, V137, P2009; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; DECLERCK Y, 1986, J IMMUNOL, V136, P3549; ELIAS JA, 1990, J IMMUNOL, V145, P161; HOLDA JH, 1985, J IMMUNOL, V134, P1397; HULEIHEL M, 1990, EUR J IMMUNOL, V20, P731, DOI 10.1002/eji.1830200404; ISHIZAKA T, 1976, J IMMUNOL, V116, P747; JAFFEE BD, 1983, CELL IMMUNOL, V77, P1, DOI 10.1016/0008-8749(83)90001-1; KRIEG T, 1981, ARCH DERMATOL RES, V270, P263, DOI 10.1007/BF00403930; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431; LEVISCHAFFER F, 1991, IMMUNOL LETT, V27, P13, DOI 10.1016/0165-2478(91)90237-5; LEVISCHAFFER F, 1990, CELL IMMUNOL, V127, P146, DOI 10.1016/0008-8749(90)90121-7; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LEVISCHAFFER F, 1989, CELL IMMUNOL, V119, P30, DOI 10.1016/0008-8749(89)90221-9; LEVISCHAFFER F, 1991, IMMUNOLOGY, V72, P174; LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454; MAYER B, 1984, BIOCHIM BIOPHYS ACTA, V795, P151, DOI 10.1016/0005-2760(84)90116-4; MEKORI YA, 1990, NETWORK, V1, P77; SHAFF RE, 1979, ANAL BIOCHEM, V94, P425, DOI 10.1016/0003-2697(79)90385-3; SPIELVOGEL MRL, 1977, ARCH DERMATOL, V113, P1424	26	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1992	89	2					501	509		10.1016/0091-6749(92)90316-T	http://dx.doi.org/10.1016/0091-6749(92)90316-T			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD753	1371296	Bronze			2022-12-18	WOS:A1992HD75300001
J	JONES, RT; BUBAK, ME; GOSSELIN, VA; YUNGINGER, JW				JONES, RT; BUBAK, ME; GOSSELIN, VA; YUNGINGER, JW			RELATIVE LATEX ALLERGEN CONTENTS OF SEVERAL COMMERCIAL LATEX GLOVES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				225	225						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000274
J	YOUNG, MC; OSLEEB, C; SLATER, J				YOUNG, MC; OSLEEB, C; SLATER, J			LATEX AND BANANA ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				226	226						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000280
J	ZEIGER, RS; HELLER, S; SAMPSON, HA				ZEIGER, RS; HELLER, S; SAMPSON, HA			GENETIC AND ENVIRONMENTAL-FACTORS AFFECTING THE DEVELOPMENT OF ATOPY FROM BIRTH THROUGH AGE 4 IN A PROSPECTIVE RANDOMIZED CONTROLLED-STUDY OF DIETARY AVOIDANCE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				192	192						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000144
J	AMBRUS, JL; HANEIWICH, S; CHESKY, L; MCFARLAND, P; ENGLER, RJ				AMBRUS, JL; HANEIWICH, S; CHESKY, L; MCFARLAND, P; ENGLER, RJ			IMPROVED INVITRO ANTIGEN-SPECIFIC ANTIBODY-SYNTHESIS IN 2 PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY TAKING AN ORAL CYCLOOXYGENASE AND LIPOXYGENASE INHIBITOR (KETOPROFEN)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						B-CELL; COMMON VARIABLE IMMUNODEFICIENCY; PROLIFERATION; ANTIBODY PRODUCTION; 5-LIPOXYGENASE; KETOPROFEN	CELL GROWTH-FACTOR; HUMAN-LYMPHOCYTES; T-CELLS; B-CELLS; VARIED IMMUNODEFICIENCY; INTERFERON-GAMMA; HYPOGAMMAGLOBULINEMIA; PROSTAGLANDIN-E2; INTERLEUKIN-4; LEUKOTRIENES	In the process of performing a previously published study examining B cell function in 16 patients with common variable immunodeficiency (CVI)(J ALLERGY CLIN IMMUNOL 1991;87:1138-49), we noted improved in vitro antibody (Ab) synthesis in a patient, H.B., while he was taking a cyclooxygenase and lipoxygenase inhibitor, ketoprofen. Addition of ketoprofen in vitro to B cells from patients with CVI resulted in improved proliferation and differentiation in four of five additional patients with CVI studied. One patient, besides H. B., M. K. B., whose B cells secreted increased amounts of antigen (Ag)-specific Ab in response to in vitro ketoprofen, underwent a trial of oral ketoprofen. M. K. B., like H. B., demonstrated improved in vitro Ag-specific Ab production while she was taking oral ketoprofen. No increase in serum Ab levels was noted in either patient taking ketoprofen, but both patients remained infection free during the time of their ketoprofen trials (H. B., 9 months, and M. K. B., 36 months). No improvement in in vitro Ag-specific Ab synthesis was noted when H. B. and M. K. B. took oral cyclooxygenase inhibitors (naproxen or ibuprofen). Thus, additional study is warranted to examine the role of lipoxygenase products of arachidonic acid in the B cell dysfunction of CVI.	NIAID,BETHESDA,MD 20892; MED UNIV S CAROLINA,CHARLESTON,SC 29425; WALTER REED ARMY MED CTR,DIV ALLERGY & IMMUNIZAT,WASHINGTON,DC 20307	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Medical University of South Carolina; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	AMBRUS, JL (corresponding author), WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DIV RHEUMATOL,216 S KINGSHIGHWAY,ST LOUIS,MO 63110, USA.							AMBRUS J, 1991, J BIOL CHEM, V266, P3701; AMBRUS JL, 1988, J IMMUNOL, V140, P2382; AMBRUS JL, 1985, J CLIN INVEST, V75, P732, DOI 10.1172/JCI111754; AMBRUS JL, 1990, J IMMUNOL, V145, P3949; AMBRUS JL, 1985, J EXP MED, V162, P1319, DOI 10.1084/jem.162.4.1319; AMBRUS JL, 1991, J ALLERGY CLIN IMMUN, V87, P1138, DOI 10.1016/0091-6749(91)92160-3; AMBRUS JL, 1988, LYMPHOCYTE ACTIVATIO, P73; ATLURU D, 1984, J CLIN INVEST, V74, P1444, DOI 10.1172/JCI111556; BEHRENS TW, 1989, J IMMUNOL, V143, P2285; ESKOLA J, 1989, J CLIN LAB IMMUNOL, V28, P55; FALKOFF RM, 1982, J IMMUNOL METHODS, V50, P39, DOI 10.1016/0022-1759(82)90302-7; FARRANT J, 1989, CLIN IMMUNOL IMMUNOP, V51, P196, DOI 10.1016/0090-1229(89)90019-6; GUHLMANN A, 1989, J EXP MED, V170, P1905, DOI 10.1084/jem.170.6.1905; ISRAEL E, 1990, NEW ENGL J MED, V323, P1740, DOI 10.1056/NEJM199012203232505; IUDICONE P, 1989, HAEMATOLOGICA, V74, P359; JELINEK DF, 1985, J CLIN INVEST, V75, P1339, DOI 10.1172/JCI111835; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; PASTORELLI G, 1990, CLIN EXP IMMUNOL, V82, P120; PAYAN DG, 1984, P NATL ACAD SCI-BIOL, V81, P3501, DOI 10.1073/pnas.81.11.3501; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; PERI R, 1985, BLOOD, V66, P345; ROLAPLESZCZYNSKI M, 1987, J IMMUNOL, V139, P513; ROLAPLESZCZYNSKI M, 1985, J IMMUNOL, V135, P1357; SAIKI O, 1984, J IMMUNOL, V133, P1920; SAIKI O, 1982, P NATL ACAD SCI-BIOL, V79, P6008, DOI 10.1073/pnas.79.19.6008; SAXON A, 1989, J ALLERGY CLIN IMMUN, V84, P44, DOI 10.1016/0091-6749(89)90177-2; SCHULAM PG, 1990, J IMMUNOL, V144, P2696; SEGAL R, 1989, J ALLERGY CLIN IMMUN, V84, P753, DOI 10.1016/0091-6749(89)90305-9; SNELLER MC, 1990, J IMMUNOL, V144, P3762; SPICKETT GP, 1989, IMMUNOL TODAY, V10, P192, DOI 10.1016/0167-5699(89)90323-X; SPURNEY RF, 1991, KIDNEY INT, V39, P95, DOI 10.1038/ki.1991.12; STOHL W, 1988, CLIN IMMUNOL IMMUNOP, V49, P273, DOI 10.1016/0090-1229(88)90117-1; WALDMANN TA, 1974, LANCET, V2, P609; WILLIAMS RL, 1988, J CLIN PHARMACOL, V28, P513	34	9	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1991	88	5					775	783		10.1016/0091-6749(91)90185-Q	http://dx.doi.org/10.1016/0091-6749(91)90185-Q			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GQ452	1955636				2022-12-18	WOS:A1991GQ45200013
J	CHAPMAN, MD				CHAPMAN, MD			USE OF NONSTIMULATORY PEPTIDES - A NEW STRATEGY FOR IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							HOUSE-DUST MITE; LYMPHOCYTE-T CLONES; IGE SYNTHESIS; DERMATOPHAGOIDES; SPECIFICITY; ASTHMA				CHAPMAN, MD (corresponding author), UNIV VIRGINIA,DEPT MED,DIV ALLERGY & IMMUNOL,BOX 225,CHARLOTTESVILLE,VA 22908, USA.							BERZOFSKY JA, 1989, FUNDAMENTAL IMMUNOLO, P169; GURKA G, 1989, J ALLERGY CLIN IMMUN, V83, P945, DOI 10.1016/0091-6749(89)90110-3; LAMB JR, 1989, CLIN EXP ALLERGY, V19, P389, DOI 10.1111/j.1365-2222.1989.tb02403.x; MACHIELS JJ, 1990, J CLIN INVEST, V85, P1024, DOI 10.1172/JCI114532; Noon L, 1911, LANCET, V1, P1572; OHEHIR RE, 1989, IMMUNOLOGY, V66, P499; OHEHIR RE, 1991, J ALLERGY CLIN IMMUN, V87, P1120, DOI 10.1016/0091-6749(91)92158-W; OHEHIR RE, 1990, INT IMMUNOL, V2, P885, DOI 10.1093/intimm/2.9.885; PLAUT M, 1990, J IMMUNOL, V144, P4497; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; STANWORTH DR, 1990, LANCET, V336, P1279, DOI 10.1016/0140-6736(90)92963-I; VANMETRE TE, 1988, ALLERGY PRINCIPLES P, V2, P1327; WIERENGA EA, 1990, EUR J IMMUNOL, V20, P1519, DOI 10.1002/eji.1830200717; WIERENGA EA, 1990, J IMMUNOL, V144, P4651	14	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1991	88	3	1				300	302		10.1016/0091-6749(91)90091-2	http://dx.doi.org/10.1016/0091-6749(91)90091-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GG126	1890259				2022-12-18	WOS:A1991GG12600002
J	GONG, H				GONG, H			AIR-TRAVEL AND PATIENTS WITH PULMONARY AND ALLERGIC CONDITIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							FLIGHT MEDICAL EMERGENCIES; ALTITUDE; DISEASE; HYPOXEMIA; AIRCRAFT				GONG, H (corresponding author), UNIV CALIF LOS ANGELES,MED CTR,DEPT MED,DIV PULM & CRIT CARE MED,LOS ANGELES,CA 90024, USA.							ANDERSON JM, 1986, JAMA-J AM MED ASSOC, V256, P167; COTTRELL JJ, 1988, CHEST, V93, P81, DOI 10.1378/chest.93.1.81; COTTRELL JJ, 1989, JAMA-J AM MED ASSOC, V262, P1653, DOI 10.1001/jama.262.12.1653; CRUICKSHANK JM, 1988, LANCET, V2, P497, DOI 10.1016/S0140-6736(88)90134-1; CUMMINS RO, 1988, JAMA-J AM MED ASSOC, V259, P1983, DOI 10.1001/jama.259.13.1983; CUMMINS RO, 1989, JAMA-J AM MED ASSOC, V261, P1295, DOI 10.1001/jama.261.9.1295; DILLARD TA, 1989, ANN INTERN MED, V111, P362, DOI 10.7326/0003-4819-111-5-362; GONG H, 1989, ANN INTERN MED, V111, P349, DOI 10.7326/0003-4819-111-5-349; GONG H, 1984, AM REV RESPIR DIS, V130, P980; GONG H, 1984, ANN INTERN MED, V100, P595, DOI 10.7326/0003-4819-100-4-595; GONG H, 1990, J RESPIR DIS, V11, P494; HANNA HH, 1985, FUNDAMENTALS AEROSPA, P511; HENDLEY JO, 1987, JAMA-J AM MED ASSOC, V258, P2764; LANGE W R, 1987, MMJ (Maryland Medical Journal), V36, P421; MILLS FJ, 1983, BRIT MED J, V286, P1204, DOI 10.1136/bmj.286.6372.1204; MILLS FJ, 1983, BRIT MED J, V287, P411, DOI 10.1136/bmj.287.6389.411; MOSER M, 1990, AVIAT SPACE ENVIR MD, V61, P662; MOSER M, 1990, AVIAT SPACE ENVIR MD, V61, P735; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; PERIN M, 1976, AVIAT SPACE ENVIR MD, V47, P1109; SCHWARTZ JS, 1984, ANN INTERN MED, V100, P473, DOI 10.7326/0003-4819-100-4-473; SPEIZER C, 1989, ANN EMERG MED, V18, P26, DOI 10.1016/S0196-0644(89)80306-3; VERVLOET D, 1982, J ALLERGY CLIN IMMUN, V69, P290, DOI 10.1016/S0091-6749(82)80006-7; ZIMMERLY JG, 1987, MD MED J, V3, P423; 1982, JAMA-J AM MED ASSOC, V247, P1007; 1986, AIRLINER CABIN ENV A; AVIAT SPACE ENV MED, V59, P683	27	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1991	87	4					879	885		10.1016/0091-6749(91)90137-D	http://dx.doi.org/10.1016/0091-6749(91)90137-D			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FG059	2013682				2022-12-18	WOS:A1991FG05900019
J	GRAMMER, LC; ROBERTS, M; WIGGINS, CA; FITZSIMONS, RR; IVANOVICH, PT; ROXE, DM; PATTERSON, R				GRAMMER, LC; ROBERTS, M; WIGGINS, CA; FITZSIMONS, RR; IVANOVICH, PT; ROXE, DM; PATTERSON, R			A COMPARISON OF CUTANEOUS TESTING AND ELISA TESTING FOR ASSESSING REACTIVITY TO ETHYLENE OXIDE-HUMAN SERUM-ALBUMIN IN HEMODIALYSIS-PATIENTS WITH ANAPHYLACTIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IGE; ANTIBODIES	In five patients who have experienced anaphylaxis and in 29 patients who have not had such episodes during hemodialysis, we have performed two immunologic studies: cutaneous testing with ethylene oxide-human serum albumin (ETO-HSA) and ELISA for IgE against ETO-HSA. Four of five patients with reactions had positive cutaneous tests, whereas only one nonreactor had a positive skin test (p < 0.0002). The same four of five patients with reactions also had positive ELISA results, whereas three nonreactors has positive ELISA results (p < 0.003). In this group of patients, the positive predictive value of cutaneous testing (80%) is somewhat higher than that of ELISA testing (57%). However, the sensitivity, specificity, and negative predictive values are similar. We conclude that cutaneous testing with ETO-HSA probably offers a small advantage over IgE against ETO-HSA as determined by ELISA.	NORTHWESTERN UNIV,SCH MED,DEPT MED,NEPHROL SECT,CHICAGO,IL 60611	Northwestern University	GRAMMER, LC (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,303 E CHICAGO AVE,CHICAGO,IL 60611, USA.			Grammer, Leslie/0000-0001-6860-2014	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DOLOVICH J, 1978, J ALLERGY CLIN IMMUN, V62, P30, DOI 10.1016/0091-6749(78)90069-6; GALEN RS, 1986, MANUAL CLIN LABORATO, P966; GRAMMER LC, 1985, J ALLERGY CLIN IMMUN, V76, P511, DOI 10.1016/0091-6749(85)90736-5; MILLER GB, 1989, MMWR-MORBID MORTAL W, V38, P873; NICHOLLS AJ, 1982, BRIT MED J, V285, P1607, DOI 10.1136/bmj.285.6355.1607; POPLI S, 1982, ARTIF ORGANS, V6, P312; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55	8	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1991	87	3					674	676		10.1016/0091-6749(91)90387-4	http://dx.doi.org/10.1016/0091-6749(91)90387-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FB801	2005319				2022-12-18	WOS:A1991FB80100011
J	PERRICK, D; STAFFORD, CT; ARMSTRONG, E; DURANT, RH				PERRICK, D; STAFFORD, CT; ARMSTRONG, E; DURANT, RH			MODIFICATION OF THE FLUORESCENT ALLERGOSORBENT TEST AS AN INHIBITION ASSAY FOR DETERMINATION OF CROSS-REACTIVITY AMONG AEROALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RADIOALLERGOSORBENT TEST; EXTRACTS; CAPACITIES; ALLERGENS; POTENCY; POLLEN	The fluorescent allergosorbent test was adapted as an inhibition assay to determine cross-reactivity between aeroallergens. With this method, similar antigenic determinants were found between short ragweed and giant ragweed, cocklebur, lamb's-quarter, rough pigweed, marsh elder, and goldenrod. Cocklebur and giant ragweed were highly potent in their ability to competitively bind to short ragweed IgE. The other pollens demonstrated lower potency of cross-reacting antigens. The fluorescent allergosorbent test-inhibition assay appears to be a useful method to determine cross-reactivity among aeroallergens.	MED COLL GEORGIA,ALLERGY IMMUNOL SECT,AUGUSTA,GA 30912	University System of Georgia; Augusta University								AGARWAL MK, 1982, J ALLERGY CLIN IMMUN, V70, P437, DOI 10.1016/0091-6749(82)90006-9; GLEICH GJ, 1976, J ALLERGY CLIN IMMUN, V58, P31, DOI 10.1016/0091-6749(76)90104-4; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; GLEICH GJ, 1980, J ALLERGY CLIN IMMUN, V65, P110, DOI 10.1016/0091-6749(80)90194-3; GUEANT JL, 1989, ALLERGY, V44, P204, DOI 10.1111/j.1398-9995.1989.tb02263.x; KARR RM, 1981, J ALLERGY CLIN IMMUN, V67, P194, DOI 10.1016/0091-6749(81)90061-0; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P140, DOI 10.1016/0091-6749(76)90149-4; MARTIN BG, 1985, ANN ALLERGY, V54, P99; ROSE NR, 1986, MANUALC LIN LABORATO, P652; SCHRODER H, 1980, ALLERGY, V35, P234, DOI 10.1111/j.1398-9995.1980.tb01758.x; STAFFORD CT, 1990, IMMUNOL ALLERGY PRAC, V12, P4; WIDE L, 1967, LANCET, V2, P1105	12	9	9	1	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1991	87	1	1				98	103		10.1016/0091-6749(91)90218-D	http://dx.doi.org/10.1016/0091-6749(91)90218-D			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EX985	1704024				2022-12-18	WOS:A1991EX98500013
J	VANMETRE, TE; ADKINSON, NF; KAGEYSOBOTKA, A; KHATTIGNAVONG, A; MARSH, DG; NORMAN, PS; ROSENBERG, GL				VANMETRE, TE; ADKINSON, NF; KAGEYSOBOTKA, A; KHATTIGNAVONG, A; MARSH, DG; NORMAN, PS; ROSENBERG, GL			IMMUNOTHERAPY DECREASES SKIN SENSITIVITY TO RAGWEED EXTRACT - DEMONSTRATION BY MIDPOINT SKIN-TEST TITRATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV CLIN IMMUNOL,BALTIMORE,MD 21205; JOHNS HOPKINS ASTHMA & ALLERGY CTR,BALTIMORE,MD	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI004866, R01AI004866] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 04866, AI 11936] Funding Source: Medline; PHS HHS [3 P50 AL 10304] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		HEDLIN G, 1986, J ALLERGY CLIN IMMUN, V77, P488, DOI 10.1016/0091-6749(86)90184-3; VANMETRE TE, 1982, J ALLERGY CLIN IMMUN, V69, P181, DOI 10.1016/0091-6749(82)90098-7; VANMETRE TE, 1988, J ALLERGY CLIN IMMUN, V82, P1055, DOI 10.1016/0091-6749(88)90144-3; VANMETRE TE, 1989, J ALLERGY CLIN IMMUN, V83, P888, DOI 10.1016/0091-6749(89)90102-4; VANMETRE TE, 1990, J ALLERGY CLIN IMMUN, V86, P583, DOI 10.1016/S0091-6749(05)80216-7; VANMETRE TE, 1980, J ALLERGY CLIN IMMUN, V66, P500, DOI 10.1016/0091-6749(80)90012-3	6	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	1				587	588		10.1016/S0091-6749(05)80217-9	http://dx.doi.org/10.1016/S0091-6749(05)80217-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EG454	2229819				2022-12-18	WOS:A1990EG45400021
J	KURTZ, AS; KAPLAN, AP				KURTZ, AS; KAPLAN, AP			REGIONAL EXPRESSION OF COLD URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									SUNY STONY BROOK,HLTH SCI CTR,DEPT MED,DIV ALLERGY RHEUMATOL & CLIN IMMUNOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook								Costanzi J J, 1967, Clin Exp Immunol, V2, P167; GERHARD HJ, 1974, HAUTARZT, V25, P197; INOUE S, 1980, J ALLERGY CLIN IMMUN, V66, P299, DOI 10.1016/0091-6749(80)90025-1; JYTTE RP, 1978, CONTACT DERMATITIS, V4, P59; KAPLAN AP, 1984, J ALLERGY CLIN IMMUN, V73, P453, DOI 10.1016/0091-6749(84)90354-3; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P438; KAPLAN AP, 1975, J ALLERGY CLIN IMMUN, V55, P394, DOI 10.1016/0091-6749(75)90078-0; SOLOMON LM, 1966, ARCH DERMATOL, V94, P156; SOTER WA, 1977, J ALLERGY CLIN IMMUN, V54, P294; WANDERER AA, 1971, J ALLERGY CLIN IMMUN, V48, P13, DOI 10.1016/0091-6749(71)90050-9	11	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1990	86	2					272	273		10.1016/S0091-6749(05)80076-4	http://dx.doi.org/10.1016/S0091-6749(05)80076-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DV316	2384655				2022-12-18	WOS:A1990DV31600020
J	BIELORY, L; CONTI, J; FROHMAN, L				BIELORY, L; CONTI, J; FROHMAN, L			COGANS SYNDROME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT OPHTHALMOL, NEWARK, NJ 07103 USA; UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT NEUROSCI, NEWARK, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	BIELORY, L (corresponding author), UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT MED, DIV ALLERGY & IMMUNOL, MSB I-512, NEWARK, NJ 07103 USA.							ALBRITE JP, 1961, ARCHIV OTOLARYNGOL, V74, P501; AMORELLI A, 1964, ARCH ITAL LARYNGOL, V72, P225; ARNOLD W, 1984, LARYNG RHINOL OTOL V, V63, P428, DOI 10.1055/s-2007-1008327; ARNOLD W, 1985, ACTA OTO-LARYNGOL, V99, P437, DOI 10.3109/00016488509108935; BACHYNSKI B, 1984, CAN J OPHTHALMOL, V19, P145; BAMMER VH, 1959, NERVENARZT, V30, P315; BARNA BP, 1988, LARYNGOSCOPE, V98, P251; BECKMAN H, 1970, ARCHIV OTOLARYNGOL, V91, P179; BELLUCCI RJ, 1974, B NEW YORK ACAD MED, V50, P672; BENNETT FM, 1963, AM J OPHTHALMOL, V55, P815, DOI 10.1016/0002-9394(63)92451-6; Bernhardt D, 1976, Dtsch Med Wochenschr, V101, P373; BICKNELL JM, 1978, NEUROLOGY, V28, P278, DOI 10.1212/WNL.28.3.278; BIELORY L, 1988, MEDICINE, V67, P40, DOI 10.1097/00005792-198801000-00003; BISCHOFF B, 1972, KLIN MONATSBL AUGENH, V161, P551; BOMHOLT A, 1982, ARCH OTO-RHINO-LARYN, V236, P53, DOI 10.1007/BF00464057; BONAMOUR M, 1961, B SOC OPHTHALMOL, V5, P382; BOYD GG, 1957, ARCHIV OTOLARYNGOL, V65, P24; CANESTRINI L, 1959, Riv Neurol, V29, P511; CARTER F, 1987, LANCET, V1, P858; CHAR DH, 1975, AM J OPHTHALMOL, V80, P491, DOI 10.1016/0002-9394(75)90213-5; CHESON BD, 1977, NEW ENGL J MED, V297, P62; CHESON BD, 1976, AM J MED, V60, P549, DOI 10.1016/0002-9343(76)90722-1; COBO LM, 1984, OPHTHALMOLOGY, V91, P903; CODY D T, 1960, Laryngoscope, V70, P447; CODY TR, 1962, MAYO CLIN PROC, V37, P372; COGAN DG, 1945, ARCH OPHTHALMOL-CHIC, V33, P144; COGAN DG, 1949, ARCH OPHTHALMOL-CHIC, V42, P42, DOI 10.1001/archopht.1949.00900050045004; COGAN DG, 1964, ARCH OPHTHALMOL-CHIC, V71, P172, DOI 10.1001/archopht.1964.00970010188005; CRAWFORD W J, 1957, Pa Med J, V60, P835; DAROUGAR S, 1978, BR J OPHTHALMOL, V62, P7089; DELCARPIO J, 1976, NEW ENGL J MED, V295, P1262; DJUPESLAND G, 1974, ARCH OTOLARYNGOL, V99, P218; DONALD RA, 1950, AM J OPHTHALMOL, V33, P889, DOI 10.1016/0002-9394(50)91604-7; EDSTROM S, 1976, ACTA OTO-LARYNGOL, V82, P212, DOI 10.3109/00016487609120886; EISENSTEIN B, 1958, NEW ENGL J MED, V258, P1074, DOI 10.1056/NEJM195805292582202; ELMIGER F, 1958, Pract Otorhinolaryngol (Basel), V20, P374; FAIR JR, 1960, AM J OPHTHALMOL, V49, P1017, DOI 10.1016/0002-9394(60)91826-2; FISHER ER, 1961, ARCH PATHOL, V72, P572; GELFAND ML, 1972, B NEW YORK ACAD MED, V48, P647; GERBER M, 1958, Q Bull Northwest Univ Med Sch, V32, P15; GILBERT WS, 1969, ARCH OPHTHALMOL-CHIC, V82, P633, DOI 10.1001/archopht.1969.00990020629010; GIORDANO R, 1959, Arch Ital Otol Rinol Laringol, V70, P664; GOKAY HK, 1955, ARCH NEURO PSYCHIATR, V73, P352; GOLDSHER M, 1985, EAR NOSE THROAT J, V64, P354; GOUET D, 1983, REV MED INTERNE, V3, P267; HALLBERG O E, 1956, Laryngoscope, V66, P1237; HAYNES BF, 1981, ARTHRITIS RHEUM, V24, P501, DOI 10.1002/art.1780240308; HAYNES BF, 1980, MEDICINE, V59, P426, DOI 10.1097/00005792-198011000-00003; HERDEMERTEN VS, 1972, MUNCHEN MED WOCHEN, V114, P2035; HESSE G, 1987, HNO, V35, P376; HUGHES GB, 1983, OTOLARYNG HEAD NECK, V91, P24, DOI 10.1177/019459988309100106; Hulse M, 1975, Laryngol Rhinol Otol (Stuttg), V54, P977; HUNDER GG, 1975, ANN INTERN MED, V82, P613, DOI 10.7326/0003-4819-82-5-613; KUNDELL SP, 1980, J PEDIATR-US, V97, P96, DOI 10.1016/S0022-3476(80)80142-9; LAFFIN MA, 1987, J OTOLARYNGOL, V16, P137; LARAJA RD, 1976, ARCH SURG-CHICAGO, V111, P1028; LEFF IL, 1967, NEW YORK STATE J MED, V67, P2249; LINDSAY JR, 1950, LARYNGOSCOPE, V60, P238; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; MCDONALD TJ, 1985, LARYNGOSCOPE, V95, P650; MCGAVIN DDM, 1977, ANN OPHTHALMOL, V9, P1287; MORGAN GJ, 1984, AM J OTOLARYNG, V5, P258; Morgan R.F., 1934, WESTERN J SURG OB GY, V42, P628; MOSCICKI R, 1988, J ALLERGY CLIN IMMUN, V81, P217, DOI 10.1016/0091-6749(88)90432-0; Negroni L, 1969, Riv Otoneurooftalmol, V44, P199; NORTON EWD, 1959, ARCH OPHTHALMOL-CHIC, V61, P695, DOI 10.1001/archopht.1959.00940090697004; OLINER L, 1953, NEW ENGL J MED, V248, P1001, DOI 10.1056/NEJM195306112482402; PEETERS GJHCM, 1986, ANN OTO RHINOL LARYN, V95, P173, DOI 10.1177/000348948609500213; PINALS RS, 1978, J RHEUMATOL, V5, P294; QUINN F B Jr, 1958, Trans Am Acad Ophthalmol Otolaryngol, V62, P716; RAREY KE, 1986, AM J OTOLARYNG, V7, P387, DOI 10.1016/S0196-0709(86)80012-6; ROBERTS J, 1965, Med J Aust, V1, P186; ROBSON JT, 1950, ARCH OPHTHALMOL-CHIC, V44, P243, DOI 10.1001/archopht.1950.00910020250006; ROSEN E, 1949, ARCH OPHTHALMOL-CHIC, V41, P24; Saraux H, 1972, Ann Ocul (Paris), V205, P431; SEELJ, 1972, A VONGRAEFES ARCH KL, V185, P281; SERRINS AJ, 1963, ARCHIV OTOLARYNGOL, V78, P785; SIL Y, 1973, HAREFUAH, V85, P452; SMITH JL, 1970, LARYNGOSCOPE, V80, P121, DOI 10.1288/00005537-197001000-00010; SQUARA P, 1986, ARCH MAL COEUR VAISS, V79, P1271; STEVENS H, 1954, AMA ARCH NEUROL PSY, V71, P337, DOI 10.1001/archneurpsyc.1954.02320390067006; SUZUKI Y, 1965, J OTORHINOLARYNGOL S, V68, P54; TOSELLI C, 1964, Ann Ottalmol Clin Ocul, V90, P513; VAGLINI F, 1964, Boll Mal Orecch Gola Naso, V82, P446; Vermeersch H, 1977, Acta Otorhinolaryngol Belg, V31, P183; VOLLERTSEN RS, 1986, MAYO CLIN PROC, V61, P344, DOI 10.1016/S0025-6196(12)61951-X; VOZZI I R, 1961, Rev Asoc Med Argent, V75, P576; WALSH FB, 1969, CLIN NEUROPHTHALMOLO, V2, P185; WOLFF D, 1965, ANN OTO RHINOL LARYN, V74, P507, DOI 10.1177/000348946507400219; 1978, J CLIN IMMUNOL, V1, P1	90	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					808	815		10.1016/0091-6749(90)90203-G	http://dx.doi.org/10.1016/0091-6749(90)90203-G			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2324419				2022-12-18	WOS:A1990DA43700020
J	SALVAGGIO, JE				SALVAGGIO, JE			THE IMPACT OF ALLERGY AND IMMUNOLOGY ON OUR EXPANDING INDUSTRIAL-ENVIRONMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SALVAGGIO, JE (corresponding author), TULANE UNIV, SCH MED, CLIN IMMUNOL & ALLERGY SECT, 1700 PERDIDO ST, NEW ORLEANS, LA 70112 USA.							AARLI JA, 1976, ARCH NEURAL, V33, P196; ALLISON AC, 1966, J EXP MED, V124, P141, DOI 10.1084/jem.124.2.141; BARDANA EJ, 1988, CLIN REV ALLERG, V6, P61; BECKLAKE MR, 1982, AM REV RESPIR DIS, V126, P187; Bigazzi P. E., 1985, IMMUNOTOXICOLOGY IMM, P277; BOZELKA BE, 1985, ENVIRON CARCINOG REV, V3, P1; BOZELKA BE, 1983, AM J PATHOL, V112, P326; BRAVERMAN IM, 1975, J INVEST DERMATOL, V64, P105, DOI 10.1111/1523-1747.ep12510321; BUTCHER B T, 1982, Journal of Allergy and Clinical Immunology, V69, P123; Campbell JM, 1932, BRIT MED J, V1932, P1143; CHADWICK J, 1982, MED WORKS HIPPOCRATE, P90; CULLEN MR, 1987, OCCUPATIONAL MED WOR, P658; DAVIES RJ, 1977, J ALLERGY CLIN IMMUN, V60, P223, DOI 10.1016/0091-6749(77)90134-8; DEAN JH, 1982, ENVIRON HEALTH PERSP, V43, P27, DOI 10.2307/3429164; Dement JM., 1979, DUSTS DIS, P131; DESHAZO RD, 1983, J ALLERGY CLIN IMMUN, V72, P454, DOI 10.1016/0091-6749(83)90581-X; DOLL NJ, 1983, CLIN CHEST MED, V4, P3; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; Figley KD, 1928, J AMER MED ASSOC, V90, P79, DOI 10.1001/jama.1928.02690290009003; FRY J, 1953, LANCET, V264, P235; FYE KH, 1977, AM J MED, V62, P783, DOI 10.1016/0002-9343(77)90884-1; HARMON CE, 1985, MED CLIN N AM, V69, P547, DOI 10.1016/S0025-7125(16)31032-X; HIRSCH F, 1982, EUR J IMMUNOL, V12, P620, DOI 10.1002/eji.1830120716; HUBER TE, 1954, AMA ARCH IND HYG OCC, V10, P399; HUNTER D, 1955, DISEASES OCCUPATIONS, P841; HUNTER D, 1975, DISEASES OCCUPATIONS; JONES JM, 1974, INT ARCH ALLER A IMM, V46, P161, DOI 10.1159/000231120; JONES RN, 1976, AM REV RESPIR DIS, V113, P393; KAGAN E, 1981, SEMIN ONCOL, V8, P258; KAGAN E, 1977, CLIN EXP IMMUNOL, V28, P261; KAGAN E, 1977, CLIN EXP IMMUNOL, V28, P268; KAGAN E, 1983, AM J CLIN PATHOL, V80, P14, DOI 10.1093/ajcp/80.1.14; KARASEK ST, 1911, USE PLATINUM PAPER, P97; KJELLMAN NIM, 1981, LANCET, V1, P993; KOLLER LD, 1985, IMMUNOL ALLERGY PRAC, V7, P405; LANGE A, 1974, INT ARCH ARBEITSMED, V32, P313, DOI 10.1007/BF02178970; LANGE A, 1983, ENVIRON RES, V31, P287, DOI 10.1016/0013-9351(83)90006-3; LANGE A, 1978, ARCH IMMUNOL THER EX, V26, P899; LEVIN AS, 1987, STATE ART REV OCC S4, V2, P6698; LOPEZ M, 1983, ALLERGY PRINCIPLES P, V2, P1203; MATSUMURA Y, 1970, AM REV RESPIR DIS, V102, P430; MELIUS J, 1984, EVALUATING OFFICE EN, V10, P3; MILLER LG, 1983, CLIN EXP IMMUNOL, V51, P110; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; OHSAWA M, 1988, CLIN EXP IMMUNOL, V73, P98; PELLETIER L, 1988, J IMMUNOL, V140, P750; PHELPS HW, 1962, AM REV RESPIR DIS, V86, P55; Ramazzini B, 1713, DISEASES WORKERS; REA WJ, 1978, ANN ALLERGY, V41, P101; ROBINSON CJG, 1983, FED PROC, V42, P1213; RODNAN GP, 1967, ANN INTERN MED, V66, P323, DOI 10.7326/0003-4819-66-2-323; ROSS R, 1982, LANCET, V2, P1118; RYU J H, 1984, American Review of Respiratory Disease, V129, pA150; SALVAGGIO J, 1971, J ALLERGY CLIN IMMUN, V48, P96, DOI 10.1016/0091-6749(71)90091-1; SALVAGGIO J, 1960, J ALLERGY, V45, P257; SALVAGGIO J, 1986, 12 P INT C ALL CLIN, P486; SALVAGGIO JE, 1967, J ALLERGY, V39, P227, DOI 10.1016/0021-8707(67)90015-9; SCHOTTENFELD RS, 1987, OCCUPATIONAL MED WOR, P739; SCHRENK HH, 1948, PUBLIC HLTH B, V306, P1948; SELIKOFF IJ, 1978, CA-CANCER J CLIN, V28, P87, DOI 10.3322/canjclin.28.2.87; SHEPPARD D, 1988, J CLIN INVEST, V81, P1111, DOI 10.1172/JCI113424; SHIMODA T, 1988, J ALLERGY CLIN IMMUN, V81, P1187, DOI 10.1016/0091-6749(88)90889-5; SPOTNITZ M, 1965, AM REV RESPIR DIS, V92, P371; STANKUS RP, 1981, J RETICULOENDOTH SOC, V29, P153; TAN EM, 1982, ADV IMMUNOL, V33, P167, DOI 10.1016/S0065-2776(08)60836-6; TAN EM, 1989, J CLIN INVEST, V84, P1, DOI 10.1172/JCI114127; TERR AI, 1986, ARCH INTERN MED, V146, P145, DOI 10.1001/archinte.146.1.145; TERR AL, 1985, IMMUNOL ALLERGY PRAC, V7, P405; TREDGOLD T, 1836, PRINCIPLES WARMING; WEISS ST, 1985, AM REV RESPIR DIS, V131, P573, DOI 10.1164/arrd.1985.131.4.573; ZEISS CR, 1980, INT ARCH ALLER A IMM, V61, P380; ZETTERSTROM O, 1985, J ALLERGY CLIN IMMUN, V75, P594, DOI 10.1016/0091-6749(85)90035-1; ZISKIND M, 1976, AM REV RESPIR DIS, V113, P643; 1986, J ALLERGY CLIN IM S2, V78, P269; [No title captured]	75	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					689	699		10.1016/0091-6749(90)90185-7	http://dx.doi.org/10.1016/0091-6749(90)90185-7			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2182694				2022-12-18	WOS:A1990DA43700002
J	TINKELMAN, DG; DEJONG, R; LUTZ, C; SPANGLER, DL				TINKELMAN, DG; DEJONG, R; LUTZ, C; SPANGLER, DL			EVALUATION OF TREMOR AND EFFICACY OF ORAL PROCATEROL IN ADULT PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											TINKELMAN, DG (corresponding author), ATLANTA ALLERGY CLIN,6667 VERNON WOODS DR,SUITE A-30,ATLANTA,GA 30328, USA.							FINDLEY LJ, 1981, BR J HOSP MED, V1, P25; JENNE JW, 1986, AM REV RESPIR DIS, V134, P708; JENNE JW, 1982, AM REV RESPIR DIS, V126, P607; THIRINGER G, 1975, SCAND J RESPIR DIS, V56, P93; VANDENBERG W, 1982, EUR J RESPIR DIS, V65, P392; [No title captured]	6	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					719	728		10.1016/0091-6749(90)90190-F	http://dx.doi.org/10.1016/0091-6749(90)90190-F			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	1969869	Bronze			2022-12-18	WOS:A1990DA43700007
J	VANBEVER, HP; DESAGER, KN; STEVENS, WJ				VANBEVER, HP; DESAGER, KN; STEVENS, WJ			THE EFFECT OF INHALED FENOTEROL, ADMINISTERED DURING THE LATE ASTHMATIC REACTION TO HOUSE DUST MITE (DERMATOPHAGOIDES-PTERONYSSINUS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV INSTELLING ANTWERP, DEPT IMMUNOL, UNIV PLEIN 1, B-2610 WILRIJK, BELGIUM; UNIV INSTELLING ANTWERP, DEPT PAEDIAT, B-2610 WILRIJK, BELGIUM	University of Antwerp; University of Antwerp								BLYTHE SA, 1988, PEDIATR PULM, V4, P173, DOI 10.1002/ppul.1950040310; CARROLL MP, 1985, J ALLERGY CLIN IMMUN, V75, P290, DOI 10.1016/0091-6749(85)90060-0; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DORSCH W, 1980, PRAX KLIN PNEUMOL, V34, P461; DURHAM SR, 1984, NEW ENGL J MED, V311, P1398, DOI 10.1056/NEJM198411293112202; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; HEGARDT B, 1981, ALLERGY, V36, P115, DOI 10.1111/j.1398-9995.1981.tb04105.x; HOLGATE ST, 1985, CLIN ALLERGY, V15, P221, DOI 10.1111/j.1365-2222.1985.tb02279.x; HOWARTH PH, 1985, AM REV RESPIR DIS, V132, P986; MOSIMANN B, 1988, J ALLERGY CLIN IMMUN, V81, P312, DOI 10.1016/0091-6749(88)90809-3; NELSON HS, 1982, CHEST, V82, pS33; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; PALMQVIST M, 1988, NER ALLERGY P, V9, P377; PAUWELS R, 1985, AEROSOLS MED, P219; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; STEVENS WJ, 1980, EUR J RESPIR DIS, V61, P203; TATTERSFIELD AE, 1983, ASTHMA, P301; VANBEVER HP, 1988, ALLERGY, V43, P378, DOI 10.1111/j.1398-9995.1988.tb00432.x	19	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					700	703		10.1016/0091-6749(90)90186-8	http://dx.doi.org/10.1016/0091-6749(90)90186-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2324409				2022-12-18	WOS:A1990DA43700003
J	BIELORY, L; KEMENY, DM; RICHARDS, D; LESSOF, MH				BIELORY, L; KEMENY, DM; RICHARDS, D; LESSOF, MH			IGG SUBCLASS ANTIBODY-PRODUCTION IN HUMAN SERUM SICKNESS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT MED,LONDON,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	BIELORY, L (corresponding author), UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DIV ALLERGY & IMMUNOL,185 S ORANGE AVE,MSB I-512,NEWARK,NJ 07103, USA.							AALBERSE RC, 1983, J IMMUNOL, V130, P722; BENVENISTE J, 1976, CLIN EXP IMMUNOL, V26, P449; BIELORY L, 1986, BRIT J HAEMATOL, V63, P729, DOI 10.1111/j.1365-2141.1986.tb07556.x; BIELORY L, 1988, MEDICINE, V67, P40, DOI 10.1097/00005792-198801000-00003; BIELORY L, 1985, J AM ACAD DERMATOL, V13, P411, DOI 10.1016/S0190-9622(85)70182-X; BRUYNZEEL PLB, 1979, INT ARCH ALLER A IMM, V58, P344, DOI 10.1159/000232211; Burton DR, 1987, MONOGR ALLERGY, V19, P7; DRAY S, 1960, SCIENCE, V132, P1313, DOI 10.1126/science.132.3436.1313; GELL PGH, 1953, CLIN ASPECTS IMMUNOL; GREY HM, 1964, J EXP MED, V120, P253, DOI 10.1084/jem.120.2.253; HAMMARSTROM L, 1986, MONOGR ALLERGY, V19, P122; HEINER DC, 1984, AM J MED, V76, P1, DOI 10.1016/0002-9343(84)90313-9; Hunt LW, 1932, J AMER MED ASSOC, V99, P909, DOI 10.1001/jama.1932.02740630035009; ISSHIZAKA T, 1979, J IMMUNOL, V123, P578; KEMENY DM, 1987, J IMMUNOL METHODS, V96, P47, DOI 10.1016/0022-1759(87)90366-8; KEMENY DM, 1986, CLIN ALLERGY, V16, P571, DOI 10.1111/j.1365-2222.1986.tb01996.x; KEMENY DM, INT ARCH ALLERGY APP; KNIKER WT, 1968, J EXP MED, V127, P119, DOI 10.1084/jem.127.1.119; Kojis FG, 1942, AM J DIS CHILD, V64, P93, DOI 10.1001/archpedi.1942.02010070094011; MORRISONSMITH J, 1975, CLIN ASPECTS IMMUNOL, P903; OCHS HD, 1987, ANNU REV MED, V38, P329; Schick B., 1951, SERUM KRANKHEIT; SCHUR PH, 1972, PROGR IMMUNOLOGY, P71; SIEQUIERA M, 1961, P SOC EXP BIOL MED, V107, P779; SKVARIL F, 1986, MONOGR ALLERGY, V19, P134; STANWORTH DR, 1987, HDB EXPT IMMUNOLOGY, pCH12; TERRY WD, 1964, SCIENCE, V146, P400, DOI 10.1126/science.146.3642.400; THEOFILOPOULOS AN, 1976, J CLIN INVEST, V57, P169, DOI 10.1172/JCI108257; URBANEK R, 1986, CLIN ALLERGY, V16, P317, DOI 10.1111/j.1365-2222.1986.tb01963.x; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; Weaver GH, 1909, ARCH INTERN MED, V3, P485; ZUBLER RH, 1976, J IMMUNOL, V116, P232	32	9	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1990	85	3					573	577		10.1016/0091-6749(90)90095-L	http://dx.doi.org/10.1016/0091-6749(90)90095-L			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CU668	2312992	Bronze			2022-12-18	WOS:A1990CU66800006
J	CLUZEL, M; BOUSQUET, J; DAURES, JP; RENON, D; CLAUZEL, AM; GODARD, PH; MICHEL, FB				CLUZEL, M; BOUSQUET, J; DAURES, JP; RENON, D; CLAUZEL, AM; GODARD, PH; MICHEL, FB			AMBULATORY LONG-TERM SUBCUTANEOUS SALBUTAMOL INFUSION IN CHRONIC SEVERE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHU MONTPELLIER, MALAD RESP CLIN, F-34059 MONTPELLIER, FRANCE; CHU MONTPELLIER, DEPT INFORMAT MED, F-34059 MONTPELLIER, FRANCE; GLAXO FRANCE, PARIS, FRANCE	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier			Bousquet, Jean/O-4221-2019					AHRENS RC, 1984, PHARMACOTHERAPY, V4, P105; ARNAUD A, 1982, EUR J RESPIR DIS, V63, P126; BANNER AS, 1979, ARCH INTERN MED, V139, P434, DOI 10.1001/archinte.139.4.434; BHATIA SP, 1975, BRIT J CLIN PHARMACO, V2, P463, DOI 10.1111/j.1365-2125.1975.tb00557.x; BOUSQET J, 1988, AIRWAYS NEURLA CONTR, V33, P119; CARMICHAEL J, 1981, BRIT MED J, V282, P1419, DOI 10.1136/bmj.282.6274.1419; CAYTON RM, 1981, BR J DIS CHEST, V72, P222; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; COFFEY RG, 1973, CHEST, V63, P25; CONOLLY ME, 1982, J ALLERGY CLIN IMMUN, V70, P423, DOI 10.1016/0091-6749(82)90004-5; COTT GR, 1988, NEW ENGL J MED, V318, P634, DOI 10.1056/NEJM198803103181010; CROMPTON G, 1979, BRIT MED J, V278, P848; CULLUM VA, 1969, BRIT J PHARMACOL, V35, P141, DOI 10.1111/j.1476-5381.1969.tb07975.x; DAVIES AO, 1983, J CLIN INVEST, V71, P565, DOI 10.1172/JCI110801; HETZEL MR, 1983, ASTHMA, P457; JENKINS SC, 1987, CHEST, V91, P804, DOI 10.1378/chest.91.6.804; JENNE JW, 1982, J ALLERGY CLIN IMMUN, V70, P413, DOI 10.1016/0091-6749(82)90002-1; LARSSON S, 1977, AM REV RESPIR DIS, V116, P861; LESLIE D, 1977, BRIT MED J, V768, P3; LOFDAHL CG, 1984, EUR J RESPIR DIS, V65, P101; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; NELSON HS, 1977, AM REV RESPIR DIS, V116, P871; PATTERSON R, 1986, J ALLERGY CLIN IMMUN, V77, P686, DOI 10.1016/0091-6749(86)90410-0; PIERCE RJ, 1981, CHEST, V79, P506, DOI 10.1378/chest.79.5.506; RYAN G, 1982, THORAX, V37, P423, DOI 10.1136/thx.37.6.423; SLY RM, 1985, J ALLERGY CLIN IMMUN, V75, P443; SMITH SR, 1984, J ROY COLL PHYS LOND, V18, P190; TATERSFIELD AE, 1983, ASTHMA, P301; TURNERWARWICK M, 1977, BRIT J DIS CHEST, V71, P73, DOI 10.1016/0007-0971(77)90086-9; TURNERWARWICK M, 1986, ASTHMA CLIN PHARM TH, P347; WEBB J, 1982, BRIT J DIS CHEST, V76, P351, DOI 10.1016/0007-0971(82)90069-9; WILLEY RF, 1984, THORAX, V39, P340, DOI 10.1136/thx.39.5.340; WILLIAMS S, 1977, THORAX, V32, P555, DOI 10.1136/thx.32.5.555; WYLLIE AH, 1986, ASTHMA CLIN PHARM TH, P306	34	9	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1990	85	3					599	605		10.1016/0091-6749(90)90099-P	http://dx.doi.org/10.1016/0091-6749(90)90099-P			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CU668	2179366				2022-12-18	WOS:A1990CU66800010
J	HERRERA, AM; SAUNDERS, NB; BAKER, JR				HERRERA, AM; SAUNDERS, NB; BAKER, JR			IMMUNOGLOBULIN COMPOSITION OF 3 COMMERCIALLY AVAILABLE INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WALTER REED ARMY MED CTR,DEPT CLIN INVEST,WASHINGTON,DC 20307	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	HERRERA, AM (corresponding author), WALTER REED ARMY MED CTR,DEPT ALLERGY & IMMUNOL,WASHINGTON,DC 20307, USA.							AMMANN AJ, 1982, CLIN IMMUNOL IMMUNOP, V22, P60, DOI 10.1016/0090-1229(82)90022-8; BARANDUN S, 1962, VOX SANG, V7, P157, DOI 10.1111/j.1423-0410.1962.tb03240.x; GARDI A, 1984, BLUT, V48, P337, DOI 10.1007/BF00319960; HEINER DC, 1984, AM J MED, V76, P1, DOI 10.1016/0002-9343(84)90313-9; JUNGI TW, 1984, BLUT, V48, P345, DOI 10.1007/BF00319961; KLEIN F, 1985, CLIN CHIM ACTA, V150, P119, DOI 10.1016/0009-8981(85)90262-1; LUNDBLAD JL, 1986, REV INFECT DIS, V8, pS382; LUNDBLAD JL, 1987, J INFECTION, V15, P3, DOI 10.1016/S0163-4453(87)92414-5; MCCUE JP, 1986, REV INFECT DIS, V8, pS374; OXELIUS VA, 1984, AM J MED, V76, P7, DOI 10.1016/0002-9343(84)90314-0; Schur P H, 1972, Prog Clin Immunol, V1, P71; SKVARIL F, 1988, PEDIATR INFECT DIS J, V7, pS43; Voller A, 1986, MANUAL CLIN LABORATO, P99; 1982, IMMUNE SERUM GLOBULI, P137	14	9	10	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	1				556	561		10.1016/0091-6749(89)90370-9	http://dx.doi.org/10.1016/0091-6749(89)90370-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW760	2794297				2022-12-18	WOS:A1989AW76000018
J	LUCAS, SK; BUCKLEY, CE				LUCAS, SK; BUCKLEY, CE			QUANTITATIVE STUDIES OF CUTANEOUS HYPERSENSITIVITY - THE PREVALENCE OF EPICUTANEOUS FLARE REACTIONS TO ALLERGENIC POLLEN EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									DUKE UNIV,DEPT MED,DURHAM,NC 27706; DUKE UNIV,DEPT MICROBIOL IMMUNOL,DURHAM,NC 27706	Duke University; Duke University								AGARWAL MK, 1983, J ALLERGY CLIN IMMUN, V72, P40, DOI 10.1016/0091-6749(83)90050-7; AGARWAL MK, 1984, J ALLERGY CLIN IMMUN, V74, P687, DOI 10.1016/0091-6749(84)90231-8; AGARWAL MK, 1981, J ALLERGY CLIN IMMUN, V68, P194, DOI 10.1016/0091-6749(81)90183-4; ANDERSON JA, 1986, J ALLERGY CLIN IMMUN, V77, P651, DOI 10.1016/0091-6749(86)90403-3; BARANIUK JN, 1988, J ALLERGY CLIN IMMUN, V81, P1126, DOI 10.1016/0091-6749(88)90880-9; BERNSTEIN IL, 1988, J ALLERGY CLIN IMMUN, V82, P487, DOI 10.1016/0091-6749(88)90958-X; BUCKLEY CE, 1982, J ALLERGY CLIN IMMUN, V69, P25, DOI 10.1016/0091-6749(82)90083-5; BUCKLEY CE, 1988, ZINSSERS TXB MICROBI, P309; CRONQUIST A, 1981, INTEGRATED SYSTEM CL; DREBORG S, 1987, THESIS LINKOPING U M; GERGEN PJ, 1987, J ALLERGY CLIN IMMUN, V80, P669, DOI 10.1016/0091-6749(87)90286-7; GERGEN PJ, 1986, DHHS PHS861685 NAT C; IMBER WE, 1977, J ALLERGY CLIN IMMUN, V60, P47, DOI 10.1016/0091-6749(77)90082-3; INDRAJANA T, 1971, ANN ALLERGY, V29, P639; Lewis WH VP, 1983, AIRBORNE ALLERGENIC; NORMAN PS, 1983, ALLERGY PRINCIPLES P, P297; Radford AE, 1964, MANUAL VASCULAR FLOR; VANARSDEL PP, 1989, ANN INTERN MED, V110, P304, DOI 10.7326/0003-4819-110-4-304; Willis JC, 1973, DICT FLOWERING PLANT, P1034; 1983, STATISTICAL REPORT P	20	9	10	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	1				465	474		10.1016/0091-6749(89)90359-X	http://dx.doi.org/10.1016/0091-6749(89)90359-X			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW760	2794291				2022-12-18	WOS:A1989AW76000007
J	PAHWA, S				PAHWA, S			INTRAVENOUS IMMUNE GLOBULIN IN PATIENTS WITH ACQUIRED IMMUNE-DEFICIENCY SYNDROME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PAHWA, S (corresponding author), N SHORE UNIV HOSP,350 COMMUNITY DR,MANHASSET,NY 11030, USA.		Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216				AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; BERNSTEIN LJ, 1985, J PEDIATR-US, V107, P352, DOI 10.1016/S0022-3476(85)80505-9; BERNSTEIN LJ, 1985, PEDIATR INFECT DIS J, V4, P472, DOI 10.1097/00006454-198509000-00005; BOPPANA SB, 1988, ANN ALLERGY, V61, P12; BORKOWSKY W, 1987, J PEDIATR-US, V110, P563, DOI 10.1016/S0022-3476(87)80549-8; BUSSEL J, 1986, BLOOD S1, V68, pA12; CALVELLI TA, 1986, PEDIATR INFECT DIS J, V5, pS207; CHIRMULE N, 1988, CLIN RES, V36, pA437; CHIRMULE N, 1988, J ACQ IMMUN DEF SYND, V1, P425; DELFRAISSY JF, 1985, ANN INTERN MED, V103, P478, DOI 10.7326/0003-4819-103-3-478_2; Ellaurie M, 1986, BLOOD S, V68, p124a; EMANUEL D, 1988, ANN INTERN MED, V109, P777, DOI 10.7326/0003-4819-109-10-777; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; KURTZBERG J, 1987, AM J PEDIAT HEMATOL, V9, P299; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LIM W, 1988, PEDIATR INFECT DIS J, V7, P354, DOI 10.1097/00006454-198805000-00014; NELSON KE, 1988, ANN INTERN MED, V109, P383, DOI 10.7326/0003-4819-109-5-383; PAHWA R, 1987, P NATL ACAD SCI USA, V84, P3826, DOI 10.1073/pnas.84.11.3826; PAHWA S, 1986, JAMA-J AM MED ASSOC, V255, P2299, DOI 10.1001/jama.255.17.2299; PAHWA S, 1985, P NATL ACAD SCI USA, V82, P8198, DOI 10.1073/pnas.82.23.8198; PAHWA S, 1986, DIAGN CLIN IMMUNOL, V4, P24; PAHWA S, 1986, P NATL ACAD SCI USA, V83, P9124, DOI 10.1073/pnas.83.23.9124; PAHWA S, 1988, JAMA-J AM MED ASSOC, V260, P19; PAHWA SG, 1984, ANN INTERN MED, V101, P757, DOI 10.7326/0003-4819-101-6-757; REED EC, 1988, ANN INTERN MED, V109, P783, DOI 10.7326/0003-4819-109-10-783; SAULSBURY FT, 1986, J PEDIATR-US, V109, P30, DOI 10.1016/S0022-3476(86)80567-4; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; YARCHOAN R, 1986, J CLIN INVEST, V78, P439, DOI 10.1172/JCI112595; 1987, MMWR, V36, P225	30	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	2	S			625	631		10.1016/0091-6749(89)90201-7	http://dx.doi.org/10.1016/0091-6749(89)90201-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZ398	2551948				2022-12-18	WOS:A1989AZ39800010
J	DJUKANOVIC, R; FINNERTY, JP; HOLGATE, ST				DJUKANOVIC, R; FINNERTY, JP; HOLGATE, ST			WHEAL-AND-FLARE RESPONSES TO INTRADERMALLY INJECTED ADENOSINE 5'-MONOPHOSPHATE, HYPERTONIC SALINE, AND HISTAMINE - COMPARISON OF ATOPIC AND NONATOPIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											DJUKANOVIC, R (corresponding author), SOUTHAMPTON GEN HOSP,IMMUNOPHARMACOL GRP,TREMONA RD,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND.			Djukanovic, Ratko/0000-0001-6039-5612				BATCHELOR KW, 1980, IMMUNOLOGY, V41, P271; BENYON RC, 1987, J IMMUNOL, V138, P861; BRANDON ML, 1980, ANN ALLERGY, V44, P71; CUSHLEY MJ, 1985, J ALLERGY CLIN IMMUN, V75, P272, DOI 10.1016/0091-6749(85)90057-0; EGGLESTON PA, 1985, J ALLERGY CLIN IMMUN, V75, P125, DOI 10.1016/0091-6749(85)90218-0; ELSTON RC, 1986, J ALLERGY CLIN IMMUN, V78, P541, DOI 10.1016/0091-6749(86)90102-8; HOLGATE ST, 1986, ARCH INT PHARMACOD T, V280, P240; HOLGATE ST, 1987, TOPICS PERSPECTIVES, P614; HUGHES PJ, 1984, BIOCHEM PHARMACOL, V33, P3847, DOI 10.1016/0006-2952(84)90050-9; LAWRENCE ID, 1987, J IMMUNOL, V139, P3062; MANI R, 1988, THESIS U SOUTHAMPTON; MANN JS, 1986, J APPL PHYSIOL, V61, P1667, DOI 10.1152/jappl.1986.61.5.1667; RAFFERTY P, 1986, J ALLERGY CLIN IMMUN, V77, P155; RAFFERTY P, 1987, AM REV RESPIR DIS, V136, P369, DOI 10.1164/ajrccm/136.2.369; WATT AH, 1987, BRIT J CLIN PHARMACO, V24, P665, DOI 10.1111/j.1365-2125.1987.tb03227.x	15	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1989	84	3					373	378		10.1016/0091-6749(89)90423-5	http://dx.doi.org/10.1016/0091-6749(89)90423-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AR199	2506263				2022-12-18	WOS:A1989AR19900016
J	MATHESON, DS; GREEN, BJ; MINUK, GY				MATHESON, DS; GREEN, BJ; MINUK, GY			NATURAL KILLER-CELL ACTIVITY AND THE RESPONSE TO INTERFERON-ALPHA, INTERFERON-BETA, AND INTERFERON-GAMMA IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALGARY,DEPT INTERNAL MED,CALGARY T2N 1N4,ALBERTA,CANADA; UNIV MANITOBA,DEPT INTERNAL MED,WINNIPEG R3T 2N2,MANITOBA,CANADA	University of Calgary; University of Manitoba								ALEXANDER GJM, 1983, LANCET, V1, P1291; BERRY J, 1987, CANCER IMMUNOL IMMUN, V24, P72; DOMZIG W, 1983, J IMMUNOL, V130, P1970; FERGUSON MM, 1985, FEBS LETT, V191, P145, DOI 10.1016/0014-5793(85)81011-5; FRIEDMAN RM, 1983, ADV IMMUNOL, V34, P97, DOI 10.1016/S0065-2776(08)60378-8; GRIMM EA, 1982, J EXP MED, V155, P1923; JAMES SP, 1985, GASTROENTEROLOGY, V89, P165, DOI 10.1016/0016-5085(85)90758-9; JAMES SP, 1983, ANN INTERN MED, V99, P500, DOI 10.7326/0003-4819-99-4-500; KAPLAN MM, 1987, NEW ENGL J MED, V316, P52; MINUK GY, 1985, J MED VIROL, V16, P55, DOI 10.1002/jmv.1890160108; SCHEUER PJ, 1973, LIVER BIOPSY INTERPR, P25; SULKE AN, 1985, BRIT MED J, V290, P884, DOI 10.1136/bmj.290.6472.884	12	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1989	84	2					214	218		10.1016/0091-6749(89)90327-8	http://dx.doi.org/10.1016/0091-6749(89)90327-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL836	2503552				2022-12-18	WOS:A1989AL83600012
J	LESOURD, B; PAUPE, J; MELANI, M; SAINTELAUDY, J; MOULIAS, R; SCHEINMANN, P				LESOURD, B; PAUPE, J; MELANI, M; SAINTELAUDY, J; MOULIAS, R; SCHEINMANN, P			HYMENOPTERA VENOM IMMUNOTHERAPY .2. T PROLIFERATIVE AND T SUPPRESSIVE ACTIVITIES INDUCED BY VESPULA IMMUNOTHERAPY - EFFECTS ON LONG-TERM ANTIBODY-RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOP NECKER ENFANTS MALAD,SERV ALLERGOL & PNEUMOL INFANTILES,F-75730 PARIS 15,FRANCE; LAB IMMUNOALLERGOL,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	LESOURD, B (corresponding author), FAC MED PITIE SALPETRIERE,IMMUNOL LAB,105 BD HOP,F-75013 PARIS,FRANCE.							BAURLE G, 1983, DEUT MED WOCHENSCHR, V198, P13151; BLAAUW PJ, 1985, J ALLERGY CLIN IMMUN, V75, P556, DOI 10.1016/0091-6749(85)90029-6; BLACK PL, 1980, J ALLERGY CLIN IMMUN, V66, P394, DOI 10.1016/0091-6749(80)90119-0; BOUSQUET J, 1987, J ALLERGY CLIN IMMUN, V79, P947, DOI 10.1016/0091-6749(87)90245-4; BROMAN P, 1984, ALLERGY, V39, P297, DOI 10.1111/j.1398-9995.1984.tb00866.x; BUCKLEY RH, 1977, J ALLERGY CLIN IMMUN, V59, P70, DOI 10.1016/0091-6749(77)90180-4; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; CHEUNG NKV, 1983, ANN ALLERGY, V50, P155; CLAYTON WF, 1983, CLIN ALLERGY, V13, P301, DOI 10.1111/j.1365-2222.1983.tb02604.x; DJURUP R, 1985, J ALLERGY CLIN IMMUN, V76, P46, DOI 10.1016/0091-6749(85)90803-6; DJURUP R, 1985, ALLERGY, V40, P469, DOI 10.1111/j.1398-9995.1985.tb00253.x; EVANS R, 1976, J CLIN INVEST, V57, P1378, DOI 10.1172/JCI108406; GATIEN JG, 1975, CLIN IMMUNOL IMMUNOP, V4, P32, DOI 10.1016/0090-1229(75)90036-7; GOLDEN DBK, 1984, ANN ALLERGY, V53, P444; GOLDEN DBK, 1986, J ALLERGY CLIN IMMUN, V77, P435, DOI 10.1016/0091-6749(86)90177-6; GOTO A, 1983, Radioisotopes, V32, P404, DOI 10.3769/radioisotopes.32.9_404; GRAFT DF, 1984, J ALLERGY CLIN IMMUN, V73, P61, DOI 10.1016/0091-6749(84)90485-8; GUILLOUX L, 1984, PATHOL BIOL, V32, P785; HOFFMAN DR, 1985, J ALLERGY CLIN IMMUN, V75, P606, DOI 10.1016/0091-6749(85)90037-5; HSIEH KH, 1985, J ALLERGY CLIN IMMUN, V76, P188, DOI 10.1016/0091-6749(85)90700-6; HSIEH KH, 1982, ANN ALLERGY, V48, P25; KEMENY DM, 1983, J ALLERGY CLIN IMMUN, V72, P376, DOI 10.1016/0091-6749(83)90503-1; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; LABROUSSE H, 1982, J IMMUNOL METHODS, V48, P133, DOI 10.1016/0022-1759(82)90188-0; LAYTON GT, 1984, J IMMUNOL METHODS, V73, P247; LESOURD B, 1987, REV FR ALLERGOL, V27, P224; MAHMOOD T, 1982, J ALLERGY CLIN IMMUN, V70, P445, DOI 10.1016/0091-6749(82)90007-0; MAINI RN, 1971, CLIN EXP IMMUNOL, V9, P449; MALLING HJ, 1985, ALLERGY, V40, P373, DOI 10.1111/j.1398-9995.1985.tb00250.x; MOLHKOU P, 1984, ALLERG IMMUNOL, V16, P7; MOLLER C, 1984, ALLERGY, V39, P291, DOI 10.1111/j.1398-9995.1984.tb00865.x; MOSBECH H, 1986, ALLERGY, V41, P95, DOI 10.1111/j.1398-9995.1986.tb00284.x; NAGAYA H, 1985, J ALLERGY CLIN IMMUN, V75, P388, DOI 10.1016/0091-6749(85)90077-6; PATTERSON R, 1985, J ALLERGY CLIN IMMUN, V76, P394, DOI 10.1016/0091-6749(85)90660-8; PAUPE G, 1988, ALLERGOLOGIE PEDIATR, P389; PERELMUTTER L, 1986, ANN ALLERGY, V57, P78; RANDOLPH CC, 1986, J ALLERGY CLIN IMMUN, V77, P823, DOI 10.1016/0091-6749(86)90379-9; REISMAN RE, 1985, J ALLERGY CLIN IMMUN, V75, P553, DOI 10.1016/0091-6749(85)90028-4; REISMAN RE, 1985, J ALLERGY CLIN IMMUN, V75, P735; ROCKLIN RE, 1980, NEW ENGL J MED, V302, P1213, DOI 10.1056/NEJM198005293022201; ROMAGNANI S, 1973, INT ARCH ALLER A IMM, V44, P40, DOI 10.1159/000230916; ROMAGNANI S, 1975, CLIN EXP IMMUNOL, V19, P83; SANSONI P, 1985, J CLIN INVEST, V75, P650, DOI 10.1172/JCI111743; SCHNEIDER H, 1984, CLIN EXP IMMUNOL, V57, P449; SIEGEL SC, 1983, ALLERGY PRINCIPLES P, P863; TAMIR R, 1987, J ALLERGY CLIN IMMUN, V79, P591, DOI 10.1016/S0091-6749(87)80154-9; WIDE L, 1967, LANCET, V2, P1105; WIDE L, 1974, 9TH P EUR C ALL CLIN, P176; WUTHRICH B, 1981, SCHWEIZ MED WSCHR, V111, P1756; ZEITZ SJ, 1966, J ALLERGY, V38, P321, DOI 10.1016/0021-8707(66)90030-X	50	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1989	83	3					572	580		10.1016/0091-6749(89)90068-7	http://dx.doi.org/10.1016/0091-6749(89)90068-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T8596	2522474				2022-12-18	WOS:A1989T859600002
J	TURNER, CR; DAROWSKI, MJ; SAMPSON, HA; SPANNHAKE, EW; HIRSHMAN, CA				TURNER, CR; DAROWSKI, MJ; SAMPSON, HA; SPANNHAKE, EW; HIRSHMAN, CA			DERMAL MAST-CELL RELEASABILITY AND END ORGAN RESPONSIVENESS IN ATOPIC AND NONATOPIC DOGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS MED INST,SCH HYG & PUBL HLTH,DEPT ANESTHESIOL,DIV ENVIRONM PHYSIOL,615 N WOLFE ST,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT ENVIRONM HLTH SCI,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT PEDIAT IMMUNOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030195, R01HL038435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024439] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-30195, HL38435] Funding Source: Medline; NIAID NIH HHS [AI24439] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECKER AB, 1985, ANAT REC, V213, P477, DOI 10.1002/ar.1092130402; BUTLER JM, 1983, J AM ACAD DERMATOL, V8, P33, DOI 10.1016/S0190-9622(83)70004-6; CASALE TB, 1984, J ALLERGY CLIN IMMUN, V73, P775, DOI 10.1016/0091-6749(84)90447-0; CHAN SC, 1985, J ALLERGY CLIN IMMUN, V76, P148, DOI 10.1016/0091-6749(85)90693-1; CLAMAN HN, 1986, J IMMUNOL, V137, P2009; DOWNES H, 1986, J PHARMACOL EXP THER, V237, P214; EBERTZ JM, 1986, AGENTS ACTIONS, V18, P455, DOI 10.1007/BF01964946; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289, DOI 10.1111/apm.1966.66.3.289; FRIEDMAN MM, 1987, AM REV RESPIR DIS, V135, P1157; HANIFIN JM, 1984, J ALLERGY CLIN IMMUN, V73, P211, DOI 10.1016/S0091-6749(84)80008-1; HIRSHMAN CA, 1985, CHEST, V87, pS172, DOI 10.1378/chest.87.5_Supplement.172S; HIRSHMAN CA, 1988, J ALLERGY CLIN IMMUN, V81, P829, DOI 10.1016/0091-6749(88)90938-4; HIRSHMAN CA, 1987, J ALLERGY CLIN IMMUN, V79, P46, DOI 10.1016/S0091-6749(87)80015-5; JAFFE JH, 1980, PHARMACOL BASIS THER, P494; JOHNSON HH, 1960, J INVEST DERMATOL, V34, P237, DOI 10.1038/jid.1960.38; JUHLIN L, 1969, ARCH DERMATOL, V100, P12, DOI 10.1001/archderm.100.1.12; MARONE G, 1983, PROGR CLIN IMMUNOLOG, P139; MASINI E, 1985, INT ARCH ALLER A IMM, V77, P184, DOI 10.1159/000233780; MIHM MC, 1976, J INVEST DERMATOL, V67, P305, DOI 10.1111/1523-1747.ep12514346; MITCHELL EB, 1984, J INVEST DERMATOL, V83, P290, DOI 10.1111/1523-1747.ep12340423; PEARCE FL, 1985, INT ARCH ALLER A IMM, V77, P274, DOI 10.1159/000233808; PLAUT M, 1986, J ALLERGY CLIN IMMUN, V78, P968, DOI 10.1016/0091-6749(86)90287-3; ROSOW C E, 1982, Anesthesiology (Hagerstown), V57, pA355, DOI 10.1097/00000542-198209001-00355; ROSOW CE, 1982, ANESTHESIOLOGY, V56, P93, DOI 10.1097/00000542-198202000-00003; SAMPSON HA, 1984, NEW ENGL J MED, V311, P372, DOI 10.1056/NEJM198408093110605; Schmidt CF, 1933, J PHARMACOL EXP THER, V47, P411; SCHWARTZ LB, 1987, AM REV RESPIR DIS, V135, P1186; SHAFF RE, 1979, ANAL BIOCHEM, V94, P425, DOI 10.1016/0003-2697(79)90385-3; SIRAGANIAN RP, 1975, J IMMUNOL METHODS, V7, P283, DOI 10.1016/0022-1759(75)90025-3; STANLEY TH, 1971, ANESTHESIOLOGY, V38, P536; THARP MD, 1987, J ALLERGY CLIN IMMUN, V79, P646, DOI 10.1016/S0091-6749(87)80162-8	31	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1989	83	3					643	648		10.1016/0091-6749(89)90077-8	http://dx.doi.org/10.1016/0091-6749(89)90077-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T8596	2466881				2022-12-18	WOS:A1989T859600011
J	DREBORG, SKG; BJORKSTEN, B; KJELLMAN, NIM; RIMAS, M				DREBORG, SKG; BJORKSTEN, B; KJELLMAN, NIM; RIMAS, M			DIAGNOSIS OF DOG RHINO-CONJUNCTIVITIS (RC) BY HISTORY (CH) - SKIN PRICK TEST (SPT) AND NASAL (NPT) AND CONJUNCTIVAL (CPT) PROVOCATION TESTS - DISCUSSION ON DEFINITION OF DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					265	265						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900394
J	FOX, R; LOCKEY, R; ALTMAN, L; LIEBERMAN, P; WASSERMAN, S; WHITCOMB, N; ALTMAN, R; LOVE, S; SAMUELS, L				FOX, R; LOCKEY, R; ALTMAN, L; LIEBERMAN, P; WASSERMAN, S; WHITCOMB, N; ALTMAN, R; LOVE, S; SAMUELS, L			CETIRIZINE IN THE TREATMENT OF SEASONAL RHINITIS - A COMPARISON WITH TERFENADINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					307	307		10.1016/0091-6749(89)90146-2	http://dx.doi.org/10.1016/0091-6749(89)90146-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419	2532231				2022-12-18	WOS:A1989T041900563
J	JENKINS, JR; LAI, CKW; HOLGATE, ST				JENKINS, JR; LAI, CKW; HOLGATE, ST			EFFECT OF INCREASING DOSES OF PLATELET-ACTIVATING-FACTOR (PAF) ON NORMAL HUMAN AIRWAYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					282	282						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900465
J	LANGLOIS, PF; SHARON, GE; GAWRYL, MS				LANGLOIS, PF; SHARON, GE; GAWRYL, MS			PLASMA-CONCENTRATIONS OF COMPLEMENT-ACTIVATION COMPLEXES CORRELATE WITH DISEASE-ACTIVITY IN PATIENTS DIAGNOSED WITH ISOLATED CENTRAL NERVOUS-SYSTEM VASCULITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT IMMUNOL MICROBIOL,CHICAGO,IL 60612	Rush University								BUDZILOVICH GN, 1963, ARCH PATHOL, V76, P250; CAMMER W, 1986, BRAIN RES, V364, P91, DOI 10.1016/0006-8993(86)90990-X; CASTLEMAN B, 1975, NEW ENGL J MED, V252, P634; COOPER NR, 1985, J INVEST DERMATOL, V85, pS39, DOI 10.1111/1523-1747.ep12275441; CRAVIOTO H, 1959, NEUROLOGY, V9, P599, DOI 10.1212/WNL.9.9.599; CUPPS TR, 1983, AM J MED, V74, P97, DOI 10.1016/0002-9343(83)91125-7; CUPPS TR, 1981, VASCULITIDES, P21; EMANCIPATOR SN, 1986, LAB INVEST, V54, P475; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; FRANK MM, 1987, NEW ENGL J MED, V316, P1525, DOI 10.1056/NEJM198706113162407; FRAYNE JH, 1986, MED J AUSTRALIA, V145, P410, DOI 10.5694/j.1326-5377.1986.tb112399.x; GAWRYL MS, 1988, ARTHRITIS RHEUM, V31, P188, DOI 10.1002/art.1780310206; GAWRYL MS, 1986, J IMMUNOL METHODS, V95, P217, DOI 10.1016/0022-1759(86)90409-6; GREER J, 1986, ENZYME, V36, P150, DOI 10.1159/000469285; Griffin J, 1973, Trans Am Neurol Assoc, V98, P145; GROOTHUIS DR, 1986, ANN NEUROL, V19, P590, DOI 10.1002/ana.410190612; HINCK VC, 1964, AMER J ROENTGENOL RA, V92, P769; HUGHES JT, 1966, NEUROLOGY, V16, P293, DOI 10.1212/WNL.16.3.293; KOLODNY EH, 1968, ARCH NEUROL-CHICAGO, V19, P510, DOI 10.1001/archneur.1968.00480050080008; LANGLOIS PF, 1988, CLIN IMMUNOL IMMUNOP, V47, P152, DOI 10.1016/0090-1229(88)90068-2; LANGLOIS PF, 1988, ATHEROSCLEROSIS, V70, P95, DOI 10.1016/0021-9150(88)90103-7; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; NURICK S, 1972, BRAIN, V95, P133, DOI 10.1093/brain/95.1.133; OJEDA VJ, 1984, AM J CLIN PATHOL, V81, P529, DOI 10.1093/ajcp/81.4.529; REYES MG, 1976, NEUROLOGY, V26, P797, DOI 10.1212/WNL.26.8.797; ROTHENBERG RJ, 1985, AM J MED, V79, P629, DOI 10.1016/0002-9343(85)90061-0; RUDDY S, 1986, MANUAL CLIN LABORATO, P175; RUDDY S, 1985, LABORATORY DIAGNOSTI, P137; RYAN US, 1983, CLIN LAB MED, V3, P577, DOI 10.1016/S0272-2712(18)30951-X; SANDERS ME, 1986, J IMMUNOL, V136, P4456; SCHUMAKER VN, 1987, ANNU REV IMMUNOL, V5, P21, DOI 10.1146/annurev.iy.05.040187.000321; STURFELT G, 1984, INT ARCH ALLER A IMM, V75, P75, DOI 10.1159/000233593; WARREN JS, 1986, AM J MED SCI, V292, P97, DOI 10.1097/00000441-198608000-00006	33	9	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					11	16		10.1016/0091-6749(89)90472-7	http://dx.doi.org/10.1016/0091-6749(89)90472-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419	2913130				2022-12-18	WOS:A1989T041900003
J	MORTON, AR; SCOTT, CA; FITCH, KD				MORTON, AR; SCOTT, CA; FITCH, KD			THE EFFECTS OF THEOPHYLLINE ON THE PHYSICAL PERFORMANCE AND WORK CAPACITY OF WELL-TRAINED ATHLETES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MORTON, AR (corresponding author), UNIV WESTERN AUSTRALIA,DEPT HUMAN MOVEMENT STUDIES,NEDLANDS,WA 6009,AUSTRALIA.							Astrand P-O., 1977, TXB WORK PHYSL PHYSL; ATOMI Y, 1978, J SPORT MED PHYS FIT, V18, P3; AUBIER M, 1981, NEW ENGL J MED, V305, P249, DOI 10.1056/NEJM198107303050503; AUBIER M, 1983, AM REV RESPIR DIS, V127, P148; BIERMAN CW, 1975, JAMA-J AM MED ASSOC, V243, P295; CHOOKANG YF, 1969, BMJ-BRIT MED J, V2, P287, DOI 10.1136/bmj.2.5652.287; CHRYSSANTHOPOULOS C, 1979, ANN ALLERGY, V42, P355; DEVRIES HA, 1980, PHYSL EXERCISE PHYSI; ELLIOTT CG, 1985, RESPIRATION, V47, P260; ELLIS EF, 1984, J ALLERGY CLIN IMMUN, V73, P690, DOI 10.1016/0091-6749(84)90307-5; FOX EL, 1981, PHYSL BASIS PHYSICAL; JOLLEY ME, 1981, CLIN CHEM, V27, P1575; JONES DA, 1982, CLIN SCI, V63, P161, DOI 10.1042/cs0630161; MARCUS ML, 1972, AM J PHYSIOL, V22, P1361; MATTHAY RA, 1982, AM HEART J, V104, P1022, DOI 10.1016/0002-8703(82)90435-5; MATTHAY RA, 1986, J ALLERGY CLIN IMMUN, V78, P793, DOI 10.1016/0091-6749(86)90063-1; MORTON AR, 1974, MED J AUSTRALIA, V2, P158, DOI 10.5694/j.1326-5377.1974.tb93664.x; MURCIANO D, 1984, NEW ENGL J MED, V311, P349, DOI 10.1056/NEJM198408093110601; OGILVIE RI, 1977, EUR J CLIN PHARMACOL, V12, P409, DOI 10.1007/BF00561059; PHILLIPS MJ, 1981, BRIT J DIS CHEST, V75, P181, DOI 10.1016/0007-0971(81)90051-6; POLLOCK J, 1977, PEDIATRICS, V60, P840; SHEPHARD RJ, 1968, B WORLD HEALTH ORGAN, V38, P757; SIDNEY K H, 1978, Canadian Journal of Applied Sport Sciences, V3, P93; SIGRIST S, 1982, AM REV RESPIR DIS, V126, P46; SUPINSKI GS, 1986, AM REV RESPIR DIS, V133, P809; SUPINSKI GS, 1984, AM REV RESPIR DIS, V130, P429; TEDDERS JG, 1976, BRIT J CLIN PRACT, V30, P212; VIIRES N, 1984, AM REV RESPIR DIS, V129, P396; WILES CM, 1983, CLIN SCI, V64, P547, DOI 10.1042/cs0640547; WYATT RA, 1984, SUSTAINED RELEASE TH, P188	30	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					55	61		10.1016/0091-6749(89)90477-6	http://dx.doi.org/10.1016/0091-6749(89)90477-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419	2913139	Bronze			2022-12-18	WOS:A1989T041900008
J	CONNOLLY, MJ; AVERY, AJ; WALTERS, EH; HENDRICK, DJ				CONNOLLY, MJ; AVERY, AJ; WALTERS, EH; HENDRICK, DJ			THE USE OF SEQUENTIAL DOSES OF INHALED HISTAMINE IN THE MEASUREMENT OF BRONCHIAL RESPONSIVENESS - CUMULATIVE EFFECT AND DISTORTION PRODUCED BY SHORTENING THE TEST PROTOCOL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV NEWCASTLE UPON TYNE,NEWCASTLE GEN HOSP,CHEST UNIT,WESTGATE RD,NEWCASTLE TYNE NE4 6BE,ENGLAND	Newcastle General Hospital; Newcastle University - UK			WALTERS, Eugene/AAL-2264-2021					BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRITTON J, 1986, THORAX, V41, P128, DOI 10.1136/thx.41.2.128; CARTIER A, 1983, J APPL PHYSIOL, V54, P821, DOI 10.1152/jappl.1983.54.3.821; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; COCKCROFT DW, 1983, THORAX, V38, P55, DOI 10.1136/thx.38.1.55; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; EISER NM, 1983, B EUR PHYSIOPATH RES, V19, P495; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HENDRICK DJ, 1986, AM REV RESPIR DIS, V133, P600; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; JUNIPER EF, 1984, THORAX, V39, P556, DOI 10.1136/thx.39.7.556; OREHEK J, 1976, B EUR PHYSIOPATH RES, V12, P565; RACHIELE A, 1983, B EUR PHYSIOPATH RES, V19, P465; RUFFIN RE, 1981, J ALLERGY CLIN IMMUN, V67, P285, DOI 10.1016/0091-6749(81)90023-3; RUFFIN RE, 1978, AM REV RESPIR DIS, V117, P485; RYAN G, 1981, AM REV RESPIR DIS, V123, P195; TREMBLAY C, 1984, THORAX, V39, P946, DOI 10.1136/thx.39.12.946; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760	18	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1988	82	5	1				863	868		10.1016/0091-6749(88)90091-7	http://dx.doi.org/10.1016/0091-6749(88)90091-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R1708	3192870				2022-12-18	WOS:A1988R170800022
J	LEE, TM; GRAMMER, LC; SHAUGHNESSY, MA				LEE, TM; GRAMMER, LC; SHAUGHNESSY, MA			ESTIMATION OF IGE ANTIBODY WITH A NONISOTOPIC TECHNIQUE WITH NO INTERFERENCE OF ISOTYPIC ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,303 E CHICAGO AVE,CHICAGO,IL 60611	Northwestern University				Grammer, Leslie/0000-0001-6860-2014	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOXER MB, 1987, J ALLERGY CLIN IMMUN, V80, P147, DOI 10.1016/0091-6749(87)90123-0; CHAPMAN MD, 1987, J ALLERGY CLIN IMMUN, V80, P184, DOI 10.1016/0091-6749(87)90128-X; CUEVAS M, 1983, INT ARCH ALLER A IMM, V72, P184, DOI 10.1159/000234864; ENGVALL E, 1972, J IMMUNOL, V109, P129; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; KEMENY DM, 1985, INT ARCH ALLER A IMM, V77, P198, DOI 10.1159/000233785; LICHTENSTEIN LM, 1968, J IMMUNOL, V101, P317; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; LIEFERMAN KM, 1979, J ALLERGY CLIN IMMUN, V64, P173; MONEO I, 1983, INT ARCH ALLER A IMM, V71, P285, DOI 10.1159/000233406; PATTERSON R, 1987, INT ARCH ALLER A IMM, V84, P93, DOI 10.1159/000234404; REID MJ, 1985, J ALLERGY CLIN IMMUN, V76, P172, DOI 10.1016/0091-6749(85)90697-9; ZEISS CR, 1981, J ALLERGY CLIN IMMUN, V67, P105, DOI 10.1016/0091-6749(81)90004-X; ZEISS CR, 1980, J ALLERGY CLIN IMMUN, V65, P346, DOI 10.1016/0091-6749(80)90211-0; ZEISS CR, 1973, J IMMUNOL, V110, P414; ZEISS CR, 1977, CLIN EXP IMMUNOL, V38, P250	16	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1988	82	5	1				812	817		10.1016/0091-6749(88)90083-8	http://dx.doi.org/10.1016/0091-6749(88)90083-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R1708	3192864				2022-12-18	WOS:A1988R170800015
J	BRICKMAN, CM; FRANK, MM; KALINER, M				BRICKMAN, CM; FRANK, MM; KALINER, M			URINE-HISTAMINE LEVELS IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								BRICKMAN CM, 1983, INT J DERMATOL, V22, P141, DOI 10.1111/j.1365-4362.1983.tb03351.x; BRICKMAN CM, 1987, J ALLERGY CLIN IMMUN, V77, P749; CURD JG, 1980, J EXP MED, V152, P742, DOI 10.1084/jem.152.3.742; DONALDSON VH, 1969, J CLIN INVEST, V48, P642, DOI 10.1172/JCI106022; DONALDSON VH, 1977, T ASSOC AM PHYSICIAN, V40, P174; FIELDS T, 1983, J ALLERGY CLIN IMMUN, V72, P54, DOI 10.1016/0091-6749(83)90052-0; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; KALINER M, 1982, J ALLERGY CLIN IMMUN, V69, P283, DOI 10.1016/S0091-6749(82)80005-5; KALINER M, 1984, INVEST RADIOL, V19, P116, DOI 10.1097/00004424-198403000-00007; LOPEZTRASCASA M, 1983, MOL IMMUNOL, V19, P1403; MYERS G, 1981, J ALLERGY CLIN IMMUN, V67, P305, DOI 10.1016/0091-6749(81)90026-9; SCHAPIRA M, 1981, BLOOD, V58, pA226; WILLMS K, 1975, CLIN IMMUNOL IMMUNOP, V4, P174, DOI 10.1016/0090-1229(75)90053-7	13	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1988	82	3	1				403	406		10.1016/0091-6749(88)90012-7	http://dx.doi.org/10.1016/0091-6749(88)90012-7			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q3229	3170987				2022-12-18	WOS:A1988Q322900012
J	ISHIZAKI, T; MINEGISHI, A; MORISHITA, M; ODAJIMA, Y; KANAGAWA, S; NAGAI, T; YAMAGUCHI, M				ISHIZAKI, T; MINEGISHI, A; MORISHITA, M; ODAJIMA, Y; KANAGAWA, S; NAGAI, T; YAMAGUCHI, M			PLASMA-CATECHOLAMINE CONCENTRATIONS DURING A 72-HOUR AMINOPHYLLINE INFUSION IN CHILDREN WITH ACUTE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL MED CTR,DEPT PEDIAT,TOKYO 162,JAPAN; NATL CHILDRENS HOSP,RES CTR,DEPT IMMUNOL & ALLERGY,TOKYO 154,JAPAN; HOSHI UNIV PHARM,FAC PHARMACEUT SCI,TOKYO,JAPAN	National Center for Child Health & Development - Japan; Hoshi University	ISHIZAKI, T (corresponding author), NATL MED CTR,CLIN RES INST,DIV CLIN PHARMACOL,TOYAMA 1-21-2,SHINJUKU KU,TOKYO 162,JAPAN.							ATUK NO, 1967, CIRCULATION, V35, P745, DOI 10.1161/01.CIR.35.4.745; BARNES P, 1980, NEW ENGL J MED, V303, P263, DOI 10.1056/NEJM198007313030506; BARNES PJ, 1981, CLIN PHYSIOL, V1, P89, DOI 10.1111/j.1475-097X.1981.tb00945.x; BERKOWIT.BA, 1970, EUR J PHARMACOL, V10, P64, DOI 10.1016/0014-2999(70)90158-5; BERKOWITZ BA, 1971, EUR J PHARMACOL, V13, P193, DOI 10.1016/0014-2999(71)90150-6; CRYER P E, 1976, Diabetes, V25, P1071; CRYER PE, 1980, NEW ENGL J MED, V303, P436; EIRIKSSON CE, 1987, AM REV RESPIR DIS, V135, P322; EKWO E, 1978, J ALLERGY CLIN IMMUN, V61, P240, DOI 10.1016/0091-6749(78)90198-7; FEINSTEIN AR, 1975, CLIN PHARMACOL THER, V18, P491; FREDHOLM BB, 1985, ACTA MED SCAND, V217, P149; HENDELES L, 1977, DRUG INTELL CLIN PHA, V11, P13; HIGBEE MD, 1982, J ALLERGY CLIN IMMUN, V70, P377, DOI 10.1016/0091-6749(82)90028-8; HOROWITZ LN, 1975, AM J CARDIOL, V35, P376, DOI 10.1016/0002-9149(75)90030-2; HORROBIN DF, 1977, NEW ENGL J MED, V297, P1181; HORROBIN DF, 1977, PROSTAGLANDINS, V13, P33, DOI 10.1016/0090-6980(77)90040-5; IND PW, 1985, BRIT MED J, V290, P267, DOI 10.1136/bmj.290.6464.267; JAMES GWL, 1967, J PHARM PHARMACOL, V19, P797, DOI 10.1111/j.2042-7158.1967.tb09546.x; JONKMAN JHG, 1986, J ALLERGY CLIN IMMUN, V78, P736, DOI 10.1016/0091-6749(86)90054-0; JONKMAN JHG, 1984, CLIN PHARMACOKINET, V9, P309, DOI 10.2165/00003088-198409040-00002; JOSEPHSON GW, 1980, CHEST, V8, P429; KATZ RM, 1983, ANN ALLERGY, V50, P23; Keppel G., 1982, DESIGN ANAL RES HDB, V2nd, P381; KOIKE K, 1982, LIFE SCI, V30, P2221, DOI 10.1016/0024-3205(82)90297-1; KOLBECK RC, 1979, LUNG, V156, P173, DOI 10.1007/BF02714008; KUBO M, 1986, J PEDIATR-US, V108, P1011, DOI 10.1016/S0022-3476(86)80951-9; MANN JS, 1985, BRIT J CLIN PHARMACO, V19, P685, DOI 10.1111/j.1365-2125.1985.tb02696.x; MATTHAY RA, 1978, AM J MED, V65, P903, DOI 10.1016/0002-9343(78)90741-6; MEFFORD IN, 1981, LIFE SCI, V28, P477, DOI 10.1016/0024-3205(81)90140-5; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; OHNISHI A, 1987, J CARDIOVASC PHARM, V10, P667, DOI 10.1097/00005344-198712000-00010; OHNISHI A, 1987, BRIT J CLIN PHARMACO, V23, P339, DOI 10.1111/j.1365-2125.1987.tb03054.x; PATEL AK, 1981, CHEST, V80, P661, DOI 10.1378/chest.80.6.661; PEACH MJ, 1972, P NATL ACAD SCI USA, V69, P834, DOI 10.1073/pnas.69.4.834; POISNER AM, 1973, BIOCHEM PHARMACOL, V22, P469, DOI 10.1016/0006-2952(73)90288-8; POLSON JB, 1978, CLIN EXP PHARMACOL P, V5, P535; POLSON JB, 1978, BIOCHEM PHARMACOL, V27, P254, DOI 10.1016/0006-2952(78)90312-X; RALL TW, 1985, PHARMACOL BASIS THER, P589; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; ROBERTSON D, 1979, CIRCULATION, V59, P637, DOI 10.1161/01.CIR.59.4.637; RUTHERFORD JD, 1981, CIRCULATION, V63, P378, DOI 10.1161/01.CIR.63.2.378; SNIDER SR, 1974, N-S ARCH PHARMACOL, V281, P257, DOI 10.1007/BF00503502; STRUBELT D, 1969, ARCH INT PHARMACOD T, V179, P215; TULINSILVER J, 1981, J ALLERGY CLIN IMMUN, V67, P45, DOI 10.1016/0091-6749(81)90044-0; VESTAL RE, 1983, CIRCULATION, V67, P162, DOI 10.1161/01.CIR.67.1.162; WEINBERGER M, 1984, J ALLERGY CLIN IMMUN, V73, P525, DOI 10.1016/0091-6749(84)90505-0; WESTFALL DP, 1968, J PHARMACOL EXP THER, V159, P98	47	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1988	82	2					146	154		10.1016/0091-6749(88)90993-1	http://dx.doi.org/10.1016/0091-6749(88)90993-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8741	3403860	Bronze			2022-12-18	WOS:A1988P874100003
J	KOPP, WC; SUELZER, MT; RICHERSON, HB				KOPP, WC; SUELZER, MT; RICHERSON, HB			ALVEOLAR MACROPHAGE IMMUNOSUPPRESSION IS MAINTAINED IN RABBIT MODELS OF HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242	University of Iowa					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019873, R01HL022676] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL19873, HL22676] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUBAS P, 1984, AM REV RESPIR DIS, V130, P875; CALVANICO NJ, 1984, IMMUNOLOGY LUNG UPPE, P365; CUMMINGS NP, 1980, J EXP MED, V152, P1659, DOI 10.1084/jem.152.6.1659; DAUGHETY TW, 1983, CELL IMMUNOL, V79, P374, DOI 10.1016/0008-8749(83)90079-5; ETTENSOHN DB, 1986, AM REV RESPIR DIS, V133, P1091; GOLDYNE ME, 1980, J INVEST DERMATOL, V74, P297, DOI 10.1111/1523-1747.ep12543495; HENGST JCD, 1985, CANCER RES, V45, P459; HIEBERT CK, 1983, J MED CHEM, V26, P1729, DOI 10.1021/jm00366a014; HOLT PG, 1980, IMMUNOLOGY, V41, P361; HOLT PG, 1978, AM REV RESPIR DIS, V118, P791, DOI 10.1164/arrd.1978.118.4.791; HOLT PG, 1980, CELL IMMUNOL, V50, P210, DOI 10.1016/0008-8749(80)90020-9; KALNITSKY G, 1982, LUNG, V160, P245, DOI 10.1007/BF02719298; KILDAHLANDERSEN O, 1985, CELL IMMUNOL, V93, P375, DOI 10.1016/0008-8749(85)90142-X; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; KOPP WC, 1985, AM REV RESPIR DIS, V132, P1027; Leclerc C, 1982, LYMPHOKINES, V7, P1; LIPSCOMB MF, 1981, J IMMUNOL, V126, P286; MCCOMBS CC, 1982, CHEST, V82, P266, DOI 10.1378/chest.82.3.266; MIZEL SB, 1981, MANUAL MACROPHAGE ME, P407; OPPENHEIM JJ, 1980, CELL IMMUNOL, V50, P71, DOI 10.1016/0008-8749(80)90007-6; PARKHOUSE RM, 1966, J IMMUNOL, V97, P663; PENNLINE KJ, 1979, J RETICULOENDOTH SOC, V25, P495; PIKE BL, 1985, P NATL ACAD SCI USA, V82, P8153, DOI 10.1073/pnas.82.23.8153; RATAJCZAK HV, 1980, AM REV RESPIR DIS, V122, P761, DOI 10.1164/arrd.1980.122.5.761; RATAJCZAK HV, 1979, CELL IMMUNOL, V47, P390, DOI 10.1016/0008-8749(79)90348-4; RICH EA, 1987, AM REV RESPIR DIS, V136, P258, DOI 10.1164/ajrccm/136.2.258; RICHERSON HB, 1981, J ALLERGY CLIN IMMUN, V68, P226, DOI 10.1016/0091-6749(81)90188-3; RICHERSON HB, 1978, AM REV RESPIR DIS, V117, P5; RICHERSON HB, 1982, AM J PATHOL, V106, P409; RICHERSON HB, 1983, CLIN REV ALLERG, V1, P469; RICHERSON HB, 1979, AM REV RESPIR DIS, V104, P568; SCHUYLER MR, 1981, AM REV RESPIR DIS, V123, P53; SCHUYLER MR, 1984, AM REV RESPIR DIS, V130, P772; SESTINI P, 1984, CLIN EXP IMMUNOL, V58, P573; SHELLITO J, 1984, AM REV RESPIR DIS, V129, P747, DOI 10.1164/arrd.1984.129.5.747; SHELLITO J, 1980, AM REV RESPIR DIS, V122, P551; TENU JP, 1980, EUR J IMMUNOL, V10, P647, DOI 10.1002/eji.1830100813; WAHL SM, 1979, J IMMUNOL, V122, P2226; WERB Z, 1980, J EXP MED, V152, P1340, DOI 10.1084/jem.152.5.1340; WING EJ, 1977, CELL IMMUNOL, V30, P108, DOI 10.1016/0008-8749(77)90052-1; ZIEGLER K, 1981, J IMMUNOL, V127, P1869	41	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1988	82	2					204	212		10.1016/0091-6749(88)91000-7	http://dx.doi.org/10.1016/0091-6749(88)91000-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8741	2457042	Bronze			2022-12-18	WOS:A1988P874100010
J	POPA, V; MAYS, CG; MUNKRES, B				POPA, V; MAYS, CG; MUNKRES, B			DOMICILIARY METAPROTERENOL NEBULIZATION - A BACTERIOLOGIC SURVEY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM OUTPATIENT CLIN,PULM CLIN,DAVIS,CA; VET ADM OUTPATIENT CLIN,ALLERGY CLIN,DAVIS,CA; VET ADM MED CTR,MARTINEZ,CA 94553; VET ADM OUTPATIENT CLIN,SACRAMENTO,CA	US Department of Veterans Affairs; Veterans Health Administration (VHA)								BOE J, 1984, EUR J RESPIR DIS, V65, P193; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; CUSHLEY MJ, 1983, THORAX, V38, P908, DOI 10.1136/thx.38.12.908; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; GRIEBLE HG, 1970, NEW ENGL J MED, V282, P531, DOI 10.1056/NEJM197003052821003; JENKINS SC, 1987, CHEST, V91, P804, DOI 10.1378/chest.91.6.804; JOHANSON WG, 1969, NEW ENGL J MED, V281, P1137, DOI 10.1056/NEJM196911202812101; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; LEES AW, 1959, LANCET, V2, P1112; MACKOWIAK PA, 1982, NEW ENGL J MED, V307, P83, DOI 10.1056/NEJM198207083070203; MCGIVERN DV, 1984, BRIT J DIS CHEST, V78, P376; MOFFET HL, 1967, AM J DIS CHILD, V114, P21, DOI 10.1001/archpedi.1967.02090220027004; MYERS CE, 1961, ARCH ENVIRON HEALTH, V2, P391; OSTROM CA, 1958, J INFECT DIS, V102, P251, DOI 10.1093/infdis/102.3.251; PIERCE AK, 1970, NEW ENGL J MED, V282, P528, DOI 10.1056/NEJM197003052821002; POPA V, 1986, CLIN CHEST MED, V7, P313; SYBERT A, 1985, BRONCHIAL ASTHMA MEC, P808; TILLOTSON JR, 1969, J INFECT DIS, V119, P597, DOI 10.1093/infdis/119.6.597; TOBIN MJ, 1983, CHEST, V84, P286, DOI 10.1378/chest.84.3.286; VALENTI WM, 1978, NEW ENGL J MED, V298, P1108, DOI 10.1056/NEJM197805182982002; WILSON RSE, 1980, THORAX, V35, P873, DOI 10.1136/thx.35.11.873; WOODS DE, 1983, RESPIRATORY INFECTIO, P25; 1962, AM REV RESPIR DIS, V85, P762	23	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1988	82	2					231	236		10.1016/0091-6749(88)91004-4	http://dx.doi.org/10.1016/0091-6749(88)91004-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8741	3403862				2022-12-18	WOS:A1988P874100014
J	SHEFFER, AL; LIEBERMAN, PL; AARONSON, DW; ANDERSON, JA; KAPLAN, AP; PIERSON, WE; ELLIS, EF; LICHTENSTEIN, LM; LOCKEY, RF; SALVAGGIO, JE; ZWEIMAN, B; ZIMMERMAN, B				SHEFFER, AL; LIEBERMAN, PL; AARONSON, DW; ANDERSON, JA; KAPLAN, AP; PIERSON, WE; ELLIS, EF; LICHTENSTEIN, LM; LOCKEY, RF; SALVAGGIO, JE; ZWEIMAN, B; ZIMMERMAN, B			MEASUREMENT OF CIRCULATING IGG AND IGE FOOD-IMMUNE COMPLEXES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									HOSP SICK CHILDREN, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)								BROSTOFF J, 1979, LANCET, V1, P1268; BROSTOFF J, 1979, MAST CELL, P380; Cochrane C G, 1973, Adv Immunol, V16, P185, DOI 10.1016/S0065-2776(08)60298-9; CUNNINGHAMRUNDLES C, 1979, AM J MED, V67, P883, DOI 10.1016/0002-9343(79)90749-6; CUNNINGHAMRUNDLES C, 1979, J CLIN INVEST, V64, P272, DOI 10.1172/JCI109448; CUNNINGHAMRUNDLES C, 1978, P NATL ACAD SCI USA, V75, P3387, DOI 10.1073/pnas.75.7.3387; DANNAEUS A, 1979, CLIN ALLERGY, V9, P263, DOI 10.1111/j.1365-2222.1979.tb01552.x; DELIRE M, 1978, NATURE, V272, P632, DOI 10.1038/272632a0; DIXON FJ, 1963, HARVEY LECT, P21; DJURUP R, 1984, ALLERGY, V39, P395, DOI 10.1111/j.1398-9995.1984.tb01958.x; GUNTHER M, 1960, IMMUNOLOGY, V3, P296; HADDAD ZH, 1983, ANN ALLERGY, V51, P255; HUSBY S, 1985, INT ARCH ALLER A IMM, V77, P416, DOI 10.1159/000233819; INGANAS M, 1980, CLIN ALLERGY, V10, P293, DOI 10.1111/j.1365-2222.1980.tb02110.x; LEARY HL, 1984, J ALLERGY CLIN IMMUN, V74, P190, DOI 10.1016/0091-6749(84)90285-9; MAY CD, 1977, CLIN ALLERGY, V7, P583, DOI 10.1111/j.1365-2222.1977.tb01489.x; MERETEY K, 1979, J IMMUNOL METHODS, V26, P223, DOI 10.1016/0022-1759(79)90247-3; PAGANELLI R, 1986, ANN ALLERGY, V57, P330; PAGANELLI R, 1979, LANCET, V1, P1270; PAGANELLI R, 1981, CLIN EXP IMMUNOL, V46, P44; PAGANELLI R, 1983, ARCH DIS CHILD, V58, P201, DOI 10.1136/adc.58.3.201; PANUSH RS, 1986, ARTHRITIS RHEUM, V29, P220, DOI 10.1002/art.1780290210; ROTHBERG RM, 1965, PEDIATRICS, V35, P571; RUSSELL BA, 1978, LANCET, V2, P359; Sackett D.L., 1985, CLIN EPIDEMIOLOGY BA; WALKER WA, 1974, GASTROENTEROLOGY, V67, P531; WOODROFFE AJ, 1977, KIDNEY INT, V12, P268, DOI 10.1038/ki.1977.111	27	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1988	81	4					758	760		10.1016/0091-6749(88)91050-0	http://dx.doi.org/10.1016/0091-6749(88)91050-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N0650	3356853				2022-12-18	WOS:A1988N065000019
J	ATKINS, FM; BALL, BD; BOCK, SA				ATKINS, FM; BALL, BD; BOCK, SA			THE RELATIONSHIP BETWEEN THE INGESTION OF SPECIFIC FOODS AND THE DEVELOPMENT OF MIGRAINE HEADACHES IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					185	185		10.1016/0091-6749(88)90304-1	http://dx.doi.org/10.1016/0091-6749(88)90304-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400091
J	BUTCHER, BT; REED, MA				BUTCHER, BT; REED, MA			CROSSED IMMUNOELECTROPHORETIC STUDIES OF WHOLE-BODY EXTRACTS AND VENOM FROM THE IMPORTED FIRE ANT SOLENOPSIS-INVICTA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TULANE UNIV,MED CTR,DEPT MED,CLIN IMMUNOL SECT,NEW ORLEANS,LA 70118	Tulane University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021552] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 21552] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADROUNY GA, 1958, SCIENCE, V128, P306; AUKRUST L, 1978, INT ARCH ALLER A IMM, V57, P253, DOI 10.1159/000232110; BAER H, 1979, TOXICON, V17, P397, DOI 10.1016/0041-0101(79)90267-8; BLOOM FL, 1978, J ALLERGY CLIN IMMUN, V61, P134, DOI 10.1016/0091-6749(78)90256-7; BLUM MS, 1958, SCIENCE, V128, P306, DOI 10.1126/science.128.3319.306-a; BRAND JM, 1976, TOXICON, V14, P69; BUTCHER BT, IN PRESS J ALLERGY C; CROWLE AJ, 1980, MANUAL CLIN IMMUNOLO, P3; DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HANNAN CJ, 1986, J ALLERGY CLIN IMMUN, V78, P331, DOI 10.1016/S0091-6749(86)80085-9; LOFGREN CS, 1975, ANNU REV ENTOMOL, V20, P1, DOI 10.1146/annurev.en.20.010175.000245; MACCONNELL JG, 1970, SCIENCE, V168, P840, DOI 10.1126/science.168.3933.840; NORDVALL SL, 1985, J ALLERGY CLIN IMMUN, V75, P122, DOI 10.1016/0091-6749(85)90207-6; ONEIL CE, 1983, INT ARCH ALLER A IMM, V72, P294, DOI 10.1159/000234886; PAULL B R, 1984, Journal of Allergy and Clinical Immunology, V73, P142; RHOADES RB, 1975, J ALLERGY CLIN IMMUN, V56, P84, DOI 10.1016/0091-6749(75)90112-8; RHOADES RB, 1977, J FLA MED ASSOC, V64, P247; RHOADES RB, 1987, IMMUNOL ALLERGY PRAC, V9, P96; SCHMID WH, 1977, CUTIS, V19, P794; STROM GB, 1983, J ALLERGY CLIN IMMUN, V72, P46, DOI 10.1016/0091-6749(83)90051-9; TRIPLETT RF, 1976, SOUTHERN MED J, V69, P258, DOI 10.1097/00007611-197603000-00002; TRIPLETT RF, 1973, SOUTHERN MED J, V66, P477, DOI 10.1097/00007611-197304000-00019; VALENTINE M, 1982, CURRENT PERSPECTIVES, P122; Yaeger W, 1978, J MED ASS GA, V67, P101	25	9	9	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					33	40		10.1016/0091-6749(88)90217-5	http://dx.doi.org/10.1016/0091-6749(88)90217-5			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274	3123537				2022-12-18	WOS:A1988M027400006
J	TURKELTAUB, PC; GERGEN, PJ				TURKELTAUB, PC; GERGEN, PJ			THE PREVALENCE OF ALLERGIC AND NON-ALLERGIC RESPIRATORY SYMPTOMS IN THE UNITED-STATES POPULATION - DATA FROM THE 2ND NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1976-80 (NHANES-II)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													turkeltaub, paul/U-7729-2019; turkeltaub, paul/AAG-6160-2019						0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					305	305						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400568
J	WEISS, M; FISHER, RH; KAGEYSOBOTKA, A; PROUD, D; LICHTENSTEIN, LM; ADKINSON, NF				WEISS, M; FISHER, RH; KAGEYSOBOTKA, A; PROUD, D; LICHTENSTEIN, LM; ADKINSON, NF			INVIVO RESPONSE TO PLATELET DERIVED HISTAMINE RELEASING-FACTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					224	224		10.1016/0091-6749(88)90459-9	http://dx.doi.org/10.1016/0091-6749(88)90459-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400246
J	LONGBOTTOM, JL; AUSTWICK, PKC				LONGBOTTOM, JL; AUSTWICK, PKC			ALLERGY TO RATS - QUANTITATIVE IMMUNOELECTROPHORETIC STUDIES OF RAT DUST AS A SOURCE OF INHALANT ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LONGBOTTOM, JL (corresponding author), BROMPTON HOSP,INST CARDIOTHORAC,DEPT ALLERGY & CLIN IMMUNOL,FULHAM RD,LONDON SW3 6HP,ENGLAND.							ALT JM, 1980, LAB ANIM, V14, P95, DOI 10.1258/002367780780942809; IRWIN JF, 1971, BIOCHIM BIOPHYS ACTA, V252, P328, DOI 10.1016/0304-4165(71)90014-6; LANE SE, 1972, BIOCHIM BIOPHYS ACTA, V257, P461, DOI 10.1016/0005-2795(72)90299-1; LANE SE, 1972, BIOCHIM BIOPHYS ACTA, V263, P433, DOI 10.1016/0005-2795(72)90095-5; LONGBOTTOM JL, 1984, J IMMUNOL METHODS, V68, P297, DOI 10.1016/0022-1759(84)90160-1; LONGBOTTOM JL, 1980, ADV ALLERGOLOGY APPL, P483; LONGBOTTOM JL, 1983, 11 P INT C ALL CLIN, P525; MILLS TAE, 1987, J ALLERGY CLIN IMMUN, V79, P505; MILLS TAE, 1986, J ALLERGY CLIN IMMUN, V77, P850; PRICE JA, 1987, CLIN ALLERGY, V17, P43, DOI 10.1111/j.1365-2222.1987.tb02318.x; ROY AK, 1966, BIOCHIM BIOPHYS ACTA, V127, P82, DOI 10.1016/0304-4165(66)90478-8; TAYLOR AN, 1977, LANCET, V2, P847; TOH YC, 1982, ENDOKRINOLOGIE, V79, P13; TOH YC, 1982, ENDOKRINOLOGIE, V79, P7; WALLS AF, 1985, J ALLERGY CLIN IMMUN, V75, P242, DOI 10.1016/0091-6749(85)90053-3; WALLS AF, 1983, ALLERGY, V38, P419, DOI 10.1111/j.1398-9995.1983.tb05085.x; WALLS AF, 1983, ALLERGY, V38, P501, DOI 10.1111/j.1398-9995.1983.tb02359.x	17	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	1				243	251		10.1016/0091-6749(87)90026-1	http://dx.doi.org/10.1016/0091-6749(87)90026-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1036	3624679				2022-12-18	WOS:A1987K103600002
J	POYNTER, D				POYNTER, D			FATAL ASTHMA - IS TREATMENT INCRIMINATED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											POYNTER, D (corresponding author), GLAXO GRP RES LTD, DIV PATHOL, WARE SG12 0DJ, HERTS, ENGLAND.							ANDERSSON E, 1977, BRIT J DIS CHEST, V71, P35; BASS M, 1970, J AMER MED ASSOC, V212, P2075, DOI 10.1001/jama.212.12.2075; BURNEY PGJ, 1986, LANCET, V2, P323; Clark DG, 1972, P EUR SOC STUD DRUG, V13, P212; COLLINS JM, 1969, BRIT J PHARMACOL, V36, P35, DOI 10.1111/j.1476-5381.1969.tb08301.x; CUTHBERT MF, 1979, IATROGENIC DISEASES; DOLLERY CT, 1970, LANCET, V2, P1164; FRASER P, 1971, BRIT J PREV SOC MED, V25, P34; GANDEVIA B, 1973, MED J AUSTRALIA, V1, P273, DOI 10.5694/j.1326-5377.1973.tb119742.x; GERBLICH A, 1985, CHEST, V87, P44, DOI 10.1378/chest.87.1.44; GRESHAM GA, 1968, BRIT MED J, V3, P186, DOI 10.1136/bmj.3.5611.186-d; HANDFORTH CP, 1962, ARCH PATHOL, V73, P161; INMAN WHW, 1969, LANCET, V2, P279; JACKSON RT, 1982, BRIT MED J, V285, P771, DOI 10.1136/bmj.285.6344.771; Joseph X, 1981, Fundam Appl Toxicol, V1, P443, DOI 10.1016/S0272-0590(81)80025-5; KEMP JP, 1984, J ALLERGY CLIN IMMUN, V73, P32, DOI 10.1016/0091-6749(84)90481-0; LLOYD PR, 1984, CHEST, V86, P289; LOCKETT MF, 1965, LANCET, V2, P104; LULICH KM, 1986, MED TOXICOL ADV DRUG, V1, P286, DOI 10.1007/BF03259844; MCCULLOCH MW, 1968, BMJ-BRIT MED J, V2, P429, DOI 10.1136/bmj.2.5602.429-a; NAYLER WG, 1971, POSTGRAD MED J, V47, P16; NICKLAS RA, 1984, J ALLERGY CLIN IMMUN, V73, P20, DOI 10.1016/0091-6749(84)90479-2; POYNTER D, 1971, POSTGRAD MED J, V47, P21; POYNTER D, 1977, BRIT J CLIN PHARMACO, V4, pS295, DOI 10.1111/j.1365-2125.1977.tb04525.x; POYNTER D, 1975, POSTGRAD MED J, V51, P27; SIMPSON WT, 1971, POSTGRAD MED J, V47, P35; SLY RM, 1984, ANN ALLERGY, V53, P20; SMITH JM, 1966, LANCET, V1, P1042; STOLLEY PD, 1972, AM REV RESPIR DIS, V105, P883; STRUBELT O, 1976, ACTA PHARMACOL TOX, V39, P383; TAYLOR GJ, 1970, J AMER MED ASSOC, V214, P81, DOI 10.1001/jama.214.1.81; TAYLOR GJ, 1971, J CLIN INVEST, V50, P1546, DOI 10.1172/JCI106640; WALKER SR, 1972, CLIN PHARMACOL THER, V13, P861; WEXLER BC, 1968, ANGIOLOGY, V19, P665, DOI 10.1177/000331976801901103; WHIMSTER WF, 1982, PATHOLOGY DRUG INDUC; WHITEHURST VE, 1983, J AM COLL TOXICOL, V2, P147, DOI 10.3109/10915818309140676; WILSON JD, 1981, LANCET, V1, P1235	37	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			423	427		10.1016/0091-6749(87)90067-4	http://dx.doi.org/10.1016/0091-6749(87)90067-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3114352				2022-12-18	WOS:A1987K103700018
J	BERNSTEIN, IL				BERNSTEIN, IL			BRONCHOALVEOLAR LAVAGE AND ASTHMA - SAMPLING THE HUMORS SPEEDS UP	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											BERNSTEIN, IL (corresponding author), UNIV CINCINNATI,MED CTR,DEPT MED,DIV IMMUNOL,231 BETHESDA AVE,CINCINNATI,OH 45267, USA.							ARNOUX B, 1980, EUR J CLIN INVEST, V10, P437, DOI 10.1111/j.1365-2362.1980.tb02082.x; CHANYEUNG M, 1986, CHEST, V89, pS500; CUSS FM, 1986, LANCET, V2, P189; DIAZ P, 1984, J ALLERGY CLIN IMMUN, V74, P41, DOI 10.1016/0091-6749(84)90085-X; DURHAM S, 1986, J ALLERGY CLIN IMMUN, V77, P173; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; GODARD J, 1984, AM REV RESPIR DIS, V129, P86; GOLDSTEIN RA, 1985, J ALLERGY CLIN IMMUN, V76, P145; HASLAM PL, 1981, CLIN EXP IMMUNOL, V44, P587; MACDERMOT J, 1984, PROSTAGLANDINS, V27, P163, DOI 10.1016/0090-6980(84)90071-6; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; RANKIN JA, 1987, J ALLERGY CLIN IMMUN, V79, P371, DOI 10.1016/0091-6749(87)90158-8; THORPE JE, IN PRESS CHEST	14	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1987	79	2					320	321		10.1016/0091-6749(87)90148-5	http://dx.doi.org/10.1016/0091-6749(87)90148-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G1791	2434545	Bronze			2022-12-18	WOS:A1987G179100003
J	FILDERMAN, RB; ROSEN, LJ				FILDERMAN, RB; ROSEN, LJ			COMPARISON OF ONSET AND OFFSET OF INHIBITION OF ANTIGEN-INDUCED SKIN WHEALING OF SELDANE (TERFENADINE), HISMANAL(ASTEMIZOLE) AND PLACEBO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					190	190						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000283
J	MEIERDAVIS, S; TAYLOR, SL; NORDLEE, J; BUSH, R				MEIERDAVIS, S; TAYLOR, SL; NORDLEE, J; BUSH, R			IDENTIFICATION OF PEANUT ALLERGENS BY IMMUNOBLOTTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		MEIERDAVIS S, 1981, JACI, V68, P376; MEIERDAVIS S, 1983, JACI, V71, P95	2	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					218	218						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000398
J	SCHUBERTH, KC; KWITEROVICH, KA; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; VALENTINE, MD				SCHUBERTH, KC; KWITEROVICH, KA; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; VALENTINE, MD			DISCONTINUING VENOM IMMUNOTHERAPY IN SKIN-TEST POSITIVE CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					126	126						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000030
J	SALVAGGIO, JE; BUTCHER, BT; ONEIL, CE				SALVAGGIO, JE; BUTCHER, BT; ONEIL, CE			OCCUPATIONAL ASTHMA DUE TO CHEMICAL-AGENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SALVAGGIO, JE (corresponding author), TULANE UNIV,MED CTR,DEPT MED,CLIN IMMUNOL SECT,NEW ORLEANS,LA 70112, USA.							BURGE PS, 1979, THORAX, V34, P308, DOI 10.1136/thx.34.3.308; BUTCHER B T, 1982, Journal of Allergy and Clinical Immunology, V69, P123; BUTCHER BT, 1982, J ALLERGY CLIN IMMUN, V70, P231, DOI 10.1016/0091-6749(82)90058-6; BUTCHER BT, 1984, OCCUPATIONAL LUNG DI, P111; CHANYEUNG M, 1982, J ALLERGY CLIN IMMUN, V70, P32, DOI 10.1016/0091-6749(82)90198-1; CLAYTON GD, 1973, IND ENV ITS EVALUATI, P1; DAVIES RJ, 1977, J ALLERGY CLIN IMMUN, V60, P233; DIEM JE, 1982, AM REV RESPIR DIS, V126, P493; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; LAN S, 1980, J ALLERGY CLIN IMMUN, V66, P458; MCCONNELL LH, 1973, ANN INTERN MED, V78, P888, DOI 10.7326/0003-4819-78-6-888; MCFADDEN ER, 1984, J ALLERGY CLIN IMMUN, V73, P413, DOI 10.1016/0091-6749(84)90347-6; NEWHOUSE ML, 1970, LANCET, V1, P689; PARROT JL, 1969, ARCH ENVIRON HEALTH, V19, P685, DOI 10.1080/00039896.1969.10666910; PATTERSON R, 1978, J CLIN INVEST, V62, P971, DOI 10.1172/JCI109226; Pepys J, 1972, Clin Allergy, V2, P391, DOI 10.1111/j.1365-2222.1972.tb01303.x; PEPYS J, 1973, CLIN ALLERGY, V3, P491, DOI 10.1111/j.1365-2222.1973.tb03057.x; PEPYS J, 1975, AM REV RESPIR DIS, V112, P289; RAMAZZINI B, 1913, MORBIS ARTIFICIUM DI; ROBERTS AE, 1951, AMA ARCH IND HYG OCC, V4, P549; SALVAGGIO J, 1979, US DHEW NIH79387 PUB; SALVAGGIO JE, 1979, J ALLERGY CLIN IMMUN, V64, P646, DOI 10.1016/0091-6749(79)90029-0; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; WEINER A, 1961, ANN ALLERGY, V19, P397; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1980, INT ARCH ALLER A IMM, V61, P380; 1980, AM THORAC SOC NE SPR, P11	27	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1053	1058		10.1016/0091-6749(86)90304-0	http://dx.doi.org/10.1016/0091-6749(86)90304-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3782666				2022-12-18	WOS:A1986E971900025
J	NICHAMAN, MZ; MCPHERSON, RS				NICHAMAN, MZ; MCPHERSON, RS			ESTIMATING PREVALENCE OF ADVERSE REACTIONS TO FOODS - PRINCIPLES AND CONSTRAINTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											NICHAMAN, MZ (corresponding author), UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH,POB 20186,HOUSTON,TX 77225, USA.							ANDERSON JA, 1984, NUTR REV, V42, P109, DOI 10.1111/j.1753-4887.1984.tb02299.x; ANDERSON JA, 1984, NIH842442 DEP HLTH H; KERR GR, 1977, J AM DIET ASSOC, V71, P263; KERR GR, 1979, ADV BIOCH PHYSL, P375; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; MAUSNER JS, 1974, EPIDEMIOLOGY; MAY CD, 1984, NUTR REV, V42, P72, DOI 10.1111/j.1753-4887.1984.tb02293.x; METCALFE DD, 1984, J ALLERGY CLIN IMMUN, V73, P749, DOI 10.1016/0091-6749(84)90442-1; RACHELEFSKY GS, 1975, PEDIATRICS, V56, P443; SAMPSON HA, 1984, J ALLERGY CLIN IMMUN, V74, P26, DOI 10.1016/0091-6749(84)90083-6; TOWNS SJ, 1984, PEDIATRICS, V73, P631	11	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	2	S			148	154		10.1016/0091-6749(86)90006-0	http://dx.doi.org/10.1016/0091-6749(86)90006-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2997	3088086				2022-12-18	WOS:A1986D299700006
J	LAGACESIMARD, J; PORTNOY, JD; WAINBERG, MA				LAGACESIMARD, J; PORTNOY, JD; WAINBERG, MA			HIGH-LEVELS OF IGE IN PATIENTS SUFFERING FROM FREQUENT RECURRENT HERPES-SIMPLEX LESIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SIR MORTIMER B DAVIS JEWISH GEN HOSP,LADY DAVIS INST MED RES,3755 COTE ST CATHERINE RD,MONTREAL H3T 1E2,QUEBEC,CANADA; MCGILL UNIV,DEPT MICROBIOL & IMMUNOL,MONTREAL H3A 2T5,QUEBEC,CANADA	Lady Davis Institute; McGill University; McGill University								BAHNA SL, 1978, J ALLERGY CLIN IMMUN, V62, P167, DOI 10.1016/0091-6749(78)90102-1; DATI F, 1982, CLIN CHEM, V28, P1556; DOUGLAS R G JR, 1970, Journal of Immunology, V104, P289; FRICK OL, 1983, AM J VET RES, V44, P440; FRICK OL, 1979, J ALLERGY CLIN IMMUN, V63, P228, DOI 10.1016/0091-6749(79)90106-4; HAMMER SM, 1982, INFECT IMMUN, V38, P795, DOI 10.1128/IAI.38.2.795-797.1982; HILL TJ, 1981, HUMAN HERPESVIRUSES, P241; IDA S, 1983, J GEN VIROL, V64, P533, DOI 10.1099/0022-1317-64-3-533; IWASAKA T, 1983, INFECT IMMUN, V42, P955, DOI 10.1128/IAI.42.3.955-964.1983; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; LAWMAN MJP, 1980, INFECT IMMUN, V27, P133, DOI 10.1128/IAI.27.1.133-139.1980; NAHMIAS AJ, 1976, CANCER RES, V36, P836; PERELMUTTER L, 1979, J ALLERGY CLIN IMMUN, V64, P127, DOI 10.1016/0091-6749(79)90046-0; THONG YH, 1975, INFECT IMMUN, V12, P76, DOI 10.1128/IAI.12.1.76-80.1975; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501; WHEELER CE, 1975, J INVEST DERMATOL, V65, P341, DOI 10.1111/1523-1747.ep12607603; WOODRUFF JF, 1975, PROG MED VIROL, V19, P120	17	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1986	77	4					582	585		10.1016/0091-6749(86)90349-0	http://dx.doi.org/10.1016/0091-6749(86)90349-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A9381	3958386				2022-12-18	WOS:A1986A938100009
J	PEDERSEN, S				PEDERSEN, S			THE IMPORTANCE OF A PAUSE BETWEEN THE INHALATION OF 2 PUFFS OF TERBUTALINE FROM A PRESSURIZED AEROSOL WITH A TUBE SPACER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PEDERSEN, S (corresponding author), AALBORG HOSP,DEPT PEDIAT,ALLERGY UNIT,DK-9100 AALBORG,DENMARK.							BLOOMFIELD P, 1979, BRIT MED J, V2, P1479, DOI 10.1136/bmj.2.6203.1479; DULFANO MJ, 1977, ANN ALLERGY, V39, P266; HEIMER D, 1980, J ALLERGY CLIN IMMUN, V66, P75, DOI 10.1016/0091-6749(80)90141-4; NEWMAN SP, 1983, THESIS LUND; RILEY DJ, 1979, CHEST, V76, P501, DOI 10.1378/chest.76.5.501; WEBER RW, 1979, J ALLERGY CLIN IMMUN, V63, P116, DOI 10.1016/0091-6749(79)90201-X; WILLIAMS MH, 1975, AM REV RESPIR DIS, V111, P321	7	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1986	77	3					505	509		10.1016/0091-6749(86)90186-7	http://dx.doi.org/10.1016/0091-6749(86)90186-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A5367	3950253				2022-12-18	WOS:A1986A536700015
J	GRAMMER, LC; SHAUGHNESSY, MA; FINKLE, SM; SHAUGHNESSY, JJ; PATTERSON, R				GRAMMER, LC; SHAUGHNESSY, MA; FINKLE, SM; SHAUGHNESSY, JJ; PATTERSON, R			SAFETY AND IMMUNOGENICITY OF IMMUNOTHERAPY WITH POLYMERIZED TREE, GRASS, AND RAGWEED IN PATIENTS WITH MULTIPLE INHALANT SENSITIVITIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; HOPE COLL,HOLLAND,MI 49423	Northwestern University; Hope College				Grammer, Leslie/0000-0001-6860-2014	NIAID NIH HHS [AI 11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACAL E, 1978, J ALLERGY CLIN IMMUN, V62, P289, DOI 10.1016/0091-6749(78)90160-4; GRAMMER LC, 1984, J ALLERGY CLIN IMMUN, V73, P484, DOI 10.1016/0091-6749(84)90359-2; GRAMMER LC, 1983, J ALLERGY CLIN IMMUN, V72, P448, DOI 10.1016/0091-6749(83)90580-8; GRAMMER LC, 1982, J ALLERGY CLIN IMMUN, V69, P494, DOI 10.1016/0091-6749(82)90173-7; GREENBERGER PA, 1982, J LAB CLIN MED, V99, P288; HENDRIX S, 1980, J ALLERGY CLIN IMMUN, V65, P57, DOI 10.1016/0091-6749(80)90177-3; HENDRIX SG, 1980, J ALLERGY CLIN IMMUN, V66, P486, DOI 10.1016/0091-6749(80)90010-X; HENDRIX SG, 1981, J ALLERGY CLIN IMMUN, V67, P124, DOI 10.1016/0091-6749(81)90007-5; KELLY JF, 1980, J ALLERGY CLIN IMMUN, V65, P50, DOI 10.1016/0091-6749(80)90176-1; LEVY DA, 1980, REGULATORY CONTROL S, P178; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; PATTERSON R, 1983, J ALLERGY CLIN IMMUN, V72, P129, DOI 10.1016/0091-6749(83)90519-5; PATTERSON R, 1981, J ALLERGY CLIN IMMUN, V67, P162, DOI 10.1016/0091-6749(81)90013-0; PATTERSON R, 1979, J ALLERGY CLIN IMMUN, V63, P47, DOI 10.1016/0091-6749(79)90161-1; PATTERSON R, 1984, INT ARCH ALLER A IMM, V73, P1, DOI 10.1159/000233427; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; ZEISS CR, 1977, CLIN EXP IMMUNOL, V28, P250; ZEISS CR, 1973, J IMMUNOL, V110, P414	19	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	1				53	58		10.1016/0091-6749(86)90322-2	http://dx.doi.org/10.1016/0091-6749(86)90322-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD36	3944375	Bronze			2022-12-18	WOS:A1986AZD3600010
J	LAWRENCE, ID; GOLDEN, DBK; KAGEYSOBOTKA, A; VALENTINE, LM				LAWRENCE, ID; GOLDEN, DBK; KAGEYSOBOTKA, A; VALENTINE, LM			PREDICTIVE VALUE OF VENOM SPECIFIC IGG ANTIBODY-LEVELS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			178	178						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800226
J	RAFFERTY, P; LEWIS, P; WHEELEY, MSG; HOLGATE, ST				RAFFERTY, P; LEWIS, P; WHEELEY, MSG; HOLGATE, ST			TERFENADINE AS A POTENT AND SPECIFIC H1HISTAMINE RECEPTOR ANTAGONIST ON ASTHMATIC AIRWAYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV SOUTHAMPTON,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND	University of Southampton									0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			155	155						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800135
J	TURKELTAUB, PC				TURKELTAUB, PC			THE IMPORTANCE OF ALLERGEN DOSE ON THE SAFETY AND EFFICACY OF IMMUNOTHERAPY OF RAGWEED HAY-FEVER WITH STANDARDIZED SHORT RAGWEED EXTRACTS (SR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													turkeltaub, paul/U-7729-2019; turkeltaub, paul/AAG-6160-2019						0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			211	211						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800360
J	CHODIRKER, WB; KOMAR, RR				CHODIRKER, WB; KOMAR, RR			ANGIOIMMUNOBLASTIC LYMPHADENOPATHY IN A CHILD WITH UNUSUAL CLINICAL AND IMMUNOLOGICAL FEATURES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WESTERN ONTARIO,DEPT MED,LONDON N6A 3K7,ONTARIO,CANADA	Western University (University of Western Ontario)	CHODIRKER, WB (corresponding author), UNIV WESTERN ONTARIO HOSP,CLIN IMMUNOL LAB,339 WINDERMERE RD,LONDON N6A 5A5,ONTARIO,CANADA.		Rosenstein, Elliot D/N-1666-2013	Rosenstein, Elliot D/0000-0001-7681-4615				ASHERSON GL, 1980, DIAGNOSIS TREATMENT, P99; BACK FH, 1976, NEW ENGL J MED, V295, P927; BUDMAN DR, 1978, NEW ENGL J MED, V298, P1204; Caldwell JR, 1972, CLIN IMMUNOL IMMUNOP, V1, P39; COSTANZI JJ, 1969, J LAB CLIN MED, V74, P902; CULLEN MH, 1979, Q J MED, V48, P151; FIORILLO A, 1981, CANCER, V48, P1611, DOI 10.1002/1097-0142(19811001)48:7<1611::AID-CNCR2820480723>3.0.CO;2-X; FRIZZERA G, 1974, LANCET, V1, P1070; HAUPTMANN G, 1975, SCAND J HAEMATOL, V15, P22; HOUSER DD, 1970, AM J MED, V49, P23, DOI 10.1016/S0002-9343(70)80110-3; KALUS MJ, 1976, ARCH PATHOL LAB MED, V100, P465; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; LUKES RJ, 1975, NEW ENGL J MED, V292, P1, DOI 10.1056/NEJM197501022920101; Mayer M.M., 1961, EXPT IMMUNOCHEMISTRY, P133; MOROZ LA, 1978, IMMUNOLOGICAL DISEAS, P570; MORRIS JA, 1979, CANCER, V44, P171, DOI 10.1002/1097-0142(197907)44:1<171::AID-CNCR2820440129>3.0.CO;2-E; NEIMAN RS, 1978, CANCER, V41, P507, DOI 10.1002/1097-0142(197802)41:2<507::AID-CNCR2820410218>3.0.CO;2-D; NEWCOM SR, 1979, LANCET, V1, P462; ODONNELL PP, 1980, ARCH NEUROL-CHICAGO, V37, P598, DOI 10.1001/archneur.1980.00500580094023; PALUTKE M, 1976, AM J CLIN PATHOL, V65, P929; PIERCE DA, 1979, ARTHRITIS RHEUM, V22, P911, DOI 10.1002/art.1780220816; POPE RM, 1977, AM J MED SCI, V274, P213, DOI 10.1097/00000441-197709000-00016; RAWNSLEY HM, 1968, ARCH DERMATOL, V98, P12, DOI 10.1001/archderm.98.1.12; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; SCHULTZ DR, 1975, NEW ENGL J MED, V292, P8, DOI 10.1056/NEJM197501022920102; SEEHAFER JR, 1980, ARCH DERMATOL, V116, P41, DOI 10.1001/archderm.116.1.41; SKIBIN A, 1980, CLIN EXP IMMUNOL, V39, P386; WANDERER AA, 1971, J ALLERGY CLIN IMMUN, V48, P13, DOI 10.1016/0091-6749(71)90050-9; WECHSLER HL, 1977, ARCH DERMATOL, V113, P636, DOI 10.1001/archderm.113.5.636; ZUBLER RH, 1976, IN VITRO METHODS CEL, P565	30	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	5					745	752		10.1016/0091-6749(85)90681-5	http://dx.doi.org/10.1016/0091-6749(85)90681-5			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AUU34	4056260				2022-12-18	WOS:A1985AUU3400015
J	FINK, JN				FINK, JN			IMMUNOTHERAPY OF ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MARCUS CTR ALLERG & IMMUNOL RES,MILWAUKEE,WI		FINK, JN (corresponding author), MED COLL WISCONSIN,DEPT MED,ALLERGY IMMUNOL SECT,8700 W WISCONSIN AVE,MILWAUKEE,WI 53226, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI019104] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 19104] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AAS K, 1971, ACTA PAEDIATR SCAND, V60, P264, DOI 10.1111/j.1651-2227.1971.tb06655.x; BOOTH BH, 1972, ALLERGIC DISEASES DI, P63; BRUUN EGON, 1949, ACTA ALLERGOL, V2, P122, DOI 10.1111/j.1398-9995.1949.tb03295.x; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; Cooke RA, 1922, J IMMUNOL, V7, P219; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; Cooke RA, 1915, LARYNGOSCOPE, V25, P108; EVANS R, 1976, J CLIN INVEST, V57, P1378, DOI 10.1172/JCI108406; FORGACS P, 1968, BRIT MED J, V3, P774; Freeman J, 1911, LANCET, V2, P814; HILL DJ, 1982, BRIT MED J, V284, P306, DOI 10.1136/bmj.284.6312.306; JOHNSTONE D, 1961, PEDIATRICS, V27, P39; LEVY DA, 1971, J CLIN INVEST, V50, P360, DOI 10.1172/JCI106503; LICHTENS.LM, 1968, AM J MED, V44, P514, DOI 10.1016/0002-9343(68)90052-1; MACGLASHAN DW, 1983, FED PROC, V42, P2504; METZGER WJ, 1983, J ALLERGY CLIN IMMUN, V71, P119, DOI 10.1016/0091-6749(83)90245-2; MURRAY AB, 1983, PEDIATRICS, V71, P418; Noon L, 1911, LANCET, V1, P1572; OHMAN JL, 1984, J ALLERGY CLIN IMMUN, V74, P230, DOI 10.1016/0091-6749(84)90251-3; PATTERSON R, 1974, CLIN EXP IMMUNOL, V16, P223; PATTERSON R, 1983, ALLERGY PRINCIPLES P, P1119; PLATTSMILLS TAE, 1982, LANCET, V2, P675; PRUZANSKY JJ, 1967, J ALLERGY, V39, P44, DOI 10.1016/0021-8707(67)90126-8; ROCKLIN RE, 1980, NEW ENGL J MED, V302, P1213, DOI 10.1056/NEJM198005293022201; SCHLEIMER RP, 1983, CLIN REV ALLERG, V1, P327; SHERMAN WILLIAM B., 1940, JOUR ALLERGY, V11, P225, DOI 10.1016/S0021-8707(40)90568-8; STARR MS, 1970, INT ARCH ALLER A IMM, V38, P514, DOI 10.1159/000230304; TAYLOR WW, 1978, J ALLERGY CLIN IMMUN, V61, P283, DOI 10.1016/0091-6749(78)90048-9; WARNER JO, 1978, LANCET, V2, P912	29	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					402	404		10.1016/0091-6749(85)90662-1	http://dx.doi.org/10.1016/0091-6749(85)90662-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE89	2410479				2022-12-18	WOS:A1985APE8900026
J	GOLDEN, DBK; KAGEYSOBOTKA, A; GADDE, J; VALENTINE, MD; LICHTENSTEIN, LM				GOLDEN, DBK; KAGEYSOBOTKA, A; GADDE, J; VALENTINE, MD; LICHTENSTEIN, LM			IS VENOM IMMUNOTHERAPY (VIT) FOREVER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					208	208		10.1016/0091-6749(85)90550-0	http://dx.doi.org/10.1016/0091-6749(85)90550-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200415
J	HOSOI, S; SHINOMIYA, K; NAKANO, H; MIKAWA, H; HARADA, S				HOSOI, S; SHINOMIYA, K; NAKANO, H; MIKAWA, H; HARADA, S			MONOCLONAL ANTI-HUMAN IGG ANTIBODIES FOR QUANTITATION OF ALLERGEN-SPECIFIC IGG IN HUMAN-SERA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SHIONOGI & CO LTD,DEPT PROD,OSAKA 553,JAPAN	Shionogi & Company Limited	HOSOI, S (corresponding author), KYOTO UNIV,FAC MED,DEPT PEDIAT,SAKYO KU,KYOTO 606,JAPAN.							ADKINSON NF, 1976, MANUAL CLIN IMMUNOLO, P590; BROWN JC, 1975, P NATL ACAD SCI USA, V72, P5111, DOI 10.1073/pnas.72.12.5111; BRUNDA MJ, 1979, J IMMUNOL, V123, P1457; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; GOLD ER, 1967, J IMMUNOL, V99, P859; HAMILTON RG, 1979, J IMMUNOL, V122, P1073; HUNNEYBALL IM, 1976, IMMUNOLOGY, V30, P579; JEFFERIS R, 1968, NATURE, V219, P646, DOI 10.1038/219646b0; JOHANSSON SGO, 1978, IMMUNOL REV, V41, P248, DOI 10.1111/j.1600-065X.1978.tb01467.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KRONVALL G, 1969, J IMMUNOL, V103, P828; MARKWELL MAK, 1978, BIOCHEMISTRY-US, V17, P4807, DOI 10.1021/bi00615a031; NEWMAN PJ, 1981, J CELL BIOL, V90, P249, DOI 10.1083/jcb.90.1.249; Oi V.T., 1980, SELECTED METHODS CEL, P351; SHIMIZU M, 1978, J IMMUNOL METHODS, V19, P317, DOI 10.1016/0022-1759(78)90016-9; SOBOTKA AK, 1976, J IMMUNOL, V117, P84; VALENTINE RC, 1967, J MOL BIOL, V27, P615, DOI 10.1016/0022-2836(67)90063-0; YUNGINGER JW, 1973, J CLIN INVEST, V52, P1268, DOI 10.1172/JCI107294	18	9	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	2					320	327		10.1016/0091-6749(85)90064-8	http://dx.doi.org/10.1016/0091-6749(85)90064-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ABZ05	2578496	Bronze			2022-12-18	WOS:A1985ABZ0500014
J	JEWETT, DL; GREENBERG, MR				JEWETT, DL; GREENBERG, MR			PLACEBO RESPONSES IN INTRADERMAL PROVOCATION TESTING WITH FOOD EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					205	205		10.1016/0091-6749(85)90537-8	http://dx.doi.org/10.1016/0091-6749(85)90537-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200402
J	SANDERS, G; BURGE, H; MUILENBERG, M; SOLOMON, W				SANDERS, G; BURGE, H; MUILENBERG, M; SOLOMON, W			DETECTION OF COCKROACH ANTIGEN IN COMMERCIAL HOUSE DUST (HD) EXTRACTS BY ELISA INHIBITION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					146	146		10.1016/0091-6749(85)90302-1	http://dx.doi.org/10.1016/0091-6749(85)90302-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200167
J	TOBIN, MJ; BIRCH, S; JENOURI, G; SACKNER, MA				TOBIN, MJ; BIRCH, S; JENOURI, G; SACKNER, MA			ACUTE EFFECTS OF AEROSOLIZED METAPROTERENOL ON BREATHING PATTERN OF PATIENTS WITH SYMPTOMATIC BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MT SINAI MED CTR,DEPT MED,DIV PULM DIS,4300 ALTON RD,MIAMI BEACH,FL 33140	Mount Sinai Medical Center					NHLBI NIH HHS [HL 10622] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOWIE D M, 1984, American Review of Respiratory Disease, V129, pA239; CHADHA TS, 1982, AM REV RESPIR DIS, V125, P644; CHADHA TS, 1984, B EUR PHYSIOPATH RES, V20, P257; CHADHA TS, 1984, J APPL PHYSIOL, V56, P1053, DOI 10.1152/jappl.1984.56.4.1053; ELDRIDGE FL, 1977, J APPL PHYSIOL, V43, P312, DOI 10.1152/jappl.1977.43.2.312; GILBERT R, 1972, J APPL PHYSIOL, V33, P252, DOI 10.1152/jappl.1972.33.2.252; JAEGER MJ, 1982, RESP PHYSIOL, V47, P325, DOI 10.1016/0034-5687(82)90061-5; KASSABIAN J, 1982, CHEST, V81, P536, DOI 10.1378/chest.81.5.536; KELSEN SG, 1979, AM REV RESPIR DIS, V120, P517; KOLLER EA, 1973, RESP PHYSIOL, V17, P113, DOI 10.1016/0034-5687(73)90114-X; MILICEMILI J, 1982, LUNG, V160, P1, DOI 10.1007/BF02719267; MORTOLA JP, 1979, J PHYSL LONDON, V285, P577; SACKNER JD, 1980, AM REV RESPIR DIS, V122, P933; SAVOY J, 1981, RESPIR PHYSL, V43, P56; TOBIN MJ, 1983, CHEST, V84, P286, DOI 10.1378/chest.84.3.286; TOBIN MJ, 1983, CHEST, V84, P202, DOI 10.1378/chest.84.2.202; TOBIN MJ, 1982, AM REV RESPIR DIS, V126, P670; TOBIN MJ, 1983, CHEST, V83, P615, DOI 10.1378/chest.83.4.615; TOBIN MJ, 1983, CRIT CARE MED, V11, P859, DOI 10.1097/00003246-198311000-00004; VIDRUK EH, 1977, J APPL PHYSIOL, V43, P397, DOI 10.1152/jappl.1977.43.3.397; WHITELAW WA, 1975, RESP PHYSIOL, V23, P181, DOI 10.1016/0034-5687(75)90059-6; ZACKON H, 1976, AM REV RESPIR DIS, V114, P917	22	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					166	172		10.1016/0091-6749(85)90696-7	http://dx.doi.org/10.1016/0091-6749(85)90696-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE88	4019949				2022-12-18	WOS:A1985APE8800008
J	VANHOEYVELD, EM; STEVENS, EAM				VANHOEYVELD, EM; STEVENS, EAM			STABILIZING EFFECT OF EPSILON-AMINOCAPROIC ACID ON ALLERGENIC EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV HOSP LEUVEN,DEPT MED,DIV CLIN IMMUNOL,LEUVEN,BELGIUM	KU Leuven; University Hospital Leuven								ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; ANDERSON HC, 1981, TECHNICAL B FOOD DRU; ANDERSON MC, 1982, J ALLERGY CLIN IMMUN, V69, P3, DOI 10.1016/0091-6749(82)90080-X; BAER H, 1980, J ALLERGY CLIN IMMUN, V66, P281, DOI 10.1016/0091-6749(80)90022-6; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; BAER H, 1980, STABILITY ALLERGENIC, P175; BAER H, 1983, STABILITY ALLERGENIC, P159; BOUSQUET J, 1978, ANN ALLERGY, V41, P164; CENTER JG, 1974, J ALLERGY CLIN IMMUN, V54, P305, DOI 10.1016/0091-6749(74)90016-5; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; COOKE RA, 1933, J ALLERGY, V4, P455; FOUCARD T, 1973, Clinical Allergy, V3, P91, DOI 10.1111/j.1365-2222.1973.tb01313.x; FRANCIS DM, 1976, CONTRIB MINERAL PETR, V58, P51, DOI 10.1007/BF00384744; HIATT CW, 1977, J BIOL STAND, V5, P39, DOI 10.1016/0092-1157(77)90017-8; KOK P, 1972, THROMB DIATH HAEMOST, V27, P77, DOI 10.1055/s-0038-1649342; NAERDAL A, 1983, CLIN ALLERGY, V13, P149, DOI 10.1111/j.1365-2222.1983.tb02582.x; NELSON HS, 1979, J ALLERGY CLIN IMMUN, V63, P417, DOI 10.1016/0091-6749(79)90216-1; NELSON HS, 1981, J ALLERGY CLIN IMMUN, V67, P64, DOI 10.1016/0091-6749(81)90047-6; NILSSON IM, 1961, ACTA MED SCAND, V170, P487; NORMAN PS, 1978, J ALLERGY CLIN IMMUN, V62, P314, DOI 10.1016/0091-6749(78)90164-1; RING J, 1978, ANASTH INTENSIVMED, P111; SCHRODER H, 1980, RAST BASED TECHNIQUE, P139; TROLL W, 1955, J BIOL CHEM, V213, P881; VOGHT W, 1975, J IMMUNOL, V144, P671; 1981, PB81182115, P8	25	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	4					543	550		10.1016/0091-6749(85)90773-0	http://dx.doi.org/10.1016/0091-6749(85)90773-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ATH66	4056242	Bronze			2022-12-18	WOS:A1985ATH6600004
J	HAMMARSTROM, S; LUNDBERG, JM; HUA, XY; DAHLEN, SE; HEDQVIST, P				HAMMARSTROM, S; LUNDBERG, JM; HUA, XY; DAHLEN, SE; HEDQVIST, P			ACTION AND METABOLISM OF CIRCULATING LEUKOTRIENE-C	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,DEPT PHYSIOL,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,NATL INST ENVIRONM MED,S-10401 STOCKHOLM 60,SWEDEN	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	HAMMARSTROM, S (corresponding author), KAROLINSKA INST,DEPT PHYSIOL CHEM,POB 60400,S-10401 STOCKHOLM 60,SWEDEN.							APPELGREN LE, 1982, J BIOL CHEM, V257, P531; BERNSTROM K, 1982, BIOCHEM BIOPH RES CO, V109, P800, DOI 10.1016/0006-291X(82)92010-1; BERNSTROM K, 1981, J BIOL CHEM, V256, P9579; BURKE JA, 1982, J PHARMACOL EXP THER, V221, P235; DAHLEN SE, 1983, ACTA PHYSIOL SCAND, V118, P415, DOI 10.1111/j.1748-1716.1983.tb07291.x; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; DAHLEN SE, 1983, ACTA PHYSL SCAN S512, V118, P1; HAMMARSTROM S, 1981, BIOCHEM BIOPH RES CO, V101, P1109, DOI 10.1016/0006-291X(81)91562-X; HAMMARSTROM S, 1983, ANNU REV BIOCHEM, V52, P355, DOI 10.1146/annurev.bi.52.070183.002035; HAMMARSTROM S, 1981, J BIOL CHEM, V256, P9573; HEDQVIST P, 1980, ACTA PHYSIOL SCAND, V110, P331, DOI 10.1111/j.1748-1716.1980.tb06676.x; LETTS LG, 1982, BRIT J PHARMACOL, V76, P169, DOI 10.1111/j.1476-5381.1982.tb09203.x; LUNDBERG JM, NAUNYNSCHMIEDEBERGS; ORNING L, 1983, FEBS LETT, V153, P253, DOI 10.1016/0014-5793(83)80618-8; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; SMEDEGARD G, 1982, NATURE, V295, P327, DOI 10.1038/295327a0	16	9	9	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					358	362		10.1016/0091-6749(84)90130-1	http://dx.doi.org/10.1016/0091-6749(84)90130-1			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633	6432878				2022-12-18	WOS:A1984TQ63300010
J	WILSON, BD; MONDLOCH, VM; KATZENSTEIN, AL; MOORE, VL				WILSON, BD; MONDLOCH, VM; KATZENSTEIN, AL; MOORE, VL			HYPERSENSITIVITY PNEUMONITIS IN RABBITS - MODULATION OF PULMONARY INFLAMMATION BY LONG-TERM AEROSOL CHALLENGE WITH ANTIGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MERCK SHARP & DOHME RES LABS,DEPT IMMUNOL & INFLAMMAT RES,POB 2000,RAHWAY,NJ 07065; VET ADM MED CTR,RES SERV,WOOD,WI 53193; MED COLL WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53226; MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53226; UNIV ALABAMA,SCH MED,DEPT PATHOL,BIRMINGHAM,AL 35233	Merck & Company; US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham					NHLBI NIH HHS [HL 15389, HL 22301] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN EM, 1977, J IMMUNOL, V119, P343; BARROWCLIFF DF, 1968, THORAX, V23, P490, DOI 10.1136/thx.23.5.490; BOROS DL, 1975, J IMMUNOL, V114, P1437; CHENSUE SW, 1979, J IMMUNOL, V123, P1409; CHRISTENSEN L T, 1975, Clinical Allergy, V5, P417, DOI 10.1111/j.1365-2222.1975.tb01881.x; FINK JN, 1972, J OCCUP MED, V15, P245; FINK JN, 1971, NY STATE J MED, V72, P1834; GHOSE T, 1974, CLIN ALLERGY, V4, P119, DOI 10.1111/j.1365-2222.1974.tb01369.x; GREEN WF, 1981, P NATL ACAD SCI-BIOL, V78, P1152, DOI 10.1073/pnas.78.2.1152; HENSLEY GT, 1969, ARCH PATHOL, V87, P572; KELLER RH, 1982, J CLIN IMMUNOL, V2, P46, DOI 10.1007/BF00915978; KELLER RH, 1982, J IMMUNOL, P128; LOPEZ M, 1976, ANNU REV MED, V27, P453, DOI 10.1146/annurev.me.27.020176.002321; MOORE VL, 1980, J ALLERGY CLIN IMMUN, V65, P365, DOI 10.1016/0091-6749(80)90214-6; MOORE VL, 1975, J CLIN INVEST, V56, P937, DOI 10.1172/JCI108173; PETERSON LB, 1977, AM REV RESPIR DIS, V116, P1007; PETERSON LB, 1979, AM REV RESPIR DIS, V119, P991; RICHERSON HB, 1971, AM REV RESPIR DIS, V104, P568; RICHERSON HB, 1974, ANN NY ACAD SCI, V221, P240; ROBERTS RC, 1977, AM REV RESPIR DIS, V116, P1075; WILSON BD, 1982, J IMMUNOL, V129, P2160; WILSON BD, 1982, CELL IMMUNOL, V67, P90, DOI 10.1016/0008-8749(82)90201-5	22	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	2					180	184		10.1016/0091-6749(84)90283-5	http://dx.doi.org/10.1016/0091-6749(84)90283-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE226	6747139				2022-12-18	WOS:A1984TE22600011
J	AGARWAL, MK; HELM, RM; HISAMATSU, K; GLEICH, GJ; YUNGINGER, JW				AGARWAL, MK; HELM, RM; HISAMATSU, K; GLEICH, GJ; YUNGINGER, JW			MONOCLONAL-ANTIBODY TO ALT-I AND ITS USE IN AFFINITY-CHROMATOGRAPHY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901	Mayo Clinic									0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					160	160		10.1016/0091-6749(83)90409-8	http://dx.doi.org/10.1016/0091-6749(83)90409-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200286
J	ALLEN, DH; DELOHERY, J; BAKER, GJ; WOOD, R				ALLEN, DH; DELOHERY, J; BAKER, GJ; WOOD, R			MONOSODIUM GLUTAMATE INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					98	98		10.1016/0091-6749(83)90163-X	http://dx.doi.org/10.1016/0091-6749(83)90163-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200040
J	ARBESMAN, C; BERNSTEIN, IL; BIERMAN, CW; BOCLES, JS; KATZ, R; LIEBERMAN, PL; MATTUCCI, K; MELTZER, EO; MIDDLETON, E; NOYES, J; PEARLMAN, DS; PENCE, HL; SLAVIN, RG; SPECTOR, SL				ARBESMAN, C; BERNSTEIN, IL; BIERMAN, CW; BOCLES, JS; KATZ, R; LIEBERMAN, PL; MATTUCCI, K; MELTZER, EO; MIDDLETON, E; NOYES, J; PEARLMAN, DS; PENCE, HL; SLAVIN, RG; SPECTOR, SL			MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FLUOCORTIN BUTYL IN PERENNIAL RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		CHAPLIN MD, 1980, CLIN PHARMACOL THER, V27, P402, DOI 10.1038/clpt.1980.54; Gunzel P, 1977, Arzneimittelforschung, V27, P2217; GUNZEL P, UNPUB; Kapp J F, 1977, Arzneimittelforschung, V27, P2191; KAPP JF, 1982, N ENGL SOC ALLERGY P; KUNKEL G, 1980, ALLERGOL IMMUNPATHOL, V8, P288; KUNKEL G, 1980, ADV CHRONIC OBSTRUCT, P537; MARTIN LE, 1974, CLIN PHARMACOL THER, V15, P267; MARTIN LE, 1975, POSTGRAD MED J, V51, P11; MAST H, 1980, ALLERGOL IMMUNPATHOL, V8, P395; SHERMAN B, 1982, J ALLERGY CLIN IMMUN, V69, P208, DOI 10.1016/0091-6749(82)90101-4; SPECTOR SL, 1982, CLIN ALLERGY, V12, P187, DOI 10.1111/j.1365-2222.1982.tb01638.x; VLASSES PH, 1981, CLIN PHARMACOL THER, V29, P643, DOI 10.1038/clpt.1981.89; Wendt H, 1977, Arzneimittelforschung, V27, P2236; WENDT H, UNPUB; WUTHRICH B, 1980, ALLERGOL IMMUNOPATHO, V8, P324	16	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	6					597	603		10.1016/0091-6749(83)90442-6	http://dx.doi.org/10.1016/0091-6749(83)90442-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QV139	6343462				2022-12-18	WOS:A1983QV13900012
J	BARDANA, EJ; MALINOW, MR; CRAIG, S; MCLAUGHLIN, P				BARDANA, EJ; MALINOW, MR; CRAIG, S; MCLAUGHLIN, P			CROSS-REACTING ANTIBODY (AB) TO ALFALFA SEED (AS) AND DEOXYRIBONUCLEIC-ACID (DNA) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1982, SCIENCE, V216, P415; 1981, LANCET, V1, P615; 1982, AM J KIDNEY DIS, V1, P345	3	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					102	102		10.1016/0091-6749(83)90177-X	http://dx.doi.org/10.1016/0091-6749(83)90177-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200054
J	BOCK, SA; REMIGIO, LK; GORDON, B				BOCK, SA; REMIGIO, LK; GORDON, B			IMMUNOCHEMICAL LOCALIZATION OF PROTEINS IN THE INTESTINAL-MUCOSA OF CHILDREN WITH DIARRHEA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BOCK, SA (corresponding author), NATL JEWISH HOSP & RES CTR, NATL ASTHMA CTR, DEPT PEDIAT, DENVER, CO 80206 USA.							BAKER AL, 1978, ANN INTERN MED, V89, P505, DOI 10.7326/0003-4819-89-4-505; BOCK SA, 1982, J ALLERGY CLIN IMMUN, V69, P173, DOI 10.1016/0091-6749(82)90096-3; BOCK SA, 1978, CLIN ALLERGY, V8, P559, DOI 10.1111/j.1365-2222.1978.tb01509.x; BOCK SA, 1977, CLIN ALLERGY, V7, P375, DOI 10.1111/j.1365-2222.1977.tb01466.x; BOCK SA, 1979, PEDIATR RES, V13, P446; FALCHUK ZM, 1974, J CLIN INVEST, V53, P487, DOI 10.1172/JCI107582; GERRARD JW, 1973, ACTA PAEDIATR SCAND, P1; JOS J, 1976, BIOMEDICINE, V24, P425; KATZ AJ, 1978, GASTROENTEROLOGY, V75, P695; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; MAY CD, 1980, ALLERGY, V35, P301, DOI 10.1111/j.1398-9995.1980.tb01771.x; MAY CD, 1977, CLIN ALLERGY, V7, P583, DOI 10.1111/j.1365-2222.1977.tb01489.x; PERKKIO M, 1980, PEDIATR RES, V14, P953, DOI 10.1203/00006450-198008000-00012; SAVILAHTI E, 1981, ALLERGY, V36, P73, DOI 10.1111/j.1398-9995.1981.tb04101.x; STINTZING G, 1979, ACTA PAEDIATR SCAND, V68, P383, DOI 10.1111/j.1651-2227.1979.tb05024.x; STREEFKERK JG, 1972, J HISTOCHEM CYTOCHEM, V20, P829, DOI 10.1177/20.10.829; STROBER W, 1975, ANN INTERN MED, V83, P242, DOI 10.7326/0003-4819-83-2-242; VITORIA JC, 1982, ARCH DIS CHILD, V57, P44	18	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	3					262	268		10.1016/0091-6749(83)90030-1	http://dx.doi.org/10.1016/0091-6749(83)90030-1			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RH938	6688435				2022-12-18	WOS:A1983RH93800006
J	DESHAZO, RD; NORDBERG, J; BASER, Y; BOZELKA, B; WEILL, H; SALVAGGIO, J				DESHAZO, RD; NORDBERG, J; BASER, Y; BOZELKA, B; WEILL, H; SALVAGGIO, J			ANALYSIS OF DEPRESSED CELL-MEDIATED-IMMUNITY IN ASBESTOS WORKERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											DESHAZO, RD (corresponding author), TULANE UNIV,SCH MED,HERBERT J HARVEY JR IMMUNOL LAB,NEW ORLEANS,LA 70112, USA.				NHLBI NIH HHS [HL 15093] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLISON AC, 1979, FRONT BIOL, V49, P149; AUERBACH O, 1980, CHEST, V77, P133, DOI 10.1378/chest.77.2.133; BARBERS R, 1980, J ALLERGY CLIN IMM S, V67, P57; BIGNON J, 1978, AM REV RESPIR DIS, V117, P56; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BOZELKA BE, ENV RES; CHESS L, 1974, J IMMUNOL, V113, P1113; DANIELE RP, 1980, ANN INTERN MED, V92, P406, DOI 10.7326/0003-4819-92-3-406; DESHAZO RD, 1981, CLIN EXP IMMUNOL, V46, P313; DESHAZO RD, 1982, J ALLERGY CLIN IMMUN, V70, P313; DEVRIES JE, 1979, J IMMUNOL, V122, P1099; Gadek J, 1981, Chest, V80, P63; Gardner LU, 1940, J AMER MED ASSOC, V114, P535; HASLAM PL, 1978, CLIN EXP IMMUNOL, V31, P178; HUNNINGHAKE GW, 1981, J CLIN INVEST, V67, P86, DOI 10.1172/JCI110036; KAGAMIMORI S, 1980, BRIT J EXP PATHOL, V61, P55; KAGAN E, 1977, CLIN EXP IMMUNOL, V28, P261; KANG KY, 1974, NEW ENGL J MED, V291, P735; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; LANGE A, 1974, INT ARCH ARBEITSMED, V32, P313, DOI 10.1007/BF02178970; LANGE A, 1978, ARCH IMMUNOL THER EX, V26, P899; LANGE A, 1977, SCAND J IMMUNOL, V6, P720; LAWRENCE C, 1980, STAIN TECHNOL, V54, P321; MENDELSOHN J, 1981, J CELL PHYSIOL, V106, P13, DOI 10.1002/jcp.1041060103; MILLER K, 1978, CRC CR REV TOXICOL, V5, P319, DOI 10.3109/10408447809081010; MORIMOTO C, 1981, J CLIN INVEST, V67, P753, DOI 10.1172/JCI110092; OSTLE FA, 1976, STATISTICS RES, P119; Parazzi E, 1968, Med Lav, V59, P561; PELLEGRINO MA, 1973, CLIN IMMUNOL IMMUNOP, V2, P67, DOI 10.1016/0090-1229(73)90037-8; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4061, DOI 10.1073/pnas.76.8.4061; ROSENSTREICH DL, 1976, IMMUNOBIOLOGY MACROP, P162; WAGNER MMF, 1980, CLIN EXP IMMUNOL, V39, P176; WEILL H, 1979, AM REV RESPIR DIS, V120, P345; WINCHESTER RJ, 1974, J CLIN INVEST, V54, P1082, DOI 10.1172/JCI107852; 1971, ILOUC INT CLASSIFICA	35	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	4					418	424		10.1016/0091-6749(83)90072-6	http://dx.doi.org/10.1016/0091-6749(83)90072-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QL121	6601125				2022-12-18	WOS:A1983QL12100011
J	GRAMMER, LC; SILVESTRI, L; SUSZKO, IM; SHAUGHNESSY, MA; PATTERSON, R				GRAMMER, LC; SILVESTRI, L; SUSZKO, IM; SHAUGHNESSY, MA; PATTERSON, R			EVALUATION AND STANDARDIZATION OF POLYMERIZED RAGWEED EXTRACTS BY CHROMATOGRAPHY, RADIOIMMUNOASSAY INHIBITION, AND ENDPOINT CUTANEOUS TITRATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											GRAMMER, LC (corresponding author), NORTHWESTERN UNIV,SCH MED,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611, USA.			Grammer, Leslie/0000-0001-6860-2014	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON MC, 1982, J ALLERGY CLIN IMMUN, V69, P3, DOI 10.1016/0091-6749(82)90080-X; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; BILLMEYER FW, 1968, J CHROMATOGR, V34, P316, DOI 10.1016/0021-9673(68)80062-7; ETTRE LS, 1963, J CHROMATOGR, V11, P267, DOI 10.1016/S0021-9673(01)80906-7; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; GRAMMER LC, 1982, J ALLERGY CLIN IMMUN, V69, P494, DOI 10.1016/0091-6749(82)90173-7; HENDRIX SG, 1980, J ALLERGY CLIN IMMUN, V66, P486, DOI 10.1016/0091-6749(80)90010-X; HORDLE DA, 1975, DEV BIOL STANDARDIZA, P370; KELLY JF, 1980, J ALLERGY CLIN IMMUN, V65, P50, DOI 10.1016/0091-6749(80)90176-1; LEIFERMAN KM, 1979, J ALLERGY CLIN IMMUN, V64, P173, DOI 10.1016/0091-6749(79)90092-7; LEVY DA, 1980, REGULATORY CONTROL S, P178; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; NORMAN PS, 1982, J ALLERGY CLIN IMMUN, V69, P1, DOI 10.1016/0091-6749(82)90079-3; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V61, P28, DOI 10.1016/0091-6749(78)90470-0; PATTERSON R, 1981, J ALLERGY CLIN IMMUN, V68, P85, DOI 10.1016/0091-6749(81)90163-9; PATTERSON R, 1973, J IMMUNOL, V110, P1413; TURKELTAUB P C, 1982, Journal of Allergy and Clinical Immunology, V69, P99; ZEISS CR, 1981, J ALLERGY CLIN IMMUN, V67, P105, DOI 10.1016/0091-6749(81)90004-X; ZEISS CR, 1977, J CLIN EXP IMMUNOL, V27, P250; ZIMMERMANN EM, 1980, J ALLERGY CLIN IMMUN, V66, P386, DOI 10.1016/0091-6749(80)90118-9	20	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	2					160	167		10.1016/0091-6749(83)90524-9	http://dx.doi.org/10.1016/0091-6749(83)90524-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RD959	6886254				2022-12-18	WOS:A1983RD95900009
J	SLAVIN, RG; LINFORD, PA; FRIEDMAN, WH				SLAVIN, RG; LINFORD, PA; FRIEDMAN, WH			SPHENOETHMOIDECTOMY (SE) IN THE TREATMENT OF NASAL POLYPS, SINUSITIS AND BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					156	156		10.1016/0091-6749(83)90394-9	http://dx.doi.org/10.1016/0091-6749(83)90394-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200271
J	PARE, PD; NICHOLLS, I				PARE, PD; NICHOLLS, I			BRONCHIAL RESPONSE TO HISTAMINE AFTER INHALED PROPRANOLOL AND ATROPINE IN MONKEYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PARE, PD (corresponding author), UNIV BRITISH COLUMBIA,ST PAULS HOSP,PULM RES LAB,VANCOUVER V6Z 1Y6,BC,CANADA.		Pare, Peter D/C-7425-2011					ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; BLEECKER ER, 1976, AM REV RESPIR DIS, V114, P909; CURRY JJ, 1946, J CLIN INVEST, V25, P785, DOI 10.1172/JCI101764; DOUGLAS JS, 1973, J PHARMACOL EXP THER, V184, P169; DOUGLAS JS, 1976, LUNG CELLS DISEASE; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FISH JE, 1976, AM REV RESPIR DIS, V113, P579; GOLDEN JA, 1978, AM REV RESPIR DIS, V118, P287; HABIB MP, 1977, CLIN RES, V25, P713; KARIMAN K, 1977, AM REV RESPIR DIS, V115, pS61; LORING SH, 1978, J APPL PHYSIOL, V45, P40, DOI 10.1152/jappl.1978.45.1.40; LORING SH, 1979, LUNG, V156, P33, DOI 10.1007/BF02713989; MCNEILL RS, 1964, LANCET, V2, P1101; MEAD J, 1953, J APPL PHYSIOL, V5, P779, DOI 10.1152/jappl.1953.5.12.779; MICHOUD MC, 1978, J APPL PHYSIOL, V45, P846, DOI 10.1152/jappl.1978.45.6.846; MITCHELL C, 1976, YALE J BIOL MED, V49, P317; OREHEK J, 1975, J ALLERGY CLIN IMMUN, V55, P164, DOI 10.1016/0091-6749(75)90012-3; PARE PD, 1976, J APPL PHYSIOL, V41, P668, DOI 10.1152/jappl.1976.41.5.668; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; SIMONSSON BG, 1967, J CLIN INVEST, V46, P1812, DOI 10.1172/JCI105671; SNAPPER JR, 1978, J APPL PHYSIOL, V44, P738, DOI 10.1152/jappl.1978.44.5.738; SNAPPER JR, 1978, AM REV RESPIR DIS, V117, P339; SUETSUGU M, 1980, J ALLERGY CLIN IMMUN, V65, P339; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TOWNLEY RG, 1976, J ALLERGY CLIN IMMUN, V57, P358, DOI 10.1016/0091-6749(76)90093-2; ZAID G, 1966, NEW ENGL J MED, V275, P580, DOI 10.1056/NEJM196609152751103	26	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	2					213	220		10.1016/0091-6749(82)90102-6	http://dx.doi.org/10.1016/0091-6749(82)90102-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NC581	6120189				2022-12-18	WOS:A1982NC58100008
J	HERNANDEZ, MJ; MARTINEZ, F; BLAIR, HT; MILLER, WC				HERNANDEZ, MJ; MARTINEZ, F; BLAIR, HT; MILLER, WC			AIRWAY RESPONSE TO INHALED HISTAMINE IN ASYMPTOMATIC LONG-TERM MARIHUANA SMOKERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV TEXAS,SCH MED,DIV PULM,HOUSTON,TX 77025	University of Texas System								BARTER CE, 1976, AM REV RESPIR DIS, V113, P305; BEACONSFIELD P, 1973, NEW ENGL J MED, V289, P1315; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; HENDERSON RL, 1972, ARCHIV OTOLARYNGOL, V95, P248; KERR HD, 1975, AM REV RESPIR DIS, V111, P763; MALO J L, 1980, American Review of Respiratory Disease, V121, P248; MINK J T, 1980, American Review of Respiratory Disease, V121, P379; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; TASHKIN DP, 1974, AM REV RESPIR DIS, V109, P420; TASHKIN DP, 1976, NEW ENGL J MED, V294, P125, DOI 10.1056/NEJM197601152940302; TASHKIN DP, 1973, NEW ENGL J MED, V289, P336, DOI 10.1056/NEJM197308162890702; TASHKIN DP, 1977, AM REV RESPIR DIS, V115, P57; VACHON L, 1973, NEW ENGL J MED, V288, P985, DOI 10.1056/NEJM197305102881902; WALDMAN MM, 1970, J AMER MED ASSOC, V211, P501, DOI 10.1001/jama.1970.03170030093019; 1962, AM REV RESPIR DIS, V85, P762	17	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	2					153	155		10.1016/0091-6749(81)90011-7	http://dx.doi.org/10.1016/0091-6749(81)90011-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	LB947	7451781				2022-12-18	WOS:A1981LB94700011
J	OLGIATI, R; BIRCH, S; RAO, A; WANNER, A				OLGIATI, R; BIRCH, S; RAO, A; WANNER, A			DIFFERENTIAL-EFFECTS OF METHACHOLINE AND ANTIGEN CHALLENGE ON GAS-EXCHANGE IN ALLERGIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MT SINAI MED CTR,DEPT MED,DIV PULM DIS,4300 ALTON RD,MIAMI BEACH,FL 33140	Mount Sinai Medical Center					NHLBI NIH HHS [HL-10622, HL-20989] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020989] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSTEN KF, 1977, ASTHMA PHYSL IMMUNOP, P111; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; DESPAS PJ, 1972, J CLIN INVEST, V51, P3235, DOI 10.1172/JCI107150; DRAZEN JM, 1974, J CLIN INVEST, V53, P1679, DOI 10.1172/JCI107719; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; DUBOIS AB, 1952, J CLIN INVEST, V31, P40; INGRAM RH, 1977, NEW ENGL J MED, V297, P596; Kanner R.E., 1975, CLIN PULMONARY FUNCT; KUNG M, 1980, J APPL PHYSIOL, V49, P22, DOI 10.1152/jappl.1980.49.1.22; MCFADDEN ER, 1968, NEW ENGL J MED, V278, P1027, DOI 10.1056/NEJM196805092781901; MELVILLE GN, 1974, RESPIRATION, V31, P381, DOI 10.1159/000193611; PERMUTT S, 1977, ASTHMA PHYSL IMMUNOP, P266; POPPIUS H, 1977, SCAND J RESPIR DIS, V58, P1; WAGNER PD, 1978, AM REV RESPIR DIS, V117, P409	15	9	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	4					325	329		10.1016/0091-6749(81)90029-4	http://dx.doi.org/10.1016/0091-6749(81)90029-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LL697	7204788				2022-12-18	WOS:A1981LL69700012
J	UNGERER, RG; TASHKIN, DP; SIEGEL, SC; DEUTSCH, RI				UNGERER, RG; TASHKIN, DP; SIEGEL, SC; DEUTSCH, RI			EFFECT OF INHALED IODOXAMIDE TROMETHAMINE IN PREVENTION OF ANTIGEN-INDUCED BRONCHOSPASM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								ALTOUNYAN RE, 1967, ACTA ALLERGOL, V22, P487; ANAND SC, 1972, ANN ALLERGY, V30, P64; BOOIJNOO.H, 1970, J ALLERGY, V46, P1, DOI 10.1016/0021-8707(70)90055-9; BROOKS CD, 1979, J ALLERGY CLIN IMMUN, V63, P161; CASE RL, 1979, J ALLERGY CLIN IMMUN, V63, P161; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FORD L, 1979, J ALLERGY CLIN IMMUN, V63, P160; JOHNSON HG, 1978, INT ARCH ALLER A IMM, V56, P416, DOI 10.1159/000232051; KATCHER ML, 1980, J ALLERGY CLIN IMMUN, V66, P223, DOI 10.1016/0091-6749(80)90043-3; KOLOTKIN BM, 1974, J ALLERGY CLIN IMMUN, V53, P288, DOI 10.1016/0091-6749(74)90108-0; Menon M P, 1976, Indian J Chest Dis Allied Sci, V18, P83; MOLK L, 1972, ANN ALLERGY, V30, P321; OREHEK J, 1976, J CLIN INVEST, V57, P301, DOI 10.1172/JCI108281; PEPYS J, 1968, LANCET, V2, P134; WATT GD, 1980, J ALLERGY CLIN IMMUN, V66, P286, DOI 10.1016/0091-6749(80)90023-8	16	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	68	6					471	478		10.1016/0091-6749(81)90201-3	http://dx.doi.org/10.1016/0091-6749(81)90201-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MU790	7310012				2022-12-18	WOS:A1981MU79000010
J	HERMAN, JJ; COLTEN, HR				HERMAN, JJ; COLTEN, HR			SPECIFIC MODULATION OF COMPLEMENT-DEPENDENT HUMAN GRANULOCYTE FUNCTION BY IMIDAZOLE ACETIC-ACID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS HOSP MED CTR, DEPT MED, DIV CELL BIOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; CHILDRENS HOSP MED CTR, INA SUE PERLMUTTER CYST FIBROSIS CTR, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital								ABRAMSON N, 1971, J IMMUNOL, V107, P19; ARNAOUT MA, 1979, CLIN IMMUNOL IMMUNOP, V14, P384, DOI 10.1016/0090-1229(79)90164-8; BAINTON DF, 1968, J CELL BIOL, V39, P299, DOI 10.1083/jcb.39.2.299; BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; BRETZ U, 1974, J CELL BIOL, V63, P251, DOI 10.1083/jcb.63.1.251; CLARK RAF, 1975, J EXP MED, V142, P1462, DOI 10.1084/jem.142.6.1462; FOREMAN JC, 1973, NATURE, V245, P249, DOI 10.1038/245249a0; GOLDSTEIN I, 1973, P NATL ACAD SCI USA, V70, P2916, DOI 10.1073/pnas.70.10.2916; GOLDSTEIN IM, 1975, J CELL BIOL, V66, P647, DOI 10.1083/jcb.66.3.647; HERMAN JJ, 1979, J CLIN INVEST, V63, P1195, DOI 10.1172/JCI109414; HERMAN JJ, 1979, SCIENCE, V206, P77, DOI 10.1126/science.113872; KAPELLERADLER R, 1960, BIOCHIM BIOPHYS ACTA, V37, P527, DOI 10.1016/0006-3002(60)90512-6; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; Metchnikoff E., 1887, ANN I PASTEUR PARIS, V1, P321; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; RAPP HJ, 1970, MOL BASIS COMPLEMENT, P75; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; SHOWELL HJ, 1976, J EXP MED, V143, P1154, DOI 10.1084/jem.143.5.1154; SIRAGANIAN RP, 1975, J IMMUNOL, V115, P1599; SMITH CW, 1972, J LAB CLIN MED, V79, P878; STOSSEL TP, 1974, NEW ENGL J MED, V290, P833, DOI 10.1056/NEJM197404112901506; STOSSEL TP, 1973, J EXP MED, V137, P690, DOI 10.1084/jem.137.3.690; STOSSEL TP, 1972, J CLIN INVEST, V51, P615, DOI 10.1172/JCI106851; STOSSEL TP, 1974, NEW ENGL J MED, V290, P774, DOI 10.1056/NEJM197404042901405; STOSSEL TP, 1974, NEW ENGL J MED, V290, P717, DOI 10.1056/NEJM197403282901306; TALALAY P, 1946, J BIOL CHEM, V166, P757; TURNBULL LW, 1976, IMMUNOLOGY, V31, P797; WARD PA, 1965, J EXP MED, V122, P327, DOI 10.1084/jem.122.2.327; WEISSMANN G, 1971, J EXP MED, V134, pS149; WRIGHT DG, 1972, J CELL BIOL, V53, P788, DOI 10.1083/jcb.53.3.788; ZEIGER RS, 1976, J LAB CLIN MED, V87, P1065; ZEIGER RS, 1976, J EXP MED, V144, P1049, DOI 10.1084/jem.144.4.1049; ZEIGER RS, 1976, J ALLERGY CLIN IMMUN, V58, P172, DOI 10.1016/0091-6749(76)90152-4; ZIGMOND SH, 1978, J CELL BIOL, V77, P269, DOI 10.1083/jcb.77.2.269	37	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	4					274	280		10.1016/0091-6749(80)90021-4	http://dx.doi.org/10.1016/0091-6749(80)90021-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KM254	6252258				2022-12-18	WOS:A1980KM25400003
J	HIRSCH, SR; KALBFLEISCH, JH				HIRSCH, SR; KALBFLEISCH, JH			EXISTENCE OF BASOPHIL CHEMOTAXIS IN SUBJECTS WITH HAY-FEVER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT PREVENT MED,MILWAUKEE,WI 53233	Medical College of Wisconsin; Medical College of Wisconsin	HIRSCH, SR (corresponding author), VET ADM HOSP,MED CTR,RES SERV,WOOD,WI 53193, USA.							ATKINS PC, 1977, ANN INTERN MED, V86, P415, DOI 10.7326/0003-4819-86-4-415; BOETCHER DA, 1973, IMMUNOL COMMUN, V2, P421, DOI 10.3109/08820137309022813; DELANO F A, 1976, IRCS (International Research Communications System) Medical Science Library Compendium, V4, P25; DVORAK HF, 1972, J EXP MED, V135, P235, DOI 10.1084/jem.135.2.235; FELARCA AB, 1971, J ALLERGY CLIN IMMUN, V48, P125, DOI 10.1016/0091-6749(71)90007-8; GEWURZ H, 1976, MANUAL CLIN IMMUNOLO, P39; HILL HR, 1976, ANN INTERN MED, V85, P39, DOI 10.7326/0003-4819-85-1-39; HIRSCH SR, 1976, J ALLERGY CLIN IMMUN, V58, P676, DOI 10.1016/0091-6749(76)90179-2; HIRSCH SR, 1974, J ALLERGY CLIN IMMUN, V53, P303, DOI 10.1016/0091-6749(74)90110-9; KAY AB, 1972, CLIN EXP IMMUNOL, V11, P557; LETTBROWN MA, 1976, J IMMUNOL, V117, P246; SOHNLE PG, 1977, J ALLERGY CLIN IMMUN, V59, P171, DOI 10.1016/0091-6749(77)90221-4; WARD PA, 1975, J IMMUNOL, V114, P1523; WINTROBE M, 1967, CLIN HEMATOLOGY, P426	14	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	4					274	277		10.1016/0091-6749(80)90155-4	http://dx.doi.org/10.1016/0091-6749(80)90155-4			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JN548	7358944				2022-12-18	WOS:A1980JN54800006
J	RHOADES, RB; FORBES, EF				RHOADES, RB; FORBES, EF			CLINICALLY APPARENT ADRENAL SUPPRESSION WITH BECLOMETHASONE (400 MU-G A DAY) INHALATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					218	218						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000178
J	SOLOMON, WR; BURGE, HA; MUILENBERG, ML				SOLOMON, WR; BURGE, HA; MUILENBERG, ML			ALLERGENIC PROPERTIES OF ALTERNARIA SPORE, MYCELIAL, AND METABOLIC EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					229	229						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000214
J	KARLIN, JM				KARLIN, JM			OCCUPATIONAL ASTHMA TO CLAMS LIVER EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					197	197						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400215
J	MEIER, HL; NEWBALL, HH; BERNINGER, RW; TALAMO, RC; LICHTENSTEIN, LM				MEIER, HL; NEWBALL, HH; BERNINGER, RW; TALAMO, RC; LICHTENSTEIN, LM			PURIFICATION OF LUNG KALLIKREIN OF ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					191	191						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400193
J	ROSENTHAL, RR; CHAI, H; MATHISON, DA; SPECTOR, SL; TOWNLEY, RG				ROSENTHAL, RR; CHAI, H; MATHISON, DA; SPECTOR, SL; TOWNLEY, RG			INDICATIONS FOR INHALATION CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											ROSENTHAL, RR (corresponding author), JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,SCH MED,BALTIMORE,MD 21239, USA.								0	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					603	603		10.1016/0091-6749(79)90021-6	http://dx.doi.org/10.1016/0091-6749(79)90021-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	512254				2022-12-18	WOS:A1979HX84300009
J	WILSON, GB; SMITH, CL; FUDENBERG, HH				WILSON, GB; SMITH, CL; FUDENBERG, HH			EFFECTS OF DIALYZABLE LEUKOCYTE EXTRACTS (DLES) WITH TRANSFER-FACTOR ACTIVITY ON LEUKOCYTE MIGRATION INVITRO .3. CHARACTERIZATION OF THE ANTIGEN-INDEPENDENT MIGRATION-INHIBITION FACTOR IN DLES AS A NEUTROPHIL IMMOBILIZING FACTOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED UNIV S CAROLINA, DEPT BAS & CLIN IMMUNOL & MICROBIOL, CHARLESTON, SC 29403 USA	Medical University of South Carolina								ARALACHAVES MP, 1976, TRANSFER FACTOR BASI, P87; BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741, DOI 10.1177/10.6.741; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; COHEN L, 1976, J EXP MED, V143, P791, DOI 10.1084/jem.143.4.791; COHEN S, 1977, AM J PATHOL, V88, P502; DUPONT B, 1974, P NATL ACAD SCI USA, V71, P867, DOI 10.1073/pnas.71.3.867; GALLIN JI, 1974, P NATL ACAD SCI USA, V71, P498, DOI 10.1073/pnas.71.2.498; GOETZL EJ, 1978, J IMMUNOL, V121, P891; GOETZL EJ, 1972, J EXP MED, V136, P1564, DOI 10.1084/jem.136.6.1564; GOETZL EJ, 1974, J CLIN INVEST, V53, P813, DOI 10.1172/JCI107620; GOETZL EJ, 1973, J IMMUNOL, V111, P938; Gomori G., 1952, MICROSCOPIC HISTOCHE; GRISCELLI C, 1973, BIOMEDICINE, V18, P220; HAMBLIN AS, 1976, CLIN EXP IMMUNOL, V23, P303; KAHN A, 1975, CANCER, V36, P86; KIRKPATRICK CH, 1976, J INVEST DERMATOL, V67, P425, DOI 10.1111/1523-1747.ep12514723; KLESIUS PH, 1977, CLIN IMMUNOL IMMUNOP, V8, P238, DOI 10.1016/0090-1229(77)90113-1; KLESIUS PH, 1977, CLIN IMMUNOL IMMUNOP, V7, P240, DOI 10.1016/0090-1229(77)90051-4; LITTMAN BH, 1977, CELL IMMUNOL, V28, P158, DOI 10.1016/S0008-8749(77)80015-4; NEWELL RT, 1979, IMMUNE REGULATORS TR, P161; PADDOCK GV, 1979, IMMUNE REGULATORS TR, P419; REPO H, 1977, SCAND J IMMUNOL, V6, P203, DOI 10.1111/j.1365-3083.1977.tb00385.x; REPO H, 1977, SCAND J IMMUNOL, V6, P211, DOI 10.1111/j.1365-3083.1977.tb00386.x; VALDIMARSSON H, 1974, CLIN EXP IMMUNOL, V16, P141; VANDERMEER JWM, 1978, J EXP MED, V147, P271, DOI 10.1084/jem.147.1.271; Welch T.M., 1976, TRANSFER FACTOR, P399; WILSON GB, 1979, J LAB CLIN MED, V93, P800; WILSON GB, 1979, J LAB CLIN MED, V93, P818; WILSON GB, 1977, CLIN IMMUNOL IMMUNOP, V7, P187, DOI 10.1016/0090-1229(77)90047-2; WILSON GB, 1977, CLIN IMMUNOL IMMUNOP, V8, P551, DOI 10.1016/0090-1229(77)90020-4; WILSON GB, 1979, IMMUNE REGULATORS TR, P137; WILSON GB, 1978, T ASSOC AM PHYSICIAN, V91, P294; WYBRAN J, 1973, NEW ENGL J MED, V288, P710, DOI 10.1056/NEJM197304052881405	33	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	1					56	66		10.1016/0091-6749(79)90084-8	http://dx.doi.org/10.1016/0091-6749(79)90084-8			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HC424	447952				2022-12-18	WOS:A1979HC42400012
J	CHIPPS, BE; TEETS, KC; SAUNDERS, JP; SOBOTKA, AK; LICHTENSTEIN, LM				CHIPPS, BE; TEETS, KC; SAUNDERS, JP; SOBOTKA, AK; LICHTENSTEIN, LM			EFFECTS OF ORAL THEOPHYLLINE AND TERBUTALINE ON SKIN-TESTS AND HISTAMINE-RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					171	172		10.1016/0091-6749(78)90382-2	http://dx.doi.org/10.1016/0091-6749(78)90382-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300143
J	KLEIN, G; DURISETI, L; MIYAMOTO, S; WRIGHT, D; GALANT, SP				KLEIN, G; DURISETI, L; MIYAMOTO, S; WRIGHT, D; GALANT, SP			NUTRITION AND GROWTH IN NONSTEROID-DEPENDENT ASTHMATIC CHILD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					158	159		10.1016/0091-6749(78)90340-8	http://dx.doi.org/10.1016/0091-6749(78)90340-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300101
J	NORRIS, DA; FINE, R; WESTON, WL; SPECTOR, S				NORRIS, DA; FINE, R; WESTON, WL; SPECTOR, S			MONOCYTE CELLULAR FUNCTION IN ASTHMATIC-PATIENTS ON ALTERNATE-DAY STEROID-THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH HOSP & RES CTR,DENVER,CO 80206	National Jewish Health	NORRIS, DA (corresponding author), UNIV COLORADO,SCH MED,DENVER,CO 80220, USA.							BALOW JE, 1973, J EXP MED, V137, P1031, DOI 10.1084/jem.137.4.1031; BOVORNKITTI S, 1960, DIS CHEST, V38, P51, DOI 10.1378/chest.38.1.51; CHAI H, 1973, J ALLERGY CLIN IMMUN, V51, P65, DOI 10.1016/S0091-6749(73)80001-6; CLAMAN HN, 1971, J LAB CLIN MED, V78, P499; CLAMAN HN, 1975, J ALLERGY CLIN IMMUN, V55, P145, DOI 10.1016/0091-6749(75)90010-X; COHEN IR, 1970, J EXP MED, V132, P1055, DOI 10.1084/jem.132.6.1055; DALE DC, 1973, MED CLIN N AM, V57, P1277, DOI 10.1016/S0025-7125(16)32228-3; DALE DC, 1974, N ENGL J MED, V291, P1159; ESTENSEN RD, 1973, NATURE, V245, P458, DOI 10.1038/245458a0; FAUCI AS, 1975, J CLIN INVEST, V55, P22, DOI 10.1172/JCI107914; FAUCI AS, 1975, IMMUNOLOGY, V28, P669; FEUERMAN E, 1972, BRIT J DERMATOL, V86, P68, DOI 10.1111/j.1365-2133.1972.tb01895.x; GENTA GE, 1976, CLIN RES, V24, P90; GREENDYK.RM, 1965, J CLIN INVEST, V44, P746, DOI 10.1172/JCI105187; IGNARRO LJ, 1975, J CYCLIC NUCL PROT, V1, P283; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; MAILLARD JL, 1972, INT ARCH ALLER A IMM, V42, P50, DOI 10.1159/000230592; MCCALL CE, 1971, INFECT IMMUN, V4, P315, DOI 10.1128/IAI.4.3.315-317.1971; MCCOLLOUGH C, 1963, STATISTICAL CONCEPTS; MENDELSOHN J, 1973, J CLIN INVEST, V52, P2129, DOI 10.1172/JCI107397; MEURET G, 1976, J INVEST DERMATOL, V66, P22, DOI 10.1111/1523-1747.ep12478028; NORRIS DA, 1977, J LAB CLIN MED, V90, P569; NORTH RJ, 1971, J EXP MED, V134, P1485, DOI 10.1084/jem.134.6.1485; OQUINN SE, 1969, ARCH DERMATOL, V99, P380, DOI 10.1001/archderm.99.4.380; PARKER CW, 1973, J CLIN INVEST, V52, P1342, DOI 10.1172/JCI107306; RINEHART JJ, 1975, NEW ENGL J MED, V292, P236, DOI 10.1056/NEJM197501302920504; RINEHART JJ, 1974, J CLIN INVEST, V54, P1337, DOI 10.1172/JCI107880; SAMS WM, 1970, ARCH DERMATOL, V102, P485, DOI 10.1001/archderm.102.5.485; SCHREIBER AD, 1975, J CLIN INVEST, V56, P1189, DOI 10.1172/JCI108196; SPECTOR SL, 1975, J ALLERGY CLIN IMMUN, V56, P308, DOI 10.1016/0091-6749(75)90105-0; TAN JS, 1971, J LAB CLIN MED, V78, P316; THOMPSON J, 1970, Journal of Experimental Medicine, V131, P429, DOI 10.1084/jem.131.3.429; VIKEN KE, 1976, ACTA PATH MICRO IM C, V84, P13; WESTON WL, 1973, J IMMUNOL, V110, P880; WESTON WL, 1975, J IMMUNOL METHODS, V8, P213, DOI 10.1016/0022-1759(75)90114-3; WESTON WL, 1972, J INVEST DERMATOL, V59, P345, DOI 10.1111/1523-1747.ep12627402; WIENER E, 1972, LAB INVEST, V26, P220; Zwet T L, 1975, Infect Immun, V12, P699	38	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					255	260		10.1016/0091-6749(78)90200-2	http://dx.doi.org/10.1016/0091-6749(78)90200-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	632474				2022-12-18	WOS:A1978EV08000025
J	EGGLESTON, PA; BEASLEY, P; GUERRANT, JG				EGGLESTON, PA; BEASLEY, P; GUERRANT, JG			STANDARDIZATION OF EXERCISE-INDUCED ASTHMA (EIA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					251	251						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000151
J	FRANKLIN, RM; BAER, H; HOOTON, ML; BROWN, H				FRANKLIN, RM; BAER, H; HOOTON, ML; BROWN, H			STABILITY OF SHORT RAGWEED POLLEN EXTRACT AS MEASURED BY SKIN-TEST AND ANTIGEN-E	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									US FDA,BUR BIOL,BETHESDA,MD 20014; GEORGE WASHINGTON UNIV,SCH MED,WASHINGTON,DC 20006	US Food & Drug Administration (FDA); George Washington University								ARBESMAN CARL E., 1939, JOUR ALLERGY, V11, P18, DOI 10.1016/S0021-8707(39)90003-1; ARBESMAN DE, 1939, J ALLERGY, V10, P521; BAER H, 1974, J ALLERGY CLIN IMMUN, V54, P157, DOI 10.1016/0091-6749(74)90052-9; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; BAER H, 1974, INT S PRESERVATIVES, V24, P115; CENTER JG, 1974, J ALLERGY CLIN IMMUN, V54, P305, DOI 10.1016/0091-6749(74)90016-5; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; REISMAN RE, 1969, J ALLERGY, V44, P82, DOI 10.1016/0021-8707(69)90004-5; SCHERR MS, 1971, ANN ALLERGY, V29, P30; YUNGINGER JW, 1973, J CLIN INVEST, V52, P1268, DOI 10.1172/JCI107294	12	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	1					51	59		10.1016/0091-6749(76)90106-8	http://dx.doi.org/10.1016/0091-6749(76)90106-8			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BX742	947977				2022-12-18	WOS:A1976BX74200006
J	JOHNSON, TF; REISMAN, RE; ARBESMAN, CE; MATTAR, AG; MURPHEY, WH				JOHNSON, TF; REISMAN, RE; ARBESMAN, CE; MATTAR, AG; MURPHEY, WH			OBSTRUCTIVE AIRWAY DISEASE ASSOCIATED WITH HETEROZYGOUS ALPHA-1 ANTITRYPSIN DEFICIENCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BUFFALO GEN HOSP,BUFFALO,NY 14203; BUFFALO GEN HOSP,ALLERGY RES LAB,BUFFALO,NY 14203; BUFFALO GEN HOSP,DEPT NUCL MED,BUFFALO,NY 14203; SUNY BUFFALO,DEPT MED,BUFFALO,NY 14214; SUNY BUFFALO,DEPT MICROBIOL,BUFFALO,NY 14214	Buffalo General Medical Center; Buffalo General Medical Center; Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								ALTAY C, 1973, ANN ALLERGY, V31, P420; ANTHONISEN NR, 1969, RESP PHYSIOL, V8, P58, DOI 10.1016/0034-5687(69)90044-9; BUIST AS, 1973, AM REV RESPIR DIS, V107, P744; COHEN AB, 1973, J CLIN INVEST, V52, P2793, DOI 10.1172/JCI107475; COOPER DM, 1974, AM REV RESPIR DIS, V110, P708; ERICKSSON S, 1964, ACTA MED SCAND, V175, P197; ERIKSSON S, 1965, ACTA MED SCAND  S432, V177, P1; EVANS HE, 1970, AM REV RESPIR DIS, V101, P359; FAGERHOL MK, 1969, ACTA ALLERGOL, V24, P107, DOI 10.1111/j.1398-9995.1969.tb03760.x; FAGERHOL MK, 1969, HUM HERED, V19, P354, DOI 10.1159/000152238; KLAYTON R, 1975, AM REV RESPIR DIS, V112, P71; KUEPPERS F, 1969, SCIENCE, V165, P899, DOI 10.1126/science.165.3896.899; KUEPPERS F, 1974, AM REV RESPIR DIS, V110, P177; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LEVINE BW, 1970, ANN INTERN MED, V73, P397, DOI 10.7326/0003-4819-73-3-397; LIEBERMA.J, 1969, NEW ENGL J MED, V281, P279, DOI 10.1056/NEJM196908072810601; LIEBERMAN J, 1969, J AMER MED ASSOC, V210, P2055, DOI 10.1001/jama.210.11.2055; LIEBERMAN J, 1974, ANN INTERN MED, V81, P850, DOI 10.7326/0003-4819-81-6-850; LOKEN MK, 1967, J NUCL MED, V9, P2; MANSELL A, 1972, J APPL PHYSIOL, V33, P711, DOI 10.1152/jappl.1972.33.6.711; MIRSKY IA, 1945, P SOC EXP BIOL MED, V59, P34; MITTMAN C, 1973, ARCH ENVIRON HEALTH, V27, P201, DOI 10.1080/00039896.1973.10666352; MITTMAN C, 1974, AM REV RESPIR DIS, V109, P295; OHLSSON K, 1971, SCAND J CLIN LAB INV, V28, P251, DOI 10.3109/00365517109095696; RAWLINGS W, 1974, ANN INTERN MED, V81, P771, DOI 10.7326/0003-4819-81-6-771; SHARP HL, 1969, J LAB CLIN MED, V73, P934; TALAMO RC, 1972, NEW ENGL J MED, V287, P1067, DOI 10.1056/NEJM197211232872104; WELCH MH, 1969, ANN INTERN MED, V71, P533, DOI 10.7326/0003-4819-71-3-533	29	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	1					69	75		10.1016/0091-6749(76)90108-1	http://dx.doi.org/10.1016/0091-6749(76)90108-1			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BX742	1084893				2022-12-18	WOS:A1976BX74200008
J	SHIMIZO, M; WICHER, K; REISMAN, RE				SHIMIZO, M; WICHER, K; REISMAN, RE			MEASUREMENT OF IGG ANTIBODIES TO BEE VENOM BY RADIOALLERGOSORBENT TEST (RAST)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					211	211						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000054
J	VALENTINE, MD; HUNT, KJ; SOBOTKA, AK; LICHTENSTEIN, LM				VALENTINE, MD; HUNT, KJ; SOBOTKA, AK; LICHTENSTEIN, LM			VENOM IMMUNOTHERAPY FOR HYMENOPTERA SENSITIVITY - RESULTS IN WHOLE-BODY EXTRACT (WBE) TREATMENT FAILURES AND NEWLY DIAGNOSED PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					247	247						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000142
J	YOO, TJ; FLINK, RJ; THOMPSON, JS				YOO, TJ; FLINK, RJ; THOMPSON, JS			RELATIONSHIP BETWEEN HL-A ANTIGENS AND LYMPHOCYTE-RESPONSE IN RAGWEED ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV IOWA,DEPT INTERN MED,DIV ALLERGY IMMUNOL,IOWA CITY,IA; VET ADM HOSP,IOWA CITY,IA 52240	University of Iowa								BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273; BENACERRAF B, 1974, ANN INST PASTEUR IMM, VC125, P143; LEVINE BB, 1972, SCIENCE, V178, P1201, DOI 10.1126/science.178.4066.1201; MARSH DG, 1973, SCIENCE, V179, P691, DOI 10.1126/science.179.4074.691; McDevitt H O, 1969, Adv Immunol, V11, P31, DOI 10.1016/S0065-2776(08)60477-0; ROCKLIN RE, 1974, J CLIN INVEST, V53, P735, DOI 10.1172/JCI107612; THOMPSON JS, 1972, J EXP MED, V135, P596, DOI 10.1084/jem.135.3.596	7	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	1					25	28		10.1016/0091-6749(76)90075-0	http://dx.doi.org/10.1016/0091-6749(76)90075-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BC141	1245681				2022-12-18	WOS:A1976BC14100003
J	BERGMAN, RK; MUNOZ, JJ				BERGMAN, RK; MUNOZ, JJ			EFFECT OF BORDETELLA-PERTUSSIS EXTRACT AND VASOACTIVE AMINES ON VASCULAR-PERMEABILITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,ROCKY MT LAB,HAMILTON,MT 59840	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								BERGMAN RK, 1965, J IMMUNOL, V95, P1; BERGMAN RK, 1971, LIFE SCI 2-BIOCH GEN, V10, P561, DOI 10.1016/0024-3205(71)90192-5; BERGMAN RK, 1968, INT ARCH ALLER A IMM, V34, P9, DOI 10.1159/000230090; BERGMAN RK, 1965, NATURE, V205, P910, DOI 10.1038/205910a0; BERGMAN RK, 1966, P SOC EXP BIOL MED, V122, P428; BERGMAN RK, 1969, P SOC EXP BIOL MED, V131, P964; BERGMAN RK, 1968, INT ARCH ALLER A IMM, V34, P331, DOI 10.1159/000230127; FISHEL CW, 1964, BACTERIAL ENDOTOXINS, P474; KELLER KF, 1967, J BACTERIOL, V94, P804, DOI 10.1128/JB.94.4.804-811.1967; KIND LS, 1958, BACTERIOL REV, V22, P173, DOI 10.1128/MMBR.22.3.173-182.1958; LEIBOWITZ S, 1972, IMMUNOLOGY, V22, P859; MORSE SI, 1967, J EXP MED, V125, P619, DOI 10.1084/jem.125.4.619; MUNOZ J, 1968, BACTERIOL REV, V32, P103, DOI 10.1128/MMBR.32.2.103-126.1968; MUNOZ J, 1961, J IMMUNOL, V86, P618; MUNOZ J, 1962, NATURE, V196, P1192, DOI 10.1038/1961192a0; PARKER CW, 1973, J EXP MED, V137, P1078, DOI 10.1084/jem.137.4.1078; SNEDECOR GW, 1956, STATISTICAL METHODS; TOWNLEY RG, 1967, J ALLERGY, V39, P177, DOI 10.1016/0021-8707(67)90036-6	18	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	6					378	385		10.1016/0091-6749(75)90076-7	http://dx.doi.org/10.1016/0091-6749(75)90076-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AE593	166102				2022-12-18	WOS:A1975AE59300004
J	BIERMAN, C; PIERSON, W; SHAPIRO, G; SIMONS, E				BIERMAN, C; PIERSON, W; SHAPIRO, G; SIMONS, E			BRAIN-DAMAGE FROM ASTHMA IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					126	126						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800141
J	DUPREE, E; FRIEDMAN, JM; LAND, RN; GOLDMAN, AS				DUPREE, E; FRIEDMAN, JM; LAND, RN; GOLDMAN, AS			CELL-MEDIATED-IMMUNITY IN ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					102	102						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800083
J	HUNT, KJ; SOBOTKA, A; VALENTINE, MD; ZELEZNICK, LD; LICHTENSTEIN, LM				HUNT, KJ; SOBOTKA, A; VALENTINE, MD; ZELEZNICK, LD; LICHTENSTEIN, LM			DIAGNOSIS OF HYMENOPTERA HYPERSENSITIVITY BY SKIN TESTING WITH HYMENOPTERA VENOMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					74	74						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800013
J	ROBINSON, LD; MILLER, ME				ROBINSON, LD; MILLER, ME			SECA, A NEW MEDIATOR OF HUMAN EOSINOPHIL RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHARLES R DREW POSTGRAD MED SCH,1621 E 120TH ST,LOS ANGELES,CA 90059	Charles R. Drew University of Medicine & Science								BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; DAY RP, 1970, IMMUNOLOGY, V18, P955; HAM TH, 1958, SYLLABUS LABORATORY, P408; KAY AB, 1971, J EXP MED, V133, P602, DOI 10.1084/jem.133.3.602; KAY AB, 1973, IMMUNOLOGY, V24, P969; NORMAN ME, 1974, J PEDIATR-US, V85, P20, DOI 10.1016/S0022-3476(74)80278-7; WARD PA, 1969, AM J PATHOL, V54, P121	7	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	4					317	322		10.1016/0091-6749(75)90106-2	http://dx.doi.org/10.1016/0091-6749(75)90106-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AS523	1176723				2022-12-18	WOS:A1975AS52300009
J	WILLIAMS, JF; SZENTIVANYI, A				WILLIAMS, JF; SZENTIVANYI, A			IMPLICATIONS OF HEPATIC DRUG-METABOLIZING ACTIVITY IN THERAPY OF BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					125	125						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800139
J	PRAKASH, N				PRAKASH, N			INCREASED CIRCULATING IGE IN TROPICAL EOSINOPHILIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									RAJENDRA MEM RES INST MED SCI,DEPT BIOCHEM,PATNA 80007,BIHAR,INDIA	Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)								ARBESMAN CE, 1972, J ALLERGY CLIN IMMUN, V49, P72, DOI 10.1016/0091-6749(72)90058-9; BASTEN A, 1970, J EXP MED, V131, P1288, DOI 10.1084/jem.131.6.1288; BASTEN A, 1970, J EXP MED, V131, P1271, DOI 10.1084/jem.131.6.1271; BERG T, 1969, INT ARCH ALLER A IMM, V36, P219, DOI 10.1159/000230745; BOYER MH, 1970, BLOOD-J HEMATOL, V36, P458, DOI 10.1182/blood.V36.4.458.458; BRIGHTON WD, 1967, PROGR MICROBIOLOGICA, pCH7; CHATTERJEA JB, 1960, HDB TROPICAL DISEASE, pCH1; CHAUDHURY RN, 1954, INDIAN J MED RES, V42, P636; COOMBS RRA, 1964, CLINICAL ASPECTS IMM, pCH13; DONOHUGH DL, 1963, NEW ENGL J MED, V269, P1357, DOI 10.1056/NEJM196312192692507; Frimodt-Moller C, 1940, Ind Med Gaz, V75, P607; HOGARTHSCOTT RS, 1969, CLIN EXP IMMUNOL, V5, P619; JOHANSSO.SG, 1967, LANCET, V2, P951; JOHANSSON SG, 1968, LANCET, V1, P1118; MANSONBAHR PH, 1960, MANSONS TROPICAL DIS, pCH43; PERRY KMA, 1963, CHEST DISEASES, pCH12; PHILLS JA, 1972, NEW ENGL J MED, V286, P965, DOI 10.1056/NEJM197205042861802; ROSENBERG EB, 1970, NEW ENGL J MED, V283, P1148, DOI 10.1056/NEJM197011192832107; ROSENBERG EB, 1971, ANN INTERN MED, V75, P575, DOI 10.7326/0003-4819-75-4-575; SANYAL RK, 1962, ARCH INT PHARMACOD T, V138, P420; VARLEY H, 1967, PRACTICAL CLINICAL B, pCH12; Weingarten RJ, 1943, LANCET, V1, P103	22	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	3					189	191		10.1016/0091-6749(74)90007-4	http://dx.doi.org/10.1016/0091-6749(74)90007-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S3550	4205188				2022-12-18	WOS:A1974S355000007
J	FRICK, OL; ASHTON, F				FRICK, OL; ASHTON, F			SEROTONIN AND HISTAMINE-RELEASE FROM RAT MAST-CELLS SENSITIZED WITH ALLERGIC SERUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					82	82		10.1016/S0091-6749(73)80012-0	http://dx.doi.org/10.1016/S0091-6749(73)80012-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300012
J	SCHWARTZ, RH; JOHNSTON.DE; TALAMO, RC; DREYFUSS, EM; VANESS, JD				SCHWARTZ, RH; JOHNSTON.DE; TALAMO, RC; DREYFUSS, EM; VANESS, JD			ALPHA-1-ANTITRYPSIN (AAT) PROTEASE INHIBITOR (PI) TYPES IN RECURRENT AND CHRONIC LUNG-DISEASE OF CHILDHOOD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					85	86		10.1016/S0091-6749(73)80018-1	http://dx.doi.org/10.1016/S0091-6749(73)80018-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300018
J	BENAIMPINTO, C				BENAIMPINTO, C			AIRBORNE ALGAE AS A POSSIBLE ETIOLOGIC FACTOR IN RESPIRATORY ALLERGY IN CARACAS, VENEZUELA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																		BERNSTEI.IL, 1969, J ALLERGY, V43, P191, DOI 10.1016/0021-8707(69)90062-8; BERNSTEIN IL, 1970, NATURE, V227, P851, DOI 10.1038/227851a0; BERNSTEIN IL, 1966, ALLERGY, V38, P166; Chu SP, 1942, J ECOL, V30, P284, DOI 10.2307/2256574; HEISE H A, 1951, Ann Allergy, V9, P100; HEISE HA, 1949, J ALLERGY, V20, P383, DOI 10.1016/0021-8707(49)90029-5; LANGE W, 1967, NATURE, V215, P1277, DOI 10.1038/2151277a0; LEWIS RA, 1962, PHYSIOLOGY BIOCHEMIS; MCELHENNEY TR, 1970, ANN ALLERGY, V28, P467; MCELHENNEY TR, 1962, ANN ALLERGY, V20, P739; MCGOVERN JP, 1966, ANN ALLERGY, V24, P145; MCGOVERN JP, 1965, ANN ALLERGY, V23, P47; MILNER HW, 1948, J BIOL CHEM, V176, P813; MYERS J, 1949, PLANT PHYSIOL, V24, P111, DOI 10.1104/pp.24.1.111; MYERS J, 1951, PLANT PHYSIOL, V26, P539, DOI 10.1104/pp.26.3.539; MYERS J, 1963, ENCYCL CHEM, V1, P649; SMITH KM, 1966, VIROLOGY, V28, P580, DOI 10.1016/0042-6822(66)90243-1; SPOEHR HA, 1949, PLANT PHYSIOL, V24, P120, DOI 10.1104/pp.24.1.120; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077	19	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	6					356	+		10.1016/0091-6749(72)90135-2	http://dx.doi.org/10.1016/0091-6749(72)90135-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M6593					2022-12-18	WOS:A1972M659300006
J	FERNANDE.E; THIERER, E; MANCINI, RE				FERNANDE.E; THIERER, E; MANCINI, RE			IMMUNOLOGICAL AND TESTICULAR RESPONSE IN GUINEA-PIGS AFTER UNILATERAL THERMAL ORCHITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		ALONSO A, 1969, ACTA EUR FERTIL, V1, P459; BISHOP DW, 1965, ANN NY ACAD SCI, V124, P247, DOI 10.1111/j.1749-6632.1965.tb18960.x; BOUGHTON BARBARA, 1963, JOUR PATH AND BACTERIOL, V86, P69, DOI 10.1002/path.1700860108; BROWN PC, 1969, J PATHOL, V98, P277, DOI 10.1002/path.1710980407; BROWN PC, 1963, J PATHOL BACTERIOL, V86, P505, DOI 10.1002/path.1700860225; BROWN PC, 1967, IMMUNOLOGY, V13, P307; EYQUEM A, 1965, ANN NY ACAD SCI, V124, P270, DOI 10.1111/j.1749-6632.1965.tb18962.x; FREUND J, 1953, J EXP MED, V97, P711, DOI 10.1084/jem.97.5.711; MANCINI RE, 1969, FERTIL STERIL, V20, P779; RAPAPORT FT, 1969, J EXP MED, V130, P1411, DOI 10.1084/jem.130.6.1411	10	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	3					167	&		10.1016/0091-6749(72)90110-8	http://dx.doi.org/10.1016/0091-6749(72)90110-8			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L8566	5011090				2022-12-18	WOS:A1972L856600004
J	PIERSON, WE; KAWABORI, I; VANARSDE.PP; BIERMAN, CW				PIERSON, WE; KAWABORI, I; VANARSDE.PP; BIERMAN, CW			INCIDENCE OF EXERCISE-INDUCED BRONCHOSPASM IN NORMAL AND ATOPIC CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					129	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700094
J	SHEFFER, AL; ROSEN, F; AUSTEN, KF				SHEFFER, AL; ROSEN, F; AUSTEN, KF			TREATMENT OF HEREDITARY ANGIOEDEMA WITH TRANS-AMCHA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	9	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					133	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700100
J	Catlett, IM; Hu, YH; Gao, L; Banerjee, S; Gordon, K; Krueger, JG				Catlett, Ian M.; Hu, Yanhua; Gao, Lu; Banerjee, Subhashis; Gordon, Kenneth; Krueger, James G.			Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Deucravacitinib; Janus kinase; psoriasis; selective; tyrosine kinase 2	RHEUMATOID-ARTHRITIS; INADEQUATE RESPONSE; JAK-1 INHIBITOR; TH17 CYTOKINES; PHASE IIB; IN-VITRO; SAFETY; TOFACITINIB; EFFICACY; RECEPTOR	Background: Psoriasis, a chronic inflammatory disease dependent on the IL-23/T(H)17 pathway, is initiated through plasmacytoid dendritic cell activation and type I IFN induction in the skin. Deucravacitinib, a selective tyrosine kinase 2 (TYK2) inhibitor, blocks IL-23, IL-12, and type I IFN signaling in cellular assays. Objective: We investigated changes in IL-23/T(H)17 and type I IFN pathway biomarkers and gene responses as well as measures of selectivity for TYK2 over Janus kinases (JAKs) 1-3 in patients with moderate to severe psoriasis receiving deucravacitinib. Methods: Deucravacitinib was evaluated in a randomized, placebo-controlled, dose-ranging trial. Biopsy samples from nonlesional (day 1) and lesional skin (days 1, 15, and 85) were assessed for changes in IL-23/IL-12 and type I IFN pathway biomarkers by quantitative reverse-transcription polymerase chain reaction, RNA sequencing, and immunohistochemistry. Laboratory markers were measured in blood. Percentage change from baseline in Psoriasis Area and Severity Index (PASI) score was assessed. Results: IL-23 pathway biomarkers in lesional skin returned toward nonlesional levels dose-dependently with deucravacitinib. IFN and IL-12 pathway genes were normalized. Markers of keratinocyte dysregulation, keratin-16, and beta-defensin genes approached nonlesional levels with effective doses. Select laboratory parameters affected by JAK1-3 inhibition were not affected by deucravacitinib. Greater improvements in PASI scores, correlated with biomarker changes, were seen with the highest doses of deucravacitinib versus lower doses or placebo. Conclusion: Robust clinical efficacy with deucravacitinib treatment was associated with decreases in IL-23/TH17 and IFN pathway biomarkers. The lack of effect seen on biomarkers specific to JAK1-3 inhibition supports selectivity of deucravacitinib for TYK2; larger confirmatory studies are needed.	[Catlett, Ian M.; Hu, Yanhua; Gao, Lu; Banerjee, Subhashis] Bristol Myers Squibb, Princeton, NJ USA; [Gordon, Kenneth] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Krueger, James G.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Bristol-Myers Squibb; Medical College of Wisconsin; Rockefeller University	Catlett, IM (corresponding author), Bristol Myers Squibb, 3401 Princeton Pike, Lawrenceville, NJ 08648 USA.	Ian.Catlett@bms.com			Bristol Myers Squibb	Bristol Myers Squibb(Bristol-Myers Squibb)	The trial was sponsored by Bristol Myers Squibb, which designed the trial, provided the trial drug and placebo, conducted blinded safety monitoring, developed the analysis plan, analyzed the results, and funded professional writing assistance. A contract research organization (ICON, Dublin, Ireland) conducted the trial under the direction of the sponsor, and medical writers paid by the sponsor wrote the article's first draft. ClinicalTrials.gov identifier: NCT02931838.	Baker KF, 2018, ANN RHEUM DIS, V77, P175, DOI 10.1136/annrheumdis-2017-211555; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Brodmerkel C, 2019, J ALLERGY CLIN IMMUN, V143, P1965, DOI 10.1016/j.jaci.2019.01.017; Burke JR, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1736; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Catlett I, 2017, ANN RHEUM DIS, V76, P859, DOI 10.1136/annrheumdis-2017-eular.3809; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Conrad C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02466-4; Curran SA, 2017, CANCER IMMUNOL RES, V5, P52, DOI 10.1158/2326-6066.CIR-16-0233; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Dhingra N, 2014, J ALLERGY CLIN IMMUN, V134, P362, DOI 10.1016/j.jaci.2014.03.009; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Drachman JG, 1999, J BIOL CHEM, V274, P13480, DOI 10.1074/jbc.274.19.13480; Ewald DA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0133-x; Furue K, 2020, SCAND J IMMUNOL, V91, DOI 10.1111/sji.12846; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Genovese MC, 2016, ARTHRITIS RHEUMATOL, V68, P2857, DOI 10.1002/art.39808; Genovese MC, 2016, ARTHRITIS RHEUMATOL, V68, P46, DOI 10.1002/art.39473; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Girolomoni G, 2017, J EUR ACAD DERMATOL, V31, P1616, DOI 10.1111/jdv.14433; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Hawkes JE, 2017, J ALLERGY CLIN IMMUN, V140, P645, DOI 10.1016/j.jaci.2017.07.004; Isaacs JD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4397; Jia YY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111085; Jorgensen SCJ, 2020, PHARMACOTHERAPY, V40, P843, DOI 10.1002/phar.2438; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Konrad RJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41609-z; Kreins AY, 2015, J EXP MED, V212, P1641, DOI 10.1084/jem.20140280; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nordstrom SM, 2013, MOL ENDOCRINOL, V27, P1333, DOI 10.1210/me.2013-1110; Papp KA, 2016, BRIT J DERMATOL, V174, P1266, DOI 10.1111/bjd.14403; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Papp K, 2018, NEW ENGL J MED, V379, P1313, DOI 10.1056/NEJMoa1806382; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Rose-John S, 2017, NAT REV RHEUMATOL, V13, P399, DOI 10.1038/nrrheum.2017.83; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seif F, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0177-y; Shi JG, 2014, J CLIN PHARMACOL, V54, P1354, DOI 10.1002/jcph.354; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Smolen JS, 2019, J RHEUMATOL, V46, P7, DOI 10.3899/jrheum.171361; Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Spencer S, 2019, J EXP MED, V216, P1986, DOI 10.1084/jem.20190344; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Tilbrook PA, 1996, CELL GROWTH DIFFER, V7, P511; van Gurp EAFJ, 2009, TRANSPLANTATION, V87, P79, DOI 10.1097/TP.0b013e31818bbea7; van Vollenhoven R, 2019, ARTHRITIS RHEUMATOL, V71, P685, DOI 10.1002/art.40780; Vanhoutte F, 2017, ARTHRITIS RHEUMATOL, V69, P1949, DOI 10.1002/art.40186; Visvanathan S, 2019, J ALLERGY CLIN IMMUN, V143, P2158, DOI 10.1016/j.jaci.2018.11.042; Wawrzycki B, 2019, ARCH IMMUNOL THER EX, V67, P103, DOI 10.1007/s00005-018-0527-5; Winthrop KL, 2017, NAT REV RHEUMATOL, V13, P234, DOI 10.1038/nrrheum.2017.23; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wolk R, 2017, J CLIN LIPIDOL, V11, P1243, DOI 10.1016/j.jacl.2017.06.012; Wu HX, 2016, JOINT BONE SPINE, V83, P525, DOI 10.1016/j.jbspin.2015.09.002; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570	66	8	8	7	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2010	+		10.1016/j.jaci.2021.11.001	http://dx.doi.org/10.1016/j.jaci.2021.11.001			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	34767869	hybrid			2022-12-18	WOS:000833525500024
J	Deuitch, NT; Yang, D; Lee, PY; Yu, XM; Moura, NS; Schnappauf, O; Ombrello, AK; Stone, D; Kuehn, HS; Rosenzweig, SD; Hoffmann, P; Cudrici, C; Levy, DM; Kessler, E; Soep, JB; Hay, AD; Dalrymple, A; Zhang, Y; Sun, L; Zhang, QY; Tang, XM; Wu, Y; Rao, K; Li, HB; Luo, H; Zhang, Y; Burnham, JM; Boehm, M; Barron, K; Kastner, DL; Aksentijevich, I; Zhou, Q				Deuitch, Natalie T.; Yang, Dan; Lee, Pui Y.; Yu, Xiaomin; Moura, Natalia Sampaio; Schnappauf, Oskar; Ombrello, Amanda K.; Stone, Deborah; Kuehn, Hye Sun; Rosenzweig, Sergio D.; Hoffmann, Patrycja; Cudrici, Cornelia; Levy, Deborah M.; Kessler, Elizabeth; Soep, Jennifer B.; Hay, Arielle D.; Dalrymple, Austin; Zhang, Yu; Sun, Li; Zhang, Qiuye; Tang, Xuemei; Wu, Yuan; Rao, Koneti; Li, Haibo; Luo, Hong; Zhang, Yao; Burnham, Jon M.; Boehm, Manfred; Barron, Karyl; Kastner, Daniel L.; Aksentijevich, Ivona; Zhou, Qing			TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ADA2; DADA2; anti-TNF; macrophages	ADA2; PHENOTYPE; DISEASE	Background: Deficiency of adenosine deaminase 2 (DADA2) is a recessively inherited autoinflammatory disorder caused by a loss of functional ADA2 protein. TNF inhibition (TNFi) has proven to be highly effective in treating inflammatory manifestations. Objective: We sought to explore the pathophysiology and the underlying mechanisms of TNF-inhibitor response in these patients. Methods: We performed Sanger sequencing of the ADA2 gene. We used flow cytometry, intracellular cytokine staining, transcriptome analysis, immunohistochemistry, and cell differentiation experiments to define an inflammatory signature in patients with DADA2 and studied their response to TNF-inhibitor treatment. Results: We demonstrated increased inflammatory signals and overproduction of cytokines mediated by IFN and nuclear factor kappa B pathways in patients' primary cells. Treatment with TNFi led to reduction in inflammation, rescued the skewed differentiation toward the proinflammatory M1 macrophage subset, and restored integrity of endothelial cells in blood vessels. We also report 8 novel disease-associated variants in 7 patients with DADA2. Conclusions: Our data explore the cellular mechanism underlying effective treatment with TNFi therapies in DADA2. DADA2 vasculitis is strongly related to the presence of activated myeloid cells, and the endothelial cell damage is rescued with anti-TNF treatment.	[Deuitch, Natalie T.; Moura, Natalia Sampaio; Schnappauf, Oskar; Ombrello, Amanda K.; Stone, Deborah; Hoffmann, Patrycja; Kastner, Daniel L.; Aksentijevich, Ivona; Zhou, Qing] NHGRI, NIH, Bethesda, MD 20892 USA; [Yang, Dan; Cudrici, Cornelia; Boehm, Manfred] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Lee, Pui Y.] Boston Childrens Hosp, Boston, MA USA; [Yu, Xiaomin; Zhou, Qing] Zhejiang Univ, Med Ctr, Liangzhu Lab, Hangzhou, Peoples R China; [Kuehn, Hye Sun; Rosenzweig, Sergio D.] NIH, Dept Lab Med, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Levy, Deborah M.] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Kessler, Elizabeth] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Soep, Jennifer B.] Univ Colorado, Sch Med, Boulder, CO 80309 USA; [Hay, Arielle D.] Nicklaus Childrens Hosp, Miami, FL USA; [Dalrymple, Austin] St Louis Univ, SSM Hlth Cardinal Glennon Childrens Hosp, Sch Med, St Louis, MO USA; [Zhang, Yu; Rao, Koneti; Barron, Karyl] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sun, Li] Fudan Univ, Childrens Hosp, Shanghai, Peoples R China; [Zhang, Qiuye] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China; [Tang, Xuemei] Chongqing Med Univ, Childrens Hosp, Chongqing, Shandong, Peoples R China; [Wu, Yuan; Zhang, Yao] Peking Univ First Hosp, Beijing, Peoples R China; [Li, Haibo] Ningbo Women & Childrens Hosp, Ningbo, Zhejiang, Peoples R China; [Luo, Hong] Cent South Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Burnham, Jon M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Zhou, Qing] Zhejiang Univ, Life Sci Inst, Hangzhou, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Boston Children's Hospital; Zhejiang University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Mercy Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; Saint Louis University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University; Qingdao University; Chongqing Medical University; Peking University; Central South University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Zhejiang University	Aksentijevich, I; Zhou, Q (corresponding author), NHGRI, DHHS, NIH, Bldg 10,B2-5235C, Bethesda, MD 20892 USA.	aksentii@mail.nih.gov; zhouq2@zju.edu.cn		Deuitch, Natalie/0000-0002-0146-1162	Intramural Research Program of the National Human Genome Research Institute; National Key Research and Development Project [2018YFC1004903]; National Natural Science Foundation of China [31771548]; Zhejiang Provincial Natural Science Foundation of China [R19H100003]	Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Key Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This research was supported by the Intramural Research Program of the National Human Genome Research Institute. Q.Z. received grants from the National Key Research and Development Project (grant no. 2018YFC1004903), the National Natural Science Foundation of China (grant no. 31771548), and Zhejiang Provincial Natural Science Foundation of China (grant no. R19H100003).	Belot A, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-44; Caorsi R, 2017, ANN RHEUM DIS, V76, P1648, DOI 10.1136/annrheumdis-2016-210802; Carmona-Rivera C, 2019, BLOOD, V134, P395, DOI 10.1182/blood.2018892752; Dhanwani R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3688; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Fayand A, 2018, REV MED INTERNE, V39, P297, DOI 10.1016/j.revmed.2017.11.006; Hashem H, 2017, BLOOD, V130, P2682, DOI 10.1182/blood-2017-07-798660; Jani M, 2014, RHEUMATOLOGY, V53, P213, DOI 10.1093/rheumatology/ket260; Jee H, 2022, J ALLERGY CLIN IMMUN, V149, P379, DOI 10.1016/j.jaci.2021.04.034; Kaljas Y, 2017, CELL MOL LIFE SCI, V74, P555, DOI 10.1007/s00018-016-2357-0; Lee PY, 2020, J ALLERGY CLIN IMMUN, V145, P1664, DOI [10.1016/j.jaci.2019.12908, 10.1016/j.jaci.2019.12.908]; Lee PY, 2018, J ALLERGY CLIN IMMUN, V142, P1363, DOI 10.1016/j.jaci.2018.05.038; Meyts I, 2018, J CLIN IMMUNOL, V38, P569, DOI 10.1007/s10875-018-0525-8; Nihira H, 2021, J ALLERGY CLIN IMMUN, V148, P550, DOI 10.1016/j.jaci.2021.01.018; Ombrello AK, 2019, NEW ENGL J MED, V380, P1582, DOI 10.1056/NEJMc1801927; Sahin S, 2020, CURR OPIN RHEUMATOL, V32, P3, DOI 10.1097/BOR.0000000000000669; Schnappauf O, 2020, J CLIN IMMUNOL, V40, P917, DOI 10.1007/s10875-020-00817-3; Springer JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01361; van Montfrans J, 2014, NEW ENGL J MED, V371, P478, DOI 10.1056/NEJMc1405506; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	21	8	8	6	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1812	+		10.1016/j.jaci.2021.10.030	http://dx.doi.org/10.1016/j.jaci.2021.10.030			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3F7FD	34780847				2022-12-18	WOS:000830829600002
J	Otani, IM; Lehman, HK; Jongco, AM; Tsao, LR; Azar, AE; Tarrant, TK; Engel, E; Walter, JE; Truong, TQ; Khan, DA; Ballow, M; Cunningham-Rundles, C; Lu, HF; Kwan, M; Barmettler, S				Otani, Iris M.; Lehman, Heather K.; Jongco, Artemio M.; Tsao, Lulu R.; Azar, Antoine E.; Tarrant, Teresa K.; Engel, Elissa; Walter, Jolan E.; Truong, Tho Q.; Khan, David A.; Ballow, Mark; Cunningham-Rundles, Charlotte; Lu, Huifang; Kwan, Mildred; Barmettler, Sara			Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Secondary hypogammaglobulinemia; immunosuppres-sion; immunosuppressive medication; B-cell-targeted therapy; ritux-imab; ocrelizumab; autoimmunity; solid organ transplant; CD19 CAR-T-cell therapy; protein-losing enteropathy; protein loss	CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-LOSING ENTEROPATHY; IMMUNOGLOBULIN REPLACEMENT THERAPY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; STEM-CELL TRANSPLANTATION; PNEUMOCYSTIS-CARINII-PNEUMONIA; PATIENTS RECEIVING RITUXIMAB; INFLAMMATORY-BOWEL-DISEASE; FIBROSIS LUNG-DISEASE; LIVED PLASMA-CELLS	Secondary hypogammaglobulinemia (SHG) is characterized by reduced immunoglobulin levels due to acquired causes of decreased antibody production or increased antibody loss. Clarification regarding whether the hypogammaglobulinemia is secondary or primary is important because this has implications for evaluation and management. Prior receipt of immunosuppressive medications and/or presence of conditions associated with SHG development, including protein loss syndromes, are histories that raise suspicion for SHG. In patients with these histories, a thorough investigation of potential etiologies of SHG reviewed in this report is needed to devise an effective treatment plan focused on removal of iatrogenic causes (eg, discontinuation of an offending drug) or treatment of the underlying condition (eg, management of nephrotic syndrome). When iatrogenic causes cannot be removed or underlying conditions cannot be reversed, therapeutic options are not clearly delineated but include heightened monitoring for clinical infections, supportive antimicrobials, and in some cases, immunoglobulin replacement therapy. This report serves to summarize the existing literature regarding immunosuppressive medications and populations (autoimmune, neurologic, hematologic/oncologic, pulmonary, posttransplant, protein-losing) associated with SHG and highlights key areas for future investigation.	[Otani, Iris M.; Tsao, Lulu R.] UCSF Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA; [Lehman, Heather K.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Div Allergy Immunol & Rheumatol, Buffalo, NY USA; [Jongco, Artemio M.] Donald & Barbara Zucker Sch Med Hofstra Northwell, Div Allergy & Immunol, Great Neck, NY USA; [Azar, Antoine E.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Tarrant, Teresa K.] Duke Univ, Div Rheumatol & Immunol, Durham, NC 27706 USA; [Engel, Elissa] Cincinnati Childrens Hosp, Div Hematol & Oncol, Cincinnati, OH USA; [Walter, Jolan E.] Johns Hopkins All Childrens Hosp, Div Allergy & Immunol, St Petersburg, FL USA; [Walter, Jolan E.] Univ S Florida, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33620 USA; [Walter, Jolan E.] Massachusetts Gen Hosp Children, Div Allergy & Immunol, Boston, MA USA; [Truong, Tho Q.] Natl Jewish Hlth, Div Rheumatol, Denver, CO USA; [Truong, Tho Q.] Natl Jewish Hlth, Div Allergy & Clin Immunol, Denver, CO USA; [Khan, David A.] Univ Texas Southwestern Med Ctr Dallas, Div Allergy & Immunol, Dallas, TX USA; [Ballow, Mark] Johns Hopkins All Childrens Hosp, Morsani Coll Med, Div Allergy & Immunol, St Petersburg, FL USA; [Cunningham-Rundles, Charlotte] Icahn Sch Med Mt Sinai, Div Clin Immunol, New York, NY 10029 USA; [Lu, Huifang] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Sect Rheumatol & Clin Immunol, Houston, TX USA; [Kwan, Mildred] Univ N Carolina, Sch Med, Dept Med, Div Rheumatol Allergy & Immunol, Chapel Hill, NC 27515 USA; [Barmettler, Sara] Massachusetts Gen Hosp, Allergy & Immunol, Boston, MA USA	University of California System; University of California San Francisco; UCSF Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University; Duke University; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of South Florida; National Jewish Health; National Jewish Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Medicine; Icahn School of Medicine at Mount Sinai; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts General Hospital	Otani, IM (corresponding author), 400 Pamassus Ave,2nd Floor,Box 0359, San Francisco, CA 94143 USA.; Barmettler, S (corresponding author), 55 Fruit St,COX 201, Boston, MA 02114 USA.	iris.otani@ucsf.edu; sbarmettler@mgh.harvard.edu	Truong, Tho/HGC-8193-2022	Tarrant, Teresa/0000-0003-4067-5363	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K23AI163350]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H. K. Lehman is a clinical trial site principal investigator for Kedrion and Leadiant Biosciences, and a consultant and clinical trial site principal investigator for Chiesi Pharmaceutical S.p. A. A. Jongco hasinvestigator-initiated grants from Takeda and Horizon Therapeutics. A. Azar has received funding from Grifols and X4 Pharmaceuticals. J. E. Walter has received funding from Takeda, Janssen, Chiesi, MustangBio, ADMA Biologicals, and Octapharma and is on consultant/advisory boards for Takeda, X4-Pharmaceuticals, CLS-Behring, Grifols, ADMA Biologicals, Enzyvant, and Regeneron. M. Ballow is a consultant or speaker for Alladapt DSMB, Grifols, Immune Deficiency Foundation, USIDNET, IgNS, UpToDate, Green Cross DSMB, and Syneos Health. S. Barmettler is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number K23AI163350. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. None of these pose a conflict of interest regarding this article. The rest of the authors declare that they have no relevant conflict of interest.	Aaron SD, 2017, JAMA-J AM MED ASSOC, V317, P269, DOI 10.1001/jama.2016.19627; Abdel-Azim H, 2017, BIOL BLOOD MARROW TR, V23, P1437, DOI 10.1016/j.bbmt.2017.05.005; Abe S, 1998, PSYCHIAT CLIN NEUROS, V52, P115, DOI 10.1111/j.1440-1819.1998.tb00983.x; Abolhassani H, 2012, J CLIN IMMUNOL, V32, P1180, DOI 10.1007/s10875-012-9720-1; Abrahamsen IW, 2005, HAEMATOLOGICA, V90, P86; Adegunsoye A, 2017, CHEST, V152, P150, DOI 10.1016/j.chest.2016.10.001; Adeli MMG, 2009, PEDIATR HEMAT ONCOL, V26, P566, DOI 10.3109/08880010903271697; Agarwal S, 2019, ANN ALLERG ASTHMA IM, V123, P454, DOI 10.1016/j.anai.2019.07.014; Agarwal S, 2013, J ALLERGY CLIN IMMUN, V131, P1699, DOI 10.1016/j.jaci.2013.01.036; Agostini C, 2016, EXPERT REV CLIN IMMU, V12, P921, DOI 10.1080/1744666X.2016.1208085; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Anaissie EJ, 1998, ANN INTERN MED, V129, P559, DOI 10.7326/0003-4819-129-7-199810010-00010; Anolik JH, 2007, CLIN IMMUNOL, V122, P139, DOI 10.1016/j.clim.2006.08.009; [Anonymous], 2017, Ann Rheum Dis, V76, P1480, DOI 10.1136/annrheumdis-2016-209133corr1; [Anonymous], 2017, NEW ENGL J MED, V377, P2545; [Anonymous], METHOTREXATE PACKAGE; Anyaegbu EI, 2012, PEDIATR TRANSPLANT, V16, pE19, DOI 10.1111/j.1399-3046.2010.01384.x; argenx BV, 2021, VYVGART EFGARTIGIMOD; Aroor Shrikiran, 2017, J Clin Diagn Res, V11, pSD03, DOI 10.7860/JCDR/2017/24989.9742; ASHIHARA E, 1994, BONE MARROW TRANSPL, V13, P377; Augusto JF, 2016, TRANSPL INFECT DIS, V18, P741, DOI 10.1111/tid.12593; Australian National Blood Authority, 2020, ACQ HYP SEC HAEM MAL; Australian National Blood Authority, 2020, SEC HYP UNR HAEM MAL; Baker D, 2020, MULT SCLER RELAT DIS, V44, DOI 10.1016/j.msard.2020.102279; Balfour-Lynn IM, 2004, ARCH DIS CHILD, V89, P315, DOI 10.1136/adc.2003.026575; Bar-Or A, 2020, NEUROLOGY, V95, pE1999, DOI 10.1212/WNL.0000000000010380; Bar-Or A, 2018, NEUROLOGY, V90, pE1805, DOI 10.1212/WNL.0000000000005516; Barmettler S, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4169; Barmettler S, 2015, J ALLERGY CLIN IMMUN, V136, P1407, DOI 10.1016/j.jaci.2015.06.035; Barsalou J, 2011, CLIN EXP RHEUMATOL, V29, P125; Bedognetti D, 2011, J IMMUNOL, V186, P6044, DOI 10.4049/jimmunol.1004095; Benbrahim O, 2018, EUR J HAEMATOL, V101, P48, DOI 10.1111/ejh.13078; BENTUR L, 1990, J PEDIATR-US, V117, P741, DOI 10.1016/S0022-3476(05)83332-3; Berger M, 2008, BONE MARROW TRANSPL, V41, P55, DOI 10.1038/sj.bmt.1705870; Berger Melvin, 2017, Respir Med, V132, P181, DOI 10.1016/j.rmed.2017.10.016; Bernardi AM, 2021, PEDIATR CARDIOL, V42, P178, DOI 10.1007/s00246-020-02468-y; BESA EC, 1992, NEW ENGL J MED, V326, P139; Besada E, 2016, AUTOIMMUNE DIS, V2016, P1; Besada E, 2014, RHEUMATOLOGY, V53, P1818, DOI 10.1093/rheumatology/keu194; Bhella S, 2018, BIOL BLOOD MARROW TR, V24, P909, DOI 10.1016/j.bbmt.2018.01.017; Bhoj VG, 2016, BLOOD, V128, P360, DOI 10.1182/blood-2016-01-694356; Bingham CO, 2010, ARTHRITIS RHEUM-US, V62, P64, DOI 10.1002/art.25034; Bisogno G, 2007, EUR J PEDIATR, V166, P85, DOI 10.1007/s00431-006-0222-0; Blombery P, 2011, ANN HEMATOL, V90, P1167, DOI 10.1007/s00277-011-1275-3; Boddana P, 2011, CLIN TRANSPLANT, V25, P417, DOI 10.1111/j.1399-0012.2010.01255.x; Boleto G, 2018, SEMIN ARTHRITIS RHEU, V48, P149, DOI 10.1016/j.semarthrit.2018.02.010; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; BOUGHTON BJ, 1995, CLIN LAB HAEMATOL, V17, P75; Bourassa-Blanchette S, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13625; Bourassa-Blanchette S, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13560; Braun WE, 1997, TRANSPL P, V29, P247, DOI 10.1016/S0041-1345(96)00082-6; Broeders EN, 2008, TRANSPL INT, V21, P57, DOI 10.1111/j.1432-2277.2007.00556.x; Brudno JN, 2019, BLOOD REV, V34, P45, DOI 10.1016/j.blre.2018.11.002; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Bukhari M, 2011, RHEUMATOLOGY, V50, P2311, DOI 10.1093/rheumatology/ker106a; BUNCH C, 1988, NEW ENGL J MED, V319, P902; BUTLER WT, 1973, J CLIN INVEST, V52, P2629, DOI 10.1172/JCI107455; Byrd JC, 2003, BLOOD, V101, P6, DOI 10.1182/blood-2002-04-1258; Cabral P, 2022, THER APHER DIAL, V26, P836, DOI 10.1111/1744-9987.13757; Carbone J, 2008, TRANSPL INFECT DIS, V10, P396, DOI 10.1111/j.1399-3062.2008.00329.x; Carbone J, 2007, TRANSPL P, V39, P2385, DOI 10.1016/j.transproceed.2007.06.050; Carbone J, 2015, HEART LUNG VESSEL, V7, P256; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Castelino DJ, 1997, AUST NZ J MED, V27, P170, DOI 10.1111/j.1445-5994.1997.tb00934.x; Castro A P, 2001, Rev Hosp Clin Fac Med Sao Paulo, V56, P189; Casulo C, 2013, CL LYMPH MYELOM LEUK, V13, P106, DOI 10.1016/j.clml.2012.11.011; Centers for Disease Control and Prevention, 2021, PNEUM VACC REC; Centers for Disease Control and Prevention, 2021, ACIP GEN BEST PRACT; Centers for Disease Control and Prevention, COVID 19 VACC MOD SE; Chakrabarti S, 2003, HEART, V89, P1130, DOI 10.1136/heart.89.10.1130; Chambers DC, 2013, J HEART LUNG TRANSPL, V32, P36, DOI 10.1016/j.healun.2012.10.006; Chan AY, 2020, CURR OPIN ALLERGY CL, V20, P582, DOI 10.1097/ACI.0000000000000689; CHAPEL H, 1988, CLIN EXP IMMUNOL, V73, P160; CHAPEL H, 1994, BRIT J HAEMATOL, V88, P209, DOI 10.1111/j.1365-2141.1994.tb05002.x; CHAPEL HM, 1994, CLIN EXP IMMUNOL, V97, P21; Cheng DR, 2016, EXPERT REV VACCINES, V15, P1567, DOI 10.1080/14760584.2016.1193438; Cheung YF, 2001, J INFECTION, V42, P206, DOI 10.1053/jinf.2001.0821; Chinen J, 2010, J ALLERGY CLIN IMMUN, V125, pS195, DOI 10.1016/j.jaci.2009.08.040; Chiricozzi A, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040769; Christou EAA, 2017, INT REV IMMUNOL, V36, P352, DOI 10.1080/08830185.2017.1346092; Chung SA, 2021, ARTHRITIS RHEUMATOL, V73, P1366, DOI 10.1002/art.41773; Claustre J, 2015, TRANSPLANTATION, V99, P444, DOI 10.1097/TP.0000000000000339; Colucci M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01653; Cooper N, 2009, BRIT J HAEMATOL, V146, P120, DOI 10.1111/j.1365-2141.2009.07715.x; Corales R, 2000, Transpl Infect Dis, V2, P133, DOI 10.1034/j.1399-3062.2000.020306.x; Cordeiro A, 2020, BIOL BLOOD MARROW TR, V26, P26, DOI 10.1016/j.bbmt.2019.08.003; Cottini F, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.575168; Cowan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142205; Cuadrado MJ, 2019, BMC RHEUMATOL, V3, DOI 10.1186/s41927-019-0079-2; Curtis JR, 2021, ARTHRITIS RHEUMATOL, V73, P1093, DOI 10.1002/art.41734; De Angelis F, 2015, LEUKEMIA RES, V39, P1382, DOI 10.1016/j.leukres.2015.10.013; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; DEGIACOMO C, 1985, CLIN EXP IMMUNOL, V60, P447; Delbe-Bertin L, 2013, PEDIATR NEPHROL, V28, P447, DOI 10.1007/s00467-012-2361-z; Dhalla F, 2015, CURR OPIN ALLERGY CL, V15, P505, DOI 10.1097/ACI.0000000000000215; Dhalla F, 2014, J CLIN IMMUNOL, V34, P277, DOI 10.1007/s10875-014-9995-5; DIGHIERO G, 1988, NOUV REV FR HEMATOL, V30, P283; Dorner T, 2015, AUTOIMMUN REV, V14, P1079, DOI 10.1016/j.autrev.2015.07.013; Dorner Thomas, 2007, Ther Clin Risk Manag, V3, P953; Doron S, 2006, TRANSPLANTATION, V81, P697, DOI 10.1097/01.tp.0000180531.66518.9e; DOSCH HM, 1982, NEW ENGL J MED, V306, P406, DOI 10.1056/NEJM198202183060707; Dransfield MT, 2012, CLIN INFECT DIS, V55, pE35, DOI 10.1093/cid/cis513; Dunleavy K, 2010, SEMIN HEMATOL, V47, P180, DOI 10.1053/j.seminhematol.2010.01.009; Duraisingham SS, 2014, EXPERT REV CLIN IMMU, V10, P583, DOI 10.1586/1744666X.2014.902314; Dury S, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0133-9; Eichhorst B, 2015, ANN ONCOL, V26, pV78, DOI 10.1093/annonc/mdv303; Eom TH, 2013, NEUROL SCI, V34, P1003, DOI 10.1007/s10072-012-1153-3; European Medicines Agency, 2018, GUID CLIN INV HUM NO, P14; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Farez MF, 2019, NEUROLOGY, V93, P584, DOI 10.1212/WNL.0000000000008157; Farhat Lara, 2018, Drug Saf Case Rep, V5, P22, DOI 10.1007/s40800-018-0087-y; FARR M, 1986, DRUGS, V32, P49, DOI 10.2165/00003495-198600321-00010; FARR M, 1985, ANN RHEUM DIS, V44, P723, DOI 10.1136/ard.44.10.723-b; FDA, FDA APPR NEW TREATM; Feldt RH, 1996, J THORAC CARDIOV SUR, V112, P672, DOI 10.1016/S0022-5223(96)70051-X; Fernandez-Ruiz M, 2012, AM J TRANSPLANT, V12, P2763, DOI 10.1111/j.1600-6143.2012.04192.x; Fernandez-Ruiz M, 2017, TRANSPL INFECT DIS, P19; Ferreira I, 2014, ANN RHEUM DIS, V73, P1446, DOI 10.1136/annrheumdis-2014-205246; Filanovsky K, 2016, RECENT PAT ANTI-CANC, V11, P228, DOI 10.2174/1574892811666160129110614; FLORENT C, 1981, GASTROENTEROLOGY, V81, P777; Florescu DF, 2013, AM J TRANSPLANT, V13, P2601, DOI 10.1111/ajt.12401; Florescu DF, 2014, CLIN TRANSPLANT, V28, P1249, DOI 10.1111/ctr.12458; Frangoul H, 2013, BONE MARROW TRANSPL, V48, P1456, DOI 10.1038/bmt.2013.76; Frerichs KA, 2020, HAEMATOLOGICA, V105, pE302, DOI 10.3324/haematol.2019.231860; Friman V, 2016, HEMATOL ONCOL, V34, P121, DOI 10.1002/hon.2323; Fujinaga S, 2020, CLIN EXP NEPHROL, V24, P386, DOI 10.1007/s10157-020-01858-z; Fujinaga S, 2019, PEDIATR NEPHROL, V34, P353, DOI 10.1007/s00467-018-4145-6; Fujinaga S, 2016, CLIN NEPHROL, V85, P340, DOI 10.5414/CN108835; Garside JP, 2005, PEDIATR PULM, V39, P135, DOI 10.1002/ppul.20050; Genentech, 2020, RIT RIT PACK INS; Genentech, 2021, OCR OCR PACK INS; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Gluchowski NL, 2017, J LIPID RES, V58, P1230, DOI 10.1194/jlr.P075119; Go T, 2004, SEIZURE-EUR J EPILEP, V13, P187, DOI 10.1016/S1059-1311(03)00086-4; Goebeler M, 2022, BRIT J DERMATOL, V186, P429, DOI 10.1111/bjd.20782; Goldberg DJ, 2010, CARDIOL YOUNG, V20, P113, DOI 10.1017/S1047951110001162; Goldberg SL, 2002, BLOOD, V99, P1486, DOI 10.1182/blood.V99.4.1486; Goldfarb NS, 2001, TRANSPLANTATION, V71, P242, DOI 10.1097/00007890-200101270-00013; Goncalves D, 2012, RESPIR MED CASE REP, V5, P6, DOI 10.1016/j.rmedc.2011.12.001; Gordon C, 2018, RHEUMATOLOGY, V57, pE1, DOI 10.1093/rheumatology/kex286; Gottenberg JE, 2018, ARTHRITIS RHEUMATOL, V70, P763, DOI 10.1002/art.40425; Greenfield AL, 2018, ANN NEUROL, V83, P13, DOI 10.1002/ana.25119; GRIFFITHS H, 1989, BLOOD, V73, P366; Grigg A, 2017, HAEMATOLOGICA, V102, P765, DOI 10.3324/haematol.2016.152272; GUERRA IC, 1986, J ALLERGY CLIN IMMUN, V77, P603, DOI 10.1016/0091-6749(86)90353-2; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Hamblin AD, 2008, BRIT MED BULL, V87, P49, DOI 10.1093/bmb/ldn034; HAMILOS DL, 1992, ANN ALLERGY, V68, P472; Han JW, 2010, YONSEI MED J, V51, P239, DOI 10.3349/ymj.2010.51.2.239; Haque S, 2003, INTERN MED J, V33, P341, DOI 10.1046/j.1445-5994.2003.t01-1-00419.x; HARRIS HW, 1986, CLIN NEPHROL, V25, P308; Hartmann Jorg T, 2006, Haematologica, V91, pECR49; Hartono S, 2019, CLIN REV ALLERG IMMU, V57, P145, DOI 10.1007/s12016-018-8689-9; Hauk M, 2019, ANN ALLERG ASTHMA IM, V123, pS111, DOI 10.1016/j.anai.2019.08.227; HERSEY P, 1980, CLIN EXP IMMUNOL, V39, P698; HESLAN JM, 1982, CLIN NEPHROL, V18, P144; Hicks LK, 2009, BONE MARROW TRANSPL, V43, P701, DOI 10.1038/bmt.2008.382; Hill JA, 2019, BLOOD REV, V38, DOI 10.1016/j.blre.2019.100596; Hill JA, 2018, BLOOD, V131, P121, DOI 10.1182/blood-2017-07-793760; Hlavackova E, 2016, INT ARCH ALLERGY IMM, V170, P251, DOI 10.1159/000449163; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hoshino C, 2011, BMJ CASE REP, V2011; Howard JF, 2021, LANCET NEUROL, V20, P526, DOI 10.1016/S1474-4422(21)00159-9; Hoyt KJ, 2020, CLIN IMMUNOL, V211, DOI 10.1016/j.clim.2019.108326; Hua C, 2014, ARTHRIT CARE RES, V66, P1016, DOI 10.1002/acr.22246; Hull RP, 2008, BMJ-BRIT MED J, V336, P1185, DOI 10.1136/bmj.39576.709711.80; Inaba H, 2012, BRIT J HAEMATOL, V156, P109, DOI 10.1111/j.1365-2141.2011.08913.x; Isa HM, 2016, SAUDI MED J, V37, P199, DOI 10.15537/smj.2016.2.13232; Isobe Y, 2004, AM J HEMATOL, V77, P370, DOI 10.1002/ajh.20200; Jain S, 2012, J ALLERGY CLIN IMMUN, V129, pAB158, DOI 10.1016/j.jaci.2011.12.353; Jeffrey Modell Foundation, 10 WARN SIGNS PRIM I; JEURISSEN MEC, 1991, ARTHRITIS RHEUM-US, V34, P961, DOI 10.1002/art.1780340805; Jiang FD, 2018, ANN ALLERG ASTHMA IM, V120, P324, DOI 10.1016/j.anai.2017.10.022; Johnson JN, 2012, NUTR CLIN PRACT, V27, P375, DOI 10.1177/0884533612444532; Jordan SC, 2011, AM J TRANSPLANT, V11, P196, DOI 10.1111/j.1600-6143.2010.03400.x; JURLANDER J, 1994, EUR J HAEMATOL, V53, P114; Kammermeier J, 2017, J CROHNS COLITIS, V11, P60, DOI 10.1093/ecco-jcc/jjw118; Kane JM, 2016, PEDIATR CARDIOL, V37, P419, DOI 10.1007/s00246-015-1294-2; Kapetanovic MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4427; Kapetanovic MC, 2011, ARTHRITIS RHEUM-US, V63, P3723, DOI 10.1002/art.30580; Kaplan B, 2019, IMMUNOL ALLERGY CLIN, V39, P31, DOI 10.1016/j.iac.2018.08.005; Kaplan B, 2014, J ALLER CL IMM-PRACT, V2, P594, DOI 10.1016/j.jaip.2014.06.003; Katz Y, 1988, PEDIATR ASTHMA ALLER, V2, P309; Kawano T, 2002, INT ARCH ALLERGY IMM, V128, P240, DOI 10.1159/000064258; Kawut SM, 2005, TRANSPLANTATION, V79, P1723, DOI 10.1097/01.TP.0000159136.72693.35; KAY NE, 1981, BLOOD, V57, P418, DOI 10.1182/blood.V57.3.418.418; Kelesidis T, 2011, INT J INFECT DIS, V15, pE2, DOI 10.1016/j.ijid.2010.03.025; Kelsen JR, 2020, J PEDIATR GASTR NUTR, V70, P389, DOI 10.1097/MPG.0000000000002567; Kemper MJ, 2002, PEDIATR NEPHROL, V17, P413, DOI 10.1007/s00467-001-0817-7; Keven K, 2003, Transpl Infect Dis, V5, P181, DOI 10.1111/j.1399-3062.2003.00035.x; Khojah AM, 2019, PEDIATR RHEUMATOL, V17, DOI 10.1186/s12969-019-0365-y; Kim DH, 2006, BONE MARROW TRANSPL, V37, P1119, DOI 10.1038/sj.bmt.1705381; Kim JH, 2017, ALLERGY ASTHMA IMMUN, V9, P526, DOI 10.4168/aair.2017.9.6.526; Kim W, 2013, EUR J NEUROL, V20, P975, DOI 10.1111/ene.12132; Kimby E, 2005, CANCER TREAT REV, V31, P456, DOI 10.1016/j.ctrv.2005.05.007; Kishiyama JL, 1999, CLIN IMMUNOL, V91, P126, DOI 10.1006/clim.1999.4714; Kochenderfer JN, 2017, MOL THER, V25, P2245, DOI 10.1016/j.ymthe.2017.07.004; Koehne G, 1997, BONE MARROW TRANSPL, V19, P149, DOI 10.1038/sj.bmt.1700624; Kogure T, 2014, CLIN RHEUMATOL, V33, P323, DOI 10.1007/s10067-013-2483-0; Koleba T, 2006, PHARMACOTHERAPY, V26, P813, DOI 10.1592/phco.26.6.813; KU G, 1973, BRIT MED J, V4, P702, DOI 10.1136/bmj.4.5894.702; Kurolap A, 2019, J PEDIATR GASTR NUTR, V68, P325, DOI 10.1097/MPG.0000000000002198; Kurolap A, 2017, NEW ENGL J MED, V377, P87, DOI 10.1056/NEJMc1707173; Labrosse R, 2021, J ALLERGY CLIN IMMUN, V148, P523, DOI 10.1016/j.jaci.2021.03.041; Lack G, 1996, J PEDIATR-US, V129, P898, DOI 10.1016/S0022-3476(96)70035-5; Lanzillotta Marco, 2019, Clin Exp Rheumatol, V37 Suppl 118, P159; Lederer DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103908; Lee J, 2016, FASEB J, V30, P2014, DOI 10.1096/fj.201500135; Lee M, 2020, J CLIN IMMUNOL, V40, P1181, DOI 10.1007/s10875-020-00861-z; Lee MY, 2008, ANN HEMATOL, V87, P285, DOI 10.1007/s00277-007-0397-0; Leitao FS, 2020, CHEST, V158, P1420, DOI 10.1016/j.chest.2020.04.058; LEVY J, 1972, J CLIN INVEST, V51, P2233, DOI 10.1172/JCI107031; Levy R, 2014, AUTOIMMUN REV, V13, P1055, DOI 10.1016/j.autrev.2014.08.036; Lew J, 2021, J CLIN IMMUNOL, V41, P1940, DOI 10.1007/s10875-021-01111-6; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036698; Lichvar AB, 2018, PROG TRANSPLANT; LILLIE MA, 1983, ARCH DERMATOL, V119, P415, DOI 10.1001/archderm.119.5.415; Lim E, 2013, LUPUS, V22, P1382, DOI 10.1177/0961203313507990; Lim SH, 2008, LEUKEMIA LYMPHOMA, V49, P152, DOI 10.1080/10428190701742506; Lim SH, 2005, BONE MARROW TRANSPL, V35, P207, DOI 10.1038/sj.bmt.1704742; Limper AH, 2011, AM J RESP CRIT CARE, V183, P96, DOI 10.1164/rccm.2008-740ST; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Los-Arcos I, 2021, INFECTION, V49, P215, DOI 10.1007/s15010-020-01521-5; Lui GK, 2017, CIRCULATION, V136, pE348, DOI 10.1161/CIR.0000000000000535; Luque Y, 2016, TRANSPL INT, V29, P1205, DOI 10.1111/tri.12833; MACDERMOTT RP, 1989, GASTROENTEROLOGY, V96, P442, DOI 10.1016/0016-5085(89)91569-2; Magdo HS, 2015, J PEDIATR-US, V167, P331, DOI 10.1016/j.jpeds.2015.04.061; Maggiore U, 2010, TRANSPL INFECT DIS, V12, P470, DOI 10.1111/j.1399-3062.2010.00512.x; Mahevas M, 2021, HAEMATOLOGICA, V106, P2449, DOI 10.3324/haematol.2020.259481; Mahmood I, 2020, ANTIBODIES, V9, DOI 10.3390/antib9020024; Makatsori M, 2014, QJM-INT J MED, V107, P821, DOI 10.1093/qjmed/hcu094; Mansharamani NG, 2000, CHEST, V118, P712, DOI 10.1378/chest.118.3.712; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Marcinno A, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000498; Maruyama S, 2016, BRAIN DEV-JPN, V38, P947, DOI 10.1016/j.braindev.2016.06.006; Marzuillo P, 2019, WORLD J CLIN CASES, V7, P1021, DOI 10.12998/wjcc.v7.i9.1021; Masur H, 2000, CLIN INFECT DIS, V30, pS29; MATHIAS R, 1989, NEW ENGL J MED, V320, P398; MATTHEWS WJ, 1980, NEW ENGL J MED, V302, P245, DOI 10.1056/NEJM198001313020501; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mawhorter S, 2008, CURR OPIN ORGAN TRAN, V13, P581, DOI 10.1097/MOT.0b013e3283186bbc; Mayor PC, 2018, J ALLERGY CLIN IMMUN, V141, P1028, DOI 10.1016/j.jaci.2017.05.024; McCullagh BN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172437; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; McMahan ZH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0506-0; Melamed IR, 2018, EUR J PHARM SCI, V118, P80, DOI 10.1016/j.ejps.2018.03.007; Mertens L, 1998, J THORAC CARDIOV SUR, V115, P1063, DOI 10.1016/S0022-5223(98)70406-4; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P1664, DOI 10.1001/jama.2013.281115; Molica S, 1996, HAEMATOLOGICA, V81, P121; Molinaro I, 2014, INT J IMMUNOPATH PH, V27, P305, DOI 10.1177/039463201402700220; Moon J, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13300; Moreno-Ancillo A, 2004, Allergol Immunopathol (Madr), V32, P86, DOI 10.1157/13059850; Morrison VA, 2010, BEST PRACT RES CL HA, V23, P145, DOI 10.1016/j.beha.2009.12.004; Morsheimer MM, 2016, J ALLER CL IMM-PRACT, V4, P491, DOI 10.1016/j.jaip.2015.11.034; Munoz P, 2007, J HEART LUNG TRANSPL, V26, P907, DOI 10.1016/j.healun.2007.07.010; MUSTO P, 1995, BRIT J HAEMATOL, V89, P945; Na IK, 2019, EUR J HAEMATOL, V102, P447, DOI 10.1111/ejh.13223; National Comprehensive Cancer Network&REG;, 2022, NCCN CLIN PRACTICE G; National Institute for Health and Care Excellence, 2016, MYEL DIAGN MAN; Nazi I, 2013, BLOOD, V122, P1946, DOI 10.1182/blood-2013-04-494096; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Niggemann B, 1998, CLIN EXP ALLERGY, V28, P205; Ntatsaki E, 2014, RHEUMATOLOGY, V53, P2306, DOI 10.1093/rheumatology/ket445; OGI M, 1994, AM J KIDNEY DIS, V24, P427, DOI 10.1016/S0272-6386(12)80899-7; Ohsumi A, 2014, EUR J CARDIO-THORAC, V45, pE61, DOI 10.1093/ejcts/ezt583; Orange JS, 2012, CLIN EXP IMMUNOL, V169, P172, DOI 10.1111/j.1365-2249.2012.04594.x; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Orange JS, 2010, CLIN IMMUNOL, V137, P21, DOI 10.1016/j.clim.2010.06.012; Origuen J, 2015, INFECTION, V43, P413, DOI 10.1007/s15010-015-0737-2; Orlowski Robert Z, 2005, Hematology Am Soc Hematol Educ Program, P220; Oscier D, 2012, BRIT J HAEMATOL, V159, P541, DOI 10.1111/bjh.12067; Ottaviano G, 2020, J ALLER CL IMM-PRACT, V8, P273, DOI 10.1016/j.jaip.2019.07.032; Overdijk MB, 2015, MABS-AUSTIN, V7, P311, DOI 10.1080/19420862.2015.1007813; Ozaras N, 2012, SEIZURE-EUR J EPILEP, V21, P229, DOI 10.1016/j.seizure.2011.12.013; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; Padmanabhan A, 2019, J CLIN APHERESIS, V34, P171, DOI 10.1002/jca.21705; Palacios T, 2015, ANN ALLERG ASTHMA IM, V115, P148, DOI 10.1016/j.anai.2015.05.007; Palazzo E, 2012, JOINT BONE SPINE, V79, P351, DOI 10.1016/j.jbspin.2011.11.002; Pan J, 2019, LEUKEMIA, V33, P2854, DOI 10.1038/s41375-019-0488-7; Papp KA, 2019, J CUTAN MED SURG, V23, P50, DOI 10.1177/1203475418811335; Park JH, 2018, CLIN INFECT DIS, V67, P533, DOI 10.1093/cid/ciy152; Park JK, 2018, ANN RHEUM DIS, V77, P898, DOI 10.1136/annrheumdis-2018-213222; Park JK, 2017, ANN RHEUM DIS, V76, P1559, DOI 10.1136/annrheumdis-2017-211128; Park S, 2015, TRANSPL INFECT DIS, V17, P679, DOI 10.1111/tid.12424; Parmentier C, 2020, PEDIATR NEPHROL, V35, P455, DOI 10.1007/s00467-019-04398-1; Patel SY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00033; Patuzzo G, 2016, EUR ANN ALLERGY CLIN, V48, P55; Paul Y, 2019, BLOOD, V134, DOI 10.1182/blood-2019-127247; Payne KM, 2013, ANN ALLERG ASTHMA IM, V111, P142, DOI 10.1016/j.anai.2013.05.018; Pazmandi J, 2019, IMMUNOL REV, V287, P162, DOI 10.1111/imr.12726; Pereira LF, 2002, SCAND J INFECT DIS, V34, P785, DOI 10.1080/00365540260348662; Perez EE, 2017, J ALLERGY CLIN IMMUN, V139, pS1, DOI 10.1016/j.jaci.2016.09.023; Pescovitz MD, 2011, J ALLERGY CLIN IMMUN, V128, P1295, DOI 10.1016/j.jaci.2011.08.008; Peter HH, 2020, J ALLERGY CLIN IMMUN, V146, P479, DOI 10.1016/j.jaci.2020.07.016; Petrov AA, 2018, TRANSPLANT DIRECT, V4, DOI 10.1097/TXD.0000000000000811; POHL MA, 1991, ANN INTERN MED, V114, P924, DOI 10.7326/0003-4819-114-11-924; POLLOCK CA, 1989, TRANSPLANTATION, V47, P952, DOI 10.1097/00007890-198906000-00007; Ponsford M, 2019, BRIT J PSYCHIAT, V214, P83, DOI 10.1192/bjp.2018.152; Ponsford MJ, 2019, CURR OPIN ALLERGY CL, V19, P553, DOI 10.1097/ACI.0000000000000592; Ponsford MJ, 2020, J CLIN PATHOL, V73, P587, DOI 10.1136/jclinpath-2019-206235; Poole JA, 2016, TRANSPL P, V48, P479, DOI 10.1016/j.transproceed.2015.12.064; Portaccio E, 2003, MULT SCLER, V9, P446, DOI 10.1191/1352458503ms926oa; POSEY WC, 1978, J ALLERGY CLIN IMMUN, V62, P340, DOI 10.1016/0091-6749(78)90134-3; Price V, 2013, PEDIATR BLOOD CANCER, V60, pS12, DOI 10.1002/pbc.24343; Proesmans M, 2011, J CYST FIBROS, V10, P128, DOI 10.1016/j.jcf.2010.12.004; Putcha N, 2019, A41 COPD EPIDEMIOLOG; Putcha N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194924; Quartier P, 2001, LANCET, V358, P1511, DOI 10.1016/S0140-6736(01)06573-4; Raanani P, 2009, LEUKEMIA LYMPHOMA, V50, P764, DOI 10.1080/10428190902856824; Radaelli M, 2016, MULT SCLER J, V22, P511, DOI 10.1177/1352458515594042; Raisch DW, 2016, EXPERT OPIN DRUG SAF, V15, P1003, DOI 10.1080/14740338.2016.1198775; Rao A, 2008, PEDIATR BLOOD CANCER, V50, P822, DOI 10.1002/pbc.21264; Reyes S, 2020, PRACT NEUROL, V20, P435, DOI 10.1136/practneurol-2020-002527; Rhee Yoona, 2020, Clin Liver Dis (Hoboken), V15, P63, DOI 10.1002/cld.898; Ribeiro ACM, 2011, ANN RHEUM DIS, V70, P2144, DOI 10.1136/ard.2011.152983; Rice CM, 2007, J NEUROL NEUROSUR PS, V78, P1011, DOI 10.1136/jnnp.2006.090266; Roberts DM, 2015, J AUTOIMMUN, V57, P60, DOI 10.1016/j.jaut.2014.11.009; Robertson J, 2009, PEDIATR TRANSPLANT, V13, P754, DOI 10.1111/j.1399-3046.2008.01067.x; Roll P, 2015, CLIN EXP RHEUMATOL, V33, P347; Rubin LG, 2014, CLIN INFECT DIS, V58, P309, DOI [10.1093/cid/cit684, 10.1093/cid/cit816]; Rychik J, 2019, CIRCULATION, V140, pE234, DOI 10.1161/CIR.0000000000000696; Rychik Jack, 2007, Congenit Heart Dis, V2, P288, DOI 10.1111/j.1747-0803.2007.00116.x; Salmun LM, 1999, J ALLERGY CLIN IMMUN, V103, P810, DOI 10.1016/S0091-6749(99)70424-0; Salter AI, 2018, BLOOD, V131, P2621, DOI 10.1182/blood-2018-01-785840; Sampalo A, 2000, BLOOD, V96, P3168; Sarmiento E, 2005, TRANSPL P, V37, P4046, DOI 10.1016/j.transproceed.2005.09.153; Sarmiento E, 2006, TRANSPL INFECT DIS, V8, P49, DOI 10.1111/j.1399-3062.2006.00136.x; Sarmiento E, 2018, J HEART LUNG TRANSPL, V37, P1001, DOI 10.1016/j.healun.2018.04.001; Sarmiento E, 2017, J HEART LUNG TRANSPL, V36, P529, DOI 10.1016/j.healun.2016.10.004; Sarmiento E, 2016, TRANSPL INFECT DIS, V18, P832, DOI 10.1111/tid.12610; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Schwartz HJ, 2006, ALLERGY ASTHMA PROC, V27, P53; Seet RCS, 2005, CLIN DIAGN LAB IMMUN, V12, P680, DOI 10.1128/CDLI.12.5.680-682.2005; Segarra A, 2020, LUPUS, V29, P118, DOI 10.1177/0961203319896018; Selter RC, 2013, MULT SCLER J, V19, P1454, DOI 10.1177/1352458513477229; Sener A, 2006, TRANSPLANTATION, V81, P117, DOI 10.1097/01.tp.0000181096.14257.c2; SEPKOWITZ KA, 1995, ARCH INTERN MED, V155, P1125, DOI 10.1001/archinte.155.11.1125; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; SETTIPANE GA, 1978, J ALLERGY CLIN IMMUN, V62, P162, DOI 10.1016/0091-6749(78)90101-X; Shah Shaili N, 2015, Clin Case Rep Rev, V1, P151; Shankar T, 2013, INT IMMUNOPHARMACOL, V15, P752, DOI 10.1016/j.intimp.2013.02.021; Sharma AP, 2009, PEDIATR TRANSPLANT, V13, P123, DOI 10.1111/j.1399-3046.2008.00958.x; Sharma S, 2008, BLOOD, V112, P1338, DOI 10.1182/blood-2007-11-124156; Sharma VR, 2000, BLOOD, V96, P1184, DOI 10.1182/blood.V96.3.1184.015k54_1184_1186; Sharman JP, 2019, LEUKEMIA LYMPHOMA, V60, P894, DOI 10.1080/10428194.2018.1515940; Shatat IF, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00287; Shock A, 2020, J ALLERGY CLIN IMMUN, V146, P492, DOI 10.1016/j.jaci.2020.06.036; Shortt J, 2006, BONE MARROW TRANSPL, V38, P433, DOI 10.1038/sj.bmt.1705463; SIMON CH, 1995, CLIN RHEUMATOL, V14, P214, DOI 10.1007/BF02214947; Sinisalo M, 2001, BRIT J HAEMATOL, V114, P107, DOI 10.1046/j.1365-2141.2001.02882.x; SKLENAR I, 1993, ONCOLOGY, V50, P466; Smets I, 2021, MULT SCLER RELAT DIS, V50, DOI 10.1016/j.msard.2021.102851; Smilek DE, 2017, LUPUS SCI MED, V4, DOI 10.1136/lupus-2017-000229; SMOLIN MR, 1988, AM J KIDNEY DIS, V11, P267, DOI 10.1016/S0272-6386(88)80161-6; Song KW, 2002, BRIT J HAEMATOL, V119, P125, DOI 10.1046/j.1365-2141.2002.03778.x; Sparchez M, 2015, PEDIATR RHEUMATOL, V13, DOI 10.1186/s12969-015-0050-8; Spickett GP, 1996, J NEUROL NEUROSUR PS, V60, P459, DOI 10.1136/jnnp.60.4.459; Srivastava S, 2016, CLIN MED, V16, P571, DOI 10.7861/clinmedicine.16-6-571; Stabler S, 2021, CLIN INFECT DIS, V72, P727, DOI 10.1093/cid/ciaa127; Stephen J, 2016, EUR J HUM GENET, V24, P1268, DOI 10.1038/ejhg.2016.5; Stepnicki P, 2018, MOLECULES, V23, DOI 10.3390/molecules23082087; STEVENS C, 1995, J PHARMACOL EXP THER, V272, P399; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Stokmaier D, 2018, NEUROLOGY, V90; Storek J, 1997, AM J HEMATOL, V54, P131, DOI 10.1002/(SICI)1096-8652(199702)54:2<131::AID-AJH6>3.0.CO;2-Y; Storek J, 2008, EXPERT OPIN BIOL TH, V8, P583, DOI 10.1517/14712598.8.5.583 ; Stump SE, 2017, PHARMACOTHERAPY, V37, P1530, DOI 10.1002/phar.2047; Subesinghe S, 2018, J RHEUMATOL, V45, P733, DOI 10.3899/jrheum.170710; Sun C, 2015, BLOOD, V126, P2213, DOI 10.1182/blood-2015-04-639203; Sundin M, 2015, PEDIATR BLOOD CANCER, V62, P890, DOI 10.1002/pbc.25409; Takata T, 2009, J CLIN EXP HEMATOP, V49, P9, DOI 10.3960/jslrt.49.9; Tallantyre EC, 2018, J NEUROL, V265, P1115, DOI 10.1007/s00415-018-8812-0; Tallantyre EC, 2018, CURR OPIN ALLERGY CL, V18, P481, DOI 10.1097/ACI.0000000000000485; Talmadge JE, 1997, BONE MARROW TRANSPL, V19, P161, DOI 10.1038/sj.bmt.1700626; Tamada T, 2009, BMJ CASE REP, V2009; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Tanriover MD, 2016, EUR J RHEUMATOL, V3, P29, DOI 10.5152/eurjrheum.2016.16100; Taylor RP, 2008, CURR OPIN IMMUNOL, V20, P444, DOI 10.1016/j.coi.2008.05.011; Tellez R, 2019, IDCases, V17, DOI 10.1016/j.idcr.2019.e00558; Tesfa D, 2011, ARTHRITIS RHEUM-US, V63, P2209, DOI 10.1002/art.30427; Thiel J, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1306-0; Tiotiu A, 2020, ALLERGOL INT, V69, P215, DOI 10.1016/j.alit.2019.10.011; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Torlen J, 2019, BIOL BLOOD MARROW TR, V25, P1260, DOI 10.1016/j.bbmt.2019.01.029; TRAVIN M, 1989, ARCH INTERN MED, V149, P1421, DOI 10.1001/archinte.149.6.1421; Tsao L, 2020, J ALLERGY CLIN IMMUN, V145, pAB215; Tsao L, 2019, J ALLERGY CLIN IMMUN, V143, pAB17; TURNER MW, 1978, ARCH DIS CHILD, V53, P631, DOI 10.1136/adc.53.8.631; U.S. Food and Drug Administration, IMM GLOB INTR IGIV I; Uchida K, 2017, J PEDIATR GASTR NUTR, V64, P565, DOI 10.1097/MPG.0000000000001321; Ueda M, 2018, BLOOD REV, V32, P106, DOI 10.1016/j.blre.2017.09.003; Umar SB, 2010, AM J GASTROENTEROL, V105, P43, DOI 10.1038/ajg.2009.561; Umeno J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005581; Vacca A, 2018, CLIN IMMUNOL, V191, P110, DOI 10.1016/j.clim.2017.11.014; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; van Assen S, 2010, ARTHRITIS RHEUM-US, V62, P75, DOI 10.1002/art.25033; van der Kolk LE, 2002, BLOOD, V100, P2257, DOI 10.1182/blood.V100.6.2257.h81802002257_2257_2259; van Vollenhoven RF, 2010, J RHEUMATOL, V37, P558, DOI 10.3899/jrheum.090856; VANTHIEL DH, 1992, TRANSPLANTATION, V54, P269, DOI 10.1097/00007890-199208000-00015; Vu D, 2015, TRANSPL P, V47, P394, DOI 10.1016/j.transproceed.2015.01.012; WALLWORK JC, 1974, CLIN EXP IMMUNOL, V18, P303; WARSHAW BL, 1989, AM J CLIN PATHOL, V92, P68, DOI 10.1093/ajcp/92.1.68; WEEKS JC, 1991, NEW ENGL J MED, V325, P81, DOI 10.1056/NEJM199107113250202; WELLS JV, 1971, CLIN EXP IMMUNOL, V9, P775; WHEELER WB, 1984, J PEDIATR-US, V104, P695, DOI 10.1016/S0022-3476(84)80946-4; Wiegering V, 2019, J PEDIAT HEMATOL ONC, V41, pE302, DOI 10.1097/MPH.0000000000001340; WING EJ, 1980, JAMA-J AM MED ASSOC, V244, P2423, DOI 10.1001/jama.244.21.2423; WINNIE GB, 1989, J PEDIATR-US, V114, P309, DOI 10.1016/S0022-3476(89)80804-2; Winthrop KL, 2016, ANN RHEUM DIS, V75, P687, DOI 10.1136/annrheumdis-2014-207191; Wirsum C, 2016, J CLIN IMMUNOL, V36, P406, DOI 10.1007/s10875-016-0264-7; Wong JCY, 2020, ANN ALLERG ASTHMA IM, V124, P89, DOI 10.1016/j.anai.2019.10.019; WOO P, 1984, J RHEUMATOL, V11, P828; Worch J, 2015, CANCERS, V7, P305, DOI 10.3390/cancers7010305; Wu HM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003964.pub3; Yamada Y, 2016, PED CARDIOL CARD SUR, V32, P432; Yamamoto T, 2010, INTERNAL MED, V49, P707, DOI 10.2169/internalmedicine.49.3087; Yamani MH, 2005, J HEART LUNG TRANSPL, V24, P1766, DOI 10.1016/j.healun.2004.11.016; Yamani MH, 2001, J HEART LUNG TRANSPL, V20, P425, DOI 10.1016/S1053-2498(00)00331-4; Yang N, 2020, J CLIN IMMUNOL, V40, pS129; Yates M, 2016, ANN RHEUM DIS, V75, P1583, DOI 10.1136/annrheumdis-2016-209133; Yip NH, 2006, AM J RESP CRIT CARE, V173, P917, DOI 10.1164/rccm.200510-1609OC; YOKOYAMA H, 1987, CLIN EXP IMMUNOL, V70, P110; Yong PFK, 2008, RHEUMATOLOGY, V47, P1400, DOI 10.1093/rheumatology/ken255; Yri OE, 2011, BLOOD, V118, P6769, DOI 10.1182/blood-2011-08-372649; Zarkhin V, 2008, AM J TRANSPLANT, V8, P2607, DOI 10.1111/j.1600-6143.2008.02411.x; Zaupper LB, 2011, CONGENIT HEART DIS, V6, P624, DOI 10.1111/j.1747-0803.2011.00568.x; Zoehner G, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419878340; Zuberi S J, 1977, J Pak Med Assoc, V27, P391	430	8	8	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1525	1560		10.1016/j.jaci.2022.01.025	http://dx.doi.org/10.1016/j.jaci.2022.01.025			36	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3W0TR	35176351	hybrid			2022-12-18	WOS:000842068800003
J	Baum, P; Visvanathan, S; Garcet, S; Roy, J; Schmid, R; Bossert, S; Lang, B; Bachelez, H; Bissonnette, R; Thoma, C; Krueger, JG				Baum, Patrick; Visvanathan, Sudha; Garcet, Sandra; Roy, Janine; Schmid, Ramona; Bossert, Sebastian; Lang, Benjamin; Bachelez, Herve; Bissonnette, Robert; Thoma, Christian; Krueger, James G.			Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Spesolimab; BI 655130; biomarkers; IL-36; IL-36R; generalized pustular psoriasis; GPP; palmoplantar pustulosis; PPP	IL36RN MUTATIONS; AP1S3 MUTATIONS; EXPRESSION; IL-36	Background: The IL-36 pathway plays a key role in the pathogenesis of generalized pustular psoriasis (GPP). In a proof-of-concept clinical trial, treatment with spesolimab, an anti-IL-36 receptor antibody, resulted in rapid skin and pustular clearance in patients presenting with GPP flares. Objective: We sought to compare the molecular profiles of lesional and nonlesional skin from patients with GPP or palmoplantar pustulosis (PPP) with skin from healthy volunteers, and to investigate the molecular changes after spesolimab treatment in the skin and blood of patients with GPP flares. Methods: Pre- and post-treatment skin and blood samples were collected from patients with GPP who participated in a single-arm, phase I study (n = 7). Skin biopsies from patients with PPP (n = 8) and healthy volunteers (n = 16) were obtained for comparison at baseline. Biomarkers were assessed by RNA-sequencing, histopathology, and immunohistochemistry. Results: In GPP and PPP lesions, 1287 transcripts were commonly upregulated or downregulated. Selected transcripts from the IL-36 signaling pathway were upregulated in untreated GPP and PPP lesions. In patients with GPP, IL-36 pathway-related signatures, T(H)1/T(H)17 and innate inflammation signaling, neutrophilic mediators, and keratinocyte-driven inflammation pathways were downregulated by spesolimab as early as week 1. Spesolimab also decreased related serum biomarkers and cell populations in the skin lesions from patients with GPP, including CD3(+) T, CD11c(+), and IL-36 gamma(+) cells and lipocalin-2-expressing cells. Conclusions: In patients with GPP, spesolimab showed rapid modulation of commonly dysregulated molecular pathways in GPP and PPP, which may be associated with improved clinical outcomes.	[Baum, Patrick; Schmid, Ramona; Bossert, Sebastian; Lang, Benjamin; Thoma, Christian] Boehringer Ingelheim GmbH & Co KG, Birkendorfer St 65, D-88397 Biberach, Germany; [Visvanathan, Sudha] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA; [Garcet, Sandra; Krueger, James G.] Rockefeller Univ, Lab Investigat Dermatol, 1230 York Ave, New York, NY 10021 USA; [Roy, Janine] Stabur GmbH, Munich, Germany; [Bachelez, Herve] Univ Paris, Inst Imagine, UMR INSERM U1163, Paris, France; [Bachelez, Herve] Hop St Louis, AP HP, Dept Dermatol, Paris, France; [Bissonnette, Robert] Innovaderm Res Inc, Montreal, PQ, Canada	Boehringer Ingelheim; Boehringer Ingelheim; Rockefeller University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Innovaderm Research Inc.	Baum, P (corresponding author), Boehringer Ingelheim GmbH & Co KG, Birkendorfer St 65, D-88397 Biberach, Germany.	patrick.baum@boehringer-ingelheim.com		Baum, Patrick/0000-0002-1399-8610	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim. Agreements between Boehringer Ingelheim and the authors included confidentiality of the study data. All authors collaborated on the writing of the manuscript and have approved the final manuscript for publication.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Arakawa A, 2018, J INVEST DERMATOL, V138, P1338, DOI 10.1016/j.jid.2017.12.024; Bachelez H, 2018, BRIT J DERMATOL, V178, P614, DOI 10.1111/bjd.16232; Bachelez H, 2020, ACTA DERM-VENEREOL, V100, P87, DOI 10.2340/00015555-3388; Bachelez H, 2019, NEW ENGL J MED, V380, P981, DOI 10.1056/NEJMc1811317; Bassoy EY, 2018, IMMUNOL REV, V281, P169, DOI 10.1111/imr.12610; Benjegerdes KE, 2016, PSORIASIS-TARGETS TH, V6, P131, DOI 10.2147/PTT.S98954; Bissonnette R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155215; Capon F, 2013, J INVEST DERMATOL, V133, P2503, DOI 10.1038/jid.2013.361; Catapano M, 2020, J INVEST DERMATOL, V140, P816, DOI 10.1016/j.jid.2019.08.444; Choon SE, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043666; Choon SE, 2014, INT J DERMATOL, V53, P676, DOI 10.1111/ijd.12070; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frey S, 2020, J INVEST DERMATOL, V140, P1451, DOI 10.1016/j.jid.2019.11.024; Fujita H, 2018, J DERMATOL, V45, P1235, DOI 10.1111/1346-8138.14523; Furue K, 2018, ACTA DERM-VENEREOL, V98, P5, DOI 10.2340/00015555-2808; Gabay C, 2015, J LEUKOCYTE BIOL, V97, P645, DOI 10.1189/jlb.3RI1014-495R; Gooderham MJ, 2019, EXPERT REV CLIN IMMU, V15, P907, DOI 10.1080/1744666X.2019.1648209; Haskamp S, 2020, AM J HUM GENET, V107, P527, DOI 10.1016/j.ajhg.2020.07.001; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Krueger JG, 2015, J ALLERGY CLIN IMMUN, V136, P116, DOI 10.1016/j.jaci.2015.01.018; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liang Y, 2017, J ALLERGY CLIN IMMUN, V139, P1217, DOI 10.1016/j.jaci.2016.10.021; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Mahil SK, 2016, J INVEST DERMATOL, V136, P2251, DOI 10.1016/j.jid.2016.06.618; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Mrowietz U, 2021, DERMATOLOGY THER, V11, P571, DOI 10.1007/s13555-021-00504-0; Murakami M, 2020, J DERMATOL SCI, V98, P13, DOI 10.1016/j.jdermsci.2020.03.003; Navarini AA, 2017, J EUR ACAD DERMATOL, V31, P1792, DOI 10.1111/jdv.14386; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schon MP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01764; Setta-Kaffetzi N, 2014, AM J HUM GENET, V94, P790, DOI 10.1016/j.ajhg.2014.04.005; Setta-Kaffetzi N, 2013, J INVEST DERMATOL, V133, P1366, DOI 10.1038/jid.2012.490; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tauber M, 2016, J INVEST DERMATOL, V136, P1811, DOI 10.1016/j.jid.2016.04.038; Twelves S, 2019, J ALLERGY CLIN IMMUN, V143, P1021, DOI 10.1016/j.jaci.2018.06.038; Vergnano M, 2020, AM J HUM GENET, V107, P539, DOI 10.1016/j.ajhg.2020.06.020; Visvanathan S, 2019, J ALLERGY CLIN IMMUN, V143, P2158, DOI 10.1016/j.jaci.2018.11.042; Wang TS, 2016, ARCH DERMATOL RES, V308, P55, DOI 10.1007/s00403-015-1611-x	43	8	8	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1402	1412		10.1016/j.jaci.2021.09.035	http://dx.doi.org/10.1016/j.jaci.2021.09.035			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34678325	hybrid			2022-12-18	WOS:000820784100007
J	Dumas, O; Erkkola, R; Bergroth, E; Hasegawa, K; Mansbach, JM; Piedra, PA; Jartti, T; Camargo, CA				Dumas, Orianne; Erkkola, Riku; Bergroth, Eija; Hasegawa, Kohei; Mansbach, Jonathan M.; Piedra, Pedro A.; Jartti, Tuomas; Camargo, Carlos A., Jr.			Severe bronchiolitis profiles and risk of asthma development in Finnish children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Respiratory infections; cluster analysis; respiratory syncytial virus; rhinovirus; asthma	LENGTH-OF-STAY; VIRAL BRONCHIOLITIS; ETIOLOGY	Background: Recent studies support the existence of several entities under the clinical diagnosis of bronchiolitis. Among infants with severe bronchiolitis, distinct profiles have been differentially associated with development of recurrent wheezing by age 3 years. However, their associations with actual asthma remain unclear. Objective: Our aim was to study the association between severe bronchiolitis profiles identified by using a clustering approach and childhood asthma. Methods: Among 408 children (aged <2 years) hospitalized with bronchiolitis in Finland (in 2008-2010), latent class analysis identified 3 bronchiolitis profiles: profile A (47%), characterized by history of wheezing and/or eczema, wheezing during acute illness, and rhinovirus infection; profile BC (38%), characterized by severe illness and respiratory syncytial virus infection; and profile D (15%), characterized by the least severely ill children, including mostly children without wheezing and with rhinovirus infection. The children were followed by questionnaire 4 years later (86% [n = 348]) and through a nationwide social insurance database 7 years later (99% [n = 403]). Current asthma at the 4-and 7-year follow-ups was defined by regular use (according to parental report and medical records) or purchase (according to the social insurance database) of asthma control medication. Results: Compared with risk of current asthma associated with profile BC, we observed increased risk of current asthma associated with profile A both at the 4-year follow-up (age-and sex-adjusted odds ratio = 2.42 [95% CI = 1.23-4.75]) and at the 7-year follow-up (age-and sex-adjusted odds ratio = 3.14 [95% CI = 1.33-7.42]). No significant difference in asthma risk was observed between profile D and profile BC. Conclusion: These longitudinal results provide further support for an association between a distinct severe bronchiolitis profile (characterized by a history of wheezing and/or eczema and rhinovirus infection) and risk of development childhood asthma.	[Dumas, Orianne] Univ Paris Saclay, UVSQ, INSERM, CESP Equipe Epidemiol Resp Integrat, F-94807 Villejuif, France; [Erkkola, Riku; Jartti, Tuomas] Turku Univ Hosp, Dept Children & Adolescents, Turku, Finland; [Erkkola, Riku; Jartti, Tuomas] Univ Turku, Turku, Finland; [Bergroth, Eija] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland; [Bergroth, Eija] Cent Hosp Cent Finland, Dept Pediat, Jyvaskyla, Finland; [Hasegawa, Kohei; Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Mansbach, Jonathan M.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Jartti, Tuomas] Univ Oulu, Med Res Ctr, PEDEGO Res Unit, Oulu, Finland; [Jartti, Tuomas] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Turku; University of Turku; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine; University of Oulu; University of Oulu	Dumas, O (corresponding author), INSERM, CESP, Equipe Epidemiol Resp Integrat, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	orianne.dumas@inserm.fr	Camargo, Carlos A./C-2145-2008; Dumas, Orianne/R-8636-2016	Camargo, Carlos A./0000-0002-5071-7654; Dumas, Orianne/0000-0001-8423-2826	Allergy Research Foundation; Sigrid Juselius Foundation; Pediatric Research Foundation	Allergy Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pediatric Research Foundation	Supported by the Allergy Research Foundation, the Sigrid Juselius Foundation, and the Pediatric Research Foundation, all in Helsinki, Finland.	Altman MC, 2020, J ALLERGY CLIN IMMUN, V145, P1332, DOI 10.1016/j.jaci.2019.12.904; Paggi DA, 2019, AM J RESP CRIT CARE, V199, P1456, DOI 10.1164/rccm.201812-2371ED; Bergroth E, 2020, J ALLER CL IMM-PRACT, V8, P588, DOI 10.1016/j.jaip.2019.08.043; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Dumas O, 2019, J ALLERGY CLIN IMMUN, V143, P1371, DOI 10.1016/j.jaci.2018.08.043; Dumas O, 2016, THORAX, V71, P712, DOI 10.1136/thoraxjnl-2016-208535; Ferrante G, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-00914-4; Fujiogi M, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2614; Garcia-Aymerich J, 2015, ALLERGY, V70, P973, DOI 10.1111/all.12640; Geller RJ, 2021, ANN EPIDEMIOL, V55, P64, DOI 10.1016/j.annepidem.2020.10.001; Hancock DG, 2017, PEDIATR PULM, V52, P1234, DOI 10.1002/ppul.23750; Hasegawa K, 2016, EXPERT REV RESP MED, V10, P891, DOI 10.1080/17476348.2016.1190647; Hose AJ, 2017, J ALLERGY CLIN IMMUN, V139, P1935, DOI 10.1016/j.jaci.2016.08.046; Jackson DJ, 2016, J ALLERGY CLIN IMMUN, V137, P659, DOI 10.1016/j.jaci.2016.01.002; Jartti T, 2014, PEDIATR INFECT DIS J, V33, P829, DOI 10.1097/INF.0000000000000313; Licari A, 2018, PEDIAT ALLER IMM PUL, V31, P44, DOI 10.1089/ped.2018.0886; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Marlow R, 2019, THORAX, V74, P503, DOI 10.1136/thoraxjnl-2018-212203; Midulla F, 2014, ACTA PAEDIATR, V103, P1094, DOI 10.1111/apa.12720; Niu HQ, 2020, PEDIATR PULM, V55, P3096, DOI 10.1002/ppul.25044; Polack FP, 2019, J INFECT DIS, V220, P184, DOI 10.1093/infdis/jiz082; Raita Y, 2021, J ALLERGY CLIN IMMUN, V147, P2108, DOI 10.1016/j.jaci.2020.11.002; Rodriguez-Martinez CE, 2021, ALLERGOL IMMUNOPATH, V49, P153, DOI 10.15586/aei.v49i1.12; Sonninen K, 2017, ACTA PAEDIATR, V106, P1830, DOI 10.1111/apa.13985	24	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1281	+		10.1016/j.jaci.2021.08.035	http://dx.doi.org/10.1016/j.jaci.2021.08.035			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3T5RO	34624392	Green Submitted			2022-12-18	WOS:000840331500020
J	Huang, JJ; Gaines, SB; Amezcua, ML; Lubell, TR; Dayan, PS; Dale, M; Boneparth, AD; Hicar, MD; Winchester, R; Gorelik, M				Huang, Janice J.; Gaines, Samantha B.; Amezcua, Mateo L.; Lubell, Tamar R.; Dayan, Peter S.; Dale, Marissa; Boneparth, Alexis D.; Hicar, Mark D.; Winchester, Robert; Gorelik, Mark			Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Multisystem inflammatory syndrome in children (MIS-C); Kawasaki disease (KD); dendritic cells; antigen cross-presentation; CLEC9A; NK cell cytotoxicity	ACTIVATION; COVID-19; RECEPTOR; DISEASE; CHILDREN	Background: Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. Objective: Our objective was to analyze immunologic features of MIS-C patients compared to febrile controls (FC). Methods: MIS-C patients were defined by narrow criteria, including having evidence of cardiohemodynamic involvement and no macrophage activation syndrome. Samples were collected from 8 completely treatment-naive patients with MIS-C (SARS-CoV-2 serology positive), 3 patients with unclassified MIS-C-like disease (serology negative), 14 FC, and 5 MIS-C recovery (RCV). Three healthy controls (HCs) were used for comparisons of normal range. Using spectral flow cytometry, we assessed 36 parameters in antigen-presenting cells (APCs) and 29 in T cells. We used biaxial analysis and uniform manifold approximation and projection (UMAP). Results: Significant elevations in cytokines including CXCL9, M-CSF, and IL-27 were found in MIS-C compared to FC. Classic monocytes and type 2 dendritic cells (DCs) were downregulated (decreased CD86, HLA-DR) versus HCs; however, type 1 DCs (CD11c(+)CD141(+)CLEC9A(+)) were highly activated in MIS-C patients versus FC, expressing higher levels of CD86, CD275, and atypical conventional DC markers such as CD64, CD115, and CX3CR1. CD169 and CD38 were upregulated in multiple monocyte subtypes. CD56(dim)/CD57(-)/KLRG(hi)/CD161(+)/CD38(-) natural killer (NK) cells were a unique subset in MIS-C versus FC without macrophage activation syndrome. Conclusion: Orchestrated by complex cytokine signaling, type 1 DC activation and NK dysregulation are key features in the pathophysiology of MIS-C. NK cell findings may suggest a relationship with macrophage activation syndrome, while type 1 DC upregulation implies a role for antigen cross-presentation.	[Huang, Janice J.; Amezcua, Mateo L.; Boneparth, Alexis D.; Gorelik, Mark] Columbia Univ, Dept Pediat, Med Ctr, Div Allergy Immunol & Rheumatol, New York, NY 10027 USA; [Gaines, Samantha B.; Winchester, Robert] Columbia Univ, Med Ctr, Dept Med, Div Rheumatol,Ctr Clin & Translat Immunol, New York, NY USA; [Lubell, Tamar R.; Dayan, Peter S.] Columbia Univ, Med Ctr, Dept Pediat Emergency Med, New York, NY USA; [Dale, Marissa] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10027 USA; [Hicar, Mark D.] Univ Buffalo, Med Ctr, Div Infect Dis, Dept Pediat, Buffalo, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gorelik, M (corresponding author), Coll Phys & Surg Bldg,P&S 10-451,630 168th St, New York, NY 10032 USA.	mg4082@cumc.columbia.edu		Gorelik, Mark/0000-0001-8132-4944	National Institutes of Health [K08 HL155033]; United States Public Health Service [S10RR027050]; American Heart Association [19TPA34910217]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association)	Supported in part by the National Institutes of Health (grant K08 HL155033 to M. Gorelik). Core flow cytometry was suported by the United States Public Health Service (grant S10RR027050) and the American Heart Association (grant 19TPA34910217).	Amici SA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01593; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bautista-Rodriguez C, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-024554; Beckmann ND, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24981-1; Belhadjer Z, 2020, CIRCULATION, V142, P2282, DOI 10.1161/CIRCULATIONAHA.120.050147; Carter MJ, 2020, NAT MED, V26, P1701, DOI 10.1038/s41591-020-1054-6; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Cueto FJ, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03146; Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970; Duarte-Neto AN, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100850; Esteve-Sole A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144554; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Grabowska J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02472; Gruber CN, 2020, CELL, V183, P982, DOI 10.1016/j.cell.2020.09.034; Hokibara S, 2016, INFLAMM RES, V65, P579, DOI 10.1007/s00011-016-0942-1; Judge SJ, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00049; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Kurioka A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00486; Kvedaraite E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018587118; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Lu J, 2002, CLIN CANCER RES, V8, P3877; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970; Moreews M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh1516; Muller-Durovic B, 2016, J IMMUNOL, V197, P2891, DOI 10.4049/jimmunol.1600590; Ochayon DE, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.645850; Ombrello MJ, 2021, TRANSL RES, V232, P1, DOI 10.1016/j.trsl.2021.03.002; Ouldali N, 2021, JAMA-J AM MED ASSOC, V325, P855, DOI 10.1001/jama.2021.0694; Park Matthew D, 2020, Nat Rev Immunol, V20, P351, DOI 10.1038/s41577-020-0317-2; Porritt RA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146614; Ramaswamy A, 2021, IMMUNITY, V54, P1083, DOI 10.1016/j.immuni.2021.04.003; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; Rodriguez-Smith JJ, 2021, LANCET RHEUMATOL, V3, pE574, DOI 10.1016/S2665-9913(21)00139-9; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944; Vella LA, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7570; Viner RM, 2020, LANCET, V395, P1741, DOI 10.1016/S0140-6736(20)31129-6; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wilk AJ, 2021, J EXP MED, V218, DOI [10.1084/jem.20210582, 10.1126/sciimmunol.aay6017]; Wohn C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba1896; Zhang ML, 2018, P NATL ACAD SCI USA, V115, pE10915, DOI 10.1073/pnas.1811615115; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	46	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					912	922		10.1016/j.jaci.2021.10.015	http://dx.doi.org/10.1016/j.jaci.2021.10.015			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34688775	Bronze, Green Published			2022-12-18	WOS:000765938100021
J	Al Heialy, S; Ramakrishnan, RK; Hamid, Q				Al Heialy, Saba; Ramakrishnan, Rakhee K.; Hamid, Qutayba			Recent advances in the immunopathogenesis of severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Severe asthma; endotypes; airway remodeling; steroid resistance; obesity; therapeutics	INNATE LYMPHOID-CELLS; CD4(+) T-CELLS; AIRWAY INFLAMMATION; BRONCHIAL THERMOPLASTY; MITOCHONDRIAL DYSFUNCTION; STRUCTURAL-CHANGES; CLINICAL-OUTCOMES; CHILDHOOD ASTHMA; GENE-EXPRESSION; NITRIC-OXIDE	Severe asthma is a heterogeneous disease encompassing different phenotypes and endotypes. Although patients with severe asthma constitute a small proportion of the total population with asthma, they largely account for the morbidity and mortality associated with asthma, indicating a clear unmet need. Being distinct from mild and moderate disease, new insights into the immunopathogenesis of severe asthma are needed. The disease endotypes have provided better insights into the immunopathogenic mechanisms underlying severe asthma. Current stratified approach of treating severe asthma based on phenotypes is met with shortcomings, necessitating unbiased multidimensional endotyping to cope with disease complexity. Therefore, in this review, we explore the distinct endotypes and their mechanistic pathways that characterize the heterogeneity observed in severe asthma.	[Al Heialy, Saba] Mohammed bin Rashid Univ Med & Hlth Sci, Coll Med, Dubai, U Arab Emirates; [Al Heialy, Saba; Hamid, Qutayba] McGill Univ, Hlth Ctr, Res Inst, Meakins Christie Labs, Montreal, PQ, Canada; [Ramakrishnan, Rakhee K.] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Ramakrishnan, Rakhee K.; Hamid, Qutayba] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates	McGill University; University of Sharjah; University of Sharjah	Hamid, Q (corresponding author), Univ Sharjah, Coll Med, Sharjah, U Arab Emirates.	qalheialy@sharjah.ac.ae	Ramakrishnan, Rakhee K/GLQ-5515-2022		Strauss Foundation-McGill University of Montreal, Quebec, Canada; Research Institute of Medical and Health Sciences, University of Sharjah; Mohammed bin Rashid University of Medicine and Health Sciences	Strauss Foundation-McGill University of Montreal, Quebec, Canada; Research Institute of Medical and Health Sciences, University of Sharjah; Mohammed bin Rashid University of Medicine and Health Sciences	We acknowledge Strauss Foundation-McGill University of Montreal, Quebec, Canada, for supporting the severe asthma program of Qutayba Hamid. We acknowledge the collaboration of Professor James G. Martin and Dr Ronald Olivenstein. We also acknowledge the support of the Research Institute of Medical and Health Sciences, University of Sharjah and Mohammed bin Rashid University of Medicine and Health Sciences.	Adeloye D, 2021, LANCET RESP MED, V9, P1467, DOI 10.1016/S2213-2600(21)00286-1; Agache I, 2019, J CLIN INVEST, V129, P1493, DOI 10.1172/JCI124611; Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Al Heialy S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01724; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Ali H, 2017, ADV IMMUNOL, V136, P123, DOI 10.1016/bs.ai.2017.06.002; Ano S, 2022, J ASTHMA, V59, P1641, DOI 10.1080/02770903.2021.1945088; Atkins JL, 2020, J GERONTOL A-BIOL, V75, P2224, DOI 10.1093/gerona/glaa183; Awadh N, 1998, THORAX, V53, P248, DOI 10.1136/thx.53.4.248; Baines KJ, 2010, EUR RESPIR J, V35, P522, DOI 10.1183/09031936.00027409; Ban GY, 2016, CLIN EXP ALLERGY, V46, P48, DOI 10.1111/cea.12585; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Beurnier A, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01875-2020; Boulet LP, 1997, CHEST, V112, P45, DOI 10.1378/chest.112.1.45; Breton JD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13669; Bruno A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607192; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Calixto MC, 2010, BRIT J PHARMACOL, V159, P617, DOI 10.1111/j.1476-5381.2009.00560.x; Calven J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21238907; Camargo LD, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01835; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; Castro M, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00204-2019; Chachi L, 2018, CLIN EXP IMMUNOL, V194, P253, DOI 10.1111/cei.13191; Chaudhuri R, 2021, LANCET RESP MED, V9, P457, DOI 10.1016/S2213-2600(20)30408-2; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; Chien JW, 2013, CLIN EXP ALLERGY, V43, P1018, DOI 10.1111/cea.12119; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Corren J, 2021, J ASTHMA ALLERGY, V14, P1, DOI 10.2147/JAA.S286036; Cosmi L, 2016, CURR OPIN ALLERGY CL, V16, P1, DOI 10.1097/ACI.0000000000000227; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Desai D, 2013, AM J RESP CRIT CARE, V188, P657, DOI 10.1164/rccm.201208-1470OC; Dias SA, 2014, EUR RESPIR J, V43, P1368, DOI 10.1183/09031936.00053413; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Domingo C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.587621; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Fox Haley M, 2021, J Pediatr Pharmacol Ther, V26, P306, DOI 10.5863/1551-6776-26.3.306; Geng B, 2020, J ALLERGY CLIN IMMUN, V145, pAB18; Gibeon D, 2013, CHEST, V143, P406, DOI 10.1378/chest.12-0872; Gibson PG, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01746-4; Gordon ED, 2016, P NATL ACAD SCI USA, V113, P8765, DOI 10.1073/pnas.1601914113; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Grotta MB, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-39; Gu C, 2020, CLIN EXP ALLERGY, V50, P1196, DOI 10.1111/cea.13696; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Heinzmann A, 2003, ALLERGY, V58, P830, DOI 10.1034/j.1398-9995.2003.00223.x; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Hilvering B, 2018, MUCOSAL IMMUNOL, V11, P1408, DOI 10.1038/s41385-018-0049-9; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Ichikawa T, 2019, RESP MED, V150, P165, DOI 10.1016/j.rmed.2019.03.005; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; Jendzjowsky N, 2021, EUR RESPIR J; Jenkins HA, 2003, CHEST, V124, P32, DOI 10.1378/chest.124.1.32; Jiang WT, 2015, CHINESE MED J-PEKING, V128, P1584, DOI 10.4103/0366-6999.158309; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kara AA, 2021, J MED VIROL, V93, P6634, DOI 10.1002/jmv.27237; Kobayashi Y, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9070787; Krishnamoorthy N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4747; Kuo CHS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02135-2016; Lachowicz-Scroggins ME, 2019, AM J RESP CRIT CARE, V199, P1076, DOI 10.1164/rccm.201810-1869OC; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Lezmi G, 2016, EUR RESPIR J, V48, P1320, DOI 10.1183/13993003.00947-2016; Li CX, 2018, LIFE SCI, V208, P276, DOI 10.1016/j.lfs.2018.07.049; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Lin TY, 2013, CURR OPIN PULM MED, V19, P18, DOI 10.1097/MCP.0b013e32835b10ec; Liu JN, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.38; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Liu WM, 2017, J ALLERGY CLIN IMMUN, V139, P1548, DOI 10.1016/j.jaci.2016.08.032; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Maggi L, 2018, EUR J IMMUNOL, V48, P2005, DOI 10.1002/eji.201847668; Mahboub B, 2021, J IMMUNOL RES, V2021; McAlinden KD, 2019, AM J RESP CELL MOL, V60, P541, DOI 10.1165/rcmb.2018-0169OC; Menzella F, 2021, J ASTHMA ALLERGY, V14, P1019, DOI 10.2147/JAA.S324099; Miyata J, 2013, J ALLERGY CLIN IMMUN, V131, P353, DOI 10.1016/j.jaci.2012.07.048; Mukadam S, 2018, J ASTHMA, V55, P720, DOI 10.1080/02770903.2017.1365886; Nadeem A, 2018, BIOCHEM PHARMACOL, V154, P222, DOI 10.1016/j.bcp.2018.05.011; Nagakumar P, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01809-2018; Nair P, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02250-2018; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Papakonstantinou E, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01774-0; Park OH, 2015, BMB REP, V48, P367, DOI 10.5483/BMBRep.2015.48.7.131; Pavel AB, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.706902; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Pham DL, 2017, CLIN EXP ALLERGY, V47, P57, DOI 10.1111/cea.12859; Pignatti P, 2020, INT J TUBERC LUNG D, V24, P1217, DOI 10.5588/ijtld.20.0608; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Poon AH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00355; Poon AH, 2012, J ALLERGY CLIN IMMUN, V129, P569, DOI 10.1016/j.jaci.2011.09.035; Pradeepan S, 2013, CURR ALLERGY ASTHM R, V13, P434, DOI 10.1007/s11882-013-0354-z; Prakash YS, 2017, CHEST, V152, P618, DOI 10.1016/j.chest.2017.03.020; Ramakrishnan RK, 2021, AM J PHYSIOL-LUNG C, V320, pL880, DOI 10.1152/ajplung.00547.2020; Ramakrishnan RK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242695; Ramakrishnan RK, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01002; Ramakrishnan RK, 2019, EXPERT REV RESP MED, V13, P1057, DOI 10.1080/17476348.2019.1666002; Ravi A, 2021, J ALLERGY CLIN IMMUN, V148, P1236, DOI 10.1016/j.jaci.2020.12.653; Rial MJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073558; Ricciardolo FLM, 2017, J ALLERGY CLIN IMMUN, V140, P395, DOI 10.1016/j.jaci.2016.10.034; Rogliani P, 2020, CURR OPIN PULM MED, V26, P47, DOI 10.1097/MCP.0000000000000640; Samitas K, 2015, EUR RESPIR REV, V24, P594, DOI 10.1183/16000617.00001715; Sandoval M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255544; Schultze A, 2020, LANCET RESP MED, V8, P1106, DOI 10.1016/S2213-2600(20)30415-X; Scott HA, 2013, CLIN EXP ALLERGY, V43, P36, DOI 10.1111/cea.12004; Scott HA, 2011, EUR RESPIR J, V38, P594, DOI 10.1183/09031936.00139810; Shale DJ, 2004, EUR RESPIR J, V23, P797, DOI 10.1183/09031936.0.00018404; Sharif-Askari NS, 2020, MOL THER-METH CLIN D, V18, P1, DOI 10.1016/j.omtm.2020.05.013; Singhania A, 2018, AM J RESP CELL MOL, V58, P261, DOI 10.1165/rcmb.2017-0162OC; Skloot GS, 2016, CURR OPIN PULM MED, V22, P3, DOI 10.1097/MCP.0000000000000225; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037; Sorbello V, 2015, ALLERGY, V70, P236, DOI 10.1111/all.12547; Sugita K, 2018, J ALLERGY CLIN IMMUN, V141, P300, DOI 10.1016/j.jaci.2017.02.038; Sutherland ER, 2008, AM J RESP CRIT CARE, V178, P682, DOI 10.1164/rccm.200801-076OC; Sweeney J, 2016, THORAX, V71, P339, DOI 10.1136/thoraxjnl-2015-207630; Tan HTT, 2019, ALLERGY, V74, P294, DOI 10.1111/all.13619; Telenga ED, 2012, ALLERGY, V67, P1060, DOI 10.1111/j.1398-9995.2012.02855.x; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; Vrugt B, 2000, EUR RESPIR J, V15, P1014, DOI 10.1034/j.1399-3003.2000.01507.x; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Wood LG, 2011, J ALLERGY CLIN IMMUN, V127, P1133, DOI 10.1016/j.jaci.2011.01.036; Yamamoto H, 2020, P NATL ACAD SCI USA, V117, P2914, DOI 10.1073/pnas.1917525117; Zhao YX, 2019, J PROTEOMICS, V205, DOI 10.1016/j.jprot.2019.103415	135	8	8	7	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					455	465		10.1016/j.jaci.2021.12.765	http://dx.doi.org/10.1016/j.jaci.2021.12.765			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	35125181				2022-12-18	WOS:000752623200001
J	Blanquart, E; Mandonnet, A; Mars, M; Cenac, C; Anesi, N; Mercier, P; Audouard, C; Roga, S; de Almeida, GS; Bevan, CL; Girard, JP; Pelletier, L; Laffont, S; Guery, JC				Blanquart, Eve; Mandonnet, Audrey; Mars, Marion; Cenac, Claire; Anesi, Nina; Mercier, Pascale; Audouard, Christophe; Roga, Stephane; de Almeida, Gilberto Serrano; Bevan, Charlotte L.; Girard, Jean-Philippe; Pelletier, Lucette; Laffont, Sophie; Guery, Jean-Charles			Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sex differences in asthma; ILC2; androgen signaling; lung inflammation; KLRG1	INNATE LYMPHOID-CELLS; CHILDHOOD ASTHMA; RECEPTOR KLRG1; E-CADHERIN; SEX; TESTOSTERONE; IL-33; RESPONSIVENESS; ASSOCIATION; ACTIVATION	Background: Allergic asthma is more severe and frequent in women than in men. In male mice, androgens negatively control group 2 innate lymphoid cell (ILC2) development and function by yet unknown mechanisms. Objectives: We sought to investigate the impact of androgen on ILC2 homeostasis and IL-33-mediated inflammation in female lungs. We evaluated the role of androgen receptor (AR) signaling and the contribution of the putative inhibitory receptor killer cell lectin-like receptor G1 (KLRG1). Methods: Subcutaneous pellets mimicking physiological levels of androgen were used to treat female mice together with mice expressing a reporter enzyme under the control of androgen response elements and mixed bone marrow chimeras to assess the cell-intrinsic role of AR activation within ILC2s. We generated KLRG1-deficient mice. Results: We established that lung ILC2s express a functionally active AR that can be in vivo targeted with exogenous androgens to negatively control ILC2 homeostasis, proliferation, and function. Androgen signaling upregulated KLRG1 on ILC2s, which inhibited their proliferation on E-cadherin interaction. Despite evidence that KLRG1 impaired the competitive fitness of lung ILC2s during inflammation, KLRG1 deficiency neither alters in vivo ILC2 numbers and functions, nor did it lead to hyperactive ILC2s in either sexes. Conclusions: AR agonists can be used in vivo to inhibit ILC2 homeostatic numbers and ILC2-dependent lung inflammation through cell-intrinsic AR activation. Although androgen signals in ILC2s to upregulate KLRG1, we demonstrate that KLRG1 is dispensable for androgen-mediated inhibition of pulmonary ILC2s. (J Allergy Clin Immunol 2022;149:237-51.)	[Blanquart, Eve; Mandonnet, Audrey; Mars, Marion; Cenac, Claire; Anesi, Nina; Pelletier, Lucette; Laffont, Sophie; Guery, Jean-Charles] Univ Toulouse, Inst Toulousain Malad Infect & Inflammatoires Inf, UPS, CNRS, Toulouse, France; [Mercier, Pascale; Roga, Stephane; Girard, Jean-Philippe] Univ Toulouse, Inst Pharmacol & Biol Struct, UPS, CNRS, Toulouse, France; [Audouard, Christophe] Univ Toulouse, Ctr Biol Dev, UPS, CNRS, Toulouse, France; [de Almeida, Gilberto Serrano; Bevan, Charlotte L.] Imperial Coll, Dept Surg & Canc, London, England	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Imperial College London	Laffont, S; Guery, JC (corresponding author), Ctr Hosp Univ Purpan, Inst Toulousain Malad InfeLliouses CI Inflammatoi, INSERM, U1291, Pl Dr Baylac, F-31024 Toulouse 3, France.	sophie.laffont-pradines@inserm.fr; jean-charles.guery@inserm.fr	GIRARD, Jean-Philippe/F-5229-2010; Bevan, Charlotte/K-2276-2012	GIRARD, Jean-Philippe/0000-0002-9154-1691; Laffont, Sophie/0000-0003-2319-0217; Bevan, Charlotte/0000-0002-7533-0552	Fondation pour la Recherche Medicale [FDT201904008017]; Societe Francaise d'Allergologie [SFA2017]; Agence Nationale de la Recherche [ANR-18-CE15-0004-01, ANR-20-CE15-0027-01]; Fonda-tion Recherche Medicale [DEQ20180339187]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Societe Francaise d'Allergologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fonda-tion Recherche Medicale	equally E.B. was supported by a fellowship from the "Fondation pour la Recherche Me?dicale" (grant no. FDT201904008017) . Work at Institut Toulousain des Maladies Infectieuses et Inflammatoires was supported by grants from Socie?te? Francaise d'Allergologie (grant no. SFA2017) , the Agence Nationale de la Recherche (grant no. ANR-18-CE15-0004-01 to J.-C.G. and grant no. ANR-20-CE15-0027-01 to S.L.) , and Fonda-tion Recherche Me?dicale (e?quipe labellise?e DEQ20180339187) . Disclosure of potential conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Blanquart E, 2021, BIOMED J, V44, P144, DOI 10.1016/j.bj.2020.11.007; Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012; Bulkhi AA, 2020, J ALLER CL IMM-PRACT, V8, P3029, DOI 10.1016/j.jaip.2020.05.022; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Cephus JY, 2017, CELL REP, V21, P2487, DOI 10.1016/j.celrep.2017.10.110; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Dart DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071694; Doherty TA, 2019, ALLERGOL INT, V68, P9, DOI 10.1016/j.alit.2018.11.001; Fontaine C, 2020, MOL CELL ENDOCRINOL, V505, DOI 10.1016/j.mce.2020.110741; Forsberg A, 2014, J ALLERGY CLIN IMMUN, V134, P228, DOI 10.1016/j.jaci.2014.01.027; Fu Liang, 2014, Ann Am Thorac Soc, V11, P939, DOI 10.1513/AnnalsATS.201402-084OC; Garnier L, 2018, J IMMUNOL, V201, P3218, DOI 10.4049/jimmunol.1800417; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Giton F, 2015, J CLIN ENDOCR METAB, V100, pE292, DOI 10.1210/jc.2014-2658; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Han YY, 2020, THORAX, V75, P849, DOI 10.1136/thoraxjnl-2020-214875; Han YY, 2020, AM J RESP CRIT CARE, V201, P158, DOI 10.1164/rccm.201905-0996OC; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Johnston LK, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00051; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kadel Sapana, 2018, Immunohorizons, V2, P74, DOI 10.4049/immunohorizons.1800008; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Klose CSN, 2020, CELL RES, V30, P475, DOI 10.1038/s41422-020-0323-8; Kouloumenta V, 2006, BRIT J PHARMACOL, V149, P1083, DOI 10.1038/sj.bjp.0706936; Laffont S, 2019, ADV IMMUNOL, V142, P35, DOI 10.1016/bs.ai.2019.04.001; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Malinczak CA, 2019, MUCOSAL IMMUNOL, V12, P969, DOI 10.1038/s41385-019-0171-3; Mandhane PJ, 2005, AM J RESP CRIT CARE, V172, P45, DOI 10.1164/rccm.200412-1738OC; Marozkina N, 2019, PULM THER, V5, P213, DOI 10.1007/s41030-019-00101-9; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Matha L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214286; Meinicke H, 2017, IMMUNOLOGY, V152, P65, DOI 10.1111/imm.12749; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Nakamura S, 2009, J BIOL CHEM, V284, P27327, DOI 10.1074/jbc.M109.038802; Narayanan R, 2018, MOL CELL ENDOCRINOL, V465, P134, DOI 10.1016/j.mce.2017.06.013; Papadopoulos NG, 2004, RESP MED, V98, P879, DOI 10.1016/j.rmed.2004.01.009; Peroni DG, 2009, RESP MED, V103, P104, DOI 10.1016/j.rmed.2008.07.016; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Ross KR, 2020, J ALLERGY CLIN IMMUN, V145, P140, DOI 10.1016/j.jaci.2019.09.030; Rosshart S, 2008, EUR J IMMUNOL, V38, P3354, DOI 10.1002/eji.200838690; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037; Stadhouders R, 2018, J ALLERGY CLIN IMMUN, V142, P1793, DOI 10.1016/j.jaci.2017.12.1006; Tantisira KG, 2008, AM J RESP CRIT CARE, V178, P325, DOI 10.1164/rccm.200708-1174OC; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Wenzel SE, 2010, ALLERGY ASTHMA PROC, V31, P461, DOI 10.2500/aap.2010.31.3384; Yeap BB, 1999, ENDOCRINOLOGY, V140, P3282, DOI 10.1210/en.140.7.3282; Yu QN, 2018, ALLERGY, V73, P1860, DOI 10.1111/all.13438; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zein J, 2020, P NATL ACAD SCI USA, V117, P2187, DOI 10.1073/pnas.1918819117; Zein JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157301; Zein JG, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0528-y; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002	69	8	8	2	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					237	+		10.1016/j.jaci.2021.04.029	http://dx.doi.org/10.1016/j.jaci.2021.04.029			27	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	33964300	Green Published			2022-12-18	WOS:000741453800006
J	Boardman, DA; Levings, MK				Boardman, Dominic A.; Levings, Megan K.			Emerging strategies for treating autoimmune disorders with genetically modified Treg cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Regulatory T cell; autoimmune disease; chimeric anti-gen receptor; CRISPR; gene editing	REGULATORY T-CELLS; CHIMERIC ANTIGEN RECEPTORS; IN-VITRO; INDIRECT ALLOSPECIFICITY; ALLOGRAFT-REJECTION; EFFECTOR FUNCTION; FOXP3 ISOFORMS; B-CELLS; THERAPY; GENERATION	Gene editing of living cells is a cornerstone of present-day medical research that has enabled scientists to address fundamental biologic questions and identify novel strategies to treat diseases. The ability to manipulate adoptive cell therapy products has revolutionized cancer immunotherapy and promises similar results for the treatment of autoimmune diseases, inflammatory disorders, and transplant rejection. Clinical trials have recently deemed polyclonal regulatory T (Treg) cell therapy to be a safe therapeutic option, but questions remain regarding the efficacy of this approach. In this review, we discuss how gene editing technologies are being applied to transform the future of Treg cell therapy, focusing on the preclinical strategies that are currently being investigated to enhance the efficacy, function, and survival of human Treg cells. We explore approaches that may be used to generate immunoregulatory cells ex vivo, detail emerging strategies that are being used to modify these cells (such as using chimeric antigen receptors to confer antigen specificity), and outline concepts that have been explored to repurpose conventional T cells to target and destroy autoreactive and alloreactive lymphocytes. We also describe the key hurdles that currently hinder the clinical adoption of Treg cell therapy and propose potential future avenues of research for this field. (J Allergy Clin Immunol 2022;149:1-11.)	[Boardman, Dominic A.; Levings, Megan K.] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Boardman, Dominic A.; Levings, Megan K.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada; [Levings, Megan K.] BC Childrens Hosp Res Inst, A4-186,950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia	Levings, MK (corresponding author), BC Childrens Hosp Res Inst, A4-186,950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	mlevings@bcchr.ca		Levings, Megan/0000-0002-0305-5790				Aarts-Riemens T, 2008, EUR J IMMUNOL, V38, P1381, DOI 10.1002/eji.200737590; Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Andolfi G, 2012, MOL THER, V20, P1778, DOI 10.1038/mt.2012.71; Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; Azhagiri MKK, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02565-6; Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011; Bacchetta R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00016; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041; Bezie S, 2019, BLOOD ADV, V3, P3522, DOI 10.1182/bloodadvances.2019000411; Blat D, 2014, MOL THER, V22, P1018, DOI 10.1038/mt.2014.41; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Boardman DA, 2017, AM J TRANSPLANT, V17, P931, DOI 10.1111/ajt.14185; Boardman D, 2016, BIOCHEM SOC T, V44, P342, DOI 10.1042/BST20150247; Boardman DA, 2019, NAT BIOMED ENG, V3, P259, DOI 10.1038/s41551-019-0359-6; Boardman Dominic A, 2016, Curr Transplant Rep, V3, P275; Boroughs AC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126194; Brockmann L, 2017, J IMMUNOL, V198, P1130, DOI 10.4049/jimmunol.1601045; Brusko TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011726; Chmielewski M, 2015, EXPERT OPIN BIOL TH, V15, P1145, DOI 10.1517/14712598.2015.1046430; Chmielewski M, 2014, IMMUNOL REV, V257, P83, DOI 10.1111/imr.12125; Chmielewski M, 2011, CANCER RES, V71, P5697, DOI 10.1158/0008-5472.CAN-11-0103; Cook L, 2019, GASTROENTEROLOGY, V157, P1584, DOI 10.1053/j.gastro.2019.09.002; Dall'Era M, 2019, ARTHRITIS RHEUMATOL, V71, P431, DOI 10.1002/art.40737; Dawson NAJ, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz3866; Dawson NAJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123672; de Sio FRS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15689-8; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Deuse T, 2019, NAT BIOTECHNOL, V37, P252, DOI 10.1038/s41587-019-0016-3; Dong S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.147474; Elinav E, 2008, GASTROENTEROLOGY, V134, P2014, DOI 10.1053/j.gastro.2008.02.060; Elinav E, 2009, GASTROENTEROLOGY, V136, P1721, DOI 10.1053/j.gastro.2009.01.049; Ellebrecht CT, 2016, SCIENCE, V353, P179, DOI 10.1126/science.aaf6756; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Ferrari Samuele, 2021, Front Genome Ed, V3, P618378, DOI 10.3389/fgeed.2021.618378; Ferreira LMR, 2019, NAT REV DRUG DISCOV, V18, P749, DOI 10.1038/s41573-019-0041-4; Fishman S, 2017, MOL THER, V25, P456, DOI 10.1016/j.ymthe.2016.12.007; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fransson M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-112; Fujio K, 2006, J IMMUNOL, V177, P8140, DOI 10.4049/jimmunol.177.11.8140; Goodwin M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0571; Gornalusse GG, 2017, NAT BIOTECHNOL, V35, P765, DOI 10.1038/nbt.3860; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Guichelaar T, 2008, J IMMUNOL, V180, P1373, DOI 10.4049/jimmunol.180.3.1373; Harden PN, 2021, AM J TRANSPLANT, V21, P1603, DOI 10.1111/ajt.16395; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hirai T, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139991; Hombach AA, 2009, GENE THER, V16, P1088, DOI 10.1038/gt.2009.75; Honaker Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay6422; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hull CM, 2017, J AUTOIMMUN, V79, P63, DOI 10.1016/j.jaut.2017.01.001; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Imura Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136185; Jandus C, 2014, J CLIN INVEST, V124, P1810, DOI 10.1172/JCI65899; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Kanamori M, 2016, TRENDS IMMUNOL, V37, P803, DOI 10.1016/j.it.2016.08.012; Kansal R, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1648; Kim YC, 2018, J AUTOIMMUN, V92, P77, DOI 10.1016/j.jaut.2018.05.003; Kim YC, 2015, BLOOD, V125, P1107, DOI 10.1182/blood-2014-04-566786; Koristka S, 2018, J AUTOIMMUN, V90, P116, DOI 10.1016/j.jaut.2018.02.006; Kuhn NF, 2019, CANCER CELL, V35, P473, DOI 10.1016/j.ccell.2019.02.006; Lam AJ, 2022, EUR J IMMUNOL, V52, P75, DOI 10.1002/eji.202149318; Lam AJ, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109494; Lam AJ, 2019, J IMMUNOL, V202, P2195, DOI 10.4049/jimmunol.1801330; Lamarthee B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26844-1; Lee JC, 2011, CANCER RES, V71, P2871, DOI 10.1158/0008-5472.CAN-10-0552; Lee J, 2020, J CLIN INVEST, V130, P6317, DOI 10.1172/JCI138416; Lee S-K, ANTIC4D CHIMERIC ANT; Lee SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34617; Leen AM, 2014, MOL THER, V22, P1211, DOI 10.1038/mt.2014.47; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Locafaro G, 2017, MOL THER, V25, P2254, DOI 10.1016/j.ymthe.2017.06.029; Lowther DE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85935; MacDonald KN, 2019, CLIN EXP IMMUNOL, V197, P52, DOI 10.1111/cei.13297; MacDonald KG, 2016, J CLIN INVEST, V126, P1413, DOI 10.1172/JCI82771; MacLeod DT, 2017, MOL THER, V25, P949, DOI 10.1016/j.ymthe.2017.02.005; Marek-Trzonkowska N, 2014, CLIN IMMUNOL, V153, P23, DOI 10.1016/j.clim.2014.03.016; Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038; Margalit A, 2003, INT IMMUNOL, V15, P1379, DOI 10.1093/intimm/dxg136; Martin A, 2021, CYTOTHERAPY, V23, P131, DOI 10.1016/j.jcyt.2020.10.002; Masiuk KE, 2019, CELL STEM CELL, V24, P309, DOI 10.1016/j.stem.2018.12.003; McGowan E, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109625; Mizoguchi A, 2018, J GASTROENTEROL, V53, P465, DOI 10.1007/s00535-017-1401-7; Mohseni YR, 2021, EUR J IMMUNOL, V51, P2522, DOI 10.1002/eji.202048934; Muller YD, 456548 BIORXIV; Nguyen P, 2003, GENE THER, V10, P594, DOI 10.1038/sj.gt.3301932; Noyan F, 2017, AM J TRANSPLANT, V17, P917, DOI 10.1111/ajt.14175; Ocklenburg F, 2006, LAB INVEST, V86, P724, DOI 10.1038/labinvest.3700432; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Parvathaneni K, 2018, BLOOD ADV, V2, P2332, DOI 10.1182/bloodadvances.2018018556; Passerini L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007320; Pierini A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92865; Plesa G, 2012, BLOOD, V119, P3420, DOI 10.1182/blood-2011-09-377051; Pohl AD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00693; Raffin C, 2020, NAT REV IMMUNOL, V20, P158, DOI 10.1038/s41577-019-0232-6; Rafiq S, 2018, NAT BIOTECHNOL, V36, P847, DOI 10.1038/nbt.4195; Roemhild A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3734; Rosado-Sanchez I, 2020, CELL IMMUNOL, V358, DOI 10.1016/j.cellimm.2020.104220; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Sanchez-Fueyo A, 2020, AM J TRANSPLANT, V20, P1125, DOI 10.1111/ajt.15700; Sawitzki B, 2020, LANCET, V395, P1627, DOI 10.1016/S0140-6736(20)30167-7; Saxton RA, 2021, SCIENCE, V371, P1222, DOI 10.1126/science.abc8433; Schmetterer KG, 2011, J ALLERGY CLIN IMMUN, V127, P238, DOI 10.1016/j.jaci.2010.10.023; Seng A, 2020, BLOOD ADV, V4, P1325, DOI 10.1182/bloodadvances.2019000965; Setoguchi K, 2000, J IMMUNOL, V165, P5980, DOI 10.4049/jimmunol.165.10.5980; Sharma MD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500845; Skuljec J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01125; Sockolosky JT, 2018, SCIENCE, V359, P1037, DOI 10.1126/science.aar3246; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Suarez ER, 2016, ONCOTARGET, V7, P34341, DOI 10.18632/oncotarget.9114; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Sutherland AR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197222; Tenspolde M, 2019, J AUTOIMMUN, V103, DOI 10.1016/j.jaut.2019.05.017; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; Tsang JYS, 2009, TRANSPL IMMUNOL, V21, P203, DOI 10.1016/j.trim.2009.05.003; van Montfrans C, 2002, GASTROENTEROLOGY, V123, P1865, DOI 10.1053/gast.2002.37067; Walsh PT, 2004, J CLIN INVEST, V114, P1398, DOI 10.1172/JCI200423238; Wang Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01691; Wilkie S, 2010, J BIOL CHEM, V285, P25538, DOI 10.1074/jbc.M110.127951; Wise MP, 1998, J IMMUNOL, V161, P5813; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Xiao J, 2019, AIDS RES HUM RETROV, V35, P444, DOI [10.1089/AID.2018.0218, 10.1089/aid.2018.0218]; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yasunaga M, 2020, SEMIN CANCER BIOL, V64, P1, DOI 10.1016/j.semcancer.2019.06.001; Yoon J, 2017, BLOOD, V129, P238, DOI 10.1182/blood-2016-07-727834; Zhang AH, 2018, J IMMUNOL, V201, P1434, DOI 10.4049/jimmunol.1701800; Zhang B, 2021, ANN RHEUM DIS, V80, P176, DOI 10.1136/annrheumdis-2020-217844; Zhang L, 2019, J AUTOIMMUN, V96, P50, DOI 10.1016/j.jaut.2018.08.004; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	133	8	8	5	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					1	11		10.1016/j.jaci.2021.11.007	http://dx.doi.org/10.1016/j.jaci.2021.11.007			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	34998473				2022-12-18	WOS:000744544500001
J	Gevaert, P; De Craemer, J; De Ruyck, N; Rottey, S; de Hoon, J; Hellings, PW; Volckaert, B; Lesneuck, K; Orengo, JM; Atanasio, A; Kamal, MA; Abdallah, H; Kamat, V; Dingman, R; DeVeaux, M; Ramesh, D; Perlee, L; Wang, CQ; Weinreich, DM; Herman, G; Yancopoulos, GD; O'Brien, MP				Gevaert, Philippe; De Craemer, Jarno; De Ruyck, Natalie; Rottey, Sylvie; de Hoon, Jan; Hellings, Peter W.; Volckaert, Bram; Lesneuck, Kristof; Orengo, Jamie M.; Atanasio, Amanda; Kamal, Mohamed A.; Abdallah, Hisham; Kamat, Vishal; Dingman, Robert; DeVeaux, Michelle; Ramesh, Divya; Perlee, Lorah; Wang, Claire Q.; Weinreich, David M.; Herman, Gary; Yancopoulos, George D.; O'Brien, Meagan P.			Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen immunotherapy; monoclonal antibodies; biologics; allergic rhinitis; Bet v 1; birch allergy	APPLE ALLERGY; POLLEN IMMUNOTHERAPY; IGE; EFFICACY; RHINITIS; HYPERSENSITIVITY; HUMANIZATION; ACTIVATION; BET-V-1; LONG	Background: The efficacy of an allergen-specific IgG cocktail to treat cat allergy suggests that allergen-specific IgG may be a major protective mechanism elicited by allergen immunotherapy. Objectives: Extending these findings, we tested a Bet v 1-specific antibody cocktail in birch-allergic subjects. Methods: This was a phase 1, randomized, double-blind, study with 2 parts. Part A administered ascending doses of the Bet v 1-specific antibody cocktail REGN5713/14/15 (150-900 mg) in 32 healthy adults. Part B administered a single subcutaneous 900-mg dose or placebo in 64 birch-allergic subjects. Total nasal symptom score response to titrated birch extract nasal allergen challenge and skin prick test (SPT) with birch and alder allergen were assessed at screening and days 8, 29, 57, and 113 (SPT only); basophil activation tests (n = 26) were conducted. Results: Single-dose REGN5713/14/15 significantly reduced total nasal symptom score following birch nasal allergen challenge relative to baseline. Differences in total nasal symptom score areas under the curve (0-1 hour) for subjects treated with REGN5713/14/15 versus those given placebo (day 8: -1.17, P = .001; day 29: -1.18, P = .001; day 57: -0.85, P = .024) and titration SPT with birch difference in area under the curve of mean wheal diameters for subjects treated with REGN5713/14/15 versus placebo (all P < .001) were sustained for >= 2 months; similar results were observed with alder SPT. REGN5713/14/15 was well tolerated. Basophil responsiveness to birch-related allergens was significantly decreased in subjects treated with REGN5713/14/15 versus those given placebo on days 8, 57, and 113 (all P < .01). Conclusions: Single-dose REGN5713/14/15 was well tolerated and provided a rapid (1 week) and durable (2 months) reduction in allergic symptoms after birch allergen nasal allergen challenge, potentially offering a new paradigm for the treatment of birch allergy symptoms.	[Gevaert, Philippe; De Craemer, Jarno; De Ruyck, Natalie; Hellings, Peter W.] Ghent Univ Hosp, Dept Otorhinolaryngol, Ghent, Belgium; [Rottey, Sylvie] Ghent Univ Hosp, Drug Res Unit Ghent, Ghent, Belgium; [de Hoon, Jan] UZ Leuven, Ctr Clin Pharmacol, Leuven, Belgium; [Hellings, Peter W.] Katholieke Univ Leuven, Allergy & Clin Immunol Res Grp, Leuven, Belgium; [Hellings, Peter W.] Univ Amsterdam, Acad Med Ctr Amsterdam, Amsterdam, Netherlands; [Volckaert, Bram; Lesneuck, Kristof] SGS Belgium Clin Pharmacol Unit Antwerpen, Antwerp, Belgium; [Orengo, Jamie M.; Atanasio, Amanda; Kamal, Mohamed A.; Abdallah, Hisham; Kamat, Vishal; Dingman, Robert; DeVeaux, Michelle; Ramesh, Divya; Perlee, Lorah; Wang, Claire Q.; Weinreich, David M.; Herman, Gary; Yancopoulos, George D.; O'Brien, Meagan P.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; KU Leuven; University of Amsterdam; Academic Medical Center Amsterdam; Regeneron	O'Brien, MP (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	meagan.obrien@regeneron.com		OBrien, Meagan/0000-0003-4476-8057	Regeneron Pharmaceuticals, Inc.	Regeneron Pharmaceuticals, Inc.(Regeneron)	This study was funded by Regeneron Pharmaceuticals, Inc.	Asero R, 2004, ALLERGY, V59, P1269, DOI 10.1111/j.1398-9995.2004.00561.x; Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x; Asero R, 2003, ALLERGY, V58, P435, DOI 10.1034/j.1398-9995.2003.00139.x; Asero R., 2015, CURR TREAT OPTIONS A, V2, P83; Atanasio A, 2022, J ALLERGY CLIN IMMUN, V149, P200, DOI 10.1016/j.jaci.2021.05.038; Bergmann KC, 2008, WORLD ALLERGY ORGAN, V1, P79, DOI 10.1097/WOX.0b013e3181752d1c; Biedermann T, 2019, ALLERGY, V74, P1237, DOI 10.1111/all.13758; Biedermann T, 2019, J ALLERGY CLIN IMMUN, V143, P1058, DOI 10.1016/j.jaci.2018.12.1001; Bolhaar STHP, 2004, CLIN EXP ALLERGY, V34, P761, DOI 10.1111/j.1365-2222.2004.1939.x; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; Bousquet J, 2019, ALLERGY, V74, P2087, DOI 10.1111/all.13805; Brozek JL, 2017, J ALLERGY CLIN IMMUN, V140, P950, DOI 10.1016/j.jaci.2017.03.050; Bucher X, 2004, ALLERGY, V59, P1272, DOI 10.1111/j.1398-9995.2004.00626.x; Burbach GJ, 2009, ALLERGY, V64, P1507, DOI 10.1111/j.1398-9995.2009.02089.x; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Downie SR, 2004, ALLERGY, V59, P406, DOI 10.1111/j.1398-9995.2003.00420.x; EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X; Ellis AK, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0156-7; ERIKSSON NE, 1982, ALLERGY, V37, P437, DOI 10.1111/j.1398-9995.1982.tb02323.x; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Frew AJ, 2006, CLIN EXP ALLERGY, V36, P251, DOI 10.1111/j.1365-2222.2006.02444.x; Frew AJ, 2010, J ALLERGY CLIN IMMUN, V125, pS306, DOI 10.1016/j.jaci.2009.10.064; Galant S, 1998, ANN ALLERG ASTHMA IM, V81, P203, DOI 10.1016/S1081-1206(10)62813-X; Hemmings O, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0831-5; HERRMANN D, 1995, J INVEST ALLERG CLIN, V5, P259; JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x; KELSO JM, 1995, ANN ALLERG ASTHMA IM, V74, P391; Kleine-Tebbe J, 2020, ALLERGY, V75, P1327, DOI 10.1111/all.14130; Lin RY, 2002, ALLERGY ASTHMA PROC, V23, P253; Lotzsch B, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0134-7; Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111; Makela MJ, 2018, CLIN THER, V40, P574, DOI 10.1016/j.clinthera.2018.02.012; Mauro M, 2007, Eur Ann Allergy Clin Immunol, V39, P119; Mobs C, 2012, J ALLERGY CLIN IMMUN, V130, P1108, DOI 10.1016/j.jaci.2012.07.056; Moote W, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0282-5; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; Niederberger V, 1998, J ALLERGY CLIN IMMUN, V102, P579, DOI 10.1016/S0091-6749(98)70273-8; Orengo JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03636-8; Pablos I, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0603-z; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Pfaar O, 2017, ALLERGY, V72, P713, DOI 10.1111/all.13092; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P179, DOI 10.1016/j.jaci.2014.09.001; Scadding GK, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100124; Schenk MF, 2011, J PROTEOMICS, V74, P1290, DOI 10.1016/j.jprot.2011.03.021; Seidman MD, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599814561600; VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003	48	8	8	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					189	199		10.1016/j.jaci.2021.05.039	http://dx.doi.org/10.1016/j.jaci.2021.05.039			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV		Green Accepted, Green Published			2022-12-18	WOS:000741453800002
J	Helou, DG; Shafiei-Jahani, P; Hurrell, BP; Painter, JD; Quach, C; Howard, E; Akbari, O				Helou, Doumet Georges; Shafiei-Jahani, Pedram; Hurrell, Benjamin P.; Painter, Jacob D.; Quach, Christine; Howard, Emily; Akbari, Omid			LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						LAIR-1; ILC2; airway hyperreactivity; immune check-points; allergic asthma	INNATE LYMPHOID-CELLS; IG-LIKE RECEPTOR-1; T-CELLS; EXPRESSION; DIFFERENTIATION; ASTHMA; C1Q; SHP-1	Background: Type 2 innate lymphoid cells (ILC2s) are relevant players in type 2 asthma. They initiate eosinophil infiltration and airway hyperreactivity (AHR) through cytokine secretion. Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) is an inhibitory receptor considered to be an immune checkpoint in different inflammatory diseases. Objective: Our aim here was to investigate the expression of LAIR-1 and assess its role in human and murine ILC2s. Methods: Wild-type and LAIR-1 knockout mice were intranasally challenged with IL-33, and pulmonary ILC2s were sorted to perform an ex vivo comparative study based on RNA sequencing and flow cytometry. We next studied the impact of LAIR-1 deficiency on AHR and lung inflammation by using knockout mice and adoptive transfer experiments in Rag2(-/-) Il2rg(-/-) mice. Knockdown antisense strategies and humanized mice were used to assess the role of LAIR-1 in human ILC2s. Results: We have demonstrated that LAIR-1 is inducible on activated ILC2s and downregulates cytokine secretion and effector function. LAIR-1 signaling in ILC2s was mediated via inhibitory pathways, including SHP1/PI3K/AKT, and LAIR-1 deficiency led to exacerbated ILC2-dependent AHR in IL-33 and Alternaria alternata models. In adoptive transfer experiments, we confirmed the LAIR-1-mediated regulation of ILC2s in vivo. Interestingly, LAIR-1 was expressed and inducible in human ILC2s, and knockdown approaches of Lair1 resulted in higher cytokine production. Finally, engagement of LAIR-1 by physiologic ligand C1q significantly reduced ILC2-dependent AHR in a humanized ILC2 murine model. Conclusion: Our results unravel a novel regulatory axis in ILC2s with the capacity to reduce allergic AHR and lung inflammation.	[Helou, Doumet Georges; Shafiei-Jahani, Pedram; Hurrell, Benjamin P.; Painter, Jacob D.; Quach, Christine; Howard, Emily; Akbari, Omid] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, NRT 5505,1450 Biggy St, Los Angeles, CA 90033 USA	University of Southern California	Akbari, O (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, NRT 5505,1450 Biggy St, Los Angeles, CA 90033 USA.	akbari@usc.edu		Painter, Jacob/0000-0003-0273-8597	National Institutes of Health Public Health Service [R01 ES025786, R01 ES021801, R01 HL144790, R01 HL151493, R01 AI145813, R01 HL151769]	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA)	Supported by the National Institutes of Health Public Health Service (grants R01 ES025786, R01 ES021801, R01 HL144790, R01 HL151493, R01 AI145813 and R01 HL151769 [to O.A.] ) .	An G, 2018, IMMUNOLOGY, V154, P637, DOI 10.1111/imm.12911; Aron JL, 2017, ALLERGY, V72, P1148, DOI 10.1111/all.13139; Bal SM, 2020, NAT REV IMMUNOL, V20, P552, DOI 10.1038/s41577-020-0282-9; Bally I, 2013, P NATL ACAD SCI USA, V110, P8650, DOI 10.1073/pnas.1304894110; Bonaccorsi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015080; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Bush A, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00068; Carvalheiro T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01793; Chopra V, 2020, ADV THER-GERMANY, V3, DOI 10.1002/adtp.201900119; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; de Vries ARV, 1999, EUR J IMMUNOL, V29, P3160; Doherty TA, 2019, ALLERGOL INT, V68, P9, DOI 10.1016/j.alit.2018.11.001; Entwistle LJ, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03114; Fante MA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052646; Galle-Treger L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08449-x; Geerdink RJ, 2018, J ALLERGY CLIN IMMUN, V141, P811, DOI 10.1016/j.jaci.2017.08.031; Gonzalez-Polo V, 2019, ANN HEPATOL, V18, P366, DOI 10.1016/j.aohep.2018.12.001; Guo N, 2020, CURR RES TRANSL MED, V68, P119, DOI 10.1016/j.retram.2020.05.003; Helfrich S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00930; Helou DG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17813-1; Helou DG, 2019, J IMMUNOL, V202, P2189, DOI 10.4049/jimmunol.1801065; Howard E, 2021, J ALLERGY CLIN IMMUN, V147, P1281, DOI 10.1016/j.jaci.2020.08.024; Hoxhaj G, 2020, NAT REV CANCER, V20, P74, DOI 10.1038/s41568-019-0216-7; Hurrell BP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.542818; Hurrell BP, 2019, CELL REP, V29, P4509, DOI 10.1016/j.celrep.2019.11.102; Jansen CA, 2007, EUR J IMMUNOL, V37, P914, DOI 10.1002/eji.200636678; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kato A, 2019, CHEST, V156, P141, DOI 10.1016/j.chest.2019.04.101; Kim HK, 2014, INT ARCH ALLERGY IMM, V163, P92, DOI 10.1159/000356341; Kim S, 2017, J IMMUNOL, V199, P2692, DOI 10.4049/jimmunol.1700271; Klose CSN, 2020, CELL RES, V30, P475, DOI 10.1038/s41422-020-0323-8; Kumawat K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00842; Kundu S, 2010, J IMMUNOL, V184, P6529, DOI 10.4049/jimmunol.0903562; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Liu G, 2017, J PATHOL, V243, P510, DOI 10.1002/path.4979; Maazi H, 2018, J ALLERGY CLIN IMMUN, V141, P893, DOI 10.1016/j.jaci.2017.04.043; Maazi H, 2017, IMMUNOL REV, V278, P192, DOI 10.1111/imr.12554; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Mascarell L, 2017, MUCOSAL IMMUNOL, V10, P695, DOI 10.1038/mi.2016.87; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Mindt BC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00840; Miyamoto C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08365-0; Molofsky AB, 2015, IMMUNITY, V42, P1005, DOI 10.1016/j.immuni.2015.06.006; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Omiya R, 2009, IMMUNOLOGY, V128, P543, DOI 10.1111/j.1365-2567.2009.03140.x; Osei ET, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65567-z; Ozsoy Y, 2009, MOLECULES, V14, P3754, DOI 10.3390/molecules14093754; Park JE, 2020, J BIOL CHEM, V295, P2239, DOI 10.1074/jbc.RA119.011150; Peng DH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18298-8; Poposki JA, 2017, IMMUN INFLAMM DIS, V5, P233, DOI 10.1002/iid3.161; Porsbjerg CM, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00260-2020; Puttur F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7638; Reid KBM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00764; Sathish JG, 2001, J IMMUNOL, V166, P1763, DOI 10.4049/jimmunol.166.3.1763; Shafiei-Jahani P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22832-7; Shafiei-Jahani P, 2021, MUCOSAL IMMUNOL, V14, P899, DOI 10.1038/s41385-021-00388-5; Shafiei-Jahani P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18601-7; Silberbrandt A, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.congress-2019.PA5211; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Son M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00290-w; Son M, 2014, MOL MED, V20, P559, DOI 10.2119/molmed.2014.00185; Son M, 2012, P NATL ACAD SCI USA, V109, pE3160, DOI 10.1073/pnas.1212753109; Tang XB, 2012, J IMMUNOL, V188, P548, DOI 10.4049/jimmunol.1102044; Tang XB, 2009, J IMMUNOL, V182, P5446, DOI 10.4049/jimmunol.0804052; Verbrugge A, 2006, J LEUKOCYTE BIOL, V79, P828, DOI 10.1189/jlb.0705370; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wen LZ, 2018, CANCER RES, V78, P4680, DOI 10.1158/0008-5472.CAN-17-3896; Winkler C, 2019, J ALLERGY CLIN IMMUN, V144, P61, DOI 10.1016/j.jaci.2019.01.027; Wu XJ, 2019, CURR PROB CANCER, V43, P18, DOI 10.1016/j.currproblcancer.2018.04.005; Zhang Y, 2014, CELL IMMUNOL, V287, P46, DOI 10.1016/j.cellimm.2013.12.005; Zhang Y, 2013, CLINICS, V68, P475, DOI 10.6061/clinics/2013(04)07	75	8	8	3	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					223	+		10.1016/j.jaci.2021.05.042	http://dx.doi.org/10.1016/j.jaci.2021.05.042			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	34144112				2022-12-18	WOS:000741453800005
J	Lee, M; Lim, S; Kim, YS; Khalmuratova, R; Shin, SH; Kim, I; Kim, HJ; Kim, DY; Rhee, CS; Park, JW; Shin, HW				Lee, Mingyu; Lim, Suha; Kim, Yi Sook; Khalmuratova, Roza; Shin, Seung-Hyun; Kim, Iljin; Kim, Hyun-Jik; Kim, Dong-Young; Rhee, Chae-Seo; Park, Jong-Wan; Shin, Hyun-Woo			DEP-induced ZEB2 promotes nasal polyp formation via epithelial-to-mesenchymal transition	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Diesel exhaust particles; air pollutants; nasal polyps; epithelial-to-mesenchymal transition; ZEB2	HOUSE-DUST MITE; DIESEL EXHAUST PARTICLES; AIR-POLLUTION; ADJUVANT ACTIVITY; CHRONIC RHINOSINUSITIS; ALLERGIC SENSITIZATION; IGE PRODUCTION; DISEASES; EXPOSURE; INFLAMMATION	Background: Diesel exhaust particles (DEPs) are associated with the prevalence and exacerbation of allergic respiratory diseases, including allergic rhinitis and allergic asthma. However, DEP-induced mechanistic pathways promoting upper airway disease and their clinical implications remain unclear. Objective: We sought to investigate the mechanisms by which DEP exposure contributes to nasal polyposis using human derived epithelial cells and a murine nasal polyp (NP) model. Methods: Gene set enrichment and weighted gene coexpression network analyses were performed. Cytotoxicity, epithelial-tomesenchymal transition (EMT) markers, and nasal polyposis were assessed. Effects of DEP exposure on EMT were determined using epithelial cells from normal people or patients with chronic rhinosinusitis with or without NPs. BALB/c mice were exposed to DEP through either a nose-only exposure system or nasal instillation, with or without house dust mite, followed by zinc finger E-box-binding homeobox (ZEB)2 small hairpin RNA delivery. Results: Bioinformatics analyses revealed that DEP exposure triggered EMT features in airway epithelial cells. Similarly, DEP-exposed human nasal epithelial cells exhibited EMT characteristics, which were dependent on ZEB2 expression. Human nasal epithelial cells derived from patients with chronic rhinosinusitis presented more prominent EMT features after DEP treatment, when compared with those from control subjects and patients with NPs. Coexposure to DEP and house dust mite synergistically increased the number of NPs, epithelial disruptions, and ZEB2 expression. Most importantly, ZEB2 inhibition prevented DEP-induced EMT, thereby alleviating NP formation in mice. Conclusions: Our data show that DEP facilitated NP formation, possibly via the promotion of ZEB2-induced EMT. ZEB2 may be a therapeutic target for DEP-induced epithelial damage and related airway diseases, including NPs. (J Allergy Clin Immunol 2022;149:340-57.)	[Lee, Mingyu; Lim, Suha; Kim, Yi Sook; Khalmuratova, Roza; Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Obstruct Upper Airway Res Lab, Dept Pharmacol, Seoul, South Korea; [Lee, Mingyu; Lim, Suha; Kim, Yi Sook; Shin, Seung-Hyun; Park, Jong-Wan; Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Lee, Mingyu; Lim, Suha; Kim, Yi Sook; Shin, Seung-Hyun; Park, Jong-Wan; Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Mingyu] Harvard Med Sch, Brigham & Womens Hosp, Div Allergy & Clin Immunol, Boston, MA 02115 USA; [Lee, Mingyu] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Kim, Iljin] Inha Univ, Dept Pharmacol, Coll Med, Incheon, South Korea; [Kim, Hyun-Jik; Kim, Dong-Young; Rhee, Chae-Seo; Shin, Hyun-Woo] Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Jong-Wan; Shin, Hyun-Woo] Seoul Natl Univ, Ischem Hypox Dis Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Inha University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Shin, HW (corresponding author), Seoul Natl Univ, Dept Pharmacol, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.	charlie@snu.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea [HI17C1669]; National Research Foundation of Korea [2020R1A4A2002903]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, the Ministry of Health & Welfare, Republic of Korea (grant no. HI17C1669), and the National Research Foundation of Korea (grant no. 2020R1A4A2002903).	Bayram H, 2006, EUR RESPIR J, V27, P705, DOI 10.1183/09031936.06.00012805; Bleck B, 2011, AM J RESP CRIT CARE, V183; Bleck B, 2010, J IMMUNOL, V185, P6636, DOI 10.4049/jimmunol.1000719; Bose S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193910; Bowatte G, 2017, J ALLERGY CLIN IMMUN, V139, P122, DOI 10.1016/j.jaci.2016.05.008; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Brauer M, 2003, EPIDEMIOLOGY, V14, P228, DOI 10.1097/00001648-200303000-00019; Burbank AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1, DOI 10.1016/j.jaci.2017.05.010; Cao DS, 2010, AM J RESP CELL MOL, V42, P88, DOI 10.1165/rcmb.2008-0455OC; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Chen F, 2018, ENVIRON POLLUT, V232, P329, DOI 10.1016/j.envpol.2017.08.072; Chi YL, 2018, J ENVIRON SCI-CHINA, V66, P155, DOI 10.1016/j.jes.2017.05.002; Cyrys J, 2003, J EXPO ANAL ENV EPID, V13, P134, DOI 10.1038/sj.jea.7500262; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fukuoka A, 2016, CLIN EXP ALLERGY, V46, P142, DOI 10.1111/cea.12597; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Grilli A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4679-9; He F, 2017, SCI REP-UK, V7, DOI 10.1038/srep45666; Jang AS, 2016, CURR OPIN ALLERGY CL, V16, P13, DOI 10.1097/ACI.0000000000000235; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karagulian F, 2015, ATMOS ENVIRON, V120, P475, DOI 10.1016/j.atmosenv.2015.08.087; Khalmuratova R, 2016, ALLERGOL IMMUNOPATH, V44, P66, DOI 10.1016/j.aller.2015.04.004; Khalmuratova R, 2017, IMMUNE NETW, V17, P60, DOI 10.4110/in.2017.17.1.60; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee M, 2019, MUCOSAL IMMUNOL, V12, P601, DOI 10.1038/s41385-019-0149-1; Lee M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40249; Lee M, 2016, J ALLERGY CLIN IMMUN, V137, P87, DOI 10.1016/j.jaci.2015.07.026; Lee YL, 2003, EUR RESPIR J, V21, P964, DOI 10.1183/09031936.03.00094602; Li H, 2017, BLOOD, V129, P497, DOI 10.1182/blood-2016-05-714493; Li MZ, 2017, AM J TRANSL RES, V9, P2838; Li NN, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0125-3; Liao EC, 2013, J INVEST ALLERG CLIN, V23, P20; Lindgren A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-25; Longhin E, 2016, ENVIRON POLLUT, V215, P366, DOI 10.1016/j.envpol.2016.05.015; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mady LJ, 2018, INT FORUM ALLERGY RH, V8, P377, DOI 10.1002/alr.22052; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; Nicolussi FH, 2014, REV SAUDE PUBL, V48, P326, DOI 10.1590/S0034-8910.2014048004940; Nilsen A, 1997, TOXICOLOGY, V124, P225, DOI 10.1016/S0300-483X(97)00150-9; Olszewska A, 2021, POL J OTOLARYNGOL, V75, P36, DOI 10.5604/01.3001.0014.2047; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Pain M, 2014, EUR RESPIR REV, V23, P118, DOI 10.1183/09059180.00004413; Park M, 2019, CLIN EXP OTORHINOLAR, V12, P294, DOI 10.21053/ceo.2018.00612; Peden DB, 2015, J ALLERGY CLIN IMMUN, V136, P866, DOI 10.1016/j.jaci.2015.08.008; Pinto JP, 2004, J AIR WASTE MANAGE, V54, P440, DOI 10.1080/10473289.2004.10470919; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramachandran S, 2013, AM J PHYSIOL-LUNG C, V305, pL23, DOI 10.1152/ajplung.00426.2012; Robinson RK, 2018, J ALLERGY CLIN IMMUN, V141, P1074, DOI 10.1016/j.jaci.2017.04.038; Rynning I, 2018, TOXICOL SCI, V166, P51, DOI 10.1093/toxsci/kfy183; Schleimer RP, 2017, J ALLERGY CLIN IMMUN, V139, P1752, DOI 10.1016/j.jaci.2017.04.010; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Schwarzbach HL, 2020, IMMUNOL ALLERGY CLIN, V40, P215, DOI 10.1016/j.iac.2019.12.011; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Shin HW, 2016, LARYNSCOPE INVESTIG, V1, P116, DOI 10.1002/lio2.29; Shin HW, 2012, AM J RESP CRIT CARE, V185, P944, DOI 10.1164/rccm.201109-1706OC; Sreekumar R, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3115; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Suzuki T, 1996, J CLIN LAB IMMUNOL, V48, P187; TAKAFUJI S, 1987, J ALLERGY CLIN IMMUN, V79, P639, DOI 10.1016/S0091-6749(87)80161-6; Takizawa H, 2000, Respirology, V5, P197, DOI 10.1046/j.1440-1843.2000.00245.x; Totlandsdal AI, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-41; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Wang TT, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3701-y; Weiland Stephan K., 1994, Annals of Epidemiology, V4, P243; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang XL, 2016, ATMOSPHERE-BASEL, V7, DOI 10.3390/atmos7120158	76	8	8	6	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					340	357		10.1016/j.jaci.2021.04.024	http://dx.doi.org/10.1016/j.jaci.2021.04.024			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	33957165				2022-12-18	WOS:000747922700004
J	Salinas, AF; Mortari, EP; Terreri, S; Milito, C; Zaffina, S; Perno, CF; Locatelli, F; Quinti, I; Carsetti, R				Salinas, Ane Fernandez; Mortari, Eva Piano; Terreri, Sara; Milito, Cinzia; Zaffina, Salvatore; Perno, Carlo Federico; Locatelli, Franco; Quinti, Isabella; Carsetti, Rita			Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Salinas, Ane Fernandez; Milito, Cinzia; Quinti, Isabella] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Locatelli, Franco] Sapienza Univ Rome, Dipartimento Materno Infantile & Sci Urol, Rome, Italy; [Salinas, Ane Fernandez; Mortari, Eva Piano; Terreri, Sara; Carsetti, Rita] IRCCS, Bambino Gesu Childrens Hosp, Diagnost Immunol Res Unit, Multimodal Med Res Area, Rome, Italy; [Zaffina, Salvatore] IRCCS, Bambino Gesu Childrens Hosp, Occupat Med Hlth Technol Assessment & Safety Res, Clin Technol Innovat Res Area, Rome, Italy; [Zaffina, Salvatore] IRCCS, Bambino Gesu Childrens Hosp, Hlth Directorate, Rome, Italy; [Perno, Carlo Federico] IRCCS, Bambino Gesu Childrens Hosp, Multimodal Med Res Area, Rome, Italy; [Perno, Carlo Federico] IRCCS, Bambino Gesu Childrens Hosp, Microbiol & Diagnost Immunol Unit, Rome, Italy; [Locatelli, Franco] IRCCS, Bambino Gesu Childrens Hosp, Dept Onco Haematol & Cell & Gene Therapy, Rome, Italy; [Carsetti, Rita] IRCCS, Bambino Gesu Childrens Hosp, Diagnost Immunol Clin Unit, Rome, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Carsetti, R (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Diagnost Immunol Res Unit, Multimodal Med Res Area, Rome, Italy.; Carsetti, R (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Diagnost Immunol Clin Unit, Rome, Italy.	rita.carsetti@opbg.net		PERNO, CARLO FEDERICO/0000-0002-0825-5388	Italian Ministry of Health [RF2013-02358960, COVID2020-12371817]	Italian Ministry of Health(Ministry of Health, Italy)	Supported by the Italian Ministry of Health (grants RF2013-02358960 and COVID2020-12371817).	del Pino-Molina L, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.603972; Hagin D, 2021, J ALLERGY CLIN IMMUN, V148, P739, DOI 10.1016/j.jaci.2021.05.029; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Illingworth A, 2018, CYTOM PART B-CLIN CY, V94, P49, DOI 10.1002/cyto.b.21609; Pollard AJ, 2021, NAT REV IMMUNOL, V21, P83, DOI 10.1038/s41577-020-00479-7	5	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					76	77		10.1016/j.jaci.2021.08.031	http://dx.doi.org/10.1016/j.jaci.2021.08.031			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	34674857	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000744544500016
J	Zhu, ZZ; Camargo, CA; Raita, Y; Fujiogi, M; Liang, LM; Rhee, EP; Woodruff, PG; Hasegawa, K				Zhu, Zhaozhong; Camargo, Carlos A. Jr Jr; Raita, Yoshihiko; Fujiogi, Michimasa; Liang, Liming; Rhee, Eugene P.; Woodruff, Prescott G.; Hasegawa, Kohei			Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe bronchiolitis; heterogeneity; subtype; asthma; metabolome; inflammatory amino acids; polyunsaturated fatty acids; transcriptome	RESPIRATORY SYNCYTIAL VIRUS; NASOPHARYNGEAL MICROBIOTA; FATTY-ACIDS; ASSOCIATION; RHINOVIRUS; INFECTION; PROFILES; TRANSCRIPTOMICS; PREGNANCY; PATTERNS	Background: Infants with bronchiolitis are at increased risk for developing asthma. Growing evidence suggests bronchiolitis is a heterogeneous condition. Objectives: We sought to identify biologically distinct subgroups based on the metabolome signatures (metabotypes) in infants with severe bronchiolitis and to examine the longitudinal relationships of metabotypes with asthma development. Methods: In a multicenter prospective cohort study of infants (age, <12 months) hospitalized for bronchiolitis, the nasopharyngeal airway metabolome was profiled at hospitalization. Using a clustering approach, this study identified mutually exclusive metabotypes. This study also examined their longitudinal association with the risk of developing asthma by 5 years of age. Results: Of 918 infants hospitalized for bronchiolitis (median age, 3 months), this study identified 5 distinct metabotypes-characterized by their nasopharyngeal metabolome profile: A, glycerophosphocholine-high; B, amino acid-high, polyunsaturated fatty acid-low; C, amino acid-high, glycerophospholipid-low; D, glycerophospholipid-high; and E, mixed. Compared with infants with metabotype A (who clinically resembled "classic" bronchiolitis), infants with metabotype B had a significantly higher risk for developing asthma (23% vs 41%; adjusted odds ratio, 2.22; 95% CI, 1.07-4.69). The pathway analysis showed that metabotype B had enriched amino acid (eg, methionine, histidine, glutathione) and alpha-linolenic/linoleic acid metabolism pathways (false discovery rate, <5 x 10(-14) for all). Finally, the transcriptome analysis revealed that infants with metabotype B had upregulated IFN-alpha and IL-6/JAK/STAT3 pathways and downregulated fatty acid metabolism pathways (false discovery rate, <0.05 for both). Conclusions: In this multicenter prospective cohort study of infants with severe bronchiolitis, the clustering analysis of metabolome data identified biologically distinct metabotypes, including a metabotype characterized by high inflammatory amino acids and low polyunsaturated fatty acids that is at significantly increased risk for developing asthma.	[Zhu, Zhaozhong; Camargo, Carlos A. Jr Jr; Raita, Yoshihiko; Fujiogi, Michimasa; Hasegawa, Kohei] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Rhee, Eugene P.] Harvard Med Sch, Massachusetts Gen Hosp, Nephrol Div, Dept Med, Boston, MA USA; [Rhee, Eugene P.] Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA USA; [Liang, Liming] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Dept Epidemiol, Boston, MA USA; [Liang, Liming] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Woodruff, Prescott G.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Woodruff, Prescott G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhu, ZZ (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, 125 Nashua St,Suite 920, Boston, MA 02114 USA.	zzhu5@mgh.harvard.edu	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654	National Institutes of Health [K01 AI-153558, U01 AI-087881, R01 AI-114552, R01 AI-127507, R01 AI-134940, R01 AI-137091, R01 AI-148338, UG3/UH3 OD-023253]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (grants K01 AI-153558, U01 AI-087881, R01 AI-114552, R01 AI-127507, R01 AI-134940, R01 AI-137091, R01 AI-148338, and UG3/UH3 OD-023253).	Abreo A, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0195-4; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Barlotta A, 2019, J INFECT DIS, V219, P1216, DOI 10.1093/infdis/jiy659; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, P1055, DOI 10.1016/j.jaci.2009.02.021; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Comhair SAA, 2015, J IMMUNOL, V195, P643, DOI 10.4049/jimmunol.1500736; Dumas O, 2019, J ALLERGY CLIN IMMUN, V143, P1371, DOI 10.1016/j.jaci.2018.08.043; Dumas O, 2016, THORAX, V71, P712, DOI 10.1136/thoraxjnl-2016-208535; Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Fujiogi M, 2021, PEDIAT ALLERG IMM-UK, V32, P905, DOI 10.1111/pai.13466; Fujiogi M, 2020, ALLERGY, V75, P2379, DOI 10.1111/all.14326; Fujiogi M, 2020, PEDIATR RES, V88, P144, DOI 10.1038/s41390-019-0742-8; Fujiogi M, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2614; Hasegawa K, 2018, ALLERGY, V73, P1135, DOI 10.1111/all.13379; Hasegawa K, 2019, JAMA PEDIATR, V173, P544, DOI 10.1001/jamapediatrics.2019.0384; Hasegawa K, 2019, ALLERGY, V74, P1374, DOI 10.1111/all.13723; Hasegawa K, 2018, PEDIATR RES, V83, P606, DOI 10.1038/pr.2017.309; Hasegawa K, 2018, PEDIAT ALLERG IMM-UK, V29, P441, DOI 10.1111/pai.12880; Hasegawa K, 2016, EUR RESPIR J, V48, P1329, DOI 10.1183/13993003.00152-2016; Hasegawa K, 2016, EXPERT REV RESP MED, V10, P891, DOI 10.1080/17476348.2016.1190647; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kelly RS, 2017, CHEST, V151, P262, DOI 10.1016/j.chest.2016.10.008; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Lee-Sarwar K, 2019, J ALLER CL IMM-PRACT, V7, P529, DOI 10.1016/j.jaip.2018.07.039; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lumia M, 2011, PEDIAT ALLERG IMM-UK, V22, P827, DOI 10.1111/j.1399-3038.2011.01202.x; Mansbach JM, 2016, J ALLERGY CLIN IMMUN, V137, P1909, DOI 10.1016/j.jaci.2016.01.036; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Institute for Health and Care Excellence, 2015, BRONCH CHILDR DIAGN; Panda L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09869-9; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Raita Y, 2021, J ALLERGY CLIN IMMUN, V147, P2108, DOI 10.1016/j.jaci.2020.11.002; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Regnier SA, 2013, PEDIATR INFECT DIS J, V32, P820, DOI 10.1097/INF.0b013e31829061e8; Reinke SN, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01740-2016; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Rosas-Salazar C, 2016, J INFECT DIS, V214, P1924, DOI 10.1093/infdis/jiw456; Sergushichev AA., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Sharma S, 2014, J ALLERGY CLIN IMMUN, V133, P1246, DOI 10.1016/j.jaci.2013.10.039; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Stewart CJ, 2017, AM J RESP CRIT CARE, V196, P882, DOI 10.1164/rccm.201701-0071OC; Stewart CJ, 2019, J INFECT DIS, V219, P2005, DOI 10.1093/infdis/jiz021; Turi KN, 2018, AM J RESP CRIT CARE, V198, P1064, DOI 10.1164/rccm.201711-2348OC; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wang CM, 2018, CELL MOL IMMUNOL, V15, P963, DOI 10.1038/cmi.2017.26; Wendell SG, 2014, J ALLERGY CLIN IMMUN, V133, P1255, DOI 10.1016/j.jaci.2013.12.1087; Zhu ZZ, 2019, EXPERT REV RESP MED, V13, P1135, DOI 10.1080/17476348.2019.1674650	53	8	8	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					102	112		10.1016/j.jaci.2021.05.036	http://dx.doi.org/10.1016/j.jaci.2021.05.036			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	34119532				2022-12-18	WOS:000744544500020
J	Lu, HY; Sharma, M; Sharma, AA; Lacson, A; Szpurko, A; Luider, J; Dharmani-Khan, P; Shameli, A; Bell, PA; Guilcher, GMT; Lewis, VA; Vasquez, MR; Desai, S; McGonigle, L; Murguia-Favela, L; Wright, NAM; Sergi, C; Wine, E; Overall, CM; Suresh, S; Turvey, SE				Lu, Henry Y.; Sharma, Mehul; Sharma, Ashish A.; Lacson, Atilano; Szpurko, Ashley; Luider, Joanne; Dharmani-Khan, Poonam; Shameli, Afshin; Bell, Peter A.; Guilcher, Gregory M. T.; Lewis, Victor A.; Vasquez, Marta Rojas; Desai, Sunil; McGonigle, Lyle; Murguia-Favela, Luis; Wright, Nicola A. M.; Sergi, Consolato; Wine, Eytan; Overall, Christopher M.; Suresh, Sneha; Turvey, Stuart E.			Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Combined immunodeficiency; CARD11; CBM complex; B-cell development; hematopoietic stem cell transplantation	NF-KAPPA-B; T-CELL-RECEPTOR; IMMUNE-RESPONSES; MALT1 MUTATION; JNK ACTIVATION; KINASE-BETA; CARMA1; DOMAIN; BCL10; PHOSPHORYLATION	Background: Germline pathogenic variants impairing the caspase recruitment domain family member 11 (CARD11)-B cell chronic lymphocytic leukemia/lymphoma 10 (BCL10)- MALT1 paracaspase (MALT1) (CBM) complex are associated with diverse human diseases including combined immunodeficiency (CID), atopy, and lymphoproliferation. However, the impact of CARD11 deficiency on human B-cell development, signaling, and function is incompletely understood. Objectives: This study sought to determine the cellular, immunological, and biochemical basis of disease for 2 unrelated patients who presented with profound CID associated with viral and fungal respiratory infections, interstitial lung disease, and severe colitis. Methods: Patients underwent next-generation sequencing, immunophenotyping by flow cytometry, signaling assays by immunoblot, and transcriptome profiling by RNA-sequencing. Results: Both patients carried identical novel pathogenic biallelic loss-of-function variants in CARD11 (c.2509C>T; p.Arg837*) leading to undetectable protein expression. This variant prevented CBM complex formation, severely impairing the activation of nuclear factor-kappa B, c-Jun N-terminal kinase, and MALT1 paracaspase activity in B and T cells. This functional defect resulted in a developmental block in B cells at the naive and type 1 transitional B-cell stage and impaired circulating T follicular helper cell (cT(FH)) development, which was associated with impaired antibody responses and absent germinal center structures on lymph node histology. Transcriptomics indicated that CARD11-dependent signaling is essential for immune signaling pathways involved in the development of these cells. Both patients underwent hematopoietic stem cell transplantations, which led to functional normalization. Conclusions: Complete human CARD11 deficiency causes profound CID by impairing naive/type 1 B-cell and cT(FH) cell development and abolishing activation of MALT1 paracaspase, NF-kappa B, and JNK activity. Hematopoietic stem cell transplantation functionally restores impaired signaling pathways.	[Lu, Henry Y.; Sharma, Mehul; Turvey, Stuart E.] Univ British Columbia, British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Lu, Henry Y.; Sharma, Mehul; Turvey, Stuart E.] Univ British Columbia, Fac Med, Expt Med Program, Vancouver, BC, Canada; [Bell, Peter A.; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Bell, Peter A.; Overall, Christopher M.] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC, Canada; [Sharma, Ashish A.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Lacson, Atilano; Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Vasquez, Marta Rojas; Desai, Sunil; Suresh, Sneha] Univ Alberta, Dept Pediat, Div Immunol Hematol Oncol & Palliat Care iHOPE, Edmonton, AB, Canada; [McGonigle, Lyle] Univ Alberta, Dept Pediat, Div Gen & Community Pediat, Edmonton, AB, Canada; [Wine, Eytan] Univ Alberta, Dept Pediat, Div Pediat Gastroenterol & Nutr, Edmonton, AB, Canada; [Szpurko, Ashley; Guilcher, Gregory M. T.; Lewis, Victor A.] Univ Calgary, Alberta Childrens Hosp, Sect Oncol Bone Marrow Therapy, Dept Oncol, Calgary, AB, Canada; [Szpurko, Ashley; Guilcher, Gregory M. T.; Lewis, Victor A.] Univ Calgary, Alberta Childrens Hosp, Sect Oncol Bone Marrow Therapy, Dept Pediat, Calgary, AB, Canada; [Murguia-Favela, Luis; Wright, Nicola A. M.] Univ Calgary, Alberta Childrens Hosp, Dept Pediat, Sect Pediat Hematol Immunol, Calgary, AB, Canada; [Luider, Joanne; Dharmani-Khan, Poonam; Shameli, Afshin] Univ Calgary, Alberta Precis Labs, Dept Pathol & Lab Med, Calgary, AB, Canada; [Sharma, Ashish A.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Case Western Reserve University; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; Emory University	Turvey, SE (corresponding author), British Columbia Childrens Hosp, 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	sturvey@cw.bc.ca	Lu, Henry/N-4567-2019; Turvey, Stuart/HGV-1191-2022	Lu, Henry/0000-0002-1645-7748; Turvey, Stuart/0000-0003-1599-1065	Canadian Institutes of Health Research [PJQ-173584, 148408]; Genome British Columbia [SIP007]; Canadian Allergy, Asthma and Immunology Foundation; Rare Disease Foundation [2918]; BC Children's Hospital Foundation; Canada Research Chair in Protease Proteomics and Systems Biology [950-20-3877]; CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS-D); Killam Doctoral Scholarship; Friedman Award for Scholars in Health; University of British Columbia Four Year Doctoral Fellowship (4YF); BC Children's Hospital Research Institute Graduate Studentship; CGS-D; 4YF	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome British Columbia; Canadian Allergy, Asthma and Immunology Foundation; Rare Disease Foundation; BC Children's Hospital Foundation; Canada Research Chair in Protease Proteomics and Systems Biology; CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS-D)(Canadian Institutes of Health Research (CIHR)); Killam Doctoral Scholarship; Friedman Award for Scholars in Health; University of British Columbia Four Year Doctoral Fellowship (4YF); BC Children's Hospital Research Institute Graduate Studentship; CGS-D; 4YF	This work was supported by grants from the Canadian Institutes of Health Research (PJQ-173584 to S.E.T. and 148408 to C.M.O.), Genome British Columbia (SIP007 to S.E.T.), the Canadian Allergy, Asthma and Immunology Foundation, Rare Disease Foundation (2918 to H.Y.L. and S.E.T.), and BC Children's Hospital Foundation. S.E.T. holds a Tier 1 Canada Research Chair in Pediatric Precision Health and the Aubrey J. Tingle Professor of Pediatric Immunology. C.M.O. holds a Canada Research Chair in Protease Proteomics and Systems Biology (#950-20-3877). H.Y.L. is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS-D), Killam Doctoral Scholarship, Friedman Award for Scholars in Health, University of British Columbia Four Year Doctoral Fellowship (4YF), and a BC Children's Hospital Research Institute Graduate Studentship. M.S. is supported by a CGS-D and 4YF.	Altin JA, 2011, J ALLERGY CLIN IMMUN, V127, P1277, DOI 10.1016/j.jaci.2010.12.1081; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Avery DT, 2018, J EXP MED, V215, P2073, DOI 10.1084/jem.20180010; Baens M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103774; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Bedsaul JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02105; Biggs CM, 2017, NAT GENET, V49, P1162, DOI 10.1038/ng.3925; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Bornancin F, 2015, J IMMUNOL, V194, P3723, DOI 10.4049/jimmunol.1402254; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; Braicu C, 2019, CANCERS, V11, DOI 10.3390/cancers11101618; Brohl AS, 2015, J CLIN IMMUNOL, V35, P32, DOI 10.1007/s10875-014-0106-4; Buchbinder D, 2015, J ALLERGY CLIN IMMUN, V136, P819, DOI 10.1016/j.jaci.2015.03.008; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Charbit-Henrion F, 2017, J PEDIATR GASTR NUTR, V64, P378, DOI 10.1097/MPG.0000000000001262; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dadi H, 2018, J ALLERGY CLIN IMMUN, V141, P1818, DOI 10.1016/j.jaci.2017.06.047; Demeyer A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01898; Desjardins M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02944; Di Pilato M, 2019, NATURE, V570, P112, DOI 10.1038/s41586-019-1215-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorjbal B, 2019, J ALLERGY CLIN IMMUN, V143, P1482, DOI 10.1016/j.jaci.2018.08.013; Frizinsky S, 2019, J CLIN IMMUNOL, V39, P401, DOI 10.1007/s10875-019-00629-0; Fuchs S, 2015, BLOOD, V126, P1658, DOI 10.1182/blood-2015-03-631374; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gewies A, 2014, CELL REP, V9, P1292, DOI 10.1016/j.celrep.2014.10.044; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Gupta M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01049; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hamilton KS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005169; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hui-Yuen J, 2011, JOVE-J VIS EXP, DOI 10.3791/3321; Jabara HH, 2013, J ALLERGY CLIN IMMUN, V132, P151, DOI 10.1016/j.jaci.2013.04.047; Jaworski M, 2014, EMBO J, V33, P2765, DOI 10.15252/embj.201488987; Juilland M, 2016, CURR OPIN HEMATOL, V23, P402, DOI 10.1097/MOH.0000000000000257; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kazanietz MG, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00471; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Kulpa DA, 2019, J VIROL, V93, DOI 10.1128/JVI.00969-19; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lee P, 2017, J IMMUNOL, V198, P1066, DOI 10.4049/jimmunol.1502518; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu HY, 2019, J ALLERGY CLIN IMMUN, V143, P1661, DOI 10.1016/j.jaci.2019.03.009; Lu HY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02078; Lu HY, 2018, PEDIAT ALLERG IMM-UK, V29, P663, DOI 10.1111/pai.12930; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Ma CA, 2017, NAT GENET, V49, P1192, DOI 10.1038/ng.3898; Torres JM, 2014, J CLIN INVEST, V124, P5239, DOI 10.1172/JCI77493; Martins TB, 2014, J ALLERGY CLIN IMMUN, V133, P589, DOI 10.1016/j.jaci.2013.08.037; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; McKinnon ML, 2014, J ALLERGY CLIN IMMUN, V133, P1458, DOI 10.1016/j.jaci.2013.10.045; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Outinen T, 2016, CLIN IMMUNOL, V165, P19, DOI 10.1016/j.clim.2016.02.002; Punwani D, 2015, J CLIN IMMUNOL, V35, P135, DOI 10.1007/s10875-014-0125-1; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosenbaum M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10203-2; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2019, NAT REV IMMUNOL, V19, P118, DOI 10.1038/s41577-018-0087-2; Schlauderer F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06573-8; Schmitt A, 2016, J INVEST DERMATOL, V136, P788, DOI 10.1016/j.jid.2015.12.027; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shields AM, 2020, J CLIN IMMUNOL, V40, P406, DOI 10.1007/s10875-019-00729-x; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Simon Q, 2016, J ALLERGY CLIN IMMUN, V137, P1577, DOI 10.1016/j.jaci.2015.09.014; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Stebegg M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02469; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Suryani S, 2010, BLOOD, V115, P519, DOI 10.1182/blood-2009-07-234799; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; Viisanen T, 2017, DIABETES, V66, P437, DOI 10.2337/db16-0714; Wang ZQ, 2019, J BIOL CHEM, V294, P14648, DOI 10.1074/jbc.RA119.009551; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Wei Z, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw5618; Wiegmann H, 2020, BRIT J DERMATOL, V182, P202, DOI 10.1111/bjd.18091; Wray-Dutra MN, 2018, J EXP MED, V215, P2445, DOI 10.1084/jem.20180230; Yamasoba D, 2019, NAT MICROBIOL, V4, P1532, DOI 10.1038/s41564-019-0460-3; Yang YK, 2016, J BIOL CHEM, V291, P25921, DOI 10.1074/jbc.M116.754028; Yu JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127083; Zhou Y, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02289-w	92	8	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1559	+		10.1016/j.jaci.2021.04.006	http://dx.doi.org/10.1016/j.jaci.2021.04.006		DEC 2021	29	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM7UO	33872653				2022-12-18	WOS:000729027300004
J	Nomura, T; Kabashima, K				Nomura, Takashi; Kabashima, Kenji			Advances in atopic dermatitis in 2019-2020: Endotypes from skin barrier, ethnicity, properties of antigen, cytokine profiles, microbiome, and engagement of immune cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; endotypes; haptens; protein antigens; racial differences; innate immunity; acquired immunity	ARYL-HYDROCARBON RECEPTOR; INNATE LYMPHOID-CELLS; KILLER T-CELLS; CONTACT HYPERSENSITIVITY; STAPHYLOCOCCUS-AUREUS; DISEASE; ACTIVATION; IMMUNOLOGY; PSORIASIS; DIFFERENTIATION	Key research advances in atopic dermatitis (AD) suggest the complexity of its endotypes. A comprehensive serum biomarker panel revealed at least 4 types of AD. Some represent classic TH2-dominant AD with filaggrin mutations commonly reported in Europeans, a simultaneously activated multipolar axis of cytokines often reported in Asian individuals, and an intrinsic type characterized by TH2 inferiority. Innate lymphoid cells, including natural killer cells, natural killer T cells, and fibroblasts, play a role in AD development and heterogeneity. Here, we discuss the endotypes of AD from the perspective of antigen types (hapten vs protein antigens), barrier function, and a novel set of immune cells. Endotypic stratification of AD may lead to the development of customized therapeutic strategies in the future. (J Allergy Clin Immunol 2021;148:1451-62.)	[Nomura, Takashi; Kabashima, Kenji] Kyoto Univ, Fac Med, Dept Dermatol, Kyoto, Japan	Kyoto University	Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawara, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp			Takeda Science Foundation; Ministry of Health, Labour and Welfare of Japan [R3-nanchi-ippan-081, 20FC1035]; KAKENHI [JSPS 20K08649]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Takeda Science Foundation, R3-nanchi-ippan-081 (Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan, grant no. 20FC1035), and Grants-in-Aid for Scientific Research (KAKENHI grant no. JSPS 20K08649).	Abuabara K, 2019, J ALLERGY CLIN IMMUN, V144, P710, DOI 10.1016/j.jaci.2019.05.040; Al Kindi A, 2021, J ALLERGY CLIN IMMUN, V147, P1354, DOI 10.1016/j.jaci.2020.09.023; Alexandraki KI, 2020, J EUR ACAD DERMATOL, V34, pE130, DOI 10.1111/jdv.16075; Alexis AF, 2019, J DRUGS DERMATOL, V18, P804; Ali Z, 2018, DERMATOLOGY, V234, P79, DOI 10.1159/000491593; Alkon N, 2022, J ALLERGY CLIN IMMUN, V149, P624, DOI 10.1016/j.jaci.2021.07.025; Almoguera B, 2019, J ALLERGY CLIN IMMUN, V143, P1229, DOI 10.1016/j.jaci.2018.10.038; Archer NK, 2019, J ALLERGY CLIN IMMUN, V143, P1426, DOI 10.1016/j.jaci.2018.08.042; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Ascott A, 2019, J ALLERGY CLIN IMMUN, V143, P1821, DOI 10.1016/j.jaci.2018.11.030; Bakker DS, 2021, J ALLERGY CLIN IMMUN, V147, P189, DOI 10.1016/j.jaci.2020.04.062; Bieber T, 2020, J ALLERGY CLIN IMMUN, V145, P489, DOI 10.1016/j.jaci.2019.12.012; Bissonnette R, 2019, J ALLERGY CLIN IMMUN, V144, P1274, DOI 10.1016/j.jaci.2019.06.047; Boothby IC, 2020, J ALLERGY CLIN IMMUN, V145, P1558, DOI 10.1016/j.jaci.2020.03.040; Brandt Eric B, 2011, J Clin Cell Immunol, V2; Brunner PM, 2019, J ALLERGY CLIN IMMUN, V143, P142, DOI 10.1016/j.jaci.2018.07.028; Brunner PM, 2017, J ALLERGY CLIN IMMUN, V139, pS65, DOI 10.1016/j.jaci.2017.01.011; Budu-Aggrey A, 2021, J ALLERGY CLIN IMMUN, V147, P400, DOI 10.1016/j.jaci.2020.04.050; Chan TC, 2018, J ALLERGY CLIN IMMUN, V142, P1013, DOI 10.1016/j.jaci.2018.06.016; CHRISTOPHERS E, 1987, ARCH DERMATOL RES, V279, pS48, DOI 10.1007/BF00585919; Clowry J, 2019, J ALLERGY CLIN IMMUN, V143, P78, DOI 10.1016/j.jaci.2018.08.038; Constantinides MG, 2018, J LEUKOCYTE BIOL, V103, P409, DOI 10.1002/JLB.3RI0917-378R; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Czarnowicki T, 2020, J ALLERGY CLIN IMMUN, V145, P215, DOI 10.1016/j.jaci.2019.09.031; Czarnowicki T, 2019, J ALLERGY CLIN IMMUN, V143, P1, DOI 10.1016/j.jaci.2018.10.032; Czarnowicki T, 2019, J ALLERGY CLIN IMMUN, V143, P2095, DOI 10.1016/j.jaci.2018.11.031; Czarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P104, DOI 10.1016/j.jaci.2015.01.020; Davidson WF, 2019, J ALLERGY CLIN IMMUN, V143, P894, DOI 10.1016/j.jaci.2019.01.003; de Wit J, 2019, J ALLERGY CLIN IMMUN, V144, P860, DOI 10.1016/j.jaci.2019.05.020; Ding XL, 2020, J ALLERGY CLIN IMMUN, V145, P283, DOI 10.1016/j.jaci.2019.07.033; Dorjbal B, 2019, J ALLERGY CLIN IMMUN, V143, P1482, DOI 10.1016/j.jaci.2018.08.013; Drucker AM, 2019, J ALLERGY CLIN IMMUN, V143, P1736, DOI 10.1016/j.jaci.2019.01.008; Elias MS, 2019, J ALLERGY CLIN IMMUN, V144, P470, DOI 10.1016/j.jaci.2019.05.024; Esaki H, 2015, J ALLERGY CLIN IMMUN, V135, P153, DOI 10.1016/j.jaci.2014.10.037; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Eyerich K, 2019, J ALLERGY CLIN IMMUN, V144, P1175, DOI 10.1016/j.jaci.2019.09.008; Eyerich K, 2019, J ALLERGY CLIN IMMUN, V143, P36, DOI 10.1016/j.jaci.2018.10.033; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Glickman JW, 2020, J ALLERGY CLIN IMMUN, V145, P1285, DOI 10.1016/j.jaci.2020.01.005; Godfrey DI, 2019, NAT IMMUNOL, V20, P1110, DOI 10.1038/s41590-019-0444-8; Golebski K, 2021, IMMUNITY, V54, P291, DOI 10.1016/j.immuni.2020.12.013; Guia S, 2020, TRENDS IMMUNOL, V41, P436, DOI 10.1016/j.it.2020.03.002; Guttman-Yassky E, 2020, J ALLERGY CLIN IMMUN, V145, P877, DOI 10.1016/j.jaci.2019.11.025; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V144, P482, DOI 10.1016/j.jaci.2018.11.053; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V143, P155, DOI 10.1016/j.jaci.2018.08.022; Hashimoto T, 2019, J ALLERGY CLIN IMMUN, V144, P375, DOI 10.1016/j.jaci.2019.04.005; He HL, 2020, J ALLERGY CLIN IMMUN, V145, P1615, DOI 10.1016/j.jaci.2020.01.042; Hijnen DJ, 2020, J ALLERGY CLIN IMMUN, V145, P1360, DOI 10.1016/j.jaci.2020.02.030; Holgado A, 2019, J ALLERGY CLIN IMMUN, V144, P204, DOI 10.1016/j.jaci.2019.02.028; Honda T, 2020, J ALLERGY CLIN IMMUN, V145, P1136, DOI 10.1016/j.jaci.2020.02.008; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Huang C, 2020, CLIN REV ALLERG IMMU, V59, P359, DOI 10.1007/s12016-019-08773-6; Hussain M, 2019, J ALLERGY CLIN IMMUN, V144, P157, DOI 10.1016/j.jaci.2019.01.043; Kabashima K, 2020, J ALLERGY CLIN IMMUN, V146, P276, DOI 10.1016/j.jaci.2020.04.052; Kabashima K, 2017, CURR OPIN IMMUNOL, V48, P99, DOI 10.1016/j.coi.2017.08.010; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kabashima-Kubo R, 2012, J DERMATOL SCI, V67, P37, DOI 10.1016/j.jdermsci.2012.04.004; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kasal DN, 2021, J EXP MED, V218, DOI 10.1084/jem.20200487; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Kim BS, 2020, J ALLERGY CLIN IMMUN, V145, P572, DOI 10.1016/j.jaci.2019.08.042; KITAGAKI H, 1995, J INVEST DERMATOL, V105, P749, DOI 10.1111/1523-1747.ep12325538; Kitagaki H, 1997, J IMMUNOL, V159, P2484; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kramer ON, 2017, CLIN DERMATOL, V35, P344, DOI 10.1016/j.clindermatol.2017.03.005; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kumar R, 2020, J ALLERGY CLIN IMMUN, V145, P108, DOI 10.1016/j.jaci.2019.11.008; Lee YS, 2020, J ALLERGY CLIN IMMUN, V146, P156, DOI 10.1016/j.jaci.2019.12.905; Leung DYM, 2020, J ALLERGY CLIN IMMUN, V145, P1485, DOI 10.1016/j.jaci.2020.02.021; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Leyva-Castillo JM, 2020, J ALLERGY CLIN IMMUN, V145, P1606, DOI 10.1016/j.jaci.2020.02.026; Liang YS, 2019, J ALLERGY CLIN IMMUN, V144, P1025, DOI 10.1016/j.jaci.2019.06.011; Liew WC, 2020, J ALLERGY CLIN IMMUN, V146, P606, DOI 10.1016/j.jaci.2020.02.007; Lowe KE, 2020, J ALLERGY CLIN IMMUN, V145, P563, DOI 10.1016/j.jaci.2019.09.015; Mack MR, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1005; Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92; Mahdavinia M, 2019, J ALLERGY CLIN IMMUN, V143, P1636, DOI 10.1016/j.jaci.2018.11.034; Malik K, 2019, J ALLERGY CLIN IMMUN, V143, P604, DOI 10.1016/j.jaci.2018.03.021; Marshall NB, 2010, ANN NY ACAD SCI, V1183, P25, DOI 10.1111/j.1749-6632.2009.05125.x; Matsumoto K, 2020, J ALLERGY CLIN IMMUN, V145, P1551, DOI 10.1016/j.jaci.2020.04.014; McFadden JP, 2011, CLIN EXP ALLERGY, V41, P327, DOI 10.1111/j.1365-2222.2010.03684.x; McFadden JP, 2009, TRENDS IMMUNOL, V30, P67, DOI 10.1016/j.it.2008.11.006; Meisser SS, 2020, J ALLERGY CLIN IMMUN, V145, P619, DOI 10.1016/j.jaci.2019.11.023; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Mohapatra SS, 2020, J ALLERGY CLIN IMMUN, V146, P72, DOI 10.1016/j.jaci.2020.04.039; Murase Y, 2019, J ALLERGY CLIN IMMUN, V143, P1656, DOI 10.1016/j.jaci.2018.11.044; Nakajima S, 2019, J ALLERGY CLIN IMMUN, V143, P13, DOI 10.1016/j.jaci.2018.11.014; Nakajima S, 2014, J INVEST DERMATOL, V134, P2122, DOI 10.1038/jid.2014.51; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Noda S, 2015, J ALLERGY CLIN IMMUN, V135, P324, DOI 10.1016/j.jaci.2014.11.015; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Nomura T, 2020, J ALLER CL IMM-PRACT, V8, P1840, DOI 10.1016/j.jaip.2020.02.022; Nomura T, 2018, INT IMMUNOL, V30, P419, DOI 10.1093/intimm/dxy015; Nomura T, 2014, J DERMATOL SCI, V76, P3, DOI 10.1016/j.jdermsci.2014.07.010; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P26, DOI 10.1016/j.jaci.2018.11.015; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P46, DOI 10.1016/j.jaci.2018.11.006; Papadopoulou M, 2020, IMMUNOL REV, V298, P99, DOI 10.1111/imr.12926; Park CO, 2013, EXP DERMATOL, V22, P6, DOI 10.1111/exd.12034; Parker ME, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00042; Pavel AB, 2019, J ALLERGY CLIN IMMUN, V144, P1011, DOI 10.1016/j.jaci.2019.07.013; Peled A, 2019, J ALLERGY CLIN IMMUN, V143, P173, DOI 10.1016/j.jaci.2018.09.002; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Reiger M, 2020, J ALLERGY CLIN IMMUN, V145, P93, DOI 10.1016/j.jaci.2019.11.004; Rothhammer V, 2019, NAT REV IMMUNOL, V19, P184, DOI 10.1038/s41577-019-0125-8; Sakata D, 2019, J ALLERGY CLIN IMMUN, V144, P1130, DOI 10.1016/j.jaci.2019.06.031; Sanyal RD, 2019, ANN ALLERG ASTHMA IM, V122, P99, DOI 10.1016/j.anai.2018.08.024; Sawada Y, 2019, J ALLERGY CLIN IMMUN, V144, P1265, DOI 10.1016/j.jaci.2019.06.036; Shalom G, 2020, J EUR ACAD DERMATOL, V34, pE131, DOI 10.1111/jdv.16072; Shalom G, 2019, J EUR ACAD DERMATOL, V33, P1762, DOI 10.1111/jdv.15642; Shimizuhira C, 2014, J INVEST DERMATOL, V134, P2709, DOI 10.1038/jid.2014.200; Shiratori-Hayashi M, 2021, J ALLERGY CLIN IMMUN, V147, P1341, DOI 10.1016/j.jaci.2020.06.039; Shiratori-Hayashi M, 2019, J ALLERGY CLIN IMMUN, V143, P1252, DOI 10.1016/j.jaci.2018.10.053; Silverberg JI, 2020, J ALLERGY CLIN IMMUN, V145, P173, DOI 10.1016/j.jaci.2019.08.013; Sozener ZC, 2020, J ALLERGY CLIN IMMUN, V145, P1517, DOI 10.1016/j.jaci.2020.04.024; Son JH, 2017, J KOREAN MED SCI, V32, P1360, DOI 10.3346/jkms.2017.32.8.1360; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stephenson W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02659-x; Stevens ML, 2020, J ALLERGY CLIN IMMUN, V146, P1442, DOI 10.1016/j.jaci.2020.04.004; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Sun ZW, 2021, J ALLERGY CLIN IMMUN, V147, P1764, DOI 10.1016/j.jaci.2020.11.049; Tauber M, 2016, J ALLERGY CLIN IMMUN, V137, P1272, DOI 10.1016/j.jaci.2015.07.052; Thaci D, 2019, J DERMATOL SCI, V94, P266, DOI 10.1016/j.jdermsci.2019.02.002; Thyssen JP, 2012, BRIT J DERMATOL, V166, P1255, DOI 10.1111/j.1365-2133.2012.10852.x; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Tsilochristou O, 2019, J ALLERGY CLIN IMMUN, V144, P494, DOI 10.1016/j.jaci.2019.04.025; Wen HC, 2018, J ALLERGY CLIN IMMUN, V142, P324, DOI 10.1016/j.jaci.2018.02.047; Werfel T, 2019, J ALLERGY CLIN IMMUN, V143, P1830, DOI 10.1016/j.jaci.2018.07.047; Withers DR, 2011, CURR BIOL, V21, pR381, DOI 10.1016/j.cub.2011.03.022; Wollenberg A, 2019, J ALLERGY CLIN IMMUN, V143, P135, DOI 10.1016/j.jaci.2018.05.029; Wu JN, 2020, EXPERT OPIN BIOL TH, V20, P525, DOI 10.1080/14712598.2020.1722998; Yang JM, 2020, J ALLERGY CLIN IMMUN, V146, P790, DOI 10.1016/j.jaci.2020.08.008; Yu JL, 2019, J ALLERGY CLIN IMMUN, V143, P2108, DOI 10.1016/j.jaci.2018.11.036; Zhou L, 2016, TRENDS IMMUNOL, V37, P17, DOI 10.1016/j.it.2015.11.007; Zhou LS, 2019, J ALLERGY CLIN IMMUN, V144, P144, DOI 10.1016/j.jaci.2019.01.015; Zimmermann P, 2019, J ALLERGY CLIN IMMUN, V143, P467, DOI 10.1016/j.jaci.2018.09.025	143	8	8	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1451	1462		10.1016/j.jaci.2021.10.022	http://dx.doi.org/10.1016/j.jaci.2021.10.022		DEC 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM1ZO	34756922				2022-12-18	WOS:000728634000009
J	Cook, Q; Argenio, K; Lovinsky-Desir, S				Cook, Quindelyn; Argenio, Kira; Lovinsky-Desir, Stephanie			The impact of environmental injustice and social determinants of health on the role of air pollution in asthma and allergic disease in the United States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Atopy; systemic racism; health equity; air quality; health disparities	EMERGENCY-DEPARTMENT VISITS; TOBACCO-SMOKE EXPOSURE; EARLY-LIFE EXPOSURE; CHILDHOOD ASTHMA; SOCIOECONOMIC-STATUS; RESIDENTIAL SEGREGATION; PERINATAL EXPOSURE; SECONDHAND SMOKE; LUNG DEVELOPMENT; STRESS AFFECTS	There is clear evidence that exposure to environmental air pollution is associated with immune dysregulation, asthma, and other allergic diseases. However, the burden of air pollution exposure is not equally distributed across the United States. Many social and environmental factors place communities of color and people who are in poverty at increased risk of exposure to pollution and morbidity from asthma and allergies. Here, we review the evidence that supports the relationship between air pollution and asthma, while considering the social determinants of health that contribute to disparities in exposures and outcomes. (J Allergy Clin Immunol 2021;148:1089-101.)	[Cook, Quindelyn] Boston Univ, Div Pediat Pulm & Allergy, Dept Pediat, Sch Med, Boston, MA USA; [Argenio, Kira; Lovinsky-Desir, Stephanie] Columbia Univ, Div Pediat Pulmonol, Coll Phys & Surg, Dept Pediat, New York, NY USA	Boston University; Columbia University	Lovinsky-Desir, S (corresponding author), 3959 Broadway CHC-745, New York, NY 10032 USA.	sl3230@cumc.columbia.edu		Lovinsky-Desir, Stephanie/0000-0003-2272-4387; Argenio, Kira/0000-0001-8272-2565	Amos Medical Faculty Development Award; National Institutes of Health [K01 HL140216]	Amos Medical Faculty Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Amos Medical Faculty Development Award, National Institutes of Health (grant no. K01 HL140216).	Alhanti BA, 2016, J EXPO SCI ENV EPID, V26, P180, DOI 10.1038/jes.2015.57; American Lung Association, 2021, STAT AIR 2021; Assari S, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020062; Astell-Burt T, 2013, HEALTH PLACE, V23, P171, DOI 10.1016/j.healthplace.2013.07.004; Becerra MB, 2021, J ASTHMA, V58, P248, DOI 10.1080/02770903.2019.1676435; Beck AF, 2016, JAMA PEDIATR, V170, P695, DOI 10.1001/jamapediatrics.2016.0269; Beck AF, 2014, PEDIATRICS, V133, P431, DOI 10.1542/peds.2013-2437; Belanger K, 2013, EPIDEMIOLOGY, V24, P320, DOI 10.1097/EDE.0b013e318280e2ac; Berkowitz SA, 2014, AM J MED, V127, P303, DOI 10.1016/j.amjmed.2014.01.002; Bilaver LA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3678; Bowatte G, 2015, ALLERGY, V70, P245, DOI 10.1111/all.12561; Bullard R.D., 1999, LOCAL ENVIRON, V4, P5, DOI DOI 10.1080/13549839908725577; Bullard RD, 1993, CONFRONTING ENV RACI; Burbank AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1, DOI 10.1016/j.jaci.2017.05.010; Cardet JC, 2018, J ALLERGY CLIN IMMUN, V141, P754, DOI 10.1016/j.jaci.2017.04.036; Castaneda AR, 2017, J TOXICOL ENV HEAL A, V80, P197, DOI 10.1080/15287394.2016.1222920; Chan MA, 2017, J ASTHMA, V54, P825, DOI 10.1080/02770903.2016.1265126; Chavez-Payan Paola, 2015, Hisp Health Care Int, V13, P119, DOI 10.1891/1540-4153.13.3.119; Chen E, 2017, J ALLERGY CLIN IMMUN, V140, P828, DOI 10.1016/j.jaci.2016.11.040; Chen E, 2016, PSYCHOSOM MED, V78, P1043, DOI 10.1097/PSY.0000000000000392; Ciaccio CE, 2013, CURR ALLERGY ASTHM R, V13, P687, DOI 10.1007/s11882-013-0389-1; Clark LP, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP959, 10.1289/ehp959]; Clougherty JE, 2009, ENVIRON HEALTH PERSP, V117, P1351, DOI 10.1289/ehp.0900612; Codispoti CD, 2015, ANN ALLERG ASTHMA IM, V114, P126, DOI 10.1016/j.anai.2014.10.020; Cremer NM, 2020, J ALLER CL IMM-PRACT, V8, P1294, DOI 10.1016/j.jaip.2019.12.014; Davis CM, 2021, J ALLERGY CLIN IMMUN, V147, P1579, DOI 10.1016/j.jaci.2021.02.034; Deng QH, 2016, RESP MED, V121, P67, DOI 10.1016/j.rmed.2016.10.016; Deng QH, 2016, ENVIRON RES, V150, P119, DOI 10.1016/j.envres.2016.05.050; DePriest K, 2018, J PEDIATR HEALTH CAR, V32, P600, DOI 10.1016/j.pedhc.2018.05.005; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Gaffney AW, 2021, JAMA INTERN MED, V181, P968, DOI 10.1001/jamainternmed.2021.2441; Garcia E, 2019, JAMA-J AM MED ASSOC, V321, P1906, DOI 10.1001/jama.2019.5357; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gharibi H, 2019, J ASTHMA, V56, P1037, DOI 10.1080/02770903.2018.1523930; Glad JA, 2012, ARCH ENVIRON OCCUP H, V67, P103, DOI 10.1080/19338244.2011.598888; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P3, DOI 10.1016/j.bbi.2004.06.003; Gostner JM, 2013, REDOX REP, V18, P88, DOI 10.1179/1351000213Y.0000000044; Gray SC, 2013, ENVIRON RES, V126, P152, DOI 10.1016/j.envres.2013.06.005; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Hassoun Y, 2019, CLIN REV ALLERG IMMU, V57, P403, DOI 10.1007/s12016-019-08730-3; Health Effects Institute, 2020, STATE GLOBAL AIR; Hew KM, 2015, CLIN EXP ALLERGY, V45, P238, DOI 10.1111/cea.12377; Homa DM, 2015, MMWR-MORBID MORTAL W, V64, P103; Hughes HK, 2017, ACAD PEDIATR, V17, P127, DOI 10.1016/j.acap.2016.11.011; Ippoliti F, 2006, PEDIAT ALLERG IMM-UK, V17, P337, DOI 10.1111/j.1399-3038.2006.00417.x; Isiugo K, 2019, SCI TOTAL ENVIRON, V663, P408, DOI 10.1016/j.scitotenv.2019.01.309; Jones MR, 2014, AM J PUBLIC HEALTH, V104, P2130, DOI 10.2105/AJPH.2014.302135; Kiecolt-Glaser JK, 2009, PSYCHONEUROENDOCRINO, V34, P670, DOI 10.1016/j.psyneuen.2008.11.010; Kim KH, 2013, ENVIRON INT, V59, P41, DOI 10.1016/j.envint.2013.05.007; Kim RY, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.37; Kramer U, 2009, J DERMATOL SCI, V56, P99, DOI 10.1016/j.jdermsci.2009.07.014; Kravitz-Wirtz N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061114; Kulig M, 1999, HUM EXP TOXICOL, V18, P241, DOI 10.1191/096032799678839987; Lannero E, 2008, THORAX, V63, P172, DOI 10.1136/thx.2007.079053; Lee A, 2018, J ALLERGY CLIN IMMUN, V141, P1880, DOI 10.1016/j.jaci.2017.07.017; Lee JY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010102; Lee YL, 2008, J INVEST DERMATOL, V128, P2412, DOI 10.1038/jid.2008.110; Li N, 2010, AM J PHYSIOL-LUNG C, V299, pL374, DOI 10.1152/ajplung.00115.2010; Li N, 2009, ENVIRON HEALTH PERSP, V117, P1116, DOI 10.1289/ehp.0800319; Li Z, 2019, ACAD PEDIATR, V19, P615, DOI 10.1016/j.acap.2019.03.010; Lovinsky-Desir S, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0364-0; Lu C, 2017, J DERMATOL SCI, V85, P85, DOI 10.1016/j.jdermsci.2016.11.004; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Manti S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8651820; Melen E, 2021, J ALLERGY CLIN IMMUN, V147, P713, DOI 10.1016/j.jaci.2020.08.030; Merianos AL, 2019, PREV MED, V123, P138, DOI 10.1016/j.ypmed.2019.03.028; Michney TM, 2020, J URBAN HIST, V46, P150, DOI 10.1177/0096144218819429; Miller GE, 2018, PEDIATR PULM, V53, P710, DOI 10.1002/ppul.23983; Moran TP, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00936-2; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Nachman KE, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-25; Nardone A, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0782-x; National Center for Environmental Health, 2020, MOST REC NAT ASTHM D; Nkoy Flory L, 2018, Hosp Pediatr, DOI 10.1542/hpeds.2017-0032; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; O'Lenick CR, 2017, J EPIDEMIOL COMMUN H, V71, P129, DOI 10.1136/jech-2015-206530; Oftedal B, 2007, CLIN EXP ALLERGY, V37, P1632, DOI 10.1111/j.1365-2222.2007.02823.x; Pate CA, 2020, J ASTHMA, V57, P1103, DOI 10.1080/02770903.2019.1640730; Pennington AF, 2018, EPIDEMIOLOGY, V29, P22, DOI [10.1097/EDE.0000000000000754, 10.1097/ede.0000000000000754]; Pfeffer PE, 2021, CHEST, V159, P1346, DOI 10.1016/j.chest.2020.10.053; Pierangeli I, 2020, ENVIRON RES, V186, DOI 10.1016/j.envres.2019.109067; Ramirez F, 1996, J IMMUNOL, V156, P2406; Ranciere F, 2017, ENVIRON HEALTH PERSP, V125, P737, DOI 10.1289/EHP239; Rider CF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0713-2; Rosa MJ, 2017, ANN ALLERG ASTHMA IM, V119, P232, DOI 10.1016/j.anai.2017.06.016; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Sbihi H, 2015, ENVIRON HEALTH PERSP, V123, P902, DOI 10.1289/ehp.1408700; Seibert RG., 2019, HLRP HLTH LITERACY R, V3, P9; Sheffield PE, 2019, J EPIDEMIOL COMMUN H, V73, P846, DOI 10.1136/jech-2018-211816; Simon AR, 1966, ATLANTIC; Sordillo JE, 2019, J ALLERGY CLIN IMMUN, V144, P1534, DOI 10.1016/j.jaci.2019.07.044; Sutherland MA, 2009, PHYSIOL BEHAV, V98, P281, DOI 10.1016/j.physbeh.2009.06.003; Tackett KJ, 2020, PEDIATR DERMATOL, V37, P142, DOI 10.1111/pde.14058; Tessum CW, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf4491; Thacher JD, 2016, ALLERGY, V71, P239, DOI 10.1111/all.12792; Thakur N, 2019, J ALLERGY CLIN IMMUN, V143, P1914, DOI 10.1016/j.jaci.2018.12.1015; Thakur N, 2017, CHEST, V151, P804, DOI 10.1016/j.chest.2016.11.027; Thurston GD, 2020, ANN AM THORAC SOC, V17, P387, DOI 10.1513/AnnalsATS.202001-046ST; U.S. Department of Health and Human Services, 2021, HLTH PEOPL 2030; United States Environmental Protection Agency, 2019, ENV JUST EJ 2020 GLO; Wang Z, 2015, ANN ALLERG ASTHMA IM, V115, P396, DOI 10.1016/j.anai.2015.08.005; Washington DM, 2018, J RACIAL ETHN HEALTH, V5, P928, DOI 10.1007/s40615-017-0441-2; Woo B, 2019, RACE SOC PROBL, V11, P60, DOI 10.1007/s12552-018-9254-0; Yu M, 2018, J ALLERGY CLIN IMMUN, V142, P1618, DOI 10.1016/j.jaci.2018.04.001; Zahran HS, 2015, J ASTHMA, V52, P318, DOI 10.3109/02770903.2014.956894; Zhang JJ, 2018, TOXICOL SCI, V164, P627, DOI 10.1093/toxsci/kfy127	113	8	8	10	21	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1089	+		10.1016/j.jaci.2021.09.018	http://dx.doi.org/10.1016/j.jaci.2021.09.018		NOV 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	WV7LX	34743831	Bronze			2022-12-18	WOS:000717415000001
J	Vaseghi-Shanjani, M; Smith, KL; Sara, RJ; Modi, BP; Branch, A; Sharma, M; Lu, HY; James, EL; Hildebrand, KJ; Biggs, CM; Turvey, SE				Vaseghi-Shanjani, Maryam; Smith, Kelsey L.; Sara, Rahnuma J.; Modi, Bhavi P.; Branch, Anna; Sharma, Mehul; Lu, Henry Y.; James, Elliot L.; Hildebrand, Kyla J.; Biggs, Catherine M.; Turvey, Stuart E.			Inborn errors of immunity manifesting as atopic disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Primary atopic disorders; inborn errors of immunity; primary immunodeficiencies; monogenic atopy; monogenic allergic diseases; allergy; genetics	SERINE-PROTEASE INHIBITOR; PRIMARY IMMUNODEFICIENCY DISEASES; GROWTH-HORMONE INSENSITIVITY; T-CELLS; DERMATITIS; MUTATIONS; SPINK5; ASSOCIATION; DIFFERENTIATION; POLYMORPHISMS	Inborn errors of immunity are traditionally best known for enhancing susceptibility to infections. However, allergic inflammation, among other types of immune dysregulation, occurs frequently in patients with inborn errors of immunity. As such, the term primary atopic disorders (PADs) was recently coined to describe the group of heritable monogenic allergic disorders. It is becoming increasingly important for clinicians to recognize that allergic diseases such as food allergy, atopic dermatitis, and allergic asthma are expressions of misdirected immunity, and in patients who present with severe, early-onset, or coexisting allergic conditions, these can be indications of an underlying PAD. Identifying monogenic allergic disease through next-generation sequencing can dramatically improve outcomes by allowing the use of precision-based therapy targeting the patient's underlying molecular defect. It is therefore imperative that clinicians recognize PADs to be able to provide informed therapeutic options and improve patient outcomes. Here, we summarize the clinical features commonly seen with each of the currently known PADs, identify clinical warning signs that warrant assessment for PADs, and lastly, discuss the benefits of timely diagnosis and management of these conditions. (J Allergy Clin Immunol 2021;148:1130-9.)	[Vaseghi-Shanjani, Maryam; Smith, Kelsey L.; Sara, Rahnuma J.; Modi, Bhavi P.; Branch, Anna; Sharma, Mehul; Lu, Henry Y.; James, Elliot L.; Hildebrand, Kyla J.; Biggs, Catherine M.; Turvey, Stuart E.] British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Vaseghi-Shanjani, Maryam; Sharma, Mehul; Turvey, Stuart E.] Univ British Columbia, Expt Med Program, Fac Med, Vancouver, BC, Canada; [Branch, Anna] Western Univ, Schulich Sch Med & Dent, London, ON, Canada	BC Childrens Hospital; University of British Columbia; University of British Columbia; Western University (University of Western Ontario)	Biggs, CM; Turvey, SE (corresponding author), BC Childrens Hosp, 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cbiggs@bcchr.ca; sturvey@cw.bc.ca	Turvey, Stuart/HGV-1191-2022; Lu, Henry/N-4567-2019; Vaseghi-Shanjani, Maryam/HDN-0218-2022	Lu, Henry/0000-0002-1645-7748; Hildebrand, Kyla/0000-0003-3825-8202; Turvey, Stuart/0000-0003-1599-1065; Biggs, Catherine/0000-0002-4363-2660	Canadian Institutes of Health Research (CIHR) [PJQ-173584]; Genome British Columbia, Canada; Canadian Institutes of Health Research, Canada [SIP007]; Tier 1 Canada Research Chair in Pediatric Precision Health; Providence Healthcare Research Institute Early Career Investigator award; Clinical & Translational Research Seed Grant from the BC Children's Hospital Research Institute; Vanier Canada Graduate Scholarship; University of British Columbia 4Year Doctoral Fellowship (4YF); Canadian Society of Allergy and Clinical Immunology Summer Studentship; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award; 4YF; CIHR Canada Graduate Scholarships Doctoral Award; Killam Doctoral Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome British Columbia, Canada; Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair in Pediatric Precision Health; Providence Healthcare Research Institute Early Career Investigator award; Clinical & Translational Research Seed Grant from the BC Children's Hospital Research Institute; Vanier Canada Graduate Scholarship; University of British Columbia 4Year Doctoral Fellowship (4YF); Canadian Society of Allergy and Clinical Immunology Summer Studentship; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR)); 4YF; CIHR Canada Graduate Scholarships Doctoral Award(Canadian Institutes of Health Research (CIHR)); Killam Doctoral Scholarship	Supported by the Canadian Institutes of Health Research (CIHR) (grant PJQ-173584 [to S.E.T.]) and Genome British Columbia, Canada; Canadian Institutes of Health Research, Canada (grant SIP007 [to S.E.T.]). S.E.T. holds a Tier 1 Canada Research Chair in Pediatric Precision Health and is the Aubrey J. Tingle Professor of Pediatric Immunology. C.M.B. is a health professional-investigator of the Michael Smith Foundation for Health Research and is supported by the Providence Healthcare Research Institute Early Career Investigator award and the Clinical & Translational Research Seed Grant from the BC Children's Hospital Research Institute. M.V.S. is funded by the Vanier Canada Graduate Scholarship and the University of British Columbia 4Year Doctoral Fellowship (4YF). K.L.S is funded by the Canadian Society of Allergy and Clinical Immunology Summer Studentship. M.S. is funded by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award and 4YF. H.Y.L is funded by a CIHR Canada Graduate Scholarships Doctoral Award, Killam Doctoral Scholarship, and 4YF. B.P.M is supported by the Clinical & Translational Research Seed Grant from the BC Children's Hospital Research Institute.	Aghamohammadi A, 2014, ALLERGOL IMMUNOPATH, V42, P336, DOI 10.1016/j.aller.2013.02.004; Al-Shaikhly T, 2019, IMMUNOL CELL BIOL, V97, P368, DOI 10.1111/imcb.12209; Aleman K, 2001, EUR J PEDIATR, V160, P718, DOI 10.1007/s004310100816; Arellano B, 2016, DISCOV MED, V22, P73; Asano T, 2021, J EXP MED, V218, DOI 10.1084/jem.20202592; Ashley SE, 2017, ALLERGY, V72, P1356, DOI 10.1111/all.13143; Aydin SE, 2015, J CLIN IMMUNOL, V35, P189, DOI 10.1007/s10875-014-0126-0; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Beziat V, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4956; Biggs CM, 2017, NAT GENET, V49, P1162, DOI 10.1038/ng.3925; Biggs CM, 2017, CLIN IMMUNOL, V181, P75, DOI 10.1016/j.clim.2017.06.003; Boisson B, 2020, HUM GENET, V139, P981, DOI 10.1007/s00439-020-02111-z; Bousfiha AA, 2013, J CLIN IMMUNOL, V33, P1, DOI 10.1007/s10875-012-9751-7; Boyarchuk O, 2018, ASIAN J PHARM CLIN R, V11, P83; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Buchbinder D, 2019, J CLIN IMMUNOL, V39, P592, DOI 10.1007/s10875-019-00663-y; Buchbinder D, 2014, APPL CLIN GENET, V7, P55, DOI 10.2147/TACG.S58444; Chapel H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00627; Charbit-Henrion F, 2017, J PEDIATR GASTR NUTR, V64, P378, DOI 10.1097/MPG.0000000000001262; Charvet E, 2021, CLIN EXP DERMATOL, V46, P1334, DOI 10.1111/ced.14686; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cirillo F, 2018, CYTOKINE GROWTH F R, V39, P1, DOI 10.1016/j.cytogfr.2017.12.004; Neto AC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01439; Dadi H, 2018, J ALLERGY CLIN IMMUN, V141, P1818, DOI 10.1016/j.jaci.2017.06.047; de Wit J, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0273-8; Del Bel KL, 2017, J ALLERGY CLIN IMMUN, V139, P2016, DOI 10.1016/j.jaci.2016.12.957; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Desjardins M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02944; Dorjbal B, 2019, J ALLERGY CLIN IMMUN, V143, P1482, DOI 10.1016/j.jaci.2018.08.013; Eisenberg R, 2021, J ALLER CL IMM-PRACT, V9, P1008, DOI 10.1016/j.jaip.2020.11.050; Ferrua F, 2019, LANCET HAEMATOL, V6, pE239, DOI 10.1016/S2352-3026(19)30021-3; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gruber CN, 2020, IMMUNITY, V53, P672, DOI 10.1016/j.immuni.2020.07.006; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hwa V, 2007, HORM RES, V68, P218, DOI 10.1159/000101334; Jamee M, 2020, J ALLER CL IMM-PRACT, V8, P2747, DOI 10.1016/j.jaip.2020.04.070; Kabesch M, 2004, CLIN EXP ALLERGY, V34, P340, DOI 10.1111/j.1365-2222.2004.01860.x; Kahr WHA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14816; Kato A, 2003, BRIT J DERMATOL, V148, P665, DOI 10.1046/j.1365-2133.2003.05243.x; Kato Masahiko, 2006, Allergol Int, V55, P115, DOI 10.2332/allergolint.55.115; Kuijpers TW, 2017, J ALLERGY CLIN IMMUN, V140, P273, DOI 10.1016/j.jaci.2016.09.061; Lehman H, 2019, J ALLER CL IMM-PRACT, V7, P788, DOI 10.1016/j.jaip.2018.11.026; Lu HY, 2021, CURR OPIN IMMUNOL, V72, P11, DOI 10.1016/j.coi.2021.02.008; Lu HY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02078; Lyons JJ, 2017, J EXP MED, V214, P669, DOI 10.1084/jem.20161435; Lyons JJ, 2019, IMMUNOL REV, V287, P135, DOI 10.1111/imr.12727; Lyons JJ, 2018, J EXP MED, V215, P1009, DOI 10.1084/jem.20172306; Ma CA, 2017, NAT GENET, V49, P1192, DOI 10.1038/ng.3898; Martinez-Aguilar NE, 2015, J ASTHMA, V52, P232, DOI 10.3109/02770903.2014.966913; McKinnon ML, 2014, J ALLERGY CLIN IMMUN, V133, P1458, DOI 10.1016/j.jaci.2013.10.045; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Milner JD, 2020, ANNU REV IMMUNOL, V38, P785, DOI 10.1146/annurev-immunol-042718-041553; Momtazmanesh S, 2022, ENDOCR METAB IMMUNE, V22, P159, DOI 10.2174/1871530321666210226143912; Myers JMB, 2014, J ALLERGY CLIN IMMUN, V134, P891, DOI 10.1016/j.jaci.2014.03.037; Ochs HD, 2009, BIOL BLOOD MARROW TR, V15, P84, DOI 10.1016/j.bbmt.2008.10.007; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; Perrett KP, 2020, LANCET, V395, P923, DOI 10.1016/S0140-6736(19)33174-5; Pillay BA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127527; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Punwani D, 2015, J CLIN IMMUNOL, V35, P135, DOI 10.1007/s10875-014-0125-1; Quancard J, 2019, NAT CHEM BIOL, V15, P304, DOI 10.1038/s41589-018-0222-1; Rozmus J, 2016, CLIN IMMUNOL, V168, P1, DOI 10.1016/j.clim.2016.04.011; Rudilla F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02325; Sacco KA, 2019, CURR OPIN IMMUNOL, V60, P148, DOI 10.1016/j.coi.2019.06.002; Shitara K, 2018, ANN NY ACAD SCI, V1417, P104, DOI 10.1111/nyas.13625; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005; Su HC, 2019, IMMUNOL REV, V287, P9, DOI 10.1111/imr.12723; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Torgerson TR, 2007, GASTROENTEROLOGY, V132, P1705, DOI 10.1053/j.gastro.2007.02.044; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Turvey SE, 2009, POSTGRAD MED J, V85, P660, DOI 10.1136/pgmj.2009.080630; van Zwol A, 2011, PAEDIATR PERINAT EP, V25, P60, DOI 10.1111/j.1365-3016.2010.01173.x; Villa A, 2008, J ALLERGY CLIN IMMUN, V122, P1082, DOI 10.1016/j.jaci.2008.09.037; Volpi S, 2019, J ALLERGY CLIN IMMUN, V143, P2296, DOI 10.1016/j.jaci.2019.02.003; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728	79	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1130	1139		10.1016/j.jaci.2021.08.008	http://dx.doi.org/10.1016/j.jaci.2021.08.008		NOV 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	34428518				2022-12-18	WOS:000717415000005
J	Berin, MC; Lozano-Ojalvo, D; Agashe, C; Baker, MG; Bird, JA; Nowak-Wegrzyn, A				Berin, M. Cecilia; Lozano-Ojalvo, Daniel; Agashe, Charuta; Baker, Mary Grace; Bird, J. Andrew; Nowak-Wegrzyn, Anna			Acute FPIES reactions are associated with an IL-17 inflammatory signature	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food protein-induced enterocolitis syndrome; FPIES; oral food challenge; proteomics; T(H)17 cells; STAT3; inflammation; innate immunity; mucosal barrier	PROTEIN-INDUCED ENTEROCOLITIS; DELTA T-CELLS; ALLERGY; ACTIVATION; RESPONSES; CD4(+)	Background: Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE-mediated food allergy characterized by profuse vomiting within hours of ingestion of the causative food. We have previously reported that FPIES is associated with systemic innate immune activation in the absence of a detectable antigen-specific antibody or T-cell response. The mechanism of specific food recognition by the immune system remains unclear. Objective: Our aim was to identify immune mechanisms underlying FPIES reactions by proteomic and flow cytometric analysis of peripheral blood. Methods: Children with a history of FPIES underwent supervised oral food challenge. Blood samples were taken at baseline, at symptom onset, and 4 hours after symptom onset. We analyzed samples from 23 children (11 reactors and 12 outgrown). A total of 184 protein markers were analyzed by proximity ligation assay and verified by multiplex immunoassay. Analysis of cell subset activation was performed by mass cytometry and spectral cytometry. Results: Symptomatic FPIES challenge results were associated with significant elevation of levels of cytokines and chemokines, including IL-17 family markers (IL-17A, IL-22, IL-17C, and CCL20) and T-cell activation (IL-2), and innate inflammatory markers (IL-8, oncostatin M, leukemia inhibitory factor, TNF-alpha, IL-10, and IL-6).The level of the mucosal damage marker regenerating family member 1 alpha (REG1A) was also significantly increased. These biomarkers were not increased in asymptomatic challenges or IgE-mediated allergy. The level of phospho-STAT3 was significantly elevated in myeloid and T cells after challenge in individuals with symptoms. Mass cytometry indicated preferential activation of nonconventional T-cell populations, including gamma delta T cells and CD3(+)CD4-CD8-CD161(+) cells; however, the potential sources of IL-17 in PBMCs were primarily CD4(+) T(H)17 cells. Conclusions: These results demonstrate a unique IL-17 signature and activation of innate lymphocytes in FPIES.	[Berin, M. Cecilia; Lozano-Ojalvo, Daniel; Agashe, Charuta; Baker, Mary Grace] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Bird, J. Andrew] Univ Texas Southwestern Med Ctr Dallas, Div Allergy & Immunol, Dept Pediat, Dallas, TX USA; [Nowak-Wegrzyn, Anna] NYU, Hassenfeld Childrens Hosp, Dept Pediat, Grossman Sch Med, New York, NY USA; [Nowak-Wegrzyn, Anna] Univ Warmia & Mazury, Dept Pediat Gastroenterol & Nutr, Coll Med, Olsztyn, Poland	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; New York University; University of Warmia & Mazury	Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, 1425 Madison Ave,11-23A, New York, NY 10029 USA.	cecilia.berin@mssm.edu	Agashe, Charuta/AFP-8581-2022; Agashe, Charuta/AAF-3847-2020	Agashe, Charuta/0000-0001-8820-8655; Nowak-Wegrzyn, Anna/0000-0002-0960-9854; Baker, Mary Grace/0000-0001-7121-3271; berin, cecilia/0000-0002-9051-9249; Lozano-Ojalvo, Daniel/0000-0002-3524-2929	Katy and Kyle Miller Family Fund; National Institutes of Health [AI136053, AI151707]; Louis and Rachel Rudin Foundation; National Institutes of Health-National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases	Katy and Kyle Miller Family Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louis and Rachel Rudin Foundation; National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded in part by the Katy and Kyle Miller Family Fund, the National Institutes of Health (grants AI136053 and AI151707), the Louis and Rachel Rudin Foundation (to M.G.B.), and the National Institutes of Health-National Institute of Allergy and Infectious Diseases (to J.A.B.). A. Nowak-Wegrzyn received research support from the National Institute of Allergy and Infectious Diseases.	Adel-Patient K, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0224-9; Bartolome-Casado R, 2021, MUCOSAL IMMUNOL, V14, P402, DOI 10.1038/s41385-020-0315-5; Berin MC, 2018, J ALLERGY CLIN IMMUN, V142, P149, DOI 10.1016/j.jaci.2018.01.044; Caubet JC, 2017, J ALLERGY CLIN IMMUN, V139, P572, DOI 10.1016/j.jaci.2016.02.047; Caubet JC, 2014, J ALLERGY CLIN IMMUN, V134, P382, DOI 10.1016/j.jaci.2014.04.008; Chiang D, 2018, J ALLERGY CLIN IMMUN, V141, P2107, DOI 10.1016/j.jaci.2017.11.060; Du Y, 2018, ANN ALLERG ASTHMA IM, V121, P736; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Goswami R, 2017, J ALLERGY CLIN IMMUN, V139, P1885, DOI 10.1016/j.jaci.2016.12.971; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Kimura M, 2017, ALLERGOL INT, V66, P452, DOI 10.1016/j.alit.2016.12.001; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mehr S, 2019, J ALLERGY CLIN IMMUN, V144, P600, DOI 10.1016/j.jaci.2019.04.021; Mehr S, 2017, J ALLERGY CLIN IMMUN, V140, P1323, DOI 10.1016/j.jaci.2017.03.027; Montaldo E, 2015, EUR J IMMUNOL, V45, P2171, DOI 10.1002/eji.201545598; Morita H, 2013, J ALLERGY CLIN IMMUN, V131, P590, DOI 10.1016/j.jaci.2012.09.005; Nowak-Wegrzyn A, 2017, J ALLERGY CLIN IMMUN, V139, P1111, DOI 10.1016/j.jaci.2016.12.966; Ruffner MA, 2013, J ALLER CL IMM-PRACT, V1, P343, DOI 10.1016/j.jaip.2013.05.011; Sarna VK, 2018, GUT, V67, P1606, DOI 10.1136/gutjnl-2017-314461	20	8	8	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					895	+		10.1016/j.jaci.2021.04.012	http://dx.doi.org/10.1016/j.jaci.2021.04.012		SEP 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UM1AT	33891982	Green Accepted			2022-12-18	WOS:000693072000003
J	Hirano, T; Honda, T; Kanameishi, S; Honda, Y; Egawa, G; Kitoh, A; Nakajima, S; Otsuka, A; Nomura, T; Dainichi, T; Yaguchi, T; Inozume, T; Kataoka, TR; Tamada, K; Kabashima, K				Hirano, Tomoko; Honda, Tetsuya; Kanameishi, Shuto; Honda, Yuki; Egawa, Gyohei; Kitoh, Akihiko; Nakajima, Saeko; Otsuka, Atsushi; Nomura, Takashi; Dainichi, Teruki; Yaguchi, Tomonori; Inozume, Takashi; Kataoka, Tatsuki R.; Tamada, Koji; Kabashima, Kenji			PD-L1 on mast cells suppresses effector CD8(+) T-cell activation in the skin in murine contact hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Contact hypersensitivity; mast cell; PD-1; PD-L1	DENDRITIC CELLS; B7 FAMILY; B7-H1; IMMUNOTHERAPY; EXPRESSION; MOLECULES; BLOCKADE; HAPTEN; MEMBER	Background: The programmed cell death-1 (PD-1)/programmed death ligand 1 (PD-L1) pathway is known to inhibit the activation of effector CD8(+) T cells. However, just how this regulatory pathway is involved in the pathophysiology of CD8(+) T-cell-mediated inflammatory skin diseases remains unclear. Objective: Our aim was to elucidate the mechanisms by which the PD-1/PD-L1 pathway exerts its regulatory roles in CD8(+) T-cell-mediated cutaneous immune responses. Methods: PD-L1-deficient (Pdl1(-/-)) mice were used for the murine contact hypersensitivity model. Inflammatory responses such as IFN-gamma production from CD8(+) T cells in the skin was evaluated by flow cytometry. Results: Compared with wild-type mice, Pdl1(-/-) mice exhibited exacerbated ear swelling and increased numbers of IFN-gamma(+) CD8(+) T cells in the skin. Adoptive T-cell transfer experiments revealed the involvement of the PD-1/PD-L1 pathway in the elicitation phase of contact hypersensitivity. Bone marrow chimera experiments showed that PD-L1 on radioresistant cells was responsible for this regulatory pathway. Flow cytometric analysis revealed that among the radioresistant cells in the skin, PD-L1 was most highly expressed on mast cells (MCs) before and after elicitation. Administration of anti-PD-L1 blocking antibody during the elicitation phase significantly enhanced ear swelling responses and increased the number of IFN-gamma(+)CD8(+) T cells in the skin of wild-type mice, whereas no significant effects were observed in MC-deficient (WBB6F1/J-Kit(W)/Kit(W-v)/J and C57BL/6-KitW(-sh)/W-sh) mice. The high level of expression of PD-L1 on human skin MCs was confirmed by database analysis and immunohistochemical analysis. Conclusion: PD-L1 on MCs negatively regulates CD8(+) T-cell activation in the skin.	[Hirano, Tomoko; Honda, Tetsuya; Kanameishi, Shuto; Honda, Yuki; Egawa, Gyohei; Kitoh, Akihiko; Nakajima, Saeko; Otsuka, Atsushi; Nomura, Takashi; Dainichi, Teruki; Kabashima, Kenji] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto, Japan; [Yaguchi, Tomonori] Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Kyoto, Japan; [Kataoka, Tatsuki R.] Kyoto Univ, Dept Pathol, Grad Sch Med, Kyoto, Japan; [Honda, Tetsuya] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan; [Yaguchi, Tomonori] Keio Univ, Inst Adv Med Res, Div Cellular Signaling, Sch Med, Tokyo, Japan; [Inozume, Takashi] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba, Japan; [Tamada, Koji] Yamaguchi Univ, Dept Immunol, Grad Sch Med, Yamaguchi, Japan; [Kabashima, Kenji] Agcy Sci Technol & Res, Biopolis, Singapore Immunol Network SIgN, Singapore, Singapore; [Kabashima, Kenji] Agcy Sci Technol & Res, Biopolis, Skin Res Inst Singapore, Singapore, Singapore	Kyoto University; Kyoto University; Kyoto University; Hamamatsu University School of Medicine; Keio University; Chiba University; Yamaguchi University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS)	Hirano, T; Kabashima, K (corresponding author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	hontetsu@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp		Nakajima, Saeko/0000-0003-0831-1447	Japan Society for the Promotion of Science [JP19K08790, JP15H05906, 263395]; Japan Agency for Medical Research and Development [19ek0410062s0201, 16ek0410011h0003, 16he0902003h0002]; Takeda Science Foundation; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) [JP19gm1210006];  [15H05790];  [15H1155];  [15K15417];  [JP15H05897]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Advanced Research and Development Programs for Medical Innovation (AMED-CREST); ; ; ; 	Supported by the Japan Society for the Promotion of Science (grants JP19K08790 and JP15H05906 [to T.H.] and 263395 [to K.K.]), Grants-in-Aid for Scientific Research (grants 15H05790, 15H1155, and 15K15417 [to K.K.] and JP15H05897), the Japan Agency for Medical Research and Development (grants 19ek0410062s0201 [to T.H.] and 16ek0410011h0003 and 16he0902003h0002 [to K.K.]), the Takeda Science Foundation (to K.K.), and the Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (grant JP19gm1210006 [to K.K.]).	Abugessaisa I, 2016, DATABASE OXFORD, V2016, P1; Bertolini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094260; Blighe K., 2020, ENHANCEDVOLCANO PUBL, DOI DOI 10.1186/1471-2105-14-128; Coleman E, 2019, J AM ACAD DERMATOL, V80, P990, DOI 10.1016/j.jaad.2018.10.062; Coleman EL, 2020, CLIN DERMATOL, V38, P94, DOI 10.1016/j.clindermatol.2019.10.015; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Dong HD, 1999, NAT MED, V5, P1365; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dudeck J, 2017, J EXP MED, V214, P3791, DOI 10.1084/jem.20160783; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Galli SJ, 2018, J ALLERGY CLIN IMMUN, V141, P92, DOI 10.1016/j.jaci.2017.05.029; Gamradt P, 2019, J ALLERGY CLIN IMMUN, V143, P2147, DOI 10.1016/j.jaci.2018.11.048; Goldinger SM, 2016, CLIN CANCER RES, V22, P4023, DOI 10.1158/1078-0432.CCR-15-2872; Griffin Liezel L, 2018, JAAD Case Rep, V4, P229, DOI 10.1016/j.jdcr.2017.09.028; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hofmann L, 2016, EUR J CANCER, V60, P190, DOI 10.1016/j.ejca.2016.02.025; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Iwai Y, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0329-9; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kabashima K, 2019, NAT REV IMMUNOL, V19, P19, DOI 10.1038/s41577-018-0084-5; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim HK, 2006, J LEUKOCYTE BIOL, V79, P686, DOI 10.1189/jlb.0805436; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Laidlaw TM, 2011, J ALLERGY CLIN IMMUN, V127, P815, DOI 10.1016/j.jaci.2010.12.1101; Lizio M, 2019, NUCLEIC ACIDS RES, V47, pD752, DOI 10.1093/nar/gky1099; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Lv YP, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0530-3; Mori T, 2008, J INVEST DERMATOL, V128, P1719, DOI 10.1038/jid.2008.5; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nakashima D, 2008, J INVEST DERMATOL, V128, P2833, DOI 10.1038/jid.2008.174; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ogawa T, 2019, ALLERGY, V74, P2257, DOI 10.1111/all.13853; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Okiyama N, 2014, J AUTOIMMUN, V53, P1, DOI 10.1016/j.jaut.2014.06.005; Ono S, 2015, EXP DERMATOL, V24, P630, DOI 10.1111/exd.12716; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ritprajak P, 2010, J IMMUNOL, V184, P4918, DOI 10.4049/jimmunol.0902478; Saw S, 2017, EUR J CANCER, V81, P237, DOI 10.1016/j.ejca.2017.03.026; Sawada Y, 2015, J EXP MED, V212, P1921, DOI 10.1084/jem.20150381; Seidel JA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00086; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Sumpter TL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123947; Takimoto R, 2019, EUR J DERMATOL, V29, P228, DOI 10.1684/ejd.2019.3522; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Tattersall IW, 2020, YALE J BIOL MED, V93, P123; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsushima F, 2003, EUR J IMMUNOL, V33, P2773, DOI 10.1002/eji.200324084; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819	54	8	8	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					563	+		10.1016/j.jaci.2020.12.654	http://dx.doi.org/10.1016/j.jaci.2020.12.654		AUG 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33581199				2022-12-18	WOS:000687104900008
J	Gracias, DT; Sethi, GS; Mehta, AK; Miki, H; Gupta, RK; Yagita, H; Croft, M				Gracias, Donald T.; Sethi, Gurupreet S.; Mehta, Amit K.; Miki, Haruka; Gupta, Rinkesh K.; Yagita, Hideo; Croft, Michael			Combination blockade of OX40L and CD30L inhibits allergen-driven memory T(H)2 cell reactivity and lung inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen; T(H)2 cell; TNF family; OX40L; CD30L; memory; asthma	CD4(+) T-CELLS; INNATE LYMPHOID-CELLS; DENDRITIC CELLS; TNFR FAMILY; ASTHMA; RESPONSES; MICE; MECHANISMS; EXPRESSION; IMMUNITY	Background: The selective reduction of memory T(H)2 cell responses could be key to affording tolerance and protection from the recurrence of damaging allergic pathology. Objective: We asked whether TNF family costimulatory molecules cooperated to promote accumulation and reactivity of effector memory CD4 T cells to inhaled complex allergen, and whether their neutralization could promote airway tolerance to subsequent reexposure to allergen. Methods: Mice were sensitized intraperitoneally or intranasally with house dust mite and challenged with intranasal allergen after memory had developed. We assessed whether single or combined blockade of OX40L/CD252 and CD30L/CD153 inhibited memory T cells from driving acute asthmatic lung inflammation and protected mice following exposure to allergen at a later time. Results: OX40- or CD30-deficient animals showed strong or partial protection against allergic airway inflammation; however, neutralizing either molecule alone during the secondary response to allergen had little effect on the frequency of effector memory CD4 T cells formed and acute lung inflammation. In contrast, a significant reduction in eosinophilic inflammation was observed when OX40L and CD30L were simultaneously neutralized, with dual blockade inhibiting effector memory T(H)2 cell expansion in the lungs, whereas formation of peripherally induced regulatory T cells remained intact. Moreover, dual blockade during the secondary response resulted in a tolerogenic state such that mice did not develop a normal tertiary memory T(H)2 cell and lung inflammatory response when challenged weeks later with allergen. Conclusion: Memory T-cell responses to complex allergens are controlled by several TNF costimulatory interactions, and their combination targeting might represent a strategy to reduce the severity of inflammatory reactions following reexposure to allergen.	[Gracias, Donald T.; Sethi, Gurupreet S.; Mehta, Amit K.; Miki, Haruka; Gupta, Rinkesh K.; Croft, Michael] La Jolla Inst Immunol, Ctr Autoimmun & Inflammat, 9420 Athena Circle, La Jolla, CA 92037 USA; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Sch Med, Tokyo, Japan; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gracias, Donald T.] Janssen Pharmaceut Co Johnson & Johnson, Spring House, PA USA; [Mehta, Amit K.] Fate Therapeut Inc, La Jolla, CA USA	La Jolla Institute for Immunology; Juntendo University; University of California System; University of California San Diego; Johnson & Johnson; Janssen Pharmaceuticals	Croft, M (corresponding author), La Jolla Inst Immunol, Ctr Autoimmun & Inflammat, 9420 Athena Circle, La Jolla, CA 92037 USA.	mick@lji.org	Gupta, Rinkesh/AEX-5045-2022; Sethi, Gurupreet/AAG-9372-2019	Sethi, Gurupreet/0000-0002-9432-5716	National Institutes of Health [AI070535]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health grant AI070535 (to M.C.) Disclosure of potential conflict of interest: M. Croft has patents on OX40/OX40L.	Akdis CA, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0063-2; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Burrows KE, 2015, EUR J IMMUNOL, V45, P1116, DOI 10.1002/eji.201445163; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chang YH, 2017, IMMUNITY, V47, P943, DOI 10.1016/j.immuni.2017.10.014; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2014, SEMIN IMMUNOL, V26, P183, DOI 10.1016/j.smim.2014.02.005; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; DELPRETE G, 1995, J EXP MED, V182, P1655, DOI 10.1084/jem.182.6.1655; DELPRETE G, 1995, FASEB J, V9, P81, DOI 10.1096/fasebj.9.1.7821763; Di CX, 2015, J BIOL CHEM, V290, P12523, DOI 10.1074/jbc.M115.642637; Duan W, 2010, J ALLERGY CLIN IMMUN, V126, P1284, DOI 10.1016/j.jaci.2010.09.021; Duan W, 2008, J IMMUNOL, V181, P8650, DOI 10.4049/jimmunol.181.12.8650; Ezzat MHM, 2011, ALLERGY ASTHMA PROC, V32, P313, DOI 10.2500/aap.2011.32.3447; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Gaspal F, 2008, J IMMUNOL, V180, P2824, DOI 10.4049/jimmunol.180.5.2824; Gaspal FM, 2011, J EXP MED, V208, P1579, DOI 10.1084/jem.20101484; Gaspal FMC, 2005, J IMMUNOL, V174, P3891, DOI 10.4049/jimmunol.174.7.3891; Gauvreau GM, 2014, CLIN EXP ALLERGY, V44, P29, DOI 10.1111/cea.12235; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Jenkins SJ, 2007, J IMMUNOL, V179, P3515, DOI 10.4049/jimmunol.179.6.3515; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee JH, 2007, CLIN EXP IMMUNOL, V148, P53, DOI 10.1111/j.1365-2249.2007.03329.x; Lei W, 2012, ANN ACAD MED SINGAP, V41, P200; Leon B, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0714-1; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; Nam SY, 2008, INT IMMUNOL, V20, P177, DOI 10.1093/intimm/dxm130; O'Hehir RE, 2009, AM J RESP CRIT CARE, V180, P936, DOI 10.1164/rccm.200905-0686OC; Pereira-Santos MC, 2008, CLIN EXP ALLERGY, V38, P291, DOI 10.1111/j.1365-2222.2007.02887.x; Pippig SD, 1999, J IMMUNOL, V163, P6520; Polte T, 2006, J ALLERGY CLIN IMMUN, V118, P942, DOI 10.1016/j.jaci.2006.07.014; Polte T, 2009, EUR J IMMUNOL, V39, P1736, DOI 10.1002/eji.200839004; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Rahimi R, 2020, J EXP MED, V217, DOI 10.1084/jem.20190865; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Ray A, 2015, AM J PHYSIOL-LUNG C, V308, pL130, DOI 10.1152/ajplung.00070.2014; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Salek-Ardakani S, 2011, J CLIN INVEST, V121, P296, DOI 10.1172/JCI42056; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; So T, 2007, J IMMUNOL, V179, P1427, DOI 10.4049/jimmunol.179.3.1427; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; Vu MD, 2006, J IMMUNOL, V176, P1394, DOI 10.4049/jimmunol.176.3.1394; Walsh GM, 2017, EXPERT REV CLIN IMMU, V13, P143, DOI 10.1080/1744666X.2016.1216316; Welten SPM, 2015, ELIFE, V4, DOI 10.7554/eLife.07486; Withers DR, 2009, J IMMUNOL, V183, P5079, DOI 10.4049/jimmunol.0901514; Xia JJ, 2010, TRANSPL INT, V23, P1154, DOI 10.1111/j.1432-2277.2010.01106.x; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390	59	8	8	4	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2316	2329		10.1016/j.jaci.2020.10.037	http://dx.doi.org/10.1016/j.jaci.2020.10.037		JUN 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7MD	33160971	Green Accepted			2022-12-18	WOS:000657783800011
J	Hirahara, K; Aoki, A; Kiuchi, M; Nakayama, T				Hirahara, Kiyoshi; Aoki, Ami; Kiuchi, Masahiro; Nakayama, Toshinori			Memory-type pathogenic T(H)2 cells and ILC2s in type 2 allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Memory-type pathogenic T(H)2 cells; tissue-resident memory T cells; ILC2s; epithelial cytokines; IL-33			[Hirahara, Kiyoshi; Aoki, Ami; Kiuchi, Masahiro; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Hirahara, Kiyoshi] AMED, AMED PRIME, 1-8-1 Inohana Chuo Ku, Chiba, Japan; [Nakayama, Toshinori] AMED, AMED CREST, 1-8-1 Inohana Chuo Ku, Chiba, Japan	Chiba University	Hirahara, K; Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	hiraharak@chiba-u.jp; tnakayama@faculty.chiba-u.jp	; Hirahara, Kiyoshi/E-2460-2017	Kiuchi, Masahiro/0000-0002-0227-4502; Hirahara, Kiyoshi/0000-0002-9128-9449	Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) [26221305, JP19H05650, 20H03685, 17K08876, 18K07164, 19K16683]; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and Development (AMED), AMED [JP20ek0410082, JP20ek0410060]; AMED-PRIME, AMED [JP20gm6110005]; AMED-CREST, AMED [JP20gm1210003]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; MSD Life Science Foundation; Naito Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and Development (AMED), AMED; AMED-PRIME, AMED; AMED-CREST, AMED; Mochida Memorial Foundation for Medical and Pharmaceutical Research; MSD Life Science Foundation; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the following grants: Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) Grants-in-Aid for Scientific Research (S) 26221305, JP19H05650, (B) 20H03685, (C) 17K08876, 18K07164, and 19K16683; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and Development (AMED), AMED (grant nos. JP20ek0410082 and JP20ek0410060); AMED-PRIME, AMED (grant no. JP20gm6110005); AMED-CREST, AMED (grant no. JP20gm1210003); and Mochida Memorial Foundation for Medical and Pharmaceutical Research, the MSD Life Science Foundation, and The Naito Foundation and Takeda Science Foundation.	Chu C, 2020, IMMUNITY, V52, P464, DOI 10.1016/j.immuni.2020.02.017; Gause WC, 2020, NAT REV IMMUNOL, V20, P603, DOI 10.1038/s41577-020-0301-x; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Ichikawa T, 2019, NAT IMMUNOL, V20, P1469, DOI 10.1038/s41590-019-0494-y; Kabata H, 2018, IMMUNOL REV, V286, P37, DOI 10.1111/imr.12706; Meininger I, 2020, TRENDS IMMUNOL, V41, P902, DOI 10.1016/j.it.2020.08.009; Morimoto Y, 2018, IMMUNITY, V49, P134, DOI 10.1016/j.immuni.2018.04.023; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Yamamoto T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06468-8	10	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2063	2066		10.1016/j.jaci.2021.02.006	http://dx.doi.org/10.1016/j.jaci.2021.02.006		JUN 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33592206	Bronze			2022-12-18	WOS:000657814800009
J	Klaeschen, AS; Numm, TJ; Herrmann, N; Leib, N; Maintz, L; Sakai, T; Wenzel, J; Bieber, T				Klaeschen, Anna Sophie; Nuemm, Tim Joachim; Herrmann, Nadine; Leib, Nicole; Maintz, Laura; Sakai, Takashi; Wenzel, Joerg; Bieber, Thomas			JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; IDEC; IL-4; IL-13; JAK; DC; skin; Fc epsilon R	FC-EPSILON-RI; ANTIGEN-PRESENTING CELLS; JANUS KINASE INHIBITOR; HIGH-AFFINITY RECEPTOR; LANGERHANS CELLS; TH2 CYTOKINES; LESIONAL SKIN; IN-VITRO; EXPRESSION; INNATE	Background: Janus kinase (JAK) inhibitors are a new class of therapeutic compounds for dermatological diseases. In atopic dermatitis (AD), data of clinical phase III trials show rapid improvement of pruritus and significant reduction of inflammation within the first weeks with a favorable safety profile. However, their mode of action in AD is not fully understood. Objectives: In our study, we investigate the effect of different JAK inhibitors on cell differentiation, phenotype, and function of inflammatory dendritic epidermal cells (IDECs). Methods: We analyzed the JAK expression in IDEC from ex vivo skin and in vitro generated IDECs using flow cytometry and PCR. Further, we studied in vitro the effect of different JAK inhibitors on IDEC cell differentiation, phenotype, and maturation. Results: IDECs express JAK1 and JAK2 ex vivo and in vitro. We found that JAK1 and JAK2 were upregulated during the differentiation from monocytes to IDECs. Conversely, JAK2 inhibition by ruxolitinib (JAK1/2 inhibitor) or BMS-911543 (JAK2 inhibitor) abrogated the differentiation from monocytes into IDECs. Differentiated IDECs can redifferentiate into a more monocyte-like phenotype in the presence of ruxolitinib or BMS-911543. Furthermore, we showed that concomitant inhibition of JAK1/2 rather than blocking JAK1 or JAK2 alone, impaired maturation and the release of proinflammatory cytokines on lipopolysaccharide stimulation. Conclusions: Our results suggest that inhibition of JAK1/2 impairs IDEC differentiation and function. We provide new insight into the mode of action of JAK inhibitors in AD and highlight the role of JAK1/2 inhibitors for the treatment of patients with AD.	[Klaeschen, Anna Sophie; Nuemm, Tim Joachim; Herrmann, Nadine; Leib, Nicole; Maintz, Laura; Sakai, Takashi; Wenzel, Joerg; Bieber, Thomas] Univ Hosp Bonn, Dept Dermatol & Allergy, Venusberg Campus 1, D-53127 Bonn, Germany; [Klaeschen, Anna Sophie; Nuemm, Tim Joachim; Herrmann, Nadine; Leib, Nicole; Maintz, Laura; Sakai, Takashi; Bieber, Thomas] Christine Kuhne Ctr Allergy Res & Educ Davos, Davos, Switzerland; [Sakai, Takashi] Oita Univ, Fac Med, Dept Dermatol, Oita, Japan	University of Bonn; Oita University	Klaeschen, AS (corresponding author), Univ Hosp Bonn, Dept Dermatol & Allergy, Venusberg Campus 1, D-53127 Bonn, Germany.	sophie.klaeschen@online.de	Herrmann, Nadine/L-3362-2019	Herrmann, Nadine/0000-0003-4924-2281; Numm, Tim J./0000-0001-6110-6712; Leib, Nicole/0000-0002-4795-5010	Christine Kuhne - Center for Allergy Research and Education, Davos, Switzerland	Christine Kuhne - Center for Allergy Research and Education, Davos, Switzerland	Supported by the Christine Kuhne - Center for Allergy Research and Education, Davos, Switzerland.	Amano W, 2016, J DERMATOL SCI, V84, P258, DOI 10.1016/j.jdermsci.2016.09.007; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; Bieber T, 2007, IMMUNOBIOLOGY, V212, P499, DOI 10.1016/j.imbio.2007.03.001; Bieber T, 2011, CLIN REV ALLERG IMMU, V41, P254, DOI 10.1007/s12016-010-8224-0; Brunner PM, 2018, ANN ALLERG ASTHMA IM, V120, P34, DOI 10.1016/j.anai.2017.09.055; Czarnowicki T, 2019, J ALLERGY CLIN IMMUN, V143, P1, DOI 10.1016/j.jaci.2018.10.032; Czarnowicki T, 2017, J ALLERGY CLIN IMMUN, V139, P1723, DOI 10.1016/j.jaci.2017.04.004; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Delgoffe Greg M, 2013, JAKSTAT, V2, pe23060, DOI 10.4161/jkst.23060; Elli EM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01186; Ferreira S, 2020, AM J CLIN DERMATOL, V21, P783, DOI 10.1007/s40257-020-00548-6; Fridman JS, 2011, J INVEST DERMATOL, V131, P1838, DOI 10.1038/jid.2011.140; Guttman-Yassky E, 2020, J ALLERGY CLIN IMMUN, V145, P877, DOI 10.1016/j.jaci.2019.11.025; Hanifin JM, 1999, ARCH DERMATOL, V135, P1551, DOI 10.1001/archderm.135.12.1551; He H, 2020, ANN ALLERG ASTHMA IM, V124, P70, DOI 10.1016/j.anai.2019.10.013; He H, 2019, AM J CLIN DERMATOL, V20, P181, DOI 10.1007/s40257-018-0413-2; Heine A, 2013, BLOOD, V122, P1192, DOI 10.1182/blood-2013-03-484642; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Jin WY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123973; Junttila IS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00888; Kim BS, 2020, J ALLERGY CLIN IMMUN, V145, P572, DOI 10.1016/j.jaci.2019.08.042; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Kubo S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01510; LEE CE, 1992, J ALLERGY CLIN IMMUN, V89, P1010, DOI 10.1016/0091-6749(92)90224-P; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Nakagawa H, 2018, BRIT J DERMATOL, V178, P424, DOI 10.1111/bjd.16014; Novak N, 2005, J AM ACAD DERMATOL, V53, pS171, DOI 10.1016/j.jaad.2005.04.060; Novak N, 2004, CURR ALLERGY ASTHM R, V4, P263, DOI 10.1007/s11882-004-0069-2; Novak N, 2004, J ALLERGY CLIN IMMUN, V113, P949, DOI 10.1016/j.jaci.2004.02.005; Novak N, 2010, J ALLERGY CLIN IMMUN, V125, P50, DOI 10.1016/j.jaci.2009.11.019; Otsuka M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01768; Rosa M, 2019, NPJ GENOM MED, V4, DOI 10.1038/s41525-019-0097-4; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Seto Y, 2003, J IMMUNOL, V170, P1077, DOI 10.4049/jimmunol.170.2.1077; Shao S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav7561; Shi JG, 2012, J CLIN PHARMACOL, V52, P809, DOI 10.1177/0091270011405663; Suzuki K, 2000, INT IMMUNOL, V12, P123, DOI 10.1093/intimm/12.2.123; Szegedi K, 2015, J EUR ACAD DERMATOL, V29, P2136, DOI 10.1111/jdv.13160; Tanimoto A, 2015, INFLAMM RES, V64, P41, DOI 10.1007/s00011-014-0782-9; Tazawa T, 2004, ARCH DERMATOL RES, V295, P459, DOI 10.1007/s00403-004-0455-6; Totsuka A, 2017, EUR J DERMATOL, V27, P247, DOI 10.1684/ejd.2017.2985; Tsakok T, 2019, BRIT J DERMATOL, V180, P464, DOI 10.1111/bjd.16934; Vakirlis E, 2011, J EUR ACAD DERMATOL, V25, P409, DOI 10.1111/j.1468-3083.2010.03800.x; Wollenberg A, 1999, CYTOMETRY, V37, P147, DOI 10.1002/(SICI)1097-0320(19991001)37:2<147::AID-CYTO8>3.0.CO;2-Y; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Zhong JX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009593	53	8	8	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2202	+		10.1016/j.jaci.2020.11.041	http://dx.doi.org/10.1016/j.jaci.2020.11.041		JUN 2021	19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7MD	33338537				2022-12-18	WOS:000657783800001
J	Lin, NY; Roach, DJ; Willmering, MM; Walkup, LL; Hossain, MM; Desirazu, P; Cleveland, ZI; Guilbert, TW; Woods, JC				Lin, Nancy Y.; Roach, David J.; Willmering, Matthew M.; Walkup, Laura L.; Hossain, Md Monir; Desirazu, Priyanka; Cleveland, Zackary I.; Guilbert, Theresa W.; Woods, Jason C.			Xe-129 MRI as a measure of clinical disease severity for pediatric asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; pediatric; hyperpolarized xenon-129 magnetic resonance imaging; spirometry; clinical severity; exacerbations; health care utilization	FIBROSIS LUNG-DISEASE; HYPERPOLARIZED XE-129; BRONCHIAL THERMOPLASTY; HEALTHY-VOLUNTEERS; REFERENCE VALUES; CHILDREN; SPIROMETRY; TOLERABILITY; CAPACITY; SAFETY	Background: Measurement of regional lung ventilation with hyperpolarized Xe-129 magnetic resonance imaging (Xe-129 MRI) in pediatric asthma is poised to advance our understanding of disease mechanisms and pathophysiology in a disorder with diverse clinical phenotypes. Xe-129 MRI has not been investigated in a pediatric asthma cohort. Objective: We hypothesized that Xe-129 MRI is feasible and can demonstrate ventilation defects that relate to and predict clinical severity in a pediatric asthma cohort. Methods: Thirty-seven children (13 with severe asthma, 8 with mild/moderate asthma, 16 age-matched healthy controls) aged 6 to 17 years old were imaged with Xe-129 MRI. Ventilation defect percentage (VDP) and image reader score were calculated and compared with clinical measures at baseline and at follow-up. Results: Children with asthma had higher VDP (P=.002) and number of defects per image slice (defects/slice) (P=.0001) than children without asthma. Children with clinically severe asthma had significantly higher VDP and number of defects/slice than healthy controls. Children with asthma who had a higher number of defects/slice had a higher rate of health care utilization (r=0.48; P=.03) and oral corticosteroid use (r=0.43; P=.05) at baseline. Receiver-operating characteristic analysis demonstrated that the VDP and number of defects/slice were predictive of increased health care utilization, asthma, and severe asthma. VDP correlated with FEV1 (r=20.35; P=.04) and FEV1/forced vital capacity ratio (r=20.41; P=.01). Conclusions: Xe-129 MRI correlates with asthma severity, health care utilization, and oral corticosteroid use. Because delineation of clinical severity is often difficult in children, Xe-129 MRI may be an important biomarker for severity, with potential to identify children at higher risk for exacerbations and improve outcomes.	[Lin, Nancy Y.; Guilbert, Theresa W.] Univ Cincinnati, Div Pulm Med, Cincinnati, OH USA; [Roach, David J.; Willmering, Matthew M.; Walkup, Laura L.; Desirazu, Priyanka; Cleveland, Zackary I.; Woods, Jason C.] Univ Cincinnati, Div Pulm Med, Ctr Pulm Imaging Res, Cincinnati, OH USA; [Roach, David J.; Willmering, Matthew M.; Walkup, Laura L.; Desirazu, Priyanka; Cleveland, Zackary I.; Woods, Jason C.] Univ Cincinnati, Dept Radiol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Walkup, Laura L.; Hossain, Md Monir; Cleveland, Zackary I.; Guilbert, Theresa W.; Woods, Jason C.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Walkup, Laura L.; Cleveland, Zackary I.] Univ Cincinnati, Dept Biomed Engn, Coll Engn & Appl Sci, Cincinnati, OH USA; [Hossain, Md Monir] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Woods, JC (corresponding author), 3333 Burnet Ave,MLC 2021, Cincinnati, OH 45229 USA.	Jason.Woods@cchmc.org	Willmering, Matthew/ABE-7392-2020	Willmering, Matthew/0000-0002-4356-9622; Lin, Nancy/0000-0003-0800-2783	Arnold W. Strauss Fellow Award at Cincinnati Children's Hospital Medical Center	Arnold W. Strauss Fellow Award at Cincinnati Children's Hospital Medical Center	This study was partially funded by the Arnold W. Strauss Fellow Award at Cincinnati Children's Hospital Medical Center.	Altes TA, 2017, CLIN IMAG, V45, P105, DOI 10.1016/j.clinimag.2017.04.004; Altes TA, 2016, J ALLERGY CLIN IMMUN, V137, P789, DOI 10.1016/j.jaci.2015.08.045; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Bender BG, 2016, J ALLER CL IMM-PRACT, V4, P849, DOI 10.1016/j.jaip.2016.07.007; Bickel S, 2014, CHEST, V146, P841, DOI 10.1378/chest.13-1875; Brough HA, 2020, PEDIAT ALLERG IMM-UK, V31, P442, DOI 10.1111/pai.13262; Burgess S, 2011, PULM MED, V2011, DOI 10.1155/2011/973849; Cadman RV, 2013, J ALLERGY CLIN IMMUN, V131, P369, DOI 10.1016/j.jaci.2012.10.032; Cho A, 2009, SCIENCE, V326, P778, DOI 10.1126/science.326_778; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; de Lange EE, 2009, RADIOLOGY, V250, P567, DOI 10.1148/radiol.2502080188; Driehuys B, 2012, RADIOLOGY, V262, P279, DOI 10.1148/radiol.11102172; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Fain SB, 2008, ACAD RADIOL, V15, P753, DOI 10.1016/j.acra.2007.10.019; Global Initiative for Asthma, 2020, GLOB STRAT ASTHM MAN; Graham BL, 2019, AM J RESP CRIT CARE, V200, pE70, DOI 10.1164/rccm.201908-1590ST; Grange ES, 2020, APPL CLIN INFORM, V11, P265, DOI 10.1055/s-0040-1709715; Guilbert TW, 2014, J ALLER CL IMM-PRACT, V2, P489, DOI 10.1016/j.jaip.2014.06.022; Hall CS, 2020, AM J RESP CRIT CARE, V202, P524, DOI 10.1164/rccm.201905-1021OC; He M, 2014, ACAD RADIOL, V21, P1530, DOI 10.1016/j.acra.2014.07.017; Jenkins HA, 2003, CHEST, V124, P1318, DOI 10.1378/chest.124.4.1318; Komarow HD, 2011, ANN ALLERG ASTHMA IM, V106, P191, DOI 10.1016/j.anai.2010.11.011; Loeb JS, 2008, PEDIATR PULM, V43, P1020, DOI 10.1002/ppul.20908; McQuaid EL, 2003, J PEDIATR PSYCHOL, V28, P323, DOI 10.1093/jpepsy/jsg022; Mummy DG, 2018, J ALLERGY CLIN IMMUN, V141, P1140, DOI 10.1016/j.jaci.2017.10.016; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nuttall AGL, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0046-2019; Paull K, 2005, PEDIATR PULM, V39, P311, DOI 10.1002/ppul.20161; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Simon MR, 2010, J ALLERGY CLIN IMMUN, V126, P527, DOI 10.1016/j.jaci.2010.05.016; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Svenningsen S, 2019, CHEST, V155, P1178, DOI 10.1016/j.chest.2019.02.403; Teague WG, 2018, J ALLER CL IMM-PRACT, V6, P545, DOI 10.1016/j.jaip.2017.05.032; Teague WG, 2014, J ASTHMA, V51, P677, DOI 10.3109/02770903.2014.914535; Thomen RP, 2020, AM J RESP CRIT CARE, V202, P290, DOI 10.1164/rccm.202001-0031LE; Thomen RP, 2017, J CYST FIBROS, V16, P275, DOI 10.1016/j.jcf.2016.07.008; Thomen RP, 2015, RADIOLOGY, V274, P250, DOI 10.1148/radiol.14140080; Trivedi M, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00256; Tsuchiya N, 2020, PEDIATR RADIOL, V50, P646, DOI 10.1007/s00247-019-04604-0; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Tustison NJ, 2010, MAGN RESON MED, V63, P1448, DOI 10.1002/mrm.22390; van Dalen C, 2008, ARCH PEDIAT ADOL MED, V162, P1169, DOI 10.1001/archpedi.162.12.1169; Walkup LL, 2016, PEDIATR RADIOL, V46, P1651, DOI 10.1007/s00247-016-3672-1; Weinkove R, 2020, MED J AUSTRALIA, V212, P481, DOI 10.5694/mja2.50607; Willmering M, 2020, AM J RESP CRIT CARE, V201, pA7893	50	8	8	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2146	+		10.1016/j.jaci.2020.11.010	http://dx.doi.org/10.1016/j.jaci.2020.11.010		JUN 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33227317				2022-12-18	WOS:000657814800019
J	MacGlashan, D; Saini, S; Schroeder, JT				MacGlashan, Donald, Jr.; Saini, Sarbjit; Schroeder, John T.			Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Human; basophil; allergy; signal transduction; phenotypes; auto-antibodies	FC-EPSILON-RI; CHRONIC IDIOPATHIC URTICARIA; IGE-MEDIATED STIMULATION; ANTI-IGE; HISTAMINE-RELEASE; IN-VIVO; MAST-CELLS; EXPRESSION; AUTOANTIBODIES; DESENSITIZATION	Background: Treatment of patients with asthma or food allergy with omalizumab results in several consistent changes in circulating basophils. The multiple basophil phenotypes observed in patients with chronic spontaneous urticaria (CSU) present some unique attributes that may not respond in a similar fashion to patients with asthma or food allergy. As part of a clinical study on the therapeutic outcomes of omalizumab treatment in CSU, the basophil compartment was examined for changes in characteristics predicted by prior studies. Objective: This study sought to examine the changes in basophil function and its relationship to auto-antibodies in serum during treatment with omalizumab. Methods: At multiple time points before and during omalizumab treatment of patients with CSU, basophil surface IgE and FceRI expression, cellular spleen tyrosine kinase (SYK) expression, IgE-mediated histamine release (HR), and the presence of auto-antibodies in serum were determined. Results: Three basophil phenotypes were enumerated in the clinical study and used to group results in this basophil study: subjects with (1) basopenia, (2) normal basophil numbers with normal IgE-mediated HR, and (3) normal basophil numbers with poor HR. Basopenia was highly associated with the presence of auto-antibodies to unoccupied FceRI and basophil numbers did not change during treatment. Likewise, subjects who are basopenic showed no changes in SYK expression or HR during treatment. In basophils of subjects who are nonbasopenic, increases in SYK expression and HR showed the expected inverse relationship to starting SYK and HR levels. Treatment with omalizumab resulted in similar kinetics for decreases in surface FceRI and IgE in all 3 groups. Conclusions: A unifying interpretation of the results revolves around the presence of auto-antibodies to FceRI in CSU. If present, basopenia and an absence of changes in basophils during omalizumab treatment are observed. If auto-antibodies are absent, the changes in the basophil compartment are consistent with prior studies of asthma and food allergy. These group differences also are related to efficacy of the treatment for clinical outcomes, as found in the parent clinical study.	[MacGlashan, Donald, Jr.; Saini, Sarbjit; Schroeder, John T.] Johns Hopkins Univ, Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University	MacGlashan, D (corresponding author), Johns Hopkins Univ, Asthma & Allergy Ctr, Baltimore, MD 21224 USA.	dmacglas@jhmi.edu			National Institutes of Health [AI100952, AI116658, AI115703]; National Institutes of Health; Novartis; Eli Lilly; Regeneron	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Eli Lilly(Eli Lilly); Regeneron(Regeneron)	Allergy Hopkins University, These studies were funded by the National Institutes of Health grants AI100952, AI116658, and AI115703.	Baker R, 2008, ANN ALLERG ASTHMA IM, V100, P244, DOI 10.1016/S1081-1206(10)60449-8; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Casale TB, 2001, JAMA-J AM MED ASSOC, V286, P2956, DOI 10.1001/jama.286.23.2956; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Eckman JA, 2008, J INVEST DERMATOL, V128, P1956, DOI 10.1038/jid.2008.55; Eckman JA, 2010, J ALLERGY CLIN IMMUN, V125, P889, DOI 10.1016/j.jaci.2009.09.012; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; GILBERT HS, 1975, BLOOD, V46, P279; Gober LM, 2008, J ALLERGY CLIN IMMUN, V121, pS147, DOI 10.1016/j.jaci.2007.12.1121; Gomez G, 2007, J IMMUNOL, V179, P1353, DOI 10.4049/jimmunol.179.2.1353; Grattan CEH, 1997, CLIN EXP ALLERGY, V27, P1417, DOI 10.1111/j.1365-2222.1997.tb02986.x; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; Grattan CEH, 2003, CLIN EXP ALLERGY, V33, P337, DOI 10.1046/j.1365-2222.2003.01589.x; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Huang AH, 2020, J ALLER CL IMM-PRACT, V8, P793, DOI 10.1016/j.jaip.2019.08.004; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Johal KJ, 2021, J ALLERGY CLIN IMMUN, V147, P2271, DOI 10.1016/j.jaci.2021.02.038; Kaplan A, 2016, J ALLERGY CLIN IMMUN, V137, P474, DOI 10.1016/j.jaci.2015.08.023; Kikuchi Y, 2001, J ALLERGY CLIN IMMUN, V107, P1056, DOI 10.1067/mai.2001.115484; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Lowe PJ, 2011, BRIT J CLIN PHARMACO, V72, P306, DOI 10.1111/j.1365-2125.2011.03962.x; MacGlashan D, 1998, BLOOD, V91, P1633, DOI 10.1182/blood.V91.5.1633.1633_1633_1643; MacGlashan D, 2004, J ALLERGY CLIN IMMUN, V114, P1472, DOI 10.1016/j.jaci.2004.07.064; MacGlashan D, 2004, J ALLERGY CLIN IMMUN, V114, P1317, DOI 10.1016/j.jaci.2004.08.037; MacGlashan D, 2001, J LEUKOCYTE BIOL, V70, P207; MacGlashan D, 2019, J ALLERGY CLIN IMMUN, V143, P1100, DOI 10.1016/j.jaci.2018.05.019; MacGlashan D, 2008, J ALLERGY CLIN IMMUN, V121, P1500, DOI 10.1016/j.jaci.2008.04.019; MacGlashan D, 2006, J IMMUNOL, V177, P1040, DOI 10.4049/jimmunol.177.2.1040; MacGlashan D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126435; MacGlashan D, 2009, J LEUKOCYTE BIOL, V85, P627, DOI 10.1189/jlb.1008668; MacGlashan DW, 2008, J IMMUNOL, V180, P4208, DOI 10.4049/jimmunol.180.6.4208; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; MacGlashan DW, 2007, J ALLERGY CLIN IMMUN, V119, P626, DOI 10.1016/j.jaci.2006.09.040; MacGlashan DW, 2017, J ALLERGY CLIN IMMUN, V139, P1680, DOI 10.1016/j.jaci.2016.12.965; MacGlashan DW, 2013, J ALLERGY CLIN IMMUN, V132, P906, DOI 10.1016/j.jaci.2013.04.056; MacGlashan DW, 2012, J ALLERGY CLIN IMMUN, V130, P1130, DOI 10.1016/j.jaci.2012.05.038; MacGlashan DW, 2009, INT ARCH ALLERGY IMM, V150, P109, DOI 10.1159/000218114; MACGLASHAN DW, 1993, J IMMUNOL, V151, P6358; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; Metz M, 2017, THERANOSTICS, V7, P1266, DOI 10.7150/thno.18304; Nejad AS, 2018, INT ARCH ALLERGY IMM, V177, P181, DOI 10.1159/000490152; NGUYEN KL, 1990, J ALLERGY CLIN IMMUN, V85, P1020, DOI 10.1016/0091-6749(90)90046-7; Nopp A, 2007, ALLERGY, V62, P1175, DOI 10.1111/j.1398-9995.2007.01476.x; Nopp A, 2006, ALLERGY, V61, P298, DOI 10.1111/j.1398-9995.2006.00987.x; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; Rauber MM, 2017, ALLERGY, V72, P1904, DOI 10.1111/all.13215; RORSMAN H, 1962, ACTA ALLERGOL, V17, P168, DOI 10.1111/j.1398-9995.1962.tb02937.x; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P1123, DOI 10.1016/j.jaci.2012.05.039; SCHLEIMER RP, 1982, J IMMUNOL, V128, P136; Schoepke N, 2019, ALLERGY, V74, P2427, DOI 10.1111/all.13949; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; Soundararajan S, 2005, J ALLERGY CLIN IMMUN, V115, P815, DOI 10.1016/j.jaci.2004.12.1120; Stellato C, 1991, J ALLERGY CLIN IMMUN, V87, p72A; Vasagar K, 2006, CLIN EXP ALLERGY, V36, P770, DOI 10.1111/j.1365-2222.2006.02494.x; Vonakis BM, 2007, J ALLERGY CLIN IMMUN, V119, P441, DOI 10.1016/j.jaci.2006.09.035; Vonakis BM, 2005, CURR ALLERGY ASTHM R, V5, P270, DOI 10.1007/s11882-005-0066-0; WARNER J, 1988, IMMUNOL LETT, V18, P129, DOI 10.1016/0165-2478(88)90053-3; Zaidi AK, 2010, J ALLERGY CLIN IMMUN, V125, P902, DOI 10.1016/j.jaci.2009.12.996	61	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2295	+		10.1016/j.jaci.2021.02.039	http://dx.doi.org/10.1016/j.jaci.2021.02.039		JUN 2021	22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7MD	33716077				2022-12-18	WOS:000657783800009
J	Nicoletti, P; Carr, DF; Barrett, S; McEvoy, L; Friedmann, PS; Shear, NH; Nelson, MR; Chiriac, AM; Blanca-Lopez, N; Cornejo-Garcia, JA; Gaeta, F; Nakonechna, A; Torres, MJ; Caruso, C; Valluzzi, RL; Floratos, A; Shen, YF; Pavlos, RK; Phillips, EJ; Demoly, P; Romano, A; Blanca, M; Pirmohamed, M				Nicoletti, Paola; Carr, Daniel F.; Barrett, Sarah; McEvoy, Laurence; Friedmann, Peter S.; Shear, Neil H.; Nelson, Matthew R.; Chiriac, Anca M.; Blanca-Lopez, Natalia; Cornejo-Garcia, Jose A.; Gaeta, Francesco; Nakonechna, Alla; Torres, Maria J.; Caruso, Cristiano; Valluzzi, Rocco L.; Floratos, Aris; Shen, Yufeng; Pavlos, Rebecca K.; Phillips, Elizabeth J.; Demoly, Pascal; Romano, Antonino; Blanca, Miguel; Pirmohamed, Munir			Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Type I hypersensitivity; beta-lactams; penicillins; cephalo-sporins; allergy; anaphylaxis; pharmacogenomics	INDUCED LIVER-INJURY; PENICILLIN ALLERGY; T-CELLS; DRUG; AMOXICILLIN; POPULATION; SUSCEPTIBILITY; MECHANISMS; GENOTYPE; DISEASE	Background: beta-lactam antibiotics are associated with a variety of immune-mediated or hypersensitivity reactions, including immediate (type I) reactions mediated by antigen-specific IgE. Objective: We sought to identify genetic predisposing factors for immediate reactions to beta-lactam antibiotics. Methods: Patients with a clinical history of immediate hypersensitivity reactions to either penicillins or cephalosporins, which were immunologically confirmed, were recruited from allergy clinics. A genome-wide association study was conducted on 662 patients (the discovery cohort) with a diagnosis of immediate hypersensitivity and the main finding was replicated in a cohort of 98 Spanish cases, recruited using the same diagnostic criteria as the discovery cohort. Results: Genome-wide association study identified rs71542416 within the Class II HLA region as the top hit (P = 2 x 10(-14)); this was in linkage disequilibrium with HLA-DRB1*10:01 (odds ratio, 2.93; P = 5.4 x 10(-7)) and HLA-DQA1*01:05 (odds ratio, 2.93, P = 5.4 x 10(-7)). Haplotype analysis identified that HLADRB1*10:01 was a risk factor even without the HLADQA1*01:05 allele. The association with HLA-DRB1*10:01 was replicated in another cohort, with the meta-analysis of the discovery and replication cohorts showing that HLA-DRB1*10:01 increased the risk of immediate hypersensitivity at a genome-wide level (odds ratio, 2.96; P = 4.1 x 10(-9)). No association with HLA-DRB1*10:01 was identified in 268 patients with delayed hypersensitivity reactions to beta-lactams. Conclusions: HLA-DRB1*10:01 predisposed to immediate hypersensitivity reactions to penicillins. Further work to identify other predisposing HLA and non-HLA loci is required.	[Nicoletti, Paola] Columbia Univ, Icahn Sch Med Mt Sinai, New York, NY USA; [Floratos, Aris; Shen, Yufeng] Columbia Univ, Dept Syst Biol, New York, NY USA; [Floratos, Aris] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Nicoletti, Paola] Sema4, Stamford, CT USA; [Carr, Daniel F.; Barrett, Sarah; McEvoy, Laurence; Pirmohamed, Munir] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Friedmann, Peter S.] Univ Southampton, Sch Med, Sir Henry Wellcome Res Labs, Dermatol Unit, Southampton, Hants, England; [Shear, Neil H.] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada; [Chiriac, Anca M.; Demoly, Pascal] Univ Hosp Montpellier, Hop Arnaud Villeneuve, Div Allergy, Montpellier, France; [Blanca-Lopez, Natalia] Infanta Leonor Univ Hosp, Madrid, Spain; [Cornejo-Garcia, Jose A.; Torres, Maria J.] ARADyAL, Inst Invest Biomed Malaga IBIMA, Allergy Res Grp, Malaga, Spain; [Torres, Maria J.; Blanca, Miguel] Hosp Reg Univ Malaga, Allergy Unit, Malaga, Spain; [Gaeta, Francesco; Caruso, Cristiano] Fdn Policlin Univ Agostino Gemelli, Ist Ricovero & Cura Carattere Sci, Columbus Hosp, Allergy Unit, Rome, Italy; [Valluzzi, Rocco L.] Univ Dept Pediat, Pediat Hosp Bambino Gesu, Div Allergy, Rome, Italy; [Nakonechna, Alla; Pirmohamed, Munir] Liverpool Univ Hosp Fdn Natl Hlth Serv Trust, Liverpool, Merseyside, England; [Pavlos, Rebecca K.] Univ Western Australia, Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Nedlands, WA, Australia; [Phillips, Elizabeth J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Phillips, Elizabeth J.] Murdoch Univ, Inst Immunol & Infect Dis, Ctr Clin Pharmacol & Infect Dis, Murdoch, WA, Australia; [Demoly, Pascal] Sorbonne Univ Equipe Epidemiol Allerg & Resp Dis, Louis Epidemiol & Sante Publ IPLESP, Inst Natl Sante & Rech Med, Unite Mixte Rech Sante UMR S 1136, Paris, France; [Romano, Antonino] Ist Ricovero & Cura Carattere Sci Oasi Maria SS, Troina, Italy; [Romano, Antonino] Fdn Mediterranea GB Morgagni, Catania, Italy; [Shear, Neil H.] Sunnybrook Hlth Sci Ctr, Dept Med, Div Dermatol, Toronto, ON, Canada	Columbia University; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; University of Liverpool; University of Southampton; Wellcome Research Laboratories; University of Toronto; Universite de Montpellier; CHU de Montpellier; Hospital Universitario Infanta Leonor; Universidad de Malaga; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; Telethon Kids Institute; University of Western Australia; Wesfarmers Limited; Vanderbilt University; Murdoch University; Institut National de la Sante et de la Recherche Medicale (Inserm); IRCCS Oasi Maria SS; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Pirmohamed, M (corresponding author), Univ Liverpool, Inst Translat Med, Wolfson Ctr Personalised Med, Block A Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England.	munirp@liverpool.ac.uk	Demoly, Pascal/Y-9938-2019; Romano, Antonino/D-3102-2017; caruso, cristiano/AAR-9502-2020; Torres, Maria/GVU-3391-2022; Cornejo-Garcia, Jose Antonio/S-7726-2016	Demoly, Pascal/0000-0001-7827-7964; Romano, Antonino/0000-0001-9742-9898; caruso, cristiano/0000-0001-7631-029X; Cornejo-Garcia, Jose Antonio/0000-0003-3465-8735; McEvoy, Laurence/0000-0002-2169-6735; Pavlos, Rebecca/0000-0002-8884-9855	International Serious Adverse Events Consortium (iSAEC); Abbott; Amgen; AstraZeneca; Daiichi Sankyo; GlaxoSmithKline; Merck; Novartis; Pfizer; Takeda; Wellcome Trust; Medical Research Council (MRC) Centre for Drug Safety Science [MR/L006758/1]; iSAEC; National Institutes of Health [1P50GM11530501, R21AI139021, R34AI136815, 1 R01 HG010863-01]; National Health and Medical Research Council of Australia	International Serious Adverse Events Consortium (iSAEC); Abbott(Abbott Laboratories); Amgen(Amgen); AstraZeneca(AstraZeneca); Daiichi Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC) Centre for Drug Safety Science(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); iSAEC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the International Serious Adverse Events Consortium (iSAEC) . The iSAEC is a nonprofit organization dedicated to identifying and validating DNA variants useful in predicting the risk of drugrelated serious adverse events. The iSAEC brings together the pharmaceutical industry, regulatory authorities, and academic centers to address clinical and scientific issues associated with the genetics of drugrelated serious adverse events. The iSAEC's funding members included: Abbott, Amgen, AstraZeneca, Daiichi Sankyo, GlaxoSmithKline, Merck, Novartis, Pfizer, Takeda, and the Wellcome Trust. M.P. is a National Institute for Health Research Senior Investigator. M.P. and D.F.C. thank the Medical Research Council (MRC) Centre for Drug Safety Science for support (MR/L006758/1) . P.N.was supported by the iSAEC. E.J.P. receives funding from the National Institutes of Health (grants 1P50GM11530501, R21AI139021, R34AI136815, and 1 R01 HG010863-01) and the National Health and Medical Research Council of Australia. The views expressed are those of the author (s) and not of any of their funders. The funders played no role in the analysis of the data and interpretation of the findings.	Apter AJ, 2008, J ALLERGY CLIN IMMUN, V122, P152, DOI 10.1016/j.jaci.2008.03.037; Bhattacharya S, 2010, J ADV PHARM TECHNOL, V1, P11; Blumenthal KG, 2019, LANCET, V393, P183, DOI 10.1016/S0140-6736(18)32218-9; Castells M, 2019, NEW ENGL J MED, V381, P2338, DOI 10.1056/NEJMra1807761; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dona I, 2014, J INVEST ALLERG CLIN, V24, P143; Fernandez CA, 2014, BLOOD, V124, P1266, DOI 10.1182/blood-2014-03-563742; Gueant JL, 2015, J ALLERGY CLIN IMMUN, V135, P253, DOI 10.1016/j.jaci.2014.07.047; Heap GA, 2014, NAT GENET, V46, P1131, DOI 10.1038/ng.3093; Jerschow E, 2014, J ALLERGY CLIN IMMUN, V134, P1318, DOI 10.1016/j.jaci.2014.08.018; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kim SH, 2015, HEPATOLOGY, V62, P887, DOI 10.1002/hep.27912; Li M, 2006, DRUG METAB DISPOS, V34, P547, DOI 10.1124/dmd.105.006791; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Macy E, 2013, J ALLER CL IMM-PRACT, V1, P258, DOI 10.1016/j.jaip.2013.02.002; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mirakian R, 2015, CLIN EXP ALLERGY, V45, P300, DOI 10.1111/cea.12468; Monshi MM, 2013, HEPATOLOGY, V57, P727, DOI 10.1002/hep.26077; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Pichler WJ, 2003, ANN INTERN MED, V139, P683, DOI 10.7326/0003-4819-139-8-200310210-00012; Pirmohamed M, 2015, J ALLERGY CLIN IMMUN, V136, P236, DOI 10.1016/j.jaci.2015.06.022; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Romano A, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0594-9; Shen Y, 2012, PHARMACOGENOMICS J, V12, P96, DOI 10.1038/tpj.2010.84; Torres MJ, 2016, CURR OPIN ALLERGY CL, V16, P308, DOI 10.1097/ACI.0000000000000285; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	34	8	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1830	+		10.1016/j.jaci.2020.10.004	http://dx.doi.org/10.1016/j.jaci.2020.10.004		MAY 2021	23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33058932	Green Published, hybrid			2022-12-18	WOS:000651594300004
J	Sconocchia, T; Hochgerner, M; Schwarzenberger, E; Tam-Amersdorfer, C; Borek, I; Benezeder, T; Bauer, T; Zyulina, V; Painsi, C; Passegger, C; Wolf, P; Sibilia, M; Strobl, H				Sconocchia, Tommaso; Hochgerner, Mathias; Schwarzenberger, Elke; Tam-Amersdorfer, Carmen; Borek, Izabela; Benezeder, Theresa; Bauer, Thomas; Zyulina, Victoria; Painsi, Clemens; Passegger, Christina; Wolf, Peter; Sibilia, Maria; Strobl, Herbert			Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Langerhans cells; regulatory T cells; monocyte-derived dendritic cell; BMP7; BMPR1a; ALK3; psoriasis	IN-VITRO DEVELOPMENT; T-CELLS; TGF-BETA; LANGERHANS CELLS; INDUCTION; PSORIASIS; BLOOD; ACTIVATION; EXPRESSION; RESPONSES	Background: Bone morphogenetic proteins (BMPs) are members of the TGF-beta family that signal via the BMP receptor (BMPR) signaling cascade, distinct from canonical TGF-beta signaling. BMP downstream signaling is strongly induced within epidermal keratinocytes in cutaneous psoriatic lesions, and BMP7 instructs monocytic cells to acquire characteristics of psoriasis-associated Langerhans dendritic cells (DCs). Regulatory T (Treg)-cell numbers strongly increase during psoriatic skin inflammation and were recently shown to limit psoriatic skin inflammation. However, the factors mediating Treg-cell accumulation in psoriatic skin currently remain unknown. Objective: We sought to investigate the role of BMP signaling in Treg-cell accumulation in psoriasis. Methods: The following methods were used: immunohistology of patients and healthy controls; ex vivo models of Treg-cell generation in the presence or absence of Langerhans cells; analysis of BMP versus canonical TGF-beta signaling in DCs and Treg cells; and modeling of psoriatic skin inflammation in mice lacking the BMPR type 1a in CD11c(+) cells. Results: We here demonstrated a positive correlation between Treg-cell numbers and epidermal BMP7 expression in cutaneous psoriatic lesions and show that unlike Treg cells from healthy skin, a portion of inflammation-associated Treg cells exhibit constitutive-active BMP signaling. We further found that BMPR signaling licenses inflammation-associated Langerhans cell/DC to gain an enhanced capacity to promote Treg cells via BMPR-mediated CD25 induction and that this effect is associated with reduced skin inflammation. Conclusions: Psoriatic lesions are marked by constitutive high BMP7/BMPR signaling in keratinocytes, which instructs inflammatory DCs to gain enhanced Treg-cell-stimulatory activity. Locally secreted BMP7 can directly promote Treg-cell generation through the BMP signaling cascade.	[Sconocchia, Tommaso; Schwarzenberger, Elke; Tam-Amersdorfer, Carmen; Borek, Izabela; Zyulina, Victoria; Passegger, Christina; Strobl, Herbert] Med Univ Graz, Otto Loewi Res Ctr, Div Immunol & Pathophysiol, Heinrichstr 31a, A-8010 Graz, Austria; [Hochgerner, Mathias; Bauer, Thomas; Sibilia, Maria] Med Univ Vienna, Inst Canc Res, Dept Internal Med 1, Vienna, Austria; [Benezeder, Theresa; Wolf, Peter] Med Univ Graz, Dept Dermatol, Graz, Austria; [Painsi, Clemens] State Hosp Klagenfurt, Dept Dermatol, Klagenfurt, Austria	Medical University of Graz; Medical University of Vienna; Medical University of Graz	Strobl, H (corresponding author), Med Univ Graz, Otto Loewi Res Ctr, Div Immunol & Pathophysiol, Heinrichstr 31a, A-8010 Graz, Austria.	herbert.strobl@medunigraz.at	Sconocchia, Tommaso/ABD-3570-2020	Sconocchia, Tommaso/0000-0001-8735-7958; Strobl, Herbert/0000-0002-8070-4977; Benezeder, Theresa/0000-0001-6218-2792; Zyulina, Victoria/0000-0001-7329-8045; Borek, Izabela/0000-0002-2527-6199; Bauer, Thomas/0000-0002-2076-7140; Sibilia, Maria/0000-0001-6129-5613; Tam-Amersdorfer, Carmen/0000-0003-3123-6342	Austrian Science Fund (FWF) [W1241, W1212]; Medical University of Graz through the PhD program in Molecular Fundamentals of Inflammation (DK-MOLIN); Medical University of Vienna through the PhD program Inflammation and Immunity; BioTechMed Graz (project "secretome'')	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical University of Graz through the PhD program in Molecular Fundamentals of Inflammation (DK-MOLIN); Medical University of Vienna through the PhD program Inflammation and Immunity; BioTechMed Graz (project "secretome'')	This work was supported by the Austrian Science Fund (FWF; grant no. W1241 to H.S.) and the Medical University of Graz through the PhD program in Molecular Fundamentals of Inflammation (DK-MOLIN). Additional funding was provided through the Austrian Science Fund (FWF; grant no.W1212 to H.S.) and the Medical University of Vienna through the PhD program Inflammation and Immunity, and by the BioTechMed Graz (project ``secretome'' to H.S.).	Borek I, 2020, J ALLERGY CLIN IMMUN, V145, P1194, DOI 10.1016/j.jaci.2019.12.011; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Doi H, 2003, J DERMATOL SCI, V33, P7, DOI 10.1016/S0923-1811(03)00107-5; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Glitzner E, 2014, EMBO MOL MED, V6, P1312, DOI 10.15252/emmm.201404114; Hartwig T, 2018, CELL REP, V25, P3564, DOI 10.1016/j.celrep.2018.12.012; Helbing T, 2011, BLOOD, V118, P5040, DOI 10.1182/blood-2011-03-339762; Heller JJ, 2014, J IMMUNOL, V193, P3934, DOI 10.4049/jimmunol.1401234; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Jiang M, 2017, J INVEST DERMATOL, V137, P2177, DOI 10.1016/j.jid.2017.06.005; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kashiwagi M, 2017, NAT IMMUNOL, V18, P334, DOI 10.1038/ni.3661; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kitashima DY, 2018, EBIOMEDICINE, V27, P293, DOI 10.1016/j.ebiom.2017.12.022; Kuczma M, 2014, J IMMUNOTOXICOL, V11, P319, DOI 10.3109/1547691X.2013.864736; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Lin SM, 2014, INT J CLIN EXP PATHO, V7, P474; Lu L, 2010, EUR J IMMUNOL, V40, P142, DOI 10.1002/eji.200939618; Martinez CG, 2011, IMMUNOL CELL BIOL, V89, P610, DOI 10.1038/icb.2010.135; Martinez VG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131453; Martinez VG, 2014, EUR J IMMUNOL, V44, P1031, DOI 10.1002/eji.201343693; Martini E, 2017, J INVEST DERMATOL, V137, P865, DOI 10.1016/j.jid.2016.11.033; Milne P, 2015, BLOOD, V125, P470, DOI 10.1182/blood-2014-08-593582; Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]; Schmidt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148474; Semitekolou M, 2009, J EXP MED, V206, P1769, DOI 10.1084/jem.20082603; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Singla DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147897; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Stary G, 2011, J IMMUNOL, V186, P103, DOI 10.4049/jimmunol.1002485; Stockenhuber K, 2018, J EXP MED, V215, P1987, DOI 10.1084/jem.20172094; Strobl H, 1997, BLOOD, V90, P1425, DOI 10.1182/blood.V90.4.1425.1425_1425_1434; Strobl H, 1996, J IMMUNOL, V157, P1499; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Takabayashi H, 2014, GASTROENTEROLOGY, V147, P396, DOI 10.1053/j.gastro.2014.04.015; Terhorst D, 2015, J IMMUNOL, V195, P4953, DOI 10.4049/jimmunol.1500551; van der Aar AMG, 2013, J INVEST DERMATOL, V133, P1240, DOI 10.1038/jid.2012.500; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; WatayaKaneda M, 1996, J DERMATOL SCI, V11, P183, DOI 10.1016/0923-1811(95)00438-6; Wollenberg A, 2002, J INVEST DERMATOL, V118, P327, DOI 10.1046/j.0022-202x.2001.01665.x; Wu DH, 2019, EXP BIOL MED, V244, P147, DOI 10.1177/1535370219828694; Yasmin N, 2013, J EXP MED, V210, P2597, DOI 10.1084/jem.20130275; Yoshioka Y, 2012, EUR J IMMUNOL, V42, P749, DOI 10.1002/eji.201141702	48	8	8	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1810	+		10.1016/j.jaci.2020.09.038	http://dx.doi.org/10.1016/j.jaci.2020.09.038		MAY 2021	22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33250156	hybrid			2022-12-18	WOS:000651594300002
J	Soler, ZM; Schlosser, RJ; Bodner, TE; Alt, JA; Ramakrishnan, VR; Mattos, JL; Mulligan, JK; Mace, JC; Smith, TL				Soler, Zachary M.; Schlosser, Rodney J.; Bodner, Todd E.; Alt, Jeremiah A.; Ramakrishnan, Vijay R.; Mattos, Jose L.; Mulligan, Jennifer K.; Mace, Jess C.; Smith, Timothy L.			Endotyping chronic rhinosinusitis based on olfactory cleft mucus biomarkers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cluster analysis; translational medical research; chronic disease; patient-reported outcome measures; sinusitis; smell	QUALITY-OF-LIFE; NASAL POLYPOSIS; OUTCOMES; DYSFUNCTION	Background: Although chronic rhinosinusitis (CRS) is considered the most treatable form of olfactory dysfunction, there has been relatively little clinical attention focused on assessing endotypes as they pertain to olfactory loss. Objectives: The goal of this study was to explore inflammatory endotypes in CRS using an unsupervised cluster analysis of olfactory cleft (OC) biomarkers in a phenotype-free approach. Methods: Patients with CRS were prospectively recruited and psychophysical olfactory testing, Questionnaire of Olfactory Dysfunction (QOD-NS), and bilateral OC endoscopy were obtained. Mucus was collected from the OC and evaluated for 26 biomarkers using principal component analysis. Cluster analysis was performed using only OC biomarkers and differences in olfactory measures were compared across clusters. Results: A total of 198 subjects (128 with CRS and 70 controls) were evaluated. Evaluation of OC biomarkers indicated 6 principal components, explaining 69.50% of the variance, with type 2, mixed type 1/T(H)17-cell, growth factor, and neutrophil chemoattractant inflammatory signatures. A total of 10 clusters were identified that differed significantly in frequency of controls, and subjects with CRS with nasal polyps, and subjects with CRS without nasal polyps across the clusters (likelihood ratio test, chi(2)(18) = 178:64; P < .001). Olfactory measures differed significantly across clusters, including olfactory testing, QOD-NS, and OC endoscopy (P < .001 for all). Conclusions: Clustering based solely on OC biomarkers can organize patients into clinically meaningful endotypes that discriminate between subjects with CRS and controls. Validation studies are necessary to confirm these findings and further refine olfactory endotypes.	[Soler, Zachary M.; Schlosser, Rodney J.] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Div Rhinol & Sinus Surg, Charleston, SC 29425 USA; [Schlosser, Rodney J.] Ralph H Johnson VA Med Ctr, Dept Surg, Charleston, SC USA; [Bodner, Todd E.] Portland State Univ, Dept Psychol, Portland, OR 97207 USA; [Mace, Jess C.; Smith, Timothy L.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Div Rhinol & Sinus Skull Base Surg, Portland, OR 97239 USA; [Alt, Jeremiah A.] Univ Utah, Dept Surg, Div Otolaryngol Head & Neck Surg, Salt Lake City, UT USA; [Ramakrishnan, Vijay R.] Univ Colorado, Dept Otolaryngol Head & Neck Surg, Anschutz Med Campus, Aurora, CO USA; [Mattos, Jose L.] Univ Virginia, Dept Otolaryngol Head & Neck Surg, Div Rhinol & Sinus Surg, Charlottesville, VA USA; [Mulligan, Jennifer K.] Univ Florida, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Portland State University; Oregon Health & Science University; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia; State University System of Florida; University of Florida	Smith, TL (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, 3181 SW Sam Jackson Pk Rd,PV-01, Portland, OR 97239 USA.	smithtim@ohsu.edu		Mulligan, Jennifer/0000-0001-6880-6092	National Institute on Deafness and Other Communication Disorders [R03 DC013651-01, R01 DC005805, K23DC014747]; National Institute of Allergy and Infectious Disease [R01 AI34698, R01 AI144364]	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institute on Deafness and Other Communication Disorders (grants R03 DC013651-01 [principal investigator: Z.M.S.] , R01 DC005805 [principal investigators: T.L.S. and Z.M.S.] , K23DC014747 [principal investigator: V.R.R.] to Z.M.S., R.J.S., T.E.B., J.A.A., V.R.R., J.K.M., J.C.M., and T.L.S.) ; the National Institute of Allergy and Infectious Disease (grants R01 AI34698 and R01 AI144364 [to J.K.M.] ) . These funding organizations did not contribute to the design or conduct of this study, preparation, review, approval of, or decision to submit this manuscript for publication.	Allinne J, 2019, J ALLERGY CLIN IMMUN, V144, P1624, DOI 10.1016/j.jaci.2019.08.039; Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Bachert C, 2018, J ALLERGY CLIN IMMUN, V141, P1543, DOI 10.1016/j.jaci.2018.03.004; Banglawala SM, 2014, INT FORUM ALLERGY RH, V4, P986, DOI 10.1002/alr.21373; Blackwell Debra L, 2014, Vital Health Stat 10, P1; Divekar R, 2017, INT FORUM ALLERGY RH, V7, P373, DOI 10.1002/alr.21904; Donovan C, 2020, ACS PHARMACOL TRANSL, V3, P56, DOI 10.1021/acsptsci.9b00099; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Games PA., 1976, J EDUC BEHAV STAT, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Garcia DS, 2017, INT FORUM ALLERGY RH, V7, P160, DOI 10.1002/alr.21855; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032; Hair J. F., 2000, READING UNDERSTANDIN, P147; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Haxel BR, 2019, LARYNGOSCOPE, V129, P1053, DOI 10.1002/lary.27764; Hoggard M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02065; Hopkins C, 2009, CLIN OTOLARYNGOL, V34, P447, DOI 10.1111/j.1749-4486.2009.01995.x; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kohli P, 2017, LARYNGOSCOPE, V127, P309, DOI 10.1002/lary.26316; Kohli P, 2016, OTOLARYNG HEAD NECK, V155, P936, DOI 10.1177/0194599816664879; Kumari E, 2020, STEM CELL REP, V14, P861, DOI 10.1016/j.stemcr.2020.03.019; Liao B, 2018, ALLERGY, V73, P1459, DOI 10.1111/all.13411; Loftus C, 2020, LARYNGOSCOPE, V130, P2311, DOI 10.1002/lary.28332; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Massey CJ, 2020, INT FORUM ALLERGY RH, V10, P303, DOI 10.1002/alr.22510; Mattos JL, 2019, INT FORUM ALLERGY RH, V9, P593, DOI 10.1002/alr.22309; Naclerio R, 2020, J ALLER CL IMM-PRACT, V8, P1532, DOI 10.1016/j.jaip.2020.02.023; Oyer SL, 2013, LARYNGOSCOPE, V123, pE72, DOI 10.1002/lary.24305; Roland LT, 2020, INT FORUM ALLERGY RH, V10, P1037, DOI 10.1002/alr.22633; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Saravanan K, 2006, ARCH OTOLARYNGOL, V132, P173, DOI 10.1001/archotol.132.2.173; Schlosser RJ, 2016, JAMA OTOLARYNGOL, V142, P731, DOI 10.1001/jamaoto.2016.0927; Simopoulos E, 2012, LARYNGOSCOPE, V122, P1450, DOI 10.1002/lary.23349; Soler ZM, 2020, INT FORUM ALLERGY RH, V10, P343, DOI 10.1002/alr.22499; Soler ZM, 2016, INT FORUM ALLERGY RH, V6, P407, DOI 10.1002/alr.21679; Soler ZM, 2016, INT FORUM ALLERGY RH, V6, P293, DOI 10.1002/alr.21655; Staudacher AG, 2020, ANN ALLERG ASTHMA IM, V124, P318, DOI 10.1016/j.anai.2020.01.013; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Turner JH, 2018, J ALLERGY CLIN IMMUN, V141, P1895, DOI 10.1016/j.jaci.2018.02.002; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wu J, 2018, LARYNGOSCOPE, V128, pE304, DOI 10.1002/lary.27112; Yoo F, 2019, INT FORUM ALLERGY RH, V9, P1151, DOI 10.1002/alr.22391; Yoshikawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35102-2; Zimmermann P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00302	45	8	10	3	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1732	+		10.1016/j.jaci.2021.01.021	http://dx.doi.org/10.1016/j.jaci.2021.01.021		MAY 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33549569	Green Accepted			2022-12-18	WOS:000647680800022
J	Bruton, K; Spill, P; Vohra, S; Baribeau, O; Manzoor, S; Gadkar, S; Davidson, M; Walker, TD; Koenig, JFE; Ellenbogen, Y; Florescu, A; Wen, JP; Chu, DK; Waserman, S; Jimenez-Saiz, R; Epelman, S; Robbins, C; Jordana, M				Bruton, Kelly; Spill, Paul; Vohra, Shabana; Baribeau, Owen; Manzoor, Saba; Gadkar, Siyon; Davidson, Malcolm; Walker, Tina D.; Koenig, Joshua F. E.; Ellenbogen, Yosef; Florescu, Alexandra; Wen, Jianping; Chu, Derek K.; Waserman, Susan; Jimenez-Saiz, Rodrigo; Epelman, Slava; Robbins, Clinton; Jordana, Manel			Interrupting reactivation of immunologic memory diverts the allergic response and prevents anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IgE; food allergy; anaphylaxis; IL-4 receptor; memory response; T(H)2 immunity	HUMAN B-CELLS; T-CELLS; CYTOKINE PRODUCTION; IL-4 PRODUCTION; IGE PRODUCTION; IN-VIVO; ANTIBODIES; CHILDREN; REACTIVITY; TOLERANCE	Background: IgE production against innocuous food antigens can result in anaphylaxis, a severe life-threatening consequence of allergic reactions. The maintenance of IgE immunity is primarily facilitated by IgG(+) memory B cells, as IgE(+) memory B cells and IgE(+) plasma cells are extremely scarce and shortlived, respectively. Objective: Our aim was to investigate the critical requirements for an IgE recall response in peanut allergy. Methods: We used a novel human PBMC culture platform, a mouse model of peanut allergy, and various experimental readouts to assess the IgE recall response in the presence and absence of IL-4R alpha blockade. Results: In human PBMCs, we have demonstrated that blockade of IL-4/IL-13 signaling aborted IgE production after activation of a recall response and skewed the cytokine response away from a dominant type 2 signature. T(H)2A cells, identified by single-cell RNA sequencing, expanded with peanut stimulation and maintained their pathogenic phenotype in spite of IL-4R alpha blockade. In mice with allergy, anti-IL-4R alpha provided long-lasting suppression of the IgE recall response beyond antibody treatment and fully protected against anaphylaxis. Conclusion: The findings reported here advance our understanding of events mediating the regeneration of IgE in food allergy.	[Bruton, Kelly; Spill, Paul; Baribeau, Owen; Manzoor, Saba; Gadkar, Siyon; Davidson, Malcolm; Walker, Tina D.; Koenig, Joshua F. E.; Florescu, Alexandra; Wen, Jianping; Jimenez-Saiz, Rodrigo; Jordana, Manel] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, MDCL 4013,1280 Main St W, Hamilton, ON L8S 4L8, Canada; [Ellenbogen, Yosef; Chu, Derek K.; Waserman, Susan] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Chu, Derek K.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Vohra, Shabana; Epelman, Slava; Robbins, Clinton] Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Jimenez-Saiz, Rodrigo] Ctr Nacl Biotecnol CSIC, Dept Immunol & Oncol, Madrid, Spain	McMaster University; McMaster University; McMaster University; University of Toronto; Peter Munk Cardiac Centre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Jordana, M (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, MDCL 4013,1280 Main St W, Hamilton, ON L8S 4L8, Canada.	jordanam@mcmaster.ca	Epelman, Slava/AAO-1728-2020; Koenig, Joshua/AAL-9339-2021; Jimenez-Saiz, Rodrigo/O-7384-2019	Epelman, Slava/0000-0003-3400-4475; Koenig, Joshua/0000-0002-8909-5039; Jimenez-Saiz, Rodrigo/0000-0002-0606-3251; Bruton, Kelly/0000-0003-0817-6134; Florescu, Alexandra/0000-0001-6652-6863; Chu, Derek/0000-0001-8269-4496	Food Allergy Canada; Walter and Maria Schroeder Foundation; Michael Zych family; Canadian Asthma, Allergy and Immunology Foundation; Canada Graduate Scholarship; Canadian Society of Allergy and Clinical Immunology; AllerGen NCE summer studentships	Food Allergy Canada; Walter and Maria Schroeder Foundation; Michael Zych family; Canadian Asthma, Allergy and Immunology Foundation; Canada Graduate Scholarship; Canadian Society of Allergy and Clinical Immunology; AllerGen NCE summer studentships	Supported by funds from Food Allergy Canada; the Walter and Maria Schroeder Foundation; the Michael Zych family; and the Canadian Asthma, Allergy and Immunology Foundation. K. Bruton holds a Canada Graduate Scholarship, and P. Spill has received Canadian Society of Allergy and Clinical Immunology and AllerGen NCE summer studentships.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Arias K, 2011, J ALLERGY CLIN IMMUN, V127, P1552, DOI 10.1016/j.jaci.2011.03.044; Bao K, 2015, CYTOKINE, V75, P25, DOI 10.1016/j.cyto.2015.05.008; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Beeh K M, 2004, Pneumologie, V58, P546, DOI 10.1055/s-2004-818483; Begin P, 2015, J ALLERGY CLIN IMMUN, V135, P1636, DOI 10.1016/j.jaci.2015.03.010; Bullens DMA, 1998, CLIN EXP IMMUNOL, V113, P320; Carballeda-Sangiao N, PLOS NEGL TROP DIS, V10; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Chiang D, 2018, J ALLERGY CLIN IMMUN, V141, P2107, DOI 10.1016/j.jaci.2017.11.060; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Chu DK, 2014, MUCOSAL IMMUNOL, V7, P1395, DOI 10.1038/mi.2014.29; COFFMAN RL, 1986, J IMMUNOL, V136, P949; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; FINKELMAN FD, 1991, INT IMMUNOL, V3, P599, DOI 10.1093/intimm/3.6.599; GASCAN H, 1991, J IMMUNOL, V147, P8; Haniuda K, 2016, NAT IMMUNOL, V17, P1109, DOI 10.1038/ni.3508; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Hofstra CL, 1998, AM J RESP CELL MOL, V19, P826, DOI 10.1165/ajrcmb.19.5.3027; Hoof I, 2020, J ALLERGY CLIN IMMUN, V146, P180, DOI 10.1016/j.jaci.2019.11.046; Horns F, 2020, CELL REP, V30, P905, DOI 10.1016/j.celrep.2019.12.063; JABARA HH, 1993, J IMMUNOL, V151, P4528; Jimenez-Saiz R, 2019, ALLERGY, V74, P165, DOI 10.1111/all.13481; Jimenez-Saiz R, 2019, J ALLERGY CLIN IMMUN, V144, P336, DOI 10.1016/j.jaci.2019.04.001; Jimenez-Saiz R, 2017, J ALLERGY CLIN IMMUN, V140, P1604, DOI 10.1016/j.jaci.2017.01.018; KATONA IM, 1991, J IMMUNOL, V146, P4215; Kong J, 2015, ALLERGY, V70, P495, DOI 10.1111/all.12579; Looney TJ, 2016, J ALLERGY CLIN IMMUN, V137, P579, DOI 10.1016/j.jaci.2015.07.014; Lund R, 2005, EUR J IMMUNOL, V35, P3307, DOI 10.1002/eji.200526079; Meli AP, 2017, J IMMUNOL, V199, P244, DOI 10.4049/jimmunol.1700141; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022; Nono JK, 2017, PLOS NEGL TROP DIS, V11; Nyborg AC, 2016, CELL MOL IMMUNOL, V13, P391, DOI 10.1038/cmi.2015.19; Ramadani F, 2017, ALLERGY, V72, P66, DOI 10.1111/all.12911; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P801, DOI 10.1016/j.jaci.2016.02.030; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Ruiz-Lafuente N, 2018, BIOCHEM BIOPHYS REP, V16, P56, DOI 10.1016/j.bbrep.2018.09.007; Russkamp D, 2019, ALLERGY, V74, P1549, DOI 10.1111/all.13759; Shan M, 2018, IMMUNITY, V49, P1; Sheehan WJ, 2018, J ALLER CL IMM-PRACT, V6, P1825, DOI 10.1016/j.jaip.2018.08.001; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Takatsuka S, 2018, NAT IMMUNOL, V19, P1025, DOI 10.1038/s41590-018-0177-0; Turcanu V, 2003, J CLIN INVEST, V111, P1065, DOI 10.1172/JCI200316142; Turqueti-Neves A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002290; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wisniewski JA, 2015, CLIN EXP ALLERGY, V45, P1201, DOI 10.1111/cea.12537; Yang ZY, 2020, J EXP MED, V217, DOI 10.1084/jem.20190472; Yang ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.21238; Yu JW, 2006, J ALLERGY CLIN IMMUN, V118, P466, DOI 10.1016/j.jaci.2006.04.024; YUNGINGER JW, 1973, J CLIN INVEST, V52, P1268, DOI 10.1172/JCI107294; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	57	8	8	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1381	1392		10.1016/j.jaci.2020.11.042	http://dx.doi.org/10.1016/j.jaci.2020.11.042		APR 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	33338539				2022-12-18	WOS:000647154500003
J	Lamri, Y; Vibhushan, S; Pacreau, E; Boedec, E; Saidoune, F; Mailleux, A; Crestani, B; Blank, U; Benhamou, M; Papo, T; Daugas, E; Sacr, K; Charles, N				Lamri, Yasmine; Vibhushan, Shamila; Pacreau, Emeline; Boedec, Erwan; Saidoune, Fanny; Mailleux, Arnaud; Crestani, Bruno; Blank, Ulrich; Benhamou, Marc; Papo, Thomas; Daugas, Eric; Sacr, Karim; Charles, Nicolas			Basophils and IgE contribute to mixed connective tissue disease development	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Basophil; IgE; mixed connective tissue disease; patho-physiology; MCTD-like mouse model; interstitial lung disease	MURINE MODEL; CELLS	Background: Mixed connective tissue disease (MCTD) is a rare and complex autoimmune disease that presents mixed features with other connective tissue diseases, such as systemic lupus erythematosus, systemic sclerosis, and myositis. It is characterized by high levels of anti-U1 small nuclear ribonucleoprotein 70k autoantibodies and a high incidence of life-threatening pulmonary involvement. The pathophysiology of MCTD is not well understood, and no specific treatment is yet available for the patients. Basophils and IgE play a role in the development of systemic lupus erythematosus and thus represent new therapeutic targets for systemic lupus erythematosus and other diseases involving basophils and IgE in their pathogenesis. Objective: We sought to investigate the role of basophils and IgE in the pathophysiology of MCTD. Methods: Basophil activation status and the presence of autoreactive IgE were assessed in peripheral blood of a cohort of patients with MCTD and in an MCTD-like mouse model. Basophil depletion and IgE-deficient animals were used to investigate the contribution of basophils and IgE in the lung pathology development of this mouse model. Results: Patients with MCTD have a peripheral basopenia and activated blood basophils overexpressing C-C chemokine receptor 3. Autoreactive IgE raised against the main MCTD autoantigen U1 small nuclear ribonucleoprotein 70k were found in nearly 80% of the patients from the cohort. Basophil activation and IgE anti U1 small nuclear ribonucleoprotein 70k were also observed in the MCTD-like mouse model along with basophil accumulation in lymph nodes and lungs. Basophil depletion dampened lung pathology, and IgE deficiency prevented its development. Conclusions: Basophils and IgE contribute to MCTD pathophysiology and represent new candidate therapeutic targets for patients with MCTD.	[Lamri, Yasmine; Vibhushan, Shamila; Pacreau, Emeline; Boedec, Erwan; Saidoune, Fanny; Blank, Ulrich; Benhamou, Marc; Papo, Thomas; Daugas, Eric; Sacr, Karim; Charles, Nicolas] Univ Paris, Ctr Rech Inflammat, CNRS ERL8252, INSERM UMR1149,Fac Med Site Bichat, 16 Rue Henri Huchard, F-75018 Paris, France; [Lamri, Yasmine; Vibhushan, Shamila; Pacreau, Emeline; Boedec, Erwan; Saidoune, Fanny; Mailleux, Arnaud; Crestani, Bruno; Blank, Ulrich; Benhamou, Marc; Papo, Thomas; Daugas, Eric; Sacr, Karim; Charles, Nicolas] Univ Paris, Lab Excellence Inflamex, Paris, France; [Mailleux, Arnaud; Crestani, Bruno] Univ Paris, INSERM UMR1152, Fac Med Site Bichat, Paris, France; [Crestani, Bruno] Univ Paris, Hop Bichat, Assistance Publ Hop Paris, Fac Med Site Bichat,DHU FIRE,Dept Pulmonol, Paris, France; [Papo, Thomas; Sacr, Karim] Univ Paris, Hop Bichat, Assistance Publ Hop Paris, Fac Med Site Bichat,DHU FIRE,Dept Internal Med, Paris, France; [Daugas, Eric] Univ Paris, Hop Bichat, Assistance Publ Hop Paris, Fac Med Site Bichat,DHU FIRE,Dept Nephrol, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Charles, N (corresponding author), Univ Paris, Ctr Rech Inflammat, CNRS ERL8252, INSERM UMR1149,Fac Med Site Bichat, 16 Rue Henri Huchard, F-75018 Paris, France.	nicolas.charles@inserm.fr	Mailleux, Arnaud/AAH-8799-2021; Mailleux, Arnaud A/J-3576-2017; CHARLES, Nicolas/P-5430-2014	Mailleux, Arnaud/0000-0003-4191-1778; Mailleux, Arnaud A/0000-0003-4191-1778; Benhamou, Marc/0000-0001-7763-3795; Sacre, Karim/0000-0002-6544-234X; Vibhushan, Shamila/0000-0001-6196-2295; CHARLES, Nicolas/0000-0002-5416-5834	ANR-PIA-INFLAMEX; CNRS; AP-HP; INSERM; French ministry for higher education, research and innovation (MESRI);  [ANR-11-JSV1-009-01 BASILE];  [ANR-15-CE17-0002 BATTLE]	ANR-PIA-INFLAMEX; CNRS(Centre National de la Recherche Scientifique (CNRS)); AP-HP; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French ministry for higher education, research and innovation (MESRI); ; 	This work was funded by ANR-11-JSV1-009-01 BASILE, ANR-15-CE17-0002 BATTLE, ANR-PIA-INFLAMEX, CNRS, AP-HP, and INSERM. PhD fellowship support for Y.L. was provided by the French ministry for higher education, research and innovation (MESRI).	Berings M, 2018, CLIN EXP ALLERGY, V48, P970, DOI 10.1111/cea.13157; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Dema B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08516-7; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Dema B, 2014, DISCOV MED, V17, P247; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Deppong Christine M, 2013, Front Biosci (Schol Ed), V5, P167; El Hachem C, 2018, EUR J IMMUNOL, V48, P861, DOI 10.1002/eji.201747351; Enomoto K, 2003, RESPIROLOGY, V8, P149, DOI 10.1046/j.1440-1843.2003.00445.x; Fanouriakis A, 2019, ANN RHEUM DIS, V78, P736, DOI 10.1136/annrheumdis-2019-215089; Greidinger EL, 2006, ARTHRITIS RHEUM, V54, P661, DOI 10.1002/art.21566; Greidinger EL, 2004, J IMMUNOL, V172, P709, DOI 10.4049/jimmunol.172.1.709; Greidinger EL, 2008, J IMMUNOL, V180, P8444, DOI 10.4049/jimmunol.180.12.8444; Hasni S, 2019, ARTHRITIS RHEUMATOL, V71, P1135, DOI 10.1002/art.40828; Henault J, 2016, NAT IMMUNOL, V17, P196, DOI 10.1038/ni.3326; Hof D, 2005, ARTHRITIS RES THER, V7, pR302, DOI 10.1186/ar1490; Hosokawa Y, 2016, CELL PHYSIOL BIOCHEM, V38, P153, DOI 10.1159/000438617; Huaux F, 2005, AM J PATHOL, V167, P1485, DOI 10.1016/S0002-9440(10)61235-7; Hussain M, 2018, J ALLERGY CLIN IMMUN, V141, P223, DOI 10.1016/j.jaci.2017.02.035; Ishida W, 2011, IMMUNOL LETT, V136, P49, DOI 10.1016/j.imlet.2010.12.002; Kaul A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.39; Kolkhir P, 2020, ANN ALLERG ASTHMA IM, V124, P2, DOI 10.1016/j.anai.2019.08.014; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Okawa-Takatsuji M, 2001, CLIN EXP IMMUNOL, V126, P345, DOI 10.1046/j.1365-2249.2001.01669.x; Oon S, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1097; Oon S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86131; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Pan QJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00348; Paradowska-Gorycka Agnieszka, 2015, Reumatologia (Warsaw), V53, P94, DOI 10.5114/reum.2015.51509; Pellefigues C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03129-8; Sapkota B, 2020, MIXED CONNECTIVE TIS; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; Shibata S, 2018, P NATL ACAD SCI USA, V115, P13057, DOI 10.1073/pnas.1813927115; Ungprasert P, 2016, ARTHRIT CARE RES, V68, P1843, DOI 10.1002/acr.22872; Venables PJW, 2006, LUPUS, V15, P132, DOI 10.1191/0961203306lu2283rr; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Yamanishi Y, 2016, SEMIN IMMUNOPATHOL, V38, P615, DOI 10.1007/s00281-016-0568-y	37	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1478	+		10.1016/j.jaci.2020.12.622	http://dx.doi.org/10.1016/j.jaci.2020.12.622		APR 2021	23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	33338538	hybrid			2022-12-18	WOS:000647154500012
J	Miki, H; Pei, H; Gracias, DT; Linden, J; Croft, M				Miki, Haruka; Pei, Hong; Gracias, Donald Tom; Linden, Joel; Croft, Michael			Clearance of apoptotic cells by lung alveolar macrophages prevents development of house dust mite-induced asthmatic lung inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Apoptotic cell clearance; asthma; alveolar macrophage; regulatory T cell; adenosine	T-CELLS	Background: Poor clearance of apoptotic cells has been suggested to contribute to severe asthma, but whether uptake of apoptotic cells by lung phagocytes might dampen house dust mite (HDM)-induced lung inflammation has not been shown. Objectives: This study investigated whether apoptotic cell engulfment in the murine lung impacts the development of allergen-induced asthmatic airway inflammation and which immune modulating mechanisms were activated. Methods: Apoptotic cells were infused into the lungs of mice challenged with HDM allergen and lung inflammation, expression of suppressive molecules, and induction of regulatory T cells were monitored. Additionally, an adenosine receptor agonist was tested to study the mechanism of suppression elicited by apoptotic cells. Results: Apoptotic cell uptake by lung alveolar macrophages suppressed HDM-driven allergic asthma. This was associated with promoting the regulatory T cell-inducing molecule retinoic acid, inhibiting inflammatory cytokine production, and making macrophages more susceptible to receiving suppressive signals from adenosine. Correspondingly, adenosine receptor agonist treatment also limited HDM-driven allergic airway inflammation through an action on alveolar macrophages. Conclusions: These data provide insight into the mechanisms by which lung macrophages dampen allergen-induced airway inflammation. They suggest that targeting lung macrophages to increase their phagocytic capacity, enhance their ability to make retinoic acid, dampen their capacity to make inflammatory cytokines, and increase their responsiveness to adenosine, could be useful to suppress allergic responses.	[Miki, Haruka; Pei, Hong; Gracias, Donald Tom; Linden, Joel; Croft, Michael] Univ Calif San Diego, Ctr Autoimmun & Inflammat, La Jolla Inst Immunol, La Jolla, CA 92093 USA; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego	Croft, M (corresponding author), 9420 Athena Circle, La Jolla, CA 92037 USA.	mick@lji.org			United States National Institutes of Health [AI103021]; Japanese Society for the Promotion of Science Overseas Research Fellowship	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Society for the Promotion of Science Overseas Research Fellowship	Supported by United States National Institutes of Health grant AI103021 to M.C. H.M. was supported by a Japanese Society for the Promotion of Science Overseas Research Fellowship.	Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Doherty TA, 2009, AM J PHYSIOL-LUNG C, V296, pL229, DOI 10.1152/ajplung.90543.2008; Draijer C, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0681-6; Erriah M, 2019, RESP RES, V20, DOI 10.1186/s12931-018-0967-9; Felton JM, 2018, J ALLERGY CLIN IMMUN, V142, P1884, DOI 10.1016/j.jaci.2018.01.029; Fernandez-Boyanapalli R, 2013, J ALLERGY CLIN IMMUN, V131, P1041, DOI 10.1016/j.jaci.2012.09.028; Grabiec AM, 2016, SEMIN IMMUNOPATHOL, V38, P409, DOI 10.1007/s00281-016-0555-3; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Imanishi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4566; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; McCubbrey AL, 2013, CHEST, V143, P1750, DOI 10.1378/chest.12-2413; Pei H, 2016, AM J PHYSIOL-LUNG C, V310, pL985, DOI 10.1152/ajplung.00330.2015; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Saas P, 2016, STEM CELLS, V34, P1464, DOI 10.1002/stem.2361; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Szondy Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00354; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923	21	8	8	2	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1087	+		10.1016/j.jaci.2020.10.005	http://dx.doi.org/10.1016/j.jaci.2020.10.005		MAR 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	33065121	Green Accepted			2022-12-18	WOS:000635524300013
J	Ubags, ND; Trompette, A; Pernot, J; Nibbering, B; Wong, NC; Pattaroni, C; Rapin, A; Nicod, LP; Harris, NL; Marsland, BJ				Ubags, Niki D.; Trompette, Aurelien; Pernot, Julie; Nibbering, Britt; Wong, Nicholas C.; Pattaroni, Celine; Rapin, Alexis; Nicod, Laurent P.; Harris, Nicola L.; Marsland, Benjamin J.			Microbiome-induced antigen-presenting cell recruitment coordinates skin and lung allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Epicutaneous sensitization; early life; allergy; immune maturation; airway inflammation		Background: Allergic skin inflammation often presents in early childhood; however, little is known about the events leading to its initiation and whether it is transient or longterm in nature. Objective: We sought to determine the immunologic rules that govern skin inflammation in early life. Methods: Neonatal and adult mice were epicutaneously sensitized with allergen followed by airway allergen challenge. Epicutaneous application of labeled allergen allowed for determination of antigen uptake and processing by antigen-presenting cells. RNAseq and microbiome analysis was performed on skin from neonatal and adult specific pathogen-free and germ-free mice. Results: A mixed TH2/TH17 inflammatory response in the skin and the lungs of adult mice was observed following sensitization and challenge. Comparatively, neonatal mice did not develop overt skin inflammation, but exhibited systemic release of IL 17a and a TH2-dominated lung response. Mechanical skin barrier disruption was not sufficient to drive allergic skin inflammation, although it did promote systemic immune priming. Skin of neonatal mice and adult germ-free mice was seeded with low numbers of antigen-presenting cells and impaired chemokine and alarmin production. Enhanced chemokine and alarmin production, and seeding of the skin with antigen-presenting cells capable of instructing recruited cells to elicit their effector function, was, at least in part, dependent on formation of the microbiome, and consequently contributed to the development of overt skin disease. Conclusions: These data shed light on the principles that underlie allergic inflammation in different tissues and highlight a window of opportunity that might exist for early-life prevention of allergic diseases	[Ubags, Niki D.; Trompette, Aurelien; Pernot, Julie; Nibbering, Britt; Rapin, Alexis; Nicod, Laurent P.; Marsland, Benjamin J.] Univ Lausanne, Fac Biol & Med, Serv Pneumol, CHUV Epalinges, Lausanne, Switzerland; [Wong, Nicholas C.] Monash Univ, Monash Bioinformat Platform, Clayton, Vic, Australia; [Pattaroni, Celine; Harris, Nicola L.; Marsland, Benjamin J.] Monash Univ, Dept Pathol & Immunol, Cent Clin Sch, Melbourne, Vic, Australia	University of Lausanne; Monash University; Monash University	Ubags, ND (corresponding author), CHUV, Serv Pneumol, CLE D02-207,Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.; Marsland, BJ (corresponding author), Monash Univ, Dept Immunol & Pathol, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	Niki.ubags@chuv.ch; Benjamin.marsland@monash.edu		Rapin, Alexis/0000-0003-3448-5459	Helmut Horten Stiftung	Helmut Horten Stiftung	This work was supported by the Helmut Horten Stiftung. B.J.M. is a VESKI innovation fellow and National Health and Medical Research Council Senior Research Fellow.	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Brauweiler AM, 2019, J INVEST DERMATOL, V139, P1753, DOI 10.1016/j.jid.2019.02.006; Brunner PM, 2019, ANN ALLERG ASTHMA IM, V122, P318, DOI 10.1016/j.anai.2018.11.025; Brunner PM, 2018, J ALLERGY CLIN IMMUN, V141, P2094, DOI 10.1016/j.jaci.2018.02.040; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Deckers J, 2018, J INVEST DERMATOL, V138, P1360, DOI 10.1016/j.jid.2017.12.023; Deckers J, 2017, J ALLERGY CLIN IMMUN, V140, P1364, DOI 10.1016/j.jaci.2016.12.970; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gollwitzer ES, 2015, TRENDS IMMUNOL, V36, P684, DOI 10.1016/j.it.2015.09.009; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Kabashima K, 2019, NAT REV IMMUNOL, V19, P19, DOI 10.1038/s41577-018-0084-5; Kelleher MM, 2016, J ALLERGY CLIN IMMUN, V137, P1111, DOI 10.1016/j.jaci.2015.12.1312; Kim JP, 2016, J AM ACAD DERMATOL, V75, P681, DOI 10.1016/j.jaad.2016.05.028; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lange-Asschenfeldt B, 2011, SKIN PHARMACOL PHYS, V24, P305, DOI 10.1159/000328728; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; MacGillivray DM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00434; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271; MONTES LF, 1969, BRIT J DERMATOL, VS 81, P23, DOI 10.1111/j.1365-2133.1969.tb12829.x; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P26, DOI 10.1016/j.jaci.2018.11.015; Pattaroni C, 2018, CELL HOST MICROBE, V24, P857, DOI 10.1016/j.chom.2018.10.019; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 2003, J INVEST DERM SYMP P, V8, P188, DOI 10.1046/j.1087-0024.2003.00807.x; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Rapin Alexis, 2017, Curr Protoc Mouse Biol, V7, P100, DOI 10.1002/cpmo.29; Scharschmidt TC, 2017, CELL HOST MICROBE, V21, P467, DOI 10.1016/j.chom.2017.03.001; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Shimura S, 2016, J INVEST DERMATOL, V136, P1408, DOI 10.1016/j.jid.2016.02.810; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Tauber M, 2016, J ALLERGY CLIN IMMUN, V137, P1272, DOI 10.1016/j.jaci.2015.07.052; Tordesillas L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07716-7; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Tsyganov K, 2018, J OPEN SOURCE SOFTW, V3; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884	51	8	8	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1049	+		10.1016/j.jaci.2020.06.030	http://dx.doi.org/10.1016/j.jaci.2020.06.030		MAR 2021	21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	32679208				2022-12-18	WOS:000635524300010
J	Xu, CJ; Gruzieva, O; Qi, CC; Esplugues, A; Gehring, U; Bergstrom, A; Mason, D; Chatzi, L; Porta, D; Carlsen, KCL; Baiz, N; Madore, AM; Alenius, H; van Rijkom, B; Jankipersadsing, SA; van der Vlies, P; Kull, I; van Hage, M; Bustamante, M; Lertxundi, A; Torrent, M; Santorelli, G; Fantini, MP; Hovland, V; Pesce, G; Fyhrquist, N; Laatikainen, T; Nawijn, MC; Li, Y; Wijmenga, C; Netea, MG; Bousquet, J; Anto, JM; Laprise, C; Haahtela, T; Annesi-Maesano, I; Carlsen, KH; Gori, D; Kogevinas, M; Wright, J; Soderhall, C; Vonk, JM; Sunyer, J; Melen, E; Koppelman, GH				Xu, Cheng-Jian; Gruzieva, Olena; Qi, Cancan; Esplugues, Ana; Gehring, Ulrike; Bergstroem, Anna; Mason, Dan; Chatzi, Leda; Porta, Daniela; Carlsen, Karin C. Lodrup; Baiz, Nour; Madore, Anne-Marie; Alenius, Harri; van Rijkom, Bianca; Jankipersadsing, Soesma A.; van der Vlies, Pieter; Kull, Inger; van Hage, Marianne; Bustamante, Mariona; Lertxundi, Aitana; Torrent, Matias; Santorelli, Gillian; Fantini, Maria Pia; Hovland, Vegard; Pesce, Giancarlo; Fyhrquist, Nanna; Laatikainen, Tiina; Nawijn, Martijn C.; Li, Yang; Wijmenga, Cisca; Netea, Mihai G.; Bousquet, Jean; Anto, Josep M.; Laprise, Catherine; Haahtela, Tari; Annesi-Maesano, Isabella; Carlsen, Kai-Hakon; Gori, Davide; Kogevinas, Manolis; Wright, John; Soederhaell, Cilla; Vonk, Judith M.; Sunyer, Jordi; Melen, Erik; Koppelman, Gerard H.		BIOS Consortium	Shared DNA methylation signatures in childhood allergy: The MeDALL study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Xu, Cheng-Jian; Qi, Cancan; Koppelman, Gerard H.] Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergy, Groningen, Netherlands; [Xu, Cheng-Jian; Qi, Cancan; Nawijn, Martijn C.; Vonk, Judith M.; Koppelman, Gerard H.] Univ Groningen, GRIAC Res Inst, Groningen, Netherlands; [van Rijkom, Bianca; Jankipersadsing, Soesma A.; van der Vlies, Pieter; Wijmenga, Cisca] Univ Groningen, Dept Genet, Groningen, Netherlands; [Nawijn, Martijn C.] Univ Groningen, Dept Pathol & Med Biol, Expt Pulmonol & Inflammat Res, Groningen, Netherlands; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Xu, Cheng-Jian] Hannover Med Sch & Helmholtz Ctr Infect Res, Ctr Individualized Infect Med, CiiM, Hannover, Germany; [Xu, Cheng-Jian; Li, Yang] Hannover Med Sch & Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Hannover, Germany; [Xu, Cheng-Jian; Li, Yang; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Xu, Cheng-Jian; Li, Yang; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Gruzieva, Olena; Bergstroem, Anna; Alenius, Harri; Fyhrquist, Nanna] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [van Hage, Marianne] Karolinska Inst, Div Immunol & Allergy, Stockholm, Sweden; [Soederhaell, Cilla] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Soederhaell, Cilla] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Gruzieva, Olena] Reg Stockholm, Ctr Occupat & Environm Med, Stockholm, Sweden; [Esplugues, Ana] Univ Valencia, Fac Nursing & Chiropody, Nursing Dept, Valencia, Spain; [Esplugues, Ana] FISABIO Univ Jaume I Univ Valencia, Joint Res Unit Epidemiol & Environm Hlth, Valencia, Spain; [Esplugues, Ana; Bustamante, Mariona; Lertxundi, Aitana; Anto, Josep M.; Sunyer, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Gehring, Ulrike] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Mason, Dan; Santorelli, Gillian; Wright, John] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Chatzi, Leda] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Porta, Daniela] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Carlsen, Karin C. Lodrup; Carlsen, Kai-Hakon] Univ Oslo, Div Paediat & Adolescent Med, Fac Med, Oslo, Norway; [Carlsen, Karin C. Lodrup; Hovland, Vegard; Carlsen, Kai-Hakon] Oslo Univ Hosp, Div Paediat & Adolescent Med, Oslo, Norway; [Baiz, Nour; Pesce, Giancarlo; Annesi-Maesano, Isabella] Sorbonne Univ, Paris, France; [Baiz, Nour; Pesce, Giancarlo; Annesi-Maesano, Isabella] Med Sch St Antoine, Epidemiol Allerg & Resp Dis EPAR Dept, IPLESP, INSERM, Paris, France; [Madore, Anne-Marie; Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondament, Saguenay, PQ, Canada; [Laprise, Catherine] Univ Quebec Chicoutimi, Ctr Intersectoriel Sante Durable, Saguenay, PQ, Canada; [van der Vlies, Pieter] HZPC Res BV, Metslawier, Netherlands; [Kull, Inger; Melen, Erik] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [van Hage, Marianne] Karolinska Univ Hosp, Stockholm, Sweden; [Bustamante, Mariona; Anto, Josep M.; Kogevinas, Manolis; Sunyer, Jordi] Inst Global Hlth, ISGlobal, Barcelona, Spain; [Bustamante, Mariona; Anto, Josep M.; Sunyer, Jordi] Univ Pompeu Fabra, Barcelona, Spain; [Lertxundi, Aitana] Univ Basque Country UPV EHU, Prevent Med & Publ Hlth Dept, Leioa, Spain; [Lertxundi, Aitana] Hlth Res Inst Biodonostia, Donostia San Sebastian, Gipuzkoa, Spain; [Torrent, Matias] Hlth Res Inst Balear Isl, Balear Isl, Spain; [Torrent, Matias] Ib Salut, Area Salut Menorca, Menorca, Spain; [Fantini, Maria Pia; Gori, Davide] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Fyhrquist, Nanna] Univ Helsinki, Human Microbiome Program, Medicum, Helsinki, Finland; [Laatikainen, Tiina] Finnish Inst Hlth & Welf, Helsinki, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, Bonn, Germany; [Bousquet, Jean] Univ Hosp, Montpellier, France; [Bousquet, Jean] Charite, Dept Dermatol, Berlin, Germany; [Bousquet, Jean] IMIM Hosp del Mar Med Res Inst, Barcelona, Spain; [Laprise, Catherine] Ctr Sante & Serv Sociaux Saguenay Lac St Jean, Quebec City, PQ, Canada; [Haahtela, Tari] Univ Helsinki, Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Melen, Erik] Sachs Childrens Hosp, Stockholm, Sweden	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Radboud University Nijmegen; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Valencia; Universitat Jaume I; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Utrecht University; University of Southern California; University of Oslo; University of Oslo; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska University Hospital; ISGlobal; Pompeu Fabra University; University of Basque Country; Atencio Primaria de Menorca; University of Bologna; University of Helsinki; University of Eastern Finland; University of Bonn; Universite de Montpellier; CHU de Montpellier; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Helsinki; Helsinki University Central Hospital	Xu, CJ (corresponding author), Ctr Individualized Infect Med, TWINCORE Feodor Lynen St 7, D-30625 Hannover, Germany.	Xu.Chengjian@mh-hannover.de	Bustamante, Mariona/ABB-9142-2021; Sunyer, Jordi/G-6909-2014; Xu, Cheng-Jian/G-9144-2018; Li, Yang/HGT-8446-2022; Laatikainen, Tiina/ABD-6622-2021; Xu, Cheng/GXH-4815-2022; Esplugues, Ana/AAX-5393-2021; Esplugues, Ana/AAX-5245-2021	Bustamante, Mariona/0000-0003-0127-2860; Sunyer, Jordi/0000-0002-2602-4110; Xu, Cheng-Jian/0000-0003-1586-4672; Li, Yang/0000-0003-4022-7341; Laatikainen, Tiina/0000-0002-6614-4782; Xu, Cheng/0000-0003-1000-733X; Esplugues, Ana/0000-0002-7647-7900; Alenius, Harri/0000-0003-0106-8923; Gori, Davide/0000-0003-4954-9419; Koppelman, Gerard/0000-0001-8567-3252; LERTXUNDI MANTEROLA, AITANA/0000-0002-9421-6237; Nawijn, Martijn/0000-0003-3372-6521; Pesce, Giancarlo/0000-0003-4925-6325; Gehring, Ulrike/0000-0003-3612-5780; Qi, Cancan/0000-0003-3825-5802; Bousquet, Jean/0000-0002-4061-4766	Seventh Framework Programme [261357]; BBMRI-NL; Dutch government [NWO 184.021.007]; European Research Council Advanced Grant [833247]; Spinoza Grant from The Netherlands Organization for Scientific Research	Seventh Framework Programme(European Commission); BBMRI-NL; Dutch government; European Research Council Advanced Grant(European Research Council (ERC)); Spinoza Grant from The Netherlands Organization for Scientific Research	The Mechanisms of the Development of Allergy (MeDALL) European Union project was supported by the Seventh Framework Programme (grant agreement 261357). The Biobank-Based Integrative Omics Studies (BIOS) Consortium was funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007). Cohort-specific funding is described in the Online Supplement (at www.jacionline.org).The funders of the study had no role in design of the study, data gathering, analysis, interpretation, writing of the article, or in the decision to submit it for publication. M.G.N. was supported by a European Research Council Advanced Grant (833247) and a Spinoza Grant from The Netherlands Organization for Scientific Research.	Afshar R, 2013, J ALLERGY CLIN IMMUN, V131, P1644, DOI 10.1016/j.jaci.2013.03.002; Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Arathimos R, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0414-7; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bigler J, 2017, AM J RESP CRIT CARE, V195, P1311, DOI 10.1164/rccm.201604-0866OC; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; Cardenas A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11058-3; Chen W, 2017, J ALLERGY CLIN IMMUN, V140, P571, DOI 10.1016/j.jaci.2016.11.030; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Everson TM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0213-8; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Forno E, 2019, LANCET RESP MED, V7, P336, DOI 10.1016/S2213-2600(18)30466-1; Fox J., 2019, R COMPANION APPL REG, V3rd; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huang T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86689; Jiang Y, 2020, EPIGENETICS-US, V15, P454, DOI 10.1080/15592294.2019.1699983; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Laprise C, 2014, GENES IMMUN, V15, P247, DOI 10.1038/gene.2014.12; Lemonnier N, 2020, ALLERGY, V75, P3248, DOI 10.1111/all.14314; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Linneberg A, 2011, ALLERGY, V66, P1, DOI 10.1111/j.1398-9995.2011.02619.x; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Paparo L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38738-w; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pedersen BS, 2012, BIOINFORMATICS, V28, P2986, DOI 10.1093/bioinformatics/bts545; Peng C, 2019, EPIGENETICS-US, V14, P445, DOI 10.1080/15592294.2019.1590085; Peng C, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0488-x; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Qi CC, 2020, J ALLERGY CLIN IMMUN, V145, P1655, DOI [10.1016/j.jaci.2020.12.911, 10.1016/j.jaci.2019.12.911]; Qi CC, 2019, EXPERT REV CLIN IMMU, V15, P1287, DOI 10.1080/1744666X.2020.1686977; Quraishi BM, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0108-y; Reese SE, 2019, J ALLERGY CLIN IMMUN, V143, P2062, DOI 10.1016/j.jaci.2018.11.043; Sakuma S, 2006, PROSTAG OTH LIPID M, V79, P271, DOI 10.1016/j.prostaglandins.2006.02.005; Salazar F, 2016, J ALLERGY CLIN IMMUN, V137, P1841, DOI 10.1016/j.jaci.2015.10.033; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tost J, 2018, J ALLERGY CLIN IMMUN, V142, P715, DOI 10.1016/j.jaci.2018.07.009; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Watson CT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02188-7; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu CJ, 2018, LANCET RESP MED, V6, P379, DOI 10.1016/S2213-2600(18)30052-3; Xu CJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3452-1; Yang IV, 2017, J ALLERGY CLIN IMMUN, V139, P1478, DOI 10.1016/j.jaci.2016.07.036; Yang IV, 2015, J ALLERGY CLIN IMMUN, V136, P69, DOI 10.1016/j.jaci.2015.01.025; Zhang HM, 2019, ALLERGY, V74, P1166, DOI 10.1111/all.13746; Zhu YC, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0617-7	49	8	8	1	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1031	1040		10.1016/j.jaci.2020.11.044	http://dx.doi.org/10.1016/j.jaci.2020.11.044		MAR 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	33338541	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-18	WOS:000635524300008
J	Fusaro, M; Rosain, J; Grandin, V; Lambert, N; Hanein, S; Fourrage, C; Renaud, N; Gil, M; Chevalier, S; Abou Chahla, W; Bader-Meunier, B; Barlogis, V; Blanche, S; Boutboul, D; Castelle, M; Comont, T; Diana, JS; Fieschi, C; Galicier, L; Hermine, O; Lefevre-Utile, A; Malphettes, M; Merlin, E; Oksenhendler, E; Pasquet, M; Suarez, F; Andre, I; Beziat, V; de Saint Basile, G; De Villartay, JP; Kracker, S; Lagresle-Peyrou, C; Latour, S; Rieux-Laucat, F; Mahlaoui, N; Bole, C; Nitschke, P; Hulier-Ammar, E; Fischer, A; Moshous, D; Neven, B; Alcais, A; Vogt, G; Bustamante, J; Picard, C				Fusaro, Mathieu; Rosain, Jeremie; Grandin, Virginie; Lambert, Nathalie; Hanein, Sylvain; Fourrage, Cecile; Renaud, Nicholas; Gil, Marine; Chevalier, Samuel; Abou Chahla, Wadih; Bader-Meunier, Brigitte; Barlogis, Vincent; Blanche, Stephane; Boutboul, David; Castelle, Martin; Comont, Thibault; Diana, Jean-Sebastien; Fieschi, Claire; Galicier, Lionel; Hermine, Olivier; Lefevre-Utile, Alain; Malphettes, Marion; Merlin, Etienne; Oksenhendler, Eric; Pasquet, Marlene; Suarez, Felipe; Andre, Isabelle; Beziat, Vivien; de Saint Basile, Genevieve; De Villartay, Jean-Pierre; Kracker, Sven; Lagresle-Peyrou, Chantal; Latour, Sylvain; Rieux-Laucat, Frederic; Mahlaoui, Nizar; Bole, Christine; Nitschke, Patrick; Hulier-Ammar, Elisabeth; Fischer, Alain; Moshous, Despina; Neven, Benedicte; Alcais, Alexandre; Vogt, Guillaume; Bustamante, Jacinta; Picard, Capucine			Improving the diagnostic efficiency of primary immunodeficiencies with targeted next-generation sequencing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MEDICAL GENETICS; AMERICAN-COLLEGE; EXOME		[Fusaro, Mathieu; Rosain, Jeremie; Hermine, Olivier; de Saint Basile, Genevieve; Moshous, Despina; Neven, Benedicte; Bustamante, Jacinta; Picard, Capucine] Univ Paris, Paris, France; [Fourrage, Cecile; Nitschke, Patrick] Bioinformat Core Facil, Paris, France; [Hanein, Sylvain; Fourrage, Cecile; Renaud, Nicholas; Andre, Isabelle; Nitschke, Patrick] INSERM, UMR 1163, Paris, France; [Fusaro, Mathieu; Rosain, Jeremie; Grandin, Virginie; Lambert, Nathalie; Chevalier, Samuel; de Saint Basile, Genevieve; Bustamante, Jacinta; Picard, Capucine] Necker Hosp Sick Children, AP HP, Study Ctr Primary Immunodeficienicias, Paris, France; [Bader-Meunier, Brigitte; Blanche, Stephane; Castelle, Martin; Diana, Jean-Sebastien; Lefevre-Utile, Alain; Picard, Capucine] Necker Hosp Sick Children, AP HP, Pediat Immunohematol & Rheumatol Unit, Paris, France; [Hermine, Olivier] Necker Hosp Sick Children, AP HP, Dept Adult Hematol, Paris, France; [Hanein, Sylvain; Fourrage, Cecile; Renaud, Nicholas; Gil, Marine] INSERM UMR 1163, Lab Lymphocyte Activat & Susceptibil EBV infect, Paris, France; [Rosain, Jeremie; Beziat, Vivien; Alcais, Alexandre] INSERM UMR 1163, Lab Human Genet Infect Dis, Necker Branch, Paris, France; [Fourrage, Cecile] INSERM UMR 1163, Lab Human Lymphohematopoiesis, Paris, France; [Fourrage, Cecile; de Saint Basile, Genevieve] INSERM UMR 1163, Lab Normal & Pathol Homeostasis Immune Syst, Paris, France; [Diana, Jean-Sebastien; De Villartay, Jean-Pierre] INSERM UMR 1163, Lab Genome Dynam Immune Syst, Paris, France; [Rieux-Laucat, Frederic; Neven, Benedicte] INSERM UMR 1163, Lab Immunogenet Pediat Autoimmune Dis, Paris, France; [Fourrage, Cecile] Univ Paris, CNRS, Unite Mixte Serv 3633, INSERM, Paris, France; [Abou Chahla, Wadih] Jeanne Flandre Hosp, Dept Pediat Hematol, Lille, France; [Barlogis, Vincent] La Timone Hosp, Dept Pediat Hematol, Marseille, France; [Hermine, Olivier; Suarez, Felipe; Mahlaoui, Nizar; Picard, Capucine] Necker Hosp Sick Children, AP HP, French Natl Reference Ctr Primary Immune Deficien, Ctr Reference Deficits Immunitaires Hereditaires, Paris, France; [Malphettes, Marion; Oksenhendler, Eric] St Louis Hosp, AP HP, Dept Clin Immunol, Paris, France; [Comont, Thibault] Inst Univ Canc Oncopole, Dept Internal Med, Toulouse, France; [Lefevre-Utile, Alain] Jean Verdier Hosp, AP HP, Dept Gen Pediat, Bondy, France; [Merlin, Etienne] Estaing Hosp, Dept Pediat, Clermont Ferrand, France; [Oksenhendler, Eric] Paris Diderot Univ, Paris, France; [Fourrage, Cecile] Children Hosp, Pediat Oncol Immunol Hematol Unit, Toulouse, France; [Fischer, Alain] Coll France, Paris, France; [Vogt, Guillaume] Univ Paris, Neglected Human Genet Lab, INSERM, Paris, France; [Vogt, Guillaume] Inst Sapiens, Paris, France; [Vogt, Guillaume] Le Commissariat Energie Atom & Energies Alternat, Neglected Human Genet Lab, Ctr Natl Rech Genom Humaine, Evry, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Clermont Ferrand; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Fusaro, M (corresponding author), Univ Paris, Paris, France.		Béziat, Vivien/AAT-4097-2021; Comont, Thibault/AAO-3974-2020; Andre, Isabelle/F-6263-2013; Hermine, Olivier/Q-7072-2018; Béziat, Vivien/G-2971-2011; Lagresle Peyrou, Chantal/H-2911-2017; Rieux-Laucat, Frederic/A-7916-2017; Merlin, Etienne/N-8315-2014; de villartay, jeanpierre/H-9353-2017	Béziat, Vivien/0000-0002-4020-824X; Andre, Isabelle/0000-0002-3905-9910; Béziat, Vivien/0000-0002-4020-824X; Lagresle Peyrou, Chantal/0000-0002-2216-6453; Rieux-Laucat, Frederic/0000-0001-7858-7866; Merlin, Etienne/0000-0001-6527-7893; de villartay, jeanpierre/0000-0001-5987-0463; Rosain, Jeremie/0000-0002-2822-161X	Centre de Reference Deficits Immunitaires Hereditaires; European Research Area Network (ERA-Net) for Research Programs on Rare Diseases (E-Rare)	Centre de Reference Deficits Immunitaires Hereditaires; European Research Area Network (ERA-Net) for Research Programs on Rare Diseases (E-Rare)	This work was supported by the Centre de Reference Deficits Immunitaires Hereditaires and European Research Area Network (ERA-Net) for Research Programs on Rare Diseases (E-Rare).	Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004; Mahlaoui N, 2019, J ALLERGY CLIN IMMUN, V143, P1646, DOI 10.1016/j.jaci.2018.12.994; Meyts I, 2016, J ALLERGY CLIN IMMUN, V138, P957, DOI 10.1016/j.jaci.2016.08.003; Notarangelo LD, 2017, J ALLERGY CLIN IMMUN, V139, P715, DOI 10.1016/j.jaci.2017.01.004; Picard C, 2014, EUR J IMMUNOL, V44, P2854, DOI 10.1002/eji.201444669; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Yska HAF, 2019, J CLIN IMMUNOL, V39, P577, DOI 10.1007/s10875-019-00656-x	9	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					734	737		10.1016/j.jaci.2020.05.046	http://dx.doi.org/10.1016/j.jaci.2020.05.046		FEB 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32531373	Green Submitted, Bronze			2022-12-18	WOS:000616665800036
J	Gabryszewski, SJ; Chang, X; Dudley, JW; Mentch, F; March, M; Holmes, JH; Moore, J; Grundmeier, RW; Hakonarson, H; Hill, DA				Gabryszewski, Stanislaw J.; Chang, Xiao; Dudley, Jesse W.; Mentch, Frank; March, Michael; Holmes, John H.; Moore, Jason; Grundmeier, Robert W.; Hakonarson, Hakon; Hill, David A.			Unsupervised modeling and genome-wide association identify novel features of allergic march trajectories	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic march; allergic march; allergic trajectory; atopic dermatitis; IgE-mediated food allergy; asthma; allergic rhinitis; epidemiology; genome-wide association study		Background: The allergic march refers to the natural history of allergic conditions during infancy and childhood. However, population-level disease incidence patterns do not necessarily reflect the development of allergic disease in individuals. A better understanding of the factors that predispose to different allergic trajectories is needed. Objective: Our aim was to determine the demographic and genetic features that are associated with the major allergic march trajectories. Methods: Presence or absence of common allergic conditions (atopic dermatitis [AD], IgE-mediated food allergy [IgE-FA], asthma, and allergic rhinitis [AR]) was ascertained in a pediatric primary care birth cohort of 158,510 subjects. Hierarchic clustering and decision tree modeling were used to associate demographic features with allergic outcomes. Genome-wide association study was used to test for risk loci associated with specific allergic trajectories. Results: We found an association between self-identified black race and progression from AD to asthma. Conversely, Asian or Pacific Islander race was associated with progression from AD to IgE-mediated food allergy, and white race was associated with progression from AD to AR. Genome-wide association study of trajectory groups identified risk loci associated with progression from AD to asthma (rs60242841) and from AD to AR (rs9565267, rs151041509, and rs78171803). Consistent with our epidemiologic associations, rs60242841 was more common in individuals of African ancestry than in individuals of European ancestry, whereas rs9565267 and rs151041509 were more common in individuals of European ancestry than in individuals of African ancestry. Conclusion: We have identified novel associations between race and progression along distinct allergic trajectories. Ancestral genetic differences may contribute to these associations. These results uncover important health disparities, refine the concept of the allergic march, and represent a step toward developing individualized medical approaches for these conditions.	[Gabryszewski, Stanislaw J.; Hill, David A.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Abramson Res Bldg,1208B,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Chang, Xiao; Mentch, Frank; March, Michael; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Dudley, Jesse W.; Grundmeier, Robert W.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Holmes, John H.; Moore, Jason] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Grundmeier, Robert W.; Hakonarson, Hakon; Hill, David A.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Hill, David A.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Hill, DA (corresponding author), Childrens Hosp Philadelphia, Div Allergy & Immunol, Abramson Res Bldg,1208B,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	hilld3@email.chop.edu	Xiao, Chang/AAO-9713-2020; Moore, Jason H./AAV-9645-2021	Moore, Jason H./0000-0002-5015-1099; Hill, David/0000-0001-9286-4268	National Institutes of Health [DK116668, LM010098, AI116794, LM012601]; Children's Hospital of Philadelphia Endowed Chair in Genomic Research; American College of Allergy, Asthma, and Immunology; American Academy of Allergy, Asthma, and Immunology; American Partnership for Eosinophilic Disorders; Children's Hospital of Philadelphia Research Institute Developmental awards; Center for Applied Genomics	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Philadelphia Endowed Chair in Genomic Research; American College of Allergy, Asthma, and Immunology; American Academy of Allergy, Asthma, and Immunology; American Partnership for Eosinophilic Disorders; Children's Hospital of Philadelphia Research Institute Developmental awards; Center for Applied Genomics	Supported by the National Institutes of Health (grants DK116668 [to D.A.H.], LM010098 [to J.M.], AI116794 [to J.M.], and LM012601 [to J.M.]); the Children's Hospital of Philadelphia Endowed Chair in Genomic Research (to H.H.); the American College of Allergy, Asthma, and Immunology (to D.A.H.); the American Academy of Allergy, Asthma, and Immunology (to D.A.H.); the American Partnership for Eosinophilic Disorders (to D.A.H.); and the Children's Hospital of Philadelphia Research Institute Developmental awards to the Hill Lab and the Center for Applied Genomics (to H.H.). The content of this work is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Almoguera B, 2019, J ALLERGY CLIN IMMUN, V143, P1229, DOI 10.1016/j.jaci.2018.10.038; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Atkinson E.J., INTRO RECURSIVE PART; Aw M, 2020, INT ARCH ALLERGY IMM, V181, P1, DOI 10.1159/000502958; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Belgrave DCM, 2015, CURR DERMATOL REP, V4, P221, DOI 10.1007/s13671-015-0121-6; Belgrave DCM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001748; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Dharmage SC, 2014, ALLERGY, V69, P17, DOI 10.1111/all.12268; Feemster KA, 2011, INTERDISCIP PERSPECT, V2011; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Gamble C, 2010, J ALLERGY CLIN IMMUN, V126, P1149, DOI 10.1016/j.jaci.2010.08.049; Greenhawt M, 2013, J ALLER CL IMM-PRACT, V1, P378, DOI 10.1016/j.jaip.2013.04.009; Hill DA, 2018, ANN ALLERG ASTHMA IM, V121, P137, DOI 10.1016/j.anai.2018.04.014; Hill DA, 2018, J ALLER CL IMM-PRACT, V6, P1528, DOI 10.1016/j.jaip.2018.05.010; Hill DA, 2018, ANN ALLERG ASTHMA IM, V120, P131, DOI 10.1016/j.anai.2017.10.037; Hill DA, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0673-z; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Jones AV, 2017, HUM MOL GENET, V26, P1391, DOI 10.1093/hmg/ddx036; Joseph CLM, 2016, ANN ALLERG ASTHMA IM, V116, P219, DOI 10.1016/j.anai.2015.12.019; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Khramtsova EA, 2019, NAT REV GENET, V20, P173, DOI 10.1038/s41576-018-0083-1; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kowalski MH, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008500; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Mahdavinia M, 2017, J ALLER CL IMM-PRACT, V5, P352, DOI 10.1016/j.jaip.2016.10.006; Moore JH, 2019, PERS MED, V16, P247, DOI 10.2217/pme-2018-0145; Ortiz RA, 2015, IMMUNOL ALLERGY CLIN, V35, P19, DOI 10.1016/j.iac.2014.09.014; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P46, DOI 10.1016/j.jaci.2018.11.006; Peters U, 2018, J ALLERGY CLIN IMMUN, V141, P1169, DOI 10.1016/j.jaci.2018.02.004; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prins BP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10812-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruffner MA, 2020, J ALLER CL IMM-PRACT, V8, P1039, DOI 10.1016/j.jaip.2019.10.047; Sitarik A, 2020, ANN ALLERG ASTHMA IM, V124, P342, DOI 10.1016/j.anai.2020.01.001; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; U.S. Department of Health and Human Services National Institutes of Health, 2007, EXPERT PANEL REPORT; Waage J, 2018, NAT GENET, V50, P1072, DOI 10.1038/s41588-018-0157-1; WILKINSON DY, 1987, MILBANK Q, V65, P56, DOI 10.2307/3349951; Yudell M, 2016, SCIENCE, V351, P564, DOI 10.1126/science.aac4951; Zhu ZZ, 2020, J ALLERGY CLIN IMMUN, V145, P537, DOI 10.1016/j.jaci.2019.09.035; Zhu ZZ, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01507-2019; Zhu ZZ, 2018, NAT GENET, V50, P857, DOI 10.1038/s41588-018-0121-0	48	8	8	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					677	+		10.1016/j.jaci.2020.06.026	http://dx.doi.org/10.1016/j.jaci.2020.06.026		FEB 2021	19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32650023	Green Accepted, Bronze			2022-12-18	WOS:000616665800029
J	Melen, E; Standl, M; Gehring, U; Altug, H; Anto, JM; Berdel, D; Bergstrom, A; Bousquet, J; Heinrich, J; Koppelman, GH; Kull, I; Lupinek, C; Markevych, I; Schikowski, T; Thiering, E; Valenta, R; van Hage, M; von Berg, A; Vonk, JM; Wickman, M; Wijga, A; Gruzieva, O				Melen, Erik; Standl, Marie; Gehring, Ulrike; Altug, Hicran; Anto, Josep Maria; Berdel, Dietrich; Bergstrom, Anna; Bousquet, Jean; Heinrich, Joachim; Koppelman, Gerard H.; Kull, Inger; Lupinek, Christian; Markevych, Iana; Schikowski, Tamara; Thiering, Elisabeth; Valenta, Rudolf; van Hage, Marianne; von Berg, Andrea; Vonk, Judith M.; Wickman, Magnus; Wijga, Alet; Gruzieva, Olena			Air pollution and IgE sensitization in 4 European birth cohorts-the MeDALL project	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; allergen; air pollution; children; cohort; IgE; sensitization; meta-analysis		Background: Whether long-term exposure air to pollution has effects on allergic sensitization is controversial. Objective: Our aim was to investigate associations of air pollution exposure at birth and at the time of later biosampling with IgE sensitization against common food and inhalant allergens, or specific allergen molecules, in children aged up to 16 years. Methods: A total of 6163 children from 4 European birth cohorts participating in the Mechanisms of the Development of ALLergy [MeDALL] consortium were included in this meta-analysis of the following studies: Children, Allergy, Milieu, Stockholm, Epidemiology (BAMSE) (Sweden), Influences of Lifestyle-Related Factors on the Human Immune System and Development of Allergies in Childhood (LISA)/German Infant Study on the Influence of Nutrition Intervention PLUS Environmental and Genetic Influences on Allergy Development (GINIplus) (Germany), and Prevention and Incidence of Asthma and Mite Allergy (PIAMA) (The Netherlands). The following indicators were modeled by land use regression: individual residential outdoor levels of particulate matter with aerodynamic diameters less than 2.5 mu m, less than 10 mu m, and between 2.5 and 10 mu m; PM2.5 absorbance (a measurement of the blackness of PM2.5 filters); and nitrogen oxides levels. Blood samples drawn at ages 4 to 6 (n = 5989), 8 to 10 (n = 6603), and 15 to 16 (n = 5825) years were analyzed for IgE sensitization to allergen extracts by ImmunoCAP. Additionally, IgE against 132 allergen molecules was measured by using the MedALL microarray chip (n = 1021). Results: Air pollution was not consistently associated with IgE sensitization to any common allergen extract up to age 16 years. However, allergen-specific analyses suggested increased risks of sensitization to birch (odds ratio [OR] = 1.12 [95% CI = 1.01-1.25] per 10-mu g/m(3) increase in NO2 exposure). In a subpopulation with microarray data, IgE to the major timothy grass allergen Phleum pratense 1 (Phl p 1) and the cat allergen Felis domesticus 1 (Fel d 1) greater than 3.5 Immuno Solid-phase Allergen Chip standardized units for detection of IgE antibodies were related to PM2.5 exposure at birth (OR = 3.33 [95% CI = 1.40-7.94] and OR = 4.98 [95% CI = 1.59-15.60], respectively, per 5-mu g/m(3) increase in exposure). Conclusion: Air pollution exposure does not seem to increase the overall risk of allergic sensitization; however, sensitization to birch as well as grass pollen Phl p 1 and cat Fel d 1 allergen molecules may be related to specific pollutants.	[Melen, Erik; Kull, Inger] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Melen, Erik; Kull, Inger] Sachs Childrens Hosp, Stockholm, Sweden; [Standl, Marie; Heinrich, Joachim; Markevych, Iana; Thiering, Elisabeth] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Gehring, Ulrike] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Altug, Hicran; Schikowski, Tamara] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Anto, Josep Maria] Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain; [Anto, Josep Maria] Univ Pompeu Fabra, Barcelona, Spain; [Anto, Josep Maria] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Anto, Josep Maria] Hosp Mar Med Res Inst, Barcelona, Spain; [Berdel, Dietrich; von Berg, Andrea] Marien Hosp Wesel, Res Inst, Dept Pediat, Wesel, Germany; [Bergstrom, Anna; Gruzieva, Olena] Karolinska Inst, Inst Environm Med, Nobels Vag 13,Box 210, SE-17177 Stockholm, Sweden; [Bousquet, Jean] MACVIA France, Malad Chron Vieillissement Actif France European, Montpellier, France; [Bousquet, Jean] INSERM U1168, VIMA Ageing & Chron Dis Epidemiol & Publ Hlth App, Villejuif, France; [Bousquet, Jean] Univ Versailles St Quentin En Yvelines, Montigny Le Bretonneux, France; [Heinrich, Joachim; Markevych, Iana] Ludwig Maximilians Univ Munchen, Inst & Clin Occupat Social & Environm Med, Univ Hosp, Munich, Germany; [Heinrich, Joachim] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Koppelman, Gerard H.; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Lupinek, Christian; Valenta, Rudolf] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Markevych, Iana] Jagielonian Univ, Inst Psychol, Krakow, Poland; [Thiering, Elisabeth] Ludwig Maximilians Univ Munchen, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Univ Hosp, Munich, Germany; [Valenta, Rudolf] Sechenov First Moscow State Med Univ, Dept Clin Immunol & Allergy, Lab Immunopathol, Moscow, Russia; [Valenta, Rudolf] Inst Immunol FMBA Russia, Natl Res Ctr, Moscow, Russia; [Valenta, Rudolf] Karl Landsteiner Univ Hlth Sci, Krems, Austria; [van Hage, Marianne] Karolinska Inst, Dept Med Solna, Div Immunol & Allergy, Stockholm, Sweden; [van Hage, Marianne] Karolinska Univ Hosp, Stockholm, Sweden; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wickman, Magnus] Uppsala Univ, Ctr Clin Res Sormland, Eskilstuna, Sweden; [Wijga, Alet] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Gruzieva, Olena] Ctr Occupat & Environm Med, Stockholm, Region Stockhol, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Utrecht University; Leibniz Institut fur Umweltmedizinische Forschung (IUF); ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; St. Marien Hospital; Karolinska Institutet; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Munich; University of Melbourne; University of Groningen; University of Groningen; Medical University of Vienna; Jagiellonian University; University of Munich; Sechenov First Moscow State Medical University; NRC Institute of Immunology FMBA of Russia; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Groningen; Uppsala University; Netherlands National Institute for Public Health & the Environment	Gruzieva, O (corresponding author), Karolinska Inst, Inst Environm Med, Nobels Vag 13,Box 210, SE-17177 Stockholm, Sweden.	olena.gruzieva@ki.se	Lupinek, Christian/I-3311-2019; Heinrich, Joachim/N-1720-2013	Lupinek, Christian/0000-0002-8612-8245; Gehring, Ulrike/0000-0003-3612-5780; Bousquet, Jean/0000-0002-4061-4766; Valenta, Rudolf/0000-0001-5944-3365; Markevych, Iana/0000-0002-5214-0748; Koppelman, Gerard/0000-0001-8567-3252; Heinrich, Joachim/0000-0002-9620-1629	European Community [211250, 261357]; Swedish Research Council; Swedish Heart-Lung Foundation; Region Stockholm; Strategic Research Programme in Epidemiology at Karolinska Institutet; Swedish Research Council Formas; Swedish Environment Protection Agency; Swedish Asthma and Allergy Research Foundation; Cancer and Allergy Foundation; European Research Council [757919]; Swedish Research Council for Health, Working Life and Welfare [FORTE 201701146]; Austrian Science Fund [F4605]; Megagrant of the Government of the Russian Federation [14.W03.31.0024]; Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health, Welfare, and Sport; Grant of The Netherlands Organization for Scientific Research; Helmholtz Zentrum Munich; IUF-Leibniz Research Institute for Environmental Medicine at the University of Dusseldorf; Federal Ministry for Environment (IUF Dusseldorf) [FKZ 20462296]; Commission of the European Communities, the Seventh Framework Program: MeDALL project; Mead Johnson; Nestle; Federal Ministry for Education, Science, Research and Technology; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Research Institute at Marien-Hospital Wesel; Pediatric Practice; Seventh Framework Program: MeDALL project; NeuroSmog: Determining the Impact of Air Pollution on the Developing Brain [POIR.04.04.00-1763/18-00]; European Union from the European Regional Development Fund under the Smart Growth Operational Programme; Bad Honnef	European Community(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Region Stockholm; Strategic Research Programme in Epidemiology at Karolinska Institutet; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Environment Protection Agency; Swedish Asthma and Allergy Research Foundation; Cancer and Allergy Foundation; European Research Council(European Research Council (ERC)European Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Austrian Science Fund(Austrian Science Fund (FWF)); Megagrant of the Government of the Russian Federation; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health, Welfare, and Sport; Grant of The Netherlands Organization for Scientific Research; Helmholtz Zentrum Munich; IUF-Leibniz Research Institute for Environmental Medicine at the University of Dusseldorf; Federal Ministry for Environment (IUF Dusseldorf); Commission of the European Communities, the Seventh Framework Program: MeDALL project; Mead Johnson; Nestle(Nestle SA); Federal Ministry for Education, Science, Research and Technology; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Research Institute at Marien-Hospital Wesel; Pediatric Practice; Seventh Framework Program: MeDALL project; NeuroSmog: Determining the Impact of Air Pollution on the Developing Brain; European Union from the European Regional Development Fund under the Smart Growth Operational Programme; Bad Honnef	The research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement numbers: 211250 (European Study of Cohorts for Air Pollution Effects [ESCAPE]), and 261357 (Mechanisms of the Development of ALLergy [MeDALL]). Children, Allergy, Milieu, Stockholm, Epidemiology (BAMSE) was supported by The Swedish Research Council, The Swedish Heart-Lung Foundation, Region Stockholm (ALF project, and database maintenance), the Strategic Research Programme in Epidemiology at Karolinska Institutet, the Swedish Research Council Formas and the Swedish Environment Protection Agency, the Swedish Asthma and Allergy Research Foundation, the Cancer and Allergy Foundation. E.M. is supported by a grant from the European Research Council (grant agreement 757919, TRIBAL). O.G. is supported by the Swedish Research Council for Health, Working Life and Welfare (FORTE 201701146). R.V. is supported the by Austrian Science Fund (grant F4605) and is a recipient of a Megagrant of the Government of the Russian Federation (grant 14.W03.31.0024). The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) study was supported by project grants from The Netherlands Organization for Health Research and Development; The Netherlands Organization for Scientific Research; The Netherlands Asthma Fund; The Netherlands Ministry of Spatial Planning, Housing, and the Environment; and The Netherlands Ministry of Health, Welfare, and Sport. U.G. was supported by a Grant of The Netherlands Organization for Scientific Research. The German Infant Study on the Influence of Nutrition Intervention PLUS Environmental and Genetic Influences on Allergy Development (GINIplus) study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (formerly GSF) (observational arm). The 4-year, 6-year, 10-year, and 15-year follow-up examinations of the GINIplus study were covered from the respective budgets of the 5 study centers (Helmholtz Zentrum Munich [formerly GSF], Research Institute at MarienHospital Wesel, LMU Munich, TU Munich), and from year 6 onward it was also supported with funding from from IUF-Leibniz Research Institute for Environmental Medicine at the University of Dusseldorf and by a grant from the Federal Ministry for Environment (IUF Dusseldorf [grant FKZ 20462296]). Furthermore, the 15-year follow-up examination of the GINIplus study was supported by the Commission of the European Communities, the Seventh Framework Program MeDALL project, and by the companies Mead Johnson and Nestl~e. The Influences of Lifestyle-Related Factors on the Human Immune System and Development of Allergies in Childhood (LISA) study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and also from Helmholtz Zentrum Munich (formerly GSF), the Helmholtz Centre for Environmental Research-UFZ, Leipzig, the Research Institute at Marien-Hospital Wesel, Pediatric Practice, and Bad Honnef for the first 2 years.; The 4-year, 6-year, 10-year, and 15-year follow-up examinations of the LISA study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich [formerly GSF], the Helmholtz Centre for Environmental Research-UFZ, Leipzig, the Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, and IUF-Leibniz-Research Institute for Environmental Medicine at the University ofD_usseldorf) and also by a grant from the Federal Ministry for Environment (IUF D_usseldorf [grant FKZ 20462296]). Furthermore, the 15-year follow-up examination of the LISA study was supported by the Commission of the European Communities, the Seventh Framework Program: MeDALL project. I.M. is supported by a grant from the NeuroSmog: Determining the Impact of Air Pollution on the Developing Brain (grant POIR.04.04.00-1763/18-00) which is implemented as part of the TEAM-NET programme of the Foundation for PXean Regional Development Fund under the Smart Growth Operational Programme.	Ackaert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104520; Alberg T, 2014, J TOXICOL ENV HEAL A, V77, P281, DOI 10.1080/15287394.2013.863746; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bousquet J, 2011, ALLERGY, V66, P596, DOI 10.1111/j.1398-9995.2010.02534.x; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; Castaneda AR, 2017, J TOXICOL ENV HEAL A, V80, P197, DOI 10.1080/15287394.2016.1222920; Cesaroni G, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-48; Cyrys J, 2012, ATMOS ENVIRON, V62, P374, DOI 10.1016/j.atmosenv.2012.07.080; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Durant JL, 2014, SCI TOTAL ENVIRON, V487, P290, DOI 10.1016/j.scitotenv.2014.04.019; Eckl-Dorna J, 2010, J ALLERGY CLIN IMMUN, V126, P1315, DOI 10.1016/j.jaci.2010.06.012; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k; Eeftens M, 2011, OCCUP ENVIRON MED, V68, P765, DOI 10.1136/oem.2010.061135; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Fuertes E, 2015, ALLERGY, V70, P1350, DOI 10.1111/all.12611; Fuertes E, 2013, PEERJ, V1, DOI 10.7717/peerj.193; Gehring U, 2015, LANCET RESP MED, V3, P933, DOI 10.1016/S2213-2600(15)00426-9; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Gruzieva O, 2014, J ALLERGY CLIN IMMUN, V133, P767, DOI 10.1016/j.jaci.2013.07.048; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Heinrich J, 2019, ALLERGO J, V28, P20, DOI 10.1007/s40629-018-0078-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Knox RB, 1997, CLIN EXP ALLERGY, V27, P246; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Madsen C, 2011, ATMOS ENVIRON, V45, P3576, DOI 10.1016/j.atmosenv.2011.03.069; Maejima K, 2001, INHAL TOXICOL, V13, P1047, DOI 10.1080/089583701753210407; Molter A, 2015, EUR RESPIR J, V45, P610, DOI 10.1183/09031936.00083614; Montagne D, 2013, ENVIRON SCI TECHNOL, V47, P8523, DOI 10.1021/es400920a; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Oftedal B, 2007, CLIN EXP ALLERGY, V37, P1632, DOI 10.1111/j.1365-2222.2007.02823.x; Ryan PH, 2008, SCI TOTAL ENVIRON, V404, P139, DOI 10.1016/j.scitotenv.2008.05.051; Schappi GF, 1997, J ALLERGY CLIN IMMUN, V100, P656, DOI 10.1016/S0091-6749(97)70170-2; Schiavoni G, 2017, ANN ALLERG ASTHMA IM, V118, P269, DOI 10.1016/j.anai.2016.12.019; Schraufnagel DE, 2019, CHEST, V155, P417, DOI 10.1016/j.chest.2018.10.041; Schultz ES, 2012, AM J RESP CRIT CARE, V186, P1286, DOI 10.1164/rccm.201206-1045OC; Schultzl ES, 2016, AM J RESP CRIT CARE, V193, P171, DOI 10.1164/rccm.201505-0928OC; Sordillo JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28216-0; Wang RR, 2013, ATMOS ENVIRON, V64, P312, DOI 10.1016/j.atmosenv.2012.09.056; Westman M, 2020, J ALLERGY CLIN IMMUN, V145, P1174, DOI 10.1016/j.jaci.2020.01.006; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Wickman M, 2017, EBIOMEDICINE, V26, P91, DOI 10.1016/j.ebiom.2017.11.009	47	8	8	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					713	722		10.1016/j.jaci.2020.08.030	http://dx.doi.org/10.1016/j.jaci.2020.08.030		FEB 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32926877	hybrid, Green Published			2022-12-18	WOS:000616665800033
J	Kottyan, LC; Trimarchi, MP; Lu, XM; Caldwell, JM; Maddox, A; Parameswaran, S; Lape, M; D'Mello, RJ; Bonfield, M; Ballaban, A; Mukkada, V; Putnam, PE; Abonia, P; Morgenstern, NBB; Eapen, AA; Wen, T; Weirauch, MT; Rothenberg, ME				Kottyan, Leah C.; Trimarchi, Michael P.; Lu, Xiaoming; Caldwell, Julie M.; Maddox, Avery; Parameswaran, Sreeja; Lape, Michael; D'Mello, Rahul J.; Bonfield, Madeline; Ballaban, Adina; Mukkada, Vincent; Putnam, Philip E.; Abonia, Pablo; Morgenstern, Netali Ben-Baruch; Eapen, Amy A.; Wen, Ting; Weirauch, Matthew T.; Rothenberg, Marc E.			Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; genetics; esophagitis; eosinophil; epithelium; polymorphism; variant; atopy	GENOME-WIDE ASSOCIATION; ENVIRONMENTAL EXPOSURES; COMMON VARIANTS; ATOPIC DISEASE; EXPRESSION; SUSCEPTIBILITY; LOCI; POLYMORPHISMS; ELIMINATION; ETIOLOGY	Background: Eosinophilic esophagitis (EoE) is an emerging, chronic, rare allergic disease associated with marked eosinophil accumulation in the esophagus. Previous genome-wide association studies have provided strong evidence for 3 genomewide susceptibility loci. Objective: We sought to replicate known and suggestive EoE genetic risk loci and conduct a meta-analysis of previously reported data sets. Methods: An EoE-Custom single-nucleotide polymophism (SNP) Chip containing 956 candidate EoE risk single-nucleotide polymorphisms was used to genotype 627 cases and 365 controls. Statistical power was enhanced by adding 1959 external controls and performing meta-analyses with 2 independent EoE genome-wide association studies. Results: Meta-analysis identified replicated association and genome-wide significance at 6 loci: 2p23 (2 independent genetic effects) and 5q22, 10p14, 11q13, and 16p13. Seven additional loci were identified at suggestive significance (P < 10(-6)): 1q31, 5q23, 6q15, 6q21, 8p21, 17q12, and 22q13. From these risk loci, 13 protein-coding EoE candidate risk genes were expressed in a genotype-dependent manner. EoE risk genes were expressed in disease-relevant cell types, including esophageal epithelia, fibroblasts, and immune cells, with some expressed as a function of disease activity. The genetic risk burden of EoE-associated genetic variants was markedly larger in cases relative to controls (P < 10(-38)); individuals with the highest decile of genetic burden had greater than 12-fold risk of EoE compared with those within the lowest decile. Conclusions: This study extends the genetic underpinnings of EoE, highlighting 13 genes whose genotype-dependent expression expands our etiologic understanding of EoE and provides a framework for a polygenic risk score to be validated in future studies.	[Kottyan, Leah C.; Trimarchi, Michael P.; Caldwell, Julie M.; D'Mello, Rahul J.; Ballaban, Adina; Abonia, Pablo; Morgenstern, Netali Ben-Baruch; Eapen, Amy A.; Wen, Ting; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Kottyan, Leah C.; Lu, Xiaoming; Maddox, Avery; Parameswaran, Sreeja; Lape, Michael; Abonia, Pablo; Eapen, Amy A.; Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Kottyan, Leah C.; Mukkada, Vincent; Putnam, Philip E.; Wen, Ting; Weirauch, Matthew T.; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Lape, Michael] Univ Cincinnati, Coll Med, Grad Program Biomed Informat, Cincinnati, OH USA; [D'Mello, Rahul J.; Bonfield, Madeline] Univ Cincinnati, Coll Med, Immunol Grad Program, Cincinnati, OH USA; [Mukkada, Vincent; Putnam, Philip E.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Rothenberg, ME (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, 3333 Burnet Ave,MLC7028, Cincinnati, OH 45229 USA.	rothenberg@cchmc.org	Lu, Xiaoming/I-5426-2018; D'Mello, Rahul/H-8030-2018	Lu, Xiaoming/0000-0002-0830-2826; Bonfield, Madeline/0000-0003-0940-7707; Eapen, Amy/0000-0003-1629-1511; Ben-Baruch Morgenstern, Netali/0000-0001-6530-0387; Kottyan, Leah/0000-0003-3979-2220; D'Mello, Rahul/0000-0001-8343-0572	Consortium of Food Allergy Researchers (COFAR, National Institute of Allergy and Infectious Diseases grant) [U19AI066738]	Consortium of Food Allergy Researchers (COFAR, National Institute of Allergy and Infectious Diseases grant)	This study was originally funded by the Consortium of Food Allergy Researchers (COFAR, National Institute of Allergy and Infectious Diseases grant no. U19AI066738), and we thank the associated investigators for their contributions. We thank Drs James Franciosi, Michael Farrell, Jose Garza, Scott Pentiuk, Conrad Cole, Tom Lin, Ajay Kaul, and numerous other physicians in the Division of Gastroenterology at Cincinnati Children's Hospital Medical Center. We thank Shawna Hottinger for editorial assistance.	Abonia JP, 2012, ANNU REV MED, V63, P421, DOI 10.1146/annurev-med-041610-134138; Alexander ES, 2014, J ALLERGY CLIN IMMUN, V134, P1084, DOI 10.1016/j.jaci.2014.07.021; Azouz NP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz7773; Azouz NP, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9736; Barski A, 2016, J IMMUNOL, V196; Benninger MS, 2017, INT FORUM ALLERGY RH, V7, P757, DOI 10.1002/alr.21968; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Capucilli P, 2019, CLIN REV ALLERG IMMU, V57, P111, DOI 10.1007/s12016-019-08733-0; Chehade M, 2018, J ALLER CL IMM-PRACT, V6, P1534, DOI 10.1016/j.jaip.2018.05.038; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; D'Mello RJ, 2016, MUCOSAL IMMUNOL, V9, P744, DOI 10.1038/mi.2015.98; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Davis BP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86355; Davis BP, 2016, ANNU REV PATHOL-MECH, V11, P365, DOI 10.1146/annurev-pathol-012615-044241; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dos Santos RS, 2019, DIABETOLOGIA, V62, P459, DOI 10.1007/s00125-018-4782-0; Doucet-Ladeveze R, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00467; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Edgar AJ, 2001, AM J RESP CELL MOL, V25, P119, DOI 10.1165/ajrcmb.25.1.4417; Elias MS, 2019, J ALLERGY CLIN IMMUN, V144, P470, DOI 10.1016/j.jaci.2019.05.024; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Geng JL, 2019, J IMMUNOL, V202, P2991, DOI 10.4049/jimmunol.1801626; Grant FM, 2020, J EXP MED, V217, DOI 10.1084/jem.20190711; Green DJ, 2015, MAYO CLIN PROC, V90, P1400, DOI 10.1016/j.mayocp.2015.07.015; Hirano I, 2020, GASTROENTEROLOGY, V158, P111, DOI 10.1053/j.gastro.2019.09.042; Hirano I, 2019, GASTROENTEROLOGY, V156, P592, DOI 10.1053/j.gastro.2018.10.051; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Huth S, 2015, EXP DERMATOL, V24, P663, DOI 10.1111/exd.12704; Jang E, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0352-x; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V141, P632, DOI 10.1016/j.jaci.2017.07.010; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V141, P214, DOI 10.1016/j.jaci.2017.05.018; Jensen ET, 2015, BEST PRACT RES CL GA, V29, P721, DOI 10.1016/j.bpg.2015.06.008; Johansson E, 2017, J ALLERGY CLIN IMMUN, V140, P595, DOI 10.1016/j.jaci.2017.02.003; Kennedy RB, 2012, HUM GENET, V131, P1403, DOI 10.1007/s00439-012-1174-2; Kliewer KL, 2016, J ALLERGY CLIN IMMUN, V137, P1011, DOI 10.1016/j.jaci.2015.10.040; Kottyan LC, 2017, MUCOSAL IMMUNOL, V10, P580, DOI 10.1038/mi.2017.4; Kottyan LC, 2020, J ALLERGY CLIN IMMUN, V145, P9, DOI 10.1016/j.jaci.2019.11.013; Kottyan LC, 2019, GENES IMMUN, V20, P281, DOI 10.1038/s41435-018-0034-z; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Labreche K, 2019, NEURO-ONCOLOGY, V21, P1039, DOI 10.1093/neuonc/noz088; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Litosh VA, 2017, J ALLERGY CLIN IMMUN, V139, P1762, DOI 10.1016/j.jaci.2016.09.027; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu XM, 2015, AM J HUM GENET, V96, P731, DOI 10.1016/j.ajhg.2015.03.002; Lv HC, 2017, ONCOTARGET, V8, P7891, DOI 10.18632/oncotarget.13631; Lyons PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12515-9; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marees AT, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1608; Martin LJ, 2018, J ALLERGY CLIN IMMUN, V141, P1690, DOI 10.1016/j.jaci.2017.09.046; Martino DJ, 2017, CLIN EXP ALLERGY, V47, P217, DOI 10.1111/cea.12863; Martino D, 2015, J ALLERGY CLIN IMMUN, V135, P1319, DOI 10.1016/j.jaci.2014.12.1933; Masterson JC, 2014, GUT, V63, P43, DOI 10.1136/gutjnl-2012-303631; Miller DE, 2019, G3-GENES GENOM GENET, V9, P729, DOI 10.1534/g3.118.200901; Mishra A, 2008, GASTROENTEROLOGY, V134, P204, DOI 10.1053/j.gastro.2007.10.002; Namjou B, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00401; Nasrallah R, 2020, NATURE, V583, P447, DOI 10.1038/s41586-020-2296-7; O'Shea KM, 2018, GASTROENTEROLOGY, V154, P333, DOI 10.1053/j.gastro.2017.06.065; Patel ZH, 2018, HUM MOL GENET, V27, P2392, DOI 10.1093/hmg/ddy140; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Peng C, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0488-x; Rothenberg ME, 2015, GASTROENTEROLOGY, V148, P1143, DOI 10.1053/j.gastro.2015.02.002; Rothenberg ME, 2015, J ALLERGY CLIN IMMUN, V135, P500, DOI 10.1016/j.jaci.2014.07.049; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Simon D, 2016, ALLERGY, V71, P611, DOI 10.1111/all.12846; Sleiman PMA, 2015, BEST PRACT RES CL GA, V29, P701, DOI 10.1016/j.bpg.2015.09.003; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suaini NHA, 2019, ALLERGY, V74, P1631, DOI 10.1111/all.13767; Tam RCY, 2017, EXP CELL RES, V352, P304, DOI 10.1016/j.yexcr.2017.02.017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Warners MJ, 2015, BEST PRACT RES CL GA, V29, P793, DOI 10.1016/j.bpg.2015.06.013; Wen T, 2019, J CLIN INVEST, V129, P2014, DOI 10.1172/JCI125917; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zheng YX, 2020, EUR J IMMUNOL, V50, P426, DOI 10.1002/eji.201948320; Zuo L, 2010, J IMMUNOL, V185, P660, DOI 10.4049/jimmunol.1000471	85	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					255	266		10.1016/j.jaci.2020.10.018	http://dx.doi.org/10.1016/j.jaci.2020.10.018		JAN 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	33446330	Green Accepted			2022-12-18	WOS:000607781700001
J	Luecke, E; Jeron, A; Kroeger, A; Bruder, D; Stegemann-Koniszewski, S; Jechorek, D; Borucki, K; Reinhold, D; Reinhold, A; Foellner, S; Walles, T; Hachenberg, T; Schreiber, J				Luecke, Eva; Jeron, Andreas; Kroeger, Andrea; Bruder, Dunja; Stegemann-Koniszewski, Sabine; Jechorek, Doerthe; Borucki, Katrin; Reinhold, Dirk; Reinhold, Annegret; Foellner, Sebastian; Walles, Thorsten; Hachenberg, Thomas; Schreiber, Jens			Eosinophilic pulmonary vasculitis as a manifestation of the hyperinflamma- tory phase of COVID-19	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									[Luecke, Eva; Stegemann-Koniszewski, Sabine; Foellner, Sebastian; Schreiber, Jens] Otto von Guericke Univ, Dept Pneumol, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany; [Jeron, Andreas; Bruder, Dunja] Otto von Guericke Univ, Infect Immunol Grp, Inst Med Microbiol & Hosp Hyg, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany; [Jeron, Andreas; Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Kroeger, Andrea] Otto von Guericke Univ, Mol Microbiol Grp, Inst Med Microbiol & Hosp Hyg, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany; [Jechorek, Doerthe] Otto von Guericke Univ, Dept Pathol, Magdeburg, Germany; [Borucki, Katrin] Otto von Guericke Univ, Inst Clin Chem, Magdeburg, Germany; [Reinhold, Dirk; Reinhold, Annegret] Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Walles, Thorsten] Otto von Guericke Univ, Dept Cardiothorac Surg, Magdeburg, Germany; [Hachenberg, Thomas] Otto von Guericke Univ, Dept Anaesthesiol & Intens Care Therapy, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University	Luecke, E (corresponding author), Otto von Guericke Univ, Dept Pneumol, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany.	eva.luecke@med.ovgu.de						Lindsley AW, 2020, J ALLERGY CLIN IMMUN, V146, P1, DOI 10.1016/j.jaci.2020.04.021; Sims JT, 2021, J ALLERGY CLIN IMMUN, V147, P107, DOI 10.1016/j.jaci.2020.08.031; Xie GG, 2021, ALLERGY, V76, P471, DOI 10.1111/all.14465; Zhao L, 2021, ALLERGY, V76, P562, DOI 10.1111/all.14455	4	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					112	113		10.1016/j.jaci.2020.09.026	http://dx.doi.org/10.1016/j.jaci.2020.09.026		JAN 2021	2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	33139059	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000613645900015
J	Tomar, S; Ganesan, V; Sharma, A; Zeng, C; Waggoner, L; Smith, A; Kim, CH; Licona-Limon, P; Reinhardt, RL; Flavell, RA; Wang, YH; Hogan, SP				Tomar, Sunil; Ganesan, Varsha; Sharma, Ankit; Zeng, Chang; Waggoner, Lisa; Smith, Andrew; Kim, Chang H.; Licona-Limon, Paula; Reinhardt, Richard L.; Flavell, Richard A.; Wang, Yui-Hsi; Hogan, Simon P.			IL-4-BATF signaling directly modulates IL-9 producing mucosal mast cell (MMC9) function in experimental food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; IL-4; IL-9; mast cell; BATF; transcriptome; metabolism	T-CELL; TRANSCRIPTION FACTOR; INTERLEUKIN-3 IL-3; MOUSE; PROGENITORS; GROWTH; BATF; ANAPHYLAXIS; EXPRESSION; PATHWAY	Background: This study group has previously identified IL-9-producing mucosal mast cell (MMC9) as the primary source of IL-9 to drive intestinal mastocytosis and experimental IgE-mediated food allergy. However, the molecular mechanisms that regulate the expansion of MMC9s remain unknown. Objectives: This study hypothesized that IL-4 regulates MMC9 development and MMC9-dependent experimental IgE-mediated food allergy. Methods: An epicutaneous sensitization model was used and bone marrow reconstitution experiments were performed to test the requirement of IL-4 receptor a (IL-4Ra) signaling on MMC9s in experimental IgE-mediated food allergy. Flow cytometric, bulk, and single-cell RNA-sequencing analyses on small intestine (SI) MMC9s were performed to illuminate MMC9 transcriptional signature and the effect of IL-4Ra signaling on MMC9 function. A bone marrow-derived MMC9 culture system was used to define IL-4-BATF signaling in MMC9 development. Results: Epicutaneous sensitization- and bone marrow reconstitution-based models of IgE-mediated food allergy revealed an IL-4 signaling-dependent cell-intrinsic effect on SI MMC9 accumulation and food allergy severity. RNA-sequencing analysis of SI-MMC9s identified 410 gene transcripts reciprocally regulated by IL-4 signaling, including Il9 and Batf. In silico analyses identified a 3491-gene MMC9 transcriptional signature and identified 2 transcriptionally distinct SI MMC9 populations enriched for metabolic or inflammatory programs. Employing an in vitro MMC9-culture model system showed that generation of MMC9-like cells was induced by IL-4 and this was in part dependent on BATF. Conclusions: IL-4Ra signaling directly modulates MMC9 function and exacerbation of experimental IgE-mediated food allergic reactions. IL-4Ra regulation of MMC9s is in part BATF-dependent and occurs via modulation of metabolic transcriptional programs.	[Tomar, Sunil; Ganesan, Varsha; Zeng, Chang; Waggoner, Lisa; Smith, Andrew; Wang, Yui-Hsi; Hogan, Simon P.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Tomar, Sunil; Ganesan, Varsha; Sharma, Ankit; Kim, Chang H.; Hogan, Simon P.] Univ Michigan, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI 48109 USA; [Tomar, Sunil; Ganesan, Varsha; Sharma, Ankit; Kim, Chang H.; Hogan, Simon P.] Univ Michigan, Dept Pathol, Michigan Med, Ann Arbor, MI 48109 USA; [Licona-Limon, Paula; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Reinhardt, Richard L.] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA; [Reinhardt, Richard L.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wang, Yui-Hsi] Sanofi, Type Inflammat & Fibrosis Cluster 2, Immunol & Inflammat Res, Cambridge, MA USA	Cincinnati Children's Hospital Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; Howard Hughes Medical Institute; Sanofi-Aventis	Hogan, SP (corresponding author), Univ Michigan, Mary H Weiser Food Allergy Ctr, Dept Pathol, 5063 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.; Wang, YH (corresponding author), Sanofi Inc, Immunol & Inflammat Therapeut Area, 270 Albany St, Cambridge, MA 02139 USA.	Yui-Hsi.Wang@sanofi.com; sihogan@med.umich.edu	Kim, Chang/ABG-8200-2020	Kim, Chang/0000-0003-4618-9139; sharma, ankit/0000-0002-0156-1948	DoD from the National Institutes of Health [W81XWH-15-1-051730]; Food Allergy Research and Education, M-FARA; Mary H. Weiser Food Allergy Center;  [DK073553];  [AI112626];  [AI138177];  [AI140133]	DoD from the National Institutes of Health; Food Allergy Research and Education, M-FARA; Mary H. Weiser Food Allergy Center; ; ; ; 	This work was supported by grants DK073553, AI112626, AI138177, AI140133, and DoD W81XWH-15-1-051730 from the National Institutes of Health (to Y.-H.W. and S.P.H.); and by the Food Allergy Research and Education, M-FARA, and Mary H. Weiser Food Allergy Center (to S.P.H).	Abonia JP, 2005, BLOOD, V105, P4308, DOI 10.1182/blood-2004-09-3578; Ahrens R, 2012, AM J PATHOL, V180, P1535, DOI 10.1016/j.ajpath.2011.12.036; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Arumugam M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-14; Bankova LG, 2015, MUCOSAL IMMUNOL, V8, P596, DOI 10.1038/mi.2014.91; Bao K, 2016, J IMMUNOL, V197, P4371, DOI 10.4049/jimmunol.1601371; Bischoff SC, 2002, INT ARCH ALLERGY IMM, V127, P118, DOI 10.1159/000048181; Bischoff SC, 1999, P NATL ACAD SCI USA, V96, P8080, DOI 10.1073/pnas.96.14.8080; Blom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021695; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Branum Amy M, 2008, NCHS Data Brief, P1; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Caslin HL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03026; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; COLEMAN JW, 1993, J IMMUNOL, V150, P556; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; EKLUND KK, 1993, J IMMUNOL, V151, P4266; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Fu YY, 2019, J IMMUNOL, V203, P1989, DOI 10.4049/jimmunol.1900128; Glover LE, 2016, J CLIN INVEST, V126, P3680, DOI 10.1172/JCI84429; Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hallgren J, 2011, ADV EXP MED BIOL, V716, P14, DOI 10.1007/978-1-4419-9533-9_2; HAMAGUCHI Y, 1987, J EXP MED, V165, P268, DOI 10.1084/jem.165.1.268; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Johnston LK, 2014, J IMMUNOL, V192, P2529, DOI 10.4049/jimmunol.1303026; Kanagaratham C, 2018, CELL MOL GASTROENTER, V6, P356, DOI 10.1016/j.jcmgh.2018.05.010; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kitahata Y, 2010, INT ARCH ALLERGY IMM, V152, P22, DOI 10.1159/000312122; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuwahara M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12596; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; Lee JB, 2016, J ALLERGY CLIN IMMUN, V137, P1216, DOI 10.1016/j.jaci.2015.09.019; Lee WH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0348-6; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Matsuzawa S, 2003, J IMMUNOL, V170, P3461, DOI 10.4049/jimmunol.170.7.3461; McInnes L, 180203426 ARXIV; McLeod JJA, 2015, CYTOKINE, V75, P57, DOI 10.1016/j.cyto.2015.05.019; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Miller MM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay3994; MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654; Noah TK, 2019, J ALLERGY CLIN IMMUN, V144, P1058, DOI 10.1016/j.jaci.2019.04.030; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Qayum AA, 2019, J IMMUNOL, V203, P1111, DOI 10.4049/jimmunol.1900272; RENNICK D, 1995, BLOOD, V85, P57, DOI 10.1182/blood.V85.1.57.bloodjournal85157; Ryan JJ, 1998, J IMMUNOL, V161, P6915; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shik D, 2017, SEMIN IMMUNOPATHOL, V39, P69, DOI 10.1007/s00281-016-0605-x; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; SMITH CA, 1986, P NATL ACAD SCI USA, V83, P1857, DOI 10.1073/pnas.83.6.1857; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tachdjian R, 2010, J ALLERGY CLIN IMMUN, V125, P1128, DOI 10.1016/j.jaci.2010.01.054; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toru H, 1997, BLOOD, V89, P3296, DOI 10.1182/blood.V89.9.3296; Tsuda M, 2019, MUCOSAL IMMUNOL, V12, P644, DOI 10.1038/s41385-018-0122-4; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; VALENT P, 1991, P NATL ACAD SCI USA, V88, P3339, DOI 10.1073/pnas.88.8.3339; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	84	8	8	8	22	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					280	295		10.1016/j.jaci.2020.08.043	http://dx.doi.org/10.1016/j.jaci.2020.08.043		JAN 2021	16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	33069715	Bronze, Green Accepted			2022-12-18	WOS:000607781700003
J	Stevens, ML; Gonzalez, T; Schauberger, E; Kyzy, AB; Andersen, H; Spagna, D; Kalra, MK; Martin, LJ; Haslam, D; Herr, AB; Myers, JMB; Hershey, GKK				Stevens, Mariana L.; Gonzalez, Tammy; Schauberger, Eric; Kyzy, Asel Baatyrbek; Andersen, Heidi; Spagna, Daniel; Kalra, Mehak K.; Martin, Lisa J.; Haslam, David; Herr, Andrew B.; Myers, Jocelyn M. Biagini; Hershey, Gurjit K. Khurana			Simultaneous skin biome and keratinocyte genomic capture reveals microbiome differences by depth of sampling	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS		[Stevens, Mariana L.; Schauberger, Eric; Kyzy, Asel Baatyrbek; Spagna, Daniel; Kalra, Mehak K.; Myers, Jocelyn M. Biagini; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Gonzalez, Tammy; Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Andersen, Heidi; Haslam, David; Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Martin, Lisa J.; Haslam, David; Herr, Andrew B.; Myers, Jocelyn M. Biagini; Hershey, Gurjit K. Khurana] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Hershey, GKK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA.	gurjit.hershey@cchmc.org	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399	Deutsche Forschungsgemeinschaft (German Research Foundation) [369799452/404459235, 369799452/404458960, 369799452/404448265]; Shenzhen Municipal Government of China [JCYJ20170817145536203]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Shenzhen Municipal Government of China	This study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation; grant no. 369799452/404459235 to M.L.-K., grant no. 369799452/404458960 to C. G_unther, and grant no. 369799452/404448265 to E.L.), and by the Shenzhen Municipal Government of China (grant no. JCYJ20170817145536203 to M.F.).	Bolin K, 2019, RHEUMATOLOGY, V58, P918, DOI 10.1093/rheumatology/key419; Demirkaya E, 2017, ARTHRITIS RHEUMATOL, V69, P1832, DOI 10.1002/art.40158; Kim H, 2018, CLIN PHARMACOL THER, V104, P364, DOI 10.1002/cpt.936; Konig N, 2017, ANN RHEUM DIS, V76, P468, DOI 10.1136/annrheumdis-2016-209841; Lintner KE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00036; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Wallace DJ, 2018, LANCET, V392, P222, DOI 10.1016/S0140-6736(18)31363-1; Zimmermann N, 2019, JAMA DERMATOL, V155, P342, DOI 10.1001/jamadermatol.2018.5077	9	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1442	1445		10.1016/j.jaci.2020.04.004	http://dx.doi.org/10.1016/j.jaci.2020.04.004			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32320735	Bronze, Green Accepted			2022-12-18	WOS:000596937900027
J	Suprun, M; Sicherer, SH; Wood, RA; Jones, SM; Leung, DYM; Henning, AK; Dawson, P; Burks, AW; Lindblad, R; Getts, R; Suarez-Farinas, M; Sampson, HA				Suprun, Maria; Sicherer, Scott H.; Wood, Robert A.; Jones, Stacie M.; Leung, Donald Y. M.; Henning, Alice K.; Dawson, Peter; Burks, A. Wesley; Lindblad, Robert; Getts, Robert; Suarez-Farinas, Mayte; Sampson, Hugh A.			Early epitope-specific IgE antibodies are predictive of childhood peanut allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Peanut allergy; epitopes; antibodies; IgE; IgG(4); Ara h 1; Ara h 2; Ara h 3; Bead-Based Epitope Assay; machine learning; precision medicine	ARA H 2; FOOD ALLERGY; MICROARRAY IMMUNOASSAY; MUTATIONAL ANALYSIS; BINDING EPITOPES; HUMAN IGG4; IGG(4); PREVALENCE; EXPRESSION; COMPONENTS	Background: Peanut allergy is characterized by the development of IgE against peanut antigen. Objective: We sought to evaluate the evolution of epitopespecific (es)IgE and esIgG(4) in a prospective cohort of high-risk infants to determine whether antibody profiles can predict peanut allergy after age 4 years. Methods: The end pointwas allergy status at age 4(+) years; samples from 293 childrenwere collected at age 3 to 15 months and 2 to 3 and 4(+) years. Levels of specific (s)IgE and sIgG4 to peanut and component proteins, and 50 esIgE and esIgG(4) were quantified. Changes were analyzed with mixed-effects models. Machine learning algorithms were developed to identify a combination of antigen- and epitope-specific antibodies that using 3- to 15-month or 2- to 3-year samples can predict allergy status at age 4(+) years. Results: At age 4(+) years, 38% of children were Tolerant or 14% had Possible, 8% Convincing, 24% Serologic, and 16% Confirmed allergy. At age 3 to 15 months, esIgE profiles were similar among groups, whereas marked increases were evident at age 2 and 4(+) years only in Confirmed and Serologic groups. In contrast, peanut sIgE level was significantly lower in the Tolerant group at age 3 to 15 months, increased in Confirmed and Serologic groups but decreased in Convincing and Possibly Allergic groups over time. An algorithm combining esIgEs with peanut sIgE outperformed different clinically relevant IgE cutoffs, predicting allergy status on an ``unseen'' set of patients with area under the curves of 0.84 at age 3 to 15 months and 0.87 at age 2 to 3 years. Conclusions: Early epitope-specific plus peanut-specific IgE is predictive of allergy status at age 4(+) years.	[Suprun, Maria; Sicherer, Scott H.; Suarez-Farinas, Mayte; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Wood, Robert A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Jones, Stacie M.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Jones, Stacie M.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Leung, Donald Y. M.] Natl Jewish Hlth, Denver, CO USA; [Henning, Alice K.; Dawson, Peter; Lindblad, Robert] Emmes, Rockville, MD USA; [Burks, A. Wesley] Univ N Carolina, Chapel Hill, NC 27515 USA; [Getts, Robert] AllerGenis LLC, Hatfield, PA USA	Icahn School of Medicine at Mount Sinai; Johns Hopkins University; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; National Jewish Health; University of North Carolina; University of North Carolina Chapel Hill	Sampson, HA (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, Box 1089, New York, NY 10029 USA.	hugh.sampson@mssm.edu	Suprun, Maria/AAE-5507-2022		National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) [AI-066738, U19AI066738, U01AI066560]; David H. and Julia Koch Research Program in Food Allergy Therapeutics; AllerGenis LLC; National Jewish Health [UL1 TR-002535]; Mount Sinai [UL1 TR-000067]; University of Arkansas for Medical Sciences [UL1 TR-003107]; University of North Carolina [UL1 TR-000083]; Johns Hopkins from the National Center for Research Resources (NCRR), a component of the NIH [UL1 TR-000424]; National Institute of General Medical Sciences [T32GM062754]	National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); David H. and Julia Koch Research Program in Food Allergy Therapeutics; AllerGenis LLC; National Jewish Health; Mount Sinai; University of Arkansas for Medical Sciences; University of North Carolina; Johns Hopkins from the National Center for Research Resources (NCRR), a component of the NIH; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded in part by a grant from the National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID; grant nos. AI-066738, U19AI066738, and U01AI066560), the David H. and Julia Koch Research Program in Food Allergy Therapeutics, and AllerGenis LLC. The project was also supported by National Jewish Health (grant no. UL1 TR-002535), Mount Sinai (grant no. UL1 TR-000067), University of Arkansas for Medical Sciences (grant no. UL1 TR-003107), University of North Carolina (grant no. UL1 TR-000083), and Johns Hopkins (grant no. UL1 TR-000424) from the National Center for Research Resources (NCRR), a component of the NIH. M.S. was funded by the Integrated Pharmacological Sciences Training Program grant from the National Institute of General Medical Sciences (grant no. T32GM062754). The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.	Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Bunyavanich S, 2014, J ALLERGY CLIN IMMUN, V134, P753, DOI 10.1016/j.jaci.2014.05.050; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; Dang TD, 2012, J ALLERGY CLIN IMMUN, V129, P1056, DOI 10.1016/j.jaci.2012.01.056; Davies AM, 2015, IMMUNOL REV, V268, P139, DOI 10.1111/imr.12349; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Flinterman AE, 2008, J ALLERGY CLIN IMMUN, V121, P737, DOI 10.1016/j.jaci.2007.11.039; Gupta RS, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1235; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Klemans RJB, 2015, CLIN EXP ALLERGY, V45, P720, DOI 10.1111/cea.12412; Klemans RJB, 2013, J ALLER CL IMM-PRACT, V1, P632, DOI 10.1016/j.jaip.2013.07.014; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Koppelman SJ, 2004, CLIN EXP ALLERGY, V34, P583, DOI 10.1111/j.1365-2222.2004.1923.x; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lipovetsky S, 2009, INT J MATH EDUC SCI, V40, P271, DOI 10.1080/00207390802213609; Malbec O, 2007, IMMUNOL REV, V217, P206, DOI 10.1111/j.1600-065X.2007.00510.x; Maloney JM, 2008, J ALLERGY CLIN IMMUN, V122, P145, DOI 10.1016/j.jaci.2008.04.014; Martinet J, 2016, INT ARCH ALLERGY IMM, V169, P216, DOI 10.1159/000446181; Matsuo H, 2015, ALLERGOL INT, V64, P332, DOI 10.1016/j.alit.2015.06.009; Otsu K, 2015, CLIN EXP ALLERGY, V45, P471, DOI 10.1111/cea.12407; Palladino C, 2018, MOL IMMUNOL, V100, P58, DOI 10.1016/j.molimm.2018.04.005; Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P144, DOI 10.1016/j.jaci.2004.04.009; Peters RL, 2015, J ALLERGY CLIN IMMUN, V135, P1257, DOI 10.1016/j.jaci.2015.01.002; Pomes A, 2018, MOL IMMUNOL, V100, P3, DOI 10.1016/j.molimm.2018.03.003; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Radauer C, 2014, ALLERGY, V69, P413, DOI 10.1111/all.12348; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Santos AF, 2020, ALLERGY, V75, P2309, DOI 10.1111/all.14301; Schwarz A, 2016, J ALLERGY CLIN IMMUN, V138, P1426, DOI 10.1016/j.jaci.2016.01.057; Shamji MH, 2015, J ALLERGY CLIN IMMUN, V135, P913, DOI 10.1016/j.jaci.2014.09.049; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Shreffler WG, 2004, J ALLERGY CLIN IMMUN, V113, P776, DOI 10.1016/j.jaci.2003.12.588; Sicherer SH, 2019, ALLERGY, V74, P2199, DOI 10.1111/all.13920; Sicherer SH, 2016, J ALLER CL IMM-PRACT, V4, P239, DOI 10.1016/j.jaip.2015.11.015; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1077, DOI 10.1016/j.jaci.2010.02.038; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; Suarez-Farinas M, 2019, J ALLERGY CLIN IMMUN, V143, P1038, DOI 10.1016/j.jaci.2018.10.028; Suprun M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58951-2; Suprun M, 2019, BIOINFORMATICS, V35, P1605, DOI 10.1093/bioinformatics/bty853; van de Veen W, 2016, J ALLERGY CLIN IMMUN, V138, P1434, DOI 10.1016/j.jaci.2016.07.022; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P603, DOI 10.1016/j.jaci.2010.09.010; Zhang YP, 2013, BIOSTATISTICS, V14, P87, DOI 10.1093/biostatistics/kxs027	46	8	8	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1080	1088		10.1016/j.jaci.2020.08.005	http://dx.doi.org/10.1016/j.jaci.2020.08.005			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32795587	Green Accepted			2022-12-18	WOS:000588153700012
J	Urban, A; Volokhina, E; Felberg, A; Stasilojc, G; Blom, AM; Jongerius, I; van den Heuvel, L; Thiel, M; Oldziej, S; Arjona, E; de Cordoba, SR; Okroj, M				Urban, Aleksandra; Volokhina, Elena; Felberg, Anna; Stasilojc, Grzegorz; Blom, Anna M.; Jongerius, Ilse; van den Heuvel, Lambertus; Thiel, Marcel; Oldziej, Stanislaw; Arjona, Emilia; Rodriguez de Cordoba, Santiago; Okroj, Marcin			Gain-of-function mutation in complement C2 protein identified in a patient with aHUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							C3		[Urban, Aleksandra; Felberg, Anna; Stasilojc, Grzegorz; Thiel, Marcel; Oldziej, Stanislaw; Okroj, Marcin] Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland; [Urban, Aleksandra; Felberg, Anna; Stasilojc, Grzegorz; Thiel, Marcel; Oldziej, Stanislaw; Okroj, Marcin] Med Univ Gdansk, Gdansk, Poland; [Volokhina, Elena; van den Heuvel, Lambertus] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Amalia Childrens Hosp, Dept Pediat Nephrol,Dept Lab Med, Nijmegen, Netherlands; [Blom, Anna M.] Lund Univ, Dept Translat Med, Malmo, Sweden; [Jongerius, Ilse] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Jongerius, Ilse] Univ Amsterdam, Amsterdam Univ Med Ctr, Landsteiner Lab, Amsterdam, Netherlands; [Jongerius, Ilse] Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat Immunol Rheumatol & Infect Dis, Amsterdam, Netherlands; [van den Heuvel, Lambertus] Univ Hosp Leuven, Dept Pediat Nephrol, Leuven, Belgium; [van den Heuvel, Lambertus] Univ Hosp Leuven, Dept Growth & Regenerat, Leuven, Belgium; [Arjona, Emilia; Rodriguez de Cordoba, Santiago] Ctr Invest Biol, Madrid, Spain; [Arjona, Emilia; Rodriguez de Cordoba, Santiago] Ctr Invest Biomed Enfermedades Raras, Madrid, Spain	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Radboud University Nijmegen; Lund University; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Okroj, M (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland.; Okroj, M (corresponding author), Med Univ Gdansk, Gdansk, Poland.	marcin.okroj@gumed.edu.pl	van den Heuvel, Lambertus/AAM-1772-2021; Blom, Anna/B-9607-2009; Blom, Anna/AFS-7343-2022; Volokhina, Elena/L-4725-2015; Blom, Anna/AFS-7369-2022	van den Heuvel, Lambertus/0000-0003-3917-6727; Blom, Anna/0000-0002-1348-1734; Volokhina, Elena/0000-0002-4294-8460; Felberg, Anna/0000-0001-6271-6483; Oldziej, Stanislaw/0000-0002-4583-3941; Thiel, Marcel/0000-0002-6403-9436; Jongerius, Ilse/0000-0002-7759-9897; Stasilojc, Grzegorz/0000-0002-4158-1935	National Science Centre Poland [2015/18/M/NZ6/00334]; Ministerio de Economia y Competitividad/FEDER [SAF2015-66287-R]; Autonomous Region of Madrid [S2017/BMD-3673]	National Science Centre Poland(National Science Centre, Poland); Ministerio de Economia y Competitividad/FEDER; Autonomous Region of Madrid	Supported by National Science Centre Poland (grant 2015/18/M/NZ6/00334), Ministerio de Economia y Competitividad/FEDER (grant SAF2015-66287-R), and Autonomous Region of Madrid (grant S2017/BMD-3673).	Blom AM, 2016, J CLIN IMMUNOL, V36, P517, DOI 10.1007/s10875-016-0290-5; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; De Vriese AS, 2015, J AM SOC NEPHROL, V26, P2917, DOI 10.1681/ASN.2015020184; Felberg A, 2019, CANCER IMMUNOL IMMUN, V68, P587, DOI 10.1007/s00262-019-02304-0; Karpman D, 2017, J INTERN MED, V281, P123, DOI 10.1111/joim.12546; Krishnan V, 2009, ACTA CRYSTALLOGR D, V65, P266, DOI 10.1107/S0907444909000389; Kuttner-Kondo LA, 2003, J BIOL CHEM, V278, P52386, DOI 10.1074/jbc.M304620200; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Zhang YZ, 2017, AM J KIDNEY DIS, V70, P834, DOI 10.1053/j.ajkd.2017.07.004	9	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					916	919		10.1016/j.jaci.2020.02.014	http://dx.doi.org/10.1016/j.jaci.2020.02.014			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32113979	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000582395800023
J	Forno, E; Zhang, R; Jiang, YL; Kim, S; Yan, Q; Ren, Z; Han, YY; Boutaoui, N; Rosser, F; Weeks, DE; Acosta-Perez, E; Colon-Semidey, A; Alvarez, M; Canino, G; Chen, W; Celedon, JC				Forno, Erick; Zhang, Rong; Jiang, Yale; Kim, Soyeon; Yan, Qi; Ren, Zhao; Han, Yueh-Ying; Boutaoui, Nadia; Rosser, Franziska; Weeks, Daniel E.; Acosta-Perez, Edna; Colon-Semidey, Angel; Alvarez, Maria; Canino, Glorisa; Chen, Wei; Celedon, Juan C.			Transcriptome-wide and differential expression network analyses of childhood asthma in nasal epithelium	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Forno, Erick; Zhang, Rong; Jiang, Yale; Kim, Soyeon; Yan, Qi; Han, Yueh-Ying; Boutaoui, Nadia; Rosser, Franziska; Chen, Wei; Celedon, Juan C.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Pulm Med, Pittsburgh, PA 15224 USA; [Forno, Erick; Kim, Soyeon; Han, Yueh-Ying; Boutaoui, Nadia; Rosser, Franziska; Chen, Wei; Celedon, Juan C.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Zhang, Rong; Ren, Zhao] Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15260 USA; [Jiang, Yale] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Acosta-Perez, Edna; Canino, Glorisa] Univ Puerto Rico, Behav Sci Res Inst, San Juan, PR 00936 USA; [Colon-Semidey, Angel; Alvarez, Maria] Univ Puerto Rico, Dept Pediat, Med Sci Campus, San Juan, PR 00936 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Celedon, JC (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Pulm Med, Pittsburgh, PA 15224 USA.	celedon@chp.edu	Alvarez, Maria/GZH-1345-2022; Chen, Wei/AAX-5994-2020; Forno, Erick/I-1476-2019; Pérez, Edna Acosta/AAW-6672-2021	Chen, Wei/0000-0001-7196-8703; Forno, Erick/0000-0001-6497-9885; acosta, edna/0000-0001-7101-3157; Weeks, Daniel/0000-0001-9410-7228	US National Institutes of Health (NIH) [HL079966, HL117191, MD011764]; US NIH [HL125666, HL149693]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the US National Institutes of Health (NIH) (grant nos. HL079966, HL117191, and MD011764 [PI: J.C.C.]). E.F.'s contribution was supported by the US NIH (grant nos. HL125666 and HL149693). J.C.C. has received research materials from Merck and GlaxoSmithKline (inhaled steroids) and Pharmavite (vitamin D and placebo tablets), to provide medications free of cost to subjects participating in 2 NIH-funded studies unrelated to the current work. The rest of the authors declare that they have no relevant conflicts of interest.	Forno E, 2019, LANCET RESP MED, V7, P336, DOI 10.1016/S2213-2600(18)30466-1; Giovannini-Chami L, 2012, EUR RESPIR J, V39, P1197, DOI 10.1183/09031936.00070511; Pandey G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27189-4; Singhania A, 2018, AM J RESP CELL MOL, V58, P261, DOI 10.1165/rcmb.2017-0162OC; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tsai YH, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01962-2017; Yang IV, 2017, J ALLERGY CLIN IMMUN, V139, P1478, DOI 10.1016/j.jaci.2016.07.036; Yang IV, 2017, AM J RESP CRIT CARE, V195, P829, DOI 10.1164/rccm.201608-1558LE	9	8	8	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					671	675		10.1016/j.jaci.2020.02.005	http://dx.doi.org/10.1016/j.jaci.2020.02.005			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NN7PN	32088307	Bronze, Green Accepted			2022-12-18	WOS:000568978400004
J	[Anonymous]				[Anonymous]			Global lockdown, pollution, and respiratory allergic diseases: Are we in or are we out?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter													Locatello, Luca Giovanni/AAW-1460-2020	Locatello, Luca Giovanni/0000-0002-1879-5580; Gallo, Oreste/0000-0003-3426-7179; Bruno, Chiara/0000-0002-2506-4452					0	8	8	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					542	544		10.1016/j.jaci.2020.05.047	http://dx.doi.org/10.1016/j.jaci.2020.05.047			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NO0HS	32605856	Bronze, Green Published			2022-12-18	WOS:000569168900019
J	Nwaru, BI; Pillinger, R; Tibble, H; Shah, SA; Ryan, D; Critchley, H; Price, D; Hawrylowicz, CM; Simpson, CR; Soyiri, IN; Appiagye, F; Sheikh, A				Nwaru, Bright I.; Pillinger, Rebecca; Tibble, Holly; Shah, Syed A.; Ryan, Dermot; Critchley, Hilary; Price, David; Hawrylowicz, Catherine M.; Simpson, Colin R.; Soyiri, Ireneous N.; Appiagye, Francis; Sheikh, Aziz			Hormonal contraceptives and onset of asthma in reproductive-age women: Population-based cohort study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; cohort study; females; hormonal contraception; incidence; estrogen; progesterone; sex hormones	SEX STEROID-HORMONES; HOSPITAL ADMISSIONS; ESTROGEN; RISK; UK; EPIDEMIOLOGY; DISEASE; CARE	Background: Despite well-described sex differences in asthma incidence, there remains uncertainty about the role of female sex hormones in the development of asthma. Objective: We sought to investigate whether hormonal contraceptive use, its subtypes, and duration of use were associated with new-onset asthma in reproductive-age women. Methods: Using the Optimum Patient Care Research Database, a UK national primary care database, we constructed an open cohort of 16- to 45-year-old women (N = 564,896) followed for up to 17 years (ie, January 1, 2000, to December 31, 2016). We fitted multilevel Cox regression models to analyze the data. Results: At baseline, 26% of women were using any hormonal contraceptives. During follow-up (3,597,146 person-years), 25,288 women developed asthma, an incidence rate of 7.0 (95% CI, 6.9-7.1) per 1000 person-years. Compared with nonuse, previous use of any hormonal contraceptives (hazard ratio [HR], 0.70; 95% CI, 0.68-0.72), combined (HR, 0.70; 95% CI, 0.68-0.72), and progestogen-only therapy (HR, 0.70; 95% CI, 0.67-0.74) was associated with reduced risk of new-onset asthma. For current use, the estimates were as follows: any (HR, 0.63; 95% CI, 0.61-0.65), combined (HR, 0.65; 95% CI, 0.62-0.67), and progestogen-only therapy (HR, 0.59; 95% CI, 0.56-0.62). Longer duration of use (1-2 years: HR, 0.83; 95% CI, 0.81-0.86; 3-4 years: HR, 0.64; 95% CI, 0.61-0.67; 5+ years: HR, 0.46; 95% CI, 0.44-0.49) was associated with a lower risk of asthma onset than nonuse. Conclusions: Hormonal contraceptive use was associated with reduced risk of new-onset asthma in women of reproductive age. Mechanistic investigations to uncover the biological processes for these observations are required. Clinical trials investigating the safety and effectiveness of hormonal contraceptives for primary prevention of asthma will be helpful to confirm these results.	[Nwaru, Bright I.] Univ Gothenburg, Inst Med, Krefting Res Ctr, SE-40530 Gothenburg, Sweden; [Nwaru, Bright I.] Univ Gothenburg, Inst Med, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Nwaru, Bright I.; Pillinger, Rebecca; Tibble, Holly; Shah, Syed A.; Ryan, Dermot; Simpson, Colin R.; Soyiri, Ireneous N.; Sheikh, Aziz] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Med Informat Ctr, Asthma UK Ctr Appl Res, Edinburgh, Midlothian, Scotland; [Ryan, Dermot; Price, David; Appiagye, Francis] Optimum Patient Care, Cambridge, England; [Critchley, Hilary] Univ Edinburgh, Queens Med Res Inst, Med Res Council, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Price, David] Univ Aberdeen, Div Appl Hlth Sci, Acad Primary Care, Aberdeen, Scotland; [Price, David] Observat & Pragmat Res Inst, Singapore, Singapore; [Hawrylowicz, Catherine M.] Kings Coll London, Guys Hosp, Sch Immunol & Microbial Sci, Asthma UK Ctr Allerg Mech Asthma, London, England; [Simpson, Colin R.] Victoria Univ Wellington, Sch Hlth, Fac Hlth, Wellington, New Zealand; [Soyiri, Ireneous N.] Univ Hull, Inst Clin & Appl Hlth Res ICAHR, Hull York Med Sch, Kingston Upon Hull, N Humberside, England	University of Gothenburg; University of Gothenburg; University of Edinburgh; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Aberdeen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Victoria University Wellington; University of Hull; University of York - UK	Nwaru, BI (corresponding author), Univ Gothenburg, Inst Med, Krefting Res Ctr, SE-40530 Gothenburg, Sweden.	bright.nwaru@gu.se	Simpson, Colin R/L-7180-2014; Ryan, Dermot/AAJ-2329-2021; CRITCHLEY, HILARY OD/C-7575-2013; Tibble, Holly/D-1379-2017; Soyiri, Ireneous/H-4594-2011; Hawrylowicz, Catherine/Q-8483-2017	Simpson, Colin R/0000-0002-5194-8083; Ryan, Dermot/0000-0002-4115-7376; Tibble, Holly/0000-0001-7169-4087; Soyiri, Ireneous/0000-0003-4697-5156; Sheikh, Aziz/0000-0001-7022-3056; Hawrylowicz, Catherine/0000-0002-2337-7463	Asthma UK [AUK-IG-2016-346]; Health Data Research UK; Knut and Alice Wallenberg Foundation; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden; VBG Group Herman Krefting Foundation on Asthma and Allergy	Asthma UK; Health Data Research UK; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden; VBG Group Herman Krefting Foundation on Asthma and Allergy	This study was supported by Asthma UK (grant no. AUK-IG-2016-346) and Health Data Research UK. B.I.N. acknowledges the support of Knut and Alice Wallenberg Foundation, theWallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden, and the VBG Group Herman Krefting Foundation on Asthma and Allergy. The funders had no influence on the design of the study, interpretation of findings, or the decision to publish.	Baibergenova A, 2006, ANN ALLERG ASTHMA IM, V96, P666, DOI 10.1016/S1081-1206(10)61063-0; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bonds RS, 2013, CURR OPIN ALLERGY CL, V13, P92, DOI 10.1097/ACI.0b013e32835a6dd6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Forbes L, 1999, EUR RESPIR J, V14, P1028, DOI 10.1183/09031936.99.14510289; Jenkins MA, 2006, CLIN EXP ALLERGY, V36, P609, DOI 10.1111/j.1365-2222.2006.02475.x; Jones RCM, 2014, LANCET RESP MED, V2, P267, DOI 10.1016/S2213-2600(14)70008-6; Keselman A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00568; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kvaskoff M, 2015, HUM REPROD UPDATE, V21, P500, DOI 10.1093/humupd/dmv013; Kynyk JA, 2011, CURR OPIN PULM MED, V17, P6, DOI 10.1097/MCP.0b013e3283410038; Lange P, 2001, THORAX, V56, P613, DOI 10.1136/thorax.56.8.613; McCleary N, 2018, J ALLERGY CLIN IMMUN, V141, P1510, DOI 10.1016/j.jaci.2017.11.034; McLennan D., 2019, ENGLISH INDICES DEPR; Newcomb DC, 2015, J ALLERGY CLIN IMMUN, V136, P1025, DOI 10.1016/j.jaci.2015.05.046; Nwaru BI, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020075; Nwaru BI, 2015, J ROY SOC MED, V108, P358, DOI 10.1177/0141076815588320; Osman Mustafa, 2007, Prim Care Respir J, V16, P28, DOI 10.3132/pcrj.2007.00006; Piccinni MP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00642; Prescott E, 1997, THORAX, V52, P287, DOI 10.1136/thx.52.3.287; Price DB, 2015, LANCET RESP MED, V3, P849, DOI 10.1016/S2213-2600(15)00367-7; Ravani P, 2007, NEPHROL DIAL TRANSPL, V22, P2785, DOI 10.1093/ndt/gfm433; Salam MT, 2006, J ALLERGY CLIN IMMUN, V117, P1001, DOI 10.1016/j.jaci.2006.02.004; Scott HA, 2016, ALLERGY, V71, P1037, DOI 10.1111/all.12891; Signorello Lisa B, 2002, Am J Ther, V9, P199, DOI 10.1097/00045391-200205000-00005; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; TROISI RJ, 1995, AM J RESP CRIT CARE, V152, P1183, DOI 10.1164/ajrccm.152.4.7551368; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Wei JX, 2015, ANN ALLERG ASTHMA IM, V115, P21, DOI 10.1016/j.anai.2015.04.019; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911	31	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					438	446		10.1016/j.jaci.2020.02.027	http://dx.doi.org/10.1016/j.jaci.2020.02.027			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32305347	Green Submitted			2022-12-18	WOS:000558835000033
J	Cunningham, L; Simmonds, P; Kimber, I; Basketter, DA; McFadden, JP				Cunningham, Louise; Simmonds, Peter; Kimber, Ian; Basketter, David Arthur; McFadden, John Paul			Perforin and resistance to SARS coronavirus 2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Perforin; COVID; SARS; coronavirus; SARS-CoV-2; hemophagocytic lymphohistiocytosis; macrophage activation syndrome; cytokine storm; cytokine release; perforinopathies; natural killer; cytotoxic T lymphocyte; BCG; metformin			[Cunningham, Louise; McFadden, John Paul] Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England; [Simmonds, Peter] Univ Oxford, Nuffield Dept Med, Oxford, England; [Kimber, Ian] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Basketter, David Arthur] DABMEB Consultancy Ltd, Sharnbrook, Beds, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; University of Manchester	Cunningham, L (corresponding author), Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England.	lcunningham73@gmail.com		Cunningham, Louise/0000-0002-2009-3588				Kumar NP, 2015, IMMUNOLOGY, V144, P677, DOI 10.1111/imm.12421; Li LF, 2018, CANCER RES, V78, P1779, DOI 10.1158/0008-5472.CAN-17-2460; Mariani E, 1996, MECH AGEING DEV, V92, P195, DOI 10.1016/S0047-6374(96)01829-5; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Rukavina D, 1998, BLOOD, V92, P2410, DOI 10.1182/blood.V92.7.2410.2410_2410_2420; Schmidt ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00678; Schulert GS, 2016, J INFECT DIS, V213, P1180, DOI 10.1093/infdis/jiv550; Semple PL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/438463; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839	10	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					52	53		10.1016/j.jaci.2020.05.007	http://dx.doi.org/10.1016/j.jaci.2020.05.007			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	32422144	Bronze, Green Published			2022-12-18	WOS:000579170500006
J	Vince, N; Limou, S; Daya, M; Morii, W; Rafaels, N; Geffard, E; Douillard, V; Walencik, A; Boorgula, MP; Chavan, S; Vergara, C; Ortega, VE; Wilson, JG; Lange, LA; Watson, H; Nicolae, DL; Meyers, DA; Hansel, NN; Ford, JG; Faruque, MU; Bleecker, ER; Campbell, M; Beaty, TH; Ruczinski, I; Mathias, RA; Taub, MA; Ober, C; Noguchi, E; Barnes, KC; Torgerson, D; Gourraud, PA				Vince, Nicolas; Limou, Sophie; Daya, Michelle; Morii, Wataru; Rafaels, Nicholas; Geffard, Estelle; Douillard, Venceslas; Walencik, Alexandre; Boorgula, Meher Preethi; Chavan, Sameer; Vergara, Candelaria; Ortega, Victor E.; Wilson, James G.; Lange, Leslie A.; Watson, Harold; Nicolae, Dan L.; Meyers, Deborah A.; Hansel, Nadia N.; Ford, Jean G.; Faruque, Mezbah U.; Bleecker, Eugene R.; Campbell, Monica; Beaty, Terri H.; Ruczinski, Ingo; Mathias, Rasika A.; Taub, Margaret A.; Ober, Carole; Noguchi, Emiko; Barnes, Kathleen C.; Torgerson, Dara; Gourraud, Pierre-Antoine		CAAPA	Association of HLA-DRB1*09:01 with tIgE levels among African-ancestry individuals with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; HLA; tIgE levels; atopy; CAAPA; imputation; admixture	GENOME-WIDE ASSOCIATION; ATOPIC ASTHMA; IGE LEVELS; GENETIC ASSOCIATION; DQ HAPLOTYPES; HLA ALLELES; CLASS-I; DISEASE; LOCI; METAANALYSIS	Background: Asthma is a complex chronic inflammatory disease of the airways. Association studies between HLA and asthma were first reported in the 1970s, and yet, the precise role of HLA alleles in asthma is not fully understood. Numerous genome-wide association studies were recently conducted on asthma, but were always limited to simple genetic markers (single nucleotide polymorphisms) and not complex HLA gene polymorphisms (alleles/haplotypes), therefore not capturing the biological relevance of this complex locus for asthma pathogenesis. Objective: To run the first HLA-centric association study with asthma and specific asthma-related phenotypes in a large cohort of African-ancestry individuals. Methods: We collected high-density genomics data for the Consortium on Asthma among African-ancestry Populations in the Americas (N = 4993) participants. Using computer-intensive machine-learning attribute bagging methods to infer HLA alleles, and Easy-HLA to infer HLA 5-gene haplotypes, we conducted a high-throughput HLA-centric association study of asthma susceptibility and total serum IgE (tIgE) levels in subjects with and without asthma. Results: Among the 1607 individuals with asthma, 972 had available tIgE levels, with a mean tIgE level of 198.7 IU/mL. We could not identify any association with asthma susceptibility. However, we showed that HLA-DRB1*09:01 was associated with increased tIgE levels (P = 8.5 x 10(-4); weighted effect size, 0.51 [0.15-0.87]). Conclusions: We identified for the first time an HLA allele associated with tIgE levels in African-ancestry individuals with asthma. Our report emphasizes that by leveraging powerful computational machine-learning methods, specific/extreme phenotypes, and population diversity, we can explore HLA gene polymorphisms in depth and reveal the full extent of complex disease associations.	[Vince, Nicolas; Limou, Sophie; Geffard, Estelle; Douillard, Venceslas; Walencik, Alexandre; Gourraud, Pierre-Antoine] Univ Nantes, CHU Nantes, Cent Nantes, Inserm,Ctr Rech Transplantat & Immunol, Nantes, France; [Daya, Michelle; Rafaels, Nicholas; Boorgula, Meher Preethi; Chavan, Sameer; Lange, Leslie A.; Campbell, Monica; Barnes, Kathleen C.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Morii, Wataru; Noguchi, Emiko] Univ Tsukuba, Fac Med, Dept Med Genet, Ibaraki, Japan; [Vergara, Candelaria; Hansel, Nadia N.; Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Ortega, Victor E.] Wake Forest Sch Med, Ctr Precis Med, Dept Internal Med, Sect Pulm Crit Care Allergy & Immunol Dis, Winston Salem, NC 27101 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Watson, Harold] Univ West Indies, Fac Med Sci, Cave Hill Campus, Bridgetown, Barbados; [Nicolae, Dan L.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Meyers, Deborah A.; Bleecker, Eugene R.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA; [Ford, Jean G.] Einstein Med Ctr, Dept Med, Philadelphia, PA USA; [Faruque, Mezbah U.] Howard Univ, Coll Med, Natl Human Genome Ctr, Washington, DC USA; [Beaty, Terri H.; Mathias, Rasika A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ruczinski, Ingo; Taub, Margaret A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Torgerson, Dara] McGill Univ, Montreal, PQ, Canada; [Torgerson, Dara] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Limou, Sophie] Ecole Cent Nantes, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Ecole Centrale de Nantes; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Tsukuba; Johns Hopkins University; Wake Forest University; University of Mississippi; University of Mississippi Medical Center; University West Indies Mona Jamaica; University of the West Indies Open Campus; University West Indies Cave Hill Campus; University of Chicago; University of Arizona; Howard University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Chicago; McGill University; Nantes Universite; Ecole Centrale de Nantes	Gourraud, PA (corresponding author), CHU Nantes Hotel Dieu, CRTI UMR1064 ITUN, ATIP Avenir Team 5, 30 Bld Jean Monnet, F-44093 Nantes 01, France.	pierre-antoine.gourraud@univ-nantes.fr	Gourraud, Pierre-Antoine FD/O-3024-2015; Vince, Nicolas/K-5882-2019; Boorgula, Meher Preethi/AAC-6252-2022; Limou, Sophie/AHD-3272-2022; Chavan, Sameer/AAU-2285-2021	Vince, Nicolas/0000-0002-3767-6210; Limou, Sophie/0000-0002-7702-8234; Chavan, Sameer/0000-0002-0220-0845; Nicolae, Dan/0000-0002-0918-4630	European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [846520]; National Institutes of Health [R01-HL129239, R01HL104608]	European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	N.V. has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sk1odowska-Curie grant agreement number 846520. Funding for this study was provided in part by the National Institutes of Health (grant nos. R01-HL129239 and R01HL104608 to K.C.B.).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anaya JM, 2012, AUTOIMMUN REV, V11, P781, DOI 10.1016/j.autrev.2012.02.002; BROSTOFF J, 1976, LANCET, V2, P872; BRUCE CA, 1976, CLIN EXP IMMUNOL, V25, P67; Daya M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08469-7; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Galanter JM, 2014, J ALLERGY CLIN IMMUN, V134, P295, DOI 10.1016/j.jaci.2013.08.055; Geffard E, 2020, BIOINFORMATICS, V36, P2157, DOI 10.1093/bioinformatics/btz875; Genc S, 2012, J ASTHMA, V49, P569, DOI 10.3109/02770903.2012.695418; Gourraud PA, 2005, HUM IMMUNOL, V66, P563, DOI 10.1016/j.humimm.2005.01.011; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Ivkovic-Jurekovic I, 2011, COLLEGIUM ANTROPOL, V35, P1243; Johnston HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46398; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Khor SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18241-w; Kim KW, 2019, ALLERGY ASTHMA IMMUN, V11, P170, DOI 10.4168/aair.2019.11.2.170; Kontakioti E, 2014, HUM IMMUNOL, V75, P930, DOI 10.1016/j.humimm.2014.06.022; Kreyszig E, 1979, ADV ENG MATH, P939; Lara-Marquez ML, 1999, CLIN EXP ALLERGY, V29, P60, DOI 10.1046/j.1365-2222.1999.00461.x; Lasky-Su J, 2012, CLIN EXP ALLERGY, V42, P1724, DOI 10.1111/cea.12000; Levin AM, 2013, J ALLERGY CLIN IMMUN, V131, P1176, DOI 10.1016/j.jaci.2012.10.002; Li XN, 2012, J ALLERGY CLIN IMMUN, V130, P861, DOI 10.1016/j.jaci.2012.04.041; Limou S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00118; Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782; Lin JM, 2017, HLA, V90, P354, DOI 10.1111/tan.13171; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Meyer D, 2018, IMMUNOGENETICS, V70, P5, DOI 10.1007/s00251-017-1017-3; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morii W, 2018, ALLERGOL INT, V67, P61, DOI 10.1016/j.alit.2017.04.004; Munthe-Kaas MC, 2007, ALLERGY, V62, P991, DOI 10.1111/j.1398-9995.2007.01377.x; Murao S, 2004, DIABETES, V53, P2684, DOI 10.2337/diabetes.53.10.2684; Naqvi M, 2007, J ALLERGY CLIN IMMUN, V120, P137, DOI 10.1016/j.jaci.2007.02.045; Nicodemus-Johnson J, 2013, J ALLERGY CLIN IMMUN, V131, P1496, DOI 10.1016/j.jaci.2013.01.037; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Pappas DJ, 2018, PHARMACOGENOMICS J, V18, P367, DOI 10.1038/tpj.2017.7; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P1502, DOI 10.1016/j.jaci.2014.10.033; R Core Team, 2017, R LANG ENV STAT COMP; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Shimane K, 2013, RHEUMATOLOGY, V52, P1172, DOI 10.1093/rheumatology/kes427; Shrine N, 2019, LANCET RESP MED, V7, P20, DOI 10.1016/S2213-2600(18)30389-8; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Torio A, 2003, HUM IMMUNOL, V64, P811, DOI 10.1016/S0198-8859(03)00109-5; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Vince N, 2014, J INFECT DIS, V210, P1047, DOI 10.1093/infdis/jiu214; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wambre E, 2012, CURR OPIN IMMUNOL, V24, P700, DOI 10.1016/j.coi.2012.07.009; Wang XY, 2010, ASIAN PAC J ALLERGY, V28, P287; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	60	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					147	155		10.1016/j.jaci.2020.01.011	http://dx.doi.org/10.1016/j.jaci.2020.01.011			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	31981624	Green Published, Bronze			2022-12-18	WOS:000579170500024
J	Alviani, C; Roberts, G; Mitchell, F; Martin, J; Zolkipli, Z; Michaelis, LJ; Vijayanand, P; Kurukulaaratchy, R; Arshad, SH				Alviani, Cherry; Roberts, Graham; Mitchell, Frances; Martin, Jane; Zolkipli, Zaraquiza; Michaelis, Louise J.; Vijayanand, Pandurangan; Kurukulaaratchy, Ramesh; Arshad, S. Hasan			Primary prevention of asthma in high risk children using HDM SLIT: Assessment at age 6 years	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMMUNOTHERAPY; ALLERGY; TRIAL		[Alviani, Cherry; Roberts, Graham; Martin, Jane; Kurukulaaratchy, Ramesh; Arshad, S. Hasan] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Alviani, Cherry; Roberts, Graham; Martin, Jane; Kurukulaaratchy, Ramesh; Arshad, S. Hasan] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Alviani, Cherry; Roberts, Graham; Mitchell, Frances; Martin, Jane; Kurukulaaratchy, Ramesh; Arshad, S. Hasan] St Marys Hosp, David Hide Asthma & Allergy Res Ctr, Isle Of Wight, England; [Roberts, Graham] Univ Southampton, Fac Med, Human Dev Hlth, Southampton, Hants, England; [Zolkipli, Zaraquiza] Addenbrookes NHS Fdn Trust, Dept Allergy, Cambridge, England; [Michaelis, Louise J.] Great North Childrens Hosp, Dept Immunol Infect Dis & Allergy, Newcastle Upon Tyne, Tyne & Wear, England; [Vijayanand, Pandurangan] La Jolla Inst Immunol, La Jolla, CA USA	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; La Jolla Institute for Immunology	Arshad, SH (corresponding author), Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.; Arshad, SH (corresponding author), Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England.; Arshad, SH (corresponding author), St Marys Hosp, David Hide Asthma & Allergy Res Ctr, Isle Of Wight, England.	sha@soton.ac.uk		Kurukulaaratchy, Ramesh/0000-0002-1588-2400; Roberts, Graham/0000-0003-2252-1248	National Institute for Health Research, UK, through its funding of Southampton National Institute for Health Research Biomedical Research Centre; National Institute of Allergy AMP; Infectious Diseases, US [R01AI121426-01]	National Institute for Health Research, UK, through its funding of Southampton National Institute for Health Research Biomedical Research Centre; National Institute of Allergy AMP; Infectious Diseases, US	This study was supported by the National Institute for Health Research, UK, through its funding of Southampton National Institute for Health Research Biomedical Research Centre, and National Institute of Allergy & Infectious Diseases, US (grant no. R01AI121426-01). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing the report.	Alviani C, 2019, ALLERGY, V74, P1406, DOI 10.1111/all.13744; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Holt PG, 2013, J ALLERGY CLIN IMMUN, V132, P991, DOI 10.1016/j.jaci.2013.04.049; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Kristiansen M, 2017, PEDIAT ALLERG IMM-UK, V28, P18, DOI 10.1111/pai.12661; Szepfalusi Z, 2014, PEDIAT ALLERG IMM-UK, V25, P788, DOI 10.1111/pai.12310; Yaghoubi M, 2019, AM J RESP CRIT CARE, V200, P1102, DOI 10.1164/rccm.201901-0016OC; Zolkipli Z, 2015, J ALLERGY CLIN IMMUN, V136, P1541, DOI 10.1016/j.jaci.2015.04.045	9	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2020	145	6					1711	1713		10.1016/j.jaci.2020.01.048	http://dx.doi.org/10.1016/j.jaci.2020.01.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LW4ZZ	32059981	Green Accepted, Bronze			2022-12-18	WOS:000539157800033
J	Kwah, JH; Somani, SN; Stevens, WW; Kern, RC; Smith, SS; Welch, KC; Conley, DB; Tan, BK; Grammer, LC; Yang, A; Schleimer, RP; Peters, AT				Kwah, Jason H.; Somani, Shaan N.; Stevens, Whitney W.; Kern, Robert C.; Smith, Stephanie S.; Welch, Kevin C.; Conley, David B.; Tan, Bruce K.; Grammer, Leslie C.; Yang, Amy; Schleimer, Robert P.; Peters, Anju T.			Clinical factors associated with acute exacerbations of chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; exacerbation; antibiotics; asthma; allergic rhinitis; eosinophils; autoimmune disease	ENDOSCOPIC SINUS SURGERY; ANTIMICROBIAL RESISTANCE; ASTHMA; PREVALENCE; FREQUENCY; DIAGNOSIS; US	Background: Chronic rhinosinusitis (CRS) is complicated by frequent acute exacerbations leading to significant health care burden and impaired quality of life. Objective: The objective of this study was to identify clinical factors associated with frequent acute exacerbation of CRS (AECRS). Methods: This is a retrospective cohort study of patients with CRS from January 1, 2014, to May 31, 2016. Frequent AECRS was defined as at least 4 episodes over a 12-month period in which an antibiotic was prescribed for worsening sinus symptoms, and infrequent AECRS was defined as 0 to 3 episodes. Clinical factors, including asthma, allergic rhinitis, eosinophil count of at least 150 cells per microliter, and autoimmune disease, were evaluated for associations between the 2 groups. Results: Of the 3109 patients with CRS who were identified, 600 (19.3%) were classified as having frequent exacerbation. Asthma, allergic rhinitis, eosinophil count of at least 150 cells Per microliter, and autoimmune disease were associated with frequent AECRS with statistically significant adjusted odds ratios (aORs) after controlling for age, race, and sex in multivariate analysis (asthma aOR = 2.61 [95% CI = 2.14-3.18]; allergic rhinitis aOR = 1.96 [95% CI = 1.58-2.42]; eosinophil count of at least 150 cells per microliter aOR = 1.54 [95% CI = 1.21-1.97]; and autoimmune disease aOR = 1.68 [95% CI = 1.36-2.07]). Antibody deficiency, antibiotic allergy, lower FEV1, radiographic sinus disease severity, nasal polyposis, and systemic corticosteroid use were also associated with frequent AECRS. Conclusion: Patients with frequent episodes of AECRS were characterized by a higher prevalence of asthma, allergic rhinitis, eosinophil count of at least 150 cells per microliter, autoimmune disease, and other allergic and immunologic diseases. These findings identify a high-risk phenotype of patients with CRS for preventive interventions to reduce exacerbation frequency.	[Kwah, Jason H.; Somani, Shaan N.; Stevens, Whitney W.; Kern, Robert C.; Grammer, Leslie C.; Schleimer, Robert P.; Peters, Anju T.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Stevens, Whitney W.; Kern, Robert C.; Smith, Stephanie S.; Welch, Kevin C.; Conley, David B.; Tan, Bruce K.; Schleimer, Robert P.; Peters, Anju T.] Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Yang, Amy] Northwestern Univ, Biostat Collaborat Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Peters, AT (corresponding author), 211 East Ontario St,Suite 1000, Chicago, IL 60611 USA.	anjupeters@northwestern.edu	Smith, Stephanie Shintani/AAY-4854-2020	Smith, Stephanie Shintani/0000-0002-0605-3993	Chronic Rhinosinusitis Integrated Studies Program [U19 AI106683-01]; Chronic Rhinosinusitis Integrated Studies Program 2 [P01AI145818]; Ernest Bazley Foundation; National Institutes of Health National Center for Advancing Translational Sciences [UL1TR001422]; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine	Chronic Rhinosinusitis Integrated Studies Program; Chronic Rhinosinusitis Integrated Studies Program 2; Ernest Bazley Foundation; National Institutes of Health National Center for Advancing Translational Sciences; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine	Supported by the Chronic Rhinosinusitis Integrated Studies Program (grant U19 AI106683-01); the Chronic Rhinosinusitis Integrated Studies Program 2 (grant P01AI145818); the Ernest Bazley Foundation; the National Institutes of Health National Center for Advancing Translational Sciences (grant UL1TR001422); and the Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine.	Alt JA, 2015, JAMA OTOLARYNGOL, V141, P873, DOI 10.1001/jamaoto.2015.1673; Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bachert C, 2017, J ALLERGY CLIN IMMUN, V140, P1024, DOI 10.1016/j.jaci.2017.05.044; Banoub RG, 2018, LARYNGOSCOPE, V128, P1033, DOI 10.1002/lary.26901; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Benjamin MR, 2019, J ALLER CL IMM-PRACT, V7, P1010, DOI 10.1016/j.jaip.2018.10.014; Benjamin MR, 2018, ANN ALLERG ASTHMA IM, V121, P126, DOI 10.1016/j.anai.2018.04.001; Bhattacharyya N, 2008, ANN OTO RHINOL LARYN, V117, P448, DOI 10.1177/000348940811700608; Braunstahl Gert-Jan, 2009, Proc Am Thorac Soc, V6, P652, DOI 10.1513/pats.200906-052DP; Campbell AP, 2018, EUR ANN OTORHINOLARY, V135, P237, DOI 10.1016/j.anorl.2017.05.005; Casale TB, 2017, J ALLERGY CLIN IMMUN, V139, P1411, DOI 10.1016/j.jaci.2017.03.006; Caulley L, 2015, J ALLERGY CLIN IMMUN, V136, P1517, DOI 10.1016/j.jaci.2015.08.037; Chandra RK, 2016, INT FORUM ALLERGY RH, V6, P472, DOI 10.1002/alr.21685; de Loos DD, 2019, J ALLERGY CLIN IMMUN, V143, P1207, DOI 10.1016/j.jaci.2018.12.986; DeConde AS, 2017, LARYNGOSCOPE, V127, P550, DOI 10.1002/lary.26391; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Kingdom TT, 2004, AM J OTOLARYNG, V25, P323, DOI 10.1016/j.amjoto.2004.03.003; Kuiper JR, 2018, ALLERGY, V73, P1244, DOI 10.1111/all.13409; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Peters AT, 2014, ANN ALLERG ASTHMA IM, V113, P347, DOI 10.1016/j.anai.2014.07.025; Ramakrishnan VR, 2017, INT FORUM ALLERGY RH, V7, P343, DOI 10.1002/alr.21903; Shashy RG, 2004, ARCH OTOLARYNGOL, V130, P320, DOI 10.1001/archotol.130.3.320; Smith SS, 2013, J ALLERGY CLIN IMMUN, V132, P1230, DOI 10.1016/j.jaci.2013.07.009; Speth MM, 2018, OTOLARYNG HEAD NECK, V159, P766, DOI 10.1177/0194599818774741; Stevens WW, 2017, J ALLER CL IMM-PRACT, V5, P1061, DOI 10.1016/j.jaip.2016.12.027; Stevens WW, 2015, IMMUN INFLAMM DIS, V3, P14, DOI 10.1002/iid3.46; Tan BK, 2013, J ALLERGY CLIN IMMUN, V131, P1350, DOI 10.1016/j.jaci.2013.02.002; US Centers for Disease Control and Prevention, 2018, ANT ANT RES AR AMR; Van Zele T, 2010, J ALLERGY CLIN IMMUN, V125, P1069, DOI 10.1016/j.jaci.2010.02.020	32	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2020	145	6					1598	1605		10.1016/j.jaci.2020.01.023	http://dx.doi.org/10.1016/j.jaci.2020.01.023			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LW4ZZ	32004523	Bronze, Green Accepted			2022-12-18	WOS:000539157800015
J	DeKruyff, RH; Zhang, WM; Nadeau, KC; Leung, DYM; Wills-Karp, M				DeKruyff, Rosemarie H.; Zhang, Wenming; Nadeau, Kari C.; Leung, Donald Y. M.; Wills-Karp, Marsha			Summary of the Keystone Symposium "Origins of allergic disease: Microbial, epithelial and immune interactions,'' March 24-27, Tahoe City, California	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; food allergy; asthma; microbiome; epithelial barrier	REGULATORY B-CELLS; FAMILY-MEMBER 3; FOOD ALLERGY; EOSINOPHILIC ESOPHAGITIS; BARRIER INTEGRITY; FILAGGRIN GENE; ASTHMA RISK; ASSOCIATION; SKIN; MECHANISMS	The aims of the Keystone Symposium conference, "Origins of allergic disease: Microbial, epithelial and immune interactions'' were to present and discuss potential microbial-epithelial-immune interactions underlying the early-life origins of allergic disorders, as well as immune mechanisms that might suggest novel disease prevention or intervention strategies. Cross-talk and sharing of ideas among participating experts in basic science and clinical aspects of allergic diseases provided substantial insight into the concept of allergic disorders as a systems disease. The overriding message distilled from the discussions was that damage to epithelial surfaces lies at the origin of the various manifestations of allergic disease. The epithelium of the lungs, gut, and skin, which operates as a critical sensor of environmental stimuli, is besieged by an onslaught of contemporary environmental forces including an altered microbiome, air pollution, food allergens in a changed diet, and chemicals in modern detergents. Collectively, this onslaught leads to alterations of lung, skin, or gut epithelial surfaces, driving a type 2 immune response that underlies most, if not all, of the atopic diseases. Possible remedies for treatment and prevention of allergic diseases were discussed, including a precision medicine approach using biologics, oral desensitization, targeted gut microbiome alterations, and behavior alteration.	[DeKruyff, Rosemarie H.; Zhang, Wenming; Nadeau, Kari C.] Stanford Univ, Dept Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [DeKruyff, Rosemarie H.; Zhang, Wenming; Nadeau, Kari C.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Div Pediat Allergy & Clin Immunol, Denver, CO USA; [Wills-Karp, Marsha] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA	Stanford University; Stanford University; National Jewish Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	DeKruyff, RH (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	rdk@stanford.edu	Zhang, Wenming/AAU-7795-2021	Zhang, Wenming/0000-0002-9298-8460	Sean N. Parker Center for Allergy and Asthma Research, Stanford University School ofMedicine, Stanford, California; National Institutes of Health [1U19AI117673, 5R01AR41256, UL1TR002535, 1UM2AI130836, UM1AI130780]	Sean N. Parker Center for Allergy and Asthma Research, Stanford University School ofMedicine, Stanford, California; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Sean N. Parker Center for Allergy and Asthma Research, Stanford University School ofMedicine, Stanford, California (R.H.D., W.Z., and K.C.N.). D.Y.M.L. is supported by National Institutes of Health grants 1U19AI117673, 5R01AR41256, UL1TR002535, 1UM2AI130836, and UM1AI130780.	Azouz NP, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9736; Baker MG, 2018, ANN ALLERG ASTHMA IM, V120, P245, DOI 10.1016/j.anai.2018.01.027; Begin P, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-27; Bello MGD, 2018, SCIENCE, V362, P33, DOI 10.1126/science.aau8816; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2018, AM J RESP CRIT CARE, V197, P589, DOI 10.1164/rccm.201705-1021OC; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Bunning BJ, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0665-y; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V138, P1122, DOI 10.1016/j.jaci.2016.03.041; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Drislane C, 2020, ANN ALLERG ASTHMA IM, V124, P36, DOI 10.1016/j.anai.2019.10.008; du Toit G, 2018, J ALLERGY CLIN IMMUN, V141, P1343, DOI 10.1016/j.jaci.2017.09.034; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Feehley T, 2019, NAT MED, V25, P448, DOI 10.1038/s41591-018-0324-z; Fisher HR, 2018, ANN ALLERG ASTHMA IM, V121, P313, DOI 10.1016/j.anai.2018.06.008; Fuchs O, 2012, J ALLERGY CLIN IMMUN, V130, P382, DOI 10.1016/j.jaci.2012.04.049; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gill MA, 2018, J ALLERGY CLIN IMMUN, V141, P1735, DOI 10.1016/j.jaci.2017.07.035; Goleva E, 2019, J CLIN INVEST, V129, P1463, DOI 10.1172/JCI124608; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gour N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aam9841; Guerra S, 2015, LANCET RESP MED, V3, P613, DOI 10.1016/S2213-2600(15)00196-4; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jones AL, 2016, J ALLERGY CLIN IMMUN, V137, P1247, DOI 10.1016/j.jaci.2016.01.010; Keet CA, 2018, J ALLERGY CLIN IMMUN, V142, P1719, DOI 10.1016/j.jaci.2018.10.020; Kelleher MM, 2016, J ALLERGY CLIN IMMUN, V137, P1111, DOI 10.1016/j.jaci.2015.12.1312; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Leung DYM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav2685; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; MacGinnitie AJ, 2017, J ALLERGY CLIN IMMUN, V139, P873, DOI 10.1016/j.jaci.2016.08.010; Margolis DJ, 2018, J INVEST DERMATOL, V138, P1501, DOI 10.1016/j.jid.2018.01.029; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Orengo JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03636-8; Paternoster L, 2018, J ALLERGY CLIN IMMUN, V141, P964, DOI 10.1016/j.jaci.2017.09.044; Pattaroni C, 2018, CELL HOST MICROBE, V24, P857, DOI 10.1016/j.chom.2018.10.019; Pattaroni C, 2015, CELL HOST MICROBE, V18, P523, DOI 10.1016/j.chom.2015.10.018; Petroni D, 2018, ANN ALLERG ASTHMA IM, V120, P237, DOI 10.1016/j.anai.2017.11.016; Pigors M, 2018, J INVEST DERMATOL, V138, P2674, DOI 10.1016/j.jid.2018.05.013; Potaczek DP, 2017, EPIGENOMICS-UK, V9, P539, DOI 10.2217/epi-2016-0162; Prescott SL, 2019, INT J ENV RES PUBLIC, V16; Prunicki M, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-017-0433-4; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Rothenberg ME, 2015, J ALLERGY CLIN IMMUN, V135, P500, DOI 10.1016/j.jaci.2014.07.049; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Satitsuksanoa P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02939; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Shoda T, 2018, LANCET GASTROENTEROL, V3, P477, DOI 10.1016/S2468-1253(18)30096-7; Steelant B, 2019, J ALLERGY CLIN IMMUN, V144, P1242, DOI 10.1016/j.jaci.2019.04.027; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Teo SM, 2018, CELL HOST MICROBE, V24, P341, DOI 10.1016/j.chom.2018.08.005; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Tsakok T, 2016, J ALLERGY CLIN IMMUN, V137, P1071, DOI 10.1016/j.jaci.2015.10.049; van de Veen W, 2016, J ALLERGY CLIN IMMUN, V138, P654, DOI 10.1016/j.jaci.2016.07.006; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Verma M, 2018, J ALLERGY CLIN IMMUN, V142, P793, DOI 10.1016/j.jaci.2017.10.020; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wang M, 2019, J ALLERGY CLIN IMMUN, V143, P1892, DOI 10.1016/j.jaci.2018.11.016; Wawrzyniak P, 2017, J ALLERGY CLIN IMMUN, V139, P93, DOI 10.1016/j.jaci.2016.03.050; Wen T, 2019, J CLIN INVEST, V129, P2014, DOI 10.1172/JCI125917; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010; Wong XFCC, 2018, J ALLERGY CLIN IMMUN, V141, P814, DOI 10.1016/j.jaci.2017.10.001; Xian M, 2016, J ALLERGY CLIN IMMUN, V138, P890, DOI 10.1016/j.jaci.2016.07.003; Yang IV, 2017, J ALLERGY CLIN IMMUN, V140, P14, DOI 10.1016/j.jaci.2017.05.011; Zhai J, 2019, AM J RESP CRIT CARE, V199, P302, DOI 10.1164/rccm.201807-1345OC	82	8	8	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1072	+		10.1016/j.jaci.2019.11.048	http://dx.doi.org/10.1016/j.jaci.2019.11.048			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31926182	Bronze			2022-12-18	WOS:000523633400004
J	Pilarowski, GO; Cazares, T; Zhang, L; Benjamin, JS; Liu, K; Jagannathan, S; Mousa, N; Kasten, J; Barski, A; Lindsley, AW; Bjornsson, HT				Pilarowski, Genay O.; Cazares, Tareian; Zhang, Li; Benjamin, Joel S.; Liu, Ke; Jagannathan, Sajjeev; Mousa, Nadeem; Kasten, Jennifer; Barski, Artem; Lindsley, Andrew W.; Bjornsson, Hans T.			Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						KMT2D; hypogammaglobulinemia; gut lymphocyte homing; ITGB7; epigenetics; B-cell maturation; B1 B cells; IgA	EXPRESSION; BINDING	Background: Kabuki syndrome (KS) is commonly caused by mutations in the histone-modifying enzyme lysine methyltransferase 2D (KMT2D). Immune dysfunction is frequently observed in individuals with KS, but the role of KMT2D in immune system function has not been identified. Objective: We sought to understand the mechanisms driving KS-associated immune deficiency (hypogammaglobulinemia [low IgA], splenomegaly, and diminished immunization responses). Methods: We performed a comprehensive evaluation of humoral immunity and secondary lymphoid tissues in an established KS (Kmt2d(+/beta Geo)) mouse model and validated select findings in a patient with KS. Results: Compared with wild-type littermates, Kmt2d(+/beta Geo) mice demonstrated deficiencies in multiple B-cell lineages and reduced serum IgA and elevated IgM levels across multiple ages. The bone marrow, spleen, and intestine of Kmt2d(+/beta Geo) mice contained diminished numbers of IgA-secreting cells, while elevated germinal center B cells were found in the mesenteric lymph node and Peyer patches. Kmt2d(+/beta Geo) mice have decreased size and numbers of Peyer patches, a finding confirmed in human samples. We identified deficiency of Itgb7 RNA and protein expression, a gene encoding an adhesion protein that mediates intestinal homing, and we demonstrated KMT2D-dependent control of ITGB7 expression in a human cell line. Conclusions: Kmt2d haploinsufficiency has broad deleterious effects on B-cell differentiation, specifically hampering gut lymphocyte homing and IgA(+) plasma cell differentiation. Intestinal lymphoid defects caused by ITGB7 deficiency have not previously been recognized in KS, and these results provide new mechanistic insights into the pathogenesis of KS-associated immune deficiency.	[Pilarowski, Genay O.; Benjamin, Joel S.] Johns Hopkins Sch Med, Predoctoral Program Human Genet, Baltimore, MD USA; [Bjornsson, Hans T.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Pilarowski, Genay O.; Zhang, Li; Benjamin, Joel S.; Bjornsson, Hans T.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Cazares, Tareian; Jagannathan, Sajjeev; Mousa, Nadeem; Barski, Artem; Lindsley, Andrew W.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Liu, Ke] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Kasten, Jennifer] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Barski, Artem] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Barski, Artem; Lindsley, Andrew W.] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45221 USA; [Bjornsson, Hans T.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Bjornsson, Hans T.] Landspitali Univ Hosp, Dept Genet & Mol Biol, Reykjavik, Iceland; [Cazares, Tareian] Cincinnati Childrens Hosp Med Ctr, Immunobiol Grad Program, Cincinnati, OH 45229 USA; [Benjamin, Joel S.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Liu, Ke] Xencor Inc, Monrovia, CA USA; [Jagannathan, Sajjeev] Baylor Coll Med, Therapeut Innovat Ctr, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Iceland; Landspitali National University Hospital; Cincinnati Children's Hospital Medical Center; Stanford University; Baylor College of Medicine	Lindsley, AW (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	andrew.lindsley@cchmc.org	Liu, Ke/AAZ-2829-2021; Bjornsson, Hans/GSN-3911-2022	Liu, Ke/0000-0001-5343-2008; Bjornsson, Hans/0000-0001-6635-6753; CAZARES, TAREIAN/0000-0003-4624-6156; Pilarowski, Genay/0000-0001-8270-8771	Center for Pediatric Genomics, Cincinnati Children's Research Foundation; National Institutes of Health [DP5OD017877, S10OD016374]; Louma G. Foundation	Center for Pediatric Genomics, Cincinnati Children's Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louma G. Foundation	Specific funding for this work was provided via a grant to A.W.L. and A.B. from the Center for Pediatric Genomics, Cincinnati Children's Research Foundation. H.T.B. is funded through an Early Independence Award from the National Institutes of Health (DP5OD017877) and a grant from the Louma G. Foundation. G.P.'s salary is supported by a grant from the Louma G. Foundation. Confocal images (Fig E7, A) were taken at the Johns Hopkins Microscope Facility on a Zeiss LSM780-FCS microscope, which was supported by a National Institutes of Health grant (S10OD016374).	Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Benjamin JS, 2017, P NATL ACAD SCI USA, V114, P125, DOI 10.1073/pnas.1611431114; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bettridge J, 2017, P NATL ACAD SCI USA, V114, P1904, DOI 10.1073/pnas.1615727114; Bjornsson HT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009278; Chappaz S, 2010, J IMMUNOL, V185, P3514, DOI 10.4049/jimmunol.1000665; CORNES JS, 1965, GUT, V6, P225, DOI 10.1136/gut.6.3.225; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; ERLE DJ, 1994, J IMMUNOL, V153, P517; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fahrner JA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129380; Fukuda K, 2003, DEV BIOL, V255, P278, DOI 10.1016/S0012-1606(02)00088-X; Guo CC, 2012, P NATL ACAD SCI USA, V109, P17603, DOI 10.1073/pnas.1208807109; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Hannibal MC, 2011, AM J MED GENET A, V155A, P1511, DOI 10.1002/ajmg.a.34074; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Ijichi O, 1996, ACTA PAEDIATR JAPON, V38, P66; Kim JH, 2014, CANCER RES, V74, P1705, DOI 10.1158/0008-5472.CAN-13-1896; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Lin JL, 2015, CLIN GENET, V88, P255, DOI 10.1111/cge.12484; Lindsley AW, 2016, J ALLERGY CLIN IMMUN, V137, P179, DOI 10.1016/j.jaci.2015.06.002; Margot H, 2019, GENET MED, DOI [10.1038/s41436-019-0623-x., DOI 10.1038/S41436-019-0623-X.]; Oliver AM, 1997, J IMMUNOL, V158, P1108; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Stagi S, 2016, IMMUNOL RES, V64, P345, DOI 10.1007/s12026-015-8707-4; VADOLAS J, 1995, EUR J IMMUNOL, V25, P969, DOI 10.1002/eji.1830250417; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wyant T, 2015, GUT, V64, P77, DOI 10.1136/gutjnl-2014-307127; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	30	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					982	992		10.1016/j.jaci.2019.11.034	http://dx.doi.org/10.1016/j.jaci.2019.11.034			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31816409	Bronze			2022-12-18	WOS:000518756700034
J	Clapp, PW; Peden, DB; Jaspers, I				Clapp, Phillip W.; Peden, David B.; Jaspers, Ilona			E-cigarettes, vaping-related pulmonary illnesses, and asthma: A perspective from inhalation toxicologists	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						E-cigarettes; vaping; toxicology; asthma			[Clapp, Phillip W.; Peden, David B.; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Peden, David B.; Jaspers, Ilona] Univ N Carolina, Dept Pediat, 116 Manning Dr, Chapel Hill, NC 27599 USA; [Peden, David B.; Jaspers, Ilona] Univ N Carolina, Curriculum Toxicol & Environm Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jaspers, I (corresponding author), Univ N Carolina, Dept Pediat, 116 Manning Dr, Chapel Hill, NC 27599 USA.; Jaspers, I (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, 116 Manning Dr, Chapel Hill, NC 27599 USA.; Jaspers, I (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, 116 Manning Dr, Chapel Hill, NC 27599 USA.	Ilona_jaspers@med.unc.edu	Jaspers, Ilona/AAZ-5035-2020	Peden, David/0000-0003-4526-4627	NHLBI NIH HHS [R01 HL139369] Funding Source: Medline; NIEHS NIH HHS [T32 ES007126, P30 ES010126] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], 2019, N ENGL J MED; Bayly JE, 2019, CHEST, V155, P88, DOI 10.1016/j.chest.2018.10.005; Bradford LE, 2020, J ASTHMA, V57, P1168, DOI 10.1080/02770903.2019.1643361; Clapp PW, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0747-5; Dai HY, 2019, DRUG ALCOHOL DEPEN, V199, P10, DOI 10.1016/j.drugalcdep.2019.01.043; Erythropel HC, 2019, NICOTINE TOB RES, V21, P1248, DOI 10.1093/ntr/nty192; Hajek P, 2019, NEW ENGL J MED, V380, P629, DOI 10.1056/NEJMoa1808779; Madison MC, 2019, J CLIN INVEST, V129, P4290, DOI 10.1172/JCI128531; Polosa R, 2016, ANN ALLERG ASTHMA IM, V116, P106, DOI 10.1016/j.anai.2015.10.012; Schweitzer RJ, 2017, PREV MED, V105, P226, DOI 10.1016/j.ypmed.2017.09.023	10	8	8	2	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					97	99		10.1016/j.jaci.2019.11.001	http://dx.doi.org/10.1016/j.jaci.2019.11.001			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31715190	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000505590800011
J	Ortolan, LS; Kim, SR; Crotts, S; Liu, LY; Craiglow, BG; Wambier, C; Paschoal, RS; King, BA; Jabbari, A				Ortolan, Luana S.; Kim, Sa Rang; Crotts, Sydney; Liu, Lucy Y.; Craiglow, Brittany G.; Wambier, Carlos; Paschoal, Renato S.; King, Brett A.; Jabbari, Ali			IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							T-CELLS; POLARIZATION		[Ortolan, Luana S.; Crotts, Sydney; Jabbari, Ali] Univ Iowa, Carver Coll Med, Dept Dermatol, Iowa City, IA USA; [Kim, Sa Rang; Liu, Lucy Y.; King, Brett A.] Yale Sch Med, New Haven, CT 06510 USA; [Craiglow, Brittany G.; Wambier, Carlos] Yale Univ, Dept Dermatol, New Haven, CT 06520 USA; [Craiglow, Brittany G.] Dermatol Phys Connecticut, Fairfield, CT USA; [Paschoal, Renato S.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Internal Med, Div Dermatol, Ribeirao Preto, Brazil; [Jabbari, Ali] Univ Iowa, Carver Coll Med, Interdisciplinary Program Immunol, Iowa City, IA USA; [Jabbari, Ali] Univ Iowa, Holden Comprehens Canc Ctr, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; Yale University; Yale University; Universidade de Sao Paulo; University of Iowa; University of Iowa	King, BA (corresponding author), Yale Sch Med, New Haven, CT 06510 USA.	brett.king@yale.edu; ali-jabbari@uiowa.edu	dos Santos Ortolan, Luana/AAU-3092-2021; Wambier, Carlos Gustavo/H-4281-2012	Wambier, Carlos Gustavo/0000-0002-4636-4489; Jabbari, Ali/0000-0002-8559-7314	Ranjini and Ajay Poddar Resource Fund for Dermatologic Diseases Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [K08AR069111]; National Cancer Institute of the National Institutes of Health [P30CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR069111] Funding Source: NIH RePORTER	Ranjini and Ajay Poddar Resource Fund for Dermatologic Diseases Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	B.A.K. received funding support from The Ranjini and Ajay Poddar Resource Fund for Dermatologic Diseases Research. A.J. received funding support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number K08AR069111. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number P30CA086862.	Aleisa A, 2019, PEDIATR DERMATOL, V36, pE44, DOI 10.1111/pde.13699; Brunner PM, 2015, EXP DERMATOL, V24, P522, DOI 10.1111/exd.12709; Crispin MK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89776; Elkady Amal, 2017, JAAD Case Rep, V3, P477, DOI 10.1016/j.jdcr.2017.07.009; Fuentes-Duculan J, 2016, EXP DERMATOL, V25, P282, DOI 10.1111/exd.12918; Guttman-Yassky E, 2016, J ALLERGY CLIN IMMUN, V137, P301, DOI 10.1016/j.jaci.2015.11.001; Jabbari A, 2018, J INVEST DERMATOL, V138, P1539, DOI 10.1016/j.jid.2018.01.032; Jabbari A, 2016, EBIOMEDICINE, V7, P240, DOI 10.1016/j.ebiom.2016.03.036; Mackay-Wiggan J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89790; McElwee KJ, 1998, J INVEST DERMATOL, V111, P797, DOI 10.1046/j.1523-1747.1998.00380.x; Noble A, 2001, EUR J IMMUNOL, V31, P2227, DOI 10.1002/1521-4141(200107)31:7<2227::AID-IMMU2227>3.0.CO;2-C; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V136, P1277, DOI 10.1016/j.jaci.2015.06.032; Tauber M, 2013, EUR J DERMATOL, V23, P912, DOI 10.1684/ejd.2013.2221; Verros Constantinos, 2012, Dermatol Online J, V18, P14; Villegas-Mendez A, 2016, INFECT IMMUN, V84, P34, DOI 10.1128/IAI.01100-15; Wang EHC, 2015, J INVEST DERMATOL, V135, P2530, DOI 10.1038/jid.2015.176; Wang EHC, 2014, NAT PROTOC EXCH, P1; Wang XF, 2013, HEPATOLOGY, V57, P373, DOI 10.1002/hep.25982; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Yu HR, 2005, EUR J IMMUNOL, V35, P3664, DOI 10.1002/eji.200526258	22	8	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1731	+		10.1016/j.jaci.2019.08.014	http://dx.doi.org/10.1016/j.jaci.2019.08.014			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31470035	Green Accepted, Bronze			2022-12-18	WOS:000500694900033
J	Zhou, LB; Zheng, YM; Liao, WJ; Song, LJ; Meng, X; Gong, X; Chen, G; Liu, WX; Wang, YQ; Han, DM; Zhong, NS; Lu, WJ; Yang, PC; Zhang, XW				Zhou, Li-Bo; Zheng, Yao-Ming; Liao, Wen-Jing; Song, Li-Juan; Meng, Xuan; Gong, Xin; Chen, Gui; Liu, Wei-Xing; Wang, Ying-Qi; Han, De-Min; Zhong, Nan-Shan; Lu, Wen-Ju; Yang, Ping-Chang; Zhang, Xiao-Wen			MUC1 deficiency promotes nasal epithelial barrier dysfunction in subjects with allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MUCOSA		[Zhou, Li-Bo; Zheng, Yao-Ming; Liao, Wen-Jing; Song, Li-Juan; Gong, Xin; Chen, Gui; Liu, Wei-Xing; Wang, Ying-Qi; Han, De-Min; Zhong, Nan-Shan; Zhang, Xiao-Wen] Guangzhou Med Univ, Lab ENT HNS Dis, State Key Lab Resp Dis, Dept Otolaryngol Head & Neck Surg,Affiliated Hos, Guangzhou, Guangdong, Peoples R China; [Zhou, Li-Bo; Zheng, Yao-Ming; Liao, Wen-Jing; Song, Li-Juan; Gong, Xin; Chen, Gui; Liu, Wei-Xing; Wang, Ying-Qi; Han, De-Min; Zhong, Nan-Shan; Zhang, Xiao-Wen] Innovat & Transformat Platform Upper Airway Dis G, Guangzhou, Guangdong, Peoples R China; [Zhou, Li-Bo; Zheng, Yao-Ming; Liao, Wen-Jing; Song, Li-Juan; Gong, Xin; Chen, Gui; Liu, Wei-Xing; Wang, Ying-Qi; Han, De-Min; Zhong, Nan-Shan; Zhang, Xiao-Wen] Guangzhou Med Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Zhou, Li-Bo; Zheng, Yao-Ming; Liao, Wen-Jing; Song, Li-Juan; Gong, Xin; Chen, Gui; Liu, Wei-Xing; Wang, Ying-Qi; Han, De-Min; Zhong, Nan-Shan; Zhang, Xiao-Wen] Guangzhou Med Univ, Affiliated Hosp 1, Dept Allergy & Clin Immunol, Guangzhou, Guangdong, Peoples R China; [Meng, Xuan; Han, De-Min; Zhong, Nan-Shan; Zhang, Xiao-Wen] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China; [Han, De-Min; Zhong, Nan-Shan; Lu, Wen-Ju; Zhang, Xiao-Wen] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Yang, Ping-Chang] Shenzhen Univ, Sch Med, Res Ctr Allergy & Immunol, Shenzhen, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Shenzhen University	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@qq.com; pcy2356@szu.edu.cn; entxiaowen@163.com	wang, yq/GWM-9918-2022		National Natural Science Foundation of China of China [81520108001, 81570904]; Guangdong Natural Science Foundation [2016A020220019]; Guangdong Sciences and Technology Program [2014A020212420]	National Natural Science Foundation of China of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Sciences and Technology Program	This study was supported by grants from the National Natural Science Foundation of China of China (grant nos. 81520108001 and 81570904), Guangdong Natural Science Foundation (grant no. 2016A020220019), and Guangdong Sciences and Technology Program (grant no. 2014A020212420).	Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Lee HJ, 2016, AM J RHINOL ALLERGY, V30, P173, DOI 10.2500/ajra.2016.30.4295; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; Ma J, 2018, CHEST, V154, P169, DOI 10.1016/j.chest.2017.11.008; McAuley JL, 2017, MUCOSAL IMMUNOL, V10, P1581, DOI 10.1038/mi.2017.16; Milara J, 2015, J ALLERGY CLIN IMMUN, V135, P470, DOI 10.1016/j.jaci.2014.07.011; Nishijima H, 2016, LAB INVEST, V96, P981, DOI 10.1038/labinvest.2016.72; Steelant B, 2016, J ALLERGY CLIN IMMUN, V137, P1043, DOI 10.1016/j.jaci.2015.10.050; Zhang N, 2016, ALLERGY, V71, P295, DOI 10.1111/all.12809	9	8	8	3	27	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1716	+		10.1016/j.jaci.2019.07.042	http://dx.doi.org/10.1016/j.jaci.2019.07.042			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31425778	Bronze			2022-12-18	WOS:000500694900029
J	Park, J; Lee, HJ; Song, D; Gi, M; Jo, S; Jeon, DK; Seo, Y; Kim, B; Lee, H; Namkung, W; Han, G; Choi, JY				Park, Jinhong; Lee, Hyun Jae; Song, Doona; Gi, Mia; Jo, Sungwoo; Jeon, Dong-kyu; Seo, Yohan; Kim, Bomin; Lee, Ho; Namkung, Wan; Han, Gyoonhee; Choi, Jae Young			Novel pendrin inhibitor attenuates airway hyperresponsiveness and mucin expression in experimental murine asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SURFACE LIQUID; SYNDROME GENE; INFLAMMATION; EXERCISE; ALLERGY; PATTERN; SPUTUM		[Park, Jinhong; Jo, Sungwoo; Jeon, Dong-kyu; Seo, Yohan; Namkung, Wan; Han, Gyoonhee] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea; [Park, Jinhong; Namkung, Wan; Han, Gyoonhee] Yonsei Univ, Dept Integrated OMICS Biomed Sci, Seoul, South Korea; [Lee, Hyun Jae; Gi, Mia; Choi, Jae Young] Yonsei Univ, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea; [Song, Doona; Han, Gyoonhee] Yonsei Univ, Dept Biotechnol, Translat Res Ctr Prot Funct Control, Seoul, South Korea; [Kim, Bomin] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Bomin] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea; [Lee, Ho] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang Si, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC)	Namkung, W (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea.; Namkung, W (corresponding author), Yonsei Univ, Dept Integrated OMICS Biomed Sci, Seoul, South Korea.	wnamkung@yonsei.ac.kr; gyoonhee@yonsei.ac.kr; jychoi@yuhs.ac	Lee, Hyun Jae/AAV-6015-2021; 서, 요한/AAZ-6433-2020	Seo, Yohan/0000-0002-9335-8604; choi, jae young/0000-0001-9493-3458	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01057695, NRF-2016M3A9B5941215, NRF-2016R1 A6A3A11932977, NRF-2017R1A6A3A11031453, NRF-2018R1A2B6002952, NRF-2018R1A6A1A03023718]; Korea Mouse Phenotyping Project of the Ministry of Science and ICT through the NRF [2016M3A9D5A01952415]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); Korea Mouse Phenotyping Project of the Ministry of Science and ICT through the NRF(National Research Foundation of Korea)	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant nos. NRF-2015R1D1A1A01057695, NRF-2016M3A9B5941215, NRF-2016R1 A6A3A11932977, NRF-2017R1A6A3A11031453, NRF-2018R1A2B6002952, and NRF-2018R1A6A1A03023718), and partially supported by Korea Mouse Phenotyping Project (grant no. 2016M3A9D5A01952415) of the Ministry of Science and ICT through the NRF.	Anderson SD, 2003, CLIN REV ALLERG IMMU, V24, P27, DOI 10.1385/CRIAI:24:1:27; Bonini M, 2009, MED SCI SPORT EXER, V41, P1034, DOI 10.1249/MSS.0b013e318193c663; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Fasola S, 2019, PEDIAT ALLERG IMM-UK, V30, P242, DOI 10.1111/pai.13006; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Haggie PM, 2016, FASEB J, V30, P2187, DOI 10.1096/fj.201600223R; Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3; Izuhara K, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1054801; Jonckheere AC, 2018, PEDIAT ALLERG IMM-UK, V29, P648, DOI 10.1111/pai.12949; Kurowski M, 2016, CLIN RESPIR J, V10, P231, DOI 10.1111/crj.12210; Lee HJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12480; Madeo AC, 2009, J MED GENET, V46, P405, DOI 10.1136/jmg.2008.063610; Nakagami Y, 2008, J IMMUNOL, V181, P2203, DOI 10.4049/jimmunol.181.3.2203; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; Seys SF, 2015, ALLERGY, V70, P187, DOI 10.1111/all.12540; Seys SF, 2013, CLIN EXP ALLERGY, V43, P1009, DOI 10.1111/cea.12125; Seys SF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0524-y; Seys SF, 2013, THORAX, V68, P906, DOI 10.1136/thoraxjnl-2013-203280; Suzuki S, 2016, J BIOL CHEM, V291, P27219, DOI 10.1074/jbc.M116.746909; Teixeira RN, 2018, CLIN J SPORT MED, V28, P268, DOI 10.1097/JSM.0000000000000444; Teixeira RN, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-7; Truyen E, 2006, THORAX, V61, P202, DOI 10.1136/thx.2005.052399; Van der Eycken S, 2016, RESP MED, V111, P91, DOI 10.1016/j.rmed.2015.12.012; Weiszhar Z, 2013, BREATHE, V9, P301, DOI 10.1183/20734735.042912; Yick CY, 2013, EUR RESPIR J, V42, P662, DOI 10.1183/09031936.00115412	27	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1425	+		10.1016/j.jaci.2019.07.016	http://dx.doi.org/10.1016/j.jaci.2019.07.016			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31362010	Bronze			2022-12-18	WOS:000495004700036
J	Volkmer, B; Planas, R; Gossweiler, E; Lunemann, A; Opitz, L; Mauracher, A; Nuesch, U; Gayden, T; Kaiser, D; Drexel, B; Dumrese, C; Jabado, N; Vavassori, S; Schmid, JP				Volkmer, Benjamin; Planas, Raquel; Gossweiler, Emanuel; Luenemann, Anna; Opitz, Lennart; Mauracher, Andrea; Nueesch, Ursina; Gayden, Tenzin; Kaiser, Daniela; Drexel, Barbara; Dumrese, Claudia; Jabado, Nada; Vavassori, Stefano; Schmid, Jana Pachlopnik			Recurrent inflammatory disease caused by a heterozygous mutation in CD48	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NATURAL-KILLER; ACTIVATION; ROLES; 2B4		[Volkmer, Benjamin; Planas, Raquel; Gossweiler, Emanuel; Opitz, Lennart; Mauracher, Andrea; Nueesch, Ursina; Drexel, Barbara; Vavassori, Stefano; Schmid, Jana Pachlopnik] Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland; [Luenemann, Anna] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany; [Dumrese, Claudia] Univ Zurich, Flow Cytometry Facil, Zurich, Switzerland; [Opitz, Lennart] Univ Zurich, Funct Genom Ctr Zurich, ETH Zurich, Zurich, Switzerland; [Gayden, Tenzin; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Gayden, Tenzin; Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Kaiser, Daniela] Childrens Hosp Lucerne, Luzern, Switzerland; [Drexel, Barbara] Private Off KinderAllergieDoktor, Zurich, Switzerland; [Schmid, Jana Pachlopnik] Univ Zurich, Zurich, Switzerland	University Children's Hospital Zurich; University of Munster; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; McGill University; McGill University; University of Zurich	Schmid, JP (corresponding author), Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland.; Schmid, JP (corresponding author), Univ Zurich, Zurich, Switzerland.	jana.pachlopnik@kispi.uzh.ch	Jabado, Nada/AAN-4026-2020; Planas, Raquel/B-6092-2019; Vavassori, Stefano/AAI-9606-2020; Pachlopnik Schmid, Jana/N-8018-2018	Planas, Raquel/0000-0002-2478-997X; Vavassori, Stefano/0000-0002-7452-7978; Nuesch, Ursina/0000-0003-3227-9176; Pachlopnik Schmid, Jana/0000-0002-6653-9047; Mauracher, Andrea/0000-0001-6847-9984	Robert A. Good/Jeffrey Modell Fellowship; Clinical Research Priority Program of the University of Zurich; Beatrice Ederer-Weber foundation; Helmut Horten foundation	Robert A. Good/Jeffrey Modell Fellowship; Clinical Research Priority Program of the University of Zurich; Beatrice Ederer-Weber foundation; Helmut Horten foundation	This study was funded by a Robert A. Good/Jeffrey Modell Fellowship (to J.P.S.), a private donation from Joe and Regula Eberhard (to B.V. and J.P.S.), and grants from the Clinical Research Priority Program of the University of Zurich for the CRPP CYTIMM-Z (to J.P.S. and R.P.) and from the Beatrice Ederer-Weber and the Helmut Horten foundation (to J.P.S. and S.V.).	Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Dong CS, 2013, GENE, V519, P279, DOI 10.1016/j.gene.2013.02.015; Elias S, 2014, BLOOD, V123, P1535, DOI 10.1182/blood-2013-09-526590; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Kim EO, 2010, J BIOL CHEM, V285, P41755, DOI 10.1074/jbc.M110.137976; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; McArdel SL, 2016, CLIN IMMUNOL, V164, P10, DOI 10.1016/j.clim.2016.01.008; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nakaseko H, 2019, RHEUMATOLOGY, V58, P182, DOI 10.1093/rheumatology/key283; Schmid JP, 2010, IMMUNOL REV, V235, P10, DOI 10.1111/j.0105-2896.2010.00890.x; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243	15	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1441	+		10.1016/j.jaci.2019.07.038	http://dx.doi.org/10.1016/j.jaci.2019.07.038			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31419545	Bronze			2022-12-18	WOS:000495004700041
J	Collins, CA; Palmquist, J; Proudfoot, JA; Qian, A; Wangberg, H; Khosh-Hemmat, E; Dohil, R; Aceves, SS				Collins, Cathleen A.; Palmquist, Jacob; Proudfoot, James A.; Qian, Alex; Wangberg, Hannah; Khosh-Hemmat, Emad; Dohil, Ranjan; Aceves, Seema S.			Evaluation of long-term course in children with eosinophilic esophagitis reveals distinct histologic patterns and clinical characteristics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Therapy response; eosinophil; eosinophilic gastrointestinal disorder; pediatric; elimination diet; topical corticosteroid; longitudinal	PEDIATRIC-PATIENTS; RISK	Background: Eosinophilic esophagitis (EoE) is a chronic and increasingly prevalent antigen-driven disease. There is a paucity of information on long-term course in children. Objective: We sought to understand the longitudinal trajectory of pediatric EoE during routine clinical care. Methods: We prospectively enrolled children into an EoE database and reviewed their medical and pathologic records over 13 years. Results: From 2011 to 2015, 146 children with EoE seen for their first visit at our center had 2 or more years of follow-up and 3 or more endoscopies over an average follow-up period of 5.13 years (range, 2-13 years). Longitudinal eosinophilic inflammation during treatment demonstrated 3 patterns over time. Children with less than 15 eosinophils/high-power field (hpf) for greater than 75% of their follow-up period were termed continuous responders (CRs). Children with waxing and waning inflammation of less than 15 eosinophils/hpf for less than 75% but 25% or more of the follow-up period were termed intermittent responders (IRs). Nonresponders (NRs) were defined as having less than 15 eosinophils/hpf for less than 25% of their follow-up. Fifty-nine (40%) of 146 patients were CRs, 65 (45%) of 146 were IRs, and 22 (15%) of 146 were NRs. CRs differed from IRs and NRs on the parameter of male/female ratio (1:1 in CRs, 4: 1 in IRs, and 6: 1 in NRs; P < .001) and in their initial response to any therapy, including proton pump inhibitors (P < .001). Endoscopic severity correlated with esophageal eosinophilia (r = 0.73, P < .001). On multivariate analysis, female sex and initial therapeutic response to medications or elimination diet were associated with long-term control of esophageal eosinophilia. Conclusions: Long-term pediatric EoE followed 3 different longitudinal trajectories of inflammation. The long-term histologic groups differed significantly in biological sex and initial therapeutic response.	[Collins, Cathleen A.; Palmquist, Jacob; Proudfoot, James A.; Qian, Alex; Wangberg, Hannah; Khosh-Hemmat, Emad; Aceves, Seema S.] Univ Calif San Diego, Div Allergy & Immunol, La Jolla, CA 92093 USA; [Dohil, Ranjan] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA; [Collins, Cathleen A.; Palmquist, Jacob; Proudfoot, James A.; Qian, Alex; Wangberg, Hannah; Khosh-Hemmat, Emad; Dohil, Ranjan; Aceves, Seema S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Wangberg, Hannah; Aceves, Seema S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Proudfoot, James A.] Univ Calif San Diego, Altman Clin Translat Res Inst, La Jolla, CA 92093 USA; [Collins, Cathleen A.; Palmquist, Jacob; Proudfoot, James A.; Khosh-Hemmat, Emad; Dohil, Ranjan; Aceves, Seema S.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Aceves, SS (corresponding author), Dept Pediat, 9500 Gilman Dr,MC 0760, La Jolla, CA 92093 USA.; Aceves, SS (corresponding author), Dept Med, 9500 Gilman Dr,MC 0760, La Jolla, CA 92093 USA.	saceves@ucsd.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Khosh-hemmat, Emad/0000-0001-6854-4707	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [AI092135, AI135034]; NIH [UL1TR001442, UL1TR000100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092135, K24AI135034] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases grants AI092135 and AI135034 (to S.S.A.) and NIH grant UL1TR001442 (to J.A.P). This project was partially supported by the NIH grants UL1TR000100 (before August 13, 2015) and UL1TR001442 (after August 13, 2015) of Clinical and Translational Sciences Award funding.	Aceves SS, 2018, J ALLERGY CLIN IMMUN, V142, P130, DOI 10.1016/j.jaci.2018.05.014; Aceves SS, 2014, DIGEST DIS, V32, P143, DOI 10.1159/000357131; Aceves SS, 2009, ANN ALLERG ASTHMA IM, V103, P401, DOI 10.1016/S1081-1206(10)60359-6; Assa'ad AH, 2007, J ALLERGY CLIN IMMUN, V119, P731, DOI 10.1016/j.jaci.2006.10.044; Carlson DA, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.47; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dellon ES, 2019, CLIN GASTROENTEROL H, V17, P666, DOI 10.1016/j.cgh.2018.05.051; Dellon ES, 2014, GASTROENTEROL CLIN N, V43, P201, DOI 10.1016/j.gtc.2014.02.002; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Eluri S, 2016, GASTROINTEST ENDOSC, V83, P1142, DOI 10.1016/j.gie.2015.11.019; Greuter T, 2019, CLIN GASTROENTEROL H, V73; Greuter T, 2017, AM J GASTROENTEROL, V112, P1527, DOI 10.1038/ajg.2017.202; Hill DA, 2018, J ALLER CL IMM-PRACT, V6, P1528, DOI 10.1016/j.jaip.2018.05.010; Jensen ET, 2019, J PEDIATR GASTR NUTR, V68, P50, DOI 10.1097/MPG.0000000000002114; Kuchen T, 2014, ALLERGY, V69, P1248, DOI 10.1111/all.12455; Lee J, 2012, CLIN GASTROENTEROL H, V10, P481, DOI 10.1016/j.cgh.2011.12.042; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lipka S, 2014, GASTROINTEST ENDOSC, V80, P592, DOI 10.1016/j.gie.2014.02.012; Ram G, 2015, ANN ALLERG ASTHMA IM, V115, P224, DOI 10.1016/j.anai.2015.07.004; Reed Craig C, 2018, HSOA J Gastroenterol Hepatol Res, V7, P2509; Ruffner MA, 2018, J ALLER CL IMM-PRACT, V6, P661, DOI 10.1016/j.jaip.2017.06.035; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Spergel JM, 2009, J PEDIATR GASTR NUTR, V48, P30, DOI 10.1097/MPG.0b013e3181788282; Straumann A, 2011, CLIN GASTROENTEROL H, V9, P400, DOI 10.1016/j.cgh.2011.01.017; Warners MJ, 2018, AM J GASTROENTEROL, V113, P836, DOI 10.1038/s41395-018-0052-5; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043	26	8	8	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					1050	+		10.1016/j.jaci.2019.06.015	http://dx.doi.org/10.1016/j.jaci.2019.06.015			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31255641	Bronze, Green Accepted			2022-12-18	WOS:000488803900020
J	Maurer, M; Koberle, M; Metz, M; Biedermann, T				Maurer, Marcus; Koeberle, Martin; Metz, Martin; Biedermann, Tilo			Mast cells: Promoters of health and modulators of disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Mast cells; inflammation; pathogenesis			[Maurer, Marcus; Metz, Martin] Charite Univ Med Berlin, Dept Dermatol & Allergy, Dermatol Allergol, Berlin, Germany; [Koeberle, Martin; Biedermann, Tilo] Tech Univ Munich, Dept Dermatol & Allergol, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Maurer, M (corresponding author), Charite Univ Med Berlin, Dept Dermatol & Allergy, Charitepl 1, D-10117 Berlin, Germany.	marcus.maurer@charite.de	Metz, Martin/B-8799-2009; Maurer, Marcus/ABG-2174-2020; Köberle, Martin/HCI-8264-2022	Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X; Köberle, Martin/0000-0001-6825-2667; Biedermann, Tilo/0000-0002-5352-5105	Priority Programme of the Deutsche Forschungsgemeinschaft (DFG) SPP 1394: Mast cells - promoters of health and modulators of disease	Priority Programme of the Deutsche Forschungsgemeinschaft (DFG) SPP 1394: Mast cells - promoters of health and modulators of disease(German Research Foundation (DFG))	This article was published as part of a supplement sponsored by the members of the Priority Programme of the Deutsche Forschungsgemeinschaft (DFG) SPP 1394: Mast cells - promoters of health and modulators of disease.	Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Dudeck A, 2019, J ALLERGY CLIN IMMUN, V144, pS4, DOI 10.1016/j.jaci.2018.10.054; Elishmereni M, 2013, ALLERGY, V68, P171, DOI 10.1111/all.12059; Huber M, 2019, J ALLERGY CLIN IMMUN, V144, pS31, DOI 10.1016/j.jaci.2019.02.004; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Maurer M, 2019, J ALLERGY CLIN IMMUN, V144, pS19, DOI 10.1016/j.jaci.2019.07.017; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Stassen M, 2019, J ALLERGY CLIN IMMUN, V144, pS46, DOI 10.1016/j.jaci.2019.01.031	8	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4		S	SI		S1	S3		10.1016/j.jaci.2019.01.048	http://dx.doi.org/10.1016/j.jaci.2019.01.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8GI	30826362				2022-12-18	WOS:000488805000001
J	Safholm, J; Manson, ML; Bood, J; Al-Ameri, M; Orre, AC; Raud, J; Dahlen, SE; Adner, M				Safholm, Jesper; Manson, Martijn L.; Bood, Johan; Al-Ameri, Mamdoh; Orre, Ann-Charlotte; Raud, Johan; Dahlen, Sven-Erik; Adner, Mikael			Mannitol triggers mast cell-dependent contractions of human small bronchi and prostacyclin bronchoprotection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hyperosmolar challenge; exercise-induced bronchoconstriction; prostaglandin D-2; prostaglandin E-2; prostaglandin I-2; EP2 receptor; EP4 receptor; prostacyclin receptor; histamine; nonsteroidal anti-inflammatory drugs	EXERCISE-INDUCED BRONCHOCONSTRICTION; SODIUM CROMOGLYCATE; ASTHMATIC SUBJECTS; SMOOTH-MUSCLE; RELEASE; RECEPTOR; REFRACTORINESS; LEUKOTRIENES; HYPERPNEA; INDOMETHACIN	Background: Clinical research supports that exercise-induced bronchoconstriction (EIB) is caused by hyperosmolar triggering of mast cells. The reaction can be mimicked by inhalation of mannitol, but it has paradoxically previously not been possible to replicate this mode of action of mannitol in isolated airways. Objective: We sought to establish an ex vivo model of EIB in human small bronchi. Methods: Small bronchi (inner diameter, 0.5-2 mm) from macroscopically healthy human lung tissue were obtained from 48 patients and mounted in organ baths. Contractions and mediator release were analyzed after challenge with hyperosmolar mannitol (850 mOsm). Results: Ten minutes of exposure to mannitol caused a small initial contraction (12% +/- 1% of maximum) that was followed by a second and much larger contraction (maximum effect [E-max], 47% +/- 5%) when mannitol was washed out. The mast cell stabilizer cromolyn reduced the second contraction (E-max, 27% +/- 3%). Furthermore, this main contraction was abolished by the combination of antagonists of histamine and cysteinyl leukotrienes in the presence of indomethacin. Mannitol increased the release of the mast cell mediators histamine (9.0-fold), cysteinyl leukotrienes (4.5-fold), and prostaglandin (PG) D-2 (5.4-fold), as well as PGE(2) (6.3-fold) and the prostacyclin metabolite 6-keto PGF(1 alpha) (5.7-fold). In contrast, indomethacin alone enhanced the bronchoconstriction (E-max, 68% +/- 6%). Likewise, receptor antagonists for PGE(2) (EP2 and EP4) and prostacyclin (IP) also enhanced the mannitol-induced bronchoconstriction (E-max, 67% +/- 5%, 66% +/- 4%, and 68% +/- 3%, respectively). In bronchi precontracted by carbachol, the IP receptor agonist cicaprost induced profound relaxation. Conclusion: This new protocol established an in vitro model for studies of EIB in isolated human bronchi. The IP receptor might be a new target for asthma treatment.	[Safholm, Jesper; Manson, Martijn L.; Bood, Johan; Raud, Johan; Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Inst Environm Med, Biomedicum 5B,Solnavagen 9, SE-17165 Solna, Sweden; [Safholm, Jesper; Manson, Martijn L.; Bood, Johan; Raud, Johan; Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Ctr Allergy Res, Solna, Sweden; [Al-Ameri, Mamdoh] Karolinska Inst, Dept Mol Med & Surg MMK, Solna, Sweden; [Al-Ameri, Mamdoh; Orre, Ann-Charlotte] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Safholm, J (corresponding author), Karolinska Inst, Inst Environm Med, Biomedicum 5B,Solnavagen 9, SE-17165 Solna, Sweden.	jesper.safholm@ki.se	Manson, Martijn L/AAE-8606-2019; Manson, Martijn/GQI-3438-2022	Manson, Martijn L/0000-0002-5508-8615; 	Swedish Heart-Lung foundation; Swedish Research Council-Medicine and Health; Stockholm County Council Research Funds (ALF); Swedish Society of Medicine; Bernard Osher Initiative for Severe Asthma Research; Centre for Allergy Research Highlights Asthma Markers of Phenotype (ChAMP) consortium - Swedish Foundation for Strategic Research (SSF); Karolinska Institutet; AstraZeneca; Science for Life Laboratory Joint Research Collaboration; Swedish Association of Allergy; Vardal Foundation	Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Swedish Research Council-Medicine and Health; Stockholm County Council Research Funds (ALF); Swedish Society of Medicine; Bernard Osher Initiative for Severe Asthma Research; Centre for Allergy Research Highlights Asthma Markers of Phenotype (ChAMP) consortium - Swedish Foundation for Strategic Research (SSF); Karolinska Institutet(Karolinska Institutet); AstraZeneca(AstraZeneca); Science for Life Laboratory Joint Research Collaboration; Swedish Association of Allergy; Vardal Foundation	Supported by the Swedish Heart-Lung foundation, the Swedish Research Council-Medicine and Health, the Stockholm County Council Research Funds (ALF), the Swedish Society of Medicine, the Bernard Osher Initiative for Severe Asthma Research, and the Centre for Allergy Research Highlights Asthma Markers of Phenotype (ChAMP) consortium, which is funded by the Swedish Foundation for Strategic Research (SSF), the Karolinska Institutet, AstraZeneca and Science for Life Laboratory Joint Research Collaboration, the Swedish Association of Allergy, and the Vardal Foundation.	Anderson SD, 1997, AM J RESP CRIT CARE, V156, P758, DOI 10.1164/ajrccm.156.3.9701113; ANDERSON SD, 1992, THORAX, V47, P748, DOI 10.1136/thx.47.9.748; BJORCK T, 1993, PULM PHARMACOL, V6, P87, DOI 10.1006/pulp.1993.1012; BJORCK T, 1992, AM REV RESPIR DIS, V145, P1087; Bood JR, 2015, J APPL PHYSIOL, V119, P272, DOI 10.1152/japplphysiol.00301.2015; Boulet LP, 2015, NEW ENGL J MED, V372, P641, DOI 10.1056/NEJMra1407552; Brannan JD, 2003, EUR RESPIR J, V22, P491, DOI 10.1183/09031936.03.00113403; Brannan JD, 2001, AM J RESP CRIT CARE, V163, P1420, DOI 10.1164/ajrccm.163.6.2006019; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568; Carlsen KH, 2008, ALLERGY, V63, P387, DOI 10.1111/j.1398-9995.2008.01662.x; Dahlen B, 2002, J ALLERGY CLIN IMMUN, V109, P789, DOI 10.1067/mai.2002.123306; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1983, P NATL ACAD SCI-BIOL, V80, P1712, DOI 10.1073/pnas.80.6.1712; EGGLESTON PA, 1990, AM REV RESPIR DIS, V141, P960, DOI 10.1164/ajrccm/141.4_Pt_1.960; Gulliksson M, 2006, ALLERGY, V61, P1473, DOI 10.1111/j.1398-9995.2006.01213.x; Harrington LS, 2008, FASEB J, V22, P4005, DOI 10.1096/fj.08-107979; HAYELEGRAND I, 1987, PROSTAGLANDINS, V33, P845, DOI 10.1016/0090-6980(87)90113-4; JONGEJAN RC, 1990, J APPL PHYSIOL, V68, P1568, DOI 10.1152/jappl.1990.68.4.1568; Kay LJ, 2013, CLIN EXP ALLERGY, V43, P741, DOI 10.1111/cea.12142; Kippelen P, 2013, IMMUNOL ALLERGY CLIN, V33, P299, DOI 10.1016/j.iac.2013.02.002; Kippelen P, 2010, MED SCI SPORT EXER, V42, P1853, DOI 10.1249/MSS.0b013e3181da4f7d; KIRKPATRICK CT, 1980, CLIN EXP PHARMACOL P, V7, P147, DOI 10.1111/j.1440-1681.1980.tb00056.x; Kolmert J, 2018, ANAL CHEM, V90, P10239, DOI 10.1021/acs.analchem.8b01651; Larsson J, 2011, J APPL PHYSIOL, V110, P1029, DOI 10.1152/japplphysiol.00978.2010; MANNING PJ, 1993, AM REV RESPIR DIS, V148, P950, DOI 10.1164/ajrccm/148.4_Pt_1.950; MANNING PJ, 1990, NEW ENGL J MED, V323, P1736, DOI 10.1056/NEJM199012203232504; MARGOLSKEE DJ, 1988, AM REV RESPIR DIS, V137, P842, DOI 10.1164/ajrccm/137.4.842; MELILLO E, 1994, AM J RESP CRIT CARE, V149, P1138, DOI 10.1164/ajrccm.149.5.8173753; Norel X, 1999, BRIT J PHARMACOL, V126, P867, DOI 10.1038/sj.bjp.0702392; OBYRNE PM, 1986, AM REV RESPIR DIS, V134, P69; Safholm J, 2015, J ALLERGY CLIN IMMUN, V136, P1232, DOI 10.1016/j.jaci.2015.04.002; Safholm J, 2013, EUR J PHARMACOL, V718, P277, DOI 10.1016/j.ejphar.2013.08.021; Serra-Pages M, 2012, J LEUKOCYTE BIOL, V92, P1155, DOI 10.1189/jlb.0212109; TULLETT WM, 1985, THORAX, V40, P41, DOI 10.1136/thx.40.1.41; Weiler JM, 2016, J ALLERGY CLIN IMMUN, V138, P1292, DOI 10.1016/j.jaci.2016.05.029; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038	37	8	8	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					984	992		10.1016/j.jaci.2019.04.031	http://dx.doi.org/10.1016/j.jaci.2019.04.031			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31207273	hybrid, Green Published			2022-12-18	WOS:000488803900014
J	Hong, XM; Liang, LM; Sun, Q; Keet, CA; Tsai, HJ; Ji, YL; Wang, GY; Ji, HK; Clish, C; Pearson, C; Wang, Y; Wood, RA; Hu, FB; Wang, XB				Hong, Xiumei; Liang, Liming; Sun, Qi; Keet, Corinne A.; Tsai, Hui-Ju; Ji, Yuelong; Wang, Guoying; Ji, Hongkai; Clish, Clary; Pearson, Colleen; Wang, You; Wood, Robert A.; Hu, Frank B.; Wang, Xiaobin			Maternal triacylglycerol signature and risk of food allergy in offspring	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; lipidomics; triacylglycerol; timing of first solid-food introduction	FATTY-ACIDS; NATIONAL-HEALTH; SENSITIZATION; ANAPHYLAXIS; CHILDREN; PEANUT; EPIDEMIOLOGY; PATHOGENESIS; EXPOSURES; PROFILES	Background: The prevalence of IgE-mediated food allergy (FA) is increasing worldwide, but the underlying mechanisms are poorly understood. Objective: We sought to examine the role of maternal lipidomic profiles in risk of FA development in offspring and to investigate the potential modification effects by timing of first solid-food introduction. Methods: This report included 1068 mother-child dyads from the Boston Birth Cohort. Maternal lipid metabolites in plasma were assessed by using liquid chromatography tandem mass spectrometry. Food sensitization (FS) was defined as a specific IgE level of 0.35 kU/L or greater to any of the 8 common food allergens determined by using ImmunoCAP. FA was defined based on FS, clinical symptoms, and food avoidance. Logistic regression was applied to analyze associations between maternal metabolites and risk of FS and FA in offspring and to explore potential effect modifications. Results: Of the 1068 children, 411 had FS, and 132 had FA. Among the 209 metabolites, maternal triacylglycerols (TAGs) of shorter carbon chains and fewer double bonds were associated with greater risk of FA, whereas TAGs of longer carbon chains and more double bonds were significantly associated with lower risk of FA in offspring. These associations were stronger in children with delayed solid-food introduction (>= 7 months of age) than those with earlier solid-food introduction (P = .010 for interaction between the maternal TAG score and timing of solid food introduction). No significant association was found for FS. Conclusion: This is the first study to demonstrate a link between maternal TAGs and risk of FA in offspring and potential risk modification by timing of solid-food introduction.	[Hong, Xiumei; Tsai, Hui-Ju; Ji, Yuelong; Wang, Guoying; Wang, You; Wang, Xiaobin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, E4132B,615 N Wolfe St, Baltimore, MD 21205 USA; [Ji, Hongkai] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Liang, Liming; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Liang, Liming] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Sun, Qi; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Sun, Qi; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Sun, Qi; Hu, Frank B.] Harvard Med Sch, Boston, MA USA; [Keet, Corinne A.; Wood, Robert A.] Johns Hopkins Sch Med, Div Pediat Allergy & Immunol, Dept Pediat, Baltimore, MD USA; [Wang, Xiaobin] Johns Hopkins Sch Med, Div Gen Pediat & Adolescent Med, Dept Pediat, Baltimore, MD USA; [Tsai, Hui-Ju] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Clish, Clary] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Pearson, Colleen] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Pearson, Colleen] Boston Med Ctr, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Health Research Institutes - Taiwan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Boston Medical Center	Hong, XM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Early Life Origins Dis, E4132B,615 N Wolfe St, Baltimore, MD 21205 USA.	xhong3@jhu.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Wang, Guoying/F-8908-2011	Clish, Clary B/0000-0001-8259-9245; JI, Yuelong/0000-0001-6901-5030	March of Dimes PERI grants [20-FY02-56, 21-FY07-605]; National Institutes of Health (NIH) [R21ES011666, R01HD041702]; Bunning family foundation; NIH [R01HD041702, U01AI090727, R21AI079872, R21HD085556, R01HD086013]; NICHD [R03HD096136]; Food Allergy Research & Education (FARE); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086013, R01HD041702, R21HD085556, R03HD096136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	March of Dimes PERI grants; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bunning family foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Food Allergy Research & Education (FARE); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Boston Birth Cohort (the parent study) was supported in part by March of Dimes PERI grants (20-FY02-56 and 21-FY07-605) and National Institutes of Health (NIH) grants (R21ES011666 and R01HD041702). The follow-up study is supported in part by grants from the Bunning family and their family foundations, Food Allergy Research & Education (FARE), and NIH grants (U01AI090727, R21AI079872, R21HD085556, R01HD041702, and R01HD086013). X. H. is supported by the NICHD (R03HD096136).	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Atkins D, 2009, CURR ALLERGY ASTHM R, V9, P179, DOI 10.1007/s11882-009-0027-0; Austin PC, 2017, STAT METHODS MED RES, V26, P2505, DOI 10.1177/0962280215601134; Baurecht H, 2018, J ALLERGY CLIN IMMUN, V141, P1668, DOI 10.1016/j.jaci.2018.01.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Brunner PM, 2018, J ALLERGY CLIN IMMUN, V141, P2094, DOI 10.1016/j.jaci.2018.02.040; Calder PC, 2010, P NUTR SOC, V69, P373, DOI 10.1017/S0029665110001552; Cherkaoui S, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0055-x; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Hong XM, 2011, J ALLERGY CLIN IMMUN, V128, P374, DOI 10.1016/j.jaci.2011.05.007; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Jin JF, 2013, AM J PHYSIOL-ENDOC M, V305, pE853, DOI 10.1152/ajpendo.00251.2013; Krauss-Etschmann S, 2008, J ALLERGY CLIN IMMUN, V121, P464, DOI 10.1016/j.jaci.2007.09.018; Kumar R, 2009, J ALLERGY CLIN IMMUN, V124, P1031, DOI 10.1016/j.jaci.2009.06.052; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li JN, 2013, J ALLERGY CLIN IMMUN, V131, P442, DOI 10.1016/j.jaci.2012.10.011; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Longo G, 2013, LANCET, V382, P1656, DOI 10.1016/S0140-6736(13)60309-8; McGowan EC, 2016, J ALLER CL IMM-PRACT, V4, P713, DOI 10.1016/j.jaip.2016.01.017; McGowan EC, 2015, J ALLERGY CLIN IMMUN, V135, P171, DOI 10.1016/j.jaci.2014.06.033; McKeever TM, 2004, J ALLERGY CLIN IMMUN, V114, P1398, DOI 10.1016/j.jaci.2004.08.006; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Nwaru BI, 2010, PEDIATRICS, V125, P50, DOI 10.1542/peds.2009-0813; O'Donovan SM, 2016, J ALLERGY CLIN IMMUN, V137, P108, DOI 10.1016/j.jaci.2015.05.035; Ouyang FX, 2009, J ALLERGY CLIN IMMUN, V123, P940, DOI 10.1016/j.jaci.2008.11.032; Patel DA, 2011, J ALLERGY CLIN IMMUN, V128, P110, DOI 10.1016/j.jaci.2011.03.013; Pesonen M, 2008, CLIN EXP ALLERGY, V38, P178, DOI 10.1111/j.1365-2222.2007.02875.x; Prescott SL, 2007, LIPIDS, V42, P801, DOI 10.1007/s11745-007-3030-z; Rauschert S, 2016, J CLIN ENDOCR METAB, V101, P871, DOI 10.1210/jc.2015-3525; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98; Schafer T, 2003, CLIN EXP ALLERGY, V33, P1360, DOI 10.1046/j.1365-2222.2003.01780.x; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; Vinding RK, 2016, J ALLERGY CLIN IMMUN, V137, P68, DOI 10.1016/j.jaci.2015.05.033; Wang GY, 2014, JAMA-J AM MED ASSOC, V311, P587, DOI 10.1001/jama.2014.1; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808	42	8	8	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					729	737		10.1016/j.jaci.2019.03.033	http://dx.doi.org/10.1016/j.jaci.2019.03.033			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31004614	Green Accepted, Bronze			2022-12-18	WOS:000485222300018
J	Mahapatra, S; Shearer, WT; Minard, CG; Mace, E; Paul, M; Orange, JS				Mahapatra, Sanjana; Shearer, William T.; Minard, Charles G.; Mace, Emily; Paul, Mary; Orange, Jordan S.			NK cells in treated HIV-infected children display altered phenotype and function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NK cell; treated HIV; flow cytomeny; children; vertical exposure	NATURAL-KILLER-CELLS; UNINFECTED CHILDREN; CD4/CD8 RATIO; ACTIVATION; POPULATION; PROTECTION; RESISTANCE; RECOVERY; RECEPTOR; THERAPY	Background: Chronic HIV infection is known to trigger a population redistribution and alteration in the functional capacity of natural killer (NK) cells. Because of improved antiretroviral treatments, there are rising numbers of adolescents and young adults worldwide who are living with HIV infection since birth. Objective: We sought to determine how NK-cell phenotypic and functional subsets are altered in treated pediatric patients. Methods: NK cells were contrasted among 29 HIV-unexposed and uninfected controls (5-19 years), 23 HIV-exposed but uninfected patients (3-19 years), and 25 HIV-infected patients (3-19 years) using multiparametric flow cytometry. Results: Although most NK-cell markers did not differ, activating receptors such as NKp46, DNAX accessory molecule-1, and NKG2C and stimulatory receptors such as CD2 and CD11c were expressed by a higher frequency of NK cells in HIV-infected patients than in controls. Interestingly, there were less differences between HIV-infected and HIV-exposed but uninfected children. There was an inverse relationship between CD4/CD8 T-cell ratio (as a marker of disease progression) and CD11c and NKG2C frequency and CD69 upregulation on stimulation among HIV-infected patients. Conclusions: A chronic NK-cell activation phenotype persists in HIV-infected children receiving antiretroviral therapy and is associated with declining CD4/CD8 T-cell ratios. A lower CD4/CD8 T-cell ratio was associated with higher baseline granzyme B (P = .0068; R-2 = 0.29) and degranulation potential (P = .022; R-2 = 0.22) in stimulated NK cells. Thus, NK cells in HIV-infected children receiving treatment have reduced functional potential and an activated phenotype that distinguishes them from uninfected children.	[Mahapatra, Sanjana; Mace, Emily; Orange, Jordan S.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Mahapatra, Sanjana; Shearer, William T.; Mace, Emily; Orange, Jordan S.] Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Shearer, William T.; Paul, Mary; Orange, Jordan S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Minard, Charles G.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Mace, Emily; Orange, Jordan S.] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Columbia University	Orange, JS (corresponding author), CUMC NewYork Presbyterian Morgan Stanley Children, 3959 Broadway, New York, NY 10032 USA.	jso2121@cumc.columbia.edu	Paul, Mary/AAA-2722-2021	orange, jordan/0000-0001-7117-7725	National Institutes of Health [R01AI120989]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (grant no. R01AI120989 to J.S.O.).	Afran L, 2014, CLIN EXP IMMUNOL, V176, P11, DOI 10.1111/cei.12251; Alter G, 2004, J IMMUNOL, V173, P5305, DOI 10.4049/jimmunol.173.8.5305; Azzoni L, 2005, J INFECT DIS, V191, P1451, DOI 10.1086/429300; Azzoni L, 2002, J IMMUNOL, V168, P5764, DOI 10.4049/jimmunol.168.11.5764; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Bernstein HB, 2004, AIDS RES HUM RETROV, V20, P1189, DOI 10.1089/aid.2004.20.1189; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f; Douglas SD, 2001, AIDS RES HUM RETROV, V17, P543, DOI 10.1089/08892220151126643; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Foster SB, 2008, J ALLERGY CLIN IMMUN, V122, P159, DOI 10.1016/j.jaci.2008.04.043; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P1, DOI 10.1189/jlb.0907650; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Jennes W, 2013, BLOOD, V121, P1157, DOI 10.1182/blood-2012-09-455352; Korner C, 2014, EUR J IMMUNOL, V44, P2938, DOI 10.1002/eji.201444751; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Leeansyah E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009643; Lichtfuss GF, 2012, J IMMUNOL, V189, P1491, DOI 10.4049/jimmunol.1200458; Lima JF, 2014, JAIDS-J ACQ IMM DEF, V67, P463, DOI 10.1097/QAI.0000000000000350; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Mahapatra S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181134; Mathias CB, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0500-2; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Parato KG, 2002, AIDS, V16, P1251, DOI 10.1097/00002030-200206140-00007; Perussia, 1996, Methods, V9, P370; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Serrano-Villar S, 2015, LANCET HIV, V2, pE76, DOI 10.1016/S2352-3018(15)00018-1; Shearer WT, 2017, J ALLERGY CLIN IMMUN, V140, P1101, DOI 10.1016/j.jaci.2017.01.031; Slyker JA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00399; Sondergaard SR, 1999, J ACQ IMMUN DEF SYND, V21, P376; Tiemessen Caroline T, 2006, Curr HIV/AIDS Rep, V3, P13, DOI 10.1007/s11904-006-0003-4; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; WELSH RM, 1984, CRC CR REV IMMUNOL, V5, P55	39	8	8	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					294	+		10.1016/j.jaci.2018.11.052	http://dx.doi.org/10.1016/j.jaci.2018.11.052			23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30735686	Bronze, Green Accepted			2022-12-18	WOS:000473432800030
J	Cho, HJ; Sheen, YH; Kang, MJ; Lee, SH; Lee, SY; Yoon, J; Jung, S; Lee, SH; Kim, YH; Yang, SI; Lee, E; Seo, JH; Ahn, K; Kim, KW; Suh, DI; Won, HS; Lee, MY; Kim, SH; Choi, SJ; Kwon, JY; Jun, JK; Kwon, SO; Oh, SY; Hong, SJ				Cho, Hyun-Ju; Sheen, Youn Ho; Kang, Mi-Jin; Lee, Seung-Hwa; Lee, So-Yeon; Yoon, Jisun; Jung, Sungsu; Lee, Si Hyeon; Kim, Young-Ho; Yang, Song-, I; Lee, Eun; Seo, Ju-Hee; Ahn, Kangmo; Kim, Kyung Won; Suh, Dong In; Won, Hye-Sung; Lee, Mi-Young; Kim, Soo Hyun; Choi, Suk-Joo; Kwon, Ja-Young; Jun, Jong Kwan; Kwon, Sung-Ok; Oh, Se-Young; Hong, Soo-Jong			Prenatal 25-hydroxyvitamin D deficiency affects development of atopic dermatitis via DNA methylation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Cho, Hyun-Ju] Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Pediat, Incheon, South Korea; [Sheen, Youn Ho] CHA Univ, Coll Med, CHA Med Ctr, Dept Pediat, Seoul, South Korea; [Kang, Mi-Jin; Lee, Seung-Hwa; Lee, Si Hyeon; Hong, Soo-Jong] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea; [Lee, So-Yeon; Jung, Sungsu; Kim, Young-Ho; Hong, Soo-Jong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat,Childhood Asthma Atopy Ctr,Environm H, Seoul, South Korea; [Yoon, Jisun] MediplexSejong Hosp, Dept Pediat, Incheon, South Korea; [Yang, Song-, I] Hallym Univ, Coll Med, Dept Pediat, Hallym Univ Sacred Heart Hosp, Anyang, South Korea; [Lee, Eun] Chonnam Natl Univ, Sch Med, Chonnam Natl Univ Hosp, Dept Pediat, Gwangju, South Korea; [Seo, Ju-Hee] Dankook Univ Hosp, Dept Pediat, Cheonan, South Korea; [Ahn, Kangmo] Sungkyunkwan Univ, Sch Med, Environm Hlth Ctr Atop Dis, Dept Pediat,Samsung Med Ctr, Seoul, South Korea; [Kim, Kyung Won] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Suh, Dong In] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Won, Hye-Sung; Lee, Mi-Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Soo Hyun] CHA Univ, Sch Med, CHA Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Choi, Suk-Joo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Kwon, Ja-Young] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Jun, Jong Kwan] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kwon, Sung-Ok] Kangwon Natl Univ Hosp, Biomed Res Inst, Chunchon, South Korea; [Oh, Se-Young] Kyung Hee Univ, Res Inst Human Ecol, Dept Food & Nutr, Seoul, South Korea	Catholic Kwandong University; Pochon Cha University; University of Ulsan; University of Ulsan; Asan Medical Center; Hallym University; Chonnam National University; Chonnam National University Hospital; Dankook University; Dankook University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); University of Ulsan; Asan Medical Center; Pochon Cha University; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Kangwon National University; Kangwon National University Hospital; Kyung Hee University	Hong, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea.; Hong, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat,Childhood Asthma Atopy Ctr,Environm H, Seoul, South Korea.	sjhong@amc.seoul.kr	Hong, Soo-Jong/AAR-1788-2020	Hong, Soo-Jong/0000-0003-1409-2113	Research of Korea Centers for Disease Control and Prevention [2008-E33030-00, 2009-E33033-00, 2011-E33021-00, 2012-E33012-00, 2013-E51003-00, 2014-E51004-00, 2014-E51004-01, 2014-E51004-02, 2017-E67002-00]; Bio AMP; Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [2017M3A9F3043834]	Research of Korea Centers for Disease Control and Prevention; Bio AMP; Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT	This study was supported by funding (2008-E33030-00, 2009-E33033-00, 2011-E33021-00, 2012-E33012-00, 2013-E51003-00, 2014-E51004-00, 2014-E51004-01, 2014-E51004-02, 2017-E67002-00) from the Research of Korea Centers for Disease Control and Prevention and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (2017M3A9F3043834).	Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.253; Jones AP, 2012, PEDIATRICS, V130, pE1128, DOI 10.1542/peds.2012-1172; Lan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111599; Palmer DJ, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0077-9; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Yang HJ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-109	9	8	8	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1215	1218		10.1016/j.jaci.2018.10.010	http://dx.doi.org/10.1016/j.jaci.2018.10.010			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30352202	Bronze			2022-12-18	WOS:000460272900041
J	Moldaver, DM; Bharhani, MS; Rudulier, CD; Wattie, J; Inman, MD; Larche, M				Moldaver, Daniel M.; Bharhani, Mantej S.; Rudulier, Christopher D.; Wattie, Jennifer; Inman, Mark D.; Larche, Mark			Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; asthma; peptide; immunotherapy; ovalbumin; cat dander; T(H)2; regulatory T cell; intermolecular tolerance	REGULATORY T-CELLS; HOUSE-DUST MITE; ALLERGIC-ASTHMA; ORAL TOLERANCE; CAT ALLERGEN; FOLLOW-UP; SUPPRESSION; INFLAMMATION; RESPONSES; INHALATION	Background: Treatment of patients with cat allergy with peptides derived from Fel d 1 (the major cat allergen) ameliorated symptoms of cat allergy in phase 2 clinical trials. Objective: We sought to demonstrate that the tolerance induced by Fel d 1 peptide immunotherapy can be exploited to reduce allergic responses to a second allergen, ovalbumin (OVA), in mice sensitized dually to OVA and Fel d 1. Methods: Induction of tolerance to OVA was achieved through simultaneous exposure to both allergens after peptide treatment. Functional tolerance to each allergen was assessed in a model of allergic airways disease in which treated mice were protected from eosinophilia, goblet cell hyperplasia, and T(H)2 cell infiltration. Results: Suppression of allergic responses to cat allergen challenge was associated with significant increases in numbers of CD4(+) CD25(+) Foxp3 1 T cells, IL-10(+) cells, and CD19(+) IL-10(+) B cells, whereas the response to OVA was associated with a marked reduction in numbers of T(H)2 cytokine-secreting T cells and less prominent changes in outcomes associated with immune regulation. Conclusions: These observations suggest that immune tolerance induced by peptide immunotherapy can be used experimentally to treat an allergic response to another allergen and that the molecular mechanisms underlying induction of tolerance to a treatment-specific allergen and a bystander allergen might be different.	[Moldaver, Daniel M.; Bharhani, Mantej S.; Rudulier, Christopher D.; Wattie, Jennifer; Inman, Mark D.; Larche, Mark] McMaster Univ, Firestone Inst Resp Hlth, Div Respirol, St Josephs Healthcare, Hamilton, ON, Canada; [Moldaver, Daniel M.; Bharhani, Mantej S.; Rudulier, Christopher D.; Wattie, Jennifer; Inman, Mark D.; Larche, Mark] McMaster Univ, Div Clin Immunol & Allergy, Dept Med, Hamilton, ON, Canada; [Rudulier, Christopher D.] Univ Saskatchewan, Div Respirol Crit Care & Sleep Med, Dept Med, Saskatoon, SK, Canada	McMaster University; McMaster University; University of Saskatchewan	Larche, M (corresponding author), McMaster Univ, St Josephs Hosp Healthcare, Firestone Inst Resp Hlth, Div Clin Immunol & Allergy, T2131-1,2nd Floor,Juravinski Tower, Hamilton, ON L8N 4A6, Canada.; Larche, M (corresponding author), McMaster Univ, St Josephs Hosp Healthcare, Div Allergy & Respirol, Dept Med, T2131-1,2nd Floor,Juravinski Tower, Hamilton, ON L8N 4A6, Canada.	larche@mcmaster.ca		Larche, Mark/0000-0002-1439-7593	Canadian Institutes for Health Research (CIHR); Canada Research Chairs Program; Canada Foundation for Innovation; McMaster University/GSK Chair in Lung Immunology at St Joseph's Healthcare; Father Sean O'Sullivan Research Committee (FSORC) Post-graduate Studentship through St Joseph's Healthcare, Hamilton; Ontario Graduate Scholarship (OGS); Eva Eugenia Lillian Cope scholarship	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); McMaster University/GSK Chair in Lung Immunology at St Joseph's Healthcare; Father Sean O'Sullivan Research Committee (FSORC) Post-graduate Studentship through St Joseph's Healthcare, Hamilton; Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Eva Eugenia Lillian Cope scholarship	Supported by the Canadian Institutes for Health Research (CIHR). M.L. is supported by the Canada Research Chairs Program, the Canada Foundation for Innovation, and the McMaster University/GSK Chair in Lung Immunology at St Joseph's Healthcare. D. M. M. was supported by a Father Sean O'Sullivan Research Committee (FSORC) Post-graduate Studentship through St Joseph's Healthcare, Hamilton; the Ontario Graduate Scholarship (OGS); and the Eva Eugenia Lillian Cope scholarship.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Ali FR, 2004, AM J RESP CRIT CARE, V169, P20, DOI 10.1164/rccm.200305-690OC; Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Bouchaud G, 2015, J ALLERGY CLIN IMMUN, V136, P197, DOI 10.1016/j.jaci.2014.12.1938; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; Chien CH, 2015, J ALLERGY CLIN IMMUN, V136, P1110, DOI 10.1016/j.jaci.2015.04.018; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; Couroux P, 2015, CLIN EXP ALLERGY, V45, P974, DOI 10.1111/cea.12488; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; DiGiovanni FA, 2009, DIS MODEL MECH, V2, P275, DOI 10.1242/dmm.001859; DURHAM SR, 1992, J IMMUNOL, V148, P2390; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Ellis AK, 2017, J ALLERGY CLIN IMMUN, V140, P486, DOI 10.1016/j.jaci.2016.11.043; Frew AJ, 2010, J ALLERGY CLIN IMMUN, V125, pS306, DOI 10.1016/j.jaci.2009.10.064; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hedlin G, 1999, J ALLERGY CLIN IMMUN, V103, P609, DOI 10.1016/S0091-6749(99)70232-0; Hirota JA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-120; HOLAN V, 1983, EUR J IMMUNOL, V13, P652, DOI 10.1002/eji.1830130809; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HOYNE GF, 1993, J EXP MED, V178, P1783, DOI 10.1084/jem.178.5.1783; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226; Lau S, 2005, ALLERGY, V60, P766, DOI 10.1111/j.1398-9995.2005.00781.x; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Lin YL, 2008, ALLERGY, V63, P67, DOI 10.1111/j.1398-9995.2007.01526.x; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; METZLER B, 1993, INT IMMUNOL, V5, P1159, DOI 10.1093/intimm/5.9.1159; Moldaver D, 2011, ALLERGY, V66, P784, DOI 10.1111/j.1398-9995.2011.02610.x; Moldaver DM, 2014, MUCOSAL IMMUNOL, V7, P379, DOI 10.1038/mi.2013.56; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Oldfield WLG, 2001, J IMMUNOL, V167, P1734, DOI 10.4049/jimmunol.167.3.1734; Pajno GB, 2001, CLIN EXP ALLERGY, V31, P1392, DOI 10.1046/j.1365-2222.2001.01161.x; Patel D, 2013, J ALLERGY CLIN IMMUN, V131, P103, DOI 10.1016/j.jaci.2012.07.028; Pene J, 1998, J ALLERGY CLIN IMMUN, V102, P571, DOI 10.1016/S0091-6749(98)70294-5; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Smith TRF, 2004, ALLERGY, V59, P1097, DOI 10.1111/j.1398-9995.2004.00601.x; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; Tarzi M, 2006, CLIN EXP ALLERGY, V36, P465, DOI 10.1111/j.1365-2222.2006.02469.x; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; Wahn U, 2013, PEDIAT ALLERG IMM-UK, V24, P308, DOI 10.1111/pai.12092; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Worm M, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Worm M, 2011, J ALLERGY CLIN IMMUN, V127, P89, DOI 10.1016/j.jaci.2010.11.029; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	59	8	8	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1087	+		10.1016/j.jaci.2018.03.023	http://dx.doi.org/10.1016/j.jaci.2018.03.023			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	29906527	Bronze			2022-12-18	WOS:000460272900029
J	Barnthaler, T; Jandl, K; Sill, H; Uhl, B; Schreiber, Y; Grill, M; Thomas, D; Schicho, R; Marsche, G; Frank, S; Heinemann, A; Schuligoi, R				Baernthaler, Thomas; Jandl, Katharina; Sill, Heinz; Uhl, Barbara; Schreiber, Yannick; Grill, Magdalena; Thomas, Dominique; Schicho, Rudolf; Marsche, Gunther; Frank, Sasa; Heinemann, Akos; Schuligoi, Rufina			Imatinib stimulates prostaglandin E-2 and attenuates cytokine release via EP4 receptor activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INHIBITION; PHARMACOKINETICS		[Baernthaler, Thomas; Grill, Magdalena; Schicho, Rudolf; Marsche, Gunther; Heinemann, Akos; Schuligoi, Rufina] Med Univ Graz, Div Pharmacol, Otto Loewi Res Ctr, Graz, Austria; [Jandl, Katharina] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Sill, Heinz; Uhl, Barbara] Med Univ Graz, Div Hematol, Dept Internal Med, Graz, Austria; [Schreiber, Yannick] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp TMP, Frankfurt, Germany; [Thomas, Dominique] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES Inst Clin Pharmacol, Frankfurt, Germany; [Schicho, Rudolf; Marsche, Gunther; Heinemann, Akos] BioTechMed, Graz, Austria; [Frank, Sasa] Med Univ Graz, Div Mol Biol & Biochem, Gottfried Schatz Res Ctr, Graz, Austria	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Fraunhofer Gesellschaft; Goethe University Frankfurt; Medical University of Graz	Schuligoi, R (corresponding author), Med Univ Graz, Div Pharmacol, Otto Loewi Res Ctr, Graz, Austria.	rufina.schuligoi@medunigraz.at	Grill, Magdalena/J-2614-2013; Sill, Heinz/AAV-4643-2021	Grill, Magdalena/0000-0002-4733-5815; Sill, Heinz/0000-0003-0993-4371; Schuligoi, Rufina/0000-0002-9338-6904; Schicho, Rudolf/0000-0002-5726-4731; Barnthaler, Thomas/0000-0002-4988-3700; Marsche, Gunther/0000-0002-2422-5381; Uhl, Barbara/0000-0002-8460-8771	Austrian Science Fund FWF [P22521-B18, P30144-B26, KLI521-B31, P22976-B18, P26185-B19]; Jubilaumsfonds of the Austrian National Bank [14263]; LOEWE program from the state of Hesse (Translational Medicine and Pharmacology, TMP); PhD Program DK-MOLIN [FWF - W1241]; DOC Fellowship of the Austrian Academy of Science; Start Funding Program of the Medical University of Graz	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Jubilaumsfonds of the Austrian National Bank; LOEWE program from the state of Hesse (Translational Medicine and Pharmacology, TMP); PhD Program DK-MOLIN; DOC Fellowship of the Austrian Academy of Science; Start Funding Program of the Medical University of Graz	This research was supported by the Austrian Science Fund FWF (grant no. P22521-B18 to A.H.; grant nos. P30144-B26 and KLI521-B31 to R.S.; grant no. P22976-B18 to G.M.; and grant no. P26185-B19 to R.S.), the Jubilaumsfonds of the Austrian National Bank (grant no. 14263 to A.H.), and the LOEWE program from the state of Hesse (Translational Medicine and Pharmacology, TMP, to D.T.). T.B. was funded by the PhD Program DK-MOLIN (FWF - W1241). T.B. is a recipient of a DOC Fellowship of the Austrian Academy of Science and the Start Funding Program of the Medical University of Graz.	Amann R, 2000, NEUROSCI LETT, V278, P173, DOI 10.1016/S0304-3940(99)00931-3; Barnthaler T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08228-y; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Fava Carmen, 2009, Drug Des Devel Ther, V2, P233; Jorgl A, 2007, BLOOD, V109, P185, DOI 10.1182/blood-2006-05-022954; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Koschmieder S, 2016, LEUKEMIA, V30, P1018, DOI 10.1038/leu.2016.12; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Patrignani P, 1997, J PHYSIOL PHARMACOL, V48, P623; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Pereira I, 2010, JOINT BONE SPINE, V77, P372, DOI 10.1016/j.jbspin.2010.03.014; Rhee CK, 2011, INT ARCH ALLERGY IMM, V155, P243, DOI 10.1159/000321261; Rizzo AN, 2015, ARTERIOSCL THROM VAS, V35, P1071, DOI 10.1161/ATVBAHA.115.305085; Torres R, 2015, MOL IMMUNOL, V63, P61, DOI 10.1016/j.molimm.2014.03.007; Vezza R, 2002, THROMB HAEMOSTASIS, V87, P114, DOI 10.1055/s-0037-1612953; Wade ML, 1997, ARCH BIOCHEM BIOPHYS, V347, P174, DOI 10.1006/abbi.1997.0348; Xia BF, 2012, BIOPHARM DRUG DISPOS, V33, P536, DOI 10.1002/bdd.1821	17	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					794	+		10.1016/j.jaci.2018.09.030	http://dx.doi.org/10.1016/j.jaci.2018.09.030			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30336225	hybrid			2022-12-18	WOS:000457718700044
J	Gerald, JK; Fisher, JM; Brown, MA; Clemens, CJ; Moore, MA; Carvajal, SC; Bryson, D; Stefan, N; Billheimer, D; Gerald, LB				Gerald, Joe K.; Fisher, Julia M.; Brown, Mark A.; Clemens, Conrad J.; Moore, Melissa A.; Carvajal, Scott C.; Bryson, Donna; Stefan, Nikki; Billheimer, Dean; Gerald, Lynn B.			School-supervised use of a once-daily inhaled corticosteroid regimen: A cluster randomized trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Schools; anti-inflammatory agent; medication adherence; asthma; child; directly observed therapy; randomized controlled trial; inhaled corticosteroid; cluster randomized trial	SEVERE ASTHMA EXACERBATIONS; RACIAL DISPARITIES; COST-EFFECTIVENESS; ADHERENCE RATE; CHILDREN; THERAPY; PROGRAM; SCHOOLCHILDREN; MANAGEMENT; OUTCOMES	Background: School-supervised use of a once-daily inhaled corticosteroid regimen (supervised therapy) can improve medication adherence and asthma control. Objective: We sought to evaluate the effectiveness of supervised therapy in a unique setting and population. Methods: We conducted a cluster randomized trial of supervised therapy in 20 elementary schools with a disproportionate enrollment of low-income Latino students. Schools were purposively selected, matched, and randomized to receive 9 months of supervised therapy with mometasone furoate or usual care. All English-or Spanish-speaking students with self-reported asthma were eligible. The Asthma Control Questionnaire (ACQ) was interviewer administered quarterly at school. Students in supervised therapy schools were hypothesized to have lower ACQ scores than students in usual-care schools. Results: Of 393 enrolled students, 189 students receiving immediate intervention and 143 students receiving delayed intervention provided 1 or more ACQ data points, were between 6 and 10 years of age, and were included in the primary analysis. At baseline, 39% of students reported taking a controller medication, and 24% had well-controlled asthma. Eighty percent of students receiving immediate intervention were prescribed mometasone. Schools administered 98% of prescribed doses when students attended school. Absences, weekends, and holidays reduced calendar adherence to 53%. During the first year, the mean ACQ score for students receiving immediate and delayed intervention was 1.55 (95% CI, 1.41-1.70) and 1.64 (95% CI, 1.47-1.80), respectively. The estimated treatment effect was 20.08 (95% CI, 20.31 to 0.14). Discussion: Compared with usual care, supervised therapy did not improve asthma control among this population of Latino students. Additional research is warranted to confirm these results.	[Gerald, Joe K.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Community Environm & Policy, Tucson, AZ USA; [Gerald, Joe K.; Gerald, Lynn B.] Univ Arizona, Asthma & Airways Dis Res Ctr, Tucson, AZ USA; [Fisher, Julia M.; Billheimer, Dean] Univ Arizona, BIO5 Inst, Tucson, AZ USA; [Brown, Mark A.] Univ Colorado, Dept Pediat, Denver, CO 80202 USA; [Brown, Mark A.] Childrens Hosp Colorado, Breathing Inst, Denver, CO USA; [Clemens, Conrad J.; Moore, Melissa A.] Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ USA; [Carvajal, Scott C.; Gerald, Lynn B.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, Tucson, AZ USA; [Bryson, Donna] Amer Lung Assoc Southern Arizona, Tucson, AZ USA; [Stefan, Nikki] Tucson Unified Sch Dist, Dept Hlth Serv, Tucson, AZ USA; [Billheimer, Dean] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Epidemiol & Biostat, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Arizona; University of Arizona; University of Arizona	Gerald, LB (corresponding author), Univ Arizona, Asthma & Airways Dis Res Ctr, Mel & Enid Zuckerman Coll Publ Hlth, Dept Community Environm & Policy, 1295 N Martin Ave,POB 245210, Tucson, AZ 85724 USA.	geraldj@email.arizona.edu		Fisher, Julia/0000-0003-4427-4882	National Institutes of Health/National Heart, Lung, and Blood Institute [1R18HL110858-01A1]; Investigator-Initiated Studies Program of Merck Sharp&Dohme Corporation; Thayer Medical Corporation	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Investigator-Initiated Studies Program of Merck Sharp&Dohme Corporation; Thayer Medical Corporation	Supported by National Institutes of Health/National Heart, Lung, and Blood Institute grant 1R18HL110858-01A1; a research grant from the Investigator-Initiated Studies Program of Merck Sharp&Dohme Corporation who provided Asmanex (mometasone furoate) and Proventil (albuterol sulfate); and Thayer Medical Corporation, who provided disposable valved holding chambers (LiteAire). The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp.	Akinbami LJ, 2014, J ALLERGY CLIN IMMUN, V134, P547, DOI 10.1016/j.jaci.2014.05.037; *AM AC ALL ASTHM I, 1999, PED ASTHM PROM BEST; [Anonymous], 2016, STAT PORTRAIT HISPAN; Balfanz R., 2012, CHRONIC ABSENTEEISM; Beck AF, 2016, JAMA PEDIATR, V170, P695, DOI 10.1001/jamapediatrics.2016.0269; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cicutto L, 2014, J ALLERGY CLIN IMMUN, V134, P1223, DOI 10.1016/j.jaci.2014.10.004; Echeverria SE, 2014, J ADOLESCENT HEALTH, V55, P402, DOI 10.1016/j.jadohealth.2014.03.012; Ellenberg SS, 2018, JAMA-J AM MED ASSOC, V319, P607, DOI 10.1001/jama.2017.21993; Engelkes M, 2015, EUR RESPIR J, V45, P396, DOI 10.1183/09031936.00075614; Gerald JK, 2015, J ALLER CL IMM-PRACT, V3, P540, DOI 10.1016/j.jaip.2015.01.023; Gerald JK, 2010, J ALLERGY CLIN IMMUN, V125, P643, DOI 10.1016/j.jaci.2009.12.984; Gerald LB, 2009, PEDIATRICS, V123, P466, DOI 10.1542/peds.2008-0499; Gupta RS, 2009, PEDIATRICS, V123, pS193, DOI 10.1542/peds.2008-2233J; Halterman JS, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2017.4938; Halterman JS, 2011, ARCH PEDIAT ADOL MED, V165, P262, DOI 10.1001/archpediatrics.2011.1; Halterman JS, 2004, ARCH PEDIAT ADOL MED, V158, P460, DOI 10.1001/archpedi.158.5.460; Holguin F, 2005, AM J RESP CRIT CARE, V171, P103, DOI 10.1164/rccm.200402-143OC; Jentzsch NS, 2012, RESP MED, V106, P338, DOI 10.1016/j.rmed.2011.12.001; Ji P, 2008, J SCHOOL HEALTH, V78, P131, DOI 10.1111/j.1746-1561.2007.00275.x; Juniper EF, 2010, EUR RESPIR J, V36, P1410, DOI 10.1183/09031936.00117509; Kelly Michael L, 2005, J Natl Med Assoc, V97, P777; Krishnan JA, 2012, J ALLERGY CLIN IMMUN, V129, P112, DOI 10.1016/j.jaci.2011.10.030; Lasmar L, 2009, ALLERGY, V64, P784, DOI 10.1111/j.1398-9995.2008.01877.x; Lynn J, 2014, J ALLERGY CLIN IMMUN, V134, P1238, DOI 10.1016/j.jaci.2014.09.040; McEwen M, 1998, J SCHOOL HEALTH, V68, P196, DOI 10.1111/j.1746-1561.1998.tb01300.x; Meng YY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110312; Millard MW, 2003, J ASTHMA, V40, P769, DOI 10.1081/JAS-120023504; Moonie SA, 2006, J SCHOOL HEALTH, V76, P18, DOI 10.1111/j.1746-1561.2006.00062.x; Nguyen JM, 2014, J ALLERGY CLIN IMMUN, V133, P91, DOI 10.1016/j.jaci.2013.06.029; Noyes K, 2013, PEDIATRICS, V131, pE709, DOI 10.1542/peds.2012-1883; Passel J.S., 2014, UNAUTHORIZED IMMIGRA; Pastor Patricia N, 2015, Natl Health Stat Report, P1; The PEW Charitable Trust, 2015, PREC STAT FAM BAL SH; Williams LK, 2011, J ALLERGY CLIN IMMUN, V128, P1185, DOI 10.1016/j.jaci.2011.09.011; Wu AC, 2015, ANN AM THORAC SOC, V12, P161, DOI 10.1513/AnnalsATS.201410-459OC	38	8	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					755	764		10.1016/j.jaci.2018.06.048	http://dx.doi.org/10.1016/j.jaci.2018.06.048			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	HK2DJ	30118728	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000457718700034
J	Acres, MJ; Gothe, F; Grainger, A; Skelton, AJ; Swan, DJ; Willet, JDP; Leech, S; Galcheva, S; Iotova, V; Hambleton, S; Engelhardt, KR				Acres, Meghan J.; Gothe, Florian; Grainger, Angela; Skelton, Andrew J.; Swan, David J.; Willet, Joseph D. P.; Leech, Suzy; Galcheva, Sonya; Iotova, Violeta; Hambleton, Sophie; Engelhardt, Karin R.			Signal transducer and activator of transcription 5B deficiency due to a novel missense mutation in the coiled-coil domain	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GROWTH-HORMONE INSENSITIVITY; STAT5B		[Acres, Meghan J.; Gothe, Florian; Grainger, Angela; Swan, David J.; Willet, Joseph D. P.; Hambleton, Sophie; Engelhardt, Karin R.] Newcastle Univ, Primary Immunodeficiency Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Gothe, Florian] Ludwig Maximilians Univ Munchen, Dept Pediat, Dr von Hauner Childrens Hosp, Munich, Germany; [Skelton, Andrew J.] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Leech, Suzy; Hambleton, Sophie] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Galcheva, Sonya; Iotova, Violeta] Med Univ Varna, Dept Pediat, Pediat Endocrinol, Univ Hosp St Marina, Varna, Bulgaria	Newcastle University - UK; University of Munich; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Medical University Varna	Engelhardt, KR (corresponding author), Newcastle Univ, Primary Immunodeficiency Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	karin.engelhardt@newcastle.ac.uk	Iotova, Violeta/AAO-2387-2021	Hambleton, Sophie/0000-0001-7954-3267; Swan, David/0000-0002-6480-9621; Engelhardt, Karin Regine/0000-0001-8513-9682; Iotova, Violeta/0000-0003-4160-1200	Sir Jules Thorn Charitable Trust [12/JTA]; Wellcome Trust; Bubble Foundation; Deutsche Forschungsgemeinschaft [GO2955/1-1]	Sir Jules Thorn Charitable Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Bubble Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Sir Jules Thorn Charitable Trust (grant no. 12/JTA), the Wellcome Trust, and the Bubble Foundation to S.G. and supported by a grant from the Deutsche Forschungsgemeinschaft (grant no. GO2955/1-1 to F.G.). Disclosure of potential conflict of interest: The authors declare that they have	Andrews S., 2010, FASTQC QUALITY CONTR; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Bezrodnik L, 2015, J CLIN IMMUNOL, V35, P264, DOI 10.1007/s10875-015-0145-5; Chia DJ, 2006, J BIOL CHEM, V281, P6552, DOI 10.1074/jbc.M510903200; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Kanai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086790; Kanai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00234; Klammt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04521-0; Majri SS, 2018, J IMMUNOL, V200, P110, DOI 10.4049/jimmunol.1701133; Niroula A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117380; Pugliese-Pires PN, 2010, EUR J ENDOCRINOL, V163, P349, DOI 10.1530/EJE-10-0272; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V43; Varco-Merth B, 2013, MOL ENDOCRINOL, V27, P150, DOI 10.1210/me.2012-1275; Zhang T, 2000, MOL CELL BIOL, V20, P7132, DOI 10.1128/MCB.20.19.7132-7139.2000	15	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					413	+		10.1016/j.jaci.2018.08.032	http://dx.doi.org/10.1016/j.jaci.2018.08.032			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30205186	Green Published, hybrid			2022-12-18	WOS:000454918300048
J	Kim, VHD; Pham-Huy, A; Grunebaum, E				Kim, Vy Hong-Diep; Pham-Huy, Anne; Grunebaum, Eyal			Neutropenia among patients with adenosine deaminase deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MYELOID DYSPLASIA		[Kim, Vy Hong-Diep] Hosp Sick Children, Div Immunol & Allergy, Toronto, ON, Canada; [Kim, Vy Hong-Diep] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Kim, Vy Hong-Diep] Univ Toronto, Toronto, ON, Canada; [Pham-Huy, Anne] Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON, Canada; [Grunebaum, Eyal] Hosp Sick Children, Div Immunol & Allergy, Dev & Stem Cell Biol Program, Res Inst, Toronto, ON, Canada; [Grunebaum, Eyal] Hosp Sick Children, Dept Pediat, Dev & Stem Cell Biol Program, Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Grunebaum, E (corresponding author), Hosp Sick Children, Div Immunol & Allergy, Dev & Stem Cell Biol Program, Res Inst, Toronto, ON, Canada.; Grunebaum, E (corresponding author), Hosp Sick Children, Dept Pediat, Dev & Stem Cell Biol Program, Res Inst, Toronto, ON, Canada.	eyal.grunebaum@sickkids.ca						Al-Dirbashi OY, 2015, LYMPHOSIGN J, V2, P135, DOI DOI 10.14785/lpsn-2014-0024; Andritsos LA, 2015, HAEMATOLOGICA, V100, pE18, DOI 10.3324/haematol.2014.113290; Barletta KE, 2012, ARTERIOSCL THROM VAS, V32, P856, DOI 10.1161/ATVBAHA.111.226845; Grunebaum E, 2013, CURR OPIN ALLERGY CL, V13, P630, DOI 10.1097/ACI.0000000000000006; Hassan A, 2012, BLOOD, V120, P3615, DOI 10.1182/blood-2011-12-396879; Nomura K, 2013, PEDIATR BLOOD CANCER, V60, P885, DOI 10.1002/pbc.24353; Scott O, 2017, J CLIN IMMUNOL, V37, P582, DOI 10.1007/s10875-017-0421-7; Sekhsaria S, 1996, BLOOD, V88, P1104; Sokolic R, 2011, BLOOD, V118, P2688, DOI 10.1182/blood-2011-01-329359	9	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					403	405		10.1016/j.jaci.2018.04.029	http://dx.doi.org/10.1016/j.jaci.2018.04.029			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	29753815	Bronze			2022-12-18	WOS:000454918300044
J	Sullivan, KE				Sullivan, Kathleen E.			Neutropenia as a sign of immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Neutropenia; metabolic conditions; bone marrow failure; severe combined immunodeficiency			[Sullivan, Kathleen E.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sullivan, KE (corresponding author), Childrens Hosp Philadelphia, Allergy Immunol, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	sullivank@email.chop.edu						Bluteau O, 2018, BLOOD, V131, P717, DOI 10.1182/blood-2017-09-806489; Boxer LA, 2012, HEMATOL-AM SOC HEMAT, P174, DOI 10.1182/asheducation-2012.1.174; Boztug K, 2013, HEMATOL ONCOL CLIN N, V27, P43, DOI 10.1016/j.hoc.2012.11.004; Boztug K, 2011, CURR OPIN PEDIATR, V23, P21, DOI 10.1097/MOP.0b013e32834262f8; Feuille EJ, 2018, J CLIN IMMUNOL, V38, P28, DOI 10.1007/s10875-017-0456-9; Kim VHD, 2019, J ALLERGY CLIN IMMUN, V143, P403, DOI 10.1016/j.jaci.2018.04.029; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Romberg N, 2019, J ALLERGY CLIN IMMUN, V143, P258, DOI 10.1016/j.jaci.2018.06.012; SOUTAR RL, 1991, ARCH DIS CHILD, V66, P982, DOI 10.1136/adc.66.8.982; STAAL GEJ, 1980, J CLIN INVEST, V65, P103, DOI 10.1172/JCI109639	10	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					96	100		10.1016/j.jaci.2018.09.018	http://dx.doi.org/10.1016/j.jaci.2018.09.018			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30312705	Bronze			2022-12-18	WOS:000454918300015
J	Davini, D; Naeem, F; Phong, A; Al-Kuhlani, M; Valentine, KM; McCarty, J; Ojcius, DM; Gravano, DM; Hoyer, KK				Davini, Dan; Naeem, Fouzia; Phong, Aron; Al-Kuhlani, Mufadhal; Valentine, Kristen M.; McCarty, James; Ojcius, David M.; Gravano, David M.; Hoyer, Katrina K.			Elevated regulatory T cells at diagnosis of Coccidioides infection associates with chronicity in pediatric patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INTERFERON		[Davini, Dan; Al-Kuhlani, Mufadhal; Valentine, Kristen M.; Hoyer, Katrina K.] Univ Calif Merced, Sch Nat Sci, Dept Mol & Cell Biol, Merced, CA 95343 USA; [Naeem, Fouzia] Valley Childrens Healthcare, Madera, CA USA; [Phong, Aron; Gravano, David M.] Univ Calif Merced, Stem Cell Instrumentat Foundry, Merced, CA USA; [Valentine, Kristen M.; Ojcius, David M.; Gravano, David M.; Hoyer, Katrina K.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA 95343 USA; [McCarty, James] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Ojcius, David M.] Univ Pacific, Arthur Dugoni Dent Sch, San Francisco, CA USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced; Stanford University; University of the Pacific	Hoyer, KK (corresponding author), Univ Calif Merced, Sch Nat Sci, Dept Mol & Cell Biol, Merced, CA 95343 USA.; Hoyer, KK (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, Merced, CA 95343 USA.	khoyer2@ucmerced.edu	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495	UC Merced Blum Center; Valley Children's Healthcare; University of California Merced Student Success Internship; University of California Merced Health Sciences Research Institute	UC Merced Blum Center; Valley Children's Healthcare; University of California Merced Student Success Internship; University of California Merced Health Sciences Research Institute	This study was funded by the UC Merced Blum Center (to D.M.O. and K.K.H.), Valley Children's Healthcare (to F.N. and J.M.), a University of California Merced Student Success Internship (to A.P.), the University of California Merced Health Sciences Research Institute (to D.M.O. and K.K.H.), and gifts from Dr E.W. & Dorothy Bizzini, and the Honorable Betty Dawson & Mr Robert Haden (to K.K.H.).	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Duplessis CA, 2011, J INFECTION, V63, P223, DOI 10.1016/j.jinf.2011.07.006; Gonzalez A, 2011, MICROB PATHOGENESIS, V51, P432, DOI 10.1016/j.micpath.2011.08.003; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Hung CY, 2016, INFECT IMMUN, V84, P1166, DOI 10.1128/IAI.01066-15; Johnson L, 2014, MICROBES INFECT, V16, P591, DOI 10.1016/j.micinf.2014.06.011; Kroetz DN, 2010, J IMMUNOL, V184, P5224, DOI 10.4049/jimmunol.1000032; Soler DC, 2013, CLIN IMMUNOL, V149, P111, DOI 10.1016/j.clim.2013.06.007; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984	9	8	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1971	+		10.1016/j.jaci.2018.10.022	http://dx.doi.org/10.1016/j.jaci.2018.10.022			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30539725	Bronze			2022-12-18	WOS:000452315800030
J	Jimenez-Saiz, R; Bruton, K; Koenig, JFE; Waserman, S; Jordana, M				Jimenez-Saiz, Rodrigo; Bruton, Kelly; Koenig, Joshua F. E.; Waserman, Susan; Jordana, Manel			The IgE memory reservoir in food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						IgG(1)(+) memory B cells; T(H)2 immunity; IgE; food allergy; anaphylaxis			[Jimenez-Saiz, Rodrigo; Bruton, Kelly; Koenig, Joshua F. E.; Jordana, Manel] McMaster Univ, Dept Pathol & Mol Med, MIRC, MDCL 4013,1280 Main St W, Hamilton, ON L8S 4K1, Canada; [Waserman, Susan] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Jimenez-Saiz, Rodrigo] Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Madrid, Spain	McMaster University; McMaster University; Complutense University of Madrid	Jordana, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, MIRC, MDCL 4013,1280 Main St W, Hamilton, ON L8S 4K1, Canada.	jordanam@mcmaster.ca	Koenig, Joshua/AAL-9339-2021; Jimenez-Saiz, Rodrigo/O-7384-2019	Koenig, Joshua/0000-0002-8909-5039; Jimenez-Saiz, Rodrigo/0000-0002-0606-3251; Bruton, Kelly/0000-0003-0817-6134	National Institutes of Health [1R21AI105502]; Food Allergy Canada; AllerGen NCE; MedImmune; Walter and Maria Schroeder Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Canada; AllerGen NCE; MedImmune(AstraZenecaMedimmune); Walter and Maria Schroeder Foundation	Some of our own research is discussed here and was supported by grants from the National Institutes of Health (1R21AI105502), Food Allergy Canada, MedImmune, AllerGen NCE, the Delaney family, the Zych family, and the Walter and Maria Schroeder Foundation.	Carballeda-Sangiao N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004864; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Heeringa JJ, 2018, ALLERGY, V73, P1331, DOI 10.1111/all.13421; Jimenez-Saiz R, 2018, ALLERGY; Jimenez-Saiz R, 2017, J ALLERGY CLIN IMMUN, V140, P1604, DOI 10.1016/j.jaci.2017.01.018; Looney TJ, 2016, J ALLERGY CLIN IMMUN, V137, P579, DOI 10.1016/j.jaci.2015.07.014; Ramadani F, 2017, ALLERGY, V72, P66, DOI 10.1111/all.12911; Turqueti-Neves A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002290; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Yang ZY, 2014, CURR OPIN IMMUNOL, V28, P64, DOI 10.1016/j.coi.2014.02.001	10	8	8	4	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1441	1443		10.1016/j.jaci.2018.08.029	http://dx.doi.org/10.1016/j.jaci.2018.08.029			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	30201515	Bronze			2022-12-18	WOS:000449429800006
J	Kroner, JD; Knoke, K; Kofler, DM; Steiger, J; Fabri, M				Kroner, Juliana de Castro; Knoke, Kristin; Kofler, David M.; Steiger, Julia; Fabri, Mario			Glucocorticoids promote intrinsic human T(H)17 differentiation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Kroner, Juliana de Castro; Knoke, Kristin; Steiger, Julia; Fabri, Mario] Univ Cologne, Dept Dermatol, Cologne, Germany; [Kofler, David M.] Univ Cologne, Dept Internal Med 1, Cologne, Germany	University of Cologne; University of Cologne	Fabri, M (corresponding author), Univ Cologne, Dept Dermatol, Cologne, Germany.	mario.fabri@uk-koeln.de			Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (Ruckkehrerprogramm); Center for Molecular Medicine, Cologne; Koln Fortune Program, Cologne; Deutsche Forschungsgemeinschaft [SFB829]	Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (Ruckkehrerprogramm); Center for Molecular Medicine, Cologne; Koln Fortune Program, Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (Ruckkehrerprogramm); the Center for Molecular Medicine, Cologne; the Koln Fortune Program, Cologne; and the Deutsche Forschungsgemeinschaft (SFB829, B13 and Z4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banuelos J, 2017, ALLERGY, V72, P331, DOI 10.1111/all.13051; Fardet L, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002024; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Noster R, 2016, J ALLERGY CLIN IMMUN, V138, P1161, DOI 10.1016/j.jaci.2015.12.1338; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Prado C, 2011, RHEUMATOLOGY, V50, P1794, DOI 10.1093/rheumatology/ker227; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	9	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1669	1673		10.1016/j.jaci.2018.07.019	http://dx.doi.org/10.1016/j.jaci.2018.07.019			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	30092286	Bronze			2022-12-18	WOS:000449429800038
J	Paramasivan, S; Lester, S; Lau, A; Ou, J; Psaltis, AJ; Wormald, PJ; Vreugde, S				Paramasivan, Sathish; Lester, Susan; Lau, Aden; Ou, Judy; Psaltis, Alkis James; Wormald, Peter-John; Vreugde, Sarah			Tertiary lymphoid organs: A novel target in patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							REGULATORY T-CELLS; ANTIMICROBIAL ACTIVITY; IL-17; EXPRESSION; PHENOTYPES; ENDOTYPES; ALLERGY; CANCER; VIVO; SKIN		[Paramasivan, Sathish; Lau, Aden; Ou, Judy; Psaltis, Alkis James; Wormald, Peter-John; Vreugde, Sarah] Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Adelaide, SA, Australia; [Lester, Susan] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Lester, Susan] Queen Elizabeth Hosp, Dept Rheumatol, Woodville, SA, Australia	University of Adelaide; University of Adelaide	Vreugde, S (corresponding author), Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Adelaide, SA, Australia.	sarah.vreugde@adelaide.edu.au		Ou, Judy/0000-0002-3085-5814; Psaltis, Alkis/0000-0003-2967-1855	Garnett Passe and Rodney Williams Memorial Foundation Academic Surgeon Scientist Research Scholarship (ASSRS)	Garnett Passe and Rodney Williams Memorial Foundation Academic Surgeon Scientist Research Scholarship (ASSRS)	Supported by a Garnett Passe and Rodney Williams Memorial Foundation Academic Surgeon Scientist Research Scholarship (ASSRS; to S.P.).	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Bachert C, 2016, J ALLER CL IMM-PRACT, V4, P621, DOI 10.1016/j.jaip.2016.05.004; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Egli N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142741; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Koten B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006424; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Lau A, 2017, J ALLERGY CLIN IMMUN, V139, P1371, DOI 10.1016/j.jaci.2016.08.052; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Meisch JP, 2013, INFLAMM BOWEL DIS, V19, P942, DOI 10.1097/MIB.0b013e318280b11a; Mercer F, 2014, J IMMUNOL, V193, P1047, DOI 10.4049/jimmunol.1302936; Miller LS, 2005, J IMMUNOL, V174, P6137, DOI 10.4049/jimmunol.174.10.6137; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Psaltis AJ, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0726-x; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Sommer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130395; Song J, 2018, J ALLERGY CLIN IMMUN, V141, P927, DOI 10.1016/j.jaci.2017.10.014; Steiger J, 2016, J IMMUNOL, V197, P222, DOI 10.4049/jimmunol.1502407; Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Wheelwright M, 2014, J IMMUNOL, V192, P2280, DOI 10.4049/jimmunol.1301686	28	8	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1673	+		10.1016/j.jaci.2018.07.024	http://dx.doi.org/10.1016/j.jaci.2018.07.024			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	30096389				2022-12-18	WOS:000449429800039
J	Bankova, LG; Boyce, JA				Bankova, Lora G.; Boyce, Joshua A.			A new spin on mast cells and cysteinyl leukotrienes: Leukotriene E-4 activates mast cells in vivo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Cysteinyl leukotrienes; mast cells; cyclooxygenase products; asthma	RECEPTOR; ASPIRIN; PROTEIN; GPR99		Brigham & Womens Hosp, Jeff & Penny Vinik Ctr Allerg Dis Res, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Boyce, JA (corresponding author), Jeff & Penny Vinik Ctr Allerg Dis Res, Hale Bldg Transformat Med, 60 Fenwood Rd,Rm 5002V, Boston, MA 02115 USA.	jboyce@bwh.harvard.edu						Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Bankova LG, 2016, P NATL ACAD SCI USA, V113, P6242, DOI 10.1073/pnas.1605957113; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1506, DOI 10.1164/ajrccm/146.6.1506; FISCHER AR, 1994, J ALLERGY CLIN IMMUN, V94, P1046, DOI 10.1016/0091-6749(94)90123-6; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Lazarinis N, 2018, J ALLERGY CLIN IMMUN, V142, P1080, DOI 10.1016/j.jaci.2018.02.024; Liu T, 2015, J IMMUNOL, V195, P3537, DOI 10.4049/jimmunol.1500905; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Safholm J, 2015, J ALLERGY CLIN IMMUN, V136, P1232, DOI 10.1016/j.jaci.2015.04.002; Salimi M, 2017, J ALLERGY CLIN IMMUN, V140, P1090, DOI 10.1016/j.jaci.2016.12.958	10	8	9	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1056	1057		10.1016/j.jaci.2018.08.008	http://dx.doi.org/10.1016/j.jaci.2018.08.008			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	30165055	Bronze			2022-12-18	WOS:000446327300004
J	Shalaby, KH; Lyons-Cohen, MR; Whitehead, GS; Thomas, SY; Prinz, I; Nakano, H; Cook, DN				Shalaby, Karim H.; Lyons-Cohen, Miranda R.; Whitehead, Gregory S.; Thomas, Seddon Y.; Prinz, Immo; Nakano, Hideki; Cook, Donald N.			Pathogenic T(H)17 inflammation is sustained in the lungs by conventional dendritic cells and Toll-like receptor 4 signaling	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T(H)17 cells; dendritic cells; chronic inflammation; house dust extract; Toll-like receptor 4	T-CELLS; AIRWAY HYPERRESPONSIVENESS; CYSTIC-FIBROSIS; PROMOTES; ASTHMA; MOUSE; IRF4; MICE; DIFFERENTIATION; DRIVES	Background: Mechanisms that elicit mucosal T(H)17 cell responses have been described, yet how these cells are sustained in chronically inflamed tissues remains unclear. Objective: We sought to understand whether maintenance of lung T(H)17 inflammation requires environmental agents in addition to antigen and to identify the lung antigen-presenting cell (APC) types that sustain the self-renewal of T(H)17 cells. Methods: Animals were exposed repeatedly to aspiration of ovalbumin alone or together with environmental adjuvants, including common house dust extract (HDE), to test their role in maintaining lung inflammation. Alternatively, antigen-specific effector/memory T(H)17 cells, generated in culture with CD4(+) T cells from Il17a fate-mapping mice, were adoptively transferred to assess their persistence in genetically modified animals lacking distinct lung APC subsets or cell-specific Toll-like receptor (TLR) 4 signaling. T(H)17 cells were also cocultured with lung APC subsets to determine which of these could revive their expansion and activation. Results: T(H)17 cells and the consequent neutrophilic inflammation were poorly sustained by inhaled antigen alone but were augmented by inhalation of antigen together with HDE. This was associated with weight loss and changes in lung physiology consistent with interstitial lung disease. The effect of HDE required TLR4 signaling predominantly in lung hematopoietic cells, including CD11c(+) cells. CD103(+) and CD11b(+) conventional dendritic cells interacted directly with T(H)17 cells in situ and revived the clonal expansion of T(H)17 cells both ex vivo and in vivo, whereas lung macrophages and B cells could not. Conclusion: T(H)17-dependent inflammation in the lungs can be sustained by persistent TLR4-mediated activation of lung conventional dendritic cells.	[Shalaby, Karim H.; Lyons-Cohen, Miranda R.; Whitehead, Gregory S.; Thomas, Seddon Y.; Nakano, Hideki; Cook, Donald N.] NIEHS, Immunogenet Grp, Immun Inflammat & Dis Lab, Div Intramural Res,NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Prinz, Immo] Med Hsch, Inst Immunol, Hannover, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cook, DN (corresponding author), NIEHS, Immun Inflammat & Dis Lab, NIH, 111 TW Alexander Dr,Rall Bldg,Room E224, Res Triangle Pk, NC 27709 USA.	cookd@niehs.nih.gov	Cook, Donald/E-5079-2019; Prinz, Immo/A-3026-2010	Cook, Donald/0000-0002-0052-3755; Thomas, Seddon/0000-0003-0075-0744; Prinz, Immo/0000-0002-8789-9578; Lyons-Cohen, Miranda R./0000-0002-6537-8827	National Institutes of Health, National Institute of Environmental Health Sciences [ZIA ES102025-09]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102025] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (ZIA ES102025-09).	Arnold IC, 2016, MUCOSAL IMMUNOL, V9, P352, DOI 10.1038/mi.2015.65; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Chan YR, 2013, J ALLERGY CLIN IMMUN, V131, P1117, DOI 10.1016/j.jaci.2012.05.036; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Furuhashi Kazuki, 2012, Am J Respir Cell Mol Biol, V46, P165, DOI 10.1165/rcmb.2011-0070OC; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Hayashi H, 2013, INFLAMMATION, V36, P830, DOI 10.1007/s10753-013-9609-z; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hsia BJ, 2015, MUCOSAL IMMUNOL, V8, P186, DOI 10.1038/mi.2014.56; Ireland SJ, 2016, J NEUROIMMUNOL, V291, P46, DOI 10.1016/j.jneuroim.2015.11.022; Ko HJ, 2014, J IMMUNOL, V192, P2202, DOI 10.4049/jimmunol.1302040; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lacasse Y, 2003, AM J RESP CRIT CARE, V168, P952, DOI 10.1164/rccm.200301-137OC; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Lyons-Cohen MR, 2017, JOVE-J VIS EXP, DOI 10.3791/55465; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nakano H, 2015, J IMMUNOL, V194, P3808, DOI 10.4049/jimmunol.1402195; Nakano H, 2013, METHODS MOL BIOL, V1032, P19, DOI 10.1007/978-1-62703-496-8_2; Pereira CA, 2016, J ASTHMA ALLERGY, V9, P171, DOI 10.2147/JAA.S81540; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Peters M, 2016, AM J RESP CELL MOL, V54, P350, DOI 10.1165/rcmb.2014-0429OC; Ricciardolo FLM, 2017, J ALLERGY CLIN IMMUN, V140, P395, DOI 10.1016/j.jaci.2016.10.034; SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97; Sansores RH, 1996, LUNG, V174, P315; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shekhar S, 2018, CELL MOL IMMUNOL, V15, P377, DOI 10.1038/cmi.2016.68; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Sorbello V, 2015, ALLERGY, V70, P236, DOI 10.1111/all.12547; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Vanfleteren LEGW, 2016, LANCET RESP MED, V4, P911, DOI 10.1016/S2213-2600(16)00097-7; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Whitehead GS, 2014, ENVIRON HEALTH PERSP, V122, P34, DOI 10.1289/ehp.1307280; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Zelante T, 2015, CELL REP, V12, P1789, DOI 10.1016/j.celrep.2015.08.030	47	8	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1229	+		10.1016/j.jaci.2017.10.023	http://dx.doi.org/10.1016/j.jaci.2017.10.023			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29154958	Bronze, Green Accepted			2022-12-18	WOS:000446327300022
J	Bae, JM; Kwon, HS; Kim, GM; Park, KS; Kim, KJ				Bae, Jung Min; Kwon, Hyuck Sun; Kim, Gyong Moon; Park, Kyung-Su; Kim, Ki-Jo			Paradoxical psoriasis following anti-TNF therapy in ankylosing spondylitis: A population-based cohort study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALPHA		[Bae, Jung Min; Kwon, Hyuck Sun; Kim, Gyong Moon] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Dermatol, Seoul, South Korea; [Park, Kyung-Su; Kim, Ki-Jo] Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Bae, JM (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Dermatol, Seoul, South Korea.	md21c@catholic.ac.kr						Bissonnette R, 2008, J Drugs Dermatol, V7, P940; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Collamer AN, 2010, SEMIN ARTHRITIS RHEU, V40, P233, DOI 10.1016/j.semarthrit.2010.04.003; Harrison MJ, 2009, ANN RHEUM DIS, V68, P209, DOI 10.1136/ard.2007.087288; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Seol JE, 2016, ANN DERMATOL, V28, P522, DOI 10.5021/ad.2016.28.4.522; Shmidt E, 2012, J AM ACAD DERMATOL, V67, pE179, DOI 10.1016/j.jaad.2011.05.038; 윤재일, 2012, [Korean Journal of Dermatology, 대한피부과학회지], V50, P387	9	8	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					1001	1003		10.1016/j.jaci.2018.05.015	http://dx.doi.org/10.1016/j.jaci.2018.05.015			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29859201	Bronze			2022-12-18	WOS:000443726500038
J	Rosa, N; Triffaux, E; Robert, V; Mars, M; Klein, M; Bouchaud, G; Canivet, A; Magnan, A; Guery, JC; Pelletier, L; Savignac, M				Rosa, Nicolas; Triffaux, Emily; Robert, Virginie; Mars, Marion; Klein, Martin; Bouchaud, Gregory; Canivet, Astrid; Magnan, Antoine; Guery, Jean-Charles; Pelletier, Lucette; Savignac, Magali			The beta and alpha 2 delta auxiliary subunits of voltage-gated Check updates calcium channel 1 (Ca(v)1) are required for T(H)2 lymphocyte function and acute allergic airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; T(H)2; voltage-gated calcium channel 1; calcium; cytokines	ALPHA(2)DELTA SUBUNITS; PROTEIN; TRAFFICKING; DOMAIN; ACTIVATION; PHYSIOLOGY	Background: T lymphocytes express not only cell membrane ORAI calcium release activated calcium modulator 1 but also voltage-gated calcium channel (Ca-v) 1 channels In excitable cells these channels are composed of the ion-forming pore al and auxiliary subunits (beta and alpha 2 delta) needed for proper trafficking and activation of the channel. Previously, we disclosed the role of Ca(v)1.2 alpha 1 in mouse and human T(H)2 but not T(H)1 cell functions and showed that knocking down Cav(1) al prevents experimental asthma. Objective: We investigated the role of beta and alpha 2 delta auxiliary subunits on Ca(v)1 alpha 1 function in T(H)2 lymphocytes and on the development of acute allergic airway inflammation. Methods: We used Ca-v beta antisense oligonucleotides to knock down Ca-v beta and gabapentin, a drug that binds to and inhibits alpha 2 delta 1 and alpha 2 delta 2, to test their effects on T(H)2 functions and their capacity to reduce allergic airway inflammation. Results: Mouse and human T(H)2 cells express mainly Ca-v beta 1, beta 3, and alpha 2 delta 2 subunits. Ca-v beta antisense reduces T-cell receptor driven calcium responses and cytokine production by mouse and human T(H)2 cells with no effect on T(H)1 cells. Ca-v beta is mainly involved in restraining Ca(v)1.2 alpha 1 degradation through the proteasome because a proteasome inhibitor partially restores the al protein level. Gabapentin impairs the T-cell receptor driven calcium response and cytokine production associated with the loss of alpha 2 delta 2 protein in T(H)2 cells. Conclusions: These results stress the role of Ca-v beta and alpha 2 delta 2 auxiliary subunits in the stability and activation of Cav1.2 channels in TH2 lymphocytes both in vitro and in vivo, as demonstrated by the beneficial effect of Cav beta antisense and gabapentin in allergic airway inflammation.	[Rosa, Nicolas; Triffaux, Emily; Robert, Virginie; Mars, Marion; Canivet, Astrid; Guery, Jean-Charles; Pelletier, Lucette; Savignac, Magali] Univ Paul Sabatier Toulouse III, Ctr Physiopathol Toulouse Purpan, INSERM, U1043,CNRS UMR 5282, Toulouse, France; [Klein, Martin; Magnan, Antoine] Univ Nantes, INSERM, CNRS, Inst Thorax, Nantes, France; [Bouchaud, Gregory] INRA, UR1268, BIA, Nantes, France; [Magnan, Antoine] Ctr Hosp Univ Nantes, Serv Pneumol, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; INRAE; Nantes Universite; CHU de Nantes	Pelletier, L; Savignac, M (corresponding author), Ctr Hosp Univ Purpan, INSERM, U1043, Ctr Physiopathol Toulouse Purpan, Pl Dr Baylac, F-31024 Toulouse 3, France.	lucette.pelletier@inserm.fr; magali.savignac@inserm.fr	Rosa, Nicolas/ABC-9459-2021; MAGNAN, ANTOINE/GVT-4308-2022; Savignac, Magali/K-1757-2014; GUERY, Jean-Charles/G-1452-2013; Pelletier, Lucette/L-2956-2014; Bouchaud, Gregory/AAC-4596-2020	Rosa, Nicolas/0000-0003-4902-177X; GUERY, Jean-Charles/0000-0003-4499-3270; Bouchaud, Gregory/0000-0002-3794-7287; Klein, Martin/0000-0003-3274-2415	French National Institute for Health and Medical research (INSERM); French Society of Allergology; Conseil Regional Midi-Pyrenees; Conseil Regional of Midi-Pyrenees; INSERM	French National Institute for Health and Medical research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Society of Allergology; Conseil Regional Midi-Pyrenees(Region Pays de la LoireRegion OccitanieRegion Ile-de-France); Conseil Regional of Midi-Pyrenees; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Supported by the French National Institute for Health and Medical research (INSERM) and grants from the French Society of Allergology and the Conseil Regional Midi-Pyrenees. N.R. was supported by a fellowship from Conseil Regional of Midi-Pyrenees and INSERM.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Becerra-Diaz Mireya, 2017, F1000Res, V6, P1014, DOI 10.12688/f1000research.11198.1; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Brunet S, 2015, J MOL CELL CARDIOL, V87, P248, DOI 10.1016/j.yjmcc.2015.08.006; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Cabral MD, 2010, AM J RESP CRIT CARE, V181, P1310, DOI [10.1164/rccm.200907-1166oc, 10.1164/rccm.200907-1166OC]; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Davenport B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00375; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Findeisen F, 2017, ACS CHEM NEUROSCI, V8, P1313, DOI 10.1021/acschemneuro.6b00454; Gomes B, 2004, CRIT REV IMMUNOL, V24, P425, DOI 10.1615/CritRevImmunol.v24.i6.30; Gomes B, 2007, AM J RESP CRIT CARE, V175, P1117, DOI 10.1164/rccm.200607-1026OC; Heblich Fay, 2008, Channels (Austin), V2, P4; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Hofmann F, 2015, CURR MOL PHARMACOL, V8, P162, DOI 10.2174/1874467208666150507110202; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Jha A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac7538; Ji RR, 2015, PULM PHARMACOL THER, V35, P81, DOI 10.1016/j.pupt.2015.09.001; Leach RN, 2007, BIOCHEM BIOPH RES CO, V352, P794, DOI 10.1016/j.bbrc.2006.11.099; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Matza D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147379; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Robert V, 2014, J ALLERGY CLIN IMMUN, V133, P1175, DOI 10.1016/j.jaci.2013.10.038; Savalli N, 2016, J GEN PHYSIOL, V148, P147, DOI 10.1085/jgp.201611586; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Segura E, 2017, J BIOL CHEM, V292, P11109, DOI 10.1074/jbc.M117.784355; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Warnier M, 2015, ONCOGENE, V34, P5383, DOI 10.1038/onc.2014.467; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654	50	8	8	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					892	+		10.1016/j.jaci.2017.09.045	http://dx.doi.org/10.1016/j.jaci.2017.09.045			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29129580	Bronze, Green Published			2022-12-18	WOS:000443726500022
J	Doan, TC; Jeong, BM; Coden, ME; Loffredo, LF; Bhattacharyya, S; Chiarella, SE; Varga, J; Abdala-Valencia, H; Berdnikovs, S				Doan, Ton C.; Jeong, Brian M.; Coden, Mackenzie E.; Loffredo, Lucas F.; Bhattacharyya, Swati; Chiarella, Sergio E.; Varga, John; Abdala-Valencia, Hiam; Berdnikovs, Sergejs			Matrix protein tenascin-C expands and reversibly blocks maturation of murine eosinophil progenitors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXTRACELLULAR-MATRIX; CELLS; PROLIFERATION; ADHESION		[Doan, Ton C.; Jeong, Brian M.; Coden, Mackenzie E.; Loffredo, Lucas F.; Chiarella, Sergio E.; Berdnikovs, Sergejs] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Bhattacharyya, Swati; Varga, John] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Rheumatol, Chicago, IL 60611 USA; [Abdala-Valencia, Hiam] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Berdnikovs, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA.	s.berdnikovs@northwestern.edu	Bhattacharyya, Swati/W-8145-2019; Varga, John/AAK-6472-2021	Chiarella, Sergio/0000-0002-0445-4929; Doan, Ton/0000-0002-8182-0654	National Institutes of Health (NIH/National Institute of Allergy and Infectious Diseases) [R21AI115055, R01AI127783, U19AI106683]; Ernest S. Bazley Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115055, R01AI127783, R01AI137174, U19AI106683] Funding Source: NIH RePORTER	National Institutes of Health (NIH/National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ernest S. Bazley Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH/National Institute of Allergy and Infectious Diseases) (grant nos. R21AI115055 and R01AI127783 to S.B., as well as grant no. U19AI106683 [Supplement 2] to Schleimer/S.B.). In addition, this study was supported by the Ernest S. Bazley Foundation.	Chitteti BR, 2013, METHODS MOL BIOL, V1035, P43, DOI 10.1007/978-1-62703-508-8_5; Choi JS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600455; De Laporte L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062076; Demange E, 2013, J TISSUE ENG REGEN M, V7, P901, DOI 10.1002/term.1482; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Karjalainen EM, 2003, RESP MED, V97, P1045, DOI 10.1016/S0954-6111(03)00136-7; Kelly EA, 2017, AM J RESP CRIT CARE, V196, P1385, DOI 10.1164/rccm.201611-2234OC; Klamer S, 2014, CELL ADHES MIGR, V8, P563, DOI 10.4161/19336918.2014.968501; Lee JJ, 2010, CLIN EXP ALLERGY, V40, P563, DOI 10.1111/j.1365-2222.2010.03484.x; Lee NA, 1997, J IMMUNOL, V158, P1332; Malara A, 2016, STEM CELLS, V34, P2263, DOI 10.1002/stem.2381; Midwood KS, 2016, J CELL SCI, V129, P4321, DOI 10.1242/jcs.190546; Nakahara H, 2006, EUR J IMMUNOL, V36, P3334, DOI 10.1002/eji.200636271; Nakamura-Ishizu A, 2012, BLOOD, V119, P5429, DOI 10.1182/blood-2011-11-393645; Ohta M, 1998, BLOOD, V91, P4074; Pas J, 2006, INT J BIOCHEM CELL B, V38, P1594, DOI 10.1016/j.biocel.2006.03.017; Patterson MF, 2015, J ASTHMA ALLERGY, V8, P125, DOI 10.2147/JAA.S74178; Radinger M, 2011, IMMUNOLOGY, V132, P144, DOI 10.1111/j.1365-2567.2010.03349.x; Saco TV, 2017, EXPERT REV CLIN IMMU, V13, P405, DOI 10.1080/1744666X.2017.1316194; Schreiber TD, 2009, HAEMATOL-HEMATOL J, V94, P1493, DOI 10.3324/haematol.2009.006072; Southam DS, 2005, J ALLERGY CLIN IMMUN, V115, P95, DOI 10.1016/j.jaci.2004.09.022; Tucker RP, 2015, INT J BIOCHEM CELL B, V65, P165, DOI 10.1016/j.biocel.2015.06.003; Wells A, 2016, MATRIX BIOL, V49, P25, DOI 10.1016/j.matbio.2015.08.001; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423	24	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					695	+		10.1016/j.jaci.2018.02.054	http://dx.doi.org/10.1016/j.jaci.2018.02.054			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29705244	Bronze, Green Accepted			2022-12-18	WOS:000440664400042
J	Ito, T; Shiromizu, T; Ohnishi, S; Suzuki, S; Mabe, K; Hasegawa, A; Ujiie, H; Fujita, Y; Sato, Y; Terai, S; Kato, M; Asaka, M; Tomonaga, T; Shimizu, H; Abe, R				Ito, Takamasa; Shiromizu, Takashi; Ohnishi, Shunsuke; Suzuki, Shotaro; Mabe, Katsuhiro; Hasegawa, Akito; Ujiie, Hideyuki; Fujita, Yasuyuki; Sato, Yuichi; Terai, Shuji; Kato, Mototsugu; Asaka, Masahiro; Tomonaga, Takeshi; Shimizu, Hiroshi; Abe, Riichiro			Potential role of extracellular vesicle-mediated antigen presentation in Helicobacter pylori hypersensitivity during eradication therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ORAL LICHEN-PLANUS; T-CELLS; PEMPHIGUS-VULGARIS; TH17 CELLS; ASSOCIATION; EPITOPES; ALLELE; SKIN; HLA-DRB1-ASTERISK-0101; INTERLEUKIN-17		[Ito, Takamasa; Suzuki, Shotaro; Ujiie, Hideyuki; Fujita, Yasuyuki; Shimizu, Hiroshi; Abe, Riichiro] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Ohnishi, Shunsuke] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Shiromizu, Takashi; Tomonaga, Takeshi] Natl Inst Biochem Innovat Hlth & Nutr, Lab Proteome Res, Amagasaki, Hyogo, Japan; [Mabe, Katsuhiro; Kato, Mototsugu] Natl Hosp Org Hakodate Hosp, Dept Gastroenterol, Hakodate, Hokkaido, Japan; [Hasegawa, Akito] Niigata Univ, Grad Sch Med & Dent Sci, Div Dermatol, Niigata, Japan; [Sato, Yuichi; Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan; [Asaka, Masahiro] Hlth Sci Univ Hokkaido, Tobetsu, Japan	Hokkaido University; Hokkaido University; Niigata University; Niigata University; Health Sciences University of Hokkaido	Shimizu, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.	shimizu@med.hokudai.ac.jp; aberi@med.niigata-u.ac.jp	Fujita, Yasuyuki/A-5464-2012; Ohnishi, Shunsuke/A-5982-2012	Fujita, Yasuyuki/0000-0001-7934-9261; Ohnishi, Shunsuke/0000-0003-1194-4149				AHMED AR, 1990, P NATL ACAD SCI USA, V87, P7658, DOI 10.1073/pnas.87.19.7658; Arakawa M, 2011, EXP DERMATOL, V20, P1022, DOI 10.1111/j.1600-0625.2011.01378.x; BOUQUOT JE, 1986, ORAL SURG ORAL MED O, V61, P373, DOI 10.1016/0030-4220(86)90422-6; CARCASSI C, 1994, EUR J IMMUNOGENET, V21, P425, DOI 10.1111/j.1744-313X.1994.tb00215.x; Delgado JC, 1996, P NATL ACAD SCI USA, V93, P8569, DOI 10.1073/pnas.93.16.8569; Eming R, 2014, J IMMUNOL, V193, P4391, DOI 10.4049/jimmunol.1401081; Esmaili N, 2013, IRAN J IMMUNOL, V10, P1, DOI IJIv10i1A1; Franceschi F, 2014, NAT REV GASTRO HEPAT, V11, P234, DOI 10.1038/nrgastro.2013.243; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; GADENNE AS, 1994, J INVEST DERMATOL, V103, P347, DOI 10.1111/1523-1747.ep12394904; Herrero-Gonzalez JE, 2016, INT J DERMATOL, V55, P634, DOI 10.1111/ijd.12990; Iijima W, 2003, AM J PATHOL, V163, P261, DOI 10.1016/S0002-9440(10)63649-8; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Khan A, 2003, J ORAL PATHOL MED, V32, P77, DOI 10.1034/j.1600-0714.2003.00077.x; Lin MS, 2000, J INVEST DERMATOL, V115, P955, DOI 10.1046/j.1523-1747.2000.00153.x; Lin MS, 1997, J CLIN INVEST, V99, P31, DOI 10.1172/JCI119130; Liu JX, 2016, J MED GENET, V53, P681, DOI 10.1136/jmedgenet-2016-103867; Luis-Montoya P, 2007, ARCH DERMATOL RES, V299, P405, DOI 10.1007/s00403-007-0769-2; Mobs C, 2016, J INVEST DERMATOL, V136, pE55, DOI 10.1016/j.jid.2016.04.009; Mobs C, 2012, J ALLERGY CLIN IMMUN, V130, P1108, DOI 10.1016/j.jaci.2012.07.056; Muller R, 2006, EXP DERMATOL, V15, P606, DOI 10.1111/j.1600-0625.2006.00451.x; Muramatsu K, 2016, J DERMATOL, V43, P1350, DOI 10.1111/1346-8138.13493; Mustafa MB, 2015, AUTOIMMUN REV, V14, P930, DOI 10.1016/j.autrev.2015.06.005; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; Nishimoto S, 2013, J IMMUNOL, V191, P3065, DOI 10.4049/jimmunol.1300348; Pavlovsky L, 2015, ACTA DERM-VENEREOL, V95, P177, DOI 10.2340/00015555-1884; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Rizzo C, 2005, CLIN EXP DERMATOL, V30, P535, DOI 10.1111/j.1365-2230.2005.01836.x; Roujeau JC, 2005, TOXICOLOGY, V209, P123, DOI 10.1016/j.tox.2004.12.022; Scully C, 1998, CRIT REV ORAL BIOL M, V9, P86, DOI 10.1177/10454411980090010501; Shaker O, 2012, BRIT J DERMATOL, V166, P1367, DOI 10.1111/j.1365-2133.2011.10793.x; Shen ZY, 2014, ARCH DERMATOL RES, V306, P441, DOI 10.1007/s00403-013-1429-3; Shimoda A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18346; Simark-Mattsson C, 1999, ARCH ORAL BIOL, V44, P499, DOI 10.1016/S0003-9969(99)00013-8; SINHA AA, 1988, SCIENCE, V239, P1026, DOI 10.1126/science.2894075; Skaria M, 1999, DERMATOLOGY, V199, P253, DOI 10.1159/000018257; Sugerman PB, 2002, CRIT REV ORAL BIOL M, V13, P350, DOI 10.1177/154411130201300405; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thoma-Uszynski S, 2006, J IMMUNOL, V176, P2015, DOI 10.4049/jimmunol.176.3.2015; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Veldman CM, 2004, J IMMUNOL, V172, P3883, DOI 10.4049/jimmunol.172.6.3883; Wang H, 2014, CLIN ORAL INVEST, V18, P1647, DOI 10.1007/s00784-013-1131-z; Wang XY, 2010, SUBCELL BIOCHEM, V53, P3, DOI 10.1007/978-90-481-9078-2_1; Zaraa I, 2013, INT J DERMATOL, V52, P406, DOI 10.1111/j.1365-4632.2012.05693.x	44	8	8	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					672	676		10.1016/j.jaci.2018.02.046	http://dx.doi.org/10.1016/j.jaci.2018.02.046			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29653117	Bronze			2022-12-18	WOS:000440664400034
J	Coverstone, AM; Wilson, B; Burgdorf, D; Schechtman, KB; Storch, GA; Holtzman, MJ; Castro, M; Bacharier, LB; Sumino, K				Coverstone, Andrea M.; Wilson, Brad; Burgdorf, Dana; Schechtman, Kenneth B.; Storch, Gregory A.; Holtzman, Michael J.; Castro, Mario; Bacharier, Leonard B.; Sumino, Kaharu			Recurrent wheezing in children following human metapneumovirus infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SYNCYTIAL-VIRUS BRONCHIOLITIS; IMPORTANT RISK-FACTOR; ASTHMA; INFANCY; ALLERGY		[Coverstone, Andrea M.; Wilson, Brad; Burgdorf, Dana; Schechtman, Kenneth B.; Storch, Gregory A.; Holtzman, Michael J.; Castro, Mario; Bacharier, Leonard B.; Sumino, Kaharu] Washington Univ, Sch Med St Louis, St Louis, MO 63130 USA	Saint Louis University; Washington University (WUSTL)	Sumino, K (corresponding author), Washington Univ, Sch Med St Louis, St Louis, MO 63130 USA.	ksumino@dom.wustl.edu	Coverstone, Andrea/K-6243-2019; Sumino, Kaharu/AAA-2028-2021	Castro, Mario/0000-0001-6328-8994; Bacharier, Leonard/0000-0003-0432-2704; Sumino, Kaharu/0000-0002-6214-2966	National Institutes of Health [1KM1CA156708-1]; National Institute of Allergy and Infectious Diseases [U19 AI070489]; National Center for Advancing Translational Sciences [5UL1 TR000448-07]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grant no. 1KM1CA156708-1 to K.S.), the National Institute of Allergy and Infectious Diseases (grant no. U19 AI070489), and the National Center for Advancing Translational Sciences (grant no. 5UL1 TR000448-07).	Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Castro M, 2008, J ALLERGY CLIN IMMUN, V122, P726, DOI 10.1016/j.jaci.2008.07.010; Garcia-Garcia ML, 2007, PEDIATR PULM, V42, P458, DOI 10.1002/ppul.20597; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Garcia-Garcia ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173504; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472	9	8	10	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					297	301		10.1016/j.jaci.2018.02.008	http://dx.doi.org/10.1016/j.jaci.2018.02.008			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29481834	Green Accepted			2022-12-18	WOS:000437837500036
J	Ueno, HM; Kato, T; Ohnishi, H; Kawamoto, N; Kato, Z; Kaneko, H; Kondo, N; Nakano, T				Ueno, Hiroshi M.; Kato, Teruhiko; Ohnishi, Hidenori; Kawamoto, Norio; Kato, Zenichiro; Kaneko, Hideo; Kondo, Naomi; Nakano, Taku			Hypoallergenic casein hydrolysate for peptide-based oral immunotherapy in cow's milk allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PROTEINS		[Ueno, Hiroshi M.; Kato, Teruhiko; Nakano, Taku] Bean Stalk Snow Co Ltd, Dept Res & Dev, Kawagoe, Saitama, Japan; [Ohnishi, Hidenori; Kawamoto, Norio; Kato, Zenichiro; Kaneko, Hideo; Kondo, Naomi] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Kato, Zenichiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Struct Med, Gifu, Japan; [Kaneko, Hideo] Natl Hosp Org, Nagara Med Ctr, Dept Clin Res, Gifu, Japan; [Kondo, Naomi] Heisei Coll Hlth Sci, Gifu, Japan	Gifu University; Gifu University	Ueno, HM (corresponding author), Bean Stalk Snow Co Ltd, Dept Res & Dev, Kawagoe, Saitama, Japan.	hiroshi-ueno@beanstalksnow.co.jp	Kawamoto, Norio/AAN-5302-2021	Kawamoto, Norio/0000-0002-3482-7781; Ueno, Hiroshi/0000-0002-8293-9163	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan [2005-2009]	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan	This study was supported in part by the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan (grant no. 2005-2009). BRAIN made no substantial contribution to the study, except for the financial support.	Archila LD, 2017, J ALLERGY CLIN IMMUN, V140, P854, DOI 10.1016/j.jaci.2017.02.028; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Liu Y, 2008, INT DAIRY J, V18, P1022, DOI 10.1016/j.idairyj.2008.05.005; Matsuo H, 2015, ALLERGOL INT, V64, P332, DOI 10.1016/j.alit.2015.06.009; Meesilpavikkai K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00274; Ruiter B, 2006, CLIN EXP ALLERGY, V36, P303, DOI 10.1111/j.1365-2222.2006.02436.x; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Ueno HM, 2016, PEDIAT ALLERG IMM-UK, V27, P818, DOI 10.1111/pai.12642; Winthrop KL, 2017, NAT REV RHEUMATOL, V13, P234, DOI 10.1038/nrrheum.2017.23; Yokooji T, 2013, ALLERGOL INT, V62, P435, DOI 10.2332/allergolint.13-OA-0561	11	8	10	3	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					330	333		10.1016/j.jaci.2018.04.005	http://dx.doi.org/10.1016/j.jaci.2018.04.005			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29704594	Bronze			2022-12-18	WOS:000437837500046
J	Scurlock, AM; Jones, SM				Scurlock, Amy M.; Jones, Stacie M.			Advances in the approach to the patient with food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; diagnosis; management; prevalence; specific IgE; prevention; IgE-mediated food allergy; oral food challenge; early intervention; primary prevention; evidence-based guidelines; oral immunotherapy; sublingual immunotherapy; epicutaneous immunotherapy	QUALITY-OF-LIFE; PEANUT ORAL IMMUNOTHERAPY; EPICUTANEOUS IMMUNOTHERAPY; MURINE MODEL; DOUBLE-BLIND; SUSTAINED UNRESPONSIVENESS; EOSINOPHILIC ESOPHAGITIS; SUBLINGUAL IMMUNOTHERAPY; INDUCED ANAPHYLAXIS; PRIMARY PREVENTION	Advances in food allergy diagnosis, management, prevention, and therapeutic interventions have been significant over the past 2 decades. Evidence-based national and international guidelines have streamlined food allergy diagnosis and management, whereas paradigm-shifting work in primary prevention of peanut allergy has resulted in significant modifications in the approach to early food introduction in infants and toddlers. Innovative investigation of food allergy epidemiology, systems biology, effect, and management has provided important insights. Although active therapeutic approaches to food allergy remain experimental, progress toward licensed therapies has been substantial. Mechanistic understanding of the immunologic processes underlying food allergy and immunotherapywill inform the future design of therapeutic approaches targeting the food-induced allergic response. Global strategies to mitigate the substantial medical, economic, and psychosocial burden of food allergy in affected subjects and families will require engagement of stakeholders across multiple sectors in research, health care, public health, government, educational institutions, and industry. However, the relationship between the well-informed allergy care provider and the patient and family remains fundamental for optimizing the care of the patient with food allergy.	[Scurlock, Amy M.; Jones, Stacie M.] Univ Arkansas Med Sci, Dept Pediat, 13 Childrens Way,Slot 512-13, Little Rock, AR 72202 USA	University of Arkansas System; University of Arkansas Medical Sciences	Jones, SM (corresponding author), Univ Arkansas Med Sci, Dept Pediat, 13 Childrens Way,Slot 512-13, Little Rock, AR 72202 USA.	jonesstaciem@uams.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases; FARE; Aimmune Therapeutics; DBV Technologies; Astellas; National Peanut Board; National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Tolerance Network; National Institutes of Health/National Institute of Allergy and Infectious Diseases Consortium of Food Allergy Research	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FARE; Aimmune Therapeutics; DBV Technologies; Astellas(Astellas Pharmaceuticals); National Peanut Board; National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Tolerance Network; National Institutes of Health/National Institute of Allergy and Infectious Diseases Consortium of Food Allergy Research	A. M. Scurlock has consultant arrangements with Aimmune Therapeutics; is employed by the University of Arkansas for Medical Science; has received grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases and FARE; and has received travel support from Aimmune Therapeutics. S. M. Jones is on the research advisory board for FARE; has consultant arrangements with Aimmune Therapeutics; has received grants from Aimmune Therapeutics, DBV Technologies, Astellas, FARE, the National Peanut Board, the National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Tolerance Network, and the National Institutes of Health/National Institute of Allergy and Infectious Diseases Consortium of Food Allergy Research; and has done CSR review/preparation for DBV Technologies on behalf of EMMES Corporation.	Acker WW, 2017, J ALLERGY CLIN IMMUN, V140, P1587, DOI 10.1016/j.jaci.2017.04.006; Agyemang A, 2018, J ALLER CL IMM-PRACT, V6, P653, DOI 10.1016/j.jaip.2017.05.016; Akuete K, 2017, ANN ALLERG ASTHMA IM, V119, P339, DOI 10.1016/j.anai.2017.07.028; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Ashley SE, 2017, ALLERGY, V72, P1356, DOI 10.1111/all.13143; Ashley SE, 2017, CLIN EXP ALLERGY, V47, P1032, DOI 10.1111/cea.12942; Bartnikas LM, 2017, J ALLERGY CLIN IMMUN, V140, P465, DOI 10.1016/j.jaci.2017.01.040; Bellach J, 2017, J ALLERGY CLIN IMMUN, V139, P1591, DOI 10.1016/j.jaci.2016.06.045; Berglund JP, 2017, J ALLER CL IMM-PRACT, V5, P1098, DOI 10.1016/j.jaip.2016.11.034; Bird JA, 2018, J ALLER CL IMM-PRACT, V6, P476, DOI 10.1016/j.jaip.2017.09.016; Bird JA, 2017, J ALLER CL IMM-PRACT, V5, P301, DOI 10.1016/j.jaip.2016.07.019; Blankestijn MA, 2017, J ALLER CL IMM-PRACT, V5, P376, DOI 10.1016/j.jaip.2016.12.005; Blazquez AB, 2017, TRANSL RES, V179, P199, DOI 10.1016/j.trsl.2016.09.003; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V138, P1122, DOI 10.1016/j.jaci.2016.03.041; Burk CM, 2016, CLIN EXP ALLERGY, V46, P347, DOI 10.1111/cea.12635; Burk CM, 2017, J ALLER CL IMM-PRACT, V5, P498, DOI 10.1016/j.jaip.2016.11.010; Burks AW, 2015, J ALLERGY CLIN IMMUN, V135, P1240, DOI 10.1016/j.jaci.2014.12.1917; Burton OT, 2018, J ALLERGY CLIN IMMUN, V141, P189, DOI 10.1016/j.jaci.2017.03.045; Burton OT, 2017, J ALLERGY CLIN IMMUN, V139, P314, DOI 10.1016/j.jaci.2016.04.034; Caubet JC, 2017, ALLERGY, V72, P1677, DOI 10.1111/all.13167; Chan JCK, 2017, J ALLER CL IMM-PRACT, V5, P398, DOI 10.1016/j.jaip.2016.12.021; Dawicki W, 2017, J ALLERGY CLIN IMMUN, V139, P1608, DOI 10.1016/j.jaci.2016.07.042; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; DunnGalvin A, 2017, J ALLER CL IMM-PRACT, V5, P363, DOI 10.1016/j.jaip.2016.09.049; Filep S, 2018, J ALLERGY CLIN IMMUN, V141; Frischmeyer-Guerrerio PA, 2017, J ALLERGY CLIN IMMUN, V140, P1043, DOI 10.1016/j.jaci.2017.03.028; Garvey AA, 2017, J ALLER CL IMM-PRACT, V5, P1757, DOI 10.1016/j.jaip.2017.03.027; Gau J, 2017, J ALLER CL IMM-PRACT, V5, P475, DOI 10.1016/j.jaip.2016.06.027; Grabenhenrich LB, 2016, J ALLERGY CLIN IMMUN, V137, P1128, DOI 10.1016/j.jaci.2015.11.015; Grimshaw KEC, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0089-8; Gupta RS, 2016, ALLERGY ASTHMA PROC, V37, pE140, DOI 10.2500/aap.2016.37.3988; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Herbert LJ, 2017, ANN ALLERG ASTHMA IM, V118, P345, DOI 10.1016/j.anai.2016.12.002; Herbert LJ, 2016, J PEDIATR PSYCHOL, V41, P363, DOI 10.1093/jpepsy/jsv099; Hill DA, 2017, J ALLER CL IMM-PRACT, V5, P369, DOI 10.1016/j.jaip.2016.11.020; Hoehn JL, 2017, J PEDIATR PSYCHOL, V42, P186, DOI 10.1093/jpepsy/jsw059; Hong XM, 2016, J ALLERGY CLIN IMMUN, V138, P908, DOI 10.1016/j.jaci.2016.01.056; Honjo A, 2017, J ALLERGY CLIN IMMUN, V139, P987, DOI 10.1016/j.jaci.2016.05.046; Hourihane JO, 2017, J ALLERGY CLIN IMMUN, V139, P1583, DOI 10.1016/j.jaci.2017.01.030; Huang YJ, 2017, J ALLERGY CLIN IMMUN, V139, P1099, DOI 10.1016/j.jaci.2017.02.007; Hussain M, 2018, J ALLERGY CLIN IMMUN, V141, P223, DOI 10.1016/j.jaci.2017.02.035; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Jimenez-Saiz R, 2017, J ALLERGY CLIN IMMUN, V140, P1604, DOI 10.1016/j.jaci.2017.01.018; Jones SM, 2017, J ALLERGY CLIN IMMUN, V139, P1242, DOI 10.1016/j.jaci.2016.08.017; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1258, DOI 10.1016/j.jaci.2016.01.008; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1117, DOI 10.1016/j.jaci.2015.12.1316; Khodoun MV, 2018, J ALLERGY CLIN IMMUN, V141, P171, DOI 10.1016/j.jaci.2017.02.046; Kinaciyan T, 2018, J ALLERGY CLIN IMMUN, V141, P1002, DOI 10.1016/j.jaci.2017.07.036; Kosoy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163831; Lanser BJ, 2016, ANN ALLERG ASTHMA IM, V116, P533, DOI 10.1016/j.anai.2016.03.031; Lowe AJ, 2018, BRIT J DERMATOL, V178, pE19, DOI 10.1111/bjd.15747; MacGinnitie AJ, 2017, J ALLERGY CLIN IMMUN, V139, P873, DOI 10.1016/j.jaci.2016.08.010; Mahdavinia M, 2017, J ALLER CL IMM-PRACT, V5, P352, DOI 10.1016/j.jaip.2016.10.006; Manso L, 2017, J INVEST ALLERG CLIN, V27, P363, DOI 10.18176/jiaci.0182; Martino DJ, 2017, CLIN EXP ALLERGY, V47, P217, DOI 10.1111/cea.12863; Masilamani M, 2017, J ALLER CL IMM-PRACT, V5, P1760, DOI 10.1016/j.jaip.2017.04.005; Muraro A, 2017, ALLERGY, V72, P1006, DOI 10.1111/all.13132; Muraro A, 2014, ALLERGY, V69, P590, DOI 10.1111/all.12398; Natsume O, 2017, LANCET, V389, P276, DOI 10.1016/S0140-6736(16)31418-0; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; Pagovich OE, 2016, J ALLERGY CLIN IMMUN, V138, P1652, DOI 10.1016/j.jaci.2016.03.053; Palmer DJ, 2017, J ALLERGY CLIN IMMUN, V139, P1600, DOI 10.1016/j.jaci.2016.06.052; Pellerin L, 2018, J ALLERGY CLIN IMMUN, V141, P202, DOI 10.1016/j.jaci.2017.05.045; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Peters RL, 2017, J ALLERGY CLIN IMMUN, V140, P145, DOI 10.1016/j.jaci.2017.02.019; Plunkett CH, 2017, J IMMUNOL, V198, P581, DOI 10.4049/jimmunol.1601266; Polloni L, 2017, PEDIAT ALLERG IMM-UK, V28, P458, DOI 10.1111/pai.12732; Rigbi NE, 2017, ALLERGY, V72, P1883, DOI 10.1111/all.13211; Ross J, 2017, J ALLER CL IMM-PRACT, V5, P494, DOI 10.1016/j.jaip.2016.06.006; Ryan JF, 2016, P NATL ACAD SCI USA, V113, pE1286, DOI 10.1073/pnas.1520180113; Sampson HA, 2017, JAMA-J AM MED ASSOC, V318, P1798, DOI 10.1001/jama.2017.16591; Sann J, 2016, J ALLER CL IMM-PRACT, V4, P989, DOI 10.1016/j.jaip.2016.03.018; Santos AF, 2017, CLIN EXP ALLERGY, V47, P1115, DOI 10.1111/cea.12964; Santos AF, 2017, J ALLER CL IMM-PRACT, V5, P237, DOI 10.1016/j.jaip.2016.12.003; Sasaki M, 2018, J ALLERGY CLIN IMMUN, V141, P391, DOI 10.1016/j.jaci.2017.05.041; Savage JH, 2018, ALLERGY, V73, P145, DOI 10.1111/all.13232; Schellpfeffer NR, 2017, J ALLER CL IMM-PRACT, V5, P358, DOI 10.1016/j.jaip.2016.10.018; Shemesh E, 2017, J ALLER CL IMM-PRACT, V5, P391, DOI 10.1016/j.jaip.2016.12.016; Sicherer SH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4006; Sicherer SH, 2016, J ALLER CL IMM-PRACT, V4, P239, DOI 10.1016/j.jaip.2015.11.015; Simberloff T, 2017, J ALLER CL IMM-PRACT, V5, P335, DOI 10.1016/j.jaip.2016.05.021; Smith PK, 2017, J ALLERGY CLIN IMMUN, V139, P429, DOI 10.1016/j.jaci.2016.05.040; Srivastava KD, 2017, CLIN EXP ALLERGY, V47, P1038, DOI 10.1111/cea.12936; Srivastava KD, 2016, J ALLERGY CLIN IMMUN, V138, P536, DOI 10.1016/j.jaci.2016.01.047; Stallings V. A., 2016, FINDING PATH SAFETY; Stensgaard A, 2017, CLIN EXP ALLERGY, V47, P530, DOI 10.1111/cea.12849; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010; Tordesillas L, 2017, IMMUNITY, V47, P32, DOI 10.1016/j.immuni.2017.07.004; Tordesillas L, 2017, J ALLERGY CLIN IMMUN, V139, P189, DOI 10.1016/j.jaci.2016.03.057; Tsuang A, 2017, J ALLER CL IMM-PRACT, V5, P1418, DOI 10.1016/j.jaip.2017.04.014; Turner PJ, 2017, JAMA-J AM MED ASSOC, V317, P1111, DOI 10.1001/jama.2017.0922; Vickery BP, 2017, J ALLERGY CLIN IMMUN, V139, P173, DOI 10.1016/j.jaci.2016.05.027; Virkud YV, 2017, J ALLERGY CLIN IMMUN, V139, P882, DOI 10.1016/j.jaci.2016.07.030; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wang J, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4005; Warren CM, 2017, J ALLER CL IMM-PRACT, V5, P381, DOI 10.1016/j.jaip.2016.12.012; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P973, DOI 10.1016/j.jaci.2016.01.001; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P1103, DOI 10.1016/j.jaci.2015.10.005; Wright BL, 2016, ALLERGY, V71, P1552, DOI 10.1111/all.12895	101	8	8	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2002	2014		10.1016/j.jaci.2017.12.1008	http://dx.doi.org/10.1016/j.jaci.2017.12.1008			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29524535	Bronze			2022-12-18	WOS:000434701600006
J	Tanaka, A; Allam, VSRR; Simpson, J; Tiberti, N; Shiels, J; To, J; Lund, M; Combes, V; Weldon, S; Taggart, C; Dalton, JP; Phipps, S; Sukkar, MB; Donnelly, S				Tanaka, Akane; Allam, Venkata Sita Rama Raju; Simpson, Jennifer; Tiberti, Natalia; Shiels, Jenna; To, Joyce; Lund, Maria; Combes, Valery; Weldon, Sinead; Taggart, Cliff; Dalton, John P.; Phipps, Simon; Sukkar, Maria B.; Donnelly, Sheila			The parasitic 68-mer peptide FhHDM-1 inhibits mixed granulocytic inflammation and airway hyperreactivity in experimental asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NLRP3 INFLAMMASOME; ACTIVATION		[Tanaka, Akane; Tiberti, Natalia; To, Joyce; Lund, Maria; Combes, Valery; Donnelly, Sheila] Univ Technol Sydney, Fac Sci, Sch Life Sci, Ultimo, Australia; [Allam, Venkata Sita Rama Raju; Sukkar, Maria B.] Univ Technol Sydney, Discipline Pharm, Grad Sch Hlth, Ultimo, Australia; [Simpson, Jennifer; Phipps, Simon] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Shiels, Jenna; Dalton, John P.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Shiels, Jenna; Weldon, Sinead; Taggart, Cliff] Queens Univ Belfast, Airway Innate Immun Grp, Ctr Expt Med, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	University of Technology Sydney; University of Technology Sydney; QIMR Berghofer Medical Research Institute; Queens University Belfast; Queens University Belfast	Donnelly, S (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, Ultimo, Australia.	Sheila.Donnelly@uts.edu.au	Phipps, Simon/F-9170-2010; Sukkar, Maria B/L-6917-2013; Tiberti, Natalia/I-7928-2018; Tanaka, Akane/B-7759-2019; Weldon, Sinead/J-5451-2014	Phipps, Simon/0000-0002-7388-3612; Tiberti, Natalia/0000-0002-2981-5233; Tanaka, Akane/0000-0001-8851-7917; Weldon, Sinead/0000-0001-5628-6624; Taggart, Clifford/0000-0002-9930-2978; Donnelly, Sheila/0000-0003-2005-3698; To, Joyce/0000-0003-3482-4369; Sukkar, Maria/0000-0003-4591-2399; allam, venkata sita rama raju/0000-0002-4330-5299; Combes, Valery/0000-0003-2178-3596	Australian Government Research Training Program Scholarship; University of Technology Sydney Postgraduate Research Scholarship; Swiss National Science Foundation [P300PA_164715]; Medical Research Council; European Research Council Advanced Grant (HELIVAC) [322725]; Horizon 2020; National Health and Medical Research Council Australia [APP1087341]	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); University of Technology Sydney Postgraduate Research Scholarship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Advanced Grant (HELIVAC); Horizon 2020; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	A.T. is supported by an Australian Government Research Training Program Scholarship. V.S.R.R.A. is supported by a University of Technology Sydney Postgraduate Research Scholarship. N.T. is supported by the Swiss National Science Foundation (grant P300PA_164715). C.T. and S.W. are supported by the Medical Research Council. J.P.D. is funded by grants from a European Research Council Advanced Grant (HELIVAC, 322725) and is a member of the Horizon 2020-funded Consortium PARAGONE. S.D. is funded by the National Health and Medical Research Council Australia (APP1087341).	Alvarado R, 2017, FASEB J, V31, P85, DOI 10.1096/fj.201500093R; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Chung KF, 2015, LANCET, V386, P1086, DOI 10.1016/S0140-6736(15)00157-9; Janicova L, 2016, PARASITE IMMUNOL, V38, P340, DOI 10.1111/pim.12322; Konstantinou GN, 2009, ALLERGY, V64, P1256, DOI 10.1111/j.1398-9995.2009.02132.x; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lund ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep37789; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Simpson JL, 2014, EUR RESPIR J, V43, P1067, DOI 10.1183/09031936.00105013; Ullah MA, 2014, J ALLERGY CLIN IMMUN, V134, P440, DOI 10.1016/j.jaci.2013.12.1035	10	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2316	2319		10.1016/j.jaci.2018.01.050	http://dx.doi.org/10.1016/j.jaci.2018.01.050			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29522851	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000434701600048
J	Kohanski, MA; Toskala, E; Kennedy, DW				Kohanski, Michael A.; Toskala, Elina; Kennedy, David W.			Evolution in the surgical management of chronic rhinosinusitis: Current indications and pitfalls	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; nasal polyps; endoscopic surgery; surgical complications	ENDOSCOPIC SINUS SURGERY; EXACERBATED RESPIRATORY-DISEASE; BUDESONIDE NASAL IRRIGATIONS; ADULT CHRONIC RHINOSINUSITIS; RANDOMIZED CONTROLLED-TRIAL; MAXIMAL MEDICAL THERAPY; ASPIRIN DESENSITIZATION; POSTOPERATIVE ENDOSCOPY; BALLOON DILATION; CLUSTER-ANALYSIS	Chronic rhinosinusitis (CRS) consists of a range of inflammatory conditions in the sinuses that can result in clinical symptoms. The underlying pathophysiology and its relationship to lower airway disease are complex. Current definitions of CRS can serve more as an indication for potential surgical intervention rather than a marker of disease state. CRS can be asymptomatic and may require medical management to avoid disease progression and minimize the risk of lower airway disease. Endoscopic surgery has undergone a significant evolution and refinement, but the most common surgical complication remains persistent inflammation and disease recurrence. It is important to recognize that surgery alone rarely cures CRS and patients require long-term medical therapy for continued asymptomatic inflammation. Careful postoperative care and endoscopic follow-up to ensure resolution of inflammation are key to ensuring optimal surgical outcomes and reduce the risk of revision surgery. Future work on CRS endotypes will allow discovery of new therapies to treat CRS, as well as refine indications for medical or surgical intervention and postoperative care.	[Kohanski, Michael A.; Kennedy, David W.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Toskala, Elina] Temple Univ, Lewis Katz Sch Med, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19122 USA	University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kennedy, DW (corresponding author), Univ Penn, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, 5th Floor,Ravdin Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	David.Kennedy@uphs.upenn.edu			Sinuwave; Sinopsys; Lannett; Medtronic	Sinuwave; Sinopsys; Lannett; Medtronic(Medtronic)	E. Toskala has received a grant from Medtronic. D. W. Kennedy has received consultant fees from Sinuwave, Sinopsys, Lannett, and Medtronic, royalties from Medtronic-Xomed, and reported partnerships with Entent Care and AcceptEnt. M. Kohanski declares no relevant conflicts of interest.	Adappa ND, 2018, INT FORUM ALLERGY RH, V8, P49, DOI 10.1002/alr.22036; Adnane C, 2017, EUR ARCH OTO-RHINO-L, V274, P879, DOI 10.1007/s00405-016-4315-8; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Anderson M, 2016, AM J RHINOL ALLERGY, V30, P161, DOI 10.2500/ajra.2016.30.4320; Asaka D, 2012, AM J RHINOL ALLERGY, V26, P61, DOI 10.2500/ajra.2012.26.3711; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bachert C, 2015, J ALLERGY CLIN IMMUN, V136, P1431, DOI 10.1016/j.jaci.2015.10.010; Baguley C, 2014, INT FORUM ALLERGY RH, V4, P525, DOI 10.1002/alr.21315; Barham HP, 2016, INT FORUM ALLERGY RH, V6, P238, DOI 10.1002/alr.21686; Bassiouni A, 2013, LARYNGOSCOPE, V123, P36, DOI 10.1002/lary.23610; Benninger MS, 2015, OTOLARYNG HEAD NECK, V152, P546, DOI 10.1177/0194599814565606; Bhandarkar ND, 2013, INT FORUM ALLERGY RH, V3, P355, DOI 10.1002/alr.21118; Brenner PS, 2011, INT FORUM ALLERGY RH, V1, P466, DOI 10.1002/alr.20085; Carey RM, 2016, LARYNSCOPE INVESTIG, V1, P88, DOI 10.1002/lio2.26; Chiu AG, 2008, AM J RHINOL, V22, P34, DOI 10.2500/ajr.2008.22.3122; Cho SH, 2016, J ALLER CL IMM-PRACT, V4, P575, DOI 10.1016/j.jaip.2016.04.015; Chowdhury NI, 2017, INT FORUM ALLERGY RH, V7, P1149, DOI 10.1002/alr.22028; Christensen DN, 2018, OTOLARYNGOL HEAD NEC; Dautremont JF, 2015, INT FORUM ALLERGY RH, V5, P1095, DOI 10.1002/alr.21601; DeConde AS, 2015, INT FORUM ALLERGY RH, V5, P691, DOI 10.1002/alr.21541; DeConde AS, 2013, INT FORUM ALLERGY RH, V3, P848, DOI 10.1002/alr.21196; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Georgalas C, 2010, CLIN OTOLARYNGOL, V35, P455, DOI 10.1111/j.1749-4486.2010.02218.x; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, pe1, DOI DOI 10.1067/MAI.2002.130051; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Goldenberg JZ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub4; Gunel C, 2017, LARYNGOSCOPE, V127, pE85, DOI 10.1002/lary.26414; Gurrola J, 2017, J ALLERGY CLIN IMMUN, V140, P1499, DOI 10.1016/j.jaci.2017.10.006; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Harvey RJ, 2018, INT FORUM ALLERGY RH; Hathorn IF, 2015, INT FORUM ALLERGY RH, V5, P167, DOI 10.1002/alr.21432; Hopkins C, 2015, RHINOLOGY, V53, P18, DOI [10.4193/Rhin14.077, 10.4193/Rhino14.077]; Huang ZX, 2015, INT FORUM ALLERGY RH, V5, P303, DOI 10.1002/alr.21485; Jang DW, 2013, INT FORUM ALLERGY RH, V3, P708, DOI 10.1002/alr.21189; Katotomichelakis M, 2014, RHINOLOGY, V52, P341, DOI [10.4193/Rhino13.231, 10.4193/Rhin13.231]; Kennedy DW, 2011, LARYNGOSCOPE, V121, P2142, DOI 10.1002/lary.22169; KENNEDY DW, 1990, OTOLARYNG HEAD NECK, V103, P884, DOI 10.1177/01945998901030S509; Kennedy DW, 1998, LARYNGOSCOPE, V108, P502, DOI 10.1097/00005537-199804000-00008; Kennedy DW, 2000, LARYNGOSCOPE, V110, P29, DOI 10.1097/00005537-200003002-00008; Krings JG, 2014, LARYNGOSCOPE, V124, P838, DOI 10.1002/lary.24401; Lee JT, 2016, AM J RHINOL ALLERGY, V30, P3, DOI 10.2500/ajra.2016.30.4255; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613; Luong A, 2017, JAMA OTOLARYNGOL HEA; Mahdavinia M, 2016, CLIN EXP ALLERGY, V46, P21, DOI 10.1111/cea.12666; Marple BF, 2012, OTOLARYNG HEAD NECK, V146, P1004, DOI 10.1177/0194599811435968; Marple BF, 2010, AM J RHINOL ALLERGY, V24, P249, DOI 10.2500/ajra.2010.24.3499; Naidoo Y, 2014, LARYNGOSCOPE, V124, P43, DOI 10.1002/lary.24258; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Patel ZM, 2017, INT FORUM ALLERGY RH, V7, P119, DOI 10.1002/alr.21872; Perloff JR, 2000, LARYNGOSCOPE, V110, P2095, DOI 10.1097/00005537-200012000-00023; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Rudmik L, 2017, JAMA OTOLARYNGOL, V143, P891, DOI 10.1001/jamaoto.2017.0752; Rudmikl L, 2016, RHINOLOGY, V54, P117, DOI 10.4193/Rhino16.023; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Schlosser RJ, 2016, INT FORUM ALLERGY RH, V6, P115, DOI 10.1002/alr.21651; Schlosser RJ, 2010, OTOLARYNG CLIN N AM, V43, P591, DOI 10.1016/j.otc.2010.02.015; Senior BA, 1998, LARYNGOSCOPE, V108, P151, DOI 10.1097/00005537-199802000-00001; Shin HW, 2012, AM J RESP CRIT CARE, V185, P944, DOI 10.1164/rccm.201109-1706OC; Smith KA, 2016, INT FORUM ALLERGY RH, V6, P228, DOI 10.1002/alr.21700; Smith TL, 2016, LARYNGOSCOPE, V126, P2659, DOI 10.1002/lary.26140; Smith TL, 2005, LARYNGOSCOPE, V115, P2199, DOI 10.1097/01.mlg.0000182825.82910.80; Snidvongs K, 2014, RHINOLOGY, V52, P53, DOI [10.4193/Rhin13.056, 10.4193/Rhino13.056]; Soler ZM, 2018, LARYNGOSCOPE, V128, P581, DOI 10.1002/lary.27008; Soler ZM, 2016, J ALLERGY CLIN IMMUN, V137, P1054, DOI 10.1016/j.jaci.2015.11.019; Soudry E, 2016, INT FORUM ALLERGY RH, V6, P568, DOI 10.1002/alr.21724; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Stankiewicz JA, 2011, LARYNGOSCOPE, V121, P2684, DOI 10.1002/lary.21446; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Waldram J, 2018, J ALLERGY CLIN IMMUN, V141, P250, DOI 10.1016/j.jaci.2017.05.006; Workman AD, 2017, CURR OPIN OTOLARYNGO; Zhao K, 2016, LARYNGOSCOPE, V126, pE90, DOI 10.1002/lary.25666	75	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1561	1569		10.1016/j.jaci.2018.03.003	http://dx.doi.org/10.1016/j.jaci.2018.03.003			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29605619	Bronze			2022-12-18	WOS:000432148200003
J	Tsai, CT; Mukai, K; Robinson, PV; Gray, MA; Waschmann, MB; Lyu, SC; Tsai, M; Chinthrajah, RS; Nadeau, KC; Bertozzi, CR; Galli, SJ				Tsai, Cheng-ting; Mukai, Kaori; Robinson, Peter V.; Gray, Melissa A.; Waschmann, Malika B.; Lyu, Shu-Chen; Tsai, Mindy; Chinthrajah, Rebecca S.; Nadeau, Kari C.; Bertozzi, Carolyn R.; Galli, Stephen J.			Isotype-specific agglutination-PCR (ISAP): A sensitive and multiplex method for measuring allergen-specific IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ANTIBODY; PEANUT		[Tsai, Cheng-ting; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Sch Humanities & Sci, Stanford, CA 94305 USA; [Mukai, Kaori; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Dept Pathol Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Robinson, Peter V.] Enable Biosci, San Francisco, CA USA; [Gray, Melissa A.] Stanford Univ, Dept Biol Chem, Sch Med, Stanford, CA 94305 USA; [Waschmann, Malika B.] Stanford Univ, Dept Human Biol, Sch Humanities & Sci, Stanford, CA 94305 USA; [Lyu, Shu-Chen; Chinthrajah, Rebecca S.; Nadeau, Kari C.] Stanford Univ, Dept Med, Div Pulm & Crit Care, Sch Med, Stanford, CA 94305 USA; [Lyu, Shu-Chen; Tsai, Mindy; Chinthrajah, Rebecca S.; Nadeau, Kari C.; Galli, Stephen J.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Bertozzi, CR (corresponding author), Stanford Univ, Dept Chem, Sch Humanities & Sci, Stanford, CA 94305 USA.; Bertozzi, CR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	bertozzi@stanford.edu; sgalli@stanford.edu		Chinthrajah, Sharon/0000-0003-2467-4256; Tsai, Mindy/0000-0002-8421-4721	National Institutes of Health [R21 DK108781A, U19 AI 104209, R01 AR067145]; Department of Pathology, Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK108781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, Stanford University(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors' laboratories are funded by the National Institutes of Health (grant no. R21 DK108781A, SPADA [Stanford Predictive and Diagnostics Accelerator] to C.R.B.; grant nos. U19 AI 104209 and R01 AR067145 to S.J.G.), and by the Department of Pathology, Stanford University.	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Balbino B, 2017, J ALLERGY CLIN IMMUN, V139, P584, DOI 10.1016/j.jaci.2016.05.047; Chapman MD, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0539-8; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Grier TJ, 2001, CLIN REV ALLERG IMMU, V21, P111, DOI 10.1385/CRIAI:21:2-3:111; Jablonski JE, 2010, J AOAC INT, V93, P213; Johnston EB, 2014, BIOANALYSIS, V6, P465, DOI 10.4155/bio.13.315; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; Moretti M, 2011, CLIN CHIM ACTA, V412, P1143, DOI 10.1016/j.cca.2011.03.002; Mukai K, 2016, J ALLERGY CLIN IMMUN; Rahmatpour S, 2016, MOL CELL PROBE; Smit JJ, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0056-9; Smoldovskaya O, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0117-1; Tsai CT, 2016, ACS CENTRAL SCI, V2, P139, DOI 10.1021/acscentsci.5b00340; Tuano KS, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0534-0; van Wijk F, 2004, CLIN EXP ALLERGY, V34, P1422, DOI 10.1111/j.1365-2222.2004.02062.x	16	8	8	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1901	+		10.1016/j.jaci.2017.11.021	http://dx.doi.org/10.1016/j.jaci.2017.11.021			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29248495	Bronze, Green Accepted			2022-12-18	WOS:000432148200038
J	Chang, EH; Stern, DA; Willis, AL; Guerra, S; Wright, AL; Martinez, FD				Chang, Eugene H.; Stern, Debra A.; Willis, Amanda L.; Guerra, Stefano; Wright, Anne L.; Martinez, Fernando D.			Early life risk factors for chronic sinusitis: A longitudinal birth cohort study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sinusitis; asthma; allergy; viral; natural history	CHRONIC RHINOSINUSITIS; ALTERNARIA SENSITIZATION; DESERT ENVIRONMENT; ALLERGIC RHINITIS; RECURRENT COUGH; YOUNG-CHILDREN; ASTHMA; ASSOCIATION; CHILDHOOD; ILLNESSES	Background: Chronic sinusitis is a commonly diagnosed condition in adults who frequently present with late-stage disease and irreversible changes to the sinus mucosa. Understanding the natural history of chronic sinusitis is critical in developing therapies designed to prevent or slow the progression of disease. Objective: We sought to determine early life risk factors for adult sinusitis in a longitudinal cohort study (Tucson Children's Respiratory Study). Methods: Physician-diagnosed sinusitis was reported at age 6. Adult sinusitis between 22 and 32 years was defined as self-reported sinusitis plus physician-ordered sinus radiologic films. Atopy was assessed by skin prick test. Individuals were grouped into 4 phenotypes: no sinusitis (n = 621), transient childhood sinusitis only (n = 57), late-onset adult sinusitis only (n = 68), and early onset chronic sinusitis (childhood and adult sinusitis, n = 26). Results: Sinusitis was present in 10.8% of children and 12.2% of adults. Childhood sinusitis was the strongest independent risk factor for adult sinusitis (odds ratio = 4.2; 95% CI: 2.5-7.1; P < .0001; n = 772). Early onset chronic sinusitis was associated with increased serum IgE levels as early as at 9 months of age, atopy (assessed by skin prick test reactivity), childhood eczema and allergic rhinitis, frequent childhood colds, maternal asthma, and with increased prevalence of concurrent asthma. No association was found between late-onset adult sinusitis and any of the early life risk factors studied. Conclusions: We identified an early onset chronic sinusitis phenotype associated with a predisposition to viral infections/colds in early life, allergies, and asthma. Elucidation of the molecular mechanisms for this phenotype may lead to future therapies to prevent the progression of the disease into adult sinusitis.	[Chang, Eugene H.; Willis, Amanda L.] Univ Arizona, Dept Otolaryngol, 1501 N Campbell Ave,POB 245074, Tucson, AZ 85721 USA; [Chang, Eugene H.; Stern, Debra A.; Willis, Amanda L.; Guerra, Stefano; Wright, Anne L.; Martinez, Fernando D.] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Chang, EH (corresponding author), Univ Arizona, Dept Otolaryngol, 1501 N Campbell Ave,POB 245074, Tucson, AZ 85721 USA.	echang@oto.arizona.edu			National Institutes of Health [NIH-R01 HL 132523]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grant NIH-R01 HL 132523 (E.H.C., S.G., A.L.W., F.D.M.).	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Bachert C, 2006, CURR OPIN ALLERGY CL, V6, P29, DOI 10.1097/01.all.0000200504.54425.0e; Bhattacharyya N, 2010, OTOLARYNG HEAD NECK, V143, P147, DOI 10.1016/j.otohns.2010.04.012; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bresciani M, 2001, J ALLERGY CLIN IMMUN, V107, P73, DOI 10.1067/mai.2001.111593; Caulley L, 2015, J ALLERGY CLIN IMMUN, V136, P1517, DOI 10.1016/j.jaci.2015.08.037; Chang EH, 2017, J ALLERGY CLIN IMMUN, V139, P1990, DOI 10.1016/j.jaci.2016.10.027; CORREN J, 1992, J ALLERGY CLIN IMMUN, V90, P250, DOI 10.1016/0091-6749(92)90079-H; DeConde AS, 2017, OTOLARYNG CLIN N AM, V50, P1, DOI 10.1016/j.otc.2016.08.003; DeMuri GP, 2016, J PEDIATR-US, V171, P133, DOI 10.1016/j.jpeds.2015.12.034; Fernandez C, 2011, CLIN EXP ALLERGY, V41, P649, DOI 10.1111/j.1365-2222.2010.03645.x; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Joe SA, 2008, OTOLARYNG CLIN N AM, V41, P297, DOI 10.1016/j.otc.2007.11.001; Leung RM, 2014, LARYNGOSCOPE, V124, P12, DOI 10.1002/lary.24100; Marom T, 2014, PEDIATR INFECT DIS J, V33, P803, DOI 10.1097/INF.0000000000000278; MARTINEZ FD, 1995, THORAX, V50, P1067, DOI 10.1136/thx.50.10.1067; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, P775, DOI 10.1016/S0091-6749(99)70287-3; Pearlman AN, 2009, AM J RHINOL ALLERGY, V23, P145, DOI 10.2500/ajra.2009.23.3284; Perzanowski MS, 1998, J ALLERGY CLIN IMMUN, V101, P626, DOI 10.1016/S0091-6749(98)70170-8; Randriamanantany ZA, 2010, ALLERGY, V65, P368, DOI 10.1111/j.1398-9995.2009.02210.x; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Seybt MW, 2007, ENT-EAR NOSE THROAT, V86, P409, DOI 10.1177/014556130708600719; Sherrill DL, 2005, RESP MED, V99, P1377, DOI 10.1016/j.rmed.2005.03.025; Simpson A, 2005, J ALLERGY CLIN IMMUN, V116, P744, DOI 10.1016/j.jaci.2005.06.032; Smith TL, 2010, OTOLARYNG HEAD NECK, V142, P55, DOI 10.1016/j.otohns.2009.10.009; Stern DA, 2004, CLIN EXP ALLERGY, V34, P1563, DOI 10.1111/j.1365-2222.2004.02088.x; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; WALD ER, 1991, PEDIATRICS, V87, P129; Wright AL, 1996, AM J RESP CRIT CARE, V153, P1259, DOI 10.1164/ajrccm.153.4.8616551	32	8	9	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1291	+		10.1016/j.jaci.2017.11.052	http://dx.doi.org/10.1016/j.jaci.2017.11.052			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29355680	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000429197800015
J	Ek, WE; Karlsson, T; Hernandes, CA; Rask-Andersen, M; Johansson, A				Ek, Weronica E.; Karlsson, Torgny; Hernandes, Carlos Azuaje; Rask-Andersen, Mathias; Johansson, Asa			Breast-feeding and risk of asthma, hay fever, and eczema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHILDHOOD ASTHMA; DISEASE; INFANT		[Ek, Weronica E.; Karlsson, Torgny; Hernandes, Carlos Azuaje; Rask-Andersen, Mathias; Johansson, Asa] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University	Ek, WE (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Weronica.ek@igp.uu.se	Johansson, Åsa/G-5270-2011; Johansson, Åsa/AAG-6799-2021	Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498	Medical Research Council [MC_qA137853] Funding Source: researchfish; Medical Research Council [MC_QA137853, MC_PC_12028] Funding Source: Medline; MRC [MC_PC_12028] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bion V, 2016, ALLERGY, V71, P661, DOI 10.1111/all.12833; BUSINCO L, 1983, ANN ALLERGY, V51, P296; Diaz-Gomez NM, 2013, AN PEDIAT, V79, pe1; Dogaru CM, 2014, AM J EPIDEMIOL, V179, P1153, DOI 10.1093/aje/kwu072; Foss KA, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-10; Grunebaum E, 2006, JAMA-J AM MED ASSOC, V295, P508, DOI 10.1001/jama.295.5.508; HANSON LA, 1959, INT ARCH ALLER A IMM, V15, P245, DOI 10.1159/000229050; Hauck FR, 2011, PEDIATRICS, V128, P103, DOI 10.1542/peds.2010-3000; HENDERSHOT GE, 1984, PEDIATRICS, V74, P591; Nickerson K, 2006, J MIDWIFERY WOM HEAL, V51, P26, DOI 10.1016/j.jmwh.2005.09.006; Oakley LL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002765; Oddy Wendy H, 2003, J Hum Lact, V19, P250, DOI 10.1177/0890334403255516; Parker William, 2013, Evolution Medicine and Public Health, P89, DOI 10.1093/emph/eot008; Picone S., 2013, EARLY HUM DEV, V89, P117; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Stewart B. W., 2014, WORLD CANC REPORT 20, P953; Ullemar V, 2016, ALLERGY, V71, P230, DOI 10.1111/all.12783; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; World Health Organization, 2001, OPT DUR EXCL BREASTF, P1	21	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1157	+		10.1016/j.jaci.2017.10.022	http://dx.doi.org/10.1016/j.jaci.2017.10.022			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	29132959	Green Submitted, Bronze			2022-12-18	WOS:000426974800046
J	Lenberg, J; Qian, Q; Sun, ZH; Alam, R; Gorska, MM				Lenberg, Jerica; Qian, Qian; Sun, Zehua; Alam, Rafeul; Gorska, Magdalena M.			Pre-pregnancy exposure to diesel exhaust predisposes offspring to asthma through IL-1 beta and IL-17A	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDHOOD ASTHMA; T-CELLS; WHEEZE; BIRTH; PARTICLES; INDUCTION; STRESS; BLOOD; LIFE		[Lenberg, Jerica; Qian, Qian; Sun, Zehua; Alam, Rafeul; Gorska, Magdalena M.] Natl Jewish Hlth, Dept Med, Div Allergy & Clin Immunol, Denver, CO 80206 USA; [Alam, Rafeul; Gorska, Magdalena M.] Univ Colorado Denver, Dept Med, Div Allergy & Clin Immunol, Aurora, CO 80204 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Gorska, MM (corresponding author), Natl Jewish Hlth, Dept Med, Div Allergy & Clin Immunol, Denver, CO 80206 USA.; Gorska, MM (corresponding author), Univ Colorado Denver, Dept Med, Div Allergy & Clin Immunol, Aurora, CO 80204 USA.	gorskam@njhealth.org			National Institutes of Health [R01HL122995]; H.G. Barsumian, MD Memorial Fund Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126895, R01HL122995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); H.G. Barsumian, MD Memorial Fund Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institutes of Health (grant no. R01HL122995) and the H.G. Barsumian, MD Memorial Fund Grant (both grants to M.M.G.).	Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Burgess SL, 2016, RESP MED, V110, P53, DOI 10.1016/j.rmed.2015.11.009; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Chien JW, 2013, CLIN EXP ALLERGY, V43, P1018, DOI 10.1111/cea.12119; Fedulov AV, 2008, AM J RESP CELL MOL, V38, P57, DOI 10.1165/rcmb.2007-0124OC; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; Herberth G, 2015, J ALLERGY CLIN IMMUN, V136, P495, DOI 10.1016/j.jaci.2015.01.022; Jedrychowski WA, 2010, PEDIAT ALLERG IMM-UK, V21, pE723, DOI 10.1111/j.1399-3038.2010.01034.x; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Kerzel S, 2012, J PEDIATR-US, V161, P1172, DOI 10.1016/j.jpeds.2012.07.051; Kobayashi T, 2013, AM J RESP CELL MOL, V49, P989, DOI 10.1165/rcmb.2012-0444OC; Manners S, 2014, J ALLERGY CLIN IMMUN, V134, P63, DOI 10.1016/j.jaci.2013.10.047; MARCIAS A, 2016, EUR J IMMUNOL, V36, P2745; Martin RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074730; Patel MM, 2011, ENVIRON RES, V111, P1222, DOI 10.1016/j.envres.2011.08.004; Perzanowski MS, 2013, J ALLERGY CLIN IMMUN, V131, P886, DOI 10.1016/j.jaci.2012.12.666; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Rosa MJ, 2011, RESP MED, V105, P869, DOI 10.1016/j.rmed.2010.11.022; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schieck M, 2014, J ALLERGY CLIN IMMUN, V133, P888, DOI 10.1016/j.jaci.2013.08.048; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Ueng TH, 2005, TOXICOL SCI, V87, P483, DOI 10.1093/toxsci/kfi251; Walzer T, 2003, J IMMUNOL, V170, P1615, DOI 10.4049/jimmunol.170.4.1615; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC	26	8	8	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1118	+		10.1016/j.jaci.2017.09.002	http://dx.doi.org/10.1016/j.jaci.2017.09.002			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	28943469	Bronze, Green Accepted			2022-12-18	WOS:000426974800032
J	Happle, C; Jirmo, AC; Meyer-Bahlburg, A; Habener, A; Hoymann, HG; Hennig, C; Skuljec, J; Hansen, G				Happle, Christine; Jirmo, Adan Chari; Meyer-Bahlburg, Almut; Habener, Anika; Hoymann, Heinz Gerd; Hennig, Christian; Skuljec, Jelena; Hansen, Gesine			B cells control maternofetal priming of allergy and tolerance in a murine model of allergic airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; asthma; tolerance; perinatal; prenatal; B cells; regulatory T cells; immunoglobulins; immune complexes; tolerance; amniotic fluid	REGULATORY T-CELLS; BREAST-MILK; ANTIBODY COMPLEXES; IMMUNE-COMPLEXES; ORAL TOLERANCE; ASTHMA; ANTIGEN; AUTOIMMUNE; PREGNANCY; EXPOSURE	Background: Allergic asthma is a chronic lung disease resulting from inappropriate immune responses to environmental antigens. Early tolerance induction is an attractive approach for primary prevention of asthma. Objective: We analyzed the mechanisms of perinatal tolerance induction to allergens, with particular focus on the role of B cells in preconception and early intrauterine immune priming. Methods: Wild-type (WT) and B cell-deficient mice received ovalbumin (OVA) intranasally before mating. Their offspring were analyzed in a murine model of allergic airway inflammation. Results: Although antigen application before conception protected WT progeny from allergy, it aggravated allergic airway inflammation in B cell-deficient offspring. B-cell transfer restored protection, demonstrating the crucial role of B cells in perinatal tolerance induction. Effective diaplacentar allergen transfer was detectable in pregnant WT mice but not in pregnant B-cell knockout dams, and antigen concentrations in WT amniotic fluid (AF) were higher than in IgG-free AF of B cell-deficient dams. Application of OVA/IgG immune complexes during pregnancy boosted OVA uptake by fetal dendritic cells (DCs). Fetal DCs in human subjects and mice expressed strikingly higher levels of Fc gamma receptors compared with DCs from adults and were highly efficient in taking up OVA/IgG immune complexes. Moreover, murine fetal DCs effectively primed antigen-specific forkhead box P3(+) regulatory T cells after in vitro coincubation with OVA/IgG-containing AF. Conclusion: Our data support a decisive role for B cells and immunoglobulins during in utero tolerance priming. These findings improve the understanding of perinatal immunity and might support the development of effective primary prevention strategies for allergy and asthma in the future.	[Happle, Christine; Jirmo, Adan Chari; Meyer-Bahlburg, Almut; Habener, Anika; Hennig, Christian; Skuljec, Jelena; Hansen, Gesine] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Happle, Christine; Jirmo, Adan Chari; Meyer-Bahlburg, Almut; Habener, Anika; Hennig, Christian; Hansen, Gesine] Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany; [Happle, Christine; Jirmo, Adan Chari; Meyer-Bahlburg, Almut; Habener, Anika; Hennig, Christian; Hansen, Gesine] German Ctr Lung Res DZL, Hannover, Germany; [Meyer-Bahlburg, Almut] Univ Med Greifswald, Dept Pediat, Greifswald, Germany; [Hoymann, Heinz Gerd] Fraunhofer Inst Toxicol & Expt Med Hannover, Working Grp Airway Pharmacol, Hannover, Germany	Hannover Medical School; Greifswald Medical School; Fraunhofer Gesellschaft	Hansen, G (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	hansen.gesine@mh-hannover.de	Skuljec, Jelena/ABF-6712-2020	Skuljec, Jelena/0000-0001-8509-6563; Jirmo, Adan Chari/0000-0002-4693-0081	Deutsche Forschungsgemeinschaft [SFB 587/TP14]; German Federal Ministry of Education and Research (BREATH/ DZL); Hannover Biomedical Research School (HBRS Molecular Medicine at Hannover Medical School); Else Dorenkamp Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BREATH/ DZL); Hannover Biomedical Research School (HBRS Molecular Medicine at Hannover Medical School); Else Dorenkamp Foundation	Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 587/TP14), the German Federal Ministry of Education and Research (BREATH/ DZL), Hannover Biomedical Research School (HBRS Molecular Medicine at Hannover Medical School), and the Else Dorenkamp Foundation.	Alpan O, 2001, J IMMUNOL, V166, P4843, DOI 10.4049/jimmunol.166.8.4843; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Baudino L, 2008, J IMMUNOL, V180, P1948, DOI 10.4049/jimmunol.180.3.1948; Bertelsen RJ, 2014, J ALLERGY CLIN IMMUN, V133, P165, DOI 10.1016/j.jaci.2013.07.032; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bloom B, 2013, VITAL HLTH STAT, V10, P2013; Blumer N, 2007, CURR OPIN GASTROEN, V23, P655; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; CAULFIELD MJ, 1987, J IMMUNOL, V138, P3680; Chiu YHM, 2012, AM J RESP CRIT CARE, V186, P147, DOI 10.1164/rccm.201201-0162OC; DACOSTA PSG, 1990, J ALLERGY CLIN IMMUN, V86, P496; Dotterud CK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-123; Edelbauer M, 2004, CLIN EXP ALLERGY, V34, P189, DOI 10.1111/j.1365-2222.2004.01848.x; Franco L, 1998, CELL IMMUNOL, V190, P1, DOI 10.1006/cimm.1998.1356; Glaab T, 2004, J APPL PHYSIOL, V97, P1104, DOI 10.1152/japplphysiol.01182.2003; Gonnella PA, 2001, J IMMUNOL, V166, P4456, DOI 10.4049/jimmunol.166.7.4456; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Gupta N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1957; Habener A, 2017, EUR J IMMUNOL, V47, P552, DOI 10.1002/eji.201646518; Holloway JA, 2000, LANCET, V356, P1900, DOI 10.1016/S0140-6736(00)03265-7; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P653, DOI 10.1016/j.jaci.2009.12.018; Holt PG, 1999, NATURE, V402, pB12; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, pe1; Hoymann HG, 2006, EXP TOXICOL PATHOL, V57, P5, DOI 10.1016/j.etp.2006.02.011; JARRETT EEE, 1984, IMMUNOLOGY, V53, P365; Jungsuwadee P, 2004, INT ARCH ALLERGY IMM, V133, P40, DOI 10.1159/000075252; Kim SR, 2012, J CLIN IMMUNOL, V32, P574, DOI 10.1007/s10875-012-9672-5; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Leme AS, 2006, J IMMUNOL, V176, P762, DOI 10.4049/jimmunol.176.2.762; Liu XD, 2011, J IMMUNOL, V186, P4674, DOI 10.4049/jimmunol.1003584; Loibichler C., 2002, Clinical and Experimental Allergy, V32, P1546, DOI 10.1046/j.1365-2222.2002.01479.x; Macchiaverni P, 2011, SCAND J IMMUNOL, V74, P619, DOI 10.1111/j.1365-3083.2011.02615.x; MACHIELS JJ, 1991, ALLERGY, V46, P335, DOI 10.1111/j.1398-9995.1991.tb00596.x; MACHIELS JJ, 1990, J CLIN INVEST, V85, P1024, DOI 10.1172/JCI114532; MacNeill SJ, 2013, ALLERGY, V68, P771, DOI 10.1111/all.12141; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Maslova E, 2012, J ALLERGY CLIN IMMUN, V130, P724, DOI 10.1016/j.jaci.2012.05.014; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Matson Adam P, 2010, Clin Mol Allergy, V8, P9, DOI 10.1186/1476-7961-8-9; May K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007986; Mosconi E, 2010, MUCOSAL IMMUNOL, V3, P461, DOI 10.1038/mi.2010.23; Nakata K, 2010, BIOCHEM BIOPH RES CO, V395, P238, DOI 10.1016/j.bbrc.2010.03.170; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Palmeira P, 2009, PEDIAT ALLERG IMM-UK, V20, P528, DOI 10.1111/j.1399-3038.2008.00828.x; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Polte T, 2008, CLIN EXP ALLERGY, V38, P1950, DOI 10.1111/j.1365-2222.2008.03096.x; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; SINCLAIR NR, 1974, J IMMUNOL, V113, P1493; Sonnenschein-van der Voort AMM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-91; Spycher BD, 2012, J ALLERGY CLIN IMMUN, V130, P503, DOI 10.1016/j.jaci.2012.06.002; Sun JB, 2008, J IMMUNOL, V181, P8278, DOI 10.4049/jimmunol.181.12.8278; Szepfalusi Z, 2000, PEDIATR RES, V48, P404, DOI 10.1203/00006450-200009000-00024; Uthoff H, 2003, J IMMUNOL, V171, P3485, DOI 10.4049/jimmunol.171.7.3485; Vance GHS, 2005, CLIN EXP ALLERGY, V35, P1318, DOI 10.1111/j.1365-2222.2005.02346.x; Vercelli D, 2009, J ALLERGY CLIN IMMUN, V123, P26, DOI 10.1016/j.jaci.2008.11.031; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Wang L, 2015, MUCOSAL IMMUNOL, V8, P1297, DOI 10.1038/mi.2015.20; Yamamoto T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/721085; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748	65	8	8	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					685	+		10.1016/j.jaci.2017.03.051	http://dx.doi.org/10.1016/j.jaci.2017.03.051			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	28601684	Bronze			2022-12-18	WOS:000424410800025
J	Husby, A; Pasanen, A; Waage, J; Sevelsted, A; Hodemaekers, H; Janssen, R; Karjalainen, MK; Stokholm, J; Chawes, BL; Korppi, M; Wennergren, G; Heinzmann, A; Bont, L; Bisgaard, H; Bonnelykke, K				Husby, Anders; Pasanen, Anu; Waage, Johannes; Sevelsted, Astrid; Hodemaekers, Hennie; Janssen, Riny; Karjalainen, Minna K.; Stokholm, Jakob; Chawes, Bo L.; Korppi, Matti; Wennergren, Goran; Heinzmann, Andrea; Bont, Louis; Bisgaard, Hans; Bonnelykke, Klaus			CDHR3 gene variation and childhood bronchiolitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RESPIRATORY-SYNCYTIAL-VIRUS; VIRAL BRONCHIOLITIS; AGE 13; ASTHMA; CHILDREN; ASSOCIATION; ALLERGY; INFANCY; RISK		[Husby, Anders; Waage, Johannes; Sevelsted, Astrid; Stokholm, Jakob; Chawes, Bo L.; Bisgaard, Hans; Bonnelykke, Klaus] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark; [Husby, Anders; Waage, Johannes; Sevelsted, Astrid; Stokholm, Jakob; Chawes, Bo L.; Bisgaard, Hans; Bonnelykke, Klaus] Univ Copenhagen, Danish Pediat Asthma Ctr, Gentofte Hosp, Copenhagen, Denmark; [Pasanen, Anu; Karjalainen, Minna K.] Univ Oulu, PEDEGO Res Ctr, Oulu, Finland; [Pasanen, Anu; Karjalainen, Minna K.] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Pasanen, Anu; Karjalainen, Minna K.] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Hodemaekers, Hennie; Janssen, Riny] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands; [Korppi, Matti] Tampere Univ, Pediat Res Ctr, Tampere, Finland; [Korppi, Matti] Tampere Univ Hosp, Tampere, Finland; [Wennergren, Goran] Univ Gothenburg, Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Heinzmann, Andrea] Univ Freiburg, Fac Med, Dept Gen Pediat Adolescent Med & Neonatol, Ctr Pediat,Med Ctr, Freiburg, Germany; [Bont, Louis] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Bont, Louis] Resp Syncytial Virus Network ReSViNET, Utrecht, Netherlands; [Husby, Anders] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Oulu; University of Oulu; University of Oulu; Netherlands National Institute for Public Health & the Environment; Tampere University; Tampere University; Tampere University Hospital; Queen Silvia Children's Hospital; University of Gothenburg; University of Freiburg; Utrecht University; Utrecht University Medical Center; Statens Serum Institut	Bisgaard, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark.; Bisgaard, H (corresponding author), Univ Copenhagen, Danish Pediat Asthma Ctr, Gentofte Hosp, Copenhagen, Denmark.	Bisgaard@copsac.com	Bisgaard, Hans/N-4761-2016	Bisgaard, Hans/0000-0003-4131-7592; Chawes, Bo/0000-0001-6846-6243; sevelsted, astrid/0000-0001-7117-2334; Karjalainen, Minna K/0000-0003-3184-3775; Pasanen, Anu/0000-0001-7460-5086; Stokholm, Jakob/0000-0003-4989-9769; Husby, Anders/0000-0002-7634-8455; Bonnelykke, Klaus/0000-0003-2003-1018	Lundbeck Foundation [R16-A1694]; Ministry of Health [903516]; Danish Council for Strategic Research [0603-00280B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129735] Funding Source: NIH RePORTER; Lundbeck Foundation [R163-2013-16235] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Ministry of Health; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lundbeck Foundation(Lundbeckfonden)	All funding received by COPSAC is listed on www.copsac.com. The Lundbeck Foundation (grant no. R16-A1694), the Ministry of Health (grant no. 903516), the Danish Council for Strategic Research (grant no. 0603-00280B), and the Capital Region Research Foundation have provided core support to the COPSAC research center.	Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bochkov YA, 2015, P NATL ACAD SCI USA; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Chang EH, 2017, J ALLERGY CLIN IMMUN, V139; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Dumas O, 2016, THORAX, V71, P712, DOI 10.1136/thoraxjnl-2016-208535; E8, RIS GEZ NED BEV; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Little J, 2009, EUR J CLIN INVEST, V39, P247, DOI 10.1111/j.1365-2362.2009.02125.x; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Ruotsalainen M, 2010, ALLERGY, V65, P503, DOI 10.1111/j.1398-9995.2009.02212.x; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Singh AM, 2007, AM J RESP CRIT CARE, V175, P108, DOI 10.1164/rccm.200603-435PP; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; WENNERGREN G, 1992, ACTA PAEDIATR, V81, P40, DOI 10.1111/j.1651-2227.1992.tb12076.x	18	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1469	+		10.1016/j.jaci.2017.06.044	http://dx.doi.org/10.1016/j.jaci.2017.06.044			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28782631	Green Accepted, Bronze			2022-12-18	WOS:000414304300037
J	Hjort, C; Schiotz, PO; Ohlin, M; Wurtzen, PA; Christensen, LH; Hoffmann, HJ				Hjort, Charlotte; Schiotz, Peter Oluf; Ohlin, Mats; Wurtzen, Peter Adler; Christensen, Lars Harder; Hoffmann, Hans Jurgen			The number and affinity of productive IgE pairs determine allergen activation of mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DIAGNOSIS; PEANUT		[Hjort, Charlotte; Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark; [Schiotz, Peter Oluf] Aarhus Univ Hosp, Dept Pediat, Aarhus, Denmark; [Ohlin, Mats] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Wurtzen, Peter Adler; Christensen, Lars Harder] ALK Abello AS, Global Res, Horsholm, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Aarhus University; Aarhus University; Lund University; ALK-Abello AS; Aarhus University	Hoffmann, HJ (corresponding author), Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark.; Hoffmann, HJ (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	hjh@clin.au.dk	Ohlin, Mats/A-7307-2010; Hoffman, Hans Jurgen/I-6969-2018	Ohlin, Mats/0000-0002-5105-1938; Hoffman, Hans Jurgen/0000-0002-6743-7931; Harder Christensen, Lars/0000-0003-4230-7820	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	M. Ohlin receives grant support from the Swedish Research Council. P.A. Wurtzen and L. H. Christensen are employees of ALK. The rest of the authors declare that they have no relevant conflicts of interest.	Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Hatzler L, 2012, J ALLERGY CLIN IMMUN, V130, P894, DOI 10.1016/j.jaci.2012.05.053; Hoffmann HJ, 2015, ALLERGY, V70, P1393, DOI 10.1111/all.12698; Krohn IK, 2013, SCAND J IMMUNOL, V78, P352, DOI 10.1111/sji.12085; Krohn IK, 2013, J ASTHMA, V50, P117, DOI 10.3109/02770903.2012.752504; Levin M, 2014, CLIN EXP ALLERGY, V44, P1409, DOI 10.1111/cea.12423; Maloney JM, 2008, J ALLERGY CLIN IMMUN, V122, P145, DOI 10.1016/j.jaci.2008.04.014; Persson H, 2007, J ALLERGY CLIN IMMUN, V120, P1186, DOI 10.1016/j.jaci.2007.06.041; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P179, DOI 10.1016/j.jaci.2014.09.001	10	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1167	+		10.1016/j.jaci.2017.04.014	http://dx.doi.org/10.1016/j.jaci.2017.04.014			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28479333	Bronze			2022-12-18	WOS:000412172900034
J	Prince, BT; Devonshire, AL; Erickson, KA; Bergerson, J; Fuleihan, D; Szychlinski, C; Schleimer, RP; Bryce, PJ; Singh, AM				Prince, Benjamin T.; Devonshire, Ashley L.; Erickson, Kristin A.; Bergerson, Jenna; Fuleihan, Dalia; Szychlinski, Christine; Schleimer, Robert P.; Bryce, Paul J.; Singh, Anne Marie			Regulatory T-cell populations in children are affected by age and food allergy diagnosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDHOOD; ASTHMA		[Prince, Benjamin T.; Devonshire, Ashley L.; Bergerson, Jenna; Szychlinski, Christine; Singh, Anne Marie] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Allergy & Immunol, Chicago, IL 60611 USA; [Prince, Benjamin T.; Erickson, Kristin A.; Fuleihan, Dalia; Schleimer, Robert P.; Bryce, Paul J.; Singh, Anne Marie] Northwestern Univ, Northwestern Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Prince, Benjamin T.] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Div Allergy & Immunol, Columbus, OH 43210 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Singh, AM (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Allergy & Immunol, Chicago, IL 60611 USA.; Singh, AM (corresponding author), Northwestern Univ, Northwestern Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA.	anne-singh@northwestern.edu			Northwestern University Allergy-Immunology T32 National Institutes of Health (NIH); Mylan Speakers Bureau; NIH; FOCIS; National Institute of Allergy and Infectious Diseases; Glen and Wendy Miller Family Foundation; Melchiorre Family Foundation; Bunning Food Allergy Initiative; Thrasher Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078860, R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI100995, P01AI106683] Funding Source: NIH RePORTER	Northwestern University Allergy-Immunology T32 National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mylan Speakers Bureau; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOCIS; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Glen and Wendy Miller Family Foundation; Melchiorre Family Foundation; Bunning Food Allergy Initiative; Thrasher Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B. T. Prince receives grant funding from Northwestern University Allergy-Immunology T32 National Institutes of Health (NIH) training grant. C. Szychlinski receives payment for lectures from the Mylan Speakers Bureau. R. P. Schleimer receives grant support from the NIH; serves as a consultant for Intersect ENT, GlaxoSmithKline, Allakos, Aurasense, Merck, BioMarck, Sanofi, AstraZeneca/Medimmune, Genentech, Ecicure, Inc, and Ostuka, Inc, and holds stock options from Allakos, Aurasense, BioMarck, and Exicure, Inc. P. J. Bryce serves as a consultant for Allakos; is an employee of Northwestern University; receives grant support from the NIH; and received payments for lectures from FOCIS. A. M. Singh receives grant support from the National Institute of Allergy and Infectious Diseases, Glen and Wendy Miller Family Foundation, Melchiorre Family Foundation, Bunning Food Allergy Initiative, and Thrasher Research Fund. The rest of the authors declare that they have no relevant conflicts of interest.	Bantz Selene K, 2014, J Clin Cell Immunol, V5; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Goenka A, 2015, J INFECTION, V71, pS112, DOI 10.1016/j.jinf.2015.04.027; Golubovskaya V, 2016, CANCERS, V8, DOI 10.3390/cancers8030036; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Hulse KE, 2008, J ALLERGY CLIN IMMUN, V121, P756, DOI 10.1016/j.jaci.2007.10.016; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Qamar N, 2015, CLIN EXP ALLERGY, V45, P1663, DOI 10.1111/cea.12570; Stelmaszczyk-Emmel A, 2013, INT ARCH ALLERGY IMM, V162, P16, DOI 10.1159/000350769; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037	13	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1194	+		10.1016/j.jaci.2017.04.039	http://dx.doi.org/10.1016/j.jaci.2017.04.039			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28549988	Green Accepted, Bronze			2022-12-18	WOS:000412172900043
J	Honda, T; Yamamoto, O; Sawada, Y; Egawa, G; Kitoh, A; Otsuka, A; Dainichi, T; Nakajima, S; Miyachi, Y; Kabashima, K				Honda, Tetsuya; Yamamoto, Osamu; Sawada, Yu; Egawa, Gyohei; Kitoh, Akihiko; Otsuka, Atsushi; Dainichi, Teruki; Nakajima, Saeko; Miyachi, Yoshiki; Kabashima, Kenji			Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis-independent manner and promotes psoriatic dermatitis in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SKIN INFLAMMATION		[Honda, Tetsuya] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Honda, Tetsuya; Sawada, Yu; Egawa, Gyohei; Kitoh, Akihiko; Otsuka, Atsushi; Dainichi, Teruki; Nakajima, Saeko; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Yamamoto, Osamu] Tottori Univ, Fac Med, Div Dermatol, Dept Med Sensory & Motor Organs, Tottori, Japan; [Sawada, Yu] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka, Japan; [Kabashima, Kenji] ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore, Singapore; [Kabashima, Kenji] ASTAR, Biopolis, Inst Med Biol, Singapore, Singapore; [Kabashima, Kenji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Tottori University; University of Occupational & Environmental Health - Japan; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Japan Science & Technology Agency (JST)	Honda, T (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.; Honda, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	hontetsu@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp	Dainichi, Teruki/AAL-5400-2020; Nakajima, Saeko/AAB-1577-2021; Kabashima, Kenji/G-2521-2014	Dainichi, Teruki/0000-0002-9497-0029; Otsuka, Atsushi/0000-0001-7365-947X; Nakajima, Saeko/0000-0003-0831-1447; Kabashima, Kenji/0000-0002-0773-0554; Egawa, Gyohei/0000-0002-6101-4719	Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Pharma Inc in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Japan Society for the Promotion of Science KAKENHI [JP15K09766, JP15H05096, 263395]; Japan Science and Technology Agency; Precursory Research for Embryonic Science and Technology (PRESTO) [16021031300]; Japan Agency for Medical Research and Development (AMED) [16ek0410011h0003, 16he0902003h0002];  [15H05790];  [15H1155];  [15K15417]; Grants-in-Aid for Scientific Research [15K09766] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Pharma Inc in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Precursory Research for Embryonic Science and Technology (PRESTO); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Special Coordination Funds by the Ministry of Education, Culture, Sports, Science and Technology of Japan and Astellas Pharma Inc in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program (T.H.), Japan Society for the Promotion of Science KAKENHI (grant nos. JP15K09766 and JP15H05096 [T.H.] and grant no. 263395 [K.K.]), Grants-in-Aid for Scientific Research (grant nos. 15H05790, 15H1155, and 15K15417 [K.K.]), Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO) (grant no. 16021031300 [K.K.]), and Japan Agency for Medical Research and Development (AMED) (grant nos. 16ek0410011h0003 and 16he0902003h0002 [K.K.]).	BRODY I, 1978, J CUTAN PATHOL, V5, P219, DOI 10.1111/j.1600-0560.1978.tb00216.x; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566	9	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					619	+		10.1016/j.jaci.2017.02.027	http://dx.doi.org/10.1016/j.jaci.2017.02.027			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28342910	Bronze			2022-12-18	WOS:000406855500046
J	Agrebi, N; Ben-Mansour, LS; Medhaffar, M; Hadiji, S; Fedhila, F; Ben-Ali, M; Mekki, N; Hachicha, M; Barsaoui, S; Barbouche, MR; Ben-Mustapha, I				Agrebi, Nourhen; Ben-Mansour, Lamia Sfaihi; Medhaffar, Moez; Hadiji, Sondes; Fedhila, Faten; Ben-Ali, Meriem; Mekki, Najla; Hachicha, Mongia; Barsaoui, Sihem; Barbouche, Mohamed-Ridha; Ben-Mustapha, Imen			Autoimmune lymphoproliferative syndrome caused by homozygous FAS mutations with normal or residual protein expression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE		[Agrebi, Nourhen; Ben-Ali, Meriem; Mekki, Najla; Barbouche, Mohamed-Ridha; Ben-Mustapha, Imen] Inst Pasteur Tunis, Lab Transmiss Control & Immunobiol Infect LR11IPT, Tunis, Tunisia; [Agrebi, Nourhen; Ben-Ali, Meriem; Mekki, Najla; Barbouche, Mohamed-Ridha; Ben-Mustapha, Imen] Univ Tunis El Manar, Tunis, Tunisia; [Agrebi, Nourhen] Univ Carthage, Fac Sci Bizerte, Bizerte, Tunisia; [Ben-Mansour, Lamia Sfaihi; Hachicha, Mongia] Hedi Chaker Hosp Sfax, Dept Pediat, Sfax, Tunisia; [Ben-Mansour, Lamia Sfaihi; Medhaffar, Moez; Hadiji, Sondes; Hachicha, Mongia] Fac Med Sfax, Sfax, Tunisia; [Medhaffar, Moez; Hadiji, Sondes] Hedi Chaker Hosp, Dept Clin Hematol, Sfax, Tunisia; [Barsaoui, Sihem] Childrens Hosp, Dept Pediat A, Tunis, Tunisia; [Fedhila, Faten; Mekki, Najla; Barsaoui, Sihem; Barbouche, Mohamed-Ridha; Ben-Mustapha, Imen] Fac Med Tunisia, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Universite de Carthage; Universite de Sfax; Hopital Hedi Chaker; Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Universite de Tunis-El-Manar; Hopital d'Enfants	Barbouche, MR (corresponding author), Inst Pasteur Tunis, Lab Transmiss Control & Immunobiol Infect LR11IPT, Tunis, Tunisia.; Barbouche, MR (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.; Barbouche, MR (corresponding author), Fac Med Tunisia, Tunis, Tunisia.	ridha.barbouche@pasteur.rns.tn	mekki, najla/AAA-6564-2019; AGREBI, Nourhen/AAP-2169-2020	AGREBI, Nourhen/0000-0001-5703-9668; MEKKI, NAJLA/0000-0002-5842-9147; sfaihi, lamia/0000-0003-4480-5313				Al-Herz W, 2014, HUM HERED, V77, P138, DOI 10.1159/000357710; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Caminha I, 2010, J ALLERGY CLIN IMMUN, V125, P946, DOI 10.1016/j.jaci.2009.12.983; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Kuehn HS, 2011, J IMMUNOL, V186, P6035, DOI 10.4049/jimmunol.1100021; Oliveira JB, 2010, BLOOD, V116, pE35, DOI 10.1182/blood-2010-04-280347; Rensing-Ehl A, 2010, CLIN IMMUNOL, V137, P357, DOI 10.1016/j.clim.2010.08.008; Worth A, 2006, BRIT J HAEMATOL, V133, P124, DOI 10.1111/j.1365-2141.2006.05993.x	9	8	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					298	+		10.1016/j.jaci.2016.11.033	http://dx.doi.org/10.1016/j.jaci.2016.11.033			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28087326	Bronze			2022-12-18	WOS:000404542000038
J	Janssen, WJM; Hoesein, FM; Van de Ven, AAJM; Maarschalk, J; van Royen, F; de Jong, PA; Sanders, EAM; van Montfrans, JM; Ellerbroek, PM				Janssen, Willemijn J. M.; Hoesein, Firdaus Mohamed; Van de Ven, Annick A. J. M.; Maarschalk, Jacobien; van Royen, Florien; de Jong, Pim A.; Sanders, Elisabeth A. M.; van Montfrans, Joris M.; Ellerbroek, Pauline M.			IgG trough levels and progression of pulmonary disease in pediatric and adult common variable immunodeficiency disorder patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INTERSTITIAL LUNG-DISEASE; CHILDREN		[Janssen, Willemijn J. M.; van Royen, Florien; Sanders, Elisabeth A. M.; van Montfrans, Joris M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, Lab Translat Immunol, Utrecht, Netherlands; [Hoesein, Firdaus Mohamed; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Van de Ven, Annick A. J. M.; Maarschalk, Jacobien; Ellerbroek, Pauline M.] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Dept Infect Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Montfrans, JM (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, Lab Translat Immunol, Utrecht, Netherlands.	J.vanMontfrans@umcutrecht.nl		van Royen, Florien/0000-0002-6785-214X	Shire (The Netherlands) [GHOL5786]	Shire (The Netherlands)	This study was financially supported by an unrestricted research grant from Baxalta, now part of Shire (The Netherlands, grant no. GHOL5786) to the Department of Pediatric Immunology and Infectious Diseases of the UMC Utrecht.	de Gracia J, 2004, INT IMMUNOPHARMACOL, V4, P745, DOI 10.1016/j.intimp.2004.02.011; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Maglione PJ, 2015, J ALLER CL IMM-PRACT, V3, P941, DOI 10.1016/j.jaip.2015.07.004; Orange JS, 2010, CLIN IMMUNOL, V137, P21, DOI 10.1016/j.clim.2010.06.012; van de Ven AAJM, 2011, CLIN EXP IMMUNOL, V165, P235, DOI 10.1111/j.1365-2249.2011.04425.x; van De Ven AAJM, 2010, CHEST, V138, P371, DOI 10.1378/chest.09-2398; van Zeggeren L, 2011, EUR RESPIR J, V38, P1437, DOI 10.1183/09031936.00173410; Verma N, 2015, LANCET RESP MED, V3, P651, DOI 10.1016/S2213-2600(15)00202-7	9	8	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					303	+		10.1016/j.jaci.2016.11.050	http://dx.doi.org/10.1016/j.jaci.2016.11.050			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28126376	Bronze			2022-12-18	WOS:000404542000040
J	Platt, CD; Massaad, MJ; Cangemi, B; Schmidt, B; Aldhekri, H; Geha, RS				Platt, Craig D.; Massaad, Michel J.; Cangemi, Brittney; Schmidt, Birgitta; Aldhekri, Hasan; Geha, Raif S.			Janus kinase 3 deficiency caused by a homozygous synonymous exonic mutation that creates a dominant splice site	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Platt, Craig D.; Massaad, Michel J.; Cangemi, Brittney; Schmidt, Birgitta; Geha, Raif S.] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Aldhekri, Hasan] King Faisal Specialist Hosp & Res Ctr, Sect Pediat Allergy & Immunol, Riyadh, Saudi Arabia	Harvard University; Boston Children's Hospital; Harvard Medical School; King Faisal Specialist Hospital & Research Center	Geha, RS (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu		Al-Dhekri, Hasan/0000-0003-2277-5782	National Institutes of Health [T32 AI007512, K12 HD052896-10]; Perkins Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perkins Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants T32 AI007512 (to C.D.P.), K12 HD052896-10 (to C.D.P.), and the Perkins Fund (to R.S.G.).	Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Harp J, 2015, INT J DERMATOL, V54, P617, DOI 10.1111/ijd.12765; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Matsumoto Y, 2011, DNA REPAIR, V10, P314, DOI 10.1016/j.dnarep.2010.12.002; Oh SH, 2016, J CROHNS COLITIS, V10, P1366, DOI 10.1093/ecco-jcc/jjw102; Platt C, 2014, J ALLERGY CLIN IMMUN, V134, P262, DOI 10.1016/j.jaci.2013.08.021; Scarselli A, 2016, J ALLERGY CLIN IMMUN, V137, P948, DOI 10.1016/j.jaci.2015.09.017; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	9	8	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					268	+		10.1016/j.jaci.2016.09.057	http://dx.doi.org/10.1016/j.jaci.2016.09.057			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	27956217	Bronze, Green Accepted			2022-12-18	WOS:000404542000028
J	Rowe, RK; Pyle, DM; Tomlinson, AR; Lv, TH; Hu, Z; Gill, MA				Rowe, Regina K.; Pyle, David M.; Tomlinson, Andrew R.; Lv, Tinghong; Hu, Zheng; Gill, Michelle A.			IgE cross-linking impairs monocyte antiviral responses and inhibits influenza-driven T(H)1 differentiation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PLASMACYTOID DENDRITIC CELLS; ASTHMA		[Rowe, Regina K.; Pyle, David M.; Lv, Tinghong; Hu, Zheng; Gill, Michelle A.] Univ Texas Southwestern, Dept Pediat, Dallas, TX 75390 USA; [Pyle, David M.; Gill, Michelle A.] Univ Texas Southwestern, Dept Immunol, Dallas, TX 75390 USA; [Tomlinson, Andrew R.; Gill, Michelle A.] Univ Texas Southwestern, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gill, MA (corresponding author), Univ Texas Southwestern, Dept Pediat, Dallas, TX 75390 USA.; Gill, MA (corresponding author), Univ Texas Southwestern, Dept Immunol, Dallas, TX 75390 USA.; Gill, MA (corresponding author), Univ Texas Southwestern, Dept Internal Med, Dallas, TX 75390 USA.	Michelle.Gill@UTSouthwestern.edu		Rowe, Regina/0000-0001-7868-3620	National Institutes of Health: the National Institute of Allergy and Infectious Diseases [R01-AI098077]; National Institutes of Health: Ruth L. Kirschstein National Research Service Award [T32-AI005284]; National Institutes of Health: National Institute of General Medical Sciences [T32-GM008014]; National Institutes of Health: National Heart, Lung, and Blood Institute [T32HL098040]; Children's Clinical Research Advisory Council; UT Southwestern William A. and Joyce M. Sellars Distinguished Chair in Allergy and Immunology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284, R01AI098077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	National Institutes of Health: the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health: Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health: National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health: National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Clinical Research Advisory Council; UT Southwestern William A. and Joyce M. Sellars Distinguished Chair in Allergy and Immunology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health: the National Institute of Allergy and Infectious Diseases (grant no. R01-AI098077 to M.A.G.), Ruth L. Kirschstein National Research Service Award (grant no. T32-AI005284 to D.M.P.), the National Institute of General Medical Sciences (grant no. T32-GM008014 to D.M.P.), and the National Heart, Lung, and Blood Institute (grant no. T32HL098040 to R.K.R. and A.R.T.); Children's Clinical Research Advisory Council (grant award to M.A.G.); and the UT Southwestern William A. and Joyce M. Sellars Distinguished Chair in Allergy and Immunology.	Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Lee YG, 2015, AM J RESP CELL MOL, V52, P772, DOI 10.1165/rcmb.2014-0255OC; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Pyle DM, 2013, J ALLERGY CLIN IMMUN, V131, P491, DOI 10.1016/j.jaci.2012.11.037; Rowe RK, 2015, IMMUNOL ALLERGY CLIN, V35, P115, DOI 10.1016/j.iac.2014.09.012; Schroeder JT, 2005, J IMMUNOL, V175, P5724, DOI 10.4049/jimmunol.175.9.5724; Slifka MK, 2014, J ALLERGY CLIN IMMUN, V133, P439, DOI 10.1016/j.jaci.2013.10.037; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Zhang YX, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4322	9	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					294	+		10.1016/j.jaci.2016.11.035	http://dx.doi.org/10.1016/j.jaci.2016.11.035			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28087327	Green Accepted, Bronze			2022-12-18	WOS:000404542000037
J	Jans, J; Pettengill, M; Kim, DY; van der Made, C; de Groot, R; Henriet, S; de Jonge, MI; Ferwerda, G; Levy, O				Jans, Jop; Pettengill, Matthew; Kim, Dhohyung; van der Made, Cas; de Groot, Ronald; Henriet, Stefanie; de Jonge, Marien I.; Ferwerda, Gerben; Levy, Ofer			Human newborn B cells mount an interferon-alpha/beta receptor-dependent humoral response to respiratory syncytial virus	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFECTION; IMMUNITY		[Jans, Jop; van der Made, Cas; de Groot, Ronald; Henriet, Stefanie; de Jonge, Marien I.; Ferwerda, Gerben] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Lab Pediat Infect Dis,Dept Pediat, Nijmegen, Netherlands; [Jans, Jop; Pettengill, Matthew; Levy, Ofer] Boston Childrens Hosp, Precis Vaccines Program, Div Infect Dis, Dept Med, Boston, MA USA; [Jans, Jop; Pettengill, Matthew; Levy, Ofer] Harvard Med Sch, Boston, MA USA; [Pettengill, Matthew] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Kim, Dhohyung] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Radboud University Nijmegen; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Rochester; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Ferwerda, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Lab Pediat Infect Dis,Dept Pediat, Nijmegen, Netherlands.	Gerben.Ferwerda@radboudumc.nl	Ferwerda, J.G./L-4305-2015; de Jonge, Marien I./P-5869-2015; van der Made, Caspar/ABC-6046-2020	de Jonge, Marien I./0000-0003-2812-5895; van der Made, Caspar/0000-0003-0763-4017; Pettengill, Matthew/0000-0002-4579-0187; Levy, Ofer/0000-0002-5859-1945	Royal Netherlands Academy of Arts and Sciences (Ter Meulen Grant); European Society of Pediatric Infectious Diseases Small Grant; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) (NIH RO1 grant); NIH (NIAID); Dutch Government [FES0908]; Netherland Genomics Initiative Project [050-060-452]	Royal Netherlands Academy of Arts and Sciences (Ter Meulen Grant); European Society of Pediatric Infectious Diseases Small Grant; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) (NIH RO1 grant); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dutch Government; Netherland Genomics Initiative Project	J. Jans has received research support from The Royal Netherlands Academy of Arts and Sciences (Ter Meulen Grant). S. Henriet has received research support from the European Society of Pediatric Infectious Diseases Small Grant. O. Levy has received research support from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) (NIH RO1 grant); is employed by the US Food & Drug Administration (serves on the Food and Drug Administration Vaccines & Related Biologic Products Advisory Committee); has provided expert testimony on behalf of US-based legal firms in medicolegal cases involving pediatric infection; has recently submitted an NIH (NIAID) grant relating to the Human Immunology Project Consortium; has a patent through Boston Children's Hospital for the use of the antimicrobial protein Bactericidal Permeability Increasing protein as a radiation mitigation agent; and has received travel support from the International Neonatal and Maternal Immunization Symposium. G. Ferwerda has received research support from the Dutch Government (project FES0908) and the Netherland Genomics Initiative Project (050-060-452). The rest of the authors declare that they have no relevant conflicts of interest.	Boukhvalova MS, 2007, J VIROL, V81, P9443, DOI 10.1128/JVI.00102-07; Chiu C, 2015, NAT IMMUNOL, V16, P18, DOI 10.1038/ni.3056; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Norrby-Teglund A, 2006, J INTERN MED, V260, P509, DOI 10.1111/j.1365-2796.2006.01726.x; Reed JL, 2009, J INFECT DIS, V199, P1128, DOI 10.1086/597386; Savage HP, 2015, ANN NY ACAD SCI, V1362, P132, DOI 10.1111/nyas.12799; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P398, DOI 10.1016/j.jaci.2008.10.043; Tangye SG, 2013, BLOOD, V121, P5109, DOI 10.1182/blood-2013-05-500074; Vissers M, 2015, CYTOKINE, V76, P458, DOI 10.1016/j.cyto.2015.07.024; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	10	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					1997	+		10.1016/j.jaci.2016.10.032	http://dx.doi.org/10.1016/j.jaci.2016.10.032			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	27931976	Bronze			2022-12-18	WOS:000402724600035
J	Haapaniemi, EM; Fogarty, CL; Keskitalo, S; Katayama, S; Vihinen, H; Ilander, M; Mustjoki, S; Krjutskov, K; Lehto, M; Hautala, T; Eriksson, O; Jokitalo, E; Velagapudi, V; Varjosalo, M; Seppanen, M; Kere, J				Haapaniemi, Emma M.; Fogarty, Christopher L.; Keskitalo, Salla; Katayama, Shintaro; Vihinen, Helena; Ilander, Mette; Mustjoki, Satu; Krjutskov, Kaarel; Lehto, Markku; Hautala, Timo; Eriksson, Ove; Jokitalo, Eija; Velagapudi, Vidya; Varjosalo, Markku; Seppanen, Mikko; Kere, Juha			Combined immunodeficiency and hypoglycemia associated with mutations in hypoxia upregulated 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONGENITAL NEUTROPENIA; CHAPERONE; PROTEIN; ORP150		[Haapaniemi, Emma M.; Katayama, Shintaro; Krjutskov, Kaarel; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Haapaniemi, Emma M.; Fogarty, Christopher L.; Lehto, Markku; Kere, Juha] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Haapaniemi, Emma M.; Kere, Juha] Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland; [Fogarty, Christopher L.; Lehto, Markku] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland; [Fogarty, Christopher L.; Lehto, Markku; Seppanen, Mikko] Helsinki Univ Hosp, Helsinki, Finland; [Fogarty, Christopher L.; Lehto, Markku] Univ Helsinki, Diabet & Obes, Res Programs Unit, Helsinki, Finland; [Keskitalo, Salla; Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Katayama, Shintaro; Krjutskov, Kaarel; Kere, Juha] Karolinska Inst, Ctr Innovat Med, Huddinge, Sweden; [Katayama, Shintaro] Sci Life Lab, Solna, Sweden; [Vihinen, Helena; Jokitalo, Eija] Univ Helsinki, Electron Microscopy Unit, Inst Biotechnol, Helsinki, Finland; [Ilander, Mette; Mustjoki, Satu] Helsinki Univ Hosp, Hematol Res Unit Helsinki, Ctr Comprehens Canc, Helsinki, Finland; [Ilander, Mette; Mustjoki, Satu] Univ Helsinki, Dept Clin Chem, Helsinki, Finland; [Krjutskov, Kaarel] Competence Ctr Hlth Technol, Tartu, Estonia; [Hautala, Timo] Oulu Univ Hosp, Oulu, Finland; [Eriksson, Ove] Univ Helsinki, Dept Biochem & Dev Biol, Fac Med, Helsinki, Finland; [Velagapudi, Vidya] Univ Helsinki, Inst Mol Med Finland FIMM, Metabol Unit, Helsinki, Finland; [Seppanen, Mikko] Univ Helsinki, Childrens Hosp, Rare Dis Ctr, Helsinki, Finland; [Seppanen, Mikko] Univ Helsinki, Adult Immunodeficiency Unit, Inflammat Ctr, Helsinki, Finland	Karolinska Institutet; Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Haapaniemi, EM (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.; Haapaniemi, EM (corresponding author), Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland.; Haapaniemi, EM (corresponding author), Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland.	emma.haapaniemi@ki.se	Katayama, Shintaro/F-2958-2010; Velagapudi, Vidya/L-7278-2015; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Mustjoki, Satu/AAD-9974-2020; Jokitalo, Eija/C-8375-2009; Eriksson-Rosenberg, Ove/GVU-6692-2022; Varjosalo, Markku/K-6424-2015	Katayama, Shintaro/0000-0001-7581-5157; Velagapudi, Vidya/0000-0002-8261-7164; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Mustjoki, Satu/0000-0002-0816-8241; Jokitalo, Eija/0000-0002-4159-6934; Vihinen, Helena/0000-0003-3862-9237; Hautala, Timo/0000-0001-7889-1614; Haapaniemi, Emma/0000-0002-6693-8208; Eriksson, Ove/0000-0002-3565-4106; Keskitalo, Salla/0000-0001-5555-1975; Seppanen, Mikko/0000-0001-9733-3650; Varjosalo, Markku/0000-0002-1340-9732	Academy of Finland; Finnish Medical Foundation; Sigrid Juselius Foundation; Karolinska Institutet Research Foundation; Swedish Research Council; Strategic Research Programme in Diabetes	Academy of Finland(Academy of Finland); Finnish Medical Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Karolinska Institutet Research Foundation(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Programme in Diabetes	The Academy of Finland, Finnish Medical Foundation, Sigrid Juselius Foundation, Karolinska Institutet Research Foundation, Swedish Research Council, and Strategic Research Programme in Diabetes supported this work.	Arrington DD, 2008, AM J PHYSIOL-CELL PH, V294, pC641, DOI 10.1152/ajpcell.00400.2007; Berard AR, 2015, J PROTEOME RES, V14, P2121, DOI 10.1021/pr5012284; Boztug K, 2014, NAT GENET, V46, P1021, DOI 10.1038/ng.3069; Haapaniemi EM, 2015, BLOOD, V125, P639, DOI 10.1182/blood-2014-04-570101; Hauck F, 2013, CURR OPIN ALLERGY CL, V13, P596, DOI 10.1097/ACI.0000000000000014; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Katayama S, 2013, BIOINFORMATICS, V29, P2943, DOI 10.1093/bioinformatics/btt511; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Takeuchi S, 2006, PROTEIN J, V25, P517, DOI 10.1007/s10930-006-9038-z; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vilboux T, 2013, NEW ENGL J MED, V369, P54, DOI 10.1056/NEJMoa1301296	13	8	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2017	139	4					1391	+		10.1016/j.jaci.2016.09.050	http://dx.doi.org/10.1016/j.jaci.2016.09.050			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ER4LR	27913302	hybrid, Green Published			2022-12-18	WOS:000398771800039
J	Etzioni, A; Ciechanover, A; Pikarsky, E				Etzioni, Amos; Ciechanover, Aaron; Pikarsky, Eli			Immune defects caused by mutations in the ubiquitin system	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Ubiquitin; nuclear factor kB; immunodeficiency	NF-KAPPA-B; ANHIDROTIC ECTODERMAL DYSPLASIA; COMMON VARIABLE IMMUNODEFICIENCY; ONSET AUTOINFLAMMATORY DISEASE; LINEAR UBIQUITINATION; ANTIGEN PRESENTATION; NONSENSE MUTATION; PROTEASOME SYSTEM; LUBAC DEFICIENCY; NUCLEAR-FACTOR	The importance of the ubiquitin system in health and disease has been widely recognized in recent decades, with better understanding of the various components of the system and their function. Ubiquitination, which is essential to almost all biological processes in eukaryotes, was also found to play an important role in innate and adaptive immune responses. Thus it is not surprising that mutations in genes coding for components of the ubiquitin system cause immune dysregulation. The first defect in the system was described 30 years ago and is due to mutations in the nuclear factor kB (NF-kB) essential modulator, a key regulator of the NF-kB pathway. With use of novel sequencing techniques, many additional mutations in different genes involved in ubiquitination and related to immune system function were identified. This can be clearly illustrated in mutations in the different activation pathways of NF-kB, which result in aberrations in production of various proinflammatory cytokines. The inherited diseases typically manifest with immunodeficiency, autoimmunity, or autoinflammation. In this perspective we provide a short description of the ubiquitin system, with specific emphasis given to its role in the immune system. The various immunodeficiency conditions identified thus far in association with defective ubiquitination are discussed in more detail.	[Etzioni, Amos] Technion Israel Inst Technol, Ruth Children Hosp, Rambam Hlth Campus, Haifa, Israel; [Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med, TICC, Haifa, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol & Canc Res, IMRIC, Jerusalem, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem	Etzioni, A (corresponding author), Ruth Children Hosp, Rambam Med Campus Bat Galim, IL-31096 Haifa, Israel.	etzioni@rambam.health.gov.il	pikarsky, eli/GXV-7099-2022; Ciechanover, Aaron J/C-9166-2017	pikarsky, eli/0000-0003-4186-7105	Israel Science Foundation (ISF); I-CORE Program of the Planning and Budgeting Committee; ISF [1775/12]; Deutsch-Israelische Projektkooperation (DIP); European Research Council (ERC-StG livermicroenv); DKFZ MOST; Dr Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation	Israel Science Foundation (ISF)(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; ISF(Israel Science Foundation); Deutsch-Israelische Projektkooperation (DIP); European Research Council (ERC-StG livermicroenv); DKFZ MOST; Dr Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation(Israel Science Foundation)	Research in A. C.' s laboratory is supported by grants from the Israel Science Foundation (ISF), the I-CORE Program of the Planning and Budgeting Committee and the ISF (Grant1775/12), and the Deutsch-Israelische Projektkooperation (DIP). A. C. is an Israel Cancer Research Fund (ICRF) USA Professor. Research in E. P.'s laboratory is supported by grants from the European Research Council (ERC-StG livermicroenv), the Israel Science Foundation, and the DKFZ-MOST collaboration in cancer research. Both A. C. and E. P. are supported by grants from the Dr Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF).	ABINUN M, 1995, ARCH DIS CHILD, V73, P185, DOI 10.1136/adc.73.2.185; Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Boztug H, 2016, J CLIN IMMUNOL, V36, P533, DOI 10.1007/s10875-016-0306-1; Burns SO, 2014, J ALLERGY CLIN IMMUN, V134, P215, DOI 10.1016/j.jaci.2013.12.1093; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Ciechanover A, 2015, NAT REV MOL CELL BIO, V16, P322, DOI 10.1038/nrm3982; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Cildir G, 2016, TRENDS MOL MED, V22, P414, DOI 10.1016/j.molmed.2016.03.002; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; DONLEY DK, 1993, SEMIN NEUROL, V13, P106, DOI 10.1055/s-2008-1041114; Dove KK, 2016, EMBO REP, V17, P1221, DOI 10.15252/embr.201642641; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Fish JD, 2009, BONE MARROW TRANSPL, V43, P217, DOI 10.1038/bmt.2008.308; Fliegauf M, 2015, AM J HUM GENET, V97, P389, DOI 10.1016/j.ajhg.2015.07.008; Frix C D 3rd, 1986, Pediatr Dermatol, V3, P464, DOI 10.1111/j.1525-1470.1986.tb00652.x; Fusco F, 2015, INT REV IMMUNOL, V34, P445, DOI 10.3109/08830185.2015.1055331; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Granados EL, 2008, HUM MUTAT, V29, P861, DOI 10.1002/humu.20740; Guirguis AA, 2015, CURR OPIN CELL BIOL, V37, P61, DOI 10.1016/j.ceb.2015.10.004; Gustin JK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00161; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hahn M, 2016, EUR J IMMUNOL, V46, P732, DOI 10.1002/eji.201546081; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Hubrau M, 2011, BLOOD, V118, P926; Ikeda F, 2015, IMMUNOL REV, V266, P222, DOI 10.1111/imr.12300; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2012, BLOOD, V119, P5458, DOI 10.1182/blood-2011-05-354167; Kawai T, 2012, ALLERGOL INT, V61, P207, DOI 10.2332/allergolint.12-RAI-0446; Keller B, 2017, J ALLERGY CLIN IMMUN, V139, P220, DOI 10.1016/j.jaci.2016.04.043; Klemann C, 2016, CLIN IMMUNOL, V164, P52, DOI 10.1016/j.clim.2016.01.010; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Lee CE, 2014, BLOOD, V124, P2964, DOI 10.1182/blood-2014-06-578542; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lougaris V, 2015, J ALLERGY CLIN IMMUN, V135, P1641, DOI 10.1016/j.jaci.2014.11.038; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Masucci MG, 2004, ONCOGENE, V23, P2107, DOI 10.1038/sj.onc.1207372; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Mousallem T, 2014, BLOOD, V124, P2046, DOI 10.1182/blood-2014-04-571265; Ombrello MJ, 2012, NAT IMMUNOL, V13, P1133, DOI 10.1038/ni.2471; ORIAN A, 1995, J BIOL CHEM, V270, P21707, DOI 10.1074/jbc.270.37.21707; Paciolla M, 2015, GENES IMMUN, V16, P239, DOI 10.1038/gene.2015.3; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Sasaki Y, 2016, CURR TOP MICROBIOL, V393, P177, DOI 10.1007/82_2015_479; Schimke LF, 2013, J CLIN IMMUNOL, V33, P1088, DOI 10.1007/s10875-013-9906-1; Senegas A, 2015, CELL MOL LIFE SCI, V72, P1275, DOI 10.1007/s00018-014-1793-y; Shimizu Y, 2015, IMMUNOL REV, V266, P190, DOI 10.1111/imr.12309; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Teicher BA, 2015, BIOCHEM PHARMACOL, V96, P1, DOI 10.1016/j.bcp.2015.04.008; Vivarelli R, 2001, BRAIN DEV-JPN, V23, P18, DOI 10.1016/S0387-7604(00)00188-1; Willmann KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6360; Yang ZF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12738; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P10127, DOI 10.1073/pnas.1612594113; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	71	8	8	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					743	753		10.1016/j.jaci.2016.11.031	http://dx.doi.org/10.1016/j.jaci.2016.11.031			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	28270366	Bronze			2022-12-18	WOS:000397295800004
J	George, KE; Ryan, DM; Keevil, B; Niven, R; Fowler, SJ				George, Kate E.; Ryan, Dorothy M.; Keevil, Brian; Niven, Robert; Fowler, Stephen J.			A pilot study to investigate the use of serum inhaled corticosteroid concentration as a potential marker of treatment adherence in severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ADALIMUMAB; ANTIBODIES; IMMUNOGENICITY; RELEVANCE		[George, Kate E.; Ryan, Dorothy M.; Keevil, Brian; Niven, Robert; Fowler, Stephen J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [George, Kate E.; Ryan, Dorothy M.; Keevil, Brian; Niven, Robert; Fowler, Stephen J.] Univ South Manchester Hosp, NIHR Translat Res Facil Resp Med, Manchester, Lancs, England; [George, Kate E.; Ryan, Dorothy M.; Keevil, Brian; Niven, Robert; Fowler, Stephen J.] Lancashire Teaching Hosp, NHS Fdn Trust, Preston, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Fowler, SJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.; Fowler, SJ (corresponding author), Univ South Manchester Hosp, NIHR Translat Res Facil Resp Med, Manchester, Lancs, England.; Fowler, SJ (corresponding author), Lancashire Teaching Hosp, NHS Fdn Trust, Preston, Lancs, England.	stephen.fowler@manchester.ac.uk	keevil, brian/AAP-6147-2020	Fowler, Stephen/0000-0002-4524-1663				Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Barnes CB, 2015, RESP CARE, V60, P455, DOI 10.4187/respcare.03200; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Derendorf H, 2006, EUR RESPIR J, V28, P1042, DOI 10.1183/09031936.00074905; Engelkes M, 2015, EUR RESPIR J, V45, P396, DOI 10.1183/09031936.00075614; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; Mortimer KJ, 2006, BRIT J CLIN PHARMACO, V62, P412, DOI 10.1111/j.1365-2125.2006.02712.x; Rispens T, 2013, J PHARMACEUT BIOMED, V85, P179, DOI 10.1016/j.jpba.2013.07.022; van Schouwenburg PA, 2014, J BIOL CHEM, V289, P34482, DOI 10.1074/jbc.M114.615500; van Schouwenburg PA, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-201445; van Schouwenburg PA, 2010, J IMMUNOL METHODS, V362, P82, DOI 10.1016/j.jim.2010.09.005; Vennegoor A, 2013, MULT SCLER J, V19, P593, DOI 10.1177/1352458512460604	12	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					1037	1039		10.1016/j.jaci.2016.08.037	http://dx.doi.org/10.1016/j.jaci.2016.08.037			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27742392	Bronze			2022-12-18	WOS:000397295800038
J	Commins, SP; Karim, S				Commins, Scott P.; Karim, Shahid			Development of a novel murine model of alpha-gal meat allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Commins, Scott P.] Univ N Carolina, Chapel Hill, NC USA; [Karim, Shahid] Univ Southern Mississippi, Hattiesburg, MS USA	University of North Carolina; University of North Carolina Chapel Hill; University of Southern Mississippi									0	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		612	AB193	AB193		10.1016/j.jaci.2016.12.628	http://dx.doi.org/10.1016/j.jaci.2016.12.628			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF		Bronze			2022-12-18	WOS:000401699800512
J	Hesla, HM; Stenius, F; Jornbert-Pettersson, H; Alm, J				Hesla, Helena Marell; Stenius, Fredrik; Jornbert-Pettersson, Hans; Alm, Johan			Allergy-related disease in relation to early life exposures-the ALADDIN birth cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDHOOD; CHILDREN; SENSITIZATION; DIVERSITY; HYGIENE; ECZEMA; ASTHMA		[Hesla, Helena Marell; Stenius, Fredrik; Jornbert-Pettersson, Hans; Alm, Johan] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Hesla, Helena Marell; Stenius, Fredrik; Alm, Johan] Soder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital	Hesla, HM (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.; Hesla, HM (corresponding author), Soder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden.	helena.marell.hesla@ki.se		Alm, Johan/0000-0002-9062-4479	Centre for Allergy Research and KID at Karolinska Institutet; "Mjolkdroppen'' Society; Swedish Asthma and Allergy Research Association; Swedish Research Council; Swedish Research Council for Working Life and Social Research; Swedish Society of Medicine; Cancer and Allergy Fund; Ekhaga; "Frimurare Barnhuset'' in Stockholm; Gyllenberg; Hesselman; Samariten foundation; Vardal foundation	Centre for Allergy Research and KID at Karolinska Institutet; "Mjolkdroppen'' Society; Swedish Asthma and Allergy Research Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Society of Medicine; Cancer and Allergy Fund; Ekhaga; "Frimurare Barnhuset'' in Stockholm; Gyllenberg; Hesselman; Samariten foundation; Vardal foundation	This study was funded and supported by grants from the Centre for Allergy Research and KID at Karolinska Institutet, the "Mjolkdroppen'' Society, the Swedish Asthma and Allergy Research Association, the Swedish Research Council, the Swedish Research Council for Working Life and Social Research, the Swedish Society of Medicine, the Cancer and Allergy Fund, and the Ekhaga, the "Frimurare Barnhuset'' in Stockholm, the Gyllenberg, the Hesselman, the Samariten, and Vardal foundations. Thermo Fisher Scientific provided the study with reagents for measuring IgE levels.	Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fuchs O, 2012, J ALLERGY CLIN IMMUN, V130, P382, DOI 10.1016/j.jaci.2012.04.049; Holm T, 2014, ALLERGY, V69, P104, DOI 10.1111/all.12308; Langan SM, 2009, BRIT J DERMATOL, V161, P640, DOI 10.1111/j.1365-2133.2009.09320.x; Roduit C, 2014, J ALLERGY CLIN IMMUN, V133, P1056, DOI 10.1016/j.jaci.2013.12.1044; Ruokolainen L, 2015, ALLERGY, V70, P195, DOI 10.1111/all.12545; Stenius F, 2011, ALLERGY, V66, P1330, DOI 10.1111/j.1398-9995.2011.02662.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TSURUDOME M, 1989, VIROLOGY, V171, P38, DOI 10.1016/0042-6822(89)90508-4	10	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					686	+		10.1016/j.jaci.2016.06.057	http://dx.doi.org/10.1016/j.jaci.2016.06.057			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27554820	Bronze			2022-12-18	WOS:000397002400035
J	Kannan, Y; Li, YD; Coomes, SM; Okoye, IS; Pelly, VS; Sriskantharajah, S; Guckel, E; Webb, L; Czieso, S; Nikolov, N; MacDonald, AS; Ley, SC; Wilson, MS				Kannan, Yashaswini; Li, Yanda; Coomes, Stephanie M.; Okoye, Isobel S.; Pelly, Victoria S.; Sriskantharajah, Srividya; Guckel, Eva; Webb, Lauren; Czieso, Stephanie; Nikolov, Nikolay; MacDonald, Andrew S.; Ley, Steven C.; Wilson, Mark S.			Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						TPL-2; Map3k8(-/-); allergy; severe asthma; house dust mite; dendritic cells; Ccl24; eotaxin-2	DUST MITE ALLERGEN; SEVERE ASTHMA; EOTAXIN-3 EXPRESSION; LUNG INFLAMMATION; HOST-RESISTANCE; RECEPTOR CCR3; IN-VIVO; KINASE; INDUCTION; MICE	Background: The molecular and cellular pathways driving the pathogenesis of severe asthma are poorly defined. Tumor progression locus 2 (TPL-2) (COT, MAP3K8) kinase activates the MEK1/2-extracellular-signal regulated kinase 1/2 MAP kinase signaling pathway following Toll-like receptor, TNFR1, and IL-1R stimulation. Objective: TPL-2 has been widely described as a critical regulator of inflammation, and we sought to investigate the role of TPL-2 in house dust mite (HDM)-mediated allergic airway inflammation. Methods: A comparative analysis of wild-type and Map3k8(-/-) mice was conducted. Mixed bone marrow chimeras, conditional knockout mice, and adoptive transfer models were also used. Differential cell counts were performed on the bronchoalveolar lavage fluid, followed by histological analysis of lung sections. Flow cytometry and quantitative PCR was used to measure type 2 cytokines. ELISA was used to assess the production of IgE, type 2 cytokines, and Ccl24. RNA sequencing was used to characterize dendritic cell (DC) transcripts. Results: TPL-2 deficiency led to exacerbated HDM-induced airway allergy, with increased airway and tissue eosinophilia, lung inflammation, and IL-4, IL-5, IL-13, and IgE production. Increased airway allergic responses in Map3k8(-/-) mice were not due to a cell-intrinsic role for TPL-2 in T cells, B cells, or LysM(+) cells but due to a regulatory role for TPL-2 in DCs. TPL-2 inhibited Ccl24 expression in lung DCs, and blockade of Ccl24 prevented the exaggerated airway eosinophilia and lung inflammation in mice given HDM-pulsed Map3k8(-/-) DCs. Conclusions: TPL-2 regulates DC-derived Ccl24 production to prevent severe type 2 airway allergy in mice.	[Kannan, Yashaswini; Li, Yanda; Coomes, Stephanie M.; Okoye, Isobel S.; Pelly, Victoria S.; Sriskantharajah, Srividya; Guckel, Eva; Czieso, Stephanie; Nikolov, Nikolay; Ley, Steven C.; Wilson, Mark S.] Mill Hill Lab, Francis Crick Inst, London NW7 1AA, England; [Webb, Lauren; MacDonald, Andrew S.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Fac Life Sci, Manchester, Lancs, England	Francis Crick Institute; University of Manchester	Ley, SC; Wilson, MS (corresponding author), Mill Hill Lab, Francis Crick Inst, London NW7 1AA, England.	Steve.Ley@crick.ac.uk; Mark.Wilson@crick.ac.uk		Pelly, Victoria S/0000-0001-7323-4105; Webb, Lauren/0000-0002-1903-7570	Medical Research Council (MRC) [MC_UP_A253_1028, MC_U117584209]; MRC [MC_U117584209, MC_UP_A253_1028] Funding Source: UKRI; Medical Research Council [MC_U117584209, MC_UP_A253_1028] Funding Source: researchfish; The Francis Crick Institute [10103, 10220] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Medical Research Council (MRC file reference nos. MC_UP_A253_1028 and MC_U117584209). The majority of this work was conducted at the MRC, National Institute for Medical Research at Mill Hill, which became the Francis Crick Institute in April 2015.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braza F, 2014, ALLERGY, V69, P1454, DOI 10.1111/all.12490; Chung KF, 2012, CURR OPIN PULM MED, V18, P35, DOI 10.1097/MCP.0b013e32834d09a5; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Coleman JM, 2012, THORAX, V67, P1061, DOI 10.1136/thoraxjnl-2012-201634; Cook PC, 2012, P NATL ACAD SCI USA, V109, P9977, DOI 10.1073/pnas.1121231109; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Isgro M, 2013, MUCOSAL IMMUNOL, V6, P718, DOI 10.1038/mi.2012.109; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Jenkins SJ, 2007, J IMMUNOL, V179, P3515, DOI 10.4049/jimmunol.179.6.3515; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohan M, 2010, ANN ALLERG ASTHMA IM, V104, P66, DOI 10.1016/j.anai.2009.11.003; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kyrmizi I, 2013, J LEUKOCYTE BIOL, V94, P751, DOI 10.1189/jlb.0113039; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Pope SM, 2005, J BIOL CHEM, V280, P13952, DOI 10.1074/jbc.M406037200; Ravensberg AJ, 2005, J ALLERGY CLIN IMMUN, V115, P779, DOI 10.1016/j.jaci.2004.11.045; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Shin HD, 2003, HUM MOL GENET, V12, P1279, DOI 10.1093/hmg/ddg142; Sriskantharajah S, 2014, J IMMUNOL, V192, P3518, DOI 10.4049/jimmunol.1300172; Tan JQ, 1999, J IMMUNOL, V162, P4285; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Xiao YC, 2014, J EXP MED, V211, P1689, DOI 10.1084/jem.20132640	52	8	9	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					655	+		10.1016/j.jaci.2016.05.031	http://dx.doi.org/10.1016/j.jaci.2016.05.031			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27484038	Green Published, hybrid			2022-12-18	WOS:000397002400031
J	Kumanovics, A; Lee, YN; Close, DW; Coonrod, EM; Ujhazi, B; Chen, KR; MacArthur, DG; Krivan, G; Notarangelo, LD; Walter, JE				Kumanovics, Attila; Lee, Yu Nee; Close, Devin W.; Coonrod, Emily M.; Ujhazi, Boglarka; Chen, Karin; MacArthur, Daniel G.; Krivan, Gergely; Notarangelo, Luigi D.; Walter, Jolan E.			Estimated disease incidence of RAG1/2 mutations: A case report and querying the Exome Aggregation Consortium	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEVERE COMBINED IMMUNODEFICIENCY; ALLERGY; DEFICIENCY; REACTIVITY; CRITERIA		[Kumanovics, Attila] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Kumanovics, Attila; Close, Devin W.; Coonrod, Emily M.] ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA; [Lee, Yu Nee; Notarangelo, Luigi D.; Walter, Jolan E.] Harvard Med Sch, Childrens Hosp, Div Immunol, Boston, MA USA; [Ujhazi, Boglarka; Walter, Jolan E.] Harvard Med Sch, Massachusetts Gen Hosp Children, Div Allergy & Immunol, Boston, MA USA; [Chen, Karin] Univ Utah, Dept Pediat, Div Allergy & Immunol, Salt Lake City, UT USA; [MacArthur, Daniel G.] Harvard Med Sch, Massachusetts Gen Hosp Children, Div Allergy & Immunol, Analyt & Translat Genet Unit, Boston, MA USA; [Krivan, Gergely] United St Laszlo & St Istvan Hosp, Budapest, Hungary	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School	Kumanovics, A (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.; Kumanovics, A (corresponding author), ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA.	attila.kumanovics@path.utah.edu; jewalter@mgh.harvard.edu	; Lee, Yu Nee/T-2360-2017	MacArthur, Daniel/0000-0002-5771-2290; Lee, Yu Nee/0000-0001-8648-5253	National Institute of Allergy and Infectious Diseases, National Institutes of Health [5P01AI076210-04, U54AI082973, 5K08AI103035, 1R03AI113631-01, 1K08AI116909, R01GM104371]; Manton Foundation; Jeffrey Modell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI103035, K08AI116909, R01AI100887, U54AI082973, R03AI113631, ZIAAI001222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Manton Foundation; Jeffrey Modell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by the National Institute of Allergy and Infectious Diseases, the National Institutes of Health (grant no. 5P01AI076210-04 and grant no. U54AI082973 to L.D.N., grant no. 5K08AI103035 to J.E.W, grant no. 1R03AI113631-01 to A.K., grant no. 1K08AI116909 to K.C., grant no. R01GM104371 to D.G.M.), the Manton Foundation (to L.D.N.), and the Jeffrey Modell Foundation (to L.D.N.).	Abolhassani H, 2014, J ALLERGY CLIN IMMUN, V134, P1375, DOI 10.1016/j.jaci.2014.04.042; Buchbinder D, 2015, J CLIN IMMUNOL, V35, P119, DOI 10.1007/s10875-014-0121-5; Chen K, 2014, J ALLERGY CLIN IMMUN, V133, P880, DOI 10.1016/j.jaci.2013.11.038; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Fernandez-Rivas M, 2015, ALLERGY, V70, P576, DOI 10.1111/all.12585; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Klemans RJB, 2013, J ALLER CL IMM-PRACT, V1, P632, DOI 10.1016/j.jaip.2013.07.014; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Mueller H L, 1966, J Asthma Res, V3, P331; Peeters KABM, 2007, CLIN EXP ALLERGY, V37, P108, DOI 10.1111/j.1365-2222.2006.02628.x; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Sobacchi C, 2006, HUM MUTAT, V27, P1174, DOI 10.1002/humu.20408; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Villalta D, 2013, CLIN CHEM LAB MED, V51, P1991, DOI 10.1515/cclm-2013-0027; Vink G, 2014, STAT NEERL, V68, P61, DOI 10.1111/stan.12023; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	22	8	8	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					690	692		10.1016/j.jaci.2016.07.027	http://dx.doi.org/10.1016/j.jaci.2016.07.027			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27609655	Green Accepted, Bronze			2022-12-18	WOS:000397002400037
J	Macy, EM; Chen, LH				Macy, Eric M.; Chen, Lie H.			The Incidence of Anaphylaxis Associated with Oral and Parenteral Penicillin-Class Antibiotic Exposures	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Macy, Eric M.] Kaiser Permanente, Southern Calif Permanente Med Grp, San Diego, CA USA; [Chen, Lie H.] Kaiser Permanente, Pasadena, CA USA	Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente									0	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		108	AB33	AB33		10.1016/j.jaci.2016.12.165	http://dx.doi.org/10.1016/j.jaci.2016.12.165			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF		Bronze			2022-12-18	WOS:000401699800011
J	Matsui, EC; Keet, CA				Matsui, Elizabeth C.; Keet, Corinne A.			Weighing the evidence: Bias and confounding in epidemiologic studies in allergy/immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Bias; confounding; allergic disease; epidemiology; asthma	MOUSE ALLERGEN; ASTHMA; RISK; ACETAMINOPHEN; CONSUMPTION; EXPOSURE; BIRTH		[Matsui, Elizabeth C.; Keet, Corinne A.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy Immunol, Baltimore, MD 21218 USA	Johns Hopkins University	Keet, CA (corresponding author), 600 N Wolfe St,CMSC 1102, Baltimore, MD 21287 USA.	ckeet1@jhmi.edu		Matsui, Elizabeth/0000-0001-8134-5593	National Institute of Environmental Health Sciences [R01ES023447, R01ES026170]; National Institute of Allergy and Infectious Diseases [1K23AI103187, 1R21AI107085, K24AI114769, U01AI08328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI083238, K24AI114769, R21AI107085, K23AI103187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023447, R01ES026170] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the National Institute of Environmental Health Sciences (R01ES023447 and R01ES026170) and the National Institute of Allergy and Infectious Diseases (1K23AI103187, 1R21AI107085, K24AI114769, and U01AI08328).	Ahluwalia SK, 2013, J ALLERGY CLIN IMMUN, V132, P830, DOI 10.1016/j.jaci.2013.05.005; Almqvist C, 2003, J ALLERGY CLIN IMMUN, V111, P800, DOI 10.1067/mai.2003.1334; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Etminan M, 2009, CHEST, V136, P1316, DOI 10.1378/chest.09-0865; Hackstadt AJ, 2014, STAT MED, V33, P4919, DOI 10.1002/sim.6291; He H, 2015, AM J RESP CRIT CARE, V192, P520, DOI 10.1164/rccm.201503-0522LE; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Keet CA, 2016, J ALLERGY CLIN IMMUN, V137, P1761, DOI 10.1016/j.jaci.2016.03.008; Koplin J, 2008, J ALLERGY CLIN IMMUN, V121, P1455, DOI 10.1016/j.jaci.2008.03.017; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Matsui EC, 2003, NEW ENGL J MED, V349, P301; Peng RD, 2011, J ALLERGY CLIN IMMUN, V128, P390, DOI 10.1016/j.jaci.2011.04.050; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V135, P441, DOI 10.1016/j.jaci.2014.07.065	13	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					448	450		10.1016/j.jaci.2016.09.030	http://dx.doi.org/10.1016/j.jaci.2016.09.030			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27833026	Green Accepted, Bronze			2022-12-18	WOS:000397002400009
J	DeBoer, EM; Spielberg, DR; Brody, AS				DeBoer, Emily M.; Spielberg, David R.; Brody, Alan S.			Clinical potential for imaging in patients with asthma and other lung disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chest computed tomography; quantitative imaging; lung magnetic resonance imaging	QUANTITATIVE COMPUTED-TOMOGRAPHY; OBSTRUCTIVE PULMONARY-DISEASE; OPTICAL COHERENCE TOMOGRAPHY; HYPERPOLARIZED HE-3 MRI; AIR-FLOW OBSTRUCTION; EXERCISE-INDUCED BRONCHOCONSTRICTION; ELECTRICAL-IMPEDANCE TOMOGRAPHY; CYSTIC-FIBROSIS; YOUNG-CHILDREN; CHEST CT	The ability of lung imaging to phenotype patients, determine prognosis, and predict response to treatment is expanding in clinical and translational research. The purpose of this perspective is to describe current imaging modalities that might be useful clinical tools in patients with asthma and other lung disorders and to explore some of the new developments in imaging modalities of the lung. These imaging modalities include chest radiography, computed tomography, lung magnetic resonance imaging, electrical impedance tomography, bronchoscopy, and others.	[DeBoer, Emily M.] Univ Colorado, Anschutz Med Campus, Dept Pediat, Aurora, CO USA; [DeBoer, Emily M.] Childrens Hosp Colorado, Breathing Inst, 13123 E 16th Ave B-395, Aurora, CO 80045 USA; [Spielberg, David R.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Brody, Alan S.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	DeBoer, EM (corresponding author), Childrens Hosp Colorado, Breathing Inst, 13123 E 16th Ave B-395, Aurora, CO 80045 USA.; DeBoer, EM (corresponding author), Univ Colorado, Anschutz Med Campus, 13123 E 16th Ave B-395, Aurora, CO 80045 USA.	Emily.DeBoer@childrenscolorado.org	Spielberg, David R./I-8543-2019	Spielberg, David/0000-0002-3720-6307				Altes TA, 2016, J ALLERGY CLIN IMMUN, V137, P789, DOI 10.1016/j.jaci.2015.08.045; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; BERGIN CJ, 1993, J THORAC IMAG, V8, P12, DOI 10.1097/00005382-199324000-00003; Bianchi A, 2013, NMR BIOMED, V26, P1451, DOI 10.1002/nbm.2975; Biederer J., 2009, MRI OF THE LUNG; Bommart S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-29; BRASFIELD D, 1980, AM J ROENTGENOL, V134, P1195, DOI 10.2214/ajr.134.6.1195; Brody AS, 1999, PEDIATR RADIOL, V29, P731, DOI 10.1007/s002470050684; Castro M, 2011, J ALLERGY CLIN IMMUN, V128, P467, DOI 10.1016/j.jaci.2011.04.051; Choi S, 2015, J APPL PHYSIOL, V118, P1286, DOI 10.1152/japplphysiol.01094.2014; Choi S, 2014, J APPL PHYSIOL, V117, P593, DOI 10.1152/japplphysiol.00280.2014; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Cleveland Robert H, 2007, Proc Am Thorac Soc, V4, P302, DOI 10.1513/pats.200611-179HT; Costella S, 2012, RESPIROLOGY, V17, P1237, DOI 10.1111/j.1440-1843.2012.02250.x; Dal Negro RW, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-32; De Backer J, 2016, EXPERT REV RESP MED, V10, P927, DOI 10.1080/17476348.2016.1192464; de Lange EE, 2007, J ALLERGY CLIN IMMUN, V119, P1072, DOI 10.1016/j.jaci.2006.12.659; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; de Lange EE, 2009, RADIOLOGY, V250, P567, DOI 10.1148/radiol.2502080188; DeBoer EM, 2014, CHEST, V145, P593, DOI 10.1378/chest.13-0588; Depeursinge A, 2015, INVEST RADIOL, V50, P261, DOI 10.1097/RLI.0000000000000127; Diaz AA, 2010, RESP MED, V104, P1145, DOI 10.1016/j.rmed.2010.02.023; Dournes G, 2016, EUR RADIOL, V26, P3811, DOI 10.1007/s00330-016-4218-5; Fain SB, 2008, ACAD RADIOL, V15, P753, DOI 10.1016/j.acra.2007.10.019; Ferris H, 2016, WORLD J RADIOL, V8, P331, DOI 10.4329/wjr.v8.i4.331; Fischer AJ, 2014, PEDIATR PULM, V49, P960, DOI 10.1002/ppul.22922; Frerichs I, 2016, PHYSIOL MEAS, V37, P698, DOI 10.1088/0967-3334/37/6/698; Gao YL, 2016, COPD, V13, P471, DOI 10.3109/15412555.2015.1102874; Gentile NT, 2003, AM J EMERG MED, V21, P451, DOI 10.1016/S0735-6757(03)00165-7; Goo HW, 2006, AM J ROENTGENOL, V187, P1019, DOI 10.2214/AJR.05.0895; Good JT, 2012, CHEST, V141, P599, DOI 10.1378/chest.11-0741; Gorska K, 2016, RESP MED, V117, P131, DOI 10.1016/j.rmed.2016.06.011; Greenblatt EE, 2016, J AEROSOL MED PULM D, V29, P260, DOI 10.1089/jamp.2014.1204; Grenier PA, 2016, QUANT IMAG MED SURG, V6, P76, DOI 10.3978/j.issn.2223-4292.2016.02.08; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; Hahn AD, 2016, J MAGN RESON IMAGING; Hahn AD, 2016, J APPL PHYSIOL, V120, P526, DOI 10.1152/japplphysiol.00197.2015; Hajian B, 2016, EXPERT REV RESP MED, V10, P193, DOI 10.1586/17476348.2016.1136216; Hoesein FAAM, 2014, COPD, V11, P503, DOI 10.3109/15412555.2014.933952; Hoffman EA, 2003, ACAD RADIOL, V10, P1104, DOI 10.1016/S1076-6332(03)00330-1; Kirby M, 2015, BIOMED OPT EXPRESS, V6, P4365, DOI 10.1364/BOE.6.004365; Kirby M, 2015, EUR RESPIR J, V46, P859, DOI 10.1183/09031936.00016815; Kirby M, 2012, RADIOLOGY, V265, P600, DOI 10.1148/radiol.12120485; Kruger SJ, 2014, J MAGN RESON IMAGING, V39, P1230, DOI 10.1002/jmri.24272; Kubo T, 2008, AM J ROENTGENOL, V190, P335, DOI 10.2214/AJR.07.2556; Lambert JW, 2016, EUR RADIOL, V26, P1387, DOI 10.1007/s00330-015-3951-5; Leawoods JC, 2001, CONCEPT MAGNETIC RES, V13, P277, DOI 10.1002/cmr.1014; Lell MM, 2016, ACAD RADIOL, V23, P406, DOI 10.1016/j.acra.2015.12.018; Leong S, 2013, J THORAC DIS, V5, pS498, DOI 10.3978/j.issn.2072-1439.2013.09.08; Long FR, 2001, PEDIATR RADIOL, V31, P413, DOI 10.1007/s002470100462; Lucaya J, 2000, AM J ROENTGENOL, V174, P235, DOI 10.2214/ajr.174.1.1740235; Ma WJ, 2015, J MAGN RESON IMAGING, V41, P1465, DOI 10.1002/jmri.24680; Miller Wallace T Jr, 2014, Ann Am Thorac Soc, V11, P874, DOI 10.1513/AnnalsATS.201311-390OC; MINIATI M, 1995, AM J RESP CRIT CARE, V151, P1359, DOI 10.1164/ajrccm.151.5.7735585; Moroni C, 2003, J COMPUT ASSIST TOMO, V27, P375, DOI 10.1097/00004728-200305000-00013; Mott LS, 2013, CHEST, V144, P1193, DOI 10.1378/chest.12-2589; Narayanan S, 2014, J ASTHMA, V51, P751, DOI 10.3109/02770903.2014.909459; Newell JD, 2013, J THORAC IMAG, V28, P266, DOI 10.1097/RTI.0b013e31829f6796; Ochs RA, 2009, ACAD RADIOL, V16, P46, DOI 10.1016/j.acra.2008.05.020; Ohno Y, 2014, RADIOLOGY, V273, P907, DOI 10.1148/radiol.14132660; Pagnozzi AM, 2013, BIOMED OPT EXPRESS, V4, P2383, DOI 10.1364/BOE.4.002383; Parikh K, 2014, PEDIATRICS, V134, P555, DOI 10.1542/peds.2014-1052; Patyk M, 2016, ADV EXP MED BIOL, V934, P41, DOI 10.1007/5584_2016_23; Ratanamaneechat S, 2014, AM J RESP CRIT CARE, V189, P743, DOI 10.1164/rccm.201310-1872LE; Reed MH, 2008, PEDIATR RADIOL, V38, pS660, DOI 10.1007/s00247-008-0982-y; Ren CL, 2016, AM J RESP CRIT CARE, V194, P356, DOI 10.1164/rccm.201604-0694ST; Richards JC, 2016, IMMUNOL ALLERGY CLIN, V36, P529, DOI 10.1016/j.iac.2016.03.005; Robinson TE, 1999, AM J ROENTGENOL, V172, P1636, DOI 10.2214/ajr.172.6.10350305; Rosenow T, 2015, AM J RESP CRIT CARE, V191, P1158, DOI 10.1164/rccm.201501-0061OC; San Jose Estepar Raul, 2008, Proc Am Thorac Soc, V5, P905, DOI 10.1513/pats.200809-104QC; Sanders DB, 2012, PEDIATR PULM, V47, P567, DOI 10.1002/ppul.21621; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Sheshadri A, 2015, J COMPUT ASSIST TOMO, V39, P584, DOI 10.1097/RCT.0000000000000238; Sieren JP, 2016, AM J RESP CRIT CARE, V194, P794, DOI 10.1164/rccm.201506-1208PP; Sileo C, 2014, J CYST FIBROS, V13, P198, DOI 10.1016/j.jcf.2013.09.003; Soja J, 2009, CHEST, V136, P797, DOI 10.1378/chest.08-2759; Sui X, 2016, EUR J RADIOL, V85, P564, DOI 10.1016/j.ejrad.2015.12.013; Svenningsen S, 2016, EUR RESPIR J, V48, P370, DOI 10.1183/13993003.00393-2016; Svenningsen S, 2014, ACAD RADIOL, V21, P1402, DOI 10.1016/j.acra.2014.08.002; Svenningsen S, 2014, THORAX, V69, P63, DOI 10.1136/thoraxjnl-2013-203711; Svenningsen S, 2013, J MAGN RESON IMAGING, V38, P1521, DOI 10.1002/jmri.24111; Tepper LA, 2014, PEDIATR PULM, V49, P1182, DOI 10.1002/ppul.22991; Teufel M, 2013, RESPIRATION, V86, P302, DOI 10.1159/000343085; Thomen RP, 2015, RADIOLOGY, V274, P250, DOI 10.1148/radiol.14140080; Thomen RP, 2016, J CYST FIBROS; Vogel-Claussen J, 2014, AM J RESP CRIT CARE, V189, P650, DOI 10.1164/rccm.201310-1825OC; Vogt B, 2012, J APPL PHYSIOL, V113, P1154, DOI 10.1152/japplphysiol.01630.2011; WEATHERLY MR, 1993, PEDIATRICS, V91, P488; Wechsler ME, 2013, J ALLERGY CLIN IMMUN, V132, P1295, DOI 10.1016/j.jaci.2013.08.009; Wofford MR, 2015, RHINOLOGY, V53, P41, DOI [10.4193/Rhino13.065, 10.4193/Rhin13.065]; Xie XQ, 2012, EUR RADIOL, V22, P2085, DOI 10.1007/s00330-012-2480-8; Yamashiro T, 2016, INT J CHRONIC OBSTR, V11, P755, DOI 10.2147/COPD.S100658; Zha NX, 2016, ACAD RADIOL, V23, P176, DOI 10.1016/j.acra.2015.10.010; Zha W, 2016, ACAD RADIOL, V23, P1104, DOI 10.1016/j.acra.2016.04.005; Zhang WJ, 2015, EUR J RADIOL, V84, P318, DOI 10.1016/j.ejrad.2014.10.021	96	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					21	28		10.1016/j.jaci.2016.11.004	http://dx.doi.org/10.1016/j.jaci.2016.11.004			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	27871877	Bronze			2022-12-18	WOS:000393996800003
J	Jorgensen, SE; Bottger, P; Kofod-Olsen, E; Holm, M; Mork, N; Orntoft, TF; Sorensen, UBS; Bernth-Jensen, JM; Herlin, T; Veirum, J; Larsen, CS; Ostergaard, L; Hartmann, R; Christiansen, M; Mogensen, TH				Jorgensen, Sofie E.; Bottger, Pernille; Kofod-Olsen, Emil; Holm, Mette; Mork, Nanna; Orntoft, Torben F.; Sorensen, Uffe B. S.; Bernth-Jensen, Jens Magnus; Herlin, Troels; Veirum, Jens; Larsen, Carsten S.; Ostergaard, Lars; Hartmann, Rune; Christiansen, Mette; Mogensen, Trine H.			Ectodermal dysplasia with immunodeficiency caused by a branch-point mutation in IKBKG/NEMO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GAMMA GENE; NEMO		[Jorgensen, Sofie E.; Mork, Nanna; Larsen, Carsten S.; Ostergaard, Lars; Mogensen, Trine H.] Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Bottger, Pernille; Kofod-Olsen, Emil; Holm, Mette; Bernth-Jensen, Jens Magnus; Herlin, Troels; Veirum, Jens; Larsen, Carsten S.; Ostergaard, Lars; Christiansen, Mette; Mogensen, Trine H.] Aarhus Univ Hosp Skejby, Int Ctr Immunodeficiency Dis, Aarhus, Denmark; [Holm, Mette; Herlin, Troels; Veirum, Jens] Aarhus Univ Hosp Skejby, Dept Pediat, Aarhus, Denmark; [Orntoft, Torben F.] Aarhus Univ Hosp Skejby, Dept Mol Med, Aarhus, Denmark; [Sorensen, Uffe B. S.; Mogensen, Trine H.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Bernth-Jensen, Jens Magnus; Christiansen, Mette] Aarhus Univ Hosp Skejby, Dept Clin Immunol, Aarhus, Denmark; [Hartmann, Rune] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Hartmann, Rune; Mogensen, Trine H.] Aarhus Univ, Aarhus Res Ctr Innate Immun, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Mogensen, TH (corresponding author), Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark.; Mogensen, TH (corresponding author), Aarhus Univ Hosp Skejby, Int Ctr Immunodeficiency Dis, Aarhus, Denmark.; Mogensen, TH (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.; Mogensen, TH (corresponding author), Aarhus Univ, Aarhus Res Ctr Innate Immun, Aarhus, Denmark.	trinmoge@rm.dk	Bernth-Jensen, Jens Magnus/H-6694-2019; Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Christiansen, Mette/0000-0001-5158-3670; Mogensen, Trine Hyrup/0000-0002-1853-9704; Hartmann, Rune/0000-0003-1159-066X; Bernth Jensen, Jens Magnus/0000-0002-5004-7822; Sorensen, Uffe B. Skov/0000-0002-6777-054X; Ostergaard, Lars/0000-0002-7619-605X				Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Karakawa S, 2011, J CLIN IMMUNOL, V31, P762, DOI 10.1007/s10875-011-9560-4; Mooster JL, 2010, J ALLERGY CLIN IMMUN, V126, P127, DOI 10.1016/j.jaci.2010.04.026; Orstavik KH, 2006, AM J MED GENET A, V140A, P31, DOI 10.1002/ajmg.a.31026; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	10	8	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1706	+		10.1016/j.jaci.2016.05.030	http://dx.doi.org/10.1016/j.jaci.2016.05.030			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27477329				2022-12-18	WOS:000390019300028
J	Cohen, RT; Rodeghier, M; Kirkham, FJ; Rosen, CL; Kirkby, J; DeBaun, MR; Strunk, RC				Cohen, Robyn T.; Rodeghier, Mark; Kirkham, Fenella J.; Rosen, Carol L.; Kirkby, Jane; DeBaun, Michael R.; Strunk, Robert C.			Exhaled nitric oxide: Not associated with asthma, symptoms, or spirometry in children with sickle cell anemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sickle cell disease; exhaled nitric oxide; asthma; airway inflammation; acute chest syndrome	ACUTE CHEST SYNDROME; AIRWAY INFLAMMATION; DISEASE; MORBIDITY; MORTALITY; MARKERS; PAIN	Background: The significance of fractional exhaled nitric oxide (FENO) levels in children with sickle cell anemia (SCA) is unclear, but increased levels can be associated with features of asthma and thus increased morbidity. Objectives: We sought to determine factors associated with FENO and whether FENO levels are associated with increased rates of acute chest syndrome (ACS) and pain. Methods: All participants had SCA, were part of the prospective observational Sleep and Asthma Cohort study, and had the following assessments: FENO levels, spirometry, blood samples analyzed for hemoglobin, white blood cell counts, eosinophil counts and total serum IgE levels, questionnaires about child medical and family history, and review of medical records. Results: The analytic sample included 131 children with SCA (median age, 11.2 years; age range, 6-18 years) followed for a mean of 16.2 years, including a mean of 5.1 years after baseline FENO data measurements. In multivariable analyses higher FENO levels were associated with ln(IgE) levels (P <.001) and the highest quartile of peripheral eosinophil counts (P=.03) but not wheezing symptoms, baseline spirometric indices, or response to bronchodilator. Multivariable analyses identified that the incident rate ofACS was associated with ln(FENO) levels (P=.03), as well as male sex (P =.025), wheezing causing shortness of breath (P=.002), andACSat less than 4 years of age (P<. 001). FENO levels were not associated with future pain episodes. Conclusions: Steady-state FENO levels were not associated with an asthma diagnosis, wheezing symptoms, lung function measures, or prior sickle cell morbidity but were associated with markers of atopy and increased risk of future ACS events.	[Cohen, Robyn T.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Rodeghier, Mark] Rodeghier Consultants, Chicago, IL USA; [Kirkham, Fenella J.] UCL, Inst Child Hlth, Neurosci Unit, London WC1E 6BT, England; [Rosen, Carol L.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Kirkby, Jane] UCL, Inst Child Hlth, Portex Resp Unit, London WC1E 6BT, England; [DeBaun, Michael R.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Strunk, Robert C.] Washington Univ, Sch Med, Dept Pediat, Div Allergy Immunol & Pulm Med, St Louis, MO 63110 USA	Boston University; University of London; University College London; Case Western Reserve University; University of London; University College London; Vanderbilt University; Washington University (WUSTL)	Cohen, RT (corresponding author), Boston Med Ctr, Dept Pediat, 850 Harrison Ave, Boston, MA 02118 USA.	robyn.cohen@bmc.org	Kirkham, Fenella/C-2442-2009; Cohen, Robyn/AAC-9326-2019	Kirkham, Fenella/0000-0002-2443-7958; Cohen, Robyn/0000-0002-6902-3118	National Institutes of Health (NIH) [R01HL079937]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079937] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health (NIH) grant R01HL079937. The project described was supported in part by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1 RR024989. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alvarez-Puebla MJ, 2015, J INVEST ALLERG CLIN, V25, P107; An P, 2011, J ALLERGY CLIN IMMUN, V127, P1440, DOI 10.1016/j.jaci.2010.12.1114; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P2104; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Boyd JH, 2007, HAEMATOLOGICA, V92, P1115, DOI 10.3324/haematol.11213; Boyd JH, 2006, BLOOD, V108, P2923, DOI 10.1182/blood-2006-01-011072; Boyd JH, 2009, PEDIATR PULM, V44, P290, DOI 10.1002/ppul.20998; Buchvald F, 2005, J ALLERGY CLIN IMMUN, V115, P1130, DOI 10.1016/j.jaci.2005.03.020; Chaudry RA, 2014, THORAX, V69, P580, DOI 10.1136/thoraxjnl-2013-204464; Chou KT, 2014, LUNG, V192, P499, DOI 10.1007/s00408-014-9591-8; Cohen RT, 2011, AM J HEMATOL, V86, P756, DOI 10.1002/ajh.22098; DeBaun MR, 2014, AM J HEMATOL, V89, pE212, DOI 10.1002/ajh.23819; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Field JJ, 2011, CHEST, V139, P563, DOI 10.1378/chest.10-1243; Field JJ, 2011, PEDIATR BLOOD CANCER, V56, P454, DOI 10.1002/pbc.22891; Franklin PJ, 1999, AM J RESP CRIT CARE, V159, P69, DOI 10.1164/ajrccm.159.1.9804134; Girgis RE, 2003, AM J HEMATOL, V72, P177, DOI 10.1002/ajh.10284; Glassberg JA, 2012, BRIT J HAEMATOL, V159, P472, DOI 10.1111/bjh.12049; Knight-Madden J, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2013.10.005; Knight-Madden JM, 2005, THORAX, V60, P206, DOI 10.1136/thx.2004.029165; Knuffman JE, 2009, J ALLERGY CLIN IMMUN, V123, P411, DOI 10.1016/j.jaci.2008.11.016; Korevaar DA, 2015, LANCET RESP MED, V3, P290, DOI 10.1016/S2213-2600(15)00050-8; Lunt A, 2016, PEDIATR RES, V79, P313, DOI 10.1038/pr.2015.217; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; Paraskakis E, 2007, PEDIATR PULM, V42, P876, DOI 10.1002/ppul.20670; Pawar SS, 2008, PEDIATR BLOOD CANCER, V50, P111, DOI 10.1002/pbc.20872; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Radhakrishnan DK, 2012, J PEDIATR-US, V160, P93, DOI 10.1016/j.jpeds.2011.06.048; Riise GC, 2011, ISRN ALLERGY, V2011; Saito J, 2004, J ALLERGY CLIN IMMUN, V114, P512, DOI 10.1016/j.jaci.2004.05.033; Silkoff PE, 2001, CHEST, V119, P1049, DOI 10.1378/chest.119.4.1049; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; Strunk RC, 2014, J PEDIATR-US, V164, P821, DOI 10.1016/j.jpeds.2013.11.034; Sullivan KJ, 2010, J PEDIAT HEMATOL ONC, V32, pE249, DOI 10.1097/MPH.0b013e3181ec0ae5; Sullivan KJ, 2001, AM J RESP CRIT CARE, V164, P2186, DOI 10.1164/ajrccm.164.12.2012090; Sylvester KP, 2007, PEDIATR PULM, V42, P103, DOI 10.1002/ppul.20430; Hua-Huy T, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/3/036007; Valletta E, 2001, BMC Gastroenterol, V1, P13, DOI 10.1186/1471-230X-1-13; Vos R, 2014, AM J TRANSPLANT, V14, P2736, DOI 10.1111/ajt.12942	41	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1338	+		10.1016/j.jaci.2016.06.043	http://dx.doi.org/10.1016/j.jaci.2016.06.043			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27521278	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000389542700012
J	Kaesler, S; Skabytska, Y; Chen, KM; Kempf, WE; Volz, T; Koberle, M; Wolbing, F; Hein, U; Hartung, T; Kirschning, C; Rocken, M; Biedermann, T				Kaesler, Susanne; Skabytska, Yuliya; Chen, Ko-Ming; Kempf, Wolfgang E.; Volz, Thomas; Koeberle, Martin; Woelbing, Florian; Hein, Ulrike; Hartung, Thomas; Kirschning, Carsten; Roecken, Martin; Biedermann, Tilo			Staphylococcus aureus-derived lipoteichoic acid induces temporary T-cell paralysis independent of Toll-like receptor 2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Lipoteichoic acid; T cell; temporary unresponsiveness; Staphylococcus aureus; atopic dermatitis; cell cycle	GROWTH-FACTOR-BETA; INNATE IMMUNE-SYSTEM; ATOPIC-DERMATITIS; SKIN MICROBIOME; POSITIVE BACTERIA; POTENT STIMULUS; DENDRITIC CELLS; CYCLE ARREST; RECOGNITION; ACTIVATION	Background: The interplay between microbes and surface organs, such as the skin, shapes a complex immune system with several checks and balances. The first-line defense is mediated by innate immune pathways leading to inflammation. In the second phase specific T cells invade the infected organ, amplifying inflammation and defense. Consecutively, termination of inflammation is crucial to avoid chronic inflammation triggered by microbes, such as in patients with atopic dermatitis. Objective: We aimed to elucidate how the Staphylococcus aureus-derived cell-wall component lipoteichoic acid (LTA) governs the second phase of immune responses when high concentrations of LTA access T cells directly through disrupted skin. Methods: We analyzed the direct exposure of T cells to LTA in vitro. For in vivo analyses, we used fluorescein isothiocyanate contact hypersensitivity and ovalbumin-induced dermatitis as models for T(H)2-mediated cutaneous inflammation. Results: We observed that LTA potently suppressed Tlymphocyte activation in a Toll-like receptor 2-independent manner. LTA-exposed T cells did not proliferate and did not produce cytokines. Importantly, these T cells remained completely viable and were responsive to consecutive activation signals on subsequent removal of LTA. Thus LTA exposure resulted in temporary functional T-cell paralysis. In vivo experiments revealed that T-cell cytokine production and cutaneous recall responses were significantly suppressed by LTA. Conclusion: We identified a new mechanism through which bacterial compounds directly but temporarily modulate adaptive immune responses.	[Kaesler, Susanne; Skabytska, Yuliya; Chen, Ko-Ming; Kempf, Wolfgang E.; Volz, Thomas; Koeberle, Martin; Woelbing, Florian; Hein, Ulrike; Roecken, Martin; Biedermann, Tilo] Eberhard Karls Univ Tubingen, Dept Dermatol, Liebermeisterstr, Tubingen, Germany; [Kaesler, Susanne; Kempf, Wolfgang E.; Volz, Thomas; Koeberle, Martin; Woelbing, Florian; Biedermann, Tilo] Tech Univ Munich, Dept Dermatol & Allergol, Biedersteinerstr 29, D-80802 Munich, Germany; [Hartung, Thomas] Univ Konstanz, Ctr Alternat Anim Testing Europe, Constance, Germany; [Hartung, Thomas] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kirschning, Carsten] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Chen, Ko-Ming] Derma Lab Dusseldorf, Dusseldorf, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; University of Konstanz; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Duisburg Essen	Biedermann, T (corresponding author), Tech Univ Munich, Dept Dermatol & Allergol, Biedersteinerstr 29, D-80802 Munich, Germany.	Tilo.Biedermann@tum.de	Köberle, Martin/HCI-8264-2022	Köberle, Martin/0000-0001-6825-2667; Biedermann, Tilo/0000-0002-5352-5105; Rocken, Martin/0000-0003-3795-7001	Baden-Wurttemberg Stiftung [P-LS-AL2/4]; Deutsche Forschungsgemeinschaft (DFG) [BI696/10-1, B1696/5-1, BI696/5-2, SFB 685, SFB 824]; Wilhelm Sander-Stiftung [2012.056.1]	Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Sander-Stiftung	Supported by contract research "Allergologie 2'' of the Baden-Wurttemberg Stiftung (P-LS-AL2/4) and by grants of the Deutsche Forschungsgemeinschaft (DFG; BI696/10-1, B1696/5-1, BI696/5-2, SFB 685 A06, C01, SFB 824 B10) and Wilhelm Sander-Stiftung (2012.056.1).	Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Biedermann T, 2006, ACTA DERM-VENEREOL, V86, P99, DOI 10.2340/00015555-047; Boguniewicz Mark, 2003, Journal of Allergy and Clinical Immunology, V112, pS140, DOI 10.1016/j.jaci.2003.09.031; Broker BM, 2014, INT J MED MICROBIOL, V304, P204, DOI 10.1016/j.ijmm.2013.11.008; Cardona ID, 2006, AM J CLIN DERMATOL, V7, P273, DOI 10.2165/00128071-200607050-00001; Cleveland MG, 1996, INFECT IMMUN, V64, P1906, DOI 10.1128/IAI.64.6.1906-1912.1996; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Edds EM, 2000, ASAIO J, V46, P33, DOI 10.1097/00002480-200001000-00011; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017; Kaesler S, 2012, EUR J IMMUNOL, V42, P831, DOI 10.1002/eji.201141690; Kapp A, 2002, J ALLERGY CLIN IMMUN, V110, P277, DOI 10.1067/mai.2002.126500; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563; KUSUNOKI T, 1995, J EXP MED, V182, P1673, DOI 10.1084/jem.182.6.1673; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; LEUNG DYM, 1983, J ALLERGY CLIN IMMUN, V71, P47, DOI 10.1016/0091-6749(83)90546-8; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Lipinski S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00479; Lowy FD, 2011, NEW ENGL J MED, V364, P1987, DOI 10.1056/NEJMp1100251; Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MIHM MC, 1976, J INVEST DERMATOL, V67, P305, DOI 10.1111/1523-1747.ep12514346; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Mosli MH, 2014, DRUGS, V74, P297, DOI 10.1007/s40265-013-0176-2; Myles IA, 2012, SEMIN IMMUNOPATHOL, V34, P181, DOI 10.1007/s00281-011-0301-9; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sheu JR, 2000, THROMB HAEMOSTASIS, V83, P777; Skabytska Y, 2014, IMMUNITY, V41, P762, DOI 10.1016/j.immuni.2014.10.009; STANDIFORD TJ, 1994, INFECT IMMUN, V62, P119, DOI 10.1128/IAI.62.1.119-125.1994; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P3804, DOI 10.4049/jimmunol.165.7.3804; Tian T, 2009, J INVEST DERMATOL, V129, P70, DOI 10.1038/jid.2008.191; Travers JB, 2010, J ALLERGY CLIN IMMUN, V125, P146, DOI 10.1016/j.jaci.2009.09.052; Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291; Volz T, 2012, EXP DERMATOL, V21, P61, DOI 10.1111/j.1600-0625.2011.01393.x; Volz T, 2010, FASEB J, V24, P4089, DOI 10.1096/fj.09-151001; von Aulock S, 2003, IMMUNOBIOLOGY, V208, P413, DOI 10.1078/0171-2985-00285	58	8	8	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					780	+		10.1016/j.jaci.2015.11.043	http://dx.doi.org/10.1016/j.jaci.2015.11.043			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	26949056	Bronze			2022-12-18	WOS:000385496000014
J	Folmsbee, SS; Budinger, GRS; Bryce, PJ; Gottardi, CJ				Folmsbee, Stephen Sai; Budinger, G. R. Scott; Bryce, Paul J.; Gottardi, Cara J.			The cardiomyocyte protein alpha T-catenin contributes to asthma through regulating pulmonary vein inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						alpha T-catenin; CTNNA3; pulmonary vein; cardiomyocyte; cell-cell adhesion	GENOME-WIDE ASSOCIATION; HOUSE-DUST MITE; NF-KAPPA-B; AIRWAY INFLAMMATION; CTNNA3; HEART; GENE	Background: Recent genome-wide association studies have identified single nucleotide polymorphisms in the gene encoding the protein alpha T-catenin (CTNNA3) that correlate with both steroid-resistant atopic asthma and asthmatic exacerbations. alpha-Catenins are important mediators of cell-cell adhesion, and alpha T-catenin is predominantly expressed in cardiomyocytes. In the lung alpha T-catenin appears to be exclusively expressed in cardiomyocytes surrounding the pulmonary veins (PVs), but its contribution to atopic asthma remains unknown. Objective: We sought to understand the role of alpha T-catenin in asthma pathogenesis. Methods: We used alpha T-catenin knockout mice and a house dust mite (HDM) extract model of atopic asthma, with assessment by means of forced oscillation, bronchoalveolar lavage, and histologic analysis. Results: We found that the genetic loss of alpha T-catenin in mice largely attenuated HDM-induced airway inflammation and airway hyperresponsiveness to methacholine. Mice lacking alpha T-catenin that were exposed to HDM extract had reduced PV inflammation, specifically near the large veins surrounded by cardiac cells. The proximity of the airways to PVs correlated with the severity of airway goblet cell metaplasia, suggesting that PVs can influence the inflammatory milieu of adjacent airways. Loss of alpha T-catenin led to compensatory upregulation of alpha E-catenin, which itself has a defined anti-inflammatory function. Conclusion: These data mechanistically support previous clinical and genetic associations between alpha T-catenin and the development of atopic asthma and suggest that PVs might have an underappreciated role in allergic airway inflammation.	[Folmsbee, Stephen Sai; Budinger, G. R. Scott; Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Medicine, Dept Pulm & Crit Care Med, Chicago, IL 60611 USA; [Bryce, Paul J.] Northwestern Univ, Feinberg Sch Medicine, Dept Allergy & Immunol, Chicago, IL 60611 USA; [Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Medicine, Dept Cellular & Mol Biol, Chicago, IL 60611 USA; [Folmsbee, Stephen Sai] Northwestern Univ, Feinberg Sch Medicine, Driskill Grad Training Program Life Sci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Gottardi, CJ (corresponding author), Northwestern Univ, 240 Huron St,McGaw Pavilion,M 323, Chicago, IL 60611 USA.	c-gottardi@northwestern.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health (NIH) [T32CA09560, F30ES024622]; American Heart Association predoctoral fellowship [15PRE21850010]; NIH [GM076561]; NATIONAL CANCER INSTITUTE [T32CA009560] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES024622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561, T32GM008152] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	S.S.F. was supported by the National Institutes of Health (NIH; T32CA09560 and F30ES024622) and an American Heart Association predoctoral fellowship (15PRE21850010). C.J.G. is supported by the NIH (GM076561).	Adcock IM, 2004, CURR OPIN PHARMACOL, V4, P257, DOI 10.1016/j.coph.2004.02.001; AKINBAMI LJ, 2011, NATL HLTH STAT REPOR, V32, P1; Bernstein DI, 2013, TOXICOL SCI, V131, P242, DOI 10.1093/toxsci/kfs272; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Clarke DL, 2014, MUCOSAL IMMUNOL, V7, P558, DOI 10.1038/mi.2013.74; Degenhardt K, 2013, NAT MED, V19, P760, DOI 10.1038/nm.3185; Folmsbee SS, 2015, AM J PHYSIOL-LUNG C, V308, pL253, DOI 10.1152/ajplung.00331.2014; Janssens B, 2001, J CELL SCI, V114, P3177; Kim SH, 2009, CLIN EXP ALLERGY, V39, P203, DOI 10.1111/j.1365-2222.2008.03117.x; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Lam AP, 2014, AM J RESP CRIT CARE, V190, P185, DOI 10.1164/rccm.201401-0079OC; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Litonjua AA, 2015, UPTODATE; McGeachie MJ, 2015, J ALLERGY CLIN IMMUN, V136, P1503, DOI 10.1016/j.jaci.2015.04.039; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Ong BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072899; Peng T, 2013, NATURE, V500, P589, DOI 10.1038/nature12358; Perin P, 2014, IMMUNOGENETICS, V66, P143, DOI 10.1007/s00251-013-0755-0; Piao HL, 2014, NAT CELL BIOL, V16, P245, DOI 10.1038/ncb2909; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; Wachtel MS, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-58; Zemans RL, 2011, P NATL ACAD SCI USA, V108, P15990, DOI 10.1073/pnas.1110144108	25	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					123	+		10.1016/j.jaci.2015.11.037	http://dx.doi.org/10.1016/j.jaci.2015.11.037			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	26947180	Green Accepted, Bronze			2022-12-18	WOS:000379659100014
J	Heeringa, JJ; Hajdarbegovic, E; Thio, HB; van Zelm, MC				Heeringa, Jorn J.; Hajdarbegovic, Enes; Thio, H. Bing; van Zelm, Menno C.			Systemic B-cell abnormalities in patients with atopic dermatitis?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEASONAL ALLERGIC RHINITIS; SUBLINGUAL IMMUNOTHERAPY; CLINICAL-EFFICACY; PLACEBO; TABLET; RHINOCONJUNCTIVITIS; STANDARDIZATION; PHARMACOTHERAPY; METAANALYSIS; CHILDREN		[Heeringa, Jorn J.; van Zelm, Menno C.] Erasmus MC, Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands; [Hajdarbegovic, Enes; Thio, H. Bing] Erasmus MC, Univ Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [van Zelm, Menno C.] Monash Univ, Cent Clin Sch, Dept Pathol & Immunol, Melbourne, Vic, Australia	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Monash University	van Zelm, MC (corresponding author), Erasmus MC, Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands.; van Zelm, MC (corresponding author), Monash Univ, Cent Clin Sch, Dept Pathol & Immunol, Melbourne, Vic, Australia.	menno.vanzelm@monash.edu	van Zelm, Menno C/O-4404-2015	van Zelm, Menno C/0000-0003-4161-1919				Aasbjerg K, 2015, BASIC CLIN PHARMACOL, V117, P73, DOI 10.1111/bcpt.12416; Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; [Anonymous], 2012, BMJ, V345, pe8386, DOI 10.1136/bmj.e8386; Berkowska MA, 2014, J ALLERGY CLIN IMMUN, V134, P688, DOI 10.1016/j.jaci.2014.03.036; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; Cohen J., 1988, STAT POWER ANAL BEHA; Cox LS, 2016, J ALLERGY CLIN IMMUN, V138, P314, DOI 10.1016/j.jaci.2016.01.039; Cox LS, 2012, J ALLERGY CLIN IMMUN, V130, P1327, DOI 10.1016/j.jaci.2012.08.032; Czarnowicki T, 2016, J ALLERGY CLIN IMMUN, V137, P118, DOI 10.1016/j.jaci.2015.08.027; Devillier P, 2014, ALLERGY, V69, P1689, DOI 10.1111/all.12518; Devillier P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-71; Di Bona D, 2015, JAMA INTERN MED, V175, P1301, DOI 10.1001/jamainternmed.2015.2840; Di Bona D, 2012, J ALLERGY CLIN IMMUN, V130, P1097, DOI 10.1016/j.jaci.2012.08.012; Dickey LW, 1976, CLIN ECOLOGY, P544; Dretzke J, 2013, J ALLERGY CLIN IMMUN, V131, P1361, DOI 10.1016/j.jaci.2013.02.013; Hansel FK, 1972, T AM SOC OPHTALMOL O, V11, P93; Hansel FK, 1936, ALLERGY NOSE PARANAS, P755; Haynes RB, 2002, BMJ-BRIT MED J, V324, P1350, DOI 10.1136/bmj.324.7350.1350; Howarth P, 2012, ALLERGY, V67, P321, DOI 10.1111/j.1398-9995.2011.02759.x; Jansen MAE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126019; Kalina T, 2012, LEUKEMIA, V26, P1986, DOI 10.1038/leu.2012.122; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kleine-Tebbe J, 2006, ALLERGY, V61, P181, DOI 10.1111/j.1398-9995.2006.00959.x; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub2, 10.1002/14651858.MR000033.pub3]; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Matricardi PM, 2011, J ALLERGY CLIN IMMUN, V128, P791, DOI 10.1016/j.jaci.2011.03.049; MORRIS DL, 1970, ANN ALLERGY, V28, P494; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, P72, DOI 10.1016/j.jaci.2010.11.035; NELSON HS, 1993, J ALLERGY CLIN IMMUN, V92, P229, DOI 10.1016/0091-6749(93)90166-D; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, pe1; PFEIFFER G O, 1970, Transactions American Society of Ophthalmologic and Otolaryngologic Allergy, V11, P104; Pradalier A, 1999, ALLERGY, V54, P819, DOI 10.1034/j.1398-9995.1999.00077.x; Ruddy LW, 1976, T AM SOC OPHTALMOL O, V17, P93; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SAMTER M, 1971, J AMER MED ASSOC, V215, P2120; Smith H, 2004, J ALLERGY CLIN IMMUN, V114, P831, DOI 10.1016/j.jaci.2004.06.058; van den Heuvel D, 2016, J INFECT DIS, V213, P233, DOI 10.1093/infdis/jiv369; van den Heuvel D, 2015, AIDS, V29, P1745, DOI 10.1097/QAD.0000000000000765; Waickman FJ, 1965, T AM SOC OPHTHALMOL, V6, P39	40	8	8	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					317	318		10.1016/j.jaci.2016.01.038	http://dx.doi.org/10.1016/j.jaci.2016.01.038			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	27068247				2022-12-18	WOS:000379659100047
J	Kojima, D; Wang, XN; Muramatsu, H; Okuno, Y; Nishio, N; Hama, A; Tsuge, I; Takahashi, Y; Kojima, S				Kojima, Daiei; Wang, Xinan; Muramatsu, Hideki; Okuno, Yusuke; Nishio, Nobuhiro; Hama, Asahito; Tsuge, Ikuya; Takahashi, Yoshiyuki; Kojima, Seiji			Application of extensively targeted next-generation sequencing for the diagnosis of primary immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Kojima, Daiei; Wang, Xinan; Muramatsu, Hideki; Okuno, Yusuke; Nishio, Nobuhiro; Hama, Asahito; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan; [Okuno, Yusuke; Nishio, Nobuhiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Tsuge, Ikuya] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi, Japan	Nagoya University; Nagoya University; Fujita Health University	Kojima, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan.	kojimas@med.nagoya-u.ac.jp	Okuno, Yusuke/C-9082-2009; Muramatsu, Hideki/I-3763-2012; Muramatsu, Hideki/ABA-3376-2021	Okuno, Yusuke/0000-0003-3139-9272; Muramatsu, Hideki/0000-0002-8801-0021				Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Bjork AH, 2012, AM J MED GENET A, V158A, P1934, DOI 10.1002/ajmg.a.35484; Justo GA, 2014, ANN HEMATOL, V93, P761, DOI 10.1007/s00277-013-1953-4; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Moens LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114901; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nijman IJ, 2014, J ALLERGY CLIN IMMUN, V133, P529, DOI 10.1016/j.jaci.2013.08.032; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Stoddard JL, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00531	10	8	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					303	305		10.1016/j.jaci.2016.01.012	http://dx.doi.org/10.1016/j.jaci.2016.01.012			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	26997321	Bronze			2022-12-18	WOS:000379659100039
J	Hamilos, DL				Hamilos, Daniel L.			Chronic rhinosinusitis endotyping: Sharpening the focus on inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Chronic rhinosinusitis; endotyping	EOSINOPHILIC MUCIN RHINOSINUSITIS; EXPRESSION; SINUSITIS; POLYPS; ASTHMA		[Hamilos, Daniel L.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, 55 Fruit St,Bulfinch 422, Boston, MA 02114 USA; [Hamilos, Daniel L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hamilos, DL (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, 55 Fruit St,Bulfinch 422, Boston, MA 02114 USA.	dhamilos@partners.org						Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Ferguson BJ, 2000, LARYNGOSCOPE, V110, P799, DOI 10.1097/00005537-200005000-00010; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Hamilos Daniel L, 2007, Clin Allergy Immunol, V20, P1; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hamilos DL, 1996, AM J RESP CELL MOL, V15, P443, DOI 10.1165/ajrcmb.15.4.8879177; Jacobs RL, 2012, J ALLERGY CLIN IMMUN, V130, P122, DOI 10.1016/j.jaci.2012.03.031; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Reh DD, 2010, AM J RHINOL ALLERGY, V24, P105, DOI 10.2500/ajra.2010.24.3446; SPECTOR SL, 1976, J ALLERGY CLIN IMMUN, V57, P499, DOI 10.1016/0091-6749(76)90067-1; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Uri N, 2013, J LARYNGOL OTOL, V127, P867, DOI 10.1017/S0022215113001680	14	8	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1457	1459		10.1016/j.jaci.2016.03.011	http://dx.doi.org/10.1016/j.jaci.2016.03.011			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	27155037	Bronze			2022-12-18	WOS:000376180200021
J	Sander, I; Rihs, HP; Bruning, T; Raulf, M				Sander, Ingrid; Rihs, Hans-Peter; Bruening, Thomas; Raulf, Monika			A further wheat allergen for baker's asthma: Tri a 40	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMPONENT-RESOLVED DIAGNOSIS; IGE; PROTEIN		[Sander, Ingrid; Rihs, Hans-Peter; Bruening, Thomas; Raulf, Monika] Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med, German Social Accid Insurance, Bochum, Germany	Ruhr University Bochum	Sander, I (corresponding author), Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med, German Social Accid Insurance, Bochum, Germany.	Sander@ipa-dguv.de	Brüning, Thomas/G-8120-2015; Sander, Ingrid/R-8940-2017	Brüning, Thomas/0000-0001-9560-5464; Sander, Ingrid/0000-0002-5014-4112				Gomez-Casado C, 2014, J ALLERGY CLIN IMMUN, V134, P480, DOI 10.1016/j.jaci.2014.03.016; LULLIEN V, 1991, PLANT MOL BIOL, V17, P1081, DOI 10.1007/BF00037147; Quirce S, 2013, ALLERGY ASTHMA IMMUN, V5, P348, DOI 10.4168/aair.2013.5.6.348; Rozynek P, 2002, ALLERGY, V57, P463, DOI 10.1034/j.1398-9995.2002.23638.x; Salcedo G, 2011, J INVEST ALLERG CLIN, V21, P81; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; Sander I, 2015, J ALLERGY CLIN IMMUN, V135, P1529, DOI 10.1016/j.jaci.2014.11.021	7	8	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2016	137	4					1286	1286		10.1016/j.jaci.2015.11.026	http://dx.doi.org/10.1016/j.jaci.2015.11.026			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DI2TG	26846378	Bronze			2022-12-18	WOS:000373351200049
J	Schoos, AMM; Kattan, JD; Gimenez, G; Sampson, HA				Schoos, Ann-Marie M.; Kattan, Jacob D.; Gimenez, Gustavo; Sampson, Hugh A.			Sensitization phenotypes based on protein groups and associations to allergic diseases in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NASAL POLYPS; CHILDHOOD; ASTHMA		[Schoos, Ann-Marie M.; Kattan, Jacob D.; Gimenez, Gustavo; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Dept Pediat, Div Allergy & Immunol, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Schoos, Ann-Marie M.] Univ Copenhagen, Copenhagen Prospect Studies Asthma Childhood, Fac Hlth & Med Sci, Copenhagen, Denmark; [Schoos, Ann-Marie M.] Univ Copenhagen, Danish Pediat Asthma Ctr, Gentofte Hosp, Copenhagen, Denmark	Icahn School of Medicine at Mount Sinai; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Schoos, AMM (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, Div Allergy & Immunol, Jaffe Food Allergy Inst, New York, NY 10029 USA.; Schoos, AMM (corresponding author), Univ Copenhagen, Copenhagen Prospect Studies Asthma Childhood, Fac Hlth & Med Sci, Copenhagen, Denmark.; Schoos, AMM (corresponding author), Univ Copenhagen, Danish Pediat Asthma Ctr, Gentofte Hosp, Copenhagen, Denmark.	ann-marie.schoos@dbac.com	Schoos, Ann-Marie Malby/AAO-7677-2020	Schoos, Ann-Marie Malby/0000-0002-5827-0885	NCRR NIH HHS [RR026134] Funding Source: Medline; NHLBI NIH HHS [5K12HL109005-03] Funding Source: Medline; NIAID NIH HHS [AI44236, AI066738] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL109005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066738] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernstein IL, 2008, ANN ALLERG ASTHMA IM, V100, pS1, DOI 10.1016/S1081-1206(10)60305-5; Brockow I, 2009, J INVEST ALLERG CLIN, V19, P180; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Konradsen JR, 2014, PEDIAT ALLERG IMM-UK, V25, P187, DOI 10.1111/pai.12198; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Ott H, 2008, ALLERGY, V63, P1521, DOI 10.1111/j.1398-9995.2008.01748.x; Poposki JA, 2015, CLIN EXP ALLERGY, V45, P384, DOI 10.1111/cea.12471; Poposki JA, 2011, J ALLERGY CLIN IMMUN, V128, P73, DOI 10.1016/j.jaci.2011.03.017; Radauer C, 2014, ALLERGY, V69, P413, DOI 10.1111/all.12348; Sicherer SH, 2011, PEDIATRICS; Stoltz DJ, 2013, CLIN EXP ALLERGY, V43, P233, DOI 10.1111/cea.12050; Twardosz-Kropfmuller A, 2010, ALLERGY, V65, P296, DOI 10.1111/j.1398-9995.2009.02202.x	13	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2016	137	4					1277	+		10.1016/j.jaci.2015.09.035	http://dx.doi.org/10.1016/j.jaci.2015.09.035			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DI2TG	26581917	Bronze			2022-12-18	WOS:000373351200046
J	Chandra, A; Zhang, F; Gilmour, KC; Webster, D; Plagnol, V; Kumararatne, DS; Burns, SO; Nejentsev, S; Thrasher, AJ				Chandra, Anita; Zhang, Fang; Gilmour, Kimberly C.; Webster, David; Plagnol, Vincent; Kumararatne, Dinakantha S.; Burns, Siobhan O.; Nejentsev, Sergey; Thrasher, Adrian J.			Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor gamma (IL2RG) gene promoter	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Chandra, Anita; Kumararatne, Dinakantha S.] Cambridge Univ Hosp NHS Fdn Trust, Dept Clin Biochem & Immunol, Cambridge, England; [Chandra, Anita] Babraham Inst, Lymphocyte Signalling & Dev, Cambridge, England; [Zhang, Fang; Thrasher, Adrian J.] UCL, Inst Child Hlth, Mol & Cellular Immunol, London, England; [Gilmour, Kimberly C.] Great Ormond St Hosp NHS Fdn Trust, Dept Immunol, London, England; [Webster, David; Burns, Siobhan O.] UCL, Inst Immun & Transplantat, London, England; [Chandra, Anita; Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Thrasher, Adrian J.] Great Ormond St Hosp NHS Fdn Trust, London, England; [Plagnol, Vincent] UCL, Genet Inst, London, England; [Burns, Siobhan O.] Royal Free London NHS Fdn Trust, Dept Immunol, London, England	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Cambridge; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust	Chandra, A (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Clin Biochem & Immunol, Cambridge, England.; Chandra, A (corresponding author), Babraham Inst, Lymphocyte Signalling & Dev, Cambridge, England.; Chandra, A (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	anita.chandra@doctors.org.uk		Plagnol, Vincent/0000-0002-5597-9215; Burns, Siobhan/0000-0002-3356-9506; Thrasher, Adrian/0000-0002-6097-6115	Wellcome Trust [095198/Z/10/Z, 095198, 103413/Z/13/Z] Funding Source: Medline; Department of Health Funding Source: Medline	Wellcome Trust(Wellcome Trust); Department of Health		Ciau-Uitz A, 2013, BLOOD CELL MOL DIS, V51, P248, DOI 10.1016/j.bcmd.2013.07.010; Estevez OA, 2014, PEDIATR BLOOD CANCER, V61, P178, DOI 10.1002/pbc.24717; Kellermayer R, 2006, J HUM GENET, V51, P495, DOI 10.1007/s10038-006-0386-5; Markiewicz S, 1996, J BIOL CHEM, V271, P14849, DOI 10.1074/jbc.271.25.14849; Modell V, 2011, IMMUNOL RES, V51, P61, DOI 10.1007/s12026-011-8241-y; Niemela JE, 2000, CLIN IMMUNOL, V95, P33, DOI 10.1006/clim.2000.4846; Ochs HD, 2014, CLIN EXP IMMUNOL, V178, P5, DOI 10.1111/cei.12491; Puck JM, 1997, BLOOD, V89, P1968; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076	9	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					940	942		10.1016/j.jaci.2015.08.049	http://dx.doi.org/10.1016/j.jaci.2015.08.049			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26525228	Green Published, hybrid			2022-12-18	WOS:000371897500043
J	Ricci, G; Caffarelli, C				Ricci, Giampaolo; Caffarelli, Carlo			Early or not delayed complementary feeding?: This is the question	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PEANUT ALLERGY; INFANTS; RISK		[Ricci, Giampaolo] Univ Bologna, Dept Med & Surg Sci, Pediat Unit, Bologna, Italy; [Caffarelli, Carlo] Univ Parma, Dept Pediat, Dept Clin & Expt Med, I-43100 Parma, Italy	University of Bologna; University of Parma; University Hospital of Parma	Ricci, G (corresponding author), Univ Bologna, Dept Med & Surg Sci, Pediat Unit, Bologna, Italy.	giampaolo.ricci@unibo.it	Caffarelli, Carlo/AAC-2488-2022					Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Fleischer DM, 2015, ANN ALLERG ASTHMA IM, V115, P87, DOI 10.1016/j.anai.2015.06.001	2	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2016	137	1					334	335		10.1016/j.jaci.2015.09.038	http://dx.doi.org/10.1016/j.jaci.2015.09.038			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA3UK	26586038	Bronze			2022-12-18	WOS:000367724300037
J	Sobh, A; Crestani, E; Cangemi, B; Kane, J; Chou, J; Pai, SY; Notarangelo, LD; Al-Herz, W; Geha, RS; Massaad, MJ				Sobh, Ali; Crestani, Elena; Cangemi, Brittney; Kane, Jennifer; Chou, Janet; Pai, Sung-Yun; Notarangelo, Luigi D.; Al-Herz, Waleed; Geha, Raif S.; Massaad, Michel J.			Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							LIGAND MUTATION; APOPTOSIS; RECEPTOR; PATIENT; DEATH		[Sobh, Ali; Crestani, Elena; Cangemi, Brittney; Kane, Jennifer; Chou, Janet; Notarangelo, Luigi D.; Geha, Raif S.; Massaad, Michel J.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Sobh, Ali; Crestani, Elena; Cangemi, Brittney; Kane, Jennifer; Chou, Janet; Notarangelo, Luigi D.; Geha, Raif S.; Massaad, Michel J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Pai, Sung-Yun] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Pai, Sung-Yun] Harvard Univ, Sch Med, Boston, MA USA; [Al-Herz, Waleed] Al Sabah Hosp, Dept Pediat, Allergy & Clin Immunol Unit, Kuwait, Kuwait; [Al-Herz, Waleed] Kuwait Univ, Dept Pediat, Kuwait, Kuwait	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Al Sabah Hospital; Kuwait University	Sobh, A (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	michel.massaad@childrens.harvard.edu	Pai, Sung-Yun/AAH-7762-2019; Sobh, Ali/Q-6160-2016; Notarangelo, Luigi D/F-9718-2016	Pai, Sung-Yun/0000-0002-0158-8147; Sobh, Ali/0000-0001-7047-076X; Notarangelo, Luigi D/0000-0002-8335-0262; Crestani, Elena/0000-0001-7718-0431	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bi LL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-41; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Del-Rey M, 2006, BLOOD, V108, P1306, DOI 10.1182/blood-2006-04-015776; Douni E, 2012, HUM MOL GENET, V21, P784, DOI 10.1093/hmg/ddr510; Fleisher TA, 2012, CURR OPIN ALLERGY CL, V12, P609, DOI 10.1097/ACI.0b013e3283588da0; Magerus-Chatinet A, 2013, J ALLERGY CLIN IMMUN, V131, P486, DOI 10.1016/j.jaci.2012.06.011; Nabhani S, 2014, CLIN IMMUNOL, V155, P231, DOI 10.1016/j.clim.2014.10.006; Orlinick JR, 1997, J BIOL CHEM, V272, P32221, DOI 10.1074/jbc.272.51.32221; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	10	8	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2016	137	1					324	327		10.1016/j.jaci.2015.08.025	http://dx.doi.org/10.1016/j.jaci.2015.08.025			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA3UK	26456038				2022-12-18	WOS:000367724300031
J	Subbarayal, B; Schiller, D; Mobs, C; Pfutzner, W; Jahn-Schmid, B; Gepp, B; Breiteneder, H; Vieths, S; Bohle, B				Subbarayal, Brinda; Schiller, Dirk; Moebs, Christian; Pfuetzner, Wolfgang; Jahn-Schmid, Beatrice; Gepp, Barbara; Breiteneder, Heimo; Vieths, Stefan; Bohle, Barbara			The diversity of Bet v 1-specific IgG(4) antibodies remains mostly constant during the course of birch pollen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CROSS-REACTIVITY; IGE; RESPONSES; ALLERGENS; EPITOPES; SURFACE		[Subbarayal, Brinda; Jahn-Schmid, Beatrice; Gepp, Barbara; Breiteneder, Heimo; Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Subbarayal, Brinda; Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Schiller, Dirk; Vieths, Stefan] Paul Ehrlich Inst, Div Allergol, Langen, Germany; [Moebs, Christian; Pfuetzner, Wolfgang] Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany	Medical University of Vienna; Medical University of Vienna; Paul Ehrlich Institute; Philipps University Marburg	Subbarayal, B (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria.	barbara.bohle@meduniwien.ac.at		Breiteneder, Heimo/0000-0003-2022-8689; Subbarayal, Brinda/0000-0002-4500-8490; Bohle, Barbara/0000-0002-5105-7985; Mobs, Christian/0000-0002-5197-7669				Dall'Antonia F, 2011, J ALLERGY CLIN IMMUN, V128, P872, DOI 10.1016/j.jaci.2011.07.007; Gepp B, 2014, J ALLERGY CLIN IMMUN, V134, P188, DOI 10.1016/j.jaci.2013.12.1073; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Holm J, 2011, J BIOL CHEM, V286, P17569, DOI 10.1074/jbc.M110.194878; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; Mobs C, 2012, J ALLERGY CLIN IMMUN, V130, P1108, DOI 10.1016/j.jaci.2012.07.056; Negi SS, 2009, BIOINFORM BIOL INSIG, V3, P71; Subbarayal B, 2013, ALLERGY, V68, P1377, DOI 10.1111/all.12236; Vickery BP, 2013, J ALLERGY CLIN IMMUN, V131, P128, DOI 10.1016/j.jaci.2012.10.048	9	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1680	1682		10.1016/j.jaci.2015.05.025	http://dx.doi.org/10.1016/j.jaci.2015.05.025			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26143181	Bronze			2022-12-18	WOS:000366044300031
J	Tobacman, JK				Tobacman, Joanne K.			The common food additive carrageenan and the alpha-gal epitope	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	jkt@uic.edu						Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002; Steinke JW, 2015, J ALLERGY CLIN IMMUN, V135, P589, DOI 10.1016/j.jaci.2014.12.1947; TARLO SM, 1995, J ALLERGY CLIN IMMUN, V95, P933, DOI 10.1016/S0091-6749(95)70091-9; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; West J., 2001, CALIFORNIAS LIVING M, P286	7	8	8	2	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1708	1709		10.1016/j.jaci.2015.08.048	http://dx.doi.org/10.1016/j.jaci.2015.08.048			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26518095	Bronze			2022-12-18	WOS:000366044300043
J	Bonilla, FA; Khan, DA; Ballas, ZK; Chinen, J; Frank, MM; Hsu, JT; Keller, M; Kobrynski, LJ; Komarow, HD; Mazer, B; Nelson, RP; Orange, JS; Routes, JM; Shearer, WT; Sorensen, RU; Verbsky, JW; Bernstein, DI; Blessing-Moore, J; Lang, D; Nicklas, RA; Oppenheimer, J; Portnoy, JM; Randolph, CR; Schuller, D; Spector, SL; Tilles, S; Wallace, D				Bonilla, Francisco A.; Khan, David A.; Ballas, Zuhair K.; Chinen, Javier; Frank, Michael M.; Hsu, Joyce T.; Keller, Michael; Kobrynski, Lisa J.; Komarow, Hirsh D.; Mazer, Bruce; Nelson, Robert P., Jr.; Orange, Jordan S.; Routes, John M.; Shearer, William T.; Sorensen, Ricardo U.; Verbsky, James W.; Bernstein, David I.; Blessing-Moore, Joann; Lang, David; Nicklas, Richard A.; Oppenheimer, John; Portnoy, Jay M.; Randolph, Christopher R.; Schuller, Diane; Spector, Sheldon L.; Tilles, Stephen; Wallace, Dana			Practice parameter for the diagnosis and management of primary immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							STEM-CELL TRANSPLANTATION; COMMON-VARIABLE-IMMUNODEFICIENCY; HYPER-IGE SYNDROME; CHRONIC GRANULOMATOUS-DISEASE; X-LINKED AGAMMAGLOBULINEMIA; PULMONARY ALVEOLAR PROTEINOSIS; BONE-MARROW-TRANSPLANTATION; COLONY-STIMULATING FACTOR; WISKOTT-ALDRICH-SYNDROME; LEUKOCYTE ADHESION DEFICIENCY	The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the diagnosis and management of primary immunodeficiency.'' This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.	[Bonilla, Francisco A.] Boston Childrens Hosp, Boston, MA 02115 USA; [Bonilla, Francisco A.] Harvard Univ, Sch Med, Pediat, Boston, MA USA; [Khan, David A.] Univ Texas SW Med Ctr Dallas, Internal Med, Dallas, TX 75390 USA; [Bernstein, David I.] Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Clin Med & Environm Hlth, Cincinnati, OH USA; [Blessing-Moore, Joann] Stanford Univ, Med Ctr, Dept Immunol, Med & Pediat, Palo Alto, CA 94304 USA; [Lang, David] Cleveland Clin Fdn, Allergy Immunol Sect, Resp Inst, Cleveland, OH 44195 USA; [Lang, David] Cleveland Clin Fdn, Allergy & Immunol Fellowship Training Program, Cleveland, OH 44195 USA; [Nicklas, Richard A.] George Washington Med Ctr, Med, Washington, DC USA; [Oppenheimer, John] Univ Med & Dent New Jersey, Pulm & Allergy Associates, Dept Internal Med, Morristown, NJ USA; [Portnoy, Jay M.] Childrens Mercy Hosp, Sect Allergy Asthma & Immunol, Kansas City, MO 64108 USA; [Portnoy, Jay M.] Univ Missouri, Kansas City Sch Med, Pediat, Kansas City, MO 64110 USA; [Randolph, Christopher R.] Yale Affiliated Hosp, Pediat Allergy Immunol, Ctr Allergy Asthma & Immunol, Waterbury, CT USA; [Schuller, Diane] Penn State Univ, Milton S Hershey Med Coll, Pediat, Hershey, PA USA; [Schuller, Diane] Penn State Univ, Milton S Hershey Med Coll, Allergy & Immunol, Hershey, PA USA; [Spector, Sheldon L.] Univ Calif Los Angeles, Sch Med, Med, Los Angeles, CA USA; [Tilles, Stephen] Univ Washington, Sch Med, Med, Redmond, WA USA; [Wallace, Dana] Nova SE Univ, Coll Osteopath Med, Med, Davie, FL USA; [Ballas, Zuhair K.] Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Ballas, Zuhair K.] Iowa City Vet Adm Med Ctr, Iowa City, IA USA; [Chinen, Javier] Lake Houston Allergy & Immunol, Allergy & Immunol, Humble, TX USA; [Frank, Michael M.] Duke Univ, Med Ctr, Pediat, Durham, NC USA; [Frank, Michael M.] Duke Univ, Med Ctr, Dept Pediat, Immunol & Med, Durham, NC 27710 USA; [Hsu, Joyce T.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Sch Med, Boston, MA 02115 USA; [Hsu, Joyce T.] Harvard Univ, Sch Med, Pediat, Boston, MA USA; [Keller, Michael] Childrens Natl Med Ctr, Pediat, Washington, DC 20010 USA; [Kobrynski, Lisa J.] Emory Univ, Sch Med, Atlanta, GA USA; [Komarow, Hirsh D.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Mazer, Bruce] McGill Univ, Montreal Childrens Hosp, Hlth Ctr, Allergy & Immunol, Montreal, PQ H3H 1P3, Canada; [Mazer, Bruce] McGill Univ, Pediat, Montreal, PQ, Canada; [Nelson, Robert P., Jr.] Indiana Univ Sch Med, Div Hematol & Oncol, Med & Pediat, Indianapolis, IN 46202 USA; [Nelson, Robert P., Jr.] Indiana Univ Sch Med, Div Stem Cell Transplantat, Med & Pediat, Indianapolis, IN 46202 USA; [Nelson, Robert P., Jr.] Indiana Univ Sch Med, Riley Hosp, Pediat Immunodeficiency Clin, Indianapolis, IN 46202 USA; [Nelson, Robert P., Jr.] IU Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Orange, Jordan S.] Texas Childrens Hosp, Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Orange, Jordan S.] Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Orange, Jordan S.] Baylor Coll Med, Pediat Pathol & Immunol, Houston, TX 77030 USA; [Orange, Jordan S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Routes, John M.] Med Coll Wisconsin, Allergy & Clin Immunol, Milwaukee, WI 53226 USA; [Routes, John M.] Med Coll Wisconsin, Pediat & Med, Milwaukee, WI 53226 USA; [Shearer, William T.] Texas Childrens Hosp, Allergy & Immunol Serv, Houston, TX 77030 USA; [Shearer, William T.] Baylor Coll Med, Pediat & Immunol, Houston, TX 77030 USA; [Sorensen, Ricardo U.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Verbsky, James W.] Med Coll Wisconsin, Pediat & Microbiol & Med Genet, Milwaukee, WI 53226 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati; Stanford University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; George Washington University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; Nova Southeastern University; University of Iowa; Duke University; Duke University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Children's National Health System; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); McGill University; McGill University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Medical College of Wisconsin; Medical College of Wisconsin; Baylor College of Medicine; Baylor College of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical College of Wisconsin	Bonilla, FA (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	francisco.bonilla@childrens.harvard.edu	Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773				Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; Abrahamian F, 2010, CLIN EXP IMMUNOL, V159, P344, DOI 10.1111/j.1365-2249.2009.04062.x; Aderibigbe OM, 2015, JAMA DERMATOL, V151, P627, DOI 10.1001/jamadermatol.2014.5641; Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Aghamohammadi A, 2008, INT ARCH ALLERGY IMM, V147, P87, DOI 10.1159/000135694; Aghamohammadi A, 2011, INT ARCH ALLERGY IMM, V156, P462, DOI 10.1159/000323903; Aghamohammadi A, 2009, J CLIN IMMUNOL, V29, P769, DOI 10.1007/s10875-009-9315-7; Agondi RC, 2010, ALLERGY, V65, P510, DOI 10.1111/j.1398-9995.2009.02211.x; Aittoniemi J, 1999, CLIN EXP IMMUNOL, V116, P505; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Akgul B, 2007, J DERMATOL SCI, V46, P214, DOI 10.1016/j.jdermsci.2007.01.002; Aksentijevich I, 2011, NAT REV RHEUMATOL, V7, P468, DOI 10.1038/nrrheum.2011.94; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Al-Ahmari A, 2010, BONE MARROW TRANSPL, V45, P1294, DOI 10.1038/bmt.2009.358; Al-Dhekri H, 2012, CLIN IMMUNOL, V143, P96, DOI 10.1016/j.clim.2012.01.012; Al-Dhekri H, 2011, BIOL BLOOD MARROW TR, V17, P1245, DOI 10.1016/j.bbmt.2010.12.714; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Al-Herz W, 2012, CLIN IMMUNOL, V143, P266, DOI 10.1016/j.clim.2012.03.002; Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Alangari A, 2012, J ALLERGY CLIN IMMUN, V130, P481, DOI 10.1016/j.jaci.2012.05.043; Alba-Dominguez M, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-42; Albert MH, 2010, BONE MARROW TRANSPL, V45, P622, DOI 10.1038/bmt.2009.207; Albert MH, 2011, CURR OPIN HEMATOL, V18, P42, DOI 10.1097/MOH.0b013e32834114bc; Albert MH, 2010, BLOOD, V115, P3231, DOI 10.1182/blood-2009-09-239087; Alizadeh Z, 2011, IRAN J ALLERGY ASTHM, V10, P227, DOI 010.03/ijaai.227230; Aloj G, 2012, INT REV IMMUNOL, V31, P43, DOI 10.3109/08830185.2011.644607; Ameratunga R, 2014, EXPERT REV CLIN IMMU, V10, P183, DOI 10.1586/1744666X.2014.875274; Ameratunga R, 2010, CLIN PEDIATR, V49, P1143, DOI 10.1177/0009922810370057; Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; Andreu N, 2003, BLOOD CELL MOL DIS, V31, P332, DOI 10.1016/S1079-9796(03)00168-2; ANDROPHY EJ, 1984, J AM ACAD DERMATOL, V11, P197, DOI 10.1016/S0190-9622(84)70149-6; ANDROPHY EJ, 1985, ARCH DERMATOL, V121, P864, DOI 10.1001/archderm.121.7.864; [Anonymous], 2012, CUADERNOS DEUSTO DER; [Anonymous], PEDIAT DIABETES; [Anonymous], ARCH DERMATOL RES; [Anonymous], J ALLERGY C IN PRESS; [Anonymous], BMJ CASE REP; [Anonymous], 2012, TRYP HUM AFR SLEEP S; Antoccia A, 2006, GENOME DYN, V1, P191, DOI 10.1159/000092508; Aprikyan AA, 2013, BRIT J HAEMATOL, V161, P330, DOI 10.1111/bjh.12271; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Arostegui JI, 2007, ARTHRITIS RHEUM-US, V56, P3805, DOI 10.1002/art.22966; Artac H, 2013, CLIN EXP MED, V13, P257, DOI 10.1007/s10238-012-0200-y; Ashrafi MR, 2010, IRAN J PEDIATR, V20, P269; Athanasakis E, 2012, MOL SYNDROMOL, V3, P30, DOI 10.1159/000338816; Atkinson AR, 2007, PEDIATRICS, V120, pE543, DOI 10.1542/peds.2006-3613; Atkinson TP, 2012, CURR OPIN RHEUMATOL, V24, P515, DOI 10.1097/BOR.0b013e32835680c6; AUCOUTURIER P, 1987, CLIN EXP IMMUNOL, V68, P392; Avitzur Y, 2014, GASTROENTEROLOGY, V146, P1028, DOI 10.1053/j.gastro.2014.01.015; Aytekin C, 2012, J CLIN IMMUNOL, V32, P961, DOI 10.1007/s10875-012-9702-3; Badolato R, 2012, BLOOD, V119, P3185, DOI 10.1182/blood-2012-01-404350; Baerlecken N, 2009, CLIN INFECT DIS, V49, pE76, DOI 10.1086/605581; Bailleul-Forestier I, 2008, J PERIODONTOL, V79, P1263, DOI 10.1902/jop.2008.070440 ; Ballanti E, 2011, AUTOIMMUN REV, V10, P617, DOI 10.1016/j.autrev.2011.04.012; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Balloch A, 2013, J CLIN IMMUNOL, V33, P335, DOI 10.1007/s10875-012-9806-9; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Bard S, 2008, ARCH DERMATOL, V144, P1662, DOI 10.1001/archdermatol.2008.510; BARTMANN P, 1991, EUR J PEDIATR, V150, P234, DOI 10.1007/BF01955519; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bateman EAL, 2012, CLIN EXP IMMUNOL, V170, P202, DOI 10.1111/j.1365-2249.2012.04643.x; Beel K, 2009, BRIT J HAEMATOL, V144, P120, DOI 10.1111/j.1365-2141.2008.07416.x; Belada D, 2010, LEUKEMIA RES, V34, pE232, DOI 10.1016/j.leukres.2010.01.024; Ben-Dov I, 2014, AUTOIMMUN REV, V13, P513, DOI 10.1016/j.autrev.2014.01.046; Berard R, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-10; Beser OF, 2015, J PEDIATR GASTR NUTR, V60, P332, DOI 10.1097/MPG.0000000000000621; Bienemann K, 2011, BRIT J HAEMATOL, V155, P468, DOI 10.1111/j.1365-2141.2011.08863.x; Bindl L, 2005, J PEDIATR-US, V147, P256, DOI 10.1016/j.jpeds.2005.04.017; Boackle Susan A, 2003, Curr Dir Autoimmun, V6, P154; Bodar EJ, 2011, ANN RHEUM DIS, V70, P2155, DOI 10.1136/ard.2011.149922; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Boisson B, 2013, J CLIN INVEST, V123, P4781, DOI 10.1172/JCI71927; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Bonagura VR, 2013, J CLIN IMMUNOL, V33, pS90, DOI 10.1007/s10875-012-9838-1; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Bonilla FA, 2008, ANN ALLERG ASTHMA IM, V101, P101, DOI 10.1016/S1081-1206(10)60842-3; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; Booth C, 2009, BIOL-TARGETS THER, V3, P349; Bordon V, 2010, BLOOD, V116, P27, DOI 10.1182/blood-2010-01-259168; Borgers H, 2010, CLIN IMMUNOL, V134, P198, DOI 10.1016/j.clim.2009.10.006; Borghini S, 2011, ARTHRITIS RHEUM-US, V63, P830, DOI 10.1002/art.30170; Borzutzky A, 2009, CLIN IMMUNOL, V133, P287, DOI 10.1016/j.clim.2009.08.006; Bouts AH, 2010, PEDIATR NEPHROL, V25, P2547, DOI 10.1007/s00467-010-1609-8; Bouvry D, 2013, EUR RESPIR J, V41, P115, DOI 10.1183/09031936.00189011; Boyle JM, 2007, J CLIN IMMUNOL, V27, P497, DOI 10.1007/s10875-007-9103-1; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Brenner M, 2009, BRIT J DERMATOL, V161, P1199, DOI 10.1111/j.1365-2133.2009.09404.x; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Browne SK, 2014, ANNU REV IMMUNOL, V32, P635, DOI 10.1146/annurev-immunol-032713-120222; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Browne SK, 2012, BLOOD, V119, P3933, DOI 10.1182/blood-2011-12-395707; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Buckley Rebecca H, 2002, Curr Allergy Asthma Rep, V2, P356, DOI 10.1007/s11882-002-0067-1; Buckley RH, 2010, J ALLERGY CLIN IMMUN, V125, P790, DOI 10.1016/j.jaci.2010.02.012; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Buckley RH, 2005, J CLIN INVEST, V115, P2974, DOI 10.1172/JCI26956; Bukowska-Strakova K, 2009, PEDIATR RES, V66, P28, DOI 10.1203/PDR.0b013e3181a7b0a2; Bulua AC, 2012, ARTHRITIS RHEUM-US, V64, P908, DOI 10.1002/art.33416; Burns SO, 2012, J ALLERGY CLIN IMMUN, V130, P1428, DOI 10.1016/j.jaci.2012.07.035; Burroughs LM, 2010, J ALLERGY CLIN IMMUN, V126, P1000, DOI 10.1016/j.jaci.2010.05.021; Burton CM, 2007, SCAND J INFECT DIS, V39, P362, DOI 10.1080/00365540600978955; Burton MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008669; Burwick N, 2012, BLOOD, V120, P5143, DOI 10.1182/blood-2012-04-420166; Bustamante J, 2011, ANN NY ACAD SCI, V1246, P92, DOI 10.1111/j.1749-6632.2011.06273.x; Cagdas D, 2012, EUR J PEDIATR, V171, P1527, DOI 10.1007/s00431-012-1765-x; Calderwood S, 2001, BLOOD, V97, P376, DOI 10.1182/blood.V97.2.376; Campo I, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-4; Capalbo D, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/353250; Carlsson G, 2011, PEDIATR BLOOD CANCER, V56, P444, DOI 10.1002/pbc.22836; Carneiro-Sampaio M, 2007, ADV IMMUNOL, V95, P51, DOI 10.1016/S0065-2776(07)95002-6; CARNEIROSAMPAIO MMS, 1991, J INVEST ALLERG CLIN, V1, P195; Carr TF, 2011, AM J RHINOL ALLERGY, V25, P241, DOI 10.2500/ajra.2011.25.3653; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Castro A P, 2001, Rev Hosp Clin Fac Med Sao Paulo, V56, P189; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Catucci M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00209; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Cedzynski M, 2004, CLIN EXP IMMUNOL, V136, P304, DOI 10.1111/j.1365-2249.2004.02453.x; Cellier C, 2000, NEW ENGL J MED, V342, P1611, DOI 10.1056/NEJM200005253422113; Cervato S, 2010, CLIN ENDOCRINOL, V73, P630, DOI 10.1111/j.1365-2265.2010.03862.x; Cervera C, 2011, EUR J HAEMATOL, V87, P87, DOI 10.1111/j.1600-0609.2011.01619.x; Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370; Chan A, 2011, CLIN IMMUNOL, V138, P3, DOI 10.1016/j.clim.2010.09.010; Chan K, 2011, MOL GENET METAB, V104, P383, DOI 10.1016/j.ymgme.2011.07.007; Chan WY, 2013, J PEDIAT HEMATOL ONC, V35, pE14, DOI 10.1097/MPH.0b013e31824e15b8; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Chapel H, 2012, J ALLERGY CLIN IMMUN, V130, P1197, DOI 10.1016/j.jaci.2012.05.046; Chase NM, 2013, J CLIN IMMUNOL, V33, P30, DOI 10.1007/s10875-012-9755-3; Chatziandreou I, 2011, EXP HEMATOL, V39, P643, DOI 10.1016/j.exphem.2011.03.003; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Chen R, 2013, J ALLERGY CLIN IMMUN, V132, P656, DOI 10.1016/j.jaci.2013.06.013; Chen Y, 2011, J ALLERGY CLIN IMMUN, V127, P1414, DOI 10.1016/j.jaci.2011.03.041; Cheng LE, 2009, CLIN IMMUNOL, V132, P124, DOI 10.1016/j.clim.2009.03.514; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Chiang PW, 2010, PEDIATR BLOOD CANCER, V55, P1438, DOI 10.1002/pbc.22793; Chinen J, 2010, J ALLERGY CLIN IMMUN, V125, pS195, DOI 10.1016/j.jaci.2009.08.040; Chinn IK, 2011, J ALLERGY CLIN IMMUN, V127, P1351, DOI 10.1016/j.jaci.2011.03.033; Chistiakov DA, 2010, ADV EXP MED BIOL, V685, P175; Chou J, 2014, J ALLERGY CLIN IMMUN, V134, P223, DOI 10.1016/j.jaci.2014.01.041; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Chularojanamontri L, 2009, ASIAN PAC J ALLERGY, V27, P233; Ciupe SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000396; Cliffe ST, 2012, J ALLERGY CLIN IMMUN, V130, P735, DOI 10.1016/j.jaci.2012.02.054; Colten Harvey R, 2002, Curr Allergy Asthma Rep, V2, P379, DOI 10.1007/s11882-002-0070-6; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Conley ME, 2005, IMMUNOL REV, V203, P216, DOI 10.1111/j.0105-2896.2005.00233.x; Conti HR, 2011, MUCOSAL IMMUNOL, V4, P448, DOI 10.1038/mi.2011.5; Crank MC, 2014, J CLIN IMMUNOL, V34, P272, DOI 10.1007/s10875-014-0012-9; Crequer A, 2013, J CLIN IMMUNOL, V33, P14, DOI 10.1007/s10875-012-9749-1; Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010; Criddle MW, 2008, AM J OTOLARYNG, V29, P372, DOI 10.1016/j.amjoto.2007.11.003; Cunningham-Rundles C, 2012, HEMATOL-AM SOC HEMAT, P301, DOI 10.1182/asheducation-2012.1.301; Cunningham-Rundles C, 2010, BLOOD, V116, P7, DOI 10.1182/blood-2010-01-254417; Cuvelier GDE, 2009, CLIN IMMUNOL, V131, P179, DOI 10.1016/j.clim.2009.01.003; d'Hennezel E, 2012, J MED GENET, V49, P291, DOI 10.1136/jmedgenet-2012-100759; Dadi HK, 2003, NEW ENGL J MED, V349, P1821, DOI 10.1056/NEJMoa031178; Dale DC, 2011, BLOOD, V118, P4963, DOI 10.1182/blood-2011-06-360586; Dasouki M, 2011, CLIN IMMUNOL, V141, P128, DOI 10.1016/j.clim.2011.06.003; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; de Greef JC, 2011, AM J HUM GENET, V88, P796, DOI 10.1016/j.ajhg.2011.04.018; de Jesus AA, 2013, CLIN IMMUNOL, V147, P155, DOI 10.1016/j.clim.2013.03.016; de la Calle-Martin O, 2001, J CLIN INVEST, V108, P117, DOI 10.1172/JCI10993; de la Fuente MA, 2011, J ALLERGY CLIN IMMUN, V128, P139, DOI 10.1016/j.jaci.2011.03.042; de Miranda NFCC, 2011, ANN NY ACAD SCI, V1246, P50, DOI 10.1111/j.1749-6632.2011.06322.x; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; de Saint Basile G, 1999, EUR J IMMUNOL, V29, P367, DOI 10.1002/(SICI)1521-4141(199901)29:01<367::AID-IMMU367>3.0.CO;2-4; de Villartay JP, 2009, ADV EXP MED BIOL, V650, P46; Deau MC, 2014, J CLIN INVEST, V124, P3923, DOI 10.1172/JCI75746; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Demidowich AP, 2012, ARTHRITIS RHEUM-US, V64, P2022, DOI 10.1002/art.34332; Dhalla F, 2011, CLIN EXP IMMUNOL, V165, P1, DOI 10.1111/j.1365-2249.2011.04384.x; Di Carlo I, 2000, J SURG ONCOL, V73, P172, DOI 10.1002/(SICI)1096-9098(200003)73:3<172::AID-JSO11>3.0.CO;2-Z; Dierselhuis MP, 2005, RHEUMATOLOGY, V44, P406, DOI 10.1093/rheumatology/keh479; Dong XY, 2010, HUM IMMUNOL, V71, P505, DOI 10.1016/j.humimm.2010.02.002; Donoso LA, 2010, SURV OPHTHALMOL, V55, P227, DOI 10.1016/j.survophthal.2009.11.001; Dorsey MJ, 2006, ANN ALLERG ASTHMA IM, V97, P590, DOI 10.1016/S1081-1206(10)61085-X; Dotis J, 2013, MYCOSES, V56, P449, DOI 10.1111/myc.12049; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Driscoll DA, 2006, METH MOLEC MED, V126, P43; Du LK, 2012, J EXP MED, V209, P291, DOI 10.1084/jem.20110325; Du SU, 2011, PEDIATR DEVEL PATHOL, V14, P64, DOI 10.2350/10-01-0787-CR.1; Duplantier JE, 2001, CLIN IMMUNOL, V98, P313, DOI 10.1006/clim.2000.4994; Durmaz A, 2012, J PEDIAT HEMATOL ONC, V34, P541, DOI 10.1097/MPH.0b013e31826781ad; Duse M, 2010, INT J IMMUNOPATH PH, V23, P349, DOI 10.1177/039463201002300134; DWYER JM, 1988, PEDIATR INFECT DIS J, V7, pS30; Dykewicz MS, 2010, J ALLERGY CLIN IMMUN, V125, pS103, DOI 10.1016/j.jaci.2009.12.989; Edey MM, 2009, NEW ENGL J MED, V361, P1511, DOI 10.1056/NEJMc091704; Edwards E, 2004, CLIN IMMUNOL, V111, P93, DOI 10.1016/j.clim.2003.12.005; Ege M, 2005, BLOOD, V105, P4179, DOI 10.1182/blood-2004-12-4861; Elhasid R, 2010, CLIN REV ALLERG IMMU, V38, P61, DOI 10.1007/s12016-009-8129-y; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Engelhardt KR, 2012, J ALLERGY CLIN IMMUN, V129, P294, DOI [10.1016/j.jaci.2011.12.966, 10.1016/j.jaci.2011.12.972]; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Erdos M, 2007, HAEMATOLOGICA, V92, P281, DOI 10.3324/haematol.10172; Esposito L, 2012, OR SURG OR MED OR PA, V114, P147, DOI 10.1016/j.oooo.2012.04.005; Fazzi E, 2013, AUTOIMMUN REV, V12, P506, DOI 10.1016/j.autrev.2012.08.012; Feder HM, 2010, ACTA PAEDIATR, V99, P178, DOI 10.1111/j.1651-2227.2009.01554.x; Federici S, 2014, BEST PRACT RES CL RH, V28, P263, DOI 10.1016/j.berh.2014.05.005; Federici S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00351; Federico P, 2010, INT J IMMUNOPATH PH, V23, P1275, DOI 10.1177/039463201002300434; Felgentreff K, 2014, CLIN IMMUNOL, V150, P43, DOI 10.1016/j.clim.2013.11.008; Felgentreff K, 2011, CLIN IMMUNOL, V141, P73, DOI 10.1016/j.clim.2011.05.007; Ferguson PJ, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0239-5; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Ferrari S, 2007, GENES IMMUN, V8, P325, DOI 10.1038/sj.gene.6364391; Ferrari S, 2007, J EXP MED, V204, P2047, DOI 10.1084/jem.20070264; Ferri L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-27; Ferrua F, 2010, CURR OPIN ALLERGY CL, V10, P551, DOI 10.1097/ACI.0b013e32833fea85; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fijen CAP, 1999, MOL IMMUNOL, V36, P863, DOI 10.1016/S0161-5890(99)00107-8; Filipovich AH, 2011, CURR OPIN ALLERGY CL, V11, P512, DOI 10.1097/ACI.0b013e32834c22f5; Fiore L, 2004, CLIN IMMUNOL, V111, P98, DOI 10.1016/j.clim.2003.11.011; Fischer A, 2005, CURR OPIN ALLERGY CL, V5, P491, DOI 10.1097/01.all.0000191886.12645.79; Fischer A, 2011, J ALLERGY CLIN IMMUN, V127, P1356, DOI 10.1016/j.jaci.2011.04.030; Fish JD, 2009, BONE MARROW TRANSPL, V43, P217, DOI 10.1038/bmt.2008.308; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Frank MM, 2010, J ALLERGY CLIN IMMUN, V125, pS262, DOI 10.1016/j.jaci.2009.10.063; Frank MM, 2000, PEDIATR CLIN N AM, V47, P1339, DOI 10.1016/S0031-3955(05)70274-1; Freeman AF, 2010, DIS MARKERS, V29, P123, DOI [10.1155/2010/580197, 10.3233/DMA-2010-0734]; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Fried AJ, 2013, J CLIN IMMUNOL, V33, P847, DOI 10.1007/s10875-013-9870-9; Fried AJ, 2011, J ALLERGY CLIN IMMUN, V128, P226, DOI 10.1016/j.jaci.2011.01.048; Fried AJ, 2009, CLIN MICROBIOL REV, V22, P396, DOI 10.1128/CMR.00001-09; Fujioka T, 2011, PEDIATR INT, V53, P611, DOI 10.1111/j.1442-200X.2011.03409.x; Fuss IJ, 2013, J CLIN IMMUNOL, V33, P748, DOI 10.1007/s10875-013-9873-6; Gafter-Gvili A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004386.pub3; Gambineri E, 2012, CELL MOL LIFE SCI, V69, P49, DOI 10.1007/s00018-011-0838-8; Gandhi C, 2009, J ALLERGY CLIN IMMUN, V124, P1245, DOI 10.1016/j.jaci.2009.09.035; Garavello W, 2011, J PEDIATR-US, V159, P138, DOI 10.1016/j.jpeds.2010.12.014; Garg A, 2010, J CLIN ENDOCR METAB, V95, pE58, DOI 10.1210/jc.2010-0488; Gaschignard J, 2014, CLIN INFECT DIS, V59, P244, DOI 10.1093/cid/ciu274; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Gatz SA, 2011, BONE MARROW TRANSPL, V46, P552, DOI 10.1038/bmt.2010.169; Gavino C, 2014, CLIN INFECT DIS, V59, P81, DOI 10.1093/cid/ciu215; Gelfand EW, 2013, J ALLERGY CLIN IMMUN, V131, P1001, DOI 10.1016/j.jaci.2013.02.028; Gencpinar P, 2012, TURKISH J PEDIATR, V54, P641; Genel F, 2005, SCAND J INFECT DIS, V37, P615, DOI 10.1080/00365540510034536; Gennery AR, 2008, CLIN EXP IMMUNOL, V153, P75, DOI 10.1111/j.1365-2249.2008.03681.x; Gennery AR, 2007, PEDIATRICS, V120, pE1341, DOI 10.1542/peds.2007-0640; Gennery AR, 2000, BONE MARROW TRANSPL, V25, P1303, DOI 10.1038/sj.bmt.1702446; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Giliani S, 2006, J PEDIATR-US, V148, P272, DOI 10.1016/j.jpeds.2005.10.004; Gineau L, 2012, J CLIN INVEST, V122, P821, DOI 10.1172/JCI61014; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gobert D, 2011, BRIT J HAEMATOL, V155, P498, DOI 10.1111/j.1365-2141.2011.08880.x; Gochuico BR, 2012, MOL MED, V18, P56, DOI 10.2119/molmed.2011.00198; Gokturk B, 2012, INT J IMMUNOGENET, V39, P362, DOI 10.1111/j.1744-313X.2012.01105.x; Goldman FD, 2012, PEDIATR BLOOD CANCER, V58, P591, DOI 10.1002/pbc.23160; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Gorska MM, 2012, CURR ALLERGY ASTHM R, V12, P396, DOI 10.1007/s11882-012-0281-4; Goussetis E, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.005; Granados EL, 2008, HUM MUTAT, V29, P861, DOI 10.1002/humu.20740; Grez M, 2011, MOL THER, V19, P28, DOI 10.1038/mt.2010.232; Grier JT, 2012, J CLIN INVEST, V122, P3769, DOI 10.1172/JCI64837; Griffith LM, 2014, J ALLERGY CLIN IMMUN, V133, P335, DOI 10.1016/j.jaci.2013.07.052; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; Griffith LM, 2008, J ALLERGY CLIN IMMUN, V122, P1087, DOI 10.1016/j.jaci.2008.09.045; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Haapaniemi EM, 2015, BLOOD, V125, P639, DOI 10.1182/blood-2014-04-570101; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hadzic N, 2000, NEW ENGL J MED, V342, P320, DOI 10.1056/NEJM200002033420504; Hagemeier SR, 2012, J VIROL, V86, P13360, DOI 10.1128/JVI.01850-12; Hagleitner MM, 2008, J MED GENET, V45, P93, DOI 10.1136/jmg.2007.053397; Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110; Hamidieh AA, 2012, BONE MARROW TRANSPL, V47, P646, DOI 10.1038/bmt.2011.140; Handisurya A, 2010, VACCINE, V28, P4837, DOI 10.1016/j.vaccine.2010.04.057; Hanna S, 2012, ANN NY ACAD SCI, V1250, P50, DOI 10.1111/j.1749-6632.2011.06389.x; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Harris ES, 2013, CURR OPIN HEMATOL, V20, P16, DOI 10.1097/MOH.0b013e32835a0091; Has C, 2015, BRIT J DERMATOL, V172, P257, DOI 10.1111/bjd.13247; Hashkes PJ, 2012, PEDIATR CLIN N AM, V59, P447, DOI 10.1016/j.pcl.2012.03.005; Hellmich B, 2002, ARTHRITIS RHEUM, V46, P2384, DOI 10.1002/art.10497; Henderson LA, 2013, J ALLERGY CLIN IMMUN, V131, P1227, DOI 10.1016/j.jaci.2012.07.045; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Herlin T, 2013, ANN RHEUM DIS, V72, P410, DOI 10.1136/annrheumdis-2012-201818; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Herpers BL, 2009, J IMMUNOL METHODS, V343, P61, DOI 10.1016/j.jim.2009.01.002; Hilcenko C, 2013, BLOOD, V121, P1028, DOI 10.1182/blood-2012-10-461491; Hirota K, 2012, EMBO REP, V13, P113, DOI 10.1038/embor.2011.248; Honig M, 2011, KLIN PADIATR, V223, P320, DOI 10.1055/s-0031-1287826; Hofer J, 2013, CLIN J AM SOC NEPHRO, V8, P407, DOI 10.2215/CJN.01260212; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Horn J, 2007, CLIN IMMUNOL, V122, P156, DOI 10.1016/j.clim.2006.10.002; Horn J, 2010, HUM IMMUNOL, V71, P916, DOI 10.1016/j.humimm.2010.06.002; Horwitz MS, 2014, BLOOD, V123, P799, DOI 10.1182/blood-2013-12-539858; Hoshina T, 2011, J CLIN IMMUNOL, V31, P309, DOI 10.1007/s10875-010-9498-y; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hsu AP, 2013, J ALLERGY CLIN IMMUN, V131, P1586, DOI 10.1016/j.jaci.2013.02.038; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Huck K, 2009, J CLIN INVEST, V119, P1350, DOI 10.1172/JCI37901; Hughes CR, 2012, J CLIN INVEST, V122, P814, DOI 10.1172/JCI60224; Hunnangkul S, 2008, ARTHRITIS RHEUM-US, V58, P1116, DOI 10.1002/art.23400; Hussain A, 2011, FEBS J, V278, P2001, DOI 10.1111/j.1742-4658.2011.08134.x; Ibanez VM, 1997, TRANSPL P, V29, P432, DOI 10.1016/S0041-1345(96)00172-8; Ikinciogullari A, 2005, THER APHER DIAL, V9, P137, DOI 10.1111/j.1774-9987.2005.00227.x; Jain A, 2011, BLOOD, V118, P3811, DOI 10.1182/blood-2011-04-351254; Janda A, 2007, PEDIATR TRANSPLANT, V11, P441, DOI 10.1111/j.1399-3046.2007.00702.x; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Janzi M, 2009, CLIN IMMUNOL, V133, P78, DOI 10.1016/j.clim.2009.05.014; Jensenius JC, 2005, ADV EXP MED BIOL, V564, P21; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P2142, DOI 10.1002/art.30378; Jesus AA, 2008, J CLIN IMMUNOL, V28, pS62, DOI 10.1007/s10875-008-9171-x; Jeurissen A, 2007, CLIN CHEM, V53, P505, DOI 10.1373/clinchem.2006.080051; Johnson D, 2006, J MED GENET, V43, P280, DOI 10.1136/jmg.2005.032946; Jorgensen GH, 2013, J CLIN IMMUNOL, V33, P742, DOI 10.1007/s10875-012-9858-x; Joshi PP, 2006, T ROY SOC TROP MED H, V100, P989, DOI 10.1016/j.trstmh.2005.11.003; Junker AK, 2004, CLIN IMMUNOL, V112, P219, DOI 10.1016/j.clim.2004.03.013; Jurk K, 2010, THROMB HAEMOSTASIS, V103, P1053, DOI 10.1160/TH09-10-0689; Jyonouchi S, 2011, PEDIAT ALLERG IMM-UK, V22, P313, DOI 10.1111/j.1399-3038.2010.01136.x; Kainulainen L, 2010, J ALLERGY CLIN IMMUN, V126, P120, DOI 10.1016/j.jaci.2010.04.016; Kamenisch Y, 2009, J INVEST DERM SYMP P, V14, P8, DOI 10.1038/jidsymp.2009.6; Kanai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00234; Kanegane H, 2009, INT J HEMATOL, V89, P716, DOI 10.1007/s12185-009-0322-5; Kang EM, 2012, METHOD ENZYMOL, V507, P125, DOI 10.1016/B978-0-12-386509-0.00007-7; Kang EM, 2011, J ALLERGY CLIN IMMUN, V127, P1319, DOI 10.1016/j.jaci.2011.03.028; Kang HJ, 2011, MOL THER, V19, P2092, DOI 10.1038/mt.2011.166; Kannan S, 2001, PEDIATR NEPHROL, V16, P423, DOI 10.1007/s004670000550; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Karaca E, 2013, GENE, V512, P189, DOI 10.1016/j.gene.2012.10.062; Karamchandani-Patel G, 2011, ANN ALLERG ASTHMA IM, V107, P50, DOI 10.1016/j.anai.2011.03.009; Kaufmann I, 2012, AM J MED SCI, V343, P174, DOI 10.1097/MAJ.0b013e31823484de; Kavuru MS, 2011, EUR RESPIR J, V38, P1361, DOI 10.1183/09031936.00197710; Kawai T, 2012, J CLIN IMMUNOL, V32, P690, DOI 10.1007/s10875-012-9684-1; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Keles S, 2010, PEDIAT ALLERG IMM-UK, V21, P843, DOI 10.1111/j.1399-3038.2010.01010.x; Kelesidis T, 2010, CLIN IMMUNOL, V135, P347, DOI 10.1016/j.clim.2010.01.006; Keller MD, 2013, PEDIATRICS, V131, pE629, DOI 10.1542/peds.2012-0899; Kemp A, 2008, J PAEDIATR CHILD H, V44, P155, DOI 10.1111/j.1440-1754.2007.01283.x; Khan WN, 2012, J IMMUNOL, V188, P2933, DOI 10.4049/jimmunol.1200490; Khanna N, 2008, CLIN INFECT DIS, V46, P402, DOI 10.1086/525263; Kilic SS, 2012, J PEDIATR-US, V160, P1055, DOI 10.1016/j.jpeds.2012.01.056; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kishimoto K, 2014, CLIN IMMUNOL, V153, P17, DOI 10.1016/j.clim.2014.03.014; Klein Christoph, 2009, Hematology Am Soc Hematol Educ Program, P344, DOI 10.1182/asheducation-2009.1.344; Kohn DB, 2010, CLIN IMMUNOL, V135, P247, DOI 10.1016/j.clim.2009.12.003; Koker MY, 2010, PEDIATR INFECT DIS J, V29, P190, DOI 10.1097/INF.0b013e3181c09067; Kollios K, 2011, J PEDIATR ENDOCR MET, V24, P599, DOI 10.1515/JPEM.2011.012; Kondratenko I, 2007, ADV EXP MED BIOL, V601, P61; Kotlarz D, 2013, J EXP MED, V210, P433, DOI 10.1084/jem.20111229; Kraus CL, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-14; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Kristinsson VH, 2001, PEDIATR HEMAT ONCOL, V18, P167, DOI 10.1080/08880010151114741; Krivan G, 2010, EUR J HAEMATOL, V84, P274, DOI 10.1111/j.1600-0609.2009.01368.x; Kroger Andrew T., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kuemmerle-Deschner JB, 2013, THER ADV MUSCULOSKEL, V5, P315, DOI 10.1177/1759720X13502629; Kuijpers TW, 2011, BLOOD, V117, P5892, DOI 10.1182/blood-2011-01-329052; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Kulinski JM, 2012, J VIROL, V86, P12826, DOI 10.1128/JVI.00917-12; Kumanovics A, 2010, J CLIN IMMUNOL, V30, P886, DOI 10.1007/s10875-010-9452-z; Kurnik K, 2013, PLATELETS, V24, P538, DOI 10.3109/09537104.2012.741275; Kuruvilla M, 2013, J ALLER CL IMM-PRACT, V1, P573, DOI 10.1016/j.jaip.2013.09.013; Kutukculer N, 2007, PEDIAT ALLERG IMM-UK, V18, P167, DOI 10.1111/j.1399-3038.2006.00491.x; Kutukculer N, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-8; Kwan A, 2012, AM J MED GENET A, V158A, P2911, DOI 10.1002/ajmg.a.35604; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; la Marca G, 2013, J ALLERGY CLIN IMMUN, V131, P1604, DOI 10.1016/j.jaci.2012.08.054; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Lalani SR, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.017640; Lambotte O, 2013, HAEMATOLOGICA, V98, P389, DOI 10.3324/haematol.2012.067488; Land MH, 2007, J ALLERGY CLIN IMMUN, V120, P908, DOI 10.1016/j.jaci.2007.08.048; LANDESMAN SH, 1981, REV INFECT DIS, V3, pS184; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Lawrence T, 2005, CURR OPIN HEMATOL, V12, P22, DOI 10.1097/01.moh.0000149609.37309.0a; Lazarczyk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039995; Leach AJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004401.pub2; Lee PPW, 2010, J CLIN IMMUNOL, V30, P121, DOI 10.1007/s10875-009-9341-5; Lee WI, 2013, IMMUNOBIOLOGY, V218, P828, DOI 10.1016/j.imbio.2012.09.001; Lee WI, 2013, IMMUNOBIOLOGY, V218, P762, DOI 10.1016/j.imbio.2012.08.281; Lee WI, 2011, J FORMOS MED ASSOC, V110, P750, DOI 10.1016/j.jfma.2011.11.004; Lee-Kirsch MA, 2014, CLIN EXP IMMUNOL, V175, P17, DOI 10.1111/cei.12160; Leiva LE, 2013, J CLIN IMMUNOL, V33, pS57, DOI 10.1007/s10875-012-9814-9; Lev A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/261470; Lev A, 2009, CLIN IMMUNOL, V133, P375, DOI 10.1016/j.clim.2009.08.017; Lhotta K, 2009, CLIN J AM SOC NEPHRO, V4, P1356, DOI 10.2215/CJN.06281208; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Licameli G, 2008, ARCH OTOLARYNGOL, V134, P136, DOI 10.1001/archoto.2007.7; Licciardi PV, 2012, J ALLERGY CLIN IMMUN, V129, P794, DOI 10.1016/j.jaci.2011.11.043; Lidar M, 2013, J EUR ACAD DERMATOL, V27, P912, DOI 10.1111/j.1468-3083.2011.04442.x; Lilic D, 1996, CLIN EXP IMMUNOL, V105, P205, DOI 10.1046/j.1365-2249.1996.d01-764.x; Lim MTC, 2012, ARCH DIS CHILD, V97, P478, DOI 10.1136/archdischild-2011-300691; Lin JL, 2015, CLIN GENET, V88, P255, DOI 10.1111/cge.12484; Lindholm Paul F., 2011, Infectious Disorders - Drug Targets, V11, P45; Linka RM, 2012, LEUKEMIA, V26, P963, DOI 10.1038/leu.2011.371; Liszewski MK, 2008, VACCINE, V26, pI22, DOI 10.1016/j.vaccine.2008.11.001; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015; Lougaris V, 2008, CURR OPIN ALLERGY CL, V8, P515, DOI 10.1097/ACI.0b013e328314b621; Lucas CL, 2014, J EXP MED, V211, P2537, DOI 10.1084/jem.20141759; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Lutskiy MI, 2002, BLOOD, V100, P2763, DOI 10.1182/blood-2002-02-0388; Lynch M, 2014, PEDIATR DERMATOL, V31, P750, DOI 10.1111/pde.12036; Maarschalk-Ellerbroek LJ, 2013, ENDOSCOPY, V45, P320, DOI 10.1055/s-0032-1326078; Maarschalk-Ellerbroek LJ, 2011, INT J ANTIMICROB AG, V37, P396, DOI 10.1016/j.ijantimicag.2010.11.027; Madkaikar M, 2011, EUR J HAEMATOL, V87, P1, DOI 10.1111/j.1600-0609.2011.01617.x; Mahamid M, 2013, INT J PEDIATR OTORHI, V77, P362, DOI 10.1016/j.ijporl.2012.11.027; MAJEWSKI S, 1990, J AM ACAD DERMATOL, V22, P423, DOI 10.1016/0190-9622(90)70058-P; Majewski S, 2006, INT J DERMATOL, V45, P192, DOI 10.1111/j.1365-4632.2006.02758.x; Malphettes M, 2009, CLIN INFECT DIS, V49, P1329, DOI 10.1086/606059; Maney P, 2009, J PERIODONTOL, V80, P492, DOI [10.1902/jop.2009.080225, 10.1902/jop.2009.080225 ]; Markert ML, 2011, BLOOD, V117, P688, DOI 10.1182/blood-2010-06-292490; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Marodi L, 2010, NEW ENGL J MED, V362, P367, DOI 10.1056/NEJMc0911468; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Marsh RA, 2011, ANN NY ACAD SCI, V1238, P106, DOI 10.1111/j.1749-6632.2011.06265.x; Marsh RA, 2010, J IMMUNOL METHODS, V362, P1, DOI 10.1016/j.jim.2010.08.010; Marsh RA, 2010, BLOOD, V116, P1079, DOI 10.1182/blood-2010-01-256099; Martel C, 2012, J CLIN IMMUNOL, V32, P942, DOI 10.1007/s10875-012-9698-8; Martin E, 2014, NATURE, V510, P288, DOI 10.1038/nature13386; Martin TM, 2009, ARTHRITIS RHEUM, V60, P611, DOI 10.1002/art.24222; Martinez CA, 2012, J ALLERGY CLIN IMMUN, V129, P176, DOI 10.1016/j.jaci.2011.10.005; Martinez-Moczygemba M, 2010, CURR ALLERGY ASTHM R, V10, P320, DOI 10.1007/s11882-010-0134-y; Masri A, 2008, J CHILD NEUROL, V23, P964, DOI 10.1177/0883073808315409; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Masuda Y, 2012, INT J HEMATOL, V95, P239, DOI 10.1007/s12185-012-1008-y; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; McDonald DR, 2010, J ALLERGY CLIN IMMUN, V126, P1304, DOI 10.1016/j.jaci.2010.07.034; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; McGhee SA, 2009, IMMUNOL RES, V45, P37, DOI 10.1007/s12026-009-8108-7; McGrath-Morrow SA, 2010, PEDIATR PULM, V45, P847, DOI 10.1002/ppul.21277; McIlwaine L, 2013, BRIT J HAEMATOL, V160, P735, DOI 10.1111/bjh.12207; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Meeths M, 2010, PEDIATR BLOOD CANCER, V54, P563, DOI 10.1002/pbc.22357; Meinzer U, 2011, SEMIN ARTHRITIS RHEU, V41, P265, DOI 10.1016/j.semarthrit.2010.11.003; Melis D, 2005, EUR J PEDIATR, V164, P501, DOI 10.1007/s00431-005-1657-4; Melki I, 2013, PEDIATRICS, V131, pE1308, DOI 10.1542/peds.2012-2255; Menis M, 2013, AM J HEMATOL, V88, P1035, DOI 10.1002/ajh.23559; Metin A, 2012, PEDIATR TRANSPLANT, V16, P398, DOI 10.1111/j.1399-3046.2011.01641.x; Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40; Micol R, 2011, J ALLERGY CLIN IMMUN, V128, P382, DOI 10.1016/j.jaci.2011.03.052; Milman N, 2006, APMIS, V114, P912, DOI 10.1111/j.1600-0463.2006.apm_522.x; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; Minegishi Y, 2011, ANN NY ACAD SCI, V1246, P34, DOI 10.1111/j.1749-6632.2011.06280.x; Minegishi Y, 2009, INT IMMUNOL, V21, P105, DOI 10.1093/intimm/dxn134; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Montiel-Equihua CA, 2012, CURR GENE THER, V12, P57; Moore SW, 2012, PEDIATR SURG INT, V28, P1045, DOI 10.1007/s00383-012-3175-6; Morales P, 2003, TRANSPL P, V35, P1942, DOI 10.1016/S0041-1345(03)00713-9; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Mori Y, 2002, CLIN NEPHROL, V57, P69; Morimoto AM, 2011, ARTHRITIS RHEUM-US, V63, P2407, DOI 10.1002/art.30399; Moschese V, 2008, INT J IMMUNOPATH PH, V21, P343, DOI 10.1177/039463200802100211; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Moylett EH, 2004, CLIN IMMUNOL, V112, P106, DOI 10.1016/j.clim.2004.02.008; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Murakawa Y, 2012, PEDIATR TRANSPLANT, V16, pE210, DOI 10.1111/j.1399-3046.2011.01545.x; Murray PR, 2010, ARCH DERMATOL, V146, P523, DOI 10.1001/archdermatol.2010.86; Muzaffar J, 2012, INT J HEMATOL, V95, P102, DOI 10.1007/s12185-011-0968-7; Myers KC, 2013, HEMATOL ONCOL CLIN N, V27, P117, DOI 10.1016/j.hoc.2012.10.003; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Nadeau K, 2011, J PEDIATR-US, V158, P701, DOI 10.1016/j.jpeds.2010.12.042; Nargund AR, 2010, J PEDIAT HEMATOL ONC, V32, pE223, DOI 10.1097/MPH.0b013e3181e62663; Nedjai B, 2011, ADV EXP MED BIOL, V691, P409, DOI 10.1007/978-1-4419-6612-4_43; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; Neven B, 2010, ARTHRITIS RHEUM-US, V62, P258, DOI 10.1002/art.25057; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Nishi M, 2012, AM J HEMATOL, V87, P637, DOI 10.1002/ajh.23190; Noone D, 2012, AM J TRANSPLANT, V12, P2546, DOI 10.1111/j.1600-6143.2012.04124.x; Notarangelo LD, 2006, J ALLERGY CLIN IMMUN, V117, P855, DOI 10.1016/j.jaci.2006.01.043; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Nunoi H, 1999, P NATL ACAD SCI USA, V96, P8693, DOI 10.1073/pnas.96.15.8693; Nurden A, 2011, J THROMB HAEMOST, V9, P76, DOI 10.1111/j.1538-7836.2011.04274.x; Oba D, 2010, ACTA NEUROPATHOL, V119, P513, DOI 10.1007/s00401-010-0639-4; Ocampo CJ, 2013, AM J RHINOL ALLERGY, V27, P34, DOI 10.2500/ajra.2013.27.3831; Ochs HD, 2009, BIOL BLOOD MARROW TR, V15, P84, DOI 10.1016/j.bbmt.2008.10.007; Ochs HD, 2002, ISR MED ASSOC J, V4, P379; Ochs HD, 2001, CLIN REV ALLERG IMMU, V20, P61, DOI 10.1385/CRIAI:20:1:61; Ogimi C, 2011, PEDIATR BLOOD CANCER, V57, P677, DOI 10.1002/pbc.23231; Ohashi K, 2012, RESP MED, V106, P284, DOI 10.1016/j.rmed.2011.10.019; Oishi T, 2013, VACCINE, V31, P845, DOI 10.1016/j.vaccine.2012.11.010; Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669; Oliveira JB, 2010, J ALLERGY CLIN IMMUN, V125, pS297, DOI 10.1016/j.jaci.2009.08.043; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Omenetti A, 2013, CLIN EXP RHEUMATOL, V31, pS118; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P961, DOI 10.1016/j.jaci.2013.11.043; Smith O, 2007, PEDIATR BLOOD CANCER, V49, P761, DOI 10.1002/pbc.21081; Garcia MSF, 2014, J BLOOD MED, V5, P157, DOI 10.2147/JBM.S47437; [Anonymous], J ALLERGY CLIN IMMUN; [Anonymous], PRIMARY IMMUNODEFICI; [Anonymous], RED BOOK 2012 REPORT; [Anonymous], PRIMARY IMMUNODEFICI; Meshaal SS, 2019, CLIN EXP IMMUNOL, V195, P202, DOI 10.1111/cei.13222; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Orange JS, 2012, J CLIN INVEST, V122, P798, DOI 10.1172/JCI62620; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Ordonez-Rueda D, 2012, EUR J IMMUNOL, V42, P2395, DOI 10.1002/eji.201242589; Orth G, 2001, J VIROL, V75, P4952, DOI 10.1128/JVI.75.10.4952-4953.2001; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Ouederni M, 2011, BLOOD, V118, P5108, DOI 10.1182/blood-2011-05-352716; Ovesen T, 2011, DAN MED BULL, V58; Ozen A, 2010, CLIN IMMUNOL, V137, P374, DOI 10.1016/j.clim.2010.08.010; Ozen S, 2014, NAT REV RHEUMATOL, V10, P135, DOI 10.1038/nrrheum.2013.174; Ozen S, 2011, J RHEUMATOL, V38, P516, DOI 10.3899/jrheum.100718; Ozkan H, 2005, J INVEST ALLERG CLIN, V15, P69; Ozsahin H, 2008, BLOOD, V111, P439, DOI 10.1182/blood-2007-03-076679; Ozturk MA, 2011, CLIN EXP RHEUMATOL, V29, pS77; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Palma-Carlos A G, 2002, Allerg Immunol (Paris), V34, P208; Palma-Carlos A G, 2001, Allerg Immunol (Paris), V33, P229; Palmer DS, 2010, TRANSFUSION, V50, P1524, DOI 10.1111/j.1537-2995.2010.02588.x; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Papadaki ME, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-S1-S6; Papiris SA, 2014, CLIN DRUG INVEST, V34, P553, DOI 10.1007/s40261-014-0208-z; Paris K, 2007, ANN ALLERG ASTHMA IM, V99, P462, DOI 10.1016/S1081-1206(10)60572-8; Park JH, 2010, CLIN IMMUNOL, V134, P97, DOI 10.1016/j.clim.2009.10.002; Pasic S, 2009, ACTA PAEDIATR, V98, P1062, DOI 10.1111/j.1651-2227.2009.01250.x; Patel K, 2012, J PEDIATR-US, V161, P950, DOI 10.1016/j.jpeds.2012.06.018; Patel NC, 2010, NEW ENGL J MED, V362, P314, DOI 10.1056/NEJMoa0904485; Patel Sandeep M, 2012, Can Respir J, V19, P243; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Pereira LF, 2002, SCAND J INFECT DIS, V34, P785, DOI 10.1080/00365540260348662; Perez EE, 2003, PEDIATRICS, V112, pE325, DOI 10.1542/peds.112.4.e325; Peridis S, 2010, INT J PEDIATR OTORHI, V74, P1203, DOI 10.1016/j.ijporl.2010.08.014; Perlman Susan, 2003, Semin Pediatr Neurol, V10, P173, DOI 10.1016/S1071-9091(03)00026-3; Permaul P, 2009, IMMUNOL RES, V44, P89, DOI 10.1007/s12026-008-8085-2; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Pessach IM, 2011, J ALLERGY CLIN IMMUN, V127, P1344, DOI 10.1016/j.jaci.2011.02.027; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Pickering M, 2011, CURR OPIN NEPHROL HY, V20, P271, DOI 10.1097/MNH.0b013e328345848b; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Pignata C, 2009, ADV EXP MED BIOL, V665, P195; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Podjasek JC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00189; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Ponranjini VC, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.103018; Powar R M, 2006, Indian J Med Microbiol, V24, P72; POZZETTO B, 1984, J INFECT DIS, V150, P707, DOI 10.1093/infdis/150.5.707; Puel A, 2012, CURR OPIN ALLERGY CL, V12, P616, DOI 10.1097/ACI.0b013e328358cc0b; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Punatar AD, 2012, J INFECTION, V65, P173, DOI 10.1016/j.jinf.2012.03.020; Qamar N, 2014, CLIN REV ALLERG IMMU, V46, P120, DOI 10.1007/s12016-013-8378-7; Quartier P, 2000, PEDIATR INFECT DIS J, V19, P1106, DOI 10.1097/00006454-200011000-00020; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Rachid R, 2012, J ALLERGY CLIN IMMUN, V129, P628, DOI 10.1016/j.jaci.2011.06.047; Rachid R, 2011, J ALLERGY CLIN IMMUN, V128, P228, DOI 10.1016/j.jaci.2011.01.061; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Ramot Y, 2010, INT J PEDIATR OTORHI, V74, P825, DOI 10.1016/j.ijporl.2010.03.053; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Rao VK, 2011, BLOOD, V118, P5741, DOI 10.1182/blood-2011-07-325217; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Reichenberger EJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-S1-S5; Renner ED, 2009, J ALLERGY CLIN IMMUN, V124, P536, DOI 10.1016/j.jaci.2009.06.009; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Ricci G, 2011, INT J IMMUNOPATH PH, V24, P721, DOI 10.1177/039463201102400318; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Rieux-Laucat F, 2010, HAEMATOL-HEMATOL J, V95, P1805, DOI 10.3324/haematol.2010.030395; Rihani R, 2012, PEDIATR TRANSPLANT, V16, pE99, DOI 10.1111/j.1399-3046.2010.01461.x; Rizzi M, 2011, J ALLERGY CLIN IMMUN, V128, P1371, DOI 10.1016/j.jaci.2011.07.055; Roberts JL, 2012, P NATL ACAD SCI USA, V109, P10456, DOI 10.1073/pnas.1202249109; Roesler J, 2004, J PEDIATR-US, V145, P806, DOI 10.1016/j.jpeds.2004.08.021; Roifman CM, 2006, J ALLERGY CLIN IMMUN, V117, P897, DOI 10.1016/j.jaci.2006.01.003; Roifman CM, 2000, PEDIATR RES, V48, P6, DOI 10.1203/00006450-200007000-00004; Romero-Quintana JG, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-7; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Rose CD, 2011, CURR OPIN RHEUMATOL, V23, P411, DOI 10.1097/BOR.0b013e328349c430; Rosen LB, 2013, J IMMUNOL, V190, P3959, DOI 10.4049/jimmunol.1202526; Rosenberg PS, 2010, BRIT J HAEMATOL, V150, P196, DOI 10.1111/j.1365-2141.2010.08216.x; Rossi A, 2009, DERMATOLOGY, V218, P376, DOI 10.1159/000203646; Rowczenio DM, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4171; Roxo P, 2013, PEDIATR PULM, V48, P81, DOI 10.1002/ppul.22532; Rubinstein A, 2000, AIDS, V14, pF55, DOI 10.1097/00002030-200003100-00004; Sabnis GR, 2011, NEUROL INDIA, V59, P435, DOI 10.4103/0028-3886.82768; Sabnis H, 2010, PEDIATR BLOOD CANCER, V55, P180, DOI 10.1002/pbc.22386; Salavoura K, 2008, ANTICANCER RES, V28, P1263; Salehi T, 2012, IRAN J ALLERGY ASTHM, V11, P51, DOI 011.01/ijaai.5156; Salt BH, 2008, J ALLERGY CLIN IMMUN, V121, P976, DOI 10.1016/j.jaci.2007.11.014; Salzer E, 2013, HAEMATOLOGICA, V98, P473, DOI 10.3324/haematol.2012.068791; Salzer U, 2009, BLOOD, V113, P1967, DOI 10.1182/blood-2008-02-141937; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Samuels ME, 2013, J MED GENET, V50, P324, DOI 10.1136/jmedgenet-2012-101483; Sanal O, 2012, J CLIN IMMUNOL, V32, P698, DOI 10.1007/s10875-012-9664-5; Sanchez GAM, 2013, RHEUM DIS CLIN N AM, V39, P701, DOI 10.1016/j.rdc.2013.08.001; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sasa GS, 2012, CLIN GENET, V81, P470, DOI 10.1111/j.1399-0004.2011.01658.x; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Sauer AV, 2009, CURR OPIN ALLERGY CL, V9, P496, DOI 10.1097/ACI.0b013e3283327da5; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Scaglia PA, 2012, J CLIN ENDOCR METAB, V97, pE830, DOI 10.1210/jc.2011-2554; Schackert HK, 2014, INT J DERMATOL, V53, P885, DOI 10.1111/j.1365-4632.2012.05769.x; Schatorje EJH, 2011, SCAND J IMMUNOL, V74, P502, DOI 10.1111/j.1365-3083.2011.02609.x; Schimke LF, 2010, J ALLERGY CLIN IMMUN, V126, P611, DOI 10.1016/j.jaci.2010.06.029; Schlapbach LJ, 2011, GUT, V60, P1438, DOI 10.1136/gut.2010.226027; Schmid JP, 2012, J EXP MED, V209, P2323, DOI 10.1084/jem.20121303; Schmid JP, 2009, BLOOD, V114, P211, DOI 10.1182/blood-2009-02-207845; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Schutze GE, 2002, PEDIATR INFECT DIS J, V21, P278, DOI 10.1097/00006454-200204000-00004; Schwarze-Zander C, 2010, J CLIN MICROBIOL, V48, P4672, DOI 10.1128/JCM.01350-10; Scott-Algara D, 2010, BLOOD, V115, P3708, DOI 10.1182/blood-2009-02-202796; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; Seidel MG, 2012, J ALLERGY CLIN IMMUN, V129, P1175, DOI 10.1016/j.jaci.2012.01.053; Selim MA, 2008, J CUTAN PATHOL, V35, P380, DOI 10.1111/j.1600-0560.2007.00816.x; Seymour JF, 2003, THORAX, V58, P252, DOI 10.1136/thorax.58.3.252; Sfriso P, 2012, AUTOIMMUN REV, V12, P44, DOI 10.1016/j.autrev.2012.07.028; Shackelford P G, 1993, Pediatr Rev, V14, P291, DOI 10.1542/pir.14-8-291; Shah SS, 2009, J ALLERGY CLIN IMMUN, V124, P1363, DOI 10.1016/j.jaci.2009.10.049; Sharp SE, 2011, J CLIN MICROBIOL, V49, P483, DOI 10.1128/JCM.02020-10; Shaw RK, 2012, BLOOD, V119, P4009, DOI 10.1182/blood-2011-10-385377; Shearer WT, 2007, J ALLERGY CLIN IMMUN, V120, P982, DOI 10.1016/j.jaci.2007.08.042; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Shearer WT, 1996, ANN ALLERG ASTHMA IM, V76, P282, DOI 10.1016/S1081-1206(10)63442-4; Shekelle PG, 1999, WESTERN J MED, V170, P348; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Sibley CH, 2012, ARTHRITIS RHEUM-US, V64, P2375, DOI 10.1002/art.34409; Sieni E, 2012, CELL MOL LIFE SCI, V69, P29, DOI 10.1007/s00018-011-0835-y; Siepermann M, 2011, PEDIATR TRANSPLANT, V15, pE80, DOI 10.1111/j.1399-3046.2010.01292.x; Sim BTT, 2013, J CLIN IMMUNOL, V33, P1057, DOI 10.1007/s10875-013-9908-z; Simon A, 2004, CLIN PHARMACOL THER, V75, P476, DOI 10.1016/j.clpt.2004.01.012; Skokowa J, 2012, NAT MED, V18, P1550, DOI 10.1038/nm.2958; Smith EJ, 2010, CURR GENOMICS, V11, P519, DOI 10.2174/138920210793175921; Smitt JHS, 2013, CURR OPIN PEDIATR, V25, P492, DOI 10.1097/MOP.0b013e3283623b9f; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; So A, 2013, NAT REV RHEUMATOL, V9, P391, DOI 10.1038/nrrheum.2013.61; Sokolic R, 2013, CURR OPIN HEMATOL, V20, P55, DOI 10.1097/MOH.0b013e32835aef1c; Solomons HD, 2012, CARDIOVASC J AFR, V23, P312; Somech R, 2013, IMMUNOL RES, V56, P150, DOI 10.1007/s12026-012-8380-9; Sonal Choudhary, 2012, J Clin Aesthet Dermatol, V5, P18; Sorensen RU, 1996, PEDIATR PULM, V22, P167, DOI 10.1002/(SICI)1099-0496(199609)22:3<167::AID-PPUL5>3.0.CO;2-M; Soresina A, 2009, J CLIN IMMUNOL, V29, P501, DOI 10.1007/s10875-008-9270-8; Sowerwine KJ, 2012, ANN NY ACAD SCI, V1250, P25, DOI 10.1111/j.1749-6632.2011.06387.x; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Speckmann C, 2008, BLOOD, V112, P4090, DOI 10.1182/blood-2008-04-153361; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Sridhar G, 2014, TRANSFUSION, V54, P2553, DOI 10.1111/trf.12663; Stagi S, 2014, INT J PEDIATR OTORHI, V78, P964, DOI 10.1016/j.ijporl.2014.03.026; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; Steichen O, 2009, J RHEUMATOL, V36, P1677, DOI 10.3899/jrheum.081313; Stepensky P, 2013, BLOOD, V121, P5078, DOI 10.1182/blood-2012-12-475566; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Stepensky P, 2011, HAEMATOL-HEMATOL J, V96, P472, DOI 10.3324/haematol.2010.033910; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stichweh DS, 2005, PEDIATR DERMATOL, V22, P262, DOI 10.1111/j.1525-1470.2005.22320.x; Stiehm ER, 2008, J IMMUNOTOXICOL, V5, P227, DOI 10.1080/15476910802129646; Stoffels M, 2011, CURR OPIN RHEUMATOL, V23, P419, DOI 10.1097/BOR.0b013e328349c3b1; Stojanov S, 2011, P NATL ACAD SCI USA, V108, P7148, DOI 10.1073/pnas.1103681108; Stone KD, 2009, CLIN IMMUNOL, V131, P41, DOI 10.1016/j.clim.2008.11.003; Stray-Pedersen A, 2004, CLIN EXP IMMUNOL, V137, P179, DOI 10.1111/j.1365-2249.2004.02492.x; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Strobel S, 2011, KIDNEY INT, V80, P397, DOI 10.1038/ki.2011.152; Sullivan KE, 2008, IMMUNOL ALLERGY CLIN, V28, P353, DOI 10.1016/j.iac.2008.01.003; Suzuki T, 2010, AM J RESP CRIT CARE, V182, P1292, DOI 10.1164/rccm.201002-0271OC; Takada H, 2004, BLOOD, V103, P185, DOI 10.1182/blood-2003-06-1964; Tardieu M, 2005, BLOOD, V106, P40, DOI 10.1182/blood-2005-01-0319; Taskinen M, 2013, J PEDIATR-US, V162, P844, DOI 10.1016/j.jpeds.2012.09.050; Tazawa R, 2014, CHEST, V145, P729, DOI 10.1378/chest.13-0603; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Teachey DT, 2012, CURR OPIN PEDIATR, V24, P1, DOI 10.1097/MOP.0b013e32834ea739; ter Haar NM, 2014, CURR OPIN RHEUMATOL, V26, P252, DOI 10.1097/BOR.0000000000000059; Tewari P, 2012, BIOL BLOOD MARROW TR, V18, P1368, DOI 10.1016/j.bbmt.2012.02.002; Thiel CT, 2011, BEST PRACT RES CL EN, V25, P131, DOI 10.1016/j.beem.2010.08.004; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Thielen N, 2010, J THROMB HAEMOST, V8, P1643, DOI 10.1111/j.1538-7836.2010.03898.x; Tison BE, 2011, J ALLERGY CLIN IMMUN, V128, P1115, DOI 10.1016/j.jaci.2011.06.043; Tofteland ND, 2010, JCR-J CLIN RHEUMATOL, V16, P244, DOI 10.1097/RHU.0b013e3181e969b9; Tommasini A, 2012, PEDIATR BLOOD CANCER, V58, P310, DOI 10.1002/pbc.23205; Torgerson TR, 2013, J CLIN IMMUNOL, V33, pS87, DOI 10.1007/s10875-012-9845-2; Torrelo A, 2010, J AM ACAD DERMATOL, V62, P489, DOI 10.1016/j.jaad.2009.04.046; Touw IP, 2007, JNCI-J NATL CANCER I, V99, P183, DOI 10.1093/jnci/djk057; Trahair TN, 2008, PEDIATR BLOOD CANCER, V50, P366, DOI 10.1002/pbc.20887; Trakadis YJ, 2014, J INHERIT METAB DIS, V37, P461, DOI 10.1007/s10545-013-9664-5; Tran H, 2008, BLOOD REV, V22, P261, DOI 10.1016/j.blre.2008.03.009; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Turvey SE, 2012, J CLIN IMMUNOL, V32, P1404, DOI 10.1007/s10875-012-9750-8; Ussowicz M, 2013, BONE MARROW TRANSPL, V48, P740, DOI 10.1038/bmt.2012.207; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; Vaitla PM, 2011, ARTHRITIS RHEUM-US, V63, P1151, DOI 10.1002/art.30215; Vale AM, 2010, J ALLERGY CLIN IMMUN, V125, P778, DOI 10.1016/j.jaci.2010.02.018; van de Ven AAJM, 2010, CLIN IMMUNOL, V135, P63, DOI 10.1016/j.clim.2009.11.010; van den Bruele T, 2010, EUR J CLIN MICROBIOL, V29, P1315, DOI 10.1007/s10096-010-0999-7; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; van der Hilst JCH, 2008, MEDICINE, V87, P301, DOI 10.1097/MD.0b013e318190cfb7; Van Eyck L, 2015, J ALLERGY CLIN IMMUN, V135, P283, DOI 10.1016/j.jaci.2014.10.010; van Montfrans JM, 2012, J ALLERGY CLIN IMMUN, V129, P787, DOI 10.1016/j.jaci.2011.11.013; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vigliano I, 2011, J MED GENET, V48, P413, DOI 10.1136/jmg.2011.089532; Vigo G, 2012, AUTOIMMUN REV, V12, P52, DOI 10.1016/j.autrev.2012.07.021; Vilboux T, 2013, NEW ENGL J MED, V369, P54, DOI 10.1056/NEJMoa1301296; Villa A, 2008, J ALLERGY CLIN IMMUN, V122, P1082, DOI 10.1016/j.jaci.2008.09.037; Villard J, 2001, MEDICINE, V80, P405, DOI 10.1097/00005792-200111000-00006; Vinh DC, 2010, BLOOD, V115, P1519, DOI 10.1182/blood-2009-03-208629; Vitale A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/939847; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wada T, 2013, J CLIN IMMUNOL, V33, P857, DOI 10.1007/s10875-012-9859-9; Wada T, 2011, J PEDIATR-US, V158, P342, DOI 10.1016/j.jpeds.2010.07.057; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Walker PLC, 2011, NUCLEOS NUCLEOT NUCL, V30, P1243, DOI 10.1080/15257770.2011.630852; Wang HY, 2013, P NATL ACAD SCI USA, V110, P5127, DOI 10.1073/pnas.1221211110; Wang LH, 2012, J MICROBIOL IMMUNOL, V45, P411, DOI 10.1016/j.jmii.2012.08.017; Wang N, 2012, CURR OPIN ALLERGY CL, V12, P602, DOI 10.1097/ACI.0b013e3283594219; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Wang T, 2012, CLIN IMMUNOL, V145, P102, DOI 10.1016/j.clim.2012.07.016; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Warnatz K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00210; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wasserman RL, 1999, PEDIATR INFECT DIS J, V18, P157, DOI 10.1097/00006454-199902000-00016; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Weemaes CMR, 2013, EUR J HUM GENET, V21, P1219, DOI 10.1038/ejhg.2013.40; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Wen L, 2004, J ALLERGY CLIN IMMUN, V113, P585, DOI 10.1016/j.jaci.2004.02.003; Westerberg LS, 2010, J EXP MED, V207, P1145, DOI 10.1084/jem.20091245; Whaley MJ, 2010, CLIN VACCINE IMMUNOL, V17, P862, DOI 10.1128/CVI.00022-10; Whelan MA, 2006, J CLIN IMMUNOL, V26, P7, DOI 10.1007/s10875-006-8144-1; Winkelstein JA, 2008, MEDICINE, V87, P253, DOI 10.1097/MD.0b013e318187ed81; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Woellner C, 2010, J ALLERGY CLIN IMMUN, V125, P424, DOI 10.1016/j.jaci.2009.10.059; Wollina U, 2014, WIEN MED WOCHENSCHR, V164, P263, DOI 10.1007/s10354-014-0285-x; Wong GK, 2013, CLIN EXP IMMUNOL, V172, P63, DOI 10.1111/cei.12039; Wood P, 2007, CLIN EXP IMMUNOL, V149, P410, DOI 10.1111/j.1365-2249.2007.03432.x; Wulffraat NM, 2013, EXPERT OPIN BIOL TH, V13, P615, DOI 10.1517/14712598.2013.778239; Wynn RF, 2006, GUT, V55, P292, DOI 10.1136/gut.2005.081927; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; YAMAMOTO S, 1995, CLIN CHEM, V41, P586; Yang D, 2011, J BIOL CHEM, V286, P23022, DOI 10.1074/jbc.M111.225870; Yasui K, 2010, ARTHRITIS RHEUM-US, V62, P250, DOI 10.1002/art.25035; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7; Yong PFK, 2009, IMMUNOL REV, V229, P101, DOI 10.1111/j.1600-065X.2009.00764.x; Yong PL, 2008, J CLIN IMMUNOL, V28, P581, DOI 10.1007/s10875-008-9196-1; Yong PL, 2010, CLIN IMMUNOL, V135, P255, DOI 10.1016/j.clim.2009.10.003; Yu GP, 2011, PEDIATR TRANSPLANT, V15, P733, DOI 10.1111/j.1399-3046.2011.01563.x; Yu XM, 2014, J ALLERGY CLIN IMMUN, V133, P1109, DOI 10.1016/j.jaci.2013.11.018; Zhan H, 2008, PEDIATRICS, V121, pE998, DOI 10.1542/peds.2007-1863; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013; Zhao M, 2011, CYTOM PART B-CLIN CY, V80B, P8, DOI 10.1002/cyto.b.20552; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006; Zielen S, 2000, INFECT IMMUN, V68, P1435, DOI 10.1128/IAI.68.3.1435-1440.2000; Zimmer J, 2005, QJM-INT J MED, V98, P719, DOI 10.1093/qjmed/hci112; Zimmer J, 2012, IMMUNOL LETT, V143, P218, DOI 10.1016/j.imlet.2012.01.007; Zonios DI, 2008, BLOOD, V112, P287, DOI 10.1182/blood-2007-12-127878; Zubakov D, 2010, CURR BIOL, V20, pR970, DOI 10.1016/j.cub.2010.10.022	766	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5												78	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CW1YE					2022-12-18	WOS:000364787200007
J	Miettinen, R; Hermansson, H; Merikukka, M; Gissler, M; Isolauri, E				Miettinen, Reetta; Hermansson, Henriina; Merikukka, Marko; Gissler, Mika; Isolauri, Erika			Mode of delivery-impact on risk of noncommunicable diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							WEIGHT-GAIN; PREGNANCY; OBESITY		[Miettinen, Reetta; Hermansson, Henriina; Isolauri, Erika] Turku Univ Hosp, Dept Pediat & Adolescent Med, FIN-20520 Turku, Finland; [Merikukka, Marko] THL Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Gissler, Mika] THL Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] NHV Nord Sch Publ Hlth, Gothenburg, Sweden	University of Turku; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Miettinen, R (corresponding author), Turku Univ Hosp, Dept Pediat & Adolescent Med, FIN-20520 Turku, Finland.	rhmiet@utu.fi		Gissler, Mika/0000-0001-8254-7525				Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Graham LE, 2014, BIRTH-ISS PERINAT C, V41, P93, DOI 10.1111/birt.12095; Harpsoe MC, 2013, J ALLERGY CLIN IMMUN, V131, P1033, DOI 10.1016/j.jaci.2012.09.008; Kohlhuber M, 2008, BRIT J NUTR, V99, P1127, DOI 10.1017/S0007114508864835; Paananen R, 2012, INT J EPIDEMIOL, V41, P941, DOI 10.1093/ije/dyr035; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637	9	8	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5					1398	1399		10.1016/j.jaci.2015.05.032	http://dx.doi.org/10.1016/j.jaci.2015.05.032			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CW1YE	26148799	Green Submitted			2022-12-18	WOS:000364787200030
J	Ronka, AL; Kinnunen, TT; Goudet, A; Rytkonen-Nissinen, MA; Sairanen, J; Kailaanmaki, AHT; Randell, JT; Maillere, B; Virtanen, TI				Ronka, Aino L.; Kinnunen, Tuure T.; Goudet, Amelie; Rytkonen-Nissinen, Marja A.; Sairanen, Joni; Kailaanmaki, Anssi H. T.; Randell, Jukka T.; Maillere, Bernard; Virtanen, Tuomas I.			Characterization of human memory CD4(+) T-cell responses to the dog allergen Can f 4	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Memory T cells; T(H)1/T(H)2; T-cell epitope; HLA class II; Can f 4; lipocalin allergen; peptide; allergy; immunotherapy	HLA-DR; IMMUNOLOGICAL CHARACTERIZATION; LIPOCALIN ALLERGENS; CROSS-REACTIVITY; IMMUNOGLOBULIN-E; IMMUNE-RESPONSE; PEPTIDE ANTIGEN; COW DANDER; IMMUNOTHERAPY; INDIVIDUALS	Background: The recently identified dog lipocalin allergen Can f 4 is an important respiratory allergen. Objective: We sought to comprehensively characterize the memory CD4(+) T-cell responses of allergic and nonallergic subjects to Can f 4. Methods: Can f 4-specific CD4(+) CD45RO 1 T-cell lines (TCLs) from allergic and healthy subjects were established and characterized by their functional and phenotypic properties. The epitope specificity of the TCLs was tested with 48 overlapping 16-mer peptides spanning the sequence of Can f 4. HLA restriction of the specific TCLs and the binding capacity of the epitope-containing peptides to common HLA class II molecules were studied. Results: Can f 4-specific memory CD4(+) TCLs were obtained at an 8-fold higher frequency from allergic than from nonallergic subjects. Functionally, the TCLs of allergic subjects exhibited a higher T-cell receptor avidity and expression of CD25 and predominantly produced IL-4 and IL-5. The TCLs of nonallergic subjects mostly secreted IFN-gamma and IL-10, with high CXCR3 expression. Several distinct T-cell epitope regions along the allergen were identified. Importantly, the peptides from the region between amino acids 43 and 67 showed promiscuous HLA-binding capacity and induced memory CD4(+) T-cell responses in 90% of the allergic donors. Conclusion: Productive T(H)2-deviated memory T-cell responses to Can f 4 are observed in allergic but not nonallergic subjects. A 19-mer peptide sequence covering the core of the immunodominant region of the allergen is a potential target for the development of peptide-based allergen immunotherapy.	[Ronka, Aino L.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Sairanen, Joni; Kailaanmaki, Anssi H. T.; Virtanen, Tuomas I.] Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, Kuopio 70211, Finland; [Ronka, Aino L.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Sairanen, Joni; Kailaanmaki, Anssi H. T.; Virtanen, Tuomas I.] Univ Eastern Finland, Bioctr Kuopio, Kuopio 70211, Finland; [Rytkonen-Nissinen, Marja A.] Univ Eastern Finland, Sch Med, Inst Dent, Kuopio 70211, Finland; [Randell, Jukka T.] Kuopio Univ Hosp, Dept Pulm Dis, Kuopio, Finland; [Goudet, Amelie; Maillere, Bernard] CEA, Inst Biol & Technol, Serv Ingn Mol Prot, Gif Sur Yvette, France	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; CEA; UDICE-French Research Universities; Universite Paris Saclay	Ronka, AL (corresponding author), Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, POB 1627, Kuopio 70211, Finland.	aino.liukko@uef.fi	Kinnunen, Tuure/D-4898-2011	Kinnunen, Tuure/0000-0003-1595-5371; Rytkonen-Nissinen, Marja/0000-0002-2014-8315; Sairanen, Joni/0000-0003-1946-1475; Kailaanmaki, Anssi/0000-0002-4737-980X; Ronka, Aino/0000-0001-6007-3648				Akdis M, 2006, CURR OPIN IMMUNOL, V18, P738, DOI 10.1016/j.coi.2006.06.003; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; Doherty DG, 1998, J IMMUNOL, V161, P3527; Fellrath JM, 2003, J ALLERGY CLIN IMMUN, V111, P854, DOI 10.1067/mai.2003.1337; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Frew AJ, 2010, J ALLERGY CLIN IMMUN, V125, pS306, DOI 10.1016/j.jaci.2009.10.064; Fu T, 2014, PEDIATR DERMATOL, V31, P21, DOI 10.1111/pde.12237; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Hermann R, 2003, TISSUE ANTIGENS, V62, P162, DOI 10.1034/j.1399-0039.2003.00071.x; Immonen A, 2005, J IMMUNOL, V175, P3614, DOI 10.4049/jimmunol.175.6.3614; Jahn-Schmid B, 2010, J ALLERGY CLIN IMMUN, V126, P1068, DOI 10.1016/j.jaci.2010.05.038; Juntunen R, 2009, MOL IMMUNOL, V46, P3320, DOI 10.1016/j.molimm.2009.07.022; Kailaanmaki A, 2014, IMMUNOLOGY, V141, P52, DOI 10.1111/imm.12166; Kauppinen A, 2012, IMMUNOBIOLOGY, V217, P8, DOI 10.1016/j.imbio.2011.08.012; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kinnunen T, 2010, EUR J IMMUNOL, V40, P2460, DOI 10.1002/eji.201040328; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; KRIEGER JI, 1991, J IMMUNOL, V146, P2331; Kwok WW, 2010, J ALLERGY CLIN IMMUN, V125, P1407, DOI 10.1016/j.jaci.2010.03.037; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Liukko ALK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098461; Macaubas C, 2006, J IMMUNOL, V176, P5069, DOI 10.4049/jimmunol.176.8.5069; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mattsson L, 2010, CLIN EXP ALLERGY, V40, P1276, DOI 10.1111/j.1365-2222.2010.03533.x; Mattsson L, 2009, J ALLERGY CLIN IMMUN, V123, P362, DOI 10.1016/j.jaci.2008.11.021; Mobs C, 2012, J ALLERGY CLIN IMMUN, V130, P1108, DOI 10.1016/j.jaci.2012.07.056; Niemi MH, 2014, MOL IMMUNOL, V61, P7, DOI 10.1016/j.molimm.2014.04.003; Nilsson OB, 2012, ALLERGY, V67, P751, DOI 10.1111/j.1398-9995.2012.02826.x; Oseroff C, 2012, J IMMUNOL, V189, P679, DOI 10.4049/jimmunol.1200694; Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405; Parviainen S, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.06.005; Patel D, 2013, J ALLERGY CLIN IMMUN, V131, P103, DOI 10.1016/j.jaci.2012.07.028; Ronmark E, 2003, PEDIAT ALLERG IMM-UK, V14, P91, DOI 10.1034/j.1399-3038.2003.00042.x; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Saarelainen S, 2004, CLIN EXP ALLERGY, V34, P1576, DOI 10.1111/j.1365-2222.2004.02071.x; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SPITZAUER S, 1994, J ALLERGY CLIN IMMUN, V93, P614, DOI 10.1016/S0091-6749(94)70073-7; Texier C, 2000, J IMMUNOL, V164, P3177, DOI 10.4049/jimmunol.164.6.3177; Van Overtvelt L, 2008, J IMMUNOL, V180, P4514, DOI 10.4049/jimmunol.180.7.4514; Virtanen T, 2012, CLIN EXP ALLERGY, V42, P494, DOI 10.1111/j.1365-2222.2011.03903.x; Wambre E, 2011, CLIN EXP ALLERGY, V41, P192, DOI 10.1111/j.1365-2222.2010.03641.x; Wambre E, 2014, J ALLERGY CLIN IMMUN, V133, P872, DOI 10.1016/j.jaci.2013.10.054; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Woodfolk JA, 2007, J ALLERGY CLIN IMMUN, V119, P280, DOI 10.1016/j.jaci.2006.11.008	46	8	9	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1047	+		10.1016/j.jaci.2015.02.025	http://dx.doi.org/10.1016/j.jaci.2015.02.025			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CT7EJ	25843313				2022-12-18	WOS:000362976300023
J	Uphoff, EP; Cabieses, B; Wright, J; Pickett, KE				Uphoff, Eleonora P.; Cabieses, Baltica; Wright, John; Pickett, Kate E.			International prevalence rates of asthma and allergy are associated with income inequality	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HEALTH; SYMPTOMS		[Uphoff, Eleonora P.; Cabieses, Baltica; Pickett, Kate E.] Univ York, York YO10 5DD, N Yorkshire, England; [Cabieses, Baltica] Univ Desarrollo, Santiago, Chile; [Wright, John] Bradford Inst Hlth Res, Bradford, W Yorkshire, England	University of York - UK; Universidad del Desarrollo	Uphoff, EP (corresponding author), Univ York, York YO10 5DD, N Yorkshire, England.	noortjeuphoff@gmail.com	Wright, John/H-1624-2012; Cabieses, Baltica/V-5024-2017	Wright, John/0000-0001-9572-7293; Cabieses, Baltica/0000-0003-0756-1954; Uphoff, Eleonora/0000-0002-9759-2502	MRC [MR/K006665/1] Funding Source: UKRI; National Institute for Health Research [CSA/03/07/014] Funding Source: researchfish; Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: Medline; Department of Health [CSA/03/07/014] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Asher MI, 2012, ALLERGOL IMMUNOPATH, V40, P267, DOI 10.1016/j.aller.2011.11.004; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Mallol J, 2013, ALLERGOL IMMUNOPATH, V41, P73, DOI 10.1016/j.aller.2012.03.001; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Sembajwe G, 2010, EUR RESPIR J, V35, P279, DOI 10.1183/09031936.00027509; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; Sturm R, 2002, BMJ-BRIT MED J, V324, P20, DOI 10.1136/bmj.324.7328.20; World Bank, WORLD BANK LIST EC	9	8	8	0	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2015	136	1					189	190		10.1016/j.jaci.2015.01.037	http://dx.doi.org/10.1016/j.jaci.2015.01.037			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CM2WE	25794657				2022-12-18	WOS:000357542200021
J	Desai, AG; Togias, A; Schechter, C; Fisher, B; Parow, A; Skloot, G				Desai, Alpa G.; Togias, Alkis; Schechter, Clyde; Fisher, Beth; Parow, Aimee; Skloot, Gwen			Peripheral airways dysfunction in obesity reflects increased bronchomotor tone	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA; LEPTIN; TESTS		[Desai, Alpa G.] SUNY Stony Brook, Dept Med, Div Pulm Crit Care & Sleep Med, Stony Brook, NY 11794 USA; [Togias, Alkis] NIAID, NIH, Bethesda, MD 20892 USA; [Schechter, Clyde] Albert Einstein Coll Med, Dept Family & Social Med, Bronx, NY 10467 USA; [Fisher, Beth; Parow, Aimee; Skloot, Gwen] Icahn Sch Med Mt Sinai, Dept Med, Div Pulm Crit Care Sleep Med, New York, NY 10029 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Desai, AG (corresponding author), SUNY Stony Brook, Dept Med, Div Pulm Crit Care & Sleep Med, Stony Brook, NY 11794 USA.	Alpa.Desai@stonybrookmedicine.edu		Togias, Alkis/0000-0001-9009-5717				Arteaga-Solis E, 2013, CELL METAB, V17, P35, DOI 10.1016/j.cmet.2012.12.004; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Newson RB, 2014, CLIN EXP ALLERGY, V44, P250, DOI 10.1111/cea.12221; Nie ZY, 2014, AM J RESP CELL MOL, V51, P251, DOI 10.1165/rcmb.2013-0452OC; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Skloot G, 2011, J APPL PHYSIOL, V111, P726, DOI 10.1152/japplphysiol.01155.2010	10	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2015	135	3					820	822		10.1016/j.jaci.2014.09.016	http://dx.doi.org/10.1016/j.jaci.2014.09.016			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CD4PF	25441295				2022-12-18	WOS:000351065000033
J	Simpson, E; Worm, M; Soong, W; Blauvelt, A; Eckert, L; Wu, R; Ardeleanu, M; Graham, N; Pirozzi, G; Sutherland, ER; Mastey, V				Simpson, Eric; Worm, Margitta; Soong, Weily; Blauvelt, Andrew; Eckert, Laurent; Wu, Richard; Ardeleanu, Marius; Graham, Neil; Pirozzi, Gianluca; Sutherland, E. Rand; Mastey, Vera			Dupilumab Improves Patient-Reported Outcomes (PROs) in a Phase 2 Study in Adults with Moderate-to-Severe Atopic Dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Simpson, Eric] OHSU, Portland, OR USA; [Worm, Margitta] Charite, D-13353 Berlin, Germany; [Soong, Weily] Alabama Allergy & Asthma Ctr, Birmingham, AL USA; [Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA; [Eckert, Laurent] Sanofi, Paris, France; [Wu, Richard; Ardeleanu, Marius; Graham, Neil; Mastey, Vera] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Pirozzi, Gianluca] Sanofi, Bridgewater, NJ USA; [Sutherland, E. Rand] Sanofi, Cambridge, MA USA	Oregon Health & Science University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sanofi-Aventis; Sanofi France; Regeneron; Sanofi-Aventis; Sanofi-Aventis									0	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		544	AB167	AB167		10.1016/j.jaci.2014.12.1484	http://dx.doi.org/10.1016/j.jaci.2014.12.1484			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN					2022-12-18	WOS:000361129600543
J	Szabolcs, P; Buckley, RH; Davis, RD; Moffet, J; Voynow, J; Antony, J; Chen, XH; Sempowski, GD; Zaas, DW				Szabolcs, Paul; Buckley, Rebecca H.; Davis, Robert Duane; Moffet, Jerelyn; Voynow, Judith; Antony, Jeyaraj; Chen, Xiaohua; Sempowski, Gregory D.; Zaas, David W.			Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							STEM-CELL TRANSPLANTATION; T-CELLS; VIVO		[Szabolcs, Paul; Buckley, Rebecca H.; Moffet, Jerelyn; Voynow, Judith; Antony, Jeyaraj] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Szabolcs, Paul; Buckley, Rebecca H.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Davis, Robert Duane] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Sempowski, Gregory D.; Zaas, David W.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Szabolcs, Paul; Voynow, Judith; Antony, Jeyaraj] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Duke University; Duke University; Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Szabolcs, P (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.	paul.szabolcs@chp.edu	Li, Dapeng/HGE-1586-2022	Li, Dapeng/0000-0003-0571-5876; Szabolcs, PAUL/0000-0001-8561-4076; Sempowski, Gregory/0000-0003-0391-6594; Buckley, Rebecca/0000-0002-6914-346X	NHLBI NIH HHS [1R01HL091749, R01 HL091749] Funding Source: Medline; NIAID NIH HHS [UC6 AI058607] Funding Source: Medline; NIA NIH HHS [R01 AG025150] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025150] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; Chen XH, 2005, BLOOD, V105, P886, DOI 10.1182/blood-2004-04-1405; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Davis CC, 2010, CANCER RES, V70, P5249, DOI 10.1158/0008-5472.CAN-09-2860; Notarangelo LD, 2007, RESPIRATION, V74, P264, DOI 10.1159/000101784; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Szabolcs P, 2004, BIOL BLOOD MARROW TR, V10, P772, DOI 10.1016/j.bbmt.2004.07.005; Szabolcs P, 2010, PEDIATR CLIN N AM, V57, P207, DOI 10.1016/j.pcl.2009.12.004; Uchida N, 1997, BLOOD, V90, P4354	9	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2					567	+		10.1016/j.jaci.2014.07.058	http://dx.doi.org/10.1016/j.jaci.2014.07.058			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CB1FL	25262460	Green Accepted			2022-12-18	WOS:000349372300036
J	Taylor, SL; Houben, GF; Baumert, JL; Crevel, RRWR; Allen, KJ; Dubois, AEJ; Knulst, AC; Remington, BC; Kruizinga, AG; Blom, WM; Brooke-Taylor, S				Taylor, Steve L.; Houben, Geert F.; Baumert, Joseph L.; Crevel, Rene R. W. R.; Allen, Katrina J.; Dubois, Anthony E. J.; Knulst, Andre C.; Remington, Benjamin C.; Kruizinga, Astrid G.; Blom, W. Marty; Brooke-Taylor, Simon			Understanding food allergen thresholds requires careful analysis of the available clinical data	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN		[Taylor, Steve L.; Baumert, Joseph L.] Univ Nebraska, FARRP, Lincoln, NE 68588 USA; [Houben, Geert F.; Remington, Benjamin C.; Kruizinga, Astrid G.; Blom, W. Marty] TNO, NL-3700 AJ Zeist, Netherlands; [Crevel, Rene R. W. R.] Safety & Environm Assurance Ctr, Sharnbrook, Beds, England; [Allen, Katrina J.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Allen, Katrina J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Allen, Katrina J.] Royal Childrens Hosp, Dept Allergy & Immunol, Parkville, Vic 3052, Australia; [Dubois, Anthony E. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergy, Groningen, Netherlands; [Dubois, Anthony E. J.] GRIAC Res Inst, Groningen, Netherlands; [Knulst, Andre C.] Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands; [Brooke-Taylor, Simon] Allergen Bur Australia, Hobart, Tas, Australia	University of Nebraska System; University of Nebraska Lincoln; Netherlands Organization Applied Science Research; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; University of Groningen; Utrecht University; Utrecht University Medical Center	Taylor, SL (corresponding author), Univ Nebraska, FARRP, Lincoln, NE 68588 USA.	staylor2@unl.edu	Allen, Katrina/I-4361-2018; Taylor, Steve L./V-1341-2019	Allen, Katrina/0000-0002-1921-4493; Knulst, Andre/0000-0002-1056-3179; Remington, Benjamin/0000-0001-5450-8334; Houben, Geert/0000-0001-7261-3912; Blom, W.M./0000-0002-6853-0900				Allen KJ, 2014, J ALLERGY CLIN IMMUN, V133, P156, DOI 10.1016/j.jaci.2013.06.042; Blumchen K, 2014, J ALLERGY CLIN IMMUN, V134, P390, DOI 10.1016/j.jaci.2014.03.035; Luccioli S, 2014, J ALLERGY CLIN IMMUN, V134, P399, DOI 10.1016/j.jaci.2014.05.007; Rolinck-Werninghaus C, 2012, ALLERGY, V67, P951, DOI 10.1111/j.1398-9995.2012.02838.x; Taylor SL, 2014, FOOD CHEM TOXICOL, V63, P9, DOI 10.1016/j.fct.2013.10.032; Taylor SL, 2010, FOOD CHEM TOXICOL, V48, P814, DOI 10.1016/j.fct.2009.12.013; Vlieg-Boerstra BJ, 2008, CLIN EXP ALLERGY, V38, P1935, DOI 10.1111/j.1365-2222.2008.03088.x	7	8	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2					583	584		10.1016/j.jaci.2014.10.022	http://dx.doi.org/10.1016/j.jaci.2014.10.022			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CB1FL	25468197				2022-12-18	WOS:000349372300042
J	Gambineri, E; Mannurita, SC; Robertson, H; Vignoli, M; Haugk, B; Lionetti, P; Hambleton, S; Barge, D; Gennery, AR; Slatter, M; Nademi, Z; Flood, TJ; Jackson, A; Abinun, M; Cant, AJ				Gambineri, Eleonora; Mannurita, Sara Ciullini; Robertson, Helen; Vignoli, Marina; Haugk, Beate; Lionetti, Paolo; Hambleton, Sophie; Barge, Dawn; Gennery, Andrew R.; Slatter, Mary; Nademi, Zohreh; Flood, Terence J.; Jackson, Anthony; Abinun, Mario; Cant, Andrew J.			Gut immune reconstitution in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome after hematopoietic stem cell transplantation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IPEX SYNDROME; FOXP3; IMMUNODEFICIENCY; MUTATIONS		[Gambineri, Eleonora; Mannurita, Sara Ciullini; Vignoli, Marina; Lionetti, Paolo] Univ Florence, Anna Meyer Childrens Hosp, Dept NEUROFARBA, Sect Childrens Hlth, Florence, Italy; [Robertson, Helen; Hambleton, Sophie; Gennery, Andrew R.; Abinun, Mario; Cant, Andrew J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Haugk, Beate] Royal Victoria Infirm, Dept Cellular Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hambleton, Sophie; Gennery, Andrew R.; Slatter, Mary; Nademi, Zohreh; Flood, Terence J.; Abinun, Mario; Cant, Andrew J.] Great North Childrens Hosp, Dept Pediat Immunol, Newcastle Upon Tyne, Tyne & Wear, England; [Barge, Dawn] Newcastle Upon Tyne Hosp Natl Hlth Serv Trust, Immunol Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Jackson, Anthony] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Inst Med Genet, Northern Mol Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Gambineri, E (corresponding author), Univ Florence, Anna Meyer Childrens Hosp, Dept NEUROFARBA, Sect Childrens Hlth, Florence, Italy.	eleonora.gambineri@unifi.it	Mannurita, Sara Ciullini/AAA-5395-2019; Lionetti, Paolo/AAC-2626-2019; Gambineri, Eleonora/J-8747-2016	Mannurita, Sara Ciullini/0000-0002-4498-6209; Gambineri, Eleonora/0000-0002-4676-6541; Lionetti, Paolo/0000-0001-8029-3904; Hambleton, Sophie/0000-0001-7954-3267	The Sir Jules Thorn Charitable Trust [12JTA] Funding Source: researchfish	The Sir Jules Thorn Charitable Trust		Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; de Serre NPM, 2009, MODERN PATHOL, V22, P95, DOI 10.1038/modpathol.2008.161; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Gjerdrum LM, 2001, J MOL DIAGN, V3, P105, DOI 10.1016/S1525-1578(10)60659-9; Nademi Z, 2014, BONE MARROW TRANSPL, V49, P310, DOI 10.1038/bmt.2013.181; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Passerini L, 2011, J ALLERGY CLIN IMMUN, V128, P1376, DOI 10.1016/j.jaci.2011.09.010; Rao A, 2007, BLOOD, V109, P383, DOI 10.1182/blood-2006-05-025072; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Seidel MG, 2009, BLOOD, V113, P5689, DOI 10.1182/blood-2009-02-206359; Slatter MA, 2011, ANN NY ACAD SCI, V1238, P122, DOI 10.1111/j.1749-6632.2011.06243.x; Thiede C, 1999, BONE MARROW TRANSPL, V23, P1055, DOI 10.1038/sj.bmt.1701779; Williams MB, 1997, J IMMUNOL, V159, P1746	15	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					260	U389		10.1016/j.jaci.2014.09.009	http://dx.doi.org/10.1016/j.jaci.2014.09.009			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25420685	Green Published, hybrid			2022-12-18	WOS:000347298200031
J	Touzot, F; Moshous, D; Cros, G; Frange, P; Chomton, M; Fremond, ML; Neven, B; Cavazzana, M; Fischer, A; Blanche, S; Helley, D				Touzot, Fabien; Moshous, Despina; Cros, Guilhem; Frange, Pierre; Chomton, Maryline; Fremond, Marie-Louise; Neven, Benedicte; Cavazzana, Marina; Fischer, Alain; Blanche, Stephane; Helley, Dominique			Circulating endothelial cells as markers of endothelial dysfunction during hematopoietic stem cell transplantation for pediatric primary immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DAMAGE		[Touzot, Fabien; Cavazzana, Marina] Hop Necker Enfants Malad, AP HP, Ctr Invest Clin Integre Biotherapies, Dept Biotherapie, Paris, France; [Touzot, Fabien; Moshous, Despina; Cros, Guilhem; Chomton, Maryline; Fremond, Marie-Louise; Neven, Benedicte; Cavazzana, Marina; Fischer, Alain; Blanche, Stephane] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [Moshous, Despina; Cros, Guilhem; Chomton, Maryline; Fremond, Marie-Louise; Neven, Benedicte; Fischer, Alain; Blanche, Stephane] Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Frange, Pierre] Hop Necker Enfants Malad, AP HP, Microbiol Lab, Paris, France; [Frange, Pierre] Univ Paris 05, Sorbonne Paris Cite, PRES Sorbonne Paris, EA 3620, Paris, France; [Fischer, Alain] Hop George Pompidou, AP HP, Coll France, Paris, France; [Helley, Dominique] Hop George Pompidou, AP HP, Serv Hematol Biol, Paris, France; [Helley, Dominique] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Touzot, F (corresponding author), Hop Necker Enfants Malad, AP HP, Ctr Invest Clin Integre Biotherapies, Dept Biotherapie, Paris, France.	fabien.touzot@nck.aphp.fr	Moshous, Despina/B-7507-2017; Frange, Pierre/O-6311-2017; Frémond, Marie-Louise/G-9371-2017; Frémond, Marie-Louise/AAH-4266-2019; Touzot, Fabien/T-7797-2018	Moshous, Despina/0000-0001-6719-3693; Frémond, Marie-Louise/0000-0002-2798-9141; Frémond, Marie-Louise/0000-0002-2798-9141; Touzot, Fabien/0000-0002-0889-4905; Cavazzana, Marina/0000-0002-0264-0891				Biedermann BC, 2002, LANCET, V359, P2078, DOI 10.1016/S0140-6736(02)08907-9; Carreras E, 2011, BONE MARROW TRANSPL, V46, P1495, DOI 10.1038/bmt.2011.65; Erdbruegger U, 2010, CURR STEM CELL RES T, V5, P294, DOI 10.2174/157488810793351721; Palomo M, 2010, BIOL BLOOD MARROW TR, V16, P985, DOI 10.1016/j.bbmt.2010.02.008; Schlichting DE, 2011, MICROVASC RES, V81, P216, DOI 10.1016/j.mvr.2010.11.011; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x; Woywodt A, 2004, BLOOD, V103, P3603, DOI 10.1182/blood-2003-10-3479	7	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2014	134	5					1203	1206		10.1016/j.jaci.2014.05.039	http://dx.doi.org/10.1016/j.jaci.2014.05.039			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AT4UN	25042984				2022-12-18	WOS:000344938900032
J	Allam, JP; Wuestenberg, E; Wolf, H; Klimek, L; Decot, E; Horn, A; Schnitker, J; Bieber, T; Novak, N				Allam, Jean-Pierre; Wuestenberg, Eike; Wolf, Hendrik; Klimek, Ludger; Decot, Elke; Horn, Andreas; Schnitker, Joerg; Bieber, Thomas; Novak, Natalija			Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy: A pilot study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELLS		[Allam, Jean-Pierre; Bieber, Thomas; Novak, Natalija] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Wuestenberg, Eike] Univ Dresden, Dept Otorhinolaryngol, Dresden, Germany; [Wuestenberg, Eike; Wolf, Hendrik] ALK Abello, Hamburg, Germany; [Klimek, Ludger] Ctr Rhinol & Allergy, Wiesbaden, Germany; [Schnitker, Joerg] Inst Angew Stat GmbH, Bielefeld, Germany	University of Bonn; Technische Universitat Dresden; ALK-Abello AS	Allam, JP (corresponding author), Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany.	Jean-Pierre.Allam@ukb.uni-bonn.de	Horn, Andreas/R-6528-2017	Horn, Andreas/0000-0002-0695-6025				Allam JP, 2008, ALLERGY, V63, P720, DOI 10.1111/j.1398-9995.2007.01611.x; Allam JP, 2011, CURR OPIN ALLERGY CL, V11, P571, DOI 10.1097/ACI.0b013e32834cbaab; Allam JP, 2010, J ALLERGY CLIN IMMUN, V126, P638, DOI 10.1016/j.jaci.2010.04.039; Amano O, 2012, ACTA HISTOCHEM CYTOC, V45, P241, DOI 10.1267/ahc.12013; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Mascarell L, 2008, J ALLERGY CLIN IMMUN, V122, P603, DOI 10.1016/j.jaci.2008.06.034; Senel Sevda, 2001, Current Pharmaceutical Biotechnology, V2, P175, DOI 10.2174/1389201013378734; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x	9	8	8	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2014	133	6					1757	1759		10.1016/j.jaci.2014.03.026	http://dx.doi.org/10.1016/j.jaci.2014.03.026			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AI2FI	24794686				2022-12-18	WOS:000336672500032
J	Holla, S; Sharma, M; Vani, J; Kaveri, SV; Balaji, KN; Bayry, J				Holla, Sahana; Sharma, Meenu; Vani, Janakiraman; Kaveri, Srini V.; Balaji, Kithiganahalli N.; Bayry, Jagadeesh			GM-CSF along with IL-4 but not alone is indispensable for the differentiation of human dendritic cells from monocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RESPONSES		[Holla, Sahana; Sharma, Meenu; Vani, Janakiraman; Kaveri, Srini V.; Bayry, Jagadeesh] INSERM, Unite 1138, Paris, France; [Holla, Sahana; Vani, Janakiraman; Balaji, Kithiganahalli N.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Sharma, Meenu] Univ Technol Compiegne, Compiegne, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent 1, Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 05, Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Natl Inst Immunohaematol, Int Associated Lab IMPACT, INSERM, Indian Council Med Res, Mumbai, Maharashtra, India	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore; Picardie Universites; Universite de Technologie de Compiegne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bayry, J (corresponding author), INSERM, Unite 1138, Paris, France.	balaji@mcbl.iisc.ernet.in; jagadeesh.bayry@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011; Sharma, Meenu/GWM-5030-2022	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053; Holla, Sahana/0000-0001-5186-0180				Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lopez-Bravo M, 2013, J ALLERGY CLIN IMMUN, V132, P1409, DOI 10.1016/j.jaci.2013.08.039; Olsen CH, 2003, INFECT IMMUN, V71, P6689, DOI 10.1128/IAI.71.12.6689-6692.2003; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Vani J, 2013, J INFECT DIS, V208, P1034, DOI 10.1093/infdis/jit281; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	8	8	8	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1500	U472		10.1016/j.jaci.2014.02.021	http://dx.doi.org/10.1016/j.jaci.2014.02.021			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24698325				2022-12-18	WOS:000335450700049
J	Greenhawt, MJ				Greenhawt, Matthew J.			Influenza vaccination in asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHILDREN; ADULTS		[Greenhawt, Matthew J.] Univ Michigan Hlth Syst, Univ Michigan Food Allergy Ctr, Div Allergy & Clin Immunol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Greenhawt, MJ (corresponding author), 24 Frank Lloyd Wright Dr,POB 442,Suite H-2100, Ann Arbor, MI 48106 USA.	mgreenha@med.umich.edu		Greenhawt, Matthew/0000-0002-2365-9372	National Center for Research Resources; National Institutes of Health; University of Michigan Food Allergy Center; Nutricia	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Food Allergy Center; Nutricia(Danone Nutricia)	M. J. Greenhawt has received research support from the National Center for Research Resources, the National Institutes of Health, and the University of Michigan Food Allergy Center; is a board member for Nutricia; has consultant arrangements with Nutricia, Deerfield Industries, and the National Peanut Board; has provided expert testimony on behalf of stock epinephrine law for the Michigan Allergy and Asthma Society; has received payment for lectures and payment for development of educational presentations from Nutricia; and is an unpaid medical advisory board member for the Kids with Food Allergies Foundation and the International Association for Food Protein Enterocolitis. J. T. Li has consulted for Abbott.	[Anonymous], FLU VACCINATION COVE; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000364.pub4; Christy C, 2004, ARCH DIS CHILD, V89, P734, DOI 10.1136/adc.2003.030999; Dawood FS, 2011, PEDIATRICS, V128, pE27, DOI 10.1542/peds.2010-3343; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; James KM, 2012, J ALLERGY CLIN IMMUN, V130, P343, DOI 10.1016/j.jaci.2012.05.056; Joshi AY, 2012, ALLERGY ASTHMA PROC, V33, pE23, DOI 10.2500/aap.2012.33.3513; Kloepfer KM, 2012, AM J RESP CRIT CARE, V185, P1275, DOI 10.1164/rccm.201109-1635OC; Kramarz P, 2001, J PEDIATR-US, V138, P306, DOI 10.1067/mpd.2001.112168; Lu PJ, 2009, AM J PREV MED, V37, P109, DOI 10.1016/j.amepre.2009.03.021; Luce BR, 2008, VACCINE, V26, P2841, DOI 10.1016/j.vaccine.2008.03.046; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Ong BA, 2009, J ASTHMA, V46, P477, DOI 10.1080/02770900902795538; Pickering LKBC, 2012, RED BOOK 2012 REPORT, P439; Savidan E, 2008, HEALTH POLICY, V86, P142, DOI 10.1016/j.healthpol.2007.09.009; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Wong KK, 2013, PEDIATRICS, V132, P796, DOI 10.1542/peds.2013-1493	18	8	9	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2014	133	4					1233	+		10.1016/j.jaci.2014.02.009	http://dx.doi.org/10.1016/j.jaci.2014.02.009			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AD8QW	24679474				2022-12-18	WOS:000333531700050
J	Karta, MR; Wickert, LE; Curran, CS; Gavala, ML; Denlinger, LC; Gern, JE; Bertics, PJ				Karta, Maya R.; Wickert, Lisa E.; Curran, Colleen S.; Gavala, Monica L.; Denlinger, Loren C.; Gern, James E.; Bertics, Paul J.			Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BRONCHOPROVOCATION; INFECTION; RESPONSES; ASTHMA		[Karta, Maya R.; Wickert, Lisa E.] Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53706 USA; [Karta, Maya R.; Wickert, Lisa E.; Gavala, Monica L.; Bertics, Paul J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Wickert, Lisa E.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Curran, Colleen S.] Univ Wisconsin, Dept Mol & Environm Toxicol, Madison, WI USA; [Denlinger, Loren C.; Gern, James E.] Univ Wisconsin, Dept Med, Madison, WI USA; [Gern, James E.] Univ Wisconsin, Dept Pediat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Karta, MR (corresponding author), Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53706 USA.	maya.karta@gmail.com			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR003186] Funding Source: Medline; NHLBI NIH HHS [P01 HL088594] Funding Source: Medline; NIAID NIH HHS [U19 AI070503] Funding Source: Medline; NIDDK NIH HHS [T32 DK007665] Funding Source: Medline; NIGMS NIH HHS [T32 GM008688] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bentley JK, 2013, J ALLERGY CLIN IMMUN, V132, P758, DOI 10.1016/j.jaci.2013.04.020; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Gavala ML, 2013, CLIN EXP ALLERGY, V43, P187, DOI 10.1111/cea.12032; Gavala ML, 2013, CURR ALLERGY ASTHM R, V13, P298, DOI 10.1007/s11882-013-0344-1; Greiff L, 1999, EUR RESPIR J, V13, P41, DOI 10.1183/09031936.99.13104199; Kelly EAB, 1997, AM J RESP CRIT CARE, V156, P1421, DOI 10.1164/ajrccm.156.5.9703054; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Melchjorsen J, 2003, J LEUKOCYTE BIOL, V74, P331, DOI 10.1189/jlb.1102577; Smit JJ, 2006, EUR J PHARMACOL, V533, P277, DOI 10.1016/j.ejphar.2005.12.064	11	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2014	133	4					1227	+		10.1016/j.jaci.2014.01.003	http://dx.doi.org/10.1016/j.jaci.2014.01.003			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AD8QW	24529411	Green Accepted			2022-12-18	WOS:000333531700041
J	Lemiere, C; Chaboillez, S; Bohadana, A; Blais, L; Maghni, K				Lemiere, Catherine; Chaboillez, Simone; Bohadana, Abraham; Blais, Lucie; Maghni, Karim			Noneosinophilic responders with occupational asthma: A phenotype associated with a poor asthma prognosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFLAMMATION		[Lemiere, Catherine; Chaboillez, Simone; Bohadana, Abraham; Blais, Lucie; Maghni, Karim] Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada; [Lemiere, Catherine; Blais, Lucie; Maghni, Karim] Univ Montreal, Montreal, PQ, Canada; [Bohadana, Abraham] INSERM, U954, Vandoeuvre Les Nancy, France	Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Lemiere, C (corresponding author), Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada.	catherine.lemiere@umontreal.ca			NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R03OH009734] Funding Source: NIH RePORTER; NIOSH CDC HHS [R03 OH009734] Funding Source: Medline	NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NIOSH CDC HHS		Ali FR, 2007, THORAX, V62, P750, DOI 10.1136/thx.2006.072041; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; CRAPO RO, 1994, NEW ENGL J MED, V331, P25, DOI 10.1056/NEJM199407073310107; Juniper E, 1994, HISTAMINE METHACHOLI; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper Elizabeth F, 2005, Health Qual Life Outcomes, V3, P58, DOI 10.1186/1477-7525-3-58; PERRIN LF, 1984, CLIN ALLERGY, V14, P581, DOI 10.1111/j.1365-2222.1984.tb02246.x; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	9	8	8	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					883	885		10.1016/j.jaci.2013.09.005	http://dx.doi.org/10.1016/j.jaci.2013.09.005			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24139830				2022-12-18	WOS:000332397600034
J	Hulse, KE; Chaung, K; Seshadri, S; Suh, L; Norton, JE; Carter, RG; Kern, RC; Conley, DB; Chandra, RK; Tan, BK; Peters, AT; Grammer, LC; Harris, KE; Torgerson, TR; Kato, A; Schleimer, RP				Hulse, Kathryn E.; Chaung, Katrina; Seshadri, Sudarshan; Suh, Lydia; Norton, James E.; Carter, Roderick G.; Kern, Robert C.; Conley, David B.; Chandra, Rakesh K.; Tan, Bruce K.; Peters, Anju T.; Grammer, Leslie C., III; Harris, Kathleen E.; Torgerson, Troy R.; Kato, Atsushi; Schleimer, Robert P.			Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFLAMMATION		[Hulse, Kathryn E.; Seshadri, Sudarshan; Suh, Lydia; Norton, James E.; Carter, Roderick G.; Peters, Anju T.; Grammer, Leslie C., III; Harris, Kathleen E.; Kato, Atsushi; Schleimer, Robert P.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Chaung, Katrina; Kern, Robert C.; Conley, David B.; Chandra, Rakesh K.; Tan, Bruce K.] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA; [Torgerson, Troy R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Torgerson, Troy R.] Seattle Childrens Hosp, Seattle, WA USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Hulse, KE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA.		Seshadri, Sudarshan/J-5544-2016	Seshadri, Sudarshan/0000-0003-4910-8664; Grammer, Leslie/0000-0001-6860-2014; Kato, Atsushi/0000-0001-9144-3138; Hulse, Kathryn/0000-0003-0969-999X; Chandra, Rakesh/0000-0002-3612-0026	NHLBI NIH HHS [R21 HL113913, R01 HL078860, R37 HL068546, R01HL078860, R21HL113913] Funding Source: Medline; NIAID NIH HHS [R01 AI072570, P01 AI106683, T32 AI083216] Funding Source: Medline; NICHD NIH HHS [K12 HD055884] Funding Source: Medline; PHS HHS [T32A1083216] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078860, R37HL068546, R21HL113913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072570, P01AI106683, T32AI083216] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, P1075, DOI 10.1016/j.jaci.2013.01.043; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Park SJ, 2013, J ALLERGY CLIN IMMUN, V131, P772, DOI 10.1016/j.jaci.2012.12.671; Peters AT, 2010, J ALLERGY CLIN IMMUN, V125, P397, DOI 10.1016/j.jaci.2009.10.072; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Seshadri S, 2013, J ALLERGY CLIN IMMUN, V132, P1227, DOI 10.1016/j.jaci.2013.05.042; Tan BK, 2010, CURR OPIN OTOLARYNGO, V18, P21, DOI 10.1097/MOO.0b013e3283350053; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	11	8	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					275	277		10.1016/j.jaci.2013.08.015	http://dx.doi.org/10.1016/j.jaci.2013.08.015			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	24084073	Green Accepted			2022-12-18	WOS:000329105700042
J	Saffari, H; Krstyen, JJ; Gonzalez, C; Clayton, FC; Leiferman, KM; Gleich, GJ; Peterson, KA; Pease, LF				Saffari, Hedieh; Krstyen, Jeffrey J.; Gonzalez, Courtney; Clayton, Frederic C.; Leiferman, Kristin M.; Gleich, Gerald J.; Peterson, Kathryn A.; Pease, Leonard F., III			(99m)Technetium-labeled heparin: A new approach to detection of eosinophilic esophagitis-associated inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DIAGNOSIS; ADULTS		[Saffari, Hedieh; Gonzalez, Courtney; Pease, Leonard F., III] Univ Utah, Dept Chem Engn, Salt Lake City, UT 84112 USA; [Krstyen, Jeffrey J.] Univ Utah, Dept Clin Radiol, Salt Lake City, UT USA; [Clayton, Frederic C.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Leiferman, Kristin M.; Gleich, Gerald J.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Gleich, Gerald J.; Peterson, Kathryn A.; Pease, Leonard F., III] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Pease, Leonard F., III] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Saffari, H (corresponding author), Univ Utah, Dept Chem Engn, Salt Lake City, UT 84112 USA.	Hedieh.Saffari@utah.edu		Gonzalez, Courtney/0000-0002-1340-371X				Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Gonsalves N, 2006, GASTROINTEST ENDOSC, V64, P313, DOI 10.1016/j.gie.2006.04.037; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; JOHNSON DA, 1992, PROTEIN SCI, V1, P370; Kephart GM, 2010, AM J GASTROENTEROL, V105, P298, DOI 10.1038/ajg.2009.584; KULKARNI PV, 1980, J NUCL MED, V21, P117; LAFOREST MD, 1991, BRIT J HAEMATOL, V77, P201, DOI 10.1111/j.1365-2141.1991.tb07978.x; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; PEREZ GL, 1993, ARCH DERMATOL, V129, P861, DOI 10.1001/archderm.129.7.861; Saffari H, 2012, J ALLERGY CLIN IMMUN, V130, P798, DOI 10.1016/j.jaci.2012.03.009; Swaminathan GJ, 2005, BIOCHEMISTRY-US, V44, P14152, DOI 10.1021/bi051112b; TALLEY NJ, 1992, GASTROENTEROLOGY, V103, P137, DOI 10.1016/0016-5085(92)91106-E; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003	14	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1446	1448		10.1016/j.jaci.2013.06.009	http://dx.doi.org/10.1016/j.jaci.2013.06.009			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	23895898	Bronze			2022-12-18	WOS:000327538200030
J	Assa'ad, AH; Rothenberg, ME				Assa'ad, Amal H.; Rothenberg, Marc E.			Eosinophilic asthma: Insights into the effects of reducing IL-5 receptor-positive cell levels	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Eosinophils; IL-5; anti-IL-5; anti-IL-5 receptor; benralizumab; steroid-dependent asthma	PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MEPOLIZUMAB; ESOPHAGITIS; RESLIZUMAB; ANTIBODY; CHILDREN		[Assa'ad, Amal H.; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Assa'ad, AH (corresponding author), Div Allergy & Immunol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	amal.assa'ad@cchmc.org			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000077] Funding Source: Medline; NIDDK NIH HHS [P30 DK090971] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Assa'ad AH, 2011, GASTROENTEROLOGY, V141, P1593, DOI 10.1053/j.gastro.2011.07.044; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Laviolette M, 2013, J ALLERGY CLIN IMMUN, V132, P1086, DOI 10.1016/j.jaci.2013.05.020; Molfino NA, 2012, AM J RESP CRIT CARE, V185, pA2753; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V129, P456, DOI 10.1016/j.jaci.2011.11.044	9	8	9	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2013	132	5					1097	1098		10.1016/j.jaci.2013.08.036	http://dx.doi.org/10.1016/j.jaci.2013.08.036			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	242JH	24094543	Green Accepted, Bronze			2022-12-18	WOS:000326235600008
J	Notarangelo, LD				Notarangelo, Luigi D.			The long road to optimal management for chronic granulomatous disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Chronic granulomatous disease; oxidase activity; hematopoietic cell transplantation; clinical outcome	CLINICAL-FEATURES; SURVIVAL		[Notarangelo, Luigi D.] Childrens Hosp Boston, Div Immunol, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Notarangelo, LD (corresponding author), Childrens Hosp Boston, Div Immunol Res, Karp Res Bldg,Rm 10217,1 Blackfan Circle, Boston, MA 02115 USA.	luigi.notarangelo@childrens.harvard.edu	Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262				Ahlin A, 2013, ACTA PAEDIAT; Cole T, 2013, J ALLERGY CLIN IMMUN, V132, P1150, DOI 10.1016/j.jaci.2013.05.031; Cole T, 2013, J CLIN IMMUNOL, V33, P8, DOI 10.1007/s10875-012-9758-0; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Griffith LM, 2013, J ALLERGY C IN PRESS; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Koker MY, 2013, J ALLERGY CLIN IMMUN, V132, P1156, DOI 10.1016/j.jaci.2013.05.039; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Martinez CA, 2012, J ALLERGY CLIN IMMUN, V129, P176, DOI 10.1016/j.jaci.2011.10.005; Martire B, 2008, CLIN IMMUNOL, V126, P155, DOI 10.1016/j.clim.2007.09.008; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	14	8	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2013	132	5					1164	1165		10.1016/j.jaci.2013.08.035	http://dx.doi.org/10.1016/j.jaci.2013.08.035			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	242JH	24094546				2022-12-18	WOS:000326235600018
J	Tam, H; Calderon, MA; Boyle, RJ				Tam, Herman; Calderon, Moises A.; Boyle, Robert J.			Efficacy of allergen-specific immunotherapy for patients with atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DOUBLE-BLIND; DERMATOPHAGOIDES-PTERONYSSINUS; CONTROLLED-TRIAL; HYPOSENSITIZATION; CHILDREN		[Tam, Herman; Boyle, Robert J.] Imperial Coll London, Dept Paediat, London, England; [Calderon, Moises A.] Imperial Coll London, Natl Heart & Lung Inst, Dept Allergy, London, England	Imperial College London; Imperial College London	Tam, H (corresponding author), Imperial Coll London, Dept Paediat, London, England.	r.boyle@imperial.ac.uk		Boyle, Robert/0000-0002-4913-7580				Bae JM, 2013, J ALLERGY CLIN IMMUN, V132, P110, DOI 10.1016/j.jaci.2013.02.044; Charman C, 2003, J INVEST DERMATOL, V120, P932, DOI 10.1046/j.1523-1747.2003.12251.x; Galli E, 1994, Allergol Immunopathol (Madr), V22, P18; GLOVER MT, 1992, CLIN EXP ALLERGY, V22, P440, DOI 10.1111/j.1365-2222.1992.tb00145.x; KAUFMAN HS, 1974, ANN ALLERGY, V32, P321; LEROY BP, 1993, J AM ACAD DERMATOL, V28, P232, DOI 10.1016/0190-9622(93)70033-P; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Novak N, 2012, J ALLERGY CLIN IMMUN, V130, P925, DOI 10.1016/j.jaci.2012.08.004; Pajno GB, 2007, J ALLERGY CLIN IMMUN, V120, P164, DOI 10.1016/j.jaci.2007.04.008; Silny W, 2006, ALLERGOLOGIE, V29, P171; WARNER JO, 1978, LANCET, V2, P912	12	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					1012	1013		10.1016/j.jaci.2013.07.021	http://dx.doi.org/10.1016/j.jaci.2013.07.021			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23993878				2022-12-18	WOS:000325096500044
J	Kaminsky, DA				Kaminsky, David A.			Multiple breath nitrogen washout profiles in asthmatic patients: What do they mean clinically?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Inert gas washout; multiple-breath nitrogen washout; slope of phase III; ventilation heterogeneity; asthma exacerbation	VENTILATION HETEROGENEITY; AIRWAY HYPERRESPONSIVENESS; DISEASE; ADULTS		Univ Vermont, Coll Med, Burlington, VT 05405 USA	University of Vermont	Kaminsky, DA (corresponding author), Univ Vermont, Coll Med, Given D213,89 Beaumont Ave, Burlington, VT 05405 USA.	david.kaminsky@uvm.edu						Downie SR, 2013, J APPL PHYSL; Downie SR, 2007, THORAX, V62, P684, DOI 10.1136/thx.2006.069682; Farah CS, 2012, J ALLERGY CLIN IMMUN, V130, P61, DOI 10.1016/j.jaci.2012.02.015; Farah CS, 2012, J ALLERGY CLIN IMMUN, V129, P381, DOI 10.1016/j.jaci.2011.11.017; Farrow CE, 2012, J APPL PHYSIOL, V113, P958, DOI 10.1152/japplphysiol.01618.2011; Hamid Q, 2012, RESPIRATION, V84, P4, DOI 10.1159/000339550; Hardaker KM, 2011, CHEST, V139, P1395, DOI 10.1378/chest.10-1839; Kaminsky DA, 2011, PULM PHARMACOL THER, V24, P199, DOI 10.1016/j.pupt.2010.12.001; Macleod KA, 2009, THORAX, V64, P33, DOI 10.1136/thx.2007.095018; Robinson PD, 2009, RESPIRATION, V78, P339, DOI 10.1159/000225373; Thompson BR, 2013, J ALLERGY CLIN IMMUN, V131, P1322, DOI 10.1016/j.jaci.2013.01.054; Verbanck S, 1999, AM J RESP CRIT CARE, V159, P1545, DOI 10.1164/ajrccm.159.5.9809017; Verbanck S, 2003, J APPL PHYSIOL, V94, P1380, DOI 10.1152/japplphysiol.00588.2002; Verbanck S, 2006, J ALLERGY CLIN IMMUN, V118, P340, DOI 10.1016/j.jaci.2006.04.056; Verbanck S, 2011, COMPR PHYSIOL, V1, P809, DOI 10.1002/cphy.c100018; Verbanck S, 2012, J APPL PHYSIOL, V112, P782, DOI 10.1152/japplphysiol.01221.2011; Verbanck S, 2010, J ALLERGY CLIN IMMUN, V125, P611, DOI 10.1016/j.jaci.2009.10.053	17	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2013	131	5					1329	1330		10.1016/j.jaci.2013.02.015	http://dx.doi.org/10.1016/j.jaci.2013.02.015			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	144AU	23541321				2022-12-18	WOS:000318912200008
J	Collier, F; Tang, MM; Ponsonby, AL; Vuillermin, P				Collier, Fiona; Tang, Mimi; Ponsonby, Anne-Louise; Vuillermin, Peter			Flow cytometric assessment of cord blood as an alternative strategy for population-based screening of severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Collier, Fiona; Vuillermin, Peter] Deakin Univ, Dept Med, Barwon Hlth, Child Hlth Res Unit, Melbourne, Vic, Australia; [Tang, Mimi; Ponsonby, Anne-Louise; Vuillermin, Peter] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Tang, Mimi; Ponsonby, Anne-Louise; Vuillermin, Peter] Univ Melbourne, Melbourne, Vic, Australia; [Collier, Fiona] Deakin Univ, Dept Med, Barwon Hlth, Barwon Biomed Res, Melbourne, Vic, Australia	Deakin University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Deakin University	Collier, F (corresponding author), Deakin Univ, Dept Med, Barwon Hlth, Child Hlth Res Unit, Melbourne, Vic, Australia.	peterv@barwonhealth.org.au	Ponsonby, Anne-Louise/AAE-4351-2019	Ponsonby, Anne-Louise/0000-0002-6581-3657; Tang, Mimi/0000-0002-3839-5293				Chan K, 2011, MOL GENET METAB, V104, P383, DOI 10.1016/j.ymgme.2011.07.007; Chase NM, 2011, ANN NY ACAD SCI, V1238, P99, DOI 10.1111/j.1749-6632.2011.06241.x; Comeau AM, 2010, J INHERIT METAB DIS, V33, pS273, DOI 10.1007/s10545-010-9103-9; Lipstein EA, 2010, PEDIATRICS, V125, pE1226, DOI 10.1542/peds.2009-1567; McGhee SA, 2005, J PEDIATR-US, V147, P603, DOI 10.1016/j.jpeds.2005.06.001; Puck JM, 2012, J ALLERGY CLIN IMMUN, V129, P607, DOI 10.1016/j.jaci.2012.01.032; Vuillermin PJ, 2009, ALLERGY, V64, P348, DOI 10.1111/j.1398-9995.2009.01970.x	7	8	10	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1251	1252		10.1016/j.jaci.2012.09.039	http://dx.doi.org/10.1016/j.jaci.2012.09.039			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23333079				2022-12-18	WOS:000317187200044
J	Hamilos, DL				Hamilos, Daniel L.			Host-microbial interactions in patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ENDOSCOPIC SINUS SURGERY; REFRACTORY CHRONIC RHINOSINUSITIS; TOLL-LIKE RECEPTORS; BACTERIAL BIOFILMS; EPITHELIAL-CELLS; INNATE IMMUNITY; STAPHYLOCOCCUS-AUREUS; NASAL POLYPOSIS; SINONASAL CAVITY; BINDING-PROTEIN		Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Hamilos, DL (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, 55 Fruit St,Bulfinch 422, Boston, MA 02114 USA.	dhamilos@partners.org						Akhtar M, 2003, FASEB J, V17, P1319, DOI 10.1096/fj.02-0950fje; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; BAROODY FM, 1995, ARCH OTOLARYNGOL, V121, P1396; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bernstein JM, 2003, AM J RHINOL, V17, P321, DOI 10.1177/194589240301700601; Braun H, 2003, LARYNGO RHINO OTOL, V82, P330; Conley DB, 2006, AM J RHINOL, V20, P451, DOI 10.2500/ajr.2006.20.2880; Cryer J, 2004, ORL-J OTO-RHIN-LARYN, V66, P155, DOI 10.1159/000079994; DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162; DEMOLY P, 1994, J ALLERGY CLIN IMMUN, V94, P95, DOI 10.1016/0091-6749(94)90076-0; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Desrosiers M, 2004, CURR ALLERGY ASTHM R, V4, P200, DOI 10.1007/s11882-004-0027-z; Dong Z, 2005, AM J RHINOL, V19, P236, DOI 10.1177/194589240501900303; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Ferguson BJ, 2000, LARYNGOSCOPE, V110, P799, DOI 10.1097/00005537-200005000-00010; Foreman A, 2010, LARYNGOSCOPE, V120, P1701, DOI 10.1002/lary.21024; Gosepath J, 2004, AM J RHINOL, V18, P9, DOI 10.1177/194589240401800104; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; HAMILOS DL, 1995, J ALLERGY CLIN IMMUN, V96, P537, DOI 10.1016/S0091-6749(95)70298-9; Hamilos DL, 2000, J ALLERGY CLIN IMMUN, V106, P213, DOI 10.1067/mai.2000.109269; HARLIN SL, 1988, J ALLERGY CLIN IMMUN, V81, P867, DOI 10.1016/0091-6749(88)90944-X; Harvey RJ, 2007, RHINOLOGY, V45, P3; Hochstim CJ, 2010, OTOLARYNG HEAD NECK, V143, P697, DOI 10.1016/j.otohns.2010.07.017; Hochstitn CJ, 2010, ARCH OTOLARYNGOL, V136, P453, DOI 10.1001/archoto.2010.62; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Jang YJ, 2006, AM J RHINOL, V20, P634, DOI 10.2500/ajr.2006.20.2899; Jervis-Bardy J, 2011, INT FORUM ALLERGY RH, V1, P308, DOI 10.1002/alr.20050; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Lane AP, 2006, AM J RHINOL, V20, P138, DOI 10.1177/194589240602000203; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P113, DOI 10.3109/00016489709118001; Meltzer EO, 2011, MAYO CLIN PROC, V86, P427, DOI 10.4065/mcp.2010.0392; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mizoguchi A, 2012, INFLAMM BOWEL DIS, V18, P1777, DOI 10.1002/ibd.22929; Okano M, 2011, CLIN EXP ALLERGY, V41, P171, DOI 10.1111/j.1365-2222.2010.03584.x; Oncel S, 2010, J OTOLARYNGOL-HEAD N, V39, P52, DOI 10.2310/7070.2009.090008; Ooi EH, 2008, AM J RHINOL, V22, P13, DOI 10.2500/ajr.2008.22.3127; Perloff JR, 2004, AM J RHINOL, V18, P377, DOI 10.1177/194589240401800607; Ponikau JU, 2003, J ALLERGY CLIN IMMUN, V112, P877, DOI 10.1016/j.jaci.2003.08.009; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Psaltis AJ, 2008, LARYNGOSCOPE, V118, P895, DOI 10.1097/MLG.0b013e31816381d4; Psaltis AJ, 2008, AM J RHINOL, V22, P1, DOI 10.2500/ajr.2008.22.3119; Psaltis AJ, 2007, LARYNGOSCOPE, V117, P2030, DOI 10.1097/MLG.0b013e31812e01ab; Psaltis AJ, 2007, LARYNGOSCOPE, V117, P1302, DOI 10.1097/MLG.0b013e31806009b0; Ramanathan M, 2007, AM J RHINOL, V21, P110, DOI 10.2500/ajr.2007.21.2997; Ramanathan M, 2008, AM J RHINOL, V22, P115, DOI 10.2500/ajr.2008.22.3136; Roeder A, 2004, TRENDS MICROBIOL, V12, P44, DOI 10.1016/j.tim.2003.11.003; Sanclement JA, 2005, LARYNGOSCOPE, V115, P578, DOI 10.1097/01.mlg.0000161346.30752.18; Schubert Mark S, 2007, Clin Allergy Immunol, V20, P263; Shin SH, 2004, J ALLERGY CLIN IMMUN, V114, P1369, DOI 10.1016/j.jaci.2004.08.012; Singhal D, 2010, AM J RHINOL ALLERGY, V24, P169, DOI 10.2500/ajra.2010.24.3462; Solyar A, 2012, OTOLARYNG HEAD NECK, V146, P1012, DOI 10.1177/0194599812437333; Stephenson MF, 2010, J OTOLARYNGOL-HEAD N, V39, P182, DOI 10.2310/7070.2009.090060; Taylor MJ, 2002, OTOLARYNG HEAD NECK, V127, P377, DOI 10.1067/mhn.2002.128896; Tripathi A, 2005, AM J RHINOL, V19, P327, DOI 10.1177/194589240501900401; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; VanderMeer J, 2004, ARCH OTOLARYNGOL, V130, P1374, DOI 10.1001/archotol.130.12.1374; Yamin M, 2008, J ALLERGY CLIN IMMUN, V122, P1145, DOI 10.1016/j.jaci.2008.09.033; Zhang Q, 2013, ACTA OTO-LARYNGOL, V133, P165, DOI 10.3109/00016489.2012.717713	63	8	8	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1263	+		10.1016/j.jaci.2013.02.020	http://dx.doi.org/10.1016/j.jaci.2013.02.020			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23540620	Bronze			2022-12-18	WOS:000317187200055
J	Peden, DB; Bush, RK				Peden, David B.; Bush, Robert K.			Advances in environmental and occupational disorders in 2012	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergens; pollens; fungi; pets; air pollution; risk factors; immune mechanisms; asthma; immunotherapy	AIR-POLLUTION; ALLERGIC SENSITIZATION; CELL RECRUITMENT; CHILDHOOD ASTHMA; INNATE IMMUNITY; RISK-FACTORS; IMMUNOTHERAPY; CHILDREN; PRESCRIPTIONS; PANCREATITIS	The year 2012 produced a number of advances in our understanding of the effect of environmental factors on allergic diseases, identification of new allergens, immune mechanisms in host defense, factors involved in asthma severity, and therapeutic approaches. This review focuses on the articles published in the Journal in 2012 that enhance our knowledge base of environmental and occupational disorders. Identification of novel allergens can improve diagnostics, risk factor analysis can aid preventative approaches, and studies of genetic-environmental interactions and immune mechanisms will lead to better therapeutics. (J Allergy Clin Immunol 2013;131:668-74.)	[Peden, David B.] Univ N Carolina, Sch Med, Div Allergy Immunol Rheumatol & Infect Dis, Dept Pediat, Chapel Hill, NC 27599 USA; [Bush, Robert K.] Univ Wisconsin, Dept Med, Div Allergy Immunol Pulm Crit Care & Sleep Med, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Peden, DB (corresponding author), Univ N Carolina, Sch Med, Div Allergy Immunol Rheumatol & Infect Dis, 104 Mason Hill Farm, Chapel Hill, NC 27599 USA.	david_peden@med.unc.edu		Peden, David/0000-0003-4526-4627	AAAAI	AAAAI	R. K. Bush has received one or more consulting fees or honoraria from the AAAAI; has received one or more payments for lecturing from or is on the speakers' bureau for the Wisconsin Allergy Society; has received one or more payments for manuscript preparation from Current Opinions in Allergy and Immunology and from Allergy and Asthma Report; and has received royalties from UpToDate. D. B. Peden declares that he has no relevant conflicts of interest.	Gonzalo-Garijo MA, 2012, J ALLERGY CLIN IMMUN, V129, P562, DOI 10.1016/j.jaci.2011.09.016; Bandino ML, 2012, J ALLERGY CLIN IMMUN, V129, P250, DOI 10.1016/j.jaci.2011.08.028; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V129, P14, DOI 10.1016/j.jaci.2011.11.004; Brown SGA, 2012, J ALLERGY CLIN IMMUN, V130, P162, DOI 10.1016/j.jaci.2012.02.022; Caillaud DM, 2012, J ALLERGY CLIN IMMUN, V130, P812, DOI 10.1016/j.jaci.2012.04.034; Cakmak S, 2012, J ALLERGY CLIN IMMUN, V129, P228, DOI 10.1016/j.jaci.2011.09.025; Chang PJ, 2012, J ALLERGY CLIN IMMUN, V130, P877, DOI 10.1016/j.jaci.2012.07.017; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; Durrani SR, 2013, J ALLERGY CLIN IMMUN, V131, P244, DOI 10.1016/j.jaci.2012.10.006; Engelhardt KR, 2012, J ALLERGY CLIN IMMUN, V129, P294, DOI [10.1016/j.jaci.2011.12.966, 10.1016/j.jaci.2011.12.972]; Farah CS, 2012, J ALLERGY CLIN IMMUN, V130, P61, DOI 10.1016/j.jaci.2012.02.015; Farah CS, 2012, J ALLERGY CLIN IMMUN, V129, P381, DOI 10.1016/j.jaci.2011.11.017; Gada S, 2012, J ALLERGY CLIN IMMUN, V129, P1151, DOI 10.1016/j.jaci.2011.10.027; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P687, DOI 10.1016/j.jaci.2011.12.001; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; Gupta P, 2012, J ALLERGY CLIN IMMUN, V129, P571, DOI 10.1016/j.jaci.2011.09.033; Hatzler L, 2012, J ALLERGY CLIN IMMUN, V130, P894, DOI 10.1016/j.jaci.2012.05.053; Hernandez ML, 2012, J ALLERGY CLIN IMMUN, V130, P869, DOI 10.1016/j.jaci.2012.05.026; Hilger C, 2012, J ALLERGY CLIN IMMUN, V129, P1149, DOI 10.1016/j.jaci.2011.10.017; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Holbreich M, 2012, J ALLERGY CLIN IMMUN, V129, P1671, DOI 10.1016/j.jaci.2012.03.016; Hoyte FCL, 2012, J ALLERGY CLIN IMMUN, V129, P1684, DOI 10.1016/j.jaci.2011.12.003; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Ji H, 2012, J ALLERGY CLIN IMMUN, V129, P33, DOI 10.1016/j.jaci.2011.11.008; Kim H, 2012, J ALLERGY CLIN IMMUN, V129, P1529, DOI 10.1016/j.jaci.2012.01.051; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Korosec P, 2012, J ALLERGY CLIN IMMUN, V129, P1406, DOI 10.1016/j.jaci.2011.12.975; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Lemiere C, 2012, J ALLERGY CLIN IMMUN, V129, P555, DOI 10.1016/j.jaci.2011.09.012; Leung TF, 2012, J ALLERGY CLIN IMMUN, V129, P42, DOI 10.1016/j.jaci.2011.11.031; Linneberg A, 2012, J ALLERGY CLIN IMMUN, V129, P413, DOI 10.1016/j.jaci.2011.09.007; Lisciandro JG, 2012, J ALLERGY CLIN IMMUN, V130, P1167, DOI 10.1016/j.jaci.2012.06.005; Lockey RF, 2012, J ALLERGY CLIN IMMUN, V130, P910, DOI 10.1016/j.jaci.2012.08.019; Marodi L, 2012, J ALLERGY CLIN IMMUN, V130, P1019, DOI 10.1016/j.jaci.2012.09.011; Mertes PM, 2012, J ALLERGY CLIN IMMUN, V130, P808, DOI 10.1016/j.jaci.2012.03.050; Millon L, 2012, J ALLERGY CLIN IMMUN, V130, P803, DOI 10.1016/j.jaci.2012.03.039; Olivieri M, 2012, J ALLERGY CLIN IMMUN, V129, P420, DOI 10.1016/j.jaci.2011.10.044; Patil SU, 2012, J ALLERGY CLIN IMMUN, V129, P443, DOI 10.1016/j.jaci.2011.10.010; Provoost S, 2012, J ALLERGY CLIN IMMUN, V129, P483, DOI 10.1016/j.jaci.2011.07.051; Rabinovitch N, 2012, J ALLERGY CLIN IMMUN, V130, P645, DOI 10.1016/j.jaci.2012.07.006; Reponen T, 2012, J ALLERGY CLIN IMMUN, V130, P639, DOI 10.1016/j.jaci.2012.05.030; Salam MT, 2012, J ALLERGY CLIN IMMUN, V129, P232, DOI 10.1016/j.jaci.2011.09.037; Santiago HC, 2012, J ALLERGY CLIN IMMUN, V130, P248, DOI 10.1016/j.jaci.2012.02.045; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Stevenson DD, 2012, J ALLERGY CLIN IMMUN, V129, P1687, DOI 10.1016/j.jaci.2012.04.016; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Vredegoor DW, 2012, J ALLERGY CLIN IMMUN, V130, P904, DOI 10.1016/j.jaci.2012.05.013; Warm K, 2012, J ALLERGY CLIN IMMUN, V129, P136, DOI 10.1016/j.jaci.2011.08.033; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	52	8	8	0	24	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					668	674		10.1016/j.jaci.2012.12.1572	http://dx.doi.org/10.1016/j.jaci.2012.12.1572			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23384680	Green Accepted			2022-12-18	WOS:000315587800006
J	Turner, PJ; Wong, M; Varese, N; Rolland, JM; O'Hehir, RE; Campbell, DE				Turner, Paul J.; Wong, Melanie; Varese, Nirupama; Rolland, Jennifer M.; O'Hehir, Robyn E.; Campbell, Dianne E.			Tolerance to wheat in whole-grain cereal biscuit in wheat-allergic children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DOUBLE-BLIND; ALLERGENICITY; PROTEINS		[Turner, Paul J.; Wong, Melanie; Campbell, Dianne E.] Childrens Hosp Westmead, Dept Allergy & Immunol, Sydney, NSW, Australia; [Turner, Paul J.; Campbell, Dianne E.] Univ Sydney, Discipline Pediat & Child Hlth, Sch Med, Sydney, NSW 2006, Australia; [Varese, Nirupama; Rolland, Jennifer M.; O'Hehir, Robyn E.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia	University of Sydney; University of Sydney; Monash University	Turner, PJ (corresponding author), Childrens Hosp Westmead, Dept Allergy & Immunol, Sydney, NSW, Australia.	paulyt@doctors.net.uk	O'Hehir, Robyn E/H-3627-2011; Varese, Nirupama P/H-3596-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Campbell, Dianne/0000-0002-0907-6963; Turner, Paul/0000-0001-9862-5161; Varese, Nirupama/0000-0001-9074-3710	National Institute for Health Research [CL-2009-18-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Alvarez-Alvarez J, 2005, J AGR FOOD CHEM, V53, P1294, DOI 10.1021/jf0490145; Battais F, 2008, EUR ANN ALLERGY CLIN, V40, P67; Inomata N, 2009, CURR OPIN ALLERGY CL, V9, P238, DOI 10.1097/ACI.0b013e32832aa5bc; Kumagai H, 2007, BIOSCI BIOTECH BIOCH, V71, P977, DOI 10.1271/bbb.60645; Pastorello EA, 2007, INT ARCH ALLERGY IMM, V144, P10, DOI 10.1159/000102609; Salcedo G, 2011, J INVEST ALLERG CLIN, V21, P81; Scibilia J, 2006, J ALLERGY CLIN IMMUN, V117, P433, DOI [10.1016/j.jaci.2005.10.014, 10.1016/J.JACI.2005.10.014]; Sotkovsky P, 2008, PROTEOMICS, V8, P1677, DOI 10.1002/pmic.200700347	8	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					920	923		10.1016/j.jaci.2012.11.016	http://dx.doi.org/10.1016/j.jaci.2012.11.016			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23270809				2022-12-18	WOS:000315587800045
J	Menon, N; Feuille, E; Huang, F; Nowak-Wegrzyn, AH				Menon, Nikhil; Feuille, Elizabeth; Huang, Faith; Nowak-Wegrzyn, Anna H.			Knowledge of Food Protein-Induced Enterocolitis (FPIES) Among General Pediatricians	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Menon, Nikhil; Feuille, Elizabeth; Nowak-Wegrzyn, Anna H.] Mt Sinai Sch Med, New York, NY USA; [Huang, Faith] Mt Sinai Hosp, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai									0	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB177	AB177		10.1016/j.jaci.2012.12.1295	http://dx.doi.org/10.1016/j.jaci.2012.12.1295			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800626
J	Kern, RC				Kern, Robert C.			Biologics and the treatment of chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Chronic rhinosinusitis; nasal polyps; asthma	ANTI-IGE		Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Kern, RC (corresponding author), Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	RKern@nmff.org						Avila PC, 2007, ANNU REV MED, V58, P185, DOI 10.1146/annurev.med.58.061705.145252; Bochner BS, 2010, J ALLERGY CLIN IMMUN, V126, P16, DOI 10.1016/j.jaci.2010.02.026; Busse W, 2012, J ALLERGY CLIN IMMUN, V129, P983, DOI 10.1016/j.jaci.2012.01.033; Chipps BE, 2012, ALLERGY ASTHMA PROC, V33, P377, DOI 10.2500/aap.2012.33.3599; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Kiwamoto T, 2012, PHARMACOL THERAPEUT, V135, P327, DOI 10.1016/j.pharmthera.2012.06.005; Lamblin C, 1999, J ALLERGY CLIN IMMUN, V104, P85, DOI 10.1016/S0091-6749(99)70118-1; Long AA, 2009, ANN ALLERG ASTHMA IM, V103, P212, DOI 10.1016/S1081-1206(10)60184-6; Pinto JM, 2010, RHINOLOGY, V48, P318, DOI [10.4193/Rhin09.144, 10.4193/Rhino09.144]; Schleimer R, 2012, EOSINOPHILS HLTH DIS; Takabayashi T, 2012, J ALLERGY CLIN IMMUN, V130, P410, DOI 10.1016/j.jaci.2012.02.046	14	8	9	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					117	118		10.1016/j.jaci.2012.11.021	http://dx.doi.org/10.1016/j.jaci.2012.11.021			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23265697				2022-12-18	WOS:000312961200014
J	Sinico, RA; Bottero, P; Guillevin, L				Sinico, Renato A.; Bottero, Paolo; Guillevin, Loic			Antineutrophil cytoplasmic autoantibodies and clinical phenotype in patients with Churg-Strauss syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIBODIES		[Sinico, Renato A.] Osped San Carlo Borromeo Milano, Azienda Osped, Clin Immunol Unit, Milan, Italy; [Sinico, Renato A.] Osped San Carlo Borromeo Milano, Azienda Osped, Renal Unit, Dept Med, Milan, Italy; [Bottero, Paolo] Azienda Osped Legnano, Osped G Fornaroli di Magenta, Allergy & Clin Immunol Outpatient Clin, Milan, Italy; [Guillevin, Loic] Univ Paris 05, Hop Cochin, AP HP, Dept Internal Med, Paris, France	Ospedale di Vimercate; San Carlo Borromeo Hospital; Ospedale di Vimercate; San Carlo Borromeo Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Sinico, RA (corresponding author), Osped San Carlo Borromeo Milano, Azienda Osped, Clin Immunol Unit, Milan, Italy.	renatoalberto.sinico@fastwebnet.it						Baldini C, 2009, REUMATISMO, V61, P118, DOI 10.4081/reumatismo.2009.118; Healy B, 2012, J ALLERGY CLIN IMMUN; Oka N, 2011, MOD RHEUMATOL, V21, P290, DOI 10.1007/s10165-010-0400-9; Radice A, 2012, AUTOIMMUNE REV; Sable-Fourtassou G, 2005, ANN INTERN MED, V143, P632, DOI 10.7326/0003-4819-143-9-200511010-00006; Savige J, 1999, AM J CLIN PATHOL, V111, P507; Sinico RA, 2005, ARTHRITIS RHEUM, V52, P2926, DOI 10.1002/art.21250	7	8	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2012	130	6					1440	1440		10.1016/j.jaci.2012.09.031	http://dx.doi.org/10.1016/j.jaci.2012.09.031			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	044RP	23098809				2022-12-18	WOS:000311641100038
J	Arbes, SJ				Arbes, Samuel J., Jr.			Do all asthmatics with atopy have atopic asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Rho Inc, Chapel Hill, NC USA	Rho	Arbes, SJ (corresponding author), Rho Inc, Chapel Hill, NC USA.	sam_arbes@rhoworld.com						Gordis L, 1996, EPIDEMIOLOGY; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, Vxiii, P737	2	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2012	130	5					1202	1204		10.1016/j.jaci.2012.06.040	http://dx.doi.org/10.1016/j.jaci.2012.06.040			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	030LE	22920493	Bronze			2022-12-18	WOS:000310571400025
J	Lockey, RF				Lockey, Richard F.			The myth of hypoallergenic dogs (and cats)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Hypoallergenic dogs; hypoallergenic cats; allergen prevention	ALLERGEN LEVELS		[Lockey, Richard F.] Univ S Florida, Coll Med, VA Med Ctr, Div Allergy & Immunol,Dept Med, Tampa, FL 33612 USA; [Lockey, Richard F.] James Haley Vet Hosp, Tampa, FL USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Lockey, RF (corresponding author), Univ S Florida, Coll Med, VA Med Ctr, Div Allergy & Immunol,Dept Med, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	rlockey@hsc.usf.edu						American Humane Association, FACTS PET OWN; Bertelsen RJ, 2010, INDOOR AIR, V20, P187, DOI 10.1111/j.1600-0668.2009.00640.x; Butt A, 2012, ANN ALLERG ASTHMA IM, V108, P74, DOI 10.1016/j.anai.2011.12.005; Chen CM, 2010, INT J HYG ENVIR HEAL, V213, P1, DOI 10.1016/j.ijheh.2009.12.003; Epstein TG, 2011, J PEDIATR-US, V158, P265, DOI 10.1016/j.jpeds.2010.07.026; Hodson T, 1999, J ALLERGY CLIN IMMUN, V103, P581, DOI 10.1016/S0091-6749(99)70227-7; Host A, 2004, CHEM IMMUNOL, V84, P135; Morris DO, 2010, VET DERMATOL, V21, P441, DOI 10.1111/j.1365-3164.2010.00882.x; Nicholas CE, 2011, AM J RHINOL ALLERGY, V25, P252, DOI 10.2500/ajra.2011.25.3606; Pelkonen AS, 2012, PEDIAT ALLERG IMM-UK, V23, P103, DOI 10.1111/j.1399-3038.2012.01298.x; TRUDEAU WL, 1993, CLIN EXP ALLERGY, V23, P377, DOI 10.1111/j.1365-2222.1993.tb00342.x; Vredegoor DW, 2012, J ALLERGY CLIN IMMUN, V130, P904, DOI 10.1016/j.jaci.2012.05.013	12	8	8	0	24	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					910	911		10.1016/j.jaci.2012.08.019	http://dx.doi.org/10.1016/j.jaci.2012.08.019			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	23021142				2022-12-18	WOS:000309594800011
J	Bara, MTG; Moreno, E; Laffond, E; Munoz, FJ; Macias, E; Davila, I				Gracia Bara, Maria Teresa; Moreno, Esther; Laffond, Elena; Javier Munoz, Francisco; Macias, Eva; Davila, Ignacio			Selection of contrast media in patients with delayed reactions should be based on challenge test results	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYPERSENSITIVITY REACTIONS; CROSS-REACTIVITY; SKIN-TESTS		[Gracia Bara, Maria Teresa; Moreno, Esther; Laffond, Elena; Javier Munoz, Francisco; Macias, Eva; Davila, Ignacio] Univ Hosp Salamanca, Allergy Serv, Salamanca, Spain		Bara, MTG (corresponding author), Univ Hosp Salamanca, Allergy Serv, Salamanca, Spain.	mtgracia@saludcastillayleon.es	Dávila, Ignacio/K-4453-2012; LAFFOND, ELENA/AAS-8242-2021; Macías, Eva/AAS-7387-2021; Munoz Bellido, Francisco Javier/B-4585-2019	Dávila, Ignacio/0000-0001-8485-5513; Munoz Bellido, Francisco Javier/0000-0003-4071-9928; LAFFOND, ELENA/0000-0003-2097-004X; Macias Iglesias, Eva Maria/0000-0002-9199-0534; GRACIA BARA, MARIA TERESA/0000-0002-1343-7303; MORENO, ESTHER/0000-0003-0953-3025				Brockow K, 2002, ALLERGY, V57, P45; Brockow K, 2009, ALLERGY, V64, P234, DOI 10.1111/j.1398-9995.2008.01832.x; Caimmi S, 2010, CLIN EXP ALLERGY, V40, P805, DOI 10.1111/j.1365-2222.2010.03493.x; Hasdenteufel F, 2011, J ALLERGY CLIN IMMUN, V128, P1356, DOI 10.1016/j.jaci.2011.05.034; Seitz CS, 2009, EUR J RADIOL, V72, P167, DOI 10.1016/j.ejrad.2008.06.010; Vernassiere C, 2004, CONTACT DERMATITIS, V50, P359, DOI 10.1111/j.0105-1873.2004.00367.x	6	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					554	555		10.1016/j.jaci.2012.04.050	http://dx.doi.org/10.1016/j.jaci.2012.04.050			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22728085				2022-12-18	WOS:000307002200049
J	Adamko, DJ; Friesen, M				Adamko, Darryl J.; Friesen, Michael			Why does respiratory syncytial virus appear to cause asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Bronchiolitis; asthma; respiratory syncytial virus	VIRAL-INFECTIONS		[Adamko, Darryl J.] Univ Saskatchewan, Dept Pediat, Fac Med, Saskatoon, SK S7N 0W8, Canada	University of Saskatchewan	Adamko, DJ (corresponding author), Univ Saskatchewan, Dept Pediat, Fac Med, 270 Ellis Hall, Saskatoon, SK S7N 0W8, Canada.	darryl.adamko@usask.ca						Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Finkelstein JA, 2000, PEDIATRICS, V106, P886; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Liu M, 2009, TRANSPL INFECT DIS, V11, P304, DOI 10.1111/j.1399-3062.2009.00397.x; Meissner HC, 2003, PEDIATR INFECT DIS J, V22, pS40, DOI 10.1097/00006454-200302001-00006; Meyer JE, 2006, RHINOLOGY, V44, P140; Pacifico L, 2000, CLIN INFECT DIS, V31, P834, DOI 10.1086/314049; PARROTT RH, 1973, AM J EPIDEMIOL, V98, P289, DOI 10.1093/oxfordjournals.aje.a121558; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; Siegle JS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-14; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Simoes EAF, 2010, J ALLERGY CLIN IMMUN, V126, P256, DOI 10.1016/j.jaci.2010.05.026; Skevaki CL, 2009, CLIN EXP ALLERGY, V39, P1700, DOI 10.1111/j.1365-2222.2009.03307.x; Thomsen SF, 2009, AM J RESP CRIT CARE, V179, P1091, DOI 10.1164/rccm.200809-1471OC; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Werk LN, 2000, PEDIATRICS, V105, P585, DOI 10.1542/peds.105.3.585; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC	17	8	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2012	130	1					101	102		10.1016/j.jaci.2012.05.024	http://dx.doi.org/10.1016/j.jaci.2012.05.024			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	977GN	22742838				2022-12-18	WOS:000306644800013
J	Kim, H; Tse, K; Levin, L; Bernstein, D; Reponen, T; LeMasters, G; Lummus, Z; Horner, AA				Kim, Haejin; Tse, Kevin; Levin, Linda; Bernstein, David; Reponen, Tiina; LeMasters, Grace; Lummus, Zana; Horner, Anthony A.			House dust bioactivities predict skin prick test reactivity for children with high risk of allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						House dust extract; aeroallergen sensitization; tolerance; allergy; skin prick test; human; innate immunity	GENE-ENVIRONMENT INTERACTIONS; MICROBIAL EXPOSURE; ATOPIC-DERMATITIS; ENDOTOXIN LEVELS; EARLY-LIFE; IN-HOUSE; ASTHMA; SENSITIZATION; INFANTS; TOLERANCE	Background: Although evidence suggests that ambient exposures to endotoxin and other immunostimulants during early life influence allergic risk, efforts to understand this host-environment relationship have been hampered by a paucity of relevant assays. Objectives: These investigations determined whether parameters of house dust extract (HDE) bioactivity were predictive of allergen skin prick test (SPT) reactivity for infants at high risk of allergy participating in the Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS). Methods: We conducted a nested case-control study, selecting 99 CCAAPS children who had positive SPT results to at least 1 aeroallergen at age 3 years and 101 subjects with negative SPT results. HDEs were prepared from dust samples collected from the subjects' homes at age 1 year. Murine splenocytes and bone marrow-derived dendritic cells were incubated with HDEs, and supernatant cytokine concentrations were determined by means of ELISA. Alternatively, bone marrow-derived dendritic cells were preincubated with HDEs, and then LPS-induced IL-6 responses were assessed. HDE endotoxin levels were determined by using the limulus amebocyte lysate assay. Results: HDEs derived from the homes of children with positive (cases) and negative (control subjects) SPT results had similar bioactivities. However, when cases were considered in isolation, HDEs with higher levels of bioactivity were significantly associated with children who had lower numbers of positive SPT results. Analogous statistical analyses did not identify any association between HDE endotoxin levels and the aeroallergen sensitization profiles of children included in this study. Conclusion: HDE immunostimulatory activities predicted the aeroallergen sensitization status of CCAAPS subjects better than HDE endotoxin levels. These results provide the first published evidence that HDE bioassays have clinical relevance in predicting atopic risk. (J Allergy Clin Immunol 2012;129:1529-37.)	[Tse, Kevin; Horner, Anthony A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Horner, Anthony A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kim, Haejin; Bernstein, David; Lummus, Zana] Univ Cincinnati, Dept Med, Cincinnati, OH 45221 USA; [Levin, Linda; Bernstein, David; Reponen, Tiina; LeMasters, Grace] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Horner, AA (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,Mail Code 0663, La Jolla, CA 92093 USA.	ahorner@ucsd.edu			National Institutes of Health [AI60515, ES10957, ES11170, T32AI07469, AI61772]; National Institute of Environmental Health Sciences; US Department of Housing and Urban Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007469, R01AI061772, T32AI060515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011170, T32ES010957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Department of Housing and Urban Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grants AI60515 (to H. K.), ES10957 (to H. K., L. L., G. L., and T. R.), ES11170 (to L. L., D. B., T. R., G. L., and Z.L.), T32AI07469 (to K. T.), and AI61772 (to A. A. H.).; D. Bernstein has received research support from a National Institute of Environmental Health Sciences R01 research grant. T. Reponen has received research support from the US Department of Housing and Urban Development. The rest of the authors declare that they have no relevant conflicts of interest.	Arruda LK, 2005, CURR OPIN ALLERGY CL, V5, P153, DOI 10.1097/01.all.0000162308.89857.6c; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boasen J, 2005, J ALLERGY CLIN IMMUN, V116, P185, DOI 10.1016/j.jaci.2005.03.015; Bottcher MF, 2003, CLIN EXP ALLERGY, V33, P295, DOI 10.1046/j.1365-2222.2003.01562.x; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Campo P, 2006, J ALLERGY CLIN IMMUN, V118, P1271, DOI 10.1016/j.jaci.2006.08.008; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Epstein TG, 2011, J PEDIAT, V158, pe1; Epstein TG, 2011, J PEDIATR-US, V158, P265, DOI 10.1016/j.jpeds.2010.07.026; Frew AJ, 2005, J ALLERGY CLIN IMMUN, V115, P1197, DOI 10.1016/j.jaci.2005.03.006; Gehring U, 2007, EUR RESPIR J, V29, P1144, DOI 10.1183/09031936.00118806; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gereda JE, 2000, JAMA-J AM MED ASSOC, V284, P1652, DOI 10.1001/jama.284.13.1652; Gereda JE, 2001, J ALLERGY CLIN IMMUN, V107, P790, DOI 10.1067/mai.2001.115245; Heine RG, 2003, CLIN EXP ALLERGY, V33, P1327, DOI 10.1046/j.1365-2222.2003.01760.x; Horner AA, 2010, J INNATE IMMUN, V2, P107, DOI 10.1159/000227761; Huss K, 2001, J ALLERGY CLIN IMMUN, V107, P48, DOI 10.1067/mai.2001.111146; Jiao L, 2009, EUR J IMMUNOL, V39, P469, DOI 10.1002/eji.200838367; Johnke H, 2006, PEDIAT ALLERG IMM-UK, V17, P591, DOI 10.1111/j.1399-3038.2006.00453.x; Lee SM, 2011, AM J RESP CELL MOL, V44, P341, DOI 10.1165/rcmb.2010-0001OC; LeMasters GK, 2006, J PEDIATR-US, V149, P505, DOI 10.1016/j.jpeds.2006.06.035; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Milton DK, 1997, AM IND HYG ASSOC J, V58, P861; Ng N, 2006, J ALLERGY CLIN IMMUN, V117, P1074, DOI 10.1016/j.jaci.2006.03.025; Ownby DR, 2003, CURR OPIN ALLERGY CL, V3, P517, DOI 10.1097/01.all.0000104444.09202.ae; Perfetti L, 2003, Monaldi Arch Chest Dis, V59, P5; Platts-Mills TAE, 2004, SPRINGER SEMIN IMMUN, V25, P271, DOI 10.1007/s00281-003-0149-8; PLATTSMILLS TAE, 1991, INT ARCH ALLER A IMM, V94, P339, DOI 10.1159/000235398; Prescott SL, 2003, CURR OPIN ALLERGY CL, V3, P125, DOI 10.1097/01.all.0000064776.57552.32; Roy SR, 2003, J ALLERGY CLIN IMMUN, V112, P571, DOI 10.1067/mai.2003.1711; Ryan PH, 2005, J ALLERGY CLIN IMMUN, V116, P279, DOI 10.1016/j.jaci.2005.05.014; Tse K, 2008, SEMIN IMMUNOPATHOL, V30, P53, DOI 10.1007/s00281-007-0098-8; van Strien RT, 2004, J ALLERGY CLIN IMMUN, V113, P860, DOI 10.1016/j.jaci.2004.01.078; Vercelli D, 2010, CURR OPIN ALLERGY CL, V10, P145, DOI 10.1097/ACI.0b013e32833653d7; von Mutius E, 2006, ALLERGY, V61, P407, DOI 10.1111/j.1398-9995.2006.01009.x; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229	39	8	8	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1529	+		10.1016/j.jaci.2012.01.051	http://dx.doi.org/10.1016/j.jaci.2012.01.051			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22385634	Green Accepted			2022-12-18	WOS:000304764600013
J	Farkas, H; Csuka, D; Zotter, Z; Varga, L; Borocz, Z; Temesszentandrasi, G; Jakab, L; Karadi, I				Farkas, Henriette; Csuka, Dorottya; Zotter, Zsuzsanna; Varga, Lilian; Boeroecz, Zoltan; Temesszentandrasi, Gyoergy; Jakab, Laszlo; Karadi, Istvan			Home treatment of hereditary angioedema with icatibant administered by health care professionals	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							C1-INHIBITOR CONCENTRATE; ANTAGONIST		[Farkas, Henriette; Csuka, Dorottya; Zotter, Zsuzsanna; Varga, Lilian; Boeroecz, Zoltan; Temesszentandrasi, Gyoergy; Jakab, Laszlo; Karadi, Istvan] Semmelweis Univ, Dept Internal Med 3, Budapest, Hungary	Semmelweis University	Farkas, H (corresponding author), Semmelweis Univ, Dept Internal Med 3, Budapest, Hungary.	henriettefarkas@gmail.com	Csuka, Dorottya/F-2224-2010	Csuka, Dorottya/0000-0003-3610-9852; Karadi, Istvan/0000-0002-8253-2654; Varga, Lilian/0000-0002-5484-364X; Farkas, Henriette/0000-0003-2929-1721				Aberer W, 2011, ALLERGY, V66, P80; Bork K, 2007, J ALLERGY CLIN IMMUN, V119, P1497, DOI 10.1016/j.jaci.2007.02.012; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Cicardi M, 2010, NEW ENGL J MED, V363, P532, DOI 10.1056/NEJMoa0906393; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Farkas Henriette, 2010, Allergy Asthma Clin Immunol, V6, P19, DOI 10.1186/1710-1492-6-19; Levi M, 2006, J ALLERGY CLIN IMMUN, V117, P904, DOI 10.1016/j.jaci.2006.01.002; Longhurst HJ, 2007, CLIN EXP IMMUNOL, V147, P11, DOI 10.1111/j.1365-2249.2006.03256.x; Longhurst Hilary J, 2010, Allergy Asthma Clin Immunol, V6, P22, DOI 10.1186/1710-1492-6-22	9	8	8	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2012	129	3					851	852		10.1016/j.jaci.2011.10.039	http://dx.doi.org/10.1016/j.jaci.2011.10.039			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	904IW	22154383	Bronze			2022-12-18	WOS:000301189300036
J	Gupta, P; Gerrish, PK; Silverman, B; Schneider, A				Gupta, Payel; Gerrish, Prianka K.; Silverman, Bernard; Schneider, Arlene			Current practices among allergists on writing self-injectable epinephrine prescriptions for immunotherapy patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNOLOGY/AMERICAN-COLLEGE; SYSTEMIC REACTIONS; AMERICAN-ACADEMY; ASTHMA		[Gupta, Payel; Silverman, Bernard; Schneider, Arlene] Long Isl Coll Hosp, Brooklyn, NY 11201 USA; [Gerrish, Prianka K.] LoCicero Med Grp, Div Asthma Allergy & Immunol, Tampa, FL USA	Long Island College Hospital	Gupta, P (corresponding author), Long Isl Coll Hosp, Brooklyn, NY 11201 USA.	payelg1@gmail.com						Bernstein DI, 2010, ANN ALLERG ASTHMA IM, V104, P530, DOI 10.1016/j.anai.2010.04.008; Cox L, 2007, J ALLERGY CLIN IMMUN, V120, P1373, DOI 10.1016/j.jaci.2007.09.032; Cox L, 2007, J ALLERGY CLIN IMMUN, V120, pS25, DOI 10.1016/j.jaci.2007.06.019; Cox L, 2011, J ALLERGY CLIN IMMUN, V128, P210, DOI 10.1016/j.jaci.2011.04.010; DaVeiga SP, 2008, J ALLERGY CLIN IMMUN, V121, pS124, DOI 10.1016/j.jaci.2007.12.495; Gupta P, 2008, ANN ALLERG ASTHMA IM, V102, p98s; Moffitt JE, 2004, J ALLERGY CLIN IMMUN, V114, P869, DOI 10.1016/j.jaci.2004.07.046; Pumphrey RSH, 2008, CURR OPIN ALLERGY CL, V8, P254, DOI 10.1097/ACI.0b013e3282ffb168; Rank MA, 2008, ALLERGY ASTHMA PROC, V29, P400, DOI 10.2500/aap.2008.29.3141	9	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2					571	U445		10.1016/j.jaci.2011.09.033	http://dx.doi.org/10.1016/j.jaci.2011.09.033			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	887TC	22036248				2022-12-18	WOS:000299951700045
J	Hong, JC; Knutsen, AP				Hong, J. C.; Knutsen, A. P.			The Role Of Skin Prick Testing And Specific IgE To Boiled Versus Unheated Cow Milk In Cow Milk Allergic Children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Hong, J. C.; Knutsen, A. P.] St Louis Univ, St Louis, MO 63103 USA	Saint Louis University									0	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB20	AB20		10.1016/j.jaci.2011.12.937	http://dx.doi.org/10.1016/j.jaci.2011.12.937			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL		Bronze			2022-12-18	WOS:000301133400078
J	Namazy, JA; Schatz, M				Namazy, Jennifer A.; Schatz, Michael			Asthma and pregnancy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							MEDICATION USE; PERINATAL OUTCOMES; MATERNAL ASTHMA; RISK; METAANALYSIS; SEVERITY; SYMPTOMS; WOMEN		[Schatz, Michael] Kaiser Permanente, San Diego, CA USA; [Namazy, Jennifer A.] Scripps Clin, San Diego, CA USA	Kaiser Permanente; Scripps Research Institute	Schatz, M (corresponding author), Kaiser Permanente, Clairemont Mesa Blvd, San Diego, CA USA.	Michael.x.schatz@kp.org						[Anonymous], 2005, J ALLERGY CLIN IMMUN, V115, P34, DOI 10.1016/j.jaci.2004.10.023; Blais L, 2008, J ALLERGY CLIN IMMUN, V121, P1379, DOI 10.1016/j.jaci.2008.02.038; Bracken MB, 2003, OBSTET GYNECOL, V102, P739, DOI 10.1016/S0029-7844(03)00621-5; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; Enriquez R, 2006, AM J OBSTET GYNECOL, V195, P149, DOI 10.1016/j.ajog.2006.01.065; Firoozi F, 2010, RESP MED, V104, P1278, DOI 10.1016/j.rmed.2010.03.010; Lin S, 2008, AM J EPIDEMIOL, V168, P73, DOI 10.1093/aje/kwn098; Lin S, 2009, BIRTH DEFECTS RES A, V85, P161, DOI 10.1002/bdra.20523; Munn M B, 1999, J Matern Fetal Med, V8, P151; Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x; Park-Wyllie L, 2000, TERATOLOGY, V62, P385, DOI 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z; Schatz M, 2004, J ALLERGY CLIN IMMUN, V113, P1040, DOI 10.1016/j.jaci.2004.03.017; SCHATZ M, 1995, AM J RESP CRIT CARE, V151, P1170; SORRI M, 1980, Rhinology (Utrecht), V18, P83; Triche EW, 2004, OBSTET GYNECOL, V104, P585, DOI 10.1097/01.AOG.0000136481.05983.91	15	8	8	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2011	128	6					1384	U799		10.1016/j.jaci.2011.10.034	http://dx.doi.org/10.1016/j.jaci.2011.10.034			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	865WX	22133321	Bronze			2022-12-18	WOS:000298342700043
J	Nelson, HS				Nelson, Harold S.			Subcutaneous immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	National Jewish Health	Nelson, HS (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	nelsonh@njhealth.org			ALK-Abello	ALK-Abello	H. S. Nelson receives research support from ALK-Abello. J. T. Li has consulted for Abbott.	[Anonymous], PHYS INSTRUCTION GUI; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Esch RE, 2004, J ALLERGY CLIN IMMUN, V113, P210, DOI 10.1016/j.jaci.2003.11.024; Nelson HS, 2009, MIDDLETONS ALERGY PR; SALVAGGIO JE, 1993, J ALLERGY CLIN IMMUN, V92, P217, DOI 10.1016/0091-6749(93)90164-B; Tabar AI, 2005, J ALLERGY CLIN IMMUN, V116, P109, DOI 10.1016/j.jaci.2005.05.005; Weber RW, 2008, J ALLERGY CLIN IMMUN, V122, P219, DOI 10.1016/j.jaci.2008.05.034	7	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2011	128	4					907	U360		10.1016/j.jaci.2011.07.006	http://dx.doi.org/10.1016/j.jaci.2011.07.006			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	841UA	21962798				2022-12-18	WOS:000296538100042
